data_2k70_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k70 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 CA--C 1.54 0.571 0 CA-C-O 122.244 1.021 . . . . 5.4800000000000004 113.038 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.98 -176.9 28.65 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 126.807 2.146 . . . . 1.3100000000000001 112.787 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.8 p90 -148.11 146.34 28.76 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.953 1.301 . . . . 2.1099999999999999 110.412 171.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.5 t -90.2 142.59 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.369 -0.974 . . . . 2.0600000000000001 108.369 170.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 64.3 ttt-85 -85.78 131.52 34.3 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.991 0.516 . . . . 4.25 112.332 -173.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -40.84 137.36 1.22 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.032 2.133 . . . . 2.8900000000000001 112.782 169.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -175.81 126.6 0.36 Allowed Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 127.142 2.177 . . . . 3.29 111.037 165.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -87.13 0.1 7.62 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.928 3.086 . . . . 2.8799999999999999 112.131 164.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.54 -166.27 40.96 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.141 1.353 . . . . 1.3799999999999999 112.852 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.08 -24.52 23.63 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.67 2.246 . . . . 2.0299999999999998 113.546 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -138.87 163.2 32.91 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.198 1.399 . . . . 2.1400000000000001 113.923 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.28 -175.74 5.48 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 130.324 3.45 . . . . 1.6499999999999999 109.394 -172.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.37 156.87 43.05 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.844 2.057 . . . . 1.52 109.169 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.89 133.54 33.97 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.711 1.141 . . . . 1.51 112.817 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.44 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 43.2 m-85 -115.79 140.98 48.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.798 2.039 . . . . 3.5800000000000001 110.332 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -168.13 156.43 8.78 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.915 1.234 . . . . 2.8100000000000001 113.318 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.5 m -95.24 108.52 20.67 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.418 1.087 . . . . 2.8100000000000001 111.119 -176.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.8 130.28 34.53 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.446 0.566 . . . . 3.3500000000000001 109.909 173.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -131.98 135.19 46.37 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.69 1.596 . . . . 4.3399999999999999 109.582 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -105.78 110.25 63.97 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 125.139 1.375 . . . . 1.3799999999999999 110.319 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.34 -11.56 10.7 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.901 2.401 . . . . 1.1299999999999999 113.927 176.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.43 174.87 50.76 Favored Glycine 0 C--N 1.338 0.693 0 CA-C-O 122.964 1.313 . . . . 1.2 112.969 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.04 -4.42 32.51 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.45 2.7 . . . . 2.8700000000000001 111.309 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -119.44 156.83 52.84 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 128.247 2.619 . . . . 2.75 109.9 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.87 143.78 26.79 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.867 2.378 . . . . 0.93000000000000005 110.964 -174.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.3 mt -102.84 150.92 23.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 122.767 1.27 . . . . 2.6899999999999999 110.036 170.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -142.63 109.83 5.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.577 -2.101 . . . . 3.1699999999999999 112.833 -172.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.0 tp -87.82 107.09 18.5 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.33 1.852 . . . . 2.7200000000000002 109.951 -175.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.8 m -108.49 -18.12 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.155 0.982 . . . . 1.6399999999999999 112.455 -172.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.31 -178.4 31.34 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 125.273 1.416 . . . . 0.60999999999999999 113.106 -175.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.17 179.82 8.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.673 0.749 . . . . 1.71 111.826 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -156.37 166.01 34.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.766 2.426 . . . . 4.71 107.815 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -175.43 151.24 1.27 Allowed Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 125.788 1.635 . . . . 1.6699999999999999 108.447 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.6 -7.89 14.74 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.939 2.426 . . . . 0.90000000000000002 112.993 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.0 m -114.16 41.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.6 1.16 . . . . 1.95 113.434 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.18 164.25 35.29 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.527 -0.733 . . . . 1.8500000000000001 112.532 166.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -100.75 -46.39 5.17 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.266 2.227 . . . . 3.21 110.664 169.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -103.18 138.24 40.26 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.223 1.409 . . . . 5.9400000000000004 108.341 163.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -99.58 152.61 4.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.3 -1.0 . . . . 2.1200000000000001 108.3 142.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -135.41 147.7 49.08 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.02 1.728 . . . . 2.9300000000000002 108.31 166.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.6 tp -102.97 118.76 37.54 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.557 0.743 . . . . 2.0499999999999998 110.651 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.408 ' CE1' ' HB2' ' A' ' 85' ' ' MET . 55.3 m170 -121.93 156.67 32.89 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 123.242 1.496 . . . . 0.58999999999999997 113.899 -173.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.444 ' CD ' HH21 ' A' ' 62' ' ' ARG . 19.4 pt-20 -98.3 177.82 5.25 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.551 1.941 . . . . 2.3900000000000001 111.577 160.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.1 m -152.89 149.97 28.82 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.297 1.839 . . . . 1.6599999999999999 106.996 166.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -158.3 165.74 34.06 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.058 0.943 . . . . 3.4199999999999999 113.054 -168.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 59.5 ttp -95.19 143.49 26.57 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.166 1.386 . . . . 3.71 110.371 167.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.49 150.68 35.02 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.6 1.16 . . . . 5.0 110.849 -173.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -108.45 137.89 45.67 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.411 1.484 . . . . 2.0699999999999998 110.262 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.8 t -139.63 128.23 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 106.7 -1.593 . . . . 2.9199999999999999 106.7 166.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.406 ' HB2' ' HE3' ' A' ' 56' ' ' LYS . 34.6 mt-10 61.49 19.1 10.02 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.085 1.354 . . . . 2.9900000000000002 114.401 -175.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.25 11.29 85.07 Favored Glycine 0 N--CA 1.48 1.609 0 O-C-N 120.242 -1.536 . . . . 1.6100000000000001 113.585 -169.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.406 ' HE3' ' HB2' ' A' ' 54' ' ' GLU . 23.5 mtmt -110.47 118.83 37.32 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.531 2.333 . . . . 3.5 108.728 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 120.19 34.29 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.689 -1.141 . . . . 4.46 112.376 -166.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.8 m -121.35 -178.4 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 128.705 2.802 . . . . 3.0699999999999998 109.872 -176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 60.9 mtt -116.06 162.94 16.67 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.359 1.064 . . . . 3.4300000000000002 111.165 168.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.61 175.06 32.86 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 124.791 1.186 . . . . 0.68999999999999995 112.591 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.3 ttm -154.78 145.29 22.19 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.055 1.742 . . . . 1.6599999999999999 109.213 -170.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.444 HH21 ' CD ' ' A' ' 47' ' ' GLU . 22.2 mtm180 -148.24 153.98 41.76 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 125.736 1.614 . . . . 6.0300000000000002 109.175 -176.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.89 154.11 42.81 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.854 1.702 . . . . 0.64000000000000001 110.399 165.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -139.46 154.35 71.52 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.458 1.503 . . . . 1.73 110.513 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.02 -27.66 4.41 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.106 2.538 . . . . 0.55000000000000004 112.949 -167.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -176.24 164.74 2.74 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.648 1.579 . . . . 3.29 111.817 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 mt -114.03 152.22 31.3 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.215 1.406 . . . . 1.71 110.014 166.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -111.93 145.93 38.69 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.756 1.222 . . . . 2.02 109.407 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.2 t -134.44 119.8 14.37 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.655 0.782 . . . . 2.02 111.124 165.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.29 159.1 54.19 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.33 2.687 . . . . 1.04 111.565 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -60.4 138.57 81.59 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.754 2.969 . . . . 1.04 112.192 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt 64.91 -4.26 0.5 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.304 1.841 . . . . 2.3199999999999998 113.991 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.08 -177.4 39.2 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 127.28 2.371 . . . . 1.1599999999999999 113.114 -176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.22 152.53 33.42 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.279 1.032 . . . . 4.7400000000000002 112.146 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.4 t -152.71 123.46 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.771 1.629 . . . . 4.3899999999999997 107.752 174.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -84.31 141.44 30.92 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.704 -0.622 . . . . 2.98 111.351 175.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.92 80.84 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.332 -0.988 . . . . 2.27 108.332 147.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.08 148.95 46.39 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.1 1.36 . . . . 3.71 112.386 -174.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.44 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 59.2 Cg_endo -63.3 -24.35 71.87 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.251 2.634 . . . . 1.99 113.806 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.84 21.72 4.58 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.942 -0.921 . . . . 1.73 114.115 170.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.95 -118.39 0.69 Allowed Glycine 0 CA--C 1.53 1.015 0 CA-C-N 118.979 1.39 . . . . 1.8700000000000001 114.654 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -71.91 140.42 49.23 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.352 -1.087 . . . . 3.1099999999999999 112.552 -164.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -162.64 156.22 20.39 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.206 1.002 . . . . 0.57999999999999996 112.259 -173.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -82.99 140.51 32.7 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.851 -0.53 . . . . 2.6299999999999999 109.623 165.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.408 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 3.1 tpt -93.14 131.94 37.73 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.261 1.024 . . . . 1.53 108.769 161.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 mp -110.9 125.23 53.43 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.654 -1.239 . . . . 1.6100000000000001 107.654 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 mp -130.82 142.62 50.4 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.305 0.642 . . . . 2.9100000000000001 110.364 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.43 43.29 16.1 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.154 0.883 . . . . 0.84999999999999998 112.96 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -56.76 154.51 9.03 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 116.102 1.89 . . . . 2.2400000000000002 116.102 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -116.53 -16.83 10.75 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 113.515 -1.675 . . . . 2.79 113.076 -170.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -113.12 127.38 26.9 Favored Pre-proline 0 N--CA 1.472 0.628 0 N-CA-C 105.896 -1.89 . . . . 6.1100000000000003 105.896 155.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.39 110.02 1.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 N-CA-C 105.369 -2.589 . . . . 2.4100000000000001 105.369 158.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.48 147.15 39.76 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 124.518 2.104 . . . . 2.98 111.567 -156.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -156.27 166.04 34.62 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 111.665 -2.516 . . . . 4.4900000000000002 112.815 -151.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.92 126.05 25.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.007 0.923 . . . . 2.02 109.636 -175.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.08 0.98 70.43 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 117.702 -1.61 . . . . 1.26 115.64 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -79.9 -167.83 1.4 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.319 2.06 . . . . 2.23 112.568 169.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.52 121.78 3.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.148 2.979 . . . . 5.7699999999999996 106.095 -148.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 49.3 t -148.83 133.45 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.602 1.161 . . . . 1.8899999999999999 111.702 -170.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.496 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 47.0 mt-10 -79.12 144.59 34.38 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 112.211 0.448 . . . . 2.5099999999999998 112.211 168.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mp -120.23 142.31 49.14 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.829 0.823 . . . . 2.48 110.507 153.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -104.8 136.34 44.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 129.265 3.026 . . . . 1.99 107.485 166.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 mp -128.12 109.75 11.82 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 120.503 1.501 . . . . 3.0099999999999998 108.903 -172.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.1 mt -79.34 110.34 14.53 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.094 1.357 . . . . 1.73 109.453 -170.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -103.48 137.44 41.56 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.309 1.444 . . . . 3.2999999999999998 110.612 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.04 127.23 30.52 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.871 1.063 . . . . 2.1200000000000001 113.871 -169.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.64 70.13 1.35 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.638 1.114 . . . . 3.4500000000000002 112.093 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.65 24.5 72.37 Favored Glycine 0 N--CA 1.471 1.03 0 N-CA-C 115.563 0.985 . . . . 2.0899999999999999 115.563 166.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -126.28 155.84 41.3 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.304 1.552 . . . . 4.1799999999999997 112.353 -173.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.12 151.46 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.813 1.245 . . . . 3.4700000000000002 110.753 171.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.1 tp -120.48 141.98 49.7 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.091 1.357 . . . . 3.9500000000000002 109.786 167.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.496 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 13.1 tppt? -106.79 134.35 50.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.582 1.153 . . . . 3.1800000000000002 109.908 170.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.74 153.59 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.099 1.359 . . . . 3.8399999999999999 110.165 167.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.22 126.39 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.683 -1.228 . . . . 2.75 107.683 165.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.1 mt -122.1 146.75 47.38 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 126.234 1.814 . . . . 2.9100000000000001 110.074 -174.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.78 164.54 35.28 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.973 2.449 . . . . 0.93000000000000005 111.377 165.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.22 139.38 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.689 0.796 . . . . 1.8200000000000001 110.482 169.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.97 147.22 40.15 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.667 1.587 . . . . 3.7400000000000002 113.093 -171.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.59 58.3 4.14 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.054 1.742 . . . . 2.3799999999999999 111.832 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 . . . . . 0 C--O 1.249 1.072 0 C-N-CA 125.956 1.703 . . . . 8.0399999999999991 112.672 -162.195 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.419 ' H ' ' CG2' ' A' ' 21' ' ' THR . 0.7 OUTLIER . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 118.55 -0.738 . . . . 5.21 109.909 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.59 172.86 37.88 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 120.515 1.507 . . . . 1.3300000000000001 115.552 159.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -148.98 147.06 28.14 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.016 1.326 . . . . 2.3799999999999999 111.276 169.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.8 t -95.03 126.87 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.08 -1.081 . . . . 2.4700000000000002 108.08 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -74.31 123.18 24.11 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.912 0.386 . . . . 5.6799999999999997 111.423 -170.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -46.99 142.18 3.68 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.956 1.302 . . . . 2.7599999999999998 111.538 163.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.1 m -155.31 152.23 24.38 Favored Pre-proline 0 CA--C 1.545 0.783 0 O-C-N 120.865 -1.147 . . . . 3.1400000000000001 111.111 161.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -95.18 43.11 0.16 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.147 3.232 . . . . 2.71 111.707 -176.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.61 -168.85 25.16 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.27 1.268 . . . . 1.1699999999999999 116.27 -167.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.98 -16.23 16.09 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.283 3.322 . . . . 1.47 114.328 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -125.24 162.57 24.41 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.052 1.741 . . . . 2.4100000000000001 114.124 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.95 -177.2 6.4 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.181 2.592 . . . . 1.6299999999999999 111.236 -175.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.08 167.33 21.74 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.352 2.261 . . . . 1.5800000000000001 108.448 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.74 141.27 33.25 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.375 0.989 . . . . 1.5 111.738 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.469 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 20.2 m-85 -128.02 114.37 17.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.256 1.822 . . . . 3.71 108.842 -171.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -163.26 165.36 24.36 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.851 -1.155 . . . . 4.0099999999999998 112.901 -167.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.419 ' CG2' ' H ' ' A' ' 5' ' ' GLU . 5.0 t -92.77 141.14 28.78 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 123.189 1.471 . . . . 3.6200000000000001 113.366 -177.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.36 123.81 38.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 113.357 -1.747 . . . . 4.3399999999999999 106.996 164.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -111.62 145.05 39.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.869 0.842 . . . . 3.9900000000000002 110.944 169.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.88 64.8 18.4 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.07 0.948 . . . . 3.48 110.277 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -63.23 -21.79 72.28 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.632 2.888 . . . . 1.5700000000000001 114.414 -173.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.09 -173.09 38.09 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 122.72 1.178 . . . . 1.22 113.001 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.446 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 10.8 m-20 -109.74 -1.19 18.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.905 1.682 . . . . 2.8300000000000001 112.684 -164.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -121.68 155.25 60.11 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 127.417 2.287 . . . . 2.8700000000000001 110.091 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.63 139.57 18.13 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.713 2.275 . . . . 1.1299999999999999 111.245 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt -95.05 153.54 17.6 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 123.306 1.527 . . . . 2.5800000000000001 112.676 174.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 ttp-105 -137.06 102.93 4.99 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 112.609 -2.087 . . . . 3.7999999999999998 110.901 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.37 113.57 20.83 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 124.443 1.097 . . . . 2.98 110.497 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.31 -19.53 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 125.124 1.37 . . . . 1.79 111.855 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.61 -175.47 29.58 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 122.531 1.073 . . . . 0.52000000000000002 115.362 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.08 -179.18 5.7 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.917 1.687 . . . . 1.6899999999999999 110.236 164.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -159.84 146.6 16.27 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.928 1.691 . . . . 5.21 106.999 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 t -162.55 151.06 12.26 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 125.038 1.335 . . . . 1.8899999999999999 108.436 -175.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.91 -13.45 31.79 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.682 1.588 . . . . 0.79000000000000004 113.378 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 m -112.31 36.14 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 113.788 1.033 . . . . 1.95 113.788 -172.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.15 140.39 10.29 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.343 1.457 . . . . 2.0899999999999999 109.134 170.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.529 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 9.4 tt0 -95.63 -40.0 9.63 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.233 1.413 . . . . 3.6099999999999999 110.292 -176.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -104.4 129.1 52.35 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.959 1.704 . . . . 6.71 107.758 155.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.07 139.31 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.069 -1.085 . . . . 2.3199999999999998 108.069 154.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.91 155.89 47.1 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.834 2.054 . . . . 3.2599999999999998 108.295 -174.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.3 tp -114.23 121.4 43.59 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.976 0.91 . . . . 2.1499999999999999 109.785 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.2 m170 -124.23 161.32 26.02 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 123.736 1.731 . . . . 0.84999999999999998 114.488 -175.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -104.22 155.16 18.96 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.085 2.554 . . . . 2.5899999999999999 111.21 160.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.9 m -122.02 147.19 46.38 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 105.902 -1.888 . . . . 1.8600000000000001 105.902 159.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -157.39 178.28 10.48 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.188 0.904 . . . . 3.7599999999999998 112.819 -174.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 63.0 ttp -111.66 135.21 52.56 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.572 1.549 . . . . 4.5999999999999996 111.5 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -110.4 143.99 39.84 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.513 1.525 . . . . 5.5199999999999996 110.862 161.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -87.45 145.4 26.29 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.556 1.143 . . . . 2.9900000000000002 108.707 149.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.4 t -143.92 120.8 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.227 1.811 . . . . 3.8999999999999999 106.701 161.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 63.94 18.12 10.99 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.483 1.513 . . . . 4.21 115.024 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.21 21.22 67.99 Favored Glycine 0 N--CA 1.478 1.482 0 O-C-N 120.6 -1.313 . . . . 2.6000000000000001 113.052 -168.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -120.36 127.99 52.82 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.253 2.221 . . . . 3.9500000000000002 107.592 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -98.46 126.81 44.14 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.735 1.214 . . . . 6.1600000000000001 111.779 -171.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.29 141.88 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 126.415 1.886 . . . . 3.0800000000000001 109.644 -175.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 60.1 mtm -92.19 156.52 17.27 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.422 0.897 . . . . 3.9100000000000001 113.422 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.67 172.06 22.08 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 126.359 1.933 . . . . 0.81000000000000005 112.332 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.5 ttm -146.53 145.66 30.23 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.231 1.812 . . . . 1.9299999999999999 109.587 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -149.35 156.57 39.64 Favored Pre-proline 0 N--CA 1.471 0.603 0 C-N-CA 125.218 1.407 . . . . 5.9400000000000004 110.12 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.99 156.54 38.65 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.469 2.113 . . . . 0.94999999999999996 110.638 166.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.6 m -137.57 153.51 74.33 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 125.357 1.463 . . . . 2.1299999999999999 110.964 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.11 -24.85 6.42 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.502 2.801 . . . . 1.0700000000000001 113.024 -171.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -176.35 164.82 2.69 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.029 1.732 . . . . 3.6400000000000001 111.67 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.4 mt -108.87 153.69 23.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.404 1.482 . . . . 1.79 110.579 163.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -114.3 144.19 43.65 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.395 1.478 . . . . 2.1699999999999999 109.763 176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.7 t -139.91 139.74 22.44 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.465 0.706 . . . . 2.0099999999999998 112.488 169.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -84.02 156.43 13.24 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.38 3.387 . . . . 1.1599999999999999 112.531 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.22 143.49 94.33 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.306 2.671 . . . . 1.0700000000000001 113.246 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.446 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 70.7 mmtt 69.97 0.2 2.98 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.775 2.43 . . . . 2.8399999999999999 114.16 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.56 151.53 34.44 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.41 1.481 . . . . 1.24 114.106 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -111.46 132.12 54.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.425 2.29 . . . . 5.21 106.547 160.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.5 t -142.59 119.01 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.746 1.219 . . . . 4.4100000000000001 108.774 -177.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -115.15 128.69 56.36 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.899 0.857 . . . . 3.98 113.24 -159.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.16 77.12 0.52 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.632 2.373 . . . . 2.21 111.163 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.65 145.01 97.74 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 126.462 1.905 . . . . 7.4000000000000004 113.525 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.469 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 30.4 Cg_endo -57.89 -42.88 54.12 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.301 2.667 . . . . 2.9900000000000002 113.335 175.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.46 31.49 1.88 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.454 1.025 . . . . 1.8400000000000001 113.533 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.12 -131.99 1.44 Allowed Glycine 0 N--CA 1.471 0.969 0 C-N-CA 125.493 1.52 . . . . 1.6200000000000001 113.175 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -70.39 139.21 51.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.906 0.853 . . . . 3.3700000000000001 110.981 -172.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -162.02 158.3 24.79 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.836 1.255 . . . . 0.69999999999999996 111.973 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -84.63 151.74 24.28 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.697 -0.627 . . . . 3.1600000000000001 110.786 168.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.2 tpt -112.06 130.98 55.7 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.531 1.132 . . . . 1.8700000000000001 109.687 166.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -111.98 118.87 36.64 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.943 1.297 . . . . 1.6100000000000001 107.869 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.6 mp -119.51 138.92 52.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.47 1.108 . . . . 2.71 109.739 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.22 37.26 32.58 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.73 -0.483 . . . . 0.87 113.006 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -48.3 154.93 0.55 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 116.571 2.063 . . . . 2.4399999999999999 116.571 177.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.529 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 69.4 mmtt -119.97 -18.77 8.09 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.155 -1.384 . . . . 3.6699999999999999 113.949 -175.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -97.01 140.96 22.39 Favored Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 108.539 -0.912 . . . . 5.9900000000000002 108.539 160.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -82.6 57.58 6.14 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.624 2.883 . . . . 3.0699999999999998 109.914 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.4 mt -23.14 104.56 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 129.044 2.938 . . . . 3.0600000000000001 116.8 -159.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm -119.54 157.96 27.28 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.187 1.795 . . . . 7.5899999999999999 114.871 170.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.14 133.88 38.92 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 113.528 -1.669 . . . . 2.6800000000000002 109.675 169.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.46 1.33 86.16 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 117.485 -1.73 . . . . 1.78 115.848 -175.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -75.28 178.11 6.05 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 120.899 2.349 . . . . 2.3999999999999999 111.145 166.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -146.2 129.74 16.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.795 2.838 . . . . 5.2199999999999998 104.827 -159.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.0 t -144.33 121.63 5.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 123.99 0.916 . . . . 2.0099999999999998 110.358 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -78.81 154.55 29.79 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.262 0.554 . . . . 2.8300000000000001 111.364 167.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.2 tt -149.91 142.8 24.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 122.82 1.295 . . . . 3.77 110.808 169.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.0 104.33 11.8 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 129.54 3.136 . . . . 2.4199999999999999 107.061 -169.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -82.46 129.37 34.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.158 0.983 . . . . 2.0499999999999998 109.622 -172.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.0 mt -106.02 123.96 48.82 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.61 1.164 . . . . 1.97 111.441 -171.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -122.6 144.98 48.76 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.945 1.298 . . . . 3.3599999999999999 112.31 -170.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.66 151.06 21.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.878 0.871 . . . . 2.21 111.974 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.16 8.86 87.0 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 119.011 -0.883 . . . . 3.5699999999999998 114.618 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.8 66.06 1.61 Allowed Glycine 0 N--CA 1.469 0.892 0 CA-C-N 119.184 1.492 . . . . 2.4500000000000002 113.326 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -138.45 152.98 48.82 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.929 1.692 . . . . 4.5099999999999998 111.455 170.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.39 148.57 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.124 1.37 . . . . 3.5299999999999998 111.178 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 tt -140.2 116.22 10.41 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.597 1.159 . . . . 4.3300000000000001 109.244 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -93.58 136.25 34.04 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.93 -1.106 . . . . 3.5099999999999998 112.054 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.8 t -131.43 165.27 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.982 1.713 . . . . 3.3300000000000001 108.751 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.9 t -129.34 129.98 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.276 1.43 . . . . 2.9199999999999999 108.781 172.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.5 mt -123.65 145.57 47.64 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 127.554 2.342 . . . . 3.25 110.063 -174.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.9 154.66 58.33 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.648 2.232 . . . . 0.87 110.475 166.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.7 t -92.88 125.28 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.224 -1.028 . . . . 2.1600000000000001 108.224 167.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -152.61 167.96 27.17 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.668 1.223 . . . . 5.2199999999999998 114.059 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -103.57 104.55 14.62 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.305 1.594 . . . . 2.4399999999999999 115.305 -166.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 . . . . . 0 N--CA 1.483 1.203 1 C-N-CA 133.973 4.909 . . . . 8.3000000000000007 112.555 162.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.431 ' CD ' HH22 ' A' ' 74' ' ' ARG . 24.3 mt-10 . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 120.889 0.376 . . . . 6.2800000000000002 110.913 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.08 -178.86 34.46 Favored Glycine 0 N--CA 1.465 0.581 0 O-C-N 121.186 -0.947 . . . . 2.1299999999999999 113.287 -173.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 26.0 p90 -152.0 148.67 28.0 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.825 0.85 . . . . 2.25 112.998 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.03 145.96 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.883 -1.154 . . . . 2.5299999999999998 107.883 170.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -86.85 127.9 35.04 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.811 0.671 . . . . 5.4800000000000004 112.811 -167.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -48.79 151.0 1.29 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.956 1.302 . . . . 4.3200000000000003 112.766 168.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 t -163.19 148.23 9.32 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 122.895 0.478 . . . . 3.0800000000000001 111.597 166.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -86.21 -6.4 8.28 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.2 2.6 . . . . 2.3100000000000001 112.109 166.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.16 178.24 20.6 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.946 1.26 . . . . 1.21 114.004 -173.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.6 -15.8 33.96 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.122 3.215 . . . . 1.5700000000000001 113.527 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -110.01 142.67 41.1 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.796 2.038 . . . . 3.1000000000000001 113.841 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.69 -176.17 5.4 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 129.066 2.946 . . . . 1.74 110.848 -172.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.99 159.88 41.41 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.955 2.102 . . . . 1.78 109.391 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.46 137.05 48.43 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.08 1.309 . . . . 2.0600000000000001 112.482 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -116.71 71.83 0.8 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.298 1.839 . . . . 3.8999999999999999 109.6 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -83.54 157.54 22.31 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.737 -1.227 . . . . 2.4900000000000002 111.685 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.78 131.53 36.38 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.263 -0.898 . . . . 2.8900000000000001 109.676 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.24 129.53 52.04 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.847 0.459 . . . . 3.75 110.057 175.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -119.9 144.07 47.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.58 1.952 . . . . 3.7599999999999998 107.638 167.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.02 79.1 0.53 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.71 0.804 . . . . 3.3100000000000001 110.683 171.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.69 -6.03 18.29 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.346 2.03 . . . . 1.8 115.733 -174.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.96 160.61 33.93 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 119.535 1.061 . . . . 1.4099999999999999 111.686 170.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.19 1.5 40.34 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.526 1.93 . . . . 3.8100000000000001 112.162 174.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mp -123.48 156.19 64.52 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 127.03 2.132 . . . . 5.8200000000000003 108.643 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.81 143.99 16.95 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.975 2.45 . . . . 1.3999999999999999 111.04 -167.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.8 mt -100.47 150.32 22.77 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 123.076 1.417 . . . . 2.6800000000000002 112.844 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -127.1 106.3 9.17 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 112.218 -2.265 . . . . 2.9300000000000002 110.62 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -85.87 110.97 19.78 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.658 1.983 . . . . 3.8700000000000001 108.752 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.89 -19.85 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.254 1.022 . . . . 1.99 112.055 -171.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.7 -177.21 32.59 Favored Glycine 0 C--N 1.343 0.94 0 C-N-CA 124.989 1.281 . . . . 0.68999999999999995 113.887 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.43 -178.78 5.66 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.709 1.204 . . . . 1.9099999999999999 110.096 161.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -150.81 158.67 44.42 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.229 2.611 . . . . 5.9199999999999999 107.072 172.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 t -169.5 153.11 5.06 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 126.438 1.895 . . . . 1.7 107.281 -171.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.58 -12.7 15.14 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.901 1.734 . . . . 0.92000000000000004 112.921 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.42 45.34 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.061 0.945 . . . . 1.98 112.983 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.43 144.45 14.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.296 1.039 . . . . 1.76 111.491 164.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.48 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 3.4 tp10 -86.49 -45.83 10.75 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.869 1.268 . . . . 2.9199999999999999 111.328 171.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -109.93 134.38 52.15 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.816 1.247 . . . . 5.9699999999999998 108.025 168.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -119.77 135.27 60.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 125.497 1.519 . . . . 2.1200000000000001 108.299 166.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -126.66 154.23 44.33 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.747 2.019 . . . . 3.0099999999999998 108.759 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.0 tp -111.18 124.44 52.2 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.741 0.816 . . . . 2.3300000000000001 109.776 174.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -123.44 161.52 24.64 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.403 1.881 . . . . 0.66000000000000003 114.262 -175.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.78 -179.2 3.87 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.721 2.409 . . . . 3.0299999999999998 111.773 162.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.1 m -157.49 145.87 19.28 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.367 1.867 . . . . 1.77 107.645 170.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -153.42 172.93 16.33 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.183 1.393 . . . . 3.1800000000000002 112.552 -168.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.4 mtm -103.44 143.64 32.44 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.905 0.882 . . . . 3.6099999999999999 110.561 167.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -149.21 146.32 27.56 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.245 1.818 . . . . 9.9700000000000006 111.144 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -86.91 145.97 26.35 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.75 1.22 . . . . 2.75 111.787 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 p -169.81 138.01 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 126.217 1.807 . . . . 4.0499999999999998 108.273 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 72.92 -3.58 2.38 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 127.612 2.365 . . . . 4.9100000000000001 114.818 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.99 33.19 24.46 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.277 0.942 . . . . 2.1899999999999999 112.599 -161.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -141.47 144.39 34.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.838 2.455 . . . . 5.6500000000000004 108.126 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.92 120.68 29.49 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.481 0.712 . . . . 8.4199999999999999 110.604 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -125.12 -179.67 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 127.308 2.243 . . . . 3.5099999999999998 107.982 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.3 mtm -113.78 159.97 19.2 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.583 -1.323 . . . . 5.1100000000000003 112.835 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.43 165.74 25.17 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 125.726 1.631 . . . . 0.77000000000000002 111.059 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.9 ttm -148.78 141.86 24.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.573 1.949 . . . . 1.98 108.453 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -150.11 151.21 31.44 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.938 1.695 . . . . 6.8600000000000003 109.266 -170.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.04 155.23 42.74 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.071 1.847 . . . . 0.59999999999999998 110.922 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.31 152.53 75.26 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.982 1.313 . . . . 1.9399999999999999 110.008 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.82 -21.64 10.94 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.294 2.663 . . . . 0.77000000000000002 112.865 -171.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -174.88 174.23 2.59 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.743 2.017 . . . . 3.2400000000000002 110.756 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.4 mt -119.81 154.31 34.44 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.527 1.931 . . . . 1.7 109.671 160.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -112.87 145.13 41.23 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.917 1.287 . . . . 1.71 109.41 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 t -137.61 139.13 26.14 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.288 0.635 . . . . 1.95 112.689 171.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -83.6 156.19 14.02 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 124.201 3.267 . . . . 1.28 112.311 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 73' ' ' GLY . 32.8 Cg_endo -63.31 138.81 68.21 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.413 3.409 . . . . 1.3300000000000001 115.109 -170.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt 67.15 -2.7 1.13 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.818 2.447 . . . . 4.2300000000000004 115.455 173.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 71' ' ' PRO . . . -78.76 176.29 54.6 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 127.431 2.443 . . . . 1.46 112.634 167.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.431 HH22 ' CD ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -155.27 144.53 21.01 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.27 1.428 . . . . 4.8200000000000003 111.279 -179.073 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.9 t -154.13 127.39 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 126.366 1.866 . . . . 5.0800000000000001 107.738 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.51 149.8 31.36 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.879 0.763 . . . . 5.0899999999999999 111.603 172.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mp -73.8 73.86 1.58 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.796 1.284 . . . . 2.2200000000000002 108.737 165.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -63.88 143.46 98.13 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 114.39 -1.277 . . . . 5.8099999999999996 113.138 -170.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -63.67 -21.11 70.0 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.346 2.697 . . . . 2.3100000000000001 113.982 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.57 48.2 2.33 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.248 0.928 . . . . 1.77 112.14 171.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.59 -121.6 1.04 Allowed Glycine 0 N--CA 1.468 0.802 0 C-N-CA 124.876 1.226 . . . . 1.52 114.085 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -74.21 134.35 42.73 Favored 'General case' 0 C--O 1.22 -0.494 0 O-C-N 121.928 -0.748 . . . . 3.4900000000000002 112.432 -170.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -161.66 163.51 29.81 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.84 0.856 . . . . 0.70999999999999996 111.358 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -90.72 150.22 21.72 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.287 -0.883 . . . . 3.8199999999999998 110.629 168.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.6 tpt -104.79 134.07 48.54 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.35 1.06 . . . . 1.6000000000000001 109.338 164.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -117.62 130.95 56.7 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.411 1.484 . . . . 1.8200000000000001 108.076 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 mp -136.02 140.9 44.21 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.932 0.787 . . . . 2.7000000000000002 111.992 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.74 44.91 11.43 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 123.744 0.688 . . . . 0.76000000000000001 111.776 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.01 148.27 11.03 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 123.452 1.596 . . . . 2.0899999999999999 115.049 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.48 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 26.2 mmtp -105.01 -7.43 19.23 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.517 -1.674 . . . . 2.6499999999999999 112.841 -176.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -144.14 138.06 14.59 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 127.61 2.364 . . . . 7.4699999999999998 108.062 162.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.05 144.21 75.0 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.163 1.909 . . . . 2.2999999999999998 108.308 164.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.13 120.85 36.48 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.826 1.65 . . . . 3.8599999999999999 109.87 -166.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -120.4 169.9 9.87 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.429 1.891 . . . . 4.2599999999999998 114.234 -160.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.05 103.56 1.89 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.38 1.072 . . . . 2.25 111.553 -170.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.03 12.67 39.05 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 118.507 -1.163 . . . . 1.8100000000000001 114.906 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -82.69 -172.87 4.31 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.742 1.271 . . . . 2.2400000000000002 111.456 166.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -146.65 138.95 24.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.714 2.806 . . . . 4.0 106.161 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.0 t -137.97 121.73 21.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 125.04 1.336 . . . . 2.23 109.51 -173.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -84.57 150.49 25.18 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 122.242 1.02 . . . . 3.1699999999999999 113.192 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.57 144.02 20.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.231 1.413 . . . . 4.5499999999999998 114.231 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -104.98 114.34 28.49 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 128.066 2.546 . . . . 2.6899999999999999 109.62 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.13 127.79 32.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.596 1.158 . . . . 2.7000000000000002 108.802 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.3 mt -103.54 112.21 25.02 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.005 0.922 . . . . 2.0499999999999998 109.882 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -108.16 146.81 32.19 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.437 1.495 . . . . 3.4199999999999999 111.237 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.84 124.37 11.01 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.342 1.057 . . . . 1.9199999999999999 113.089 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.2 70.75 1.22 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.457 1.027 . . . . 2.9300000000000002 113.267 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.8 4.06 57.18 Favored Glycine 0 N--CA 1.476 1.331 0 N-CA-C 117.011 1.564 . . . . 2.2000000000000002 117.011 163.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -93.47 110.69 22.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.55 1.675 . . . . 3.8900000000000001 111.024 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.63 135.3 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.048 1.339 . . . . 3.0099999999999998 109.319 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.1 tp -137.01 115.29 11.72 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.443 1.097 . . . . 3.2599999999999998 110.571 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -79.77 131.8 36.0 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.762 -0.586 . . . . 3.3500000000000001 112.316 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.3 t -124.87 169.85 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 128.509 2.724 . . . . 3.1800000000000002 107.658 172.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.9 t -144.55 134.87 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.583 1.553 . . . . 2.7799999999999998 108.094 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -131.11 152.34 80.47 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.185 0.994 . . . . 5.1699999999999999 110.52 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.97 168.42 12.21 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 124.018 3.145 . . . . 0.84999999999999998 112.955 171.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.5 t -108.56 128.62 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.28 1.032 . . . . 1.9099999999999999 110.996 173.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -120.57 147.11 45.62 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.459 1.504 . . . . 5.1200000000000001 112.402 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.87 71.85 2.54 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.78 1.232 . . . . 2.71 111.766 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 127.276 2.231 . . . . 9.2699999999999996 110.647 -178.81 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 . . . . . 0 CA--C 1.541 0.605 0 N-CA-C 109.318 -0.623 . . . . 6.7000000000000002 109.318 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.84 169.48 15.21 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 121.621 -0.674 . . . . 1.4199999999999999 114.779 -168.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -157.18 151.49 25.07 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.029 1.732 . . . . 2.4900000000000002 112.125 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.4 t -87.22 121.4 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 107.486 -1.302 . . . . 2.27 107.486 164.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.24 118.23 20.26 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.488 0.715 . . . . 4.5599999999999996 109.876 -175.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -55.85 153.71 8.13 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.186 1.395 . . . . 3.0600000000000001 113.835 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.9 t -163.89 147.04 7.87 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.143 1.377 . . . . 2.7200000000000002 110.395 173.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -86.85 6.37 5.37 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.889 3.059 . . . . 2.1200000000000001 112.665 171.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.14 -170.19 15.72 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.15 1.357 . . . . 1.22 115.082 -168.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.78 -17.78 42.05 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.867 3.045 . . . . 2.1200000000000001 113.717 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -138.22 156.16 47.96 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 116.048 1.87 . . . . 2.4300000000000002 116.048 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.7 -178.73 5.26 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 131.01 3.724 . . . . 2.1899999999999999 109.59 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.31 161.64 33.02 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.39 1.476 . . . . 1.8300000000000001 108.442 168.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.04 135.73 50.27 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.197 0.999 . . . . 1.78 110.067 172.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -127.08 132.41 50.65 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.671 1.988 . . . . 3.9300000000000002 107.673 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pp -170.07 149.86 3.65 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.413 1.006 . . . . 2.9399999999999999 113.408 -164.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.6 m -79.15 121.84 25.52 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.023 1.729 . . . . 3.0600000000000001 111.267 172.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.18 125.37 29.76 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.754 -0.832 . . . . 4.0199999999999996 108.754 157.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -95.77 142.46 28.02 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.65 1.18 . . . . 3.8999999999999999 107.943 161.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.44 72.51 2.53 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.217 1.007 . . . . 3.21 109.882 174.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.31 -20.11 61.97 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.979 2.453 . . . . 1.48 114.692 -172.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.67 -177.95 47.63 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 122.952 1.307 . . . . 1.25 113.096 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.412 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 11.3 m-20 -104.96 -1.9 25.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.769 2.028 . . . . 2.8599999999999999 112.204 -168.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -122.23 155.87 61.08 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 127.804 2.442 . . . . 2.9900000000000002 109.973 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.98 140.45 20.24 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.781 2.321 . . . . 1.5 111.048 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.2 mt -93.87 151.16 19.78 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 123.197 1.475 . . . . 2.8199999999999998 112.115 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.4 ttp-105 -135.53 106.71 6.74 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 112.589 -2.096 . . . . 3.2599999999999998 110.568 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.6 tp -91.94 108.17 19.73 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.022 1.729 . . . . 2.7999999999999998 109.95 -172.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -100.81 -20.94 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.107 1.363 . . . . 1.5900000000000001 111.399 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.06 -178.31 31.97 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.006 1.289 . . . . 0.67000000000000004 114.708 -176.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.27 -178.11 7.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.242 2.217 . . . . 2.02 110.437 172.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -160.84 151.76 18.63 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.494 1.043 . . . . 5.9699999999999998 109.439 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -150.06 153.91 36.09 Favored Pre-proline 0 N--CA 1.472 0.645 0 O-C-N 121.101 -1.0 . . . . 1.9399999999999999 109.836 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.58 -7.89 21.6 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.665 2.244 . . . . 1.1200000000000001 113.604 171.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 m -124.25 44.9 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 114.246 1.202 . . . . 1.96 114.246 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.36 175.2 14.31 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.56 1.544 . . . . 1.75 109.3 164.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.516 ' CD ' ' HZ1' ' A' ' 90' ' ' LYS . 4.6 tp10 -114.45 -60.15 1.92 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.028 0.931 . . . . 3.5 108.826 160.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.6 mtp85 -82.35 106.83 14.54 Favored 'General case' 0 N--CA 1.458 -0.059 0 O-C-N 121.244 -0.91 . . . . 6.6799999999999997 108.799 168.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.73 152.55 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 107.904 -1.147 . . . . 1.95 107.904 148.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -156.39 115.5 3.46 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.469 0.577 . . . . 3.0 111.31 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.1 tp -80.83 118.96 22.8 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.882 -1.136 . . . . 2.1200000000000001 111.753 -174.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -125.24 152.96 43.89 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 123.219 1.485 . . . . 0.56999999999999995 114.483 -172.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -95.31 177.11 5.95 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.36 1.864 . . . . 2.3900000000000001 111.307 162.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.6 m -156.03 144.08 19.77 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.998 2.119 . . . . 1.8200000000000001 106.6 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -160.04 163.38 34.01 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.723 1.379 . . . . 3.6400000000000001 114.723 -165.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.88 145.33 27.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.852 1.261 . . . . 5.7300000000000004 111.169 164.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.42 147.23 21.89 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.515 -0.741 . . . . 5.2699999999999996 112.259 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -105.66 142.23 35.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 126.63 1.972 . . . . 2.7799999999999998 111.84 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.2 t -144.95 133.54 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.566 1.946 . . . . 3.48 106.903 166.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 68.49 1.1 2.82 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 126.609 1.963 . . . . 3.0 114.71 -172.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.71 18.33 61.94 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.431 1.015 . . . . 2.2599999999999998 113.572 -163.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -120.55 134.85 55.23 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.75 2.42 . . . . 3.7000000000000002 108.282 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.63 142.45 28.24 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 125.545 1.538 . . . . 4.3799999999999999 114.052 -173.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.16 169.6 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 129.241 3.016 . . . . 3.9100000000000001 107.259 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.0 mtp -117.33 139.83 50.34 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.194 -0.941 . . . . 4.4000000000000004 110.728 165.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.98 -179.81 16.07 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.487 1.041 . . . . 0.62 113.772 -175.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ttm -152.89 144.88 23.73 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.617 1.967 . . . . 1.6399999999999999 109.1 -176.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -146.11 156.95 50.63 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 126.022 1.729 . . . . 6.0499999999999998 108.924 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.89 156.34 43.48 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 121.886 1.724 . . . . 0.64000000000000001 110.667 166.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.7 m -139.12 152.16 69.27 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 124.799 1.24 . . . . 1.78 110.543 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.3 -29.33 7.88 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.862 2.375 . . . . 0.56999999999999995 112.175 -168.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -174.39 165.45 3.94 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.53 1.532 . . . . 3.46 111.867 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.8 mt -109.48 154.12 23.1 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.109 1.364 . . . . 1.8200000000000001 110.386 164.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -113.49 147.35 38.06 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.975 1.31 . . . . 2.0499999999999998 109.962 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.6 t -140.78 140.25 21.52 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.85 0.86 . . . . 1.98 111.959 169.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -88.1 155.9 7.03 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.648 3.565 . . . . 1.3200000000000001 112.846 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.39 142.76 80.29 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.992 3.128 . . . . 1.2 113.75 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.412 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 70.5 mmtt 67.61 -9.65 0.42 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.763 2.425 . . . . 2.6899999999999999 114.251 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.46 160.92 46.14 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.788 1.185 . . . . 1.54 111.98 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -116.63 140.87 48.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.752 0.821 . . . . 5.9400000000000004 109.302 160.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.3 t -148.32 143.92 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.875 2.07 . . . . 4.5 106.895 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.21 150.51 39.96 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.288 1.404 . . . . 4.0199999999999996 114.76 -165.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.2 mp -66.73 75.25 0.11 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.208 -1.405 . . . . 2.25 107.208 151.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.8 140.54 74.59 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 114.466 -1.243 . . . . 3.9900000000000002 111.538 -167.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -55.52 -35.55 92.6 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.901 2.401 . . . . 2.1499999999999999 112.321 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.68 6.9 57.01 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 116.88 -2.067 . . . . 2.23 116.27 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.19 -8.56 0.02 OUTLIER Glycine 0 N--CA 1.478 1.441 0 N-CA-C 122.331 3.692 . . . . 2.1099999999999999 122.331 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -145.43 143.74 30.23 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 122.188 2.994 . . . . 3.29 113.163 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -162.26 157.77 23.39 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.508 0.723 . . . . 0.56000000000000005 111.369 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -82.99 138.64 33.68 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 107.945 -1.132 . . . . 2.7000000000000002 107.945 158.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -79.2 134.79 36.67 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.203 1.401 . . . . 1.5700000000000001 108.051 156.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 mp -116.61 125.87 52.43 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 106.591 -1.633 . . . . 2.0800000000000001 106.591 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.4 tt -147.46 136.22 22.0 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.759 -0.588 . . . . 3.3700000000000001 110.325 -167.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.25 47.36 8.32 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.129 -0.788 . . . . 1.03 111.129 -167.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mt -50.64 150.54 2.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 123.044 1.402 . . . . 4.46 112.706 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.516 ' HZ1' ' CD ' ' A' ' 41' ' ' GLU . 34.1 mmtp -106.83 -2.4 21.46 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.065 -1.425 . . . . 3.48 113.256 -169.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -153.29 154.27 30.5 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.652 1.181 . . . . 7.3799999999999999 111.682 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.35 94.67 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.476 2.117 . . . . 2.54 107.667 160.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.15 164.93 15.44 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 125.826 1.651 . . . . 3.7599999999999998 109.358 176.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -146.71 165.2 30.34 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 112.764 -2.016 . . . . 5.1699999999999999 113.751 -160.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.9 118.54 10.53 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.701 -1.136 . . . . 2.3900000000000001 108.777 166.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.9 10.13 43.84 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.378 -1.234 . . . . 1.4199999999999999 115.974 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -86.24 -175.28 5.45 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.647 1.724 . . . . 2.1400000000000001 112.122 165.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -146.46 156.22 43.13 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 130.056 3.342 . . . . 5.1900000000000004 107.556 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 78.6 t -156.06 128.04 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 127.487 2.315 . . . . 2.1200000000000001 109.812 -170.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -91.81 130.61 37.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.079 0.466 . . . . 4.8399999999999999 110.536 168.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.5 tt -111.78 136.75 50.63 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.914 1.685 . . . . 4.0 110.821 173.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -87.32 150.28 23.95 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.744 2.018 . . . . 2.3399999999999999 110.004 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.3 mp -123.83 134.44 53.6 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.059 1.344 . . . . 2.3700000000000001 110.408 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.7 mt -112.78 118.13 34.09 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.011 1.324 . . . . 1.6899999999999999 110.324 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -112.31 149.59 32.2 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.821 1.248 . . . . 3.2799999999999998 110.906 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.95 149.22 27.8 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.474 0.71 . . . . 2.3799999999999999 112.191 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.25 12.47 84.56 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 119.123 -0.821 . . . . 3.5 114.844 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.68 63.55 1.83 Allowed Glycine 0 N--CA 1.471 1.004 0 CA-C-N 118.965 1.383 . . . . 2.3700000000000001 113.581 172.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -135.78 147.69 48.46 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.744 1.618 . . . . 4.6200000000000001 111.611 169.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.2 t -138.34 146.69 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.437 1.095 . . . . 3.3399999999999999 110.189 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.0 tp -145.38 169.88 17.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.209 1.804 . . . . 2.8900000000000001 110.128 -177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -128.55 144.65 51.19 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.282 1.216 . . . . 3.0899999999999999 114.282 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.6 m -130.7 162.44 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 126.057 1.743 . . . . 3.46 110.978 168.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 86.5 t -121.28 141.29 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.918 2.087 . . . . 3.25 107.113 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.1 mt -152.94 106.08 2.66 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 125.11 1.364 . . . . 3.0299999999999998 109.718 -160.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.53 149.92 89.11 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.904 2.403 . . . . 0.92000000000000004 110.822 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.5 t -91.83 116.87 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.646 -0.872 . . . . 2.3199999999999998 108.646 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.94 149.88 27.75 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.5 1.12 . . . . 3.29 111.358 -153.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -106.23 91.97 3.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.125 0.97 . . . . 2.3199999999999998 113.102 -164.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 125.925 1.69 . . . . 9.1699999999999999 110.195 167.875 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 103.826 -2.657 . . . . 7.3600000000000003 103.826 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.77 -175.49 41.32 Favored Glycine 0 N--CA 1.463 0.49 0 C-N-CA 124.239 0.923 . . . . 1.9399999999999999 115.402 -168.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -142.21 -179.26 6.15 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.904 1.682 . . . . 2.1699999999999999 111.572 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.7 142.87 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 121.114 -0.991 . . . . 2.6899999999999999 109.804 174.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.444 HH11 ' HG3' ' A' ' 9' ' ' ARG . 1.0 OUTLIER -86.69 126.64 34.69 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.766 0.426 . . . . 5.0999999999999996 112.08 -176.051 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -50.54 139.12 16.44 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.416 1.886 . . . . 2.9500000000000002 113.458 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 m -157.55 149.11 16.97 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.556 1.142 . . . . 2.6400000000000001 110.588 163.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -84.53 42.72 1.21 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.416 3.411 . . . . 2.1600000000000001 110.762 167.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.95 158.56 15.09 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.605 1.097 . . . . 1.54 114.502 -164.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.37 -13.99 25.32 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.848 3.032 . . . . 1.4199999999999999 112.574 165.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -135.22 155.33 50.83 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 129.398 3.079 . . . . 2.21 112.62 -175.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.94 -176.29 5.47 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.072 1.749 . . . . 1.6000000000000001 112.138 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -154.56 130.14 9.91 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.709 1.604 . . . . 1.76 110.385 -177.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.29 141.5 49.94 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.627 1.171 . . . . 1.49 113.28 -169.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.43 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 39.9 m-85 -126.18 115.48 19.83 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.896 1.678 . . . . 3.6800000000000002 109.986 -170.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.259 0.0 OUTLIER -159.73 -174.87 4.83 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.591 1.7 . . . . 4.21 115.591 -166.491 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.1 m -108.45 135.24 50.07 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.451 1.1 . . . . 3.1499999999999999 111.34 -158.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.71 108.86 17.35 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.803 1.241 . . . . 4.3600000000000003 108.394 171.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -99.32 138.6 36.18 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.014 0.926 . . . . 3.9500000000000002 109.174 170.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -109.33 89.17 6.76 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 122.902 0.481 . . . . 1.6200000000000001 109.924 161.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.41 -9.24 20.14 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.545 2.163 . . . . 1.21 113.065 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.95 -175.54 49.24 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 124.766 1.174 . . . . 1.2 113.195 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.438 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.7 m-20 -111.81 -4.21 14.7 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.959 2.103 . . . . 3.27 112.41 -166.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mp -125.94 163.34 40.11 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 127.713 2.405 . . . . 5.4400000000000004 108.664 174.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.62 145.79 18.59 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.38 2.054 . . . . 1.3700000000000001 111.273 -171.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mp -105.21 148.24 27.16 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.62 1.168 . . . . 4.1299999999999999 110.058 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -139.35 103.21 4.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.801 -1.545 . . . . 4.4800000000000004 109.703 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.0 tt -80.96 119.53 23.6 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 124.527 1.131 . . . . 3.54 108.207 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.1 m -111.08 -12.53 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.291 1.036 . . . . 1.9399999999999999 111.258 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.45 -176.21 30.24 Favored Glycine 0 C--N 1.343 0.936 0 C-N-CA 125.316 1.436 . . . . 0.66000000000000003 114.085 -174.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.72 -179.5 8.06 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.93 1.692 . . . . 1.6599999999999999 110.069 173.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.02 -177.99 6.98 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 125.85 1.66 . . . . 5.9199999999999999 109.143 165.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 t -179.62 153.7 0.69 Allowed Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 128.043 2.537 . . . . 1.8500000000000001 106.46 -169.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -73.71 -16.58 23.66 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 120.77 1.311 . . . . 0.92000000000000004 112.602 172.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.3 m -113.19 41.5 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 114.631 1.345 . . . . 1.8500000000000001 114.631 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.14 142.48 4.1 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.22 -0.925 . . . . 1.8 111.828 168.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.527 ' CD ' ' HZ1' ' A' ' 90' ' ' LYS . 1.3 tp10 -74.65 -57.02 4.19 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.912 0.885 . . . . 2.71 110.095 173.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -85.02 139.99 31.36 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.91 1.284 . . . . 6.3399999999999999 108.385 163.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 p -108.91 153.89 10.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.368 -1.287 . . . . 1.95 108.207 140.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -135.02 151.86 51.18 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.704 2.002 . . . . 3.0 108.294 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.2 tp -106.53 124.46 49.64 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.288 0.635 . . . . 2.3999999999999999 109.892 173.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.2 m170 -123.95 159.77 29.02 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.277 1.431 . . . . 0.65000000000000002 114.131 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.58 159.39 22.98 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.388 1.875 . . . . 2.3100000000000001 110.743 163.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 m -135.33 145.33 47.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.079 1.751 . . . . 2.0499999999999998 106.796 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -157.97 171.0 21.04 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.18 0.99 . . . . 3.2799999999999998 113.54 -167.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.6 ttp -100.7 135.99 41.28 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.265 1.826 . . . . 3.8300000000000001 110.134 168.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.14 138.45 40.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.636 1.175 . . . . 6.5 110.731 171.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -92.43 126.32 37.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.411 1.484 . . . . 3.4300000000000002 112.9 -177.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 m -136.01 142.57 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.722 1.609 . . . . 3.77 108.249 169.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 70.15 -3.18 1.86 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 126.003 1.721 . . . . 4.1299999999999999 115.065 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.43 22.82 39.04 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.769 1.176 . . . . 2.0899999999999999 113.791 -161.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt -133.97 132.31 40.01 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.722 2.409 . . . . 4.8399999999999999 109.56 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.402 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -67.36 121.36 15.57 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 120.575 -1.328 . . . . 5.7400000000000002 112.28 170.189 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.7 m -97.94 171.36 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.703 1.201 . . . . 3.1299999999999999 108.759 151.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 70.0 mtm -111.23 156.63 21.17 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.477 0.711 . . . . 4.46 111.103 164.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.39 176.04 23.07 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.898 1.237 . . . . 0.57999999999999996 112.288 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.0 ttm -151.41 143.47 23.94 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.836 1.654 . . . . 1.74 109.748 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -148.97 154.03 39.2 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.624 1.57 . . . . 6.5999999999999996 109.604 -173.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -76.67 161.03 34.25 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.425 2.084 . . . . 0.63 111.364 172.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.25 155.83 64.61 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.692 1.597 . . . . 2.1200000000000001 110.977 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -82.62 -27.82 1.99 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.592 2.861 . . . . 0.76000000000000001 113.375 -169.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -174.44 165.4 3.9 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.178 1.391 . . . . 3.46 111.916 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 mt -114.82 158.47 21.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.484 1.914 . . . . 1.97 109.727 161.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -141.33 148.13 39.24 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.908 0.883 . . . . 2.2599999999999998 111.353 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -145.68 131.92 9.66 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.104 0.962 . . . . 2.3900000000000001 112.438 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.4 161.71 41.92 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.578 3.519 . . . . 1.8500000000000001 112.83 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.36 140.96 79.45 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.065 3.177 . . . . 1.47 113.435 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.438 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 68.6 mmtt 67.73 -1.65 1.59 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.135 2.174 . . . . 2.7000000000000002 113.818 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.95 164.2 38.73 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.721 1.629 . . . . 1.49 111.952 171.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.03 139.77 20.76 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.693 1.197 . . . . 5.0 110.439 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.2 t -152.85 144.95 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.216 1.807 . . . . 4.7199999999999998 108.34 -165.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -126.31 145.05 50.58 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 122.034 0.921 . . . . 4.3300000000000001 113.464 -168.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 mp -75.75 74.09 2.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.097 2.559 . . . . 2.2400000000000002 109.495 171.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.0 146.5 97.26 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.175 0.99 . . . . 3.9700000000000002 112.798 176.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.43 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 36.2 Cg_endo -60.43 -36.93 84.71 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.683 2.256 . . . . 2.3300000000000001 113.37 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.89 44.33 2.77 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.162 0.887 . . . . 1.6799999999999999 113.498 171.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.63 -124.3 1.14 Allowed Glycine 0 C--N 1.338 0.669 0 C-N-CA 125.44 1.495 . . . . 1.5900000000000001 113.018 176.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -73.28 139.74 46.33 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.816 -0.814 . . . . 3.6600000000000001 112.314 -171.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -162.19 166.97 24.86 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.326 1.45 . . . . 0.73999999999999999 111.708 -174.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -95.04 148.4 22.38 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.885 -0.509 . . . . 2.79 110.112 167.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.3 tpt -105.28 139.81 39.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.589 1.556 . . . . 1.8 109.347 165.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -113.5 135.26 54.09 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.461 1.504 . . . . 1.9199999999999999 108.344 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.89 133.19 41.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.649 0.78 . . . . 3.2400000000000002 110.663 174.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.11 50.88 4.17 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 124.148 0.88 . . . . 0.79000000000000004 113.013 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.9 mt -52.31 156.84 1.58 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.674 1.731 . . . . 3.6600000000000001 115.674 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.527 ' HZ1' ' CD ' ' A' ' 41' ' ' GLU . 72.3 mmtt -116.89 -25.09 7.38 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.861 -1.063 . . . . 2.6000000000000001 113.68 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -114.49 138.68 23.25 Favored Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 126.649 1.98 . . . . 6.7000000000000002 107.075 158.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.88 133.49 31.53 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 N-CA-C 107.097 -1.924 . . . . 1.8 107.097 162.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.25 78.92 1.31 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.294 0.637 . . . . 3.6400000000000001 110.439 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -68.7 163.87 22.93 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.948 0.88 . . . . 5.2000000000000002 112.502 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.89 117.44 10.56 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.435 -1.32 . . . . 3.3300000000000001 107.435 168.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.86 14.55 59.27 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 117.903 -1.498 . . . . 1.8600000000000001 115.227 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.56 175.18 5.79 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.957 1.879 . . . . 3.1299999999999999 109.378 155.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.44 171.56 8.45 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.455 -1.683 . . . . 5.5099999999999998 106.455 150.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.4 t -138.17 119.89 17.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 C-N-CA 128.775 2.83 . . . . 3.02 107.505 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.414 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -79.81 141.68 36.0 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.399 0.68 . . . . 3.5299999999999998 109.857 167.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.28 139.23 53.48 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.863 1.265 . . . . 2.7400000000000002 110.951 171.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.02 149.54 23.94 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 129.698 3.199 . . . . 2.04 110.303 158.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -127.93 119.81 26.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.592 1.957 . . . . 1.97 108.537 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.2 mt -103.58 121.14 42.3 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.307 1.043 . . . . 1.72 111.147 -171.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -114.5 144.52 43.22 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.039 1.336 . . . . 3.3599999999999999 112.361 -174.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.86 144.63 48.2 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.411 -0.813 . . . . 2.6400000000000001 110.963 169.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.81 27.36 38.44 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 118.828 -0.984 . . . . 3.48 114.015 -174.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.99 36.24 32.58 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 124.703 1.144 . . . . 1.8799999999999999 115.243 163.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -129.65 143.59 50.89 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.39 1.095 . . . . 4.1100000000000003 112.897 -168.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.6 p -133.01 150.89 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.828 1.651 . . . . 3.3100000000000001 111.034 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 31.4 tp -144.43 159.62 42.43 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.334 2.254 . . . . 3.0499999999999998 108.764 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.414 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 62.1 mttm -126.85 167.99 15.07 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.335 0.971 . . . . 4.0300000000000002 113.439 177.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.9 m -149.05 159.33 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 127.111 2.164 . . . . 3.6200000000000001 110.73 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.9 t -118.86 123.52 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.466 1.106 . . . . 2.8100000000000001 110.148 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.9 mt -124.9 123.89 25.51 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.701 1.2 . . . . 2.8900000000000001 110.083 -170.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.37 155.37 36.7 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.927 2.418 . . . . 1.01 111.504 174.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.4 t -94.94 115.11 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.427 0.632 . . . . 2.3700000000000001 111.062 172.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -93.95 130.16 40.15 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.504 1.122 . . . . 4.0499999999999998 111.249 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.34 152.01 22.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.261 1.024 . . . . 4.54 108.528 151.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 . . . . . 0 C--O 1.245 0.857 0 C-N-CA 127.322 2.249 . . . . 10.35 109.62 -175.243 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 CA--C 1.541 0.611 0 CA-C-O 122.611 1.196 . . . . 4.9100000000000001 112.766 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.29 -178.19 27.49 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 125.142 1.353 . . . . 1.3 112.064 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -155.67 164.77 38.17 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.537 0.94 . . . . 2.23 113.537 171.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.4 t -106.86 141.25 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.337 1.455 . . . . 1.9399999999999999 108.751 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -74.69 -1.63 22.7 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.416 1.636 . . . . 5.2599999999999998 115.416 -172.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 64.16 172.38 0.18 Allowed 'General case' 0 CA--C 1.554 1.129 0 CA-C-N 119.919 1.236 . . . . 2.8199999999999998 111.567 -170.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.4 t -160.24 154.52 19.98 Favored Pre-proline 0 N--CA 1.468 0.457 0 O-C-N 120.275 -1.515 . . . . 3.6299999999999999 110.38 163.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -85.23 -3.48 9.49 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.576 2.85 . . . . 2.3599999999999999 112.312 161.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.15 -173.51 13.35 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.426 1.488 . . . . 1.45 114.587 -173.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.23 -18.83 20.48 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.948 3.099 . . . . 2.2000000000000002 113.849 -175.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -104.77 143.44 33.12 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.485 1.914 . . . . 2.7599999999999998 113.868 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.61 -178.86 7.3 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.59 1.956 . . . . 1.8100000000000001 112.405 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.34 134.33 25.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.924 2.089 . . . . 1.8700000000000001 108.661 177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.81 138.01 53.63 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.888 1.275 . . . . 1.8799999999999999 111.314 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -116.81 64.57 0.72 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.707 1.603 . . . . 3.6299999999999999 111.209 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.26 155.75 40.33 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.125 1.157 . . . . 2.8999999999999999 114.125 -172.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.5 m -92.66 147.21 23.06 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.556 1.143 . . . . 3.2200000000000002 109.769 166.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 tp -130.86 114.11 14.88 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.282 2.233 . . . . 4.3700000000000001 110.135 173.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -98.79 121.34 40.61 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.798 1.639 . . . . 5.1900000000000004 110.122 170.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -95.68 104.09 15.02 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 120.89 -1.132 . . . . 1.8200000000000001 110.101 165.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -83.18 -10.15 10.26 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.961 2.441 . . . . 1.3899999999999999 113.443 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.66 171.4 54.64 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 123.154 1.419 . . . . 1.3 113.166 -173.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.458 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 6.6 m-20 -97.41 -6.1 34.79 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 128.609 2.764 . . . . 3.2799999999999998 112.171 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.5 mt -117.76 162.59 28.25 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 127.49 2.316 . . . . 5.0499999999999998 109.178 171.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -81.51 153.23 17.93 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.66 2.24 . . . . 1.23 111.211 -172.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.8 mt -102.32 155.08 18.47 Favored 'General case' 0 C--O 1.227 -0.101 0 CA-C-O 122.758 1.266 . . . . 2.8500000000000001 110.374 166.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -140.24 118.89 12.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 113.661 -1.609 . . . . 2.9100000000000001 109.624 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.2 tp -100.53 108.79 20.81 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.902 1.281 . . . . 2.71 109.909 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 m -104.38 -17.84 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.15 0.98 . . . . 1.8500000000000001 111.833 -173.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.99 -179.04 31.63 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 125.412 1.482 . . . . 0.56000000000000005 112.304 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.96 178.16 7.55 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.073 1.349 . . . . 1.8400000000000001 109.926 165.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -157.38 178.65 10.07 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.005 1.722 . . . . 7.9299999999999997 108.18 176.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 t 177.29 152.05 0.4 Allowed Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 126.642 1.977 . . . . 1.78 109.527 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.06 -10.49 27.33 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.731 2.287 . . . . 1.1599999999999999 114.22 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.3 m -116.72 41.43 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.691 0.997 . . . . 1.8700000000000001 113.691 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.84 144.97 23.83 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.259 -0.9 . . . . 2.0699999999999998 110.87 162.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -93.21 -47.46 6.93 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.07 1.348 . . . . 3.71 111.447 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.11 161.23 19.77 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.313 1.845 . . . . 7.8799999999999999 107.659 168.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.74 138.66 10.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 126.178 1.791 . . . . 2.77 108.979 -173.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.55 145.52 48.79 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.884 1.674 . . . . 3.0499999999999998 109.873 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.8 tp -101.35 120.21 39.92 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.216 1.006 . . . . 2.1099999999999999 110.783 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -123.53 155.38 37.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.102 1.761 . . . . 0.66000000000000003 113.65 -174.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -99.97 162.69 12.83 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.153 -1.385 . . . . 2.4700000000000002 111.685 156.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 m -121.61 136.76 54.93 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.153 1.781 . . . . 1.77 106.571 162.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -134.83 176.16 8.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.965 1.306 . . . . 3.21 112.895 -175.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.5 ptm -123.62 146.04 48.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.012 1.325 . . . . 4.0999999999999996 112.863 167.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.19 138.9 24.18 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.855 2.062 . . . . 7.0099999999999998 110.122 -176.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -95.13 121.88 37.22 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.833 1.253 . . . . 3.4100000000000001 110.809 175.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.2 m -88.67 -120.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.973 -1.121 . . . . 4.8399999999999999 107.973 172.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.07 37.67 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 130.106 3.362 . . . . 4.3499999999999996 116.429 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.81 22.1 68.02 Favored Glycine 0 CA--C 1.528 0.879 0 O-C-N 119.182 -2.199 . . . . 2.3599999999999999 111.504 -164.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.87 132.26 56.74 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.767 2.027 . . . . 7.8700000000000001 108.264 174.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.83 131.76 34.49 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.944 1.298 . . . . 9.2599999999999998 110.822 -175.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.58 150.6 20.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 124.369 1.068 . . . . 3.71 110.663 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -111.34 136.89 49.81 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.641 1.176 . . . . 3.8199999999999998 110.27 -175.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.12 -176.67 14.52 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 124.968 1.27 . . . . 0.56999999999999995 112.262 -174.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ttm -152.85 146.62 25.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.175 1.39 . . . . 1.5800000000000001 108.914 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -156.5 152.84 23.63 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 123.779 0.832 . . . . 6.8099999999999996 110.815 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.29 152.39 55.51 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.953 1.769 . . . . 0.59999999999999998 111.176 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.99 153.62 71.87 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.847 1.659 . . . . 1.74 109.747 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.63 -25.3 3.76 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.961 2.44 . . . . 0.59999999999999998 113.279 -166.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -177.18 164.61 2.23 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.729 1.611 . . . . 3.1099999999999999 111.751 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.7 mt -111.79 153.96 25.78 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.424 1.49 . . . . 1.6000000000000001 109.967 163.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -110.11 147.25 34.01 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.388 1.075 . . . . 2.1499999999999999 109.2 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.5 t -139.85 129.53 13.84 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 113.018 0.747 . . . . 2.0899999999999999 113.018 170.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -71.1 164.97 33.91 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.484 2.79 . . . . 1.3600000000000001 112.494 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -59.63 143.48 99.65 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.347 2.698 . . . . 1.23 111.929 172.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.458 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 68.9 mmtt 67.02 -4.06 0.86 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.318 1.847 . . . . 3.02 114.26 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.36 134.8 13.15 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.713 1.625 . . . . 1.3899999999999999 113.088 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -97.84 138.89 34.52 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.646 1.178 . . . . 6.29 110.139 164.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.3 t -144.9 132.12 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.059 1.343 . . . . 3.7400000000000002 108.0 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.49 136.48 49.56 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.6 0.714 . . . . 3.27 110.827 172.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mp -71.19 78.13 0.7 Allowed 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 125.45 1.5 . . . . 2.6299999999999999 109.1 165.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -76.08 156.13 84.17 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.248 1.419 . . . . 4.5199999999999996 114.159 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.79 -18.29 62.03 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.571 2.18 . . . . 2.5299999999999998 113.093 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.22 36.18 2.18 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.154 -0.804 . . . . 2.5099999999999998 112.819 166.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.71 -118.88 0.91 Allowed Glycine 0 C--N 1.344 0.974 0 C-N-CA 124.751 1.167 . . . . 1.79 115.066 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -72.15 142.07 49.1 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 121.812 -0.817 . . . . 3.1499999999999999 111.937 -165.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -161.98 171.35 17.75 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.354 1.062 . . . . 0.76000000000000001 112.251 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -107.33 133.4 51.93 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.14 0.576 . . . . 3.0299999999999998 110.758 170.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.1 tpt -82.08 128.64 34.33 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.23 1.412 . . . . 2.0299999999999998 109.324 163.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.4 mp -116.6 134.32 54.97 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.838 1.255 . . . . 2.25 108.971 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.8 mt -135.58 132.94 37.78 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.752 0.821 . . . . 3.3199999999999998 110.738 -170.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.49 36.56 26.23 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.606 -1.108 . . . . 0.91000000000000003 114.065 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -45.05 150.62 0.38 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 116.528 2.047 . . . . 2.1600000000000001 116.528 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -106.74 7.13 30.25 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 113.713 -1.585 . . . . 3.25 113.901 -169.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.9 ptm85 -145.32 147.6 34.5 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.959 1.304 . . . . 5.4199999999999999 111.627 167.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.07 149.64 71.54 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.297 1.998 . . . . 2.1200000000000001 108.435 158.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.72 134.54 25.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.462 1.105 . . . . 5.2599999999999998 110.512 -156.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.5 mmtm -103.32 171.99 7.06 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.068 1.347 . . . . 4.5 111.489 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.58 134.6 46.54 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.822 -1.177 . . . . 1.8799999999999999 107.822 148.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.24 21.91 16.36 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.44 1.495 . . . . 1.23 115.405 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -105.79 -174.96 2.66 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.412 1.606 . . . . 1.8600000000000001 111.815 168.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -147.45 131.63 17.39 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 129.747 3.219 . . . . 5.5800000000000001 105.344 -169.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.1 t -140.5 130.5 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.093 0.957 . . . . 1.79 110.985 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -76.09 141.66 41.94 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.326 1.051 . . . . 2.71 110.052 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 mp -128.15 136.81 51.63 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.816 0.846 . . . . 2.5699999999999998 111.969 167.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -90.77 134.19 34.62 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 127.131 2.172 . . . . 2.54 109.339 173.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.73 118.01 35.49 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 119.702 1.137 . . . . 2.1400000000000001 110.065 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 72.2 mt -90.42 102.18 14.92 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.577 -0.897 . . . . 1.8400000000000001 108.577 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -92.43 142.65 27.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.467 0.707 . . . . 3.9199999999999999 111.274 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.15 124.0 10.64 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.54 1.136 . . . . 2.3199999999999998 112.109 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.1 46.99 19.8 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.712 -1.049 . . . . 2.9900000000000002 114.296 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.84 25.29 25.36 Favored Glycine 0 N--CA 1.475 1.246 0 N-CA-C 117.172 1.629 . . . . 1.8899999999999999 117.172 156.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.57 148.1 39.96 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.453 1.626 . . . . 4.6900000000000004 111.221 168.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -140.28 151.63 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.786 1.234 . . . . 2.98 110.935 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.9 tp -155.38 138.09 15.2 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.874 1.669 . . . . 3.2799999999999998 109.548 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -110.21 115.71 30.21 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.692 0.678 . . . . 2.96 112.504 -173.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.6 m -89.31 178.12 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.057 1.743 . . . . 3.2599999999999998 111.592 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.7 p -142.42 145.28 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.078 1.351 . . . . 3.7000000000000002 109.041 170.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.4 143.75 13.82 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.078 0.951 . . . . 3.2200000000000002 113.126 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.54 156.69 63.23 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.965 3.11 . . . . 0.90000000000000002 112.953 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.7 t -106.34 124.93 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.513 1.525 . . . . 1.8700000000000001 109.314 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -146.83 155.21 42.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.267 1.827 . . . . 3.8500000000000001 110.541 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -112.55 129.5 56.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.083 0.953 . . . . 3.73 113.011 -165.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 C-N-CA 126.379 1.872 . . . . 8.5099999999999998 111.968 167.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 N--CA 1.468 0.468 0 CA-C-O 122.156 0.979 . . . . 7.2300000000000004 108.554 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.35 165.71 33.96 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.866 1.698 . . . . 1.4299999999999999 112.407 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 21.8 p90 -155.65 152.11 28.27 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.319 1.448 . . . . 2.0800000000000001 111.971 174.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.0 t -89.39 137.87 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.388 -0.82 . . . . 2.4100000000000001 109.021 171.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -62.53 -4.6 2.02 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.121 1.768 . . . . 4.9299999999999997 115.729 -168.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 72.6 159.89 0.22 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.569 1.948 . . . . 3.7000000000000002 111.154 -167.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.9 t -168.87 135.71 1.53 Allowed Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 121.155 -0.966 . . . . 3.1499999999999999 111.077 163.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -81.42 -6.88 12.81 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.271 2.648 . . . . 1.9399999999999999 112.235 169.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.59 171.99 15.06 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.48 1.515 . . . . 1.04 113.551 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.76 -13.45 34.31 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.944 3.763 . . . . 1.5600000000000001 115.454 -172.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -123.41 144.4 49.51 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.639 1.575 . . . . 4.8600000000000003 112.256 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.69 -176.49 4.67 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.367 1.867 . . . . 1.5900000000000001 112.012 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.97 154.3 39.18 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.694 1.997 . . . . 1.75 108.504 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.51 146.48 42.02 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.75 1.22 . . . . 1.8500000000000001 114.227 -173.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.427 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 30.2 m-85 -120.7 143.6 48.66 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.867 2.067 . . . . 3.6699999999999999 110.184 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pp -171.38 151.62 3.11 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.441 1.275 . . . . 3.46 114.441 -175.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.4 m -79.13 144.27 34.67 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.923 1.689 . . . . 2.5800000000000001 111.359 174.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.5 126.99 54.97 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 129.502 3.121 . . . . 4.5599999999999996 108.057 168.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -118.94 127.46 53.5 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.802 1.241 . . . . 4.2400000000000002 109.663 168.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -100.46 93.44 2.76 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 123.606 0.762 . . . . 1.4299999999999999 110.061 170.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.54 -8.89 18.52 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.025 1.817 . . . . 1.53 112.983 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.42 162.45 34.83 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 122.684 1.158 . . . . 1.23 111.643 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.454 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 5.3 m-20 -94.53 3.27 55.33 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.352 2.661 . . . . 2.9900000000000002 112.046 -170.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -122.21 154.32 61.87 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 129.242 3.017 . . . . 2.7799999999999998 109.678 174.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.78 147.01 30.59 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.759 2.306 . . . . 0.93000000000000005 111.024 -172.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.6 mt -104.2 147.93 26.9 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 122.465 1.126 . . . . 2.9199999999999999 110.537 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -136.73 99.04 3.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.562 -2.108 . . . . 3.3300000000000001 110.725 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.2 tp -80.73 106.43 12.73 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.669 1.588 . . . . 3.1299999999999999 109.727 -173.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -99.19 -21.18 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.771 1.229 . . . . 1.8500000000000001 112.209 -175.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.16 -177.16 31.98 Favored Glycine 0 C--N 1.343 0.947 0 C-N-CA 124.96 1.266 . . . . 0.73999999999999999 114.937 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.07 -177.24 5.35 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.562 1.945 . . . . 1.6799999999999999 111.131 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.425 HH12 HG12 ' A' ' 110' ' ' VAL . 40.9 mtt85 -146.55 -179.42 6.76 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.809 2.044 . . . . 7.8799999999999999 108.062 158.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t -174.77 152.08 1.54 Allowed Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 127.12 2.168 . . . . 1.8799999999999999 108.299 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.78 -6.29 15.94 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.025 1.817 . . . . 1.0900000000000001 113.899 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.23 45.31 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.532 1.133 . . . . 2.1400000000000001 112.854 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.33 171.76 19.81 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.665 1.186 . . . . 1.78 111.8 168.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -104.96 -23.49 12.97 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 128.464 2.706 . . . . 2.8300000000000001 111.221 166.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -152.26 160.49 43.34 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.44 2.296 . . . . 7.7699999999999996 110.858 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.2 p -156.93 117.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 125.815 1.646 . . . . 2.3799999999999999 110.301 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -131.28 130.68 43.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.954 -1.021 . . . . 5.0 111.352 -166.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 31.3 tp -83.3 122.51 28.54 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.958 0.903 . . . . 2.6000000000000001 111.746 -168.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.3 m170 -124.75 160.78 27.87 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.618 1.567 . . . . 0.80000000000000004 113.356 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -107.18 154.17 21.59 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 113.467 -1.697 . . . . 2.3700000000000001 110.721 157.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.0 m -111.18 138.33 47.75 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.265 1.826 . . . . 2.1899999999999999 106.521 162.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -133.78 174.19 10.72 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.191 1.396 . . . . 3.1899999999999999 112.968 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.0 ttp -113.0 143.0 45.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.628 1.571 . . . . 4.5800000000000001 109.833 166.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -138.31 152.67 48.72 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.135 1.374 . . . . 5.4500000000000002 112.036 171.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -95.84 146.93 24.17 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.104 1.762 . . . . 2.2000000000000002 110.602 163.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 m -147.93 130.71 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.885 2.074 . . . . 3.5499999999999998 108.837 162.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 62.98 15.84 8.74 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.577 1.551 . . . . 3.3500000000000001 114.34 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.71 16.79 69.63 Favored Glycine 0 N--CA 1.479 1.513 0 O-C-N 121.054 -1.029 . . . . 1.6799999999999999 113.741 -169.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.9 mtmt -119.27 122.17 41.3 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.974 2.11 . . . . 4.3200000000000003 108.071 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.47 128.43 38.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.869 1.268 . . . . 4.1900000000000004 111.76 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 t -143.69 141.73 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 127.208 2.203 . . . . 3.8399999999999999 108.662 -174.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 50.6 mtp -83.54 162.93 20.72 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.358 0.663 . . . . 4.54 112.655 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.56 -177.47 28.83 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 125.118 1.342 . . . . 0.94999999999999996 112.397 -177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.1 ttm -154.79 148.25 25.16 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.531 1.133 . . . . 2.1800000000000002 109.844 -172.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -155.89 153.7 26.36 Favored Pre-proline 0 N--CA 1.474 0.736 0 C-N-CA 123.779 0.832 . . . . 7.1299999999999999 111.475 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.77 156.56 39.65 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.499 2.133 . . . . 0.75 111.262 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.7 m -138.88 153.03 71.54 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 125.114 1.366 . . . . 1.8400000000000001 110.148 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.32 -24.7 5.27 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.656 2.904 . . . . 0.79000000000000004 113.337 -167.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -174.99 167.0 3.58 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.621 1.968 . . . . 3.4199999999999999 110.929 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.4 mt -109.6 153.34 24.31 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.526 1.13 . . . . 1.96 110.31 159.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -108.94 143.65 37.91 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.234 1.014 . . . . 1.8600000000000001 109.167 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.7 t -136.88 124.3 14.28 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.386 0.674 . . . . 2.04 110.989 165.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -69.82 164.51 34.33 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.773 2.982 . . . . 1.03 111.643 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.66 147.89 92.49 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.017 2.478 . . . . 1.01 113.301 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.454 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 21.2 mmmt 69.73 -14.04 0.37 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.335 2.654 . . . . 2.8399999999999999 114.219 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.62 172.63 42.9 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.18 1.372 . . . . 1.4199999999999999 113.572 -171.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.68 143.94 35.37 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.89 0.876 . . . . 5.1100000000000003 111.119 168.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.5 t -151.17 158.49 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 127.379 2.272 . . . . 4.9000000000000004 107.213 -168.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.43 152.74 42.91 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 121.075 1.761 . . . . 3.77 114.088 176.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.1 mp -59.95 91.16 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 107.311 -1.366 . . . . 2.0099999999999998 107.311 155.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -49.93 126.0 18.8 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 125.351 1.46 . . . . 4.3700000000000001 111.831 -165.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.427 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 19.7 Cg_endo -60.96 -13.75 29.04 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.878 2.385 . . . . 2.9900000000000002 116.678 -172.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.39 -1.39 29.5 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-N 120.101 1.319 . . . . 2.7200000000000002 115.277 167.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.94 -103.8 1.2 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.359 1.933 . . . . 1.9399999999999999 112.466 -168.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -72.49 139.12 47.45 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.269 -1.136 . . . . 3.21 112.059 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -160.22 149.74 17.72 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.561 1.144 . . . . 0.69999999999999996 110.519 -173.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -83.25 130.09 35.05 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.298 -1.001 . . . . 2.6699999999999999 108.298 165.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -80.04 133.08 36.11 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.279 0.945 . . . . 1.8 108.832 163.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 mp -109.56 126.92 54.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.342 1.057 . . . . 1.8 109.369 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -118.89 130.1 55.55 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 124.227 1.011 . . . . 4.6200000000000001 109.647 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.54 54.74 3.87 Favored Glycine 0 N--CA 1.476 1.363 0 C-N-CA 123.744 0.688 . . . . 0.76000000000000001 114.662 167.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.34 158.68 4.06 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 117.673 2.471 . . . . 2.4900000000000002 117.673 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -116.29 -25.62 7.48 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 113.08 -1.873 . . . . 2.5600000000000001 112.855 -171.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -117.81 151.83 49.2 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 129.48 3.112 . . . . 8.1699999999999999 107.811 159.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.99 140.66 38.52 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.229 1.953 . . . . 2.04 108.611 164.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.6 mp -95.74 89.21 5.23 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.158 0.504 . . . . 3.4700000000000002 110.259 -175.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -75.21 174.16 9.85 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.268 0.556 . . . . 6.04 111.758 167.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.72 146.45 44.41 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.501 -1.296 . . . . 2.2599999999999998 107.501 165.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.32 34.5 63.96 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 117.866 -1.519 . . . . 1.6000000000000001 114.163 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -94.73 174.04 7.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.14 1.47 . . . . 2.6499999999999999 109.185 157.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -135.5 127.77 30.14 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 105.092 -2.188 . . . . 4.3499999999999996 105.092 169.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.7 t -152.45 140.05 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.944 1.298 . . . . 3.25 110.331 -175.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -78.3 154.67 30.69 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 113.394 0.887 . . . . 3.6400000000000001 113.394 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.9 137.36 51.79 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.264 -1.334 . . . . 2.73 110.4 149.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.41 150.6 31.28 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.582 1.153 . . . . 2.5899999999999999 108.611 159.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.0 mp -123.86 127.69 48.39 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.025 1.33 . . . . 1.99 110.209 175.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.3 mt -110.65 114.12 27.26 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.99 1.716 . . . . 2.4399999999999999 110.226 -172.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -113.21 123.59 50.55 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.759 1.224 . . . . 3.2599999999999998 111.613 -172.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 48.01 32.13 2.75 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.308 1.843 . . . . 2.8799999999999999 113.502 176.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.25 -73.96 2.35 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.107 1.337 . . . . 4.9699999999999998 112.689 -172.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.15 -26.36 44.62 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 116.44 1.336 . . . . 2.0699999999999998 116.44 -161.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -83.81 109.46 17.56 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.58 1.69 . . . . 5.8799999999999999 111.716 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.425 HG12 HH12 ' A' ' 36' ' ' ARG . 58.8 t -98.52 134.46 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.399 1.48 . . . . 2.8799999999999999 110.712 174.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -136.68 171.62 14.22 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.811 1.644 . . . . 4.2800000000000002 109.606 166.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -149.6 143.96 25.88 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.786 -1.196 . . . . 2.96 112.007 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.84 150.57 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.137 0.975 . . . . 3.4900000000000002 110.011 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.83 133.51 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.523 1.529 . . . . 2.5 107.641 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.4 mt -139.07 145.58 45.76 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.422 1.089 . . . . 3.7200000000000002 109.918 -173.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.14 162.46 35.61 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.796 2.331 . . . . 0.80000000000000004 112.444 167.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 42.6 t -112.07 122.5 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.189 -1.411 . . . . 2.21 107.189 165.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -146.48 154.54 41.69 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.467 1.507 . . . . 4.4800000000000004 110.391 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.03 141.85 28.4 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.484 0.92 . . . . 2.8799999999999999 113.484 -168.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.976 0 C-N-CA 126.157 1.783 . . . . 9.2599999999999998 112.103 169.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 123.078 1.418 . . . . 6.3700000000000001 112.065 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.98 179.03 21.62 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 121.161 -0.962 . . . . 1.28 111.393 173.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.3 p90 -148.94 157.06 43.14 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.778 0.831 . . . . 2.1400000000000001 112.053 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.2 t -97.56 143.65 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 107.65 -1.241 . . . . 2.4199999999999999 107.65 173.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -73.87 127.27 32.4 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.438 -0.789 . . . . 5.7599999999999998 110.816 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -36.02 148.49 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.675 1.99 . . . . 3.4300000000000002 113.333 155.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.9 t -160.25 146.75 11.96 Favored Pre-proline 0 CA--C 1.536 0.439 0 O-C-N 120.884 -1.135 . . . . 3.04 112.333 166.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -85.89 -6.81 8.52 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.18 2.587 . . . . 2.4300000000000002 112.693 170.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -137.58 -176.58 14.53 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.73 1.157 . . . . 1.1200000000000001 114.423 -172.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.3 -17.92 44.56 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.483 3.455 . . . . 1.8899999999999999 115.097 -169.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -97.85 142.07 30.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.19 1.396 . . . . 3.4700000000000002 112.64 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.14 -176.48 5.69 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.484 1.514 . . . . 2.0099999999999998 111.944 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.21 152.3 32.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.675 1.59 . . . . 1.8500000000000001 109.708 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.08 124.27 47.65 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.09 1.314 . . . . 2.1899999999999999 111.773 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -102.16 57.39 0.81 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.812 1.645 . . . . 4.1299999999999999 109.635 173.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -75.12 162.93 28.08 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.057 0.943 . . . . 3.0899999999999999 113.163 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.0 m -143.58 137.38 28.33 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.892 1.677 . . . . 2.7999999999999998 110.869 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.1 156.52 48.87 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.255 2.222 . . . . 5.7300000000000004 109.018 169.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -84.79 160.89 20.15 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.196 1.362 . . . . 3.9100000000000001 110.507 154.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -97.86 94.33 2.09 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 109.042 -0.725 . . . . 1.8300000000000001 109.042 155.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.98 -6.27 14.96 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.063 2.509 . . . . 1.99 113.433 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.33 164.52 52.53 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-O 122.722 1.179 . . . . 1.76 112.082 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -87.02 -5.89 58.92 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.661 1.584 . . . . 3.7799999999999998 111.742 175.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 pp -116.04 159.13 40.57 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 127.666 2.387 . . . . 3.6200000000000001 111.198 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.01 145.29 22.07 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.576 2.184 . . . . 1.4399999999999999 111.046 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.1 mt -99.33 142.84 30.29 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 123.018 1.39 . . . . 3.48 111.727 170.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.41 ' HD2' ' CD2' ' A' ' 66' ' ' PHE . 16.4 tpp85 -131.47 98.38 4.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 112.119 -2.31 . . . . 3.0499999999999998 109.474 -174.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.9 tp -91.39 109.27 20.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.565 1.546 . . . . 2.8700000000000001 109.691 -171.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.7 m -103.68 -22.07 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.826 0.85 . . . . 1.8100000000000001 112.084 -173.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.88 -177.08 30.65 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.466 1.508 . . . . 0.52000000000000002 114.288 -173.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.35 178.38 8.83 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.8 1.64 . . . . 1.48 112.269 171.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.8 161.08 36.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.54 2.336 . . . . 7.3300000000000001 109.12 174.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 t -176.25 154.08 1.33 Allowed Pre-proline 0 N--CA 1.471 0.6 0 C-N-CA 128.08 2.552 . . . . 1.8799999999999999 107.176 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.16 -20.16 19.27 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.85 1.7 . . . . 1.0 112.499 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.6 m -99.1 35.27 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.799 0.809 . . . . 1.8 112.899 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.14 143.05 16.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.982 1.313 . . . . 1.6299999999999999 109.234 166.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -91.51 -49.42 6.32 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.63 1.572 . . . . 3.8100000000000001 110.592 -176.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.99 160.15 22.53 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.468 1.907 . . . . 7.8200000000000003 107.665 167.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.1 p -142.52 145.45 23.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 126.067 1.747 . . . . 2.1499999999999999 108.049 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -129.47 148.74 51.41 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.057 1.743 . . . . 3.0600000000000001 108.771 174.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.5 tp -101.16 121.28 41.54 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.349 -0.845 . . . . 1.97 109.911 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.1 m170 -123.61 154.28 39.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.436 1.494 . . . . 0.62 113.871 -174.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.402 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 9.0 pt-20 -100.68 179.8 4.31 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.341 1.456 . . . . 2.1499999999999999 112.098 162.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.5 m -145.63 128.44 16.32 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 106.665 -1.606 . . . . 1.72 106.665 172.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -129.16 167.96 16.84 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 114.357 1.243 . . . . 3.6400000000000001 114.357 -166.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -109.2 147.6 32.28 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.864 1.666 . . . . 5.7699999999999996 110.994 171.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.55 151.76 24.69 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.776 0.83 . . . . 5.9299999999999997 112.004 -174.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -103.72 143.29 32.99 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.702 1.601 . . . . 2.2599999999999998 109.671 167.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -158.99 139.97 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.613 1.165 . . . . 4.1900000000000004 108.336 167.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 62.25 27.17 16.29 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.334 1.053 . . . . 3.4500000000000002 111.844 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.99 18.2 78.99 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 120.912 -1.118 . . . . 1.6899999999999999 113.605 -175.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -132.48 129.33 39.04 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.046 1.338 . . . . 3.4900000000000002 110.179 -174.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.547 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -71.29 130.09 40.51 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.311 2.244 . . . . 4.6399999999999997 111.315 173.493 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.1 m -141.43 175.12 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 129.171 2.988 . . . . 3.2599999999999998 110.235 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.25 162.9 21.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.079 1.351 . . . . 4.5199999999999996 111.172 177.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.3 -178.14 29.25 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.089 1.328 . . . . 0.53000000000000003 113.704 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.3 ttm -154.82 148.49 25.39 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.507 1.923 . . . . 1.6000000000000001 108.286 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.402 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 17.0 ptt180 -160.43 156.4 22.64 Favored Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 124.814 1.246 . . . . 6.6600000000000001 110.471 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.64 155.44 44.68 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.254 1.969 . . . . 0.63 111.519 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.99 154.72 70.76 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.655 1.582 . . . . 1.9399999999999999 110.156 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.69 -24.49 3.44 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.178 2.585 . . . . 0.63 113.367 -167.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.41 ' CD2' ' HD2' ' A' ' 31' ' ' ARG . 50.6 p90 -178.24 163.05 1.61 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.334 1.853 . . . . 3.1800000000000002 111.073 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.1 mt -109.6 153.01 24.78 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.006 1.323 . . . . 1.8899999999999999 110.377 166.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CD ' ' HE ' ' A' ' 31' ' ' ARG . 3.5 tp10 -121.39 137.33 54.75 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.288 1.435 . . . . 2.0899999999999999 109.194 177.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.9 t -140.32 130.99 13.89 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 123.667 0.787 . . . . 2.5299999999999998 111.544 175.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.3 163.76 37.53 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.356 2.704 . . . . 1.3100000000000001 112.39 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -60.03 140.36 92.25 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.42 2.747 . . . . 1.55 111.012 171.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp 65.78 0.75 1.6 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.137 1.375 . . . . 4.5599999999999996 113.374 -175.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.11 -175.18 41.9 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.225 1.869 . . . . 1.77 109.907 163.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -139.19 138.45 36.91 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.712 -0.876 . . . . 8.6600000000000001 112.865 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -93.04 57.23 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 128.189 2.595 . . . . 6.21 108.43 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.4 125.3 30.24 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.136 0.974 . . . . 3.6099999999999999 108.859 163.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 mp -72.48 -53.94 10.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.162 -0.472 . . . . 3.1400000000000001 110.477 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.314 0.0 OUTLIER 79.94 123.55 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.081 0 C-N-CA 128.157 2.583 . . . . 4.29 114.228 176.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.41 -15.19 48.68 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.065 2.51 . . . . 2.1600000000000001 113.9 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.86 5.12 84.86 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 117.073 -1.959 . . . . 1.53 114.745 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.49 -24.14 0.02 OUTLIER Glycine 0 C--N 1.348 1.23 0 N-CA-C 121.596 3.398 . . . . 2.0699999999999998 121.596 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -145.77 147.62 32.09 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.022 1.911 . . . . 3.4700000000000002 113.215 171.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -162.18 155.41 20.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.12 0.968 . . . . 0.71999999999999997 110.889 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -80.32 137.16 36.55 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.108 0.867 . . . . 2.9199999999999999 109.119 158.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.8 tpt -85.21 129.73 34.75 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.881 1.272 . . . . 1.6599999999999999 108.43 162.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -111.62 126.41 54.98 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.466 1.107 . . . . 1.8700000000000001 108.866 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.96 128.63 55.91 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.243 1.017 . . . . 3.96 109.432 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.48 44.48 10.91 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 118.561 -1.133 . . . . 0.94999999999999996 114.834 169.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -43.52 149.82 0.25 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 117.734 2.494 . . . . 2.3700000000000001 117.734 176.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -115.82 -22.56 9.04 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 114.19 -1.368 . . . . 3.8900000000000001 114.526 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -91.38 168.62 13.05 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 107.553 -1.277 . . . . 6.6500000000000004 107.553 149.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -63.38 177.93 1.41 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 121.153 1.236 . . . . 3.1400000000000001 109.907 148.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.0 mt -129.13 95.08 3.96 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.135 -0.978 . . . . 3.48 109.314 167.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -99.33 159.44 15.0 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.967 0.889 . . . . 6.6699999999999999 112.829 176.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.74 130.62 44.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.275 -1.329 . . . . 2.3399999999999999 107.915 159.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.92 0.68 83.23 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.484 1.992 . . . . 1.4399999999999999 116.797 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -81.48 -171.46 3.31 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.482 2.141 . . . . 2.6600000000000001 113.312 175.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -152.51 124.98 8.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 128.62 2.768 . . . . 5.0099999999999998 105.899 -155.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 38.1 t -144.02 125.34 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 O-C-N 121.578 -0.701 . . . . 2.3999999999999999 110.333 -173.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -79.56 151.21 30.8 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.497 -0.774 . . . . 3.0299999999999998 111.325 168.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.23 147.22 34.5 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.828 2.051 . . . . 2.9500000000000002 110.793 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -121.53 108.0 13.09 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 128.946 2.898 . . . . 2.2000000000000002 108.312 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.0 mp -83.98 128.09 34.31 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.355 -0.84 . . . . 2.1400000000000001 110.584 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.6 mt -97.82 103.41 15.35 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.362 1.065 . . . . 1.79 110.557 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -98.02 143.11 28.93 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.675 1.19 . . . . 3.52 111.435 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.64 131.69 39.39 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.282 1.033 . . . . 2.4199999999999999 112.421 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.18 41.93 7.27 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.801 -0.999 . . . . 2.9500000000000002 113.938 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.16 7.21 88.61 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 116.018 1.167 . . . . 2.1299999999999999 116.018 165.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -90.43 112.62 24.31 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.963 1.382 . . . . 4.1699999999999999 111.382 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.13 134.15 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.917 1.287 . . . . 3.2999999999999998 109.999 173.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.0 tp -128.49 111.01 12.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.776 0.83 . . . . 2.8500000000000001 111.465 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -81.76 135.16 35.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.417 0.687 . . . . 3.1000000000000001 112.354 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.7 m -144.84 162.2 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 127.458 2.303 . . . . 3.23 111.019 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.2 t -131.91 132.45 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.625 0.77 . . . . 2.77 109.881 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.89 153.69 64.54 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 126.251 1.82 . . . . 2.9300000000000002 110.142 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.04 167.11 27.62 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.674 2.916 . . . . 0.73999999999999999 112.278 175.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.85 135.29 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.786 1.234 . . . . 2.1099999999999999 109.358 167.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -150.26 165.45 32.92 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 115.991 1.849 . . . . 4.2999999999999998 115.991 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.14 149.55 27.91 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 116.963 2.209 . . . . 2.6099999999999999 116.963 -159.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.186 1 C-N-CA 134.05 4.94 . . . . 9.3200000000000003 108.462 161.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 107.947 -1.131 . . . . 7.0599999999999996 107.947 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.85 164.24 31.23 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 123.541 0.591 . . . . 1.9399999999999999 111.961 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -108.36 168.58 9.21 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.147 0.979 . . . . 2.46 112.206 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.8 t -90.88 131.52 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.083 0.953 . . . . 2.46 109.011 167.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 107.67 11.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.972 0.909 . . . . 5.7800000000000002 108.828 171.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -42.78 149.69 0.18 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.317 1.847 . . . . 2.9199999999999999 114.806 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.6 t -152.51 151.56 27.31 Favored Pre-proline 0 CA--C 1.538 0.492 0 O-C-N 121.132 -0.98 . . . . 3.5299999999999998 111.08 163.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -88.32 -2.66 6.88 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.429 2.753 . . . . 2.3100000000000001 111.968 164.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.7 -179.38 20.0 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.929 1.252 . . . . 1.3700000000000001 114.716 -170.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.81 -17.21 37.46 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.635 3.556 . . . . 1.7 114.635 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -110.28 153.9 24.2 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.495 1.518 . . . . 2.4900000000000002 113.738 172.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.39 -178.47 6.68 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 128.132 2.573 . . . . 1.8500000000000001 110.647 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.13 152.74 36.65 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.338 1.455 . . . . 1.72 110.448 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.62 146.61 36.42 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.239 1.2 . . . . 1.6599999999999999 114.239 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -117.51 29.74 7.69 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 115.663 1.727 . . . . 4.3200000000000003 115.663 -167.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -49.74 161.88 0.2 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 117.876 2.547 . . . . 2.8599999999999999 117.876 -169.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 15.8 m -79.64 119.81 23.1 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.448 0.642 . . . . 3.1699999999999999 111.589 172.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.35 139.24 33.14 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.55 -0.907 . . . . 4.5499999999999998 108.55 164.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -147.39 172.45 13.9 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.368 0.667 . . . . 6.1500000000000004 111.551 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -155.71 110.38 2.17 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.338 1.455 . . . . 1.3799999999999999 110.74 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.7 -5.82 4.39 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.844 3.03 . . . . 1.5900000000000001 114.292 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.99 178.23 41.99 Favored Glycine 0 C--N 1.341 0.818 0 CA-C-N 119.55 1.068 . . . . 1.1799999999999999 112.956 -174.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -101.25 3.2 40.66 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.408 2.283 . . . . 3.29 112.323 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -118.74 160.21 41.27 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 127.116 2.166 . . . . 2.8999999999999999 110.254 171.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.75 142.26 15.87 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.344 2.03 . . . . 1.1599999999999999 111.422 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -102.95 157.11 17.2 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.359 1.464 . . . . 3.77 111.975 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -152.99 104.54 2.84 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.02 -1.446 . . . . 3.3100000000000001 111.649 -169.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.2 tt -83.03 123.64 29.67 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.702 1.201 . . . . 3.4100000000000001 108.61 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 m -110.91 -15.12 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.665 0.786 . . . . 1.97 111.662 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.48 -177.12 30.28 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 125.6 1.571 . . . . 0.52000000000000002 114.051 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.9 -179.55 7.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.46 1.504 . . . . 1.8300000000000001 111.699 171.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -155.92 173.26 17.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.605 2.362 . . . . 7.7800000000000002 109.212 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 t 178.54 146.75 0.36 Allowed Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 129.106 2.963 . . . . 1.8300000000000001 106.87 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.0 -15.62 36.26 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 121.736 1.624 . . . . 1.49 113.544 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.0 22.17 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.609 1.164 . . . . 1.9099999999999999 113.288 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.75 138.47 28.83 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.786 1.176 . . . . 1.55 110.382 169.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -83.21 -41.03 18.88 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.007 0.923 . . . . 3.8100000000000001 111.062 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -131.16 152.84 50.03 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 128.537 2.735 . . . . 7.7400000000000002 106.396 -175.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.6 p -146.57 146.27 18.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 124.555 1.142 . . . . 2.0699999999999998 108.772 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -132.36 145.36 51.19 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.97 1.708 . . . . 3.1200000000000001 108.841 175.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.4 tp -99.63 118.79 36.93 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.809 -0.557 . . . . 2.2799999999999998 109.639 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.0 m170 -122.53 154.12 38.31 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.245 1.418 . . . . 0.63 114.068 -174.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -102.04 163.66 12.12 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.354 -1.294 . . . . 2.3100000000000001 111.622 161.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.4 m -120.88 130.63 53.99 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 105.906 -1.887 . . . . 1.8700000000000001 105.906 163.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -127.37 168.52 14.71 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.518 1.303 . . . . 3.4900000000000002 114.518 -170.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -109.49 148.21 31.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.853 1.661 . . . . 5.7300000000000004 111.425 170.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.58 148.48 24.37 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.414 1.086 . . . . 5.7999999999999998 110.56 -174.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -98.53 140.02 33.39 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.564 1.145 . . . . 2.9300000000000002 109.895 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.1 t -137.81 118.41 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.353 1.061 . . . . 3.23 108.241 168.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 66.49 15.14 10.02 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 126.191 1.796 . . . . 4.1299999999999999 114.85 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.6 21.64 55.7 Favored Glycine 0 CA--C 1.535 1.32 0 O-C-N 121.356 -0.84 . . . . 2.5800000000000001 112.943 -166.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.5 mttt -124.53 113.53 18.22 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.604 1.562 . . . . 4.2599999999999998 109.133 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.8 123.01 28.94 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.604 -0.685 . . . . 6.75 110.519 -171.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.29 179.76 3.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 128.451 2.7 . . . . 3.7999999999999998 110.764 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.83 162.56 31.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.88 1.272 . . . . 3.5 111.862 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.35 -176.54 27.65 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.53 1.538 . . . . 0.64000000000000001 113.662 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.0 ttm -150.8 148.02 27.99 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.195 1.798 . . . . 2.1099999999999999 108.873 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -158.65 157.34 28.49 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 124.659 1.184 . . . . 6.7400000000000002 111.131 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.99 154.77 53.04 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.011 1.807 . . . . 0.72999999999999998 111.699 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.45 156.5 74.99 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 126.283 1.833 . . . . 2.0499999999999998 110.091 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.44 -26.76 3.09 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.023 2.482 . . . . 0.68000000000000005 113.371 -167.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -175.3 164.68 3.24 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.501 1.521 . . . . 3.48 111.231 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.4 mt -113.33 153.92 27.7 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.897 1.679 . . . . 2.0 110.119 164.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -136.34 147.99 47.68 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.355 0.662 . . . . 2.2599999999999998 111.836 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.0 t -141.56 131.47 12.79 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.161 0.985 . . . . 1.8 112.366 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -69.97 161.98 43.9 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.742 2.962 . . . . 0.97999999999999998 111.704 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.24 140.91 81.64 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.598 2.866 . . . . 1.03 113.517 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp 66.94 2.88 2.85 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.476 1.91 . . . . 2.8500000000000001 114.552 176.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.78 160.31 31.16 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.843 1.687 . . . . 1.2 114.24 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.19 146.04 33.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.333 1.053 . . . . 4.8799999999999999 110.85 168.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.2 t -155.81 132.92 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 125.491 1.516 . . . . 5.2999999999999998 108.642 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 2.8 mp0 -83.21 141.66 31.74 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.137 1.335 . . . . 3.7400000000000002 111.102 176.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mp -46.49 -43.57 16.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.989 1.316 . . . . 2.9399999999999999 112.007 -177.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 108.13 128.56 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 128.019 2.528 . . . . 4.71 111.019 158.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -59.98 116.16 3.12 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 N-CA-C 107.463 -1.783 . . . . 2.7000000000000002 107.463 165.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.78 26.07 59.27 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 116.98 -2.011 . . . . 3.29 116.463 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.58 -42.74 0.04 OUTLIER Glycine 0 N--CA 1.482 1.729 0 N-CA-C 119.252 2.461 . . . . 1.79 119.252 166.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -137.2 145.94 44.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.745 1.26 . . . . 3.1299999999999999 110.753 160.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -160.56 153.02 20.67 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.176 -0.953 . . . . 0.81999999999999995 109.339 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -78.72 151.02 32.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.82 -0.807 . . . . 3.8199999999999998 108.82 162.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.3 tpt -101.0 129.42 46.84 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.912 1.685 . . . . 1.8999999999999999 107.391 159.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.84 137.62 49.55 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.671 1.188 . . . . 1.8300000000000001 108.479 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -139.44 146.61 40.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.516 1.127 . . . . 3.5800000000000001 112.69 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.78 26.94 68.05 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.464 1.03 . . . . 1.3300000000000001 113.728 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.5 148.12 2.99 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 117.07 2.248 . . . . 2.5299999999999998 117.07 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -120.7 2.48 10.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 112.065 -2.334 . . . . 3.0 113.494 -165.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -145.25 144.51 23.55 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 127.094 2.158 . . . . 7.0499999999999998 108.22 164.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.07 158.3 45.81 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.111 2.541 . . . . 1.74 110.343 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -106.18 99.55 9.13 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.973 1.709 . . . . 3.7599999999999998 109.294 -169.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.91 132.69 35.15 Favored 'General case' 0 C--N 1.332 -0.155 0 O-C-N 120.446 -1.409 . . . . 4.9400000000000004 112.423 175.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.7 115.55 1.69 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 113.923 -1.49 . . . . 2.8700000000000001 109.889 169.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.92 -3.74 45.26 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 117.673 -1.626 . . . . 1.8799999999999999 115.736 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -76.41 -178.58 4.69 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 120.242 2.021 . . . . 2.7599999999999998 111.661 167.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -140.66 139.05 34.74 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 129.236 3.014 . . . . 3.5299999999999998 105.535 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.66 126.63 44.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 126.616 1.966 . . . . 1.97 108.504 -173.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -78.29 139.6 38.86 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.836 0.826 . . . . 3.8199999999999998 111.857 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.38 146.47 39.42 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.125 1.37 . . . . 4.3099999999999996 109.321 163.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -102.46 139.23 38.33 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.04 2.536 . . . . 2.6400000000000001 108.859 171.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.2 mp -109.37 138.06 46.3 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.592 1.557 . . . . 1.9399999999999999 110.395 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.4 mt -112.14 110.06 20.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.687 1.195 . . . . 1.75 110.917 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -107.62 151.8 25.15 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.359 1.464 . . . . 3.3500000000000001 112.505 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.82 114.61 1.47 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.899 1.28 . . . . 2.0699999999999998 113.538 -174.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.42 69.32 1.4 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.928 1.252 . . . . 2.8100000000000001 112.965 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.28 7.92 73.58 Favored Glycine 0 N--CA 1.476 1.311 0 N-CA-C 116.291 1.277 . . . . 2.02 116.291 164.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -96.56 125.98 41.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.861 1.331 . . . . 4.1600000000000001 111.309 -171.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.99 141.98 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 124.297 0.998 . . . . 2.8999999999999999 110.893 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.3 tp -140.59 159.8 41.41 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.491 2.316 . . . . 3.0299999999999998 108.6 177.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -132.83 145.18 50.74 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.983 0.913 . . . . 3.2400000000000002 111.992 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.12 160.31 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 127.299 2.24 . . . . 3.5600000000000001 110.836 -172.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.2 t -130.03 94.62 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.034 0.921 . . . . 3.5499999999999998 110.618 -158.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.8 mt -98.55 123.78 48.84 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-O 118.062 -0.971 . . . . 3.4100000000000001 111.051 -168.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.13 153.98 73.52 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.11 1.873 . . . . 0.97999999999999998 111.041 170.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 90.1 t -92.99 121.09 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.305 0.642 . . . . 2.5 109.986 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -117.78 135.82 53.8 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.372 1.069 . . . . 3.4900000000000002 110.59 167.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.93 57.46 4.34 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.202 -0.936 . . . . 4.0899999999999999 112.74 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.335 0 CA-C-O 115.926 -1.988 . . . . 8.0500000000000007 112.605 -171.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.475 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 3.6 tt0 . . . . . 0 CA--C 1.542 0.663 0 N-CA-C 108.019 -1.104 . . . . 5.8399999999999999 108.019 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.475 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -99.29 176.01 28.74 Favored Glycine 0 CA--C 1.527 0.793 0 O-C-N 121.324 -0.86 . . . . 1.5900000000000001 112.385 169.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -157.64 172.08 19.18 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.53 1.132 . . . . 2.3799999999999999 112.073 154.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.2 t -105.53 139.02 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.534 1.133 . . . . 2.4399999999999999 109.323 172.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.0 ttp85 -60.47 -35.36 75.7 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.882 1.067 . . . . 4.6200000000000001 113.882 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.2 t80 64.89 158.95 0.1 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.79 2.036 . . . . 4.7199999999999998 110.343 -157.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 m -166.07 147.65 5.92 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 126.195 1.798 . . . . 3.5699999999999998 109.017 162.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -83.58 49.74 3.01 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.591 3.527 . . . . 2.9399999999999999 111.682 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.17 179.09 25.31 Favored Glycine 0 CA--C 1.537 1.423 0 N-CA-C 115.892 1.117 . . . . 1.29 115.892 -171.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.92 -20.15 19.91 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 124.073 3.182 . . . . 1.52 112.52 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -112.09 145.92 38.89 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.413 1.885 . . . . 3.0699999999999998 113.646 173.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -131.28 -177.68 4.5 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.637 1.975 . . . . 1.8700000000000001 110.802 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.54 148.65 31.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.771 1.228 . . . . 1.48 110.417 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.03 150.91 49.38 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.385 1.254 . . . . 1.8400000000000001 114.385 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -127.3 52.61 1.8 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.838 2.055 . . . . 3.75 111.43 -165.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.35 162.14 25.92 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.367 1.247 . . . . 3.1600000000000001 114.367 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.06 124.3 29.7 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.389 1.076 . . . . 4.9500000000000002 110.847 166.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.73 119.84 29.58 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.624 -1.621 . . . . 4.8700000000000001 106.624 163.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -135.87 144.02 45.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.028 0.918 . . . . 4.2300000000000004 113.12 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -120.76 90.31 46.2 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 114.507 -1.224 . . . . 1.73 110.821 -172.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.56 -7.94 20.94 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.341 2.027 . . . . 2.2599999999999998 112.886 172.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.15 -178.11 51.52 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 122.407 1.004 . . . . 1.8200000000000001 112.858 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.436 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.4 m-20 -111.5 -1.57 15.81 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.223 2.209 . . . . 4.0300000000000002 111.83 -167.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -132.58 159.89 70.57 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 128.415 2.686 . . . . 3.3399999999999999 109.339 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.45 156.87 57.68 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.434 2.089 . . . . 0.85999999999999999 111.879 -167.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mp -114.38 152.9 30.77 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.606 1.562 . . . . 3.8999999999999999 110.181 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -141.79 106.29 4.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 112.665 -2.061 . . . . 2.8900000000000001 110.969 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.5 tp -90.14 109.17 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.083 1.353 . . . . 2.9199999999999999 109.194 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 m -104.27 -18.37 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.041 0.937 . . . . 1.8799999999999999 111.692 -173.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.63 -177.78 29.2 Favored Glycine 0 C--N 1.344 0.997 0 C-N-CA 125.951 1.739 . . . . 0.58999999999999997 113.02 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.57 178.29 7.88 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.4 1.48 . . . . 1.9399999999999999 110.687 171.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -158.6 150.31 21.11 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.851 2.06 . . . . 5.7699999999999996 108.261 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -162.31 148.84 10.79 Favored Pre-proline 0 N--CA 1.478 0.937 0 O-C-N 120.984 -1.073 . . . . 1.8600000000000001 109.34 -171.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.46 -1.25 10.77 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.634 2.89 . . . . 0.76000000000000001 114.62 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.6 m -134.36 47.46 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 125.089 1.355 . . . . 1.9099999999999999 112.676 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.87 178.78 9.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.242 1.417 . . . . 1.78 109.97 162.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -127.45 -34.04 2.29 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.774 1.63 . . . . 3.8300000000000001 112.01 168.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -121.26 149.78 42.36 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 106.567 -1.642 . . . . 7.0800000000000001 106.567 172.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.51 141.64 18.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 125.014 1.326 . . . . 1.96 110.005 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -134.52 147.54 50.34 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.601 1.96 . . . . 3.2200000000000002 109.068 -173.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.7 tp -101.73 120.79 40.91 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.547 -0.721 . . . . 2.3599999999999999 109.842 175.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.5 m170 -121.26 150.09 41.9 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 123.486 1.612 . . . . 0.64000000000000001 114.447 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.443 ' C ' ' HG1' ' A' ' 48' ' ' THR . 17.7 pt-20 -96.0 173.5 7.4 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 113.275 -1.784 . . . . 2.3500000000000001 111.218 162.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.443 ' HG1' ' C ' ' A' ' 47' ' ' GLU . 63.2 m -150.39 146.64 26.82 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 106.453 -1.684 . . . . 1.8999999999999999 106.453 173.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -161.72 171.46 17.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.959 0.885 . . . . 3.2000000000000002 113.378 -167.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.0 ttp -105.11 142.05 35.57 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.134 1.774 . . . . 4.1900000000000004 110.453 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -157.36 151.02 24.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.228 1.411 . . . . 9.5999999999999996 112.73 -173.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.47 133.38 35.39 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.494 0.718 . . . . 2.9199999999999999 111.222 172.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t -141.82 134.79 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 105.443 -2.058 . . . . 3.0699999999999998 105.443 162.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 70.93 4.17 4.95 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.39 1.876 . . . . 4.4900000000000002 114.255 -170.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.21 22.86 69.9 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 121.473 -0.767 . . . . 1.76 113.109 -163.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -124.48 131.33 53.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.612 1.965 . . . . 4.6600000000000001 109.76 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.89 92.63 1.27 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.495 1.118 . . . . 7.5700000000000003 112.591 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.4 m -94.49 -174.94 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 127.177 2.191 . . . . 3.5699999999999998 109.47 171.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -117.7 167.81 11.02 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.36 0.664 . . . . 3.8399999999999999 111.937 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.46 169.63 31.64 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 125.683 1.611 . . . . 0.68999999999999995 112.28 -176.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ttm -149.16 147.43 28.43 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.71 2.004 . . . . 1.55 107.971 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -148.33 153.69 41.04 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 125.966 1.707 . . . . 6.6900000000000004 108.88 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.06 154.55 42.29 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 121.69 1.593 . . . . 0.67000000000000004 110.352 164.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 m -137.11 154.77 76.1 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 125.34 1.456 . . . . 1.9099999999999999 109.87 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.2 -27.03 4.69 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.58 2.186 . . . . 0.83999999999999997 112.745 -166.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -175.17 168.37 3.39 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.363 1.465 . . . . 3.3399999999999999 111.98 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.7 mt -111.13 153.72 25.33 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.276 1.431 . . . . 2.1600000000000001 110.871 161.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -124.88 141.4 52.14 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.861 1.664 . . . . 2.21 110.043 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.0 t -146.52 134.69 10.7 Favored Pre-proline 0 N--CA 1.482 1.151 0 N-CA-C 113.426 0.899 . . . . 1.8999999999999999 113.426 173.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.74 163.36 39.33 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 124.443 3.429 . . . . 1.3600000000000001 113.558 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.02 145.06 78.39 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.86 3.04 . . . . 1.6699999999999999 114.18 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.436 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 70.0 mmtt 69.21 -5.1 1.14 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.08 2.552 . . . . 3.6099999999999999 114.657 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.03 168.4 34.0 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.411 1.482 . . . . 1.8999999999999999 113.243 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -144.24 148.95 35.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.713 0.805 . . . . 7.4900000000000002 112.231 162.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.9 t -155.71 100.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.456 1.902 . . . . 4.7400000000000002 108.631 -168.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.89 171.55 15.03 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 121.876 0.846 . . . . 3.6800000000000002 112.236 -169.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 mp -82.56 70.02 9.44 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.152 -1.592 . . . . 2.0499999999999998 110.133 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -36.6 119.86 0.76 Allowed Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 127.167 2.187 . . . . 4.9699999999999998 113.307 172.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.99 -9.36 22.12 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.817 3.012 . . . . 2.29 115.635 -154.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.33 -2.16 55.68 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 117.836 -1.536 . . . . 1.8999999999999999 114.34 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.68 -17.47 0.49 Allowed Glycine 0 N--CA 1.479 1.542 0 CA-C-N 119.946 1.873 . . . . 1.98 117.776 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -145.12 145.03 31.23 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.128 1.464 . . . . 3.6800000000000002 112.24 170.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -161.31 155.59 22.76 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.598 1.559 . . . . 0.92000000000000004 109.941 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -79.45 150.97 31.1 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.259 -0.901 . . . . 3.9399999999999999 108.862 157.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.6 tpt -100.12 130.84 46.31 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.11 1.764 . . . . 1.48 108.335 162.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.8 mp -116.01 135.54 53.86 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.388 1.475 . . . . 1.8 108.32 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mp -135.78 146.02 47.15 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.747 0.703 . . . . 2.6400000000000001 111.633 -176.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.66 40.23 32.41 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.306 -0.719 . . . . 1.02 113.225 172.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.23 148.31 3.6 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 115.799 1.778 . . . . 2.4100000000000001 115.799 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -104.05 -4.52 23.16 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.481 -1.691 . . . . 3.1699999999999999 113.592 -170.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -146.63 156.09 48.74 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.92 2.088 . . . . 7.6799999999999997 109.112 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -67.38 163.73 33.43 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.853 1.702 . . . . 2.2799999999999998 109.022 153.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 pp -160.86 152.1 19.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.575 1.55 . . . . 3.3700000000000001 108.298 -172.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -147.79 168.31 22.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 123.123 1.44 . . . . 5.5700000000000003 114.715 -174.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.43 135.34 56.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.053 -0.976 . . . . 2.21 111.212 172.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.83 -1.14 74.3 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.72 1.629 . . . . 2.0699999999999998 114.365 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -85.76 -176.91 6.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.869 1.335 . . . . 2.5 112.244 171.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -138.44 140.0 39.09 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 129.459 3.104 . . . . 3.5499999999999998 105.768 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.3 t -141.06 133.36 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.216 1.806 . . . . 2.04 109.773 -172.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -95.58 158.01 15.64 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 122.491 1.139 . . . . 2.3999999999999999 113.478 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.17 151.8 31.47 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.964 1.305 . . . . 4.6600000000000001 112.841 169.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.64 137.12 36.2 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 127.26 2.224 . . . . 2.5600000000000001 109.516 169.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.21 133.94 37.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.804 1.641 . . . . 2.3100000000000001 109.113 170.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 56.3 mt -106.2 104.65 14.39 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.732 1.213 . . . . 2.1699999999999999 108.934 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -91.97 163.37 14.03 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.562 0.696 . . . . 3.3999999999999999 111.484 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.54 117.69 5.18 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.934 -0.479 . . . . 2.2000000000000002 110.947 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.67 -135.94 16.73 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.835 0.731 . . . . 3.23 112.204 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.57 41.74 2.86 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.426 1.012 . . . . 2.9100000000000001 115.481 -165.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -134.48 123.22 23.62 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.441 1.62 . . . . 4.7300000000000004 112.085 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.3 t -136.64 138.56 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.806 1.642 . . . . 3.54 107.677 168.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.9 tp -159.14 133.45 7.76 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.488 1.115 . . . . 3.54 111.581 -170.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -98.1 149.0 22.97 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.631 1.715 . . . . 3.2999999999999998 115.631 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.9 t -125.0 165.88 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 129.237 3.015 . . . . 3.0699999999999998 107.994 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 t -142.18 142.36 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.247 1.819 . . . . 3.0 107.832 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.01 159.48 30.27 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 114.134 1.161 . . . . 3.9199999999999999 114.134 -173.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -77.81 160.58 30.84 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.1 3.2 . . . . 0.91000000000000003 114.671 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.0 t -103.61 130.1 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.525 1.53 . . . . 2.0899999999999999 110.829 171.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.427 ' CD ' ' HE ' ' A' ' 120' ' ' ARG . 11.8 pt-20 -95.21 -172.52 2.69 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.621 1.968 . . . . 5.9699999999999998 111.432 172.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -126.41 117.66 23.4 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.712 -1.243 . . . . 2.7999999999999998 112.014 154.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.427 ' HE ' ' CD ' ' A' ' 118' ' ' GLU . 42.4 mtm180 . . . . . 0 C--O 1.248 1.008 0 C-N-CA 126.781 2.033 . . . . 8.6799999999999997 111.5 161.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 . . . . . 0 CA--C 1.547 0.836 0 CA-C-O 119.173 -0.441 . . . . 5.1600000000000001 110.416 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.49 175.83 17.37 Favored Glycine 0 N--CA 1.473 1.155 0 N-CA-C 116.87 1.508 . . . . 1.1699999999999999 116.87 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -151.35 142.91 23.58 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.389 2.275 . . . . 2.0699999999999998 110.966 169.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.7 t -94.4 141.72 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 120.448 -1.407 . . . . 2.3700000000000001 109.773 175.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.0 ttm-85 -73.12 118.13 15.7 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.514 0.726 . . . . 7.0700000000000003 111.567 -172.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -68.19 138.51 55.68 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.534 -0.729 . . . . 4.0700000000000003 110.558 159.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -167.72 149.75 5.27 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.703 1.601 . . . . 4.1900000000000004 109.977 164.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -82.03 47.93 2.66 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 125.216 3.944 . . . . 3.2799999999999998 111.756 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.34 158.52 20.49 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.872 1.701 . . . . 1.8400000000000001 112.605 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.36 -19.08 33.72 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.729 2.953 . . . . 1.6200000000000001 112.822 174.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -106.96 160.74 15.3 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.213 1.805 . . . . 2.96 112.908 167.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.34 -173.58 4.61 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.686 2.795 . . . . 1.7 110.287 -176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.48 160.29 41.82 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.348 1.459 . . . . 1.8999999999999999 109.821 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.32 137.5 53.49 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.71 1.141 . . . . 2.0099999999999998 112.976 174.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 79' ' ' PRO . 61.7 m-85 -113.06 138.72 49.48 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.691 1.996 . . . . 3.98 110.032 172.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.267 0.0 OUTLIER -165.99 145.14 6.06 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.528 1.307 . . . . 3.9700000000000002 114.528 177.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.3 m -80.98 130.09 34.85 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.345 1.058 . . . . 2.8100000000000001 109.536 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.4 tp -119.09 142.37 47.94 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.319 1.848 . . . . 4.0300000000000002 109.843 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -128.13 149.71 50.3 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.751 1.22 . . . . 3.52 110.966 170.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -103.9 102.01 28.73 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.07 0.948 . . . . 1.4399999999999999 109.459 169.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.76 -10.19 19.93 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.495 2.13 . . . . 1.1100000000000001 113.359 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.59 178.61 53.29 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-O 122.76 1.2 . . . . 1.1200000000000001 113.018 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.418 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 6.7 m-20 -105.44 -3.65 22.31 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.818 2.447 . . . . 2.7799999999999998 111.659 -174.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -121.2 156.27 57.55 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 127.9 2.48 . . . . 2.6899999999999999 109.501 173.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.86 151.77 24.66 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.922 2.414 . . . . 0.93000000000000005 111.992 -169.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.2 mt -104.57 146.99 28.12 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.154 0.982 . . . . 2.52 111.101 169.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.415 HH21 ' CD ' ' A' ' 68' ' ' GLU . 37.2 ttm180 -134.09 111.67 10.54 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.01 -1.45 . . . . 2.8100000000000001 110.788 175.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -92.23 106.95 18.85 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 127.555 2.342 . . . . 3.77 109.974 -173.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -107.26 -17.92 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.729 1.211 . . . . 1.75 111.765 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.66 -175.24 29.37 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 125.726 1.631 . . . . 0.65000000000000002 114.33 -175.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -157.05 -177.34 6.54 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.197 1.399 . . . . 1.6399999999999999 112.681 177.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -154.48 165.43 36.46 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 127.434 2.294 . . . . 5.4299999999999997 107.309 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 t -169.15 147.29 3.27 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 125.509 1.524 . . . . 1.6799999999999999 107.426 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.59 -17.42 38.35 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.31 1.34 . . . . 1.1799999999999999 111.865 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.6 m -111.17 40.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.185 1.394 . . . . 2.25 113.258 -172.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.78 169.29 23.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.411 1.084 . . . . 1.8 110.588 167.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -108.55 -63.14 1.37 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.454 1.502 . . . . 4.0300000000000002 107.304 164.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -84.34 124.1 30.91 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 121.502 -0.749 . . . . 8.2400000000000002 109.054 166.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.6 p -94.64 158.21 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.796 -1.093 . . . . 1.8799999999999999 108.696 149.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.39 157.13 42.01 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.86 2.464 . . . . 4.2699999999999996 107.446 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.6 tp -124.67 112.98 17.4 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.926 1.239 . . . . 2.0299999999999998 112.17 -171.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.2 m170 -122.18 158.01 30.31 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 123.476 1.608 . . . . 0.70999999999999996 114.661 -171.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.69 -176.42 3.26 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.463 1.905 . . . . 3.1400000000000001 111.297 159.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -156.75 145.01 19.61 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.123 1.769 . . . . 1.74 106.798 167.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -153.13 -177.63 6.43 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.103 0.961 . . . . 3.25 113.003 -165.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -118.89 143.32 47.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.131 1.772 . . . . 4.9699999999999998 111.446 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -154.78 160.33 41.22 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.401 1.88 . . . . 5.5300000000000002 110.145 -172.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -116.57 142.61 46.66 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.883 1.673 . . . . 2.9100000000000001 110.526 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.269 1.3 t -95.73 -126.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 107.753 -1.203 . . . . 3.5 107.753 161.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -70.67 44.26 0.08 Allowed 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 125.792 1.637 . . . . 2.9500000000000002 114.81 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.06 18.15 80.19 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 120.271 -1.518 . . . . 1.95 111.738 -160.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -96.28 106.04 18.2 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 121.997 -0.707 . . . . 3.3999999999999999 109.399 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.59 124.29 26.95 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.276 0.63 . . . . 8.5600000000000005 109.951 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.78 175.9 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 126.003 1.721 . . . . 3.8100000000000001 110.079 -174.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.88 149.16 47.83 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.619 1.168 . . . . 3.8599999999999999 110.654 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.99 167.86 21.56 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.507 1.527 . . . . 0.69999999999999996 112.188 -174.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.0 ttm -150.63 137.1 18.77 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.059 1.344 . . . . 1.8600000000000001 110.581 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -145.4 150.51 44.6 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.429 1.892 . . . . 9.5399999999999991 110.066 -173.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -76.48 155.58 36.25 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.977 1.785 . . . . 0.68999999999999995 110.283 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.67 147.78 66.93 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 124.219 1.008 . . . . 2.0800000000000001 110.213 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -71.44 -22.6 24.67 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.438 2.759 . . . . 0.69999999999999996 111.958 -173.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -172.96 172.61 3.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.421 1.888 . . . . 3.25 111.246 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.4 mt -115.01 161.06 18.85 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.265 1.826 . . . . 1.73 109.013 156.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.415 ' CD ' HH21 ' A' ' 31' ' ' ARG . 23.6 tt0 -133.2 151.21 51.95 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.341 -0.849 . . . . 2.0099999999999998 112.072 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.1 t -138.19 129.13 15.61 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 123.785 0.834 . . . . 2.2999999999999998 111.815 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.89 164.67 34.84 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.379 2.72 . . . . 1.0 111.365 174.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.35 140.82 90.24 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.007 2.471 . . . . 1.02 112.485 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.418 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 67.0 mmtt 67.07 -2.75 1.1 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.848 2.059 . . . . 2.27 114.135 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.99 170.64 43.7 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.864 1.697 . . . . 1.22 114.024 -177.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -122.3 154.35 37.72 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.262 1.425 . . . . 6.5199999999999996 111.388 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.2 t -141.36 137.04 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.734 1.613 . . . . 4.5 107.262 159.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.57 136.27 43.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.627 0.727 . . . . 3.75 109.942 168.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.52 101.39 3.54 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 105.951 -1.87 . . . . 2.3199999999999998 105.951 158.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -113.7 152.3 45.39 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.787 2.035 . . . . 3.5899999999999999 114.36 -158.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 19' ' ' TYR . 10.4 Cg_endo -49.19 -57.69 2.2 Favored 'Trans proline' 0 C--N 1.356 0.97 1 C-N-CA 125.437 4.091 . . . . 2.23 113.667 -173.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.81 57.91 5.0 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.217 -0.768 . . . . 1.8 112.728 173.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.1 -126.52 1.6 Allowed Glycine 0 N--CA 1.467 0.766 0 C-N-CA 124.256 0.931 . . . . 1.9299999999999999 114.828 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -71.05 141.91 50.88 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.845 -0.797 . . . . 3.1899999999999999 112.707 -159.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -161.87 152.79 17.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.995 -0.548 . . . . 0.64000000000000001 111.681 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -77.35 142.79 39.18 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 108.283 -1.006 . . . . 2.9900000000000002 108.283 163.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.1 tpt -92.37 135.59 33.91 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.293 1.037 . . . . 1.72 108.47 162.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.1 mp -117.85 138.79 51.86 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.925 1.29 . . . . 1.74 108.509 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mp -138.56 148.15 43.86 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.544 1.137 . . . . 2.6200000000000001 110.041 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.42 40.45 19.21 Favored Glycine 0 N--CA 1.47 0.96 0 CA-C-O 119.876 -0.402 . . . . 0.94999999999999996 112.79 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -43.82 143.13 1.12 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 115.719 1.748 . . . . 2.3300000000000001 115.719 174.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -110.47 -3.57 15.98 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 113.653 -1.612 . . . . 3.79 114.472 -168.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -137.62 153.43 74.18 Favored Pre-proline 0 N--CA 1.473 0.704 0 C-N-CA 125.921 1.688 . . . . 6.6900000000000004 109.56 170.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -68.65 144.94 61.97 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.111 1.874 . . . . 2.7599999999999998 108.583 162.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.8 mp -125.62 116.92 22.47 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.538 0.735 . . . . 3.96 109.747 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.82 15.55 26.6 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 116.205 1.928 . . . . 6.4199999999999999 116.205 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 60.41 157.55 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.137 2.575 . . . . 2.7200000000000002 111.338 -166.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.47 42.38 99.01 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 120.759 -1.213 . . . . 1.3200000000000001 110.563 -170.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -100.18 179.89 4.34 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.744 1.617 . . . . 2.4100000000000001 107.574 169.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.82 150.79 33.01 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 128.104 2.562 . . . . 5.0999999999999996 106.908 163.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.5 t -149.05 143.53 18.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 128.784 2.833 . . . . 2.2599999999999998 108.811 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -98.69 146.3 26.01 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.997 -0.439 . . . . 3.0099999999999998 111.493 168.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.78 133.14 56.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.469 1.108 . . . . 3.8500000000000001 109.23 160.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.73 143.17 26.57 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.357 2.663 . . . . 2.2000000000000002 107.239 162.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.93 127.39 51.79 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.386 1.474 . . . . 2.3999999999999999 110.19 177.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.0 mt -102.25 117.3 34.46 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.754 1.622 . . . . 1.76 109.844 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -107.67 155.23 20.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.391 1.076 . . . . 3.27 111.296 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.93 146.77 25.68 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.16 -0.473 . . . . 2.1200000000000001 110.415 162.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.63 7.53 66.66 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-O 119.127 -0.818 . . . . 3.1400000000000001 114.59 -173.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.36 6.4 88.93 Favored Glycine 0 N--CA 1.474 1.169 0 CA-C-N 118.886 1.343 . . . . 2.1899999999999999 114.163 175.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -79.48 133.34 36.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.724 1.21 . . . . 8.0399999999999991 111.58 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.6 p -113.22 151.39 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.225 1.81 . . . . 3.1499999999999999 109.766 166.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 tt -158.9 135.11 9.09 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.84 1.656 . . . . 3.2400000000000002 109.481 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -103.27 163.0 12.52 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.313 1.227 . . . . 3.23 114.313 176.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.3 m -134.41 146.29 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 128.803 2.841 . . . . 3.1000000000000001 109.136 168.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.4 p -109.31 138.35 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.899 1.28 . . . . 4.2800000000000002 109.457 176.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.98 154.93 28.6 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 123.631 0.772 . . . . 3.23 113.066 -168.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.22 169.93 19.49 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.806 2.337 . . . . 0.98999999999999999 112.787 171.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 70.1 t -104.5 131.25 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.478 1.511 . . . . 1.8700000000000001 108.635 159.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -134.37 174.89 10.03 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.817 0.847 . . . . 4.6100000000000003 112.55 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -95.07 57.22 2.03 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 116.265 1.95 . . . . 3.1000000000000001 116.265 -143.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.251 23.1 mtp-105 . . . . . 0 N--CA 1.49 1.526 0 C-N-CA 131.611 3.965 . . . . 10.09 114.523 161.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 107.414 -1.328 . . . . 5.79 107.414 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.01 170.12 34.81 Favored Glycine 0 N--CA 1.463 0.438 0 C-N-CA 124.872 1.225 . . . . 1.6200000000000001 111.873 176.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.6 p90 -159.03 141.57 14.1 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.296 1.038 . . . . 2.3199999999999998 111.922 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.12 142.24 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 107.882 -1.155 . . . . 2.3799999999999999 107.882 166.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -89.1 15.33 8.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.676 1.19 . . . . 4.6500000000000004 114.176 -175.182 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.3 t80 64.98 164.03 0.15 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.278 1.431 . . . . 4.0700000000000003 113.37 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 m -172.6 154.0 2.91 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 127.187 2.195 . . . . 2.7000000000000002 110.973 157.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -87.41 30.51 0.46 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 124.509 3.472 . . . . 2.0 112.08 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.24 178.95 31.6 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.716 1.151 . . . . 1.1699999999999999 114.163 -171.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.48 -21.72 29.76 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.135 3.223 . . . . 1.8100000000000001 113.546 -173.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -88.05 148.73 24.36 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.969 1.307 . . . . 3.0899999999999999 111.932 173.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.46 -178.66 6.55 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.201 1.401 . . . . 1.8400000000000001 111.353 165.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.52 150.64 40.71 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.688 1.595 . . . . 2.0600000000000001 108.702 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.65 143.27 29.72 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.223 1.194 . . . . 2.2599999999999998 114.223 -175.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -111.27 156.22 21.82 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.032 2.133 . . . . 3.7200000000000002 111.276 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -169.59 158.35 7.69 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.597 1.559 . . . . 3.1800000000000002 113.671 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 p -93.18 107.47 19.27 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.007 2.123 . . . . 3.6400000000000001 110.862 173.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.46 139.01 37.77 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.336 1.454 . . . . 4.2400000000000002 109.089 176.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -114.62 160.68 19.03 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.678 1.191 . . . . 5.3899999999999997 112.244 177.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -135.82 109.96 10.12 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 123.687 0.795 . . . . 1.49 109.611 158.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -88.25 -8.45 5.56 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.281 2.654 . . . . 1.5800000000000001 114.951 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.95 178.04 33.13 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 119.783 1.174 . . . . 1.24 112.482 -176.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -93.29 0.57 57.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.546 2.338 . . . . 3.5600000000000001 112.485 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -113.46 156.96 42.58 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 127.33 2.252 . . . . 2.8700000000000001 110.583 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.31 145.56 24.15 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.719 2.279 . . . . 1.0900000000000001 111.183 -176.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.423 HD11 ' CD2' ' A' ' 105' ' ' PHE . 2.9 mm? -107.34 157.7 17.74 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 124.716 1.207 . . . . 3.7400000000000002 110.565 172.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -147.22 110.34 4.79 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 113.459 -1.7 . . . . 3.27 110.677 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.26 112.51 24.07 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.47 1.908 . . . . 3.1499999999999999 109.39 -176.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.4 m -108.62 -20.38 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.956 1.302 . . . . 1.8999999999999999 111.642 -172.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.28 -175.06 28.79 Favored Glycine 0 C--N 1.346 1.088 0 C-N-CA 125.43 1.491 . . . . 0.68000000000000005 113.798 -174.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.66 -177.3 5.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.747 2.019 . . . . 1.5700000000000001 111.241 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -155.85 169.52 24.22 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.327 2.251 . . . . 5.25 109.029 170.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.7 t -175.96 150.96 1.13 Allowed Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 126.92 2.088 . . . . 1.8200000000000001 108.007 173.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.4 -17.65 26.93 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.676 1.584 . . . . 0.89000000000000001 112.734 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.9 m -97.05 52.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.737 1.215 . . . . 1.6899999999999999 112.131 174.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.68 167.33 30.74 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.329 1.051 . . . . 1.8799999999999999 112.203 166.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -102.01 -39.19 7.43 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.851 2.06 . . . . 4.9900000000000002 110.492 162.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -146.04 169.59 18.35 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.378 1.871 . . . . 5.5700000000000003 110.128 169.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.14 145.27 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.586 1.554 . . . . 2.0 108.321 -177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -128.68 151.26 49.72 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.479 1.912 . . . . 3.1600000000000001 108.208 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -103.66 136.91 42.49 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.115 0.87 . . . . 3.0 112.088 160.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -120.74 152.95 37.64 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.707 2.003 . . . . 1.0 112.667 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -97.2 163.25 12.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.374 1.47 . . . . 2.3100000000000001 109.634 162.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.6 m -115.99 143.12 45.88 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.213 -1.403 . . . . 2.3100000000000001 107.213 162.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -139.93 172.14 13.2 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.003 1.112 . . . . 3.6499999999999999 114.003 -173.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 85.7 mtp -113.35 143.7 44.0 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.868 1.667 . . . . 4.4000000000000004 110.99 166.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -146.76 146.97 30.47 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.953 1.701 . . . . 7.9500000000000002 110.441 172.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -94.01 141.97 27.92 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 125.145 1.378 . . . . 2.4300000000000002 110.957 171.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 m -139.59 126.96 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.532 1.133 . . . . 3.3900000000000001 108.917 167.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 64.7 10.86 6.32 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.722 1.609 . . . . 3.7200000000000002 115.062 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.87 26.43 41.64 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 123.907 0.765 . . . . 2.3700000000000001 113.278 -166.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -124.76 123.44 40.0 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.514 1.926 . . . . 4.46 109.045 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.85 121.18 25.09 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.926 0.89 . . . . 6.9400000000000004 111.463 -175.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.6 t -121.64 160.14 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 127.386 2.274 . . . . 3.3599999999999999 108.601 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.7 mtp -121.25 156.56 32.22 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.547 1.539 . . . . 3.5 110.337 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.99 -175.57 26.2 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.203 0.906 . . . . 0.63 113.585 -172.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.1 ttm -153.33 151.05 29.54 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.404 1.882 . . . . 1.73 108.691 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.97 158.08 18.25 Favored Pre-proline 0 N--CA 1.477 0.895 0 CA-C-O 117.736 -1.126 . . . . 6.4800000000000004 111.3 175.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.55 146.26 49.11 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.979 1.786 . . . . 1.29 112.647 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.64 159.51 43.83 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 125.104 1.362 . . . . 2.6499999999999999 110.397 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.74 -30.8 2.19 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.616 2.211 . . . . 1.1599999999999999 112.465 -172.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -179.15 165.28 1.47 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.398 1.879 . . . . 3.3799999999999999 111.148 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt -110.37 152.96 25.61 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.504 1.121 . . . . 1.98 110.216 163.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -110.33 145.71 37.0 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.722 1.209 . . . . 1.78 108.716 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -138.16 127.24 14.62 Favored Pre-proline 0 N--CA 1.473 0.688 0 N-CA-C 112.594 0.59 . . . . 1.79 112.594 169.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.88 159.17 48.79 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.049 3.166 . . . . 1.1499999999999999 112.402 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.47 142.52 95.31 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 124.337 3.358 . . . . 1.21 113.847 -175.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp 64.54 -3.41 0.53 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.646 1.978 . . . . 2.9300000000000002 114.637 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.64 174.58 55.15 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.824 1.678 . . . . 1.28 114.089 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.66 126.4 6.91 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.387 1.475 . . . . 4.7300000000000004 108.963 173.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.9 t -147.32 145.34 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.131 1.772 . . . . 5.0199999999999996 107.836 -163.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.3 142.0 35.84 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.349 -0.844 . . . . 3.79 112.545 -167.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mp -69.55 79.7 0.41 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.891 -1.152 . . . . 2.2000000000000002 107.891 151.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.99 147.1 85.79 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 112.943 0.72 . . . . 5.1699999999999999 112.943 -171.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -57.83 133.41 55.9 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.63 1.553 . . . . 3.6800000000000002 109.13 162.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.58 -12.54 66.17 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 116.637 -2.202 . . . . 2.27 115.657 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.43 -31.67 0.07 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 120.498 2.959 . . . . 2.0499999999999998 120.498 175.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -144.06 139.31 28.88 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.619 2.209 . . . . 3.5499999999999998 112.491 175.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -163.13 153.62 16.3 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.236 -0.29 . . . . 0.92000000000000004 111.345 -176.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -79.48 142.5 35.78 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.596 -0.52 . . . . 4.2300000000000004 109.596 164.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.6 tpt -105.68 127.03 52.82 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 126.334 1.854 . . . . 1.8500000000000001 107.143 165.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -105.63 131.84 52.51 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.116 0.967 . . . . 2.0800000000000001 108.732 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.43 131.93 55.0 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.199 0.999 . . . . 4.6600000000000001 110.367 -175.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.62 47.13 28.45 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.552 1.072 . . . . 0.84999999999999998 114.203 170.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.73 149.31 4.75 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 116.112 1.893 . . . . 2.2400000000000002 116.112 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -104.86 3.91 31.51 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 113.897 -1.502 . . . . 3.0699999999999998 113.67 -171.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.9 mmt-85 -145.2 139.39 15.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 127.928 2.491 . . . . 7.4299999999999997 108.25 167.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -64.14 155.3 65.8 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 N-CA-C 107.659 -1.708 . . . . 1.97 107.659 154.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.3 121.18 17.58 Favored 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 108.058 -1.09 . . . . 3.9700000000000002 108.058 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.441 ' HE2' ' OE1' ' A' ' 97' ' ' GLU 0.299 0.0 OUTLIER -87.64 13.18 10.87 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 116.032 1.864 . . . . 6.21 116.032 -168.998 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 62.81 154.06 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.993 2.917 . . . . 3.1299999999999999 111.495 -163.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.98 51.17 55.57 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 109.839 -1.305 . . . . 1.6699999999999999 109.839 -166.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.441 ' OE1' ' HE2' ' A' ' 94' ' ' LYS . 6.3 mm-40 -116.86 -177.6 3.23 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.761 2.025 . . . . 2.3799999999999999 107.774 173.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -155.66 135.59 12.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.357 1.863 . . . . 3.27 107.744 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -151.23 151.13 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.765 1.626 . . . . 4.3200000000000003 109.661 -177.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.6 150.05 32.81 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.842 1.052 . . . . 2.96 113.842 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mp -125.68 140.96 52.28 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.129 1.772 . . . . 3.0 110.238 169.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.447 ' CG ' ' HZ2' ' A' ' 112' ' ' LYS . 1.1 m-20 -98.67 148.32 23.95 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.95 1.7 . . . . 2.3300000000000001 108.882 164.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.7 mp -120.97 133.62 55.28 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.84 1.256 . . . . 2.4100000000000001 109.679 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.6 mt -110.31 122.65 48.19 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.32 1.448 . . . . 1.8400000000000001 110.3 -174.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.423 ' CD2' HD11 ' A' ' 30' ' ' LEU . 97.9 m-85 -120.03 150.7 40.13 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.995 0.918 . . . . 3.3399999999999999 111.591 -173.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.3 135.83 56.51 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.6 -0.687 . . . . 2.1699999999999999 111.759 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.6 31.53 21.33 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.798 -1.001 . . . . 3.1800000000000002 114.448 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.99 8.78 87.05 Favored Glycine 0 N--CA 1.474 1.233 0 CA-C-N 118.572 1.186 . . . . 1.8 115.984 167.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -88.04 138.2 31.66 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.686 1.243 . . . . 4.5099999999999998 112.006 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.5 p -131.98 145.75 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 125.784 1.634 . . . . 3.1800000000000002 110.103 175.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.4 tt -146.09 121.56 10.35 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.0 0.92 . . . . 3.75 110.67 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.447 ' HZ2' ' CG ' ' A' ' 102' ' ' ASP . 0.1 OUTLIER -90.99 134.67 34.3 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.659 0.784 . . . . 4.1399999999999997 112.867 176.697 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.2 m -120.19 160.7 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.497 1.919 . . . . 3.4500000000000002 110.116 165.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 52.9 t -115.45 132.49 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 107.688 -1.227 . . . . 2.79 107.688 167.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.3 mt -135.81 144.13 47.46 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.206 1.002 . . . . 3.2999999999999998 112.076 -171.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.68 174.42 12.68 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.212 3.275 . . . . 0.81999999999999995 113.054 170.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.1 t -122.42 129.63 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.755 2.022 . . . . 2.0499999999999998 110.127 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.6 167.64 11.14 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.059 2.144 . . . . 3.9900000000000002 110.271 171.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.93 -177.66 4.79 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 116.686 2.106 . . . . 2.6299999999999999 116.686 -159.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.714 0 C-N-CA 127.519 2.328 . . . . 11.77 110.139 148.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 . . . . . 0 CA--C 1.538 0.508 0 N-CA-C 109.311 -0.626 . . . . 5.3600000000000003 109.311 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.2 -178.84 20.33 Favored Glycine 0 N--CA 1.466 0.661 0 C-N-CA 123.571 0.605 . . . . 1.3200000000000001 113.458 -167.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 23.3 p90 -152.23 154.99 36.87 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.153 0.981 . . . . 2.0800000000000001 112.161 176.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.8 t -90.31 144.8 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.908 1.283 . . . . 2.04 107.989 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -82.26 129.32 34.82 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.285 0.493 . . . . 7.1799999999999997 111.147 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -41.51 133.93 2.46 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.078 2.151 . . . . 2.8799999999999999 112.69 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.5 t -173.99 127.11 0.45 Allowed Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.128 1.771 . . . . 3.2599999999999998 110.587 169.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -88.88 3.12 5.8 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.023 3.149 . . . . 3.3300000000000001 112.457 167.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.74 -172.57 45.3 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.742 1.163 . . . . 1.46 113.041 -173.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.11 -22.7 40.74 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.871 2.381 . . . . 1.52 113.209 -176.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -132.5 167.42 20.01 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.488 1.515 . . . . 2.2400000000000002 114.174 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.48 -174.03 4.69 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 128.658 2.783 . . . . 1.77 110.859 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.35 148.89 32.83 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.273 1.429 . . . . 1.5600000000000001 110.137 173.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.24 145.05 51.76 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.327 1.232 . . . . 1.55 114.327 -173.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -116.78 43.2 2.3 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.723 2.009 . . . . 3.71 112.89 -170.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -68.39 162.06 26.2 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.385 1.254 . . . . 3.02 114.385 -169.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.1 m -94.65 139.61 30.98 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.067 0.947 . . . . 2.9700000000000002 112.821 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.85 127.64 56.08 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.684 1.194 . . . . 3.6899999999999999 110.235 167.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -131.11 136.7 48.61 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.229 1.812 . . . . 3.5699999999999998 106.186 171.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -108.29 93.03 10.57 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 122.601 0.361 . . . . 1.46 110.754 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.5 -12.92 20.54 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.425 2.083 . . . . 1.3 113.159 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.98 -177.29 51.45 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-O 122.352 0.973 . . . . 1.22 112.577 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.455 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 28.5 m-20 -109.94 0.26 18.51 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.969 2.108 . . . . 2.9700000000000002 112.47 -173.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 pp -115.54 159.58 38.0 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 127.701 2.4 . . . . 3.2799999999999998 110.401 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.14 139.5 15.05 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.252 1.968 . . . . 0.93999999999999995 110.799 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.1 mt -93.36 149.02 21.54 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 122.249 1.023 . . . . 2.77 110.478 170.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -137.96 102.15 4.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.805 -1.998 . . . . 3.0899999999999999 111.237 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.5 tp -84.8 104.12 14.48 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.535 1.534 . . . . 2.7200000000000002 109.902 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.3 m -100.03 -21.9 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.003 1.321 . . . . 1.51 112.185 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.45 -177.67 32.75 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.908 1.242 . . . . 0.46999999999999997 114.035 -172.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.34 -179.56 8.05 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.057 1.343 . . . . 1.53 112.581 171.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -158.81 143.06 15.59 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.471 1.908 . . . . 5.6900000000000004 108.083 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.55 149.17 25.49 Favored Pre-proline 0 N--CA 1.481 1.077 0 CA-C-N 121.312 1.869 . . . . 1.8500000000000001 110.647 168.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -62.81 -10.47 20.08 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.67 2.247 . . . . 1.27 114.032 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.55 34.69 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 113.647 0.981 . . . . 2.0699999999999998 113.647 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.63 115.69 1.44 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.111 1.765 . . . . 2.5 108.836 159.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -69.51 -34.8 74.82 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.202 1.186 . . . . 2.8300000000000001 114.202 -175.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -135.58 92.2 2.8 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 107.167 -1.419 . . . . 8.6699999999999999 107.167 -166.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -85.65 166.46 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.95 0.9 . . . . 2.2200000000000002 110.464 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.1 149.96 26.66 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.571 1.948 . . . . 4.4000000000000004 108.229 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.2 tp -121.01 110.83 16.73 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.014 1.279 . . . . 2.1699999999999999 111.09 -171.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 63.4 m170 -121.05 151.11 40.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 123.102 1.429 . . . . 0.83999999999999997 114.316 -170.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -93.41 177.82 5.91 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 113.463 -1.699 . . . . 2.52 111.337 156.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.9 m -146.1 127.47 14.92 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.419 1.888 . . . . 1.8700000000000001 105.989 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -131.37 169.25 16.28 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.073 0.949 . . . . 3.1400000000000001 113.131 -162.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.0 mtt -99.87 141.86 32.12 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.674 1.19 . . . . 4.3200000000000003 110.233 167.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -146.48 176.84 9.5 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.102 1.761 . . . . 6.9900000000000002 111.329 173.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -141.07 138.57 33.68 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.036 1.734 . . . . 2.54 108.547 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.5 m -143.74 144.83 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 127.372 2.269 . . . . 3.3100000000000001 108.028 167.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 56.86 20.79 5.51 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 115.493 1.664 . . . . 3.3999999999999999 115.493 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.31 19.0 77.42 Favored Glycine 0 CA--C 1.537 1.458 0 O-C-N 121.041 -1.037 . . . . 1.6200000000000001 114.056 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -110.47 118.52 36.47 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.916 1.686 . . . . 3.5899999999999999 107.487 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -71.55 118.93 14.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.404 1.082 . . . . 5.6200000000000001 108.349 171.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.09 176.6 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.889 1.675 . . . . 3.3900000000000001 111.188 -172.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 77.0 mtm -127.29 163.65 23.47 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.009 1.323 . . . . 3.4700000000000002 111.275 172.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.69 -176.68 28.13 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.37 1.462 . . . . 0.48999999999999999 112.207 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.0 ttm -147.28 149.57 33.11 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.972 1.309 . . . . 1.5600000000000001 109.489 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -163.1 158.25 18.09 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 124.379 1.072 . . . . 7.1699999999999999 111.948 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.44 151.37 33.16 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.465 2.11 . . . . 0.81999999999999995 113.578 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.76 151.5 64.34 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 125.855 1.662 . . . . 2.0099999999999998 109.944 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.13 -28.93 10.37 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.052 2.501 . . . . 0.95999999999999996 112.161 -174.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -175.51 168.06 3.23 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.456 1.902 . . . . 3.6099999999999999 111.207 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.7 mt -111.18 150.06 30.05 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.888 1.275 . . . . 1.7 110.534 162.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -113.53 141.18 47.45 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.729 1.211 . . . . 1.9399999999999999 108.694 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.6 t -139.16 124.02 11.61 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-O 119.162 -0.447 . . . . 2.27 111.243 166.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.77 162.74 41.11 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.743 2.962 . . . . 0.96999999999999997 111.649 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.02 144.77 99.59 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.67 2.913 . . . . 1.1399999999999999 112.594 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.455 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 12.5 mptt 65.2 -8.67 0.24 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.54 2.336 . . . . 2.9100000000000001 115.157 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.68 166.02 50.29 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.532 1.539 . . . . 1.1100000000000001 112.844 174.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -144.77 144.54 31.23 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.639 1.175 . . . . 6.8399999999999999 110.559 170.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -156.83 125.32 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.496 1.918 . . . . 4.7599999999999998 107.586 -174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -91.79 157.4 16.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.464 0.706 . . . . 4.0099999999999998 111.829 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.79 73.24 0.57 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.725 1.25 . . . . 2.0899999999999999 108.647 164.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -57.02 129.98 79.18 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.183 1.393 . . . . 5.79 111.452 -174.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -58.28 -32.48 96.05 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.797 2.331 . . . . 2.0099999999999998 112.159 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.35 57.62 4.42 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 119.377 -0.679 . . . . 2.5299999999999998 112.078 165.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.31 -11.39 2.02 Favored Glycine 0 N--CA 1.473 1.125 0 N-CA-C 119.685 2.634 . . . . 2.0600000000000001 119.685 158.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -144.39 146.84 32.75 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.995 2.398 . . . . 3.6099999999999999 112.721 171.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -162.21 155.53 20.59 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.047 0.939 . . . . 0.84999999999999998 110.858 172.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -79.33 140.93 37.38 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.543 -0.91 . . . . 2.6699999999999999 108.543 157.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.4 tpt -87.05 132.47 33.8 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.301 1.441 . . . . 1.6799999999999999 107.665 161.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 mp -114.34 119.74 37.99 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.009 -1.108 . . . . 1.8999999999999999 108.009 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.96 148.07 42.56 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.48 0.712 . . . . 2.6699999999999999 109.877 172.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.03 48.58 31.96 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 119.391 -0.672 . . . . 1.0600000000000001 112.28 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pp -61.54 155.56 21.78 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 115.042 1.497 . . . . 2.1600000000000001 115.042 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.34 -4.41 9.92 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 114.062 -1.426 . . . . 3.1000000000000001 114.107 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -115.83 114.78 41.66 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 106.442 -1.688 . . . . 5.7599999999999998 106.442 152.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.62 122.2 9.36 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 N-CA-C 105.38 -2.585 . . . . 2.7799999999999998 105.38 158.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.2 mt -87.15 178.06 7.01 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 124.576 2.132 . . . . 3.25 112.821 -152.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -127.82 -169.62 2.09 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 129.329 3.052 . . . . 5.1600000000000001 109.929 169.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.0 155.58 17.04 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 106.635 -1.617 . . . . 2.6699999999999999 106.635 146.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.65 1.98 89.51 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.435 -1.203 . . . . 1.6399999999999999 115.771 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -78.72 -176.21 4.8 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.579 1.689 . . . . 2.3399999999999999 110.289 159.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -155.09 149.88 26.6 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 128.285 2.634 . . . . 3.3700000000000001 107.122 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.1 t -145.65 122.22 3.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 125.909 1.684 . . . . 2.1299999999999999 109.325 -166.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.41 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 4.9 pt-20 -81.51 154.5 26.26 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.788 0.804 . . . . 2.46 112.251 167.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.6 tt -154.97 132.67 11.36 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.263 1.425 . . . . 4.4699999999999998 111.023 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.47 130.4 36.97 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.76 2.424 . . . . 2.9100000000000001 108.509 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.0 mp -100.74 119.56 38.8 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.421 1.088 . . . . 2.29 109.219 175.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 86.4 mt -87.41 108.71 19.12 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.812 0.815 . . . . 2.1800000000000002 109.734 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -104.53 116.58 32.34 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.409 1.483 . . . . 3.48 111.048 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 54.36 24.78 5.39 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.006 1.722 . . . . 2.7999999999999998 113.392 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.72 -59.37 2.11 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.962 1.744 . . . . 4.7999999999999998 112.867 -171.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -84.55 9.21 65.57 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 116.399 1.32 . . . . 2.3799999999999999 116.399 -167.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -136.66 152.53 50.51 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.296 1.838 . . . . 5.7199999999999998 111.967 171.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.5 p -148.47 147.14 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 125.069 1.348 . . . . 3.3700000000000001 111.158 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.4 tp -156.33 132.86 10.15 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.263 1.825 . . . . 3.71 108.281 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.41 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 62.5 pttt -96.53 146.61 24.65 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.908 1.447 . . . . 2.9300000000000002 114.908 176.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.7 t -130.2 168.1 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 126.986 2.114 . . . . 3.6699999999999999 108.268 175.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 t -130.88 147.27 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.6 1.56 . . . . 3.0600000000000001 108.431 -171.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.92 146.2 17.85 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.892 1.277 . . . . 3.0600000000000001 110.976 -177.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.51 164.31 29.23 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.4 3.4 . . . . 0.89000000000000001 112.394 172.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.2 t -105.54 135.97 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.151 1.38 . . . . 2.3300000000000001 108.768 165.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -147.3 164.03 34.54 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.653 1.181 . . . . 3.5 111.503 -175.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.67 -176.27 3.23 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 127.228 2.211 . . . . 2.9199999999999999 115.699 -160.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.44 ' C ' HH11 ' A' ' 120' ' ' ARG . 11.0 tpt85 . . . . . 0 N--CA 1.48 1.069 0 C-N-CA 127.65 2.38 . . . . 9.2400000000000002 113.243 -175.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 108.567 -0.901 . . . . 5.1699999999999999 108.567 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -94.65 -177.11 38.44 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 123.58 0.61 . . . . 1.3999999999999999 114.429 -170.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -144.55 154.34 42.77 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.095 1.146 . . . . 2.54 114.095 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.58 135.9 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.537 -0.912 . . . . 1.9099999999999999 108.537 170.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -70.56 -10.95 60.52 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.956 1.836 . . . . 4.5099999999999998 115.956 -162.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 63.82 169.82 0.16 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.078 1.351 . . . . 3.3500000000000001 111.723 -170.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -166.77 162.99 11.1 Favored Pre-proline 0 CA--C 1.542 0.644 0 O-C-N 120.773 -1.205 . . . . 2.8199999999999998 112.221 160.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -85.09 11.45 3.37 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.248 3.299 . . . . 2.7999999999999998 112.823 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -150.37 -165.69 12.86 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 124.451 1.024 . . . . 1.1000000000000001 115.368 -170.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -80.58 -20.43 8.05 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.625 3.55 . . . . 1.46 115.06 -169.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -99.39 164.79 11.96 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.955 1.302 . . . . 2.8799999999999999 112.98 169.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.63 -177.02 6.27 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.792 2.437 . . . . 1.6499999999999999 111.077 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.72 165.71 26.27 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.552 2.341 . . . . 1.51 108.47 173.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.85 156.34 37.43 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.265 1.209 . . . . 1.72 114.265 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -140.66 143.59 35.21 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.443 1.897 . . . . 3.6299999999999999 110.325 -173.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.417 ' HA ' ' HA3' ' A' ' 6' ' ' GLY 0.263 0.0 OUTLIER -163.39 166.83 22.46 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.676 1.19 . . . . 3.6600000000000001 113.45 -177.723 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.6 m -91.78 123.62 35.3 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 127.255 2.222 . . . . 2.8100000000000001 109.373 -174.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.3 126.72 46.66 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.707 -0.849 . . . . 3.96 108.707 165.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -126.2 120.78 30.93 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.469 -1.308 . . . . 3.9100000000000001 107.469 161.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -92.45 115.49 64.87 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.464 -0.779 . . . . 1.48 108.94 170.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -87.98 -9.79 5.26 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.318 2.678 . . . . 1.45 114.822 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.52 159.39 27.09 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 119.65 1.114 . . . . 1.6000000000000001 111.914 -175.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.81 7.61 6.79 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 128.346 2.658 . . . . 3.7000000000000002 112.485 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -125.92 150.24 68.43 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 128.592 2.757 . . . . 2.7999999999999998 109.367 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.44 149.52 27.53 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.852 2.368 . . . . 1.0600000000000001 111.306 -171.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.2 mt -102.75 153.19 20.39 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 122.809 1.29 . . . . 2.5899999999999999 110.431 164.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 ttp-105 -140.21 103.14 4.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.197 -1.82 . . . . 3.71 110.45 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.5 tt -80.38 113.62 18.7 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 109.13 -0.693 . . . . 3.46 109.13 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -104.31 -20.15 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.385 1.074 . . . . 1.71 111.771 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.05 -176.24 30.87 Favored Glycine 0 C--N 1.343 0.956 0 C-N-CA 124.808 1.194 . . . . 0.57999999999999996 114.71 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.5 -177.61 6.18 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.182 1.393 . . . . 1.6100000000000001 111.884 174.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -156.2 176.71 12.32 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.896 2.479 . . . . 5.0899999999999999 107.261 163.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -167.87 151.41 5.88 Favored Pre-proline 0 N--CA 1.466 0.329 0 C-N-CA 128.348 2.659 . . . . 1.75 106.9 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.95 -5.22 16.64 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.386 2.058 . . . . 1.1299999999999999 113.108 174.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.61 49.24 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.632 1.173 . . . . 1.79 113.501 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.99 151.67 14.44 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.492 0.717 . . . . 1.8300000000000001 112.374 163.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.494 ' CD ' ' HZ2' ' A' ' 90' ' ' LYS . 1.2 tp10 -89.73 -44.25 10.14 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.069 1.747 . . . . 3.0600000000000001 110.951 168.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -114.15 130.79 56.59 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.193 1.797 . . . . 6.4900000000000002 108.255 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -109.14 149.81 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.322 -0.992 . . . . 1.9299999999999999 108.322 154.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -134.06 148.67 51.08 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.606 1.562 . . . . 2.9100000000000001 108.369 171.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.4 tp -100.98 118.65 37.41 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.637 -0.505 . . . . 2.0800000000000001 109.637 175.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 48.1 m170 -119.92 162.5 19.07 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 123.819 1.771 . . . . 0.69999999999999996 113.284 -177.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -110.99 153.2 25.89 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 112.889 -1.959 . . . . 2.8300000000000001 112.055 155.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.0 m -109.67 152.39 25.65 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 106.251 -1.759 . . . . 1.9199999999999999 106.251 160.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -149.88 171.49 16.69 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.174 0.99 . . . . 3.4199999999999999 111.771 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 57.3 ttm -102.06 143.39 31.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.726 1.21 . . . . 4.8700000000000001 109.566 168.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.32 157.56 43.19 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.875 1.27 . . . . 5.1399999999999997 111.369 -172.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.92 176.38 8.73 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.129 1.372 . . . . 3.5899999999999999 114.599 178.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.0 p 159.76 123.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 1 C-N-CA 132.334 4.254 . . . . 4.9199999999999999 106.974 -164.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 64.63 9.93 5.53 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 117.248 2.314 . . . . 3.1499999999999999 117.248 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.77 7.34 60.11 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 120.745 -1.222 . . . . 2.3700000000000001 113.28 -171.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -112.37 100.84 9.1 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.24 1.816 . . . . 3.4100000000000001 109.213 -162.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -79.49 114.34 18.34 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.194 -0.941 . . . . 4.6600000000000001 108.995 -173.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.1 t -126.82 133.52 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.169 1.788 . . . . 3.8999999999999999 108.769 -173.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 60.2 mtm -88.25 128.17 35.47 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.82 0.848 . . . . 4.25 110.688 175.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.72 177.71 16.5 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 124.957 1.265 . . . . 0.63 112.631 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.6 ttm -157.52 137.66 12.61 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.589 1.155 . . . . 1.6100000000000001 111.974 -172.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -146.81 150.01 38.05 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.864 1.666 . . . . 9.9499999999999993 111.038 -177.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.56 151.8 53.26 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.38 2.053 . . . . 0.75 110.12 169.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.78 154.75 76.61 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 125.293 1.437 . . . . 2.0699999999999998 110.638 -175.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.66 -25.9 4.15 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.2 2.6 . . . . 0.66000000000000003 113.189 -166.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -177.77 161.68 1.65 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.144 1.778 . . . . 3.2599999999999998 111.433 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.69 153.83 22.88 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.429 1.492 . . . . 1.9399999999999999 109.62 163.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -105.52 152.36 23.14 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.929 0.891 . . . . 1.8600000000000001 110.685 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.3 124.01 13.62 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 123.301 0.64 . . . . 2.54 110.263 163.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.35 165.03 31.88 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.181 2.587 . . . . 1.0600000000000001 111.181 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.92 138.85 76.23 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.516 2.144 . . . . 1.3200000000000001 112.848 175.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.26 15.3 mtmt 57.66 36.82 27.07 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.355 1.462 . . . . 3.96 113.606 171.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.29 140.06 11.48 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.561 2.029 . . . . 1.27 114.84 -172.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.1 ttt85 -87.52 138.11 31.75 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.851 2.06 . . . . 5.21 110.439 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.5 t -148.93 142.58 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 127.421 2.288 . . . . 3.96 107.313 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -142.35 147.5 36.39 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 120.537 1.517 . . . . 4.2599999999999998 113.463 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mp -82.59 168.08 17.68 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.044 2.138 . . . . 2.5800000000000001 111.168 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -169.82 157.9 6.5 Favored Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 125.868 1.667 . . . . 3.4100000000000001 113.667 -176.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.18 -47.24 15.38 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 124.19 3.26 . . . . 3.3399999999999999 113.254 176.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.02 36.11 1.47 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.851 1.215 . . . . 1.8899999999999999 113.66 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.3 -134.1 2.51 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 125.107 1.337 . . . . 1.6100000000000001 113.456 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -71.05 136.63 48.41 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.897 -0.766 . . . . 3.25 111.658 -169.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.5 p-80 -162.08 154.68 19.81 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.826 1.25 . . . . 0.80000000000000004 112.465 -170.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -84.32 146.57 27.66 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.855 -0.528 . . . . 4.0099999999999998 109.753 168.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.6 tpt -100.4 136.51 40.17 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.739 1.216 . . . . 1.76 108.9 162.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.5 mp -118.59 139.87 50.8 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.032 1.333 . . . . 1.74 109.148 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mp -140.2 146.63 38.95 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.693 0.797 . . . . 2.7599999999999998 110.699 171.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.59 37.09 24.46 Favored Glycine 0 N--CA 1.473 1.106 0 O-C-N 122.073 -0.392 . . . . 1.1100000000000001 112.904 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.27 146.12 9.8 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.856 1.662 . . . . 2.1400000000000001 115.467 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.494 ' HZ2' ' CD ' ' A' ' 41' ' ' GLU . 74.0 mmtt -109.1 -23.49 11.62 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 113.646 -1.615 . . . . 2.7799999999999998 113.255 -168.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -97.61 142.67 24.92 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.056 0.942 . . . . 6.7999999999999998 109.19 158.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.69 79.54 3.32 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.279 2.652 . . . . 2.5 109.439 173.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 72.8 mt -42.63 122.93 2.46 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 127.604 2.362 . . . . 3.1299999999999999 115.13 -167.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -119.97 156.8 30.13 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 127.078 2.151 . . . . 7.1200000000000001 113.357 165.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.26 135.98 56.75 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.784 -1.098 . . . . 2.48 108.435 171.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.13 1.56 72.39 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.052 1.31 . . . . 1.78 115.117 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -74.97 -173.09 1.81 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.012 1.406 . . . . 2.3700000000000001 112.834 169.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -139.05 125.52 20.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.99 3.316 . . . . 5.0999999999999996 105.354 -165.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.2 t -145.18 128.42 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 O-C-N 121.298 -0.876 . . . . 2.1299999999999999 110.957 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.526 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 43.1 mt-10 -78.82 143.58 35.87 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.421 -0.809 . . . . 2.48 110.658 169.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mp -118.27 134.33 55.12 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.876 0.871 . . . . 2.6600000000000001 109.569 156.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -93.44 139.4 30.75 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.185 2.594 . . . . 2.7799999999999998 108.355 169.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.4 mp -118.43 129.02 55.16 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.729 1.612 . . . . 1.9099999999999999 109.743 -173.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.8 mt -106.28 114.81 29.16 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.371 1.468 . . . . 1.99 110.518 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -112.24 115.06 28.2 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.067 1.347 . . . . 3.2000000000000002 111.841 -172.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 48.53 26.94 1.3 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.519 1.928 . . . . 3.0299999999999998 114.223 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.33 -59.49 4.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.42 1.486 . . . . 4.4000000000000004 112.861 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.63 3.42 68.79 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 116.987 1.555 . . . . 2.21 116.987 -165.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -136.1 143.36 44.54 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.702 1.751 . . . . 4.3200000000000003 112.519 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.4 t -134.34 147.43 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.473 1.509 . . . . 3.3999999999999999 109.659 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -153.78 166.52 32.62 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.936 2.494 . . . . 3.1000000000000001 108.094 175.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.526 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 54.9 pttt -144.35 160.55 40.85 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.878 1.217 . . . . 2.71 113.679 171.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.66 158.21 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.525 1.53 . . . . 3.46 108.886 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.5 p -114.63 132.72 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.325 1.05 . . . . 3.7400000000000002 110.003 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -124.93 148.89 61.32 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 126.975 2.11 . . . . 4.29 108.713 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.15 161.73 44.9 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.742 2.295 . . . . 0.85999999999999999 111.775 162.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.4 t -96.59 137.61 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.847 0.859 . . . . 2.1099999999999999 109.41 168.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.54 141.31 29.4 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.884 1.674 . . . . 3.8199999999999998 111.036 177.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -95.39 86.35 4.48 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.674 1.189 . . . . 2.7599999999999998 112.051 -169.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 . . . . . 0 C--O 1.246 0.881 0 C-N-CA 124.87 1.268 . . . . 8.9800000000000004 111.153 -173.934 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 CA--C 1.544 0.749 0 CA-C-O 121.873 0.844 . . . . 6.2199999999999998 112.231 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.0 -177.54 23.26 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.809 1.671 . . . . 1.28 111.714 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -148.98 157.61 43.55 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 115.351 1.611 . . . . 2.25 115.351 -173.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.0 t -92.89 134.73 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.958 1.303 . . . . 2.6600000000000001 108.631 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.9 tpp85 -69.16 118.87 12.6 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.144 0.977 . . . . 5.5999999999999996 111.872 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -66.64 142.32 57.5 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.87 1.268 . . . . 2.73 111.414 162.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -174.48 161.48 2.7 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 126.451 1.9 . . . . 3.73 110.684 170.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -84.55 38.2 0.67 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.998 3.132 . . . . 2.4900000000000002 112.122 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.85 151.52 18.21 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 124.942 1.258 . . . . 1.46 115.122 -165.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.29 -22.11 14.65 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.253 2.635 . . . . 1.53 111.841 166.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -105.99 158.58 16.69 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 127.272 2.229 . . . . 2.96 112.072 165.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.38 -171.79 3.92 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.027 2.131 . . . . 1.9199999999999999 110.752 -173.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.34 159.86 43.58 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.188 1.395 . . . . 1.7 109.707 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.75 131.21 37.3 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.65 1.114 . . . . 1.75 112.778 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -123.0 81.96 1.94 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.664 1.986 . . . . 4.0899999999999999 110.28 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -92.24 158.08 16.33 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.664 1.186 . . . . 2.7999999999999998 113.923 -173.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.7 m -119.89 144.33 47.46 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.725 1.61 . . . . 2.7000000000000002 108.443 162.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.9 tp -158.57 171.7 19.65 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.574 2.75 . . . . 5.6900000000000004 107.517 173.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -136.23 144.75 45.02 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 120.391 -1.443 . . . . 4.4199999999999999 108.382 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -97.59 106.7 34.82 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 125.381 1.472 . . . . 1.3999999999999999 109.493 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -81.62 -7.3 12.59 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.731 2.287 . . . . 1.4399999999999999 114.083 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.64 168.5 54.78 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-O 123.108 1.393 . . . . 1.4399999999999999 113.228 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.463 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 16.6 m-20 -101.44 -2.38 30.94 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 128.606 2.763 . . . . 3.0499999999999998 111.648 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 pp -117.03 159.16 42.12 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 127.665 2.386 . . . . 3.02 110.342 171.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.87 138.07 12.95 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.873 2.382 . . . . 1.1399999999999999 111.025 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.55 156.68 16.33 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 123.185 1.469 . . . . 3.46 111.834 176.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -152.01 98.26 2.42 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.104 -1.862 . . . . 3.8700000000000001 110.246 -164.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.4 tt -85.59 115.75 23.47 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.945 1.698 . . . . 3.6099999999999999 107.403 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.93 -16.39 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.202 1.001 . . . . 1.6899999999999999 111.969 -174.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.18 -176.53 31.34 Favored Glycine 0 C--N 1.342 0.881 0 C-N-CA 125.887 1.708 . . . . 0.65000000000000002 113.392 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -153.74 178.03 10.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.39 1.476 . . . . 1.6899999999999999 112.785 166.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -151.42 159.04 44.42 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 129.622 3.169 . . . . 5.4699999999999998 108.568 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 t -173.79 152.23 1.97 Allowed Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 128.111 2.565 . . . . 1.6499999999999999 107.229 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.92 -15.88 20.71 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.688 1.592 . . . . 1.1399999999999999 113.513 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.12 32.54 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.319 1.047 . . . . 1.8200000000000001 112.326 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.93 140.12 17.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.608 0.763 . . . . 1.6000000000000001 109.395 165.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -85.93 -33.89 21.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.038 1.335 . . . . 3.79 110.847 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -139.06 144.45 38.79 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.066 2.146 . . . . 8.0 106.597 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.2 p -135.92 146.84 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.109 1.364 . . . . 2.25 109.338 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.449 ' CD ' ' HE2' ' A' ' 46' ' ' HIS . 13.5 tt0 -135.49 146.97 48.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.755 2.022 . . . . 3.9900000000000002 108.781 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.8 tp -109.12 115.65 30.45 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.697 1.135 . . . . 2.1499999999999999 111.1 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.449 ' HE2' ' CD ' ' A' ' 44' ' ' GLU . 65.6 m170 -116.4 154.65 29.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.497 1.519 . . . . 1.03 113.923 -175.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' CD ' ' HD2' ' A' ' 62' ' ' ARG . 6.5 pt-20 -95.86 179.86 4.95 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.806 1.243 . . . . 2.21 111.442 159.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 84.1 m -137.69 134.81 35.83 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.351 -1.352 . . . . 2.04 107.351 164.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -129.7 163.81 25.33 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.165 1.172 . . . . 3.4399999999999999 114.165 -168.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -106.5 150.22 26.32 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.458 1.503 . . . . 4.5800000000000001 111.4 167.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.67 157.66 35.59 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.055 0.942 . . . . 5.0199999999999996 111.217 -168.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.467 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS . 2.5 tp10 -110.32 146.83 35.05 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.174 1.79 . . . . 2.7200000000000002 108.415 167.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.2 129.42 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 107.748 -1.205 . . . . 4.1200000000000001 107.748 161.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 61.97 32.99 17.61 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.161 0.984 . . . . 4.5300000000000002 112.298 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.73 8.69 82.14 Favored Glycine 0 CA--C 1.536 1.384 0 O-C-N 120.575 -1.328 . . . . 2.02 114.019 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -121.11 129.63 53.38 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.391 1.876 . . . . 3.6800000000000002 109.174 -172.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.467 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 2.9 mmtt -69.34 134.9 49.64 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.992 2.117 . . . . 4.9400000000000004 109.492 -176.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.5 p -146.36 170.79 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 125.895 1.678 . . . . 3.9700000000000002 109.835 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 32.2 mtm -131.85 159.32 38.91 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.768 1.627 . . . . 3.3199999999999998 110.684 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.13 -174.9 27.43 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.924 1.25 . . . . 0.90000000000000002 113.956 -173.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.3 ttm -155.74 145.69 21.42 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.169 1.787 . . . . 1.8100000000000001 108.565 -174.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.416 ' HD2' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -162.46 154.0 15.33 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.573 1.149 . . . . 6.1500000000000004 111.59 -178.159 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.79 157.53 35.28 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.143 1.896 . . . . 0.62 112.976 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.34 156.78 67.18 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 126.487 1.915 . . . . 1.8700000000000001 110.211 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.5 -21.82 4.13 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.743 2.962 . . . . 0.77000000000000002 113.892 -169.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -177.0 164.61 2.3 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.626 1.97 . . . . 3.3399999999999999 110.368 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.9 mt -110.31 153.44 24.88 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.342 1.057 . . . . 2.0600000000000001 109.962 166.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -122.07 146.52 47.12 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.466 1.106 . . . . 2.6600000000000001 110.875 174.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.1 t -140.13 131.42 14.29 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.898 1.279 . . . . 1.8899999999999999 109.756 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.46 166.27 27.8 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.115 2.543 . . . . 1.0600000000000001 112.182 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -58.41 139.85 92.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.164 2.576 . . . . 1.3300000000000001 111.235 171.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.463 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 61.3 mmtt 65.1 3.96 2.37 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.977 1.311 . . . . 2.3300000000000001 113.286 -175.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.11 176.54 53.08 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 127.107 2.289 . . . . 1.4299999999999999 114.73 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 -98.66 129.98 45.16 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.441 1.496 . . . . 4.3499999999999996 112.84 -174.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.8 t -108.12 57.59 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.63 1.572 . . . . 7.0899999999999999 108.947 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -101.65 127.6 48.32 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.038 0.935 . . . . 3.1600000000000001 109.331 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.7 mp -67.82 -37.43 81.92 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.247 1.019 . . . . 3.1000000000000001 111.219 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.2 tptt 91.91 126.35 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 127.176 2.19 . . . . 4.8899999999999997 111.385 171.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.82 29.38 0.21 Allowed 'Trans proline' 0 CA--C 1.551 1.338 0 C-N-CA 125.027 3.818 . . . . 2.8700000000000001 115.037 -177.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.03 26.13 0.03 OUTLIER Glycine 0 CA--C 1.539 1.532 0 C-N-CA 127.05 2.262 . . . . 2.4700000000000002 115.284 -174.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.28 -29.59 0.02 OUTLIER Glycine 0 N--CA 1.481 1.683 0 N-CA-C 119.208 2.443 . . . . 2.2999999999999998 119.208 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -142.23 151.24 41.92 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.493 1.517 . . . . 3.6499999999999999 111.422 159.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -163.2 157.3 20.27 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.797 -1.189 . . . . 0.91000000000000003 111.998 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -78.43 139.55 38.73 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.073 -0.651 . . . . 4.0999999999999996 109.397 161.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -91.72 131.02 37.4 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.773 1.629 . . . . 1.79 108.116 159.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 mp -113.64 143.29 44.83 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.973 1.309 . . . . 2.02 109.071 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mt -137.96 139.4 39.71 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.239 1.016 . . . . 3.3399999999999999 111.355 -176.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.57 38.84 36.58 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.924 -0.931 . . . . 0.93000000000000005 113.897 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.61 150.89 0.91 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 117.17 2.285 . . . . 2.29 117.17 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -115.76 -13.28 11.41 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 113.746 -1.57 . . . . 3.5699999999999998 114.269 -172.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -119.57 154.26 54.46 Favored Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 125.954 1.702 . . . . 6.7300000000000004 108.902 168.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -70.66 149.3 60.93 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.662 2.241 . . . . 2.9700000000000002 110.067 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.5 mt -89.54 115.06 26.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 122.87 1.319 . . . . 4.2000000000000002 107.672 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -116.65 172.02 7.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.621 -1.627 . . . . 5.4199999999999999 110.473 169.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.45 136.79 39.41 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.832 -1.544 . . . . 2.77 106.832 145.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.1 45.24 9.09 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 123.161 0.41 . . . . 2.1299999999999999 113.721 174.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -111.64 177.71 4.56 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.35 0.575 . . . . 2.8199999999999998 110.775 148.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -146.35 134.81 21.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.1 2.16 . . . . 3.3599999999999999 108.146 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.8 t -139.49 136.09 40.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 127.768 2.427 . . . . 2.4300000000000002 109.636 -160.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -84.11 145.74 28.26 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.754 0.787 . . . . 3.0800000000000001 112.808 173.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mp -121.79 146.83 46.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.907 2.083 . . . . 2.8900000000000001 109.862 163.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -117.91 111.62 19.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.379 2.272 . . . . 2.3100000000000001 107.844 168.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.3 mp -83.0 140.23 32.84 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.864 0.866 . . . . 2.1299999999999999 109.352 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.8 mt -105.23 109.38 21.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.454 1.102 . . . . 1.8 110.098 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -97.63 150.52 21.06 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.758 1.223 . . . . 3.2599999999999998 111.117 172.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.43 126.62 22.02 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.287 1.435 . . . . 1.97 113.487 -169.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.43 49.0 6.98 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.086 -0.841 . . . . 2.6899999999999999 112.649 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.17 12.1 84.36 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 116.174 1.23 . . . . 2.6499999999999999 116.174 165.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -92.14 102.99 15.52 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.333 1.567 . . . . 4.7599999999999998 111.128 -168.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.3 p -93.18 139.45 18.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 O-C-N 124.603 1.19 . . . . 3.2599999999999998 111.818 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 123.39 19.95 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.467 0.707 . . . . 3.7799999999999998 111.514 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -89.84 129.51 36.21 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.273 1.429 . . . . 2.8300000000000001 111.473 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.18 143.97 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.952 1.301 . . . . 2.9399999999999999 109.935 168.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.0 p -112.77 134.89 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.358 1.063 . . . . 3.71 110.023 176.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 mp -138.87 148.71 59.11 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.967 1.307 . . . . 4.04 110.535 -167.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.66 153.12 79.09 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.468 2.112 . . . . 1.04 111.934 169.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.31 120.95 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.012 -1.477 . . . . 2.48 107.012 165.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -153.46 165.66 35.13 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 122.805 1.288 . . . . 5.3499999999999996 113.703 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.29 155.5 28.48 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.75 -1.114 . . . . 3.27 113.859 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.168 0 C-N-CA 131.248 3.819 . . . . 8.5999999999999996 107.374 157.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 121.871 0.843 . . . . 6.4000000000000004 109.751 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.06 176.17 19.43 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.565 -1.014 . . . . 1.3200000000000001 110.565 170.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -155.58 -178.65 7.43 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.387 0.613 . . . . 2.1099999999999999 112.568 -176.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.8 t -112.88 134.69 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.112 1.765 . . . . 2.4700000000000002 109.184 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -21.79 38.5 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.082 1.512 . . . . 6.5800000000000001 115.082 -172.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 82.9 t80 69.99 146.98 0.06 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 128.884 2.874 . . . . 3.5 113.792 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.3 m -170.93 154.81 4.36 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.79 2.036 . . . . 3.0899999999999999 111.886 173.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -82.68 -24.6 3.4 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.75 2.967 . . . . 2.1699999999999999 112.865 169.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.08 148.54 24.47 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 109.843 -1.303 . . . . 2.3100000000000001 109.843 166.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.87 -38.9 9.16 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.974 2.449 . . . . 3.3300000000000001 114.523 -163.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -80.03 139.51 36.93 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 123.352 1.549 . . . . 4.4000000000000004 112.779 -175.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.8 -175.31 5.31 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.341 1.457 . . . . 1.8799999999999999 112.502 -156.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.86 156.83 43.81 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.997 1.719 . . . . 1.79 109.932 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.4 143.92 39.99 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.175 0.805 . . . . 1.8600000000000001 113.175 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.458 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 31.0 m-85 -125.53 75.45 1.48 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.408 1.883 . . . . 3.6299999999999999 110.918 -168.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.83 162.92 28.6 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.816 -1.178 . . . . 2.8399999999999999 113.965 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 68.3 m -121.1 141.64 50.6 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.386 1.075 . . . . 2.6299999999999999 109.223 157.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.64 -179.35 7.53 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 128.473 2.709 . . . . 6.2999999999999998 107.776 175.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -138.89 157.36 46.19 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.16 -0.963 . . . . 3.8700000000000001 111.847 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -103.65 95.11 6.91 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 126.072 1.749 . . . . 1.3700000000000001 109.469 165.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.0 -3.94 12.47 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.009 2.473 . . . . 1.3400000000000001 114.337 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.26 160.41 31.9 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-O 122.456 1.031 . . . . 1.4099999999999999 111.759 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -87.23 10.02 18.36 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.815 2.446 . . . . 3.8999999999999999 112.179 175.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -116.01 152.88 48.14 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 128.812 2.845 . . . . 3.0099999999999998 109.744 171.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.38 153.58 24.11 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.22 2.614 . . . . 0.92000000000000004 111.489 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.9 mt -111.8 146.9 36.83 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 123.296 1.522 . . . . 2.6499999999999999 111.774 167.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -133.85 103.63 5.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 112.263 -2.244 . . . . 3.1099999999999999 110.04 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -82.7 109.73 17.13 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.185 1.394 . . . . 3.73 108.296 -174.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 m -105.65 -22.04 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.305 1.042 . . . . 1.51 111.908 -172.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.15 -176.72 31.52 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 125.279 1.419 . . . . 0.47999999999999998 113.737 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.27 179.16 9.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.263 1.425 . . . . 1.6899999999999999 111.679 168.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -146.19 174.33 11.42 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.783 2.033 . . . . 6.46 108.998 164.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 t -170.86 149.53 2.84 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 127.721 2.409 . . . . 1.7 108.149 175.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.91 -3.66 14.13 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.746 2.298 . . . . 1.1200000000000001 113.682 176.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 m -121.74 57.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.843 1.257 . . . . 2.2400000000000002 112.339 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.09 173.83 16.13 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.544 1.138 . . . . 1.8799999999999999 112.005 162.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.431 ' CD ' ' HZ1' ' A' ' 90' ' ' LYS . 4.1 tp10 -114.87 -51.95 2.72 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.277 1.831 . . . . 2.7200000000000002 109.446 165.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -101.66 132.13 47.52 Favored 'General case' 0 C--N 1.342 0.243 0 O-C-N 121.319 -0.863 . . . . 6.0999999999999996 109.489 161.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -97.06 150.65 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.108 -0.951 . . . . 2.1000000000000001 108.458 140.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -136.17 154.02 51.09 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.1 1.76 . . . . 3.0 109.013 169.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.8 tp -110.66 117.31 33.14 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.364 0.665 . . . . 2.0800000000000001 111.235 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -125.29 149.34 48.15 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.784 1.234 . . . . 0.78000000000000003 114.177 -172.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.409 ' CD ' HH21 ' A' ' 62' ' ' ARG . 19.9 pt-20 -87.51 169.92 11.78 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.507 1.923 . . . . 2.5699999999999998 112.15 163.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.407 ' HG1' ' C ' ' A' ' 47' ' ' GLU . 52.1 m -148.25 146.16 28.52 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 106.711 -1.589 . . . . 2.1299999999999999 106.711 173.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -157.99 163.09 38.12 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.116 1.154 . . . . 3.6600000000000001 114.116 -170.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.6 ttp -91.53 148.85 21.99 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.49 1.116 . . . . 3.8100000000000001 109.346 161.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.09 167.18 30.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.285 1.834 . . . . 5.1699999999999999 110.258 -170.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.455 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS . 2.9 tp10 -124.53 135.21 52.99 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.586 1.554 . . . . 2.5 110.553 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 t -136.8 120.33 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.035 -0.728 . . . . 3.0499999999999998 109.035 165.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.488 ' CD ' ' HZ2' ' A' ' 56' ' ' LYS . 3.7 mt-10 65.96 26.25 10.97 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.757 2.023 . . . . 3.1699999999999999 112.962 -176.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.25 10.71 85.77 Favored Glycine 0 CA--C 1.536 1.364 0 O-C-N 120.218 -1.551 . . . . 2.1099999999999999 113.366 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.488 ' HZ2' ' CD ' ' A' ' 54' ' ' GLU . 8.6 mtmp? -110.25 116.46 31.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.796 1.638 . . . . 4.2300000000000004 110.355 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.506 ' H ' ' HE2' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -58.66 129.25 41.2 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.961 2.104 . . . . 4.7699999999999996 110.407 174.354 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.8 p -156.72 146.01 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.369 1.867 . . . . 3.3399999999999999 109.752 -174.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.21 161.16 14.07 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.765 0.826 . . . . 4.4000000000000004 111.882 -174.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.44 -179.47 30.59 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 123.976 0.798 . . . . 0.68000000000000005 114.294 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.8 ttm -159.92 148.48 17.31 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.675 1.99 . . . . 1.79 109.09 -173.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.409 HH21 ' CD ' ' A' ' 47' ' ' GLU . 19.1 mtm105 -150.69 156.01 36.05 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.545 1.538 . . . . 5.9800000000000004 109.993 178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -77.05 152.94 31.96 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.03 1.82 . . . . 0.67000000000000004 110.82 168.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.3 m -139.1 151.85 68.67 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.897 1.279 . . . . 1.98 110.542 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.39 -24.01 11.08 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.27 2.647 . . . . 0.78000000000000003 112.624 -170.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -173.04 172.96 3.8 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.098 1.759 . . . . 3.23 110.912 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.1 mt -118.56 154.93 31.78 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.228 1.811 . . . . 1.9099999999999999 109.819 161.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -114.63 140.59 48.69 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.203 1.001 . . . . 1.8700000000000001 110.281 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.4 t -137.71 127.51 15.29 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 123.565 0.746 . . . . 1.8600000000000001 110.913 167.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.66 169.95 16.3 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.849 3.032 . . . . 1.04 111.941 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.06 143.17 96.9 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.112 2.541 . . . . 1.2 113.003 173.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm 64.15 8.28 3.97 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.549 1.54 . . . . 3.25 113.794 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.99 163.8 38.3 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 127.149 2.309 . . . . 1.2 113.639 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.4 mtt-85 -93.62 148.45 22.09 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.802 0.841 . . . . 6.5800000000000001 110.567 174.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.7 t -118.08 57.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.704 2.002 . . . . 6.8099999999999996 107.564 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.2 129.2 35.82 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.017 -0.734 . . . . 2.8999999999999999 109.017 168.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 tp -74.78 -24.56 58.69 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 112.925 0.713 . . . . 3.1299999999999999 112.925 -164.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? 76.97 100.89 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 127.319 2.248 . . . . 4.5999999999999996 110.342 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.458 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 35.0 Cg_endo -60.92 -29.46 88.11 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 121.829 1.686 . . . . 2.27 114.153 -175.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.88 10.5 70.09 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.148 -1.918 . . . . 1.73 115.07 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.47 -25.66 0.03 OUTLIER Glycine 0 N--CA 1.475 1.28 0 N-CA-C 121.414 3.326 . . . . 2.27 121.414 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -140.29 147.92 40.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 121.337 2.569 . . . . 3.5899999999999999 113.17 164.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -158.48 152.54 23.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.668 -1.151 . . . . 0.81000000000000005 112.209 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -78.25 139.08 38.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.094 -0.706 . . . . 3.7799999999999998 109.094 161.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -88.04 129.45 35.27 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.745 -1.206 . . . . 1.73 107.745 159.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 mp -108.74 127.43 53.99 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.06 -1.089 . . . . 1.7 108.06 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.42 143.42 50.75 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.75 0.82 . . . . 2.5299999999999998 110.591 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.17 45.81 47.01 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.291 -0.727 . . . . 0.81999999999999995 113.737 176.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pp -54.39 147.94 12.77 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 123.52 1.629 . . . . 2.3700000000000001 114.954 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.431 ' HZ1' ' CD ' ' A' ' 41' ' ' GLU . 33.4 mmtp -103.79 -5.78 22.11 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 113.328 -1.76 . . . . 2.8999999999999999 113.242 -169.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -148.57 144.47 18.51 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 127.585 2.354 . . . . 9.2400000000000002 109.402 171.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.56 152.54 17.59 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 124.069 3.179 . . . . 2.0499999999999998 111.281 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 93' ' ' LEU . 2.0 pt? -120.06 142.16 49.11 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.849 2.46 . . . . 4.9800000000000004 110.152 -166.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -96.2 -165.8 1.33 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 125.647 1.579 . . . . 4.5499999999999998 110.21 159.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.18 139.01 36.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 107.92 -1.141 . . . . 2.6299999999999999 107.92 148.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.45 4.55 34.85 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.66 1.6 . . . . 1.8200000000000001 115.501 -170.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.19 174.51 11.49 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.065 1.346 . . . . 2.8500000000000001 110.579 171.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -136.3 149.09 48.27 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.175 1.79 . . . . 4.0199999999999996 106.22 156.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.1 t -145.06 134.56 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.571 1.948 . . . . 2.0800000000000001 110.195 -165.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.424 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 35.2 tt0 -78.9 135.09 36.89 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.842 1.257 . . . . 3.3900000000000001 112.208 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mp -123.41 145.01 49.12 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.155 1.382 . . . . 2.8500000000000001 111.153 162.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -109.25 133.99 52.33 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.562 1.945 . . . . 2.8100000000000001 108.578 170.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 mp -108.5 131.44 54.81 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.883 0.873 . . . . 1.8400000000000001 109.686 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.2 mt -106.52 114.77 29.08 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.206 1.003 . . . . 1.95 109.844 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -113.36 121.11 43.38 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.981 1.713 . . . . 3.3199999999999998 111.498 -175.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.96 22.45 2.43 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.598 1.959 . . . . 2.6600000000000001 114.475 174.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.77 -58.39 3.46 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.127 1.346 . . . . 4.2199999999999998 112.66 -169.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.38 0.73 79.46 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 116.821 1.489 . . . . 2.1299999999999999 116.821 -167.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -130.94 140.15 50.14 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.774 1.787 . . . . 4.4699999999999998 112.344 173.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.0 p -127.73 147.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.42 1.888 . . . . 3.5800000000000001 110.347 172.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.1 tp -150.73 124.48 9.15 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.039 1.336 . . . . 2.9700000000000002 110.236 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.424 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 11.2 ttpt -113.25 135.75 53.5 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.266 0.626 . . . . 3.54 112.579 -172.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.4 t -146.45 163.93 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.465 1.506 . . . . 4.5599999999999996 108.956 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -114.56 138.03 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.179 1.392 . . . . 3.23 109.113 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mp -124.22 151.57 66.16 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.841 1.256 . . . . 3.6299999999999999 110.562 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -69.06 155.43 68.27 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.229 2.62 . . . . 1.3400000000000001 111.489 172.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.6 t -106.41 81.73 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 107.499 -1.297 . . . . 1.9399999999999999 107.499 161.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.19 156.09 27.09 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.748 -1.205 . . . . 4.0499999999999998 107.748 140.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -83.43 178.98 7.79 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.05 1.34 . . . . 3.6800000000000002 110.849 172.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.427 HH11 ' HG2' ' A' ' 120' ' ' ARG 0.268 12.1 ptt-85 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 114.78 -2.533 . . . . 10.32 113.494 162.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 CA--C 1.545 0.774 0 CA-C-O 121.545 0.688 . . . . 7.21 109.799 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.82 -179.93 32.16 Favored Glycine 0 N--CA 1.471 0.999 0 O-C-N 120.717 -1.239 . . . . 1.3600000000000001 114.689 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.5 p90 -141.87 165.82 26.41 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.418 1.487 . . . . 2.4199999999999999 112.206 172.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.6 t -106.14 135.56 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.044 -1.095 . . . . 2.23 108.044 166.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.04 113.95 15.3 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 120.766 0.317 . . . . 4.46 110.278 175.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -61.36 135.71 57.79 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.658 -0.497 . . . . 4.54 109.658 156.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.2 m -160.59 139.84 7.92 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.991 1.317 . . . . 4.29 108.952 167.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -85.08 48.23 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.692 3.595 . . . . 3.1200000000000001 112.353 -168.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -124.09 -175.45 14.39 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.411 1.482 . . . . 1.75 112.897 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.78 -17.46 20.13 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.673 2.915 . . . . 2.1099999999999999 113.516 174.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -122.16 167.33 13.3 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.728 2.011 . . . . 3.3700000000000001 113.431 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.34 -176.06 5.15 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 127.127 2.171 . . . . 2.0899999999999999 111.739 175.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.22 150.7 44.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.718 2.007 . . . . 1.75 108.658 176.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.47 138.41 48.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.153 0.888 . . . . 2.2000000000000002 111.308 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -129.02 133.55 47.78 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.057 1.743 . . . . 3.5899999999999999 110.656 -171.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 pp -165.7 152.12 9.7 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.149 0.886 . . . . 3.4700000000000002 113.1 -170.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 62.6 m -77.22 120.85 22.86 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.355 -0.841 . . . . 4.2999999999999998 109.035 171.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.14 118.97 23.0 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.541 -1.281 . . . . 4.1299999999999999 107.541 168.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -111.44 126.9 55.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.875 1.67 . . . . 4.0899999999999999 109.07 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -103.62 98.7 13.38 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 121.652 -0.655 . . . . 1.3799999999999999 111.552 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.17 -7.27 17.09 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.903 2.402 . . . . 1.52 114.112 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.76 172.35 53.18 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-O 122.658 1.143 . . . . 1.1899999999999999 112.656 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -103.78 -4.52 23.52 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.21 2.604 . . . . 3.0699999999999998 111.837 -174.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -116.55 162.41 26.9 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 129.106 2.963 . . . . 4.0700000000000003 109.577 172.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.12 142.59 24.76 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.131 1.888 . . . . 0.92000000000000004 109.991 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -105.67 158.04 16.99 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.076 1.351 . . . . 3.4500000000000002 111.308 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -149.42 107.45 3.72 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.154 -1.385 . . . . 3.8300000000000001 111.434 -171.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.5 tp -90.39 109.65 20.76 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 127.051 2.14 . . . . 2.8100000000000001 109.272 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -106.77 -17.76 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.445 1.098 . . . . 1.9099999999999999 112.238 -171.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.87 -175.38 28.73 Favored Glycine 0 C--N 1.344 0.985 0 C-N-CA 125.878 1.704 . . . . 0.45000000000000001 113.089 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.76 -176.91 5.45 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.532 1.533 . . . . 1.6499999999999999 110.794 168.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.71 175.87 13.34 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.418 2.687 . . . . 5.5999999999999996 108.2 169.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.0 159.3 7.85 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 127.135 2.174 . . . . 1.98 107.267 168.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.56 -9.68 16.67 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.638 2.225 . . . . 1.01 115.168 166.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.75 41.36 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 114.821 1.415 . . . . 2.1099999999999999 114.821 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.46 149.91 8.65 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.314 1.446 . . . . 2.4399999999999999 110.133 161.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.571 ' CD ' ' HZ2' ' A' ' 90' ' ' LYS . 27.7 tt0 -123.17 -58.78 1.62 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.817 1.247 . . . . 3.3799999999999999 111.376 -173.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -78.21 68.17 4.17 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 120.887 -1.133 . . . . 5.8200000000000003 108.989 168.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.7 p -78.03 150.47 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.054 -0.975 . . . . 1.6899999999999999 108.857 168.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.97 158.36 37.77 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.065 2.146 . . . . 4.75 107.038 -164.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -134.47 133.3 40.27 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 123.794 1.759 . . . . 2.96 114.102 171.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -120.41 149.13 42.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 112.728 -2.033 . . . . 0.80000000000000004 111.188 -171.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.65 -178.9 7.0 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.293 -1.321 . . . . 2.8999999999999999 110.837 155.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.7 m -153.22 138.68 17.65 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.893 1.277 . . . . 2.1600000000000001 108.465 172.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -147.73 164.27 34.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 122.84 1.305 . . . . 3.52 113.45 -171.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.5 ttm -97.32 138.71 34.37 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.313 1.445 . . . . 4.9800000000000004 109.758 172.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -149.08 161.51 41.8 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.431 1.271 . . . . 10.029999999999999 114.431 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -83.27 151.91 25.39 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.627 1.571 . . . . 3.2400000000000002 110.53 162.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.9 t -139.4 117.39 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.17 1.788 . . . . 3.3900000000000001 106.642 152.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 62.68 21.54 12.78 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.819 1.414 . . . . 3.9100000000000001 114.819 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.26 0.53 82.59 Favored Glycine 0 N--CA 1.48 1.612 0 O-C-N 120.378 -1.451 . . . . 2.3999999999999999 114.034 -170.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -104.27 119.88 39.94 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.139 2.576 . . . . 4.5800000000000001 107.644 -175.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -88.05 126.11 34.92 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.28 1.432 . . . . 5.75 110.03 -167.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.8 p -154.43 -178.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.732 1.613 . . . . 3.6400000000000001 109.691 -165.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 39.2 mmm -119.31 161.87 19.72 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.451 1.101 . . . . 4.2199999999999998 111.176 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -142.81 168.61 25.9 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 126.322 1.915 . . . . 0.65000000000000002 111.509 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.7 ttm -157.67 132.43 8.58 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.328 1.451 . . . . 1.97 109.226 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -145.43 148.99 39.34 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 126.476 1.91 . . . . 9.5399999999999991 109.704 -170.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.89 155.43 34.36 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.105 1.87 . . . . 0.81000000000000005 111.118 -176.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.4 m -131.41 151.6 79.04 Favored Pre-proline 0 N--CA 1.477 0.895 0 CA-C-O 118.453 -0.784 . . . . 2.1099999999999999 110.709 176.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.89 -20.6 11.64 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.397 2.732 . . . . 0.62 113.165 -167.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -179.29 164.0 1.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.04 2.136 . . . . 3.3300000000000001 110.467 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.6 mt -110.4 154.65 23.28 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.88 0.872 . . . . 1.75 110.57 162.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -134.6 146.17 49.34 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.329 0.652 . . . . 1.96 110.736 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.4 t -142.83 132.14 11.84 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 124.244 0.965 . . . . 2.0499999999999998 112.681 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.33 160.53 48.49 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.499 2.799 . . . . 0.94999999999999996 111.912 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -60.53 139.8 88.0 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.491 2.794 . . . . 0.92000000000000004 112.141 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.8 mptt 66.02 -6.42 0.46 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 127.7 2.4 . . . . 2.75 114.168 -174.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.59 153.73 37.23 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.759 1.647 . . . . 1.3799999999999999 113.202 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -107.23 147.16 30.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.15 0.98 . . . . 4.4100000000000001 109.647 163.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.9 t -145.14 125.9 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.907 1.683 . . . . 4.7599999999999998 107.013 166.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -93.77 130.91 39.6 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.708 1.003 . . . . 4.6500000000000004 113.708 -168.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -75.96 68.73 2.5 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.155 0.979 . . . . 2.29 109.507 157.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -90.64 156.58 45.02 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 125.705 1.602 . . . . 4.8399999999999999 113.675 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.28 -20.99 71.92 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.743 2.295 . . . . 2.6600000000000001 113.103 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.5 52.78 3.87 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-N 119.106 0.866 . . . . 3.1099999999999999 111.813 163.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.69 -117.9 2.08 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.472 1.511 . . . . 1.6299999999999999 115.679 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -74.44 143.83 44.53 Favored 'General case' 0 C--O 1.224 -0.276 0 O-C-N 121.574 -0.957 . . . . 3.5899999999999999 112.741 -161.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -161.8 154.28 19.9 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.454 -0.779 . . . . 0.88 113.024 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -78.08 136.22 37.86 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.296 -0.631 . . . . 3.0 109.296 166.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.9 tpt -97.94 133.45 42.41 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 107.801 -1.185 . . . . 1.8200000000000001 107.801 163.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -114.68 115.77 27.63 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.758 1.223 . . . . 1.98 108.29 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mp -120.08 155.34 33.17 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.826 0.822 . . . . 2.5899999999999999 110.19 168.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.08 45.81 24.51 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 116.004 -0.544 . . . . 1.5800000000000001 112.458 176.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.36 153.11 4.17 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 123.03 1.395 . . . . 2.73 113.99 169.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.571 ' HZ2' ' CD ' ' A' ' 41' ' ' GLU . 71.4 mmtt -113.78 -12.17 12.79 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.011 -1.45 . . . . 2.8999999999999999 113.029 -171.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -145.65 151.71 47.15 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 127.095 2.158 . . . . 6.0499999999999998 108.542 174.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.88 154.5 72.78 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.664 2.243 . . . . 2.1400000000000001 109.816 167.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 pp -148.18 143.69 27.23 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 126.172 1.789 . . . . 3.29 108.996 -168.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -127.35 173.02 10.13 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.925 1.69 . . . . 4.5 111.754 -168.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.31 130.76 35.77 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.323 -0.991 . . . . 1.9399999999999999 108.323 162.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.24 5.64 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.999 1.285 . . . . 1.8100000000000001 114.02 -176.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -129.16 -178.34 4.6 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.757 1.223 . . . . 2.3700000000000001 110.11 169.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -136.48 142.58 43.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.669 1.988 . . . . 4.9900000000000002 107.083 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.3 t -152.79 134.77 5.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 128.194 2.598 . . . . 2.2999999999999998 108.572 -168.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -93.17 156.12 17.04 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.241 1.2 . . . . 2.8700000000000001 114.241 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mp -115.07 162.74 16.59 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.11 1.764 . . . . 2.73 110.82 165.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -121.87 125.46 46.48 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 129.656 3.182 . . . . 3.1200000000000001 107.163 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -104.18 129.04 51.92 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.307 -1.496 . . . . 2.1499999999999999 110.181 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.5 mt -102.71 108.32 19.53 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.954 1.302 . . . . 2.1600000000000001 110.173 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -96.22 154.28 17.34 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.899 0.88 . . . . 3.27 110.562 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.93 135.72 29.91 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.616 0.767 . . . . 2.0 111.212 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.04 -6.53 69.27 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.437 1.018 . . . . 2.9900000000000002 114.348 -173.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.82 14.64 42.44 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-N 118.485 1.143 . . . . 3.3300000000000001 114.572 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 52.8 tttt -77.32 126.42 30.9 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.118 1.459 . . . . 6.9699999999999998 111.126 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 49.7 t -100.97 131.57 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.084 1.754 . . . . 3.5600000000000001 109.491 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.1 tp -128.27 114.34 16.79 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.603 1.161 . . . . 2.9900000000000002 109.251 169.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.36 134.56 49.31 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.298 1.222 . . . . 3.3500000000000001 114.298 -175.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.2 m -139.62 148.16 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 127.852 2.461 . . . . 3.3300000000000001 110.04 -152.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.4 t -118.05 124.47 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-N 120.096 1.316 . . . . 2.6000000000000001 110.563 -165.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.99 143.37 47.58 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.992 1.317 . . . . 3.5499999999999998 110.868 -169.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.34 149.43 35.33 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.192 2.594 . . . . 0.94999999999999996 111.917 165.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.1 t -102.28 124.78 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.941 0.896 . . . . 2.02 109.179 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.422 ' CD ' HH21 ' A' ' 120' ' ' ARG . 47.5 mt-10 -150.7 155.82 40.08 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.971 1.308 . . . . 3.5699999999999998 111.691 -174.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.95 59.35 3.18 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.088 0.955 . . . . 2.6800000000000002 113.206 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.422 HH21 ' CD ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.99 0 C-N-CA 126.275 1.83 . . . . 10.33 111.873 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 108.943 -0.762 . . . . 5.4800000000000004 108.943 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.4 171.85 46.26 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 121.252 -0.905 . . . . 2.2999999999999998 113.868 161.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -155.42 162.35 40.79 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.664 2.386 . . . . 2.3399999999999999 110.71 167.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.6 t -112.71 139.91 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.673 -1.267 . . . . 2.0899999999999999 110.264 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.34 124.63 29.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.596 0.359 . . . . 5.5800000000000001 110.96 176.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -36.14 145.2 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.996 2.518 . . . . 2.6400000000000001 115.039 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.4 t -163.22 140.19 5.78 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 121.427 -0.796 . . . . 3.2999999999999998 112.996 166.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -92.02 -8.9 2.75 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.276 3.317 . . . . 2.8100000000000001 112.56 167.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.05 -179.38 24.23 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.458 1.504 . . . . 1.4199999999999999 113.791 -169.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.49 -20.33 36.23 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 124.23 3.287 . . . . 1.49 114.58 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -113.17 162.95 15.37 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.176 1.39 . . . . 2.3799999999999999 113.855 172.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.9 -177.46 6.63 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.881 2.472 . . . . 1.71 111.262 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.49 136.07 27.28 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.817 1.247 . . . . 1.5600000000000001 110.363 174.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.83 143.18 49.01 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.717 1.207 . . . . 1.6899999999999999 112.676 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -115.59 128.87 56.26 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.863 1.665 . . . . 3.6899999999999999 109.433 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.27 3.7 pp -123.77 153.05 41.51 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.409 1.263 . . . . 3.1000000000000001 114.409 176.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.9 m -86.85 129.14 35.0 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.666 -1.235 . . . . 2.46 107.666 161.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.66 117.87 35.61 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.981 1.312 . . . . 3.8100000000000001 108.87 -176.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -98.58 134.13 41.96 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.356 0.662 . . . . 3.77 110.655 175.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -121.58 96.91 47.23 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.131 0.973 . . . . 1.45 111.151 164.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.39 -3.28 9.36 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.332 2.688 . . . . 1.3700000000000001 114.44 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.81 161.86 23.9 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 119.95 1.25 . . . . 1.6000000000000001 111.957 -176.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.08 3.7 14.27 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 128.12 2.568 . . . . 3.02 112.803 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -118.39 153.59 51.84 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 128.037 2.535 . . . . 3.3700000000000001 110.494 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.67 142.14 17.88 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.842 2.362 . . . . 1.01 110.473 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.3 mt -104.99 148.42 26.75 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 122.974 1.369 . . . . 2.79 111.562 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.7 ttp-105 -139.31 103.13 4.66 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 111.835 -2.439 . . . . 3.5899999999999999 111.506 -176.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.8 tt -81.88 115.17 20.95 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 124.424 1.09 . . . . 3.8599999999999999 109.404 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.6 m -103.13 -20.63 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.039 1.336 . . . . 2.1499999999999999 112.457 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.97 -175.47 27.93 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 126.105 1.812 . . . . 0.76000000000000001 113.028 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.42 -178.96 5.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.721 0.808 . . . . 1.8700000000000001 110.725 167.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -149.77 178.68 8.65 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.94 2.496 . . . . 5.54 107.145 159.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -176.9 152.68 1.05 Allowed Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 127.364 2.266 . . . . 1.8500000000000001 107.838 -174.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.57 -11.23 30.64 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.407 2.071 . . . . 1.1799999999999999 113.779 170.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.06 47.12 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 114.237 1.199 . . . . 2.3999999999999999 114.237 -175.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.76 152.65 11.83 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.429 1.892 . . . . 1.52 109.145 164.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.514 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 5.3 tp10 -101.3 -31.28 11.05 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.348 0.522 . . . . 4.5 111.857 167.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -113.73 133.71 55.19 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 126.283 1.833 . . . . 5.5999999999999996 108.66 168.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.4 p -139.56 127.29 25.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 124.752 1.221 . . . . 1.9399999999999999 108.844 172.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -146.79 119.91 8.84 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.332 1.053 . . . . 3.5099999999999998 108.85 -163.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -83.3 136.84 34.23 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 123.442 1.591 . . . . 3.2599999999999998 114.31 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -120.78 154.09 36.16 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.333 2.253 . . . . 0.73999999999999999 111.307 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -92.05 160.39 15.25 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.742 1.217 . . . . 2.23 110.15 155.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.1 m -103.62 141.32 36.25 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 106.96 -1.496 . . . . 2.3599999999999999 106.96 150.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -140.35 166.03 25.81 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 122.474 1.13 . . . . 3.1800000000000002 113.616 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.0 mtm -95.18 141.77 28.4 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.696 1.198 . . . . 6.0099999999999998 112.304 -176.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -142.25 153.32 43.86 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 115.409 1.633 . . . . 5.8700000000000001 115.409 168.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.461 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS . 2.7 tp10 -87.5 146.25 25.89 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.97 1.308 . . . . 3.0499999999999998 108.808 146.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.2 m -130.61 -10.03 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 116.946 2.202 . . . . 3.5299999999999998 116.946 169.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -162.98 22.77 0.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.174 1.39 . . . . 3.7400000000000002 112.728 -167.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.93 4.15 46.88 Favored Glycine 0 N--CA 1.482 1.744 0 O-C-N 119.958 -1.714 . . . . 1.8899999999999999 112.767 -159.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -120.12 134.5 55.24 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 129.055 2.942 . . . . 3.2400000000000002 107.76 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.461 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 2.7 mmtt -75.1 146.46 41.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.051 2.14 . . . . 5.4400000000000004 109.475 -175.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.4 p -155.03 168.45 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 126.635 1.974 . . . . 3.6200000000000001 109.538 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.7 mmm -122.93 144.39 49.26 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.071 1.349 . . . . 4.4699999999999998 110.101 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.73 179.23 16.21 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.554 1.549 . . . . 0.91000000000000003 112.075 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ttm -142.11 141.55 32.71 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.798 1.639 . . . . 1.6899999999999999 108.693 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.21 134.84 10.96 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 125.705 1.602 . . . . 7.6699999999999999 109.006 -164.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.28 143.37 35.21 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 CA-C-N 121.537 1.585 . . . . 0.85999999999999999 110.36 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.8 m -129.02 152.81 79.93 Favored Pre-proline 0 N--CA 1.481 1.125 0 CA-C-O 118.617 -0.706 . . . . 1.8899999999999999 111.262 -173.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.25 -26.06 4.43 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.04 2.494 . . . . 0.81999999999999995 112.782 -165.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -176.83 166.08 2.51 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.065 1.346 . . . . 3.3300000000000001 112.079 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.2 mt -117.2 150.89 37.99 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.596 1.958 . . . . 1.79 111.463 166.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -113.57 145.06 41.84 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.839 1.256 . . . . 2.0299999999999998 110.328 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.2 t -137.91 126.89 14.71 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 124.019 0.927 . . . . 2.0099999999999998 110.638 162.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.35 166.4 25.57 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 124.027 3.151 . . . . 0.93000000000000005 111.893 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.69 148.14 92.32 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.259 2.64 . . . . 1.1399999999999999 114.176 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.289 19.1 mtmt 49.16 43.24 22.47 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.67 1.988 . . . . 3.77 114.13 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.35 169.06 24.69 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 127.738 2.59 . . . . 1.8700000000000001 111.587 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.51 135.18 19.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.395 0.678 . . . . 5.3700000000000001 110.834 175.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -151.45 137.41 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.39 1.476 . . . . 5.1699999999999999 109.092 -162.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.99 158.24 15.52 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.684 1.231 . . . . 2.96 113.611 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.88 -32.99 74.81 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.78 2.032 . . . . 3.5899999999999999 114.208 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt 99.18 130.49 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.415 0 C-N-CA 131.424 3.89 . . . . 4.25 111.142 174.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.32 -5.12 10.58 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.704 2.936 . . . . 3.0099999999999998 115.584 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.4 -11.91 6.48 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-O 117.761 -1.577 . . . . 2.8900000000000001 115.168 167.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.13 -110.5 3.31 Favored Glycine 0 N--CA 1.474 1.177 0 CA-C-N 119.958 1.879 . . . . 1.8700000000000001 112.641 -172.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -73.16 145.61 46.22 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 122.035 -0.686 . . . . 3.4900000000000002 110.656 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.7 p-80 -163.92 153.11 14.05 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.814 -0.554 . . . . 0.60999999999999999 111.383 -177.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -80.43 131.81 35.64 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.441 -0.948 . . . . 2.8700000000000001 108.441 164.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.9 tpt -84.55 129.63 34.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.056 -1.461 . . . . 1.74 107.056 157.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.0 mp -107.49 131.22 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.087 -1.079 . . . . 1.75 108.087 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mp -130.25 145.81 51.79 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.908 1.283 . . . . 2.4100000000000001 110.138 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.8 40.82 93.81 Favored Glycine 0 CA--C 1.528 0.896 0 O-C-N 121.649 -0.657 . . . . 1.0800000000000001 111.494 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.68 145.98 32.45 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 122.909 1.337 . . . . 2.1400000000000001 113.689 175.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.514 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 27.7 mttt -101.8 -6.81 23.16 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.793 -1.548 . . . . 4.71 112.396 -172.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -132.98 139.06 33.3 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.802 1.641 . . . . 5.8200000000000003 108.763 154.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -63.6 142.72 85.17 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 N-CA-C 107.285 -1.852 . . . . 2.4500000000000002 107.285 156.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.1 mt -104.76 95.96 6.24 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.584 1.554 . . . . 3.3100000000000001 109.975 -157.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.69 135.55 36.57 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.26 1.024 . . . . 4.4299999999999997 111.293 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.51 106.49 0.66 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.954 1.302 . . . . 2.46 110.462 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.02 -0.02 21.09 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.872 1.701 . . . . 1.6000000000000001 115.032 -170.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -81.11 -176.4 5.93 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.149 1.475 . . . . 2.21 112.346 169.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -141.7 138.92 32.77 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 129.422 3.089 . . . . 3.3100000000000001 106.249 -168.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 79.0 t -150.62 158.04 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 128.827 2.851 . . . . 2.23 108.805 -167.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -123.25 154.45 38.79 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.504 0.722 . . . . 4.1100000000000003 110.613 164.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.89 135.8 55.1 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.556 1.142 . . . . 3.04 109.488 160.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.32 140.52 29.41 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.422 2.289 . . . . 2.3700000000000001 109.175 166.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.05 119.19 37.62 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.247 1.819 . . . . 2.1499999999999999 110.06 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.7 mt -90.25 105.28 17.7 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.479 1.112 . . . . 2.3100000000000001 109.594 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -99.78 144.05 29.3 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.075 1.35 . . . . 3.3100000000000001 111.036 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.05 123.58 10.82 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.552 1.141 . . . . 2.3399999999999999 114.042 -168.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.45 72.71 0.88 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.782 1.182 . . . . 3.0899999999999999 112.816 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.17 19.81 77.59 Favored Glycine 0 N--CA 1.473 1.11 0 N-CA-C 116.013 1.165 . . . . 2.3999999999999999 116.013 166.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -106.96 139.41 41.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.171 1.486 . . . . 5.29 111.114 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.0 p -147.01 147.22 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.717 0.807 . . . . 3.5800000000000001 112.413 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 24.3 tp -156.69 175.78 13.6 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.204 2.602 . . . . 3.6099999999999999 108.253 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -147.8 155.97 42.23 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.747 -1.221 . . . . 4.0599999999999996 113.169 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.6 t -140.2 157.78 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.635 1.574 . . . . 3.4199999999999999 109.571 -175.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.2 t -95.63 145.04 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.619 1.968 . . . . 3.6299999999999999 110.993 -170.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mp -145.11 120.18 5.77 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 126.09 1.756 . . . . 3.5299999999999998 111.164 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.65 165.74 26.54 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.541 2.16 . . . . 1.1799999999999999 110.456 161.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.4 t -100.26 141.36 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 O-C-N 121.279 -0.888 . . . . 2.2799999999999998 111.231 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -122.42 146.22 47.56 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.045 2.138 . . . . 4.9699999999999998 111.197 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.24 105.4 12.4 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.547 -0.721 . . . . 2.6699999999999999 112.089 167.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 . . . . . 0 C--O 1.25 1.091 0 C-N-CA 129.715 3.206 . . . . 8.0999999999999996 108.299 170.117 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.417 ' CD ' HH12 ' A' ' 74' ' ' ARG . 2.4 mt-10 . . . . . 0 CA--C 1.542 0.642 0 CA-C-O 122.365 1.079 . . . . 5.8099999999999996 110.353 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.74 179.93 33.11 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 124.654 1.121 . . . . 1.8300000000000001 113.232 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.8 p90 -156.69 153.55 28.65 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.035 0.754 . . . . 2.79 113.035 169.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.1 t -100.53 136.69 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.388 0.675 . . . . 2.3199999999999998 109.331 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -72.56 109.2 6.05 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.755 0.822 . . . . 7.1900000000000004 109.962 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.35 134.54 8.85 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.408 1.483 . . . . 3.2999999999999998 112.864 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.8 t -150.5 143.84 16.83 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 114.676 1.362 . . . . 3.2200000000000002 114.676 167.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -86.58 -4.62 8.29 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.54 2.826 . . . . 2.77 112.052 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.46 -176.03 25.1 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.216 1.388 . . . . 1.52 114.129 -169.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.52 -14.55 30.68 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.267 3.312 . . . . 1.6299999999999999 114.362 -175.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -131.07 153.34 49.41 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.184 2.194 . . . . 2.46 114.308 -172.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.13 -176.12 5.73 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 127.628 2.371 . . . . 1.71 113.261 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.18 157.64 45.89 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.928 2.091 . . . . 1.9199999999999999 109.595 172.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.81 152.57 46.65 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.524 1.056 . . . . 1.73 113.027 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -139.85 146.81 39.82 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.4 2.28 . . . . 3.6200000000000001 110.686 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -172.92 172.55 3.99 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.077 1.51 . . . . 3.5699999999999998 115.077 -170.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.24 143.03 39.24 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 129.323 3.049 . . . . 2.9300000000000002 110.569 -175.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.73 110.68 7.72 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.617 -0.512 . . . . 4.0 109.617 171.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -123.82 140.34 53.08 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.803 1.241 . . . . 3.4500000000000002 111.29 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -104.44 112.04 65.31 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.634 0.774 . . . . 1.4199999999999999 111.472 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -82.73 -19.53 6.05 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.948 2.432 . . . . 1.51 114.276 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.35 -177.12 51.73 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 119.029 0.831 . . . . 1.1599999999999999 112.022 -174.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -107.79 0.86 22.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.375 1.87 . . . . 2.9900000000000002 111.764 -174.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -118.94 160.24 41.52 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 128.287 2.635 . . . . 3.23 109.726 171.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.61 147.72 32.09 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.679 2.253 . . . . 1.27 110.947 -176.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.9 mt -103.81 149.53 24.96 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 122.518 1.151 . . . . 2.75 110.943 173.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -133.8 106.9 7.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 112.348 -2.206 . . . . 3.2999999999999998 110.669 -176.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 tt -81.25 115.67 20.76 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.253 1.021 . . . . 3.1499999999999999 108.652 177.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.17 -18.22 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.077 0.951 . . . . 2.0600000000000001 112.298 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.34 -173.95 27.41 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 126.059 1.79 . . . . 0.68999999999999995 112.701 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.94 -174.85 4.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.728 1.611 . . . . 1.8300000000000001 110.641 166.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.19 178.62 10.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.761 2.424 . . . . 6.0800000000000001 108.654 171.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -178.4 154.93 0.92 Allowed Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 127.03 2.132 . . . . 1.6799999999999999 107.939 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.16 -6.9 17.73 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.082 1.855 . . . . 0.84999999999999998 113.042 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.0 m -124.91 46.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 114.062 1.134 . . . . 2.0899999999999999 114.062 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.18 156.23 14.35 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.556 1.142 . . . . 1.8200000000000001 111.854 167.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.515 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 1.3 tp10 -92.83 -26.25 17.76 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.525 1.93 . . . . 2.9300000000000002 112.816 170.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -143.24 140.29 30.62 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 129.378 3.071 . . . . 8.5399999999999991 107.836 -168.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -157.2 59.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 125.101 2.381 . . . . 3.0299999999999998 111.954 -165.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.61 135.24 35.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 111.453 -2.612 . . . . 5.25 112.72 -162.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 31.9 tp -86.06 121.33 28.51 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.974 1.309 . . . . 2.4300000000000002 111.95 -165.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -123.38 153.86 39.77 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.363 1.465 . . . . 0.67000000000000004 113.771 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' C ' ' HG1' ' A' ' 48' ' ' THR . 23.2 pt-20 -98.83 173.26 6.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.692 1.997 . . . . 2.3500000000000001 111.673 163.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.411 ' HG1' ' C ' ' A' ' 47' ' ' GLU . 85.2 m -152.64 143.76 23.12 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.398 1.879 . . . . 1.8200000000000001 107.889 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -156.94 167.23 31.08 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.554 0.946 . . . . 3.2599999999999998 113.554 -167.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.1 mtt -94.55 154.62 17.3 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.98 0.912 . . . . 6.6100000000000003 110.877 160.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.67 157.04 34.47 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.613 1.165 . . . . 5.2599999999999998 110.307 -173.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -103.25 139.67 38.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.684 1.193 . . . . 2.6600000000000001 110.81 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.4 t -136.76 125.87 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.063 -1.458 . . . . 3.2599999999999998 107.063 162.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.519 ' CD ' ' HZ2' ' A' ' 56' ' ' LYS . 28.5 mt-10 60.79 22.29 12.32 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.672 1.589 . . . . 3.3300000000000001 114.162 -178.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.08 8.45 87.4 Favored Glycine 0 CA--C 1.538 1.475 0 O-C-N 120.051 -1.656 . . . . 1.8200000000000001 113.861 -171.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.519 ' HZ2' ' CD ' ' A' ' 54' ' ' GLU . 52.0 mtmt -108.35 124.26 50.08 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 127.235 2.214 . . . . 3.98 108.192 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.31 119.35 20.08 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.273 -1.33 . . . . 5.3099999999999996 110.198 -175.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.8 m -121.61 -178.6 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 128.313 2.645 . . . . 3.48 109.975 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.7 mtm -125.89 162.55 24.93 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.84 1.256 . . . . 4.8899999999999997 111.142 174.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.43 176.75 32.92 Favored Glycine 0 N--CA 1.462 0.417 0 CA-C-O 121.774 0.652 . . . . 0.65000000000000002 113.361 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.0 ttm -159.44 137.11 10.03 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.598 1.959 . . . . 2.1899999999999999 108.969 -173.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -138.91 153.23 71.66 Favored Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 125.949 1.7 . . . . 9.2300000000000004 109.399 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.62 152.21 25.8 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.923 1.749 . . . . 0.82999999999999996 109.501 170.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.57 151.84 75.23 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 124.128 0.971 . . . . 1.8300000000000001 110.621 -176.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.8 -25.99 5.91 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.166 2.577 . . . . 0.93999999999999995 112.882 -167.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -176.79 164.76 2.43 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.67 1.588 . . . . 3.8199999999999998 111.602 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.2 mt -109.06 152.19 25.37 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.653 1.181 . . . . 1.9299999999999999 109.982 160.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -117.69 141.6 48.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.748 1.219 . . . . 1.8899999999999999 110.074 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.4 t -137.32 128.27 16.16 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 113.754 1.02 . . . . 1.8400000000000001 113.754 171.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.19 158.43 41.44 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.125 3.217 . . . . 1.0900000000000001 112.574 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.82 133.66 46.06 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.135 3.224 . . . . 1.1200000000000001 112.764 -175.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.14 -12.84 0.55 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 128.721 2.808 . . . . 3.1400000000000001 113.872 -175.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.48 166.42 51.0 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.719 1.628 . . . . 1.3500000000000001 113.116 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.417 HH12 ' CD ' ' A' ' 5' ' ' GLU . 65.3 mtt180 -122.53 146.02 47.79 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.715 1.606 . . . . 5.46 111.785 172.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.3 t -152.96 89.77 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 124.801 1.241 . . . . 4.8200000000000003 110.146 170.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.04 147.57 44.93 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.294 -0.867 . . . . 4.79 109.59 -172.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.74 127.25 31.04 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.276 1.036 . . . . 2.46 109.419 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.35 122.49 87.65 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 117.305 -1.331 . . . . 4.04 109.979 -168.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -61.86 -10.62 17.88 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.747 2.964 . . . . 3.1000000000000001 114.618 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -125.92 0.39 7.78 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 117.355 -1.803 . . . . 2.2999999999999998 116.143 166.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.56 -20.4 1.24 Allowed Glycine 0 N--CA 1.481 1.676 0 CA-C-N 120.674 2.237 . . . . 1.97 118.483 -172.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -150.81 135.66 17.4 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.166 1.983 . . . . 3.7400000000000002 111.557 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -158.04 152.77 25.0 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.019 0.928 . . . . 0.75 110.602 -173.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -79.16 145.84 33.46 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.661 -0.866 . . . . 2.9500000000000002 108.661 161.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 tpt -106.64 124.14 49.17 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 126.73 2.012 . . . . 2.29 108.627 168.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -107.48 133.43 51.97 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.807 1.643 . . . . 1.8600000000000001 109.462 -173.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.57 148.87 49.24 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.186 0.995 . . . . 3.4500000000000002 111.473 176.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.17 40.15 30.07 Favored Glycine 0 N--CA 1.468 0.823 0 C-N-CA 123.766 0.698 . . . . 0.87 113.539 169.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 pp -56.98 156.29 7.02 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 116.075 1.88 . . . . 2.7400000000000002 116.075 -177.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.515 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 72.7 mmtt -111.42 -19.8 12.46 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 112.298 -2.228 . . . . 2.6200000000000001 112.684 -170.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -145.59 136.55 12.45 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 128.102 2.561 . . . . 6.8099999999999996 108.004 165.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.43 137.33 39.32 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.212 2.608 . . . . 1.8799999999999999 110.955 -176.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.73 84.74 2.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.992 2.117 . . . . 3.5800000000000001 110.055 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -86.36 169.81 12.59 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.467 1.507 . . . . 4.4699999999999998 111.629 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.93 112.62 3.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.814 -1.084 . . . . 2.79 111.892 -175.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.31 0.18 28.08 Favored Glycine 0 CA--C 1.539 1.536 0 N-CA-C 117.188 1.635 . . . . 2.1000000000000001 117.188 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -92.14 180.0 5.42 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.777 1.289 . . . . 2.3199999999999998 113.756 -169.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.54 77.57 1.18 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.57 1.948 . . . . 5.4100000000000001 113.498 -162.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 77.0 t -95.22 127.73 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.66 -1.275 . . . . 2.3700000000000001 111.979 -169.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -78.25 136.48 37.78 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.995 0.918 . . . . 2.54 112.568 173.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.23 151.59 35.45 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.15 0.976 . . . . 2.6699999999999999 111.744 155.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -104.22 141.68 35.85 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.62 2.768 . . . . 2.23 107.933 160.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.02 130.95 54.57 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.852 1.261 . . . . 1.99 108.833 172.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.8 mt -100.68 111.02 23.19 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.131 0.973 . . . . 2.0600000000000001 109.593 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -98.77 141.3 31.74 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.104 1.361 . . . . 3.3399999999999999 110.863 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.47 125.94 7.53 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.753 1.621 . . . . 2.4900000000000002 112.729 -172.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.74 33.79 20.72 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.065 -0.853 . . . . 2.6099999999999999 114.026 -175.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.3 14.13 74.95 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 116.596 1.399 . . . . 2.9300000000000002 116.596 162.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -88.89 123.65 33.46 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.588 1.694 . . . . 4.4199999999999999 111.414 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.8 t -115.83 131.22 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 O-C-N 124.07 0.857 . . . . 3.4700000000000002 111.38 -173.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.5 tp -124.75 122.92 38.82 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.11 1.364 . . . . 3.2799999999999998 111.073 177.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.89 148.84 32.6 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.405 -0.81 . . . . 3.3100000000000001 112.305 171.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -146.66 157.61 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.642 1.577 . . . . 3.4100000000000001 109.29 163.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.8 t -104.97 136.84 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.118 1.367 . . . . 2.9199999999999999 109.696 173.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.9 mp -125.25 130.67 24.08 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.916 1.687 . . . . 3.6200000000000001 110.762 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.68 138.71 38.74 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.004 1.803 . . . . 1.22 109.842 164.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.9 t -77.92 141.41 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 O-C-N 120.699 -1.251 . . . . 2.4399999999999999 108.485 162.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.53 -174.24 2.55 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.989 1.716 . . . . 6.96 113.45 -177.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -126.34 151.57 47.4 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.524 1.13 . . . . 3.1600000000000001 110.407 166.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.178 0 C-N-CA 129.637 3.175 . . . . 10.07 109.936 -165.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.3 pm0 . . . . . 0 CA--C 1.537 0.448 0 CA-C-O 120.599 0.238 . . . . 7.1799999999999997 110.543 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.89 172.23 38.0 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 121.338 -0.851 . . . . 2.0 113.337 159.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.9 p90 -155.8 153.28 29.57 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.112 1.365 . . . . 2.2400000000000002 112.234 164.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.38 139.94 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.16 -0.963 . . . . 2.0699999999999998 108.556 173.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -75.71 109.16 9.07 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.876 0.87 . . . . 5.9400000000000004 111.768 -178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -47.29 130.26 13.08 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.569 1.548 . . . . 4.1399999999999997 111.469 171.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -154.92 167.5 13.92 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 124.465 1.106 . . . . 3.0499999999999998 113.51 162.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -94.39 -1.73 2.83 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 124.268 3.312 . . . . 2.1400000000000001 114.071 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.71 -168.02 26.36 Favored Glycine 0 CA--C 1.542 1.774 0 C-N-CA 124.788 1.185 . . . . 1.5 115.517 -167.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.79 -10.23 16.95 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 124.817 3.678 . . . . 1.55 114.328 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -135.04 158.68 43.73 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.845 2.458 . . . . 2.4300000000000002 113.83 -170.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.82 -175.04 5.14 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.399 2.28 . . . . 1.8300000000000001 112.344 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.28 151.47 47.64 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.777 2.431 . . . . 1.75 107.726 172.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.94 144.68 51.01 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.552 1.069 . . . . 1.9099999999999999 112.268 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.459 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 65.6 m-85 -124.21 143.24 50.63 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.439 1.896 . . . . 3.6000000000000001 110.661 -178.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -173.23 166.33 4.86 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.942 1.697 . . . . 4.4400000000000004 111.832 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 t -102.75 160.12 14.87 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.719 1.208 . . . . 2.96 113.436 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.6 tp -129.69 129.26 44.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.491 1.517 . . . . 4.75 109.808 169.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -117.61 142.48 47.16 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.11 0.564 . . . . 3.3399999999999999 109.809 157.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -94.84 110.46 49.73 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.162 0.985 . . . . 1.49 109.371 173.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -84.62 -9.12 9.2 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.287 2.658 . . . . 1.1499999999999999 114.48 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.99 177.14 47.77 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 122.564 1.091 . . . . 1.2 113.101 -172.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -89.71 -6.5 56.02 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.614 1.165 . . . . 4.0999999999999996 112.043 174.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.69 160.17 45.47 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 127.63 2.372 . . . . 2.6600000000000001 110.823 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -77.16 148.98 27.87 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.636 2.224 . . . . 1.05 111.476 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.7 mp -110.8 152.46 26.61 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.63 1.572 . . . . 3.77 109.509 172.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -138.77 113.94 9.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 113.674 -1.603 . . . . 3.2999999999999998 109.574 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.3 tt -86.88 123.9 32.52 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.684 1.194 . . . . 3.0600000000000001 108.311 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.1 m -115.31 -14.65 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.413 1.085 . . . . 1.7 111.994 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.15 -174.64 28.11 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 125.708 1.623 . . . . 0.54000000000000004 113.879 -174.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.42 -176.35 5.35 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.838 1.655 . . . . 1.6299999999999999 111.542 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -153.67 168.82 24.94 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.023 1.729 . . . . 7.3399999999999999 109.03 164.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 t -165.73 148.07 6.44 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 126.028 1.731 . . . . 1.8899999999999999 108.381 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.06 -0.22 9.73 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.597 2.198 . . . . 1.1100000000000001 113.232 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.67 43.46 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.651 1.58 . . . . 1.8799999999999999 113.656 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.02 135.3 5.32 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.368 1.067 . . . . 2.0600000000000001 110.409 160.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -83.68 -26.41 29.86 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.508 1.123 . . . . 3.7200000000000002 113.219 174.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -108.64 132.2 54.14 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 108.074 -1.084 . . . . 5.7300000000000004 108.074 160.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -116.23 141.37 34.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.298 -1.001 . . . . 2.1400000000000001 108.298 150.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -132.6 153.43 51.05 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.397 1.879 . . . . 2.9199999999999999 108.461 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.4 tp -109.59 120.38 42.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.644 0.778 . . . . 2.3500000000000001 110.18 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -121.87 161.52 22.62 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.803 1.241 . . . . 0.69999999999999996 112.753 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.51 160.63 29.04 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.149 -0.932 . . . . 3.5499999999999998 110.886 161.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.6 m -132.36 123.77 27.43 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.98 1.712 . . . . 2.3500000000000001 107.189 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -113.72 170.61 8.13 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.121 1.768 . . . . 3.5299999999999998 112.522 -174.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 50.6 ttp -99.64 141.67 32.13 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.527 1.131 . . . . 3.77 110.284 164.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -133.55 161.02 35.72 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.429 1.892 . . . . 5.6500000000000004 110.108 170.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.485 ' CD ' ' HZ2' ' A' ' 57' ' ' LYS . 3.0 tp10 -90.18 147.9 23.29 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.483 1.113 . . . . 2.4199999999999999 109.11 154.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.41 137.7 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.713 -1.217 . . . . 4.1399999999999997 107.713 149.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.405 ' HB2' ' HE2' ' A' ' 56' ' ' LYS . 25.5 mt-10 61.9 9.8 3.19 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 115.921 1.823 . . . . 3.1400000000000001 115.921 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.0 5.95 59.39 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 124.657 1.122 . . . . 1.6399999999999999 115.194 -171.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.405 ' HE2' ' HB2' ' A' ' 54' ' ' GLU . 44.9 pttt -121.91 134.23 54.86 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.409 2.284 . . . . 3.9700000000000002 110.585 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.485 ' HZ2' ' CD ' ' A' ' 52' ' ' GLU . 2.2 mmtt -73.05 131.59 42.3 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.54 2.336 . . . . 4.8399999999999999 109.406 -176.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 m -138.5 166.41 23.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 127.447 2.299 . . . . 3.1299999999999999 109.702 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -129.42 129.67 44.98 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.204 1.002 . . . . 4.0199999999999996 110.812 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.67 175.25 16.46 Favored Glycine 0 N--CA 1.467 0.748 0 C-N-CA 125.677 1.608 . . . . 0.85999999999999999 111.88 -176.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.7 ttm -139.13 156.8 46.88 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.225 1.41 . . . . 1.6599999999999999 110.077 -172.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -161.33 151.1 14.06 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.36 1.464 . . . . 7.6100000000000003 110.837 -175.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.33 153.49 45.37 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.17 1.913 . . . . 0.71999999999999997 110.607 172.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.3 m -137.5 153.04 74.1 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 124.683 1.193 . . . . 1.77 109.895 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -82.36 -28.36 1.9 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.866 2.378 . . . . 0.66000000000000003 113.287 -166.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -175.25 167.19 3.42 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.497 1.519 . . . . 3.3799999999999999 111.982 -176.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.2 mt -115.14 148.67 38.72 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.267 1.827 . . . . 1.8700000000000001 110.418 165.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -115.06 138.91 50.34 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.74 1.216 . . . . 1.74 108.858 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.4 t -140.29 124.84 10.95 Favored Pre-proline 0 N--CA 1.471 0.578 0 N-CA-C 112.92 0.711 . . . . 1.8999999999999999 112.92 170.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.33 161.25 44.9 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.855 3.037 . . . . 1.0600000000000001 111.67 178.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -58.16 136.75 76.79 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.664 2.909 . . . . 1.02 111.893 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.78 -9.05 1.14 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 127.363 2.265 . . . . 3.9700000000000002 113.099 -178.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.14 146.27 29.1 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.226 1.394 . . . . 1.21 113.142 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.36 140.44 45.94 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.747 2.019 . . . . 5.1200000000000001 109.529 171.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.8 t -145.89 123.85 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.451 1.9 . . . . 4.1600000000000001 108.234 175.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -109.03 141.76 40.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.745 1.218 . . . . 5.1900000000000004 110.935 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -79.0 65.91 4.3 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.487 1.115 . . . . 2.1800000000000002 109.328 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 136.57 49.66 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-O 118.288 -0.863 . . . . 6.25 112.149 -167.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.459 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 33.9 Cg_endo -62.75 -20.9 72.35 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.89 3.06 . . . . 2.3999999999999999 116.973 -158.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.76 -3.66 87.94 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-O 118.734 -1.036 . . . . 2.6099999999999999 115.093 173.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.5 -108.07 1.3 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.504 1.526 . . . . 1.8999999999999999 113.615 -174.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -71.87 142.66 49.56 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.745 -0.856 . . . . 3.5499999999999998 110.594 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -162.78 168.15 21.87 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.461 1.104 . . . . 0.65000000000000002 110.251 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -93.79 147.26 23.22 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.468 -0.568 . . . . 3.1400000000000001 109.468 163.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.8 tpt -102.32 136.53 41.99 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.887 1.275 . . . . 2.21 109.67 166.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -117.72 128.03 54.49 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.179 1.391 . . . . 1.9399999999999999 109.264 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.67 145.35 50.61 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.036 0.934 . . . . 3.3900000000000001 110.235 173.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.63 51.56 11.66 Favored Glycine 0 N--CA 1.469 0.872 0 O-C-N 121.701 -0.624 . . . . 0.81999999999999995 112.409 174.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.26 155.97 10.66 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 115.064 1.505 . . . . 2.48 115.064 173.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.5 -7.13 12.84 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 113.973 -1.467 . . . . 3.8999999999999999 113.707 -176.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -139.93 168.61 14.35 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 128.22 2.608 . . . . 5.4000000000000004 108.775 166.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -58.7 160.92 16.14 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.578 1.519 . . . . 2.5800000000000001 110.935 161.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.2 103.4 6.22 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.218 1.007 . . . . 3.79 110.147 161.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.5 mmtm -115.34 158.91 21.74 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.723 2.409 . . . . 7.6200000000000001 112.155 174.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.64 120.18 10.1 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.695 -0.854 . . . . 2.5699999999999998 108.695 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.53 -0.73 53.13 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.156 1.36 . . . . 1.3799999999999999 115.141 -174.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.42 -174.66 5.29 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.574 1.687 . . . . 2.8599999999999999 110.272 161.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -155.71 145.56 21.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.834 2.054 . . . . 3.2000000000000002 107.789 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.4 t -148.54 130.35 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 125.785 1.634 . . . . 2.1699999999999999 109.922 -163.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.514 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 10.6 mt-10 -79.05 138.82 38.15 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.868 -0.606 . . . . 3.3999999999999999 111.316 176.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -123.83 132.3 53.75 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.909 1.283 . . . . 4.0199999999999996 110.468 171.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.24 140.22 30.05 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.446 1.898 . . . . 2.4300000000000002 108.669 165.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -107.28 130.18 54.79 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.396 1.878 . . . . 2.1600000000000001 107.926 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.8 mt -109.74 126.94 54.25 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.907 1.283 . . . . 2.0800000000000001 110.678 -176.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -119.97 151.76 38.47 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.484 1.114 . . . . 3.3399999999999999 112.917 -171.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.43 151.57 19.75 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.283 1.033 . . . . 2.0600000000000001 112.798 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.18 16.87 75.42 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.884 -0.954 . . . . 3.4199999999999999 114.738 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.19 78.08 0.93 Allowed Glycine 0 CA--C 1.529 0.959 0 CA-C-N 118.876 1.338 . . . . 2.2599999999999998 113.461 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -152.23 141.09 21.05 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.516 2.726 . . . . 4.29 110.872 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.3 t -138.76 147.88 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.959 1.704 . . . . 2.96 108.092 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 tt -150.56 116.83 5.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.924 0.889 . . . . 3.6499999999999999 110.598 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.514 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 0.8 OUTLIER -95.44 122.06 37.76 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.905 0.705 . . . . 4.9500000000000002 112.905 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -105.31 175.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 126.699 1.999 . . . . 3.3700000000000001 110.604 166.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.7 t -138.8 132.41 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.102 0.961 . . . . 2.8199999999999998 109.364 173.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -125.01 149.93 64.9 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.731 1.612 . . . . 4.2599999999999998 109.703 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.18 159.09 48.65 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.334 2.023 . . . . 1.1299999999999999 110.642 163.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 42.1 t -90.97 134.77 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.374 -1.713 . . . . 2.2599999999999998 106.374 156.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -136.5 174.43 10.62 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.369 0.667 . . . . 3.8199999999999998 111.769 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.6 55.23 1.61 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.538 1.535 . . . . 3.3300000000000001 113.643 -170.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.143 1 C-N-CA 131.739 4.016 . . . . 8.1400000000000006 114.41 161.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 . . . . . 0 CA--C 1.54 0.585 0 CA-C-O 121.843 0.83 . . . . 4.4500000000000002 111.297 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.47 171.9 42.33 Favored Glycine 0 C--N 1.336 0.535 0 O-C-N 121.792 -0.568 . . . . 1.6299999999999999 114.326 179.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -152.54 144.3 23.58 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.483 1.113 . . . . 2.29 111.032 166.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.6 t -88.96 133.4 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 107.635 -1.246 . . . . 2.0800000000000001 107.635 175.185 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.84 115.23 27.92 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.145 0.578 . . . . 4.8099999999999996 109.629 -172.061 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -62.88 151.65 38.57 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.91 1.284 . . . . 3.1400000000000001 113.408 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.8 t -162.86 151.41 12.13 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.997 1.719 . . . . 3.0699999999999998 110.207 164.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.1 -12.84 21.32 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.801 2.334 . . . . 2.1899999999999999 112.647 166.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.85 138.86 18.0 Favored Glycine 0 CA--C 1.537 1.46 0 N-CA-C 110.125 -1.19 . . . . 2.5099999999999998 110.125 168.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.33 -26.98 20.04 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.048 2.499 . . . . 2.7799999999999998 114.818 -167.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -84.16 138.58 32.92 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.992 1.269 . . . . 4.4400000000000004 110.829 171.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.76 -176.4 3.97 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.036 1.735 . . . . 1.75 112.178 -166.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.72 149.36 37.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.921 1.288 . . . . 1.6499999999999999 109.71 175.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.35 152.9 47.53 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.248 1.023 . . . . 1.8799999999999999 113.627 -175.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -129.7 143.52 50.86 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.05 2.14 . . . . 3.9199999999999999 108.634 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.52 170.48 14.32 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.474 1.51 . . . . 3.7200000000000002 111.827 -178.612 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.1 m -112.13 130.42 55.9 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 124.455 1.102 . . . . 3.2799999999999998 110.983 -166.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.83 123.0 47.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.418 1.487 . . . . 4.21 107.744 168.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -126.95 134.0 50.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.993 -1.484 . . . . 4.5800000000000001 106.993 161.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -94.21 105.51 17.96 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.031 0.933 . . . . 2.0099999999999998 110.514 -176.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.14 -11.91 16.09 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.515 2.143 . . . . 1.9199999999999999 113.427 176.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.8 178.26 53.25 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 119.204 0.911 . . . . 1.76 111.782 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -107.24 -0.06 22.89 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 126.772 2.029 . . . . 3.5600000000000001 111.745 -173.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.8 157.99 66.95 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 128.301 2.641 . . . . 3.0899999999999999 109.353 175.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.69 159.75 41.97 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.369 2.046 . . . . 1.46 112.137 -170.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.1 mt -112.91 149.28 33.4 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.378 1.471 . . . . 2.6899999999999999 110.279 170.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.4 ttp-105 -128.92 110.8 12.41 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 112.989 -1.914 . . . . 4.0599999999999996 109.325 173.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.1 tp -94.4 114.5 26.55 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 126.097 1.759 . . . . 2.9300000000000002 108.891 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -114.11 -16.82 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.335 1.054 . . . . 1.6000000000000001 112.064 -169.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.93 -175.55 28.98 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.877 1.703 . . . . 0.46000000000000002 113.031 -176.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.74 -178.61 6.44 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.566 1.546 . . . . 1.8 110.845 173.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 -147.02 -179.25 6.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.978 1.711 . . . . 6.2699999999999996 109.245 156.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 t -170.83 148.49 2.61 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 127.316 2.246 . . . . 1.97 107.806 174.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.54 -11.49 24.38 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.825 2.35 . . . . 0.85999999999999999 113.258 -178.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.9 m -110.89 58.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.502 1.521 . . . . 1.9299999999999999 110.883 172.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.57 172.02 16.08 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.944 1.697 . . . . 2.0600000000000001 110.034 167.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -118.28 -21.41 8.14 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.937 0.895 . . . . 3.5600000000000001 111.844 159.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -143.17 150.79 39.88 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 126.15 1.78 . . . . 7.7000000000000002 108.439 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.39 148.17 20.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 C-N-CA 125.803 1.641 . . . . 1.9099999999999999 107.346 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.405 ' HG2' ' HE2' ' A' ' 46' ' ' HIS . 7.2 tp10 -135.67 139.79 43.99 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.02 1.728 . . . . 4.0999999999999996 107.963 -167.052 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.7 tp -102.02 120.07 39.82 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 120.391 1.451 . . . . 2.6000000000000001 110.942 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.405 ' HE2' ' HG2' ' A' ' 44' ' ' GLU . 58.7 m170 -123.93 160.31 27.81 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.794 1.638 . . . . 0.80000000000000004 115.258 -174.397 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' CD ' HH21 ' A' ' 62' ' ' ARG . 15.4 pt-20 -103.66 146.9 27.89 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.791 2.436 . . . . 2.3599999999999999 111.24 158.151 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 100.0 m -107.15 148.57 28.68 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 106.323 -1.732 . . . . 2.23 106.323 156.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -158.49 -179.49 8.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.639 1.176 . . . . 3.2799999999999998 112.671 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.3 mmt -107.78 143.38 36.41 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.055 1.342 . . . . 6.3399999999999999 114.002 -178.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.73 143.87 33.74 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.708 2.003 . . . . 7.0300000000000002 111.803 178.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -99.27 130.93 45.6 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.146 0.978 . . . . 3.3599999999999999 109.011 156.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.5 t -139.98 131.8 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 107.696 -1.224 . . . . 2.8700000000000001 107.696 172.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 59.81 20.92 9.78 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.03 1.732 . . . . 3.8100000000000001 114.552 -173.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.53 25.77 73.38 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.484 -1.385 . . . . 2.75 113.105 -168.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -118.65 123.91 46.12 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.014 1.726 . . . . 4.3899999999999997 108.248 173.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.565 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -73.72 121.85 21.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.037 1.735 . . . . 5.0499999999999998 110.793 170.02 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 m -145.64 156.58 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 128.096 2.558 . . . . 3.6200000000000001 109.764 -172.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 37.8 mtp -95.73 146.27 24.65 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.289 -0.882 . . . . 4.9299999999999997 112.19 173.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.86 168.87 13.72 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.66 1.6 . . . . 0.70999999999999996 111.436 175.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.8 ttm -150.48 142.6 24.07 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.831 1.252 . . . . 1.8999999999999999 109.596 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.416 HH21 ' CD ' ' A' ' 47' ' ' GLU . 31.3 mtm180 -143.0 157.45 60.85 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 125.598 1.559 . . . . 6.5099999999999998 109.792 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.74 157.15 39.76 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.015 1.81 . . . . 0.94999999999999996 111.243 163.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.6 m -138.7 153.41 72.2 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 126.032 1.733 . . . . 2.0 109.402 176.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.56 -22.97 2.91 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.968 2.446 . . . . 0.81999999999999995 113.821 -163.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -179.74 165.6 1.3 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.711 1.604 . . . . 3.3900000000000001 111.899 -179.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -111.54 155.11 23.79 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.869 1.668 . . . . 1.99 110.224 164.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -115.99 146.45 42.12 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.622 1.169 . . . . 2.2999999999999998 109.227 173.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.0 t -140.22 125.06 11.13 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 113.115 0.783 . . . . 2.48 113.115 170.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.14 159.47 40.82 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.945 3.097 . . . . 1.5700000000000001 112.049 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.07 138.1 65.62 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.921 3.08 . . . . 1.7 112.607 -178.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.8 mptt 66.23 -6.58 0.47 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 128.264 2.626 . . . . 3.0699999999999998 114.122 -175.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.97 167.49 34.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.789 1.662 . . . . 1.52 112.65 176.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -132.91 157.93 43.87 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.164 0.985 . . . . 5.2000000000000002 113.526 175.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.3 t -145.59 138.75 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 127.95 2.5 . . . . 3.8599999999999999 107.129 172.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.1 134.4 34.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.296 -1.001 . . . . 4.0300000000000002 108.296 -173.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.76 162.0 27.26 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 125.177 1.391 . . . . 2.6899999999999999 111.379 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.33 154.1 13.98 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 119.884 -1.76 . . . . 5.0999999999999996 115.047 -178.052 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.59 -38.78 80.12 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 124.577 3.518 . . . . 2.7400000000000002 115.089 -174.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.05 9.84 6.34 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 119.203 -0.776 . . . . 1.72 114.374 175.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.52 -132.85 1.4 Allowed Glycine 0 C--N 1.339 0.723 0 C-N-CA 124.909 1.242 . . . . 1.78 114.401 -176.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.402 ' CE1' ' CB ' ' A' ' 47' ' ' GLU . 3.5 m-30 -72.98 139.61 46.81 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 121.51 -0.994 . . . . 3.52 111.483 -169.049 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 -161.19 157.8 26.38 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.093 1.357 . . . . 0.81000000000000005 111.986 -169.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.66 146.79 26.68 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.452 -0.78 . . . . 3.77 109.722 166.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.6 tpt -98.19 134.83 40.71 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.379 1.472 . . . . 1.73 108.54 161.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -110.09 140.99 43.56 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.624 1.169 . . . . 1.71 109.51 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.06 140.54 43.87 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.184 0.809 . . . . 2.9700000000000002 113.184 -178.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.39 49.25 15.83 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.878 0.751 . . . . 0.90000000000000002 114.37 168.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.54 150.0 12.8 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 116.553 2.057 . . . . 2.4100000000000001 116.553 -177.084 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -103.53 2.22 33.27 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 113.509 -1.678 . . . . 2.98 113.111 -174.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -151.38 151.12 28.46 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 127.573 2.349 . . . . 6.1500000000000004 108.622 172.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -66.93 156.03 68.11 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 N-CA-C 108.307 -1.459 . . . . 2.1099999999999999 108.307 152.02 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 pp -151.4 155.25 38.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.032 1.733 . . . . 3.5800000000000001 107.408 -175.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -138.72 156.53 47.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 123.451 1.595 . . . . 5.8300000000000001 114.111 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.6 121.0 11.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.143 -0.935 . . . . 2.46 109.444 173.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.55 49.69 1.38 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.885 1.231 . . . . 1.5900000000000001 112.45 -167.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -148.8 -175.04 4.79 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 129.781 3.232 . . . . 2.4300000000000002 109.339 175.329 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -144.61 140.61 28.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.464 2.305 . . . . 4.0300000000000002 106.69 179.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.7 t -142.61 139.74 28.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 126.289 1.836 . . . . 2.0800000000000001 109.349 -170.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.476 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 21.9 mt-10 -78.72 144.26 35.44 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.075 0.55 . . . . 2.6299999999999999 111.683 177.075 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.38 139.57 50.7 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.89 0.852 . . . . 2.5499999999999998 110.104 150.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.85 152.21 19.05 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.507 1.523 . . . . 2.1099999999999999 108.982 162.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 mp -122.01 130.94 53.72 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.812 1.645 . . . . 2.1099999999999999 109.253 -176.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.5 mt -110.44 118.29 35.87 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.792 1.237 . . . . 1.9099999999999999 110.408 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -114.58 160.45 19.26 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.967 1.307 . . . . 3.73 111.287 -178.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.14 146.45 50.51 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.513 -0.742 . . . . 2.29 111.844 167.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.98 23.95 28.64 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.185 0.898 . . . . 3.1699999999999999 115.041 176.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.04 6.6 83.03 Favored Glycine 0 N--CA 1.478 1.438 0 CA-C-N 118.479 1.14 . . . . 2.2999999999999998 113.592 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -79.97 115.4 19.53 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.247 1.019 . . . . 3.9900000000000002 111.398 -177.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.41 145.17 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.282 1.433 . . . . 3.3599999999999999 109.523 165.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.8 tp -143.23 175.4 9.92 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.916 1.686 . . . . 3.6699999999999999 109.334 175.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.476 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 0.8 OUTLIER -155.4 156.71 35.85 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.358 0.873 . . . . 3.1099999999999999 113.358 170.994 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.9 t -144.08 162.52 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.681 1.992 . . . . 3.48 108.398 179.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.7 t -118.24 144.41 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.104 1.362 . . . . 2.5800000000000001 108.647 -179.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.82 142.13 14.59 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.2 1.0 . . . . 3.1800000000000002 112.441 -168.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.63 156.43 65.69 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.934 3.089 . . . . 0.77000000000000002 113.242 179.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.14 118.32 39.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.301 -0.999 . . . . 1.9199999999999999 108.301 167.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -109.92 -178.74 3.61 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.286 1.035 . . . . 4.1799999999999997 110.719 168.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.01 179.91 7.41 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 117.059 2.244 . . . . 3.29 117.059 -156.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.872 0 CA-C-O 116.62 -1.657 . . . . 9.9399999999999995 112.623 172.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.45 ' HG3' ' H ' ' A' ' 6' ' ' GLY . 2.9 tp10 . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 107.341 -1.355 . . . . 4.5099999999999998 107.341 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.45 ' H ' ' HG3' ' A' ' 5' ' ' GLU . . . -94.38 173.24 32.51 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 119.526 1.057 . . . . 1.6000000000000001 113.04 -179.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -156.87 161.05 39.69 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.835 1.654 . . . . 9.1699999999999999 111.651 178.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.2 t -130.48 132.53 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.127 1.371 . . . . 2.23 109.053 173.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -91.2 112.96 25.09 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.354 0.597 . . . . 5.8600000000000003 110.467 -174.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -57.76 147.13 28.99 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.952 2.101 . . . . 4.2800000000000002 114.133 179.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 t -162.67 150.82 11.88 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.344 1.458 . . . . 3.1800000000000002 109.641 162.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -83.81 45.98 1.92 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.013 3.142 . . . . 2.8599999999999999 111.188 171.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -124.25 167.92 16.48 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.481 1.515 . . . . 1.54 113.855 -174.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.72 -20.77 22.53 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.715 2.943 . . . . 1.3799999999999999 114.064 -177.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.3 152.24 48.32 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.55 1.54 . . . . 3.0699999999999998 113.467 -176.236 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.47 -174.37 4.58 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.689 1.996 . . . . 1.8700000000000001 112.31 -171.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.02 136.08 43.81 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.657 1.583 . . . . 1.6899999999999999 109.329 172.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.26 123.99 46.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.612 1.565 . . . . 1.9299999999999999 111.627 -176.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -106.02 65.48 0.7 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.853 1.661 . . . . 4.0800000000000001 109.397 -173.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp -73.29 148.71 43.31 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.189 -0.944 . . . . 3.0499999999999998 113.239 -170.082 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.468 ' HG1' ' NH1' ' A' ' 74' ' ' ARG . 9.5 t -83.23 139.63 33.0 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.102 -0.999 . . . . 4.7599999999999998 110.347 168.82 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.83 131.44 56.83 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.728 1.611 . . . . 3.9100000000000001 107.942 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -120.56 131.31 54.6 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.173 1.389 . . . . 4.2699999999999996 109.656 173.32 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -107.38 100.36 33.22 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.993 -0.743 . . . . 1.51 108.993 161.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.98 -9.26 15.54 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.027 2.484 . . . . 1.51 113.393 174.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.69 -179.51 51.31 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 122.433 1.019 . . . . 1.21 113.033 -175.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.424 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 14.6 m-20 -106.35 -3.51 21.03 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 127.776 2.431 . . . . 2.9900000000000002 111.717 -172.532 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -119.25 159.18 46.35 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 127.89 2.476 . . . . 2.6699999999999999 110.202 172.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.75 146.11 20.77 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.741 2.294 . . . . 1.1200000000000001 111.167 -175.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mp -103.93 153.49 20.74 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.532 1.133 . . . . 4.0300000000000002 110.711 173.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.69 112.66 12.74 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.098 1.359 . . . . 4.2000000000000002 110.0 178.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.9 tp -91.98 113.28 25.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.762 1.625 . . . . 2.8500000000000001 108.86 -177.186 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.5 m -111.41 -15.55 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.855 1.262 . . . . 1.77 111.668 -170.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.59 -178.17 31.39 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.916 1.722 . . . . 0.71999999999999997 113.694 -176.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.05 -179.61 8.31 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.886 1.674 . . . . 1.8500000000000001 112.41 168.303 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -157.34 152.56 26.1 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.331 2.252 . . . . 6.5999999999999996 108.532 177.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -159.74 150.21 15.44 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 117.837 -1.077 . . . . 1.79 110.936 177.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.96 0.08 7.71 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.393 3.395 . . . . 1.27 113.66 174.034 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.413 ' HA ' ' H ' ' A' ' 90' ' ' LYS . 15.2 m -116.32 49.86 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.979 1.312 . . . . 2.8799999999999999 110.791 166.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.75 164.65 35.65 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.398 1.094 . . . . 2.27 112.012 161.194 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -104.05 -30.62 10.15 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 127.648 2.379 . . . . 4.1200000000000001 111.371 163.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 -149.55 140.03 22.43 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.751 1.62 . . . . 7.1500000000000004 109.459 172.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 p -100.05 167.34 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.028 1.331 . . . . 2.6499999999999999 109.204 174.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.79 150.76 35.96 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.8 2.04 . . . . 4.2999999999999998 108.069 176.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.5 tp -120.8 114.67 21.96 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.572 1.078 . . . . 2.1000000000000001 111.258 -172.056 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -122.77 157.36 32.54 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 115.091 1.515 . . . . 0.91000000000000003 115.091 -170.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.74 -178.6 4.3 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.129 2.171 . . . . 3.0499999999999998 111.75 158.434 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.7 m -145.34 148.41 33.37 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 107.904 -1.147 . . . . 1.8700000000000001 107.904 162.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -152.08 167.56 28.08 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 123.193 1.473 . . . . 3.7599999999999998 114.802 -170.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.6 ttp -100.81 140.62 34.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.398 1.479 . . . . 4.0099999999999998 110.745 172.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.79 176.01 10.2 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.599 1.56 . . . . 8.2300000000000004 112.063 178.1 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -146.15 133.48 20.65 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.076 1.751 . . . . 2.1699999999999999 106.743 -179.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 m -149.84 135.86 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.784 1.634 . . . . 3.5800000000000001 107.447 -169.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 60.88 12.41 3.83 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.734 1.614 . . . . 4.3200000000000003 114.19 -172.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.9 20.69 55.19 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.096 0.855 . . . . 1.7 114.302 -171.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -132.83 135.5 45.68 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.935 1.294 . . . . 5.4500000000000002 111.216 174.519 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -71.19 143.92 50.32 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.021 2.528 . . . . 4.9400000000000004 110.904 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.1 p -156.7 172.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 126.666 1.986 . . . . 3.5600000000000001 109.932 -172.567 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 64.1 mtt -114.0 153.22 29.73 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.077 0.951 . . . . 3.71 111.158 167.076 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.21 175.02 20.05 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 126.427 1.965 . . . . 0.68000000000000005 111.766 176.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 ttm -150.17 146.01 26.62 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.631 1.573 . . . . 1.97 109.368 174.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.57 146.86 23.4 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 124.364 1.066 . . . . 6.4800000000000004 111.109 -169.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -78.43 153.57 27.37 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.032 1.821 . . . . 0.87 111.515 171.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.1 m -140.77 152.03 64.61 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 125.843 1.657 . . . . 1.99 110.777 -175.148 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.74 -23.85 6.59 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.546 2.831 . . . . 0.75 113.504 -167.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -178.29 163.54 1.64 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.68 1.992 . . . . 3.23 110.442 179.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.6 mt -110.25 157.16 19.75 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.211 1.404 . . . . 1.9099999999999999 110.057 164.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -118.58 146.64 44.45 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.084 0.954 . . . . 2.3300000000000001 110.32 168.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.78 128.98 17.14 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.489 0.716 . . . . 2.2599999999999998 110.982 172.051 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -71.42 165.03 33.74 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.107 3.205 . . . . 1.4099999999999999 112.318 -176.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.31 141.68 96.36 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.637 2.891 . . . . 1.3200000000000001 112.733 178.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.424 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 67.8 mmtt 66.05 0.64 1.67 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.554 1.942 . . . . 2.9399999999999999 113.592 -176.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.51 126.81 7.64 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.587 1.565 . . . . 1.6000000000000001 113.881 -174.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.468 ' NH1' ' HG1' ' A' ' 21' ' ' THR . 4.6 mmt180 -88.31 123.13 32.59 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.886 1.274 . . . . 7.0599999999999996 107.642 156.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.7 t -149.65 98.07 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.892 0.877 . . . . 4.2199999999999998 109.614 175.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.54 142.46 42.78 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.865 -0.522 . . . . 3.23 110.751 -177.068 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -65.16 95.39 0.18 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.248 -1.389 . . . . 2.6000000000000001 107.248 159.083 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.98 150.45 37.44 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.529 1.132 . . . . 4.71 113.93 -164.014 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.25 142.62 92.16 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.791 2.328 . . . . 3.3500000000000001 110.187 174.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.73 -2.73 85.46 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-O 118.709 -1.05 . . . . 2.5099999999999998 114.163 -168.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.78 -127.69 1.36 Allowed Glycine 0 C--N 1.34 0.759 0 CA-C-N 118.892 1.346 . . . . 1.6599999999999999 113.114 172.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -72.99 140.54 47.42 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.655 -0.909 . . . . 3.52 112.695 -164.335 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -163.54 158.97 21.4 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.284 1.034 . . . . 0.93999999999999995 113.405 -176.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -87.11 136.65 32.85 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.853 -0.529 . . . . 3.04 110.678 166.063 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.2 tpt -84.06 138.76 32.9 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.488 1.115 . . . . 1.6499999999999999 108.496 159.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -117.84 134.77 54.6 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.099 1.36 . . . . 1.78 108.63 179.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 mp -132.86 137.43 46.7 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 122.991 0.516 . . . . 2.6200000000000001 111.918 177.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.64 47.74 7.72 Favored Glycine 0 N--CA 1.467 0.709 0 C-N-CA 125.208 1.385 . . . . 0.81000000000000005 113.162 171.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.51 147.37 14.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.634 1.716 . . . . 2.25 115.634 -177.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.413 ' H ' ' HA ' ' A' ' 39' ' ' VAL . 59.1 mmtt -104.04 -3.79 24.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.937 -1.483 . . . . 3.29 113.907 -172.116 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -149.24 139.23 13.2 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.331 1.453 . . . . 6.6600000000000001 112.021 171.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.75 135.08 15.6 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.526 2.818 . . . . 2.2400000000000002 109.651 173.374 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.7 mp -93.59 -167.94 1.8 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.032 1.333 . . . . 3.8199999999999998 110.789 -168.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -134.13 172.74 12.42 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 127.478 2.311 . . . . 4.5800000000000001 108.843 164.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.51 129.31 34.43 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 118.113 -1.435 . . . . 2.2000000000000002 107.871 138.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.93 58.64 1.23 Allowed Glycine 0 CA--C 1.528 0.846 0 O-C-N 124.301 1.001 . . . . 1.3600000000000001 111.654 -168.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -141.37 175.73 9.42 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.323 1.449 . . . . 2.9900000000000002 111.317 161.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.28 87.41 1.96 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.906 2.482 . . . . 3.3999999999999999 109.827 -170.25 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 91.2 t -113.18 144.29 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 120.586 -1.321 . . . . 2.6800000000000002 112.119 -156.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.513 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 46.5 mt-10 -79.0 141.35 37.55 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.999 1.111 . . . . 2.5899999999999999 113.999 -167.6 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -125.11 143.5 50.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.565 1.546 . . . . 3.79 108.834 159.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -114.5 123.02 48.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.345 2.258 . . . . 2.1800000000000002 107.899 172.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.3 mp -98.69 127.25 44.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.665 1.986 . . . . 2.9300000000000002 109.931 -169.054 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.7 mt -104.96 112.61 25.81 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.437 1.113 . . . . 1.6499999999999999 110.612 -178.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -101.02 154.88 18.33 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.789 1.236 . . . . 3.3399999999999999 110.508 178.101 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.25 141.34 14.99 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.443 -0.798 . . . . 2.1000000000000001 110.771 170.019 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.52 -1.19 81.47 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.693 -1.06 . . . . 3.0499999999999998 114.399 -171.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.57 13.08 61.83 Favored Glycine 0 N--CA 1.473 1.106 0 CA-C-N 119.038 1.419 . . . . 3.2799999999999998 114.361 173.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.57 134.82 38.16 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.948 -1.325 . . . . 7.0099999999999998 111.047 -179.101 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -113.22 140.6 32.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 126.228 1.811 . . . . 3.21 110.191 172.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.1 tp -145.64 126.68 14.61 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.496 1.119 . . . . 3.29 110.921 176.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.513 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 32.3 ttmt -85.8 139.41 31.32 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.043 0.757 . . . . 3.3500000000000001 113.043 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.01 161.93 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 127.67 2.388 . . . . 3.46 110.847 164.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 83.7 t -121.53 135.62 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.585 1.154 . . . . 2.48 108.824 174.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.2 mt -131.41 132.32 23.49 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.886 1.275 . . . . 3.0800000000000001 110.972 -169.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -57.19 141.82 94.46 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 124.168 3.245 . . . . 2.21 114.75 172.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.6 t -114.14 128.9 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.685 1.194 . . . . 2.3100000000000001 111.603 175.297 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.402 ' CD ' HH21 ' A' ' 120' ' ' ARG . 4.2 tt0 -156.72 163.64 39.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.92 1.688 . . . . 3.6800000000000002 112.147 -179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.05 104.72 16.69 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.27 1.028 . . . . 2.8599999999999999 110.43 176.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.402 HH21 ' CD ' ' A' ' 118' ' ' GLU . 98.4 mtt180 . . . . . 0 C--O 1.247 0.922 0 C-N-CA 126.093 1.757 . . . . 11.0 108.033 178.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 19.2 tt0 . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 109.277 -0.638 . . . . 6.96 109.277 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.438 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -131.19 -175.24 13.93 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.445 1.974 . . . . 1.3300000000000001 111.116 176.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.5 p90 -135.27 -178.49 5.13 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.231 1.515 . . . . 2.25 113.402 -168.153 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.72 152.25 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 126.774 2.03 . . . . 3.5499999999999998 112.114 -178.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 -71.77 -26.41 62.42 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 116.11 1.893 . . . . 6.1799999999999997 116.11 -174.433 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.0 t80 71.75 157.05 0.17 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.066 2.547 . . . . 2.79 111.978 -160.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -155.53 149.04 18.66 Favored Pre-proline 0 CA--C 1.538 0.488 0 O-C-N 121.535 -0.728 . . . . 3.2000000000000002 111.217 162.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -85.7 -2.67 9.07 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.649 2.899 . . . . 2.4100000000000001 112.018 167.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -121.01 -179.99 16.22 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.672 1.606 . . . . 1.2 114.065 -175.099 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.56 -18.1 48.65 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.439 3.426 . . . . 1.48 113.986 -174.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -114.61 137.77 51.47 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.055 2.142 . . . . 2.2999999999999998 113.863 -178.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.28 -177.26 5.38 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.79 2.436 . . . . 1.6599999999999999 111.738 -172.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.38 149.24 30.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.143 1.377 . . . . 1.8899999999999999 110.862 178.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.18 147.21 51.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.893 1.277 . . . . 1.79 113.832 -174.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -128.32 43.11 3.2 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 127.424 2.29 . . . . 4.4299999999999997 114.703 -168.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -73.0 150.58 42.33 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 119.569 -1.957 . . . . 3.8399999999999999 115.598 -168.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 m -96.27 149.4 21.71 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.831 1.653 . . . . 2.4399999999999999 109.16 173.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.47 166.47 33.44 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.671 1.589 . . . . 3.8300000000000001 112.153 -176.433 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -128.79 140.97 51.46 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.91 2.084 . . . . 4.2400000000000002 112.334 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -96.52 99.57 5.72 Favored Pre-proline 0 CA--C 1.542 0.667 0 O-C-N 121.478 -0.764 . . . . 1.6000000000000001 109.354 158.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.65 -12.11 12.52 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.493 2.128 . . . . 1.3799999999999999 113.71 176.136 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.78 178.35 53.71 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-O 122.552 1.084 . . . . 1.21 112.936 -175.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.444 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 15.2 m-20 -104.75 0.91 28.73 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.87 2.468 . . . . 2.9300000000000002 112.318 -173.689 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mp -125.48 160.8 53.84 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 127.767 2.427 . . . . 5.3300000000000001 108.798 174.079 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.65 155.75 21.1 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.231 1.954 . . . . 1.1000000000000001 111.732 -167.689 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.75 147.76 28.23 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.88 1.272 . . . . 3.4500000000000002 110.224 170.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.0 ttp180 -136.64 103.92 5.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.016 -1.902 . . . . 5.1399999999999997 109.297 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -84.85 110.05 18.55 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.478 1.911 . . . . 3.3799999999999999 108.847 -175.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.9 m -106.34 -20.88 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.764 1.226 . . . . 1.6100000000000001 111.932 -174.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.48 -175.76 31.83 Favored Glycine 0 C--N 1.343 0.947 0 C-N-CA 125.004 1.287 . . . . 0.42999999999999999 114.13 -173.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.43 -177.28 5.98 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.754 2.021 . . . . 1.53 111.0 173.383 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -157.95 170.78 21.55 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.89 2.476 . . . . 5.6900000000000004 107.626 171.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 t -173.44 149.74 1.71 Allowed Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 125.294 1.438 . . . . 1.71 110.364 174.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.54 -8.12 21.28 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.773 2.316 . . . . 0.78000000000000003 114.037 172.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.3 m -118.87 49.39 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.545 1.138 . . . . 1.8100000000000001 113.295 174.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.23 151.34 17.39 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.643 1.177 . . . . 1.74 110.704 161.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -95.7 -30.77 13.56 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.382 1.473 . . . . 3.3500000000000001 111.948 169.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.6 mtp-105 -133.08 141.15 48.05 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.693 1.597 . . . . 6.2000000000000002 108.915 171.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -125.3 148.6 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.157 1.383 . . . . 1.8200000000000001 109.558 168.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -137.45 151.46 48.52 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.649 1.98 . . . . 2.8700000000000001 109.736 178.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.8 tp -104.61 118.51 36.75 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.492 0.717 . . . . 2.1099999999999999 110.56 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -124.53 148.87 47.5 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 123.084 1.421 . . . . 0.66000000000000003 113.914 -174.506 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -89.08 176.38 7.01 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 113.889 -1.505 . . . . 2.46 111.521 162.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 64.9 m -155.01 136.47 14.18 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 105.457 -2.053 . . . . 1.9099999999999999 105.457 175.175 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -149.43 161.52 41.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 122.952 1.358 . . . . 3.3799999999999999 114.184 -166.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -87.41 136.22 33.03 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.333 -1.303 . . . . 4.5199999999999996 110.588 172.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.01 143.22 20.28 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.204 1.002 . . . . 5.6699999999999999 113.699 -177.501 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.55 130.9 36.54 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 125.655 1.582 . . . . 3.0699999999999998 111.63 172.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.5 t -141.45 134.8 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 126.066 1.746 . . . . 2.9700000000000002 107.274 169.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 65.9 16.76 10.61 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.645 1.178 . . . . 3.9199999999999999 113.352 -176.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.24 21.05 68.27 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 121.188 -0.945 . . . . 1.51 113.396 -171.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -138.86 133.33 31.84 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.169 1.787 . . . . 4.46 109.717 -170.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.31 117.09 17.62 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.109 1.364 . . . . 4.7199999999999998 113.506 -178.641 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -117.14 174.06 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 128.669 2.787 . . . . 3.1499999999999999 109.103 170.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.41 130.34 56.42 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.946 0.898 . . . . 4.0599999999999996 109.901 177.422 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.31 172.91 15.01 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.573 1.083 . . . . 0.59999999999999998 113.286 -179.328 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ttm -148.78 143.07 26.13 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.573 1.549 . . . . 1.8300000000000001 109.765 177.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -144.92 152.19 51.12 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.369 1.868 . . . . 8.8300000000000001 109.143 -176.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -80.83 150.71 18.59 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.593 2.195 . . . . 0.69999999999999996 110.206 170.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.24 155.49 80.84 Favored Pre-proline 0 N--CA 1.48 1.05 0 C-N-CA 124.496 1.119 . . . . 1.8200000000000001 110.379 -177.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.76 -30.04 2.53 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.746 2.297 . . . . 0.60999999999999999 112.713 -170.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -176.2 164.73 2.76 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.735 1.614 . . . . 3.46 112.042 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.5 mt -109.03 158.73 17.45 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.04 1.336 . . . . 1.9199999999999999 109.282 161.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -139.74 144.66 37.57 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.96 0.904 . . . . 2.21 111.242 174.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.2 t -146.74 140.1 14.82 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.447 1.099 . . . . 2.7200000000000002 112.323 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.64 170.62 8.15 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 124.417 3.411 . . . . 1.75 114.092 176.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.96 150.12 80.12 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.616 3.544 . . . . 1.25 113.774 171.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.444 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 69.2 mmtt 68.49 -7.24 0.72 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.912 2.085 . . . . 2.71 115.085 176.252 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.81 149.34 32.95 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.438 1.018 . . . . 1.2 112.683 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 mtt-85 -86.8 162.03 18.03 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 122.003 -0.704 . . . . 7.4199999999999999 110.155 161.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.1 150.44 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.054 1.741 . . . . 5.0199999999999996 108.724 172.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.75 137.9 30.1 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.945 0.898 . . . . 3.29 110.344 161.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -78.54 80.72 4.91 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 122.283 1.04 . . . . 2.1600000000000001 108.336 170.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.39 136.57 88.9 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 115.403 -0.817 . . . . 4.0899999999999999 112.908 -177.083 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -60.84 -25.62 81.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.236 2.624 . . . . 2.0699999999999998 112.553 176.284 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.7 9.66 28.68 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 117.652 -1.638 . . . . 1.8700000000000001 114.722 174.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.65 -10.55 0.03 OUTLIER Glycine 0 C--N 1.346 1.107 0 N-CA-C 121.56 3.384 . . . . 2.1299999999999999 121.56 167.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -143.99 145.3 32.13 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 121.124 2.462 . . . . 3.4199999999999999 112.843 172.195 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -158.68 152.0 22.82 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.599 0.76 . . . . 0.65000000000000002 110.816 175.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -78.7 141.56 37.81 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.418 -0.956 . . . . 2.7000000000000002 108.418 160.062 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.0 tpt -99.42 130.23 45.67 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.399 1.88 . . . . 1.54 108.489 168.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.9 mp -111.61 139.61 46.9 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.47 1.508 . . . . 1.6599999999999999 108.357 -179.262 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.2 mp -137.82 143.73 41.15 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.418 1.087 . . . . 2.4300000000000002 109.576 175.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.91 42.42 45.32 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.957 -0.457 . . . . 1.0 111.957 -178.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.35 141.9 28.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 122.865 1.317 . . . . 2.5099999999999998 113.342 170.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -100.65 0.78 39.8 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.084 -1.416 . . . . 3.5 113.05 -171.334 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -123.86 146.63 51.32 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 126.959 2.104 . . . . 6.2300000000000004 107.821 167.013 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -62.34 120.27 7.74 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 N-CA-C 105.166 -2.667 . . . . 1.8 105.166 149.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 tp -76.79 79.95 3.4 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 122.177 0.989 . . . . 3.6200000000000001 111.387 -157.077 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . 0.268 5.6 tmtt? -64.74 114.5 4.5 Favored 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 120.368 -1.458 . . . . 7.0999999999999996 110.949 -169.334 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.71 114.83 1.25 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.216 1.406 . . . . 2.4300000000000002 111.443 170.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.67 44.81 6.3 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.201 1.381 . . . . 1.6000000000000001 112.699 -169.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -101.3 -177.22 3.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.919 1.688 . . . . 3.0099999999999998 109.209 145.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -130.68 125.5 34.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 129.328 3.051 . . . . 3.8900000000000001 103.91 178.064 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.9 t -128.66 122.25 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.381 1.873 . . . . 2.23 108.985 -171.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.489 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 14.7 pt-20 -81.8 146.66 29.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.933 0.873 . . . . 2.3300000000000001 112.582 171.133 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.77 138.03 54.22 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.665 1.586 . . . . 2.6800000000000002 109.77 163.433 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -78.32 149.0 33.55 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.343 1.857 . . . . 2.71 108.125 158.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.2 mp -127.16 132.59 50.48 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.667 1.587 . . . . 2.0299999999999998 108.482 175.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.5 mt -105.95 118.43 36.58 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.806 1.242 . . . . 1.9399999999999999 109.456 -175.258 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -116.55 118.23 32.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.422 1.489 . . . . 3.23 111.786 -172.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.86 20.84 1.75 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.5 1.92 . . . . 2.9300000000000002 114.277 176.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.28 -61.73 4.13 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.208 1.385 . . . . 4.4199999999999999 112.286 -167.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.94 4.68 60.74 Favored Glycine 0 N--CA 1.474 1.21 0 N-CA-C 117.089 1.596 . . . . 2.04 117.089 -166.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -131.99 140.06 48.83 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.481 1.64 . . . . 4.1900000000000004 112.178 175.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.17 146.88 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.361 1.464 . . . . 3.25 109.334 171.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 tt -150.7 160.88 43.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.91 2.484 . . . . 3.0299999999999998 107.593 176.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.489 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 57.1 pttt -144.89 152.94 41.03 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.027 1.285 . . . . 2.75 114.436 175.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.51 157.79 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.416 1.486 . . . . 3.4399999999999999 109.409 -174.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 66.6 t -87.39 161.76 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.951 1.3 . . . . 2.7000000000000002 109.127 175.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.25 140.08 11.42 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 126.239 1.816 . . . . 3.4700000000000002 110.223 164.168 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.97 146.2 64.31 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.247 2.632 . . . . 0.72999999999999998 111.987 174.109 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.77 116.56 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.768 -0.827 . . . . 2.29 108.768 167.357 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.43 ' CD ' HH22 ' A' ' 120' ' ' ARG . 39.3 mt-10 -137.05 176.57 8.6 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.798 1.639 . . . . 4.4100000000000001 110.116 -177.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -113.36 136.72 52.46 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.298 1.039 . . . . 2.6000000000000001 111.518 174.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.43 HH22 ' CD ' ' A' ' 118' ' ' GLU 0.277 19.9 ptt-85 . . . . . 0 N--CA 1.485 1.297 0 C-N-CA 131.175 3.79 . . . . 10.34 111.415 168.68 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 CA--C 1.543 0.688 0 CA-C-O 121.203 0.525 . . . . 7.8600000000000003 110.408 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.51 -175.33 19.59 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 125.1 1.333 . . . . 1.8 112.565 177.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -141.59 175.29 9.81 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.995 1.109 . . . . 2.5499999999999998 113.995 178.471 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.6 t -111.93 126.12 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 126.284 1.833 . . . . 3.1299999999999999 106.166 162.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.6 ttp85 -87.19 131.77 34.08 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.296 -1.001 . . . . 6.2699999999999996 108.296 171.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -57.35 117.59 4.26 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.122 0.569 . . . . 2.98 110.98 -175.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.5 m -174.68 106.11 0.27 Allowed Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 128.851 2.86 . . . . 4.8700000000000001 107.036 167.052 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -93.42 -125.53 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.603 3.535 . . . . 6.0599999999999996 109.515 -176.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.73 -155.41 30.5 Favored Glycine 0 CA--C 1.543 1.785 0 O-C-N 121.425 -0.797 . . . . 2.5800000000000001 113.164 178.423 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.82 -31.19 13.21 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.914 2.409 . . . . 4.1799999999999997 112.091 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.09 123.36 21.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.889 1.675 . . . . 4.2400000000000002 111.049 169.306 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.18 -179.04 4.96 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.131 1.772 . . . . 2.0099999999999998 111.336 172.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.96 135.93 29.86 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 121.052 -1.03 . . . . 2.0899999999999999 111.097 -176.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.78 146.14 51.98 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.819 1.648 . . . . 2.0 112.05 -176.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -135.89 62.78 1.61 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.19 0.996 . . . . 4.7800000000000002 111.488 -157.062 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.06 162.71 24.0 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.468 -0.787 . . . . 2.6299999999999999 113.015 -173.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.6 m -125.78 145.83 50.04 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.782 1.633 . . . . 2.71 107.571 171.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.47 164.62 38.39 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.96 1.304 . . . . 5.3700000000000001 110.176 174.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -127.94 154.98 44.95 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.391 1.076 . . . . 3.96 110.594 168.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -101.35 95.1 4.61 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 124.552 1.141 . . . . 1.3600000000000001 109.221 171.334 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.92 -19.18 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.151 1.9 . . . . 1.6699999999999999 113.28 -177.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.46 -177.02 51.47 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-O 122.351 0.973 . . . . 1.46 112.455 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -112.85 2.85 16.08 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.517 1.927 . . . . 4.1699999999999999 112.389 -170.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -98.38 157.04 35.06 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.634 1.974 . . . . 3.29 110.243 164.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.57 148.63 14.32 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.243 2.628 . . . . 0.95999999999999996 111.179 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.1 mt -102.65 146.04 28.77 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 122.8 1.286 . . . . 2.98 111.87 170.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.9 ttp-105 -129.77 109.61 11.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 111.984 -2.371 . . . . 3.7000000000000002 108.967 176.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -95.41 111.66 23.51 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.402 1.881 . . . . 3.6400000000000001 108.606 -174.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -111.21 -21.26 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.145 0.978 . . . . 1.6200000000000001 112.033 -168.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.54 -174.26 30.14 Favored Glycine 0 C--N 1.344 1.018 0 C-N-CA 124.596 1.093 . . . . 0.56999999999999995 114.277 -174.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.16 -178.79 6.4 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.563 1.545 . . . . 1.8200000000000001 111.466 170.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -151.6 167.07 29.24 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.804 2.442 . . . . 5.4199999999999999 107.746 164.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 t -174.07 149.23 1.45 Allowed Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 125.164 1.386 . . . . 1.9299999999999999 108.536 -171.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.18 -3.5 13.49 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.185 2.59 . . . . 0.82999999999999996 114.281 177.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.4 m -119.4 28.39 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 115.22 1.563 . . . . 1.75 115.22 -174.009 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.33 167.03 31.72 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.781 1.632 . . . . 1.7 111.481 173.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -96.67 -31.13 12.86 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.458 1.503 . . . . 3.0699999999999998 111.056 173.278 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -139.1 153.35 48.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 129.889 3.276 . . . . 5.8700000000000001 108.034 -173.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.5 p -155.07 121.76 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 124.896 1.279 . . . . 2.6400000000000001 109.775 178.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -140.66 129.95 23.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.143 -0.935 . . . . 4.1399999999999997 109.795 -165.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -82.23 140.43 33.67 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 123.261 1.505 . . . . 3.04 113.285 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -117.11 157.16 26.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.612 2.365 . . . . 0.89000000000000001 112.304 175.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.423 ' CD ' HH21 ' A' ' 62' ' ' ARG . 13.8 pt-20 -95.33 149.01 21.83 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.642 1.977 . . . . 2.6000000000000001 109.541 158.182 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.0 m -115.62 149.63 37.98 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.369 1.868 . . . . 2.2000000000000002 106.012 159.654 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -158.93 177.39 11.2 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.817 0.847 . . . . 3.2400000000000002 113.146 -177.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 76.1 mtm -108.76 144.22 36.86 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.234 1.414 . . . . 4.0800000000000001 111.612 172.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -139.78 146.95 40.11 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.418 1.487 . . . . 6.0300000000000002 111.597 173.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -93.94 140.48 29.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.725 1.21 . . . . 2.25 108.167 156.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.8 t -138.83 119.2 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.175 1.39 . . . . 3.0800000000000001 107.252 170.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 62.46 20.08 11.64 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.087 1.355 . . . . 3.4500000000000002 113.95 -177.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.83 15.4 75.41 Favored Glycine 0 N--CA 1.477 1.413 0 O-C-N 120.47 -1.394 . . . . 1.5 113.504 -170.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -117.02 115.71 25.95 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.696 2.398 . . . . 4.25 108.314 -179.587 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.469 ' H ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -93.72 131.26 39.22 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.588 1.155 . . . . 5.0499999999999998 111.47 -170.62 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.9 p -155.32 148.96 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.9 1.68 . . . . 3.7599999999999998 109.99 -168.112 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.9 mtt -89.22 155.48 19.37 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.521 0.728 . . . . 3.46 111.956 176.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.5 176.05 20.82 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 124.612 1.101 . . . . 0.58999999999999997 112.714 179.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ttm -153.83 144.81 22.74 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 126.058 1.743 . . . . 1.6399999999999999 109.205 -178.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.423 HH21 ' CD ' ' A' ' 47' ' ' GLU . 26.0 mtm180 -151.0 157.99 35.05 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 125.658 1.583 . . . . 5.6500000000000004 109.472 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -73.6 157.26 48.82 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.146 1.897 . . . . 0.89000000000000001 111.266 168.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.17 158.81 71.85 Favored Pre-proline 0 N--CA 1.481 1.12 0 CA-C-O 118.53 -0.747 . . . . 2.5099999999999998 110.729 173.873 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -83.18 -24.98 2.9 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.277 2.651 . . . . 1.02 113.355 -170.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -179.39 164.61 1.35 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.88 2.072 . . . . 3.6800000000000002 110.781 -178.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.2 mt -109.43 154.3 22.8 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.757 1.223 . . . . 1.7 110.26 163.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -115.53 140.4 49.2 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.25 1.02 . . . . 1.9199999999999999 108.987 170.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.3 t -141.86 129.04 11.47 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 123.886 0.874 . . . . 2.1400000000000001 111.365 174.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.45 170.42 16.24 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.428 2.752 . . . . 1.1299999999999999 112.545 -178.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -57.63 139.54 90.57 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.142 2.561 . . . . 1.51 111.172 166.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm 65.22 0.75 1.37 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.279 1.831 . . . . 3.5499999999999998 114.524 -174.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.56 177.54 52.75 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.291 1.9 . . . . 1.8799999999999999 112.395 171.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.6 ptt85 -131.83 132.94 44.14 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.515 1.126 . . . . 9.5199999999999996 112.876 -172.432 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.88 73.29 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 127.071 2.148 . . . . 6.4100000000000001 109.094 -174.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.33 117.87 35.12 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.605 1.962 . . . . 3.7599999999999998 110.064 -172.075 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.29 58.03 0.61 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.493 1.917 . . . . 2.73 111.58 -171.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.457 ' H ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -61.97 146.59 91.39 Favored Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 125.973 1.709 . . . . 4.1100000000000003 115.364 178.533 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -61.12 -33.5 91.06 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 124.319 3.346 . . . . 3.2999999999999998 114.782 -177.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.25 5.25 44.08 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.153 0.882 . . . . 1.53 114.182 177.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.22 -124.96 0.97 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.955 1.264 . . . . 1.6100000000000001 111.591 170.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -71.11 138.01 49.35 Favored 'General case' 0 C--O 1.219 -0.527 0 O-C-N 121.653 -0.91 . . . . 3.3500000000000001 111.274 -174.07 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -159.93 158.16 30.26 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.416 0.687 . . . . 0.70999999999999996 112.451 -176.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -89.71 137.49 32.29 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.181 -0.949 . . . . 2.9900000000000002 111.737 174.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.9 tpt -97.35 127.69 43.53 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.416 1.886 . . . . 1.8799999999999999 109.146 163.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.78 121.81 44.8 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.939 1.296 . . . . 1.8200000000000001 108.525 -178.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.8 136.52 52.49 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.155 0.582 . . . . 3.6899999999999999 110.875 -163.329 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.32 38.44 62.7 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.867 -0.521 . . . . 1.22 112.554 -170.584 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.87 148.02 0.87 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 116.546 2.054 . . . . 3.1400000000000001 116.546 176.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -99.74 1.75 43.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.816 -1.538 . . . . 2.6000000000000001 113.705 -177.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -159.32 150.53 16.34 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 125.658 1.583 . . . . 5.6500000000000004 111.027 -177.105 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.91 83.85 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.016 2.477 . . . . 3.0 107.812 164.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 96.94 0.09 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.503 1.521 . . . . 3.8100000000000001 111.923 -172.426 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.48 161.34 13.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.09 -1.868 . . . . 4.9900000000000002 112.606 -173.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.71 133.17 54.42 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.037 0.935 . . . . 2.2000000000000002 110.389 177.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.92 55.61 3.52 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 114.176 -1.374 . . . . 2.8500000000000001 111.077 -170.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -138.33 -178.02 5.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.233 2.213 . . . . 2.4199999999999999 108.3 163.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -156.37 132.53 9.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.278 2.231 . . . . 3.46 105.571 -167.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.6 t -142.0 132.21 24.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 125.249 1.42 . . . . 1.9099999999999999 109.466 -164.035 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -77.13 145.59 37.69 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 122.685 0.394 . . . . 2.4199999999999999 111.131 172.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.54 137.44 54.73 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 122.662 1.22 . . . . 2.6200000000000001 111.122 151.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -87.3 139.78 30.21 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.365 2.266 . . . . 2.0800000000000001 108.028 155.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -110.4 141.21 43.78 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.367 1.467 . . . . 1.6899999999999999 109.952 173.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -112.42 113.92 26.36 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.958 1.303 . . . . 1.6200000000000001 109.579 178.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -115.14 152.68 32.15 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.623 1.569 . . . . 3.48 111.094 178.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.23 137.55 55.81 Favored 'General case' 0 CA--C 1.548 0.865 0 CA-C-O 122.293 1.044 . . . . 2.3700000000000001 113.795 -178.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.23 56.97 4.93 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.266 0.936 . . . . 3.5600000000000001 113.239 176.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.47 11.84 80.1 Favored Glycine 0 N--CA 1.473 1.158 0 N-CA-C 115.784 1.074 . . . . 2.1600000000000001 115.784 168.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -94.68 114.97 26.97 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.043 1.421 . . . . 3.6600000000000001 111.356 -174.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.65 136.12 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.134 1.374 . . . . 3.1899999999999999 109.537 177.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 tt -145.42 125.32 13.51 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.85 0.86 . . . . 3.7599999999999998 111.033 -168.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -101.09 134.68 43.73 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.792 1.237 . . . . 3.3399999999999999 112.144 -178.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.8 t -147.11 168.3 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 126.412 1.885 . . . . 3.8500000000000001 109.71 173.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.94 155.84 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 119.672 1.123 . . . . 2.7599999999999998 111.01 -170.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.9 mt -141.29 117.52 7.39 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.212 1.805 . . . . 3.4199999999999999 110.129 -174.437 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.46 146.46 62.14 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.705 2.27 . . . . 1.0900000000000001 110.432 168.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.4 t -94.79 115.81 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.845 0.858 . . . . 2.1400000000000001 109.209 170.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -129.81 137.73 50.64 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.428 1.091 . . . . 4.21 112.01 -170.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.43 83.46 5.43 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.994 -1.066 . . . . 3.8100000000000001 110.693 170.065 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.408 0 C-N-CA 127.249 2.22 . . . . 9.8900000000000006 110.848 -175.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 14.4 tt0 . . . . . 0 C--O 1.238 0.458 0 N-CA-C 106.001 -1.851 . . . . 6.4199999999999999 106.001 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.427 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -118.69 -170.95 14.94 Favored Glycine 0 N--CA 1.462 0.387 0 CA-C-O 122.436 1.02 . . . . 1.3999999999999999 112.038 -172.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 41.0 p90 -134.11 162.98 30.61 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.598 -0.801 . . . . 2.4399999999999999 111.325 167.206 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.46 139.03 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.894 1.278 . . . . 2.5800000000000001 109.147 173.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -58.0 112.73 1.6 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.743 1.617 . . . . 7.2199999999999998 112.555 -177.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.59 132.36 51.45 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.324 2.249 . . . . 4.1900000000000004 111.455 166.175 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -179.05 154.55 0.79 Allowed Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.535 1.934 . . . . 3.7799999999999998 112.867 166.392 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -88.28 40.69 0.58 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 125.23 3.953 . . . . 2.79 111.055 166.316 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -114.88 157.37 15.03 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.948 1.261 . . . . 1.3899999999999999 113.019 -172.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -71.77 -18.52 28.41 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.133 3.222 . . . . 1.74 113.923 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -108.17 164.82 11.97 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.541 1.936 . . . . 2.8700000000000001 112.629 170.253 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.3 -171.72 3.72 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.474 2.709 . . . . 1.7 111.107 170.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -155.19 133.89 12.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.639 1.976 . . . . 1.8 108.867 -175.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.42 132.57 54.97 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.267 1.394 . . . . 2.1699999999999999 111.351 -176.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -114.84 32.04 6.27 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.673 1.731 . . . . 4.0499999999999998 115.673 -167.061 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -64.93 158.88 24.17 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 115.972 1.841 . . . . 3.3599999999999999 115.972 -172.306 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.8 m -79.74 126.6 31.15 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.519 1.128 . . . . 2.6000000000000001 109.679 166.191 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.9 tp -99.08 127.91 45.11 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.262 1.425 . . . . 5.2599999999999998 108.898 168.859 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.71 154.74 42.0 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.628 0.728 . . . . 3.6099999999999999 111.676 175.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -119.12 97.93 50.69 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.388 1.075 . . . . 1.53 109.088 169.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.6 -10.76 14.42 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.08 2.52 . . . . 1.28 113.03 177.05 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.93 -173.38 48.81 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.795 1.188 . . . . 1.26 113.115 -176.154 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.41 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 14.7 m-20 -112.82 1.17 15.45 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.606 1.963 . . . . 3.2599999999999998 112.368 -168.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -124.45 161.86 45.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 128.013 2.525 . . . . 3.23 110.256 174.122 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -81.01 141.91 13.42 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.484 2.122 . . . . 1.48 111.898 -173.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.98 149.33 25.24 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.145 1.378 . . . . 3.8399999999999999 110.134 174.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 42.4 ttm105 -135.44 103.3 5.43 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.633 1.173 . . . . 3.4500000000000002 110.157 178.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -79.4 114.66 18.51 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.24 1.816 . . . . 3.7000000000000002 108.047 -178.34 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.2 m -110.1 -19.47 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.254 1.022 . . . . 1.9399999999999999 112.408 -177.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.24 -175.8 29.58 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 125.509 1.528 . . . . 0.51000000000000001 113.889 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.91 -179.87 6.02 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.965 0.906 . . . . 1.54 111.035 166.004 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -137.32 177.4 7.9 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.313 1.445 . . . . 4.9400000000000004 107.845 155.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 t -175.7 148.88 1.02 Allowed Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 128.151 2.58 . . . . 1.71 106.394 177.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.44 -9.46 20.16 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.591 2.194 . . . . 0.79000000000000004 112.21 178.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.3 m -112.96 51.82 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.679 1.591 . . . . 1.72 111.586 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.01 158.16 30.05 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.056 1.343 . . . . 2.0099999999999998 111.64 167.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -98.57 -33.81 10.83 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.987 1.715 . . . . 2.6699999999999999 110.152 160.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -128.65 130.12 46.8 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.619 1.968 . . . . 6.0599999999999996 109.53 177.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -128.43 128.93 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.404 1.081 . . . . 2.1099999999999999 108.993 166.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -144.39 137.57 27.16 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.165 0.986 . . . . 3.1600000000000001 110.442 -162.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 20.7 tp -91.85 125.17 36.46 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.663 -0.648 . . . . 2.52 112.324 -167.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -122.41 160.28 25.79 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.896 1.678 . . . . 0.82999999999999996 114.119 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.408 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 17.6 pt-20 -120.27 147.68 44.67 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.696 1.598 . . . . 3.9199999999999999 110.189 161.499 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.3 m -108.54 139.14 43.72 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 107.54 -1.282 . . . . 1.9399999999999999 107.54 172.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -130.22 170.77 13.65 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.567 1.947 . . . . 3.5 111.895 -172.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.8 mtt -103.36 141.58 35.69 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.518 1.127 . . . . 4.9500000000000002 111.909 172.158 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -141.47 145.02 34.71 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.078 1.351 . . . . 7.9699999999999998 112.52 174.423 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -79.93 134.51 36.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.769 -1.197 . . . . 2.5699999999999998 107.769 146.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.3 t -146.41 136.86 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 106.894 -1.521 . . . . 3.54 106.894 164.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.514 ' CD ' ' HZ2' ' A' ' 56' ' ' LYS . 23.8 mt-10 66.31 13.84 9.39 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.64 1.576 . . . . 5.5300000000000002 113.927 -177.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.03 27.11 67.13 Favored Glycine 0 N--CA 1.476 1.309 0 O-C-N 120.946 -1.096 . . . . 2.7400000000000002 113.017 -168.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.514 ' HZ2' ' CD ' ' A' ' 54' ' ' GLU . 53.7 mtmt -130.93 143.68 50.91 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 126.861 2.065 . . . . 5.4400000000000004 109.098 178.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -81.35 119.61 23.89 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.308 1.843 . . . . 4.79 109.458 178.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.7 m -139.3 169.91 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.343 1.857 . . . . 3.6099999999999999 110.976 -177.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 53.6 mtm -134.14 137.84 44.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.039 1.335 . . . . 3.7599999999999998 110.75 174.464 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.44 174.83 21.57 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 125.786 1.66 . . . . 1.03 111.627 -177.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.25 141.63 47.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.329 1.064 . . . . 3.3199999999999998 111.832 -179.166 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -122.24 156.08 60.81 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 125.343 1.457 . . . . 7.4800000000000004 110.19 173.291 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.26 159.0 44.44 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.021 1.814 . . . . 0.79000000000000004 111.575 170.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.68 156.21 78.84 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 126.215 1.806 . . . . 2.5800000000000001 110.49 177.194 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.57 -24.13 6.54 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.51 2.806 . . . . 0.73999999999999999 112.859 -175.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -176.68 165.36 2.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.08 1.752 . . . . 3.25 111.703 -178.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -109.56 160.1 16.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.118 1.367 . . . . 2.02 109.53 155.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -134.84 148.42 50.15 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.235 1.014 . . . . 2.2799999999999998 109.91 174.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 t -142.32 128.46 10.77 Favored Pre-proline 0 CA--C 1.541 0.596 0 O-C-N 123.817 0.698 . . . . 2.1699999999999999 112.086 178.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.11 162.53 41.48 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.776 2.984 . . . . 1.5800000000000001 111.458 176.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.44 141.28 97.01 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.224 2.616 . . . . 1.54 113.02 -178.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.41 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 66.5 mmtt 70.14 -2.32 2.13 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.469 2.308 . . . . 3.0699999999999998 114.265 -178.643 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.6 158.35 43.13 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.581 1.562 . . . . 1.1499999999999999 114.316 -179.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.95 143.63 51.01 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.133 1.773 . . . . 7.5899999999999999 109.592 167.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.7 t -143.61 131.87 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 106.313 -1.736 . . . . 3.98 106.313 174.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -120.22 128.44 53.36 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.61 1.095 . . . . 3.9399999999999999 110.77 -170.416 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mp -77.65 58.06 1.73 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.48 1.512 . . . . 2.3300000000000001 111.229 -178.513 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.54 150.18 90.69 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 114.795 1.406 . . . . 6.0199999999999996 114.795 -178.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -58.06 151.11 60.5 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.456 2.104 . . . . 2.73 109.888 169.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.29 -9.52 33.39 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.355 -1.247 . . . . 3.3700000000000001 114.206 -171.271 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -135.01 -129.62 2.9 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 119.443 1.622 . . . . 1.5800000000000001 114.444 175.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.408 ' CE1' ' HB3' ' A' ' 47' ' ' GLU . 80.8 m-85 -71.97 141.03 49.4 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.543 -0.975 . . . . 3.2400000000000002 110.703 -177.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -164.41 156.74 16.66 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.962 1.305 . . . . 0.82999999999999996 110.88 -176.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -82.42 145.24 29.97 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.24 -0.652 . . . . 2.8399999999999999 109.24 161.043 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 tpt -96.56 132.99 41.61 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.919 1.288 . . . . 1.8600000000000001 108.42 164.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 mp -109.37 140.01 43.61 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.758 1.223 . . . . 1.6799999999999999 109.363 176.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.3 mt -141.74 142.91 33.28 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.747 1.619 . . . . 3.0600000000000001 110.107 -176.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 68.47 36.71 84.44 Favored Glycine 0 CA--C 1.532 1.098 0 O-C-N 121.894 -0.504 . . . . 0.93999999999999995 112.993 177.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.11 145.57 13.08 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 123.609 1.671 . . . . 2.27 115.231 -178.506 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -93.15 -7.67 44.73 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 113.762 -1.563 . . . . 2.5099999999999998 113.031 -174.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -142.67 145.06 32.53 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 127.469 2.307 . . . . 6.7400000000000002 107.495 169.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -66.25 151.2 84.03 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.152 1.901 . . . . 2.3999999999999999 108.822 158.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mp -117.46 112.41 20.6 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 125.977 1.711 . . . . 3.5899999999999999 107.596 -165.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -86.11 171.02 11.67 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.332 0.587 . . . . 4.5700000000000003 112.078 179.079 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.81 137.31 58.21 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.396 -0.964 . . . . 1.9199999999999999 108.396 153.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.81 23.05 75.98 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 116.44 1.336 . . . . 1.4099999999999999 116.44 173.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -93.42 -170.24 2.33 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.662 1.731 . . . . 2.3300000000000001 111.74 169.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -154.66 138.31 16.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 128.264 2.626 . . . . 3.1400000000000001 106.647 -173.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.6 t -149.09 136.1 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.804 1.641 . . . . 1.8600000000000001 110.027 -163.196 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.495 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 37.1 mt-10 -77.31 147.76 36.04 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.104 0.478 . . . . 2.8399999999999999 110.83 173.37 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mp -127.3 149.93 49.81 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.878 1.271 . . . . 2.5 108.747 159.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -107.39 150.55 26.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.661 0.784 . . . . 2.2400000000000002 108.935 158.01 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.3 mp -109.81 133.48 53.11 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.399 1.48 . . . . 2.4500000000000002 109.267 172.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.4 mt -103.55 112.18 24.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.176 1.39 . . . . 1.8899999999999999 109.559 -179.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -106.14 111.53 24.18 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.924 1.69 . . . . 3.4300000000000002 111.572 -175.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 49.76 32.58 5.38 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.774 1.63 . . . . 3.3900000000000001 112.948 -178.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.43 -71.1 1.84 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.41 1.481 . . . . 5.1200000000000001 112.212 -171.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.44 9.46 21.21 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 117.146 1.618 . . . . 2.2400000000000002 117.146 -163.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -130.9 134.28 46.63 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.721 1.76 . . . . 5.04 110.463 169.51 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.7 p -125.22 145.09 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.048 1.339 . . . . 3.2999999999999998 110.977 178.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.8 tp -139.92 126.47 20.36 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.254 1.422 . . . . 3.5800000000000001 109.588 178.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.495 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 25.7 ttmt -84.27 141.38 31.0 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.061 0.393 . . . . 3.0699999999999998 112.061 173.618 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.19 -179.91 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 127.203 2.201 . . . . 3.9500000000000002 110.361 167.084 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.5 t -138.31 155.43 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.515 1.526 . . . . 2.6800000000000002 106.979 171.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.27 153.29 26.62 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.954 1.302 . . . . 2.9700000000000002 111.231 171.314 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.95 168.17 12.63 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.75 2.967 . . . . 1.03 112.842 171.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.6 t -112.36 128.73 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.039 1.336 . . . . 2.0299999999999998 108.712 169.525 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -154.41 178.53 9.95 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.257 1.823 . . . . 4.4000000000000004 112.946 177.048 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.55 162.26 29.71 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.849 1.426 . . . . 4.0499999999999998 114.849 -167.228 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.478 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 117.744 -1.122 . . . . 8.3900000000000006 109.886 171.069 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 112.294 0.479 . . . . 5.0700000000000003 112.294 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -150.28 164.88 29.81 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.99 1.281 . . . . 1.4099999999999999 114.122 171.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -157.2 151.47 25.01 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.615 2.366 . . . . 2.6699999999999999 110.638 176.285 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.9 t -97.62 145.55 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 120.957 -1.089 . . . . 2.1400000000000001 109.868 -178.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.77 -15.64 63.73 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.024 1.49 . . . . 5.6399999999999997 115.024 -172.782 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 77.57 145.88 0.09 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.053 2.141 . . . . 5.2699999999999996 114.116 -171.539 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.4 t -178.66 133.78 0.3 Allowed Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 128.27 2.628 . . . . 3.3199999999999998 110.808 165.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -82.51 -11.42 10.56 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.224 2.616 . . . . 3.1899999999999999 112.202 172.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.34 169.37 31.72 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.958 1.266 . . . . 1.45 112.212 178.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.59 -15.9 52.39 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.597 3.531 . . . . 1.9299999999999999 114.779 -170.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -100.99 140.55 35.13 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.248 1.419 . . . . 3.02 112.428 173.642 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.44 -177.42 5.94 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.285 1.834 . . . . 1.7 111.926 172.312 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.26 147.18 25.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.598 1.959 . . . . 1.8100000000000001 110.02 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.99 149.82 47.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.745 1.017 . . . . 1.8 113.745 -172.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -117.19 142.73 46.67 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.161 1.784 . . . . 4.4000000000000004 109.862 174.515 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.84 160.12 14.25 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.399 1.08 . . . . 4.1699999999999999 113.208 178.171 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.9 m -136.95 147.04 46.11 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 125.129 1.371 . . . . 2.9399999999999999 110.167 -171.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.51 134.11 10.87 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.987 1.315 . . . . 6.4699999999999998 109.498 -178.046 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.29 154.16 18.78 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.211 0.914 . . . . 5.2999999999999998 112.376 177.104 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -105.28 83.34 0.88 Allowed Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.71 1.204 . . . . 1.5900000000000001 110.132 171.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -71.65 -4.68 15.52 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.476 2.117 . . . . 2.21 113.437 176.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.79 169.73 49.06 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-O 123.284 1.491 . . . . 1.24 112.811 177.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.458 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 5.7 m-20 -101.25 -2.24 31.69 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 127.54 2.336 . . . . 2.8500000000000001 112.518 -171.219 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -116.71 159.59 39.89 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.931 2.092 . . . . 5.3499999999999996 109.459 169.755 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.97 170.77 14.91 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.844 2.363 . . . . 1.8600000000000001 112.206 -166.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.4 mt -117.07 147.88 42.0 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 123.243 1.497 . . . . 3.0499999999999998 110.945 165.843 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -138.54 109.65 6.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 111.449 -2.614 . . . . 4.0499999999999998 108.97 166.819 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 tp -84.95 110.21 18.72 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.033 1.733 . . . . 2.5800000000000001 108.826 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.81 -14.77 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.155 0.982 . . . . 1.8 112.059 -176.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.34 -179.03 31.95 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-O 122.324 0.958 . . . . 0.47999999999999998 114.276 -178.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.64 -179.15 6.39 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.98 1.712 . . . . 1.73 109.588 162.668 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -153.27 -178.97 7.31 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.917 1.287 . . . . 6.0300000000000002 108.568 156.164 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 t -171.53 153.0 3.37 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 125.986 1.714 . . . . 1.6899999999999999 108.056 -172.604 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.11 -3.16 13.2 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.151 1.901 . . . . 0.75 113.847 174.175 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.5 m -119.15 39.26 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.796 1.239 . . . . 1.8999999999999999 114.267 -176.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.36 167.26 29.29 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.134 1.374 . . . . 1.71 110.721 169.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -98.47 -50.97 4.1 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.72 1.608 . . . . 2.6499999999999999 110.023 171.415 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -114.99 139.33 49.93 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 127.215 2.206 . . . . 5.4800000000000004 107.293 171.054 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.1 149.55 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.521 -0.763 . . . . 2.1200000000000001 109.003 154.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -127.94 151.79 48.68 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.675 1.99 . . . . 2.9700000000000002 107.54 166.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -100.73 138.34 37.91 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.082 1.31 . . . . 3.0 112.102 160.465 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -123.79 160.21 27.84 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.066 2.146 . . . . 0.77000000000000002 112.235 -178.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.36 178.58 4.52 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 112.491 -2.141 . . . . 3.46 111.397 166.101 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.8 m -148.34 139.15 23.0 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.285 -1.376 . . . . 1.6699999999999999 107.285 163.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -148.37 178.54 8.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.983 1.313 . . . . 3.5099999999999998 112.4 -168.864 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -110.04 145.49 36.96 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.332 1.453 . . . . 5.0899999999999999 113.117 179.331 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.8 mtp85 -127.43 152.81 47.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.445 1.498 . . . . 5.5899999999999999 110.711 166.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.438 ' OE1' ' HE2' ' A' ' 57' ' ' LYS . 3.1 tp10 -91.75 143.31 26.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.536 -0.912 . . . . 2.52 108.536 147.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 50.6 t -140.27 127.7 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 106.937 -1.505 . . . . 3.0299999999999998 106.937 158.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 65.03 25.64 12.63 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.24 1.016 . . . . 4.3799999999999999 113.715 173.404 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.11 9.1 85.64 Favored Glycine 0 CA--C 1.538 1.471 0 O-C-N 120.536 -1.352 . . . . 1.6200000000000001 113.94 -173.52 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -122.21 119.25 30.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.17 2.188 . . . . 3.8799999999999999 108.746 -170.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.453 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -89.04 116.52 27.38 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.655 1.982 . . . . 4.8899999999999997 111.401 -173.033 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.1 t -149.13 139.69 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.962 2.105 . . . . 4.0800000000000001 109.328 -166.112 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -84.08 170.86 13.44 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.586 1.328 . . . . 3.4700000000000002 114.586 -172.059 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.55 165.63 29.13 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 126.807 2.146 . . . . 0.5 112.694 177.427 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 ttm -148.11 141.38 25.15 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.979 1.712 . . . . 1.79 109.705 177.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -148.18 159.6 39.24 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.695 1.998 . . . . 5.7999999999999998 109.749 -176.71 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.81 153.02 53.29 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.276 1.984 . . . . 1.01 111.358 168.274 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.89 159.45 56.14 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 123.734 0.814 . . . . 2.23 109.898 174.51 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.63 -25.88 3.45 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.856 2.371 . . . . 0.76000000000000001 112.951 -172.063 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -179.64 167.17 1.4 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.092 2.157 . . . . 3.5299999999999998 110.73 -178.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.2 mt -112.1 152.18 28.56 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.24 1.016 . . . . 1.79 110.179 162.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -120.48 139.32 53.05 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.216 1.406 . . . . 2.1899999999999999 110.042 -176.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.4 t -146.05 135.65 11.59 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 113.147 0.795 . . . . 2.7000000000000002 113.147 176.419 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.26 168.87 23.77 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.479 2.786 . . . . 1.5600000000000001 112.189 176.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -59.76 140.9 95.59 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.71 2.273 . . . . 1.6899999999999999 110.959 165.074 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.458 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 56.4 mmtt 66.33 1.86 2.19 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.773 1.629 . . . . 2.4399999999999999 113.577 -176.412 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.85 -175.65 51.07 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.644 2.069 . . . . 1.8899999999999999 111.533 166.44 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -147.43 150.46 34.68 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 114.253 1.205 . . . . 6.6299999999999999 114.253 175.694 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.1 t -98.23 106.13 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 128.243 2.617 . . . . 6.6799999999999997 107.405 -174.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.14 110.38 13.42 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 122.199 0.999 . . . . 3.9399999999999999 111.204 -179.416 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mp -83.49 78.7 9.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.006 -1.479 . . . . 2.3599999999999999 107.006 167.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -73.0 140.67 80.8 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 113.777 -1.556 . . . . 4.3300000000000001 112.992 -175.113 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -61.12 142.54 97.23 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.712 2.275 . . . . 3.48 110.81 -179.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.84 -12.93 58.34 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.222 -1.321 . . . . 2.6099999999999999 114.786 -177.053 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.68 -109.53 1.45 Allowed Glycine 0 N--CA 1.474 1.173 0 CA-C-N 119.154 1.477 . . . . 1.8700000000000001 111.62 172.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -75.54 137.07 40.6 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.832 -0.805 . . . . 3.4900000000000002 111.957 -172.405 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -161.37 152.37 18.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.548 -0.751 . . . . 0.64000000000000001 111.267 -171.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -83.94 140.36 31.98 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.392 -0.818 . . . . 3.8500000000000001 109.879 166.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.3 tpt -100.51 131.28 46.5 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.255 1.822 . . . . 1.73 108.183 167.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 mp -109.48 126.6 53.68 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.801 1.24 . . . . 2.1099999999999999 108.184 -179.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.83 128.03 49.86 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.953 1.301 . . . . 4.0 109.281 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.93 51.91 5.2 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.578 1.085 . . . . 0.81000000000000005 113.24 176.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.6 mt -47.33 155.98 0.29 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.846 1.424 . . . . 4.2400000000000002 114.846 176.285 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -108.61 4.38 23.91 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.853 -1.067 . . . . 2.52 113.691 -177.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -161.31 163.1 20.77 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 129.43 3.092 . . . . 5.9400000000000004 108.12 176.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.09 118.33 5.57 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.708 1.605 . . . . 2.0299999999999998 108.617 165.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mp -80.15 57.14 2.62 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.14 1.376 . . . . 4.0800000000000001 109.917 175.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -59.47 167.17 2.04 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 120.519 -1.363 . . . . 5.04 111.964 174.31 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.34 128.98 33.81 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.393 1.092 . . . . 2.4199999999999999 110.025 161.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.13 34.59 36.91 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.017 1.294 . . . . 2.46 114.092 177.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -90.79 -176.85 4.81 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.65 1.225 . . . . 3.2000000000000002 109.92 153.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -144.66 153.93 42.26 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 127.712 2.405 . . . . 3.7599999999999998 106.904 171.344 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.4 t -149.03 157.66 6.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 128.509 2.724 . . . . 2.1899999999999999 108.791 -163.328 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -120.61 152.85 37.61 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.096 0.474 . . . . 2.6099999999999999 112.079 158.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mp -126.24 137.54 53.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.784 2.033 . . . . 2.6200000000000001 109.869 171.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -90.1 148.3 23.09 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.092 1.357 . . . . 1.8799999999999999 110.135 161.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -112.47 115.81 29.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.331 1.852 . . . . 1.8200000000000001 109.59 172.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.1 mt -93.94 111.36 23.05 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.728 1.211 . . . . 1.74 110.221 -176.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -110.19 124.5 51.69 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.571 0.748 . . . . 3.1899999999999999 111.362 -177.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.95 -17.69 63.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.624 0.972 . . . . 3.2999999999999998 113.624 176.382 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.07 38.08 1.33 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.248 1.404 . . . . 5.4699999999999998 113.653 175.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.97 28.08 72.25 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 125.754 1.645 . . . . 3.5600000000000001 114.851 174.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -140.14 152.71 46.31 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.027 1.414 . . . . 4.5899999999999999 113.359 -168.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.3 t -141.72 144.31 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.861 1.264 . . . . 3.3100000000000001 107.697 163.093 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 22.6 mt -139.93 168.04 20.74 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.45 1.9 . . . . 4.0599999999999996 108.274 170.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.5 pttp -147.42 151.87 37.18 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.199 1.185 . . . . 2.8900000000000001 114.199 177.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.91 141.14 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 127.083 2.153 . . . . 3.4300000000000002 110.923 -171.497 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.5 p -91.8 145.92 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.823 1.249 . . . . 3.6299999999999999 109.408 166.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -157.34 142.76 12.46 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.049 1.34 . . . . 3.8300000000000001 112.105 -174.1 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.6 166.01 27.96 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 124.083 3.189 . . . . 1.27 111.444 172.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.7 t -107.68 115.67 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.302 1.041 . . . . 1.9199999999999999 109.17 169.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -127.1 153.63 45.75 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.905 1.282 . . . . 4.75 111.812 -170.434 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.6 58.8 4.47 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.794 1.035 . . . . 2.77 113.794 -159.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.26 -0.876 . . . . 8.5800000000000001 112.285 174.202 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 . . . . . 0 CA--C 1.549 0.937 0 CA-C-O 121.303 0.573 . . . . 6.8200000000000003 111.787 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.7 169.09 26.16 Favored Glycine 0 C--N 1.337 0.609 0 O-C-N 119.714 -1.866 . . . . 1.4299999999999999 113.287 -174.428 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -155.85 174.92 14.62 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.051 1.13 . . . . 2.1499999999999999 114.051 -176.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.6 t -119.1 139.46 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 127.332 2.253 . . . . 2.1299999999999999 109.779 177.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -97.36 109.66 22.37 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.009 1.324 . . . . 5.2800000000000002 110.684 171.564 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -52.58 150.05 5.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.461 1.104 . . . . 4.6799999999999997 110.935 168.189 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 m -162.06 147.65 10.37 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 125.097 1.359 . . . . 3.5499999999999998 109.865 166.323 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -81.4 44.39 1.73 Allowed 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 124.671 3.581 . . . . 3.2799999999999998 112.011 179.73 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -122.52 160.96 16.9 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.677 1.608 . . . . 2.1600000000000001 112.93 -176.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.81 -17.49 56.22 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.584 2.856 . . . . 2.2799999999999998 112.791 172.131 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -110.53 146.44 36.03 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.103 1.761 . . . . 3.2999999999999998 113.565 164.426 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.08 -178.81 3.65 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.188 1.795 . . . . 1.74 110.275 163.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.94 145.36 34.43 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.57 1.077 . . . . 1.8 111.135 177.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.5 148.87 44.79 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.964 1.098 . . . . 1.9199999999999999 113.964 -175.644 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -127.89 77.39 1.75 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.732 2.413 . . . . 3.7200000000000002 110.414 -173.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -74.16 158.65 33.79 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.817 -1.177 . . . . 2.9500000000000002 112.077 178.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.6 m -118.24 146.93 43.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.252 -1.018 . . . . 2.6899999999999999 108.252 157.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.454 ' CD1' ' H ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -154.35 -174.76 5.1 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.264 1.826 . . . . 6.5800000000000001 108.427 171.433 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.454 ' H ' ' CD1' ' A' ' 22' ' ' LEU . 37.3 mt-10 -138.69 146.4 41.53 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 120.69 -1.256 . . . . 3.6200000000000001 110.416 -174.304 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -95.31 102.26 9.3 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.666 0.786 . . . . 1.46 109.067 156.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.84 -12.92 14.63 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.725 2.283 . . . . 2.0 113.35 176.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.04 -175.72 50.93 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-O 122.424 1.013 . . . . 1.9099999999999999 113.339 -172.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.457 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 15.7 m-20 -111.09 -1.16 16.34 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.165 2.186 . . . . 4.0999999999999996 112.038 -172.367 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -111.82 158.9 35.34 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 127.771 2.428 . . . . 2.9900000000000002 110.198 171.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.11 146.65 18.13 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.518 2.145 . . . . 1.3300000000000001 111.581 -174.26 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -113.75 161.94 16.9 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.868 1.667 . . . . 3.6899999999999999 110.931 176.002 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -154.81 119.54 4.85 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.517 -1.22 . . . . 2.8799999999999999 111.012 -167.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.0 tp -101.21 108.95 20.74 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.273 1.829 . . . . 2.9399999999999999 110.404 -173.352 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.1 m -109.38 -20.56 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.351 1.06 . . . . 1.95 112.12 -167.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.09 -174.36 29.78 Favored Glycine 0 C--N 1.343 0.963 0 C-N-CA 125.059 1.314 . . . . 0.75 113.367 -174.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.0 -179.67 7.19 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.066 0.946 . . . . 1.8899999999999999 112.025 169.08 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -153.14 145.25 23.8 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.201 1.8 . . . . 6.3200000000000003 107.634 178.529 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -164.11 151.19 10.2 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 119.416 1.007 . . . . 1.74 109.477 -172.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.0 -4.2 13.74 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.137 2.558 . . . . 0.88 114.428 175.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.23 30.3 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 115.212 1.56 . . . . 1.7 115.212 -175.189 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -174.88 167.95 3.59 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 128.357 2.663 . . . . 2.1899999999999999 108.313 174.277 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -119.94 -45.9 2.46 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.2 0.909 . . . . 6.1699999999999999 111.248 169.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.7 mtt-85 -78.6 141.46 38.03 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.585 -1.265 . . . . 5.5899999999999999 107.585 164.387 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -158.52 74.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 127.806 2.442 . . . . 2.6400000000000001 110.027 -174.469 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -99.97 131.64 45.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 111.766 -2.47 . . . . 4.9199999999999999 110.72 -169.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -90.1 136.51 33.0 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 123.753 1.739 . . . . 3.2999999999999998 114.026 -176.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -115.1 160.85 19.16 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 127.143 2.177 . . . . 0.97999999999999998 110.856 174.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.12 -177.86 4.28 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.236 -1.802 . . . . 3.3900000000000001 111.202 156.776 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.8 m -152.82 141.18 20.62 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.174 1.389 . . . . 1.6499999999999999 107.829 170.306 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -151.04 170.41 19.44 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.929 1.455 . . . . 3.6299999999999999 114.929 -168.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.0 ttp -109.75 142.47 40.94 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.369 1.868 . . . . 4.25 109.479 169.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -151.92 159.23 43.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.682 1.993 . . . . 9.5299999999999994 111.391 -175.608 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -91.28 147.47 23.02 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.193 1.397 . . . . 2.5 111.897 170.198 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.6 t -140.54 120.33 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.389 1.475 . . . . 2.9900000000000002 107.956 166.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 64.44 8.64 4.41 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 127.371 2.268 . . . . 2.8999999999999999 114.763 -178.019 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.92 23.23 33.37 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 123.958 0.79 . . . . 1.79 113.89 -168.049 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.1 132.62 53.11 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.772 1.229 . . . . 3.3500000000000001 109.634 166.549 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 138.89 44.87 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.079 1.352 . . . . 7.4000000000000004 110.636 -178.86 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.8 p -154.26 -179.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 C-N-CA 126.882 2.073 . . . . 3.5099999999999998 109.328 -177.479 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.75 166.4 12.18 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 121.299 -0.875 . . . . 4.2599999999999998 112.28 -176.686 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.66 171.22 29.77 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.972 1.749 . . . . 0.55000000000000004 111.994 -179.291 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 ttm -155.4 138.44 15.49 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 126.646 1.979 . . . . 1.6699999999999999 109.227 173.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -144.65 149.94 45.29 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 127.645 2.378 . . . . 10.1 109.424 -172.025 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.1 154.87 52.52 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.574 2.183 . . . . 0.66000000000000003 110.019 176.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.14 151.6 75.5 Favored Pre-proline 0 N--CA 1.483 1.213 0 CA-C-O 117.974 -1.012 . . . . 1.73 110.71 175.053 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.38 -23.77 9.8 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.192 2.595 . . . . 0.81999999999999995 112.873 -169.575 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -179.55 165.58 1.36 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.472 2.309 . . . . 3.54 109.85 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.0 mt -109.15 150.52 27.75 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.004 0.922 . . . . 1.8799999999999999 110.044 165.137 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -109.71 143.82 38.95 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.297 1.039 . . . . 2.0800000000000001 109.149 178.059 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.6 t -140.3 125.25 11.16 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 122.971 0.509 . . . . 2.1499999999999999 112.093 173.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.81 168.35 20.5 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.95 2.433 . . . . 1.3400000000000001 111.697 179.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -55.25 140.12 81.32 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.027 2.485 . . . . 1.6899999999999999 111.43 168.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.457 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 56.4 mmtt 67.68 0.91 2.41 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.721 1.609 . . . . 2.9900000000000002 113.616 -177.183 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.62 156.96 45.22 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.902 1.715 . . . . 1.8 112.45 -179.048 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.9 mtm105 -104.99 132.51 51.14 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.025 1.33 . . . . 7.8700000000000001 109.581 -178.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.9 t -93.42 55.33 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 127.589 2.356 . . . . 6.54 108.248 -173.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.71 93.02 8.69 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.641 1.976 . . . . 3.9199999999999999 109.742 -175.223 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 tp -52.21 -56.23 16.02 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.326 1.45 . . . . 3.3900000000000001 111.608 -164.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.462 ' HB2' ' HZ3' ' A' ' 78' ' ' LYS . 1.8 ttmp? 112.09 128.37 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 128.977 2.911 . . . . 3.8300000000000001 114.429 161.516 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.62 -45.91 12.88 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.891 2.394 . . . . 2.1200000000000001 110.847 174.065 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.72 40.69 3.07 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.938 -0.924 . . . . 1.8100000000000001 112.37 172.315 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.4 -117.5 0.56 Allowed Glycine 0 C--N 1.337 0.638 0 CA-C-N 118.139 0.97 . . . . 1.77 113.783 175.029 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -76.5 137.1 39.41 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 123.399 1.571 . . . . 3.0899999999999999 113.646 -163.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -158.17 138.54 12.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.301 -1.318 . . . . 0.82999999999999996 113.424 -173.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -77.03 135.24 38.64 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.018 -1.104 . . . . 4.1399999999999997 108.018 167.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.8 mtp -99.64 117.69 34.54 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.651 0.739 . . . . 3.0299999999999998 110.619 160.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -86.71 107.74 18.36 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.608 1.963 . . . . 2.0699999999999998 107.426 -176.716 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.0 mp -111.35 141.5 44.81 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.09 1.756 . . . . 2.96 111.005 -173.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.44 42.44 41.32 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 111.459 -0.656 . . . . 0.94999999999999996 111.459 178.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . 0.258 0.5 OUTLIER -44.01 138.84 2.68 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 123.479 1.609 . . . . 3.1099999999999999 115.324 176.828 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -101.12 -12.71 18.58 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.051 -1.886 . . . . 5.4299999999999997 112.893 -173.137 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -143.8 150.59 50.59 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 128.305 2.642 . . . . 6.4699999999999998 108.2 172.681 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -72.37 150.58 52.66 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.597 2.198 . . . . 1.9099999999999999 110.082 167.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.9 mp -108.8 143.79 37.5 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.087 2.155 . . . . 3.8500000000000001 106.395 176.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.52 162.5 15.05 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.466 2.306 . . . . 4.6600000000000001 110.424 170.796 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.54 125.8 26.87 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.43 -0.794 . . . . 2.9300000000000002 109.171 157.399 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.86 32.0 6.72 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.866 1.222 . . . . 1.71 115.025 173.241 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -112.16 -167.49 1.19 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.488 1.115 . . . . 2.1200000000000001 112.801 175.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -147.11 147.94 31.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 128.116 2.567 . . . . 3.1299999999999999 107.233 172.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.9 t -146.31 126.69 6.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 127.823 2.449 . . . . 2.1299999999999999 108.667 -165.354 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.494 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -90.11 154.45 19.78 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 122.732 1.253 . . . . 2.54 113.75 176.224 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.7 tt -156.82 144.87 19.42 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.125 1.77 . . . . 3.3799999999999999 109.945 176.042 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.08 140.86 39.24 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.696 1.598 . . . . 3.3500000000000001 110.55 170.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.1 mp -84.91 127.7 34.29 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.388 1.475 . . . . 2.5 109.64 174.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.6 mt -90.75 104.86 17.39 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.696 -0.853 . . . . 1.8300000000000001 108.696 168.691 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.69 149.27 22.46 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.187 0.995 . . . . 3.6299999999999999 111.101 172.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.57 129.05 34.9 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.518 0.933 . . . . 2.1699999999999999 113.518 -174.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.32 62.03 2.84 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.663 1.125 . . . . 3.1499999999999999 113.542 174.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.19 13.18 81.44 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 115.709 1.044 . . . . 2.4199999999999999 115.709 167.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -97.07 122.19 39.79 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.794 1.297 . . . . 3.8999999999999999 110.56 -179.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.8 t -137.0 128.83 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.152 0.981 . . . . 3.2000000000000002 109.977 -176.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -140.43 127.62 21.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.564 1.146 . . . . 3.8799999999999999 111.811 -176.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.494 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 24.4 ttmm -83.25 140.59 32.42 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.179 1.392 . . . . 3.9100000000000001 113.766 -178.867 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.36 153.9 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.446 1.898 . . . . 3.3300000000000001 109.971 163.307 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.31 127.57 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 107.337 -1.357 . . . . 2.7599999999999998 107.337 163.014 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.4 mt -125.44 129.46 24.42 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.256 1.422 . . . . 2.75 108.668 -170.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.65 153.06 65.07 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.159 2.573 . . . . 1.04 112.147 172.675 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.4 t -103.91 112.3 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.445 1.498 . . . . 2.1200000000000001 109.904 173.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -100.38 178.66 4.68 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.802 1.241 . . . . 4.9100000000000001 109.896 160.43 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.33 158.66 43.91 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.935 0.894 . . . . 3.4700000000000002 112.158 -171.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.352 0 C-N-CA 126.817 2.047 . . . . 10.26 110.639 176.153 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.588 0 CA-C-O 121.789 0.804 . . . . 5.0599999999999996 111.362 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.18 -175.25 32.0 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 128.456 2.932 . . . . 1.27 110.98 174.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -116.43 157.03 25.78 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.665 0.987 . . . . 2.6200000000000001 113.665 175.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.2 t -89.46 141.97 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 O-C-N 120.877 -1.139 . . . . 2.3199999999999998 108.163 157.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.0 ttt85 -77.15 131.43 38.29 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.988 -0.445 . . . . 5.8099999999999996 111.894 -173.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -45.02 135.06 5.57 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.412 1.485 . . . . 2.96 112.067 166.186 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.0 t -176.68 129.68 0.35 Allowed Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.188 1.395 . . . . 3.0800000000000001 112.448 172.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -91.19 0.76 4.77 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.133 3.222 . . . . 2.6299999999999999 112.413 165.324 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.19 -175.33 46.44 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.644 1.116 . . . . 1.1299999999999999 113.374 -173.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -69.02 -22.13 35.9 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.161 2.574 . . . . 1.9399999999999999 113.057 -178.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.6 p30 -128.38 166.06 19.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.302 1.841 . . . . 2.3900000000000001 114.076 -178.657 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.44 -177.2 6.3 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 128.258 2.623 . . . . 1.74 111.045 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.75 171.09 10.38 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.294 1.837 . . . . 2.1499999999999999 108.925 169.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.5 160.7 43.59 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.759 1.223 . . . . 1.8500000000000001 111.557 174.472 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -155.34 144.95 21.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.841 -1.072 . . . . 9.5999999999999996 111.558 -161.019 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -161.89 156.51 22.62 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.393 1.477 . . . . 3.2200000000000002 111.375 -172.083 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.1 m -83.95 146.07 28.22 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.081 0.953 . . . . 2.7599999999999998 108.857 162.254 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.49 114.27 23.22 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.639 0.775 . . . . 4.3499999999999996 109.449 170.064 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -104.88 145.62 30.14 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.988 1.315 . . . . 3.96 109.093 168.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.21 73.49 1.33 Allowed Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.088 0.955 . . . . 3.0600000000000001 110.986 177.735 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.3 -19.3 62.02 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.902 2.401 . . . . 1.6399999999999999 114.659 -174.23 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.42 -179.95 51.43 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-O 122.885 1.269 . . . . 1.23 113.066 174.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.403 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 11.0 m-20 -103.27 -2.48 27.1 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.87 2.068 . . . . 2.8900000000000001 112.151 -169.005 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -122.48 155.79 61.93 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 128.099 2.56 . . . . 2.9300000000000002 109.782 175.547 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.63 140.65 21.34 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.777 2.318 . . . . 1.3300000000000001 111.086 -172.186 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.8 mt -93.31 150.01 20.8 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 123.21 1.481 . . . . 3.0600000000000001 112.029 172.275 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -134.89 113.87 11.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 112.303 -2.226 . . . . 3.0600000000000001 110.165 177.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.8 tp -95.86 111.57 23.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.669 1.588 . . . . 3.1099999999999999 108.93 -177.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.2 m -107.22 -19.81 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.548 1.139 . . . . 2.2599999999999998 112.273 -169.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.42 -174.61 28.36 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.384 1.468 . . . . 0.84999999999999998 113.22 177.487 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.57 -176.73 4.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.764 1.626 . . . . 1.8100000000000001 109.348 167.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.12 175.23 13.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.767 1.627 . . . . 6.0 108.42 161.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.9 t -171.57 156.14 4.2 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 125.657 1.583 . . . . 1.73 108.417 -173.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.91 -10.55 14.06 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.805 1.67 . . . . 0.97999999999999998 112.895 171.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.6 46.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.232 1.013 . . . . 2.25 113.461 -176.384 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.58 153.28 14.96 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.216 1.406 . . . . 1.8999999999999999 110.68 164.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.537 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 1.5 tp10 -88.39 -47.22 8.53 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.649 1.18 . . . . 2.8599999999999999 110.229 172.511 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' ' 44' ' ' GLU . 16.0 mtp180 -104.89 133.7 49.25 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 126.33 1.852 . . . . 7.5300000000000002 107.53 166.755 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.11 148.0 22.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.812 -1.181 . . . . 2.5699999999999998 107.812 150.357 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 42' ' ' ARG . 7.6 pt-20 -156.81 149.3 23.37 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 126.26 1.824 . . . . 3.5699999999999998 107.73 -172.189 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -100.48 139.92 35.48 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 122.894 1.33 . . . . 2.96 112.614 173.097 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -119.93 149.75 41.61 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.724 2.009 . . . . 0.88 111.5 178.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -86.62 162.38 18.0 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.335 1.454 . . . . 2.6699999999999999 110.925 162.849 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.9 m -129.26 130.45 46.24 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 106.409 -1.701 . . . . 2.2599999999999998 106.409 167.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -135.44 168.46 19.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.698 1.135 . . . . 3.4700000000000002 113.949 -174.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.7 ttm -100.25 146.13 27.26 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.601 1.56 . . . . 4.8399999999999999 109.972 165.218 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.75 153.66 32.61 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.627 1.171 . . . . 5.5099999999999998 110.475 -171.777 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -95.26 137.81 33.81 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.124 0.97 . . . . 3.6099999999999999 109.871 169.431 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.0 t -130.8 119.32 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 106.703 -1.591 . . . . 3.4300000000000002 106.703 164.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 60.88 18.0 8.33 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 116.154 1.909 . . . . 5.46 116.154 178.004 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.38 2.69 67.78 Favored Glycine 0 N--CA 1.479 1.552 0 O-C-N 120.826 -1.171 . . . . 2.21 114.354 -171.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.23 125.56 52.38 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.464 1.906 . . . . 4.6600000000000001 109.852 176.529 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -74.95 119.17 18.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.667 -1.606 . . . . 6.1200000000000001 109.45 -179.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.0 m -122.53 177.72 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 127.594 2.358 . . . . 3.1499999999999999 109.674 177.68 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 56.5 mtt -118.0 158.45 24.92 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.232 1.013 . . . . 3.6499999999999999 111.243 167.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.82 -177.38 25.5 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 126.16 1.838 . . . . 0.68999999999999995 112.243 -176.447 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.9 ttm -157.57 142.94 17.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.856 1.662 . . . . 1.8700000000000001 109.426 -171.656 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.15 159.18 43.25 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 127.327 2.251 . . . . 9.3499999999999996 109.545 -174.361 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -84.65 144.9 10.2 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.129 2.553 . . . . 0.89000000000000001 111.343 173.285 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.7 m -133.51 162.38 58.02 Favored Pre-proline 0 N--CA 1.486 1.368 0 CA-C-O 118.317 -0.849 . . . . 1.99 111.749 -175.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -89.89 -25.06 0.53 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.282 1.988 . . . . 0.91000000000000003 114.215 -163.087 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -178.76 166.34 1.68 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.865 1.266 . . . . 3.4100000000000001 112.96 -177.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.9 mt -114.81 153.14 30.95 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.892 1.677 . . . . 2.1499999999999999 110.837 165.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -120.2 142.96 48.52 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.489 1.516 . . . . 1.8899999999999999 109.448 177.828 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.7 t -138.57 139.22 23.9 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.469 0.708 . . . . 2.23 112.139 172.022 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -84.86 156.15 11.64 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 124.392 3.395 . . . . 1.4399999999999999 112.869 177.643 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.58 143.77 82.49 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.979 3.12 . . . . 1.27 113.94 -173.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.403 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 70.2 mmtt 68.7 -11.28 0.43 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.234 2.614 . . . . 2.6600000000000001 114.763 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.98 168.49 50.94 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.787 1.184 . . . . 1.8300000000000001 112.752 172.554 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.87 151.24 49.31 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.969 0.908 . . . . 5.9800000000000004 110.646 162.488 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.2 t -136.19 174.6 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 129.338 3.055 . . . . 4.79 106.038 175.312 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -154.14 161.12 42.09 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 119.738 -1.851 . . . . 4.0099999999999998 108.593 171.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 mp -56.0 -43.75 77.99 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.091 1.145 . . . . 3.71 114.091 -164.798 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt 71.43 110.88 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 128.632 2.773 . . . . 6.2599999999999998 111.236 -178.707 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -62.87 -34.79 70.76 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.886 1.724 . . . . 2.7999999999999998 111.683 -176.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.48 43.07 2.85 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.235 1.397 . . . . 2.1800000000000002 113.253 164.602 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.66 -36.04 0.06 OUTLIER Glycine 0 C--O 1.219 -0.799 0 N-CA-C 120.698 3.039 . . . . 2.5699999999999998 120.698 162.352 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -144.64 146.22 32.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 119.549 1.674 . . . . 3.52 113.236 168.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -161.76 153.2 18.61 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.413 -0.804 . . . . 0.80000000000000004 111.096 175.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -78.72 141.44 37.87 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.693 -0.484 . . . . 2.9399999999999999 109.693 167.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -105.73 134.75 48.35 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.027 1.731 . . . . 1.74 109.242 165.465 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -111.1 122.91 49.09 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.518 1.527 . . . . 1.95 108.468 176.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.0 mp -120.98 138.3 54.21 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.612 0.765 . . . . 2.96 109.335 176.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.12 45.42 11.62 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.319 -0.712 . . . . 0.94999999999999996 112.543 178.422 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 pp -53.67 154.75 3.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 123.271 1.51 . . . . 2.4399999999999999 114.82 176.513 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.537 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 71.7 mmtt -109.69 -10.47 14.81 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 113.224 -1.807 . . . . 3.1600000000000001 113.541 -175.13 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 mtp-105 -145.16 143.64 21.06 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 126.775 2.03 . . . . 6.04 108.19 169.545 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -68.69 151.3 74.81 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.405 2.07 . . . . 2.1099999999999999 109.698 171.02 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 64.8 mt -116.73 92.35 3.84 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.019 0.928 . . . . 3.3300000000000001 110.131 -166.588 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.6 pttm -83.63 164.03 19.96 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.54 -0.725 . . . . 6.1500000000000004 112.126 170.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.27 126.21 26.76 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.314 -0.866 . . . . 2.27 108.676 168.775 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.23 33.12 50.14 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.428 1.013 . . . . 1.4199999999999999 113.81 179.187 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -81.74 179.86 7.66 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.482 1.141 . . . . 2.71 108.483 143.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -134.54 150.61 50.77 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.085 -1.82 . . . . 3.8799999999999999 106.085 164.23 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 49.8 t -138.25 133.51 43.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 126.443 1.897 . . . . 2.0600000000000001 110.239 -173.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -78.84 137.05 37.51 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.177 -0.465 . . . . 2.75 110.815 172.738 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.75 133.9 54.93 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.92 1.288 . . . . 2.75 110.684 168.251 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -84.87 141.67 30.27 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 125.483 1.513 . . . . 2.7200000000000002 108.799 158.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -110.28 126.33 54.07 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.454 1.502 . . . . 2.2999999999999998 109.026 168.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.2 mt -104.36 117.86 35.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.897 1.279 . . . . 2.1499999999999999 110.061 -178.68 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -116.73 149.11 40.41 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.781 1.232 . . . . 3.29 111.839 -174.468 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.7 139.35 58.32 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.249 1.203 . . . . 2.2400000000000002 114.249 -172.294 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.39 45.5 29.8 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.195 -0.781 . . . . 3.2000000000000002 113.255 175.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.46 35.74 11.59 Favored Glycine 0 N--CA 1.47 0.917 0 N-CA-C 116.074 1.19 . . . . 1.72 116.074 163.587 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -122.81 145.98 47.94 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.832 1.816 . . . . 4.0199999999999996 112.579 172.32 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.7 t -143.6 142.47 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.009 1.323 . . . . 3.1000000000000001 108.955 177.281 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 42.1 tp -143.43 119.74 10.89 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.795 0.838 . . . . 4.2000000000000002 110.874 -178.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 125.76 38.27 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.767 0.827 . . . . 3.8599999999999999 111.62 178.334 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 114' ' ' VAL . 0.3 OUTLIER -138.77 -174.46 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.851 1.66 . . . . 4.3700000000000001 109.954 176.438 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.47 ' H ' HG12 ' A' ' 113' ' ' VAL . 11.3 t -137.2 150.04 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.431 1.492 . . . . 3.0499999999999998 109.565 -168.626 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.6 mt -142.8 143.74 26.87 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 127.366 2.266 . . . . 2.8199999999999998 109.048 -176.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.32 162.12 43.53 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.027 2.484 . . . . 0.85999999999999999 111.443 168.291 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 85.1 t -94.03 122.32 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 121.744 -0.598 . . . . 2.25 110.227 165.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.11 164.76 18.78 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.356 1.862 . . . . 4.4900000000000002 110.731 178.166 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.46 67.8 1.08 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.526 1.306 . . . . 2.3999999999999999 114.526 -154.241 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 . . . . . 0 C--O 1.251 1.132 1 C-N-CA 133.154 4.582 . . . . 9.3800000000000008 113.049 170.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 . . . . . 0 CA--C 1.549 0.942 0 N-CA-C 109.391 -0.596 . . . . 4.7800000000000002 109.391 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.69 177.75 40.6 Favored Glycine 0 N--CA 1.469 0.892 0 O-C-N 121.189 -0.944 . . . . 1.22 114.42 -165.291 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -155.62 138.49 15.33 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.108 1.363 . . . . 2.48 112.097 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.1 t -77.56 142.81 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 120.447 -1.408 . . . . 1.8799999999999999 107.343 167.361 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 -85.0 127.13 34.06 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.661 -0.649 . . . . 7.8600000000000003 110.373 -178.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -44.77 141.47 2.09 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.09 1.356 . . . . 2.9199999999999999 112.109 172.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.5 t -148.11 148.99 31.27 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 122.877 0.471 . . . . 3.4300000000000002 111.502 165.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.0 -23.83 8.87 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.299 2.0 . . . . 2.5800000000000001 112.899 172.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -125.38 -156.64 9.4 Favored Glycine 0 CA--C 1.544 1.878 0 C-N-CA 125.332 1.444 . . . . 1.48 115.76 -160.495 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.24 -14.47 10.67 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.873 3.715 . . . . 1.75 115.171 -167.757 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -122.49 151.35 41.41 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.05 2.14 . . . . 2.4100000000000001 112.746 -178.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.16 -176.77 6.16 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.435 1.894 . . . . 2.1499999999999999 112.986 -163.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.79 158.52 44.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.568 1.947 . . . . 1.99 109.343 174.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.56 134.85 31.16 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.706 1.139 . . . . 1.6299999999999999 112.965 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -107.61 135.79 48.46 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.55 1.54 . . . . 4.4199999999999999 108.37 172.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 pp -150.72 156.44 41.31 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.437 -1.414 . . . . 2.6800000000000002 113.347 -166.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.4 m -119.03 146.73 44.81 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.397 1.879 . . . . 2.8599999999999999 109.864 179.379 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 tt -149.6 162.67 39.74 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 128.355 2.662 . . . . 5.9100000000000001 106.989 155.262 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -134.49 133.52 40.47 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.598 -1.314 . . . . 4.1399999999999997 111.053 163.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -76.96 111.76 18.44 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 127.298 2.239 . . . . 1.77 110.251 -174.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.51 -20.22 41.72 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.166 1.911 . . . . 1.9099999999999999 113.338 177.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.06 129.88 3.24 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 124.753 1.168 . . . . 2.9700000000000002 115.897 154.199 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -175.38 -46.41 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 130.831 3.652 . . . . 6.96 105.623 -169.303 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -126.86 163.01 44.02 Favored Pre-proline 0 C--O 1.24 0.597 0 C-N-CA 127.075 2.15 . . . . 5.2000000000000002 112.052 177.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -81.03 144.44 14.94 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.127 2.551 . . . . 1.74 109.43 166.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.4 mt -98.58 147.54 24.69 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 122.442 1.115 . . . . 2.8999999999999999 110.815 174.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -132.57 104.77 6.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 111.775 -2.466 . . . . 3.0800000000000001 110.638 172.061 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.8 tp -88.19 100.51 13.03 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.228 1.411 . . . . 2.8199999999999998 108.914 -173.121 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -101.95 -18.59 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 125.272 1.429 . . . . 1.8300000000000001 112.42 -169.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.82 -179.59 31.89 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 124.201 0.905 . . . . 0.47999999999999998 112.956 177.379 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.91 -178.21 5.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.099 1.36 . . . . 1.72 109.701 166.685 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.62 -178.42 7.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.022 2.129 . . . . 6.3899999999999997 108.09 165.645 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 t -178.77 154.82 0.85 Allowed Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 127.52 2.328 . . . . 1.6699999999999999 108.796 -176.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.63 -8.64 23.81 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.046 1.83 . . . . 0.89000000000000001 113.802 169.409 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.54 44.6 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 114.108 1.151 . . . . 2.04 114.108 -173.055 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.99 147.29 13.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.365 1.066 . . . . 1.96 111.107 166.129 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.551 ' CD ' ' HZ2' ' A' ' 90' ' ' LYS . 0.8 OUTLIER -89.71 -38.48 13.83 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.038 1.735 . . . . 2.79 111.991 173.788 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 mtp85 -124.7 149.29 47.38 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 127.668 2.387 . . . . 6.4800000000000004 109.175 177.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -157.23 120.52 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 125.642 1.577 . . . . 2.0099999999999998 110.586 -174.02 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -139.11 132.19 29.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.884 -1.053 . . . . 4.4699999999999998 110.962 -164.474 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.7 tp -81.62 125.56 30.7 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.922 0.489 . . . . 2.6099999999999999 111.755 -173.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -121.02 155.65 33.88 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.747 1.619 . . . . 0.65000000000000002 113.464 175.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.99 -176.77 3.34 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.537 1.935 . . . . 3.4399999999999999 110.528 166.415 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.4 m -150.35 143.74 25.05 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.922 1.289 . . . . 1.8200000000000001 108.007 171.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -148.34 168.85 21.51 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.346 1.609 . . . . 3.98 115.346 -170.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.6 mtp -110.92 145.17 38.8 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.283 1.433 . . . . 5.5099999999999998 111.206 162.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -137.14 149.4 47.27 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.697 1.999 . . . . 6.0700000000000003 109.985 171.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -89.79 140.49 29.54 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.501 -0.926 . . . . 2.7200000000000002 108.501 153.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.4 t -140.97 121.71 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 106.112 -1.81 . . . . 3.1600000000000001 106.112 171.597 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 66.89 22.54 10.15 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.93 0.892 . . . . 3.71 112.798 176.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.83 19.43 77.68 Favored Glycine 0 N--CA 1.477 1.394 0 O-C-N 120.627 -1.296 . . . . 1.7 113.337 -173.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -132.6 127.91 36.01 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.426 1.891 . . . . 3.3300000000000001 108.89 -178.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -79.33 125.45 29.52 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.845 0.858 . . . . 6.8200000000000003 112.524 -175.271 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.3 t -121.54 134.05 66.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 128.65 2.78 . . . . 3.4100000000000001 108.583 -176.016 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 37.3 mtt -98.11 149.02 22.95 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.82 0.848 . . . . 3.2599999999999998 110.266 169.179 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.32 -179.13 30.22 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-O 121.917 0.732 . . . . 0.89000000000000001 113.668 -175.039 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ttm -159.88 147.57 16.81 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 125.926 1.69 . . . . 1.6399999999999999 109.886 -171.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.59 152.84 23.49 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 113.602 -1.636 . . . . 6.2000000000000002 109.52 -163.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -83.33 157.87 14.81 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.289 1.993 . . . . 0.88 111.555 176.607 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.97 157.09 54.87 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 125.779 1.632 . . . . 2.4100000000000001 110.429 -178.49 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.76 -31.77 0.53 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.19 2.593 . . . . 0.63 113.389 -166.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -173.39 167.12 4.74 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.087 1.755 . . . . 3.6000000000000001 110.886 -178.601 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.8 mt -110.22 155.2 22.33 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.463 1.105 . . . . 1.8700000000000001 110.936 162.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -117.62 137.99 52.25 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.318 1.447 . . . . 2.1499999999999999 108.851 175.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.3 t -149.44 132.16 8.06 Favored Pre-proline 0 N--CA 1.476 0.845 0 N-CA-C 113.499 0.926 . . . . 2.1899999999999999 113.499 173.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.4 169.55 21.42 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 124.1 3.2 . . . . 1.3300000000000001 114.234 -177.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.04 146.38 96.18 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.93 3.087 . . . . 1.4299999999999999 111.806 168.201 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.6 mmtt 70.37 -7.73 0.97 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.217 1.807 . . . . 2.2999999999999998 114.089 -176.223 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.42 148.69 20.75 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.386 1.469 . . . . 1.22 113.511 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.95 129.21 34.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.121 1.369 . . . . 4.96 111.805 177.113 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.7 t -108.05 80.98 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 128.19 2.596 . . . . 7.0199999999999996 108.469 -165.123 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -138.58 123.04 18.4 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.727 0.775 . . . . 4.1200000000000001 112.994 -158.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -80.55 84.19 6.19 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-O 122.857 1.313 . . . . 2.46 108.45 175.58 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.29 145.85 97.64 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 113.249 -1.796 . . . . 5.0300000000000002 114.83 -171.749 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -55.81 143.32 81.53 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 123.567 2.845 . . . . 4.0899999999999999 110.693 176.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.54 -5.49 44.85 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 116.772 -2.127 . . . . 1.8700000000000001 115.811 176.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.81 -22.64 0.33 Allowed Glycine 0 N--CA 1.475 1.292 0 N-CA-C 119.713 2.645 . . . . 2.1800000000000002 119.713 178.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -152.47 141.83 21.57 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.683 1.742 . . . . 3.5699999999999998 113.078 179.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -162.83 155.46 19.04 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.197 1.399 . . . . 0.76000000000000001 110.977 174.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -84.55 134.5 34.41 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.968 -1.123 . . . . 3.2999999999999998 107.968 163.141 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -82.71 134.06 35.15 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.736 1.214 . . . . 1.73 108.06 164.016 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 mp -117.27 135.49 53.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.519 1.128 . . . . 1.98 109.345 -179.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 mp -132.61 148.89 52.37 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.966 0.906 . . . . 2.5600000000000001 110.975 178.731 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.17 39.58 31.6 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 123.543 0.592 . . . . 1.02 113.836 173.424 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.38 156.41 7.83 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 116.365 1.987 . . . . 2.4100000000000001 116.365 179.382 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.551 ' HZ2' ' CD ' ' A' ' 41' ' ' GLU . 71.3 mmtt -112.35 -16.14 13.0 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 113.018 -1.901 . . . . 2.73 113.409 -170.102 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -128.47 173.67 5.32 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 129.878 3.271 . . . . 7.8899999999999997 110.95 177.321 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -63.78 -176.75 0.37 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.438 2.092 . . . . 3.8399999999999999 110.917 155.599 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.423 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -167.24 66.32 0.09 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.344 2.658 . . . . 4.2599999999999998 108.287 179.223 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.423 ' HD3' ' H ' ' A' ' 93' ' ' LEU . 2.4 mptt -99.65 164.84 11.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.773 1.229 . . . . 8.1500000000000004 111.06 179.277 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.27 122.01 13.42 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.502 1.121 . . . . 2.3100000000000001 110.727 -174.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.07 4.15 63.25 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.231 1.396 . . . . 1.54 114.574 179.275 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -79.96 -175.05 4.75 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.644 1.222 . . . . 2.4399999999999999 110.501 164.944 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -156.28 139.9 15.97 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.948 1.699 . . . . 3.0899999999999999 108.644 -174.532 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.0 t -146.79 134.98 15.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 126.526 1.93 . . . . 1.78 110.874 -163.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.448 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 37.6 tt0 -78.32 136.13 37.65 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.62 1.168 . . . . 3.25 111.176 173.933 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 mp -121.13 136.76 54.92 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.196 0.998 . . . . 2.7999999999999998 111.688 160.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -86.3 145.41 26.93 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.201 2.201 . . . . 2.4900000000000002 110.216 164.423 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -116.52 126.52 53.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.491 1.917 . . . . 1.8899999999999999 109.439 172.295 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.1 mt -103.26 111.75 24.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.308 1.443 . . . . 1.78 110.225 -177.176 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -110.44 105.26 14.17 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.901 1.28 . . . . 3.2999999999999998 112.471 -171.188 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 56.36 18.0 3.18 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.283 1.833 . . . . 2.9300000000000002 114.372 175.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.97 -57.88 3.12 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.368 1.461 . . . . 3.8500000000000001 112.085 -166.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.97 19.51 2.11 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.66 1.6 . . . . 3.0 116.799 -172.021 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.17 147.97 19.89 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.957 2.903 . . . . 3.8300000000000001 112.047 167.145 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.3 t -143.15 150.09 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.332 1.453 . . . . 3.4199999999999999 108.307 176.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.56 171.16 18.55 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.131 1.772 . . . . 4.4100000000000001 108.793 173.449 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.448 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 37.8 pttt -154.89 154.98 33.51 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.694 0.998 . . . . 3.1099999999999999 113.694 179.648 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.4 t -149.11 154.72 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.702 1.201 . . . . 3.25 109.578 -172.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.81 133.54 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.101 0.96 . . . . 2.7200000000000002 109.319 177.365 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -120.77 147.6 46.34 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 126.507 1.923 . . . . 4.0 108.346 175.194 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.23 168.03 15.1 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.51 2.807 . . . . 0.76000000000000001 111.704 163.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.7 t -108.27 122.98 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.483 1.113 . . . . 1.9099999999999999 110.827 170.188 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -119.5 152.46 36.91 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.878 1.271 . . . . 4.6500000000000004 113.763 -174.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.96 152.4 33.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.597 1.559 . . . . 2.6200000000000001 114.08 -175.026 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.977 0 C-N-CA 129.211 3.004 . . . . 8.7799999999999994 116.33 -165.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 . . . . . 0 CA--C 1.543 0.711 0 CA-C-O 121.05 0.452 . . . . 5.9800000000000004 110.063 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.73 172.81 52.22 Favored Glycine 0 C--O 1.221 -0.66 0 O-C-N 121.423 -0.798 . . . . 1.8500000000000001 112.721 167.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -149.61 144.57 26.26 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.828 -0.807 . . . . 2.4300000000000002 110.445 161.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -93.82 128.8 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.586 -0.894 . . . . 2.6400000000000001 108.586 177.596 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -74.15 106.7 5.93 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.123 0.569 . . . . 5.1799999999999997 111.609 -170.613 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -43.44 132.74 4.53 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.03 1.332 . . . . 3.2999999999999998 111.421 171.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.7 m -151.33 138.27 11.88 Favored Pre-proline 0 CA--C 1.539 0.555 0 O-C-N 120.976 -1.078 . . . . 3.46 111.503 175.315 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -86.29 48.18 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.405 3.403 . . . . 2.21 111.076 178.657 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.49 -179.0 30.28 Favored Glycine 0 CA--C 1.539 1.536 0 N-CA-C 115.774 1.07 . . . . 1.52 115.774 -168.168 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.48 -15.88 21.9 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.624 3.55 . . . . 1.4099999999999999 114.112 -176.042 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -134.62 170.67 15.44 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.801 2.04 . . . . 2.2000000000000002 113.195 -175.596 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.65 -179.3 8.03 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.732 2.013 . . . . 1.78 112.413 -177.544 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.95 162.96 20.12 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.49 1.516 . . . . 1.95 110.064 165.677 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.65 146.67 33.41 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.126 1.33 . . . . 1.6699999999999999 113.525 174.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -115.71 160.95 19.41 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.228 1.811 . . . . 4.29 111.178 173.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.4 tp -146.58 138.7 24.85 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.477 1.911 . . . . 3.9700000000000002 109.765 -170.429 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.9 m -131.47 133.6 45.32 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.377 1.471 . . . . 2.9900000000000002 107.196 160.387 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.5 tp -159.67 -178.17 6.9 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 128.149 2.58 . . . . 6.0300000000000002 108.89 -176.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -135.16 151.81 51.02 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.277 1.831 . . . . 3.98 112.457 171.195 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -91.84 106.89 18.94 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.558 1.543 . . . . 1.73 108.33 168.493 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.72 -13.07 14.76 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.998 1.799 . . . . 1.54 113.543 177.51 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.41 173.35 55.23 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-O 123.059 1.366 . . . . 1.1599999999999999 112.754 -175.421 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.451 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 7.1 m-20 -100.71 -2.41 32.59 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 128.189 2.595 . . . . 2.8900000000000001 111.478 -179.248 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -113.64 156.09 44.03 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 127.843 2.457 . . . . 2.98 110.346 171.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.81 151.84 24.88 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.826 2.35 . . . . 0.94999999999999996 111.312 -175.093 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt -99.29 154.04 18.48 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 122.591 1.186 . . . . 2.7599999999999998 111.405 168.134 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.1 ttp180 -140.96 111.03 6.6 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 113.532 -1.667 . . . . 3.71 110.041 177.37 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.58 111.26 23.61 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.981 1.712 . . . . 2.6600000000000001 109.576 -171.073 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 m -113.38 -18.29 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.444 1.098 . . . . 2.21 112.645 -168.219 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.6 -174.49 29.42 Favored Glycine 0 N--CA 1.469 0.843 0 C-N-CA 125.364 1.459 . . . . 0.68000000000000005 112.837 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.46 -178.0 5.93 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.413 1.085 . . . . 1.8100000000000001 111.535 169.452 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -157.15 177.95 10.9 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 128.19 2.596 . . . . 6.1399999999999997 108.246 164.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -177.68 155.42 1.08 Allowed Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 126.738 2.015 . . . . 2.0699999999999998 108.674 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.53 -9.19 24.54 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.752 2.301 . . . . 1.3799999999999999 114.032 167.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.44 48.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 125.063 1.345 . . . . 2.77 114.155 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.47 163.29 30.48 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.337 1.055 . . . . 2.1600000000000001 112.53 164.013 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -96.2 -33.24 12.1 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.085 2.154 . . . . 2.8399999999999999 111.483 170.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.0 mtp85 -155.48 156.74 35.78 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 128.446 2.698 . . . . 7.8700000000000001 108.999 -176.564 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.1 p -158.45 107.8 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 125.553 1.541 . . . . 2.4399999999999999 111.157 -172.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -123.78 137.63 54.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.996 -1.456 . . . . 4.9299999999999997 111.068 -167.358 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.6 tp -88.09 126.07 34.91 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.331 1.452 . . . . 2.6499999999999999 111.958 -169.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 37.6 m170 -119.42 158.34 26.4 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.228 1.811 . . . . 0.77000000000000002 113.171 176.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -102.31 158.74 15.98 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 113.819 -1.537 . . . . 2.3199999999999998 110.61 157.525 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.405 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 48.0 m -113.42 135.38 53.94 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 106.032 -1.84 . . . . 2.3199999999999998 106.032 159.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -128.87 166.67 18.64 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.493 1.14 . . . . 3.4199999999999999 113.582 -175.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 61.0 mtt -100.57 146.27 27.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.126 1.37 . . . . 5.4199999999999999 110.655 167.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.55 150.32 26.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.789 0.836 . . . . 5.6900000000000004 111.665 -176.413 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -103.88 127.68 51.39 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.119 1.368 . . . . 3.21 107.787 166.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.3 t -146.56 138.24 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 106.064 -1.828 . . . . 3.6099999999999999 106.064 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.573 ' CD ' ' HZ3' ' A' ' 56' ' ' LYS . 8.9 tt0 66.58 22.19 10.58 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 119.002 0.819 . . . . 3.27 112.07 177.23 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.31 18.57 79.95 Favored Glycine 0 N--CA 1.475 1.258 0 O-C-N 121.101 -1.0 . . . . 1.72 113.523 -173.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.573 ' HZ3' ' CD ' ' A' ' 54' ' ' GLU . 5.4 mtmp? -141.23 132.63 26.77 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.822 1.649 . . . . 4.0700000000000003 110.833 -168.704 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -70.68 129.4 39.04 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.586 1.554 . . . . 5.2599999999999998 111.435 173.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.6 m -138.32 169.47 18.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 129.188 2.995 . . . . 3.8199999999999998 109.515 -177.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 49.6 mtm -116.39 146.01 42.81 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.431 1.092 . . . . 3.3100000000000001 110.712 168.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.73 -177.13 14.73 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 126.016 1.77 . . . . 0.82999999999999996 111.916 -178.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.1 ttm -150.55 148.9 29.24 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.512 1.525 . . . . 2.1099999999999999 108.746 -177.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -155.86 155.45 29.39 Favored Pre-proline 0 N--CA 1.476 0.85 0 CA-C-O 118.309 -0.853 . . . . 6.8099999999999996 111.327 172.689 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -70.35 153.42 66.23 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.93 1.753 . . . . 0.83999999999999997 110.805 172.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.4 m -140.47 151.2 63.27 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 125.145 1.378 . . . . 1.96 109.767 -179.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.81 -26.28 3.79 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.897 2.398 . . . . 0.80000000000000004 113.178 -164.02 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -174.82 165.65 3.63 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.584 1.554 . . . . 3.3799999999999999 112.209 -179.272 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.7 mt -108.33 154.6 21.59 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.008 1.323 . . . . 1.8700000000000001 110.346 161.677 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -110.36 147.89 33.05 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.166 1.386 . . . . 1.8600000000000001 109.186 172.76 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.7 t -144.24 133.65 11.49 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 123.259 0.624 . . . . 1.9199999999999999 112.122 169.602 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.19 168.18 21.55 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.049 2.5 . . . . 1.1799999999999999 112.881 176.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.0 144.83 96.72 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.888 3.059 . . . . 1.0600000000000001 111.845 167.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.451 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 64.0 mmtt 66.74 -7.19 0.47 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.877 1.671 . . . . 2.7599999999999998 114.207 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.92 165.78 51.32 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.526 1.536 . . . . 1.1599999999999999 112.299 -179.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -82.75 135.74 34.9 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 121.886 0.85 . . . . 6.1600000000000001 110.146 172.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.3 t -98.94 81.74 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 127.786 2.435 . . . . 7.7999999999999998 105.822 -176.119 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -138.37 129.26 26.81 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.07 1.414 . . . . 3.8999999999999999 112.674 -161.754 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mp -71.19 167.55 19.12 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 113.459 -1.7 . . . . 3.4700000000000002 109.276 167.462 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.59 133.37 21.9 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 120.205 -1.559 . . . . 4.5300000000000002 108.018 179.315 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.53 -17.88 60.55 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.036 2.49 . . . . 4.46 114.525 -171.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.48 -21.15 4.46 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 124.551 1.072 . . . . 3.0800000000000001 115.257 164.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HB ' ' A' ' 48' ' ' THR . . . -83.85 -110.53 0.57 Allowed Glycine 0 N--CA 1.473 1.126 0 C-N-CA 125.475 1.512 . . . . 1.9399999999999999 111.933 -176.58 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -68.69 139.17 55.4 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.641 0.734 . . . . 3.0499999999999998 111.653 -171.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -159.43 143.98 15.27 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.517 1.127 . . . . 0.81999999999999995 110.63 -174.451 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -78.28 156.01 29.9 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.14 -0.689 . . . . 2.75 109.14 166.283 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.2 mtp -117.8 129.76 55.87 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 122.874 0.47 . . . . 3.1600000000000001 111.459 159.472 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.07 136.62 43.36 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.441 1.896 . . . . 1.9399999999999999 108.243 -172.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mp -124.49 152.43 43.4 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.354 1.061 . . . . 2.77 110.939 -177.233 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.34 -36.11 2.59 Favored Glycine 0 N--CA 1.469 0.852 0 C-N-CA 125.112 1.339 . . . . 2.5699999999999998 113.712 175.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 68.95 -32.39 0.22 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 128.496 2.718 . . . . 4.5999999999999996 116.883 166.05 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 66.37 -23.85 0.1 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 129.637 3.175 . . . . 2.8399999999999999 115.519 178.595 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -145.42 146.51 30.18 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.688 1.995 . . . . 7.9500000000000002 111.508 -171.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.53 155.75 36.05 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.357 2.705 . . . . 2.6299999999999999 109.525 158.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -166.53 160.2 15.06 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.097 1.759 . . . . 4.2800000000000002 109.386 -170.271 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -174.45 2.5 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.991 1.317 . . . . 6.8899999999999997 111.068 168.077 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.04 169.39 3.39 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 120.841 -1.162 . . . . 2.3100000000000001 109.522 154.281 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.56 35.34 90.96 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.038 1.304 . . . . 1.3100000000000001 113.58 178.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -105.45 -177.88 3.49 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.222 1.009 . . . . 3.3399999999999999 108.866 167.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -134.57 143.52 47.42 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.202 1.801 . . . . 3.6800000000000002 106.824 169.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.2 t -142.18 138.11 30.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 128.476 2.71 . . . . 2.1600000000000001 109.226 -172.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -98.7 154.23 18.13 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.395 0.887 . . . . 2.4199999999999999 113.395 172.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.19 132.58 30.12 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.055 1.742 . . . . 3.1800000000000002 110.839 -177.334 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -78.62 130.25 35.69 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.576 1.55 . . . . 2.5800000000000001 108.782 163.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.2 mp -97.56 126.7 43.0 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.221 1.008 . . . . 2.1699999999999999 109.087 166.527 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.0 mt -96.66 109.75 22.32 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.265 1.026 . . . . 2.0800000000000001 109.173 176.481 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -105.63 143.53 33.65 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.685 1.194 . . . . 3.2000000000000002 111.109 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.41 145.48 51.52 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.829 0.852 . . . . 2.6499999999999999 113.118 -177.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.92 30.94 56.85 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 118.645 -1.086 . . . . 3.4900000000000002 113.852 172.378 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.97 44.27 5.45 Favored Glycine 0 N--CA 1.471 1.033 0 CA-C-N 118.421 1.111 . . . . 2.0800000000000001 115.094 168.376 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -131.63 145.03 51.47 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.587 1.193 . . . . 4.46 112.031 174.491 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 94.1 t -143.8 146.51 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.103 1.361 . . . . 3.3700000000000001 109.066 176.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tt -147.17 120.21 8.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.967 1.307 . . . . 3.6099999999999999 109.276 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp -94.39 112.64 24.43 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.902 -0.499 . . . . 3.29 111.657 179.081 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.3 m -89.69 166.24 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 125.594 1.558 . . . . 3.7200000000000002 111.43 176.825 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.7 p -126.84 143.18 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.039 0.936 . . . . 4.4199999999999999 109.17 165.602 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.92 154.05 25.57 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.881 1.672 . . . . 3.5800000000000001 112.17 -171.171 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.39 162.38 40.84 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.353 2.702 . . . . 1.23 114.002 174.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.0 t -103.58 124.46 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.535 1.534 . . . . 2.1099999999999999 108.148 164.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -152.95 173.91 14.79 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.947 1.299 . . . . 4.5899999999999999 109.965 -178.624 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.93 167.76 15.63 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.961 1.467 . . . . 3.8199999999999998 114.961 -172.5 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.531 ' HG3' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.231 0 C-N-CA 128.914 2.886 . . . . 9.1300000000000008 108.671 150.572 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.473 ' C ' ' HG1' ' A' ' 21' ' ' THR . 3.2 pm0 . . . . . 0 CA--C 1.544 0.735 0 CA-C-O 121.697 0.761 . . . . 5.5599999999999996 110.625 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -145.19 166.96 27.47 Favored Glycine 0 N--CA 1.47 0.916 0 O-C-N 120.714 -1.241 . . . . 1.6599999999999999 111.882 -175.517 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -155.29 167.74 29.37 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.93 1.456 . . . . 2.0600000000000001 114.93 -175.919 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.2 t -119.41 137.78 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 126.428 1.891 . . . . 2.0899999999999999 110.628 -177.606 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.99 -31.76 3.43 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 118.178 2.658 . . . . 5.0 118.178 -158.281 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 70.47 136.25 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 125.481 1.513 . . . . 4.1699999999999999 112.902 -164.348 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.5 t 176.52 151.45 0.35 Allowed Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 128.749 2.82 . . . . 3.1600000000000001 110.726 166.353 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.69 -7.59 18.64 Favored 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 122.937 2.424 . . . . 2.7999999999999998 113.586 164.938 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.49 172.99 49.33 Favored Glycine 0 CA--C 1.543 1.795 0 C-N-CA 124.834 1.207 . . . . 1.28 115.552 -172.122 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.95 -15.8 11.64 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 125.237 3.958 . . . . 1.54 115.018 -171.64 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -125.04 149.48 47.73 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.076 2.15 . . . . 2.25 112.657 179.093 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.17 -176.22 5.85 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.453 1.501 . . . . 1.72 112.599 -166.012 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.62 162.15 37.37 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.791 2.036 . . . . 1.6399999999999999 109.732 177.874 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.07 141.57 30.14 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.693 1.133 . . . . 1.53 113.378 -178.492 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -130.48 62.88 1.58 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.428 1.891 . . . . 4.0199999999999996 111.891 -163.019 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -81.24 158.63 24.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.651 1.215 . . . . 2.8399999999999999 114.12 179.354 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.473 ' HG1' ' C ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -92.78 101.83 14.22 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.096 1.758 . . . . 4.2199999999999998 109.447 -179.161 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.86 114.46 20.49 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.325 -0.62 . . . . 3.7799999999999998 109.325 178.486 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -122.68 125.68 46.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.198 1.799 . . . . 4.0700000000000003 108.08 174.694 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -91.1 118.87 68.82 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.869 0.868 . . . . 1.55 109.303 178.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.35 -12.29 29.55 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.632 2.222 . . . . 1.5900000000000001 113.878 177.903 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.81 115.94 0.22 Allowed Glycine 0 C--N 1.338 0.671 0 C-N-CA 126.943 2.211 . . . . 2.8300000000000001 113.247 171.666 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 t0 176.08 -42.46 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 105.231 -2.137 . . . . 8.5800000000000001 105.231 -141.846 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -165.78 178.22 1.37 Allowed Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 130.212 3.405 . . . . 5.7800000000000002 108.557 170.129 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.15 127.48 8.43 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 N-CA-C 107.315 -1.84 . . . . 1.1699999999999999 107.315 156.297 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.0 mt -86.5 145.65 26.71 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.578 -1.192 . . . . 3.0699999999999998 110.526 -177.132 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.1 100.96 5.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 112.257 -2.247 . . . . 4.4299999999999997 109.073 174.632 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.17 108.58 12.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.885 -1.524 . . . . 3.5099999999999998 106.885 176.227 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -103.86 -23.1 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.129 0.972 . . . . 1.6299999999999999 111.619 -174.743 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.59 -179.05 33.17 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 124.406 1.003 . . . . 0.46999999999999997 114.213 -175.464 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.72 -176.63 6.01 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.953 0.901 . . . . 1.71 112.894 173.548 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -157.44 165.96 34.28 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.456 2.302 . . . . 5.7999999999999998 108.111 -173.512 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -166.0 153.75 9.52 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.375 1.07 . . . . 1.72 109.527 168.017 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.37 -8.18 18.11 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.205 1.937 . . . . 0.75 113.211 167.897 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.83 50.15 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.005 1.322 . . . . 2.02 113.17 -179.84 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.08 123.38 1.16 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.977 1.311 . . . . 1.7 110.247 160.191 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.529 ' CD ' ' HZ1' ' A' ' 90' ' ' LYS . 3.4 tp10 -69.59 -24.07 63.63 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.571 0.952 . . . . 3.7200000000000002 113.571 173.581 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -141.31 142.39 33.84 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.813 1.245 . . . . 6.46 109.898 174.428 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.27 145.85 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.599 1.56 . . . . 2.2000000000000002 109.287 171.236 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -114.98 158.76 21.61 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.187 1.795 . . . . 3.48 109.157 163.696 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.1 tp -112.02 119.1 37.32 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 122.965 0.506 . . . . 1.9399999999999999 110.546 170.117 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -122.92 163.04 21.1 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.008 1.323 . . . . 0.71999999999999997 114.117 -174.304 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -115.34 -178.02 3.28 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.825 1.65 . . . . 3.4199999999999999 113.901 159.023 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.2 m -154.88 141.49 18.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.133 1.773 . . . . 1.74 108.92 179.259 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -148.93 170.49 18.2 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.705 1.202 . . . . 3.29 112.842 -165.627 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.9 mtt -95.63 147.55 23.47 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.296 1.038 . . . . 5.1299999999999999 110.582 167.655 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.95 156.01 33.79 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.761 1.224 . . . . 5.2199999999999998 110.713 -175.084 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.44 ' OE1' ' HE3' ' A' ' 57' ' ' LYS . 3.6 tp10 -104.55 137.87 41.74 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.779 1.232 . . . . 2.6899999999999999 109.938 169.615 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.7 t -131.54 118.37 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 106.694 -1.595 . . . . 2.8599999999999999 106.694 163.026 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 62.77 33.17 15.58 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.282 1.033 . . . . 3.5499999999999998 113.265 175.353 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.58 5.56 86.13 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 120.5 -1.375 . . . . 1.6200000000000001 113.692 -175.212 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -115.34 124.85 52.31 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.333 1.853 . . . . 3.5499999999999998 110.132 -176.604 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.44 ' HE3' ' OE1' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -57.36 128.51 37.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.093 2.157 . . . . 4.6600000000000001 109.859 179.668 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.39 151.41 35.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 127.967 2.507 . . . . 4.1699999999999999 107.971 175.471 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 36.6 mtt -115.39 129.73 56.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.144 0.578 . . . . 3.4100000000000001 109.563 160.429 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.31 175.69 16.41 Favored Glycine 0 N--CA 1.466 0.663 0 C-N-CA 124.293 0.949 . . . . 0.68999999999999995 112.732 -172.166 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.1 ttm -152.21 139.02 18.9 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.498 1.519 . . . . 1.8400000000000001 110.677 -172.292 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -146.06 151.31 44.65 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 125.783 1.633 . . . . 9.3399999999999999 110.982 -177.067 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.77 150.7 50.48 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.447 2.098 . . . . 0.73999999999999999 110.637 172.619 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.51 147.89 61.65 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.846 1.258 . . . . 1.78 110.057 -176.443 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.96 -19.87 13.57 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.983 3.122 . . . . 0.79000000000000004 113.342 -164.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -177.2 168.5 2.35 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.355 2.262 . . . . 3.5299999999999998 109.461 178.266 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.8 mt -111.65 153.52 26.25 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.874 1.27 . . . . 1.8899999999999999 109.04 159.327 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -124.23 142.09 51.53 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.741 0.816 . . . . 2.5699999999999998 110.284 177.689 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.6 t -141.27 129.81 12.36 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 123.664 0.786 . . . . 1.8300000000000001 111.362 174.678 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.79 158.31 46.87 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.832 3.021 . . . . 1.0700000000000001 112.116 178.787 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.49 137.99 77.56 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.541 2.828 . . . . 1.3 112.305 -177.177 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt 73.88 -13.08 0.79 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.188 2.195 . . . . 3.1099999999999999 114.237 -177.038 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.73 179.32 44.37 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.659 1.6 . . . . 1.3200000000000001 114.819 -176.97 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -126.41 156.16 41.03 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.56 1.544 . . . . 4.6299999999999999 112.054 175.692 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.0 t -149.29 116.84 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.573 1.549 . . . . 4.7400000000000002 107.763 154.349 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -76.69 142.98 40.34 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.941 -1.099 . . . . 3.1699999999999999 112.348 -179.576 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 mp -71.53 73.41 0.75 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 123.338 1.542 . . . . 2.5 108.04 160.254 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -69.49 142.62 92.13 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.921 1.688 . . . . 6.4800000000000004 113.688 -171.279 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -66.88 -4.52 11.45 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.947 3.098 . . . . 2.2999999999999998 114.501 178.993 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.32 51.53 0.77 Allowed Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.534 1.54 . . . . 1.6699999999999999 110.57 165.835 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.01 -123.26 1.05 Allowed Glycine 0 N--CA 1.464 0.537 0 C-N-CA 124.196 0.903 . . . . 1.5900000000000001 113.913 -177.166 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -73.25 136.84 44.65 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 121.573 0.701 . . . . 3.4900000000000002 111.392 -169.13 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -162.62 156.28 20.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.774 -0.648 . . . . 0.59999999999999998 111.288 -179.352 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -81.45 146.46 30.24 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.714 -0.476 . . . . 3.0699999999999998 109.714 164.627 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 tpt -100.05 130.84 46.25 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.206 -1.035 . . . . 1.5800000000000001 108.206 161.016 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -113.41 138.95 49.34 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.19 1.396 . . . . 1.76 109.574 -178.292 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mp -137.66 146.41 43.82 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.046 1.338 . . . . 2.75 110.794 179.15 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.18 44.43 66.37 Favored Glycine 0 N--CA 1.472 1.051 0 O-C-N 121.691 -0.631 . . . . 0.85999999999999999 112.342 176.338 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 pp -62.14 151.3 36.18 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 123.194 1.473 . . . . 2.23 114.785 178.56 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.529 ' HZ1' ' CD ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -109.31 -2.22 18.01 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 113.748 -1.569 . . . . 3.7000000000000002 112.971 -177.121 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -137.21 131.83 17.78 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 126.529 1.932 . . . . 6.4800000000000004 107.695 153.751 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -63.03 154.2 68.74 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.858 1.705 . . . . 2.6600000000000001 108.137 160.407 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.6 mt -111.97 97.41 6.66 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.682 1.193 . . . . 3.3700000000000001 109.7 -155.693 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 136.65 34.94 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.474 1.11 . . . . 4.7699999999999996 111.774 173.716 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.59 121.3 6.84 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.779 -1.101 . . . . 2.4700000000000002 108.527 164.165 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.68 -2.35 52.83 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.872 1.701 . . . . 1.6000000000000001 116.037 -176.825 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -82.17 -170.67 3.01 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.906 1.853 . . . . 2.3900000000000001 112.327 168.327 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -147.87 136.44 21.69 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 129.194 2.998 . . . . 3.4500000000000002 106.598 -172.28 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.4 t -140.07 132.69 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.804 1.642 . . . . 2.1000000000000001 111.618 -175.684 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.49 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 20.5 mt-10 -79.56 143.82 34.45 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.318 0.647 . . . . 2.8799999999999999 112.409 172.138 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mp -127.67 139.67 52.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.026 1.33 . . . . 2.7799999999999998 110.987 161.535 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -102.23 122.85 45.0 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 127.533 2.333 . . . . 2.8700000000000001 108.359 174.238 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -104.29 116.67 32.57 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.418 1.008 . . . . 2.0699999999999998 111.123 -167.786 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -84.92 105.28 15.57 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.897 0.879 . . . . 1.95 110.319 -177.387 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -103.11 106.41 16.92 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.889 1.676 . . . . 3.3700000000000001 111.172 -179.23 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 56.33 20.63 4.79 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.491 1.916 . . . . 3.0699999999999998 113.711 177.334 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.22 -56.64 3.65 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.381 1.467 . . . . 4.04 112.485 -171.454 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.02 -10.12 77.26 Favored Glycine 0 CA--C 1.533 1.214 0 N-CA-C 116.118 1.207 . . . . 2.0 116.118 -169.486 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -125.47 145.1 50.23 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.944 1.298 . . . . 5.5499999999999998 111.077 171.779 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.7 p -144.1 146.29 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 125.836 1.654 . . . . 3.21 110.474 173.328 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.8 tt -156.29 134.85 11.61 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.644 1.978 . . . . 3.25 108.226 -175.446 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.49 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 53.6 pttt -101.05 153.91 19.15 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.148 1.166 . . . . 3.4100000000000001 114.148 176.079 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.4 t -135.82 158.66 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.568 1.947 . . . . 3.0 108.525 175.04 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.7 p -129.98 128.64 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.102 0.961 . . . . 3.4900000000000002 110.046 -177.929 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.99 144.24 43.01 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.671 1.188 . . . . 2.9700000000000002 111.493 -168.368 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -62.52 155.59 57.29 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.27 2.647 . . . . 0.75 112.666 176.545 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 67.4 t -91.59 125.14 44.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 107.475 -1.306 . . . . 1.8300000000000001 107.475 165.16 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -153.45 167.21 30.2 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.01 1.724 . . . . 3.9399999999999999 110.565 175.188 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.78 152.71 37.3 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.264 1.209 . . . . 3.7999999999999998 114.264 -165.96 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.554 1.942 . . . . 9.9399999999999995 114.713 166.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.144 0 N-CA-C 108.764 -1.735 . . . . 9.8300000000000001 108.764 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.9 t 131.71 -116.46 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 130.029 3.332 . . . . 8.6099999999999994 103.497 -158.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -132.59 112.82 12.39 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.699 1.2 . . . . 9.5700000000000003 109.211 158.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.453 ' H ' HG23 ' A' ' 21' ' ' THR 0.422 0.4 OUTLIER 82.9 -2.42 1.28 Allowed 'General case' 0 N--CA 1.489 1.478 1 C-N-CA 135.744 5.618 . . . . 6.2300000000000004 115.428 -11.728 . . . . . . . . 5 4 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -124.5 -179.45 4.49 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.037 1.335 . . . . 5.4800000000000004 113.038 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.98 -176.9 28.65 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 126.807 2.146 . . . . 1.3100000000000001 112.787 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.8 p90 -148.11 146.34 28.76 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.953 1.301 . . . . 2.1099999999999999 110.412 171.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.5 t -90.2 142.59 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.369 -0.974 . . . . 2.0600000000000001 108.369 170.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 64.3 ttt-85 -85.78 131.52 34.3 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.991 0.516 . . . . 4.25 112.332 -173.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -40.84 137.36 1.22 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.032 2.133 . . . . 2.8900000000000001 112.782 169.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -175.81 126.6 0.36 Allowed Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 127.142 2.177 . . . . 3.29 111.037 165.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -87.13 0.1 7.62 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.928 3.086 . . . . 2.8799999999999999 112.131 164.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.54 -166.27 40.96 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.141 1.353 . . . . 1.3799999999999999 112.852 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.08 -24.52 23.63 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.67 2.246 . . . . 2.0299999999999998 113.546 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -138.87 163.2 32.91 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.198 1.399 . . . . 2.1400000000000001 113.923 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.28 -175.74 5.48 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 130.324 3.45 . . . . 1.6499999999999999 109.394 -172.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.37 156.87 43.05 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.844 2.057 . . . . 1.52 109.169 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.89 133.54 33.97 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.711 1.141 . . . . 1.51 112.817 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.44 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 43.2 m-85 -115.79 140.98 48.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.798 2.039 . . . . 3.5800000000000001 110.332 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -168.13 156.43 8.78 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.915 1.234 . . . . 2.8100000000000001 113.318 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 4' ' ' THR . 86.5 m -95.24 108.52 20.67 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.418 1.087 . . . . 2.8100000000000001 111.119 -176.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.8 130.28 34.53 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.446 0.566 . . . . 3.3500000000000001 109.909 173.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -131.98 135.19 46.37 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.69 1.596 . . . . 4.3399999999999999 109.582 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -105.78 110.25 63.97 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 125.139 1.375 . . . . 1.3799999999999999 110.319 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.34 -11.56 10.7 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.901 2.401 . . . . 1.1299999999999999 113.927 176.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.43 174.87 50.76 Favored Glycine 0 C--N 1.338 0.693 0 CA-C-O 122.964 1.313 . . . . 1.2 112.969 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.04 -4.42 32.51 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.45 2.7 . . . . 2.8700000000000001 111.309 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -119.44 156.83 52.84 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 128.247 2.619 . . . . 2.75 109.9 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.87 143.78 26.79 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.867 2.378 . . . . 0.93000000000000005 110.964 -174.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.3 mt -102.84 150.92 23.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 122.767 1.27 . . . . 2.6899999999999999 110.036 170.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -142.63 109.83 5.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.577 -2.101 . . . . 3.1699999999999999 112.833 -172.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.0 tp -87.82 107.09 18.5 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.33 1.852 . . . . 2.7200000000000002 109.951 -175.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.8 m -108.49 -18.12 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.155 0.982 . . . . 1.6399999999999999 112.455 -172.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.31 -178.4 31.34 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 125.273 1.416 . . . . 0.60999999999999999 113.106 -175.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.17 179.82 8.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.673 0.749 . . . . 1.71 111.826 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -156.37 166.01 34.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.766 2.426 . . . . 4.71 107.815 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -175.43 151.24 1.27 Allowed Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 125.788 1.635 . . . . 1.6699999999999999 108.447 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.6 -7.89 14.74 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.939 2.426 . . . . 0.90000000000000002 112.993 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.0 m -114.16 41.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.6 1.16 . . . . 1.95 113.434 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.18 164.25 35.29 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.527 -0.733 . . . . 1.8500000000000001 112.532 166.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -100.75 -46.39 5.17 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.266 2.227 . . . . 3.21 110.664 169.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -103.18 138.24 40.26 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.223 1.409 . . . . 5.9400000000000004 108.341 163.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -99.58 152.61 4.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.3 -1.0 . . . . 2.1200000000000001 108.3 142.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -135.41 147.7 49.08 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.02 1.728 . . . . 2.9300000000000002 108.31 166.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.6 tp -102.97 118.76 37.54 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.557 0.743 . . . . 2.0499999999999998 110.651 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.408 ' CE1' ' HB2' ' A' ' 85' ' ' MET . 55.3 m170 -121.93 156.67 32.89 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 123.242 1.496 . . . . 0.58999999999999997 113.899 -173.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.444 ' CD ' HH21 ' A' ' 62' ' ' ARG . 19.4 pt-20 -98.3 177.82 5.25 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.551 1.941 . . . . 2.3900000000000001 111.577 160.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.1 m -152.89 149.97 28.82 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.297 1.839 . . . . 1.6599999999999999 106.996 166.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -158.3 165.74 34.06 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.058 0.943 . . . . 3.4199999999999999 113.054 -168.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 59.5 ttp -95.19 143.49 26.57 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.166 1.386 . . . . 3.71 110.371 167.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.49 150.68 35.02 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.6 1.16 . . . . 5.0 110.849 -173.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -108.45 137.89 45.67 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.411 1.484 . . . . 2.0699999999999998 110.262 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.8 t -139.63 128.23 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 106.7 -1.593 . . . . 2.9199999999999999 106.7 166.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.406 ' HB2' ' HE3' ' A' ' 56' ' ' LYS . 34.6 mt-10 61.49 19.1 10.02 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.085 1.354 . . . . 2.9900000000000002 114.401 -175.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.25 11.29 85.07 Favored Glycine 0 N--CA 1.48 1.609 0 O-C-N 120.242 -1.536 . . . . 1.6100000000000001 113.585 -169.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.406 ' HE3' ' HB2' ' A' ' 54' ' ' GLU . 23.5 mtmt -110.47 118.83 37.32 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.531 2.333 . . . . 3.5 108.728 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 120.19 34.29 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.689 -1.141 . . . . 4.46 112.376 -166.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.8 m -121.35 -178.4 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 128.705 2.802 . . . . 3.0699999999999998 109.872 -176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 60.9 mtt -116.06 162.94 16.67 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.359 1.064 . . . . 3.4300000000000002 111.165 168.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.61 175.06 32.86 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 124.791 1.186 . . . . 0.68999999999999995 112.591 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.3 ttm -154.78 145.29 22.19 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.055 1.742 . . . . 1.6599999999999999 109.213 -170.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.444 HH21 ' CD ' ' A' ' 47' ' ' GLU . 22.2 mtm180 -148.24 153.98 41.76 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 125.736 1.614 . . . . 6.0300000000000002 109.175 -176.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.89 154.11 42.81 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.854 1.702 . . . . 0.64000000000000001 110.399 165.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -139.46 154.35 71.52 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.458 1.503 . . . . 1.73 110.513 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.02 -27.66 4.41 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.106 2.538 . . . . 0.55000000000000004 112.949 -167.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -176.24 164.74 2.74 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.648 1.579 . . . . 3.29 111.817 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 mt -114.03 152.22 31.3 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.215 1.406 . . . . 1.71 110.014 166.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -111.93 145.93 38.69 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.756 1.222 . . . . 2.02 109.407 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.2 t -134.44 119.8 14.37 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.655 0.782 . . . . 2.02 111.124 165.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.29 159.1 54.19 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.33 2.687 . . . . 1.04 111.565 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -60.4 138.57 81.59 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.754 2.969 . . . . 1.04 112.192 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt 64.91 -4.26 0.5 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.304 1.841 . . . . 2.3199999999999998 113.991 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.08 -177.4 39.2 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 127.28 2.371 . . . . 1.1599999999999999 113.114 -176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.22 152.53 33.42 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.279 1.032 . . . . 4.7400000000000002 112.146 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.4 t -152.71 123.46 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.771 1.629 . . . . 4.3899999999999997 107.752 174.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -84.31 141.44 30.92 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.704 -0.622 . . . . 2.98 111.351 175.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.92 80.84 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.332 -0.988 . . . . 2.27 108.332 147.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.08 148.95 46.39 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.1 1.36 . . . . 3.71 112.386 -174.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.44 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 59.2 Cg_endo -63.3 -24.35 71.87 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.251 2.634 . . . . 1.99 113.806 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.84 21.72 4.58 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.942 -0.921 . . . . 1.73 114.115 170.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.95 -118.39 0.69 Allowed Glycine 0 CA--C 1.53 1.015 0 CA-C-N 118.979 1.39 . . . . 1.8700000000000001 114.654 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -71.91 140.42 49.23 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.352 -1.087 . . . . 3.1099999999999999 112.552 -164.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -162.64 156.22 20.39 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.206 1.002 . . . . 0.57999999999999996 112.259 -173.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -82.99 140.51 32.7 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.851 -0.53 . . . . 2.6299999999999999 109.623 165.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.408 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 3.1 tpt -93.14 131.94 37.73 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.261 1.024 . . . . 1.53 108.769 161.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 mp -110.9 125.23 53.43 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.654 -1.239 . . . . 1.6100000000000001 107.654 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 mp -130.82 142.62 50.4 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.305 0.642 . . . . 2.9100000000000001 110.364 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.43 43.29 16.1 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.154 0.883 . . . . 0.84999999999999998 112.96 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -56.76 154.51 9.03 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 116.102 1.89 . . . . 2.2400000000000002 116.102 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -116.53 -16.83 10.75 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 113.515 -1.675 . . . . 2.79 113.076 -170.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -113.12 127.38 26.9 Favored Pre-proline 0 N--CA 1.472 0.628 0 N-CA-C 105.896 -1.89 . . . . 6.1100000000000003 105.896 155.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.39 110.02 1.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 N-CA-C 105.369 -2.589 . . . . 2.4100000000000001 105.369 158.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.48 147.15 39.76 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 124.518 2.104 . . . . 2.98 111.567 -156.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -156.27 166.04 34.62 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 111.665 -2.516 . . . . 4.4900000000000002 112.815 -151.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.92 126.05 25.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.007 0.923 . . . . 2.02 109.636 -175.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.08 0.98 70.43 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 117.702 -1.61 . . . . 1.26 115.64 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -79.9 -167.83 1.4 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.319 2.06 . . . . 2.23 112.568 169.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.52 121.78 3.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.148 2.979 . . . . 5.7699999999999996 106.095 -148.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 49.3 t -148.83 133.45 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.602 1.161 . . . . 1.8899999999999999 111.702 -170.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.496 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 47.0 mt-10 -79.12 144.59 34.38 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 112.211 0.448 . . . . 2.5099999999999998 112.211 168.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mp -120.23 142.31 49.14 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.829 0.823 . . . . 2.48 110.507 153.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -104.8 136.34 44.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 129.265 3.026 . . . . 1.99 107.485 166.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 mp -128.12 109.75 11.82 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 120.503 1.501 . . . . 3.0099999999999998 108.903 -172.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.1 mt -79.34 110.34 14.53 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.094 1.357 . . . . 1.73 109.453 -170.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -103.48 137.44 41.56 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.309 1.444 . . . . 3.2999999999999998 110.612 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.04 127.23 30.52 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.871 1.063 . . . . 2.1200000000000001 113.871 -169.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.64 70.13 1.35 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.638 1.114 . . . . 3.4500000000000002 112.093 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.65 24.5 72.37 Favored Glycine 0 N--CA 1.471 1.03 0 N-CA-C 115.563 0.985 . . . . 2.0899999999999999 115.563 166.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -126.28 155.84 41.3 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.304 1.552 . . . . 4.1799999999999997 112.353 -173.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.12 151.46 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.813 1.245 . . . . 3.4700000000000002 110.753 171.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.1 tp -120.48 141.98 49.7 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.091 1.357 . . . . 3.9500000000000002 109.786 167.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.496 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 13.1 tppt? -106.79 134.35 50.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.582 1.153 . . . . 3.1800000000000002 109.908 170.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.74 153.59 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.099 1.359 . . . . 3.8399999999999999 110.165 167.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.22 126.39 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.683 -1.228 . . . . 2.75 107.683 165.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.1 mt -122.1 146.75 47.38 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 126.234 1.814 . . . . 2.9100000000000001 110.074 -174.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.78 164.54 35.28 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.973 2.449 . . . . 0.93000000000000005 111.377 165.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.22 139.38 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.689 0.796 . . . . 1.8200000000000001 110.482 169.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.97 147.22 40.15 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.667 1.587 . . . . 3.7400000000000002 113.093 -171.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.59 58.3 4.14 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.054 1.742 . . . . 2.3799999999999999 111.832 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 . . . . . 0 C--O 1.249 1.072 0 C-N-CA 125.956 1.703 . . . . 8.0399999999999991 112.672 -162.195 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.876 0 N-CA-C 107.463 -2.255 . . . . 9.3300000000000001 107.463 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.2 t -62.82 176.94 0.61 Allowed 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 117.139 0.469 . . . . 9.5099999999999998 110.657 144.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -70.05 -28.42 65.45 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.878 -1.139 . . . . 14.0 111.795 168.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 t -136.44 133.01 36.18 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 127.101 2.16 . . . . 8.1999999999999993 109.222 171.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.419 ' H ' ' CG2' ' A' ' 21' ' ' THR . 0.7 OUTLIER -100.72 119.11 38.12 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.975 2.11 . . . . 5.21 109.909 -174.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.59 172.86 37.88 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 120.515 1.507 . . . . 1.3300000000000001 115.552 159.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -148.98 147.06 28.14 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.016 1.326 . . . . 2.3799999999999999 111.276 169.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.8 t -95.03 126.87 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.08 -1.081 . . . . 2.4700000000000002 108.08 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -74.31 123.18 24.11 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.912 0.386 . . . . 5.6799999999999997 111.423 -170.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -46.99 142.18 3.68 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.956 1.302 . . . . 2.7599999999999998 111.538 163.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.1 m -155.31 152.23 24.38 Favored Pre-proline 0 CA--C 1.545 0.783 0 O-C-N 120.865 -1.147 . . . . 3.1400000000000001 111.111 161.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -95.18 43.11 0.16 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.147 3.232 . . . . 2.71 111.707 -176.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.61 -168.85 25.16 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.27 1.268 . . . . 1.1699999999999999 116.27 -167.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.98 -16.23 16.09 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.283 3.322 . . . . 1.47 114.328 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -125.24 162.57 24.41 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.052 1.741 . . . . 2.4100000000000001 114.124 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.95 -177.2 6.4 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.181 2.592 . . . . 1.6299999999999999 111.236 -175.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.08 167.33 21.74 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.352 2.261 . . . . 1.5800000000000001 108.448 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.74 141.27 33.25 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.375 0.989 . . . . 1.5 111.738 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.469 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 20.2 m-85 -128.02 114.37 17.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.256 1.822 . . . . 3.71 108.842 -171.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -163.26 165.36 24.36 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.851 -1.155 . . . . 4.0099999999999998 112.901 -167.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.419 ' CG2' ' H ' ' A' ' 5' ' ' GLU . 5.0 t -92.77 141.14 28.78 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 123.189 1.471 . . . . 3.6200000000000001 113.366 -177.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.36 123.81 38.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 113.357 -1.747 . . . . 4.3399999999999999 106.996 164.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -111.62 145.05 39.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.869 0.842 . . . . 3.9900000000000002 110.944 169.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.88 64.8 18.4 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.07 0.948 . . . . 3.48 110.277 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -63.23 -21.79 72.28 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.632 2.888 . . . . 1.5700000000000001 114.414 -173.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.09 -173.09 38.09 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 122.72 1.178 . . . . 1.22 113.001 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.446 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 10.8 m-20 -109.74 -1.19 18.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.905 1.682 . . . . 2.8300000000000001 112.684 -164.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -121.68 155.25 60.11 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 127.417 2.287 . . . . 2.8700000000000001 110.091 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.63 139.57 18.13 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.713 2.275 . . . . 1.1299999999999999 111.245 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt -95.05 153.54 17.6 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 123.306 1.527 . . . . 2.5800000000000001 112.676 174.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 ttp-105 -137.06 102.93 4.99 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 112.609 -2.087 . . . . 3.7999999999999998 110.901 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.37 113.57 20.83 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 124.443 1.097 . . . . 2.98 110.497 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.31 -19.53 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 125.124 1.37 . . . . 1.79 111.855 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.61 -175.47 29.58 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 122.531 1.073 . . . . 0.52000000000000002 115.362 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.08 -179.18 5.7 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.917 1.687 . . . . 1.6899999999999999 110.236 164.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -159.84 146.6 16.27 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.928 1.691 . . . . 5.21 106.999 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 t -162.55 151.06 12.26 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 125.038 1.335 . . . . 1.8899999999999999 108.436 -175.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.91 -13.45 31.79 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.682 1.588 . . . . 0.79000000000000004 113.378 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 m -112.31 36.14 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 113.788 1.033 . . . . 1.95 113.788 -172.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.15 140.39 10.29 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.343 1.457 . . . . 2.0899999999999999 109.134 170.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.529 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 9.4 tt0 -95.63 -40.0 9.63 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.233 1.413 . . . . 3.6099999999999999 110.292 -176.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -104.4 129.1 52.35 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.959 1.704 . . . . 6.71 107.758 155.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.07 139.31 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.069 -1.085 . . . . 2.3199999999999998 108.069 154.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.91 155.89 47.1 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.834 2.054 . . . . 3.2599999999999998 108.295 -174.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.3 tp -114.23 121.4 43.59 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.976 0.91 . . . . 2.1499999999999999 109.785 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.2 m170 -124.23 161.32 26.02 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 123.736 1.731 . . . . 0.84999999999999998 114.488 -175.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -104.22 155.16 18.96 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.085 2.554 . . . . 2.5899999999999999 111.21 160.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.9 m -122.02 147.19 46.38 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 105.902 -1.888 . . . . 1.8600000000000001 105.902 159.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -157.39 178.28 10.48 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.188 0.904 . . . . 3.7599999999999998 112.819 -174.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 63.0 ttp -111.66 135.21 52.56 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.572 1.549 . . . . 4.5999999999999996 111.5 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -110.4 143.99 39.84 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.513 1.525 . . . . 5.5199999999999996 110.862 161.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -87.45 145.4 26.29 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.556 1.143 . . . . 2.9900000000000002 108.707 149.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.4 t -143.92 120.8 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.227 1.811 . . . . 3.8999999999999999 106.701 161.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 63.94 18.12 10.99 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.483 1.513 . . . . 4.21 115.024 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.21 21.22 67.99 Favored Glycine 0 N--CA 1.478 1.482 0 O-C-N 120.6 -1.313 . . . . 2.6000000000000001 113.052 -168.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -120.36 127.99 52.82 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.253 2.221 . . . . 3.9500000000000002 107.592 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -98.46 126.81 44.14 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.735 1.214 . . . . 6.1600000000000001 111.779 -171.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.29 141.88 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 126.415 1.886 . . . . 3.0800000000000001 109.644 -175.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 60.1 mtm -92.19 156.52 17.27 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.422 0.897 . . . . 3.9100000000000001 113.422 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.67 172.06 22.08 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 126.359 1.933 . . . . 0.81000000000000005 112.332 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.5 ttm -146.53 145.66 30.23 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.231 1.812 . . . . 1.9299999999999999 109.587 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -149.35 156.57 39.64 Favored Pre-proline 0 N--CA 1.471 0.603 0 C-N-CA 125.218 1.407 . . . . 5.9400000000000004 110.12 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.99 156.54 38.65 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.469 2.113 . . . . 0.94999999999999996 110.638 166.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.6 m -137.57 153.51 74.33 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 125.357 1.463 . . . . 2.1299999999999999 110.964 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.11 -24.85 6.42 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.502 2.801 . . . . 1.0700000000000001 113.024 -171.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -176.35 164.82 2.69 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.029 1.732 . . . . 3.6400000000000001 111.67 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.4 mt -108.87 153.69 23.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.404 1.482 . . . . 1.79 110.579 163.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -114.3 144.19 43.65 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.395 1.478 . . . . 2.1699999999999999 109.763 176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.7 t -139.91 139.74 22.44 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.465 0.706 . . . . 2.0099999999999998 112.488 169.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -84.02 156.43 13.24 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.38 3.387 . . . . 1.1599999999999999 112.531 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.22 143.49 94.33 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.306 2.671 . . . . 1.0700000000000001 113.246 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.446 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 70.7 mmtt 69.97 0.2 2.98 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.775 2.43 . . . . 2.8399999999999999 114.16 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.56 151.53 34.44 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.41 1.481 . . . . 1.24 114.106 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -111.46 132.12 54.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.425 2.29 . . . . 5.21 106.547 160.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.5 t -142.59 119.01 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.746 1.219 . . . . 4.4100000000000001 108.774 -177.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -115.15 128.69 56.36 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.899 0.857 . . . . 3.98 113.24 -159.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.16 77.12 0.52 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.632 2.373 . . . . 2.21 111.163 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.65 145.01 97.74 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 126.462 1.905 . . . . 7.4000000000000004 113.525 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.469 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 30.4 Cg_endo -57.89 -42.88 54.12 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.301 2.667 . . . . 2.9900000000000002 113.335 175.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.46 31.49 1.88 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.454 1.025 . . . . 1.8400000000000001 113.533 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.12 -131.99 1.44 Allowed Glycine 0 N--CA 1.471 0.969 0 C-N-CA 125.493 1.52 . . . . 1.6200000000000001 113.175 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -70.39 139.21 51.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.906 0.853 . . . . 3.3700000000000001 110.981 -172.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -162.02 158.3 24.79 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.836 1.255 . . . . 0.69999999999999996 111.973 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -84.63 151.74 24.28 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.697 -0.627 . . . . 3.1600000000000001 110.786 168.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.2 tpt -112.06 130.98 55.7 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.531 1.132 . . . . 1.8700000000000001 109.687 166.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -111.98 118.87 36.64 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.943 1.297 . . . . 1.6100000000000001 107.869 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.6 mp -119.51 138.92 52.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.47 1.108 . . . . 2.71 109.739 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.22 37.26 32.58 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.73 -0.483 . . . . 0.87 113.006 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -48.3 154.93 0.55 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 116.571 2.063 . . . . 2.4399999999999999 116.571 177.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.529 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 69.4 mmtt -119.97 -18.77 8.09 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.155 -1.384 . . . . 3.6699999999999999 113.949 -175.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -97.01 140.96 22.39 Favored Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 108.539 -0.912 . . . . 5.9900000000000002 108.539 160.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -82.6 57.58 6.14 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.624 2.883 . . . . 3.0699999999999998 109.914 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.4 mt -23.14 104.56 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 129.044 2.938 . . . . 3.0600000000000001 116.8 -159.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm -119.54 157.96 27.28 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.187 1.795 . . . . 7.5899999999999999 114.871 170.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.14 133.88 38.92 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 113.528 -1.669 . . . . 2.6800000000000002 109.675 169.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.46 1.33 86.16 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 117.485 -1.73 . . . . 1.78 115.848 -175.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -75.28 178.11 6.05 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 120.899 2.349 . . . . 2.3999999999999999 111.145 166.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -146.2 129.74 16.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.795 2.838 . . . . 5.2199999999999998 104.827 -159.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.0 t -144.33 121.63 5.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 123.99 0.916 . . . . 2.0099999999999998 110.358 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -78.81 154.55 29.79 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.262 0.554 . . . . 2.8300000000000001 111.364 167.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.2 tt -149.91 142.8 24.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 122.82 1.295 . . . . 3.77 110.808 169.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.0 104.33 11.8 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 129.54 3.136 . . . . 2.4199999999999999 107.061 -169.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -82.46 129.37 34.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.158 0.983 . . . . 2.0499999999999998 109.622 -172.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.0 mt -106.02 123.96 48.82 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.61 1.164 . . . . 1.97 111.441 -171.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -122.6 144.98 48.76 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.945 1.298 . . . . 3.3599999999999999 112.31 -170.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.66 151.06 21.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.878 0.871 . . . . 2.21 111.974 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.16 8.86 87.0 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 119.011 -0.883 . . . . 3.5699999999999998 114.618 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.8 66.06 1.61 Allowed Glycine 0 N--CA 1.469 0.892 0 CA-C-N 119.184 1.492 . . . . 2.4500000000000002 113.326 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -138.45 152.98 48.82 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.929 1.692 . . . . 4.5099999999999998 111.455 170.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.39 148.57 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.124 1.37 . . . . 3.5299999999999998 111.178 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 tt -140.2 116.22 10.41 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.597 1.159 . . . . 4.3300000000000001 109.244 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -93.58 136.25 34.04 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.93 -1.106 . . . . 3.5099999999999998 112.054 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.8 t -131.43 165.27 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.982 1.713 . . . . 3.3300000000000001 108.751 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.9 t -129.34 129.98 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.276 1.43 . . . . 2.9199999999999999 108.781 172.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.5 mt -123.65 145.57 47.64 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 127.554 2.342 . . . . 3.25 110.063 -174.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.9 154.66 58.33 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.648 2.232 . . . . 0.87 110.475 166.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.7 t -92.88 125.28 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.224 -1.028 . . . . 2.1600000000000001 108.224 167.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -152.61 167.96 27.17 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.668 1.223 . . . . 5.2199999999999998 114.059 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -103.57 104.55 14.62 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.305 1.594 . . . . 2.4399999999999999 115.305 -166.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 . . . . . 0 N--CA 1.483 1.203 1 C-N-CA 133.973 4.909 . . . . 8.3000000000000007 112.555 162.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.957 0 N-CA-C 107.371 -2.291 . . . . 12.68 107.371 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 m -76.98 145.1 38.29 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 115.325 1.602 . . . . 12.5 115.325 -145.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.56 136.61 49.41 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.006 1.722 . . . . 11.890000000000001 111.524 -168.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.4 p -84.15 58.47 4.78 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.312 1.845 . . . . 8.5399999999999991 112.113 -170.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.431 ' CD ' HH22 ' A' ' 74' ' ' ARG . 24.3 mt-10 -97.35 60.97 1.66 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.328 1.051 . . . . 6.2800000000000002 110.913 -174.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.08 -178.86 34.46 Favored Glycine 0 N--CA 1.465 0.581 0 O-C-N 121.186 -0.947 . . . . 2.1299999999999999 113.287 -173.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 26.0 p90 -152.0 148.67 28.0 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.825 0.85 . . . . 2.25 112.998 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.03 145.96 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.883 -1.154 . . . . 2.5299999999999998 107.883 170.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -86.85 127.9 35.04 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.811 0.671 . . . . 5.4800000000000004 112.811 -167.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -48.79 151.0 1.29 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.956 1.302 . . . . 4.3200000000000003 112.766 168.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 t -163.19 148.23 9.32 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 122.895 0.478 . . . . 3.0800000000000001 111.597 166.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -86.21 -6.4 8.28 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.2 2.6 . . . . 2.3100000000000001 112.109 166.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.16 178.24 20.6 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.946 1.26 . . . . 1.21 114.004 -173.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.6 -15.8 33.96 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.122 3.215 . . . . 1.5700000000000001 113.527 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -110.01 142.67 41.1 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.796 2.038 . . . . 3.1000000000000001 113.841 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.69 -176.17 5.4 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 129.066 2.946 . . . . 1.74 110.848 -172.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.99 159.88 41.41 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.955 2.102 . . . . 1.78 109.391 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.46 137.05 48.43 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.08 1.309 . . . . 2.0600000000000001 112.482 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -116.71 71.83 0.8 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.298 1.839 . . . . 3.8999999999999999 109.6 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -83.54 157.54 22.31 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.737 -1.227 . . . . 2.4900000000000002 111.685 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.78 131.53 36.38 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.263 -0.898 . . . . 2.8900000000000001 109.676 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.24 129.53 52.04 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.847 0.459 . . . . 3.75 110.057 175.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -119.9 144.07 47.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.58 1.952 . . . . 3.7599999999999998 107.638 167.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.02 79.1 0.53 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.71 0.804 . . . . 3.3100000000000001 110.683 171.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.69 -6.03 18.29 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.346 2.03 . . . . 1.8 115.733 -174.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.96 160.61 33.93 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 119.535 1.061 . . . . 1.4099999999999999 111.686 170.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.19 1.5 40.34 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.526 1.93 . . . . 3.8100000000000001 112.162 174.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mp -123.48 156.19 64.52 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 127.03 2.132 . . . . 5.8200000000000003 108.643 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.81 143.99 16.95 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.975 2.45 . . . . 1.3999999999999999 111.04 -167.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.8 mt -100.47 150.32 22.77 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 123.076 1.417 . . . . 2.6800000000000002 112.844 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -127.1 106.3 9.17 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 112.218 -2.265 . . . . 2.9300000000000002 110.62 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -85.87 110.97 19.78 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.658 1.983 . . . . 3.8700000000000001 108.752 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.89 -19.85 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.254 1.022 . . . . 1.99 112.055 -171.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.7 -177.21 32.59 Favored Glycine 0 C--N 1.343 0.94 0 C-N-CA 124.989 1.281 . . . . 0.68999999999999995 113.887 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.43 -178.78 5.66 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.709 1.204 . . . . 1.9099999999999999 110.096 161.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -150.81 158.67 44.42 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.229 2.611 . . . . 5.9199999999999999 107.072 172.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 t -169.5 153.11 5.06 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 126.438 1.895 . . . . 1.7 107.281 -171.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.58 -12.7 15.14 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.901 1.734 . . . . 0.92000000000000004 112.921 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.42 45.34 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.061 0.945 . . . . 1.98 112.983 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.43 144.45 14.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.296 1.039 . . . . 1.76 111.491 164.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.48 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 3.4 tp10 -86.49 -45.83 10.75 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.869 1.268 . . . . 2.9199999999999999 111.328 171.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -109.93 134.38 52.15 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.816 1.247 . . . . 5.9699999999999998 108.025 168.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -119.77 135.27 60.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 125.497 1.519 . . . . 2.1200000000000001 108.299 166.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -126.66 154.23 44.33 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.747 2.019 . . . . 3.0099999999999998 108.759 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.0 tp -111.18 124.44 52.2 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.741 0.816 . . . . 2.3300000000000001 109.776 174.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -123.44 161.52 24.64 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.403 1.881 . . . . 0.66000000000000003 114.262 -175.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.78 -179.2 3.87 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.721 2.409 . . . . 3.0299999999999998 111.773 162.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.1 m -157.49 145.87 19.28 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.367 1.867 . . . . 1.77 107.645 170.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -153.42 172.93 16.33 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.183 1.393 . . . . 3.1800000000000002 112.552 -168.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.4 mtm -103.44 143.64 32.44 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.905 0.882 . . . . 3.6099999999999999 110.561 167.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -149.21 146.32 27.56 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.245 1.818 . . . . 9.9700000000000006 111.144 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -86.91 145.97 26.35 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.75 1.22 . . . . 2.75 111.787 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 p -169.81 138.01 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 126.217 1.807 . . . . 4.0499999999999998 108.273 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 72.92 -3.58 2.38 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 127.612 2.365 . . . . 4.9100000000000001 114.818 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.99 33.19 24.46 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.277 0.942 . . . . 2.1899999999999999 112.599 -161.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -141.47 144.39 34.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.838 2.455 . . . . 5.6500000000000004 108.126 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.92 120.68 29.49 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.481 0.712 . . . . 8.4199999999999999 110.604 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -125.12 -179.67 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 127.308 2.243 . . . . 3.5099999999999998 107.982 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.3 mtm -113.78 159.97 19.2 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.583 -1.323 . . . . 5.1100000000000003 112.835 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.43 165.74 25.17 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 125.726 1.631 . . . . 0.77000000000000002 111.059 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.9 ttm -148.78 141.86 24.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.573 1.949 . . . . 1.98 108.453 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -150.11 151.21 31.44 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.938 1.695 . . . . 6.8600000000000003 109.266 -170.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.04 155.23 42.74 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.071 1.847 . . . . 0.59999999999999998 110.922 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.31 152.53 75.26 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.982 1.313 . . . . 1.9399999999999999 110.008 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.82 -21.64 10.94 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.294 2.663 . . . . 0.77000000000000002 112.865 -171.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -174.88 174.23 2.59 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.743 2.017 . . . . 3.2400000000000002 110.756 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.4 mt -119.81 154.31 34.44 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.527 1.931 . . . . 1.7 109.671 160.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -112.87 145.13 41.23 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.917 1.287 . . . . 1.71 109.41 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 t -137.61 139.13 26.14 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.288 0.635 . . . . 1.95 112.689 171.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -83.6 156.19 14.02 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 124.201 3.267 . . . . 1.28 112.311 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 73' ' ' GLY . 32.8 Cg_endo -63.31 138.81 68.21 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.413 3.409 . . . . 1.3300000000000001 115.109 -170.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt 67.15 -2.7 1.13 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.818 2.447 . . . . 4.2300000000000004 115.455 173.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 71' ' ' PRO . . . -78.76 176.29 54.6 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 127.431 2.443 . . . . 1.46 112.634 167.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.431 HH22 ' CD ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -155.27 144.53 21.01 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.27 1.428 . . . . 4.8200000000000003 111.279 -179.073 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.9 t -154.13 127.39 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 126.366 1.866 . . . . 5.0800000000000001 107.738 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.51 149.8 31.36 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.879 0.763 . . . . 5.0899999999999999 111.603 172.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mp -73.8 73.86 1.58 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.796 1.284 . . . . 2.2200000000000002 108.737 165.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -63.88 143.46 98.13 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 114.39 -1.277 . . . . 5.8099999999999996 113.138 -170.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -63.67 -21.11 70.0 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.346 2.697 . . . . 2.3100000000000001 113.982 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.57 48.2 2.33 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.248 0.928 . . . . 1.77 112.14 171.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.59 -121.6 1.04 Allowed Glycine 0 N--CA 1.468 0.802 0 C-N-CA 124.876 1.226 . . . . 1.52 114.085 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -74.21 134.35 42.73 Favored 'General case' 0 C--O 1.22 -0.494 0 O-C-N 121.928 -0.748 . . . . 3.4900000000000002 112.432 -170.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -161.66 163.51 29.81 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.84 0.856 . . . . 0.70999999999999996 111.358 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -90.72 150.22 21.72 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.287 -0.883 . . . . 3.8199999999999998 110.629 168.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.6 tpt -104.79 134.07 48.54 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.35 1.06 . . . . 1.6000000000000001 109.338 164.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -117.62 130.95 56.7 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.411 1.484 . . . . 1.8200000000000001 108.076 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 mp -136.02 140.9 44.21 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.932 0.787 . . . . 2.7000000000000002 111.992 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.74 44.91 11.43 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 123.744 0.688 . . . . 0.76000000000000001 111.776 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.01 148.27 11.03 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 123.452 1.596 . . . . 2.0899999999999999 115.049 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.48 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 26.2 mmtp -105.01 -7.43 19.23 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.517 -1.674 . . . . 2.6499999999999999 112.841 -176.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -144.14 138.06 14.59 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 127.61 2.364 . . . . 7.4699999999999998 108.062 162.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.05 144.21 75.0 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.163 1.909 . . . . 2.2999999999999998 108.308 164.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.13 120.85 36.48 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.826 1.65 . . . . 3.8599999999999999 109.87 -166.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -120.4 169.9 9.87 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.429 1.891 . . . . 4.2599999999999998 114.234 -160.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.05 103.56 1.89 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.38 1.072 . . . . 2.25 111.553 -170.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.03 12.67 39.05 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 118.507 -1.163 . . . . 1.8100000000000001 114.906 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -82.69 -172.87 4.31 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.742 1.271 . . . . 2.2400000000000002 111.456 166.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -146.65 138.95 24.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.714 2.806 . . . . 4.0 106.161 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.0 t -137.97 121.73 21.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 125.04 1.336 . . . . 2.23 109.51 -173.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -84.57 150.49 25.18 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 122.242 1.02 . . . . 3.1699999999999999 113.192 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.57 144.02 20.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.231 1.413 . . . . 4.5499999999999998 114.231 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -104.98 114.34 28.49 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 128.066 2.546 . . . . 2.6899999999999999 109.62 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.13 127.79 32.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.596 1.158 . . . . 2.7000000000000002 108.802 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.3 mt -103.54 112.21 25.02 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.005 0.922 . . . . 2.0499999999999998 109.882 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -108.16 146.81 32.19 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.437 1.495 . . . . 3.4199999999999999 111.237 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.84 124.37 11.01 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.342 1.057 . . . . 1.9199999999999999 113.089 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.2 70.75 1.22 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.457 1.027 . . . . 2.9300000000000002 113.267 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.8 4.06 57.18 Favored Glycine 0 N--CA 1.476 1.331 0 N-CA-C 117.011 1.564 . . . . 2.2000000000000002 117.011 163.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -93.47 110.69 22.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.55 1.675 . . . . 3.8900000000000001 111.024 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.63 135.3 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.048 1.339 . . . . 3.0099999999999998 109.319 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.1 tp -137.01 115.29 11.72 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.443 1.097 . . . . 3.2599999999999998 110.571 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -79.77 131.8 36.0 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.762 -0.586 . . . . 3.3500000000000001 112.316 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.3 t -124.87 169.85 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 128.509 2.724 . . . . 3.1800000000000002 107.658 172.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.9 t -144.55 134.87 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.583 1.553 . . . . 2.7799999999999998 108.094 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -131.11 152.34 80.47 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.185 0.994 . . . . 5.1699999999999999 110.52 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.97 168.42 12.21 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 124.018 3.145 . . . . 0.84999999999999998 112.955 171.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.5 t -108.56 128.62 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.28 1.032 . . . . 1.9099999999999999 110.996 173.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -120.57 147.11 45.62 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.459 1.504 . . . . 5.1200000000000001 112.402 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.87 71.85 2.54 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.78 1.232 . . . . 2.71 111.766 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 127.276 2.231 . . . . 9.2699999999999996 110.647 -178.81 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.386 0 N-CA-C 107.288 -2.325 . . . . 14.99 107.288 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.8 m -60.59 179.29 0.17 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 119.959 -0.696 . . . . 12.869999999999999 110.96 142.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -66.64 178.53 1.27 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.697 0.799 . . . . 11.220000000000001 111.381 163.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.9 t -168.82 147.4 4.05 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 127.002 2.121 . . . . 7.9100000000000001 107.396 171.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -93.16 59.49 3.08 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.743 0.701 . . . . 6.7000000000000002 109.318 171.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.84 169.48 15.21 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 121.621 -0.674 . . . . 1.4199999999999999 114.779 -168.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -157.18 151.49 25.07 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.029 1.732 . . . . 2.4900000000000002 112.125 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.4 t -87.22 121.4 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 107.486 -1.302 . . . . 2.27 107.486 164.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.24 118.23 20.26 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.488 0.715 . . . . 4.5599999999999996 109.876 -175.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -55.85 153.71 8.13 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.186 1.395 . . . . 3.0600000000000001 113.835 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.9 t -163.89 147.04 7.87 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.143 1.377 . . . . 2.7200000000000002 110.395 173.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -86.85 6.37 5.37 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.889 3.059 . . . . 2.1200000000000001 112.665 171.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.14 -170.19 15.72 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.15 1.357 . . . . 1.22 115.082 -168.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.78 -17.78 42.05 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.867 3.045 . . . . 2.1200000000000001 113.717 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -138.22 156.16 47.96 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 116.048 1.87 . . . . 2.4300000000000002 116.048 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.7 -178.73 5.26 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 131.01 3.724 . . . . 2.1899999999999999 109.59 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.31 161.64 33.02 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.39 1.476 . . . . 1.8300000000000001 108.442 168.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.04 135.73 50.27 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.197 0.999 . . . . 1.78 110.067 172.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -127.08 132.41 50.65 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.671 1.988 . . . . 3.9300000000000002 107.673 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pp -170.07 149.86 3.65 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.413 1.006 . . . . 2.9399999999999999 113.408 -164.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.6 m -79.15 121.84 25.52 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.023 1.729 . . . . 3.0600000000000001 111.267 172.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.18 125.37 29.76 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.754 -0.832 . . . . 4.0199999999999996 108.754 157.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -95.77 142.46 28.02 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.65 1.18 . . . . 3.8999999999999999 107.943 161.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.44 72.51 2.53 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.217 1.007 . . . . 3.21 109.882 174.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.31 -20.11 61.97 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.979 2.453 . . . . 1.48 114.692 -172.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.67 -177.95 47.63 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 122.952 1.307 . . . . 1.25 113.096 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.412 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 11.3 m-20 -104.96 -1.9 25.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.769 2.028 . . . . 2.8599999999999999 112.204 -168.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -122.23 155.87 61.08 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 127.804 2.442 . . . . 2.9900000000000002 109.973 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.98 140.45 20.24 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.781 2.321 . . . . 1.5 111.048 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.2 mt -93.87 151.16 19.78 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 123.197 1.475 . . . . 2.8199999999999998 112.115 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.4 ttp-105 -135.53 106.71 6.74 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 112.589 -2.096 . . . . 3.2599999999999998 110.568 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.6 tp -91.94 108.17 19.73 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.022 1.729 . . . . 2.7999999999999998 109.95 -172.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -100.81 -20.94 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.107 1.363 . . . . 1.5900000000000001 111.399 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.06 -178.31 31.97 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.006 1.289 . . . . 0.67000000000000004 114.708 -176.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.27 -178.11 7.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.242 2.217 . . . . 2.02 110.437 172.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -160.84 151.76 18.63 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.494 1.043 . . . . 5.9699999999999998 109.439 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -150.06 153.91 36.09 Favored Pre-proline 0 N--CA 1.472 0.645 0 O-C-N 121.101 -1.0 . . . . 1.9399999999999999 109.836 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.58 -7.89 21.6 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.665 2.244 . . . . 1.1200000000000001 113.604 171.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 m -124.25 44.9 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 114.246 1.202 . . . . 1.96 114.246 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.36 175.2 14.31 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.56 1.544 . . . . 1.75 109.3 164.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.516 ' CD ' ' HZ1' ' A' ' 90' ' ' LYS . 4.6 tp10 -114.45 -60.15 1.92 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.028 0.931 . . . . 3.5 108.826 160.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.6 mtp85 -82.35 106.83 14.54 Favored 'General case' 0 N--CA 1.458 -0.059 0 O-C-N 121.244 -0.91 . . . . 6.6799999999999997 108.799 168.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.73 152.55 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 107.904 -1.147 . . . . 1.95 107.904 148.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -156.39 115.5 3.46 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.469 0.577 . . . . 3.0 111.31 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.1 tp -80.83 118.96 22.8 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.882 -1.136 . . . . 2.1200000000000001 111.753 -174.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -125.24 152.96 43.89 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 123.219 1.485 . . . . 0.56999999999999995 114.483 -172.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -95.31 177.11 5.95 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.36 1.864 . . . . 2.3900000000000001 111.307 162.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.6 m -156.03 144.08 19.77 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.998 2.119 . . . . 1.8200000000000001 106.6 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -160.04 163.38 34.01 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.723 1.379 . . . . 3.6400000000000001 114.723 -165.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.88 145.33 27.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.852 1.261 . . . . 5.7300000000000004 111.169 164.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.42 147.23 21.89 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.515 -0.741 . . . . 5.2699999999999996 112.259 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -105.66 142.23 35.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 126.63 1.972 . . . . 2.7799999999999998 111.84 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.2 t -144.95 133.54 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.566 1.946 . . . . 3.48 106.903 166.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 68.49 1.1 2.82 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 126.609 1.963 . . . . 3.0 114.71 -172.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.71 18.33 61.94 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.431 1.015 . . . . 2.2599999999999998 113.572 -163.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -120.55 134.85 55.23 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.75 2.42 . . . . 3.7000000000000002 108.282 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.63 142.45 28.24 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 125.545 1.538 . . . . 4.3799999999999999 114.052 -173.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.16 169.6 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 129.241 3.016 . . . . 3.9100000000000001 107.259 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.0 mtp -117.33 139.83 50.34 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.194 -0.941 . . . . 4.4000000000000004 110.728 165.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.98 -179.81 16.07 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.487 1.041 . . . . 0.62 113.772 -175.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ttm -152.89 144.88 23.73 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.617 1.967 . . . . 1.6399999999999999 109.1 -176.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -146.11 156.95 50.63 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 126.022 1.729 . . . . 6.0499999999999998 108.924 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.89 156.34 43.48 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 121.886 1.724 . . . . 0.64000000000000001 110.667 166.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.7 m -139.12 152.16 69.27 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 124.799 1.24 . . . . 1.78 110.543 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.3 -29.33 7.88 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.862 2.375 . . . . 0.56999999999999995 112.175 -168.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -174.39 165.45 3.94 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.53 1.532 . . . . 3.46 111.867 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.8 mt -109.48 154.12 23.1 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.109 1.364 . . . . 1.8200000000000001 110.386 164.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -113.49 147.35 38.06 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.975 1.31 . . . . 2.0499999999999998 109.962 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.6 t -140.78 140.25 21.52 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.85 0.86 . . . . 1.98 111.959 169.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -88.1 155.9 7.03 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.648 3.565 . . . . 1.3200000000000001 112.846 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.39 142.76 80.29 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.992 3.128 . . . . 1.2 113.75 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.412 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 70.5 mmtt 67.61 -9.65 0.42 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.763 2.425 . . . . 2.6899999999999999 114.251 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.46 160.92 46.14 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.788 1.185 . . . . 1.54 111.98 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -116.63 140.87 48.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.752 0.821 . . . . 5.9400000000000004 109.302 160.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.3 t -148.32 143.92 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.875 2.07 . . . . 4.5 106.895 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.21 150.51 39.96 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.288 1.404 . . . . 4.0199999999999996 114.76 -165.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.2 mp -66.73 75.25 0.11 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.208 -1.405 . . . . 2.25 107.208 151.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.8 140.54 74.59 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 114.466 -1.243 . . . . 3.9900000000000002 111.538 -167.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -55.52 -35.55 92.6 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.901 2.401 . . . . 2.1499999999999999 112.321 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.68 6.9 57.01 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 116.88 -2.067 . . . . 2.23 116.27 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.19 -8.56 0.02 OUTLIER Glycine 0 N--CA 1.478 1.441 0 N-CA-C 122.331 3.692 . . . . 2.1099999999999999 122.331 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -145.43 143.74 30.23 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 122.188 2.994 . . . . 3.29 113.163 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -162.26 157.77 23.39 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.508 0.723 . . . . 0.56000000000000005 111.369 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -82.99 138.64 33.68 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 107.945 -1.132 . . . . 2.7000000000000002 107.945 158.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -79.2 134.79 36.67 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.203 1.401 . . . . 1.5700000000000001 108.051 156.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 mp -116.61 125.87 52.43 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 106.591 -1.633 . . . . 2.0800000000000001 106.591 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.4 tt -147.46 136.22 22.0 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.759 -0.588 . . . . 3.3700000000000001 110.325 -167.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.25 47.36 8.32 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.129 -0.788 . . . . 1.03 111.129 -167.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mt -50.64 150.54 2.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 123.044 1.402 . . . . 4.46 112.706 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.516 ' HZ1' ' CD ' ' A' ' 41' ' ' GLU . 34.1 mmtp -106.83 -2.4 21.46 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.065 -1.425 . . . . 3.48 113.256 -169.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -153.29 154.27 30.5 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.652 1.181 . . . . 7.3799999999999999 111.682 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.35 94.67 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.476 2.117 . . . . 2.54 107.667 160.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.15 164.93 15.44 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 125.826 1.651 . . . . 3.7599999999999998 109.358 176.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -146.71 165.2 30.34 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 112.764 -2.016 . . . . 5.1699999999999999 113.751 -160.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.9 118.54 10.53 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.701 -1.136 . . . . 2.3900000000000001 108.777 166.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.9 10.13 43.84 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.378 -1.234 . . . . 1.4199999999999999 115.974 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -86.24 -175.28 5.45 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.647 1.724 . . . . 2.1400000000000001 112.122 165.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -146.46 156.22 43.13 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 130.056 3.342 . . . . 5.1900000000000004 107.556 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 78.6 t -156.06 128.04 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 127.487 2.315 . . . . 2.1200000000000001 109.812 -170.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -91.81 130.61 37.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.079 0.466 . . . . 4.8399999999999999 110.536 168.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.5 tt -111.78 136.75 50.63 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.914 1.685 . . . . 4.0 110.821 173.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -87.32 150.28 23.95 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.744 2.018 . . . . 2.3399999999999999 110.004 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.3 mp -123.83 134.44 53.6 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.059 1.344 . . . . 2.3700000000000001 110.408 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.7 mt -112.78 118.13 34.09 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.011 1.324 . . . . 1.6899999999999999 110.324 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -112.31 149.59 32.2 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.821 1.248 . . . . 3.2799999999999998 110.906 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.95 149.22 27.8 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.474 0.71 . . . . 2.3799999999999999 112.191 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.25 12.47 84.56 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 119.123 -0.821 . . . . 3.5 114.844 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.68 63.55 1.83 Allowed Glycine 0 N--CA 1.471 1.004 0 CA-C-N 118.965 1.383 . . . . 2.3700000000000001 113.581 172.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -135.78 147.69 48.46 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.744 1.618 . . . . 4.6200000000000001 111.611 169.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.2 t -138.34 146.69 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.437 1.095 . . . . 3.3399999999999999 110.189 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.0 tp -145.38 169.88 17.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.209 1.804 . . . . 2.8900000000000001 110.128 -177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -128.55 144.65 51.19 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.282 1.216 . . . . 3.0899999999999999 114.282 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.6 m -130.7 162.44 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 126.057 1.743 . . . . 3.46 110.978 168.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 86.5 t -121.28 141.29 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.918 2.087 . . . . 3.25 107.113 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.1 mt -152.94 106.08 2.66 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 125.11 1.364 . . . . 3.0299999999999998 109.718 -160.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.53 149.92 89.11 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.904 2.403 . . . . 0.92000000000000004 110.822 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.5 t -91.83 116.87 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.646 -0.872 . . . . 2.3199999999999998 108.646 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.94 149.88 27.75 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.5 1.12 . . . . 3.29 111.358 -153.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -106.23 91.97 3.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.125 0.97 . . . . 2.3199999999999998 113.102 -164.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 125.925 1.69 . . . . 9.1699999999999999 110.195 167.875 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.228 0 N-CA-C 105.681 -2.968 . . . . 10.779999999999999 105.681 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.0 m 59.55 176.14 0.08 Allowed 'General case' 0 N--CA 1.481 1.115 0 O-C-N 124.759 0.917 . . . . 10.800000000000001 110.902 -133.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -69.76 148.73 48.8 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.778 -0.452 . . . . 12.01 109.778 162.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.6 t -158.18 12.99 0.19 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.942 2.097 . . . . 6.2300000000000004 111.14 169.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -158.55 161.87 37.35 Favored 'General case' 0 CA--C 1.542 0.649 1 C-N-CA 131.857 4.063 . . . . 7.3600000000000003 103.826 -175.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.77 -175.49 41.32 Favored Glycine 0 N--CA 1.463 0.49 0 C-N-CA 124.239 0.923 . . . . 1.9399999999999999 115.402 -168.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -142.21 -179.26 6.15 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.904 1.682 . . . . 2.1699999999999999 111.572 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.7 142.87 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 121.114 -0.991 . . . . 2.6899999999999999 109.804 174.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.444 HH11 ' HG3' ' A' ' 9' ' ' ARG . 1.0 OUTLIER -86.69 126.64 34.69 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.766 0.426 . . . . 5.0999999999999996 112.08 -176.051 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -50.54 139.12 16.44 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.416 1.886 . . . . 2.9500000000000002 113.458 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 m -157.55 149.11 16.97 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.556 1.142 . . . . 2.6400000000000001 110.588 163.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -84.53 42.72 1.21 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.416 3.411 . . . . 2.1600000000000001 110.762 167.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.95 158.56 15.09 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.605 1.097 . . . . 1.54 114.502 -164.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.37 -13.99 25.32 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.848 3.032 . . . . 1.4199999999999999 112.574 165.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -135.22 155.33 50.83 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 129.398 3.079 . . . . 2.21 112.62 -175.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.94 -176.29 5.47 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.072 1.749 . . . . 1.6000000000000001 112.138 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -154.56 130.14 9.91 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.709 1.604 . . . . 1.76 110.385 -177.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.29 141.5 49.94 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.627 1.171 . . . . 1.49 113.28 -169.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.43 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 39.9 m-85 -126.18 115.48 19.83 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.896 1.678 . . . . 3.6800000000000002 109.986 -170.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.259 0.0 OUTLIER -159.73 -174.87 4.83 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.591 1.7 . . . . 4.21 115.591 -166.491 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.1 m -108.45 135.24 50.07 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.451 1.1 . . . . 3.1499999999999999 111.34 -158.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.71 108.86 17.35 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.803 1.241 . . . . 4.3600000000000003 108.394 171.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -99.32 138.6 36.18 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.014 0.926 . . . . 3.9500000000000002 109.174 170.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -109.33 89.17 6.76 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 122.902 0.481 . . . . 1.6200000000000001 109.924 161.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.41 -9.24 20.14 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.545 2.163 . . . . 1.21 113.065 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.95 -175.54 49.24 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 124.766 1.174 . . . . 1.2 113.195 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.438 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.7 m-20 -111.81 -4.21 14.7 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.959 2.103 . . . . 3.27 112.41 -166.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mp -125.94 163.34 40.11 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 127.713 2.405 . . . . 5.4400000000000004 108.664 174.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.62 145.79 18.59 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.38 2.054 . . . . 1.3700000000000001 111.273 -171.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mp -105.21 148.24 27.16 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.62 1.168 . . . . 4.1299999999999999 110.058 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -139.35 103.21 4.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.801 -1.545 . . . . 4.4800000000000004 109.703 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.0 tt -80.96 119.53 23.6 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 124.527 1.131 . . . . 3.54 108.207 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.1 m -111.08 -12.53 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.291 1.036 . . . . 1.9399999999999999 111.258 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.45 -176.21 30.24 Favored Glycine 0 C--N 1.343 0.936 0 C-N-CA 125.316 1.436 . . . . 0.66000000000000003 114.085 -174.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.72 -179.5 8.06 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.93 1.692 . . . . 1.6599999999999999 110.069 173.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.02 -177.99 6.98 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 125.85 1.66 . . . . 5.9199999999999999 109.143 165.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 t -179.62 153.7 0.69 Allowed Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 128.043 2.537 . . . . 1.8500000000000001 106.46 -169.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -73.71 -16.58 23.66 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 120.77 1.311 . . . . 0.92000000000000004 112.602 172.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.3 m -113.19 41.5 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 114.631 1.345 . . . . 1.8500000000000001 114.631 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.14 142.48 4.1 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.22 -0.925 . . . . 1.8 111.828 168.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.527 ' CD ' ' HZ1' ' A' ' 90' ' ' LYS . 1.3 tp10 -74.65 -57.02 4.19 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.912 0.885 . . . . 2.71 110.095 173.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -85.02 139.99 31.36 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.91 1.284 . . . . 6.3399999999999999 108.385 163.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 p -108.91 153.89 10.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.368 -1.287 . . . . 1.95 108.207 140.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -135.02 151.86 51.18 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.704 2.002 . . . . 3.0 108.294 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.2 tp -106.53 124.46 49.64 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.288 0.635 . . . . 2.3999999999999999 109.892 173.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.2 m170 -123.95 159.77 29.02 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.277 1.431 . . . . 0.65000000000000002 114.131 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.58 159.39 22.98 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.388 1.875 . . . . 2.3100000000000001 110.743 163.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 m -135.33 145.33 47.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.079 1.751 . . . . 2.0499999999999998 106.796 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -157.97 171.0 21.04 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.18 0.99 . . . . 3.2799999999999998 113.54 -167.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.6 ttp -100.7 135.99 41.28 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.265 1.826 . . . . 3.8300000000000001 110.134 168.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.14 138.45 40.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.636 1.175 . . . . 6.5 110.731 171.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -92.43 126.32 37.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.411 1.484 . . . . 3.4300000000000002 112.9 -177.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 m -136.01 142.57 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.722 1.609 . . . . 3.77 108.249 169.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 70.15 -3.18 1.86 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 126.003 1.721 . . . . 4.1299999999999999 115.065 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.43 22.82 39.04 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.769 1.176 . . . . 2.0899999999999999 113.791 -161.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt -133.97 132.31 40.01 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.722 2.409 . . . . 4.8399999999999999 109.56 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.402 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -67.36 121.36 15.57 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 120.575 -1.328 . . . . 5.7400000000000002 112.28 170.189 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.7 m -97.94 171.36 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.703 1.201 . . . . 3.1299999999999999 108.759 151.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 70.0 mtm -111.23 156.63 21.17 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.477 0.711 . . . . 4.46 111.103 164.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.39 176.04 23.07 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.898 1.237 . . . . 0.57999999999999996 112.288 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.0 ttm -151.41 143.47 23.94 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.836 1.654 . . . . 1.74 109.748 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -148.97 154.03 39.2 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.624 1.57 . . . . 6.5999999999999996 109.604 -173.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -76.67 161.03 34.25 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.425 2.084 . . . . 0.63 111.364 172.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.25 155.83 64.61 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.692 1.597 . . . . 2.1200000000000001 110.977 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -82.62 -27.82 1.99 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.592 2.861 . . . . 0.76000000000000001 113.375 -169.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -174.44 165.4 3.9 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.178 1.391 . . . . 3.46 111.916 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 mt -114.82 158.47 21.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.484 1.914 . . . . 1.97 109.727 161.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -141.33 148.13 39.24 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.908 0.883 . . . . 2.2599999999999998 111.353 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -145.68 131.92 9.66 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.104 0.962 . . . . 2.3900000000000001 112.438 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.4 161.71 41.92 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.578 3.519 . . . . 1.8500000000000001 112.83 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.36 140.96 79.45 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.065 3.177 . . . . 1.47 113.435 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.438 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 68.6 mmtt 67.73 -1.65 1.59 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.135 2.174 . . . . 2.7000000000000002 113.818 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.95 164.2 38.73 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.721 1.629 . . . . 1.49 111.952 171.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.03 139.77 20.76 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.693 1.197 . . . . 5.0 110.439 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.2 t -152.85 144.95 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.216 1.807 . . . . 4.7199999999999998 108.34 -165.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -126.31 145.05 50.58 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 122.034 0.921 . . . . 4.3300000000000001 113.464 -168.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 mp -75.75 74.09 2.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.097 2.559 . . . . 2.2400000000000002 109.495 171.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.0 146.5 97.26 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.175 0.99 . . . . 3.9700000000000002 112.798 176.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.43 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 36.2 Cg_endo -60.43 -36.93 84.71 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.683 2.256 . . . . 2.3300000000000001 113.37 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.89 44.33 2.77 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.162 0.887 . . . . 1.6799999999999999 113.498 171.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.63 -124.3 1.14 Allowed Glycine 0 C--N 1.338 0.669 0 C-N-CA 125.44 1.495 . . . . 1.5900000000000001 113.018 176.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -73.28 139.74 46.33 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.816 -0.814 . . . . 3.6600000000000001 112.314 -171.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -162.19 166.97 24.86 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.326 1.45 . . . . 0.73999999999999999 111.708 -174.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -95.04 148.4 22.38 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.885 -0.509 . . . . 2.79 110.112 167.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.3 tpt -105.28 139.81 39.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.589 1.556 . . . . 1.8 109.347 165.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -113.5 135.26 54.09 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.461 1.504 . . . . 1.9199999999999999 108.344 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.89 133.19 41.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.649 0.78 . . . . 3.2400000000000002 110.663 174.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.11 50.88 4.17 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 124.148 0.88 . . . . 0.79000000000000004 113.013 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.9 mt -52.31 156.84 1.58 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.674 1.731 . . . . 3.6600000000000001 115.674 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.527 ' HZ1' ' CD ' ' A' ' 41' ' ' GLU . 72.3 mmtt -116.89 -25.09 7.38 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.861 -1.063 . . . . 2.6000000000000001 113.68 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -114.49 138.68 23.25 Favored Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 126.649 1.98 . . . . 6.7000000000000002 107.075 158.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.88 133.49 31.53 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 N-CA-C 107.097 -1.924 . . . . 1.8 107.097 162.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.25 78.92 1.31 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.294 0.637 . . . . 3.6400000000000001 110.439 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -68.7 163.87 22.93 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.948 0.88 . . . . 5.2000000000000002 112.502 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.89 117.44 10.56 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.435 -1.32 . . . . 3.3300000000000001 107.435 168.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.86 14.55 59.27 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 117.903 -1.498 . . . . 1.8600000000000001 115.227 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.56 175.18 5.79 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.957 1.879 . . . . 3.1299999999999999 109.378 155.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.44 171.56 8.45 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.455 -1.683 . . . . 5.5099999999999998 106.455 150.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.4 t -138.17 119.89 17.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 C-N-CA 128.775 2.83 . . . . 3.02 107.505 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.414 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -79.81 141.68 36.0 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.399 0.68 . . . . 3.5299999999999998 109.857 167.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.28 139.23 53.48 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.863 1.265 . . . . 2.7400000000000002 110.951 171.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.02 149.54 23.94 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 129.698 3.199 . . . . 2.04 110.303 158.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -127.93 119.81 26.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.592 1.957 . . . . 1.97 108.537 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.2 mt -103.58 121.14 42.3 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.307 1.043 . . . . 1.72 111.147 -171.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -114.5 144.52 43.22 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.039 1.336 . . . . 3.3599999999999999 112.361 -174.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.86 144.63 48.2 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.411 -0.813 . . . . 2.6400000000000001 110.963 169.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.81 27.36 38.44 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 118.828 -0.984 . . . . 3.48 114.015 -174.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.99 36.24 32.58 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 124.703 1.144 . . . . 1.8799999999999999 115.243 163.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -129.65 143.59 50.89 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.39 1.095 . . . . 4.1100000000000003 112.897 -168.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.6 p -133.01 150.89 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.828 1.651 . . . . 3.3100000000000001 111.034 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 31.4 tp -144.43 159.62 42.43 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.334 2.254 . . . . 3.0499999999999998 108.764 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.414 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 62.1 mttm -126.85 167.99 15.07 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.335 0.971 . . . . 4.0300000000000002 113.439 177.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.9 m -149.05 159.33 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 127.111 2.164 . . . . 3.6200000000000001 110.73 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.9 t -118.86 123.52 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.466 1.106 . . . . 2.8100000000000001 110.148 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.9 mt -124.9 123.89 25.51 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.701 1.2 . . . . 2.8900000000000001 110.083 -170.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.37 155.37 36.7 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.927 2.418 . . . . 1.01 111.504 174.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.4 t -94.94 115.11 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.427 0.632 . . . . 2.3700000000000001 111.062 172.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -93.95 130.16 40.15 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.504 1.122 . . . . 4.0499999999999998 111.249 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.34 152.01 22.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.261 1.024 . . . . 4.54 108.528 151.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 . . . . . 0 C--O 1.245 0.857 0 C-N-CA 127.322 2.249 . . . . 10.35 109.62 -175.243 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.547 0 CA-C-O 118.24 -1.311 . . . . 13.92 109.847 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.8 p -170.08 166.46 9.1 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.896 1.348 . . . . 10.76 111.752 -172.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -124.98 -176.47 3.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.69 1.996 . . . . 10.380000000000001 110.585 168.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.93 137.77 17.08 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.578 1.551 . . . . 8.4700000000000006 110.2 -173.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -78.76 169.59 17.99 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.495 1.518 . . . . 4.9100000000000001 112.766 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.29 -178.19 27.49 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 125.142 1.353 . . . . 1.3 112.064 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -155.67 164.77 38.17 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.537 0.94 . . . . 2.23 113.537 171.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.4 t -106.86 141.25 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.337 1.455 . . . . 1.9399999999999999 108.751 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -74.69 -1.63 22.7 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.416 1.636 . . . . 5.2599999999999998 115.416 -172.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 64.16 172.38 0.18 Allowed 'General case' 0 CA--C 1.554 1.129 0 CA-C-N 119.919 1.236 . . . . 2.8199999999999998 111.567 -170.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.4 t -160.24 154.52 19.98 Favored Pre-proline 0 N--CA 1.468 0.457 0 O-C-N 120.275 -1.515 . . . . 3.6299999999999999 110.38 163.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -85.23 -3.48 9.49 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.576 2.85 . . . . 2.3599999999999999 112.312 161.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.15 -173.51 13.35 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.426 1.488 . . . . 1.45 114.587 -173.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.23 -18.83 20.48 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.948 3.099 . . . . 2.2000000000000002 113.849 -175.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -104.77 143.44 33.12 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.485 1.914 . . . . 2.7599999999999998 113.868 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.61 -178.86 7.3 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.59 1.956 . . . . 1.8100000000000001 112.405 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.34 134.33 25.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.924 2.089 . . . . 1.8700000000000001 108.661 177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.81 138.01 53.63 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.888 1.275 . . . . 1.8799999999999999 111.314 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -116.81 64.57 0.72 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.707 1.603 . . . . 3.6299999999999999 111.209 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.26 155.75 40.33 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.125 1.157 . . . . 2.8999999999999999 114.125 -172.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.5 m -92.66 147.21 23.06 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.556 1.143 . . . . 3.2200000000000002 109.769 166.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 tp -130.86 114.11 14.88 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.282 2.233 . . . . 4.3700000000000001 110.135 173.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -98.79 121.34 40.61 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.798 1.639 . . . . 5.1900000000000004 110.122 170.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -95.68 104.09 15.02 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 120.89 -1.132 . . . . 1.8200000000000001 110.101 165.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -83.18 -10.15 10.26 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.961 2.441 . . . . 1.3899999999999999 113.443 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.66 171.4 54.64 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 123.154 1.419 . . . . 1.3 113.166 -173.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.458 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 6.6 m-20 -97.41 -6.1 34.79 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 128.609 2.764 . . . . 3.2799999999999998 112.171 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.5 mt -117.76 162.59 28.25 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 127.49 2.316 . . . . 5.0499999999999998 109.178 171.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -81.51 153.23 17.93 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.66 2.24 . . . . 1.23 111.211 -172.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.8 mt -102.32 155.08 18.47 Favored 'General case' 0 C--O 1.227 -0.101 0 CA-C-O 122.758 1.266 . . . . 2.8500000000000001 110.374 166.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -140.24 118.89 12.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 113.661 -1.609 . . . . 2.9100000000000001 109.624 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.2 tp -100.53 108.79 20.81 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.902 1.281 . . . . 2.71 109.909 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 m -104.38 -17.84 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.15 0.98 . . . . 1.8500000000000001 111.833 -173.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.99 -179.04 31.63 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 125.412 1.482 . . . . 0.56000000000000005 112.304 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.96 178.16 7.55 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.073 1.349 . . . . 1.8400000000000001 109.926 165.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -157.38 178.65 10.07 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.005 1.722 . . . . 7.9299999999999997 108.18 176.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 t 177.29 152.05 0.4 Allowed Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 126.642 1.977 . . . . 1.78 109.527 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.06 -10.49 27.33 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.731 2.287 . . . . 1.1599999999999999 114.22 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.3 m -116.72 41.43 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.691 0.997 . . . . 1.8700000000000001 113.691 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.84 144.97 23.83 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.259 -0.9 . . . . 2.0699999999999998 110.87 162.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -93.21 -47.46 6.93 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.07 1.348 . . . . 3.71 111.447 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.11 161.23 19.77 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.313 1.845 . . . . 7.8799999999999999 107.659 168.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.74 138.66 10.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 126.178 1.791 . . . . 2.77 108.979 -173.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.55 145.52 48.79 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.884 1.674 . . . . 3.0499999999999998 109.873 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.8 tp -101.35 120.21 39.92 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.216 1.006 . . . . 2.1099999999999999 110.783 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -123.53 155.38 37.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.102 1.761 . . . . 0.66000000000000003 113.65 -174.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -99.97 162.69 12.83 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.153 -1.385 . . . . 2.4700000000000002 111.685 156.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 m -121.61 136.76 54.93 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.153 1.781 . . . . 1.77 106.571 162.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -134.83 176.16 8.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.965 1.306 . . . . 3.21 112.895 -175.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.5 ptm -123.62 146.04 48.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.012 1.325 . . . . 4.0999999999999996 112.863 167.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.19 138.9 24.18 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.855 2.062 . . . . 7.0099999999999998 110.122 -176.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -95.13 121.88 37.22 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.833 1.253 . . . . 3.4100000000000001 110.809 175.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.2 m -88.67 -120.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.973 -1.121 . . . . 4.8399999999999999 107.973 172.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.07 37.67 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 130.106 3.362 . . . . 4.3499999999999996 116.429 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.81 22.1 68.02 Favored Glycine 0 CA--C 1.528 0.879 0 O-C-N 119.182 -2.199 . . . . 2.3599999999999999 111.504 -164.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.87 132.26 56.74 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.767 2.027 . . . . 7.8700000000000001 108.264 174.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.83 131.76 34.49 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.944 1.298 . . . . 9.2599999999999998 110.822 -175.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.58 150.6 20.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 124.369 1.068 . . . . 3.71 110.663 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -111.34 136.89 49.81 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.641 1.176 . . . . 3.8199999999999998 110.27 -175.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.12 -176.67 14.52 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 124.968 1.27 . . . . 0.56999999999999995 112.262 -174.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ttm -152.85 146.62 25.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.175 1.39 . . . . 1.5800000000000001 108.914 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -156.5 152.84 23.63 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 123.779 0.832 . . . . 6.8099999999999996 110.815 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.29 152.39 55.51 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.953 1.769 . . . . 0.59999999999999998 111.176 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.99 153.62 71.87 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.847 1.659 . . . . 1.74 109.747 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.63 -25.3 3.76 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.961 2.44 . . . . 0.59999999999999998 113.279 -166.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -177.18 164.61 2.23 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.729 1.611 . . . . 3.1099999999999999 111.751 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.7 mt -111.79 153.96 25.78 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.424 1.49 . . . . 1.6000000000000001 109.967 163.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -110.11 147.25 34.01 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.388 1.075 . . . . 2.1499999999999999 109.2 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.5 t -139.85 129.53 13.84 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 113.018 0.747 . . . . 2.0899999999999999 113.018 170.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -71.1 164.97 33.91 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.484 2.79 . . . . 1.3600000000000001 112.494 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -59.63 143.48 99.65 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.347 2.698 . . . . 1.23 111.929 172.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.458 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 68.9 mmtt 67.02 -4.06 0.86 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.318 1.847 . . . . 3.02 114.26 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.36 134.8 13.15 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.713 1.625 . . . . 1.3899999999999999 113.088 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -97.84 138.89 34.52 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.646 1.178 . . . . 6.29 110.139 164.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.3 t -144.9 132.12 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.059 1.343 . . . . 3.7400000000000002 108.0 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.49 136.48 49.56 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.6 0.714 . . . . 3.27 110.827 172.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mp -71.19 78.13 0.7 Allowed 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 125.45 1.5 . . . . 2.6299999999999999 109.1 165.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -76.08 156.13 84.17 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.248 1.419 . . . . 4.5199999999999996 114.159 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.79 -18.29 62.03 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.571 2.18 . . . . 2.5299999999999998 113.093 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.22 36.18 2.18 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.154 -0.804 . . . . 2.5099999999999998 112.819 166.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.71 -118.88 0.91 Allowed Glycine 0 C--N 1.344 0.974 0 C-N-CA 124.751 1.167 . . . . 1.79 115.066 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -72.15 142.07 49.1 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 121.812 -0.817 . . . . 3.1499999999999999 111.937 -165.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -161.98 171.35 17.75 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.354 1.062 . . . . 0.76000000000000001 112.251 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -107.33 133.4 51.93 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.14 0.576 . . . . 3.0299999999999998 110.758 170.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.1 tpt -82.08 128.64 34.33 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.23 1.412 . . . . 2.0299999999999998 109.324 163.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.4 mp -116.6 134.32 54.97 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.838 1.255 . . . . 2.25 108.971 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.8 mt -135.58 132.94 37.78 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.752 0.821 . . . . 3.3199999999999998 110.738 -170.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.49 36.56 26.23 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.606 -1.108 . . . . 0.91000000000000003 114.065 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -45.05 150.62 0.38 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 116.528 2.047 . . . . 2.1600000000000001 116.528 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -106.74 7.13 30.25 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 113.713 -1.585 . . . . 3.25 113.901 -169.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.9 ptm85 -145.32 147.6 34.5 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.959 1.304 . . . . 5.4199999999999999 111.627 167.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.07 149.64 71.54 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.297 1.998 . . . . 2.1200000000000001 108.435 158.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.72 134.54 25.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.462 1.105 . . . . 5.2599999999999998 110.512 -156.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.5 mmtm -103.32 171.99 7.06 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.068 1.347 . . . . 4.5 111.489 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.58 134.6 46.54 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.822 -1.177 . . . . 1.8799999999999999 107.822 148.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.24 21.91 16.36 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.44 1.495 . . . . 1.23 115.405 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -105.79 -174.96 2.66 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.412 1.606 . . . . 1.8600000000000001 111.815 168.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -147.45 131.63 17.39 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 129.747 3.219 . . . . 5.5800000000000001 105.344 -169.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.1 t -140.5 130.5 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.093 0.957 . . . . 1.79 110.985 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -76.09 141.66 41.94 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.326 1.051 . . . . 2.71 110.052 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 mp -128.15 136.81 51.63 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.816 0.846 . . . . 2.5699999999999998 111.969 167.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -90.77 134.19 34.62 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 127.131 2.172 . . . . 2.54 109.339 173.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.73 118.01 35.49 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 119.702 1.137 . . . . 2.1400000000000001 110.065 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 72.2 mt -90.42 102.18 14.92 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.577 -0.897 . . . . 1.8400000000000001 108.577 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -92.43 142.65 27.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.467 0.707 . . . . 3.9199999999999999 111.274 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.15 124.0 10.64 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.54 1.136 . . . . 2.3199999999999998 112.109 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.1 46.99 19.8 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.712 -1.049 . . . . 2.9900000000000002 114.296 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.84 25.29 25.36 Favored Glycine 0 N--CA 1.475 1.246 0 N-CA-C 117.172 1.629 . . . . 1.8899999999999999 117.172 156.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.57 148.1 39.96 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.453 1.626 . . . . 4.6900000000000004 111.221 168.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -140.28 151.63 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.786 1.234 . . . . 2.98 110.935 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.9 tp -155.38 138.09 15.2 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.874 1.669 . . . . 3.2799999999999998 109.548 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -110.21 115.71 30.21 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.692 0.678 . . . . 2.96 112.504 -173.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.6 m -89.31 178.12 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.057 1.743 . . . . 3.2599999999999998 111.592 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.7 p -142.42 145.28 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.078 1.351 . . . . 3.7000000000000002 109.041 170.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.4 143.75 13.82 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.078 0.951 . . . . 3.2200000000000002 113.126 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.54 156.69 63.23 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.965 3.11 . . . . 0.90000000000000002 112.953 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.7 t -106.34 124.93 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.513 1.525 . . . . 1.8700000000000001 109.314 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -146.83 155.21 42.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.267 1.827 . . . . 3.8500000000000001 110.541 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -112.55 129.5 56.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.083 0.953 . . . . 3.73 113.011 -165.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 C-N-CA 126.379 1.872 . . . . 8.5099999999999998 111.968 167.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.191 0 N-CA-C 106.084 -2.806 . . . . 12.199999999999999 106.084 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.5 p -65.1 175.74 1.5 Allowed 'General case' 0 CA--C 1.549 0.933 0 O-C-N 123.773 0.337 . . . . 13.029999999999999 111.733 133.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -144.24 -97.68 0.11 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.403 1.481 . . . . 9.3699999999999992 110.928 171.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 174.95 108.37 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.844 2.458 . . . . 7.8700000000000001 110.785 -174.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -156.76 73.23 0.76 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.579 1.152 . . . . 7.2300000000000004 108.554 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.35 165.71 33.96 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.866 1.698 . . . . 1.4299999999999999 112.407 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 21.8 p90 -155.65 152.11 28.27 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.319 1.448 . . . . 2.0800000000000001 111.971 174.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.0 t -89.39 137.87 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.388 -0.82 . . . . 2.4100000000000001 109.021 171.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -62.53 -4.6 2.02 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.121 1.768 . . . . 4.9299999999999997 115.729 -168.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 72.6 159.89 0.22 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.569 1.948 . . . . 3.7000000000000002 111.154 -167.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.9 t -168.87 135.71 1.53 Allowed Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 121.155 -0.966 . . . . 3.1499999999999999 111.077 163.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -81.42 -6.88 12.81 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.271 2.648 . . . . 1.9399999999999999 112.235 169.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.59 171.99 15.06 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.48 1.515 . . . . 1.04 113.551 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.76 -13.45 34.31 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.944 3.763 . . . . 1.5600000000000001 115.454 -172.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -123.41 144.4 49.51 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.639 1.575 . . . . 4.8600000000000003 112.256 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.69 -176.49 4.67 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.367 1.867 . . . . 1.5900000000000001 112.012 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.97 154.3 39.18 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.694 1.997 . . . . 1.75 108.504 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.51 146.48 42.02 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.75 1.22 . . . . 1.8500000000000001 114.227 -173.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.427 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 30.2 m-85 -120.7 143.6 48.66 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.867 2.067 . . . . 3.6699999999999999 110.184 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pp -171.38 151.62 3.11 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.441 1.275 . . . . 3.46 114.441 -175.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.4 m -79.13 144.27 34.67 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.923 1.689 . . . . 2.5800000000000001 111.359 174.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.5 126.99 54.97 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 129.502 3.121 . . . . 4.5599999999999996 108.057 168.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -118.94 127.46 53.5 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.802 1.241 . . . . 4.2400000000000002 109.663 168.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -100.46 93.44 2.76 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 123.606 0.762 . . . . 1.4299999999999999 110.061 170.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.54 -8.89 18.52 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.025 1.817 . . . . 1.53 112.983 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.42 162.45 34.83 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 122.684 1.158 . . . . 1.23 111.643 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.454 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 5.3 m-20 -94.53 3.27 55.33 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.352 2.661 . . . . 2.9900000000000002 112.046 -170.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -122.21 154.32 61.87 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 129.242 3.017 . . . . 2.7799999999999998 109.678 174.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.78 147.01 30.59 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.759 2.306 . . . . 0.93000000000000005 111.024 -172.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.6 mt -104.2 147.93 26.9 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 122.465 1.126 . . . . 2.9199999999999999 110.537 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -136.73 99.04 3.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.562 -2.108 . . . . 3.3300000000000001 110.725 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.2 tp -80.73 106.43 12.73 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.669 1.588 . . . . 3.1299999999999999 109.727 -173.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -99.19 -21.18 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.771 1.229 . . . . 1.8500000000000001 112.209 -175.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.16 -177.16 31.98 Favored Glycine 0 C--N 1.343 0.947 0 C-N-CA 124.96 1.266 . . . . 0.73999999999999999 114.937 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.07 -177.24 5.35 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.562 1.945 . . . . 1.6799999999999999 111.131 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.425 HH12 HG12 ' A' ' 110' ' ' VAL . 40.9 mtt85 -146.55 -179.42 6.76 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.809 2.044 . . . . 7.8799999999999999 108.062 158.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t -174.77 152.08 1.54 Allowed Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 127.12 2.168 . . . . 1.8799999999999999 108.299 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.78 -6.29 15.94 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.025 1.817 . . . . 1.0900000000000001 113.899 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.23 45.31 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.532 1.133 . . . . 2.1400000000000001 112.854 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.33 171.76 19.81 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.665 1.186 . . . . 1.78 111.8 168.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -104.96 -23.49 12.97 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 128.464 2.706 . . . . 2.8300000000000001 111.221 166.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -152.26 160.49 43.34 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.44 2.296 . . . . 7.7699999999999996 110.858 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.2 p -156.93 117.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 125.815 1.646 . . . . 2.3799999999999999 110.301 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -131.28 130.68 43.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.954 -1.021 . . . . 5.0 111.352 -166.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 31.3 tp -83.3 122.51 28.54 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.958 0.903 . . . . 2.6000000000000001 111.746 -168.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.3 m170 -124.75 160.78 27.87 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.618 1.567 . . . . 0.80000000000000004 113.356 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -107.18 154.17 21.59 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 113.467 -1.697 . . . . 2.3700000000000001 110.721 157.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.0 m -111.18 138.33 47.75 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.265 1.826 . . . . 2.1899999999999999 106.521 162.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -133.78 174.19 10.72 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.191 1.396 . . . . 3.1899999999999999 112.968 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.0 ttp -113.0 143.0 45.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.628 1.571 . . . . 4.5800000000000001 109.833 166.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -138.31 152.67 48.72 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.135 1.374 . . . . 5.4500000000000002 112.036 171.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -95.84 146.93 24.17 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.104 1.762 . . . . 2.2000000000000002 110.602 163.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 m -147.93 130.71 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.885 2.074 . . . . 3.5499999999999998 108.837 162.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 62.98 15.84 8.74 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.577 1.551 . . . . 3.3500000000000001 114.34 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.71 16.79 69.63 Favored Glycine 0 N--CA 1.479 1.513 0 O-C-N 121.054 -1.029 . . . . 1.6799999999999999 113.741 -169.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.9 mtmt -119.27 122.17 41.3 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.974 2.11 . . . . 4.3200000000000003 108.071 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.47 128.43 38.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.869 1.268 . . . . 4.1900000000000004 111.76 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 t -143.69 141.73 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 127.208 2.203 . . . . 3.8399999999999999 108.662 -174.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 50.6 mtp -83.54 162.93 20.72 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.358 0.663 . . . . 4.54 112.655 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.56 -177.47 28.83 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 125.118 1.342 . . . . 0.94999999999999996 112.397 -177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.1 ttm -154.79 148.25 25.16 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.531 1.133 . . . . 2.1800000000000002 109.844 -172.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -155.89 153.7 26.36 Favored Pre-proline 0 N--CA 1.474 0.736 0 C-N-CA 123.779 0.832 . . . . 7.1299999999999999 111.475 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.77 156.56 39.65 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.499 2.133 . . . . 0.75 111.262 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.7 m -138.88 153.03 71.54 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 125.114 1.366 . . . . 1.8400000000000001 110.148 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.32 -24.7 5.27 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.656 2.904 . . . . 0.79000000000000004 113.337 -167.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -174.99 167.0 3.58 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.621 1.968 . . . . 3.4199999999999999 110.929 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.4 mt -109.6 153.34 24.31 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.526 1.13 . . . . 1.96 110.31 159.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -108.94 143.65 37.91 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.234 1.014 . . . . 1.8600000000000001 109.167 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.7 t -136.88 124.3 14.28 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.386 0.674 . . . . 2.04 110.989 165.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -69.82 164.51 34.33 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.773 2.982 . . . . 1.03 111.643 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.66 147.89 92.49 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.017 2.478 . . . . 1.01 113.301 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.454 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 21.2 mmmt 69.73 -14.04 0.37 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.335 2.654 . . . . 2.8399999999999999 114.219 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.62 172.63 42.9 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.18 1.372 . . . . 1.4199999999999999 113.572 -171.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.68 143.94 35.37 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.89 0.876 . . . . 5.1100000000000003 111.119 168.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.5 t -151.17 158.49 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 127.379 2.272 . . . . 4.9000000000000004 107.213 -168.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.43 152.74 42.91 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 121.075 1.761 . . . . 3.77 114.088 176.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.1 mp -59.95 91.16 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 107.311 -1.366 . . . . 2.0099999999999998 107.311 155.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -49.93 126.0 18.8 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 125.351 1.46 . . . . 4.3700000000000001 111.831 -165.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.427 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 19.7 Cg_endo -60.96 -13.75 29.04 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.878 2.385 . . . . 2.9900000000000002 116.678 -172.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.39 -1.39 29.5 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-N 120.101 1.319 . . . . 2.7200000000000002 115.277 167.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.94 -103.8 1.2 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.359 1.933 . . . . 1.9399999999999999 112.466 -168.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -72.49 139.12 47.45 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.269 -1.136 . . . . 3.21 112.059 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -160.22 149.74 17.72 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.561 1.144 . . . . 0.69999999999999996 110.519 -173.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -83.25 130.09 35.05 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.298 -1.001 . . . . 2.6699999999999999 108.298 165.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -80.04 133.08 36.11 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.279 0.945 . . . . 1.8 108.832 163.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 mp -109.56 126.92 54.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.342 1.057 . . . . 1.8 109.369 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -118.89 130.1 55.55 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 124.227 1.011 . . . . 4.6200000000000001 109.647 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.54 54.74 3.87 Favored Glycine 0 N--CA 1.476 1.363 0 C-N-CA 123.744 0.688 . . . . 0.76000000000000001 114.662 167.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.34 158.68 4.06 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 117.673 2.471 . . . . 2.4900000000000002 117.673 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -116.29 -25.62 7.48 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 113.08 -1.873 . . . . 2.5600000000000001 112.855 -171.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -117.81 151.83 49.2 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 129.48 3.112 . . . . 8.1699999999999999 107.811 159.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.99 140.66 38.52 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.229 1.953 . . . . 2.04 108.611 164.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.6 mp -95.74 89.21 5.23 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.158 0.504 . . . . 3.4700000000000002 110.259 -175.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -75.21 174.16 9.85 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.268 0.556 . . . . 6.04 111.758 167.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.72 146.45 44.41 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.501 -1.296 . . . . 2.2599999999999998 107.501 165.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.32 34.5 63.96 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 117.866 -1.519 . . . . 1.6000000000000001 114.163 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -94.73 174.04 7.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.14 1.47 . . . . 2.6499999999999999 109.185 157.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -135.5 127.77 30.14 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 105.092 -2.188 . . . . 4.3499999999999996 105.092 169.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.7 t -152.45 140.05 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.944 1.298 . . . . 3.25 110.331 -175.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -78.3 154.67 30.69 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 113.394 0.887 . . . . 3.6400000000000001 113.394 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.9 137.36 51.79 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.264 -1.334 . . . . 2.73 110.4 149.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.41 150.6 31.28 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.582 1.153 . . . . 2.5899999999999999 108.611 159.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.0 mp -123.86 127.69 48.39 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.025 1.33 . . . . 1.99 110.209 175.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.3 mt -110.65 114.12 27.26 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.99 1.716 . . . . 2.4399999999999999 110.226 -172.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -113.21 123.59 50.55 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.759 1.224 . . . . 3.2599999999999998 111.613 -172.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 48.01 32.13 2.75 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.308 1.843 . . . . 2.8799999999999999 113.502 176.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.25 -73.96 2.35 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.107 1.337 . . . . 4.9699999999999998 112.689 -172.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.15 -26.36 44.62 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 116.44 1.336 . . . . 2.0699999999999998 116.44 -161.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -83.81 109.46 17.56 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.58 1.69 . . . . 5.8799999999999999 111.716 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.425 HG12 HH12 ' A' ' 36' ' ' ARG . 58.8 t -98.52 134.46 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.399 1.48 . . . . 2.8799999999999999 110.712 174.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -136.68 171.62 14.22 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.811 1.644 . . . . 4.2800000000000002 109.606 166.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -149.6 143.96 25.88 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.786 -1.196 . . . . 2.96 112.007 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.84 150.57 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.137 0.975 . . . . 3.4900000000000002 110.011 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.83 133.51 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.523 1.529 . . . . 2.5 107.641 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.4 mt -139.07 145.58 45.76 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.422 1.089 . . . . 3.7200000000000002 109.918 -173.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.14 162.46 35.61 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.796 2.331 . . . . 0.80000000000000004 112.444 167.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 42.6 t -112.07 122.5 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.189 -1.411 . . . . 2.21 107.189 165.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -146.48 154.54 41.69 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.467 1.507 . . . . 4.4800000000000004 110.391 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.03 141.85 28.4 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.484 0.92 . . . . 2.8799999999999999 113.484 -168.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.976 0 C-N-CA 126.157 1.783 . . . . 9.2599999999999998 112.103 169.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.01 0 N-CA-C 104.748 -3.341 . . . . 13.369999999999999 104.748 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p 168.5 163.44 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 O-C-N 124.771 0.924 . . . . 11.890000000000001 109.383 -139.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -158.96 145.61 17.05 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.797 1.239 . . . . 8.9199999999999999 113.928 -170.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.0 p -104.73 63.17 0.72 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.245 1.418 . . . . 8.5199999999999996 111.922 -165.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -77.88 76.05 4.41 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 123.078 1.418 . . . . 6.3700000000000001 112.065 -174.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.98 179.03 21.62 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 121.161 -0.962 . . . . 1.28 111.393 173.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.3 p90 -148.94 157.06 43.14 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.778 0.831 . . . . 2.1400000000000001 112.053 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.2 t -97.56 143.65 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 107.65 -1.241 . . . . 2.4199999999999999 107.65 173.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -73.87 127.27 32.4 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.438 -0.789 . . . . 5.7599999999999998 110.816 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -36.02 148.49 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.675 1.99 . . . . 3.4300000000000002 113.333 155.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.9 t -160.25 146.75 11.96 Favored Pre-proline 0 CA--C 1.536 0.439 0 O-C-N 120.884 -1.135 . . . . 3.04 112.333 166.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -85.89 -6.81 8.52 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.18 2.587 . . . . 2.4300000000000002 112.693 170.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -137.58 -176.58 14.53 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.73 1.157 . . . . 1.1200000000000001 114.423 -172.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.3 -17.92 44.56 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.483 3.455 . . . . 1.8899999999999999 115.097 -169.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -97.85 142.07 30.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.19 1.396 . . . . 3.4700000000000002 112.64 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.14 -176.48 5.69 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.484 1.514 . . . . 2.0099999999999998 111.944 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.21 152.3 32.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.675 1.59 . . . . 1.8500000000000001 109.708 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.08 124.27 47.65 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.09 1.314 . . . . 2.1899999999999999 111.773 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -102.16 57.39 0.81 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.812 1.645 . . . . 4.1299999999999999 109.635 173.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -75.12 162.93 28.08 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.057 0.943 . . . . 3.0899999999999999 113.163 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.0 m -143.58 137.38 28.33 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.892 1.677 . . . . 2.7999999999999998 110.869 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.1 156.52 48.87 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.255 2.222 . . . . 5.7300000000000004 109.018 169.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -84.79 160.89 20.15 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.196 1.362 . . . . 3.9100000000000001 110.507 154.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -97.86 94.33 2.09 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 109.042 -0.725 . . . . 1.8300000000000001 109.042 155.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.98 -6.27 14.96 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.063 2.509 . . . . 1.99 113.433 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.33 164.52 52.53 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-O 122.722 1.179 . . . . 1.76 112.082 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -87.02 -5.89 58.92 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.661 1.584 . . . . 3.7799999999999998 111.742 175.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 pp -116.04 159.13 40.57 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 127.666 2.387 . . . . 3.6200000000000001 111.198 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.01 145.29 22.07 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.576 2.184 . . . . 1.4399999999999999 111.046 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.1 mt -99.33 142.84 30.29 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 123.018 1.39 . . . . 3.48 111.727 170.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.41 ' HD2' ' CD2' ' A' ' 66' ' ' PHE . 16.4 tpp85 -131.47 98.38 4.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 112.119 -2.31 . . . . 3.0499999999999998 109.474 -174.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.9 tp -91.39 109.27 20.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.565 1.546 . . . . 2.8700000000000001 109.691 -171.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.7 m -103.68 -22.07 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.826 0.85 . . . . 1.8100000000000001 112.084 -173.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.88 -177.08 30.65 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.466 1.508 . . . . 0.52000000000000002 114.288 -173.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.35 178.38 8.83 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.8 1.64 . . . . 1.48 112.269 171.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.8 161.08 36.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.54 2.336 . . . . 7.3300000000000001 109.12 174.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 t -176.25 154.08 1.33 Allowed Pre-proline 0 N--CA 1.471 0.6 0 C-N-CA 128.08 2.552 . . . . 1.8799999999999999 107.176 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.16 -20.16 19.27 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.85 1.7 . . . . 1.0 112.499 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.6 m -99.1 35.27 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.799 0.809 . . . . 1.8 112.899 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.14 143.05 16.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.982 1.313 . . . . 1.6299999999999999 109.234 166.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -91.51 -49.42 6.32 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.63 1.572 . . . . 3.8100000000000001 110.592 -176.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.99 160.15 22.53 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.468 1.907 . . . . 7.8200000000000003 107.665 167.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.1 p -142.52 145.45 23.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 126.067 1.747 . . . . 2.1499999999999999 108.049 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -129.47 148.74 51.41 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.057 1.743 . . . . 3.0600000000000001 108.771 174.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.5 tp -101.16 121.28 41.54 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.349 -0.845 . . . . 1.97 109.911 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.1 m170 -123.61 154.28 39.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.436 1.494 . . . . 0.62 113.871 -174.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 9.0 pt-20 -100.68 179.8 4.31 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.341 1.456 . . . . 2.1499999999999999 112.098 162.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.5 m -145.63 128.44 16.32 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 106.665 -1.606 . . . . 1.72 106.665 172.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -129.16 167.96 16.84 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 114.357 1.243 . . . . 3.6400000000000001 114.357 -166.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -109.2 147.6 32.28 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.864 1.666 . . . . 5.7699999999999996 110.994 171.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.55 151.76 24.69 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.776 0.83 . . . . 5.9299999999999997 112.004 -174.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -103.72 143.29 32.99 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.702 1.601 . . . . 2.2599999999999998 109.671 167.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -158.99 139.97 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.613 1.165 . . . . 4.1900000000000004 108.336 167.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 62.25 27.17 16.29 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.334 1.053 . . . . 3.4500000000000002 111.844 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.99 18.2 78.99 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 120.912 -1.118 . . . . 1.6899999999999999 113.605 -175.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -132.48 129.33 39.04 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.046 1.338 . . . . 3.4900000000000002 110.179 -174.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.547 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -71.29 130.09 40.51 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.311 2.244 . . . . 4.6399999999999997 111.315 173.493 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.1 m -141.43 175.12 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 129.171 2.988 . . . . 3.2599999999999998 110.235 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.25 162.9 21.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.079 1.351 . . . . 4.5199999999999996 111.172 177.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.3 -178.14 29.25 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.089 1.328 . . . . 0.53000000000000003 113.704 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.3 ttm -154.82 148.49 25.39 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.507 1.923 . . . . 1.6000000000000001 108.286 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.402 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 17.0 ptt180 -160.43 156.4 22.64 Favored Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 124.814 1.246 . . . . 6.6600000000000001 110.471 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.64 155.44 44.68 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.254 1.969 . . . . 0.63 111.519 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.99 154.72 70.76 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.655 1.582 . . . . 1.9399999999999999 110.156 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.69 -24.49 3.44 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.178 2.585 . . . . 0.63 113.367 -167.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.41 ' CD2' ' HD2' ' A' ' 31' ' ' ARG . 50.6 p90 -178.24 163.05 1.61 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.334 1.853 . . . . 3.1800000000000002 111.073 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.1 mt -109.6 153.01 24.78 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.006 1.323 . . . . 1.8899999999999999 110.377 166.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CD ' ' HE ' ' A' ' 31' ' ' ARG . 3.5 tp10 -121.39 137.33 54.75 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.288 1.435 . . . . 2.0899999999999999 109.194 177.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.9 t -140.32 130.99 13.89 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 123.667 0.787 . . . . 2.5299999999999998 111.544 175.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.3 163.76 37.53 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.356 2.704 . . . . 1.3100000000000001 112.39 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -60.03 140.36 92.25 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.42 2.747 . . . . 1.55 111.012 171.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp 65.78 0.75 1.6 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.137 1.375 . . . . 4.5599999999999996 113.374 -175.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.11 -175.18 41.9 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.225 1.869 . . . . 1.77 109.907 163.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -139.19 138.45 36.91 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.712 -0.876 . . . . 8.6600000000000001 112.865 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -93.04 57.23 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 128.189 2.595 . . . . 6.21 108.43 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.4 125.3 30.24 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.136 0.974 . . . . 3.6099999999999999 108.859 163.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 mp -72.48 -53.94 10.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.162 -0.472 . . . . 3.1400000000000001 110.477 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.314 0.0 OUTLIER 79.94 123.55 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.081 0 C-N-CA 128.157 2.583 . . . . 4.29 114.228 176.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.41 -15.19 48.68 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.065 2.51 . . . . 2.1600000000000001 113.9 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.86 5.12 84.86 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 117.073 -1.959 . . . . 1.53 114.745 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.49 -24.14 0.02 OUTLIER Glycine 0 C--N 1.348 1.23 0 N-CA-C 121.596 3.398 . . . . 2.0699999999999998 121.596 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -145.77 147.62 32.09 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.022 1.911 . . . . 3.4700000000000002 113.215 171.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -162.18 155.41 20.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.12 0.968 . . . . 0.71999999999999997 110.889 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -80.32 137.16 36.55 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.108 0.867 . . . . 2.9199999999999999 109.119 158.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.8 tpt -85.21 129.73 34.75 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.881 1.272 . . . . 1.6599999999999999 108.43 162.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -111.62 126.41 54.98 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.466 1.107 . . . . 1.8700000000000001 108.866 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.96 128.63 55.91 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.243 1.017 . . . . 3.96 109.432 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.48 44.48 10.91 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 118.561 -1.133 . . . . 0.94999999999999996 114.834 169.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -43.52 149.82 0.25 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 117.734 2.494 . . . . 2.3700000000000001 117.734 176.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -115.82 -22.56 9.04 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 114.19 -1.368 . . . . 3.8900000000000001 114.526 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -91.38 168.62 13.05 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 107.553 -1.277 . . . . 6.6500000000000004 107.553 149.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -63.38 177.93 1.41 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 121.153 1.236 . . . . 3.1400000000000001 109.907 148.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.0 mt -129.13 95.08 3.96 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.135 -0.978 . . . . 3.48 109.314 167.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -99.33 159.44 15.0 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.967 0.889 . . . . 6.6699999999999999 112.829 176.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.74 130.62 44.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.275 -1.329 . . . . 2.3399999999999999 107.915 159.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.92 0.68 83.23 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.484 1.992 . . . . 1.4399999999999999 116.797 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -81.48 -171.46 3.31 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.482 2.141 . . . . 2.6600000000000001 113.312 175.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -152.51 124.98 8.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 128.62 2.768 . . . . 5.0099999999999998 105.899 -155.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 38.1 t -144.02 125.34 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 O-C-N 121.578 -0.701 . . . . 2.3999999999999999 110.333 -173.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -79.56 151.21 30.8 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.497 -0.774 . . . . 3.0299999999999998 111.325 168.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.23 147.22 34.5 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.828 2.051 . . . . 2.9500000000000002 110.793 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -121.53 108.0 13.09 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 128.946 2.898 . . . . 2.2000000000000002 108.312 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.0 mp -83.98 128.09 34.31 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.355 -0.84 . . . . 2.1400000000000001 110.584 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.6 mt -97.82 103.41 15.35 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.362 1.065 . . . . 1.79 110.557 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -98.02 143.11 28.93 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.675 1.19 . . . . 3.52 111.435 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.64 131.69 39.39 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.282 1.033 . . . . 2.4199999999999999 112.421 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.18 41.93 7.27 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.801 -0.999 . . . . 2.9500000000000002 113.938 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.16 7.21 88.61 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 116.018 1.167 . . . . 2.1299999999999999 116.018 165.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -90.43 112.62 24.31 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.963 1.382 . . . . 4.1699999999999999 111.382 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.13 134.15 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.917 1.287 . . . . 3.2999999999999998 109.999 173.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.0 tp -128.49 111.01 12.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.776 0.83 . . . . 2.8500000000000001 111.465 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -81.76 135.16 35.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.417 0.687 . . . . 3.1000000000000001 112.354 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.7 m -144.84 162.2 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 127.458 2.303 . . . . 3.23 111.019 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.2 t -131.91 132.45 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.625 0.77 . . . . 2.77 109.881 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.89 153.69 64.54 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 126.251 1.82 . . . . 2.9300000000000002 110.142 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.04 167.11 27.62 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.674 2.916 . . . . 0.73999999999999999 112.278 175.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.85 135.29 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.786 1.234 . . . . 2.1099999999999999 109.358 167.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -150.26 165.45 32.92 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 115.991 1.849 . . . . 4.2999999999999998 115.991 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.14 149.55 27.91 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 116.963 2.209 . . . . 2.6099999999999999 116.963 -159.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.186 1 C-N-CA 134.05 4.94 . . . . 9.3200000000000003 108.462 161.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.375 0 N-CA-C 109.48 -1.448 . . . . 12.949999999999999 109.48 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.1 p -171.35 167.85 6.75 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.5 1.15 . . . . 9.5600000000000005 112.364 -165.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -87.24 172.31 9.99 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.045 1.338 . . . . 10.359999999999999 111.851 170.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.05 163.04 34.67 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.42 2.688 . . . . 7.6500000000000004 107.566 170.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -133.23 152.18 51.93 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.965 1.706 . . . . 7.0599999999999996 107.947 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.85 164.24 31.23 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 123.541 0.591 . . . . 1.9399999999999999 111.961 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -108.36 168.58 9.21 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.147 0.979 . . . . 2.46 112.206 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.8 t -90.88 131.52 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.083 0.953 . . . . 2.46 109.011 167.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 107.67 11.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.972 0.909 . . . . 5.7800000000000002 108.828 171.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -42.78 149.69 0.18 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.317 1.847 . . . . 2.9199999999999999 114.806 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.6 t -152.51 151.56 27.31 Favored Pre-proline 0 CA--C 1.538 0.492 0 O-C-N 121.132 -0.98 . . . . 3.5299999999999998 111.08 163.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -88.32 -2.66 6.88 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.429 2.753 . . . . 2.3100000000000001 111.968 164.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.7 -179.38 20.0 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.929 1.252 . . . . 1.3700000000000001 114.716 -170.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.81 -17.21 37.46 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.635 3.556 . . . . 1.7 114.635 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -110.28 153.9 24.2 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.495 1.518 . . . . 2.4900000000000002 113.738 172.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.39 -178.47 6.68 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 128.132 2.573 . . . . 1.8500000000000001 110.647 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.13 152.74 36.65 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.338 1.455 . . . . 1.72 110.448 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.62 146.61 36.42 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.239 1.2 . . . . 1.6599999999999999 114.239 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -117.51 29.74 7.69 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 115.663 1.727 . . . . 4.3200000000000003 115.663 -167.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -49.74 161.88 0.2 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 117.876 2.547 . . . . 2.8599999999999999 117.876 -169.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 15.8 m -79.64 119.81 23.1 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.448 0.642 . . . . 3.1699999999999999 111.589 172.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.35 139.24 33.14 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.55 -0.907 . . . . 4.5499999999999998 108.55 164.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -147.39 172.45 13.9 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.368 0.667 . . . . 6.1500000000000004 111.551 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -155.71 110.38 2.17 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.338 1.455 . . . . 1.3799999999999999 110.74 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.7 -5.82 4.39 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.844 3.03 . . . . 1.5900000000000001 114.292 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.99 178.23 41.99 Favored Glycine 0 C--N 1.341 0.818 0 CA-C-N 119.55 1.068 . . . . 1.1799999999999999 112.956 -174.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -101.25 3.2 40.66 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.408 2.283 . . . . 3.29 112.323 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -118.74 160.21 41.27 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 127.116 2.166 . . . . 2.8999999999999999 110.254 171.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.75 142.26 15.87 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.344 2.03 . . . . 1.1599999999999999 111.422 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -102.95 157.11 17.2 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.359 1.464 . . . . 3.77 111.975 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -152.99 104.54 2.84 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.02 -1.446 . . . . 3.3100000000000001 111.649 -169.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.2 tt -83.03 123.64 29.67 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.702 1.201 . . . . 3.4100000000000001 108.61 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 m -110.91 -15.12 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.665 0.786 . . . . 1.97 111.662 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.48 -177.12 30.28 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 125.6 1.571 . . . . 0.52000000000000002 114.051 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.9 -179.55 7.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.46 1.504 . . . . 1.8300000000000001 111.699 171.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -155.92 173.26 17.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.605 2.362 . . . . 7.7800000000000002 109.212 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 t 178.54 146.75 0.36 Allowed Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 129.106 2.963 . . . . 1.8300000000000001 106.87 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.0 -15.62 36.26 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 121.736 1.624 . . . . 1.49 113.544 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.0 22.17 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.609 1.164 . . . . 1.9099999999999999 113.288 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.75 138.47 28.83 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.786 1.176 . . . . 1.55 110.382 169.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -83.21 -41.03 18.88 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.007 0.923 . . . . 3.8100000000000001 111.062 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -131.16 152.84 50.03 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 128.537 2.735 . . . . 7.7400000000000002 106.396 -175.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.6 p -146.57 146.27 18.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 124.555 1.142 . . . . 2.0699999999999998 108.772 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -132.36 145.36 51.19 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.97 1.708 . . . . 3.1200000000000001 108.841 175.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.4 tp -99.63 118.79 36.93 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.809 -0.557 . . . . 2.2799999999999998 109.639 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.0 m170 -122.53 154.12 38.31 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.245 1.418 . . . . 0.63 114.068 -174.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -102.04 163.66 12.12 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.354 -1.294 . . . . 2.3100000000000001 111.622 161.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.4 m -120.88 130.63 53.99 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 105.906 -1.887 . . . . 1.8700000000000001 105.906 163.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -127.37 168.52 14.71 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.518 1.303 . . . . 3.4900000000000002 114.518 -170.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -109.49 148.21 31.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.853 1.661 . . . . 5.7300000000000004 111.425 170.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.58 148.48 24.37 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.414 1.086 . . . . 5.7999999999999998 110.56 -174.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -98.53 140.02 33.39 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.564 1.145 . . . . 2.9300000000000002 109.895 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.1 t -137.81 118.41 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.353 1.061 . . . . 3.23 108.241 168.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 66.49 15.14 10.02 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 126.191 1.796 . . . . 4.1299999999999999 114.85 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.6 21.64 55.7 Favored Glycine 0 CA--C 1.535 1.32 0 O-C-N 121.356 -0.84 . . . . 2.5800000000000001 112.943 -166.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.5 mttt -124.53 113.53 18.22 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.604 1.562 . . . . 4.2599999999999998 109.133 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.8 123.01 28.94 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.604 -0.685 . . . . 6.75 110.519 -171.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.29 179.76 3.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 128.451 2.7 . . . . 3.7999999999999998 110.764 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.83 162.56 31.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.88 1.272 . . . . 3.5 111.862 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.35 -176.54 27.65 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.53 1.538 . . . . 0.64000000000000001 113.662 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.0 ttm -150.8 148.02 27.99 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.195 1.798 . . . . 2.1099999999999999 108.873 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -158.65 157.34 28.49 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 124.659 1.184 . . . . 6.7400000000000002 111.131 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.99 154.77 53.04 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.011 1.807 . . . . 0.72999999999999998 111.699 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.45 156.5 74.99 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 126.283 1.833 . . . . 2.0499999999999998 110.091 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.44 -26.76 3.09 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.023 2.482 . . . . 0.68000000000000005 113.371 -167.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -175.3 164.68 3.24 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.501 1.521 . . . . 3.48 111.231 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.4 mt -113.33 153.92 27.7 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.897 1.679 . . . . 2.0 110.119 164.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -136.34 147.99 47.68 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.355 0.662 . . . . 2.2599999999999998 111.836 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.0 t -141.56 131.47 12.79 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.161 0.985 . . . . 1.8 112.366 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -69.97 161.98 43.9 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.742 2.962 . . . . 0.97999999999999998 111.704 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.24 140.91 81.64 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.598 2.866 . . . . 1.03 113.517 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp 66.94 2.88 2.85 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.476 1.91 . . . . 2.8500000000000001 114.552 176.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.78 160.31 31.16 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.843 1.687 . . . . 1.2 114.24 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.19 146.04 33.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.333 1.053 . . . . 4.8799999999999999 110.85 168.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.2 t -155.81 132.92 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 125.491 1.516 . . . . 5.2999999999999998 108.642 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 2.8 mp0 -83.21 141.66 31.74 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.137 1.335 . . . . 3.7400000000000002 111.102 176.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mp -46.49 -43.57 16.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.989 1.316 . . . . 2.9399999999999999 112.007 -177.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 108.13 128.56 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 128.019 2.528 . . . . 4.71 111.019 158.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -59.98 116.16 3.12 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 N-CA-C 107.463 -1.783 . . . . 2.7000000000000002 107.463 165.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.78 26.07 59.27 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 116.98 -2.011 . . . . 3.29 116.463 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.58 -42.74 0.04 OUTLIER Glycine 0 N--CA 1.482 1.729 0 N-CA-C 119.252 2.461 . . . . 1.79 119.252 166.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -137.2 145.94 44.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.745 1.26 . . . . 3.1299999999999999 110.753 160.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -160.56 153.02 20.67 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.176 -0.953 . . . . 0.81999999999999995 109.339 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -78.72 151.02 32.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.82 -0.807 . . . . 3.8199999999999998 108.82 162.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.3 tpt -101.0 129.42 46.84 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.912 1.685 . . . . 1.8999999999999999 107.391 159.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.84 137.62 49.55 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.671 1.188 . . . . 1.8300000000000001 108.479 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -139.44 146.61 40.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.516 1.127 . . . . 3.5800000000000001 112.69 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.78 26.94 68.05 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.464 1.03 . . . . 1.3300000000000001 113.728 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.5 148.12 2.99 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 117.07 2.248 . . . . 2.5299999999999998 117.07 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -120.7 2.48 10.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 112.065 -2.334 . . . . 3.0 113.494 -165.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -145.25 144.51 23.55 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 127.094 2.158 . . . . 7.0499999999999998 108.22 164.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.07 158.3 45.81 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.111 2.541 . . . . 1.74 110.343 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -106.18 99.55 9.13 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.973 1.709 . . . . 3.7599999999999998 109.294 -169.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.91 132.69 35.15 Favored 'General case' 0 C--N 1.332 -0.155 0 O-C-N 120.446 -1.409 . . . . 4.9400000000000004 112.423 175.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.7 115.55 1.69 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 113.923 -1.49 . . . . 2.8700000000000001 109.889 169.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.92 -3.74 45.26 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 117.673 -1.626 . . . . 1.8799999999999999 115.736 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -76.41 -178.58 4.69 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 120.242 2.021 . . . . 2.7599999999999998 111.661 167.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -140.66 139.05 34.74 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 129.236 3.014 . . . . 3.5299999999999998 105.535 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.66 126.63 44.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 126.616 1.966 . . . . 1.97 108.504 -173.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -78.29 139.6 38.86 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.836 0.826 . . . . 3.8199999999999998 111.857 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.38 146.47 39.42 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.125 1.37 . . . . 4.3099999999999996 109.321 163.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -102.46 139.23 38.33 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.04 2.536 . . . . 2.6400000000000001 108.859 171.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.2 mp -109.37 138.06 46.3 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.592 1.557 . . . . 1.9399999999999999 110.395 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.4 mt -112.14 110.06 20.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.687 1.195 . . . . 1.75 110.917 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -107.62 151.8 25.15 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.359 1.464 . . . . 3.3500000000000001 112.505 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.82 114.61 1.47 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.899 1.28 . . . . 2.0699999999999998 113.538 -174.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.42 69.32 1.4 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.928 1.252 . . . . 2.8100000000000001 112.965 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.28 7.92 73.58 Favored Glycine 0 N--CA 1.476 1.311 0 N-CA-C 116.291 1.277 . . . . 2.02 116.291 164.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -96.56 125.98 41.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.861 1.331 . . . . 4.1600000000000001 111.309 -171.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.99 141.98 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 124.297 0.998 . . . . 2.8999999999999999 110.893 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.3 tp -140.59 159.8 41.41 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.491 2.316 . . . . 3.0299999999999998 108.6 177.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -132.83 145.18 50.74 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.983 0.913 . . . . 3.2400000000000002 111.992 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.12 160.31 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 127.299 2.24 . . . . 3.5600000000000001 110.836 -172.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.2 t -130.03 94.62 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.034 0.921 . . . . 3.5499999999999998 110.618 -158.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.8 mt -98.55 123.78 48.84 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-O 118.062 -0.971 . . . . 3.4100000000000001 111.051 -168.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.13 153.98 73.52 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.11 1.873 . . . . 0.97999999999999998 111.041 170.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 90.1 t -92.99 121.09 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.305 0.642 . . . . 2.5 109.986 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -117.78 135.82 53.8 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.372 1.069 . . . . 3.4900000000000002 110.59 167.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.93 57.46 4.34 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.202 -0.936 . . . . 4.0899999999999999 112.74 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.335 0 CA-C-O 115.926 -1.988 . . . . 8.0500000000000007 112.605 -171.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.299 0 N-CA-C 106.448 -2.661 . . . . 12.92 106.448 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.9 p -60.5 169.84 1.6 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 119.18 -1.008 . . . . 11.949999999999999 110.352 130.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -143.87 118.68 9.9 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.151 -1.055 . . . . 10.779999999999999 108.151 175.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 78.7 p -79.56 86.23 5.23 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.987 0.915 . . . . 8.0199999999999996 110.294 -173.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.475 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 3.6 tt0 -146.26 -173.69 4.25 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.544 2.338 . . . . 5.8399999999999999 108.019 176.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.475 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -99.29 176.01 28.74 Favored Glycine 0 CA--C 1.527 0.793 0 O-C-N 121.324 -0.86 . . . . 1.5900000000000001 112.385 169.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -157.64 172.08 19.18 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.53 1.132 . . . . 2.3799999999999999 112.073 154.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.2 t -105.53 139.02 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.534 1.133 . . . . 2.4399999999999999 109.323 172.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.0 ttp85 -60.47 -35.36 75.7 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.882 1.067 . . . . 4.6200000000000001 113.882 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.2 t80 64.89 158.95 0.1 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.79 2.036 . . . . 4.7199999999999998 110.343 -157.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 m -166.07 147.65 5.92 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 126.195 1.798 . . . . 3.5699999999999998 109.017 162.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -83.58 49.74 3.01 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.591 3.527 . . . . 2.9399999999999999 111.682 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.17 179.09 25.31 Favored Glycine 0 CA--C 1.537 1.423 0 N-CA-C 115.892 1.117 . . . . 1.29 115.892 -171.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.92 -20.15 19.91 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 124.073 3.182 . . . . 1.52 112.52 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -112.09 145.92 38.89 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.413 1.885 . . . . 3.0699999999999998 113.646 173.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -131.28 -177.68 4.5 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.637 1.975 . . . . 1.8700000000000001 110.802 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.54 148.65 31.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.771 1.228 . . . . 1.48 110.417 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.03 150.91 49.38 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.385 1.254 . . . . 1.8400000000000001 114.385 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -127.3 52.61 1.8 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.838 2.055 . . . . 3.75 111.43 -165.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.35 162.14 25.92 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.367 1.247 . . . . 3.1600000000000001 114.367 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.06 124.3 29.7 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.389 1.076 . . . . 4.9500000000000002 110.847 166.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.73 119.84 29.58 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.624 -1.621 . . . . 4.8700000000000001 106.624 163.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -135.87 144.02 45.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.028 0.918 . . . . 4.2300000000000004 113.12 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -120.76 90.31 46.2 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 114.507 -1.224 . . . . 1.73 110.821 -172.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.56 -7.94 20.94 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.341 2.027 . . . . 2.2599999999999998 112.886 172.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.15 -178.11 51.52 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 122.407 1.004 . . . . 1.8200000000000001 112.858 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.436 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.4 m-20 -111.5 -1.57 15.81 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.223 2.209 . . . . 4.0300000000000002 111.83 -167.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -132.58 159.89 70.57 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 128.415 2.686 . . . . 3.3399999999999999 109.339 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.45 156.87 57.68 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.434 2.089 . . . . 0.85999999999999999 111.879 -167.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mp -114.38 152.9 30.77 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.606 1.562 . . . . 3.8999999999999999 110.181 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -141.79 106.29 4.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 112.665 -2.061 . . . . 2.8900000000000001 110.969 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.5 tp -90.14 109.17 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.083 1.353 . . . . 2.9199999999999999 109.194 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 m -104.27 -18.37 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.041 0.937 . . . . 1.8799999999999999 111.692 -173.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.63 -177.78 29.2 Favored Glycine 0 C--N 1.344 0.997 0 C-N-CA 125.951 1.739 . . . . 0.58999999999999997 113.02 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.57 178.29 7.88 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.4 1.48 . . . . 1.9399999999999999 110.687 171.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -158.6 150.31 21.11 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.851 2.06 . . . . 5.7699999999999996 108.261 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -162.31 148.84 10.79 Favored Pre-proline 0 N--CA 1.478 0.937 0 O-C-N 120.984 -1.073 . . . . 1.8600000000000001 109.34 -171.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.46 -1.25 10.77 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.634 2.89 . . . . 0.76000000000000001 114.62 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.6 m -134.36 47.46 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 125.089 1.355 . . . . 1.9099999999999999 112.676 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.87 178.78 9.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.242 1.417 . . . . 1.78 109.97 162.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -127.45 -34.04 2.29 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.774 1.63 . . . . 3.8300000000000001 112.01 168.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -121.26 149.78 42.36 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 106.567 -1.642 . . . . 7.0800000000000001 106.567 172.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.51 141.64 18.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 125.014 1.326 . . . . 1.96 110.005 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -134.52 147.54 50.34 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.601 1.96 . . . . 3.2200000000000002 109.068 -173.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.7 tp -101.73 120.79 40.91 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.547 -0.721 . . . . 2.3599999999999999 109.842 175.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.5 m170 -121.26 150.09 41.9 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 123.486 1.612 . . . . 0.64000000000000001 114.447 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.443 ' C ' ' HG1' ' A' ' 48' ' ' THR . 17.7 pt-20 -96.0 173.5 7.4 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 113.275 -1.784 . . . . 2.3500000000000001 111.218 162.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.443 ' HG1' ' C ' ' A' ' 47' ' ' GLU . 63.2 m -150.39 146.64 26.82 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 106.453 -1.684 . . . . 1.8999999999999999 106.453 173.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -161.72 171.46 17.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.959 0.885 . . . . 3.2000000000000002 113.378 -167.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.0 ttp -105.11 142.05 35.57 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.134 1.774 . . . . 4.1900000000000004 110.453 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -157.36 151.02 24.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.228 1.411 . . . . 9.5999999999999996 112.73 -173.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.47 133.38 35.39 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.494 0.718 . . . . 2.9199999999999999 111.222 172.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t -141.82 134.79 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 105.443 -2.058 . . . . 3.0699999999999998 105.443 162.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 70.93 4.17 4.95 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.39 1.876 . . . . 4.4900000000000002 114.255 -170.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.21 22.86 69.9 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 121.473 -0.767 . . . . 1.76 113.109 -163.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -124.48 131.33 53.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.612 1.965 . . . . 4.6600000000000001 109.76 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.89 92.63 1.27 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.495 1.118 . . . . 7.5700000000000003 112.591 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.4 m -94.49 -174.94 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 127.177 2.191 . . . . 3.5699999999999998 109.47 171.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -117.7 167.81 11.02 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.36 0.664 . . . . 3.8399999999999999 111.937 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.46 169.63 31.64 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 125.683 1.611 . . . . 0.68999999999999995 112.28 -176.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ttm -149.16 147.43 28.43 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.71 2.004 . . . . 1.55 107.971 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -148.33 153.69 41.04 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 125.966 1.707 . . . . 6.6900000000000004 108.88 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.06 154.55 42.29 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 121.69 1.593 . . . . 0.67000000000000004 110.352 164.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 m -137.11 154.77 76.1 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 125.34 1.456 . . . . 1.9099999999999999 109.87 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.2 -27.03 4.69 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.58 2.186 . . . . 0.83999999999999997 112.745 -166.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -175.17 168.37 3.39 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.363 1.465 . . . . 3.3399999999999999 111.98 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.7 mt -111.13 153.72 25.33 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.276 1.431 . . . . 2.1600000000000001 110.871 161.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -124.88 141.4 52.14 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.861 1.664 . . . . 2.21 110.043 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.0 t -146.52 134.69 10.7 Favored Pre-proline 0 N--CA 1.482 1.151 0 N-CA-C 113.426 0.899 . . . . 1.8999999999999999 113.426 173.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.74 163.36 39.33 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 124.443 3.429 . . . . 1.3600000000000001 113.558 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.02 145.06 78.39 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.86 3.04 . . . . 1.6699999999999999 114.18 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.436 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 70.0 mmtt 69.21 -5.1 1.14 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.08 2.552 . . . . 3.6099999999999999 114.657 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.03 168.4 34.0 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.411 1.482 . . . . 1.8999999999999999 113.243 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -144.24 148.95 35.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.713 0.805 . . . . 7.4900000000000002 112.231 162.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.9 t -155.71 100.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.456 1.902 . . . . 4.7400000000000002 108.631 -168.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.89 171.55 15.03 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 121.876 0.846 . . . . 3.6800000000000002 112.236 -169.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 mp -82.56 70.02 9.44 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.152 -1.592 . . . . 2.0499999999999998 110.133 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -36.6 119.86 0.76 Allowed Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 127.167 2.187 . . . . 4.9699999999999998 113.307 172.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.99 -9.36 22.12 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.817 3.012 . . . . 2.29 115.635 -154.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.33 -2.16 55.68 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 117.836 -1.536 . . . . 1.8999999999999999 114.34 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.68 -17.47 0.49 Allowed Glycine 0 N--CA 1.479 1.542 0 CA-C-N 119.946 1.873 . . . . 1.98 117.776 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -145.12 145.03 31.23 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.128 1.464 . . . . 3.6800000000000002 112.24 170.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -161.31 155.59 22.76 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.598 1.559 . . . . 0.92000000000000004 109.941 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -79.45 150.97 31.1 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.259 -0.901 . . . . 3.9399999999999999 108.862 157.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.6 tpt -100.12 130.84 46.31 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.11 1.764 . . . . 1.48 108.335 162.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.8 mp -116.01 135.54 53.86 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.388 1.475 . . . . 1.8 108.32 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mp -135.78 146.02 47.15 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.747 0.703 . . . . 2.6400000000000001 111.633 -176.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.66 40.23 32.41 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.306 -0.719 . . . . 1.02 113.225 172.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.23 148.31 3.6 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 115.799 1.778 . . . . 2.4100000000000001 115.799 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -104.05 -4.52 23.16 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.481 -1.691 . . . . 3.1699999999999999 113.592 -170.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -146.63 156.09 48.74 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.92 2.088 . . . . 7.6799999999999997 109.112 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -67.38 163.73 33.43 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.853 1.702 . . . . 2.2799999999999998 109.022 153.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 pp -160.86 152.1 19.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.575 1.55 . . . . 3.3700000000000001 108.298 -172.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -147.79 168.31 22.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 123.123 1.44 . . . . 5.5700000000000003 114.715 -174.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.43 135.34 56.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.053 -0.976 . . . . 2.21 111.212 172.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.83 -1.14 74.3 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.72 1.629 . . . . 2.0699999999999998 114.365 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -85.76 -176.91 6.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.869 1.335 . . . . 2.5 112.244 171.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -138.44 140.0 39.09 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 129.459 3.104 . . . . 3.5499999999999998 105.768 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.3 t -141.06 133.36 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.216 1.806 . . . . 2.04 109.773 -172.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -95.58 158.01 15.64 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 122.491 1.139 . . . . 2.3999999999999999 113.478 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.17 151.8 31.47 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.964 1.305 . . . . 4.6600000000000001 112.841 169.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.64 137.12 36.2 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 127.26 2.224 . . . . 2.5600000000000001 109.516 169.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.21 133.94 37.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.804 1.641 . . . . 2.3100000000000001 109.113 170.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 56.3 mt -106.2 104.65 14.39 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.732 1.213 . . . . 2.1699999999999999 108.934 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -91.97 163.37 14.03 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.562 0.696 . . . . 3.3999999999999999 111.484 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.54 117.69 5.18 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.934 -0.479 . . . . 2.2000000000000002 110.947 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.67 -135.94 16.73 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.835 0.731 . . . . 3.23 112.204 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.57 41.74 2.86 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.426 1.012 . . . . 2.9100000000000001 115.481 -165.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -134.48 123.22 23.62 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.441 1.62 . . . . 4.7300000000000004 112.085 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.3 t -136.64 138.56 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.806 1.642 . . . . 3.54 107.677 168.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.9 tp -159.14 133.45 7.76 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.488 1.115 . . . . 3.54 111.581 -170.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -98.1 149.0 22.97 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.631 1.715 . . . . 3.2999999999999998 115.631 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.9 t -125.0 165.88 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 129.237 3.015 . . . . 3.0699999999999998 107.994 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 t -142.18 142.36 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.247 1.819 . . . . 3.0 107.832 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.01 159.48 30.27 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 114.134 1.161 . . . . 3.9199999999999999 114.134 -173.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -77.81 160.58 30.84 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.1 3.2 . . . . 0.91000000000000003 114.671 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.0 t -103.61 130.1 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.525 1.53 . . . . 2.0899999999999999 110.829 171.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.427 ' CD ' ' HE ' ' A' ' 120' ' ' ARG . 11.8 pt-20 -95.21 -172.52 2.69 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.621 1.968 . . . . 5.9699999999999998 111.432 172.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -126.41 117.66 23.4 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.712 -1.243 . . . . 2.7999999999999998 112.014 154.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.427 ' HE ' ' CD ' ' A' ' 118' ' ' GLU . 42.4 mtm180 . . . . . 0 C--O 1.248 1.008 0 C-N-CA 126.781 2.033 . . . . 8.6799999999999997 111.5 161.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.915 0 CA-C-O 117.22 -1.878 . . . . 11.890000000000001 111.478 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . 0.257 96.7 p 103.8 -97.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 131.091 3.756 . . . . 10.77 110.119 -166.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -66.41 120.64 13.68 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.825 -1.172 . . . . 11.59 109.576 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 m 92.61 37.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 128.54 2.736 . . . . 7.3700000000000001 110.886 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -148.32 -168.1 2.99 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.719 2.008 . . . . 5.1600000000000001 110.416 -166.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.49 175.83 17.37 Favored Glycine 0 N--CA 1.473 1.155 0 N-CA-C 116.87 1.508 . . . . 1.1699999999999999 116.87 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -151.35 142.91 23.58 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.389 2.275 . . . . 2.0699999999999998 110.966 169.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.7 t -94.4 141.72 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 120.448 -1.407 . . . . 2.3700000000000001 109.773 175.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.0 ttm-85 -73.12 118.13 15.7 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.514 0.726 . . . . 7.0700000000000003 111.567 -172.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -68.19 138.51 55.68 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.534 -0.729 . . . . 4.0700000000000003 110.558 159.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -167.72 149.75 5.27 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.703 1.601 . . . . 4.1900000000000004 109.977 164.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -82.03 47.93 2.66 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 125.216 3.944 . . . . 3.2799999999999998 111.756 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.34 158.52 20.49 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.872 1.701 . . . . 1.8400000000000001 112.605 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.36 -19.08 33.72 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.729 2.953 . . . . 1.6200000000000001 112.822 174.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -106.96 160.74 15.3 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.213 1.805 . . . . 2.96 112.908 167.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.34 -173.58 4.61 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.686 2.795 . . . . 1.7 110.287 -176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.48 160.29 41.82 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.348 1.459 . . . . 1.8999999999999999 109.821 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.32 137.5 53.49 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.71 1.141 . . . . 2.0099999999999998 112.976 174.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 79' ' ' PRO . 61.7 m-85 -113.06 138.72 49.48 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.691 1.996 . . . . 3.98 110.032 172.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.267 0.0 OUTLIER -165.99 145.14 6.06 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.528 1.307 . . . . 3.9700000000000002 114.528 177.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.3 m -80.98 130.09 34.85 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.345 1.058 . . . . 2.8100000000000001 109.536 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.4 tp -119.09 142.37 47.94 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.319 1.848 . . . . 4.0300000000000002 109.843 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -128.13 149.71 50.3 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.751 1.22 . . . . 3.52 110.966 170.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -103.9 102.01 28.73 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.07 0.948 . . . . 1.4399999999999999 109.459 169.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.76 -10.19 19.93 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.495 2.13 . . . . 1.1100000000000001 113.359 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.59 178.61 53.29 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-O 122.76 1.2 . . . . 1.1200000000000001 113.018 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.418 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 6.7 m-20 -105.44 -3.65 22.31 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.818 2.447 . . . . 2.7799999999999998 111.659 -174.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -121.2 156.27 57.55 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 127.9 2.48 . . . . 2.6899999999999999 109.501 173.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.86 151.77 24.66 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.922 2.414 . . . . 0.93000000000000005 111.992 -169.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.2 mt -104.57 146.99 28.12 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.154 0.982 . . . . 2.52 111.101 169.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.415 HH21 ' CD ' ' A' ' 68' ' ' GLU . 37.2 ttm180 -134.09 111.67 10.54 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.01 -1.45 . . . . 2.8100000000000001 110.788 175.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -92.23 106.95 18.85 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 127.555 2.342 . . . . 3.77 109.974 -173.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -107.26 -17.92 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.729 1.211 . . . . 1.75 111.765 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.66 -175.24 29.37 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 125.726 1.631 . . . . 0.65000000000000002 114.33 -175.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -157.05 -177.34 6.54 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.197 1.399 . . . . 1.6399999999999999 112.681 177.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -154.48 165.43 36.46 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 127.434 2.294 . . . . 5.4299999999999997 107.309 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 t -169.15 147.29 3.27 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 125.509 1.524 . . . . 1.6799999999999999 107.426 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.59 -17.42 38.35 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.31 1.34 . . . . 1.1799999999999999 111.865 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.6 m -111.17 40.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.185 1.394 . . . . 2.25 113.258 -172.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.78 169.29 23.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.411 1.084 . . . . 1.8 110.588 167.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -108.55 -63.14 1.37 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.454 1.502 . . . . 4.0300000000000002 107.304 164.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -84.34 124.1 30.91 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 121.502 -0.749 . . . . 8.2400000000000002 109.054 166.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.6 p -94.64 158.21 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.796 -1.093 . . . . 1.8799999999999999 108.696 149.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.39 157.13 42.01 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.86 2.464 . . . . 4.2699999999999996 107.446 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.6 tp -124.67 112.98 17.4 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.926 1.239 . . . . 2.0299999999999998 112.17 -171.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.2 m170 -122.18 158.01 30.31 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 123.476 1.608 . . . . 0.70999999999999996 114.661 -171.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.69 -176.42 3.26 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.463 1.905 . . . . 3.1400000000000001 111.297 159.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -156.75 145.01 19.61 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.123 1.769 . . . . 1.74 106.798 167.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -153.13 -177.63 6.43 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.103 0.961 . . . . 3.25 113.003 -165.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -118.89 143.32 47.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.131 1.772 . . . . 4.9699999999999998 111.446 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -154.78 160.33 41.22 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.401 1.88 . . . . 5.5300000000000002 110.145 -172.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -116.57 142.61 46.66 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.883 1.673 . . . . 2.9100000000000001 110.526 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.269 1.3 t -95.73 -126.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 107.753 -1.203 . . . . 3.5 107.753 161.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -70.67 44.26 0.08 Allowed 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 125.792 1.637 . . . . 2.9500000000000002 114.81 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.06 18.15 80.19 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 120.271 -1.518 . . . . 1.95 111.738 -160.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -96.28 106.04 18.2 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 121.997 -0.707 . . . . 3.3999999999999999 109.399 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.59 124.29 26.95 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.276 0.63 . . . . 8.5600000000000005 109.951 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.78 175.9 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 126.003 1.721 . . . . 3.8100000000000001 110.079 -174.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.88 149.16 47.83 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.619 1.168 . . . . 3.8599999999999999 110.654 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.99 167.86 21.56 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.507 1.527 . . . . 0.69999999999999996 112.188 -174.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.0 ttm -150.63 137.1 18.77 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.059 1.344 . . . . 1.8600000000000001 110.581 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -145.4 150.51 44.6 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.429 1.892 . . . . 9.5399999999999991 110.066 -173.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -76.48 155.58 36.25 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.977 1.785 . . . . 0.68999999999999995 110.283 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.67 147.78 66.93 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 124.219 1.008 . . . . 2.0800000000000001 110.213 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -71.44 -22.6 24.67 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.438 2.759 . . . . 0.69999999999999996 111.958 -173.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -172.96 172.61 3.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.421 1.888 . . . . 3.25 111.246 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.4 mt -115.01 161.06 18.85 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.265 1.826 . . . . 1.73 109.013 156.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.415 ' CD ' HH21 ' A' ' 31' ' ' ARG . 23.6 tt0 -133.2 151.21 51.95 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.341 -0.849 . . . . 2.0099999999999998 112.072 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.1 t -138.19 129.13 15.61 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 123.785 0.834 . . . . 2.2999999999999998 111.815 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.89 164.67 34.84 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.379 2.72 . . . . 1.0 111.365 174.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.35 140.82 90.24 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.007 2.471 . . . . 1.02 112.485 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.418 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 67.0 mmtt 67.07 -2.75 1.1 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.848 2.059 . . . . 2.27 114.135 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.99 170.64 43.7 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.864 1.697 . . . . 1.22 114.024 -177.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -122.3 154.35 37.72 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.262 1.425 . . . . 6.5199999999999996 111.388 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.2 t -141.36 137.04 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.734 1.613 . . . . 4.5 107.262 159.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.57 136.27 43.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.627 0.727 . . . . 3.75 109.942 168.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.52 101.39 3.54 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 105.951 -1.87 . . . . 2.3199999999999998 105.951 158.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -113.7 152.3 45.39 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.787 2.035 . . . . 3.5899999999999999 114.36 -158.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 19' ' ' TYR . 10.4 Cg_endo -49.19 -57.69 2.2 Favored 'Trans proline' 0 C--N 1.356 0.97 1 C-N-CA 125.437 4.091 . . . . 2.23 113.667 -173.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.81 57.91 5.0 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.217 -0.768 . . . . 1.8 112.728 173.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.1 -126.52 1.6 Allowed Glycine 0 N--CA 1.467 0.766 0 C-N-CA 124.256 0.931 . . . . 1.9299999999999999 114.828 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -71.05 141.91 50.88 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.845 -0.797 . . . . 3.1899999999999999 112.707 -159.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -161.87 152.79 17.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.995 -0.548 . . . . 0.64000000000000001 111.681 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -77.35 142.79 39.18 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 108.283 -1.006 . . . . 2.9900000000000002 108.283 163.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.1 tpt -92.37 135.59 33.91 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.293 1.037 . . . . 1.72 108.47 162.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.1 mp -117.85 138.79 51.86 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.925 1.29 . . . . 1.74 108.509 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mp -138.56 148.15 43.86 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.544 1.137 . . . . 2.6200000000000001 110.041 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.42 40.45 19.21 Favored Glycine 0 N--CA 1.47 0.96 0 CA-C-O 119.876 -0.402 . . . . 0.94999999999999996 112.79 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -43.82 143.13 1.12 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 115.719 1.748 . . . . 2.3300000000000001 115.719 174.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -110.47 -3.57 15.98 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 113.653 -1.612 . . . . 3.79 114.472 -168.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -137.62 153.43 74.18 Favored Pre-proline 0 N--CA 1.473 0.704 0 C-N-CA 125.921 1.688 . . . . 6.6900000000000004 109.56 170.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -68.65 144.94 61.97 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.111 1.874 . . . . 2.7599999999999998 108.583 162.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.8 mp -125.62 116.92 22.47 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.538 0.735 . . . . 3.96 109.747 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.82 15.55 26.6 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 116.205 1.928 . . . . 6.4199999999999999 116.205 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 60.41 157.55 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.137 2.575 . . . . 2.7200000000000002 111.338 -166.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.47 42.38 99.01 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 120.759 -1.213 . . . . 1.3200000000000001 110.563 -170.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -100.18 179.89 4.34 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.744 1.617 . . . . 2.4100000000000001 107.574 169.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.82 150.79 33.01 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 128.104 2.562 . . . . 5.0999999999999996 106.908 163.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.5 t -149.05 143.53 18.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 128.784 2.833 . . . . 2.2599999999999998 108.811 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -98.69 146.3 26.01 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.997 -0.439 . . . . 3.0099999999999998 111.493 168.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.78 133.14 56.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.469 1.108 . . . . 3.8500000000000001 109.23 160.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.73 143.17 26.57 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.357 2.663 . . . . 2.2000000000000002 107.239 162.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.93 127.39 51.79 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.386 1.474 . . . . 2.3999999999999999 110.19 177.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.0 mt -102.25 117.3 34.46 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.754 1.622 . . . . 1.76 109.844 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -107.67 155.23 20.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.391 1.076 . . . . 3.27 111.296 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.93 146.77 25.68 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.16 -0.473 . . . . 2.1200000000000001 110.415 162.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.63 7.53 66.66 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-O 119.127 -0.818 . . . . 3.1400000000000001 114.59 -173.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.36 6.4 88.93 Favored Glycine 0 N--CA 1.474 1.169 0 CA-C-N 118.886 1.343 . . . . 2.1899999999999999 114.163 175.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -79.48 133.34 36.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.724 1.21 . . . . 8.0399999999999991 111.58 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.6 p -113.22 151.39 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.225 1.81 . . . . 3.1499999999999999 109.766 166.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 tt -158.9 135.11 9.09 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.84 1.656 . . . . 3.2400000000000002 109.481 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -103.27 163.0 12.52 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.313 1.227 . . . . 3.23 114.313 176.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.3 m -134.41 146.29 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 128.803 2.841 . . . . 3.1000000000000001 109.136 168.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.4 p -109.31 138.35 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.899 1.28 . . . . 4.2800000000000002 109.457 176.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.98 154.93 28.6 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 123.631 0.772 . . . . 3.23 113.066 -168.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.22 169.93 19.49 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.806 2.337 . . . . 0.98999999999999999 112.787 171.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 70.1 t -104.5 131.25 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.478 1.511 . . . . 1.8700000000000001 108.635 159.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -134.37 174.89 10.03 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.817 0.847 . . . . 4.6100000000000003 112.55 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -95.07 57.22 2.03 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 116.265 1.95 . . . . 3.1000000000000001 116.265 -143.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.251 23.1 mtp-105 . . . . . 0 N--CA 1.49 1.526 0 C-N-CA 131.611 3.965 . . . . 10.09 114.523 161.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.799 0 N-CA-C 108.387 -1.885 . . . . 13.539999999999999 108.387 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -81.72 124.83 29.95 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.308 0.855 . . . . 13.119999999999999 113.308 -155.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -71.92 -18.58 62.01 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.083 0.772 . . . . 12.460000000000001 113.083 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 42.1 p 57.53 19.51 5.37 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.997 2.119 . . . . 8.7699999999999996 115.169 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -78.0 90.13 4.18 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.414 -1.328 . . . . 5.79 107.414 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.01 170.12 34.81 Favored Glycine 0 N--CA 1.463 0.438 0 C-N-CA 124.872 1.225 . . . . 1.6200000000000001 111.873 176.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.6 p90 -159.03 141.57 14.1 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.296 1.038 . . . . 2.3199999999999998 111.922 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.12 142.24 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 107.882 -1.155 . . . . 2.3799999999999999 107.882 166.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -89.1 15.33 8.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.676 1.19 . . . . 4.6500000000000004 114.176 -175.182 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.3 t80 64.98 164.03 0.15 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.278 1.431 . . . . 4.0700000000000003 113.37 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 m -172.6 154.0 2.91 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 127.187 2.195 . . . . 2.7000000000000002 110.973 157.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -87.41 30.51 0.46 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 124.509 3.472 . . . . 2.0 112.08 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.24 178.95 31.6 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.716 1.151 . . . . 1.1699999999999999 114.163 -171.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.48 -21.72 29.76 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.135 3.223 . . . . 1.8100000000000001 113.546 -173.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -88.05 148.73 24.36 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.969 1.307 . . . . 3.0899999999999999 111.932 173.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.46 -178.66 6.55 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.201 1.401 . . . . 1.8400000000000001 111.353 165.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.52 150.64 40.71 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.688 1.595 . . . . 2.0600000000000001 108.702 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.65 143.27 29.72 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.223 1.194 . . . . 2.2599999999999998 114.223 -175.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -111.27 156.22 21.82 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.032 2.133 . . . . 3.7200000000000002 111.276 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -169.59 158.35 7.69 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.597 1.559 . . . . 3.1800000000000002 113.671 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 p -93.18 107.47 19.27 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.007 2.123 . . . . 3.6400000000000001 110.862 173.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.46 139.01 37.77 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.336 1.454 . . . . 4.2400000000000002 109.089 176.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -114.62 160.68 19.03 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.678 1.191 . . . . 5.3899999999999997 112.244 177.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -135.82 109.96 10.12 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 123.687 0.795 . . . . 1.49 109.611 158.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -88.25 -8.45 5.56 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.281 2.654 . . . . 1.5800000000000001 114.951 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.95 178.04 33.13 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 119.783 1.174 . . . . 1.24 112.482 -176.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -93.29 0.57 57.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.546 2.338 . . . . 3.5600000000000001 112.485 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -113.46 156.96 42.58 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 127.33 2.252 . . . . 2.8700000000000001 110.583 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.31 145.56 24.15 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.719 2.279 . . . . 1.0900000000000001 111.183 -176.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.423 HD11 ' CD2' ' A' ' 105' ' ' PHE . 2.9 mm? -107.34 157.7 17.74 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 124.716 1.207 . . . . 3.7400000000000002 110.565 172.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -147.22 110.34 4.79 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 113.459 -1.7 . . . . 3.27 110.677 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.26 112.51 24.07 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.47 1.908 . . . . 3.1499999999999999 109.39 -176.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.4 m -108.62 -20.38 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.956 1.302 . . . . 1.8999999999999999 111.642 -172.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.28 -175.06 28.79 Favored Glycine 0 C--N 1.346 1.088 0 C-N-CA 125.43 1.491 . . . . 0.68000000000000005 113.798 -174.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.66 -177.3 5.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.747 2.019 . . . . 1.5700000000000001 111.241 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -155.85 169.52 24.22 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.327 2.251 . . . . 5.25 109.029 170.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.7 t -175.96 150.96 1.13 Allowed Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 126.92 2.088 . . . . 1.8200000000000001 108.007 173.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.4 -17.65 26.93 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.676 1.584 . . . . 0.89000000000000001 112.734 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.9 m -97.05 52.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.737 1.215 . . . . 1.6899999999999999 112.131 174.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.68 167.33 30.74 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.329 1.051 . . . . 1.8799999999999999 112.203 166.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -102.01 -39.19 7.43 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.851 2.06 . . . . 4.9900000000000002 110.492 162.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -146.04 169.59 18.35 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.378 1.871 . . . . 5.5700000000000003 110.128 169.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.14 145.27 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.586 1.554 . . . . 2.0 108.321 -177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -128.68 151.26 49.72 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.479 1.912 . . . . 3.1600000000000001 108.208 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -103.66 136.91 42.49 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.115 0.87 . . . . 3.0 112.088 160.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -120.74 152.95 37.64 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.707 2.003 . . . . 1.0 112.667 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -97.2 163.25 12.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.374 1.47 . . . . 2.3100000000000001 109.634 162.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.6 m -115.99 143.12 45.88 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.213 -1.403 . . . . 2.3100000000000001 107.213 162.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -139.93 172.14 13.2 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.003 1.112 . . . . 3.6499999999999999 114.003 -173.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 85.7 mtp -113.35 143.7 44.0 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.868 1.667 . . . . 4.4000000000000004 110.99 166.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -146.76 146.97 30.47 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.953 1.701 . . . . 7.9500000000000002 110.441 172.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -94.01 141.97 27.92 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 125.145 1.378 . . . . 2.4300000000000002 110.957 171.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 m -139.59 126.96 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.532 1.133 . . . . 3.3900000000000001 108.917 167.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 64.7 10.86 6.32 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.722 1.609 . . . . 3.7200000000000002 115.062 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.87 26.43 41.64 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 123.907 0.765 . . . . 2.3700000000000001 113.278 -166.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -124.76 123.44 40.0 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.514 1.926 . . . . 4.46 109.045 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.85 121.18 25.09 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.926 0.89 . . . . 6.9400000000000004 111.463 -175.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.6 t -121.64 160.14 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 127.386 2.274 . . . . 3.3599999999999999 108.601 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.7 mtp -121.25 156.56 32.22 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.547 1.539 . . . . 3.5 110.337 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.99 -175.57 26.2 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.203 0.906 . . . . 0.63 113.585 -172.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.1 ttm -153.33 151.05 29.54 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.404 1.882 . . . . 1.73 108.691 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.97 158.08 18.25 Favored Pre-proline 0 N--CA 1.477 0.895 0 CA-C-O 117.736 -1.126 . . . . 6.4800000000000004 111.3 175.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.55 146.26 49.11 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.979 1.786 . . . . 1.29 112.647 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.64 159.51 43.83 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 125.104 1.362 . . . . 2.6499999999999999 110.397 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.74 -30.8 2.19 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.616 2.211 . . . . 1.1599999999999999 112.465 -172.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -179.15 165.28 1.47 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.398 1.879 . . . . 3.3799999999999999 111.148 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt -110.37 152.96 25.61 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.504 1.121 . . . . 1.98 110.216 163.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -110.33 145.71 37.0 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.722 1.209 . . . . 1.78 108.716 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -138.16 127.24 14.62 Favored Pre-proline 0 N--CA 1.473 0.688 0 N-CA-C 112.594 0.59 . . . . 1.79 112.594 169.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.88 159.17 48.79 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.049 3.166 . . . . 1.1499999999999999 112.402 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.47 142.52 95.31 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 124.337 3.358 . . . . 1.21 113.847 -175.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp 64.54 -3.41 0.53 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.646 1.978 . . . . 2.9300000000000002 114.637 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.64 174.58 55.15 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.824 1.678 . . . . 1.28 114.089 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.66 126.4 6.91 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.387 1.475 . . . . 4.7300000000000004 108.963 173.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.9 t -147.32 145.34 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.131 1.772 . . . . 5.0199999999999996 107.836 -163.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.3 142.0 35.84 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.349 -0.844 . . . . 3.79 112.545 -167.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mp -69.55 79.7 0.41 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.891 -1.152 . . . . 2.2000000000000002 107.891 151.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.99 147.1 85.79 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 112.943 0.72 . . . . 5.1699999999999999 112.943 -171.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -57.83 133.41 55.9 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.63 1.553 . . . . 3.6800000000000002 109.13 162.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.58 -12.54 66.17 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 116.637 -2.202 . . . . 2.27 115.657 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.43 -31.67 0.07 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 120.498 2.959 . . . . 2.0499999999999998 120.498 175.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -144.06 139.31 28.88 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.619 2.209 . . . . 3.5499999999999998 112.491 175.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -163.13 153.62 16.3 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.236 -0.29 . . . . 0.92000000000000004 111.345 -176.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -79.48 142.5 35.78 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.596 -0.52 . . . . 4.2300000000000004 109.596 164.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.6 tpt -105.68 127.03 52.82 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 126.334 1.854 . . . . 1.8500000000000001 107.143 165.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -105.63 131.84 52.51 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.116 0.967 . . . . 2.0800000000000001 108.732 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.43 131.93 55.0 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.199 0.999 . . . . 4.6600000000000001 110.367 -175.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.62 47.13 28.45 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.552 1.072 . . . . 0.84999999999999998 114.203 170.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.73 149.31 4.75 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 116.112 1.893 . . . . 2.2400000000000002 116.112 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -104.86 3.91 31.51 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 113.897 -1.502 . . . . 3.0699999999999998 113.67 -171.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.9 mmt-85 -145.2 139.39 15.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 127.928 2.491 . . . . 7.4299999999999997 108.25 167.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -64.14 155.3 65.8 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 N-CA-C 107.659 -1.708 . . . . 1.97 107.659 154.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.3 121.18 17.58 Favored 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 108.058 -1.09 . . . . 3.9700000000000002 108.058 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.441 ' HE2' ' OE1' ' A' ' 97' ' ' GLU 0.299 0.0 OUTLIER -87.64 13.18 10.87 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 116.032 1.864 . . . . 6.21 116.032 -168.998 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 62.81 154.06 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.993 2.917 . . . . 3.1299999999999999 111.495 -163.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.98 51.17 55.57 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 109.839 -1.305 . . . . 1.6699999999999999 109.839 -166.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.441 ' OE1' ' HE2' ' A' ' 94' ' ' LYS . 6.3 mm-40 -116.86 -177.6 3.23 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.761 2.025 . . . . 2.3799999999999999 107.774 173.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -155.66 135.59 12.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.357 1.863 . . . . 3.27 107.744 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -151.23 151.13 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.765 1.626 . . . . 4.3200000000000003 109.661 -177.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.6 150.05 32.81 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.842 1.052 . . . . 2.96 113.842 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mp -125.68 140.96 52.28 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.129 1.772 . . . . 3.0 110.238 169.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.447 ' CG ' ' HZ2' ' A' ' 112' ' ' LYS . 1.1 m-20 -98.67 148.32 23.95 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.95 1.7 . . . . 2.3300000000000001 108.882 164.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.7 mp -120.97 133.62 55.28 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.84 1.256 . . . . 2.4100000000000001 109.679 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.6 mt -110.31 122.65 48.19 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.32 1.448 . . . . 1.8400000000000001 110.3 -174.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.423 ' CD2' HD11 ' A' ' 30' ' ' LEU . 97.9 m-85 -120.03 150.7 40.13 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.995 0.918 . . . . 3.3399999999999999 111.591 -173.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.3 135.83 56.51 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.6 -0.687 . . . . 2.1699999999999999 111.759 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.6 31.53 21.33 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.798 -1.001 . . . . 3.1800000000000002 114.448 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.99 8.78 87.05 Favored Glycine 0 N--CA 1.474 1.233 0 CA-C-N 118.572 1.186 . . . . 1.8 115.984 167.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -88.04 138.2 31.66 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.686 1.243 . . . . 4.5099999999999998 112.006 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.5 p -131.98 145.75 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 125.784 1.634 . . . . 3.1800000000000002 110.103 175.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.4 tt -146.09 121.56 10.35 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.0 0.92 . . . . 3.75 110.67 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.447 ' HZ2' ' CG ' ' A' ' 102' ' ' ASP . 0.1 OUTLIER -90.99 134.67 34.3 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.659 0.784 . . . . 4.1399999999999997 112.867 176.697 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.2 m -120.19 160.7 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.497 1.919 . . . . 3.4500000000000002 110.116 165.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 52.9 t -115.45 132.49 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 107.688 -1.227 . . . . 2.79 107.688 167.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.3 mt -135.81 144.13 47.46 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.206 1.002 . . . . 3.2999999999999998 112.076 -171.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.68 174.42 12.68 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.212 3.275 . . . . 0.81999999999999995 113.054 170.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.1 t -122.42 129.63 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.755 2.022 . . . . 2.0499999999999998 110.127 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.6 167.64 11.14 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.059 2.144 . . . . 3.9900000000000002 110.271 171.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.93 -177.66 4.79 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 116.686 2.106 . . . . 2.6299999999999999 116.686 -159.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.714 0 C-N-CA 127.519 2.328 . . . . 11.77 110.139 148.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.986 0 N-CA-C 110.456 -1.057 . . . . 9.5500000000000007 110.456 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m 93.46 -130.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 128.767 2.827 . . . . 8.2699999999999996 111.39 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -77.06 45.4 0.44 Allowed 'General case' 0 N--CA 1.475 0.8 0 O-C-N 119.898 -1.751 . . . . 11.07 111.387 168.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -174.72 53.64 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.518 1 C-N-CA 131.989 4.116 . . . . 7.9100000000000001 105.35 -162.123 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -154.92 160.48 41.19 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.945 1.698 . . . . 5.3600000000000003 109.311 -172.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.2 -178.84 20.33 Favored Glycine 0 N--CA 1.466 0.661 0 C-N-CA 123.571 0.605 . . . . 1.3200000000000001 113.458 -167.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 23.3 p90 -152.23 154.99 36.87 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.153 0.981 . . . . 2.0800000000000001 112.161 176.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.8 t -90.31 144.8 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.908 1.283 . . . . 2.04 107.989 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -82.26 129.32 34.82 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.285 0.493 . . . . 7.1799999999999997 111.147 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -41.51 133.93 2.46 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.078 2.151 . . . . 2.8799999999999999 112.69 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.5 t -173.99 127.11 0.45 Allowed Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.128 1.771 . . . . 3.2599999999999998 110.587 169.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -88.88 3.12 5.8 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.023 3.149 . . . . 3.3300000000000001 112.457 167.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.74 -172.57 45.3 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.742 1.163 . . . . 1.46 113.041 -173.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.11 -22.7 40.74 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.871 2.381 . . . . 1.52 113.209 -176.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -132.5 167.42 20.01 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.488 1.515 . . . . 2.2400000000000002 114.174 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.48 -174.03 4.69 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 128.658 2.783 . . . . 1.77 110.859 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.35 148.89 32.83 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.273 1.429 . . . . 1.5600000000000001 110.137 173.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.24 145.05 51.76 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.327 1.232 . . . . 1.55 114.327 -173.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -116.78 43.2 2.3 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.723 2.009 . . . . 3.71 112.89 -170.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -68.39 162.06 26.2 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.385 1.254 . . . . 3.02 114.385 -169.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.1 m -94.65 139.61 30.98 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.067 0.947 . . . . 2.9700000000000002 112.821 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.85 127.64 56.08 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.684 1.194 . . . . 3.6899999999999999 110.235 167.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -131.11 136.7 48.61 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.229 1.812 . . . . 3.5699999999999998 106.186 171.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -108.29 93.03 10.57 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 122.601 0.361 . . . . 1.46 110.754 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.5 -12.92 20.54 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.425 2.083 . . . . 1.3 113.159 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.98 -177.29 51.45 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-O 122.352 0.973 . . . . 1.22 112.577 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.455 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 28.5 m-20 -109.94 0.26 18.51 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.969 2.108 . . . . 2.9700000000000002 112.47 -173.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 pp -115.54 159.58 38.0 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 127.701 2.4 . . . . 3.2799999999999998 110.401 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.14 139.5 15.05 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.252 1.968 . . . . 0.93999999999999995 110.799 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.1 mt -93.36 149.02 21.54 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 122.249 1.023 . . . . 2.77 110.478 170.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -137.96 102.15 4.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.805 -1.998 . . . . 3.0899999999999999 111.237 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.5 tp -84.8 104.12 14.48 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.535 1.534 . . . . 2.7200000000000002 109.902 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.3 m -100.03 -21.9 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.003 1.321 . . . . 1.51 112.185 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.45 -177.67 32.75 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.908 1.242 . . . . 0.46999999999999997 114.035 -172.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.34 -179.56 8.05 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.057 1.343 . . . . 1.53 112.581 171.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -158.81 143.06 15.59 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.471 1.908 . . . . 5.6900000000000004 108.083 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.55 149.17 25.49 Favored Pre-proline 0 N--CA 1.481 1.077 0 CA-C-N 121.312 1.869 . . . . 1.8500000000000001 110.647 168.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -62.81 -10.47 20.08 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.67 2.247 . . . . 1.27 114.032 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.55 34.69 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 113.647 0.981 . . . . 2.0699999999999998 113.647 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.63 115.69 1.44 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.111 1.765 . . . . 2.5 108.836 159.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -69.51 -34.8 74.82 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.202 1.186 . . . . 2.8300000000000001 114.202 -175.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -135.58 92.2 2.8 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 107.167 -1.419 . . . . 8.6699999999999999 107.167 -166.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -85.65 166.46 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.95 0.9 . . . . 2.2200000000000002 110.464 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.1 149.96 26.66 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.571 1.948 . . . . 4.4000000000000004 108.229 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.2 tp -121.01 110.83 16.73 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.014 1.279 . . . . 2.1699999999999999 111.09 -171.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 63.4 m170 -121.05 151.11 40.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 123.102 1.429 . . . . 0.83999999999999997 114.316 -170.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -93.41 177.82 5.91 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 113.463 -1.699 . . . . 2.52 111.337 156.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.9 m -146.1 127.47 14.92 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.419 1.888 . . . . 1.8700000000000001 105.989 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -131.37 169.25 16.28 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.073 0.949 . . . . 3.1400000000000001 113.131 -162.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.0 mtt -99.87 141.86 32.12 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.674 1.19 . . . . 4.3200000000000003 110.233 167.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -146.48 176.84 9.5 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.102 1.761 . . . . 6.9900000000000002 111.329 173.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -141.07 138.57 33.68 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.036 1.734 . . . . 2.54 108.547 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.5 m -143.74 144.83 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 127.372 2.269 . . . . 3.3100000000000001 108.028 167.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 56.86 20.79 5.51 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 115.493 1.664 . . . . 3.3999999999999999 115.493 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.31 19.0 77.42 Favored Glycine 0 CA--C 1.537 1.458 0 O-C-N 121.041 -1.037 . . . . 1.6200000000000001 114.056 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -110.47 118.52 36.47 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.916 1.686 . . . . 3.5899999999999999 107.487 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -71.55 118.93 14.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.404 1.082 . . . . 5.6200000000000001 108.349 171.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.09 176.6 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.889 1.675 . . . . 3.3900000000000001 111.188 -172.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 77.0 mtm -127.29 163.65 23.47 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.009 1.323 . . . . 3.4700000000000002 111.275 172.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.69 -176.68 28.13 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.37 1.462 . . . . 0.48999999999999999 112.207 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.0 ttm -147.28 149.57 33.11 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.972 1.309 . . . . 1.5600000000000001 109.489 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -163.1 158.25 18.09 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 124.379 1.072 . . . . 7.1699999999999999 111.948 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.44 151.37 33.16 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.465 2.11 . . . . 0.81999999999999995 113.578 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.76 151.5 64.34 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 125.855 1.662 . . . . 2.0099999999999998 109.944 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.13 -28.93 10.37 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.052 2.501 . . . . 0.95999999999999996 112.161 -174.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -175.51 168.06 3.23 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.456 1.902 . . . . 3.6099999999999999 111.207 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.7 mt -111.18 150.06 30.05 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.888 1.275 . . . . 1.7 110.534 162.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -113.53 141.18 47.45 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.729 1.211 . . . . 1.9399999999999999 108.694 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.6 t -139.16 124.02 11.61 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-O 119.162 -0.447 . . . . 2.27 111.243 166.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.77 162.74 41.11 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.743 2.962 . . . . 0.96999999999999997 111.649 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.02 144.77 99.59 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.67 2.913 . . . . 1.1399999999999999 112.594 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.455 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 12.5 mptt 65.2 -8.67 0.24 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.54 2.336 . . . . 2.9100000000000001 115.157 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.68 166.02 50.29 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.532 1.539 . . . . 1.1100000000000001 112.844 174.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -144.77 144.54 31.23 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.639 1.175 . . . . 6.8399999999999999 110.559 170.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -156.83 125.32 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.496 1.918 . . . . 4.7599999999999998 107.586 -174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -91.79 157.4 16.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.464 0.706 . . . . 4.0099999999999998 111.829 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.79 73.24 0.57 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.725 1.25 . . . . 2.0899999999999999 108.647 164.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -57.02 129.98 79.18 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.183 1.393 . . . . 5.79 111.452 -174.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -58.28 -32.48 96.05 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.797 2.331 . . . . 2.0099999999999998 112.159 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.35 57.62 4.42 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 119.377 -0.679 . . . . 2.5299999999999998 112.078 165.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.31 -11.39 2.02 Favored Glycine 0 N--CA 1.473 1.125 0 N-CA-C 119.685 2.634 . . . . 2.0600000000000001 119.685 158.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -144.39 146.84 32.75 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.995 2.398 . . . . 3.6099999999999999 112.721 171.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -162.21 155.53 20.59 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.047 0.939 . . . . 0.84999999999999998 110.858 172.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -79.33 140.93 37.38 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.543 -0.91 . . . . 2.6699999999999999 108.543 157.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.4 tpt -87.05 132.47 33.8 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.301 1.441 . . . . 1.6799999999999999 107.665 161.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 mp -114.34 119.74 37.99 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.009 -1.108 . . . . 1.8999999999999999 108.009 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.96 148.07 42.56 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.48 0.712 . . . . 2.6699999999999999 109.877 172.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.03 48.58 31.96 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 119.391 -0.672 . . . . 1.0600000000000001 112.28 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pp -61.54 155.56 21.78 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 115.042 1.497 . . . . 2.1600000000000001 115.042 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.34 -4.41 9.92 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 114.062 -1.426 . . . . 3.1000000000000001 114.107 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -115.83 114.78 41.66 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 106.442 -1.688 . . . . 5.7599999999999998 106.442 152.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.62 122.2 9.36 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 N-CA-C 105.38 -2.585 . . . . 2.7799999999999998 105.38 158.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.2 mt -87.15 178.06 7.01 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 124.576 2.132 . . . . 3.25 112.821 -152.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -127.82 -169.62 2.09 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 129.329 3.052 . . . . 5.1600000000000001 109.929 169.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.0 155.58 17.04 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 106.635 -1.617 . . . . 2.6699999999999999 106.635 146.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.65 1.98 89.51 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.435 -1.203 . . . . 1.6399999999999999 115.771 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -78.72 -176.21 4.8 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.579 1.689 . . . . 2.3399999999999999 110.289 159.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -155.09 149.88 26.6 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 128.285 2.634 . . . . 3.3700000000000001 107.122 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.1 t -145.65 122.22 3.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 125.909 1.684 . . . . 2.1299999999999999 109.325 -166.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.41 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 4.9 pt-20 -81.51 154.5 26.26 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.788 0.804 . . . . 2.46 112.251 167.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.6 tt -154.97 132.67 11.36 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.263 1.425 . . . . 4.4699999999999998 111.023 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.47 130.4 36.97 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.76 2.424 . . . . 2.9100000000000001 108.509 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.0 mp -100.74 119.56 38.8 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.421 1.088 . . . . 2.29 109.219 175.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 86.4 mt -87.41 108.71 19.12 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.812 0.815 . . . . 2.1800000000000002 109.734 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -104.53 116.58 32.34 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.409 1.483 . . . . 3.48 111.048 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 54.36 24.78 5.39 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.006 1.722 . . . . 2.7999999999999998 113.392 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.72 -59.37 2.11 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.962 1.744 . . . . 4.7999999999999998 112.867 -171.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -84.55 9.21 65.57 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 116.399 1.32 . . . . 2.3799999999999999 116.399 -167.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -136.66 152.53 50.51 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.296 1.838 . . . . 5.7199999999999998 111.967 171.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.5 p -148.47 147.14 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 125.069 1.348 . . . . 3.3700000000000001 111.158 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.4 tp -156.33 132.86 10.15 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.263 1.825 . . . . 3.71 108.281 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.41 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 62.5 pttt -96.53 146.61 24.65 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.908 1.447 . . . . 2.9300000000000002 114.908 176.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.7 t -130.2 168.1 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 126.986 2.114 . . . . 3.6699999999999999 108.268 175.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 t -130.88 147.27 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.6 1.56 . . . . 3.0600000000000001 108.431 -171.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.92 146.2 17.85 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.892 1.277 . . . . 3.0600000000000001 110.976 -177.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.51 164.31 29.23 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.4 3.4 . . . . 0.89000000000000001 112.394 172.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.2 t -105.54 135.97 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.151 1.38 . . . . 2.3300000000000001 108.768 165.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -147.3 164.03 34.54 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.653 1.181 . . . . 3.5 111.503 -175.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.67 -176.27 3.23 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 127.228 2.211 . . . . 2.9199999999999999 115.699 -160.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.44 ' C ' HH11 ' A' ' 120' ' ' ARG . 11.0 tpt85 . . . . . 0 N--CA 1.48 1.069 0 C-N-CA 127.65 2.38 . . . . 9.2400000000000002 113.243 -175.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.172 0 N-CA-C 106.952 -2.459 . . . . 11.289999999999999 106.952 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 m -55.7 127.86 32.01 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 116.906 -1.918 . . . . 11.42 106.564 126.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -79.79 123.27 27.56 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.202 0.815 . . . . 12.69 113.202 -158.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.0 t -170.23 42.93 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.813 2.445 . . . . 7.25 110.249 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -128.26 178.43 6.26 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.849 2.06 . . . . 5.1699999999999999 108.567 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -94.65 -177.11 38.44 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 123.58 0.61 . . . . 1.3999999999999999 114.429 -170.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -144.55 154.34 42.77 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.095 1.146 . . . . 2.54 114.095 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.58 135.9 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.537 -0.912 . . . . 1.9099999999999999 108.537 170.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -70.56 -10.95 60.52 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.956 1.836 . . . . 4.5099999999999998 115.956 -162.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 63.82 169.82 0.16 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.078 1.351 . . . . 3.3500000000000001 111.723 -170.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -166.77 162.99 11.1 Favored Pre-proline 0 CA--C 1.542 0.644 0 O-C-N 120.773 -1.205 . . . . 2.8199999999999998 112.221 160.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -85.09 11.45 3.37 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.248 3.299 . . . . 2.7999999999999998 112.823 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -150.37 -165.69 12.86 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 124.451 1.024 . . . . 1.1000000000000001 115.368 -170.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -80.58 -20.43 8.05 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.625 3.55 . . . . 1.46 115.06 -169.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -99.39 164.79 11.96 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.955 1.302 . . . . 2.8799999999999999 112.98 169.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.63 -177.02 6.27 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.792 2.437 . . . . 1.6499999999999999 111.077 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.72 165.71 26.27 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.552 2.341 . . . . 1.51 108.47 173.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.85 156.34 37.43 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.265 1.209 . . . . 1.72 114.265 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -140.66 143.59 35.21 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.443 1.897 . . . . 3.6299999999999999 110.325 -173.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.417 ' HA ' ' HA3' ' A' ' 6' ' ' GLY 0.263 0.0 OUTLIER -163.39 166.83 22.46 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.676 1.19 . . . . 3.6600000000000001 113.45 -177.723 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.6 m -91.78 123.62 35.3 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 127.255 2.222 . . . . 2.8100000000000001 109.373 -174.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.3 126.72 46.66 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.707 -0.849 . . . . 3.96 108.707 165.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -126.2 120.78 30.93 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.469 -1.308 . . . . 3.9100000000000001 107.469 161.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -92.45 115.49 64.87 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.464 -0.779 . . . . 1.48 108.94 170.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -87.98 -9.79 5.26 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.318 2.678 . . . . 1.45 114.822 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.52 159.39 27.09 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 119.65 1.114 . . . . 1.6000000000000001 111.914 -175.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.81 7.61 6.79 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 128.346 2.658 . . . . 3.7000000000000002 112.485 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -125.92 150.24 68.43 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 128.592 2.757 . . . . 2.7999999999999998 109.367 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.44 149.52 27.53 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.852 2.368 . . . . 1.0600000000000001 111.306 -171.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.2 mt -102.75 153.19 20.39 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 122.809 1.29 . . . . 2.5899999999999999 110.431 164.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 ttp-105 -140.21 103.14 4.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.197 -1.82 . . . . 3.71 110.45 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.5 tt -80.38 113.62 18.7 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 109.13 -0.693 . . . . 3.46 109.13 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -104.31 -20.15 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.385 1.074 . . . . 1.71 111.771 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.05 -176.24 30.87 Favored Glycine 0 C--N 1.343 0.956 0 C-N-CA 124.808 1.194 . . . . 0.57999999999999996 114.71 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.5 -177.61 6.18 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.182 1.393 . . . . 1.6100000000000001 111.884 174.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -156.2 176.71 12.32 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.896 2.479 . . . . 5.0899999999999999 107.261 163.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -167.87 151.41 5.88 Favored Pre-proline 0 N--CA 1.466 0.329 0 C-N-CA 128.348 2.659 . . . . 1.75 106.9 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.95 -5.22 16.64 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.386 2.058 . . . . 1.1299999999999999 113.108 174.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.61 49.24 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.632 1.173 . . . . 1.79 113.501 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.99 151.67 14.44 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.492 0.717 . . . . 1.8300000000000001 112.374 163.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.494 ' CD ' ' HZ2' ' A' ' 90' ' ' LYS . 1.2 tp10 -89.73 -44.25 10.14 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.069 1.747 . . . . 3.0600000000000001 110.951 168.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -114.15 130.79 56.59 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.193 1.797 . . . . 6.4900000000000002 108.255 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -109.14 149.81 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.322 -0.992 . . . . 1.9299999999999999 108.322 154.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -134.06 148.67 51.08 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.606 1.562 . . . . 2.9100000000000001 108.369 171.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.4 tp -100.98 118.65 37.41 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.637 -0.505 . . . . 2.0800000000000001 109.637 175.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 48.1 m170 -119.92 162.5 19.07 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 123.819 1.771 . . . . 0.69999999999999996 113.284 -177.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -110.99 153.2 25.89 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 112.889 -1.959 . . . . 2.8300000000000001 112.055 155.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.0 m -109.67 152.39 25.65 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 106.251 -1.759 . . . . 1.9199999999999999 106.251 160.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -149.88 171.49 16.69 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.174 0.99 . . . . 3.4199999999999999 111.771 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 57.3 ttm -102.06 143.39 31.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.726 1.21 . . . . 4.8700000000000001 109.566 168.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.32 157.56 43.19 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.875 1.27 . . . . 5.1399999999999997 111.369 -172.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.92 176.38 8.73 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.129 1.372 . . . . 3.5899999999999999 114.599 178.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.0 p 159.76 123.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 1 C-N-CA 132.334 4.254 . . . . 4.9199999999999999 106.974 -164.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 64.63 9.93 5.53 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 117.248 2.314 . . . . 3.1499999999999999 117.248 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.77 7.34 60.11 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 120.745 -1.222 . . . . 2.3700000000000001 113.28 -171.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -112.37 100.84 9.1 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.24 1.816 . . . . 3.4100000000000001 109.213 -162.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -79.49 114.34 18.34 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.194 -0.941 . . . . 4.6600000000000001 108.995 -173.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.1 t -126.82 133.52 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.169 1.788 . . . . 3.8999999999999999 108.769 -173.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 60.2 mtm -88.25 128.17 35.47 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.82 0.848 . . . . 4.25 110.688 175.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.72 177.71 16.5 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 124.957 1.265 . . . . 0.63 112.631 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.6 ttm -157.52 137.66 12.61 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.589 1.155 . . . . 1.6100000000000001 111.974 -172.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -146.81 150.01 38.05 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.864 1.666 . . . . 9.9499999999999993 111.038 -177.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.56 151.8 53.26 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.38 2.053 . . . . 0.75 110.12 169.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.78 154.75 76.61 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 125.293 1.437 . . . . 2.0699999999999998 110.638 -175.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.66 -25.9 4.15 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.2 2.6 . . . . 0.66000000000000003 113.189 -166.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -177.77 161.68 1.65 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.144 1.778 . . . . 3.2599999999999998 111.433 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.69 153.83 22.88 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.429 1.492 . . . . 1.9399999999999999 109.62 163.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -105.52 152.36 23.14 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.929 0.891 . . . . 1.8600000000000001 110.685 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.3 124.01 13.62 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 123.301 0.64 . . . . 2.54 110.263 163.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.35 165.03 31.88 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.181 2.587 . . . . 1.0600000000000001 111.181 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.92 138.85 76.23 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.516 2.144 . . . . 1.3200000000000001 112.848 175.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.26 15.3 mtmt 57.66 36.82 27.07 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.355 1.462 . . . . 3.96 113.606 171.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.29 140.06 11.48 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.561 2.029 . . . . 1.27 114.84 -172.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.1 ttt85 -87.52 138.11 31.75 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.851 2.06 . . . . 5.21 110.439 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.5 t -148.93 142.58 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 127.421 2.288 . . . . 3.96 107.313 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -142.35 147.5 36.39 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 120.537 1.517 . . . . 4.2599999999999998 113.463 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mp -82.59 168.08 17.68 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.044 2.138 . . . . 2.5800000000000001 111.168 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -169.82 157.9 6.5 Favored Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 125.868 1.667 . . . . 3.4100000000000001 113.667 -176.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.18 -47.24 15.38 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 124.19 3.26 . . . . 3.3399999999999999 113.254 176.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.02 36.11 1.47 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.851 1.215 . . . . 1.8899999999999999 113.66 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.3 -134.1 2.51 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 125.107 1.337 . . . . 1.6100000000000001 113.456 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -71.05 136.63 48.41 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.897 -0.766 . . . . 3.25 111.658 -169.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.5 p-80 -162.08 154.68 19.81 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.826 1.25 . . . . 0.80000000000000004 112.465 -170.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -84.32 146.57 27.66 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.855 -0.528 . . . . 4.0099999999999998 109.753 168.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.6 tpt -100.4 136.51 40.17 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.739 1.216 . . . . 1.76 108.9 162.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.5 mp -118.59 139.87 50.8 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.032 1.333 . . . . 1.74 109.148 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mp -140.2 146.63 38.95 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.693 0.797 . . . . 2.7599999999999998 110.699 171.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.59 37.09 24.46 Favored Glycine 0 N--CA 1.473 1.106 0 O-C-N 122.073 -0.392 . . . . 1.1100000000000001 112.904 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.27 146.12 9.8 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.856 1.662 . . . . 2.1400000000000001 115.467 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.494 ' HZ2' ' CD ' ' A' ' 41' ' ' GLU . 74.0 mmtt -109.1 -23.49 11.62 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 113.646 -1.615 . . . . 2.7799999999999998 113.255 -168.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -97.61 142.67 24.92 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.056 0.942 . . . . 6.7999999999999998 109.19 158.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.69 79.54 3.32 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.279 2.652 . . . . 2.5 109.439 173.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 72.8 mt -42.63 122.93 2.46 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 127.604 2.362 . . . . 3.1299999999999999 115.13 -167.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -119.97 156.8 30.13 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 127.078 2.151 . . . . 7.1200000000000001 113.357 165.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.26 135.98 56.75 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.784 -1.098 . . . . 2.48 108.435 171.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.13 1.56 72.39 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.052 1.31 . . . . 1.78 115.117 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -74.97 -173.09 1.81 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.012 1.406 . . . . 2.3700000000000001 112.834 169.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -139.05 125.52 20.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.99 3.316 . . . . 5.0999999999999996 105.354 -165.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.2 t -145.18 128.42 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 O-C-N 121.298 -0.876 . . . . 2.1299999999999999 110.957 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.526 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 43.1 mt-10 -78.82 143.58 35.87 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.421 -0.809 . . . . 2.48 110.658 169.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mp -118.27 134.33 55.12 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.876 0.871 . . . . 2.6600000000000001 109.569 156.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -93.44 139.4 30.75 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.185 2.594 . . . . 2.7799999999999998 108.355 169.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.4 mp -118.43 129.02 55.16 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.729 1.612 . . . . 1.9099999999999999 109.743 -173.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.8 mt -106.28 114.81 29.16 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.371 1.468 . . . . 1.99 110.518 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -112.24 115.06 28.2 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.067 1.347 . . . . 3.2000000000000002 111.841 -172.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 48.53 26.94 1.3 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.519 1.928 . . . . 3.0299999999999998 114.223 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.33 -59.49 4.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.42 1.486 . . . . 4.4000000000000004 112.861 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.63 3.42 68.79 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 116.987 1.555 . . . . 2.21 116.987 -165.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -136.1 143.36 44.54 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.702 1.751 . . . . 4.3200000000000003 112.519 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.4 t -134.34 147.43 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.473 1.509 . . . . 3.3999999999999999 109.659 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -153.78 166.52 32.62 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.936 2.494 . . . . 3.1000000000000001 108.094 175.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.526 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 54.9 pttt -144.35 160.55 40.85 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.878 1.217 . . . . 2.71 113.679 171.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.66 158.21 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.525 1.53 . . . . 3.46 108.886 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.5 p -114.63 132.72 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.325 1.05 . . . . 3.7400000000000002 110.003 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -124.93 148.89 61.32 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 126.975 2.11 . . . . 4.29 108.713 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.15 161.73 44.9 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.742 2.295 . . . . 0.85999999999999999 111.775 162.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.4 t -96.59 137.61 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.847 0.859 . . . . 2.1099999999999999 109.41 168.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.54 141.31 29.4 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.884 1.674 . . . . 3.8199999999999998 111.036 177.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -95.39 86.35 4.48 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.674 1.189 . . . . 2.7599999999999998 112.051 -169.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 . . . . . 0 C--O 1.246 0.881 0 C-N-CA 124.87 1.268 . . . . 8.9800000000000004 111.153 -173.934 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.355 0 N-CA-C 108.503 -1.839 . . . . 15.710000000000001 108.503 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.0 m -145.42 147.48 32.27 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.68 1.24 . . . . 11.039999999999999 110.365 -169.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -143.14 143.08 31.67 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.971 0.908 . . . . 11.48 111.126 -173.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.8 t -135.79 -10.99 2.06 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.757 1.623 . . . . 6.1699999999999999 112.753 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -99.54 171.72 7.76 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.415 1.486 . . . . 6.2199999999999998 112.231 174.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.0 -177.54 23.26 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.809 1.671 . . . . 1.28 111.714 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -148.98 157.61 43.55 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 115.351 1.611 . . . . 2.25 115.351 -173.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.0 t -92.89 134.73 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.958 1.303 . . . . 2.6600000000000001 108.631 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.9 tpp85 -69.16 118.87 12.6 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.144 0.977 . . . . 5.5999999999999996 111.872 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -66.64 142.32 57.5 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.87 1.268 . . . . 2.73 111.414 162.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -174.48 161.48 2.7 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 126.451 1.9 . . . . 3.73 110.684 170.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -84.55 38.2 0.67 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.998 3.132 . . . . 2.4900000000000002 112.122 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.85 151.52 18.21 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 124.942 1.258 . . . . 1.46 115.122 -165.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.29 -22.11 14.65 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.253 2.635 . . . . 1.53 111.841 166.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -105.99 158.58 16.69 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 127.272 2.229 . . . . 2.96 112.072 165.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.38 -171.79 3.92 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.027 2.131 . . . . 1.9199999999999999 110.752 -173.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.34 159.86 43.58 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.188 1.395 . . . . 1.7 109.707 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.75 131.21 37.3 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.65 1.114 . . . . 1.75 112.778 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -123.0 81.96 1.94 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.664 1.986 . . . . 4.0899999999999999 110.28 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -92.24 158.08 16.33 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.664 1.186 . . . . 2.7999999999999998 113.923 -173.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.7 m -119.89 144.33 47.46 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.725 1.61 . . . . 2.7000000000000002 108.443 162.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.9 tp -158.57 171.7 19.65 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.574 2.75 . . . . 5.6900000000000004 107.517 173.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -136.23 144.75 45.02 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 120.391 -1.443 . . . . 4.4199999999999999 108.382 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -97.59 106.7 34.82 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 125.381 1.472 . . . . 1.3999999999999999 109.493 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -81.62 -7.3 12.59 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.731 2.287 . . . . 1.4399999999999999 114.083 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.64 168.5 54.78 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-O 123.108 1.393 . . . . 1.4399999999999999 113.228 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.463 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 16.6 m-20 -101.44 -2.38 30.94 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 128.606 2.763 . . . . 3.0499999999999998 111.648 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 pp -117.03 159.16 42.12 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 127.665 2.386 . . . . 3.02 110.342 171.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.87 138.07 12.95 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.873 2.382 . . . . 1.1399999999999999 111.025 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.55 156.68 16.33 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 123.185 1.469 . . . . 3.46 111.834 176.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -152.01 98.26 2.42 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.104 -1.862 . . . . 3.8700000000000001 110.246 -164.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.4 tt -85.59 115.75 23.47 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.945 1.698 . . . . 3.6099999999999999 107.403 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.93 -16.39 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.202 1.001 . . . . 1.6899999999999999 111.969 -174.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.18 -176.53 31.34 Favored Glycine 0 C--N 1.342 0.881 0 C-N-CA 125.887 1.708 . . . . 0.65000000000000002 113.392 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -153.74 178.03 10.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.39 1.476 . . . . 1.6899999999999999 112.785 166.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -151.42 159.04 44.42 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 129.622 3.169 . . . . 5.4699999999999998 108.568 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 t -173.79 152.23 1.97 Allowed Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 128.111 2.565 . . . . 1.6499999999999999 107.229 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.92 -15.88 20.71 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.688 1.592 . . . . 1.1399999999999999 113.513 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.12 32.54 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.319 1.047 . . . . 1.8200000000000001 112.326 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.93 140.12 17.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.608 0.763 . . . . 1.6000000000000001 109.395 165.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -85.93 -33.89 21.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.038 1.335 . . . . 3.79 110.847 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -139.06 144.45 38.79 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.066 2.146 . . . . 8.0 106.597 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.2 p -135.92 146.84 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.109 1.364 . . . . 2.25 109.338 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.449 ' CD ' ' HE2' ' A' ' 46' ' ' HIS . 13.5 tt0 -135.49 146.97 48.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.755 2.022 . . . . 3.9900000000000002 108.781 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.8 tp -109.12 115.65 30.45 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.697 1.135 . . . . 2.1499999999999999 111.1 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.449 ' HE2' ' CD ' ' A' ' 44' ' ' GLU . 65.6 m170 -116.4 154.65 29.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.497 1.519 . . . . 1.03 113.923 -175.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' CD ' ' HD2' ' A' ' 62' ' ' ARG . 6.5 pt-20 -95.86 179.86 4.95 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.806 1.243 . . . . 2.21 111.442 159.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 84.1 m -137.69 134.81 35.83 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.351 -1.352 . . . . 2.04 107.351 164.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -129.7 163.81 25.33 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.165 1.172 . . . . 3.4399999999999999 114.165 -168.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -106.5 150.22 26.32 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.458 1.503 . . . . 4.5800000000000001 111.4 167.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.67 157.66 35.59 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.055 0.942 . . . . 5.0199999999999996 111.217 -168.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.467 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS . 2.5 tp10 -110.32 146.83 35.05 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.174 1.79 . . . . 2.7200000000000002 108.415 167.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.2 129.42 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 107.748 -1.205 . . . . 4.1200000000000001 107.748 161.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 61.97 32.99 17.61 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.161 0.984 . . . . 4.5300000000000002 112.298 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.73 8.69 82.14 Favored Glycine 0 CA--C 1.536 1.384 0 O-C-N 120.575 -1.328 . . . . 2.02 114.019 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -121.11 129.63 53.38 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.391 1.876 . . . . 3.6800000000000002 109.174 -172.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.467 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 2.9 mmtt -69.34 134.9 49.64 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.992 2.117 . . . . 4.9400000000000004 109.492 -176.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.5 p -146.36 170.79 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 125.895 1.678 . . . . 3.9700000000000002 109.835 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 32.2 mtm -131.85 159.32 38.91 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.768 1.627 . . . . 3.3199999999999998 110.684 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.13 -174.9 27.43 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.924 1.25 . . . . 0.90000000000000002 113.956 -173.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.3 ttm -155.74 145.69 21.42 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.169 1.787 . . . . 1.8100000000000001 108.565 -174.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.416 ' HD2' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -162.46 154.0 15.33 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.573 1.149 . . . . 6.1500000000000004 111.59 -178.159 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.79 157.53 35.28 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.143 1.896 . . . . 0.62 112.976 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.34 156.78 67.18 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 126.487 1.915 . . . . 1.8700000000000001 110.211 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.5 -21.82 4.13 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.743 2.962 . . . . 0.77000000000000002 113.892 -169.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -177.0 164.61 2.3 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.626 1.97 . . . . 3.3399999999999999 110.368 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.9 mt -110.31 153.44 24.88 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.342 1.057 . . . . 2.0600000000000001 109.962 166.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -122.07 146.52 47.12 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.466 1.106 . . . . 2.6600000000000001 110.875 174.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.1 t -140.13 131.42 14.29 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.898 1.279 . . . . 1.8899999999999999 109.756 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.46 166.27 27.8 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.115 2.543 . . . . 1.0600000000000001 112.182 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -58.41 139.85 92.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.164 2.576 . . . . 1.3300000000000001 111.235 171.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.463 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 61.3 mmtt 65.1 3.96 2.37 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.977 1.311 . . . . 2.3300000000000001 113.286 -175.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.11 176.54 53.08 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 127.107 2.289 . . . . 1.4299999999999999 114.73 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 -98.66 129.98 45.16 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.441 1.496 . . . . 4.3499999999999996 112.84 -174.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.8 t -108.12 57.59 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.63 1.572 . . . . 7.0899999999999999 108.947 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -101.65 127.6 48.32 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.038 0.935 . . . . 3.1600000000000001 109.331 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.7 mp -67.82 -37.43 81.92 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.247 1.019 . . . . 3.1000000000000001 111.219 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.2 tptt 91.91 126.35 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 127.176 2.19 . . . . 4.8899999999999997 111.385 171.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.82 29.38 0.21 Allowed 'Trans proline' 0 CA--C 1.551 1.338 0 C-N-CA 125.027 3.818 . . . . 2.8700000000000001 115.037 -177.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.03 26.13 0.03 OUTLIER Glycine 0 CA--C 1.539 1.532 0 C-N-CA 127.05 2.262 . . . . 2.4700000000000002 115.284 -174.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.28 -29.59 0.02 OUTLIER Glycine 0 N--CA 1.481 1.683 0 N-CA-C 119.208 2.443 . . . . 2.2999999999999998 119.208 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -142.23 151.24 41.92 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.493 1.517 . . . . 3.6499999999999999 111.422 159.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -163.2 157.3 20.27 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.797 -1.189 . . . . 0.91000000000000003 111.998 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -78.43 139.55 38.73 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.073 -0.651 . . . . 4.0999999999999996 109.397 161.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -91.72 131.02 37.4 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.773 1.629 . . . . 1.79 108.116 159.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 mp -113.64 143.29 44.83 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.973 1.309 . . . . 2.02 109.071 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mt -137.96 139.4 39.71 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.239 1.016 . . . . 3.3399999999999999 111.355 -176.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.57 38.84 36.58 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.924 -0.931 . . . . 0.93000000000000005 113.897 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.61 150.89 0.91 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 117.17 2.285 . . . . 2.29 117.17 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -115.76 -13.28 11.41 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 113.746 -1.57 . . . . 3.5699999999999998 114.269 -172.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -119.57 154.26 54.46 Favored Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 125.954 1.702 . . . . 6.7300000000000004 108.902 168.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -70.66 149.3 60.93 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.662 2.241 . . . . 2.9700000000000002 110.067 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.5 mt -89.54 115.06 26.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 122.87 1.319 . . . . 4.2000000000000002 107.672 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -116.65 172.02 7.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.621 -1.627 . . . . 5.4199999999999999 110.473 169.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.45 136.79 39.41 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.832 -1.544 . . . . 2.77 106.832 145.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.1 45.24 9.09 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 123.161 0.41 . . . . 2.1299999999999999 113.721 174.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -111.64 177.71 4.56 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.35 0.575 . . . . 2.8199999999999998 110.775 148.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -146.35 134.81 21.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.1 2.16 . . . . 3.3599999999999999 108.146 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.8 t -139.49 136.09 40.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 127.768 2.427 . . . . 2.4300000000000002 109.636 -160.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -84.11 145.74 28.26 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.754 0.787 . . . . 3.0800000000000001 112.808 173.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mp -121.79 146.83 46.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.907 2.083 . . . . 2.8900000000000001 109.862 163.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -117.91 111.62 19.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.379 2.272 . . . . 2.3100000000000001 107.844 168.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.3 mp -83.0 140.23 32.84 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.864 0.866 . . . . 2.1299999999999999 109.352 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.8 mt -105.23 109.38 21.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.454 1.102 . . . . 1.8 110.098 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -97.63 150.52 21.06 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.758 1.223 . . . . 3.2599999999999998 111.117 172.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.43 126.62 22.02 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.287 1.435 . . . . 1.97 113.487 -169.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.43 49.0 6.98 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.086 -0.841 . . . . 2.6899999999999999 112.649 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.17 12.1 84.36 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 116.174 1.23 . . . . 2.6499999999999999 116.174 165.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -92.14 102.99 15.52 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.333 1.567 . . . . 4.7599999999999998 111.128 -168.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.3 p -93.18 139.45 18.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 O-C-N 124.603 1.19 . . . . 3.2599999999999998 111.818 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 123.39 19.95 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.467 0.707 . . . . 3.7799999999999998 111.514 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -89.84 129.51 36.21 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.273 1.429 . . . . 2.8300000000000001 111.473 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.18 143.97 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.952 1.301 . . . . 2.9399999999999999 109.935 168.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.0 p -112.77 134.89 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.358 1.063 . . . . 3.71 110.023 176.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 mp -138.87 148.71 59.11 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.967 1.307 . . . . 4.04 110.535 -167.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.66 153.12 79.09 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.468 2.112 . . . . 1.04 111.934 169.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.31 120.95 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.012 -1.477 . . . . 2.48 107.012 165.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -153.46 165.66 35.13 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 122.805 1.288 . . . . 5.3499999999999996 113.703 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.29 155.5 28.48 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.75 -1.114 . . . . 3.27 113.859 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.168 0 C-N-CA 131.248 3.819 . . . . 8.5999999999999996 107.374 157.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.401 0 N-CA-C 108.805 -1.718 . . . . 13.0 108.805 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 p -88.72 -32.6 17.86 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.714 1.257 . . . . 13.07 114.235 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -140.01 163.37 32.87 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.455 1.102 . . . . 11.109999999999999 111.674 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.9 t -135.34 20.06 3.39 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.702 2.001 . . . . 6.1299999999999999 111.586 169.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -99.98 171.69 7.69 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.029 1.731 . . . . 6.4000000000000004 109.751 175.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.06 176.17 19.43 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.565 -1.014 . . . . 1.3200000000000001 110.565 170.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -155.58 -178.65 7.43 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.387 0.613 . . . . 2.1099999999999999 112.568 -176.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.8 t -112.88 134.69 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.112 1.765 . . . . 2.4700000000000002 109.184 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -21.79 38.5 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.082 1.512 . . . . 6.5800000000000001 115.082 -172.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 82.9 t80 69.99 146.98 0.06 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 128.884 2.874 . . . . 3.5 113.792 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.3 m -170.93 154.81 4.36 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.79 2.036 . . . . 3.0899999999999999 111.886 173.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -82.68 -24.6 3.4 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.75 2.967 . . . . 2.1699999999999999 112.865 169.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.08 148.54 24.47 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 109.843 -1.303 . . . . 2.3100000000000001 109.843 166.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.87 -38.9 9.16 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.974 2.449 . . . . 3.3300000000000001 114.523 -163.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -80.03 139.51 36.93 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 123.352 1.549 . . . . 4.4000000000000004 112.779 -175.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.8 -175.31 5.31 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.341 1.457 . . . . 1.8799999999999999 112.502 -156.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.86 156.83 43.81 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.997 1.719 . . . . 1.79 109.932 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.4 143.92 39.99 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.175 0.805 . . . . 1.8600000000000001 113.175 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.458 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 31.0 m-85 -125.53 75.45 1.48 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.408 1.883 . . . . 3.6299999999999999 110.918 -168.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.83 162.92 28.6 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.816 -1.178 . . . . 2.8399999999999999 113.965 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 68.3 m -121.1 141.64 50.6 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.386 1.075 . . . . 2.6299999999999999 109.223 157.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.64 -179.35 7.53 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 128.473 2.709 . . . . 6.2999999999999998 107.776 175.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -138.89 157.36 46.19 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.16 -0.963 . . . . 3.8700000000000001 111.847 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -103.65 95.11 6.91 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 126.072 1.749 . . . . 1.3700000000000001 109.469 165.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.0 -3.94 12.47 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.009 2.473 . . . . 1.3400000000000001 114.337 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.26 160.41 31.9 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-O 122.456 1.031 . . . . 1.4099999999999999 111.759 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -87.23 10.02 18.36 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.815 2.446 . . . . 3.8999999999999999 112.179 175.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -116.01 152.88 48.14 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 128.812 2.845 . . . . 3.0099999999999998 109.744 171.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.38 153.58 24.11 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.22 2.614 . . . . 0.92000000000000004 111.489 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.9 mt -111.8 146.9 36.83 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 123.296 1.522 . . . . 2.6499999999999999 111.774 167.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -133.85 103.63 5.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 112.263 -2.244 . . . . 3.1099999999999999 110.04 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -82.7 109.73 17.13 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.185 1.394 . . . . 3.73 108.296 -174.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 m -105.65 -22.04 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.305 1.042 . . . . 1.51 111.908 -172.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.15 -176.72 31.52 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 125.279 1.419 . . . . 0.47999999999999998 113.737 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.27 179.16 9.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.263 1.425 . . . . 1.6899999999999999 111.679 168.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -146.19 174.33 11.42 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.783 2.033 . . . . 6.46 108.998 164.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 t -170.86 149.53 2.84 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 127.721 2.409 . . . . 1.7 108.149 175.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.91 -3.66 14.13 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.746 2.298 . . . . 1.1200000000000001 113.682 176.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 m -121.74 57.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.843 1.257 . . . . 2.2400000000000002 112.339 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.09 173.83 16.13 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.544 1.138 . . . . 1.8799999999999999 112.005 162.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.431 ' CD ' ' HZ1' ' A' ' 90' ' ' LYS . 4.1 tp10 -114.87 -51.95 2.72 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.277 1.831 . . . . 2.7200000000000002 109.446 165.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -101.66 132.13 47.52 Favored 'General case' 0 C--N 1.342 0.243 0 O-C-N 121.319 -0.863 . . . . 6.0999999999999996 109.489 161.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -97.06 150.65 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.108 -0.951 . . . . 2.1000000000000001 108.458 140.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -136.17 154.02 51.09 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.1 1.76 . . . . 3.0 109.013 169.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.8 tp -110.66 117.31 33.14 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.364 0.665 . . . . 2.0800000000000001 111.235 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -125.29 149.34 48.15 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.784 1.234 . . . . 0.78000000000000003 114.177 -172.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.409 ' CD ' HH21 ' A' ' 62' ' ' ARG . 19.9 pt-20 -87.51 169.92 11.78 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.507 1.923 . . . . 2.5699999999999998 112.15 163.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.407 ' HG1' ' C ' ' A' ' 47' ' ' GLU . 52.1 m -148.25 146.16 28.52 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 106.711 -1.589 . . . . 2.1299999999999999 106.711 173.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -157.99 163.09 38.12 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.116 1.154 . . . . 3.6600000000000001 114.116 -170.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.6 ttp -91.53 148.85 21.99 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.49 1.116 . . . . 3.8100000000000001 109.346 161.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.09 167.18 30.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.285 1.834 . . . . 5.1699999999999999 110.258 -170.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.455 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS . 2.9 tp10 -124.53 135.21 52.99 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.586 1.554 . . . . 2.5 110.553 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 t -136.8 120.33 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.035 -0.728 . . . . 3.0499999999999998 109.035 165.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.488 ' CD ' ' HZ2' ' A' ' 56' ' ' LYS . 3.7 mt-10 65.96 26.25 10.97 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.757 2.023 . . . . 3.1699999999999999 112.962 -176.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.25 10.71 85.77 Favored Glycine 0 CA--C 1.536 1.364 0 O-C-N 120.218 -1.551 . . . . 2.1099999999999999 113.366 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.488 ' HZ2' ' CD ' ' A' ' 54' ' ' GLU . 8.6 mtmp? -110.25 116.46 31.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.796 1.638 . . . . 4.2300000000000004 110.355 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.506 ' H ' ' HE2' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -58.66 129.25 41.2 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.961 2.104 . . . . 4.7699999999999996 110.407 174.354 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.8 p -156.72 146.01 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.369 1.867 . . . . 3.3399999999999999 109.752 -174.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.21 161.16 14.07 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.765 0.826 . . . . 4.4000000000000004 111.882 -174.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.44 -179.47 30.59 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 123.976 0.798 . . . . 0.68000000000000005 114.294 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.8 ttm -159.92 148.48 17.31 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.675 1.99 . . . . 1.79 109.09 -173.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.409 HH21 ' CD ' ' A' ' 47' ' ' GLU . 19.1 mtm105 -150.69 156.01 36.05 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.545 1.538 . . . . 5.9800000000000004 109.993 178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -77.05 152.94 31.96 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.03 1.82 . . . . 0.67000000000000004 110.82 168.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.3 m -139.1 151.85 68.67 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.897 1.279 . . . . 1.98 110.542 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.39 -24.01 11.08 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.27 2.647 . . . . 0.78000000000000003 112.624 -170.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -173.04 172.96 3.8 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.098 1.759 . . . . 3.23 110.912 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.1 mt -118.56 154.93 31.78 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.228 1.811 . . . . 1.9099999999999999 109.819 161.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -114.63 140.59 48.69 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.203 1.001 . . . . 1.8700000000000001 110.281 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.4 t -137.71 127.51 15.29 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 123.565 0.746 . . . . 1.8600000000000001 110.913 167.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.66 169.95 16.3 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.849 3.032 . . . . 1.04 111.941 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.06 143.17 96.9 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.112 2.541 . . . . 1.2 113.003 173.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm 64.15 8.28 3.97 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.549 1.54 . . . . 3.25 113.794 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.99 163.8 38.3 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 127.149 2.309 . . . . 1.2 113.639 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.4 mtt-85 -93.62 148.45 22.09 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.802 0.841 . . . . 6.5800000000000001 110.567 174.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.7 t -118.08 57.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.704 2.002 . . . . 6.8099999999999996 107.564 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.2 129.2 35.82 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.017 -0.734 . . . . 2.8999999999999999 109.017 168.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 tp -74.78 -24.56 58.69 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 112.925 0.713 . . . . 3.1299999999999999 112.925 -164.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? 76.97 100.89 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 127.319 2.248 . . . . 4.5999999999999996 110.342 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.458 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 35.0 Cg_endo -60.92 -29.46 88.11 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 121.829 1.686 . . . . 2.27 114.153 -175.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.88 10.5 70.09 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.148 -1.918 . . . . 1.73 115.07 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.47 -25.66 0.03 OUTLIER Glycine 0 N--CA 1.475 1.28 0 N-CA-C 121.414 3.326 . . . . 2.27 121.414 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -140.29 147.92 40.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 121.337 2.569 . . . . 3.5899999999999999 113.17 164.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -158.48 152.54 23.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.668 -1.151 . . . . 0.81000000000000005 112.209 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -78.25 139.08 38.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.094 -0.706 . . . . 3.7799999999999998 109.094 161.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -88.04 129.45 35.27 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.745 -1.206 . . . . 1.73 107.745 159.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 mp -108.74 127.43 53.99 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.06 -1.089 . . . . 1.7 108.06 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.42 143.42 50.75 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.75 0.82 . . . . 2.5299999999999998 110.591 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.17 45.81 47.01 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.291 -0.727 . . . . 0.81999999999999995 113.737 176.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pp -54.39 147.94 12.77 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 123.52 1.629 . . . . 2.3700000000000001 114.954 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.431 ' HZ1' ' CD ' ' A' ' 41' ' ' GLU . 33.4 mmtp -103.79 -5.78 22.11 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 113.328 -1.76 . . . . 2.8999999999999999 113.242 -169.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -148.57 144.47 18.51 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 127.585 2.354 . . . . 9.2400000000000002 109.402 171.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.56 152.54 17.59 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 124.069 3.179 . . . . 2.0499999999999998 111.281 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 93' ' ' LEU . 2.0 pt? -120.06 142.16 49.11 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.849 2.46 . . . . 4.9800000000000004 110.152 -166.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -96.2 -165.8 1.33 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 125.647 1.579 . . . . 4.5499999999999998 110.21 159.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.18 139.01 36.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 107.92 -1.141 . . . . 2.6299999999999999 107.92 148.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.45 4.55 34.85 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.66 1.6 . . . . 1.8200000000000001 115.501 -170.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.19 174.51 11.49 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.065 1.346 . . . . 2.8500000000000001 110.579 171.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -136.3 149.09 48.27 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.175 1.79 . . . . 4.0199999999999996 106.22 156.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.1 t -145.06 134.56 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.571 1.948 . . . . 2.0800000000000001 110.195 -165.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.424 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 35.2 tt0 -78.9 135.09 36.89 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.842 1.257 . . . . 3.3900000000000001 112.208 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mp -123.41 145.01 49.12 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.155 1.382 . . . . 2.8500000000000001 111.153 162.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -109.25 133.99 52.33 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.562 1.945 . . . . 2.8100000000000001 108.578 170.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 mp -108.5 131.44 54.81 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.883 0.873 . . . . 1.8400000000000001 109.686 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.2 mt -106.52 114.77 29.08 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.206 1.003 . . . . 1.95 109.844 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -113.36 121.11 43.38 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.981 1.713 . . . . 3.3199999999999998 111.498 -175.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.96 22.45 2.43 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.598 1.959 . . . . 2.6600000000000001 114.475 174.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.77 -58.39 3.46 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.127 1.346 . . . . 4.2199999999999998 112.66 -169.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.38 0.73 79.46 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 116.821 1.489 . . . . 2.1299999999999999 116.821 -167.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -130.94 140.15 50.14 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.774 1.787 . . . . 4.4699999999999998 112.344 173.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.0 p -127.73 147.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.42 1.888 . . . . 3.5800000000000001 110.347 172.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.1 tp -150.73 124.48 9.15 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.039 1.336 . . . . 2.9700000000000002 110.236 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.424 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 11.2 ttpt -113.25 135.75 53.5 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.266 0.626 . . . . 3.54 112.579 -172.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.4 t -146.45 163.93 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.465 1.506 . . . . 4.5599999999999996 108.956 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -114.56 138.03 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.179 1.392 . . . . 3.23 109.113 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mp -124.22 151.57 66.16 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.841 1.256 . . . . 3.6299999999999999 110.562 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -69.06 155.43 68.27 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.229 2.62 . . . . 1.3400000000000001 111.489 172.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.6 t -106.41 81.73 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 107.499 -1.297 . . . . 1.9399999999999999 107.499 161.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.19 156.09 27.09 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.748 -1.205 . . . . 4.0499999999999998 107.748 140.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -83.43 178.98 7.79 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.05 1.34 . . . . 3.6800000000000002 110.849 172.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.427 HH11 ' HG2' ' A' ' 120' ' ' ARG 0.268 12.1 ptt-85 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 114.78 -2.533 . . . . 10.32 113.494 162.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 113' ' ' VAL . . . . . . . . 0 N--CA 1.471 0.969 0 CA-C-O 118.915 -0.936 . . . . 16.539999999999999 110.903 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.2 m -129.67 138.01 50.95 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 106.242 -1.762 . . . . 14.43 106.242 167.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 46.72 -122.16 1.22 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 118.263 -0.875 . . . . 13.24 108.934 -163.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.2 m 104.6 69.26 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 129.891 3.276 . . . . 8.9900000000000002 108.675 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -81.19 70.36 8.01 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.989 0.915 . . . . 7.21 109.799 177.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.82 -179.93 32.16 Favored Glycine 0 N--CA 1.471 0.999 0 O-C-N 120.717 -1.239 . . . . 1.3600000000000001 114.689 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.5 p90 -141.87 165.82 26.41 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.418 1.487 . . . . 2.4199999999999999 112.206 172.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.6 t -106.14 135.56 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.044 -1.095 . . . . 2.23 108.044 166.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.04 113.95 15.3 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 120.766 0.317 . . . . 4.46 110.278 175.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -61.36 135.71 57.79 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.658 -0.497 . . . . 4.54 109.658 156.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.2 m -160.59 139.84 7.92 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.991 1.317 . . . . 4.29 108.952 167.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -85.08 48.23 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.692 3.595 . . . . 3.1200000000000001 112.353 -168.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -124.09 -175.45 14.39 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.411 1.482 . . . . 1.75 112.897 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.78 -17.46 20.13 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.673 2.915 . . . . 2.1099999999999999 113.516 174.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -122.16 167.33 13.3 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.728 2.011 . . . . 3.3700000000000001 113.431 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.34 -176.06 5.15 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 127.127 2.171 . . . . 2.0899999999999999 111.739 175.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.22 150.7 44.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.718 2.007 . . . . 1.75 108.658 176.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.47 138.41 48.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.153 0.888 . . . . 2.2000000000000002 111.308 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -129.02 133.55 47.78 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.057 1.743 . . . . 3.5899999999999999 110.656 -171.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 pp -165.7 152.12 9.7 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.149 0.886 . . . . 3.4700000000000002 113.1 -170.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 62.6 m -77.22 120.85 22.86 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.355 -0.841 . . . . 4.2999999999999998 109.035 171.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.14 118.97 23.0 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.541 -1.281 . . . . 4.1299999999999999 107.541 168.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -111.44 126.9 55.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.875 1.67 . . . . 4.0899999999999999 109.07 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -103.62 98.7 13.38 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 121.652 -0.655 . . . . 1.3799999999999999 111.552 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.17 -7.27 17.09 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.903 2.402 . . . . 1.52 114.112 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.76 172.35 53.18 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-O 122.658 1.143 . . . . 1.1899999999999999 112.656 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -103.78 -4.52 23.52 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.21 2.604 . . . . 3.0699999999999998 111.837 -174.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -116.55 162.41 26.9 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 129.106 2.963 . . . . 4.0700000000000003 109.577 172.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.12 142.59 24.76 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.131 1.888 . . . . 0.92000000000000004 109.991 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -105.67 158.04 16.99 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.076 1.351 . . . . 3.4500000000000002 111.308 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -149.42 107.45 3.72 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.154 -1.385 . . . . 3.8300000000000001 111.434 -171.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.5 tp -90.39 109.65 20.76 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 127.051 2.14 . . . . 2.8100000000000001 109.272 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -106.77 -17.76 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.445 1.098 . . . . 1.9099999999999999 112.238 -171.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.87 -175.38 28.73 Favored Glycine 0 C--N 1.344 0.985 0 C-N-CA 125.878 1.704 . . . . 0.45000000000000001 113.089 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.76 -176.91 5.45 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.532 1.533 . . . . 1.6499999999999999 110.794 168.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.71 175.87 13.34 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.418 2.687 . . . . 5.5999999999999996 108.2 169.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.0 159.3 7.85 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 127.135 2.174 . . . . 1.98 107.267 168.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.56 -9.68 16.67 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.638 2.225 . . . . 1.01 115.168 166.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.75 41.36 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 114.821 1.415 . . . . 2.1099999999999999 114.821 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.46 149.91 8.65 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.314 1.446 . . . . 2.4399999999999999 110.133 161.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.571 ' CD ' ' HZ2' ' A' ' 90' ' ' LYS . 27.7 tt0 -123.17 -58.78 1.62 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.817 1.247 . . . . 3.3799999999999999 111.376 -173.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -78.21 68.17 4.17 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 120.887 -1.133 . . . . 5.8200000000000003 108.989 168.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.7 p -78.03 150.47 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.054 -0.975 . . . . 1.6899999999999999 108.857 168.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.97 158.36 37.77 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.065 2.146 . . . . 4.75 107.038 -164.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -134.47 133.3 40.27 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 123.794 1.759 . . . . 2.96 114.102 171.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -120.41 149.13 42.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 112.728 -2.033 . . . . 0.80000000000000004 111.188 -171.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.65 -178.9 7.0 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.293 -1.321 . . . . 2.8999999999999999 110.837 155.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.7 m -153.22 138.68 17.65 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.893 1.277 . . . . 2.1600000000000001 108.465 172.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -147.73 164.27 34.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 122.84 1.305 . . . . 3.52 113.45 -171.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.5 ttm -97.32 138.71 34.37 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.313 1.445 . . . . 4.9800000000000004 109.758 172.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -149.08 161.51 41.8 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.431 1.271 . . . . 10.029999999999999 114.431 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -83.27 151.91 25.39 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.627 1.571 . . . . 3.2400000000000002 110.53 162.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.9 t -139.4 117.39 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.17 1.788 . . . . 3.3900000000000001 106.642 152.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 62.68 21.54 12.78 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.819 1.414 . . . . 3.9100000000000001 114.819 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.26 0.53 82.59 Favored Glycine 0 N--CA 1.48 1.612 0 O-C-N 120.378 -1.451 . . . . 2.3999999999999999 114.034 -170.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -104.27 119.88 39.94 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.139 2.576 . . . . 4.5800000000000001 107.644 -175.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -88.05 126.11 34.92 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.28 1.432 . . . . 5.75 110.03 -167.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.8 p -154.43 -178.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.732 1.613 . . . . 3.6400000000000001 109.691 -165.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 39.2 mmm -119.31 161.87 19.72 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.451 1.101 . . . . 4.2199999999999998 111.176 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -142.81 168.61 25.9 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 126.322 1.915 . . . . 0.65000000000000002 111.509 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.7 ttm -157.67 132.43 8.58 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.328 1.451 . . . . 1.97 109.226 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -145.43 148.99 39.34 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 126.476 1.91 . . . . 9.5399999999999991 109.704 -170.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.89 155.43 34.36 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.105 1.87 . . . . 0.81000000000000005 111.118 -176.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.4 m -131.41 151.6 79.04 Favored Pre-proline 0 N--CA 1.477 0.895 0 CA-C-O 118.453 -0.784 . . . . 2.1099999999999999 110.709 176.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.89 -20.6 11.64 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.397 2.732 . . . . 0.62 113.165 -167.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -179.29 164.0 1.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.04 2.136 . . . . 3.3300000000000001 110.467 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.6 mt -110.4 154.65 23.28 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.88 0.872 . . . . 1.75 110.57 162.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -134.6 146.17 49.34 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.329 0.652 . . . . 1.96 110.736 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.4 t -142.83 132.14 11.84 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 124.244 0.965 . . . . 2.0499999999999998 112.681 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.33 160.53 48.49 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.499 2.799 . . . . 0.94999999999999996 111.912 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -60.53 139.8 88.0 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.491 2.794 . . . . 0.92000000000000004 112.141 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.8 mptt 66.02 -6.42 0.46 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 127.7 2.4 . . . . 2.75 114.168 -174.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.59 153.73 37.23 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.759 1.647 . . . . 1.3799999999999999 113.202 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -107.23 147.16 30.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.15 0.98 . . . . 4.4100000000000001 109.647 163.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.9 t -145.14 125.9 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.907 1.683 . . . . 4.7599999999999998 107.013 166.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -93.77 130.91 39.6 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.708 1.003 . . . . 4.6500000000000004 113.708 -168.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -75.96 68.73 2.5 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.155 0.979 . . . . 2.29 109.507 157.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -90.64 156.58 45.02 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 125.705 1.602 . . . . 4.8399999999999999 113.675 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.28 -20.99 71.92 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.743 2.295 . . . . 2.6600000000000001 113.103 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.5 52.78 3.87 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-N 119.106 0.866 . . . . 3.1099999999999999 111.813 163.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.69 -117.9 2.08 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.472 1.511 . . . . 1.6299999999999999 115.679 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -74.44 143.83 44.53 Favored 'General case' 0 C--O 1.224 -0.276 0 O-C-N 121.574 -0.957 . . . . 3.5899999999999999 112.741 -161.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -161.8 154.28 19.9 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.454 -0.779 . . . . 0.88 113.024 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -78.08 136.22 37.86 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.296 -0.631 . . . . 3.0 109.296 166.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.9 tpt -97.94 133.45 42.41 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 107.801 -1.185 . . . . 1.8200000000000001 107.801 163.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -114.68 115.77 27.63 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.758 1.223 . . . . 1.98 108.29 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mp -120.08 155.34 33.17 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.826 0.822 . . . . 2.5899999999999999 110.19 168.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.08 45.81 24.51 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 116.004 -0.544 . . . . 1.5800000000000001 112.458 176.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.36 153.11 4.17 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 123.03 1.395 . . . . 2.73 113.99 169.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.571 ' HZ2' ' CD ' ' A' ' 41' ' ' GLU . 71.4 mmtt -113.78 -12.17 12.79 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.011 -1.45 . . . . 2.8999999999999999 113.029 -171.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -145.65 151.71 47.15 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 127.095 2.158 . . . . 6.0499999999999998 108.542 174.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.88 154.5 72.78 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.664 2.243 . . . . 2.1400000000000001 109.816 167.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 pp -148.18 143.69 27.23 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 126.172 1.789 . . . . 3.29 108.996 -168.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -127.35 173.02 10.13 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.925 1.69 . . . . 4.5 111.754 -168.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.31 130.76 35.77 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.323 -0.991 . . . . 1.9399999999999999 108.323 162.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.24 5.64 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.999 1.285 . . . . 1.8100000000000001 114.02 -176.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -129.16 -178.34 4.6 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.757 1.223 . . . . 2.3700000000000001 110.11 169.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -136.48 142.58 43.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.669 1.988 . . . . 4.9900000000000002 107.083 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.3 t -152.79 134.77 5.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 128.194 2.598 . . . . 2.2999999999999998 108.572 -168.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -93.17 156.12 17.04 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.241 1.2 . . . . 2.8700000000000001 114.241 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mp -115.07 162.74 16.59 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.11 1.764 . . . . 2.73 110.82 165.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -121.87 125.46 46.48 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 129.656 3.182 . . . . 3.1200000000000001 107.163 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -104.18 129.04 51.92 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.307 -1.496 . . . . 2.1499999999999999 110.181 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.5 mt -102.71 108.32 19.53 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.954 1.302 . . . . 2.1600000000000001 110.173 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -96.22 154.28 17.34 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.899 0.88 . . . . 3.27 110.562 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.93 135.72 29.91 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.616 0.767 . . . . 2.0 111.212 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.04 -6.53 69.27 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.437 1.018 . . . . 2.9900000000000002 114.348 -173.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.82 14.64 42.44 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-N 118.485 1.143 . . . . 3.3300000000000001 114.572 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 52.8 tttt -77.32 126.42 30.9 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.118 1.459 . . . . 6.9699999999999998 111.126 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 49.7 t -100.97 131.57 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.084 1.754 . . . . 3.5600000000000001 109.491 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.1 tp -128.27 114.34 16.79 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.603 1.161 . . . . 2.9900000000000002 109.251 169.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.36 134.56 49.31 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.298 1.222 . . . . 3.3500000000000001 114.298 -175.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.458 ' HA ' ' HA2' ' A' ' 1' ' ' GLY . 13.2 m -139.62 148.16 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 127.852 2.461 . . . . 3.3300000000000001 110.04 -152.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.4 t -118.05 124.47 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-N 120.096 1.316 . . . . 2.6000000000000001 110.563 -165.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.99 143.37 47.58 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.992 1.317 . . . . 3.5499999999999998 110.868 -169.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.34 149.43 35.33 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.192 2.594 . . . . 0.94999999999999996 111.917 165.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.1 t -102.28 124.78 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.941 0.896 . . . . 2.02 109.179 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.422 ' CD ' HH21 ' A' ' 120' ' ' ARG . 47.5 mt-10 -150.7 155.82 40.08 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.971 1.308 . . . . 3.5699999999999998 111.691 -174.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.95 59.35 3.18 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.088 0.955 . . . . 2.6800000000000002 113.206 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.422 HH21 ' CD ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.99 0 C-N-CA 126.275 1.83 . . . . 10.33 111.873 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.246 0 N-CA-C 105.971 -2.852 . . . . 13.609999999999999 105.971 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 p 161.91 141.48 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.162 -1.051 . . . . 10.949999999999999 108.162 -135.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -69.68 161.36 29.87 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.003 0.921 . . . . 11.66 111.535 170.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.3 p -140.36 63.02 1.48 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.765 2.026 . . . . 7.0300000000000002 108.916 169.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -143.67 -169.09 3.0 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 129.678 3.191 . . . . 5.4800000000000004 108.943 -166.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.4 171.85 46.26 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 121.252 -0.905 . . . . 2.2999999999999998 113.868 161.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -155.42 162.35 40.79 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.664 2.386 . . . . 2.3399999999999999 110.71 167.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.6 t -112.71 139.91 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.673 -1.267 . . . . 2.0899999999999999 110.264 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.34 124.63 29.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.596 0.359 . . . . 5.5800000000000001 110.96 176.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -36.14 145.2 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.996 2.518 . . . . 2.6400000000000001 115.039 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.4 t -163.22 140.19 5.78 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 121.427 -0.796 . . . . 3.2999999999999998 112.996 166.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -92.02 -8.9 2.75 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.276 3.317 . . . . 2.8100000000000001 112.56 167.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.05 -179.38 24.23 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.458 1.504 . . . . 1.4199999999999999 113.791 -169.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.49 -20.33 36.23 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 124.23 3.287 . . . . 1.49 114.58 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -113.17 162.95 15.37 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.176 1.39 . . . . 2.3799999999999999 113.855 172.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.9 -177.46 6.63 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.881 2.472 . . . . 1.71 111.262 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.49 136.07 27.28 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.817 1.247 . . . . 1.5600000000000001 110.363 174.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.83 143.18 49.01 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.717 1.207 . . . . 1.6899999999999999 112.676 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -115.59 128.87 56.26 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.863 1.665 . . . . 3.6899999999999999 109.433 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.27 3.7 pp -123.77 153.05 41.51 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.409 1.263 . . . . 3.1000000000000001 114.409 176.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.9 m -86.85 129.14 35.0 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.666 -1.235 . . . . 2.46 107.666 161.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.66 117.87 35.61 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.981 1.312 . . . . 3.8100000000000001 108.87 -176.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -98.58 134.13 41.96 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.356 0.662 . . . . 3.77 110.655 175.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -121.58 96.91 47.23 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.131 0.973 . . . . 1.45 111.151 164.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.39 -3.28 9.36 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.332 2.688 . . . . 1.3700000000000001 114.44 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.81 161.86 23.9 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 119.95 1.25 . . . . 1.6000000000000001 111.957 -176.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.08 3.7 14.27 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 128.12 2.568 . . . . 3.02 112.803 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -118.39 153.59 51.84 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 128.037 2.535 . . . . 3.3700000000000001 110.494 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.67 142.14 17.88 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.842 2.362 . . . . 1.01 110.473 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.3 mt -104.99 148.42 26.75 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 122.974 1.369 . . . . 2.79 111.562 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.7 ttp-105 -139.31 103.13 4.66 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 111.835 -2.439 . . . . 3.5899999999999999 111.506 -176.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.8 tt -81.88 115.17 20.95 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 124.424 1.09 . . . . 3.8599999999999999 109.404 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.6 m -103.13 -20.63 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.039 1.336 . . . . 2.1499999999999999 112.457 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.97 -175.47 27.93 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 126.105 1.812 . . . . 0.76000000000000001 113.028 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.42 -178.96 5.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.721 0.808 . . . . 1.8700000000000001 110.725 167.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -149.77 178.68 8.65 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.94 2.496 . . . . 5.54 107.145 159.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -176.9 152.68 1.05 Allowed Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 127.364 2.266 . . . . 1.8500000000000001 107.838 -174.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.57 -11.23 30.64 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.407 2.071 . . . . 1.1799999999999999 113.779 170.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.06 47.12 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 114.237 1.199 . . . . 2.3999999999999999 114.237 -175.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.76 152.65 11.83 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.429 1.892 . . . . 1.52 109.145 164.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.514 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 5.3 tp10 -101.3 -31.28 11.05 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.348 0.522 . . . . 4.5 111.857 167.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -113.73 133.71 55.19 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 126.283 1.833 . . . . 5.5999999999999996 108.66 168.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.4 p -139.56 127.29 25.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 124.752 1.221 . . . . 1.9399999999999999 108.844 172.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -146.79 119.91 8.84 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.332 1.053 . . . . 3.5099999999999998 108.85 -163.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -83.3 136.84 34.23 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 123.442 1.591 . . . . 3.2599999999999998 114.31 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -120.78 154.09 36.16 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.333 2.253 . . . . 0.73999999999999999 111.307 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -92.05 160.39 15.25 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.742 1.217 . . . . 2.23 110.15 155.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.1 m -103.62 141.32 36.25 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 106.96 -1.496 . . . . 2.3599999999999999 106.96 150.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -140.35 166.03 25.81 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 122.474 1.13 . . . . 3.1800000000000002 113.616 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.0 mtm -95.18 141.77 28.4 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.696 1.198 . . . . 6.0099999999999998 112.304 -176.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -142.25 153.32 43.86 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 115.409 1.633 . . . . 5.8700000000000001 115.409 168.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.461 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS . 2.7 tp10 -87.5 146.25 25.89 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.97 1.308 . . . . 3.0499999999999998 108.808 146.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.2 m -130.61 -10.03 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 116.946 2.202 . . . . 3.5299999999999998 116.946 169.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -162.98 22.77 0.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.174 1.39 . . . . 3.7400000000000002 112.728 -167.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.93 4.15 46.88 Favored Glycine 0 N--CA 1.482 1.744 0 O-C-N 119.958 -1.714 . . . . 1.8899999999999999 112.767 -159.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -120.12 134.5 55.24 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 129.055 2.942 . . . . 3.2400000000000002 107.76 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.461 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 2.7 mmtt -75.1 146.46 41.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.051 2.14 . . . . 5.4400000000000004 109.475 -175.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.4 p -155.03 168.45 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 126.635 1.974 . . . . 3.6200000000000001 109.538 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.7 mmm -122.93 144.39 49.26 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.071 1.349 . . . . 4.4699999999999998 110.101 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.73 179.23 16.21 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.554 1.549 . . . . 0.91000000000000003 112.075 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ttm -142.11 141.55 32.71 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.798 1.639 . . . . 1.6899999999999999 108.693 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.21 134.84 10.96 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 125.705 1.602 . . . . 7.6699999999999999 109.006 -164.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.28 143.37 35.21 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 CA-C-N 121.537 1.585 . . . . 0.85999999999999999 110.36 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.8 m -129.02 152.81 79.93 Favored Pre-proline 0 N--CA 1.481 1.125 0 CA-C-O 118.617 -0.706 . . . . 1.8899999999999999 111.262 -173.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.25 -26.06 4.43 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.04 2.494 . . . . 0.81999999999999995 112.782 -165.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -176.83 166.08 2.51 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.065 1.346 . . . . 3.3300000000000001 112.079 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.2 mt -117.2 150.89 37.99 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.596 1.958 . . . . 1.79 111.463 166.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -113.57 145.06 41.84 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.839 1.256 . . . . 2.0299999999999998 110.328 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.2 t -137.91 126.89 14.71 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 124.019 0.927 . . . . 2.0099999999999998 110.638 162.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.35 166.4 25.57 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 124.027 3.151 . . . . 0.93000000000000005 111.893 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.69 148.14 92.32 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.259 2.64 . . . . 1.1399999999999999 114.176 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.289 19.1 mtmt 49.16 43.24 22.47 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.67 1.988 . . . . 3.77 114.13 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.35 169.06 24.69 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 127.738 2.59 . . . . 1.8700000000000001 111.587 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.51 135.18 19.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.395 0.678 . . . . 5.3700000000000001 110.834 175.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -151.45 137.41 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.39 1.476 . . . . 5.1699999999999999 109.092 -162.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.99 158.24 15.52 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.684 1.231 . . . . 2.96 113.611 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.88 -32.99 74.81 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.78 2.032 . . . . 3.5899999999999999 114.208 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt 99.18 130.49 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.415 0 C-N-CA 131.424 3.89 . . . . 4.25 111.142 174.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.32 -5.12 10.58 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.704 2.936 . . . . 3.0099999999999998 115.584 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.4 -11.91 6.48 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-O 117.761 -1.577 . . . . 2.8900000000000001 115.168 167.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.13 -110.5 3.31 Favored Glycine 0 N--CA 1.474 1.177 0 CA-C-N 119.958 1.879 . . . . 1.8700000000000001 112.641 -172.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -73.16 145.61 46.22 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 122.035 -0.686 . . . . 3.4900000000000002 110.656 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.7 p-80 -163.92 153.11 14.05 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.814 -0.554 . . . . 0.60999999999999999 111.383 -177.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -80.43 131.81 35.64 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.441 -0.948 . . . . 2.8700000000000001 108.441 164.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.9 tpt -84.55 129.63 34.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.056 -1.461 . . . . 1.74 107.056 157.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.0 mp -107.49 131.22 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.087 -1.079 . . . . 1.75 108.087 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mp -130.25 145.81 51.79 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.908 1.283 . . . . 2.4100000000000001 110.138 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.8 40.82 93.81 Favored Glycine 0 CA--C 1.528 0.896 0 O-C-N 121.649 -0.657 . . . . 1.0800000000000001 111.494 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.68 145.98 32.45 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 122.909 1.337 . . . . 2.1400000000000001 113.689 175.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.514 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 27.7 mttt -101.8 -6.81 23.16 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.793 -1.548 . . . . 4.71 112.396 -172.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -132.98 139.06 33.3 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.802 1.641 . . . . 5.8200000000000003 108.763 154.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -63.6 142.72 85.17 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 N-CA-C 107.285 -1.852 . . . . 2.4500000000000002 107.285 156.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.1 mt -104.76 95.96 6.24 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.584 1.554 . . . . 3.3100000000000001 109.975 -157.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.69 135.55 36.57 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.26 1.024 . . . . 4.4299999999999997 111.293 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.51 106.49 0.66 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.954 1.302 . . . . 2.46 110.462 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.02 -0.02 21.09 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.872 1.701 . . . . 1.6000000000000001 115.032 -170.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -81.11 -176.4 5.93 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.149 1.475 . . . . 2.21 112.346 169.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -141.7 138.92 32.77 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 129.422 3.089 . . . . 3.3100000000000001 106.249 -168.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 79.0 t -150.62 158.04 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 128.827 2.851 . . . . 2.23 108.805 -167.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -123.25 154.45 38.79 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.504 0.722 . . . . 4.1100000000000003 110.613 164.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.89 135.8 55.1 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.556 1.142 . . . . 3.04 109.488 160.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.32 140.52 29.41 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.422 2.289 . . . . 2.3700000000000001 109.175 166.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.05 119.19 37.62 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.247 1.819 . . . . 2.1499999999999999 110.06 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.7 mt -90.25 105.28 17.7 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.479 1.112 . . . . 2.3100000000000001 109.594 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -99.78 144.05 29.3 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.075 1.35 . . . . 3.3100000000000001 111.036 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.05 123.58 10.82 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.552 1.141 . . . . 2.3399999999999999 114.042 -168.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.45 72.71 0.88 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.782 1.182 . . . . 3.0899999999999999 112.816 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.17 19.81 77.59 Favored Glycine 0 N--CA 1.473 1.11 0 N-CA-C 116.013 1.165 . . . . 2.3999999999999999 116.013 166.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -106.96 139.41 41.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.171 1.486 . . . . 5.29 111.114 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.0 p -147.01 147.22 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.717 0.807 . . . . 3.5800000000000001 112.413 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 24.3 tp -156.69 175.78 13.6 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.204 2.602 . . . . 3.6099999999999999 108.253 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -147.8 155.97 42.23 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.747 -1.221 . . . . 4.0599999999999996 113.169 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.6 t -140.2 157.78 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.635 1.574 . . . . 3.4199999999999999 109.571 -175.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.2 t -95.63 145.04 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.619 1.968 . . . . 3.6299999999999999 110.993 -170.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mp -145.11 120.18 5.77 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 126.09 1.756 . . . . 3.5299999999999998 111.164 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.65 165.74 26.54 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.541 2.16 . . . . 1.1799999999999999 110.456 161.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.4 t -100.26 141.36 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 O-C-N 121.279 -0.888 . . . . 2.2799999999999998 111.231 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -122.42 146.22 47.56 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.045 2.138 . . . . 4.9699999999999998 111.197 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.24 105.4 12.4 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.547 -0.721 . . . . 2.6699999999999999 112.089 167.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 . . . . . 0 C--O 1.25 1.091 0 C-N-CA 129.715 3.206 . . . . 8.0999999999999996 108.299 170.117 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.916 0 N-CA-C 108.364 -1.894 . . . . 13.76 108.364 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 p -176.34 145.33 0.58 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 126.029 1.732 . . . . 13.31 108.047 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -139.66 18.21 2.52 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.954 1.094 . . . . 13.16 113.954 -164.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 79.66 12.81 1.11 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.877 1.671 . . . . 9.2899999999999991 112.247 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.417 ' CD ' HH12 ' A' ' 74' ' ' ARG . 2.4 mt-10 -82.42 67.96 8.66 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.795 1.238 . . . . 5.8099999999999996 110.353 -172.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.74 179.93 33.11 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 124.654 1.121 . . . . 1.8300000000000001 113.232 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.8 p90 -156.69 153.55 28.65 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.035 0.754 . . . . 2.79 113.035 169.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.1 t -100.53 136.69 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.388 0.675 . . . . 2.3199999999999998 109.331 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -72.56 109.2 6.05 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.755 0.822 . . . . 7.1900000000000004 109.962 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.35 134.54 8.85 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.408 1.483 . . . . 3.2999999999999998 112.864 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.8 t -150.5 143.84 16.83 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 114.676 1.362 . . . . 3.2200000000000002 114.676 167.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -86.58 -4.62 8.29 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.54 2.826 . . . . 2.77 112.052 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.46 -176.03 25.1 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.216 1.388 . . . . 1.52 114.129 -169.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.52 -14.55 30.68 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.267 3.312 . . . . 1.6299999999999999 114.362 -175.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -131.07 153.34 49.41 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.184 2.194 . . . . 2.46 114.308 -172.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.13 -176.12 5.73 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 127.628 2.371 . . . . 1.71 113.261 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.18 157.64 45.89 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.928 2.091 . . . . 1.9199999999999999 109.595 172.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.81 152.57 46.65 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.524 1.056 . . . . 1.73 113.027 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -139.85 146.81 39.82 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.4 2.28 . . . . 3.6200000000000001 110.686 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -172.92 172.55 3.99 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.077 1.51 . . . . 3.5699999999999998 115.077 -170.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.24 143.03 39.24 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 129.323 3.049 . . . . 2.9300000000000002 110.569 -175.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.73 110.68 7.72 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.617 -0.512 . . . . 4.0 109.617 171.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -123.82 140.34 53.08 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.803 1.241 . . . . 3.4500000000000002 111.29 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -104.44 112.04 65.31 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.634 0.774 . . . . 1.4199999999999999 111.472 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -82.73 -19.53 6.05 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.948 2.432 . . . . 1.51 114.276 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.35 -177.12 51.73 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 119.029 0.831 . . . . 1.1599999999999999 112.022 -174.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -107.79 0.86 22.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.375 1.87 . . . . 2.9900000000000002 111.764 -174.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -118.94 160.24 41.52 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 128.287 2.635 . . . . 3.23 109.726 171.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.61 147.72 32.09 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.679 2.253 . . . . 1.27 110.947 -176.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.9 mt -103.81 149.53 24.96 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 122.518 1.151 . . . . 2.75 110.943 173.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -133.8 106.9 7.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 112.348 -2.206 . . . . 3.2999999999999998 110.669 -176.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 tt -81.25 115.67 20.76 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.253 1.021 . . . . 3.1499999999999999 108.652 177.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.17 -18.22 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.077 0.951 . . . . 2.0600000000000001 112.298 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.34 -173.95 27.41 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 126.059 1.79 . . . . 0.68999999999999995 112.701 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.94 -174.85 4.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.728 1.611 . . . . 1.8300000000000001 110.641 166.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.19 178.62 10.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.761 2.424 . . . . 6.0800000000000001 108.654 171.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -178.4 154.93 0.92 Allowed Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 127.03 2.132 . . . . 1.6799999999999999 107.939 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.16 -6.9 17.73 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.082 1.855 . . . . 0.84999999999999998 113.042 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.0 m -124.91 46.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 114.062 1.134 . . . . 2.0899999999999999 114.062 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.18 156.23 14.35 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.556 1.142 . . . . 1.8200000000000001 111.854 167.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.515 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 1.3 tp10 -92.83 -26.25 17.76 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.525 1.93 . . . . 2.9300000000000002 112.816 170.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -143.24 140.29 30.62 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 129.378 3.071 . . . . 8.5399999999999991 107.836 -168.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -157.2 59.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 125.101 2.381 . . . . 3.0299999999999998 111.954 -165.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.61 135.24 35.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 111.453 -2.612 . . . . 5.25 112.72 -162.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 31.9 tp -86.06 121.33 28.51 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.974 1.309 . . . . 2.4300000000000002 111.95 -165.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -123.38 153.86 39.77 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.363 1.465 . . . . 0.67000000000000004 113.771 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' C ' ' HG1' ' A' ' 48' ' ' THR . 23.2 pt-20 -98.83 173.26 6.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.692 1.997 . . . . 2.3500000000000001 111.673 163.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.411 ' HG1' ' C ' ' A' ' 47' ' ' GLU . 85.2 m -152.64 143.76 23.12 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.398 1.879 . . . . 1.8200000000000001 107.889 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -156.94 167.23 31.08 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.554 0.946 . . . . 3.2599999999999998 113.554 -167.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.1 mtt -94.55 154.62 17.3 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.98 0.912 . . . . 6.6100000000000003 110.877 160.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.67 157.04 34.47 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.613 1.165 . . . . 5.2599999999999998 110.307 -173.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -103.25 139.67 38.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.684 1.193 . . . . 2.6600000000000001 110.81 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.4 t -136.76 125.87 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.063 -1.458 . . . . 3.2599999999999998 107.063 162.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.519 ' CD ' ' HZ2' ' A' ' 56' ' ' LYS . 28.5 mt-10 60.79 22.29 12.32 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.672 1.589 . . . . 3.3300000000000001 114.162 -178.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.08 8.45 87.4 Favored Glycine 0 CA--C 1.538 1.475 0 O-C-N 120.051 -1.656 . . . . 1.8200000000000001 113.861 -171.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.519 ' HZ2' ' CD ' ' A' ' 54' ' ' GLU . 52.0 mtmt -108.35 124.26 50.08 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 127.235 2.214 . . . . 3.98 108.192 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.31 119.35 20.08 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.273 -1.33 . . . . 5.3099999999999996 110.198 -175.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.8 m -121.61 -178.6 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 128.313 2.645 . . . . 3.48 109.975 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.7 mtm -125.89 162.55 24.93 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.84 1.256 . . . . 4.8899999999999997 111.142 174.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.43 176.75 32.92 Favored Glycine 0 N--CA 1.462 0.417 0 CA-C-O 121.774 0.652 . . . . 0.65000000000000002 113.361 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.0 ttm -159.44 137.11 10.03 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.598 1.959 . . . . 2.1899999999999999 108.969 -173.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -138.91 153.23 71.66 Favored Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 125.949 1.7 . . . . 9.2300000000000004 109.399 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.62 152.21 25.8 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.923 1.749 . . . . 0.82999999999999996 109.501 170.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.57 151.84 75.23 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 124.128 0.971 . . . . 1.8300000000000001 110.621 -176.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.8 -25.99 5.91 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.166 2.577 . . . . 0.93999999999999995 112.882 -167.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -176.79 164.76 2.43 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.67 1.588 . . . . 3.8199999999999998 111.602 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.2 mt -109.06 152.19 25.37 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.653 1.181 . . . . 1.9299999999999999 109.982 160.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -117.69 141.6 48.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.748 1.219 . . . . 1.8899999999999999 110.074 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.4 t -137.32 128.27 16.16 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 113.754 1.02 . . . . 1.8400000000000001 113.754 171.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.19 158.43 41.44 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.125 3.217 . . . . 1.0900000000000001 112.574 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.82 133.66 46.06 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.135 3.224 . . . . 1.1200000000000001 112.764 -175.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.14 -12.84 0.55 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 128.721 2.808 . . . . 3.1400000000000001 113.872 -175.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.48 166.42 51.0 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.719 1.628 . . . . 1.3500000000000001 113.116 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.417 HH12 ' CD ' ' A' ' 5' ' ' GLU . 65.3 mtt180 -122.53 146.02 47.79 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.715 1.606 . . . . 5.46 111.785 172.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.3 t -152.96 89.77 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 124.801 1.241 . . . . 4.8200000000000003 110.146 170.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.04 147.57 44.93 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.294 -0.867 . . . . 4.79 109.59 -172.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.74 127.25 31.04 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.276 1.036 . . . . 2.46 109.419 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.35 122.49 87.65 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 117.305 -1.331 . . . . 4.04 109.979 -168.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -61.86 -10.62 17.88 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.747 2.964 . . . . 3.1000000000000001 114.618 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -125.92 0.39 7.78 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 117.355 -1.803 . . . . 2.2999999999999998 116.143 166.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.56 -20.4 1.24 Allowed Glycine 0 N--CA 1.481 1.676 0 CA-C-N 120.674 2.237 . . . . 1.97 118.483 -172.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -150.81 135.66 17.4 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.166 1.983 . . . . 3.7400000000000002 111.557 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -158.04 152.77 25.0 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.019 0.928 . . . . 0.75 110.602 -173.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -79.16 145.84 33.46 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.661 -0.866 . . . . 2.9500000000000002 108.661 161.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 tpt -106.64 124.14 49.17 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 126.73 2.012 . . . . 2.29 108.627 168.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -107.48 133.43 51.97 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.807 1.643 . . . . 1.8600000000000001 109.462 -173.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.57 148.87 49.24 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.186 0.995 . . . . 3.4500000000000002 111.473 176.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.17 40.15 30.07 Favored Glycine 0 N--CA 1.468 0.823 0 C-N-CA 123.766 0.698 . . . . 0.87 113.539 169.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 pp -56.98 156.29 7.02 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 116.075 1.88 . . . . 2.7400000000000002 116.075 -177.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.515 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 72.7 mmtt -111.42 -19.8 12.46 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 112.298 -2.228 . . . . 2.6200000000000001 112.684 -170.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -145.59 136.55 12.45 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 128.102 2.561 . . . . 6.8099999999999996 108.004 165.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.43 137.33 39.32 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.212 2.608 . . . . 1.8799999999999999 110.955 -176.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.73 84.74 2.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.992 2.117 . . . . 3.5800000000000001 110.055 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -86.36 169.81 12.59 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.467 1.507 . . . . 4.4699999999999998 111.629 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.93 112.62 3.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.814 -1.084 . . . . 2.79 111.892 -175.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.31 0.18 28.08 Favored Glycine 0 CA--C 1.539 1.536 0 N-CA-C 117.188 1.635 . . . . 2.1000000000000001 117.188 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -92.14 180.0 5.42 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.777 1.289 . . . . 2.3199999999999998 113.756 -169.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.54 77.57 1.18 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.57 1.948 . . . . 5.4100000000000001 113.498 -162.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 77.0 t -95.22 127.73 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.66 -1.275 . . . . 2.3700000000000001 111.979 -169.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -78.25 136.48 37.78 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.995 0.918 . . . . 2.54 112.568 173.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.23 151.59 35.45 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.15 0.976 . . . . 2.6699999999999999 111.744 155.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -104.22 141.68 35.85 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.62 2.768 . . . . 2.23 107.933 160.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.02 130.95 54.57 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.852 1.261 . . . . 1.99 108.833 172.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.8 mt -100.68 111.02 23.19 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.131 0.973 . . . . 2.0600000000000001 109.593 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -98.77 141.3 31.74 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.104 1.361 . . . . 3.3399999999999999 110.863 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.47 125.94 7.53 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.753 1.621 . . . . 2.4900000000000002 112.729 -172.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.74 33.79 20.72 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.065 -0.853 . . . . 2.6099999999999999 114.026 -175.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.3 14.13 74.95 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 116.596 1.399 . . . . 2.9300000000000002 116.596 162.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -88.89 123.65 33.46 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.588 1.694 . . . . 4.4199999999999999 111.414 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.8 t -115.83 131.22 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 O-C-N 124.07 0.857 . . . . 3.4700000000000002 111.38 -173.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.5 tp -124.75 122.92 38.82 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.11 1.364 . . . . 3.2799999999999998 111.073 177.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.89 148.84 32.6 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.405 -0.81 . . . . 3.3100000000000001 112.305 171.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -146.66 157.61 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.642 1.577 . . . . 3.4100000000000001 109.29 163.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.8 t -104.97 136.84 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.118 1.367 . . . . 2.9199999999999999 109.696 173.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.9 mp -125.25 130.67 24.08 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.916 1.687 . . . . 3.6200000000000001 110.762 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.68 138.71 38.74 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.004 1.803 . . . . 1.22 109.842 164.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.9 t -77.92 141.41 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 O-C-N 120.699 -1.251 . . . . 2.4399999999999999 108.485 162.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.53 -174.24 2.55 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.989 1.716 . . . . 6.96 113.45 -177.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -126.34 151.57 47.4 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.524 1.13 . . . . 3.1600000000000001 110.407 166.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.178 0 C-N-CA 129.637 3.175 . . . . 10.07 109.936 -165.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.092 0 N-CA-C 107.311 -2.316 . . . . 11.779999999999999 107.311 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m -142.47 178.84 7.32 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.601 0.963 . . . . 9.7300000000000004 113.601 -150.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -63.74 159.79 18.54 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.26 -0.427 . . . . 9.0899999999999999 110.943 159.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.6 p -123.62 106.41 10.54 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.601 1.56 . . . . 7.7400000000000002 111.164 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.3 pm0 -77.6 121.77 24.39 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.191 0.996 . . . . 7.1799999999999997 110.543 174.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.89 172.23 38.0 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 121.338 -0.851 . . . . 2.0 113.337 159.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.9 p90 -155.8 153.28 29.57 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.112 1.365 . . . . 2.2400000000000002 112.234 164.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.38 139.94 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.16 -0.963 . . . . 2.0699999999999998 108.556 173.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -75.71 109.16 9.07 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.876 0.87 . . . . 5.9400000000000004 111.768 -178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -47.29 130.26 13.08 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.569 1.548 . . . . 4.1399999999999997 111.469 171.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -154.92 167.5 13.92 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 124.465 1.106 . . . . 3.0499999999999998 113.51 162.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -94.39 -1.73 2.83 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 124.268 3.312 . . . . 2.1400000000000001 114.071 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.71 -168.02 26.36 Favored Glycine 0 CA--C 1.542 1.774 0 C-N-CA 124.788 1.185 . . . . 1.5 115.517 -167.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.79 -10.23 16.95 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 124.817 3.678 . . . . 1.55 114.328 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -135.04 158.68 43.73 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.845 2.458 . . . . 2.4300000000000002 113.83 -170.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.82 -175.04 5.14 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.399 2.28 . . . . 1.8300000000000001 112.344 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.28 151.47 47.64 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.777 2.431 . . . . 1.75 107.726 172.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.94 144.68 51.01 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.552 1.069 . . . . 1.9099999999999999 112.268 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.459 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 65.6 m-85 -124.21 143.24 50.63 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.439 1.896 . . . . 3.6000000000000001 110.661 -178.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -173.23 166.33 4.86 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.942 1.697 . . . . 4.4400000000000004 111.832 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 t -102.75 160.12 14.87 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.719 1.208 . . . . 2.96 113.436 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.6 tp -129.69 129.26 44.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.491 1.517 . . . . 4.75 109.808 169.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -117.61 142.48 47.16 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.11 0.564 . . . . 3.3399999999999999 109.809 157.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -94.84 110.46 49.73 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.162 0.985 . . . . 1.49 109.371 173.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -84.62 -9.12 9.2 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.287 2.658 . . . . 1.1499999999999999 114.48 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.99 177.14 47.77 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 122.564 1.091 . . . . 1.2 113.101 -172.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -89.71 -6.5 56.02 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.614 1.165 . . . . 4.0999999999999996 112.043 174.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.69 160.17 45.47 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 127.63 2.372 . . . . 2.6600000000000001 110.823 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -77.16 148.98 27.87 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.636 2.224 . . . . 1.05 111.476 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.7 mp -110.8 152.46 26.61 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.63 1.572 . . . . 3.77 109.509 172.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -138.77 113.94 9.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 113.674 -1.603 . . . . 3.2999999999999998 109.574 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.3 tt -86.88 123.9 32.52 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.684 1.194 . . . . 3.0600000000000001 108.311 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.1 m -115.31 -14.65 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.413 1.085 . . . . 1.7 111.994 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.15 -174.64 28.11 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 125.708 1.623 . . . . 0.54000000000000004 113.879 -174.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.42 -176.35 5.35 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.838 1.655 . . . . 1.6299999999999999 111.542 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -153.67 168.82 24.94 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.023 1.729 . . . . 7.3399999999999999 109.03 164.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 t -165.73 148.07 6.44 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 126.028 1.731 . . . . 1.8899999999999999 108.381 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.06 -0.22 9.73 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.597 2.198 . . . . 1.1100000000000001 113.232 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.67 43.46 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.651 1.58 . . . . 1.8799999999999999 113.656 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.02 135.3 5.32 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.368 1.067 . . . . 2.0600000000000001 110.409 160.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -83.68 -26.41 29.86 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.508 1.123 . . . . 3.7200000000000002 113.219 174.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -108.64 132.2 54.14 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 108.074 -1.084 . . . . 5.7300000000000004 108.074 160.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -116.23 141.37 34.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.298 -1.001 . . . . 2.1400000000000001 108.298 150.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -132.6 153.43 51.05 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.397 1.879 . . . . 2.9199999999999999 108.461 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.4 tp -109.59 120.38 42.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.644 0.778 . . . . 2.3500000000000001 110.18 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -121.87 161.52 22.62 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.803 1.241 . . . . 0.69999999999999996 112.753 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.51 160.63 29.04 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.149 -0.932 . . . . 3.5499999999999998 110.886 161.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.6 m -132.36 123.77 27.43 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.98 1.712 . . . . 2.3500000000000001 107.189 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -113.72 170.61 8.13 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.121 1.768 . . . . 3.5299999999999998 112.522 -174.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 50.6 ttp -99.64 141.67 32.13 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.527 1.131 . . . . 3.77 110.284 164.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -133.55 161.02 35.72 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.429 1.892 . . . . 5.6500000000000004 110.108 170.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.485 ' CD ' ' HZ2' ' A' ' 57' ' ' LYS . 3.0 tp10 -90.18 147.9 23.29 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.483 1.113 . . . . 2.4199999999999999 109.11 154.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.41 137.7 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.713 -1.217 . . . . 4.1399999999999997 107.713 149.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.405 ' HB2' ' HE2' ' A' ' 56' ' ' LYS . 25.5 mt-10 61.9 9.8 3.19 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 115.921 1.823 . . . . 3.1400000000000001 115.921 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.0 5.95 59.39 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 124.657 1.122 . . . . 1.6399999999999999 115.194 -171.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.405 ' HE2' ' HB2' ' A' ' 54' ' ' GLU . 44.9 pttt -121.91 134.23 54.86 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.409 2.284 . . . . 3.9700000000000002 110.585 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.485 ' HZ2' ' CD ' ' A' ' 52' ' ' GLU . 2.2 mmtt -73.05 131.59 42.3 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.54 2.336 . . . . 4.8399999999999999 109.406 -176.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 m -138.5 166.41 23.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 127.447 2.299 . . . . 3.1299999999999999 109.702 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -129.42 129.67 44.98 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.204 1.002 . . . . 4.0199999999999996 110.812 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.67 175.25 16.46 Favored Glycine 0 N--CA 1.467 0.748 0 C-N-CA 125.677 1.608 . . . . 0.85999999999999999 111.88 -176.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.7 ttm -139.13 156.8 46.88 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.225 1.41 . . . . 1.6599999999999999 110.077 -172.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -161.33 151.1 14.06 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.36 1.464 . . . . 7.6100000000000003 110.837 -175.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.33 153.49 45.37 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.17 1.913 . . . . 0.71999999999999997 110.607 172.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.3 m -137.5 153.04 74.1 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 124.683 1.193 . . . . 1.77 109.895 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -82.36 -28.36 1.9 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.866 2.378 . . . . 0.66000000000000003 113.287 -166.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -175.25 167.19 3.42 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.497 1.519 . . . . 3.3799999999999999 111.982 -176.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.2 mt -115.14 148.67 38.72 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.267 1.827 . . . . 1.8700000000000001 110.418 165.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -115.06 138.91 50.34 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.74 1.216 . . . . 1.74 108.858 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.4 t -140.29 124.84 10.95 Favored Pre-proline 0 N--CA 1.471 0.578 0 N-CA-C 112.92 0.711 . . . . 1.8999999999999999 112.92 170.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.33 161.25 44.9 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.855 3.037 . . . . 1.0600000000000001 111.67 178.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -58.16 136.75 76.79 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.664 2.909 . . . . 1.02 111.893 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.78 -9.05 1.14 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 127.363 2.265 . . . . 3.9700000000000002 113.099 -178.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.14 146.27 29.1 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.226 1.394 . . . . 1.21 113.142 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.36 140.44 45.94 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.747 2.019 . . . . 5.1200000000000001 109.529 171.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.8 t -145.89 123.85 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.451 1.9 . . . . 4.1600000000000001 108.234 175.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -109.03 141.76 40.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.745 1.218 . . . . 5.1900000000000004 110.935 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -79.0 65.91 4.3 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.487 1.115 . . . . 2.1800000000000002 109.328 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 136.57 49.66 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-O 118.288 -0.863 . . . . 6.25 112.149 -167.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.459 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 33.9 Cg_endo -62.75 -20.9 72.35 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.89 3.06 . . . . 2.3999999999999999 116.973 -158.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.76 -3.66 87.94 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-O 118.734 -1.036 . . . . 2.6099999999999999 115.093 173.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.5 -108.07 1.3 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.504 1.526 . . . . 1.8999999999999999 113.615 -174.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -71.87 142.66 49.56 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.745 -0.856 . . . . 3.5499999999999998 110.594 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -162.78 168.15 21.87 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.461 1.104 . . . . 0.65000000000000002 110.251 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -93.79 147.26 23.22 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.468 -0.568 . . . . 3.1400000000000001 109.468 163.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.8 tpt -102.32 136.53 41.99 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.887 1.275 . . . . 2.21 109.67 166.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -117.72 128.03 54.49 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.179 1.391 . . . . 1.9399999999999999 109.264 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.67 145.35 50.61 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.036 0.934 . . . . 3.3900000000000001 110.235 173.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.63 51.56 11.66 Favored Glycine 0 N--CA 1.469 0.872 0 O-C-N 121.701 -0.624 . . . . 0.81999999999999995 112.409 174.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.26 155.97 10.66 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 115.064 1.505 . . . . 2.48 115.064 173.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.5 -7.13 12.84 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 113.973 -1.467 . . . . 3.8999999999999999 113.707 -176.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -139.93 168.61 14.35 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 128.22 2.608 . . . . 5.4000000000000004 108.775 166.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -58.7 160.92 16.14 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.578 1.519 . . . . 2.5800000000000001 110.935 161.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.2 103.4 6.22 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.218 1.007 . . . . 3.79 110.147 161.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.5 mmtm -115.34 158.91 21.74 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.723 2.409 . . . . 7.6200000000000001 112.155 174.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.64 120.18 10.1 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.695 -0.854 . . . . 2.5699999999999998 108.695 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.53 -0.73 53.13 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.156 1.36 . . . . 1.3799999999999999 115.141 -174.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.42 -174.66 5.29 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.574 1.687 . . . . 2.8599999999999999 110.272 161.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -155.71 145.56 21.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.834 2.054 . . . . 3.2000000000000002 107.789 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.4 t -148.54 130.35 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 125.785 1.634 . . . . 2.1699999999999999 109.922 -163.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.514 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 10.6 mt-10 -79.05 138.82 38.15 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.868 -0.606 . . . . 3.3999999999999999 111.316 176.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -123.83 132.3 53.75 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.909 1.283 . . . . 4.0199999999999996 110.468 171.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.24 140.22 30.05 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.446 1.898 . . . . 2.4300000000000002 108.669 165.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -107.28 130.18 54.79 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.396 1.878 . . . . 2.1600000000000001 107.926 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.8 mt -109.74 126.94 54.25 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.907 1.283 . . . . 2.0800000000000001 110.678 -176.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -119.97 151.76 38.47 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.484 1.114 . . . . 3.3399999999999999 112.917 -171.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.43 151.57 19.75 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.283 1.033 . . . . 2.0600000000000001 112.798 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.18 16.87 75.42 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.884 -0.954 . . . . 3.4199999999999999 114.738 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.19 78.08 0.93 Allowed Glycine 0 CA--C 1.529 0.959 0 CA-C-N 118.876 1.338 . . . . 2.2599999999999998 113.461 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -152.23 141.09 21.05 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.516 2.726 . . . . 4.29 110.872 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.3 t -138.76 147.88 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.959 1.704 . . . . 2.96 108.092 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 tt -150.56 116.83 5.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.924 0.889 . . . . 3.6499999999999999 110.598 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.514 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 0.8 OUTLIER -95.44 122.06 37.76 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.905 0.705 . . . . 4.9500000000000002 112.905 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -105.31 175.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 126.699 1.999 . . . . 3.3700000000000001 110.604 166.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.7 t -138.8 132.41 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.102 0.961 . . . . 2.8199999999999998 109.364 173.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -125.01 149.93 64.9 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.731 1.612 . . . . 4.2599999999999998 109.703 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.18 159.09 48.65 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.334 2.023 . . . . 1.1299999999999999 110.642 163.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 42.1 t -90.97 134.77 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.374 -1.713 . . . . 2.2599999999999998 106.374 156.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -136.5 174.43 10.62 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.369 0.667 . . . . 3.8199999999999998 111.769 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.6 55.23 1.61 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.538 1.535 . . . . 3.3300000000000001 113.643 -170.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.143 1 C-N-CA 131.739 4.016 . . . . 8.1400000000000006 114.41 161.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.402 0 N-CA-C 107.515 -2.234 . . . . 11.74 107.515 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -61.24 142.93 56.46 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 115.646 -2.422 . . . . 11.140000000000001 107.243 123.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 69.91 136.72 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.628 1.971 . . . . 11.17 112.912 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.479 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 19.0 p -143.44 19.6 1.88 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.159 1.784 . . . . 7.4299999999999997 112.351 -179.268 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.479 ' CD ' ' H ' ' A' ' 4' ' ' THR . 17.2 mp0 -105.72 -174.03 2.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.469 1.908 . . . . 4.4500000000000002 111.297 -165.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.47 171.9 42.33 Favored Glycine 0 C--N 1.336 0.535 0 O-C-N 121.792 -0.568 . . . . 1.6299999999999999 114.326 179.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -152.54 144.3 23.58 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.483 1.113 . . . . 2.29 111.032 166.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.6 t -88.96 133.4 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 107.635 -1.246 . . . . 2.0800000000000001 107.635 175.185 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.84 115.23 27.92 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.145 0.578 . . . . 4.8099999999999996 109.629 -172.061 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -62.88 151.65 38.57 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.91 1.284 . . . . 3.1400000000000001 113.408 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.8 t -162.86 151.41 12.13 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.997 1.719 . . . . 3.0699999999999998 110.207 164.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.1 -12.84 21.32 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.801 2.334 . . . . 2.1899999999999999 112.647 166.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.85 138.86 18.0 Favored Glycine 0 CA--C 1.537 1.46 0 N-CA-C 110.125 -1.19 . . . . 2.5099999999999998 110.125 168.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.33 -26.98 20.04 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.048 2.499 . . . . 2.7799999999999998 114.818 -167.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -84.16 138.58 32.92 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.992 1.269 . . . . 4.4400000000000004 110.829 171.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.76 -176.4 3.97 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.036 1.735 . . . . 1.75 112.178 -166.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.72 149.36 37.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.921 1.288 . . . . 1.6499999999999999 109.71 175.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.35 152.9 47.53 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.248 1.023 . . . . 1.8799999999999999 113.627 -175.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -129.7 143.52 50.86 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.05 2.14 . . . . 3.9199999999999999 108.634 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.52 170.48 14.32 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.474 1.51 . . . . 3.7200000000000002 111.827 -178.612 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.1 m -112.13 130.42 55.9 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 124.455 1.102 . . . . 3.2799999999999998 110.983 -166.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.83 123.0 47.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.418 1.487 . . . . 4.21 107.744 168.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -126.95 134.0 50.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.993 -1.484 . . . . 4.5800000000000001 106.993 161.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -94.21 105.51 17.96 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.031 0.933 . . . . 2.0099999999999998 110.514 -176.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.14 -11.91 16.09 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.515 2.143 . . . . 1.9199999999999999 113.427 176.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.8 178.26 53.25 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 119.204 0.911 . . . . 1.76 111.782 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -107.24 -0.06 22.89 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 126.772 2.029 . . . . 3.5600000000000001 111.745 -173.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.8 157.99 66.95 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 128.301 2.641 . . . . 3.0899999999999999 109.353 175.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.69 159.75 41.97 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.369 2.046 . . . . 1.46 112.137 -170.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.1 mt -112.91 149.28 33.4 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.378 1.471 . . . . 2.6899999999999999 110.279 170.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.4 ttp-105 -128.92 110.8 12.41 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 112.989 -1.914 . . . . 4.0599999999999996 109.325 173.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.1 tp -94.4 114.5 26.55 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 126.097 1.759 . . . . 2.9300000000000002 108.891 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -114.11 -16.82 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.335 1.054 . . . . 1.6000000000000001 112.064 -169.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.93 -175.55 28.98 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.877 1.703 . . . . 0.46000000000000002 113.031 -176.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.74 -178.61 6.44 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.566 1.546 . . . . 1.8 110.845 173.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 -147.02 -179.25 6.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.978 1.711 . . . . 6.2699999999999996 109.245 156.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 t -170.83 148.49 2.61 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 127.316 2.246 . . . . 1.97 107.806 174.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.54 -11.49 24.38 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.825 2.35 . . . . 0.85999999999999999 113.258 -178.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.9 m -110.89 58.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.502 1.521 . . . . 1.9299999999999999 110.883 172.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.57 172.02 16.08 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.944 1.697 . . . . 2.0600000000000001 110.034 167.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -118.28 -21.41 8.14 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.937 0.895 . . . . 3.5600000000000001 111.844 159.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -143.17 150.79 39.88 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 126.15 1.78 . . . . 7.7000000000000002 108.439 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.39 148.17 20.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 C-N-CA 125.803 1.641 . . . . 1.9099999999999999 107.346 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.405 ' HG2' ' HE2' ' A' ' 46' ' ' HIS . 7.2 tp10 -135.67 139.79 43.99 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.02 1.728 . . . . 4.0999999999999996 107.963 -167.052 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.7 tp -102.02 120.07 39.82 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 120.391 1.451 . . . . 2.6000000000000001 110.942 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.405 ' HE2' ' HG2' ' A' ' 44' ' ' GLU . 58.7 m170 -123.93 160.31 27.81 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.794 1.638 . . . . 0.80000000000000004 115.258 -174.397 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' CD ' HH21 ' A' ' 62' ' ' ARG . 15.4 pt-20 -103.66 146.9 27.89 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.791 2.436 . . . . 2.3599999999999999 111.24 158.151 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 100.0 m -107.15 148.57 28.68 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 106.323 -1.732 . . . . 2.23 106.323 156.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -158.49 -179.49 8.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.639 1.176 . . . . 3.2799999999999998 112.671 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.3 mmt -107.78 143.38 36.41 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.055 1.342 . . . . 6.3399999999999999 114.002 -178.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.73 143.87 33.74 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.708 2.003 . . . . 7.0300000000000002 111.803 178.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -99.27 130.93 45.6 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.146 0.978 . . . . 3.3599999999999999 109.011 156.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.5 t -139.98 131.8 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 107.696 -1.224 . . . . 2.8700000000000001 107.696 172.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 59.81 20.92 9.78 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.03 1.732 . . . . 3.8100000000000001 114.552 -173.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.53 25.77 73.38 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.484 -1.385 . . . . 2.75 113.105 -168.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -118.65 123.91 46.12 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.014 1.726 . . . . 4.3899999999999997 108.248 173.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.565 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -73.72 121.85 21.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.037 1.735 . . . . 5.0499999999999998 110.793 170.02 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 m -145.64 156.58 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 128.096 2.558 . . . . 3.6200000000000001 109.764 -172.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 37.8 mtp -95.73 146.27 24.65 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.289 -0.882 . . . . 4.9299999999999997 112.19 173.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.86 168.87 13.72 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.66 1.6 . . . . 0.70999999999999996 111.436 175.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.8 ttm -150.48 142.6 24.07 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.831 1.252 . . . . 1.8999999999999999 109.596 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.416 HH21 ' CD ' ' A' ' 47' ' ' GLU . 31.3 mtm180 -143.0 157.45 60.85 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 125.598 1.559 . . . . 6.5099999999999998 109.792 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.74 157.15 39.76 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.015 1.81 . . . . 0.94999999999999996 111.243 163.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.6 m -138.7 153.41 72.2 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 126.032 1.733 . . . . 2.0 109.402 176.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.56 -22.97 2.91 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.968 2.446 . . . . 0.81999999999999995 113.821 -163.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -179.74 165.6 1.3 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.711 1.604 . . . . 3.3900000000000001 111.899 -179.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -111.54 155.11 23.79 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.869 1.668 . . . . 1.99 110.224 164.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -115.99 146.45 42.12 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.622 1.169 . . . . 2.2999999999999998 109.227 173.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.0 t -140.22 125.06 11.13 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 113.115 0.783 . . . . 2.48 113.115 170.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.14 159.47 40.82 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.945 3.097 . . . . 1.5700000000000001 112.049 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.07 138.1 65.62 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.921 3.08 . . . . 1.7 112.607 -178.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.8 mptt 66.23 -6.58 0.47 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 128.264 2.626 . . . . 3.0699999999999998 114.122 -175.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.97 167.49 34.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.789 1.662 . . . . 1.52 112.65 176.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -132.91 157.93 43.87 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.164 0.985 . . . . 5.2000000000000002 113.526 175.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.3 t -145.59 138.75 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 127.95 2.5 . . . . 3.8599999999999999 107.129 172.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.1 134.4 34.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.296 -1.001 . . . . 4.0300000000000002 108.296 -173.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.76 162.0 27.26 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 125.177 1.391 . . . . 2.6899999999999999 111.379 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.33 154.1 13.98 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 119.884 -1.76 . . . . 5.0999999999999996 115.047 -178.052 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.59 -38.78 80.12 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 124.577 3.518 . . . . 2.7400000000000002 115.089 -174.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.05 9.84 6.34 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 119.203 -0.776 . . . . 1.72 114.374 175.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.52 -132.85 1.4 Allowed Glycine 0 C--N 1.339 0.723 0 C-N-CA 124.909 1.242 . . . . 1.78 114.401 -176.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.402 ' CE1' ' CB ' ' A' ' 47' ' ' GLU . 3.5 m-30 -72.98 139.61 46.81 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 121.51 -0.994 . . . . 3.52 111.483 -169.049 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 -161.19 157.8 26.38 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.093 1.357 . . . . 0.81000000000000005 111.986 -169.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.66 146.79 26.68 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.452 -0.78 . . . . 3.77 109.722 166.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.6 tpt -98.19 134.83 40.71 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.379 1.472 . . . . 1.73 108.54 161.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -110.09 140.99 43.56 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.624 1.169 . . . . 1.71 109.51 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.06 140.54 43.87 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.184 0.809 . . . . 2.9700000000000002 113.184 -178.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.39 49.25 15.83 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.878 0.751 . . . . 0.90000000000000002 114.37 168.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.54 150.0 12.8 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 116.553 2.057 . . . . 2.4100000000000001 116.553 -177.084 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -103.53 2.22 33.27 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 113.509 -1.678 . . . . 2.98 113.111 -174.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -151.38 151.12 28.46 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 127.573 2.349 . . . . 6.1500000000000004 108.622 172.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -66.93 156.03 68.11 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 N-CA-C 108.307 -1.459 . . . . 2.1099999999999999 108.307 152.02 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 pp -151.4 155.25 38.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.032 1.733 . . . . 3.5800000000000001 107.408 -175.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -138.72 156.53 47.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 123.451 1.595 . . . . 5.8300000000000001 114.111 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.6 121.0 11.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.143 -0.935 . . . . 2.46 109.444 173.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.55 49.69 1.38 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.885 1.231 . . . . 1.5900000000000001 112.45 -167.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -148.8 -175.04 4.79 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 129.781 3.232 . . . . 2.4300000000000002 109.339 175.329 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -144.61 140.61 28.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.464 2.305 . . . . 4.0300000000000002 106.69 179.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.7 t -142.61 139.74 28.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 126.289 1.836 . . . . 2.0800000000000001 109.349 -170.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.476 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 21.9 mt-10 -78.72 144.26 35.44 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.075 0.55 . . . . 2.6299999999999999 111.683 177.075 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.38 139.57 50.7 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.89 0.852 . . . . 2.5499999999999998 110.104 150.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.85 152.21 19.05 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.507 1.523 . . . . 2.1099999999999999 108.982 162.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 mp -122.01 130.94 53.72 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.812 1.645 . . . . 2.1099999999999999 109.253 -176.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.5 mt -110.44 118.29 35.87 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.792 1.237 . . . . 1.9099999999999999 110.408 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -114.58 160.45 19.26 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.967 1.307 . . . . 3.73 111.287 -178.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.14 146.45 50.51 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.513 -0.742 . . . . 2.29 111.844 167.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.98 23.95 28.64 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.185 0.898 . . . . 3.1699999999999999 115.041 176.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.04 6.6 83.03 Favored Glycine 0 N--CA 1.478 1.438 0 CA-C-N 118.479 1.14 . . . . 2.2999999999999998 113.592 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -79.97 115.4 19.53 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.247 1.019 . . . . 3.9900000000000002 111.398 -177.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.41 145.17 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.282 1.433 . . . . 3.3599999999999999 109.523 165.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.8 tp -143.23 175.4 9.92 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.916 1.686 . . . . 3.6699999999999999 109.334 175.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.476 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 0.8 OUTLIER -155.4 156.71 35.85 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.358 0.873 . . . . 3.1099999999999999 113.358 170.994 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.9 t -144.08 162.52 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.681 1.992 . . . . 3.48 108.398 179.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.7 t -118.24 144.41 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.104 1.362 . . . . 2.5800000000000001 108.647 -179.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.82 142.13 14.59 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.2 1.0 . . . . 3.1800000000000002 112.441 -168.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.63 156.43 65.69 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.934 3.089 . . . . 0.77000000000000002 113.242 179.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.14 118.32 39.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.301 -0.999 . . . . 1.9199999999999999 108.301 167.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -109.92 -178.74 3.61 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.286 1.035 . . . . 4.1799999999999997 110.719 168.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.01 179.91 7.41 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 117.059 2.244 . . . . 3.29 117.059 -156.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.872 0 CA-C-O 116.62 -1.657 . . . . 9.9399999999999995 112.623 172.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.206 0 N-CA-C 106.052 -2.819 . . . . 10.390000000000001 106.052 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 p -52.1 171.9 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 121.469 0.652 . . . . 8.2799999999999994 111.875 134.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -166.08 -43.68 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.325 1.85 . . . . 11.41 109.011 -178.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.5 p -69.64 122.09 18.42 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 107.945 -1.132 . . . . 9.7699999999999996 107.945 140.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.45 ' HG3' ' H ' ' A' ' 6' ' ' GLY . 2.9 tp10 -157.41 168.74 26.47 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.262 2.625 . . . . 4.5099999999999998 107.341 178.093 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.45 ' H ' ' HG3' ' A' ' 5' ' ' GLU . . . -94.38 173.24 32.51 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 119.526 1.057 . . . . 1.6000000000000001 113.04 -179.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -156.87 161.05 39.69 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.835 1.654 . . . . 9.1699999999999999 111.651 178.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.2 t -130.48 132.53 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.127 1.371 . . . . 2.23 109.053 173.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -91.2 112.96 25.09 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.354 0.597 . . . . 5.8600000000000003 110.467 -174.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -57.76 147.13 28.99 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.952 2.101 . . . . 4.2800000000000002 114.133 179.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 t -162.67 150.82 11.88 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.344 1.458 . . . . 3.1800000000000002 109.641 162.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -83.81 45.98 1.92 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.013 3.142 . . . . 2.8599999999999999 111.188 171.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -124.25 167.92 16.48 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.481 1.515 . . . . 1.54 113.855 -174.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.72 -20.77 22.53 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.715 2.943 . . . . 1.3799999999999999 114.064 -177.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.3 152.24 48.32 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.55 1.54 . . . . 3.0699999999999998 113.467 -176.236 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.47 -174.37 4.58 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.689 1.996 . . . . 1.8700000000000001 112.31 -171.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.02 136.08 43.81 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.657 1.583 . . . . 1.6899999999999999 109.329 172.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.26 123.99 46.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.612 1.565 . . . . 1.9299999999999999 111.627 -176.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -106.02 65.48 0.7 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.853 1.661 . . . . 4.0800000000000001 109.397 -173.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp -73.29 148.71 43.31 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.189 -0.944 . . . . 3.0499999999999998 113.239 -170.082 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.468 ' HG1' ' NH1' ' A' ' 74' ' ' ARG . 9.5 t -83.23 139.63 33.0 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.102 -0.999 . . . . 4.7599999999999998 110.347 168.82 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.83 131.44 56.83 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.728 1.611 . . . . 3.9100000000000001 107.942 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -120.56 131.31 54.6 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.173 1.389 . . . . 4.2699999999999996 109.656 173.32 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -107.38 100.36 33.22 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.993 -0.743 . . . . 1.51 108.993 161.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.98 -9.26 15.54 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.027 2.484 . . . . 1.51 113.393 174.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.69 -179.51 51.31 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 122.433 1.019 . . . . 1.21 113.033 -175.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.424 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 14.6 m-20 -106.35 -3.51 21.03 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 127.776 2.431 . . . . 2.9900000000000002 111.717 -172.532 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -119.25 159.18 46.35 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 127.89 2.476 . . . . 2.6699999999999999 110.202 172.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.75 146.11 20.77 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.741 2.294 . . . . 1.1200000000000001 111.167 -175.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mp -103.93 153.49 20.74 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.532 1.133 . . . . 4.0300000000000002 110.711 173.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.69 112.66 12.74 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.098 1.359 . . . . 4.2000000000000002 110.0 178.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.9 tp -91.98 113.28 25.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.762 1.625 . . . . 2.8500000000000001 108.86 -177.186 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.5 m -111.41 -15.55 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.855 1.262 . . . . 1.77 111.668 -170.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.59 -178.17 31.39 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.916 1.722 . . . . 0.71999999999999997 113.694 -176.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.05 -179.61 8.31 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.886 1.674 . . . . 1.8500000000000001 112.41 168.303 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -157.34 152.56 26.1 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.331 2.252 . . . . 6.5999999999999996 108.532 177.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -159.74 150.21 15.44 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 117.837 -1.077 . . . . 1.79 110.936 177.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.96 0.08 7.71 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.393 3.395 . . . . 1.27 113.66 174.034 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.413 ' HA ' ' H ' ' A' ' 90' ' ' LYS . 15.2 m -116.32 49.86 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.979 1.312 . . . . 2.8799999999999999 110.791 166.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.75 164.65 35.65 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.398 1.094 . . . . 2.27 112.012 161.194 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -104.05 -30.62 10.15 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 127.648 2.379 . . . . 4.1200000000000001 111.371 163.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 -149.55 140.03 22.43 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.751 1.62 . . . . 7.1500000000000004 109.459 172.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 p -100.05 167.34 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.028 1.331 . . . . 2.6499999999999999 109.204 174.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.79 150.76 35.96 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.8 2.04 . . . . 4.2999999999999998 108.069 176.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.5 tp -120.8 114.67 21.96 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.572 1.078 . . . . 2.1000000000000001 111.258 -172.056 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -122.77 157.36 32.54 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 115.091 1.515 . . . . 0.91000000000000003 115.091 -170.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.74 -178.6 4.3 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.129 2.171 . . . . 3.0499999999999998 111.75 158.434 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.7 m -145.34 148.41 33.37 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 107.904 -1.147 . . . . 1.8700000000000001 107.904 162.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -152.08 167.56 28.08 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 123.193 1.473 . . . . 3.7599999999999998 114.802 -170.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.6 ttp -100.81 140.62 34.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.398 1.479 . . . . 4.0099999999999998 110.745 172.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.79 176.01 10.2 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.599 1.56 . . . . 8.2300000000000004 112.063 178.1 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -146.15 133.48 20.65 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.076 1.751 . . . . 2.1699999999999999 106.743 -179.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 m -149.84 135.86 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.784 1.634 . . . . 3.5800000000000001 107.447 -169.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 60.88 12.41 3.83 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.734 1.614 . . . . 4.3200000000000003 114.19 -172.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.9 20.69 55.19 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.096 0.855 . . . . 1.7 114.302 -171.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -132.83 135.5 45.68 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.935 1.294 . . . . 5.4500000000000002 111.216 174.519 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -71.19 143.92 50.32 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.021 2.528 . . . . 4.9400000000000004 110.904 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.1 p -156.7 172.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 126.666 1.986 . . . . 3.5600000000000001 109.932 -172.567 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 64.1 mtt -114.0 153.22 29.73 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.077 0.951 . . . . 3.71 111.158 167.076 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.21 175.02 20.05 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 126.427 1.965 . . . . 0.68000000000000005 111.766 176.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 ttm -150.17 146.01 26.62 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.631 1.573 . . . . 1.97 109.368 174.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.57 146.86 23.4 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 124.364 1.066 . . . . 6.4800000000000004 111.109 -169.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -78.43 153.57 27.37 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.032 1.821 . . . . 0.87 111.515 171.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.1 m -140.77 152.03 64.61 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 125.843 1.657 . . . . 1.99 110.777 -175.148 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.74 -23.85 6.59 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.546 2.831 . . . . 0.75 113.504 -167.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -178.29 163.54 1.64 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.68 1.992 . . . . 3.23 110.442 179.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.6 mt -110.25 157.16 19.75 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.211 1.404 . . . . 1.9099999999999999 110.057 164.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -118.58 146.64 44.45 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.084 0.954 . . . . 2.3300000000000001 110.32 168.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.78 128.98 17.14 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.489 0.716 . . . . 2.2599999999999998 110.982 172.051 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -71.42 165.03 33.74 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.107 3.205 . . . . 1.4099999999999999 112.318 -176.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.31 141.68 96.36 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.637 2.891 . . . . 1.3200000000000001 112.733 178.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.424 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 67.8 mmtt 66.05 0.64 1.67 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.554 1.942 . . . . 2.9399999999999999 113.592 -176.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.51 126.81 7.64 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.587 1.565 . . . . 1.6000000000000001 113.881 -174.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.468 ' NH1' ' HG1' ' A' ' 21' ' ' THR . 4.6 mmt180 -88.31 123.13 32.59 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.886 1.274 . . . . 7.0599999999999996 107.642 156.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.7 t -149.65 98.07 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.892 0.877 . . . . 4.2199999999999998 109.614 175.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.54 142.46 42.78 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.865 -0.522 . . . . 3.23 110.751 -177.068 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -65.16 95.39 0.18 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.248 -1.389 . . . . 2.6000000000000001 107.248 159.083 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.98 150.45 37.44 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.529 1.132 . . . . 4.71 113.93 -164.014 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.25 142.62 92.16 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.791 2.328 . . . . 3.3500000000000001 110.187 174.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.73 -2.73 85.46 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-O 118.709 -1.05 . . . . 2.5099999999999998 114.163 -168.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.78 -127.69 1.36 Allowed Glycine 0 C--N 1.34 0.759 0 CA-C-N 118.892 1.346 . . . . 1.6599999999999999 113.114 172.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -72.99 140.54 47.42 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.655 -0.909 . . . . 3.52 112.695 -164.335 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -163.54 158.97 21.4 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.284 1.034 . . . . 0.93999999999999995 113.405 -176.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -87.11 136.65 32.85 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.853 -0.529 . . . . 3.04 110.678 166.063 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.2 tpt -84.06 138.76 32.9 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.488 1.115 . . . . 1.6499999999999999 108.496 159.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -117.84 134.77 54.6 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.099 1.36 . . . . 1.78 108.63 179.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 mp -132.86 137.43 46.7 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 122.991 0.516 . . . . 2.6200000000000001 111.918 177.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.64 47.74 7.72 Favored Glycine 0 N--CA 1.467 0.709 0 C-N-CA 125.208 1.385 . . . . 0.81000000000000005 113.162 171.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.51 147.37 14.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.634 1.716 . . . . 2.25 115.634 -177.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.413 ' H ' ' HA ' ' A' ' 39' ' ' VAL . 59.1 mmtt -104.04 -3.79 24.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.937 -1.483 . . . . 3.29 113.907 -172.116 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -149.24 139.23 13.2 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.331 1.453 . . . . 6.6600000000000001 112.021 171.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.75 135.08 15.6 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.526 2.818 . . . . 2.2400000000000002 109.651 173.374 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.7 mp -93.59 -167.94 1.8 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.032 1.333 . . . . 3.8199999999999998 110.789 -168.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -134.13 172.74 12.42 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 127.478 2.311 . . . . 4.5800000000000001 108.843 164.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.51 129.31 34.43 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 118.113 -1.435 . . . . 2.2000000000000002 107.871 138.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.93 58.64 1.23 Allowed Glycine 0 CA--C 1.528 0.846 0 O-C-N 124.301 1.001 . . . . 1.3600000000000001 111.654 -168.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -141.37 175.73 9.42 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.323 1.449 . . . . 2.9900000000000002 111.317 161.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.28 87.41 1.96 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.906 2.482 . . . . 3.3999999999999999 109.827 -170.25 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 91.2 t -113.18 144.29 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 120.586 -1.321 . . . . 2.6800000000000002 112.119 -156.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.513 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 46.5 mt-10 -79.0 141.35 37.55 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.999 1.111 . . . . 2.5899999999999999 113.999 -167.6 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -125.11 143.5 50.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.565 1.546 . . . . 3.79 108.834 159.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -114.5 123.02 48.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.345 2.258 . . . . 2.1800000000000002 107.899 172.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.3 mp -98.69 127.25 44.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.665 1.986 . . . . 2.9300000000000002 109.931 -169.054 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.7 mt -104.96 112.61 25.81 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.437 1.113 . . . . 1.6499999999999999 110.612 -178.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -101.02 154.88 18.33 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.789 1.236 . . . . 3.3399999999999999 110.508 178.101 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.25 141.34 14.99 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.443 -0.798 . . . . 2.1000000000000001 110.771 170.019 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.52 -1.19 81.47 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.693 -1.06 . . . . 3.0499999999999998 114.399 -171.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.57 13.08 61.83 Favored Glycine 0 N--CA 1.473 1.106 0 CA-C-N 119.038 1.419 . . . . 3.2799999999999998 114.361 173.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.57 134.82 38.16 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.948 -1.325 . . . . 7.0099999999999998 111.047 -179.101 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -113.22 140.6 32.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 126.228 1.811 . . . . 3.21 110.191 172.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.1 tp -145.64 126.68 14.61 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.496 1.119 . . . . 3.29 110.921 176.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.513 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 32.3 ttmt -85.8 139.41 31.32 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.043 0.757 . . . . 3.3500000000000001 113.043 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.01 161.93 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 127.67 2.388 . . . . 3.46 110.847 164.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 83.7 t -121.53 135.62 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.585 1.154 . . . . 2.48 108.824 174.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.2 mt -131.41 132.32 23.49 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.886 1.275 . . . . 3.0800000000000001 110.972 -169.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -57.19 141.82 94.46 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 124.168 3.245 . . . . 2.21 114.75 172.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.6 t -114.14 128.9 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.685 1.194 . . . . 2.3100000000000001 111.603 175.297 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.402 ' CD ' HH21 ' A' ' 120' ' ' ARG . 4.2 tt0 -156.72 163.64 39.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.92 1.688 . . . . 3.6800000000000002 112.147 -179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.05 104.72 16.69 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.27 1.028 . . . . 2.8599999999999999 110.43 176.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.402 HH21 ' CD ' ' A' ' 118' ' ' GLU . 98.4 mtt180 . . . . . 0 C--O 1.247 0.922 0 C-N-CA 126.093 1.757 . . . . 11.0 108.033 178.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.271 0 N-CA-C 105.623 -2.991 . . . . 12.76 105.623 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -56.05 160.38 2.86 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 117.512 0.656 . . . . 10.73 109.831 136.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -89.84 157.19 18.02 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.569 0.748 . . . . 11.699999999999999 111.838 177.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 p -154.04 -57.28 0.11 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.217 1.807 . . . . 6.71 107.303 -174.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 19.2 tt0 -91.89 177.96 6.03 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.758 2.023 . . . . 6.96 109.277 153.712 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.438 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -131.19 -175.24 13.93 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.445 1.974 . . . . 1.3300000000000001 111.116 176.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.5 p90 -135.27 -178.49 5.13 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.231 1.515 . . . . 2.25 113.402 -168.153 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.72 152.25 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 126.774 2.03 . . . . 3.5499999999999998 112.114 -178.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 -71.77 -26.41 62.42 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 116.11 1.893 . . . . 6.1799999999999997 116.11 -174.433 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.0 t80 71.75 157.05 0.17 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.066 2.547 . . . . 2.79 111.978 -160.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -155.53 149.04 18.66 Favored Pre-proline 0 CA--C 1.538 0.488 0 O-C-N 121.535 -0.728 . . . . 3.2000000000000002 111.217 162.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -85.7 -2.67 9.07 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.649 2.899 . . . . 2.4100000000000001 112.018 167.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -121.01 -179.99 16.22 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.672 1.606 . . . . 1.2 114.065 -175.099 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.56 -18.1 48.65 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.439 3.426 . . . . 1.48 113.986 -174.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -114.61 137.77 51.47 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.055 2.142 . . . . 2.2999999999999998 113.863 -178.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.28 -177.26 5.38 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.79 2.436 . . . . 1.6599999999999999 111.738 -172.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.38 149.24 30.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.143 1.377 . . . . 1.8899999999999999 110.862 178.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.18 147.21 51.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.893 1.277 . . . . 1.79 113.832 -174.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -128.32 43.11 3.2 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 127.424 2.29 . . . . 4.4299999999999997 114.703 -168.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -73.0 150.58 42.33 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 119.569 -1.957 . . . . 3.8399999999999999 115.598 -168.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 m -96.27 149.4 21.71 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.831 1.653 . . . . 2.4399999999999999 109.16 173.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.47 166.47 33.44 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.671 1.589 . . . . 3.8300000000000001 112.153 -176.433 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -128.79 140.97 51.46 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.91 2.084 . . . . 4.2400000000000002 112.334 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -96.52 99.57 5.72 Favored Pre-proline 0 CA--C 1.542 0.667 0 O-C-N 121.478 -0.764 . . . . 1.6000000000000001 109.354 158.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.65 -12.11 12.52 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.493 2.128 . . . . 1.3799999999999999 113.71 176.136 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.78 178.35 53.71 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-O 122.552 1.084 . . . . 1.21 112.936 -175.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.444 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 15.2 m-20 -104.75 0.91 28.73 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.87 2.468 . . . . 2.9300000000000002 112.318 -173.689 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mp -125.48 160.8 53.84 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 127.767 2.427 . . . . 5.3300000000000001 108.798 174.079 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.65 155.75 21.1 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.231 1.954 . . . . 1.1000000000000001 111.732 -167.689 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.75 147.76 28.23 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.88 1.272 . . . . 3.4500000000000002 110.224 170.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.0 ttp180 -136.64 103.92 5.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.016 -1.902 . . . . 5.1399999999999997 109.297 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -84.85 110.05 18.55 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.478 1.911 . . . . 3.3799999999999999 108.847 -175.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.9 m -106.34 -20.88 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.764 1.226 . . . . 1.6100000000000001 111.932 -174.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.48 -175.76 31.83 Favored Glycine 0 C--N 1.343 0.947 0 C-N-CA 125.004 1.287 . . . . 0.42999999999999999 114.13 -173.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.43 -177.28 5.98 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.754 2.021 . . . . 1.53 111.0 173.383 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -157.95 170.78 21.55 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.89 2.476 . . . . 5.6900000000000004 107.626 171.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 t -173.44 149.74 1.71 Allowed Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 125.294 1.438 . . . . 1.71 110.364 174.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.54 -8.12 21.28 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.773 2.316 . . . . 0.78000000000000003 114.037 172.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.3 m -118.87 49.39 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.545 1.138 . . . . 1.8100000000000001 113.295 174.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.23 151.34 17.39 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.643 1.177 . . . . 1.74 110.704 161.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -95.7 -30.77 13.56 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.382 1.473 . . . . 3.3500000000000001 111.948 169.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.6 mtp-105 -133.08 141.15 48.05 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.693 1.597 . . . . 6.2000000000000002 108.915 171.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -125.3 148.6 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.157 1.383 . . . . 1.8200000000000001 109.558 168.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -137.45 151.46 48.52 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.649 1.98 . . . . 2.8700000000000001 109.736 178.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.8 tp -104.61 118.51 36.75 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.492 0.717 . . . . 2.1099999999999999 110.56 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -124.53 148.87 47.5 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 123.084 1.421 . . . . 0.66000000000000003 113.914 -174.506 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -89.08 176.38 7.01 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 113.889 -1.505 . . . . 2.46 111.521 162.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 64.9 m -155.01 136.47 14.18 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 105.457 -2.053 . . . . 1.9099999999999999 105.457 175.175 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -149.43 161.52 41.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 122.952 1.358 . . . . 3.3799999999999999 114.184 -166.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -87.41 136.22 33.03 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.333 -1.303 . . . . 4.5199999999999996 110.588 172.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.01 143.22 20.28 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.204 1.002 . . . . 5.6699999999999999 113.699 -177.501 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.55 130.9 36.54 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 125.655 1.582 . . . . 3.0699999999999998 111.63 172.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.5 t -141.45 134.8 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 126.066 1.746 . . . . 2.9700000000000002 107.274 169.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 65.9 16.76 10.61 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.645 1.178 . . . . 3.9199999999999999 113.352 -176.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.24 21.05 68.27 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 121.188 -0.945 . . . . 1.51 113.396 -171.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -138.86 133.33 31.84 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.169 1.787 . . . . 4.46 109.717 -170.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.31 117.09 17.62 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.109 1.364 . . . . 4.7199999999999998 113.506 -178.641 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -117.14 174.06 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 128.669 2.787 . . . . 3.1499999999999999 109.103 170.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.41 130.34 56.42 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.946 0.898 . . . . 4.0599999999999996 109.901 177.422 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.31 172.91 15.01 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.573 1.083 . . . . 0.59999999999999998 113.286 -179.328 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ttm -148.78 143.07 26.13 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.573 1.549 . . . . 1.8300000000000001 109.765 177.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -144.92 152.19 51.12 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.369 1.868 . . . . 8.8300000000000001 109.143 -176.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -80.83 150.71 18.59 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.593 2.195 . . . . 0.69999999999999996 110.206 170.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.24 155.49 80.84 Favored Pre-proline 0 N--CA 1.48 1.05 0 C-N-CA 124.496 1.119 . . . . 1.8200000000000001 110.379 -177.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.76 -30.04 2.53 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.746 2.297 . . . . 0.60999999999999999 112.713 -170.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -176.2 164.73 2.76 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.735 1.614 . . . . 3.46 112.042 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.5 mt -109.03 158.73 17.45 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.04 1.336 . . . . 1.9199999999999999 109.282 161.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -139.74 144.66 37.57 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.96 0.904 . . . . 2.21 111.242 174.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.2 t -146.74 140.1 14.82 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.447 1.099 . . . . 2.7200000000000002 112.323 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.64 170.62 8.15 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 124.417 3.411 . . . . 1.75 114.092 176.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.96 150.12 80.12 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.616 3.544 . . . . 1.25 113.774 171.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.444 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 69.2 mmtt 68.49 -7.24 0.72 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.912 2.085 . . . . 2.71 115.085 176.252 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.81 149.34 32.95 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.438 1.018 . . . . 1.2 112.683 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 mtt-85 -86.8 162.03 18.03 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 122.003 -0.704 . . . . 7.4199999999999999 110.155 161.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.1 150.44 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.054 1.741 . . . . 5.0199999999999996 108.724 172.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.75 137.9 30.1 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.945 0.898 . . . . 3.29 110.344 161.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -78.54 80.72 4.91 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 122.283 1.04 . . . . 2.1600000000000001 108.336 170.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.39 136.57 88.9 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 115.403 -0.817 . . . . 4.0899999999999999 112.908 -177.083 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -60.84 -25.62 81.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.236 2.624 . . . . 2.0699999999999998 112.553 176.284 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.7 9.66 28.68 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 117.652 -1.638 . . . . 1.8700000000000001 114.722 174.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.65 -10.55 0.03 OUTLIER Glycine 0 C--N 1.346 1.107 0 N-CA-C 121.56 3.384 . . . . 2.1299999999999999 121.56 167.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -143.99 145.3 32.13 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 121.124 2.462 . . . . 3.4199999999999999 112.843 172.195 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -158.68 152.0 22.82 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.599 0.76 . . . . 0.65000000000000002 110.816 175.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -78.7 141.56 37.81 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.418 -0.956 . . . . 2.7000000000000002 108.418 160.062 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.0 tpt -99.42 130.23 45.67 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.399 1.88 . . . . 1.54 108.489 168.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.9 mp -111.61 139.61 46.9 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.47 1.508 . . . . 1.6599999999999999 108.357 -179.262 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.2 mp -137.82 143.73 41.15 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.418 1.087 . . . . 2.4300000000000002 109.576 175.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.91 42.42 45.32 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.957 -0.457 . . . . 1.0 111.957 -178.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.35 141.9 28.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 122.865 1.317 . . . . 2.5099999999999998 113.342 170.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -100.65 0.78 39.8 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.084 -1.416 . . . . 3.5 113.05 -171.334 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -123.86 146.63 51.32 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 126.959 2.104 . . . . 6.2300000000000004 107.821 167.013 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -62.34 120.27 7.74 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 N-CA-C 105.166 -2.667 . . . . 1.8 105.166 149.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 tp -76.79 79.95 3.4 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 122.177 0.989 . . . . 3.6200000000000001 111.387 -157.077 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . 0.268 5.6 tmtt? -64.74 114.5 4.5 Favored 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 120.368 -1.458 . . . . 7.0999999999999996 110.949 -169.334 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.71 114.83 1.25 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.216 1.406 . . . . 2.4300000000000002 111.443 170.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.67 44.81 6.3 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.201 1.381 . . . . 1.6000000000000001 112.699 -169.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -101.3 -177.22 3.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.919 1.688 . . . . 3.0099999999999998 109.209 145.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -130.68 125.5 34.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 129.328 3.051 . . . . 3.8900000000000001 103.91 178.064 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.9 t -128.66 122.25 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.381 1.873 . . . . 2.23 108.985 -171.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.489 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 14.7 pt-20 -81.8 146.66 29.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.933 0.873 . . . . 2.3300000000000001 112.582 171.133 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.77 138.03 54.22 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.665 1.586 . . . . 2.6800000000000002 109.77 163.433 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -78.32 149.0 33.55 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.343 1.857 . . . . 2.71 108.125 158.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.2 mp -127.16 132.59 50.48 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.667 1.587 . . . . 2.0299999999999998 108.482 175.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.5 mt -105.95 118.43 36.58 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.806 1.242 . . . . 1.9399999999999999 109.456 -175.258 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -116.55 118.23 32.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.422 1.489 . . . . 3.23 111.786 -172.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.86 20.84 1.75 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.5 1.92 . . . . 2.9300000000000002 114.277 176.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.28 -61.73 4.13 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.208 1.385 . . . . 4.4199999999999999 112.286 -167.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.94 4.68 60.74 Favored Glycine 0 N--CA 1.474 1.21 0 N-CA-C 117.089 1.596 . . . . 2.04 117.089 -166.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -131.99 140.06 48.83 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.481 1.64 . . . . 4.1900000000000004 112.178 175.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.17 146.88 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.361 1.464 . . . . 3.25 109.334 171.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 tt -150.7 160.88 43.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.91 2.484 . . . . 3.0299999999999998 107.593 176.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.489 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 57.1 pttt -144.89 152.94 41.03 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.027 1.285 . . . . 2.75 114.436 175.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.51 157.79 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.416 1.486 . . . . 3.4399999999999999 109.409 -174.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 66.6 t -87.39 161.76 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.951 1.3 . . . . 2.7000000000000002 109.127 175.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.25 140.08 11.42 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 126.239 1.816 . . . . 3.4700000000000002 110.223 164.168 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.97 146.2 64.31 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.247 2.632 . . . . 0.72999999999999998 111.987 174.109 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.77 116.56 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.768 -0.827 . . . . 2.29 108.768 167.357 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.43 ' CD ' HH22 ' A' ' 120' ' ' ARG . 39.3 mt-10 -137.05 176.57 8.6 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.798 1.639 . . . . 4.4100000000000001 110.116 -177.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -113.36 136.72 52.46 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.298 1.039 . . . . 2.6000000000000001 111.518 174.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.43 HH22 ' CD ' ' A' ' 118' ' ' GLU 0.277 19.9 ptt-85 . . . . . 0 N--CA 1.485 1.297 0 C-N-CA 131.175 3.79 . . . . 10.34 111.415 168.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.111 0 N-CA-C 107.418 -2.273 . . . . 10.539999999999999 107.418 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.8 p -52.3 130.06 29.89 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 117.576 -1.65 . . . . 10.0 107.639 129.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -108.42 150.12 27.83 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.852 0.861 . . . . 11.640000000000001 110.695 -175.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.0 p -147.59 123.77 10.84 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.756 1.622 . . . . 6.7599999999999998 108.181 -179.028 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -83.81 179.42 7.57 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 123.872 0.732 . . . . 7.8600000000000003 110.408 173.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.51 -175.33 19.59 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 125.1 1.333 . . . . 1.8 112.565 177.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -141.59 175.29 9.81 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.995 1.109 . . . . 2.5499999999999998 113.995 178.471 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.6 t -111.93 126.12 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 126.284 1.833 . . . . 3.1299999999999999 106.166 162.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.6 ttp85 -87.19 131.77 34.08 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.296 -1.001 . . . . 6.2699999999999996 108.296 171.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -57.35 117.59 4.26 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.122 0.569 . . . . 2.98 110.98 -175.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.5 m -174.68 106.11 0.27 Allowed Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 128.851 2.86 . . . . 4.8700000000000001 107.036 167.052 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -93.42 -125.53 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.603 3.535 . . . . 6.0599999999999996 109.515 -176.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.73 -155.41 30.5 Favored Glycine 0 CA--C 1.543 1.785 0 O-C-N 121.425 -0.797 . . . . 2.5800000000000001 113.164 178.423 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.82 -31.19 13.21 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.914 2.409 . . . . 4.1799999999999997 112.091 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.09 123.36 21.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.889 1.675 . . . . 4.2400000000000002 111.049 169.306 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.18 -179.04 4.96 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.131 1.772 . . . . 2.0099999999999998 111.336 172.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.96 135.93 29.86 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 121.052 -1.03 . . . . 2.0899999999999999 111.097 -176.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.78 146.14 51.98 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.819 1.648 . . . . 2.0 112.05 -176.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -135.89 62.78 1.61 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.19 0.996 . . . . 4.7800000000000002 111.488 -157.062 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.06 162.71 24.0 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.468 -0.787 . . . . 2.6299999999999999 113.015 -173.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.6 m -125.78 145.83 50.04 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.782 1.633 . . . . 2.71 107.571 171.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.47 164.62 38.39 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.96 1.304 . . . . 5.3700000000000001 110.176 174.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -127.94 154.98 44.95 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.391 1.076 . . . . 3.96 110.594 168.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -101.35 95.1 4.61 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 124.552 1.141 . . . . 1.3600000000000001 109.221 171.334 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.92 -19.18 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.151 1.9 . . . . 1.6699999999999999 113.28 -177.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.46 -177.02 51.47 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-O 122.351 0.973 . . . . 1.46 112.455 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -112.85 2.85 16.08 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.517 1.927 . . . . 4.1699999999999999 112.389 -170.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -98.38 157.04 35.06 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.634 1.974 . . . . 3.29 110.243 164.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.57 148.63 14.32 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.243 2.628 . . . . 0.95999999999999996 111.179 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.1 mt -102.65 146.04 28.77 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 122.8 1.286 . . . . 2.98 111.87 170.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.9 ttp-105 -129.77 109.61 11.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 111.984 -2.371 . . . . 3.7000000000000002 108.967 176.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -95.41 111.66 23.51 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.402 1.881 . . . . 3.6400000000000001 108.606 -174.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -111.21 -21.26 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.145 0.978 . . . . 1.6200000000000001 112.033 -168.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.54 -174.26 30.14 Favored Glycine 0 C--N 1.344 1.018 0 C-N-CA 124.596 1.093 . . . . 0.56999999999999995 114.277 -174.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.16 -178.79 6.4 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.563 1.545 . . . . 1.8200000000000001 111.466 170.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -151.6 167.07 29.24 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.804 2.442 . . . . 5.4199999999999999 107.746 164.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 t -174.07 149.23 1.45 Allowed Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 125.164 1.386 . . . . 1.9299999999999999 108.536 -171.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.18 -3.5 13.49 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.185 2.59 . . . . 0.82999999999999996 114.281 177.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.4 m -119.4 28.39 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 115.22 1.563 . . . . 1.75 115.22 -174.009 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.33 167.03 31.72 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.781 1.632 . . . . 1.7 111.481 173.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -96.67 -31.13 12.86 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.458 1.503 . . . . 3.0699999999999998 111.056 173.278 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -139.1 153.35 48.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 129.889 3.276 . . . . 5.8700000000000001 108.034 -173.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.5 p -155.07 121.76 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 124.896 1.279 . . . . 2.6400000000000001 109.775 178.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -140.66 129.95 23.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.143 -0.935 . . . . 4.1399999999999997 109.795 -165.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -82.23 140.43 33.67 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 123.261 1.505 . . . . 3.04 113.285 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -117.11 157.16 26.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.612 2.365 . . . . 0.89000000000000001 112.304 175.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.423 ' CD ' HH21 ' A' ' 62' ' ' ARG . 13.8 pt-20 -95.33 149.01 21.83 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.642 1.977 . . . . 2.6000000000000001 109.541 158.182 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.0 m -115.62 149.63 37.98 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.369 1.868 . . . . 2.2000000000000002 106.012 159.654 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -158.93 177.39 11.2 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.817 0.847 . . . . 3.2400000000000002 113.146 -177.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 76.1 mtm -108.76 144.22 36.86 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.234 1.414 . . . . 4.0800000000000001 111.612 172.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -139.78 146.95 40.11 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.418 1.487 . . . . 6.0300000000000002 111.597 173.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -93.94 140.48 29.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.725 1.21 . . . . 2.25 108.167 156.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.8 t -138.83 119.2 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.175 1.39 . . . . 3.0800000000000001 107.252 170.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 62.46 20.08 11.64 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.087 1.355 . . . . 3.4500000000000002 113.95 -177.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.83 15.4 75.41 Favored Glycine 0 N--CA 1.477 1.413 0 O-C-N 120.47 -1.394 . . . . 1.5 113.504 -170.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -117.02 115.71 25.95 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.696 2.398 . . . . 4.25 108.314 -179.587 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.469 ' H ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -93.72 131.26 39.22 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.588 1.155 . . . . 5.0499999999999998 111.47 -170.62 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.9 p -155.32 148.96 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.9 1.68 . . . . 3.7599999999999998 109.99 -168.112 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.9 mtt -89.22 155.48 19.37 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.521 0.728 . . . . 3.46 111.956 176.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.5 176.05 20.82 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 124.612 1.101 . . . . 0.58999999999999997 112.714 179.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ttm -153.83 144.81 22.74 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 126.058 1.743 . . . . 1.6399999999999999 109.205 -178.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.423 HH21 ' CD ' ' A' ' 47' ' ' GLU . 26.0 mtm180 -151.0 157.99 35.05 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 125.658 1.583 . . . . 5.6500000000000004 109.472 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -73.6 157.26 48.82 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.146 1.897 . . . . 0.89000000000000001 111.266 168.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.17 158.81 71.85 Favored Pre-proline 0 N--CA 1.481 1.12 0 CA-C-O 118.53 -0.747 . . . . 2.5099999999999998 110.729 173.873 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -83.18 -24.98 2.9 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.277 2.651 . . . . 1.02 113.355 -170.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -179.39 164.61 1.35 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.88 2.072 . . . . 3.6800000000000002 110.781 -178.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.2 mt -109.43 154.3 22.8 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.757 1.223 . . . . 1.7 110.26 163.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -115.53 140.4 49.2 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.25 1.02 . . . . 1.9199999999999999 108.987 170.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.3 t -141.86 129.04 11.47 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 123.886 0.874 . . . . 2.1400000000000001 111.365 174.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.45 170.42 16.24 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.428 2.752 . . . . 1.1299999999999999 112.545 -178.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -57.63 139.54 90.57 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.142 2.561 . . . . 1.51 111.172 166.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm 65.22 0.75 1.37 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.279 1.831 . . . . 3.5499999999999998 114.524 -174.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.56 177.54 52.75 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.291 1.9 . . . . 1.8799999999999999 112.395 171.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.6 ptt85 -131.83 132.94 44.14 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.515 1.126 . . . . 9.5199999999999996 112.876 -172.432 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.88 73.29 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 127.071 2.148 . . . . 6.4100000000000001 109.094 -174.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.33 117.87 35.12 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.605 1.962 . . . . 3.7599999999999998 110.064 -172.075 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.29 58.03 0.61 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.493 1.917 . . . . 2.73 111.58 -171.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.457 ' H ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -61.97 146.59 91.39 Favored Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 125.973 1.709 . . . . 4.1100000000000003 115.364 178.533 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -61.12 -33.5 91.06 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 124.319 3.346 . . . . 3.2999999999999998 114.782 -177.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.25 5.25 44.08 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.153 0.882 . . . . 1.53 114.182 177.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.22 -124.96 0.97 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.955 1.264 . . . . 1.6100000000000001 111.591 170.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -71.11 138.01 49.35 Favored 'General case' 0 C--O 1.219 -0.527 0 O-C-N 121.653 -0.91 . . . . 3.3500000000000001 111.274 -174.07 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -159.93 158.16 30.26 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.416 0.687 . . . . 0.70999999999999996 112.451 -176.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -89.71 137.49 32.29 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.181 -0.949 . . . . 2.9900000000000002 111.737 174.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.9 tpt -97.35 127.69 43.53 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.416 1.886 . . . . 1.8799999999999999 109.146 163.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.78 121.81 44.8 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.939 1.296 . . . . 1.8200000000000001 108.525 -178.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.8 136.52 52.49 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.155 0.582 . . . . 3.6899999999999999 110.875 -163.329 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.32 38.44 62.7 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.867 -0.521 . . . . 1.22 112.554 -170.584 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.87 148.02 0.87 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 116.546 2.054 . . . . 3.1400000000000001 116.546 176.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -99.74 1.75 43.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.816 -1.538 . . . . 2.6000000000000001 113.705 -177.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -159.32 150.53 16.34 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 125.658 1.583 . . . . 5.6500000000000004 111.027 -177.105 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.91 83.85 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.016 2.477 . . . . 3.0 107.812 164.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 96.94 0.09 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.503 1.521 . . . . 3.8100000000000001 111.923 -172.426 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.48 161.34 13.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.09 -1.868 . . . . 4.9900000000000002 112.606 -173.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.71 133.17 54.42 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.037 0.935 . . . . 2.2000000000000002 110.389 177.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.92 55.61 3.52 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 114.176 -1.374 . . . . 2.8500000000000001 111.077 -170.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -138.33 -178.02 5.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.233 2.213 . . . . 2.4199999999999999 108.3 163.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -156.37 132.53 9.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.278 2.231 . . . . 3.46 105.571 -167.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.6 t -142.0 132.21 24.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 125.249 1.42 . . . . 1.9099999999999999 109.466 -164.035 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -77.13 145.59 37.69 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 122.685 0.394 . . . . 2.4199999999999999 111.131 172.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.54 137.44 54.73 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 122.662 1.22 . . . . 2.6200000000000001 111.122 151.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -87.3 139.78 30.21 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.365 2.266 . . . . 2.0800000000000001 108.028 155.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -110.4 141.21 43.78 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.367 1.467 . . . . 1.6899999999999999 109.952 173.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -112.42 113.92 26.36 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.958 1.303 . . . . 1.6200000000000001 109.579 178.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -115.14 152.68 32.15 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.623 1.569 . . . . 3.48 111.094 178.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.23 137.55 55.81 Favored 'General case' 0 CA--C 1.548 0.865 0 CA-C-O 122.293 1.044 . . . . 2.3700000000000001 113.795 -178.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.23 56.97 4.93 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.266 0.936 . . . . 3.5600000000000001 113.239 176.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.47 11.84 80.1 Favored Glycine 0 N--CA 1.473 1.158 0 N-CA-C 115.784 1.074 . . . . 2.1600000000000001 115.784 168.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -94.68 114.97 26.97 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.043 1.421 . . . . 3.6600000000000001 111.356 -174.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.65 136.12 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.134 1.374 . . . . 3.1899999999999999 109.537 177.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 tt -145.42 125.32 13.51 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.85 0.86 . . . . 3.7599999999999998 111.033 -168.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -101.09 134.68 43.73 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.792 1.237 . . . . 3.3399999999999999 112.144 -178.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.8 t -147.11 168.3 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 126.412 1.885 . . . . 3.8500000000000001 109.71 173.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.94 155.84 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 119.672 1.123 . . . . 2.7599999999999998 111.01 -170.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.9 mt -141.29 117.52 7.39 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.212 1.805 . . . . 3.4199999999999999 110.129 -174.437 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.46 146.46 62.14 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.705 2.27 . . . . 1.0900000000000001 110.432 168.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.4 t -94.79 115.81 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.845 0.858 . . . . 2.1400000000000001 109.209 170.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -129.81 137.73 50.64 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.428 1.091 . . . . 4.21 112.01 -170.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.43 83.46 5.43 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.994 -1.066 . . . . 3.8100000000000001 110.693 170.065 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.408 0 C-N-CA 127.249 2.22 . . . . 9.8900000000000006 110.848 -175.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.209 0 N-CA-C 106.101 -2.8 . . . . 12.890000000000001 106.101 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 p 167.6 143.17 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 118.446 -0.788 . . . . 10.49 109.805 -137.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -109.8 158.02 18.57 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.5 1.12 . . . . 11.34 111.744 -178.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.6 t -167.19 25.51 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 127.659 2.384 . . . . 6.4299999999999997 111.042 168.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 14.4 tt0 -150.34 164.84 34.79 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 127.344 2.257 . . . . 6.4199999999999999 106.001 173.49 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.427 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -118.69 -170.95 14.94 Favored Glycine 0 N--CA 1.462 0.387 0 CA-C-O 122.436 1.02 . . . . 1.3999999999999999 112.038 -172.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 41.0 p90 -134.11 162.98 30.61 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.598 -0.801 . . . . 2.4399999999999999 111.325 167.206 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.46 139.03 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.894 1.278 . . . . 2.5800000000000001 109.147 173.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -58.0 112.73 1.6 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.743 1.617 . . . . 7.2199999999999998 112.555 -177.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.59 132.36 51.45 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.324 2.249 . . . . 4.1900000000000004 111.455 166.175 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -179.05 154.55 0.79 Allowed Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.535 1.934 . . . . 3.7799999999999998 112.867 166.392 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -88.28 40.69 0.58 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 125.23 3.953 . . . . 2.79 111.055 166.316 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -114.88 157.37 15.03 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.948 1.261 . . . . 1.3899999999999999 113.019 -172.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -71.77 -18.52 28.41 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.133 3.222 . . . . 1.74 113.923 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -108.17 164.82 11.97 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.541 1.936 . . . . 2.8700000000000001 112.629 170.253 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.3 -171.72 3.72 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.474 2.709 . . . . 1.7 111.107 170.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -155.19 133.89 12.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.639 1.976 . . . . 1.8 108.867 -175.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.42 132.57 54.97 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.267 1.394 . . . . 2.1699999999999999 111.351 -176.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -114.84 32.04 6.27 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.673 1.731 . . . . 4.0499999999999998 115.673 -167.061 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -64.93 158.88 24.17 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 115.972 1.841 . . . . 3.3599999999999999 115.972 -172.306 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.8 m -79.74 126.6 31.15 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.519 1.128 . . . . 2.6000000000000001 109.679 166.191 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.9 tp -99.08 127.91 45.11 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.262 1.425 . . . . 5.2599999999999998 108.898 168.859 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.71 154.74 42.0 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.628 0.728 . . . . 3.6099999999999999 111.676 175.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -119.12 97.93 50.69 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.388 1.075 . . . . 1.53 109.088 169.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.6 -10.76 14.42 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.08 2.52 . . . . 1.28 113.03 177.05 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.93 -173.38 48.81 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.795 1.188 . . . . 1.26 113.115 -176.154 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.41 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 14.7 m-20 -112.82 1.17 15.45 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.606 1.963 . . . . 3.2599999999999998 112.368 -168.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -124.45 161.86 45.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 128.013 2.525 . . . . 3.23 110.256 174.122 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -81.01 141.91 13.42 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.484 2.122 . . . . 1.48 111.898 -173.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.98 149.33 25.24 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.145 1.378 . . . . 3.8399999999999999 110.134 174.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 42.4 ttm105 -135.44 103.3 5.43 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.633 1.173 . . . . 3.4500000000000002 110.157 178.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -79.4 114.66 18.51 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.24 1.816 . . . . 3.7000000000000002 108.047 -178.34 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.2 m -110.1 -19.47 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.254 1.022 . . . . 1.9399999999999999 112.408 -177.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.24 -175.8 29.58 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 125.509 1.528 . . . . 0.51000000000000001 113.889 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.91 -179.87 6.02 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.965 0.906 . . . . 1.54 111.035 166.004 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -137.32 177.4 7.9 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.313 1.445 . . . . 4.9400000000000004 107.845 155.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 t -175.7 148.88 1.02 Allowed Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 128.151 2.58 . . . . 1.71 106.394 177.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.44 -9.46 20.16 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.591 2.194 . . . . 0.79000000000000004 112.21 178.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.3 m -112.96 51.82 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.679 1.591 . . . . 1.72 111.586 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.01 158.16 30.05 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.056 1.343 . . . . 2.0099999999999998 111.64 167.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -98.57 -33.81 10.83 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.987 1.715 . . . . 2.6699999999999999 110.152 160.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -128.65 130.12 46.8 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.619 1.968 . . . . 6.0599999999999996 109.53 177.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -128.43 128.93 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.404 1.081 . . . . 2.1099999999999999 108.993 166.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -144.39 137.57 27.16 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.165 0.986 . . . . 3.1600000000000001 110.442 -162.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 20.7 tp -91.85 125.17 36.46 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.663 -0.648 . . . . 2.52 112.324 -167.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -122.41 160.28 25.79 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.896 1.678 . . . . 0.82999999999999996 114.119 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.408 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 17.6 pt-20 -120.27 147.68 44.67 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.696 1.598 . . . . 3.9199999999999999 110.189 161.499 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.3 m -108.54 139.14 43.72 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 107.54 -1.282 . . . . 1.9399999999999999 107.54 172.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -130.22 170.77 13.65 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.567 1.947 . . . . 3.5 111.895 -172.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.8 mtt -103.36 141.58 35.69 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.518 1.127 . . . . 4.9500000000000002 111.909 172.158 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -141.47 145.02 34.71 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.078 1.351 . . . . 7.9699999999999998 112.52 174.423 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -79.93 134.51 36.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.769 -1.197 . . . . 2.5699999999999998 107.769 146.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.3 t -146.41 136.86 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 106.894 -1.521 . . . . 3.54 106.894 164.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.514 ' CD ' ' HZ2' ' A' ' 56' ' ' LYS . 23.8 mt-10 66.31 13.84 9.39 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.64 1.576 . . . . 5.5300000000000002 113.927 -177.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.03 27.11 67.13 Favored Glycine 0 N--CA 1.476 1.309 0 O-C-N 120.946 -1.096 . . . . 2.7400000000000002 113.017 -168.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.514 ' HZ2' ' CD ' ' A' ' 54' ' ' GLU . 53.7 mtmt -130.93 143.68 50.91 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 126.861 2.065 . . . . 5.4400000000000004 109.098 178.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -81.35 119.61 23.89 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.308 1.843 . . . . 4.79 109.458 178.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.7 m -139.3 169.91 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.343 1.857 . . . . 3.6099999999999999 110.976 -177.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 53.6 mtm -134.14 137.84 44.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.039 1.335 . . . . 3.7599999999999998 110.75 174.464 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.44 174.83 21.57 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 125.786 1.66 . . . . 1.03 111.627 -177.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.25 141.63 47.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.329 1.064 . . . . 3.3199999999999998 111.832 -179.166 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -122.24 156.08 60.81 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 125.343 1.457 . . . . 7.4800000000000004 110.19 173.291 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.26 159.0 44.44 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.021 1.814 . . . . 0.79000000000000004 111.575 170.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.68 156.21 78.84 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 126.215 1.806 . . . . 2.5800000000000001 110.49 177.194 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.57 -24.13 6.54 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.51 2.806 . . . . 0.73999999999999999 112.859 -175.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -176.68 165.36 2.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.08 1.752 . . . . 3.25 111.703 -178.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -109.56 160.1 16.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.118 1.367 . . . . 2.02 109.53 155.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -134.84 148.42 50.15 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.235 1.014 . . . . 2.2799999999999998 109.91 174.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 t -142.32 128.46 10.77 Favored Pre-proline 0 CA--C 1.541 0.596 0 O-C-N 123.817 0.698 . . . . 2.1699999999999999 112.086 178.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.11 162.53 41.48 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.776 2.984 . . . . 1.5800000000000001 111.458 176.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.44 141.28 97.01 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.224 2.616 . . . . 1.54 113.02 -178.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.41 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 66.5 mmtt 70.14 -2.32 2.13 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.469 2.308 . . . . 3.0699999999999998 114.265 -178.643 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.6 158.35 43.13 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.581 1.562 . . . . 1.1499999999999999 114.316 -179.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.95 143.63 51.01 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.133 1.773 . . . . 7.5899999999999999 109.592 167.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.7 t -143.61 131.87 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 106.313 -1.736 . . . . 3.98 106.313 174.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -120.22 128.44 53.36 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.61 1.095 . . . . 3.9399999999999999 110.77 -170.416 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mp -77.65 58.06 1.73 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.48 1.512 . . . . 2.3300000000000001 111.229 -178.513 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.54 150.18 90.69 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 114.795 1.406 . . . . 6.0199999999999996 114.795 -178.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -58.06 151.11 60.5 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.456 2.104 . . . . 2.73 109.888 169.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.29 -9.52 33.39 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.355 -1.247 . . . . 3.3700000000000001 114.206 -171.271 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -135.01 -129.62 2.9 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 119.443 1.622 . . . . 1.5800000000000001 114.444 175.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.408 ' CE1' ' HB3' ' A' ' 47' ' ' GLU . 80.8 m-85 -71.97 141.03 49.4 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.543 -0.975 . . . . 3.2400000000000002 110.703 -177.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -164.41 156.74 16.66 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.962 1.305 . . . . 0.82999999999999996 110.88 -176.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -82.42 145.24 29.97 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.24 -0.652 . . . . 2.8399999999999999 109.24 161.043 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 tpt -96.56 132.99 41.61 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.919 1.288 . . . . 1.8600000000000001 108.42 164.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 mp -109.37 140.01 43.61 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.758 1.223 . . . . 1.6799999999999999 109.363 176.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.3 mt -141.74 142.91 33.28 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.747 1.619 . . . . 3.0600000000000001 110.107 -176.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 68.47 36.71 84.44 Favored Glycine 0 CA--C 1.532 1.098 0 O-C-N 121.894 -0.504 . . . . 0.93999999999999995 112.993 177.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.11 145.57 13.08 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 123.609 1.671 . . . . 2.27 115.231 -178.506 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -93.15 -7.67 44.73 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 113.762 -1.563 . . . . 2.5099999999999998 113.031 -174.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -142.67 145.06 32.53 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 127.469 2.307 . . . . 6.7400000000000002 107.495 169.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -66.25 151.2 84.03 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.152 1.901 . . . . 2.3999999999999999 108.822 158.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mp -117.46 112.41 20.6 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 125.977 1.711 . . . . 3.5899999999999999 107.596 -165.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -86.11 171.02 11.67 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.332 0.587 . . . . 4.5700000000000003 112.078 179.079 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.81 137.31 58.21 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.396 -0.964 . . . . 1.9199999999999999 108.396 153.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.81 23.05 75.98 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 116.44 1.336 . . . . 1.4099999999999999 116.44 173.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -93.42 -170.24 2.33 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.662 1.731 . . . . 2.3300000000000001 111.74 169.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -154.66 138.31 16.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 128.264 2.626 . . . . 3.1400000000000001 106.647 -173.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.6 t -149.09 136.1 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.804 1.641 . . . . 1.8600000000000001 110.027 -163.196 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.495 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 37.1 mt-10 -77.31 147.76 36.04 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.104 0.478 . . . . 2.8399999999999999 110.83 173.37 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mp -127.3 149.93 49.81 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.878 1.271 . . . . 2.5 108.747 159.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -107.39 150.55 26.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.661 0.784 . . . . 2.2400000000000002 108.935 158.01 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.3 mp -109.81 133.48 53.11 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.399 1.48 . . . . 2.4500000000000002 109.267 172.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.4 mt -103.55 112.18 24.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.176 1.39 . . . . 1.8899999999999999 109.559 -179.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -106.14 111.53 24.18 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.924 1.69 . . . . 3.4300000000000002 111.572 -175.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 49.76 32.58 5.38 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.774 1.63 . . . . 3.3900000000000001 112.948 -178.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.43 -71.1 1.84 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.41 1.481 . . . . 5.1200000000000001 112.212 -171.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.44 9.46 21.21 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 117.146 1.618 . . . . 2.2400000000000002 117.146 -163.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -130.9 134.28 46.63 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.721 1.76 . . . . 5.04 110.463 169.51 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.7 p -125.22 145.09 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.048 1.339 . . . . 3.2999999999999998 110.977 178.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.8 tp -139.92 126.47 20.36 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.254 1.422 . . . . 3.5800000000000001 109.588 178.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.495 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 25.7 ttmt -84.27 141.38 31.0 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.061 0.393 . . . . 3.0699999999999998 112.061 173.618 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.19 -179.91 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 127.203 2.201 . . . . 3.9500000000000002 110.361 167.084 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.5 t -138.31 155.43 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.515 1.526 . . . . 2.6800000000000002 106.979 171.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.27 153.29 26.62 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.954 1.302 . . . . 2.9700000000000002 111.231 171.314 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.95 168.17 12.63 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.75 2.967 . . . . 1.03 112.842 171.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.6 t -112.36 128.73 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.039 1.336 . . . . 2.0299999999999998 108.712 169.525 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -154.41 178.53 9.95 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.257 1.823 . . . . 4.4000000000000004 112.946 177.048 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.55 162.26 29.71 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.849 1.426 . . . . 4.0499999999999998 114.849 -167.228 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.478 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 117.744 -1.122 . . . . 8.3900000000000006 109.886 171.069 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.5 0 CA-C-O 118.409 -1.217 . . . . 9.8499999999999996 111.243 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.419 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 58.3 m 147.5 -40.48 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.268 1 C-N-CA 133.247 4.619 . . . . 10.25 111.457 176.342 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -151.26 44.04 0.79 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.029 1.732 . . . . 12.81 112.286 -173.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.7 t -163.52 31.72 0.09 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.963 1.705 . . . . 6.3799999999999999 113.308 -170.884 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 2' ' ' SER . 0.6 OUTLIER -155.49 178.24 10.45 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.601 1.96 . . . . 5.0700000000000003 112.294 -172.581 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -150.28 164.88 29.81 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.99 1.281 . . . . 1.4099999999999999 114.122 171.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -157.2 151.47 25.01 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.615 2.366 . . . . 2.6699999999999999 110.638 176.285 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.9 t -97.62 145.55 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 120.957 -1.089 . . . . 2.1400000000000001 109.868 -178.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.77 -15.64 63.73 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.024 1.49 . . . . 5.6399999999999997 115.024 -172.782 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 77.57 145.88 0.09 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.053 2.141 . . . . 5.2699999999999996 114.116 -171.539 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.4 t -178.66 133.78 0.3 Allowed Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 128.27 2.628 . . . . 3.3199999999999998 110.808 165.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -82.51 -11.42 10.56 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.224 2.616 . . . . 3.1899999999999999 112.202 172.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.34 169.37 31.72 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.958 1.266 . . . . 1.45 112.212 178.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.59 -15.9 52.39 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.597 3.531 . . . . 1.9299999999999999 114.779 -170.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -100.99 140.55 35.13 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.248 1.419 . . . . 3.02 112.428 173.642 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.44 -177.42 5.94 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.285 1.834 . . . . 1.7 111.926 172.312 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.26 147.18 25.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.598 1.959 . . . . 1.8100000000000001 110.02 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.99 149.82 47.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.745 1.017 . . . . 1.8 113.745 -172.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -117.19 142.73 46.67 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.161 1.784 . . . . 4.4000000000000004 109.862 174.515 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.84 160.12 14.25 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.399 1.08 . . . . 4.1699999999999999 113.208 178.171 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.9 m -136.95 147.04 46.11 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 125.129 1.371 . . . . 2.9399999999999999 110.167 -171.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.51 134.11 10.87 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.987 1.315 . . . . 6.4699999999999998 109.498 -178.046 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.29 154.16 18.78 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.211 0.914 . . . . 5.2999999999999998 112.376 177.104 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -105.28 83.34 0.88 Allowed Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.71 1.204 . . . . 1.5900000000000001 110.132 171.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -71.65 -4.68 15.52 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.476 2.117 . . . . 2.21 113.437 176.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.79 169.73 49.06 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-O 123.284 1.491 . . . . 1.24 112.811 177.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.458 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 5.7 m-20 -101.25 -2.24 31.69 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 127.54 2.336 . . . . 2.8500000000000001 112.518 -171.219 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -116.71 159.59 39.89 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.931 2.092 . . . . 5.3499999999999996 109.459 169.755 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.97 170.77 14.91 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.844 2.363 . . . . 1.8600000000000001 112.206 -166.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.4 mt -117.07 147.88 42.0 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 123.243 1.497 . . . . 3.0499999999999998 110.945 165.843 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -138.54 109.65 6.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 111.449 -2.614 . . . . 4.0499999999999998 108.97 166.819 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 tp -84.95 110.21 18.72 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.033 1.733 . . . . 2.5800000000000001 108.826 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.81 -14.77 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.155 0.982 . . . . 1.8 112.059 -176.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.34 -179.03 31.95 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-O 122.324 0.958 . . . . 0.47999999999999998 114.276 -178.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.64 -179.15 6.39 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.98 1.712 . . . . 1.73 109.588 162.668 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -153.27 -178.97 7.31 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.917 1.287 . . . . 6.0300000000000002 108.568 156.164 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 t -171.53 153.0 3.37 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 125.986 1.714 . . . . 1.6899999999999999 108.056 -172.604 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.11 -3.16 13.2 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.151 1.901 . . . . 0.75 113.847 174.175 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.5 m -119.15 39.26 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.796 1.239 . . . . 1.8999999999999999 114.267 -176.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.36 167.26 29.29 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.134 1.374 . . . . 1.71 110.721 169.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -98.47 -50.97 4.1 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.72 1.608 . . . . 2.6499999999999999 110.023 171.415 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -114.99 139.33 49.93 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 127.215 2.206 . . . . 5.4800000000000004 107.293 171.054 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.1 149.55 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.521 -0.763 . . . . 2.1200000000000001 109.003 154.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -127.94 151.79 48.68 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.675 1.99 . . . . 2.9700000000000002 107.54 166.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -100.73 138.34 37.91 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.082 1.31 . . . . 3.0 112.102 160.465 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -123.79 160.21 27.84 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.066 2.146 . . . . 0.77000000000000002 112.235 -178.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.36 178.58 4.52 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 112.491 -2.141 . . . . 3.46 111.397 166.101 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.8 m -148.34 139.15 23.0 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.285 -1.376 . . . . 1.6699999999999999 107.285 163.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -148.37 178.54 8.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.983 1.313 . . . . 3.5099999999999998 112.4 -168.864 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -110.04 145.49 36.96 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.332 1.453 . . . . 5.0899999999999999 113.117 179.331 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.8 mtp85 -127.43 152.81 47.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.445 1.498 . . . . 5.5899999999999999 110.711 166.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.438 ' OE1' ' HE2' ' A' ' 57' ' ' LYS . 3.1 tp10 -91.75 143.31 26.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.536 -0.912 . . . . 2.52 108.536 147.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 50.6 t -140.27 127.7 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 106.937 -1.505 . . . . 3.0299999999999998 106.937 158.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 65.03 25.64 12.63 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.24 1.016 . . . . 4.3799999999999999 113.715 173.404 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.11 9.1 85.64 Favored Glycine 0 CA--C 1.538 1.471 0 O-C-N 120.536 -1.352 . . . . 1.6200000000000001 113.94 -173.52 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -122.21 119.25 30.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.17 2.188 . . . . 3.8799999999999999 108.746 -170.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.453 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -89.04 116.52 27.38 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.655 1.982 . . . . 4.8899999999999997 111.401 -173.033 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.1 t -149.13 139.69 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.962 2.105 . . . . 4.0800000000000001 109.328 -166.112 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -84.08 170.86 13.44 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.586 1.328 . . . . 3.4700000000000002 114.586 -172.059 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.55 165.63 29.13 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 126.807 2.146 . . . . 0.5 112.694 177.427 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 ttm -148.11 141.38 25.15 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.979 1.712 . . . . 1.79 109.705 177.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -148.18 159.6 39.24 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.695 1.998 . . . . 5.7999999999999998 109.749 -176.71 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.81 153.02 53.29 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.276 1.984 . . . . 1.01 111.358 168.274 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.89 159.45 56.14 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 123.734 0.814 . . . . 2.23 109.898 174.51 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.63 -25.88 3.45 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.856 2.371 . . . . 0.76000000000000001 112.951 -172.063 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -179.64 167.17 1.4 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.092 2.157 . . . . 3.5299999999999998 110.73 -178.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.2 mt -112.1 152.18 28.56 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.24 1.016 . . . . 1.79 110.179 162.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -120.48 139.32 53.05 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.216 1.406 . . . . 2.1899999999999999 110.042 -176.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.4 t -146.05 135.65 11.59 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 113.147 0.795 . . . . 2.7000000000000002 113.147 176.419 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.26 168.87 23.77 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.479 2.786 . . . . 1.5600000000000001 112.189 176.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -59.76 140.9 95.59 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.71 2.273 . . . . 1.6899999999999999 110.959 165.074 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.458 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 56.4 mmtt 66.33 1.86 2.19 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.773 1.629 . . . . 2.4399999999999999 113.577 -176.412 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.85 -175.65 51.07 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.644 2.069 . . . . 1.8899999999999999 111.533 166.44 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -147.43 150.46 34.68 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 114.253 1.205 . . . . 6.6299999999999999 114.253 175.694 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.1 t -98.23 106.13 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 128.243 2.617 . . . . 6.6799999999999997 107.405 -174.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.14 110.38 13.42 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 122.199 0.999 . . . . 3.9399999999999999 111.204 -179.416 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mp -83.49 78.7 9.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.006 -1.479 . . . . 2.3599999999999999 107.006 167.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -73.0 140.67 80.8 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 113.777 -1.556 . . . . 4.3300000000000001 112.992 -175.113 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -61.12 142.54 97.23 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.712 2.275 . . . . 3.48 110.81 -179.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.84 -12.93 58.34 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.222 -1.321 . . . . 2.6099999999999999 114.786 -177.053 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.68 -109.53 1.45 Allowed Glycine 0 N--CA 1.474 1.173 0 CA-C-N 119.154 1.477 . . . . 1.8700000000000001 111.62 172.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -75.54 137.07 40.6 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.832 -0.805 . . . . 3.4900000000000002 111.957 -172.405 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -161.37 152.37 18.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.548 -0.751 . . . . 0.64000000000000001 111.267 -171.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -83.94 140.36 31.98 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.392 -0.818 . . . . 3.8500000000000001 109.879 166.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.3 tpt -100.51 131.28 46.5 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.255 1.822 . . . . 1.73 108.183 167.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 mp -109.48 126.6 53.68 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.801 1.24 . . . . 2.1099999999999999 108.184 -179.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.83 128.03 49.86 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.953 1.301 . . . . 4.0 109.281 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.93 51.91 5.2 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.578 1.085 . . . . 0.81000000000000005 113.24 176.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.6 mt -47.33 155.98 0.29 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.846 1.424 . . . . 4.2400000000000002 114.846 176.285 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -108.61 4.38 23.91 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.853 -1.067 . . . . 2.52 113.691 -177.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -161.31 163.1 20.77 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 129.43 3.092 . . . . 5.9400000000000004 108.12 176.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.09 118.33 5.57 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.708 1.605 . . . . 2.0299999999999998 108.617 165.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mp -80.15 57.14 2.62 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.14 1.376 . . . . 4.0800000000000001 109.917 175.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -59.47 167.17 2.04 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 120.519 -1.363 . . . . 5.04 111.964 174.31 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.34 128.98 33.81 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.393 1.092 . . . . 2.4199999999999999 110.025 161.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.13 34.59 36.91 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.017 1.294 . . . . 2.46 114.092 177.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -90.79 -176.85 4.81 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.65 1.225 . . . . 3.2000000000000002 109.92 153.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -144.66 153.93 42.26 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 127.712 2.405 . . . . 3.7599999999999998 106.904 171.344 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.4 t -149.03 157.66 6.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 128.509 2.724 . . . . 2.1899999999999999 108.791 -163.328 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -120.61 152.85 37.61 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.096 0.474 . . . . 2.6099999999999999 112.079 158.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mp -126.24 137.54 53.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.784 2.033 . . . . 2.6200000000000001 109.869 171.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -90.1 148.3 23.09 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.092 1.357 . . . . 1.8799999999999999 110.135 161.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -112.47 115.81 29.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.331 1.852 . . . . 1.8200000000000001 109.59 172.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.1 mt -93.94 111.36 23.05 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.728 1.211 . . . . 1.74 110.221 -176.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -110.19 124.5 51.69 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.571 0.748 . . . . 3.1899999999999999 111.362 -177.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.95 -17.69 63.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.624 0.972 . . . . 3.2999999999999998 113.624 176.382 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.07 38.08 1.33 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.248 1.404 . . . . 5.4699999999999998 113.653 175.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.97 28.08 72.25 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 125.754 1.645 . . . . 3.5600000000000001 114.851 174.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -140.14 152.71 46.31 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.027 1.414 . . . . 4.5899999999999999 113.359 -168.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.3 t -141.72 144.31 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.861 1.264 . . . . 3.3100000000000001 107.697 163.093 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 22.6 mt -139.93 168.04 20.74 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.45 1.9 . . . . 4.0599999999999996 108.274 170.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.5 pttp -147.42 151.87 37.18 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.199 1.185 . . . . 2.8900000000000001 114.199 177.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.91 141.14 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 127.083 2.153 . . . . 3.4300000000000002 110.923 -171.497 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.5 p -91.8 145.92 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.823 1.249 . . . . 3.6299999999999999 109.408 166.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -157.34 142.76 12.46 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.049 1.34 . . . . 3.8300000000000001 112.105 -174.1 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.6 166.01 27.96 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 124.083 3.189 . . . . 1.27 111.444 172.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.7 t -107.68 115.67 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.302 1.041 . . . . 1.9199999999999999 109.17 169.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -127.1 153.63 45.75 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.905 1.282 . . . . 4.75 111.812 -170.434 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.6 58.8 4.47 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.794 1.035 . . . . 2.77 113.794 -159.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.26 -0.876 . . . . 8.5800000000000001 112.285 174.202 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.448 ' H1 ' ' CD ' ' A' ' 23' ' ' GLU . . . . . . . . 0 N--CA 1.468 0.79 0 N-CA-C 108.619 -1.792 . . . . 12.42 108.619 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.6 p -150.11 59.11 0.97 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.455 1.102 . . . . 12.779999999999999 110.098 170.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -60.39 -15.8 29.52 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 117.833 2.531 . . . . 12.34 117.833 -159.646 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.8 m 69.46 19.89 7.4 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 120.42 1.464 . . . . 8.1699999999999999 113.508 163.051 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -76.38 57.16 1.15 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.827 1.651 . . . . 6.8200000000000003 111.787 -177.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.7 169.09 26.16 Favored Glycine 0 C--N 1.337 0.609 0 O-C-N 119.714 -1.866 . . . . 1.4299999999999999 113.287 -174.428 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -155.85 174.92 14.62 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.051 1.13 . . . . 2.1499999999999999 114.051 -176.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.6 t -119.1 139.46 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 127.332 2.253 . . . . 2.1299999999999999 109.779 177.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -97.36 109.66 22.37 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.009 1.324 . . . . 5.2800000000000002 110.684 171.564 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -52.58 150.05 5.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.461 1.104 . . . . 4.6799999999999997 110.935 168.189 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 m -162.06 147.65 10.37 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 125.097 1.359 . . . . 3.5499999999999998 109.865 166.323 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -81.4 44.39 1.73 Allowed 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 124.671 3.581 . . . . 3.2799999999999998 112.011 179.73 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -122.52 160.96 16.9 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.677 1.608 . . . . 2.1600000000000001 112.93 -176.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.81 -17.49 56.22 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.584 2.856 . . . . 2.2799999999999998 112.791 172.131 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -110.53 146.44 36.03 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.103 1.761 . . . . 3.2999999999999998 113.565 164.426 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.08 -178.81 3.65 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.188 1.795 . . . . 1.74 110.275 163.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.94 145.36 34.43 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.57 1.077 . . . . 1.8 111.135 177.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.5 148.87 44.79 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.964 1.098 . . . . 1.9199999999999999 113.964 -175.644 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -127.89 77.39 1.75 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.732 2.413 . . . . 3.7200000000000002 110.414 -173.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -74.16 158.65 33.79 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.817 -1.177 . . . . 2.9500000000000002 112.077 178.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.6 m -118.24 146.93 43.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.252 -1.018 . . . . 2.6899999999999999 108.252 157.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.454 ' CD1' ' H ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -154.35 -174.76 5.1 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.264 1.826 . . . . 6.5800000000000001 108.427 171.433 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.454 ' H ' ' CD1' ' A' ' 22' ' ' LEU . 37.3 mt-10 -138.69 146.4 41.53 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 120.69 -1.256 . . . . 3.6200000000000001 110.416 -174.304 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -95.31 102.26 9.3 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.666 0.786 . . . . 1.46 109.067 156.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.84 -12.92 14.63 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.725 2.283 . . . . 2.0 113.35 176.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.04 -175.72 50.93 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-O 122.424 1.013 . . . . 1.9099999999999999 113.339 -172.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.457 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 15.7 m-20 -111.09 -1.16 16.34 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.165 2.186 . . . . 4.0999999999999996 112.038 -172.367 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -111.82 158.9 35.34 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 127.771 2.428 . . . . 2.9900000000000002 110.198 171.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.11 146.65 18.13 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.518 2.145 . . . . 1.3300000000000001 111.581 -174.26 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -113.75 161.94 16.9 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.868 1.667 . . . . 3.6899999999999999 110.931 176.002 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -154.81 119.54 4.85 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.517 -1.22 . . . . 2.8799999999999999 111.012 -167.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.0 tp -101.21 108.95 20.74 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.273 1.829 . . . . 2.9399999999999999 110.404 -173.352 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.1 m -109.38 -20.56 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.351 1.06 . . . . 1.95 112.12 -167.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.09 -174.36 29.78 Favored Glycine 0 C--N 1.343 0.963 0 C-N-CA 125.059 1.314 . . . . 0.75 113.367 -174.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.0 -179.67 7.19 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.066 0.946 . . . . 1.8899999999999999 112.025 169.08 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -153.14 145.25 23.8 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.201 1.8 . . . . 6.3200000000000003 107.634 178.529 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -164.11 151.19 10.2 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 119.416 1.007 . . . . 1.74 109.477 -172.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.0 -4.2 13.74 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.137 2.558 . . . . 0.88 114.428 175.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.23 30.3 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 115.212 1.56 . . . . 1.7 115.212 -175.189 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -174.88 167.95 3.59 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 128.357 2.663 . . . . 2.1899999999999999 108.313 174.277 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -119.94 -45.9 2.46 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.2 0.909 . . . . 6.1699999999999999 111.248 169.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.7 mtt-85 -78.6 141.46 38.03 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.585 -1.265 . . . . 5.5899999999999999 107.585 164.387 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -158.52 74.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 127.806 2.442 . . . . 2.6400000000000001 110.027 -174.469 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -99.97 131.64 45.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 111.766 -2.47 . . . . 4.9199999999999999 110.72 -169.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -90.1 136.51 33.0 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 123.753 1.739 . . . . 3.2999999999999998 114.026 -176.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -115.1 160.85 19.16 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 127.143 2.177 . . . . 0.97999999999999998 110.856 174.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.12 -177.86 4.28 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.236 -1.802 . . . . 3.3900000000000001 111.202 156.776 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.8 m -152.82 141.18 20.62 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.174 1.389 . . . . 1.6499999999999999 107.829 170.306 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -151.04 170.41 19.44 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.929 1.455 . . . . 3.6299999999999999 114.929 -168.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.0 ttp -109.75 142.47 40.94 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.369 1.868 . . . . 4.25 109.479 169.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -151.92 159.23 43.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.682 1.993 . . . . 9.5299999999999994 111.391 -175.608 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -91.28 147.47 23.02 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.193 1.397 . . . . 2.5 111.897 170.198 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.6 t -140.54 120.33 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.389 1.475 . . . . 2.9900000000000002 107.956 166.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 64.44 8.64 4.41 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 127.371 2.268 . . . . 2.8999999999999999 114.763 -178.019 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.92 23.23 33.37 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 123.958 0.79 . . . . 1.79 113.89 -168.049 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.1 132.62 53.11 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.772 1.229 . . . . 3.3500000000000001 109.634 166.549 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 138.89 44.87 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.079 1.352 . . . . 7.4000000000000004 110.636 -178.86 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.8 p -154.26 -179.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 C-N-CA 126.882 2.073 . . . . 3.5099999999999998 109.328 -177.479 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.75 166.4 12.18 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 121.299 -0.875 . . . . 4.2599999999999998 112.28 -176.686 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.66 171.22 29.77 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.972 1.749 . . . . 0.55000000000000004 111.994 -179.291 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 ttm -155.4 138.44 15.49 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 126.646 1.979 . . . . 1.6699999999999999 109.227 173.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -144.65 149.94 45.29 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 127.645 2.378 . . . . 10.1 109.424 -172.025 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.1 154.87 52.52 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.574 2.183 . . . . 0.66000000000000003 110.019 176.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.14 151.6 75.5 Favored Pre-proline 0 N--CA 1.483 1.213 0 CA-C-O 117.974 -1.012 . . . . 1.73 110.71 175.053 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.38 -23.77 9.8 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.192 2.595 . . . . 0.81999999999999995 112.873 -169.575 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -179.55 165.58 1.36 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.472 2.309 . . . . 3.54 109.85 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.0 mt -109.15 150.52 27.75 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.004 0.922 . . . . 1.8799999999999999 110.044 165.137 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -109.71 143.82 38.95 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.297 1.039 . . . . 2.0800000000000001 109.149 178.059 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.6 t -140.3 125.25 11.16 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 122.971 0.509 . . . . 2.1499999999999999 112.093 173.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.81 168.35 20.5 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.95 2.433 . . . . 1.3400000000000001 111.697 179.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -55.25 140.12 81.32 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.027 2.485 . . . . 1.6899999999999999 111.43 168.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.457 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 56.4 mmtt 67.68 0.91 2.41 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.721 1.609 . . . . 2.9900000000000002 113.616 -177.183 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.62 156.96 45.22 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.902 1.715 . . . . 1.8 112.45 -179.048 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.9 mtm105 -104.99 132.51 51.14 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.025 1.33 . . . . 7.8700000000000001 109.581 -178.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.9 t -93.42 55.33 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 127.589 2.356 . . . . 6.54 108.248 -173.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.71 93.02 8.69 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.641 1.976 . . . . 3.9199999999999999 109.742 -175.223 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 tp -52.21 -56.23 16.02 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.326 1.45 . . . . 3.3900000000000001 111.608 -164.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.462 ' HB2' ' HZ3' ' A' ' 78' ' ' LYS . 1.8 ttmp? 112.09 128.37 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 128.977 2.911 . . . . 3.8300000000000001 114.429 161.516 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.62 -45.91 12.88 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.891 2.394 . . . . 2.1200000000000001 110.847 174.065 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.72 40.69 3.07 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.938 -0.924 . . . . 1.8100000000000001 112.37 172.315 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.4 -117.5 0.56 Allowed Glycine 0 C--N 1.337 0.638 0 CA-C-N 118.139 0.97 . . . . 1.77 113.783 175.029 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -76.5 137.1 39.41 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 123.399 1.571 . . . . 3.0899999999999999 113.646 -163.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -158.17 138.54 12.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.301 -1.318 . . . . 0.82999999999999996 113.424 -173.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -77.03 135.24 38.64 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.018 -1.104 . . . . 4.1399999999999997 108.018 167.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.8 mtp -99.64 117.69 34.54 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.651 0.739 . . . . 3.0299999999999998 110.619 160.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -86.71 107.74 18.36 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.608 1.963 . . . . 2.0699999999999998 107.426 -176.716 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.0 mp -111.35 141.5 44.81 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.09 1.756 . . . . 2.96 111.005 -173.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.44 42.44 41.32 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 111.459 -0.656 . . . . 0.94999999999999996 111.459 178.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . 0.258 0.5 OUTLIER -44.01 138.84 2.68 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 123.479 1.609 . . . . 3.1099999999999999 115.324 176.828 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -101.12 -12.71 18.58 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.051 -1.886 . . . . 5.4299999999999997 112.893 -173.137 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -143.8 150.59 50.59 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 128.305 2.642 . . . . 6.4699999999999998 108.2 172.681 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -72.37 150.58 52.66 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.597 2.198 . . . . 1.9099999999999999 110.082 167.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.9 mp -108.8 143.79 37.5 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.087 2.155 . . . . 3.8500000000000001 106.395 176.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.52 162.5 15.05 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.466 2.306 . . . . 4.6600000000000001 110.424 170.796 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.54 125.8 26.87 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.43 -0.794 . . . . 2.9300000000000002 109.171 157.399 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.86 32.0 6.72 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.866 1.222 . . . . 1.71 115.025 173.241 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -112.16 -167.49 1.19 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.488 1.115 . . . . 2.1200000000000001 112.801 175.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -147.11 147.94 31.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 128.116 2.567 . . . . 3.1299999999999999 107.233 172.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.9 t -146.31 126.69 6.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 127.823 2.449 . . . . 2.1299999999999999 108.667 -165.354 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.494 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -90.11 154.45 19.78 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 122.732 1.253 . . . . 2.54 113.75 176.224 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.7 tt -156.82 144.87 19.42 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.125 1.77 . . . . 3.3799999999999999 109.945 176.042 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.08 140.86 39.24 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.696 1.598 . . . . 3.3500000000000001 110.55 170.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.1 mp -84.91 127.7 34.29 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.388 1.475 . . . . 2.5 109.64 174.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.6 mt -90.75 104.86 17.39 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.696 -0.853 . . . . 1.8300000000000001 108.696 168.691 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.69 149.27 22.46 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.187 0.995 . . . . 3.6299999999999999 111.101 172.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.57 129.05 34.9 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.518 0.933 . . . . 2.1699999999999999 113.518 -174.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.32 62.03 2.84 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.663 1.125 . . . . 3.1499999999999999 113.542 174.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.19 13.18 81.44 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 115.709 1.044 . . . . 2.4199999999999999 115.709 167.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -97.07 122.19 39.79 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.794 1.297 . . . . 3.8999999999999999 110.56 -179.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.8 t -137.0 128.83 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.152 0.981 . . . . 3.2000000000000002 109.977 -176.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -140.43 127.62 21.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.564 1.146 . . . . 3.8799999999999999 111.811 -176.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.494 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 24.4 ttmm -83.25 140.59 32.42 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.179 1.392 . . . . 3.9100000000000001 113.766 -178.867 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.36 153.9 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.446 1.898 . . . . 3.3300000000000001 109.971 163.307 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.31 127.57 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 107.337 -1.357 . . . . 2.7599999999999998 107.337 163.014 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.4 mt -125.44 129.46 24.42 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.256 1.422 . . . . 2.75 108.668 -170.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.65 153.06 65.07 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.159 2.573 . . . . 1.04 112.147 172.675 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.4 t -103.91 112.3 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.445 1.498 . . . . 2.1200000000000001 109.904 173.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -100.38 178.66 4.68 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.802 1.241 . . . . 4.9100000000000001 109.896 160.43 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.33 158.66 43.91 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.935 0.894 . . . . 3.4700000000000002 112.158 -171.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.352 0 C-N-CA 126.817 2.047 . . . . 10.26 110.639 176.153 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.316 0 N-CA-C 108.355 -1.898 . . . . 11.140000000000001 108.355 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.1 t -59.56 142.92 51.65 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 117.049 -1.86 . . . . 9.8399999999999999 107.352 129.365 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -159.48 -16.1 0.06 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 117.102 2.26 . . . . 15.68 117.102 -153.315 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.05 4.81 44.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.957 1.303 . . . . 9.8499999999999996 112.071 -166.391 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.24 116.43 10.59 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.789 0.804 . . . . 5.0599999999999996 111.362 -148.639 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.18 -175.25 32.0 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 128.456 2.932 . . . . 1.27 110.98 174.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -116.43 157.03 25.78 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.665 0.987 . . . . 2.6200000000000001 113.665 175.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.2 t -89.46 141.97 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 O-C-N 120.877 -1.139 . . . . 2.3199999999999998 108.163 157.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.0 ttt85 -77.15 131.43 38.29 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.988 -0.445 . . . . 5.8099999999999996 111.894 -173.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -45.02 135.06 5.57 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.412 1.485 . . . . 2.96 112.067 166.186 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.0 t -176.68 129.68 0.35 Allowed Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.188 1.395 . . . . 3.0800000000000001 112.448 172.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -91.19 0.76 4.77 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.133 3.222 . . . . 2.6299999999999999 112.413 165.324 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.19 -175.33 46.44 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.644 1.116 . . . . 1.1299999999999999 113.374 -173.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -69.02 -22.13 35.9 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.161 2.574 . . . . 1.9399999999999999 113.057 -178.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.6 p30 -128.38 166.06 19.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.302 1.841 . . . . 2.3900000000000001 114.076 -178.657 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.44 -177.2 6.3 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 128.258 2.623 . . . . 1.74 111.045 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.75 171.09 10.38 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.294 1.837 . . . . 2.1499999999999999 108.925 169.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.5 160.7 43.59 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.759 1.223 . . . . 1.8500000000000001 111.557 174.472 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -155.34 144.95 21.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.841 -1.072 . . . . 9.5999999999999996 111.558 -161.019 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -161.89 156.51 22.62 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.393 1.477 . . . . 3.2200000000000002 111.375 -172.083 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.1 m -83.95 146.07 28.22 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.081 0.953 . . . . 2.7599999999999998 108.857 162.254 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.49 114.27 23.22 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.639 0.775 . . . . 4.3499999999999996 109.449 170.064 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -104.88 145.62 30.14 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.988 1.315 . . . . 3.96 109.093 168.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.21 73.49 1.33 Allowed Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.088 0.955 . . . . 3.0600000000000001 110.986 177.735 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.3 -19.3 62.02 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.902 2.401 . . . . 1.6399999999999999 114.659 -174.23 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.42 -179.95 51.43 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-O 122.885 1.269 . . . . 1.23 113.066 174.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.403 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 11.0 m-20 -103.27 -2.48 27.1 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.87 2.068 . . . . 2.8900000000000001 112.151 -169.005 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -122.48 155.79 61.93 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 128.099 2.56 . . . . 2.9300000000000002 109.782 175.547 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.63 140.65 21.34 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.777 2.318 . . . . 1.3300000000000001 111.086 -172.186 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.8 mt -93.31 150.01 20.8 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 123.21 1.481 . . . . 3.0600000000000001 112.029 172.275 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -134.89 113.87 11.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 112.303 -2.226 . . . . 3.0600000000000001 110.165 177.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.8 tp -95.86 111.57 23.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.669 1.588 . . . . 3.1099999999999999 108.93 -177.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.2 m -107.22 -19.81 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.548 1.139 . . . . 2.2599999999999998 112.273 -169.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.42 -174.61 28.36 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.384 1.468 . . . . 0.84999999999999998 113.22 177.487 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.57 -176.73 4.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.764 1.626 . . . . 1.8100000000000001 109.348 167.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.12 175.23 13.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.767 1.627 . . . . 6.0 108.42 161.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.9 t -171.57 156.14 4.2 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 125.657 1.583 . . . . 1.73 108.417 -173.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.91 -10.55 14.06 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.805 1.67 . . . . 0.97999999999999998 112.895 171.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.6 46.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.232 1.013 . . . . 2.25 113.461 -176.384 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.58 153.28 14.96 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.216 1.406 . . . . 1.8999999999999999 110.68 164.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.537 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 1.5 tp10 -88.39 -47.22 8.53 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.649 1.18 . . . . 2.8599999999999999 110.229 172.511 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' ' 44' ' ' GLU . 16.0 mtp180 -104.89 133.7 49.25 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 126.33 1.852 . . . . 7.5300000000000002 107.53 166.755 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.11 148.0 22.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.812 -1.181 . . . . 2.5699999999999998 107.812 150.357 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 42' ' ' ARG . 7.6 pt-20 -156.81 149.3 23.37 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 126.26 1.824 . . . . 3.5699999999999998 107.73 -172.189 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -100.48 139.92 35.48 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 122.894 1.33 . . . . 2.96 112.614 173.097 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -119.93 149.75 41.61 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.724 2.009 . . . . 0.88 111.5 178.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -86.62 162.38 18.0 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.335 1.454 . . . . 2.6699999999999999 110.925 162.849 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.9 m -129.26 130.45 46.24 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 106.409 -1.701 . . . . 2.2599999999999998 106.409 167.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -135.44 168.46 19.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.698 1.135 . . . . 3.4700000000000002 113.949 -174.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.7 ttm -100.25 146.13 27.26 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.601 1.56 . . . . 4.8399999999999999 109.972 165.218 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.75 153.66 32.61 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.627 1.171 . . . . 5.5099999999999998 110.475 -171.777 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -95.26 137.81 33.81 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.124 0.97 . . . . 3.6099999999999999 109.871 169.431 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.0 t -130.8 119.32 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 106.703 -1.591 . . . . 3.4300000000000002 106.703 164.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 60.88 18.0 8.33 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 116.154 1.909 . . . . 5.46 116.154 178.004 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.38 2.69 67.78 Favored Glycine 0 N--CA 1.479 1.552 0 O-C-N 120.826 -1.171 . . . . 2.21 114.354 -171.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.23 125.56 52.38 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.464 1.906 . . . . 4.6600000000000001 109.852 176.529 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -74.95 119.17 18.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.667 -1.606 . . . . 6.1200000000000001 109.45 -179.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.0 m -122.53 177.72 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 127.594 2.358 . . . . 3.1499999999999999 109.674 177.68 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 56.5 mtt -118.0 158.45 24.92 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.232 1.013 . . . . 3.6499999999999999 111.243 167.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.82 -177.38 25.5 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 126.16 1.838 . . . . 0.68999999999999995 112.243 -176.447 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.9 ttm -157.57 142.94 17.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.856 1.662 . . . . 1.8700000000000001 109.426 -171.656 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.15 159.18 43.25 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 127.327 2.251 . . . . 9.3499999999999996 109.545 -174.361 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -84.65 144.9 10.2 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.129 2.553 . . . . 0.89000000000000001 111.343 173.285 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.7 m -133.51 162.38 58.02 Favored Pre-proline 0 N--CA 1.486 1.368 0 CA-C-O 118.317 -0.849 . . . . 1.99 111.749 -175.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -89.89 -25.06 0.53 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.282 1.988 . . . . 0.91000000000000003 114.215 -163.087 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -178.76 166.34 1.68 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.865 1.266 . . . . 3.4100000000000001 112.96 -177.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.9 mt -114.81 153.14 30.95 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.892 1.677 . . . . 2.1499999999999999 110.837 165.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -120.2 142.96 48.52 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.489 1.516 . . . . 1.8899999999999999 109.448 177.828 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.7 t -138.57 139.22 23.9 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.469 0.708 . . . . 2.23 112.139 172.022 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -84.86 156.15 11.64 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 124.392 3.395 . . . . 1.4399999999999999 112.869 177.643 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.58 143.77 82.49 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.979 3.12 . . . . 1.27 113.94 -173.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.403 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 70.2 mmtt 68.7 -11.28 0.43 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.234 2.614 . . . . 2.6600000000000001 114.763 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.98 168.49 50.94 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.787 1.184 . . . . 1.8300000000000001 112.752 172.554 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.87 151.24 49.31 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.969 0.908 . . . . 5.9800000000000004 110.646 162.488 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.2 t -136.19 174.6 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 129.338 3.055 . . . . 4.79 106.038 175.312 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -154.14 161.12 42.09 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 119.738 -1.851 . . . . 4.0099999999999998 108.593 171.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 mp -56.0 -43.75 77.99 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.091 1.145 . . . . 3.71 114.091 -164.798 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt 71.43 110.88 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 128.632 2.773 . . . . 6.2599999999999998 111.236 -178.707 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -62.87 -34.79 70.76 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.886 1.724 . . . . 2.7999999999999998 111.683 -176.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.48 43.07 2.85 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.235 1.397 . . . . 2.1800000000000002 113.253 164.602 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.66 -36.04 0.06 OUTLIER Glycine 0 C--O 1.219 -0.799 0 N-CA-C 120.698 3.039 . . . . 2.5699999999999998 120.698 162.352 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -144.64 146.22 32.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 119.549 1.674 . . . . 3.52 113.236 168.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -161.76 153.2 18.61 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.413 -0.804 . . . . 0.80000000000000004 111.096 175.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -78.72 141.44 37.87 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.693 -0.484 . . . . 2.9399999999999999 109.693 167.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -105.73 134.75 48.35 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.027 1.731 . . . . 1.74 109.242 165.465 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -111.1 122.91 49.09 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.518 1.527 . . . . 1.95 108.468 176.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.0 mp -120.98 138.3 54.21 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.612 0.765 . . . . 2.96 109.335 176.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.12 45.42 11.62 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.319 -0.712 . . . . 0.94999999999999996 112.543 178.422 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 pp -53.67 154.75 3.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 123.271 1.51 . . . . 2.4399999999999999 114.82 176.513 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.537 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 71.7 mmtt -109.69 -10.47 14.81 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 113.224 -1.807 . . . . 3.1600000000000001 113.541 -175.13 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 mtp-105 -145.16 143.64 21.06 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 126.775 2.03 . . . . 6.04 108.19 169.545 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -68.69 151.3 74.81 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.405 2.07 . . . . 2.1099999999999999 109.698 171.02 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 64.8 mt -116.73 92.35 3.84 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.019 0.928 . . . . 3.3300000000000001 110.131 -166.588 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.6 pttm -83.63 164.03 19.96 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.54 -0.725 . . . . 6.1500000000000004 112.126 170.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.27 126.21 26.76 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.314 -0.866 . . . . 2.27 108.676 168.775 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.23 33.12 50.14 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.428 1.013 . . . . 1.4199999999999999 113.81 179.187 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -81.74 179.86 7.66 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.482 1.141 . . . . 2.71 108.483 143.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -134.54 150.61 50.77 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.085 -1.82 . . . . 3.8799999999999999 106.085 164.23 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 49.8 t -138.25 133.51 43.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 126.443 1.897 . . . . 2.0600000000000001 110.239 -173.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -78.84 137.05 37.51 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.177 -0.465 . . . . 2.75 110.815 172.738 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.75 133.9 54.93 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.92 1.288 . . . . 2.75 110.684 168.251 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -84.87 141.67 30.27 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 125.483 1.513 . . . . 2.7200000000000002 108.799 158.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -110.28 126.33 54.07 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.454 1.502 . . . . 2.2999999999999998 109.026 168.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.2 mt -104.36 117.86 35.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.897 1.279 . . . . 2.1499999999999999 110.061 -178.68 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -116.73 149.11 40.41 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.781 1.232 . . . . 3.29 111.839 -174.468 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.7 139.35 58.32 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.249 1.203 . . . . 2.2400000000000002 114.249 -172.294 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.39 45.5 29.8 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.195 -0.781 . . . . 3.2000000000000002 113.255 175.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.46 35.74 11.59 Favored Glycine 0 N--CA 1.47 0.917 0 N-CA-C 116.074 1.19 . . . . 1.72 116.074 163.587 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -122.81 145.98 47.94 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.832 1.816 . . . . 4.0199999999999996 112.579 172.32 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.7 t -143.6 142.47 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.009 1.323 . . . . 3.1000000000000001 108.955 177.281 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 42.1 tp -143.43 119.74 10.89 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.795 0.838 . . . . 4.2000000000000002 110.874 -178.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 125.76 38.27 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.767 0.827 . . . . 3.8599999999999999 111.62 178.334 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 114' ' ' VAL . 0.3 OUTLIER -138.77 -174.46 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.851 1.66 . . . . 4.3700000000000001 109.954 176.438 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.47 ' H ' HG12 ' A' ' 113' ' ' VAL . 11.3 t -137.2 150.04 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.431 1.492 . . . . 3.0499999999999998 109.565 -168.626 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.6 mt -142.8 143.74 26.87 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 127.366 2.266 . . . . 2.8199999999999998 109.048 -176.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.32 162.12 43.53 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.027 2.484 . . . . 0.85999999999999999 111.443 168.291 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 85.1 t -94.03 122.32 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 121.744 -0.598 . . . . 2.25 110.227 165.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.11 164.76 18.78 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.356 1.862 . . . . 4.4900000000000002 110.731 178.166 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.46 67.8 1.08 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.526 1.306 . . . . 2.3999999999999999 114.526 -154.241 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 . . . . . 0 C--O 1.251 1.132 1 C-N-CA 133.154 4.582 . . . . 9.3800000000000008 113.049 170.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.344 0 N-CA-C 108.534 -1.827 . . . . 8.8000000000000007 108.534 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.0 t -71.48 -126.54 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 106.73 -1.582 . . . . 11.369999999999999 106.73 131.38 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -75.61 113.47 13.09 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 120.422 -1.424 . . . . 12.210000000000001 107.234 137.057 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -163.67 58.57 0.17 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.136 1.374 . . . . 8.7300000000000004 108.514 -172.08 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -127.49 -176.21 3.68 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.165 1.386 . . . . 4.7800000000000002 109.391 -171.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.69 177.75 40.6 Favored Glycine 0 N--CA 1.469 0.892 0 O-C-N 121.189 -0.944 . . . . 1.22 114.42 -165.291 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -155.62 138.49 15.33 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.108 1.363 . . . . 2.48 112.097 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.1 t -77.56 142.81 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 120.447 -1.408 . . . . 1.8799999999999999 107.343 167.361 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 -85.0 127.13 34.06 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.661 -0.649 . . . . 7.8600000000000003 110.373 -178.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -44.77 141.47 2.09 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.09 1.356 . . . . 2.9199999999999999 112.109 172.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.5 t -148.11 148.99 31.27 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 122.877 0.471 . . . . 3.4300000000000002 111.502 165.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.0 -23.83 8.87 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.299 2.0 . . . . 2.5800000000000001 112.899 172.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -125.38 -156.64 9.4 Favored Glycine 0 CA--C 1.544 1.878 0 C-N-CA 125.332 1.444 . . . . 1.48 115.76 -160.495 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.24 -14.47 10.67 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.873 3.715 . . . . 1.75 115.171 -167.757 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -122.49 151.35 41.41 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.05 2.14 . . . . 2.4100000000000001 112.746 -178.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.16 -176.77 6.16 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.435 1.894 . . . . 2.1499999999999999 112.986 -163.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.79 158.52 44.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.568 1.947 . . . . 1.99 109.343 174.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.56 134.85 31.16 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.706 1.139 . . . . 1.6299999999999999 112.965 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -107.61 135.79 48.46 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.55 1.54 . . . . 4.4199999999999999 108.37 172.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 pp -150.72 156.44 41.31 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.437 -1.414 . . . . 2.6800000000000002 113.347 -166.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.4 m -119.03 146.73 44.81 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.397 1.879 . . . . 2.8599999999999999 109.864 179.379 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 tt -149.6 162.67 39.74 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 128.355 2.662 . . . . 5.9100000000000001 106.989 155.262 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -134.49 133.52 40.47 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.598 -1.314 . . . . 4.1399999999999997 111.053 163.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -76.96 111.76 18.44 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 127.298 2.239 . . . . 1.77 110.251 -174.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.51 -20.22 41.72 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.166 1.911 . . . . 1.9099999999999999 113.338 177.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.06 129.88 3.24 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 124.753 1.168 . . . . 2.9700000000000002 115.897 154.199 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -175.38 -46.41 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 130.831 3.652 . . . . 6.96 105.623 -169.303 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -126.86 163.01 44.02 Favored Pre-proline 0 C--O 1.24 0.597 0 C-N-CA 127.075 2.15 . . . . 5.2000000000000002 112.052 177.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -81.03 144.44 14.94 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.127 2.551 . . . . 1.74 109.43 166.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.4 mt -98.58 147.54 24.69 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 122.442 1.115 . . . . 2.8999999999999999 110.815 174.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -132.57 104.77 6.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 111.775 -2.466 . . . . 3.0800000000000001 110.638 172.061 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.8 tp -88.19 100.51 13.03 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.228 1.411 . . . . 2.8199999999999998 108.914 -173.121 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -101.95 -18.59 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 125.272 1.429 . . . . 1.8300000000000001 112.42 -169.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.82 -179.59 31.89 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 124.201 0.905 . . . . 0.47999999999999998 112.956 177.379 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.91 -178.21 5.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.099 1.36 . . . . 1.72 109.701 166.685 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.62 -178.42 7.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.022 2.129 . . . . 6.3899999999999997 108.09 165.645 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 t -178.77 154.82 0.85 Allowed Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 127.52 2.328 . . . . 1.6699999999999999 108.796 -176.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.63 -8.64 23.81 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.046 1.83 . . . . 0.89000000000000001 113.802 169.409 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.54 44.6 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 114.108 1.151 . . . . 2.04 114.108 -173.055 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.99 147.29 13.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.365 1.066 . . . . 1.96 111.107 166.129 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.551 ' CD ' ' HZ2' ' A' ' 90' ' ' LYS . 0.8 OUTLIER -89.71 -38.48 13.83 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.038 1.735 . . . . 2.79 111.991 173.788 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 mtp85 -124.7 149.29 47.38 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 127.668 2.387 . . . . 6.4800000000000004 109.175 177.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -157.23 120.52 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 125.642 1.577 . . . . 2.0099999999999998 110.586 -174.02 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -139.11 132.19 29.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.884 -1.053 . . . . 4.4699999999999998 110.962 -164.474 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.7 tp -81.62 125.56 30.7 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.922 0.489 . . . . 2.6099999999999999 111.755 -173.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -121.02 155.65 33.88 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.747 1.619 . . . . 0.65000000000000002 113.464 175.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.99 -176.77 3.34 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.537 1.935 . . . . 3.4399999999999999 110.528 166.415 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.4 m -150.35 143.74 25.05 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.922 1.289 . . . . 1.8200000000000001 108.007 171.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -148.34 168.85 21.51 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.346 1.609 . . . . 3.98 115.346 -170.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.6 mtp -110.92 145.17 38.8 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.283 1.433 . . . . 5.5099999999999998 111.206 162.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -137.14 149.4 47.27 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.697 1.999 . . . . 6.0700000000000003 109.985 171.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -89.79 140.49 29.54 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.501 -0.926 . . . . 2.7200000000000002 108.501 153.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.4 t -140.97 121.71 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 106.112 -1.81 . . . . 3.1600000000000001 106.112 171.597 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 66.89 22.54 10.15 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.93 0.892 . . . . 3.71 112.798 176.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.83 19.43 77.68 Favored Glycine 0 N--CA 1.477 1.394 0 O-C-N 120.627 -1.296 . . . . 1.7 113.337 -173.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -132.6 127.91 36.01 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.426 1.891 . . . . 3.3300000000000001 108.89 -178.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -79.33 125.45 29.52 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.845 0.858 . . . . 6.8200000000000003 112.524 -175.271 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.3 t -121.54 134.05 66.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 128.65 2.78 . . . . 3.4100000000000001 108.583 -176.016 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 37.3 mtt -98.11 149.02 22.95 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.82 0.848 . . . . 3.2599999999999998 110.266 169.179 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.32 -179.13 30.22 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-O 121.917 0.732 . . . . 0.89000000000000001 113.668 -175.039 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ttm -159.88 147.57 16.81 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 125.926 1.69 . . . . 1.6399999999999999 109.886 -171.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.59 152.84 23.49 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 113.602 -1.636 . . . . 6.2000000000000002 109.52 -163.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -83.33 157.87 14.81 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.289 1.993 . . . . 0.88 111.555 176.607 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.97 157.09 54.87 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 125.779 1.632 . . . . 2.4100000000000001 110.429 -178.49 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.76 -31.77 0.53 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.19 2.593 . . . . 0.63 113.389 -166.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -173.39 167.12 4.74 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.087 1.755 . . . . 3.6000000000000001 110.886 -178.601 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.8 mt -110.22 155.2 22.33 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.463 1.105 . . . . 1.8700000000000001 110.936 162.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -117.62 137.99 52.25 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.318 1.447 . . . . 2.1499999999999999 108.851 175.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.3 t -149.44 132.16 8.06 Favored Pre-proline 0 N--CA 1.476 0.845 0 N-CA-C 113.499 0.926 . . . . 2.1899999999999999 113.499 173.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.4 169.55 21.42 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 124.1 3.2 . . . . 1.3300000000000001 114.234 -177.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.04 146.38 96.18 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.93 3.087 . . . . 1.4299999999999999 111.806 168.201 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.6 mmtt 70.37 -7.73 0.97 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.217 1.807 . . . . 2.2999999999999998 114.089 -176.223 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.42 148.69 20.75 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.386 1.469 . . . . 1.22 113.511 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.95 129.21 34.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.121 1.369 . . . . 4.96 111.805 177.113 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.7 t -108.05 80.98 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 128.19 2.596 . . . . 7.0199999999999996 108.469 -165.123 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -138.58 123.04 18.4 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.727 0.775 . . . . 4.1200000000000001 112.994 -158.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -80.55 84.19 6.19 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-O 122.857 1.313 . . . . 2.46 108.45 175.58 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.29 145.85 97.64 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 113.249 -1.796 . . . . 5.0300000000000002 114.83 -171.749 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -55.81 143.32 81.53 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 123.567 2.845 . . . . 4.0899999999999999 110.693 176.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.54 -5.49 44.85 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 116.772 -2.127 . . . . 1.8700000000000001 115.811 176.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.81 -22.64 0.33 Allowed Glycine 0 N--CA 1.475 1.292 0 N-CA-C 119.713 2.645 . . . . 2.1800000000000002 119.713 178.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -152.47 141.83 21.57 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.683 1.742 . . . . 3.5699999999999998 113.078 179.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -162.83 155.46 19.04 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.197 1.399 . . . . 0.76000000000000001 110.977 174.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -84.55 134.5 34.41 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.968 -1.123 . . . . 3.2999999999999998 107.968 163.141 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -82.71 134.06 35.15 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.736 1.214 . . . . 1.73 108.06 164.016 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 mp -117.27 135.49 53.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.519 1.128 . . . . 1.98 109.345 -179.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 mp -132.61 148.89 52.37 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.966 0.906 . . . . 2.5600000000000001 110.975 178.731 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.17 39.58 31.6 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 123.543 0.592 . . . . 1.02 113.836 173.424 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.38 156.41 7.83 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 116.365 1.987 . . . . 2.4100000000000001 116.365 179.382 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.551 ' HZ2' ' CD ' ' A' ' 41' ' ' GLU . 71.3 mmtt -112.35 -16.14 13.0 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 113.018 -1.901 . . . . 2.73 113.409 -170.102 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -128.47 173.67 5.32 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 129.878 3.271 . . . . 7.8899999999999997 110.95 177.321 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -63.78 -176.75 0.37 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.438 2.092 . . . . 3.8399999999999999 110.917 155.599 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.423 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -167.24 66.32 0.09 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.344 2.658 . . . . 4.2599999999999998 108.287 179.223 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.423 ' HD3' ' H ' ' A' ' 93' ' ' LEU . 2.4 mptt -99.65 164.84 11.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.773 1.229 . . . . 8.1500000000000004 111.06 179.277 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.27 122.01 13.42 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.502 1.121 . . . . 2.3100000000000001 110.727 -174.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.07 4.15 63.25 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.231 1.396 . . . . 1.54 114.574 179.275 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -79.96 -175.05 4.75 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.644 1.222 . . . . 2.4399999999999999 110.501 164.944 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -156.28 139.9 15.97 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.948 1.699 . . . . 3.0899999999999999 108.644 -174.532 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.0 t -146.79 134.98 15.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 126.526 1.93 . . . . 1.78 110.874 -163.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.448 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 37.6 tt0 -78.32 136.13 37.65 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.62 1.168 . . . . 3.25 111.176 173.933 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 mp -121.13 136.76 54.92 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.196 0.998 . . . . 2.7999999999999998 111.688 160.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -86.3 145.41 26.93 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.201 2.201 . . . . 2.4900000000000002 110.216 164.423 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -116.52 126.52 53.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.491 1.917 . . . . 1.8899999999999999 109.439 172.295 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.1 mt -103.26 111.75 24.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.308 1.443 . . . . 1.78 110.225 -177.176 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -110.44 105.26 14.17 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.901 1.28 . . . . 3.2999999999999998 112.471 -171.188 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 56.36 18.0 3.18 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.283 1.833 . . . . 2.9300000000000002 114.372 175.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.97 -57.88 3.12 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.368 1.461 . . . . 3.8500000000000001 112.085 -166.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.97 19.51 2.11 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.66 1.6 . . . . 3.0 116.799 -172.021 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.17 147.97 19.89 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.957 2.903 . . . . 3.8300000000000001 112.047 167.145 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.3 t -143.15 150.09 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.332 1.453 . . . . 3.4199999999999999 108.307 176.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.56 171.16 18.55 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.131 1.772 . . . . 4.4100000000000001 108.793 173.449 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.448 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 37.8 pttt -154.89 154.98 33.51 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.694 0.998 . . . . 3.1099999999999999 113.694 179.648 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.4 t -149.11 154.72 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.702 1.201 . . . . 3.25 109.578 -172.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.81 133.54 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.101 0.96 . . . . 2.7200000000000002 109.319 177.365 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -120.77 147.6 46.34 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 126.507 1.923 . . . . 4.0 108.346 175.194 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.23 168.03 15.1 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.51 2.807 . . . . 0.76000000000000001 111.704 163.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.7 t -108.27 122.98 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.483 1.113 . . . . 1.9099999999999999 110.827 170.188 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -119.5 152.46 36.91 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.878 1.271 . . . . 4.6500000000000004 113.763 -174.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.96 152.4 33.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.597 1.559 . . . . 2.6200000000000001 114.08 -175.026 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.977 0 C-N-CA 129.211 3.004 . . . . 8.7799999999999994 116.33 -165.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.341 0 N-CA-C 105.511 -3.035 . . . . 14.34 105.511 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -50.14 161.54 0.27 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.332 0.566 . . . . 12.09 111.116 136.441 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -76.18 170.79 15.64 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.477 0.711 . . . . 13.41 111.158 169.19 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 p -139.67 -52.71 0.53 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.187 2.195 . . . . 7.1900000000000004 110.807 -169.4 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -134.69 -175.42 3.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.747 2.419 . . . . 5.9800000000000004 110.063 -169.396 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.73 172.81 52.22 Favored Glycine 0 C--O 1.221 -0.66 0 O-C-N 121.423 -0.798 . . . . 1.8500000000000001 112.721 167.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -149.61 144.57 26.26 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.828 -0.807 . . . . 2.4300000000000002 110.445 161.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -93.82 128.8 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.586 -0.894 . . . . 2.6400000000000001 108.586 177.596 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -74.15 106.7 5.93 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.123 0.569 . . . . 5.1799999999999997 111.609 -170.613 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -43.44 132.74 4.53 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.03 1.332 . . . . 3.2999999999999998 111.421 171.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.7 m -151.33 138.27 11.88 Favored Pre-proline 0 CA--C 1.539 0.555 0 O-C-N 120.976 -1.078 . . . . 3.46 111.503 175.315 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -86.29 48.18 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.405 3.403 . . . . 2.21 111.076 178.657 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.49 -179.0 30.28 Favored Glycine 0 CA--C 1.539 1.536 0 N-CA-C 115.774 1.07 . . . . 1.52 115.774 -168.168 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.48 -15.88 21.9 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.624 3.55 . . . . 1.4099999999999999 114.112 -176.042 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -134.62 170.67 15.44 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.801 2.04 . . . . 2.2000000000000002 113.195 -175.596 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.65 -179.3 8.03 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.732 2.013 . . . . 1.78 112.413 -177.544 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.95 162.96 20.12 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.49 1.516 . . . . 1.95 110.064 165.677 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.65 146.67 33.41 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.126 1.33 . . . . 1.6699999999999999 113.525 174.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -115.71 160.95 19.41 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.228 1.811 . . . . 4.29 111.178 173.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.4 tp -146.58 138.7 24.85 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.477 1.911 . . . . 3.9700000000000002 109.765 -170.429 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.9 m -131.47 133.6 45.32 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.377 1.471 . . . . 2.9900000000000002 107.196 160.387 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.5 tp -159.67 -178.17 6.9 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 128.149 2.58 . . . . 6.0300000000000002 108.89 -176.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -135.16 151.81 51.02 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.277 1.831 . . . . 3.98 112.457 171.195 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -91.84 106.89 18.94 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.558 1.543 . . . . 1.73 108.33 168.493 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.72 -13.07 14.76 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.998 1.799 . . . . 1.54 113.543 177.51 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.41 173.35 55.23 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-O 123.059 1.366 . . . . 1.1599999999999999 112.754 -175.421 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.451 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 7.1 m-20 -100.71 -2.41 32.59 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 128.189 2.595 . . . . 2.8900000000000001 111.478 -179.248 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -113.64 156.09 44.03 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 127.843 2.457 . . . . 2.98 110.346 171.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.81 151.84 24.88 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.826 2.35 . . . . 0.94999999999999996 111.312 -175.093 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt -99.29 154.04 18.48 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 122.591 1.186 . . . . 2.7599999999999998 111.405 168.134 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.1 ttp180 -140.96 111.03 6.6 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 113.532 -1.667 . . . . 3.71 110.041 177.37 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.58 111.26 23.61 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.981 1.712 . . . . 2.6600000000000001 109.576 -171.073 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 m -113.38 -18.29 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.444 1.098 . . . . 2.21 112.645 -168.219 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.6 -174.49 29.42 Favored Glycine 0 N--CA 1.469 0.843 0 C-N-CA 125.364 1.459 . . . . 0.68000000000000005 112.837 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.46 -178.0 5.93 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.413 1.085 . . . . 1.8100000000000001 111.535 169.452 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -157.15 177.95 10.9 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 128.19 2.596 . . . . 6.1399999999999997 108.246 164.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -177.68 155.42 1.08 Allowed Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 126.738 2.015 . . . . 2.0699999999999998 108.674 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.53 -9.19 24.54 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.752 2.301 . . . . 1.3799999999999999 114.032 167.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.44 48.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 125.063 1.345 . . . . 2.77 114.155 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.47 163.29 30.48 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.337 1.055 . . . . 2.1600000000000001 112.53 164.013 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -96.2 -33.24 12.1 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.085 2.154 . . . . 2.8399999999999999 111.483 170.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.0 mtp85 -155.48 156.74 35.78 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 128.446 2.698 . . . . 7.8700000000000001 108.999 -176.564 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.1 p -158.45 107.8 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 125.553 1.541 . . . . 2.4399999999999999 111.157 -172.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -123.78 137.63 54.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.996 -1.456 . . . . 4.9299999999999997 111.068 -167.358 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.6 tp -88.09 126.07 34.91 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.331 1.452 . . . . 2.6499999999999999 111.958 -169.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 37.6 m170 -119.42 158.34 26.4 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.228 1.811 . . . . 0.77000000000000002 113.171 176.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -102.31 158.74 15.98 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 113.819 -1.537 . . . . 2.3199999999999998 110.61 157.525 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.405 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 48.0 m -113.42 135.38 53.94 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 106.032 -1.84 . . . . 2.3199999999999998 106.032 159.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -128.87 166.67 18.64 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.493 1.14 . . . . 3.4199999999999999 113.582 -175.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 61.0 mtt -100.57 146.27 27.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.126 1.37 . . . . 5.4199999999999999 110.655 167.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.55 150.32 26.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.789 0.836 . . . . 5.6900000000000004 111.665 -176.413 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -103.88 127.68 51.39 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.119 1.368 . . . . 3.21 107.787 166.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.3 t -146.56 138.24 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 106.064 -1.828 . . . . 3.6099999999999999 106.064 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.573 ' CD ' ' HZ3' ' A' ' 56' ' ' LYS . 8.9 tt0 66.58 22.19 10.58 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 119.002 0.819 . . . . 3.27 112.07 177.23 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.31 18.57 79.95 Favored Glycine 0 N--CA 1.475 1.258 0 O-C-N 121.101 -1.0 . . . . 1.72 113.523 -173.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.573 ' HZ3' ' CD ' ' A' ' 54' ' ' GLU . 5.4 mtmp? -141.23 132.63 26.77 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.822 1.649 . . . . 4.0700000000000003 110.833 -168.704 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -70.68 129.4 39.04 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.586 1.554 . . . . 5.2599999999999998 111.435 173.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.6 m -138.32 169.47 18.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 129.188 2.995 . . . . 3.8199999999999998 109.515 -177.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 49.6 mtm -116.39 146.01 42.81 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.431 1.092 . . . . 3.3100000000000001 110.712 168.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.73 -177.13 14.73 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 126.016 1.77 . . . . 0.82999999999999996 111.916 -178.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.1 ttm -150.55 148.9 29.24 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.512 1.525 . . . . 2.1099999999999999 108.746 -177.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -155.86 155.45 29.39 Favored Pre-proline 0 N--CA 1.476 0.85 0 CA-C-O 118.309 -0.853 . . . . 6.8099999999999996 111.327 172.689 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -70.35 153.42 66.23 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.93 1.753 . . . . 0.83999999999999997 110.805 172.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.4 m -140.47 151.2 63.27 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 125.145 1.378 . . . . 1.96 109.767 -179.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.81 -26.28 3.79 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.897 2.398 . . . . 0.80000000000000004 113.178 -164.02 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -174.82 165.65 3.63 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.584 1.554 . . . . 3.3799999999999999 112.209 -179.272 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.7 mt -108.33 154.6 21.59 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.008 1.323 . . . . 1.8700000000000001 110.346 161.677 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -110.36 147.89 33.05 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.166 1.386 . . . . 1.8600000000000001 109.186 172.76 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.7 t -144.24 133.65 11.49 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 123.259 0.624 . . . . 1.9199999999999999 112.122 169.602 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.19 168.18 21.55 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.049 2.5 . . . . 1.1799999999999999 112.881 176.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.0 144.83 96.72 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.888 3.059 . . . . 1.0600000000000001 111.845 167.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.451 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 64.0 mmtt 66.74 -7.19 0.47 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.877 1.671 . . . . 2.7599999999999998 114.207 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.92 165.78 51.32 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.526 1.536 . . . . 1.1599999999999999 112.299 -179.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -82.75 135.74 34.9 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 121.886 0.85 . . . . 6.1600000000000001 110.146 172.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.3 t -98.94 81.74 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 127.786 2.435 . . . . 7.7999999999999998 105.822 -176.119 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -138.37 129.26 26.81 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.07 1.414 . . . . 3.8999999999999999 112.674 -161.754 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mp -71.19 167.55 19.12 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 113.459 -1.7 . . . . 3.4700000000000002 109.276 167.462 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.59 133.37 21.9 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 120.205 -1.559 . . . . 4.5300000000000002 108.018 179.315 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.53 -17.88 60.55 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.036 2.49 . . . . 4.46 114.525 -171.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.48 -21.15 4.46 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 124.551 1.072 . . . . 3.0800000000000001 115.257 164.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HB ' ' A' ' 48' ' ' THR . . . -83.85 -110.53 0.57 Allowed Glycine 0 N--CA 1.473 1.126 0 C-N-CA 125.475 1.512 . . . . 1.9399999999999999 111.933 -176.58 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -68.69 139.17 55.4 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.641 0.734 . . . . 3.0499999999999998 111.653 -171.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -159.43 143.98 15.27 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.517 1.127 . . . . 0.81999999999999995 110.63 -174.451 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -78.28 156.01 29.9 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.14 -0.689 . . . . 2.75 109.14 166.283 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.2 mtp -117.8 129.76 55.87 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 122.874 0.47 . . . . 3.1600000000000001 111.459 159.472 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.07 136.62 43.36 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.441 1.896 . . . . 1.9399999999999999 108.243 -172.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mp -124.49 152.43 43.4 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.354 1.061 . . . . 2.77 110.939 -177.233 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.34 -36.11 2.59 Favored Glycine 0 N--CA 1.469 0.852 0 C-N-CA 125.112 1.339 . . . . 2.5699999999999998 113.712 175.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 68.95 -32.39 0.22 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 128.496 2.718 . . . . 4.5999999999999996 116.883 166.05 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 66.37 -23.85 0.1 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 129.637 3.175 . . . . 2.8399999999999999 115.519 178.595 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -145.42 146.51 30.18 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.688 1.995 . . . . 7.9500000000000002 111.508 -171.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.53 155.75 36.05 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.357 2.705 . . . . 2.6299999999999999 109.525 158.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -166.53 160.2 15.06 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.097 1.759 . . . . 4.2800000000000002 109.386 -170.271 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -174.45 2.5 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.991 1.317 . . . . 6.8899999999999997 111.068 168.077 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.04 169.39 3.39 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 120.841 -1.162 . . . . 2.3100000000000001 109.522 154.281 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.56 35.34 90.96 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.038 1.304 . . . . 1.3100000000000001 113.58 178.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -105.45 -177.88 3.49 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.222 1.009 . . . . 3.3399999999999999 108.866 167.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -134.57 143.52 47.42 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.202 1.801 . . . . 3.6800000000000002 106.824 169.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.2 t -142.18 138.11 30.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 128.476 2.71 . . . . 2.1600000000000001 109.226 -172.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -98.7 154.23 18.13 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.395 0.887 . . . . 2.4199999999999999 113.395 172.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.19 132.58 30.12 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.055 1.742 . . . . 3.1800000000000002 110.839 -177.334 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -78.62 130.25 35.69 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.576 1.55 . . . . 2.5800000000000001 108.782 163.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.2 mp -97.56 126.7 43.0 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.221 1.008 . . . . 2.1699999999999999 109.087 166.527 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.0 mt -96.66 109.75 22.32 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.265 1.026 . . . . 2.0800000000000001 109.173 176.481 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -105.63 143.53 33.65 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.685 1.194 . . . . 3.2000000000000002 111.109 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.41 145.48 51.52 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.829 0.852 . . . . 2.6499999999999999 113.118 -177.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.92 30.94 56.85 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 118.645 -1.086 . . . . 3.4900000000000002 113.852 172.378 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.97 44.27 5.45 Favored Glycine 0 N--CA 1.471 1.033 0 CA-C-N 118.421 1.111 . . . . 2.0800000000000001 115.094 168.376 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -131.63 145.03 51.47 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.587 1.193 . . . . 4.46 112.031 174.491 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 94.1 t -143.8 146.51 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.103 1.361 . . . . 3.3700000000000001 109.066 176.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tt -147.17 120.21 8.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.967 1.307 . . . . 3.6099999999999999 109.276 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp -94.39 112.64 24.43 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.902 -0.499 . . . . 3.29 111.657 179.081 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.3 m -89.69 166.24 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 125.594 1.558 . . . . 3.7200000000000002 111.43 176.825 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.7 p -126.84 143.18 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.039 0.936 . . . . 4.4199999999999999 109.17 165.602 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.92 154.05 25.57 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.881 1.672 . . . . 3.5800000000000001 112.17 -171.171 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.39 162.38 40.84 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.353 2.702 . . . . 1.23 114.002 174.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.0 t -103.58 124.46 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.535 1.534 . . . . 2.1099999999999999 108.148 164.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -152.95 173.91 14.79 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.947 1.299 . . . . 4.5899999999999999 109.965 -178.624 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.93 167.76 15.63 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.961 1.467 . . . . 3.8199999999999998 114.961 -172.5 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.531 ' HG3' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.231 0 C-N-CA 128.914 2.886 . . . . 9.1300000000000008 108.671 150.572 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.144 0 N-CA-C 107.009 -2.436 . . . . 10.390000000000001 107.009 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p 175.79 162.52 0.32 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 117.778 0.789 . . . . 9.4000000000000004 109.053 -134.064 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -126.89 -25.39 3.34 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.606 1.163 . . . . 9.3100000000000005 112.987 170.602 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.9 m 119.82 68.48 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.943 1 C-N-CA 132.236 4.214 . . . . 8.5199999999999996 108.007 -171.709 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.473 ' C ' ' HG1' ' A' ' 21' ' ' THR . 3.2 pm0 -78.13 57.65 1.86 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.056 1.743 . . . . 5.5599999999999996 110.625 178.321 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -145.19 166.96 27.47 Favored Glycine 0 N--CA 1.47 0.916 0 O-C-N 120.714 -1.241 . . . . 1.6599999999999999 111.882 -175.517 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -155.29 167.74 29.37 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.93 1.456 . . . . 2.0600000000000001 114.93 -175.919 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.2 t -119.41 137.78 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 126.428 1.891 . . . . 2.0899999999999999 110.628 -177.606 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.99 -31.76 3.43 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 118.178 2.658 . . . . 5.0 118.178 -158.281 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 70.47 136.25 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 125.481 1.513 . . . . 4.1699999999999999 112.902 -164.348 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.5 t 176.52 151.45 0.35 Allowed Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 128.749 2.82 . . . . 3.1600000000000001 110.726 166.353 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.69 -7.59 18.64 Favored 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 122.937 2.424 . . . . 2.7999999999999998 113.586 164.938 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.49 172.99 49.33 Favored Glycine 0 CA--C 1.543 1.795 0 C-N-CA 124.834 1.207 . . . . 1.28 115.552 -172.122 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.95 -15.8 11.64 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 125.237 3.958 . . . . 1.54 115.018 -171.64 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -125.04 149.48 47.73 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.076 2.15 . . . . 2.25 112.657 179.093 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.17 -176.22 5.85 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.453 1.501 . . . . 1.72 112.599 -166.012 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.62 162.15 37.37 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.791 2.036 . . . . 1.6399999999999999 109.732 177.874 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.07 141.57 30.14 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.693 1.133 . . . . 1.53 113.378 -178.492 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -130.48 62.88 1.58 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.428 1.891 . . . . 4.0199999999999996 111.891 -163.019 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -81.24 158.63 24.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.651 1.215 . . . . 2.8399999999999999 114.12 179.354 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.473 ' HG1' ' C ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -92.78 101.83 14.22 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.096 1.758 . . . . 4.2199999999999998 109.447 -179.161 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.86 114.46 20.49 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.325 -0.62 . . . . 3.7799999999999998 109.325 178.486 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -122.68 125.68 46.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.198 1.799 . . . . 4.0700000000000003 108.08 174.694 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -91.1 118.87 68.82 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.869 0.868 . . . . 1.55 109.303 178.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.35 -12.29 29.55 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.632 2.222 . . . . 1.5900000000000001 113.878 177.903 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.81 115.94 0.22 Allowed Glycine 0 C--N 1.338 0.671 0 C-N-CA 126.943 2.211 . . . . 2.8300000000000001 113.247 171.666 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 t0 176.08 -42.46 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 105.231 -2.137 . . . . 8.5800000000000001 105.231 -141.846 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -165.78 178.22 1.37 Allowed Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 130.212 3.405 . . . . 5.7800000000000002 108.557 170.129 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.15 127.48 8.43 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 N-CA-C 107.315 -1.84 . . . . 1.1699999999999999 107.315 156.297 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.0 mt -86.5 145.65 26.71 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.578 -1.192 . . . . 3.0699999999999998 110.526 -177.132 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.1 100.96 5.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 112.257 -2.247 . . . . 4.4299999999999997 109.073 174.632 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.17 108.58 12.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.885 -1.524 . . . . 3.5099999999999998 106.885 176.227 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -103.86 -23.1 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.129 0.972 . . . . 1.6299999999999999 111.619 -174.743 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.59 -179.05 33.17 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 124.406 1.003 . . . . 0.46999999999999997 114.213 -175.464 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.72 -176.63 6.01 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.953 0.901 . . . . 1.71 112.894 173.548 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -157.44 165.96 34.28 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.456 2.302 . . . . 5.7999999999999998 108.111 -173.512 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -166.0 153.75 9.52 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.375 1.07 . . . . 1.72 109.527 168.017 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.37 -8.18 18.11 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.205 1.937 . . . . 0.75 113.211 167.897 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.83 50.15 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.005 1.322 . . . . 2.02 113.17 -179.84 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.08 123.38 1.16 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.977 1.311 . . . . 1.7 110.247 160.191 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.529 ' CD ' ' HZ1' ' A' ' 90' ' ' LYS . 3.4 tp10 -69.59 -24.07 63.63 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.571 0.952 . . . . 3.7200000000000002 113.571 173.581 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -141.31 142.39 33.84 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.813 1.245 . . . . 6.46 109.898 174.428 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.27 145.85 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.599 1.56 . . . . 2.2000000000000002 109.287 171.236 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -114.98 158.76 21.61 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.187 1.795 . . . . 3.48 109.157 163.696 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.1 tp -112.02 119.1 37.32 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 122.965 0.506 . . . . 1.9399999999999999 110.546 170.117 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -122.92 163.04 21.1 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.008 1.323 . . . . 0.71999999999999997 114.117 -174.304 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -115.34 -178.02 3.28 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.825 1.65 . . . . 3.4199999999999999 113.901 159.023 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.2 m -154.88 141.49 18.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.133 1.773 . . . . 1.74 108.92 179.259 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -148.93 170.49 18.2 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.705 1.202 . . . . 3.29 112.842 -165.627 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.9 mtt -95.63 147.55 23.47 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.296 1.038 . . . . 5.1299999999999999 110.582 167.655 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.95 156.01 33.79 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.761 1.224 . . . . 5.2199999999999998 110.713 -175.084 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.44 ' OE1' ' HE3' ' A' ' 57' ' ' LYS . 3.6 tp10 -104.55 137.87 41.74 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.779 1.232 . . . . 2.6899999999999999 109.938 169.615 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.7 t -131.54 118.37 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 106.694 -1.595 . . . . 2.8599999999999999 106.694 163.026 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 62.77 33.17 15.58 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.282 1.033 . . . . 3.5499999999999998 113.265 175.353 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.58 5.56 86.13 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 120.5 -1.375 . . . . 1.6200000000000001 113.692 -175.212 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -115.34 124.85 52.31 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.333 1.853 . . . . 3.5499999999999998 110.132 -176.604 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.44 ' HE3' ' OE1' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -57.36 128.51 37.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.093 2.157 . . . . 4.6600000000000001 109.859 179.668 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.39 151.41 35.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 127.967 2.507 . . . . 4.1699999999999999 107.971 175.471 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 36.6 mtt -115.39 129.73 56.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.144 0.578 . . . . 3.4100000000000001 109.563 160.429 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.31 175.69 16.41 Favored Glycine 0 N--CA 1.466 0.663 0 C-N-CA 124.293 0.949 . . . . 0.68999999999999995 112.732 -172.166 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.1 ttm -152.21 139.02 18.9 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.498 1.519 . . . . 1.8400000000000001 110.677 -172.292 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -146.06 151.31 44.65 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 125.783 1.633 . . . . 9.3399999999999999 110.982 -177.067 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.77 150.7 50.48 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.447 2.098 . . . . 0.73999999999999999 110.637 172.619 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.51 147.89 61.65 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.846 1.258 . . . . 1.78 110.057 -176.443 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.96 -19.87 13.57 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.983 3.122 . . . . 0.79000000000000004 113.342 -164.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -177.2 168.5 2.35 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.355 2.262 . . . . 3.5299999999999998 109.461 178.266 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.8 mt -111.65 153.52 26.25 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.874 1.27 . . . . 1.8899999999999999 109.04 159.327 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -124.23 142.09 51.53 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.741 0.816 . . . . 2.5699999999999998 110.284 177.689 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.6 t -141.27 129.81 12.36 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 123.664 0.786 . . . . 1.8300000000000001 111.362 174.678 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.79 158.31 46.87 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.832 3.021 . . . . 1.0700000000000001 112.116 178.787 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.49 137.99 77.56 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.541 2.828 . . . . 1.3 112.305 -177.177 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt 73.88 -13.08 0.79 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.188 2.195 . . . . 3.1099999999999999 114.237 -177.038 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.73 179.32 44.37 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.659 1.6 . . . . 1.3200000000000001 114.819 -176.97 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -126.41 156.16 41.03 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.56 1.544 . . . . 4.6299999999999999 112.054 175.692 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.0 t -149.29 116.84 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.573 1.549 . . . . 4.7400000000000002 107.763 154.349 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -76.69 142.98 40.34 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.941 -1.099 . . . . 3.1699999999999999 112.348 -179.576 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 mp -71.53 73.41 0.75 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 123.338 1.542 . . . . 2.5 108.04 160.254 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -69.49 142.62 92.13 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.921 1.688 . . . . 6.4800000000000004 113.688 -171.279 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -66.88 -4.52 11.45 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.947 3.098 . . . . 2.2999999999999998 114.501 178.993 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.32 51.53 0.77 Allowed Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.534 1.54 . . . . 1.6699999999999999 110.57 165.835 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.01 -123.26 1.05 Allowed Glycine 0 N--CA 1.464 0.537 0 C-N-CA 124.196 0.903 . . . . 1.5900000000000001 113.913 -177.166 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -73.25 136.84 44.65 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 121.573 0.701 . . . . 3.4900000000000002 111.392 -169.13 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -162.62 156.28 20.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.774 -0.648 . . . . 0.59999999999999998 111.288 -179.352 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -81.45 146.46 30.24 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.714 -0.476 . . . . 3.0699999999999998 109.714 164.627 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 tpt -100.05 130.84 46.25 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.206 -1.035 . . . . 1.5800000000000001 108.206 161.016 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -113.41 138.95 49.34 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.19 1.396 . . . . 1.76 109.574 -178.292 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mp -137.66 146.41 43.82 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.046 1.338 . . . . 2.75 110.794 179.15 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.18 44.43 66.37 Favored Glycine 0 N--CA 1.472 1.051 0 O-C-N 121.691 -0.631 . . . . 0.85999999999999999 112.342 176.338 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 pp -62.14 151.3 36.18 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 123.194 1.473 . . . . 2.23 114.785 178.56 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.529 ' HZ1' ' CD ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -109.31 -2.22 18.01 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 113.748 -1.569 . . . . 3.7000000000000002 112.971 -177.121 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -137.21 131.83 17.78 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 126.529 1.932 . . . . 6.4800000000000004 107.695 153.751 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -63.03 154.2 68.74 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.858 1.705 . . . . 2.6600000000000001 108.137 160.407 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.6 mt -111.97 97.41 6.66 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.682 1.193 . . . . 3.3700000000000001 109.7 -155.693 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 136.65 34.94 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.474 1.11 . . . . 4.7699999999999996 111.774 173.716 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.59 121.3 6.84 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.779 -1.101 . . . . 2.4700000000000002 108.527 164.165 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.68 -2.35 52.83 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.872 1.701 . . . . 1.6000000000000001 116.037 -176.825 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -82.17 -170.67 3.01 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.906 1.853 . . . . 2.3900000000000001 112.327 168.327 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -147.87 136.44 21.69 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 129.194 2.998 . . . . 3.4500000000000002 106.598 -172.28 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.4 t -140.07 132.69 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.804 1.642 . . . . 2.1000000000000001 111.618 -175.684 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.49 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 20.5 mt-10 -79.56 143.82 34.45 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.318 0.647 . . . . 2.8799999999999999 112.409 172.138 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mp -127.67 139.67 52.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.026 1.33 . . . . 2.7799999999999998 110.987 161.535 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -102.23 122.85 45.0 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 127.533 2.333 . . . . 2.8700000000000001 108.359 174.238 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -104.29 116.67 32.57 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.418 1.008 . . . . 2.0699999999999998 111.123 -167.786 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -84.92 105.28 15.57 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.897 0.879 . . . . 1.95 110.319 -177.387 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -103.11 106.41 16.92 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.889 1.676 . . . . 3.3700000000000001 111.172 -179.23 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 56.33 20.63 4.79 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.491 1.916 . . . . 3.0699999999999998 113.711 177.334 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.22 -56.64 3.65 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.381 1.467 . . . . 4.04 112.485 -171.454 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.02 -10.12 77.26 Favored Glycine 0 CA--C 1.533 1.214 0 N-CA-C 116.118 1.207 . . . . 2.0 116.118 -169.486 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -125.47 145.1 50.23 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.944 1.298 . . . . 5.5499999999999998 111.077 171.779 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.7 p -144.1 146.29 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 125.836 1.654 . . . . 3.21 110.474 173.328 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.8 tt -156.29 134.85 11.61 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.644 1.978 . . . . 3.25 108.226 -175.446 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.49 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 53.6 pttt -101.05 153.91 19.15 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.148 1.166 . . . . 3.4100000000000001 114.148 176.079 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.4 t -135.82 158.66 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.568 1.947 . . . . 3.0 108.525 175.04 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.7 p -129.98 128.64 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.102 0.961 . . . . 3.4900000000000002 110.046 -177.929 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.99 144.24 43.01 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.671 1.188 . . . . 2.9700000000000002 111.493 -168.368 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -62.52 155.59 57.29 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.27 2.647 . . . . 0.75 112.666 176.545 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 67.4 t -91.59 125.14 44.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 107.475 -1.306 . . . . 1.8300000000000001 107.475 165.16 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -153.45 167.21 30.2 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.01 1.724 . . . . 3.9399999999999999 110.565 175.188 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.78 152.71 37.3 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.264 1.209 . . . . 3.7999999999999998 114.264 -165.96 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.554 1.942 . . . . 9.9399999999999995 114.713 166.979 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 CA--C 1.54 0.571 0 CA-C-O 122.244 1.021 . . . . 5.4800000000000004 113.038 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.98 -176.9 28.65 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 126.807 2.146 . . . . 1.01 112.787 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.8 p90 -148.11 146.34 28.76 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.953 1.301 . . . . 1.75 110.412 171.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.5 t -90.2 142.59 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.369 -0.974 . . . . 1.1299999999999999 108.369 170.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 64.3 ttt-85 -85.78 131.52 34.3 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.991 0.516 . . . . 3.5099999999999998 112.332 -173.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -40.84 137.36 1.22 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.032 2.133 . . . . 2.02 112.782 169.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -175.81 126.6 0.36 Allowed Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 127.142 2.177 . . . . 2.7599999999999998 111.037 165.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -87.13 0.1 7.62 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.928 3.086 . . . . 2.5699999999999998 112.131 164.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.54 -166.27 40.96 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.141 1.353 . . . . 1.3799999999999999 112.852 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.08 -24.52 23.63 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.67 2.246 . . . . 1.6599999999999999 113.546 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -138.87 163.2 32.91 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.198 1.399 . . . . 2.1400000000000001 113.923 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.28 -175.74 5.48 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 130.324 3.45 . . . . 0.51000000000000001 109.394 -172.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.37 156.87 43.05 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.844 2.057 . . . . 0.60999999999999999 109.169 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.89 133.54 33.97 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.711 1.141 . . . . 0.52000000000000002 112.817 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 43.2 m-85 -115.79 140.98 48.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.798 2.039 . . . . 2.3199999999999998 110.332 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -168.13 156.43 8.78 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.915 1.234 . . . . 1.77 113.318 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.451 HG23 ' HG3' ' A' ' 76' ' ' GLU . 86.5 m -95.24 108.52 20.67 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.418 1.087 . . . . 2.0099999999999998 111.119 -176.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.8 130.28 34.53 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.446 0.566 . . . . 2.71 109.909 173.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -131.98 135.19 46.37 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.69 1.596 . . . . 4.3399999999999999 109.582 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -105.78 110.25 63.97 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 125.139 1.375 . . . . 1.3799999999999999 110.319 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.34 -11.56 10.7 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.901 2.401 . . . . 1.02 113.927 176.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.43 174.87 50.76 Favored Glycine 0 C--N 1.338 0.693 0 CA-C-O 122.964 1.313 . . . . 1.2 112.969 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.04 -4.42 32.51 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.45 2.7 . . . . 2.8700000000000001 111.309 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -119.44 156.83 52.84 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 128.247 2.619 . . . . 1.8999999999999999 109.9 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.87 143.78 26.79 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.867 2.378 . . . . 0.82999999999999996 110.964 -174.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.3 mt -102.84 150.92 23.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 122.767 1.27 . . . . 1.79 110.036 170.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -142.63 109.83 5.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.577 -2.101 . . . . 2.1600000000000001 112.833 -172.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.0 tp -87.82 107.09 18.5 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.33 1.852 . . . . 1.8300000000000001 109.951 -175.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.8 m -108.49 -18.12 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.155 0.982 . . . . 0.51000000000000001 112.455 -172.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.31 -178.4 31.34 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 125.273 1.416 . . . . 0.60999999999999999 113.106 -175.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.17 179.82 8.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.673 0.749 . . . . 0.68999999999999995 111.826 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -156.37 166.01 34.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.766 2.426 . . . . 3.96 107.815 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -175.43 151.24 1.27 Allowed Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 125.788 1.635 . . . . 0.76000000000000001 108.447 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.6 -7.89 14.74 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.939 2.426 . . . . 0.82999999999999996 112.993 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.0 m -114.16 41.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.6 1.16 . . . . 0.94999999999999996 113.434 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.18 164.25 35.29 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.527 -0.733 . . . . 1.1200000000000001 112.532 166.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -100.75 -46.39 5.17 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.266 2.227 . . . . 3.21 110.664 169.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -103.18 138.24 40.26 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.223 1.409 . . . . 5.0599999999999996 108.341 163.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -99.58 152.61 4.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.3 -1.0 . . . . 1.3400000000000001 108.3 142.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -135.41 147.7 49.08 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.02 1.728 . . . . 2.9300000000000002 108.31 166.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.6 tp -102.97 118.76 37.54 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.557 0.743 . . . . 1.05 110.651 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.417 ' CE1' ' HB2' ' A' ' 85' ' ' MET . 55.3 m170 -121.93 156.67 32.89 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 123.242 1.496 . . . . 0.53000000000000003 113.899 -173.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -98.3 177.82 5.25 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.551 1.941 . . . . 2.3900000000000001 111.577 160.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.1 m -152.89 149.97 28.82 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.297 1.839 . . . . 0.77000000000000002 106.996 166.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -158.3 165.74 34.06 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.058 0.943 . . . . 2.1400000000000001 113.054 -168.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 59.5 ttp -95.19 143.49 26.57 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.166 1.386 . . . . 3.0499999999999998 110.371 167.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.49 150.68 35.02 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.6 1.16 . . . . 4.3499999999999996 110.849 -173.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -108.45 137.89 45.67 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.411 1.484 . . . . 2.0699999999999998 110.262 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.8 t -139.63 128.23 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 106.7 -1.593 . . . . 2.0099999999999998 106.7 166.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.433 ' HB2' ' HE3' ' A' ' 56' ' ' LYS . 34.6 mt-10 61.49 19.1 10.02 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.085 1.354 . . . . 2.9900000000000002 114.401 -175.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.25 11.29 85.07 Favored Glycine 0 N--CA 1.48 1.609 0 O-C-N 120.242 -1.536 . . . . 1.6100000000000001 113.585 -169.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.433 ' HE3' ' HB2' ' A' ' 54' ' ' GLU . 23.5 mtmt -110.47 118.83 37.32 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.531 2.333 . . . . 2.6600000000000001 108.728 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 120.19 34.29 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.689 -1.141 . . . . 3.8300000000000001 112.376 -166.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.8 m -121.35 -178.4 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 128.705 2.802 . . . . 2.0499999999999998 109.872 -176.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 60.9 mtt -116.06 162.94 16.67 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.359 1.064 . . . . 2.4900000000000002 111.165 168.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.61 175.06 32.86 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 124.791 1.186 . . . . 0.56999999999999995 112.591 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.3 ttm -154.78 145.29 22.19 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.055 1.742 . . . . 0.60999999999999999 109.213 -170.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -148.24 153.98 41.76 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 125.736 1.614 . . . . 5.1699999999999999 109.175 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.89 154.11 42.81 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.854 1.702 . . . . 0.59999999999999998 110.399 165.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -139.46 154.35 71.52 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.458 1.503 . . . . 0.64000000000000001 110.513 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.02 -27.66 4.41 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.106 2.538 . . . . 0.52000000000000002 112.949 -167.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -176.24 164.74 2.74 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.648 1.579 . . . . 1.96 111.817 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 mt -114.03 152.22 31.3 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.215 1.406 . . . . 0.60999999999999999 110.014 166.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -111.93 145.93 38.69 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.756 1.222 . . . . 2.02 109.407 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.2 t -134.44 119.8 14.37 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.655 0.782 . . . . 1.1100000000000001 111.124 165.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.29 159.1 54.19 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.33 2.687 . . . . 0.93000000000000005 111.565 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -60.4 138.57 81.59 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.754 2.969 . . . . 0.96999999999999997 112.192 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt 64.91 -4.26 0.5 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.304 1.841 . . . . 1.6200000000000001 113.991 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.08 -177.4 39.2 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 127.28 2.371 . . . . 1.1599999999999999 113.114 -176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.22 152.53 33.42 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.279 1.032 . . . . 3.9900000000000002 112.146 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.4 t -152.71 123.46 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.771 1.629 . . . . 3.7200000000000002 107.752 174.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.451 ' HG3' HG23 ' A' ' 21' ' ' THR . 6.9 mp0 -84.31 141.44 30.92 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.704 -0.622 . . . . 2.98 111.351 175.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.92 80.84 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.332 -0.988 . . . . 2.2000000000000002 108.332 147.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.08 148.95 46.39 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.1 1.36 . . . . 3.0899999999999999 112.386 -174.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.422 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 59.2 Cg_endo -63.3 -24.35 71.87 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.251 2.634 . . . . 1.99 113.806 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.84 21.72 4.58 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.942 -0.921 . . . . 1.6299999999999999 114.115 170.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.95 -118.39 0.69 Allowed Glycine 0 CA--C 1.53 1.015 0 CA-C-N 118.979 1.39 . . . . 1.8700000000000001 114.654 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -71.91 140.42 49.23 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.352 -1.087 . . . . 1.8700000000000001 112.552 -164.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -162.64 156.22 20.39 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.206 1.002 . . . . 0.51000000000000001 112.259 -173.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -82.99 140.51 32.7 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.851 -0.53 . . . . 1.5900000000000001 109.623 165.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.417 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 3.1 tpt -93.14 131.94 37.73 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.261 1.024 . . . . 0.62 108.769 161.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 mp -110.9 125.23 53.43 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.654 -1.239 . . . . 0.58999999999999997 107.654 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 mp -130.82 142.62 50.4 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.305 0.642 . . . . 1.8600000000000001 110.364 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.43 43.29 16.1 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.154 0.883 . . . . 0.84999999999999998 112.96 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -56.76 154.51 9.03 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 116.102 1.89 . . . . 1.3799999999999999 116.102 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -116.53 -16.83 10.75 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 113.515 -1.675 . . . . 1.98 113.076 -170.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -113.12 127.38 26.9 Favored Pre-proline 0 N--CA 1.472 0.628 0 N-CA-C 105.896 -1.89 . . . . 5.4299999999999997 105.896 155.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.39 110.02 1.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 N-CA-C 105.369 -2.589 . . . . 2.2200000000000002 105.369 158.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.48 147.15 39.76 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 124.518 2.104 . . . . 2.0499999999999998 111.567 -156.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -156.27 166.04 34.62 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 111.665 -2.516 . . . . 3.8300000000000001 112.815 -151.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.92 126.05 25.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.007 0.923 . . . . 1.1899999999999999 109.636 -175.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.08 0.98 70.43 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 117.702 -1.61 . . . . 1.26 115.64 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -79.9 -167.83 1.4 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.319 2.06 . . . . 2.23 112.568 169.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.52 121.78 3.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.148 2.979 . . . . 5.7699999999999996 106.095 -148.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 49.3 t -148.83 133.45 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.602 1.161 . . . . 0.96999999999999997 111.702 -170.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -79.12 144.59 34.38 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 112.211 0.448 . . . . 2.5099999999999998 112.211 168.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mp -120.23 142.31 49.14 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.829 0.823 . . . . 1.6000000000000001 110.507 153.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -104.8 136.34 44.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 129.265 3.026 . . . . 1.99 107.485 166.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 mp -128.12 109.75 11.82 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 120.503 1.501 . . . . 2.0099999999999998 108.903 -172.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.1 mt -79.34 110.34 14.53 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.094 1.357 . . . . 0.67000000000000004 109.453 -170.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -103.48 137.44 41.56 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.309 1.444 . . . . 2.0600000000000001 110.612 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.04 127.23 30.52 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.871 1.063 . . . . 2.1200000000000001 113.871 -169.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.64 70.13 1.35 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.638 1.114 . . . . 3.4500000000000002 112.093 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.65 24.5 72.37 Favored Glycine 0 N--CA 1.471 1.03 0 N-CA-C 115.563 0.985 . . . . 2.0899999999999999 115.563 166.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -126.28 155.84 41.3 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.304 1.552 . . . . 3.4700000000000002 112.353 -173.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.12 151.46 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.813 1.245 . . . . 2.3199999999999998 110.753 171.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.1 tp -120.48 141.98 49.7 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.091 1.357 . . . . 3.1299999999999999 109.786 167.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -106.79 134.35 50.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.582 1.153 . . . . 2.2000000000000002 109.908 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.74 153.59 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.099 1.359 . . . . 2.7200000000000002 110.165 167.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.22 126.39 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.683 -1.228 . . . . 1.8600000000000001 107.683 165.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.1 mt -122.1 146.75 47.38 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 126.234 1.814 . . . . 1.97 110.074 -174.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.78 164.54 35.28 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.973 2.449 . . . . 0.89000000000000001 111.377 165.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.22 139.38 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.689 0.796 . . . . 0.76000000000000001 110.482 169.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.97 147.22 40.15 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.667 1.587 . . . . 3.7400000000000002 113.093 -171.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.59 58.3 4.14 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.054 1.742 . . . . 2.3799999999999999 111.832 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 . . . . . 0 C--O 1.249 1.072 0 C-N-CA 125.956 1.703 . . . . 7.4699999999999998 112.672 -162.195 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 118.55 -0.738 . . . . 5.21 109.909 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.59 172.86 37.88 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 120.515 1.507 . . . . 0.87 115.552 159.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -148.98 147.06 28.14 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.016 1.326 . . . . 1.96 111.276 169.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.8 t -95.03 126.87 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.08 -1.081 . . . . 1.3500000000000001 108.08 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -74.31 123.18 24.11 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.912 0.386 . . . . 4.8399999999999999 111.423 -170.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -46.99 142.18 3.68 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.956 1.302 . . . . 1.8899999999999999 111.538 163.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.1 m -155.31 152.23 24.38 Favored Pre-proline 0 CA--C 1.545 0.783 0 O-C-N 120.865 -1.147 . . . . 2.5299999999999998 111.111 161.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -95.18 43.11 0.16 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.147 3.232 . . . . 2.71 111.707 -176.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.61 -168.85 25.16 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.27 1.268 . . . . 1.1699999999999999 116.27 -167.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.98 -16.23 16.09 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.283 3.322 . . . . 1.24 114.328 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -125.24 162.57 24.41 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.052 1.741 . . . . 2.4100000000000001 114.124 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.95 -177.2 6.4 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.181 2.592 . . . . 0.5 111.236 -175.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.08 167.33 21.74 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.352 2.261 . . . . 0.72999999999999998 108.448 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.74 141.27 33.25 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.375 0.989 . . . . 0.56999999999999995 111.738 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.452 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 20.2 m-85 -128.02 114.37 17.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.256 1.822 . . . . 2.48 108.842 -171.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -163.26 165.36 24.36 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.851 -1.155 . . . . 2.71 112.901 -167.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 t -92.77 141.14 28.78 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 123.189 1.471 . . . . 3.29 113.366 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.36 123.81 38.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 113.357 -1.747 . . . . 3.5 106.996 164.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -111.62 145.05 39.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.869 0.842 . . . . 3.9900000000000002 110.944 169.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.88 64.8 18.4 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.07 0.948 . . . . 3.48 110.277 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -63.23 -21.79 72.28 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.632 2.888 . . . . 1.3799999999999999 114.414 -173.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.09 -173.09 38.09 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 122.72 1.178 . . . . 1.22 113.001 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -109.74 -1.19 18.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.905 1.682 . . . . 2.8300000000000001 112.684 -164.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -121.68 155.25 60.11 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 127.417 2.287 . . . . 2.0600000000000001 110.091 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.63 139.57 18.13 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.713 2.275 . . . . 1.01 111.245 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt -95.05 153.54 17.6 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 123.306 1.527 . . . . 1.6000000000000001 112.676 174.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 ttp-105 -137.06 102.93 4.99 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 112.609 -2.087 . . . . 2.4900000000000002 110.901 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.37 113.57 20.83 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 124.443 1.097 . . . . 1.98 110.497 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.31 -19.53 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 125.124 1.37 . . . . 0.65000000000000002 111.855 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.61 -175.47 29.58 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 122.531 1.073 . . . . 0.52000000000000002 115.362 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.459 ' HB2' ' CE1' ' A' ' 84' ' ' PHE . . . -139.08 -179.18 5.7 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.917 1.687 . . . . 0.56000000000000005 110.236 164.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -159.84 146.6 16.27 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.928 1.691 . . . . 4.3899999999999997 106.999 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 t -162.55 151.06 12.26 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 125.038 1.335 . . . . 0.72999999999999998 108.436 -175.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.91 -13.45 31.79 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.682 1.588 . . . . 0.68000000000000005 113.378 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 m -112.31 36.14 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 113.788 1.033 . . . . 0.85999999999999999 113.788 -172.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.15 140.39 10.29 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.343 1.457 . . . . 1.03 109.134 170.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -95.63 -40.0 9.63 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.233 1.413 . . . . 3.6099999999999999 110.292 -176.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -104.4 129.1 52.35 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.959 1.704 . . . . 5.8200000000000003 107.758 155.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.07 139.31 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.069 -1.085 . . . . 1.25 108.069 154.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.91 155.89 47.1 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.834 2.054 . . . . 3.2599999999999998 108.295 -174.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.3 tp -114.23 121.4 43.59 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.976 0.91 . . . . 1.0 109.785 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.405 ' CE1' ' HB2' ' A' ' 85' ' ' MET . 50.2 m170 -124.23 161.32 26.02 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 123.736 1.731 . . . . 0.72999999999999998 114.488 -175.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -104.22 155.16 18.96 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.085 2.554 . . . . 2.5899999999999999 111.21 160.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.9 m -122.02 147.19 46.38 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 105.902 -1.888 . . . . 0.84999999999999998 105.902 159.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -157.39 178.28 10.48 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.188 0.904 . . . . 2.3900000000000001 112.819 -174.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 63.0 ttp -111.66 135.21 52.56 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.572 1.549 . . . . 3.6200000000000001 111.5 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -110.4 143.99 39.84 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.513 1.525 . . . . 4.7699999999999996 110.862 161.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -87.45 145.4 26.29 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.556 1.143 . . . . 2.9900000000000002 108.707 149.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.4 t -143.92 120.8 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.227 1.811 . . . . 2.73 106.701 161.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 63.94 18.12 10.99 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.483 1.513 . . . . 4.21 115.024 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.21 21.22 67.99 Favored Glycine 0 N--CA 1.478 1.482 0 O-C-N 120.6 -1.313 . . . . 2.6000000000000001 113.052 -168.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -120.36 127.99 52.82 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.253 2.221 . . . . 3.21 107.592 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -98.46 126.81 44.14 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.735 1.214 . . . . 5.2999999999999998 111.779 -171.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.29 141.88 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 126.415 1.886 . . . . 2.2200000000000002 109.644 -175.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 60.1 mtm -92.19 156.52 17.27 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.422 0.897 . . . . 2.9500000000000002 113.422 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.67 172.06 22.08 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 126.359 1.933 . . . . 0.81000000000000005 112.332 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.5 ttm -146.53 145.66 30.23 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.231 1.812 . . . . 0.75 109.587 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -149.35 156.57 39.64 Favored Pre-proline 0 N--CA 1.471 0.603 0 C-N-CA 125.218 1.407 . . . . 5.0199999999999996 110.12 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.99 156.54 38.65 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.469 2.113 . . . . 0.92000000000000004 110.638 166.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.6 m -137.57 153.51 74.33 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 125.357 1.463 . . . . 0.92000000000000004 110.964 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.11 -24.85 6.42 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.502 2.801 . . . . 0.96999999999999997 113.024 -171.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -176.35 164.82 2.69 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.029 1.732 . . . . 2.2799999999999998 111.67 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.4 mt -108.87 153.69 23.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.404 1.482 . . . . 0.70999999999999996 110.579 163.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -114.3 144.19 43.65 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.395 1.478 . . . . 2.1699999999999999 109.763 176.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.7 t -139.91 139.74 22.44 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.465 0.706 . . . . 1.0600000000000001 112.488 169.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -84.02 156.43 13.24 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.38 3.387 . . . . 1.1200000000000001 112.531 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.22 143.49 94.33 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.306 2.671 . . . . 1.0700000000000001 113.246 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt 69.97 0.2 2.98 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.775 2.43 . . . . 1.77 114.16 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.56 151.53 34.44 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.41 1.481 . . . . 1.24 114.106 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -111.46 132.12 54.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.425 2.29 . . . . 4.6299999999999999 106.547 160.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.5 t -142.59 119.01 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.746 1.219 . . . . 3.5 108.774 -177.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -115.15 128.69 56.36 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.899 0.857 . . . . 3.98 113.24 -159.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.16 77.12 0.52 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.632 2.373 . . . . 2.21 111.163 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.65 145.01 97.74 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 126.462 1.905 . . . . 6.25 113.525 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.452 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 30.4 Cg_endo -57.89 -42.88 54.12 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.301 2.667 . . . . 2.9900000000000002 113.335 175.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.46 31.49 1.88 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.454 1.025 . . . . 1.5800000000000001 113.533 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.12 -131.99 1.44 Allowed Glycine 0 N--CA 1.471 0.969 0 C-N-CA 125.493 1.52 . . . . 1.6200000000000001 113.175 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -70.39 139.21 51.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.906 0.853 . . . . 2.1400000000000001 110.981 -172.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -162.02 158.3 24.79 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.836 1.255 . . . . 0.57999999999999996 111.973 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.459 ' CE1' ' HB2' ' A' ' 35' ' ' ALA . 98.5 m-85 -84.63 151.74 24.28 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.697 -0.627 . . . . 2.0699999999999998 110.786 168.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.405 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 3.2 tpt -112.06 130.98 55.7 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.531 1.132 . . . . 0.60999999999999999 109.687 166.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -111.98 118.87 36.64 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.943 1.297 . . . . 0.62 107.869 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.6 mp -119.51 138.92 52.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.47 1.108 . . . . 1.7 109.739 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.22 37.26 32.58 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.73 -0.483 . . . . 0.87 113.006 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -48.3 154.93 0.55 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 116.571 2.063 . . . . 1.3 116.571 177.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -119.97 -18.77 8.09 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.155 -1.384 . . . . 2.7000000000000002 113.949 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -97.01 140.96 22.39 Favored Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 108.539 -0.912 . . . . 5.3499999999999996 108.539 160.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -82.6 57.58 6.14 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.624 2.883 . . . . 3.0699999999999998 109.914 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.4 mt -23.14 104.56 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 129.044 2.938 . . . . 2.2000000000000002 116.8 -159.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm -119.54 157.96 27.28 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.187 1.795 . . . . 6.5700000000000003 114.871 170.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.14 133.88 38.92 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 113.528 -1.669 . . . . 1.76 109.675 169.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.46 1.33 86.16 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 117.485 -1.73 . . . . 1.78 115.848 -175.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -75.28 178.11 6.05 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 120.899 2.349 . . . . 2.3999999999999999 111.145 166.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -146.2 129.74 16.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.795 2.838 . . . . 5.2199999999999998 104.827 -159.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.0 t -144.33 121.63 5.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 123.99 0.916 . . . . 1.04 110.358 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -78.81 154.55 29.79 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.262 0.554 . . . . 2.8300000000000001 111.364 167.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.2 tt -149.91 142.8 24.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 122.82 1.295 . . . . 2.8500000000000001 110.808 169.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.0 104.33 11.8 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 129.54 3.136 . . . . 2.4199999999999999 107.061 -169.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -82.46 129.37 34.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.158 0.983 . . . . 0.95999999999999996 109.622 -172.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.0 mt -106.02 123.96 48.82 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.61 1.164 . . . . 0.83999999999999997 111.441 -171.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -122.6 144.98 48.76 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.945 1.298 . . . . 2.04 112.31 -170.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.66 151.06 21.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.878 0.871 . . . . 1.9199999999999999 111.974 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.16 8.86 87.0 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 119.011 -0.883 . . . . 3.5699999999999998 114.618 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.8 66.06 1.61 Allowed Glycine 0 N--CA 1.469 0.892 0 CA-C-N 119.184 1.492 . . . . 2.4500000000000002 113.326 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -138.45 152.98 48.82 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.929 1.692 . . . . 3.79 111.455 170.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.39 148.57 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.124 1.37 . . . . 2.4399999999999999 111.178 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 tt -140.2 116.22 10.41 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.597 1.159 . . . . 3.4199999999999999 109.244 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -93.58 136.25 34.04 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.93 -1.106 . . . . 2.4100000000000001 112.054 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.8 t -131.43 165.27 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.982 1.713 . . . . 2.1299999999999999 108.751 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.9 t -129.34 129.98 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.276 1.43 . . . . 1.71 108.781 172.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.5 mt -123.65 145.57 47.64 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 127.554 2.342 . . . . 2.1699999999999999 110.063 -174.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.9 154.66 58.33 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.648 2.232 . . . . 0.85999999999999999 110.475 166.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.7 t -92.88 125.28 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.224 -1.028 . . . . 1.03 108.224 167.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -152.61 167.96 27.17 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.668 1.223 . . . . 5.2199999999999998 114.059 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -103.57 104.55 14.62 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.305 1.594 . . . . 2.23 115.305 -166.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 . . . . . 0 N--CA 1.483 1.203 1 C-N-CA 133.973 4.909 . . . . 7.6299999999999999 112.555 162.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.567 ' N ' ' HG1' ' A' ' 21' ' ' THR . 24.3 mt-10 . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 120.889 0.376 . . . . 6.2800000000000002 110.913 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.08 -178.86 34.46 Favored Glycine 0 N--CA 1.465 0.581 0 O-C-N 121.186 -0.947 . . . . 1.6799999999999999 113.287 -173.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 26.0 p90 -152.0 148.67 28.0 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.825 0.85 . . . . 1.9199999999999999 112.998 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.03 145.96 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.883 -1.154 . . . . 1.3899999999999999 107.883 170.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -86.85 127.9 35.04 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.811 0.671 . . . . 4.4699999999999998 112.811 -167.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -48.79 151.0 1.29 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.956 1.302 . . . . 2.73 112.766 168.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 t -163.19 148.23 9.32 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 122.895 0.478 . . . . 2.3900000000000001 111.597 166.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -86.21 -6.4 8.28 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.2 2.6 . . . . 1.96 112.109 166.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.16 178.24 20.6 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.946 1.26 . . . . 1.1100000000000001 114.004 -173.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.6 -15.8 33.96 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.122 3.215 . . . . 1.28 113.527 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -110.01 142.67 41.1 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.796 2.038 . . . . 2.3999999999999999 113.841 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.69 -176.17 5.4 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 129.066 2.946 . . . . 0.5 110.848 -172.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.99 159.88 41.41 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.955 2.102 . . . . 0.83999999999999997 109.391 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.46 137.05 48.43 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.08 1.309 . . . . 0.68999999999999995 112.482 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -116.71 71.83 0.8 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.298 1.839 . . . . 2.5600000000000001 109.6 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -83.54 157.54 22.31 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.737 -1.227 . . . . 1.6899999999999999 111.685 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.567 ' HG1' ' N ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -90.78 131.53 36.38 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.263 -0.898 . . . . 2.4500000000000002 109.676 179.013 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.24 129.53 52.04 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.847 0.459 . . . . 3.0699999999999998 110.057 175.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -119.9 144.07 47.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.58 1.952 . . . . 3.7599999999999998 107.638 167.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.02 79.1 0.53 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.71 0.804 . . . . 3.3100000000000001 110.683 171.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.69 -6.03 18.29 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.346 2.03 . . . . 1.6000000000000001 115.733 -174.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.96 160.61 33.93 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 119.535 1.061 . . . . 1.4099999999999999 111.686 170.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.19 1.5 40.34 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.526 1.93 . . . . 3.8100000000000001 112.162 174.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mp -123.48 156.19 64.52 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 127.03 2.132 . . . . 4.4800000000000004 108.643 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.81 143.99 16.95 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.975 2.45 . . . . 1.25 111.04 -167.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.8 mt -100.47 150.32 22.77 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 123.076 1.417 . . . . 1.6799999999999999 112.844 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -127.1 106.3 9.17 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 112.218 -2.265 . . . . 1.8899999999999999 110.62 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.441 HD11 ' CZ ' ' A' ' 84' ' ' PHE . 2.7 tm? -85.87 110.97 19.78 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.658 1.983 . . . . 2.4500000000000002 108.752 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.89 -19.85 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.254 1.022 . . . . 0.76000000000000001 112.055 -171.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.7 -177.21 32.59 Favored Glycine 0 C--N 1.343 0.94 0 C-N-CA 124.989 1.281 . . . . 0.68999999999999995 113.887 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.43 -178.78 5.66 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.709 1.204 . . . . 0.76000000000000001 110.096 161.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -150.81 158.67 44.42 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.229 2.611 . . . . 4.7300000000000004 107.072 172.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 t -169.5 153.11 5.06 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 126.438 1.895 . . . . 0.66000000000000003 107.281 -171.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.58 -12.7 15.14 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.901 1.734 . . . . 0.83999999999999997 112.921 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.42 45.34 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.061 0.945 . . . . 0.81000000000000005 112.983 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.43 144.45 14.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.296 1.039 . . . . 0.97999999999999998 111.491 164.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -86.49 -45.83 10.75 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.869 1.268 . . . . 2.9199999999999999 111.328 171.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -109.93 134.38 52.15 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.816 1.247 . . . . 5.0499999999999998 108.025 168.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -119.77 135.27 60.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 125.497 1.519 . . . . 1.0900000000000001 108.299 166.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -126.66 154.23 44.33 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.747 2.019 . . . . 3.0099999999999998 108.759 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.0 tp -111.18 124.44 52.2 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.741 0.816 . . . . 1.1200000000000001 109.776 174.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -123.44 161.52 24.64 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.403 1.881 . . . . 0.66000000000000003 114.262 -175.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.78 -179.2 3.87 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.721 2.409 . . . . 3.0299999999999998 111.773 162.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.1 m -157.49 145.87 19.28 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.367 1.867 . . . . 0.91000000000000003 107.645 170.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -153.42 172.93 16.33 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.183 1.393 . . . . 1.97 112.552 -168.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.4 mtm -103.44 143.64 32.44 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.905 0.882 . . . . 2.9900000000000002 110.561 167.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -149.21 146.32 27.56 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.245 1.818 . . . . 8.8100000000000005 111.144 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -86.91 145.97 26.35 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.75 1.22 . . . . 2.75 111.787 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 p -169.81 138.01 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 126.217 1.807 . . . . 3.0 108.273 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 72.92 -3.58 2.38 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 127.612 2.365 . . . . 4.9100000000000001 114.818 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.99 33.19 24.46 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.277 0.942 . . . . 2.1000000000000001 112.599 -161.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -141.47 144.39 34.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.838 2.455 . . . . 4.4100000000000001 108.126 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.92 120.68 29.49 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.481 0.712 . . . . 7.4800000000000004 110.604 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.451 HG12 ' H ' ' A' ' 59' ' ' MET . 39.8 t -125.12 -179.67 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 127.308 2.243 . . . . 2.29 107.982 -175.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.451 ' H ' HG12 ' A' ' 58' ' ' VAL . 8.3 mtm -113.78 159.97 19.2 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.583 -1.323 . . . . 4.1200000000000001 112.835 175.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.43 165.74 25.17 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 125.726 1.631 . . . . 0.77000000000000002 111.059 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.9 ttm -148.78 141.86 24.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.573 1.949 . . . . 0.81000000000000005 108.453 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -150.11 151.21 31.44 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.938 1.695 . . . . 5.7699999999999996 109.266 -170.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.04 155.23 42.74 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.071 1.847 . . . . 0.56000000000000005 110.922 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.31 152.53 75.26 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.982 1.313 . . . . 0.77000000000000002 110.008 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.82 -21.64 10.94 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.294 2.663 . . . . 0.69999999999999996 112.865 -171.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -174.88 174.23 2.59 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.743 2.017 . . . . 1.9099999999999999 110.756 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.4 mt -119.81 154.31 34.44 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.527 1.931 . . . . 0.48999999999999999 109.671 160.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -112.87 145.13 41.23 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.917 1.287 . . . . 1.71 109.41 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 t -137.61 139.13 26.14 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.288 0.635 . . . . 0.97999999999999998 112.689 171.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -83.6 156.19 14.02 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 124.201 3.267 . . . . 1.28 112.311 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.31 138.81 68.21 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.413 3.409 . . . . 1.27 115.109 -170.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt 67.15 -2.7 1.13 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.818 2.447 . . . . 3.1899999999999999 115.455 173.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.76 176.29 54.6 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 127.431 2.443 . . . . 1.46 112.634 167.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.27 144.53 21.01 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.27 1.428 . . . . 4.1900000000000004 111.279 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.9 t -154.13 127.39 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 126.366 1.866 . . . . 4.1699999999999999 107.738 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.51 149.8 31.36 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.879 0.763 . . . . 5.0899999999999999 111.603 172.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mp -73.8 73.86 1.58 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.796 1.284 . . . . 2.2200000000000002 108.737 165.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -63.88 143.46 98.13 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 114.39 -1.277 . . . . 5.04 113.138 -170.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -63.67 -21.11 70.0 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.346 2.697 . . . . 2.3100000000000001 113.982 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.57 48.2 2.33 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.248 0.928 . . . . 1.77 112.14 171.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.59 -121.6 1.04 Allowed Glycine 0 N--CA 1.468 0.802 0 C-N-CA 124.876 1.226 . . . . 1.52 114.085 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -74.21 134.35 42.73 Favored 'General case' 0 C--O 1.22 -0.494 0 O-C-N 121.928 -0.748 . . . . 2.1200000000000001 112.432 -170.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -161.66 163.51 29.81 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.84 0.856 . . . . 0.60999999999999999 111.358 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.441 ' CZ ' HD11 ' A' ' 32' ' ' LEU . 96.4 m-85 -90.72 150.22 21.72 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.287 -0.883 . . . . 2.25 110.629 168.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.6 tpt -104.79 134.07 48.54 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.35 1.06 . . . . 0.58999999999999997 109.338 164.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -117.62 130.95 56.7 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.411 1.484 . . . . 0.52000000000000002 108.076 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 mp -136.02 140.9 44.21 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.932 0.787 . . . . 1.77 111.992 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.74 44.91 11.43 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 123.744 0.688 . . . . 0.76000000000000001 111.776 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.01 148.27 11.03 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 123.452 1.596 . . . . 1.28 115.049 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -105.01 -7.43 19.23 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.517 -1.674 . . . . 1.78 112.841 -176.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -144.14 138.06 14.59 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 127.61 2.364 . . . . 6.1900000000000004 108.062 162.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.05 144.21 75.0 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.163 1.909 . . . . 1.9399999999999999 108.308 164.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.427 ' H ' HD23 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -121.13 120.85 36.48 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.826 1.65 . . . . 2.75 109.87 -166.419 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -120.4 169.9 9.87 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.429 1.891 . . . . 3.7599999999999998 114.234 -160.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.05 103.56 1.89 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.38 1.072 . . . . 1.75 111.553 -170.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.03 12.67 39.05 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 118.507 -1.163 . . . . 1.8100000000000001 114.906 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -82.69 -172.87 4.31 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.742 1.271 . . . . 2.2400000000000002 111.456 166.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 40.1 mt-10 -146.65 138.95 24.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.714 2.806 . . . . 4.0 106.161 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.0 t -137.97 121.73 21.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 125.04 1.336 . . . . 1.1799999999999999 109.51 -173.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -84.57 150.49 25.18 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 122.242 1.02 . . . . 3.1699999999999999 113.192 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.57 144.02 20.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.231 1.413 . . . . 3.5 114.231 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -104.98 114.34 28.49 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 128.066 2.546 . . . . 2.6899999999999999 109.62 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.13 127.79 32.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.596 1.158 . . . . 1.4299999999999999 108.802 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.3 mt -103.54 112.21 25.02 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.005 0.922 . . . . 0.93999999999999995 109.882 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -108.16 146.81 32.19 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.437 1.495 . . . . 2.0899999999999999 111.237 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.84 124.37 11.01 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.342 1.057 . . . . 1.8700000000000001 113.089 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.2 70.75 1.22 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.457 1.027 . . . . 2.9300000000000002 113.267 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.8 4.06 57.18 Favored Glycine 0 N--CA 1.476 1.331 0 N-CA-C 117.011 1.564 . . . . 2.2000000000000002 117.011 163.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -93.47 110.69 22.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.55 1.675 . . . . 3.1499999999999999 111.024 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.63 135.3 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.048 1.339 . . . . 1.99 109.319 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.1 tp -137.01 115.29 11.72 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.443 1.097 . . . . 2.1800000000000002 110.571 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -79.77 131.8 36.0 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.762 -0.586 . . . . 2.2000000000000002 112.316 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.3 t -124.87 169.85 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 128.509 2.724 . . . . 2.1000000000000001 107.658 172.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.9 t -144.55 134.87 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.583 1.553 . . . . 1.8999999999999999 108.094 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -131.11 152.34 80.47 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.185 0.994 . . . . 4.2699999999999996 110.52 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 57.3 Cg_endo -63.97 168.42 12.21 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 124.018 3.145 . . . . 0.83999999999999997 112.955 171.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.5 t -108.56 128.62 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.28 1.032 . . . . 1.1399999999999999 110.996 173.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -120.57 147.11 45.62 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.459 1.504 . . . . 5.1200000000000001 112.402 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.87 71.85 2.54 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.78 1.232 . . . . 2.71 111.766 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 127.276 2.231 . . . . 8.1699999999999999 110.647 -178.81 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 . . . . . 0 CA--C 1.541 0.605 0 N-CA-C 109.318 -0.623 . . . . 6.7000000000000002 109.318 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.84 169.48 15.21 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 121.621 -0.674 . . . . 1.1899999999999999 114.779 -168.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -157.18 151.49 25.07 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.029 1.732 . . . . 2.0699999999999998 112.125 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.4 t -87.22 121.4 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 107.486 -1.302 . . . . 1.28 107.486 164.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.24 118.23 20.26 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.488 0.715 . . . . 3.6899999999999999 109.876 -175.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -55.85 153.71 8.13 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.186 1.395 . . . . 2.1000000000000001 113.835 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.9 t -163.89 147.04 7.87 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.143 1.377 . . . . 2.0699999999999998 110.395 173.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -86.85 6.37 5.37 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.889 3.059 . . . . 1.99 112.665 171.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.14 -170.19 15.72 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.15 1.357 . . . . 1.21 115.082 -168.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.78 -17.78 42.05 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.867 3.045 . . . . 1.76 113.717 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -138.22 156.16 47.96 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 116.048 1.87 . . . . 2.25 116.048 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.7 -178.73 5.26 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 131.01 3.724 . . . . 0.97999999999999998 109.59 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.31 161.64 33.02 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.39 1.476 . . . . 0.81000000000000005 108.442 168.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.04 135.73 50.27 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.197 0.999 . . . . 0.78000000000000003 110.067 172.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -127.08 132.41 50.65 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.671 1.988 . . . . 2.6600000000000001 107.673 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pp -170.07 149.86 3.65 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.413 1.006 . . . . 1.96 113.408 -164.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.6 m -79.15 121.84 25.52 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.023 1.729 . . . . 2.25 111.267 172.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.18 125.37 29.76 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.754 -0.832 . . . . 3.1800000000000002 108.754 157.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -95.77 142.46 28.02 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.65 1.18 . . . . 3.8999999999999999 107.943 161.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.44 72.51 2.53 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.217 1.007 . . . . 3.21 109.882 174.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.31 -20.11 61.97 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.979 2.453 . . . . 1.3100000000000001 114.692 -172.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.67 -177.95 47.63 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 122.952 1.307 . . . . 1.25 113.096 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -104.96 -1.9 25.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.769 2.028 . . . . 2.8599999999999999 112.204 -168.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -122.23 155.87 61.08 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 127.804 2.442 . . . . 2.0499999999999998 109.973 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.98 140.45 20.24 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.781 2.321 . . . . 1.3600000000000001 111.048 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.2 mt -93.87 151.16 19.78 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 123.197 1.475 . . . . 1.8200000000000001 112.115 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.4 ttp-105 -135.53 106.71 6.74 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 112.589 -2.096 . . . . 2.25 110.568 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.6 tp -91.94 108.17 19.73 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.022 1.729 . . . . 1.8600000000000001 109.95 -172.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -100.81 -20.94 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.107 1.363 . . . . 0.58999999999999997 111.399 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.06 -178.31 31.97 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.006 1.289 . . . . 0.67000000000000004 114.708 -176.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -156.27 -178.11 7.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.242 2.217 . . . . 0.89000000000000001 110.437 172.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -160.84 151.76 18.63 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.494 1.043 . . . . 4.9900000000000002 109.439 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -150.06 153.91 36.09 Favored Pre-proline 0 N--CA 1.472 0.645 0 O-C-N 121.101 -1.0 . . . . 0.78000000000000003 109.836 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.58 -7.89 21.6 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.665 2.244 . . . . 1.02 113.604 171.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 m -124.25 44.9 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 114.246 1.202 . . . . 0.95999999999999996 114.246 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.36 175.2 14.31 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.56 1.544 . . . . 1.3 109.3 164.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -114.45 -60.15 1.92 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.028 0.931 . . . . 3.5 108.826 160.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.6 mtp85 -82.35 106.83 14.54 Favored 'General case' 0 N--CA 1.458 -0.059 0 O-C-N 121.244 -0.91 . . . . 5.7300000000000004 108.799 168.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.73 152.55 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 107.904 -1.147 . . . . 1.3999999999999999 107.904 148.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -156.39 115.5 3.46 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.469 0.577 . . . . 3.0 111.31 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.1 tp -80.83 118.96 22.8 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.882 -1.136 . . . . 1.0800000000000001 111.753 -174.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -125.24 152.96 43.89 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 123.219 1.485 . . . . 0.51000000000000001 114.483 -172.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -95.31 177.11 5.95 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.36 1.864 . . . . 2.3900000000000001 111.307 162.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.6 m -156.03 144.08 19.77 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.998 2.119 . . . . 0.70999999999999996 106.6 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -160.04 163.38 34.01 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.723 1.379 . . . . 2.21 114.723 -165.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.88 145.33 27.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.852 1.261 . . . . 5.0499999999999998 111.169 164.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.42 147.23 21.89 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.515 -0.741 . . . . 4.6200000000000001 112.259 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -105.66 142.23 35.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 126.63 1.972 . . . . 2.7799999999999998 111.84 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.2 t -144.95 133.54 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.566 1.946 . . . . 2.54 106.903 166.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 68.49 1.1 2.82 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 126.609 1.963 . . . . 3.0 114.71 -172.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.71 18.33 61.94 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.431 1.015 . . . . 2.2599999999999998 113.572 -163.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -120.55 134.85 55.23 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.75 2.42 . . . . 2.8100000000000001 108.282 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.63 142.45 28.24 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 125.545 1.538 . . . . 3.8300000000000001 114.052 -173.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.16 169.6 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 129.241 3.016 . . . . 2.71 107.259 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.0 mtp -117.33 139.83 50.34 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.194 -0.941 . . . . 3.3300000000000001 110.728 165.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.98 -179.81 16.07 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.487 1.041 . . . . 0.56999999999999995 113.772 -175.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ttm -152.89 144.88 23.73 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.617 1.967 . . . . 0.58999999999999997 109.1 -176.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -146.11 156.95 50.63 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 126.022 1.729 . . . . 5.1500000000000004 108.924 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.89 156.34 43.48 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 121.886 1.724 . . . . 0.58999999999999997 110.667 166.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.7 m -139.12 152.16 69.27 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 124.799 1.24 . . . . 0.56999999999999995 110.543 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.3 -29.33 7.88 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.862 2.375 . . . . 0.53000000000000003 112.175 -168.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -174.39 165.45 3.94 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.53 1.532 . . . . 2.0899999999999999 111.867 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.8 mt -109.48 154.12 23.1 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.109 1.364 . . . . 0.60999999999999999 110.386 164.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -113.49 147.35 38.06 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.975 1.31 . . . . 2.0499999999999998 109.962 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.6 t -140.78 140.25 21.52 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.85 0.86 . . . . 0.92000000000000004 111.959 169.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -88.1 155.9 7.03 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.648 3.565 . . . . 1.3200000000000001 112.846 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.39 142.76 80.29 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.992 3.128 . . . . 1.2 113.75 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt 67.61 -9.65 0.42 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.763 2.425 . . . . 1.8700000000000001 114.251 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.46 160.92 46.14 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.788 1.185 . . . . 1.54 111.98 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -116.63 140.87 48.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.752 0.821 . . . . 5.2300000000000004 109.302 160.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.3 t -148.32 143.92 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.875 2.07 . . . . 3.71 106.895 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.21 150.51 39.96 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.288 1.404 . . . . 4.0199999999999996 114.76 -165.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.2 mp -66.73 75.25 0.11 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.208 -1.405 . . . . 1.8899999999999999 107.208 151.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.8 140.54 74.59 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 114.466 -1.243 . . . . 3.1600000000000001 111.538 -167.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -55.52 -35.55 92.6 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.901 2.401 . . . . 2.02 112.321 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.68 6.9 57.01 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 116.88 -2.067 . . . . 1.8500000000000001 116.27 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.19 -8.56 0.02 OUTLIER Glycine 0 N--CA 1.478 1.441 0 N-CA-C 122.331 3.692 . . . . 2.1099999999999999 122.331 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -145.43 143.74 30.23 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 122.188 2.994 . . . . 2.0600000000000001 113.163 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -162.26 157.77 23.39 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.508 0.723 . . . . 0.48999999999999999 111.369 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 60.7 m-85 -82.99 138.64 33.68 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 107.945 -1.132 . . . . 1.6399999999999999 107.945 158.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -79.2 134.79 36.67 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.203 1.401 . . . . 0.88 108.051 156.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 mp -116.61 125.87 52.43 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 106.591 -1.633 . . . . 1.0600000000000001 106.591 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.4 tt -147.46 136.22 22.0 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.759 -0.588 . . . . 2.1499999999999999 110.325 -167.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.25 47.36 8.32 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.129 -0.788 . . . . 1.03 111.129 -167.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mt -50.64 150.54 2.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 123.044 1.402 . . . . 3.27 112.706 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -106.83 -2.4 21.46 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.065 -1.425 . . . . 2.3500000000000001 113.256 -169.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -153.29 154.27 30.5 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.652 1.181 . . . . 6.4400000000000004 111.682 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.35 94.67 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.476 2.117 . . . . 2.54 107.667 160.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.15 164.93 15.44 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 125.826 1.651 . . . . 2.6600000000000001 109.358 176.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -146.71 165.2 30.34 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 112.764 -2.016 . . . . 4.2199999999999998 113.751 -160.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.9 118.54 10.53 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.701 -1.136 . . . . 1.4299999999999999 108.777 166.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.9 10.13 43.84 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.378 -1.234 . . . . 1.4199999999999999 115.974 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -86.24 -175.28 5.45 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.647 1.724 . . . . 2.1400000000000001 112.122 165.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -146.46 156.22 43.13 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 130.056 3.342 . . . . 5.1900000000000004 107.556 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 78.6 t -156.06 128.04 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 127.487 2.315 . . . . 1.1899999999999999 109.812 -170.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -91.81 130.61 37.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.079 0.466 . . . . 4.8399999999999999 110.536 168.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.5 tt -111.78 136.75 50.63 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.914 1.685 . . . . 2.8399999999999999 110.821 173.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -87.32 150.28 23.95 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.744 2.018 . . . . 2.3399999999999999 110.004 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.419 HD11 HG22 ' A' ' 113' ' ' VAL . 5.3 mp -123.83 134.44 53.6 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.059 1.344 . . . . 1.22 110.408 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.7 mt -112.78 118.13 34.09 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.011 1.324 . . . . 0.64000000000000001 110.324 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -112.31 149.59 32.2 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.821 1.248 . . . . 1.9199999999999999 110.906 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.95 149.22 27.8 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.474 0.71 . . . . 1.9399999999999999 112.191 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.25 12.47 84.56 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 119.123 -0.821 . . . . 3.5 114.844 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.68 63.55 1.83 Allowed Glycine 0 N--CA 1.471 1.004 0 CA-C-N 118.965 1.383 . . . . 2.3700000000000001 113.581 172.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -135.78 147.69 48.46 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.744 1.618 . . . . 3.9199999999999999 111.611 169.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.2 t -138.34 146.69 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.437 1.095 . . . . 2.0299999999999998 110.189 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.0 tp -145.38 169.88 17.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.209 1.804 . . . . 2.1400000000000001 110.128 -177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -128.55 144.65 51.19 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.282 1.216 . . . . 2.4199999999999999 114.282 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.419 HG22 HD11 ' A' ' 103' ' ' LEU . 11.6 m -130.7 162.44 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 126.057 1.743 . . . . 2.4900000000000002 110.978 168.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 86.5 t -121.28 141.29 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.918 2.087 . . . . 2.21 107.113 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.1 mt -152.94 106.08 2.66 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 125.11 1.364 . . . . 2.0699999999999998 109.718 -160.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.53 149.92 89.11 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.904 2.403 . . . . 0.92000000000000004 110.822 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.5 t -91.83 116.87 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.646 -0.872 . . . . 1.1100000000000001 108.646 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.94 149.88 27.75 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.5 1.12 . . . . 3.29 111.358 -153.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -106.23 91.97 3.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.125 0.97 . . . . 2.27 113.102 -164.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 125.925 1.69 . . . . 8.0700000000000003 110.195 167.875 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 103.826 -2.657 . . . . 7.3600000000000003 103.826 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.77 -175.49 41.32 Favored Glycine 0 N--CA 1.463 0.49 0 C-N-CA 124.239 0.923 . . . . 1.1499999999999999 115.402 -168.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -142.21 -179.26 6.15 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.904 1.682 . . . . 1.8300000000000001 111.572 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.7 142.87 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 121.114 -0.991 . . . . 1.49 109.804 174.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.44 HH11 ' HG3' ' A' ' 9' ' ' ARG . 1.0 OUTLIER -86.69 126.64 34.69 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.766 0.426 . . . . 3.96 112.08 -176.051 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -50.54 139.12 16.44 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.416 1.886 . . . . 2.1200000000000001 113.458 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 m -157.55 149.11 16.97 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.556 1.142 . . . . 2.3199999999999998 110.588 163.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -84.53 42.72 1.21 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.416 3.411 . . . . 1.8899999999999999 110.762 167.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.95 158.56 15.09 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.605 1.097 . . . . 1.3200000000000001 114.502 -164.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.37 -13.99 25.32 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.848 3.032 . . . . 1.1899999999999999 112.574 165.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -135.22 155.33 50.83 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 129.398 3.079 . . . . 2.21 112.62 -175.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.94 -176.29 5.47 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.072 1.749 . . . . 0.56999999999999995 112.138 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -154.56 130.14 9.91 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.709 1.604 . . . . 0.94999999999999996 110.385 -177.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.29 141.5 49.94 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.627 1.171 . . . . 0.54000000000000004 113.28 -169.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.425 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 39.9 m-85 -126.18 115.48 19.83 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.896 1.678 . . . . 2.4300000000000002 109.986 -170.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.259 0.0 OUTLIER -159.73 -174.87 4.83 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.591 1.7 . . . . 2.9199999999999999 115.591 -166.491 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.1 m -108.45 135.24 50.07 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.451 1.1 . . . . 2.0899999999999999 111.34 -158.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.71 108.86 17.35 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.803 1.241 . . . . 3.6899999999999999 108.394 171.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -99.32 138.6 36.18 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.014 0.926 . . . . 3.9500000000000002 109.174 170.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -109.33 89.17 6.76 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 122.902 0.481 . . . . 1.51 109.924 161.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.41 -9.24 20.14 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.545 2.163 . . . . 1.0700000000000001 113.065 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.95 -175.54 49.24 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 124.766 1.174 . . . . 1.2 113.195 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -111.81 -4.21 14.7 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.959 2.103 . . . . 3.27 112.41 -166.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mp -125.94 163.34 40.11 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 127.713 2.405 . . . . 3.9900000000000002 108.664 174.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.62 145.79 18.59 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.38 2.054 . . . . 1.28 111.273 -171.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mp -105.21 148.24 27.16 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.62 1.168 . . . . 2.8900000000000001 110.058 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -139.35 103.21 4.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.801 -1.545 . . . . 3.2000000000000002 109.703 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.0 tt -80.96 119.53 23.6 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 124.527 1.131 . . . . 2.3599999999999999 108.207 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.1 m -111.08 -12.53 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.291 1.036 . . . . 0.82999999999999996 111.258 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.45 -176.21 30.24 Favored Glycine 0 C--N 1.343 0.936 0 C-N-CA 125.316 1.436 . . . . 0.66000000000000003 114.085 -174.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.408 ' HB2' ' CE1' ' A' ' 84' ' ' PHE . . . -154.72 -179.5 8.06 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.93 1.692 . . . . 0.66000000000000003 110.069 173.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.02 -177.99 6.98 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 125.85 1.66 . . . . 5.3099999999999996 109.143 165.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 t -179.62 153.7 0.69 Allowed Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 128.043 2.537 . . . . 0.66000000000000003 106.46 -169.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -73.71 -16.58 23.66 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 120.77 1.311 . . . . 0.80000000000000004 112.602 172.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.3 m -113.19 41.5 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 114.631 1.345 . . . . 0.78000000000000003 114.631 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.14 142.48 4.1 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.22 -0.925 . . . . 1.1200000000000001 111.828 168.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -74.65 -57.02 4.19 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.912 0.885 . . . . 2.71 110.095 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -85.02 139.99 31.36 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.91 1.284 . . . . 5.3700000000000001 108.385 163.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 p -108.91 153.89 10.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.368 -1.287 . . . . 1.1599999999999999 108.207 140.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -135.02 151.86 51.18 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.704 2.002 . . . . 3.0 108.294 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.2 tp -106.53 124.46 49.64 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.288 0.635 . . . . 1.1000000000000001 109.892 173.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.2 m170 -123.95 159.77 29.02 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.277 1.431 . . . . 0.54000000000000004 114.131 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.58 159.39 22.98 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.388 1.875 . . . . 2.3100000000000001 110.743 163.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 m -135.33 145.33 47.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.079 1.751 . . . . 0.82999999999999996 106.796 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -157.97 171.0 21.04 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.18 0.99 . . . . 1.99 113.54 -167.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.6 ttp -100.7 135.99 41.28 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.265 1.826 . . . . 3.1699999999999999 110.134 168.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.14 138.45 40.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.636 1.175 . . . . 5.6500000000000004 110.731 171.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -92.43 126.32 37.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.411 1.484 . . . . 3.4300000000000002 112.9 -177.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 m -136.01 142.57 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.722 1.609 . . . . 2.4900000000000002 108.249 169.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 70.15 -3.18 1.86 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 126.003 1.721 . . . . 4.1299999999999999 115.065 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.43 22.82 39.04 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.769 1.176 . . . . 2.0899999999999999 113.791 -161.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt -133.97 132.31 40.01 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.722 2.409 . . . . 3.73 109.56 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.421 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -67.36 121.36 15.57 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 120.575 -1.328 . . . . 4.75 112.28 170.189 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.7 m -97.94 171.36 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.703 1.201 . . . . 2.25 108.759 151.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 70.0 mtm -111.23 156.63 21.17 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.477 0.711 . . . . 3.46 111.103 164.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.39 176.04 23.07 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.898 1.237 . . . . 0.57999999999999996 112.288 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.0 ttm -151.41 143.47 23.94 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.836 1.654 . . . . 0.64000000000000001 109.748 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -148.97 154.03 39.2 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.624 1.57 . . . . 5.5899999999999999 109.604 -173.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -76.67 161.03 34.25 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.425 2.084 . . . . 0.59999999999999998 111.364 172.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.25 155.83 64.61 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.692 1.597 . . . . 0.79000000000000004 110.977 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -82.62 -27.82 1.99 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.592 2.861 . . . . 0.71999999999999997 113.375 -169.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -174.44 165.4 3.9 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.178 1.391 . . . . 2.1699999999999999 111.916 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 mt -114.82 158.47 21.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.484 1.914 . . . . 0.89000000000000001 109.727 161.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -141.33 148.13 39.24 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.908 0.883 . . . . 2.2599999999999998 111.353 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -145.68 131.92 9.66 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.104 0.962 . . . . 1.1699999999999999 112.438 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.4 161.71 41.92 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.578 3.519 . . . . 1.6699999999999999 112.83 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.36 140.96 79.45 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.065 3.177 . . . . 1.47 113.435 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 67.73 -1.65 1.59 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.135 2.174 . . . . 2.0299999999999998 113.818 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.95 164.2 38.73 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.721 1.629 . . . . 1.49 111.952 171.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.03 139.77 20.76 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.693 1.197 . . . . 4.25 110.439 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.2 t -152.85 144.95 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.216 1.807 . . . . 3.75 108.34 -165.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -126.31 145.05 50.58 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 122.034 0.921 . . . . 4.3300000000000001 113.464 -168.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 mp -75.75 74.09 2.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.097 2.559 . . . . 1.98 109.495 171.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.438 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -64.0 146.5 97.26 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.175 0.99 . . . . 3.23 112.798 176.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.425 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 36.2 Cg_endo -60.43 -36.93 84.71 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.683 2.256 . . . . 2.3300000000000001 113.37 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.89 44.33 2.77 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.162 0.887 . . . . 1.6799999999999999 113.498 171.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.63 -124.3 1.14 Allowed Glycine 0 C--N 1.338 0.669 0 C-N-CA 125.44 1.495 . . . . 1.5900000000000001 113.018 176.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -73.28 139.74 46.33 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.816 -0.814 . . . . 2.3799999999999999 112.314 -171.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -162.19 166.97 24.86 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.326 1.45 . . . . 0.68999999999999995 111.708 -174.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 35' ' ' ALA . 95.0 m-85 -95.04 148.4 22.38 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.885 -0.509 . . . . 1.72 110.112 167.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.3 tpt -105.28 139.81 39.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.589 1.556 . . . . 0.60999999999999999 109.347 165.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -113.5 135.26 54.09 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.461 1.504 . . . . 0.71999999999999997 108.344 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.89 133.19 41.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.649 0.78 . . . . 2.1099999999999999 110.663 174.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.11 50.88 4.17 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 124.148 0.88 . . . . 0.79000000000000004 113.013 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.9 mt -52.31 156.84 1.58 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.674 1.731 . . . . 2.5299999999999998 115.674 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -116.89 -25.09 7.38 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.861 -1.063 . . . . 1.8200000000000001 113.68 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -114.49 138.68 23.25 Favored Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 126.649 1.98 . . . . 5.7400000000000002 107.075 158.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.88 133.49 31.53 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 N-CA-C 107.097 -1.924 . . . . 1.6599999999999999 107.097 162.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.25 78.92 1.31 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.294 0.637 . . . . 2.8300000000000001 110.439 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -68.7 163.87 22.93 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.948 0.88 . . . . 4.5599999999999996 112.502 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.89 117.44 10.56 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.435 -1.32 . . . . 2.25 107.435 168.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.86 14.55 59.27 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 117.903 -1.498 . . . . 1.8600000000000001 115.227 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.56 175.18 5.79 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.957 1.879 . . . . 2.7000000000000002 109.378 155.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.44 171.56 8.45 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.455 -1.683 . . . . 5.5099999999999998 106.455 150.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.4 t -138.17 119.89 17.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 C-N-CA 128.775 2.83 . . . . 1.9199999999999999 107.505 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.81 141.68 36.0 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.399 0.68 . . . . 3.5299999999999998 109.857 167.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.28 139.23 53.48 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.863 1.265 . . . . 1.71 110.951 171.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.02 149.54 23.94 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 129.698 3.199 . . . . 2.04 110.303 158.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -127.93 119.81 26.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.592 1.957 . . . . 0.80000000000000004 108.537 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.2 mt -103.58 121.14 42.3 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.307 1.043 . . . . 0.67000000000000004 111.147 -171.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -114.5 144.52 43.22 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.039 1.336 . . . . 2.0800000000000001 112.361 -174.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.86 144.63 48.2 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.411 -0.813 . . . . 1.8400000000000001 110.963 169.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.81 27.36 38.44 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 118.828 -0.984 . . . . 3.48 114.015 -174.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.99 36.24 32.58 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 124.703 1.144 . . . . 1.8799999999999999 115.243 163.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -129.65 143.59 50.89 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.39 1.095 . . . . 3.3799999999999999 112.897 -168.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.6 p -133.01 150.89 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.828 1.651 . . . . 2.0099999999999998 111.034 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 31.4 tp -144.43 159.62 42.43 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.334 2.254 . . . . 2.29 108.764 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -126.85 167.99 15.07 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.335 0.971 . . . . 3.0800000000000001 113.439 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.9 m -149.05 159.33 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 127.111 2.164 . . . . 2.6400000000000001 110.73 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.9 t -118.86 123.52 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.466 1.106 . . . . 1.6399999999999999 110.148 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.9 mt -124.9 123.89 25.51 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.701 1.2 . . . . 2.0899999999999999 110.083 -170.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.37 155.37 36.7 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.927 2.418 . . . . 1.01 111.504 174.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.4 t -94.94 115.11 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.427 0.632 . . . . 1.0600000000000001 111.062 172.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -93.95 130.16 40.15 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.504 1.122 . . . . 4.0499999999999998 111.249 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.34 152.01 22.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.261 1.024 . . . . 4.54 108.528 151.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 . . . . . 0 C--O 1.245 0.857 0 C-N-CA 127.322 2.249 . . . . 9.3000000000000007 109.62 -175.243 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 CA--C 1.541 0.611 0 CA-C-O 122.611 1.196 . . . . 4.9100000000000001 112.766 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.29 -178.19 27.49 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 125.142 1.353 . . . . 1.01 112.064 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -155.67 164.77 38.17 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.537 0.94 . . . . 1.8600000000000001 113.537 171.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.4 t -106.86 141.25 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.337 1.455 . . . . 0.97999999999999998 108.751 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -74.69 -1.63 22.7 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.416 1.636 . . . . 4.3600000000000003 115.416 -172.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 64.16 172.38 0.18 Allowed 'General case' 0 CA--C 1.554 1.129 0 CA-C-N 119.919 1.236 . . . . 2.2000000000000002 111.567 -170.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.4 t -160.24 154.52 19.98 Favored Pre-proline 0 N--CA 1.468 0.457 0 O-C-N 120.275 -1.515 . . . . 3.0800000000000001 110.38 163.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -85.23 -3.48 9.49 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.576 2.85 . . . . 2.0800000000000001 112.312 161.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.15 -173.51 13.35 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.426 1.488 . . . . 1.45 114.587 -173.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.23 -18.83 20.48 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.948 3.099 . . . . 1.8500000000000001 113.849 -175.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -104.77 143.44 33.12 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.485 1.914 . . . . 2.6600000000000001 113.868 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.61 -178.86 7.3 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.59 1.956 . . . . 0.66000000000000003 112.405 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.34 134.33 25.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.924 2.089 . . . . 0.75 108.661 177.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.81 138.01 53.63 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.888 1.275 . . . . 0.84999999999999998 111.314 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -116.81 64.57 0.72 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.707 1.603 . . . . 2.4199999999999999 111.209 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.26 155.75 40.33 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.125 1.157 . . . . 2.1600000000000001 114.125 -172.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.5 m -92.66 147.21 23.06 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.556 1.143 . . . . 2.1499999999999999 109.769 166.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 tp -130.86 114.11 14.88 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.282 2.233 . . . . 3.4700000000000002 110.135 173.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -98.79 121.34 40.61 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.798 1.639 . . . . 5.1900000000000004 110.122 170.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -95.68 104.09 15.02 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 120.89 -1.132 . . . . 1.8200000000000001 110.101 165.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -83.18 -10.15 10.26 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.961 2.441 . . . . 1.28 113.443 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.66 171.4 54.64 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 123.154 1.419 . . . . 1.3 113.166 -173.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.41 -6.1 34.79 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 128.609 2.764 . . . . 3.2799999999999998 112.171 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.5 mt -117.76 162.59 28.25 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 127.49 2.316 . . . . 3.6499999999999999 109.178 171.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -81.51 153.23 17.93 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.66 2.24 . . . . 1.1799999999999999 111.211 -172.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.8 mt -102.32 155.08 18.47 Favored 'General case' 0 C--O 1.227 -0.101 0 CA-C-O 122.758 1.266 . . . . 1.9399999999999999 110.374 166.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -140.24 118.89 12.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 113.661 -1.609 . . . . 1.9099999999999999 109.624 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.2 tp -100.53 108.79 20.81 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.902 1.281 . . . . 1.6699999999999999 109.909 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 m -104.38 -17.84 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.15 0.98 . . . . 0.59999999999999998 111.833 -173.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.99 -179.04 31.63 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 125.412 1.482 . . . . 0.56000000000000005 112.304 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.96 178.16 7.55 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.073 1.349 . . . . 0.88 109.926 165.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -157.38 178.65 10.07 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.005 1.722 . . . . 6.4900000000000002 108.18 176.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 t 177.29 152.05 0.4 Allowed Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 126.642 1.977 . . . . 0.84999999999999998 109.527 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.06 -10.49 27.33 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.731 2.287 . . . . 1.03 114.22 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.3 m -116.72 41.43 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.691 0.997 . . . . 0.85999999999999999 113.691 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.84 144.97 23.83 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.259 -0.9 . . . . 1.01 110.87 162.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -93.21 -47.46 6.93 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.07 1.348 . . . . 3.71 111.447 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.11 161.23 19.77 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.313 1.845 . . . . 6.96 107.659 168.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.74 138.66 10.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 126.178 1.791 . . . . 1.48 108.979 -173.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.55 145.52 48.79 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.884 1.674 . . . . 3.0499999999999998 109.873 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.8 tp -101.35 120.21 39.92 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.216 1.006 . . . . 1.0700000000000001 110.783 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -123.53 155.38 37.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.102 1.761 . . . . 0.58999999999999997 113.65 -174.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -99.97 162.69 12.83 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.153 -1.385 . . . . 2.4700000000000002 111.685 156.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 m -121.61 136.76 54.93 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.153 1.781 . . . . 0.68000000000000005 106.571 162.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -134.83 176.16 8.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.965 1.306 . . . . 1.9199999999999999 112.895 -175.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.5 ptm -123.62 146.04 48.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.012 1.325 . . . . 3.2000000000000002 112.863 167.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.19 138.9 24.18 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.855 2.062 . . . . 6.0899999999999999 110.122 -176.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -95.13 121.88 37.22 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.833 1.253 . . . . 3.4100000000000001 110.809 175.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.2 m -88.67 -120.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.973 -1.121 . . . . 3.5699999999999998 107.973 172.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.07 37.67 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 130.106 3.362 . . . . 4.3499999999999996 116.429 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.81 22.1 68.02 Favored Glycine 0 CA--C 1.528 0.879 0 O-C-N 119.182 -2.199 . . . . 2.3599999999999999 111.504 -164.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.87 132.26 56.74 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.767 2.027 . . . . 6.6100000000000003 108.264 174.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.83 131.76 34.49 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.944 1.298 . . . . 8.3100000000000005 110.822 -175.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.58 150.6 20.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 124.369 1.068 . . . . 2.4500000000000002 110.663 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -111.34 136.89 49.81 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.641 1.176 . . . . 2.9399999999999999 110.27 -175.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.12 -176.67 14.52 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 124.968 1.27 . . . . 0.56999999999999995 112.262 -174.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ttm -152.85 146.62 25.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.175 1.39 . . . . 0.63 108.914 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -156.5 152.84 23.63 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 123.779 0.832 . . . . 5.9500000000000002 110.815 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.29 152.39 55.51 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.953 1.769 . . . . 0.56999999999999995 111.176 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.99 153.62 71.87 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.847 1.659 . . . . 0.67000000000000004 109.747 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.63 -25.3 3.76 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.961 2.44 . . . . 0.56000000000000005 113.279 -166.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -177.18 164.61 2.23 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.729 1.611 . . . . 1.8100000000000001 111.751 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.7 mt -111.79 153.96 25.78 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.424 1.49 . . . . 0.56999999999999995 109.967 163.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -110.11 147.25 34.01 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.388 1.075 . . . . 2.1499999999999999 109.2 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.5 t -139.85 129.53 13.84 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 113.018 0.747 . . . . 1.1100000000000001 113.018 170.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -71.1 164.97 33.91 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.484 2.79 . . . . 1.25 112.494 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -59.63 143.48 99.65 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.347 2.698 . . . . 1.23 111.929 172.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt 67.02 -4.06 0.86 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.318 1.847 . . . . 2.0899999999999999 114.26 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.36 134.8 13.15 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.713 1.625 . . . . 1.3899999999999999 113.088 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -97.84 138.89 34.52 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.646 1.178 . . . . 5.3300000000000001 110.139 164.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.3 t -144.9 132.12 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.059 1.343 . . . . 3.1200000000000001 108.0 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.49 136.48 49.56 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.6 0.714 . . . . 3.25 110.827 172.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mp -71.19 78.13 0.7 Allowed 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 125.45 1.5 . . . . 2.5099999999999998 109.1 165.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -76.08 156.13 84.17 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.248 1.419 . . . . 3.6000000000000001 114.159 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.79 -18.29 62.03 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.571 2.18 . . . . 2.0699999999999998 113.093 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.22 36.18 2.18 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.154 -0.804 . . . . 2.5099999999999998 112.819 166.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.71 -118.88 0.91 Allowed Glycine 0 C--N 1.344 0.974 0 C-N-CA 124.751 1.167 . . . . 1.79 115.066 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -72.15 142.07 49.1 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 121.812 -0.817 . . . . 1.9299999999999999 111.937 -165.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -161.98 171.35 17.75 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.354 1.062 . . . . 0.76000000000000001 112.251 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -107.33 133.4 51.93 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.14 0.576 . . . . 2.0 110.758 170.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.1 tpt -82.08 128.64 34.33 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.23 1.412 . . . . 0.75 109.324 163.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.4 mp -116.6 134.32 54.97 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.838 1.255 . . . . 0.96999999999999997 108.971 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.8 mt -135.58 132.94 37.78 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.752 0.821 . . . . 2.0899999999999999 110.738 -170.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.49 36.56 26.23 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.606 -1.108 . . . . 0.91000000000000003 114.065 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -45.05 150.62 0.38 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 116.528 2.047 . . . . 1.3100000000000001 116.528 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -106.74 7.13 30.25 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 113.713 -1.585 . . . . 2.3199999999999998 113.901 -169.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.9 ptm85 -145.32 147.6 34.5 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.959 1.304 . . . . 4.7800000000000002 111.627 167.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.07 149.64 71.54 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.297 1.998 . . . . 1.8899999999999999 108.435 158.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.72 134.54 25.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.462 1.105 . . . . 3.9500000000000002 110.512 -156.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.5 mmtm -103.32 171.99 7.06 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.068 1.347 . . . . 3.7999999999999998 111.489 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.58 134.6 46.54 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.822 -1.177 . . . . 1.1899999999999999 107.822 148.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.24 21.91 16.36 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.44 1.495 . . . . 1.23 115.405 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -105.79 -174.96 2.66 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.412 1.606 . . . . 1.8600000000000001 111.815 168.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -147.45 131.63 17.39 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 129.747 3.219 . . . . 5.5800000000000001 105.344 -169.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.1 t -140.5 130.5 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.093 0.957 . . . . 0.94999999999999996 110.985 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -76.09 141.66 41.94 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.326 1.051 . . . . 2.71 110.052 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 mp -128.15 136.81 51.63 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.816 0.846 . . . . 1.76 111.969 167.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -90.77 134.19 34.62 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 127.131 2.172 . . . . 2.54 109.339 173.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.73 118.01 35.49 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 119.702 1.137 . . . . 0.93000000000000005 110.065 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 72.2 mt -90.42 102.18 14.92 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.577 -0.897 . . . . 0.88 108.577 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -92.43 142.65 27.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.467 0.707 . . . . 2.5499999999999998 111.274 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.15 124.0 10.64 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.54 1.136 . . . . 1.5900000000000001 112.109 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.1 46.99 19.8 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.712 -1.049 . . . . 2.9900000000000002 114.296 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.84 25.29 25.36 Favored Glycine 0 N--CA 1.475 1.246 0 N-CA-C 117.172 1.629 . . . . 1.8899999999999999 117.172 156.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.57 148.1 39.96 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.453 1.626 . . . . 3.8999999999999999 111.221 168.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -140.28 151.63 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.786 1.234 . . . . 1.8300000000000001 110.935 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.9 tp -155.38 138.09 15.2 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.874 1.669 . . . . 2.48 109.548 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -110.21 115.71 30.21 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.692 0.678 . . . . 1.96 112.504 -173.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.6 m -89.31 178.12 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.057 1.743 . . . . 2.2999999999999998 111.592 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.7 p -142.42 145.28 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.078 1.351 . . . . 2.3799999999999999 109.041 170.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.4 143.75 13.82 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.078 0.951 . . . . 2.27 113.126 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.54 156.69 63.23 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.965 3.11 . . . . 0.90000000000000002 112.953 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.7 t -106.34 124.93 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.513 1.525 . . . . 0.90000000000000002 109.314 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -146.83 155.21 42.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.267 1.827 . . . . 3.8500000000000001 110.541 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -112.55 129.5 56.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.083 0.953 . . . . 2.7400000000000002 113.011 -165.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 C-N-CA 126.379 1.872 . . . . 7.6399999999999997 111.968 167.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 N--CA 1.468 0.468 0 CA-C-O 122.156 0.979 . . . . 7.2300000000000004 108.554 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.35 165.71 33.96 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.866 1.698 . . . . 0.91000000000000003 112.407 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 21.8 p90 -155.65 152.11 28.27 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.319 1.448 . . . . 1.72 111.971 174.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.0 t -89.39 137.87 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.388 -0.82 . . . . 1.3400000000000001 109.021 171.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -62.53 -4.6 2.02 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.121 1.768 . . . . 4.1500000000000004 115.729 -168.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 72.6 159.89 0.22 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.569 1.948 . . . . 2.71 111.154 -167.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.9 t -168.87 135.71 1.53 Allowed Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 121.155 -0.966 . . . . 2.4500000000000002 111.077 163.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -81.42 -6.88 12.81 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.271 2.648 . . . . 1.9399999999999999 112.235 169.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.59 171.99 15.06 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.48 1.515 . . . . 1.04 113.551 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.76 -13.45 34.31 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.944 3.763 . . . . 1.27 115.454 -172.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -123.41 144.4 49.51 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.639 1.575 . . . . 3.6699999999999999 112.256 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.69 -176.49 4.67 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.367 1.867 . . . . 0.45000000000000001 112.012 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.97 154.3 39.18 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.694 1.997 . . . . 0.76000000000000001 108.504 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.51 146.48 42.02 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.75 1.22 . . . . 0.79000000000000004 114.227 -173.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.464 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 30.2 m-85 -120.7 143.6 48.66 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.867 2.067 . . . . 2.4500000000000002 110.184 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pp -171.38 151.62 3.11 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.441 1.275 . . . . 2.0299999999999998 114.441 -175.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.4 m -79.13 144.27 34.67 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.923 1.689 . . . . 1.96 111.359 174.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.5 126.99 54.97 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 129.502 3.121 . . . . 3.54 108.057 168.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -118.94 127.46 53.5 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.802 1.241 . . . . 4.2400000000000002 109.663 168.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -100.46 93.44 2.76 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 123.606 0.762 . . . . 1.4299999999999999 110.061 170.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.54 -8.89 18.52 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.025 1.817 . . . . 1.3600000000000001 112.983 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.42 162.45 34.83 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 122.684 1.158 . . . . 1.23 111.643 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -94.53 3.27 55.33 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.352 2.661 . . . . 2.9900000000000002 112.046 -170.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -122.21 154.32 61.87 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 129.242 3.017 . . . . 1.98 109.678 174.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.78 147.01 30.59 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.759 2.306 . . . . 0.85999999999999999 111.024 -172.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.6 mt -104.2 147.93 26.9 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 122.465 1.126 . . . . 1.95 110.537 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -136.73 99.04 3.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.562 -2.108 . . . . 2.2599999999999998 110.725 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.2 tp -80.73 106.43 12.73 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.669 1.588 . . . . 2.0 109.727 -173.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -99.19 -21.18 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.771 1.229 . . . . 0.81000000000000005 112.209 -175.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.16 -177.16 31.98 Favored Glycine 0 C--N 1.343 0.947 0 C-N-CA 124.96 1.266 . . . . 0.73999999999999999 114.937 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.07 -177.24 5.35 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.562 1.945 . . . . 0.73999999999999999 111.131 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.429 HH12 HG11 ' A' ' 110' ' ' VAL . 40.9 mtt85 -146.55 -179.42 6.76 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.809 2.044 . . . . 6.6500000000000004 108.062 158.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t -174.77 152.08 1.54 Allowed Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 127.12 2.168 . . . . 0.81999999999999995 108.299 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.78 -6.29 15.94 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.025 1.817 . . . . 0.98999999999999999 113.899 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.434 HG22 HG11 ' A' ' 99' ' ' VAL . 35.7 m -115.23 45.31 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.532 1.133 . . . . 0.90000000000000002 112.854 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.33 171.76 19.81 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.665 1.186 . . . . 1.28 111.8 168.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -104.96 -23.49 12.97 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 128.464 2.706 . . . . 2.8300000000000001 111.221 166.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -152.26 160.49 43.34 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.44 2.296 . . . . 6.5899999999999999 110.858 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.2 p -156.93 117.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 125.815 1.646 . . . . 1.8 110.301 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -131.28 130.68 43.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.954 -1.021 . . . . 5.0 111.352 -166.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 31.3 tp -83.3 122.51 28.54 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.958 0.903 . . . . 1.3999999999999999 111.746 -168.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.3 m170 -124.75 160.78 27.87 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.618 1.567 . . . . 0.68999999999999995 113.356 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -107.18 154.17 21.59 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 113.467 -1.697 . . . . 2.3700000000000001 110.721 157.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.0 m -111.18 138.33 47.75 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.265 1.826 . . . . 1.04 106.521 162.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -133.78 174.19 10.72 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.191 1.396 . . . . 2.0 112.968 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.0 ttp -113.0 143.0 45.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.628 1.571 . . . . 3.52 109.833 166.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -138.31 152.67 48.72 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.135 1.374 . . . . 4.7699999999999996 112.036 171.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -95.84 146.93 24.17 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.104 1.762 . . . . 2.2000000000000002 110.602 163.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 m -147.93 130.71 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.885 2.074 . . . . 2.2599999999999998 108.837 162.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 62.98 15.84 8.74 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.577 1.551 . . . . 3.3500000000000001 114.34 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.71 16.79 69.63 Favored Glycine 0 N--CA 1.479 1.513 0 O-C-N 121.054 -1.029 . . . . 1.6799999999999999 113.741 -169.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.9 mtmt -119.27 122.17 41.3 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.974 2.11 . . . . 3.46 108.071 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.47 128.43 38.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.869 1.268 . . . . 3.6899999999999999 111.76 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 t -143.69 141.73 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 127.208 2.203 . . . . 2.7599999999999998 108.662 -174.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 50.6 mtp -83.54 162.93 20.72 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.358 0.663 . . . . 3.3300000000000001 112.655 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.56 -177.47 28.83 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 125.118 1.342 . . . . 0.91000000000000003 112.397 -177.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.1 ttm -154.79 148.25 25.16 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.531 1.133 . . . . 0.92000000000000004 109.844 -172.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -155.89 153.7 26.36 Favored Pre-proline 0 N--CA 1.474 0.736 0 C-N-CA 123.779 0.832 . . . . 6.1699999999999999 111.475 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.77 156.56 39.65 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.499 2.133 . . . . 0.68000000000000005 111.262 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.7 m -138.88 153.03 71.54 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 125.114 1.366 . . . . 0.65000000000000002 110.148 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.32 -24.7 5.27 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.656 2.904 . . . . 0.75 113.337 -167.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -174.99 167.0 3.58 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.621 1.968 . . . . 2.1299999999999999 110.929 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.4 mt -109.6 153.34 24.31 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.526 1.13 . . . . 0.72999999999999998 110.31 159.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -108.94 143.65 37.91 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.234 1.014 . . . . 1.8600000000000001 109.167 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.7 t -136.88 124.3 14.28 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.386 0.674 . . . . 0.95999999999999996 110.989 165.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -69.82 164.51 34.33 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.773 2.982 . . . . 0.95999999999999996 111.643 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.66 147.89 92.49 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.017 2.478 . . . . 0.96999999999999997 113.301 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt 69.73 -14.04 0.37 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.335 2.654 . . . . 1.74 114.219 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.62 172.63 42.9 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.18 1.372 . . . . 1.4199999999999999 113.572 -171.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.68 143.94 35.37 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.89 0.876 . . . . 4.4400000000000004 111.119 168.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.5 t -151.17 158.49 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 127.379 2.272 . . . . 3.7999999999999998 107.213 -168.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.43 152.74 42.91 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 121.075 1.761 . . . . 3.77 114.088 176.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.1 mp -59.95 91.16 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 107.311 -1.366 . . . . 1.9099999999999999 107.311 155.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -49.93 126.0 18.8 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 125.351 1.46 . . . . 3.4700000000000002 111.831 -165.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 19.7 Cg_endo -60.96 -13.75 29.04 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.878 2.385 . . . . 2.71 116.678 -172.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.39 -1.39 29.5 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-N 120.101 1.319 . . . . 2.7200000000000002 115.277 167.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.94 -103.8 1.2 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.359 1.933 . . . . 1.9399999999999999 112.466 -168.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -72.49 139.12 47.45 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.269 -1.136 . . . . 2.0 112.059 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -160.22 149.74 17.72 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.561 1.144 . . . . 0.59999999999999998 110.519 -173.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -83.25 130.09 35.05 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.298 -1.001 . . . . 1.6200000000000001 108.298 165.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -80.04 133.08 36.11 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.279 0.945 . . . . 0.65000000000000002 108.832 163.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 mp -109.56 126.92 54.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.342 1.057 . . . . 0.57999999999999996 109.369 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -118.89 130.1 55.55 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 124.227 1.011 . . . . 3.3900000000000001 109.647 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.54 54.74 3.87 Favored Glycine 0 N--CA 1.476 1.363 0 C-N-CA 123.744 0.688 . . . . 0.76000000000000001 114.662 167.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.34 158.68 4.06 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 117.673 2.471 . . . . 1.55 117.673 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -116.29 -25.62 7.48 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 113.08 -1.873 . . . . 1.76 112.855 -171.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -117.81 151.83 49.2 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 129.48 3.112 . . . . 7.0499999999999998 107.811 159.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.99 140.66 38.52 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.229 1.953 . . . . 1.8 108.611 164.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.6 mp -95.74 89.21 5.23 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.158 0.504 . . . . 2.4399999999999999 110.259 -175.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -75.21 174.16 9.85 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.268 0.556 . . . . 5.0700000000000003 111.758 167.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.72 146.45 44.41 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.501 -1.296 . . . . 1.3500000000000001 107.501 165.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.32 34.5 63.96 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 117.866 -1.519 . . . . 1.6000000000000001 114.163 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -94.73 174.04 7.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.14 1.47 . . . . 2.6499999999999999 109.185 157.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -135.5 127.77 30.14 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 105.092 -2.188 . . . . 4.3499999999999996 105.092 169.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.434 HG11 HG22 ' A' ' 39' ' ' VAL . 10.7 t -152.45 140.05 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.944 1.298 . . . . 2.04 110.331 -175.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -78.3 154.67 30.69 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 113.394 0.887 . . . . 3.6400000000000001 113.394 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.9 137.36 51.79 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.264 -1.334 . . . . 1.8100000000000001 110.4 149.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.41 150.6 31.28 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.582 1.153 . . . . 2.5899999999999999 108.611 159.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.0 mp -123.86 127.69 48.39 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.025 1.33 . . . . 1.02 110.209 175.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.3 mt -110.65 114.12 27.26 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.99 1.716 . . . . 1.1200000000000001 110.226 -172.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -113.21 123.59 50.55 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.759 1.224 . . . . 1.95 111.613 -172.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 48.01 32.13 2.75 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.308 1.843 . . . . 2.25 113.502 176.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.25 -73.96 2.35 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.107 1.337 . . . . 4.9699999999999998 112.689 -172.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.15 -26.36 44.62 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 116.44 1.336 . . . . 2.0699999999999998 116.44 -161.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -83.81 109.46 17.56 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.58 1.69 . . . . 4.8200000000000003 111.716 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.429 HG11 HH12 ' A' ' 36' ' ' ARG . 58.8 t -98.52 134.46 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.399 1.48 . . . . 1.78 110.712 174.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -136.68 171.62 14.22 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.811 1.644 . . . . 3.3599999999999999 109.606 166.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -149.6 143.96 25.88 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.786 -1.196 . . . . 2.02 112.007 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.84 150.57 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.137 0.975 . . . . 2.3500000000000001 110.011 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.83 133.51 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.523 1.529 . . . . 1.6499999999999999 107.641 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.4 mt -139.07 145.58 45.76 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.422 1.089 . . . . 2.5600000000000001 109.918 -173.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.14 162.46 35.61 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.796 2.331 . . . . 0.72999999999999998 112.444 167.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 42.6 t -112.07 122.5 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.189 -1.411 . . . . 0.98999999999999999 107.189 165.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -146.48 154.54 41.69 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.467 1.507 . . . . 4.4800000000000004 110.391 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.03 141.85 28.4 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.484 0.92 . . . . 2.3500000000000001 113.484 -168.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.541 ' HB2' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.976 0 C-N-CA 126.157 1.783 . . . . 8.5999999999999996 112.103 169.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 123.078 1.418 . . . . 6.3700000000000001 112.065 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.98 179.03 21.62 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 121.161 -0.962 . . . . 1.0 111.393 173.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.3 p90 -148.94 157.06 43.14 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.778 0.831 . . . . 1.78 112.053 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.2 t -97.56 143.65 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 107.65 -1.241 . . . . 1.3 107.65 173.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -73.87 127.27 32.4 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.438 -0.789 . . . . 4.7800000000000002 110.816 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -36.02 148.49 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.675 1.99 . . . . 2.52 113.333 155.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.9 t -160.25 146.75 11.96 Favored Pre-proline 0 CA--C 1.536 0.439 0 O-C-N 120.884 -1.135 . . . . 2.3100000000000001 112.333 166.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -85.89 -6.81 8.52 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.18 2.587 . . . . 2.0 112.693 170.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -137.58 -176.58 14.53 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.73 1.157 . . . . 1.1200000000000001 114.423 -172.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.3 -17.92 44.56 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.483 3.455 . . . . 1.49 115.097 -169.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -97.85 142.07 30.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.19 1.396 . . . . 2.8100000000000001 112.64 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.14 -176.48 5.69 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.484 1.514 . . . . 0.68999999999999995 111.944 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.21 152.3 32.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.675 1.59 . . . . 0.71999999999999997 109.708 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.08 124.27 47.65 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.09 1.314 . . . . 0.81999999999999995 111.773 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -102.16 57.39 0.81 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.812 1.645 . . . . 2.8100000000000001 109.635 173.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -75.12 162.93 28.08 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.057 0.943 . . . . 1.9299999999999999 113.163 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 99.0 m -143.58 137.38 28.33 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.892 1.677 . . . . 2.5 110.869 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.616 HD21 HG11 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -135.1 156.52 48.87 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.255 2.222 . . . . 4.9400000000000004 109.018 169.815 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -84.79 160.89 20.15 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.196 1.362 . . . . 3.3900000000000001 110.507 154.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -97.86 94.33 2.09 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 109.042 -0.725 . . . . 1.8 109.042 155.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.98 -6.27 14.96 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.063 2.509 . . . . 1.8600000000000001 113.433 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.33 164.52 52.53 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-O 122.722 1.179 . . . . 1.76 112.082 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -87.02 -5.89 58.92 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.661 1.584 . . . . 3.7799999999999998 111.742 175.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 pp -116.04 159.13 40.57 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 127.666 2.387 . . . . 2.5600000000000001 111.198 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.01 145.29 22.07 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.576 2.184 . . . . 1.3400000000000001 111.046 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.1 mt -99.33 142.84 30.29 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 123.018 1.39 . . . . 2.46 111.727 170.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.42 ' HD2' ' CD2' ' A' ' 66' ' ' PHE . 16.4 tpp85 -131.47 98.38 4.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 112.119 -2.31 . . . . 1.97 109.474 -174.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.9 tp -91.39 109.27 20.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.565 1.546 . . . . 1.8999999999999999 109.691 -171.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.7 m -103.68 -22.07 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.826 0.85 . . . . 0.56999999999999995 112.084 -173.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.88 -177.08 30.65 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.466 1.508 . . . . 0.52000000000000002 114.288 -173.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.35 178.38 8.83 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.8 1.64 . . . . 0.52000000000000002 112.269 171.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.8 161.08 36.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.54 2.336 . . . . 6.2199999999999998 109.12 174.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 t -176.25 154.08 1.33 Allowed Pre-proline 0 N--CA 1.471 0.6 0 C-N-CA 128.08 2.552 . . . . 0.70999999999999996 107.176 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.16 -20.16 19.27 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.85 1.7 . . . . 0.93999999999999995 112.499 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.6 m -99.1 35.27 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.799 0.809 . . . . 0.83999999999999997 112.899 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.14 143.05 16.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.982 1.313 . . . . 1.03 109.234 166.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -91.51 -49.42 6.32 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.63 1.572 . . . . 3.8100000000000001 110.592 -176.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.99 160.15 22.53 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.468 1.907 . . . . 6.4800000000000004 107.665 167.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.1 p -142.52 145.45 23.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 126.067 1.747 . . . . 1.3500000000000001 108.049 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -129.47 148.74 51.41 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.057 1.743 . . . . 3.0600000000000001 108.771 174.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.5 tp -101.16 121.28 41.54 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.349 -0.845 . . . . 0.97999999999999998 109.911 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.1 m170 -123.61 154.28 39.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.436 1.494 . . . . 0.55000000000000004 113.871 -174.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -100.68 179.8 4.31 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.341 1.456 . . . . 2.1499999999999999 112.098 162.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.5 m -145.63 128.44 16.32 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 106.665 -1.606 . . . . 0.65000000000000002 106.665 172.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -129.16 167.96 16.84 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 114.357 1.243 . . . . 2.2599999999999998 114.357 -166.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -109.2 147.6 32.28 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.864 1.666 . . . . 4.9900000000000002 110.994 171.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.55 151.76 24.69 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.776 0.83 . . . . 5.1600000000000001 112.004 -174.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -103.72 143.29 32.99 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.702 1.601 . . . . 2.2599999999999998 109.671 167.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -158.99 139.97 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.613 1.165 . . . . 3.0899999999999999 108.336 167.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 62.25 27.17 16.29 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.334 1.053 . . . . 3.4500000000000002 111.844 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.99 18.2 78.99 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 120.912 -1.118 . . . . 1.6899999999999999 113.605 -175.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -132.48 129.33 39.04 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.046 1.338 . . . . 2.5499999999999998 110.179 -174.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.599 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -71.29 130.09 40.51 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.311 2.244 . . . . 3.98 111.315 173.493 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.1 m -141.43 175.12 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 129.171 2.988 . . . . 2.25 110.235 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.25 162.9 21.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.079 1.351 . . . . 3.6800000000000002 111.172 177.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.3 -178.14 29.25 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.089 1.328 . . . . 0.52000000000000002 113.704 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.3 ttm -154.82 148.49 25.39 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.507 1.923 . . . . 0.59999999999999998 108.286 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -160.43 156.4 22.64 Favored Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 124.814 1.246 . . . . 5.7599999999999998 110.471 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.64 155.44 44.68 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.254 1.969 . . . . 0.59999999999999998 111.519 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.99 154.72 70.76 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.655 1.582 . . . . 0.68000000000000005 110.156 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.69 -24.49 3.44 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.178 2.585 . . . . 0.56999999999999995 113.367 -167.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.42 ' CD2' ' HD2' ' A' ' 31' ' ' ARG . 50.6 p90 -178.24 163.05 1.61 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.334 1.853 . . . . 1.8600000000000001 111.073 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.1 mt -109.6 153.01 24.78 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.006 1.323 . . . . 0.68999999999999995 110.377 166.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -121.39 137.33 54.75 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.288 1.435 . . . . 2.0899999999999999 109.194 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.9 t -140.32 130.99 13.89 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 123.667 0.787 . . . . 1.3500000000000001 111.544 175.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.3 163.76 37.53 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.356 2.704 . . . . 1.3100000000000001 112.39 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -60.03 140.36 92.25 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.42 2.747 . . . . 1.55 111.012 171.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp 65.78 0.75 1.6 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.137 1.375 . . . . 3.2799999999999998 113.374 -175.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.11 -175.18 41.9 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.225 1.869 . . . . 1.77 109.907 163.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -139.19 138.45 36.91 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.712 -0.876 . . . . 7.4699999999999998 112.865 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -93.04 57.23 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 128.189 2.595 . . . . 5.21 108.43 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -81.4 125.3 30.24 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.136 0.974 . . . . 3.6099999999999999 108.859 163.272 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 83' ' ' HIS . 5.1 mp -72.48 -53.94 10.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.162 -0.472 . . . . 3.1400000000000001 110.477 175.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.314 0.0 OUTLIER 79.94 123.55 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.081 0 C-N-CA 128.157 2.583 . . . . 3.3599999999999999 114.228 176.698 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.41 -15.19 48.68 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.065 2.51 . . . . 2.1600000000000001 113.9 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.86 5.12 84.86 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 117.073 -1.959 . . . . 1.5 114.745 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.49 -24.14 0.02 OUTLIER Glycine 0 C--N 1.348 1.23 0 N-CA-C 121.596 3.398 . . . . 2.0699999999999998 121.596 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -145.77 147.62 32.09 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.022 1.911 . . . . 2.0699999999999998 113.215 171.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.581 ' HA ' HD23 ' A' ' 77' ' ' LEU . 50.2 p-80 -162.18 155.41 20.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.12 0.968 . . . . 0.63 110.889 177.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -80.32 137.16 36.55 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.108 0.867 . . . . 1.8899999999999999 109.119 158.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.8 tpt -85.21 129.73 34.75 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.881 1.272 . . . . 0.69999999999999996 108.43 162.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -111.62 126.41 54.98 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.466 1.107 . . . . 0.57999999999999996 108.866 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.96 128.63 55.91 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.243 1.017 . . . . 2.8999999999999999 109.432 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.48 44.48 10.91 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 118.561 -1.133 . . . . 0.94999999999999996 114.834 169.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -43.52 149.82 0.25 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 117.734 2.494 . . . . 1.3700000000000001 117.734 176.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -115.82 -22.56 9.04 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 114.19 -1.368 . . . . 2.8599999999999999 114.526 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -91.38 168.62 13.05 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 107.553 -1.277 . . . . 5.7000000000000002 107.553 149.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -63.38 177.93 1.41 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 121.153 1.236 . . . . 2.6600000000000001 109.907 148.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.0 mt -129.13 95.08 3.96 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.135 -0.978 . . . . 2.5600000000000001 109.314 167.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -99.33 159.44 15.0 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.967 0.889 . . . . 5.6699999999999999 112.829 176.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.74 130.62 44.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.275 -1.329 . . . . 1.45 107.915 159.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.92 0.68 83.23 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.484 1.992 . . . . 1.4399999999999999 116.797 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.412 ' HB3' ' H ' ' A' ' 98' ' ' GLU . 33.9 mt-10 -81.48 -171.46 3.31 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.482 2.141 . . . . 2.6600000000000001 113.312 175.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 97' ' ' GLU . 16.5 pt-20 -152.51 124.98 8.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 128.62 2.768 . . . . 5.0099999999999998 105.899 -155.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 38.1 t -144.02 125.34 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 O-C-N 121.578 -0.701 . . . . 1.1299999999999999 110.333 -173.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -79.56 151.21 30.8 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.497 -0.774 . . . . 3.0299999999999998 111.325 168.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.23 147.22 34.5 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.828 2.051 . . . . 1.99 110.793 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -121.53 108.0 13.09 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 128.946 2.898 . . . . 2.2000000000000002 108.312 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.0 mp -83.98 128.09 34.31 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.355 -0.84 . . . . 0.98999999999999999 110.584 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.6 mt -97.82 103.41 15.35 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.362 1.065 . . . . 0.69999999999999996 110.557 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -98.02 143.11 28.93 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.675 1.19 . . . . 2.23 111.435 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.64 131.69 39.39 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.282 1.033 . . . . 2.0099999999999998 112.421 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.18 41.93 7.27 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.801 -0.999 . . . . 2.9500000000000002 113.938 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.16 7.21 88.61 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 116.018 1.167 . . . . 2.1299999999999999 116.018 165.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -90.43 112.62 24.31 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.963 1.382 . . . . 3.3199999999999998 111.382 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.13 134.15 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.917 1.287 . . . . 2.23 109.999 173.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.0 tp -128.49 111.01 12.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.776 0.83 . . . . 1.9099999999999999 111.465 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -81.76 135.16 35.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.417 0.687 . . . . 2.1699999999999999 112.354 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.616 HG11 HD21 ' A' ' 22' ' ' LEU . 7.7 m -144.84 162.2 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 127.458 2.303 . . . . 2.02 111.019 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.2 t -131.91 132.45 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.625 0.77 . . . . 1.6399999999999999 109.881 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.89 153.69 64.54 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 126.251 1.82 . . . . 1.8500000000000001 110.142 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.04 167.11 27.62 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.674 2.916 . . . . 0.73999999999999999 112.278 175.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.85 135.29 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.786 1.234 . . . . 0.89000000000000001 109.358 167.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -150.26 165.45 32.92 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 115.991 1.849 . . . . 4.2999999999999998 115.991 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.14 149.55 27.91 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 116.963 2.209 . . . . 2.6099999999999999 116.963 -159.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.186 1 C-N-CA 134.05 4.94 . . . . 8.4800000000000004 108.462 161.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 107.947 -1.131 . . . . 7.0599999999999996 107.947 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.85 164.24 31.23 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 123.541 0.591 . . . . 1.3300000000000001 111.961 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -108.36 168.58 9.21 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.147 0.979 . . . . 2.0899999999999999 112.206 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.8 t -90.88 131.52 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.083 0.953 . . . . 1.25 109.011 167.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 107.67 11.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.972 0.909 . . . . 4.9000000000000004 108.828 171.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -42.78 149.69 0.18 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.317 1.847 . . . . 2.0600000000000001 114.806 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.6 t -152.51 151.56 27.31 Favored Pre-proline 0 CA--C 1.538 0.492 0 O-C-N 121.132 -0.98 . . . . 2.8500000000000001 111.08 163.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -88.32 -2.66 6.88 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.429 2.753 . . . . 2.3100000000000001 111.968 164.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.7 -179.38 20.0 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.929 1.252 . . . . 1.3700000000000001 114.716 -170.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.81 -17.21 37.46 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.635 3.556 . . . . 1.45 114.635 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -110.28 153.9 24.2 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.495 1.518 . . . . 2.3900000000000001 113.738 172.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.39 -178.47 6.68 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 128.132 2.573 . . . . 0.70999999999999996 110.647 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.13 152.74 36.65 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.338 1.455 . . . . 0.65000000000000002 110.448 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.62 146.61 36.42 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.239 1.2 . . . . 0.56000000000000005 114.239 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -117.51 29.74 7.69 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 115.663 1.727 . . . . 2.8999999999999999 115.663 -167.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -49.74 161.88 0.2 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 117.876 2.547 . . . . 1.8799999999999999 117.876 -169.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 15.8 m -79.64 119.81 23.1 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.448 0.642 . . . . 2.0099999999999998 111.589 172.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.467 HD12 HG21 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -83.35 139.24 33.14 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.55 -0.907 . . . . 3.75 108.55 164.861 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -147.39 172.45 13.9 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.368 0.667 . . . . 6.1500000000000004 111.551 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -155.71 110.38 2.17 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.338 1.455 . . . . 1.3799999999999999 110.74 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.7 -5.82 4.39 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.844 3.03 . . . . 1.3899999999999999 114.292 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.99 178.23 41.99 Favored Glycine 0 C--N 1.341 0.818 0 CA-C-N 119.55 1.068 . . . . 1.1799999999999999 112.956 -174.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -101.25 3.2 40.66 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.408 2.283 . . . . 3.29 112.323 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -118.74 160.21 41.27 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 127.116 2.166 . . . . 2.0600000000000001 110.254 171.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.75 142.26 15.87 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.344 2.03 . . . . 1.0600000000000001 111.422 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.471 HD12 ' CD1' ' A' ' 105' ' ' PHE . 1.9 mm? -102.95 157.11 17.2 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.359 1.464 . . . . 2.5299999999999998 111.975 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -152.99 104.54 2.84 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.02 -1.446 . . . . 2.0699999999999998 111.649 -169.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.2 tt -83.03 123.64 29.67 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.702 1.201 . . . . 2.3999999999999999 108.61 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 m -110.91 -15.12 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.665 0.786 . . . . 0.69999999999999996 111.662 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.48 -177.12 30.28 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 125.6 1.571 . . . . 0.52000000000000002 114.051 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.9 -179.55 7.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.46 1.504 . . . . 0.56000000000000005 111.699 171.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -155.92 173.26 17.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.605 2.362 . . . . 6.3099999999999996 109.212 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 t 178.54 146.75 0.36 Allowed Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 129.106 2.963 . . . . 0.81999999999999995 106.87 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.0 -15.62 36.26 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 121.736 1.624 . . . . 1.3 113.544 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.0 22.17 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.609 1.164 . . . . 1.22 113.288 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.75 138.47 28.83 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.786 1.176 . . . . 1.02 110.382 169.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -83.21 -41.03 18.88 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.007 0.923 . . . . 3.8100000000000001 111.062 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -131.16 152.84 50.03 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 128.537 2.735 . . . . 6.6900000000000004 106.396 -175.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.6 p -146.57 146.27 18.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 124.555 1.142 . . . . 1.4299999999999999 108.772 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -132.36 145.36 51.19 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.97 1.708 . . . . 3.1200000000000001 108.841 175.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.4 tp -99.63 118.79 36.93 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.809 -0.557 . . . . 0.97999999999999998 109.639 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.0 m170 -122.53 154.12 38.31 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.245 1.418 . . . . 0.63 114.068 -174.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -102.04 163.66 12.12 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.354 -1.294 . . . . 2.3100000000000001 111.622 161.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.4 m -120.88 130.63 53.99 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 105.906 -1.887 . . . . 0.88 105.906 163.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -127.37 168.52 14.71 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.518 1.303 . . . . 2.0800000000000001 114.518 -170.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -109.49 148.21 31.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.853 1.661 . . . . 4.9900000000000002 111.425 170.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.58 148.48 24.37 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.414 1.086 . . . . 5.04 110.56 -174.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -98.53 140.02 33.39 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.564 1.145 . . . . 2.9300000000000002 109.895 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.1 t -137.81 118.41 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.353 1.061 . . . . 2.2999999999999998 108.241 168.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 66.49 15.14 10.02 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 126.191 1.796 . . . . 4.1299999999999999 114.85 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.6 21.64 55.7 Favored Glycine 0 CA--C 1.535 1.32 0 O-C-N 121.356 -0.84 . . . . 2.5800000000000001 112.943 -166.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.5 mttt -124.53 113.53 18.22 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.604 1.562 . . . . 3.3900000000000001 109.133 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.8 123.01 28.94 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.604 -0.685 . . . . 5.7300000000000004 110.519 -171.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.29 179.76 3.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 128.451 2.7 . . . . 2.6000000000000001 110.764 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.83 162.56 31.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.88 1.272 . . . . 2.5699999999999998 111.862 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.35 -176.54 27.65 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.53 1.538 . . . . 0.64000000000000001 113.662 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.0 ttm -150.8 148.02 27.99 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.195 1.798 . . . . 0.88 108.873 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -158.65 157.34 28.49 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 124.659 1.184 . . . . 5.8600000000000003 111.131 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.99 154.77 53.04 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.011 1.807 . . . . 0.67000000000000004 111.699 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.45 156.5 74.99 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 126.283 1.833 . . . . 0.76000000000000001 110.091 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.44 -26.76 3.09 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.023 2.482 . . . . 0.60999999999999999 113.371 -167.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -175.3 164.68 3.24 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.501 1.521 . . . . 2.1000000000000001 111.231 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.4 mt -113.33 153.92 27.7 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.897 1.679 . . . . 0.72999999999999998 110.119 164.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -136.34 147.99 47.68 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.355 0.662 . . . . 2.2599999999999998 111.836 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.467 HG21 HD12 ' A' ' 22' ' ' LEU . 88.0 t -141.56 131.47 12.79 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.161 0.985 . . . . 0.82999999999999996 112.366 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -69.97 161.98 43.9 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.742 2.962 . . . . 0.92000000000000004 111.704 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.24 140.91 81.64 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.598 2.866 . . . . 0.97999999999999998 113.517 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp 66.94 2.88 2.85 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.476 1.91 . . . . 1.75 114.552 176.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.78 160.31 31.16 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.843 1.687 . . . . 1.2 114.24 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.19 146.04 33.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.333 1.053 . . . . 4.1600000000000001 110.85 168.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.2 t -155.81 132.92 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 125.491 1.516 . . . . 4.46 108.642 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 2.8 mp0 -83.21 141.66 31.74 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.137 1.335 . . . . 3.7400000000000002 111.102 176.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mp -46.49 -43.57 16.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.989 1.316 . . . . 2.9399999999999999 112.007 -177.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 108.13 128.56 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 128.019 2.528 . . . . 3.8399999999999999 111.019 158.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -59.98 116.16 3.12 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 N-CA-C 107.463 -1.783 . . . . 2.7000000000000002 107.463 165.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.78 26.07 59.27 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 116.98 -2.011 . . . . 2.0099999999999998 116.463 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.58 -42.74 0.04 OUTLIER Glycine 0 N--CA 1.482 1.729 0 N-CA-C 119.252 2.461 . . . . 1.79 119.252 166.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -137.2 145.94 44.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.745 1.26 . . . . 1.9199999999999999 110.753 160.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -160.56 153.02 20.67 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.176 -0.953 . . . . 0.72999999999999998 109.339 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -78.72 151.02 32.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.82 -0.807 . . . . 2.27 108.82 162.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.3 tpt -101.0 129.42 46.84 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.912 1.685 . . . . 0.77000000000000002 107.391 159.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.84 137.62 49.55 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.671 1.188 . . . . 0.66000000000000003 108.479 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -139.44 146.61 40.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.516 1.127 . . . . 2.3599999999999999 112.69 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.78 26.94 68.05 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.464 1.03 . . . . 1.3300000000000001 113.728 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.5 148.12 2.99 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 117.07 2.248 . . . . 1.48 117.07 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -120.7 2.48 10.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 112.065 -2.334 . . . . 2.3100000000000001 113.494 -165.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -145.25 144.51 23.55 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 127.094 2.158 . . . . 6.0300000000000002 108.22 164.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.07 158.3 45.81 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.111 2.541 . . . . 1.74 110.343 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -106.18 99.55 9.13 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.973 1.709 . . . . 2.8100000000000001 109.294 -169.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.445 ' H ' ' HZ3' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -82.91 132.69 35.15 Favored 'General case' 0 C--N 1.332 -0.155 0 O-C-N 120.446 -1.409 . . . . 4.2800000000000002 112.423 175.146 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.7 115.55 1.69 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 113.923 -1.49 . . . . 1.8600000000000001 109.889 169.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.92 -3.74 45.26 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 117.673 -1.626 . . . . 1.8799999999999999 115.736 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -76.41 -178.58 4.69 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 120.242 2.021 . . . . 2.7599999999999998 111.661 167.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -140.66 139.05 34.74 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 129.236 3.014 . . . . 3.5299999999999998 105.535 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.66 126.63 44.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 126.616 1.966 . . . . 1.02 108.504 -173.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -78.29 139.6 38.86 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.836 0.826 . . . . 3.8199999999999998 111.857 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.38 146.47 39.42 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.125 1.37 . . . . 3.1899999999999999 109.321 163.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -102.46 139.23 38.33 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.04 2.536 . . . . 2.6400000000000001 108.859 171.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.2 mp -109.37 138.06 46.3 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.592 1.557 . . . . 0.87 110.395 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.4 mt -112.14 110.06 20.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.687 1.195 . . . . 0.63 110.917 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.471 ' CD1' HD12 ' A' ' 30' ' ' LEU . 97.6 m-85 -107.62 151.8 25.15 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.359 1.464 . . . . 2.04 112.505 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.82 114.61 1.47 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.899 1.28 . . . . 1.75 113.538 -174.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.42 69.32 1.4 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.928 1.252 . . . . 2.8100000000000001 112.965 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.28 7.92 73.58 Favored Glycine 0 N--CA 1.476 1.311 0 N-CA-C 116.291 1.277 . . . . 2.02 116.291 164.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -96.56 125.98 41.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.861 1.331 . . . . 3.6099999999999999 111.309 -171.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.99 141.98 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 124.297 0.998 . . . . 1.8999999999999999 110.893 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.3 tp -140.59 159.8 41.41 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.491 2.316 . . . . 2.1000000000000001 108.6 177.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -132.83 145.18 50.74 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.983 0.913 . . . . 2.1400000000000001 111.992 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.12 160.31 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 127.299 2.24 . . . . 2.6099999999999999 110.836 -172.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.2 t -130.03 94.62 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.034 0.921 . . . . 2.25 110.618 -158.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.8 mt -98.55 123.78 48.84 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-O 118.062 -0.971 . . . . 2.3999999999999999 111.051 -168.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.13 153.98 73.52 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.11 1.873 . . . . 0.97999999999999998 111.041 170.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 90.1 t -92.99 121.09 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.305 0.642 . . . . 1.49 109.986 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -117.78 135.82 53.8 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.372 1.069 . . . . 3.4900000000000002 110.59 167.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.93 57.46 4.34 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.202 -0.936 . . . . 4.0899999999999999 112.74 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.335 0 CA-C-O 115.926 -1.988 . . . . 7.2000000000000002 112.605 -171.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 . . . . . 0 CA--C 1.542 0.663 0 N-CA-C 108.019 -1.104 . . . . 5.8399999999999999 108.019 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.29 176.01 28.74 Favored Glycine 0 CA--C 1.527 0.793 0 O-C-N 121.324 -0.86 . . . . 1.52 112.385 169.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -157.64 172.08 19.18 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.53 1.132 . . . . 2.0600000000000001 112.073 154.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 10' ' ' PHE . 10.2 t -105.53 139.02 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.534 1.133 . . . . 1.1200000000000001 109.323 172.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.0 ttp85 -60.47 -35.36 75.7 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.882 1.067 . . . . 3.79 113.882 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.436 ' H ' HG12 ' A' ' 8' ' ' VAL . 6.2 t80 64.89 158.95 0.1 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.79 2.036 . . . . 3.1600000000000001 110.343 -157.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 m -166.07 147.65 5.92 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 126.195 1.798 . . . . 3.1200000000000001 109.017 162.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -83.58 49.74 3.01 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.591 3.527 . . . . 2.9399999999999999 111.682 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.17 179.09 25.31 Favored Glycine 0 CA--C 1.537 1.423 0 N-CA-C 115.892 1.117 . . . . 1.29 115.892 -171.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.92 -20.15 19.91 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 124.073 3.182 . . . . 1.27 112.52 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -112.09 145.92 38.89 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.413 1.885 . . . . 2.4700000000000002 113.646 173.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -131.28 -177.68 4.5 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.637 1.975 . . . . 0.65000000000000002 110.802 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.54 148.65 31.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.771 1.228 . . . . 0.62 110.417 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.03 150.91 49.38 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.385 1.254 . . . . 0.56999999999999995 114.385 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -127.3 52.61 1.8 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.838 2.055 . . . . 2.4900000000000002 111.43 -165.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.35 162.14 25.92 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.367 1.247 . . . . 2.1000000000000001 114.367 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.06 124.3 29.7 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.389 1.076 . . . . 3.9300000000000002 110.847 166.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.73 119.84 29.58 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.624 -1.621 . . . . 3.8199999999999998 106.624 163.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -135.87 144.02 45.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.028 0.918 . . . . 4.2300000000000004 113.12 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -120.76 90.31 46.2 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 114.507 -1.224 . . . . 1.73 110.821 -172.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.56 -7.94 20.94 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.341 2.027 . . . . 2.2599999999999998 112.886 172.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.15 -178.11 51.52 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 122.407 1.004 . . . . 1.8200000000000001 112.858 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -111.5 -1.57 15.81 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.223 2.209 . . . . 4.0300000000000002 111.83 -167.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -132.58 159.89 70.57 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 128.415 2.686 . . . . 2.23 109.339 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.45 156.87 57.68 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.434 2.089 . . . . 0.80000000000000004 111.879 -167.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mp -114.38 152.9 30.77 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.606 1.562 . . . . 2.5600000000000001 110.181 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -141.79 106.29 4.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 112.665 -2.061 . . . . 1.8700000000000001 110.969 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.5 tp -90.14 109.17 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.083 1.353 . . . . 1.8999999999999999 109.194 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 m -104.27 -18.37 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.041 0.937 . . . . 0.69999999999999996 111.692 -173.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.63 -177.78 29.2 Favored Glycine 0 C--N 1.344 0.997 0 C-N-CA 125.951 1.739 . . . . 0.56999999999999995 113.02 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.57 178.29 7.88 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.4 1.48 . . . . 0.57999999999999996 110.687 171.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -158.6 150.31 21.11 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.851 2.06 . . . . 4.8799999999999999 108.261 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -162.31 148.84 10.79 Favored Pre-proline 0 N--CA 1.478 0.937 0 O-C-N 120.984 -1.073 . . . . 0.90000000000000002 109.34 -171.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.46 -1.25 10.77 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.634 2.89 . . . . 0.69999999999999996 114.62 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.6 m -134.36 47.46 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 125.089 1.355 . . . . 0.91000000000000003 112.676 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.87 178.78 9.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.242 1.417 . . . . 1.3100000000000001 109.97 162.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -127.45 -34.04 2.29 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.774 1.63 . . . . 3.8300000000000001 112.01 168.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -121.26 149.78 42.36 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 106.567 -1.642 . . . . 6.1600000000000001 106.567 172.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.51 141.64 18.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 125.014 1.326 . . . . 1.22 110.005 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -134.52 147.54 50.34 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.601 1.96 . . . . 3.2200000000000002 109.068 -173.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.464 HD13 ' CZ ' ' A' ' 84' ' ' PHE . 36.7 tp -101.73 120.79 40.91 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.547 -0.721 . . . . 1.27 109.842 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.5 m170 -121.26 150.09 41.9 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 123.486 1.612 . . . . 0.64000000000000001 114.447 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -96.0 173.5 7.4 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 113.275 -1.784 . . . . 2.3500000000000001 111.218 162.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.2 m -150.39 146.64 26.82 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 106.453 -1.684 . . . . 0.67000000000000004 106.453 173.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -161.72 171.46 17.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.959 0.885 . . . . 2.0 113.378 -167.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.0 ttp -105.11 142.05 35.57 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.134 1.774 . . . . 3.4500000000000002 110.453 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -157.36 151.02 24.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.228 1.411 . . . . 8.5600000000000005 112.73 -173.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.47 133.38 35.39 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.494 0.718 . . . . 2.9199999999999999 111.222 172.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t -141.82 134.79 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 105.443 -2.058 . . . . 2.2400000000000002 105.443 162.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 70.93 4.17 4.95 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.39 1.876 . . . . 4.4900000000000002 114.255 -170.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.21 22.86 69.9 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 121.473 -0.767 . . . . 1.6399999999999999 113.109 -163.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -124.48 131.33 53.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.612 1.965 . . . . 3.8300000000000001 109.76 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.89 92.63 1.27 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.495 1.118 . . . . 6.2599999999999998 112.591 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.4 m -94.49 -174.94 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 127.177 2.191 . . . . 2.5 109.47 171.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -117.7 167.81 11.02 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.36 0.664 . . . . 2.96 111.937 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.46 169.63 31.64 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 125.683 1.611 . . . . 0.60999999999999999 112.28 -176.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ttm -149.16 147.43 28.43 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.71 2.004 . . . . 0.70999999999999996 107.971 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -148.33 153.69 41.04 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 125.966 1.707 . . . . 5.71 108.88 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.06 154.55 42.29 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 121.69 1.593 . . . . 0.65000000000000002 110.352 164.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 m -137.11 154.77 76.1 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 125.34 1.456 . . . . 0.72999999999999998 109.87 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.2 -27.03 4.69 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.58 2.186 . . . . 0.76000000000000001 112.745 -166.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -175.17 168.37 3.39 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.363 1.465 . . . . 2.0299999999999998 111.98 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.7 mt -111.13 153.72 25.33 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.276 1.431 . . . . 0.79000000000000004 110.871 161.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -124.88 141.4 52.14 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.861 1.664 . . . . 2.21 110.043 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.0 t -146.52 134.69 10.7 Favored Pre-proline 0 N--CA 1.482 1.151 0 N-CA-C 113.426 0.899 . . . . 0.91000000000000003 113.426 173.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.74 163.36 39.33 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 124.443 3.429 . . . . 1.28 113.558 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.02 145.06 78.39 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.86 3.04 . . . . 1.6699999999999999 114.18 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt 69.21 -5.1 1.14 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.08 2.552 . . . . 3.1000000000000001 114.657 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.03 168.4 34.0 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.411 1.482 . . . . 1.8999999999999999 113.243 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -144.24 148.95 35.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.713 0.805 . . . . 6.5099999999999998 112.231 162.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.9 t -155.71 100.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.456 1.902 . . . . 3.8300000000000001 108.631 -168.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.89 171.55 15.03 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 121.876 0.846 . . . . 3.6800000000000002 112.236 -169.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 mp -82.56 70.02 9.44 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.152 -1.592 . . . . 2.0499999999999998 110.133 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.482 ' H ' ' CD ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -36.6 119.86 0.76 Allowed Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 127.167 2.187 . . . . 4.3300000000000001 113.307 172.757 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.99 -9.36 22.12 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.817 3.012 . . . . 2.29 115.635 -154.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.33 -2.16 55.68 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 117.836 -1.536 . . . . 1.8999999999999999 114.34 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.68 -17.47 0.49 Allowed Glycine 0 N--CA 1.479 1.542 0 CA-C-N 119.946 1.873 . . . . 1.98 117.776 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -145.12 145.03 31.23 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.128 1.464 . . . . 2.4700000000000002 112.24 170.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -161.31 155.59 22.76 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.598 1.559 . . . . 0.82999999999999996 109.941 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.464 ' CZ ' HD13 ' A' ' 45' ' ' LEU . 73.7 m-85 -79.45 150.97 31.1 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.259 -0.901 . . . . 2.3900000000000001 108.862 157.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.6 tpt -100.12 130.84 46.31 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.11 1.764 . . . . 0.63 108.335 162.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.8 mp -116.01 135.54 53.86 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.388 1.475 . . . . 0.68000000000000005 108.32 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mp -135.78 146.02 47.15 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.747 0.703 . . . . 1.6899999999999999 111.633 -176.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.66 40.23 32.41 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.306 -0.719 . . . . 1.02 113.225 172.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.23 148.31 3.6 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 115.799 1.778 . . . . 1.54 115.799 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -104.05 -4.52 23.16 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.481 -1.691 . . . . 2.4700000000000002 113.592 -170.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -146.63 156.09 48.74 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.92 2.088 . . . . 6.4800000000000004 109.112 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -67.38 163.73 33.43 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.853 1.702 . . . . 2.2799999999999998 109.022 153.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 pp -160.86 152.1 19.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.575 1.55 . . . . 2.3500000000000001 108.298 -172.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -147.79 168.31 22.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 123.123 1.44 . . . . 4.7300000000000004 114.715 -174.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.43 135.34 56.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.053 -0.976 . . . . 1.3300000000000001 111.212 172.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.83 -1.14 74.3 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.72 1.629 . . . . 2.0699999999999998 114.365 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -85.76 -176.91 6.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.869 1.335 . . . . 2.5 112.244 171.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -138.44 140.0 39.09 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 129.459 3.104 . . . . 3.5499999999999998 105.768 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.3 t -141.06 133.36 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.216 1.806 . . . . 0.96999999999999997 109.773 -172.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -95.58 158.01 15.64 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 122.491 1.139 . . . . 2.2999999999999998 113.478 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.17 151.8 31.47 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.964 1.305 . . . . 3.54 112.841 169.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.64 137.12 36.2 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 127.26 2.224 . . . . 2.5600000000000001 109.516 169.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.21 133.94 37.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.804 1.641 . . . . 1.1899999999999999 109.113 170.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 56.3 mt -106.2 104.65 14.39 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.732 1.213 . . . . 0.90000000000000002 108.934 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -91.97 163.37 14.03 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.562 0.696 . . . . 2.1099999999999999 111.484 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.54 117.69 5.18 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.934 -0.479 . . . . 1.55 110.947 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.67 -135.94 16.73 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.835 0.731 . . . . 3.23 112.204 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.57 41.74 2.86 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.426 1.012 . . . . 2.3399999999999999 115.481 -165.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -134.48 123.22 23.62 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.441 1.62 . . . . 3.8799999999999999 112.085 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.3 t -136.64 138.56 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.806 1.642 . . . . 2.5099999999999998 107.677 168.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.9 tp -159.14 133.45 7.76 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.488 1.115 . . . . 2.4300000000000002 111.581 -170.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -98.1 149.0 22.97 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.631 1.715 . . . . 1.99 115.631 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.9 t -125.0 165.88 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 129.237 3.015 . . . . 2.1299999999999999 107.994 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 t -142.18 142.36 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.247 1.819 . . . . 1.95 107.832 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.01 159.48 30.27 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 114.134 1.161 . . . . 2.8500000000000001 114.134 -173.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -77.81 160.58 30.84 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.1 3.2 . . . . 0.85999999999999999 114.671 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.0 t -103.61 130.1 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.525 1.53 . . . . 0.98999999999999999 110.829 171.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.42 ' CD ' ' HE ' ' A' ' 120' ' ' ARG . 11.8 pt-20 -95.21 -172.52 2.69 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.621 1.968 . . . . 5.9699999999999998 111.432 172.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -126.41 117.66 23.4 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.712 -1.243 . . . . 2.5299999999999998 112.014 154.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.42 ' HE ' ' CD ' ' A' ' 118' ' ' GLU . 42.4 mtm180 . . . . . 0 C--O 1.248 1.008 0 C-N-CA 126.781 2.033 . . . . 7.5599999999999996 111.5 161.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 . . . . . 0 CA--C 1.547 0.836 0 CA-C-O 119.173 -0.441 . . . . 5.1600000000000001 110.416 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.49 175.83 17.37 Favored Glycine 0 N--CA 1.473 1.155 0 N-CA-C 116.87 1.508 . . . . 0.87 116.87 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -151.35 142.91 23.58 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.389 2.275 . . . . 1.73 110.966 169.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.7 t -94.4 141.72 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 120.448 -1.407 . . . . 1.27 109.773 175.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.0 ttm-85 -73.12 118.13 15.7 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.514 0.726 . . . . 5.9800000000000004 111.567 -172.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -68.19 138.51 55.68 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.534 -0.729 . . . . 2.5499999999999998 110.558 159.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -167.72 149.75 5.27 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.703 1.601 . . . . 3.52 109.977 164.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -82.03 47.93 2.66 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 125.216 3.944 . . . . 3.2799999999999998 111.756 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.34 158.52 20.49 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.872 1.701 . . . . 1.8400000000000001 112.605 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.36 -19.08 33.72 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.729 2.953 . . . . 1.3600000000000001 112.822 174.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -106.96 160.74 15.3 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.213 1.805 . . . . 2.96 112.908 167.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.34 -173.58 4.61 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.686 2.795 . . . . 0.53000000000000003 110.287 -176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.48 160.29 41.82 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.348 1.459 . . . . 0.71999999999999997 109.821 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.32 137.5 53.49 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.71 1.141 . . . . 0.72999999999999998 112.976 174.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 79' ' ' PRO . 61.7 m-85 -113.06 138.72 49.48 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.691 1.996 . . . . 2.6499999999999999 110.032 172.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.267 0.0 OUTLIER -165.99 145.14 6.06 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.528 1.307 . . . . 2.5600000000000001 114.528 177.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.3 m -80.98 130.09 34.85 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.345 1.058 . . . . 2.04 109.536 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.4 tp -119.09 142.37 47.94 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.319 1.848 . . . . 3.1400000000000001 109.843 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -128.13 149.71 50.3 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.751 1.22 . . . . 3.52 110.966 170.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -103.9 102.01 28.73 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.07 0.948 . . . . 1.4399999999999999 109.459 169.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.76 -10.19 19.93 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.495 2.13 . . . . 1.01 113.359 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.59 178.61 53.29 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-O 122.76 1.2 . . . . 1.1200000000000001 113.018 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -105.44 -3.65 22.31 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.818 2.447 . . . . 2.7799999999999998 111.659 -174.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -121.2 156.27 57.55 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 127.9 2.48 . . . . 1.9199999999999999 109.501 173.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.86 151.77 24.66 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.922 2.414 . . . . 0.84999999999999998 111.992 -169.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.2 mt -104.57 146.99 28.12 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.154 0.982 . . . . 1.55 111.101 169.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -134.09 111.67 10.54 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.01 -1.45 . . . . 2.0099999999999998 110.788 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -92.23 106.95 18.85 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 127.555 2.342 . . . . 2.5899999999999999 109.974 -173.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -107.26 -17.92 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.729 1.211 . . . . 0.65000000000000002 111.765 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.66 -175.24 29.37 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 125.726 1.631 . . . . 0.65000000000000002 114.33 -175.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -157.05 -177.34 6.54 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.197 1.399 . . . . 0.73999999999999999 112.681 177.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -154.48 165.43 36.46 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 127.434 2.294 . . . . 4.54 107.309 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 t -169.15 147.29 3.27 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 125.509 1.524 . . . . 0.91000000000000003 107.426 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.59 -17.42 38.35 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.31 1.34 . . . . 1.0700000000000001 111.865 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.6 m -111.17 40.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.185 1.394 . . . . 1.1499999999999999 113.258 -172.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.78 169.29 23.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.411 1.084 . . . . 1.1299999999999999 110.588 167.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -108.55 -63.14 1.37 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.454 1.502 . . . . 4.0300000000000002 107.304 164.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -84.34 124.1 30.91 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 121.502 -0.749 . . . . 6.9199999999999999 109.054 166.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.404 HG21 ' HB3' ' A' ' 35' ' ' ALA . 4.6 p -94.64 158.21 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.796 -1.093 . . . . 1.46 108.696 149.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.39 157.13 42.01 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.86 2.464 . . . . 4.2699999999999996 107.446 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.6 tp -124.67 112.98 17.4 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.926 1.239 . . . . 1.1100000000000001 112.17 -171.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.2 m170 -122.18 158.01 30.31 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 123.476 1.608 . . . . 0.66000000000000003 114.661 -171.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.69 -176.42 3.26 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.463 1.905 . . . . 3.1400000000000001 111.297 159.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -156.75 145.01 19.61 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.123 1.769 . . . . 0.84999999999999998 106.798 167.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -153.13 -177.63 6.43 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.103 0.961 . . . . 2.0 113.003 -165.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -118.89 143.32 47.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.131 1.772 . . . . 4.25 111.446 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -154.78 160.33 41.22 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.401 1.88 . . . . 4.7999999999999998 110.145 -172.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -116.57 142.61 46.66 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.883 1.673 . . . . 2.9100000000000001 110.526 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.269 1.3 t -95.73 -126.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 107.753 -1.203 . . . . 2.8100000000000001 107.753 161.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -70.67 44.26 0.08 Allowed 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 125.792 1.637 . . . . 2.9500000000000002 114.81 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.06 18.15 80.19 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 120.271 -1.518 . . . . 1.95 111.738 -160.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -96.28 106.04 18.2 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 121.997 -0.707 . . . . 2.7799999999999998 109.399 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.59 124.29 26.95 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.276 0.63 . . . . 7.5199999999999996 109.951 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.538 HG22 ' H ' ' A' ' 59' ' ' MET . 8.7 p -142.78 175.9 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 126.003 1.721 . . . . 2.5499999999999998 110.079 -174.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.538 ' H ' HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -124.88 149.16 47.83 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.619 1.168 . . . . 3.0299999999999998 110.654 -175.15 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.99 167.86 21.56 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.507 1.527 . . . . 0.69999999999999996 112.188 -174.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.0 ttm -150.63 137.1 18.77 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.059 1.344 . . . . 0.65000000000000002 110.581 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -145.4 150.51 44.6 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.429 1.892 . . . . 8.1300000000000008 110.066 -173.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -76.48 155.58 36.25 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.977 1.785 . . . . 0.66000000000000003 110.283 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.67 147.78 66.93 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 124.219 1.008 . . . . 0.87 110.213 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -71.44 -22.6 24.67 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.438 2.759 . . . . 0.66000000000000003 111.958 -173.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -172.96 172.61 3.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.421 1.888 . . . . 1.8799999999999999 111.246 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.4 mt -115.01 161.06 18.85 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.265 1.826 . . . . 0.69999999999999996 109.013 156.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -133.2 151.21 51.95 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.341 -0.849 . . . . 2.0099999999999998 112.072 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.1 t -138.19 129.13 15.61 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 123.785 0.834 . . . . 1.0700000000000001 111.815 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.89 164.67 34.84 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.379 2.72 . . . . 0.94999999999999996 111.365 174.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.35 140.82 90.24 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.007 2.471 . . . . 1.02 112.485 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt 67.07 -2.75 1.1 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.848 2.059 . . . . 1.6100000000000001 114.135 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.99 170.64 43.7 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.864 1.697 . . . . 1.22 114.024 -177.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -122.3 154.35 37.72 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.262 1.425 . . . . 5.4199999999999999 111.388 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.2 t -141.36 137.04 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.734 1.613 . . . . 3.6099999999999999 107.262 159.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.416 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -103.57 136.27 43.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.627 0.727 . . . . 3.75 109.942 168.645 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.52 101.39 3.54 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 105.951 -1.87 . . . . 2.3199999999999998 105.951 158.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HE2' ' O ' ' A' ' 76' ' ' GLU . 6.1 ptpt -113.7 152.3 45.39 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.787 2.035 . . . . 3.0099999999999998 114.36 -158.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 19' ' ' TYR . 10.4 Cg_endo -49.19 -57.69 2.2 Favored 'Trans proline' 0 C--N 1.356 0.97 1 C-N-CA 125.437 4.091 . . . . 2.0099999999999998 113.667 -173.501 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.81 57.91 5.0 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.217 -0.768 . . . . 1.79 112.728 173.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.1 -126.52 1.6 Allowed Glycine 0 N--CA 1.467 0.766 0 C-N-CA 124.256 0.931 . . . . 1.9299999999999999 114.828 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -71.05 141.91 50.88 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.845 -0.797 . . . . 1.97 112.707 -159.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -161.87 152.79 17.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.995 -0.548 . . . . 0.58999999999999997 111.681 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 69.4 m-85 -77.35 142.79 39.18 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 108.283 -1.006 . . . . 1.8999999999999999 108.283 163.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.1 tpt -92.37 135.59 33.91 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.293 1.037 . . . . 0.75 108.47 162.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.1 mp -117.85 138.79 51.86 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.925 1.29 . . . . 0.55000000000000004 108.509 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mp -138.56 148.15 43.86 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.544 1.137 . . . . 1.5600000000000001 110.041 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.42 40.45 19.21 Favored Glycine 0 N--CA 1.47 0.96 0 CA-C-O 119.876 -0.402 . . . . 0.94999999999999996 112.79 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -43.82 143.13 1.12 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 115.719 1.748 . . . . 1.46 115.719 174.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -110.47 -3.57 15.98 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 113.653 -1.612 . . . . 2.5600000000000001 114.472 -168.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -137.62 153.43 74.18 Favored Pre-proline 0 N--CA 1.473 0.704 0 C-N-CA 125.921 1.688 . . . . 5.8499999999999996 109.56 170.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -68.65 144.94 61.97 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.111 1.874 . . . . 2.3999999999999999 108.583 162.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.8 mp -125.62 116.92 22.47 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.538 0.735 . . . . 2.7999999999999998 109.747 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.82 15.55 26.6 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 116.205 1.928 . . . . 5.7999999999999998 116.205 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 60.41 157.55 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.137 2.575 . . . . 1.5800000000000001 111.338 -166.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.47 42.38 99.01 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 120.759 -1.213 . . . . 1.3200000000000001 110.563 -170.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -100.18 179.89 4.34 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.744 1.617 . . . . 2.4100000000000001 107.574 169.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.82 150.79 33.01 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 128.104 2.562 . . . . 5.0999999999999996 106.908 163.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.5 t -149.05 143.53 18.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 128.784 2.833 . . . . 1.24 108.811 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -98.69 146.3 26.01 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.997 -0.439 . . . . 3.0099999999999998 111.493 168.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.78 133.14 56.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.469 1.108 . . . . 2.5299999999999998 109.23 160.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.73 143.17 26.57 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.357 2.663 . . . . 2.2000000000000002 107.239 162.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.93 127.39 51.79 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.386 1.474 . . . . 1.3200000000000001 110.19 177.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.0 mt -102.25 117.3 34.46 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.754 1.622 . . . . 0.68999999999999995 109.844 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -107.67 155.23 20.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.391 1.076 . . . . 1.99 111.296 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.93 146.77 25.68 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.16 -0.473 . . . . 1.8799999999999999 110.415 162.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.63 7.53 66.66 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-O 119.127 -0.818 . . . . 3.1400000000000001 114.59 -173.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.36 6.4 88.93 Favored Glycine 0 N--CA 1.474 1.169 0 CA-C-N 118.886 1.343 . . . . 2.1899999999999999 114.163 175.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -79.48 133.34 36.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.724 1.21 . . . . 6.8499999999999996 111.58 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.6 p -113.22 151.39 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.225 1.81 . . . . 2.0 109.766 166.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 tt -158.9 135.11 9.09 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.84 1.656 . . . . 2.0600000000000001 109.481 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -103.27 163.0 12.52 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.313 1.227 . . . . 2.1200000000000001 114.313 176.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.3 m -134.41 146.29 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 128.803 2.841 . . . . 2.0699999999999998 109.136 168.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.4 p -109.31 138.35 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.899 1.28 . . . . 3.04 109.457 176.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.98 154.93 28.6 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 123.631 0.772 . . . . 2.0699999999999998 113.066 -168.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.22 169.93 19.49 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.806 2.337 . . . . 0.98999999999999999 112.787 171.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 70.1 t -104.5 131.25 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.478 1.511 . . . . 0.91000000000000003 108.635 159.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -134.37 174.89 10.03 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.817 0.847 . . . . 4.6100000000000003 112.55 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -95.07 57.22 2.03 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 116.265 1.95 . . . . 2.46 116.265 -143.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.251 23.1 mtp-105 . . . . . 0 N--CA 1.49 1.526 0 C-N-CA 131.611 3.965 . . . . 9.3699999999999992 114.523 161.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 107.414 -1.328 . . . . 5.79 107.414 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.01 170.12 34.81 Favored Glycine 0 N--CA 1.463 0.438 0 C-N-CA 124.872 1.225 . . . . 1.05 111.873 176.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.6 p90 -159.03 141.57 14.1 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.296 1.038 . . . . 1.9199999999999999 111.922 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.12 142.24 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 107.882 -1.155 . . . . 1.2 107.882 166.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.407 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -89.1 15.33 8.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.676 1.19 . . . . 3.6400000000000001 114.176 -175.182 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.3 t80 64.98 164.03 0.15 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.278 1.431 . . . . 2.5499999999999998 113.37 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 m -172.6 154.0 2.91 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 127.187 2.195 . . . . 2.1000000000000001 110.973 157.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -87.41 30.51 0.46 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 124.509 3.472 . . . . 2.0 112.08 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.24 178.95 31.6 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.716 1.151 . . . . 1.1599999999999999 114.163 -171.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.48 -21.72 29.76 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.135 3.223 . . . . 1.49 113.546 -173.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -88.05 148.73 24.36 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.969 1.307 . . . . 2.3500000000000001 111.932 173.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.46 -178.66 6.55 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.201 1.401 . . . . 0.65000000000000002 111.353 165.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.52 150.64 40.71 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.688 1.595 . . . . 0.97999999999999998 108.702 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.65 143.27 29.72 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.223 1.194 . . . . 1.1699999999999999 114.223 -175.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -111.27 156.22 21.82 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.032 2.133 . . . . 2.5600000000000001 111.276 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -169.59 158.35 7.69 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.597 1.559 . . . . 2.0499999999999998 113.671 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 p -93.18 107.47 19.27 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.007 2.123 . . . . 2.5299999999999998 110.862 173.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.611 HD12 HG21 ' A' ' 69' ' ' VAL . 0.6 OUTLIER -79.46 139.01 37.77 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.336 1.454 . . . . 3.2599999999999998 109.089 176.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.415 ' N ' HD13 ' A' ' 22' ' ' LEU . 11.7 pt-20 -114.62 160.68 19.03 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.678 1.191 . . . . 5.3899999999999997 112.244 177.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -135.82 109.96 10.12 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 123.687 0.795 . . . . 1.49 109.611 158.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -88.25 -8.45 5.56 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.281 2.654 . . . . 1.3600000000000001 114.951 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.95 178.04 33.13 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 119.783 1.174 . . . . 1.24 112.482 -176.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -93.29 0.57 57.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.546 2.338 . . . . 3.5600000000000001 112.485 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -113.46 156.96 42.58 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 127.33 2.252 . . . . 1.9399999999999999 110.583 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.31 145.56 24.15 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.719 2.279 . . . . 0.97999999999999998 111.183 -176.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.471 HD12 ' CD2' ' A' ' 105' ' ' PHE . 2.9 mm? -107.34 157.7 17.74 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 124.716 1.207 . . . . 2.4199999999999999 110.565 172.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -147.22 110.34 4.79 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 113.459 -1.7 . . . . 2.3199999999999998 110.677 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.26 112.51 24.07 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.47 1.908 . . . . 2.0499999999999998 109.39 -176.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.4 m -108.62 -20.38 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.956 1.302 . . . . 0.73999999999999999 111.642 -172.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.28 -175.06 28.79 Favored Glycine 0 C--N 1.346 1.088 0 C-N-CA 125.43 1.491 . . . . 0.68000000000000005 113.798 -174.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.66 -177.3 5.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.747 2.019 . . . . 0.62 111.241 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -155.85 169.52 24.22 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.327 2.251 . . . . 4.3799999999999999 109.029 170.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.7 t -175.96 150.96 1.13 Allowed Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 126.92 2.088 . . . . 0.73999999999999999 108.007 173.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.4 -17.65 26.93 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.676 1.584 . . . . 0.76000000000000001 112.734 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.9 m -97.05 52.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.737 1.215 . . . . 0.77000000000000002 112.131 174.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.68 167.33 30.74 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.329 1.051 . . . . 1.3899999999999999 112.203 166.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -102.01 -39.19 7.43 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.851 2.06 . . . . 4.9900000000000002 110.492 162.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -146.04 169.59 18.35 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.378 1.871 . . . . 4.6600000000000001 110.128 169.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.14 145.27 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.586 1.554 . . . . 1.1499999999999999 108.321 -177.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -128.68 151.26 49.72 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.479 1.912 . . . . 3.1600000000000001 108.208 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -103.66 136.91 42.49 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.115 0.87 . . . . 1.8700000000000001 112.088 160.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -120.74 152.95 37.64 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.707 2.003 . . . . 0.94999999999999996 112.667 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -97.2 163.25 12.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.374 1.47 . . . . 2.3100000000000001 109.634 162.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.6 m -115.99 143.12 45.88 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.213 -1.403 . . . . 1.24 107.213 162.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -139.93 172.14 13.2 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.003 1.112 . . . . 2.3300000000000001 114.003 -173.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 85.7 mtp -113.35 143.7 44.0 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.868 1.667 . . . . 3.5499999999999998 110.99 166.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -146.76 146.97 30.47 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.953 1.701 . . . . 6.7599999999999998 110.441 172.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -94.01 141.97 27.92 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 125.145 1.378 . . . . 2.4300000000000002 110.957 171.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 m -139.59 126.96 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.532 1.133 . . . . 2.29 108.917 167.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 64.7 10.86 6.32 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.722 1.609 . . . . 3.7200000000000002 115.062 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.87 26.43 41.64 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 123.907 0.765 . . . . 2.3700000000000001 113.278 -166.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -124.76 123.44 40.0 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.514 1.926 . . . . 3.54 109.045 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.85 121.18 25.09 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.926 0.89 . . . . 5.9800000000000004 111.463 -175.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.6 t -121.64 160.14 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 127.386 2.274 . . . . 2.5600000000000001 108.601 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.7 mtp -121.25 156.56 32.22 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.547 1.539 . . . . 2.6699999999999999 110.337 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.99 -175.57 26.2 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.203 0.906 . . . . 0.63 113.585 -172.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.1 ttm -153.33 151.05 29.54 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.404 1.882 . . . . 0.85999999999999999 108.691 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.97 158.08 18.25 Favored Pre-proline 0 N--CA 1.477 0.895 0 CA-C-O 117.736 -1.126 . . . . 5.6699999999999999 111.3 175.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.55 146.26 49.11 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.979 1.786 . . . . 1.1200000000000001 112.647 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.64 159.51 43.83 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 125.104 1.362 . . . . 1.3899999999999999 110.397 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.74 -30.8 2.19 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.616 2.211 . . . . 1.0600000000000001 112.465 -172.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -179.15 165.28 1.47 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.398 1.879 . . . . 2.0899999999999999 111.148 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt -110.37 152.96 25.61 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.504 1.121 . . . . 0.82999999999999996 110.216 163.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -110.33 145.71 37.0 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.722 1.209 . . . . 1.78 108.716 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.611 HG21 HD12 ' A' ' 22' ' ' LEU . 61.8 t -138.16 127.24 14.62 Favored Pre-proline 0 N--CA 1.473 0.688 0 N-CA-C 112.594 0.59 . . . . 0.83999999999999997 112.594 169.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.88 159.17 48.79 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.049 3.166 . . . . 1.0600000000000001 112.402 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.47 142.52 95.31 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 124.337 3.358 . . . . 1.1000000000000001 113.847 -175.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp 64.54 -3.41 0.53 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.646 1.978 . . . . 1.96 114.637 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.64 174.58 55.15 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.824 1.678 . . . . 1.28 114.089 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.66 126.4 6.91 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.387 1.475 . . . . 4.1200000000000001 108.963 173.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.9 t -147.32 145.34 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.131 1.772 . . . . 4.1399999999999997 107.836 -163.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.3 142.0 35.84 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.349 -0.844 . . . . 3.79 112.545 -167.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mp -69.55 79.7 0.41 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.891 -1.152 . . . . 2.0600000000000001 107.891 151.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.99 147.1 85.79 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 112.943 0.72 . . . . 4.1200000000000001 112.943 -171.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -57.83 133.41 55.9 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.63 1.553 . . . . 3.6800000000000002 109.13 162.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.58 -12.54 66.17 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 116.637 -2.202 . . . . 1.72 115.657 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.43 -31.67 0.07 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 120.498 2.959 . . . . 2.0499999999999998 120.498 175.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -144.06 139.31 28.88 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.619 2.209 . . . . 2.3399999999999999 112.491 175.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -163.13 153.62 16.3 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.236 -0.29 . . . . 0.88 111.345 -176.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -79.48 142.5 35.78 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.596 -0.52 . . . . 2.6499999999999999 109.596 164.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.6 tpt -105.68 127.03 52.82 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 126.334 1.854 . . . . 0.92000000000000004 107.143 165.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -105.63 131.84 52.51 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.116 0.967 . . . . 0.84999999999999998 108.732 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.43 131.93 55.0 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.199 0.999 . . . . 3.5299999999999998 110.367 -175.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.62 47.13 28.45 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.552 1.072 . . . . 0.80000000000000004 114.203 170.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.73 149.31 4.75 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 116.112 1.893 . . . . 1.3500000000000001 116.112 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -104.86 3.91 31.51 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 113.897 -1.502 . . . . 1.98 113.67 -171.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.9 mmt-85 -145.2 139.39 15.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 127.928 2.491 . . . . 6.0999999999999996 108.25 167.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -64.14 155.3 65.8 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 N-CA-C 107.659 -1.708 . . . . 1.73 107.659 154.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.3 121.18 17.58 Favored 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 108.058 -1.09 . . . . 2.8199999999999998 108.058 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.47 ' HE2' ' OE1' ' A' ' 97' ' ' GLU 0.299 0.0 OUTLIER -87.64 13.18 10.87 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 116.032 1.864 . . . . 5.6500000000000004 116.032 -168.998 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 62.81 154.06 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.993 2.917 . . . . 1.77 111.495 -163.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.98 51.17 55.57 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 109.839 -1.305 . . . . 1.6699999999999999 109.839 -166.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.47 ' OE1' ' HE2' ' A' ' 94' ' ' LYS . 6.3 mm-40 -116.86 -177.6 3.23 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.761 2.025 . . . . 2.3799999999999999 107.774 173.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -155.66 135.59 12.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.357 1.863 . . . . 3.27 107.744 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -151.23 151.13 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.765 1.626 . . . . 3.0699999999999998 109.661 -177.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.6 150.05 32.81 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.842 1.052 . . . . 2.96 113.842 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mp -125.68 140.96 52.28 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.129 1.772 . . . . 1.99 110.238 169.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.67 148.32 23.95 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.95 1.7 . . . . 2.3300000000000001 108.882 164.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.7 mp -120.97 133.62 55.28 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.84 1.256 . . . . 1.0800000000000001 109.679 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.6 mt -110.31 122.65 48.19 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.32 1.448 . . . . 0.70999999999999996 110.3 -174.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.471 ' CD2' HD12 ' A' ' 30' ' ' LEU . 97.9 m-85 -120.03 150.7 40.13 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.995 0.918 . . . . 1.99 111.591 -173.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.3 135.83 56.51 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.6 -0.687 . . . . 2.1699999999999999 111.759 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.6 31.53 21.33 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.798 -1.001 . . . . 3.1800000000000002 114.448 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.99 8.78 87.05 Favored Glycine 0 N--CA 1.474 1.233 0 CA-C-N 118.572 1.186 . . . . 1.8 115.984 167.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -88.04 138.2 31.66 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.686 1.243 . . . . 3.7599999999999998 112.006 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.5 p -131.98 145.75 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 125.784 1.634 . . . . 1.95 110.103 175.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.4 tt -146.09 121.56 10.35 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.0 0.92 . . . . 2.6400000000000001 110.67 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.99 134.67 34.3 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.659 0.784 . . . . 3.0899999999999999 112.867 176.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.2 m -120.19 160.7 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.497 1.919 . . . . 2.27 110.116 165.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 52.9 t -115.45 132.49 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 107.688 -1.227 . . . . 1.72 107.688 167.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.3 mt -135.81 144.13 47.46 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.206 1.002 . . . . 2.46 112.076 -171.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.68 174.42 12.68 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.212 3.275 . . . . 0.81999999999999995 113.054 170.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.1 t -122.42 129.63 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.755 2.022 . . . . 0.79000000000000004 110.127 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.6 167.64 11.14 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.059 2.144 . . . . 3.9900000000000002 110.271 171.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.93 -177.66 4.79 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 116.686 2.106 . . . . 2.6299999999999999 116.686 -159.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.714 0 C-N-CA 127.519 2.328 . . . . 11.06 110.139 148.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 . . . . . 0 CA--C 1.538 0.508 0 N-CA-C 109.311 -0.626 . . . . 5.3600000000000003 109.311 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.2 -178.84 20.33 Favored Glycine 0 N--CA 1.466 0.661 0 C-N-CA 123.571 0.605 . . . . 0.93999999999999995 113.458 -167.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 23.3 p90 -152.23 154.99 36.87 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.153 0.981 . . . . 1.73 112.161 176.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.8 t -90.31 144.8 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.908 1.283 . . . . 0.93999999999999995 107.989 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -82.26 129.32 34.82 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.285 0.493 . . . . 6.2800000000000002 111.147 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -41.51 133.93 2.46 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.078 2.151 . . . . 1.9099999999999999 112.69 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.5 t -173.99 127.11 0.45 Allowed Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.128 1.771 . . . . 2.73 110.587 169.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -88.88 3.12 5.8 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.023 3.149 . . . . 3.0600000000000001 112.457 167.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.74 -172.57 45.3 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.742 1.163 . . . . 1.46 113.041 -173.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.11 -22.7 40.74 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.871 2.381 . . . . 1.24 113.209 -176.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -132.5 167.42 20.01 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.488 1.515 . . . . 2.2400000000000002 114.174 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.48 -174.03 4.69 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 128.658 2.783 . . . . 0.53000000000000003 110.859 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.35 148.89 32.83 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.273 1.429 . . . . 0.70999999999999996 110.137 173.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.24 145.05 51.76 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.327 1.232 . . . . 0.55000000000000004 114.327 -173.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -116.78 43.2 2.3 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.723 2.009 . . . . 2.4399999999999999 112.89 -170.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.45 HD22 HD22 ' A' ' 101' ' ' LEU . 2.4 pp -68.39 162.06 26.2 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.385 1.254 . . . . 2.2000000000000002 114.385 -169.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.1 m -94.65 139.61 30.98 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.067 0.947 . . . . 2.0 112.821 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.85 127.64 56.08 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.684 1.194 . . . . 2.9900000000000002 110.235 167.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -131.11 136.7 48.61 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.229 1.812 . . . . 3.5699999999999998 106.186 171.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -108.29 93.03 10.57 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 122.601 0.361 . . . . 1.46 110.754 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.5 -12.92 20.54 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.425 2.083 . . . . 1.1799999999999999 113.159 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.98 -177.29 51.45 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-O 122.352 0.973 . . . . 1.22 112.577 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -109.94 0.26 18.51 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.969 2.108 . . . . 2.9700000000000002 112.47 -173.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 pp -115.54 159.58 38.0 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 127.701 2.4 . . . . 2.2000000000000002 110.401 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.14 139.5 15.05 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.252 1.968 . . . . 0.88 110.799 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.1 mt -93.36 149.02 21.54 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 122.249 1.023 . . . . 1.9199999999999999 110.478 170.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -137.96 102.15 4.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.805 -1.998 . . . . 2.0699999999999998 111.237 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.5 tp -84.8 104.12 14.48 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.535 1.534 . . . . 1.78 109.902 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.3 m -100.03 -21.9 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.003 1.321 . . . . 0.46999999999999997 112.185 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.45 -177.67 32.75 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.908 1.242 . . . . 0.46999999999999997 114.035 -172.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.34 -179.56 8.05 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.057 1.343 . . . . 0.56000000000000005 112.581 171.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -158.81 143.06 15.59 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.471 1.908 . . . . 4.7999999999999998 108.083 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.55 149.17 25.49 Favored Pre-proline 0 N--CA 1.481 1.077 0 CA-C-N 121.312 1.869 . . . . 0.81000000000000005 110.647 168.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -62.81 -10.47 20.08 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.67 2.247 . . . . 1.05 114.032 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.55 34.69 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 113.647 0.981 . . . . 1.0600000000000001 113.647 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.63 115.69 1.44 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.111 1.765 . . . . 1.9199999999999999 108.836 159.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -69.51 -34.8 74.82 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.202 1.186 . . . . 2.8300000000000001 114.202 -175.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -135.58 92.2 2.8 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 107.167 -1.419 . . . . 7.5899999999999999 107.167 -166.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -85.65 166.46 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.95 0.9 . . . . 1.48 110.464 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.1 149.96 26.66 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.571 1.948 . . . . 4.4000000000000004 108.229 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.2 tp -121.01 110.83 16.73 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.014 1.279 . . . . 1.02 111.09 -171.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 63.4 m170 -121.05 151.11 40.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 123.102 1.429 . . . . 0.66000000000000003 114.316 -170.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -93.41 177.82 5.91 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 113.463 -1.699 . . . . 2.52 111.337 156.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.9 m -146.1 127.47 14.92 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.419 1.888 . . . . 0.68999999999999995 105.989 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -131.37 169.25 16.28 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.073 0.949 . . . . 1.8899999999999999 113.131 -162.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.0 mtt -99.87 141.86 32.12 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.674 1.19 . . . . 3.48 110.233 167.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -146.48 176.84 9.5 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.102 1.761 . . . . 6.1399999999999997 111.329 173.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -141.07 138.57 33.68 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.036 1.734 . . . . 2.54 108.547 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.5 m -143.74 144.83 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 127.372 2.269 . . . . 2.1899999999999999 108.028 167.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 56.86 20.79 5.51 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 115.493 1.664 . . . . 3.3999999999999999 115.493 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.31 19.0 77.42 Favored Glycine 0 CA--C 1.537 1.458 0 O-C-N 121.041 -1.037 . . . . 1.6200000000000001 114.056 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -110.47 118.52 36.47 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.916 1.686 . . . . 2.71 107.487 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -71.55 118.93 14.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.404 1.082 . . . . 4.9699999999999998 108.349 171.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.09 176.6 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.889 1.675 . . . . 2.3599999999999999 111.188 -172.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 77.0 mtm -127.29 163.65 23.47 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.009 1.323 . . . . 2.5499999999999998 111.275 172.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.69 -176.68 28.13 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.37 1.462 . . . . 0.47999999999999998 112.207 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.0 ttm -147.28 149.57 33.11 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.972 1.309 . . . . 0.59999999999999998 109.489 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -163.1 158.25 18.09 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 124.379 1.072 . . . . 6.2400000000000002 111.948 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.44 151.37 33.16 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.465 2.11 . . . . 0.78000000000000003 113.578 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.76 151.5 64.34 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 125.855 1.662 . . . . 0.95999999999999996 109.944 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.13 -28.93 10.37 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.052 2.501 . . . . 0.83999999999999997 112.161 -174.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -175.51 168.06 3.23 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.456 1.902 . . . . 2.2400000000000002 111.207 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.7 mt -111.18 150.06 30.05 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.888 1.275 . . . . 0.64000000000000001 110.534 162.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -113.53 141.18 47.45 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.729 1.211 . . . . 1.9399999999999999 108.694 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.6 t -139.16 124.02 11.61 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-O 119.162 -0.447 . . . . 0.97999999999999998 111.243 166.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.77 162.74 41.11 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.743 2.962 . . . . 0.90000000000000002 111.649 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.02 144.77 99.59 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.67 2.913 . . . . 1.0600000000000001 112.594 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.5 mptt 65.2 -8.67 0.24 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.54 2.336 . . . . 1.9199999999999999 115.157 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.68 166.02 50.29 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.532 1.539 . . . . 1.1100000000000001 112.844 174.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -144.77 144.54 31.23 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.639 1.175 . . . . 5.8200000000000003 110.559 170.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -156.83 125.32 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.496 1.918 . . . . 3.71 107.586 -174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -91.79 157.4 16.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.464 0.706 . . . . 4.0099999999999998 111.829 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.79 73.24 0.57 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.725 1.25 . . . . 2.0899999999999999 108.647 164.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -57.02 129.98 79.18 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.183 1.393 . . . . 4.7599999999999998 111.452 -174.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -58.28 -32.48 96.05 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.797 2.331 . . . . 2.0099999999999998 112.159 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.35 57.62 4.42 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 119.377 -0.679 . . . . 2.5299999999999998 112.078 165.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.31 -11.39 2.02 Favored Glycine 0 N--CA 1.473 1.125 0 N-CA-C 119.685 2.634 . . . . 2.0600000000000001 119.685 158.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -144.39 146.84 32.75 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.995 2.398 . . . . 2.3700000000000001 112.721 171.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -162.21 155.53 20.59 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.047 0.939 . . . . 0.67000000000000004 110.858 172.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.407 ' CE2' HD21 ' A' ' 20' ' ' LEU . 73.2 m-85 -79.33 140.93 37.38 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.543 -0.91 . . . . 1.6200000000000001 108.543 157.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.4 tpt -87.05 132.47 33.8 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.301 1.441 . . . . 0.68999999999999995 107.665 161.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 mp -114.34 119.74 37.99 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.009 -1.108 . . . . 0.63 108.009 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.96 148.07 42.56 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.48 0.712 . . . . 1.6000000000000001 109.877 172.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.03 48.58 31.96 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 119.391 -0.672 . . . . 1.0600000000000001 112.28 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pp -61.54 155.56 21.78 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 115.042 1.497 . . . . 1.29 115.042 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.34 -4.41 9.92 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 114.062 -1.426 . . . . 1.8799999999999999 114.107 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -115.83 114.78 41.66 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 106.442 -1.688 . . . . 4.8099999999999996 106.442 152.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.62 122.2 9.36 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 N-CA-C 105.38 -2.585 . . . . 2.27 105.38 158.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.2 mt -87.15 178.06 7.01 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 124.576 2.132 . . . . 2.21 112.821 -152.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -127.82 -169.62 2.09 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 129.329 3.052 . . . . 4.2800000000000002 109.929 169.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.0 155.58 17.04 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 106.635 -1.617 . . . . 1.6899999999999999 106.635 146.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.65 1.98 89.51 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.435 -1.203 . . . . 1.6399999999999999 115.771 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -78.72 -176.21 4.8 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.579 1.689 . . . . 2.3399999999999999 110.289 159.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 17.1 pt-20 -155.09 149.88 26.6 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 128.285 2.634 . . . . 3.3700000000000001 107.122 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.1 t -145.65 122.22 3.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 125.909 1.684 . . . . 1.2 109.325 -166.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -81.51 154.5 26.26 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.788 0.804 . . . . 2.46 112.251 167.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.45 HD22 HD22 ' A' ' 20' ' ' LEU . 5.6 tt -154.97 132.67 11.36 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.263 1.425 . . . . 3.1299999999999999 111.023 -177.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.47 130.4 36.97 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.76 2.424 . . . . 2.9100000000000001 108.509 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.0 mp -100.74 119.56 38.8 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.421 1.088 . . . . 0.96999999999999997 109.219 175.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 86.4 mt -87.41 108.71 19.12 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.812 0.815 . . . . 0.88 109.734 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -104.53 116.58 32.34 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.409 1.483 . . . . 2.1600000000000001 111.048 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 54.36 24.78 5.39 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.006 1.722 . . . . 2.79 113.392 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.72 -59.37 2.11 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.962 1.744 . . . . 4.7999999999999998 112.867 -171.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -84.55 9.21 65.57 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 116.399 1.32 . . . . 2.3799999999999999 116.399 -167.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -136.66 152.53 50.51 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.296 1.838 . . . . 5.0999999999999996 111.967 171.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.5 p -148.47 147.14 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 125.069 1.348 . . . . 2.21 111.158 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.4 tp -156.33 132.86 10.15 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.263 1.825 . . . . 2.8999999999999999 108.281 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -96.53 146.61 24.65 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.908 1.447 . . . . 2.1499999999999999 114.908 176.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.7 t -130.2 168.1 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 126.986 2.114 . . . . 2.7200000000000002 108.268 175.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 t -130.88 147.27 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.6 1.56 . . . . 1.8899999999999999 108.431 -171.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.92 146.2 17.85 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.892 1.277 . . . . 2.0899999999999999 110.976 -177.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 57.6 Cg_endo -66.51 164.31 29.23 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.4 3.4 . . . . 0.89000000000000001 112.394 172.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.2 t -105.54 135.97 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.151 1.38 . . . . 1.0700000000000001 108.768 165.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -147.3 164.03 34.54 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.653 1.181 . . . . 3.5 111.503 -175.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.67 -176.27 3.23 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 127.228 2.211 . . . . 2.6899999999999999 115.699 -160.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.436 ' C ' HH11 ' A' ' 120' ' ' ARG . 11.0 tpt85 . . . . . 0 N--CA 1.48 1.069 0 C-N-CA 127.65 2.38 . . . . 8.4000000000000004 113.243 -175.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 108.567 -0.901 . . . . 5.1699999999999999 108.567 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -94.65 -177.11 38.44 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 123.58 0.61 . . . . 0.95999999999999996 114.429 -170.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -144.55 154.34 42.77 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.095 1.146 . . . . 2.1299999999999999 114.095 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.58 135.9 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.537 -0.912 . . . . 0.95999999999999996 108.537 170.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -70.56 -10.95 60.52 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.956 1.836 . . . . 3.6800000000000002 115.956 -162.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 63.82 169.82 0.16 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.078 1.351 . . . . 2.3700000000000001 111.723 -170.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -166.77 162.99 11.1 Favored Pre-proline 0 CA--C 1.542 0.644 0 O-C-N 120.773 -1.205 . . . . 2.25 112.221 160.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -85.09 11.45 3.37 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.248 3.299 . . . . 2.3900000000000001 112.823 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -150.37 -165.69 12.86 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 124.451 1.024 . . . . 1.1000000000000001 115.368 -170.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -80.58 -20.43 8.05 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.625 3.55 . . . . 1.23 115.06 -169.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -99.39 164.79 11.96 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.955 1.302 . . . . 2.8799999999999999 112.98 169.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.63 -177.02 6.27 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.792 2.437 . . . . 0.5 111.077 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.72 165.71 26.27 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.552 2.341 . . . . 0.68999999999999995 108.47 173.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.85 156.34 37.43 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.265 1.209 . . . . 0.60999999999999999 114.265 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -140.66 143.59 35.21 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.443 1.897 . . . . 2.4100000000000001 110.325 -173.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.419 ' HA ' ' HA3' ' A' ' 6' ' ' GLY 0.263 0.0 OUTLIER -163.39 166.83 22.46 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.676 1.19 . . . . 2.4100000000000001 113.45 -177.723 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.6 m -91.78 123.62 35.3 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 127.255 2.222 . . . . 1.8700000000000001 109.373 -174.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.3 126.72 46.66 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.707 -0.849 . . . . 3.1299999999999999 108.707 165.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -126.2 120.78 30.93 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.469 -1.308 . . . . 3.9100000000000001 107.469 161.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -92.45 115.49 64.87 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.464 -0.779 . . . . 1.48 108.94 170.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -87.98 -9.79 5.26 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.318 2.678 . . . . 1.3100000000000001 114.822 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.52 159.39 27.09 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 119.65 1.114 . . . . 1.6000000000000001 111.914 -175.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.81 7.61 6.79 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 128.346 2.658 . . . . 3.7000000000000002 112.485 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -125.92 150.24 68.43 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 128.592 2.757 . . . . 1.95 109.367 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.44 149.52 27.53 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.852 2.368 . . . . 0.95999999999999996 111.306 -171.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.2 mt -102.75 153.19 20.39 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 122.809 1.29 . . . . 1.6000000000000001 110.431 164.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 ttp-105 -140.21 103.14 4.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.197 -1.82 . . . . 2.4500000000000002 110.45 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.5 tt -80.38 113.62 18.7 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 109.13 -0.693 . . . . 2.2599999999999998 109.13 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -104.31 -20.15 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.385 1.074 . . . . 0.63 111.771 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.05 -176.24 30.87 Favored Glycine 0 C--N 1.343 0.956 0 C-N-CA 124.808 1.194 . . . . 0.57999999999999996 114.71 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.5 -177.61 6.18 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.182 1.393 . . . . 0.60999999999999999 111.884 174.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -156.2 176.71 12.32 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.896 2.479 . . . . 4.2300000000000004 107.261 163.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -167.87 151.41 5.88 Favored Pre-proline 0 N--CA 1.466 0.329 0 C-N-CA 128.348 2.659 . . . . 0.73999999999999999 106.9 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.95 -5.22 16.64 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.386 2.058 . . . . 1.01 113.108 174.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.61 49.24 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.632 1.173 . . . . 0.89000000000000001 113.501 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.99 151.67 14.44 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.492 0.717 . . . . 0.89000000000000001 112.374 163.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -89.73 -44.25 10.14 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.069 1.747 . . . . 3.0600000000000001 110.951 168.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -114.15 130.79 56.59 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.193 1.797 . . . . 5.6699999999999999 108.255 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -109.14 149.81 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.322 -0.992 . . . . 1.24 108.322 154.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -134.06 148.67 51.08 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.606 1.562 . . . . 2.9100000000000001 108.369 171.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.4 tp -100.98 118.65 37.41 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.637 -0.505 . . . . 1.04 109.637 175.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 48.1 m170 -119.92 162.5 19.07 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 123.819 1.771 . . . . 0.69999999999999996 113.284 -177.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.438 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 15.9 pt-20 -110.99 153.2 25.89 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 112.889 -1.959 . . . . 2.8300000000000001 112.055 155.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.0 m -109.67 152.39 25.65 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 106.251 -1.759 . . . . 0.91000000000000003 106.251 160.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -149.88 171.49 16.69 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.174 0.99 . . . . 2.1499999999999999 111.771 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 57.3 ttm -102.06 143.39 31.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.726 1.21 . . . . 3.9399999999999999 109.566 168.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.32 157.56 43.19 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.875 1.27 . . . . 4.4900000000000002 111.369 -172.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.92 176.38 8.73 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.129 1.372 . . . . 2.6200000000000001 114.599 178.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.0 p 159.76 123.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 1 C-N-CA 132.334 4.254 . . . . 3.7200000000000002 106.974 -164.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 64.63 9.93 5.53 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 117.248 2.314 . . . . 3.1499999999999999 117.248 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.77 7.34 60.11 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 120.745 -1.222 . . . . 2.3700000000000001 113.28 -171.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -112.37 100.84 9.1 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.24 1.816 . . . . 2.8599999999999999 109.213 -162.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -79.49 114.34 18.34 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.194 -0.941 . . . . 4.0499999999999998 108.995 -173.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.1 t -126.82 133.52 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.169 1.788 . . . . 2.6899999999999999 108.769 -173.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 60.2 mtm -88.25 128.17 35.47 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.82 0.848 . . . . 3.2400000000000002 110.688 175.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.72 177.71 16.5 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 124.957 1.265 . . . . 0.63 112.631 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.6 ttm -157.52 137.66 12.61 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.589 1.155 . . . . 0.72999999999999998 111.974 -172.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -146.81 150.01 38.05 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.864 1.666 . . . . 8.4900000000000002 111.038 -177.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.56 151.8 53.26 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.38 2.053 . . . . 0.75 110.12 169.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.78 154.75 76.61 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 125.293 1.437 . . . . 0.76000000000000001 110.638 -175.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.66 -25.9 4.15 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.2 2.6 . . . . 0.63 113.189 -166.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -177.77 161.68 1.65 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.144 1.778 . . . . 1.97 111.433 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.69 153.83 22.88 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.429 1.492 . . . . 0.70999999999999996 109.62 163.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -105.52 152.36 23.14 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.929 0.891 . . . . 1.8600000000000001 110.685 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.3 124.01 13.62 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 123.301 0.64 . . . . 1.46 110.263 163.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.35 165.03 31.88 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.181 2.587 . . . . 1.01 111.181 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.92 138.85 76.23 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.516 2.144 . . . . 1.23 112.848 175.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.26 15.3 mtmt 57.66 36.82 27.07 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.355 1.462 . . . . 2.9500000000000002 113.606 171.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.29 140.06 11.48 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.561 2.029 . . . . 1.1799999999999999 114.84 -172.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.1 ttt85 -87.52 138.11 31.75 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.851 2.06 . . . . 4.3700000000000001 110.439 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.5 t -148.93 142.58 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 127.421 2.288 . . . . 3.27 107.313 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -142.35 147.5 36.39 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 120.537 1.517 . . . . 4.2599999999999998 113.463 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mp -82.59 168.08 17.68 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.044 2.138 . . . . 2.5800000000000001 111.168 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -169.82 157.9 6.5 Favored Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 125.868 1.667 . . . . 2.9199999999999999 113.667 -176.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.18 -47.24 15.38 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 124.19 3.26 . . . . 3.1200000000000001 113.254 176.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.02 36.11 1.47 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.851 1.215 . . . . 1.6000000000000001 113.66 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.3 -134.1 2.51 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 125.107 1.337 . . . . 1.6100000000000001 113.456 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.438 ' CE1' ' HB3' ' A' ' 47' ' ' GLU . 97.1 m-85 -71.05 136.63 48.41 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.897 -0.766 . . . . 2.0299999999999998 111.658 -169.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.5 p-80 -162.08 154.68 19.81 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.826 1.25 . . . . 0.68999999999999995 112.465 -170.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -84.32 146.57 27.66 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.855 -0.528 . . . . 2.4399999999999999 109.753 168.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.6 tpt -100.4 136.51 40.17 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.739 1.216 . . . . 0.63 108.9 162.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.5 mp -118.59 139.87 50.8 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.032 1.333 . . . . 0.52000000000000002 109.148 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mp -140.2 146.63 38.95 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.693 0.797 . . . . 1.75 110.699 171.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.59 37.09 24.46 Favored Glycine 0 N--CA 1.473 1.106 0 O-C-N 122.073 -0.392 . . . . 1.1100000000000001 112.904 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.27 146.12 9.8 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.856 1.662 . . . . 1.29 115.467 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -109.1 -23.49 11.62 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 113.646 -1.615 . . . . 1.99 113.255 -168.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -97.61 142.67 24.92 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.056 0.942 . . . . 5.8300000000000001 109.19 158.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.69 79.54 3.32 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.279 2.652 . . . . 2.5 109.439 173.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 72.8 mt -42.63 122.93 2.46 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 127.604 2.362 . . . . 2.25 115.13 -167.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -119.97 156.8 30.13 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 127.078 2.151 . . . . 6.0499999999999998 113.357 165.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.26 135.98 56.75 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.784 -1.098 . . . . 1.4399999999999999 108.435 171.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.13 1.56 72.39 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.052 1.31 . . . . 1.78 115.117 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -74.97 -173.09 1.81 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.012 1.406 . . . . 2.3700000000000001 112.834 169.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -139.05 125.52 20.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.99 3.316 . . . . 5.0999999999999996 105.354 -165.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.2 t -145.18 128.42 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 O-C-N 121.298 -0.876 . . . . 1.1799999999999999 110.957 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.82 143.58 35.87 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.421 -0.809 . . . . 2.48 110.658 169.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mp -118.27 134.33 55.12 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.876 0.871 . . . . 1.78 109.569 156.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -93.44 139.4 30.75 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.185 2.594 . . . . 2.7799999999999998 108.355 169.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.4 mp -118.43 129.02 55.16 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.729 1.612 . . . . 0.91000000000000003 109.743 -173.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.8 mt -106.28 114.81 29.16 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.371 1.468 . . . . 0.75 110.518 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -112.24 115.06 28.2 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.067 1.347 . . . . 1.8999999999999999 111.841 -172.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 48.53 26.94 1.3 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.519 1.928 . . . . 3.0299999999999998 114.223 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.33 -59.49 4.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.42 1.486 . . . . 4.4000000000000004 112.861 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.63 3.42 68.79 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 116.987 1.555 . . . . 2.21 116.987 -165.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -136.1 143.36 44.54 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.702 1.751 . . . . 3.4300000000000002 112.519 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.4 t -134.34 147.43 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.473 1.509 . . . . 2.29 109.659 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -153.78 166.52 32.62 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.936 2.494 . . . . 1.8899999999999999 108.094 175.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -144.35 160.55 40.85 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.878 1.217 . . . . 1.74 113.679 171.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.66 158.21 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.525 1.53 . . . . 2.3799999999999999 108.886 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.5 p -114.63 132.72 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.325 1.05 . . . . 2.4500000000000002 110.003 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -124.93 148.89 61.32 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 126.975 2.11 . . . . 3.29 108.713 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.15 161.73 44.9 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.742 2.295 . . . . 0.85999999999999999 111.775 162.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.4 t -96.59 137.61 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.847 0.859 . . . . 1.1399999999999999 109.41 168.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.54 141.31 29.4 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.884 1.674 . . . . 3.8199999999999998 111.036 177.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -95.39 86.35 4.48 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.674 1.189 . . . . 2.3100000000000001 112.051 -169.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 . . . . . 0 C--O 1.246 0.881 0 C-N-CA 124.87 1.268 . . . . 8.1799999999999997 111.153 -173.934 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 CA--C 1.544 0.749 0 CA-C-O 121.873 0.844 . . . . 6.2199999999999998 112.231 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.0 -177.54 23.26 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.809 1.671 . . . . 1.0 111.714 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -148.98 157.61 43.55 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 115.351 1.611 . . . . 1.8799999999999999 115.351 -173.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.0 t -92.89 134.73 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.958 1.303 . . . . 1.3400000000000001 108.631 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.9 tpp85 -69.16 118.87 12.6 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.144 0.977 . . . . 4.8300000000000001 111.872 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -66.64 142.32 57.5 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.87 1.268 . . . . 1.8500000000000001 111.414 162.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -174.48 161.48 2.7 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 126.451 1.9 . . . . 2.9199999999999999 110.684 170.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -84.55 38.2 0.67 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.998 3.132 . . . . 2.4900000000000002 112.122 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.85 151.52 18.21 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 124.942 1.258 . . . . 1.46 115.122 -165.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.29 -22.11 14.65 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.253 2.635 . . . . 1.25 111.841 166.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -105.99 158.58 16.69 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 127.272 2.229 . . . . 2.3100000000000001 112.072 165.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.38 -171.79 3.92 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.027 2.131 . . . . 0.73999999999999999 110.752 -173.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.34 159.86 43.58 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.188 1.395 . . . . 1.1100000000000001 109.707 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.75 131.21 37.3 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.65 1.114 . . . . 0.88 112.778 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -123.0 81.96 1.94 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.664 1.986 . . . . 2.8100000000000001 110.28 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -92.24 158.08 16.33 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.664 1.186 . . . . 1.9099999999999999 113.923 -173.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.7 m -119.89 144.33 47.46 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.725 1.61 . . . . 2.1299999999999999 108.443 162.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.9 tp -158.57 171.7 19.65 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.574 2.75 . . . . 5.0300000000000002 107.517 173.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -136.23 144.75 45.02 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 120.391 -1.443 . . . . 4.4199999999999999 108.382 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -97.59 106.7 34.82 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 125.381 1.472 . . . . 1.3999999999999999 109.493 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -81.62 -7.3 12.59 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.731 2.287 . . . . 1.3500000000000001 114.083 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.64 168.5 54.78 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-O 123.108 1.393 . . . . 1.4399999999999999 113.228 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.436 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 16.6 m-20 -101.44 -2.38 30.94 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 128.606 2.763 . . . . 3.0499999999999998 111.648 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 pp -117.03 159.16 42.12 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 127.665 2.386 . . . . 2.1800000000000002 110.342 171.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.87 138.07 12.95 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.873 2.382 . . . . 1.0800000000000001 111.025 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.55 156.68 16.33 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 123.185 1.469 . . . . 2.1600000000000001 111.834 176.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -152.01 98.26 2.42 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.104 -1.862 . . . . 2.8599999999999999 110.246 -164.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.473 HD21 ' CZ ' ' A' ' 84' ' ' PHE . 5.4 tt -85.59 115.75 23.47 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.945 1.698 . . . . 2.2799999999999998 107.403 -177.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.93 -16.39 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.202 1.001 . . . . 0.72999999999999998 111.969 -174.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.18 -176.53 31.34 Favored Glycine 0 C--N 1.342 0.881 0 C-N-CA 125.887 1.708 . . . . 0.65000000000000002 113.392 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -153.74 178.03 10.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.39 1.476 . . . . 0.68999999999999995 112.785 166.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -151.42 159.04 44.42 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 129.622 3.169 . . . . 4.4699999999999998 108.568 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 t -173.79 152.23 1.97 Allowed Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 128.111 2.565 . . . . 0.60999999999999999 107.229 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.92 -15.88 20.71 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.688 1.592 . . . . 0.97999999999999998 113.513 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.12 32.54 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.319 1.047 . . . . 0.75 112.326 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.93 140.12 17.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.608 0.763 . . . . 0.90000000000000002 109.395 165.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -85.93 -33.89 21.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.038 1.335 . . . . 3.79 110.847 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -139.06 144.45 38.79 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.066 2.146 . . . . 6.9400000000000004 106.597 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.2 p -135.92 146.84 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.109 1.364 . . . . 1.5600000000000001 109.338 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -135.49 146.97 48.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.755 2.022 . . . . 3.9900000000000002 108.781 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.8 tp -109.12 115.65 30.45 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.697 1.135 . . . . 1.1699999999999999 111.1 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 65.6 m170 -116.4 154.65 29.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.497 1.519 . . . . 0.73999999999999999 113.923 -175.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.479 ' CD ' ' HD2' ' A' ' 62' ' ' ARG . 6.5 pt-20 -95.86 179.86 4.95 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.806 1.243 . . . . 2.21 111.442 159.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 84.1 m -137.69 134.81 35.83 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.351 -1.352 . . . . 0.93999999999999995 107.351 164.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -129.7 163.81 25.33 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.165 1.172 . . . . 2.1499999999999999 114.165 -168.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -106.5 150.22 26.32 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.458 1.503 . . . . 3.7599999999999998 111.4 167.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.67 157.66 35.59 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.055 0.942 . . . . 4.3499999999999996 111.217 -168.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -110.32 146.83 35.05 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.174 1.79 . . . . 2.7200000000000002 108.415 167.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.2 129.42 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 107.748 -1.205 . . . . 2.9700000000000002 107.748 161.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 61.97 32.99 17.61 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.161 0.984 . . . . 4.5300000000000002 112.298 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.73 8.69 82.14 Favored Glycine 0 CA--C 1.536 1.384 0 O-C-N 120.575 -1.328 . . . . 2.02 114.019 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -121.11 129.63 53.38 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.391 1.876 . . . . 2.77 109.174 -172.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -69.34 134.9 49.64 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.992 2.117 . . . . 4.3700000000000001 109.492 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.5 p -146.36 170.79 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 125.895 1.678 . . . . 2.6200000000000001 109.835 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 32.2 mtm -131.85 159.32 38.91 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.768 1.627 . . . . 2.5699999999999998 110.684 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.13 -174.9 27.43 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.924 1.25 . . . . 0.89000000000000001 113.956 -173.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.3 ttm -155.74 145.69 21.42 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.169 1.787 . . . . 0.79000000000000004 108.565 -174.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.479 ' HD2' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -162.46 154.0 15.33 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.573 1.149 . . . . 5.3200000000000003 111.59 -178.159 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.79 157.53 35.28 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.143 1.896 . . . . 0.58999999999999997 112.976 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.34 156.78 67.18 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 126.487 1.915 . . . . 0.72999999999999998 110.211 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.5 -21.82 4.13 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.743 2.962 . . . . 0.70999999999999996 113.892 -169.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -177.0 164.61 2.3 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.626 1.97 . . . . 2.04 110.368 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.9 mt -110.31 153.44 24.88 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.342 1.057 . . . . 0.82999999999999996 109.962 166.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -122.07 146.52 47.12 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.466 1.106 . . . . 2.6600000000000001 110.875 174.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.1 t -140.13 131.42 14.29 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.898 1.279 . . . . 0.83999999999999997 109.756 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.46 166.27 27.8 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.115 2.543 . . . . 0.98999999999999999 112.182 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -58.41 139.85 92.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.164 2.576 . . . . 1.25 111.235 171.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.436 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 61.3 mmtt 65.1 3.96 2.37 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.977 1.311 . . . . 1.6899999999999999 113.286 -175.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.11 176.54 53.08 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 127.107 2.289 . . . . 1.4299999999999999 114.73 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 -98.66 129.98 45.16 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.441 1.496 . . . . 3.7000000000000002 112.84 -174.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.8 t -108.12 57.59 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.63 1.572 . . . . 6.0300000000000002 108.947 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -101.65 127.6 48.32 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.038 0.935 . . . . 3.1600000000000001 109.331 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' A' ' 83' ' ' HIS . 3.7 mp -67.82 -37.43 81.92 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.247 1.019 . . . . 3.1000000000000001 111.219 173.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.2 tptt 91.91 126.35 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 127.176 2.19 . . . . 4.1200000000000001 111.385 171.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.82 29.38 0.21 Allowed 'Trans proline' 0 CA--C 1.551 1.338 0 C-N-CA 125.027 3.818 . . . . 2.8100000000000001 115.037 -177.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.03 26.13 0.03 OUTLIER Glycine 0 CA--C 1.539 1.532 0 C-N-CA 127.05 2.262 . . . . 1.6899999999999999 115.284 -174.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.28 -29.59 0.02 OUTLIER Glycine 0 N--CA 1.481 1.683 0 N-CA-C 119.208 2.443 . . . . 2.2999999999999998 119.208 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -142.23 151.24 41.92 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.493 1.517 . . . . 2.25 111.422 159.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.527 ' HA ' HD23 ' A' ' 77' ' ' LEU . 44.3 p-80 -163.2 157.3 20.27 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.797 -1.189 . . . . 0.77000000000000002 111.998 175.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 70.8 m-85 -78.43 139.55 38.73 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.073 -0.651 . . . . 2.5899999999999999 109.397 161.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -91.72 131.02 37.4 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.773 1.629 . . . . 0.64000000000000001 108.116 159.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 mp -113.64 143.29 44.83 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.973 1.309 . . . . 0.69999999999999996 109.071 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mt -137.96 139.4 39.71 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.239 1.016 . . . . 2.1600000000000001 111.355 -176.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.57 38.84 36.58 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.924 -0.931 . . . . 0.93000000000000005 113.897 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.61 150.89 0.91 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 117.17 2.285 . . . . 1.3899999999999999 117.17 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -115.76 -13.28 11.41 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 113.746 -1.57 . . . . 2.6699999999999999 114.269 -172.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -119.57 154.26 54.46 Favored Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 125.954 1.702 . . . . 5.6699999999999999 108.902 168.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -70.66 149.3 60.93 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.662 2.241 . . . . 2.3999999999999999 110.067 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.5 mt -89.54 115.06 26.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 122.87 1.319 . . . . 3.0800000000000001 107.672 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -116.65 172.02 7.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.621 -1.627 . . . . 4.6699999999999999 110.473 169.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.45 136.79 39.41 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.832 -1.544 . . . . 1.6299999999999999 106.832 145.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.1 45.24 9.09 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 123.161 0.41 . . . . 2.1299999999999999 113.721 174.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -111.64 177.71 4.56 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.35 0.575 . . . . 2.8199999999999998 110.775 148.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -146.35 134.81 21.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.1 2.16 . . . . 3.3599999999999999 108.146 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.8 t -139.49 136.09 40.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 127.768 2.427 . . . . 1.3200000000000001 109.636 -160.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -84.11 145.74 28.26 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.754 0.787 . . . . 3.0800000000000001 112.808 173.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mp -121.79 146.83 46.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.907 2.083 . . . . 1.76 109.862 163.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -117.91 111.62 19.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.379 2.272 . . . . 2.3100000000000001 107.844 168.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.3 mp -83.0 140.23 32.84 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.864 0.866 . . . . 0.96999999999999997 109.352 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.8 mt -105.23 109.38 21.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.454 1.102 . . . . 0.72999999999999998 110.098 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -97.63 150.52 21.06 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.758 1.223 . . . . 1.95 111.117 172.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.43 126.62 22.02 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.287 1.435 . . . . 1.6000000000000001 113.487 -169.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.43 49.0 6.98 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.086 -0.841 . . . . 2.6899999999999999 112.649 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.17 12.1 84.36 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 116.174 1.23 . . . . 2.6499999999999999 116.174 165.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -92.14 102.99 15.52 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.333 1.567 . . . . 3.98 111.128 -168.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.3 p -93.18 139.45 18.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 O-C-N 124.603 1.19 . . . . 2.1600000000000001 111.818 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 123.39 19.95 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.467 0.707 . . . . 2.5800000000000001 111.514 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -89.84 129.51 36.21 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.273 1.429 . . . . 1.99 111.473 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.18 143.97 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.952 1.301 . . . . 1.8200000000000001 109.935 168.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.0 p -112.77 134.89 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.358 1.063 . . . . 2.3599999999999999 110.023 176.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 mp -138.87 148.71 59.11 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.967 1.307 . . . . 2.77 110.535 -167.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.66 153.12 79.09 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.468 2.112 . . . . 1.04 111.934 169.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.31 120.95 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.012 -1.477 . . . . 1.3999999999999999 107.012 165.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -153.46 165.66 35.13 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 122.805 1.288 . . . . 5.3499999999999996 113.703 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.29 155.5 28.48 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.75 -1.114 . . . . 3.27 113.859 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.168 0 C-N-CA 131.248 3.819 . . . . 7.8499999999999996 107.374 157.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 121.871 0.843 . . . . 6.4000000000000004 109.751 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.06 176.17 19.43 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.565 -1.014 . . . . 0.97999999999999998 110.565 170.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -155.58 -178.65 7.43 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.387 0.613 . . . . 1.74 112.568 -176.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.8 t -112.88 134.69 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.112 1.765 . . . . 1.4199999999999999 109.184 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -21.79 38.5 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.082 1.512 . . . . 5.5700000000000003 115.082 -172.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 82.9 t80 69.99 146.98 0.06 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 128.884 2.874 . . . . 2.5099999999999998 113.792 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.3 m -170.93 154.81 4.36 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.79 2.036 . . . . 2.2799999999999998 111.886 173.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -82.68 -24.6 3.4 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.75 2.967 . . . . 2.1699999999999999 112.865 169.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.08 148.54 24.47 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 109.843 -1.303 . . . . 2.3100000000000001 109.843 166.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.87 -38.9 9.16 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.974 2.449 . . . . 2.8300000000000001 114.523 -163.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -80.03 139.51 36.93 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 123.352 1.549 . . . . 4.3300000000000001 112.779 -175.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.8 -175.31 5.31 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.341 1.457 . . . . 0.88 112.502 -156.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.86 156.83 43.81 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.997 1.719 . . . . 0.79000000000000004 109.932 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.4 143.92 39.99 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.175 0.805 . . . . 0.63 113.175 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.438 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 31.0 m-85 -125.53 75.45 1.48 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.408 1.883 . . . . 2.3799999999999999 110.918 -168.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.83 162.92 28.6 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.816 -1.178 . . . . 1.8600000000000001 113.965 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 68.3 m -121.1 141.64 50.6 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.386 1.075 . . . . 2.27 109.223 157.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.64 -179.35 7.53 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 128.473 2.709 . . . . 5.4400000000000004 107.776 175.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -138.89 157.36 46.19 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.16 -0.963 . . . . 3.8700000000000001 111.847 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -103.65 95.11 6.91 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 126.072 1.749 . . . . 1.3700000000000001 109.469 165.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.0 -3.94 12.47 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.009 2.473 . . . . 1.1699999999999999 114.337 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.26 160.41 31.9 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-O 122.456 1.031 . . . . 1.4099999999999999 111.759 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -87.23 10.02 18.36 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.815 2.446 . . . . 3.8999999999999999 112.179 175.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -116.01 152.88 48.14 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 128.812 2.845 . . . . 2.1699999999999999 109.744 171.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.38 153.58 24.11 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.22 2.614 . . . . 0.82999999999999996 111.489 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.9 mt -111.8 146.9 36.83 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 123.296 1.522 . . . . 1.71 111.774 167.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -133.85 103.63 5.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 112.263 -2.244 . . . . 2.0600000000000001 110.04 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -82.7 109.73 17.13 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.185 1.394 . . . . 2.5899999999999999 108.296 -174.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 m -105.65 -22.04 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.305 1.042 . . . . 0.5 111.908 -172.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.15 -176.72 31.52 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 125.279 1.419 . . . . 0.47999999999999998 113.737 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -154.27 179.16 9.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.263 1.425 . . . . 0.57999999999999996 111.679 168.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -146.19 174.33 11.42 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.783 2.033 . . . . 5.4699999999999998 108.998 164.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 t -170.86 149.53 2.84 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 127.721 2.409 . . . . 0.73999999999999999 108.149 175.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.91 -3.66 14.13 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.746 2.298 . . . . 1.05 113.682 176.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 m -121.74 57.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.843 1.257 . . . . 1.22 112.339 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.09 173.83 16.13 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.544 1.138 . . . . 1.5700000000000001 112.005 162.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -114.87 -51.95 2.72 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.277 1.831 . . . . 2.7200000000000002 109.446 165.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -101.66 132.13 47.52 Favored 'General case' 0 C--N 1.342 0.243 0 O-C-N 121.319 -0.863 . . . . 5.25 109.489 161.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -97.06 150.65 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.108 -0.951 . . . . 1.3 108.458 140.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -136.17 154.02 51.09 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.1 1.76 . . . . 3.0 109.013 169.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.8 tp -110.66 117.31 33.14 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.364 0.665 . . . . 1.0900000000000001 111.235 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -125.29 149.34 48.15 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.784 1.234 . . . . 0.72999999999999998 114.177 -172.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -87.51 169.92 11.78 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.507 1.923 . . . . 2.5699999999999998 112.15 163.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.1 m -148.25 146.16 28.52 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 106.711 -1.589 . . . . 1.01 106.711 173.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -157.99 163.09 38.12 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.116 1.154 . . . . 2.2799999999999998 114.116 -170.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.6 ttp -91.53 148.85 21.99 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.49 1.116 . . . . 3.1099999999999999 109.346 161.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.09 167.18 30.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.285 1.834 . . . . 4.4199999999999999 110.258 -170.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -124.53 135.21 52.99 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.586 1.554 . . . . 2.5 110.553 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 t -136.8 120.33 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.035 -0.728 . . . . 2.0499999999999998 109.035 165.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 65.96 26.25 10.97 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.757 2.023 . . . . 3.1699999999999999 112.962 -176.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.25 10.71 85.77 Favored Glycine 0 CA--C 1.536 1.364 0 O-C-N 120.218 -1.551 . . . . 2.1099999999999999 113.366 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -110.25 116.46 31.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.796 1.638 . . . . 3.3100000000000001 110.355 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.493 ' H ' ' HE2' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -58.66 129.25 41.2 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.961 2.104 . . . . 4.1799999999999997 110.407 174.354 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.8 p -156.72 146.01 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.369 1.867 . . . . 2.4900000000000002 109.752 -174.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.21 161.16 14.07 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.765 0.826 . . . . 3.2799999999999998 111.882 -174.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.44 -179.47 30.59 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 123.976 0.798 . . . . 0.58999999999999997 114.294 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.8 ttm -159.92 148.48 17.31 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.675 1.99 . . . . 0.81000000000000005 109.09 -173.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.1 mtm105 -150.69 156.01 36.05 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.545 1.538 . . . . 5.1699999999999999 109.993 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -77.05 152.94 31.96 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.03 1.82 . . . . 0.63 110.82 168.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.3 m -139.1 151.85 68.67 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.897 1.279 . . . . 0.73999999999999999 110.542 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.39 -24.01 11.08 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.27 2.647 . . . . 0.71999999999999997 112.624 -170.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -173.04 172.96 3.8 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.098 1.759 . . . . 1.9199999999999999 110.912 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.1 mt -118.56 154.93 31.78 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.228 1.811 . . . . 0.70999999999999996 109.819 161.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -114.63 140.59 48.69 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.203 1.001 . . . . 1.8700000000000001 110.281 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.4 t -137.71 127.51 15.29 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 123.565 0.746 . . . . 0.85999999999999999 110.913 167.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.66 169.95 16.3 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.849 3.032 . . . . 0.97999999999999998 111.941 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.06 143.17 96.9 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.112 2.541 . . . . 1.1599999999999999 113.003 173.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm 64.15 8.28 3.97 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.549 1.54 . . . . 2.4100000000000001 113.794 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.99 163.8 38.3 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 127.149 2.309 . . . . 1.2 113.639 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.4 mtt-85 -93.62 148.45 22.09 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.802 0.841 . . . . 5.5800000000000001 110.567 174.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.7 t -118.08 57.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.704 2.002 . . . . 5.5199999999999996 107.564 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -89.2 129.2 35.82 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.017 -0.734 . . . . 2.8999999999999999 109.017 168.082 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 83' ' ' HIS . 2.6 tp -74.78 -24.56 58.69 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 112.925 0.713 . . . . 3.1299999999999999 112.925 -164.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? 76.97 100.89 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 127.319 2.248 . . . . 4.0 110.342 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.438 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 35.0 Cg_endo -60.92 -29.46 88.11 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 121.829 1.686 . . . . 2.27 114.153 -175.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.88 10.5 70.09 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.148 -1.918 . . . . 1.51 115.07 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.47 -25.66 0.03 OUTLIER Glycine 0 N--CA 1.475 1.28 0 N-CA-C 121.414 3.326 . . . . 2.27 121.414 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -140.29 147.92 40.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 121.337 2.569 . . . . 2.1800000000000002 113.17 164.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.524 ' HA ' HD23 ' A' ' 77' ' ' LEU . 54.8 p-80 -158.48 152.54 23.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.668 -1.151 . . . . 0.72999999999999998 112.209 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 75.7 m-85 -78.25 139.08 38.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.094 -0.706 . . . . 2.23 109.094 161.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -88.04 129.45 35.27 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.745 -1.206 . . . . 0.79000000000000004 107.745 159.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 mp -108.74 127.43 53.99 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.06 -1.089 . . . . 0.51000000000000001 108.06 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.42 143.42 50.75 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.75 0.82 . . . . 1.6399999999999999 110.591 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.17 45.81 47.01 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.291 -0.727 . . . . 0.81999999999999995 113.737 176.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pp -54.39 147.94 12.77 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 123.52 1.629 . . . . 1.3799999999999999 114.954 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -103.79 -5.78 22.11 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 113.328 -1.76 . . . . 2.02 113.242 -169.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -148.57 144.47 18.51 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 127.585 2.354 . . . . 7.9400000000000004 109.402 171.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.56 152.54 17.59 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 124.069 3.179 . . . . 2.0499999999999998 111.281 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.645 ' H ' HD23 ' A' ' 93' ' ' LEU . 2.0 pt? -120.06 142.16 49.11 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.849 2.46 . . . . 3.6200000000000001 110.152 -166.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -96.2 -165.8 1.33 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 125.647 1.579 . . . . 3.9399999999999999 110.21 159.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.18 139.01 36.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 107.92 -1.141 . . . . 1.52 107.92 148.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.45 4.55 34.85 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.66 1.6 . . . . 1.8200000000000001 115.501 -170.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.19 174.51 11.49 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.065 1.346 . . . . 2.8500000000000001 110.579 171.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -136.3 149.09 48.27 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.175 1.79 . . . . 4.0199999999999996 106.22 156.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.1 t -145.06 134.56 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.571 1.948 . . . . 1.1399999999999999 110.195 -165.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -78.9 135.09 36.89 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.842 1.257 . . . . 3.3900000000000001 112.208 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mp -123.41 145.01 49.12 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.155 1.382 . . . . 1.71 111.153 162.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -109.25 133.99 52.33 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.562 1.945 . . . . 2.8100000000000001 108.578 170.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 mp -108.5 131.44 54.81 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.883 0.873 . . . . 0.80000000000000004 109.686 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.2 mt -106.52 114.77 29.08 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.206 1.003 . . . . 0.69999999999999996 109.844 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -113.36 121.11 43.38 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.981 1.713 . . . . 2.0299999999999998 111.498 -175.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.96 22.45 2.43 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.598 1.959 . . . . 2.6099999999999999 114.475 174.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.77 -58.39 3.46 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.127 1.346 . . . . 4.2199999999999998 112.66 -169.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.38 0.73 79.46 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 116.821 1.489 . . . . 2.1299999999999999 116.821 -167.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -130.94 140.15 50.14 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.774 1.787 . . . . 3.71 112.344 173.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.0 p -127.73 147.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.42 1.888 . . . . 2.25 110.347 172.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.1 tp -150.73 124.48 9.15 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.039 1.336 . . . . 2.0600000000000001 110.236 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -113.25 135.75 53.5 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.266 0.626 . . . . 2.6400000000000001 112.579 -172.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.4 t -146.45 163.93 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.465 1.506 . . . . 3.23 108.956 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -114.56 138.03 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.179 1.392 . . . . 2.2999999999999998 109.113 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mp -124.22 151.57 66.16 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.841 1.256 . . . . 2.6000000000000001 110.562 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -69.06 155.43 68.27 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.229 2.62 . . . . 1.23 111.489 172.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.6 t -106.41 81.73 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 107.499 -1.297 . . . . 1.46 107.499 161.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.19 156.09 27.09 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.748 -1.205 . . . . 4.0499999999999998 107.748 140.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -83.43 178.98 7.79 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.05 1.34 . . . . 3.6800000000000002 110.849 172.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.268 12.1 ptt-85 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 114.78 -2.533 . . . . 9.4700000000000006 113.494 162.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 CA--C 1.545 0.774 0 CA-C-O 121.545 0.688 . . . . 7.21 109.799 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.82 -179.93 32.16 Favored Glycine 0 N--CA 1.471 0.999 0 O-C-N 120.717 -1.239 . . . . 1.0 114.689 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.5 p90 -141.87 165.82 26.41 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.418 1.487 . . . . 2.02 112.206 172.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.6 t -106.14 135.56 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.044 -1.095 . . . . 1.0700000000000001 108.044 166.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.04 113.95 15.3 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 120.766 0.317 . . . . 3.7200000000000002 110.278 175.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -61.36 135.71 57.79 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.658 -0.497 . . . . 2.9900000000000002 109.658 156.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.2 m -160.59 139.84 7.92 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.991 1.317 . . . . 3.6400000000000001 108.952 167.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -85.08 48.23 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.692 3.595 . . . . 3.1200000000000001 112.353 -168.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -124.09 -175.45 14.39 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.411 1.482 . . . . 1.75 112.897 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.78 -17.46 20.13 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.673 2.915 . . . . 1.77 113.516 174.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -122.16 167.33 13.3 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.728 2.011 . . . . 3.3700000000000001 113.431 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.34 -176.06 5.15 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 127.127 2.171 . . . . 0.83999999999999997 111.739 175.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.22 150.7 44.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.718 2.007 . . . . 0.82999999999999996 108.658 176.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.47 138.41 48.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.153 0.888 . . . . 0.87 111.308 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -129.02 133.55 47.78 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.057 1.743 . . . . 2.3500000000000001 110.656 -171.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 pp -165.7 152.12 9.7 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.149 0.886 . . . . 2.3700000000000001 113.1 -170.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 62.6 m -77.22 120.85 22.86 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.355 -0.841 . . . . 3.2599999999999998 109.035 171.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.14 118.97 23.0 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.541 -1.281 . . . . 3.3100000000000001 107.541 168.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -111.44 126.9 55.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.875 1.67 . . . . 4.0899999999999999 109.07 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -103.62 98.7 13.38 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 121.652 -0.655 . . . . 1.3799999999999999 111.552 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.17 -7.27 17.09 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.903 2.402 . . . . 1.3700000000000001 114.112 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.76 172.35 53.18 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-O 122.658 1.143 . . . . 1.1899999999999999 112.656 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -103.78 -4.52 23.52 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.21 2.604 . . . . 3.0699999999999998 111.837 -174.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.664 ' H ' HD23 ' A' ' 28' ' ' LEU . 2.6 pt? -116.55 162.41 26.9 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 129.106 2.963 . . . . 2.8900000000000001 109.577 172.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.12 142.59 24.76 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.131 1.888 . . . . 0.83999999999999997 109.991 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.494 HD12 ' CD1' ' A' ' 105' ' ' PHE . 1.1 mm? -105.67 158.04 16.99 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.076 1.351 . . . . 2.2999999999999998 111.308 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -149.42 107.45 3.72 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.154 -1.385 . . . . 2.5899999999999999 111.434 -171.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.5 tp -90.39 109.65 20.76 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 127.051 2.14 . . . . 1.8400000000000001 109.272 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -106.77 -17.76 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.445 1.098 . . . . 0.69999999999999996 112.238 -171.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.87 -175.38 28.73 Favored Glycine 0 C--N 1.344 0.985 0 C-N-CA 125.878 1.704 . . . . 0.45000000000000001 113.089 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.76 -176.91 5.45 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.532 1.533 . . . . 0.52000000000000002 110.794 168.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.71 175.87 13.34 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.418 2.687 . . . . 4.5899999999999999 108.2 169.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.0 159.3 7.85 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 127.135 2.174 . . . . 0.96999999999999997 107.267 168.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.56 -9.68 16.67 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.638 2.225 . . . . 0.93999999999999995 115.168 166.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.75 41.36 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 114.821 1.415 . . . . 0.89000000000000001 114.821 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.46 149.91 8.65 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.314 1.446 . . . . 2.0699999999999998 110.133 161.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -123.17 -58.78 1.62 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.817 1.247 . . . . 3.3799999999999999 111.376 -173.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -78.21 68.17 4.17 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 120.887 -1.133 . . . . 4.9299999999999997 108.989 168.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.7 p -78.03 150.47 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.054 -0.975 . . . . 1.1100000000000001 108.857 168.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.97 158.36 37.77 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.065 2.146 . . . . 4.75 107.038 -164.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -134.47 133.3 40.27 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 123.794 1.759 . . . . 1.75 114.102 171.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -120.41 149.13 42.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 112.728 -2.033 . . . . 0.77000000000000002 111.188 -171.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.65 -178.9 7.0 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.293 -1.321 . . . . 2.8999999999999999 110.837 155.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.7 m -153.22 138.68 17.65 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.893 1.277 . . . . 0.92000000000000004 108.465 172.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -147.73 164.27 34.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 122.84 1.305 . . . . 2.2799999999999998 113.45 -171.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.5 ttm -97.32 138.71 34.37 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.313 1.445 . . . . 3.8900000000000001 109.758 172.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -149.08 161.51 41.8 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.431 1.271 . . . . 8.9000000000000004 114.431 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.479 ' CD ' ' HZ2' ' A' ' 57' ' ' LYS . 3.6 tp10 -83.27 151.91 25.39 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.627 1.571 . . . . 3.2400000000000002 110.53 162.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.9 t -139.4 117.39 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.17 1.788 . . . . 2.6699999999999999 106.642 152.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 62.68 21.54 12.78 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.819 1.414 . . . . 3.9100000000000001 114.819 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.26 0.53 82.59 Favored Glycine 0 N--CA 1.48 1.612 0 O-C-N 120.378 -1.451 . . . . 2.3999999999999999 114.034 -170.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -104.27 119.88 39.94 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.139 2.576 . . . . 4.0899999999999999 107.644 -175.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.479 ' HZ2' ' CD ' ' A' ' 52' ' ' GLU . 42.6 mttp -88.05 126.11 34.92 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.28 1.432 . . . . 5.1900000000000004 110.03 -167.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.56 HG22 ' H ' ' A' ' 59' ' ' MET . 8.8 p -154.43 -178.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.732 1.613 . . . . 2.6699999999999999 109.691 -165.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.56 ' H ' HG22 ' A' ' 58' ' ' VAL . 39.2 mmm -119.31 161.87 19.72 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.451 1.101 . . . . 3.0899999999999999 111.176 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -142.81 168.61 25.9 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 126.322 1.915 . . . . 0.65000000000000002 111.509 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.7 ttm -157.67 132.43 8.58 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.328 1.451 . . . . 0.73999999999999999 109.226 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -145.43 148.99 39.34 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 126.476 1.91 . . . . 8.1400000000000006 109.704 -170.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.89 155.43 34.36 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.105 1.87 . . . . 0.78000000000000003 111.118 -176.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.4 m -131.41 151.6 79.04 Favored Pre-proline 0 N--CA 1.477 0.895 0 CA-C-O 118.453 -0.784 . . . . 0.83999999999999997 110.709 176.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.89 -20.6 11.64 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.397 2.732 . . . . 0.56999999999999995 113.165 -167.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -179.29 164.0 1.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.04 2.136 . . . . 1.98 110.467 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.6 mt -110.4 154.65 23.28 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.88 0.872 . . . . 0.55000000000000004 110.57 162.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -134.6 146.17 49.34 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.329 0.652 . . . . 1.96 110.736 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.4 t -142.83 132.14 11.84 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 124.244 0.965 . . . . 0.88 112.681 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.33 160.53 48.49 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.499 2.799 . . . . 0.88 111.912 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -60.53 139.8 88.0 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.491 2.794 . . . . 0.92000000000000004 112.141 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.8 mptt 66.02 -6.42 0.46 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 127.7 2.4 . . . . 1.8400000000000001 114.168 -174.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.59 153.73 37.23 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.759 1.647 . . . . 1.3799999999999999 113.202 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -107.23 147.16 30.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.15 0.98 . . . . 3.8199999999999998 109.647 163.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.9 t -145.14 125.9 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.907 1.683 . . . . 4.0899999999999999 107.013 166.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -93.77 130.91 39.6 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.708 1.003 . . . . 4.6500000000000004 113.708 -168.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -75.96 68.73 2.5 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.155 0.979 . . . . 1.9399999999999999 109.507 157.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 78' ' ' LYS . 8.0 pttp -90.64 156.58 45.02 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 125.705 1.602 . . . . 3.96 113.675 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.28 -20.99 71.92 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.743 2.295 . . . . 2.6600000000000001 113.103 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.5 52.78 3.87 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-N 119.106 0.866 . . . . 3.1099999999999999 111.813 163.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.69 -117.9 2.08 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.472 1.511 . . . . 1.4399999999999999 115.679 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -74.44 143.83 44.53 Favored 'General case' 0 C--O 1.224 -0.276 0 O-C-N 121.574 -0.957 . . . . 2.23 112.741 -161.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -161.8 154.28 19.9 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.454 -0.779 . . . . 0.80000000000000004 113.024 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -78.08 136.22 37.86 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.296 -0.631 . . . . 1.95 109.296 166.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.9 tpt -97.94 133.45 42.41 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 107.801 -1.185 . . . . 0.83999999999999997 107.801 163.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -114.68 115.77 27.63 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.758 1.223 . . . . 0.85999999999999999 108.29 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mp -120.08 155.34 33.17 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.826 0.822 . . . . 1.6699999999999999 110.19 168.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.08 45.81 24.51 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 116.004 -0.544 . . . . 1.5800000000000001 112.458 176.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.36 153.11 4.17 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 123.03 1.395 . . . . 1.6699999999999999 113.99 169.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -113.78 -12.17 12.79 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.011 -1.45 . . . . 2.0099999999999998 113.029 -171.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -145.65 151.71 47.15 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 127.095 2.158 . . . . 5.0300000000000002 108.542 174.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.88 154.5 72.78 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.664 2.243 . . . . 2.1099999999999999 109.816 167.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 pp -148.18 143.69 27.23 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 126.172 1.789 . . . . 2.1899999999999999 108.996 -168.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -127.35 173.02 10.13 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.925 1.69 . . . . 3.8799999999999999 111.754 -168.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.31 130.76 35.77 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.323 -0.991 . . . . 1.26 108.323 162.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.24 5.64 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.999 1.285 . . . . 1.8100000000000001 114.02 -176.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -129.16 -178.34 4.6 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.757 1.223 . . . . 2.3700000000000001 110.11 169.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -136.48 142.58 43.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.669 1.988 . . . . 4.9900000000000002 107.083 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.3 t -152.79 134.77 5.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 128.194 2.598 . . . . 1.4399999999999999 108.572 -168.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -93.17 156.12 17.04 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.241 1.2 . . . . 2.8700000000000001 114.241 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mp -115.07 162.74 16.59 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.11 1.764 . . . . 1.8500000000000001 110.82 165.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -121.87 125.46 46.48 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 129.656 3.182 . . . . 3.1200000000000001 107.163 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -104.18 129.04 51.92 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.307 -1.496 . . . . 1.02 110.181 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.5 mt -102.71 108.32 19.53 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.954 1.302 . . . . 0.90000000000000002 110.173 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.494 ' CD1' HD12 ' A' ' 30' ' ' LEU . 92.4 m-85 -96.22 154.28 17.34 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.899 0.88 . . . . 1.9399999999999999 110.562 174.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.93 135.72 29.91 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.616 0.767 . . . . 2.0 111.212 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.04 -6.53 69.27 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.437 1.018 . . . . 2.9900000000000002 114.348 -173.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.82 14.64 42.44 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-N 118.485 1.143 . . . . 3.3300000000000001 114.572 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 52.8 tttt -77.32 126.42 30.9 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.118 1.459 . . . . 6.1100000000000003 111.126 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 49.7 t -100.97 131.57 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.084 1.754 . . . . 2.73 109.491 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.1 tp -128.27 114.34 16.79 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.603 1.161 . . . . 2.1299999999999999 109.251 169.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.496 ' HZ2' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -106.36 134.56 49.31 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.298 1.222 . . . . 2.1400000000000001 114.298 -175.574 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.2 m -139.62 148.16 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 127.852 2.461 . . . . 2.1099999999999999 110.04 -152.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.4 t -118.05 124.47 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-N 120.096 1.316 . . . . 1.6899999999999999 110.563 -165.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.99 143.37 47.58 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.992 1.317 . . . . 2.25 110.868 -169.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.34 149.43 35.33 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.192 2.594 . . . . 0.93999999999999995 111.917 165.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.1 t -102.28 124.78 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.941 0.896 . . . . 0.91000000000000003 109.179 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -150.7 155.82 40.08 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.971 1.308 . . . . 3.5699999999999998 111.691 -174.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.95 59.35 3.18 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.088 0.955 . . . . 2.3700000000000001 113.206 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.99 0 C-N-CA 126.275 1.83 . . . . 9.6999999999999993 111.873 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 108.943 -0.762 . . . . 5.4800000000000004 108.943 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.41 ' CA ' ' HA ' ' A' ' 20' ' ' LEU . . . -85.4 171.85 46.26 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 121.252 -0.905 . . . . 1.9299999999999999 113.868 161.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -155.42 162.35 40.79 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.664 2.386 . . . . 2.04 110.71 167.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.6 t -112.71 139.91 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.673 -1.267 . . . . 0.96999999999999997 110.264 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.34 124.63 29.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.596 0.359 . . . . 4.7800000000000002 110.96 176.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -36.14 145.2 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.996 2.518 . . . . 1.75 115.039 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.4 t -163.22 140.19 5.78 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 121.427 -0.796 . . . . 2.7799999999999998 112.996 166.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -92.02 -8.9 2.75 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.276 3.317 . . . . 2.8100000000000001 112.56 167.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.05 -179.38 24.23 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.458 1.504 . . . . 1.4199999999999999 113.791 -169.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.49 -20.33 36.23 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 124.23 3.287 . . . . 1.27 114.58 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -113.17 162.95 15.37 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.176 1.39 . . . . 2.3799999999999999 113.855 172.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.9 -177.46 6.63 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.881 2.472 . . . . 0.57999999999999996 111.262 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.49 136.07 27.28 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.817 1.247 . . . . 0.81000000000000005 110.363 174.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.83 143.18 49.01 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.717 1.207 . . . . 0.55000000000000004 112.676 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -115.59 128.87 56.26 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.863 1.665 . . . . 2.4100000000000001 109.433 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.41 ' HA ' ' CA ' ' A' ' 6' ' ' GLY 0.27 3.7 pp -123.77 153.05 41.51 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.409 1.263 . . . . 2.23 114.409 176.529 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.9 m -86.85 129.14 35.0 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.666 -1.235 . . . . 1.7 107.666 161.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.66 117.87 35.61 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.981 1.312 . . . . 3.0699999999999998 108.87 -176.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -98.58 134.13 41.96 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.356 0.662 . . . . 3.77 110.655 175.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -121.58 96.91 47.23 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.131 0.973 . . . . 1.45 111.151 164.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.39 -3.28 9.36 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.332 2.688 . . . . 1.3700000000000001 114.44 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.81 161.86 23.9 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 119.95 1.25 . . . . 1.6000000000000001 111.957 -176.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.08 3.7 14.27 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 128.12 2.568 . . . . 3.02 112.803 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -118.39 153.59 51.84 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 128.037 2.535 . . . . 2.29 110.494 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.67 142.14 17.88 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.842 2.362 . . . . 0.91000000000000003 110.473 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.3 mt -104.99 148.42 26.75 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 122.974 1.369 . . . . 1.76 111.562 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.7 ttp-105 -139.31 103.13 4.66 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 111.835 -2.439 . . . . 2.3100000000000001 111.506 -176.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.8 tt -81.88 115.17 20.95 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 124.424 1.09 . . . . 2.46 109.404 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.6 m -103.13 -20.63 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.039 1.336 . . . . 0.90000000000000002 112.457 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.97 -175.47 27.93 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 126.105 1.812 . . . . 0.73999999999999999 113.028 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.42 -178.96 5.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.721 0.808 . . . . 0.68999999999999995 110.725 167.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -149.77 178.68 8.65 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.94 2.496 . . . . 4.6500000000000004 107.145 159.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -176.9 152.68 1.05 Allowed Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 127.364 2.266 . . . . 0.81999999999999995 107.838 -174.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.57 -11.23 30.64 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.407 2.071 . . . . 1.1000000000000001 113.779 170.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.06 47.12 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 114.237 1.199 . . . . 1.0 114.237 -175.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.76 152.65 11.83 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.429 1.892 . . . . 1.0700000000000001 109.145 164.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -101.3 -31.28 11.05 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.348 0.522 . . . . 4.5 111.857 167.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -113.73 133.71 55.19 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 126.283 1.833 . . . . 4.7300000000000004 108.66 168.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.4 p -139.56 127.29 25.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 124.752 1.221 . . . . 1.23 108.844 172.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -146.79 119.91 8.84 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.332 1.053 . . . . 3.5099999999999998 108.85 -163.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.401 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.6 pt? -83.3 136.84 34.23 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 123.442 1.591 . . . . 2.04 114.31 -177.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -120.78 154.09 36.16 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.333 2.253 . . . . 0.68000000000000005 111.307 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -92.05 160.39 15.25 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.742 1.217 . . . . 2.23 110.15 155.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.1 m -103.62 141.32 36.25 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 106.96 -1.496 . . . . 1.1299999999999999 106.96 150.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -140.35 166.03 25.81 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 122.474 1.13 . . . . 1.98 113.616 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.0 mtm -95.18 141.77 28.4 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.696 1.198 . . . . 5.1399999999999997 112.304 -176.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -142.25 153.32 43.86 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 115.409 1.633 . . . . 5.0899999999999999 115.409 168.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -87.5 146.25 25.89 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.97 1.308 . . . . 3.0499999999999998 108.808 146.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.2 m -130.61 -10.03 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 116.946 2.202 . . . . 3.5299999999999998 116.946 169.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -162.98 22.77 0.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.174 1.39 . . . . 3.7400000000000002 112.728 -167.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.93 4.15 46.88 Favored Glycine 0 N--CA 1.482 1.744 0 O-C-N 119.958 -1.714 . . . . 1.8899999999999999 112.767 -159.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -120.12 134.5 55.24 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 129.055 2.942 . . . . 2.5899999999999999 107.76 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -75.1 146.46 41.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.051 2.14 . . . . 4.8899999999999997 109.475 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.4 p -155.03 168.45 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 126.635 1.974 . . . . 2.5600000000000001 109.538 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.7 mmm -122.93 144.39 49.26 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.071 1.349 . . . . 3.6400000000000001 110.101 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.73 179.23 16.21 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.554 1.549 . . . . 0.70999999999999996 112.075 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ttm -142.11 141.55 32.71 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.798 1.639 . . . . 0.67000000000000004 108.693 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.21 134.84 10.96 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 125.705 1.602 . . . . 6.6900000000000004 109.006 -164.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.28 143.37 35.21 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 CA-C-N 121.537 1.585 . . . . 0.76000000000000001 110.36 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.8 m -129.02 152.81 79.93 Favored Pre-proline 0 N--CA 1.481 1.125 0 CA-C-O 118.617 -0.706 . . . . 0.83999999999999997 111.262 -173.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.25 -26.06 4.43 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.04 2.494 . . . . 0.73999999999999999 112.782 -165.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -176.83 166.08 2.51 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.065 1.346 . . . . 1.97 112.079 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.2 mt -117.2 150.89 37.99 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.596 1.958 . . . . 0.62 111.463 166.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -113.57 145.06 41.84 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.839 1.256 . . . . 2.0299999999999998 110.328 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.2 t -137.91 126.89 14.71 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 124.019 0.927 . . . . 0.87 110.638 162.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.35 166.4 25.57 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 124.027 3.151 . . . . 0.93000000000000005 111.893 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.69 148.14 92.32 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.259 2.64 . . . . 1.1200000000000001 114.176 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.289 19.1 mtmt 49.16 43.24 22.47 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.67 1.988 . . . . 2.7200000000000002 114.13 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.35 169.06 24.69 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 127.738 2.59 . . . . 1.78 111.587 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.51 135.18 19.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.395 0.678 . . . . 4.5599999999999996 110.834 175.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -151.45 137.41 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.39 1.476 . . . . 4.1699999999999999 109.092 -162.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.99 158.24 15.52 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.684 1.231 . . . . 2.96 113.611 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.88 -32.99 74.81 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.78 2.032 . . . . 3.5899999999999999 114.208 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt 99.18 130.49 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.415 0 C-N-CA 131.424 3.89 . . . . 3.6000000000000001 111.142 174.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.32 -5.12 10.58 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.704 2.936 . . . . 3.0099999999999998 115.584 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.4 -11.91 6.48 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-O 117.761 -1.577 . . . . 2.8900000000000001 115.168 167.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.13 -110.5 3.31 Favored Glycine 0 N--CA 1.474 1.177 0 CA-C-N 119.958 1.879 . . . . 1.8700000000000001 112.641 -172.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -73.16 145.61 46.22 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 122.035 -0.686 . . . . 2.0899999999999999 110.656 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.7 p-80 -163.92 153.11 14.05 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.814 -0.554 . . . . 0.60999999999999999 111.383 -177.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -80.43 131.81 35.64 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.441 -0.948 . . . . 1.79 108.441 164.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.9 tpt -84.55 129.63 34.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.056 -1.461 . . . . 0.73999999999999999 107.056 157.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.0 mp -107.49 131.22 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.087 -1.079 . . . . 0.55000000000000004 108.087 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mp -130.25 145.81 51.79 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.908 1.283 . . . . 1.52 110.138 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.8 40.82 93.81 Favored Glycine 0 CA--C 1.528 0.896 0 O-C-N 121.649 -0.657 . . . . 1.0800000000000001 111.494 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.68 145.98 32.45 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 122.909 1.337 . . . . 1.3300000000000001 113.689 175.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -101.8 -6.81 23.16 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.793 -1.548 . . . . 3.7400000000000002 112.396 -172.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -132.98 139.06 33.3 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.802 1.641 . . . . 5.2699999999999996 108.763 154.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -63.6 142.72 85.17 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 N-CA-C 107.285 -1.852 . . . . 2.0800000000000001 107.285 156.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.1 mt -104.76 95.96 6.24 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.584 1.554 . . . . 2.46 109.975 -157.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.69 135.55 36.57 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.26 1.024 . . . . 3.9399999999999999 111.293 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.51 106.49 0.66 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.954 1.302 . . . . 1.6499999999999999 110.462 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.02 -0.02 21.09 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.872 1.701 . . . . 1.6000000000000001 115.032 -170.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -81.11 -176.4 5.93 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.149 1.475 . . . . 2.21 112.346 169.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -141.7 138.92 32.77 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 129.422 3.089 . . . . 3.3100000000000001 106.249 -168.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 79.0 t -150.62 158.04 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 128.827 2.851 . . . . 1.27 108.805 -167.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -123.25 154.45 38.79 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.504 0.722 . . . . 4.1100000000000003 110.613 164.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.89 135.8 55.1 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.556 1.142 . . . . 1.9099999999999999 109.488 160.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.32 140.52 29.41 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.422 2.289 . . . . 2.3700000000000001 109.175 166.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.05 119.19 37.62 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.247 1.819 . . . . 1.1399999999999999 110.06 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.7 mt -90.25 105.28 17.7 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.479 1.112 . . . . 1.1299999999999999 109.594 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -99.78 144.05 29.3 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.075 1.35 . . . . 2.0099999999999998 111.036 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.05 123.58 10.82 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.552 1.141 . . . . 1.7 114.042 -168.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.45 72.71 0.88 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.782 1.182 . . . . 3.0899999999999999 112.816 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.17 19.81 77.59 Favored Glycine 0 N--CA 1.473 1.11 0 N-CA-C 116.013 1.165 . . . . 2.23 116.013 166.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -106.96 139.41 41.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.171 1.486 . . . . 4.6600000000000001 111.114 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.0 p -147.01 147.22 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.717 0.807 . . . . 2.3599999999999999 112.413 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 24.3 tp -156.69 175.78 13.6 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.204 2.602 . . . . 2.46 108.253 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -147.8 155.97 42.23 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.747 -1.221 . . . . 3.0299999999999998 113.169 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.6 t -140.2 157.78 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.635 1.574 . . . . 2.54 109.571 -175.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.2 t -95.63 145.04 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.619 1.968 . . . . 2.5499999999999998 110.993 -170.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mp -145.11 120.18 5.77 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 126.09 1.756 . . . . 2.6000000000000001 111.164 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.65 165.74 26.54 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.541 2.16 . . . . 0.95999999999999996 110.456 161.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.4 t -100.26 141.36 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 O-C-N 121.279 -0.888 . . . . 1.1699999999999999 111.231 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -122.42 146.22 47.56 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.045 2.138 . . . . 4.9699999999999998 111.197 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.24 105.4 12.4 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.547 -0.721 . . . . 2.4399999999999999 112.089 167.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 . . . . . 0 C--O 1.25 1.091 0 C-N-CA 129.715 3.206 . . . . 7.1699999999999999 108.299 170.117 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 . . . . . 0 CA--C 1.542 0.642 0 CA-C-O 122.365 1.079 . . . . 5.8099999999999996 110.353 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.74 179.93 33.11 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 124.654 1.121 . . . . 1.3999999999999999 113.232 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.8 p90 -156.69 153.55 28.65 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.035 0.754 . . . . 2.2400000000000002 113.035 169.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.1 t -100.53 136.69 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.388 0.675 . . . . 1.1200000000000001 109.331 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -72.56 109.2 6.05 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.755 0.822 . . . . 5.9000000000000004 109.962 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.35 134.54 8.85 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.408 1.483 . . . . 2.27 112.864 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.8 t -150.5 143.84 16.83 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 114.676 1.362 . . . . 2.75 114.676 167.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -86.58 -4.62 8.29 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.54 2.826 . . . . 2.77 112.052 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.46 -176.03 25.1 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.216 1.388 . . . . 1.52 114.129 -169.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.52 -14.55 30.68 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.267 3.312 . . . . 1.4099999999999999 114.362 -175.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -131.07 153.34 49.41 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.184 2.194 . . . . 2.46 114.308 -172.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.13 -176.12 5.73 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 127.628 2.371 . . . . 0.5 113.261 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.18 157.64 45.89 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.928 2.091 . . . . 0.57999999999999996 109.595 172.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.81 152.57 46.65 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.524 1.056 . . . . 0.55000000000000004 113.027 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -139.85 146.81 39.82 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.4 2.28 . . . . 2.3399999999999999 110.686 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -172.92 172.55 3.99 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.077 1.51 . . . . 2.2799999999999998 115.077 -170.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.24 143.03 39.24 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 129.323 3.049 . . . . 2.8999999999999999 110.569 -175.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.437 HD12 HG21 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -137.73 110.68 7.72 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.617 -0.512 . . . . 3.21 109.617 171.42 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -123.82 140.34 53.08 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.803 1.241 . . . . 3.4500000000000002 111.29 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -104.44 112.04 65.31 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.634 0.774 . . . . 1.4199999999999999 111.472 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -82.73 -19.53 6.05 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.948 2.432 . . . . 1.3400000000000001 114.276 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.35 -177.12 51.73 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 119.029 0.831 . . . . 1.1599999999999999 112.022 -174.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -107.79 0.86 22.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.375 1.87 . . . . 2.9900000000000002 111.764 -174.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -118.94 160.24 41.52 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 128.287 2.635 . . . . 2.0499999999999998 109.726 171.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.61 147.72 32.09 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.679 2.253 . . . . 1.1399999999999999 110.947 -176.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.9 mt -103.81 149.53 24.96 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 122.518 1.151 . . . . 1.7 110.943 173.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -133.8 106.9 7.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 112.348 -2.206 . . . . 2.4300000000000002 110.669 -176.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.508 HD21 ' CZ ' ' A' ' 84' ' ' PHE . 2.9 tt -81.25 115.67 20.76 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.253 1.021 . . . . 1.9099999999999999 108.652 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.17 -18.22 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.077 0.951 . . . . 0.80000000000000004 112.298 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.34 -173.95 27.41 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 126.059 1.79 . . . . 0.68999999999999995 112.701 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -143.94 -174.85 4.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.728 1.611 . . . . 0.71999999999999997 110.641 166.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.19 178.62 10.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.761 2.424 . . . . 5.0099999999999998 108.654 171.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -178.4 154.93 0.92 Allowed Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 127.03 2.132 . . . . 0.72999999999999998 107.939 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.16 -6.9 17.73 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.082 1.855 . . . . 0.72999999999999998 113.042 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.0 m -124.91 46.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 114.062 1.134 . . . . 0.84999999999999998 114.062 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.18 156.23 14.35 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.556 1.142 . . . . 0.95999999999999996 111.854 167.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -92.83 -26.25 17.76 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.525 1.93 . . . . 2.9300000000000002 112.816 170.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -143.24 140.29 30.62 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 129.378 3.071 . . . . 7.21 107.836 -168.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -157.2 59.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 125.101 2.381 . . . . 3.0299999999999998 111.954 -165.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.61 135.24 35.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 111.453 -2.612 . . . . 5.25 112.72 -162.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 31.9 tp -86.06 121.33 28.51 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.974 1.309 . . . . 1.3799999999999999 111.95 -165.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -123.38 153.86 39.77 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.363 1.465 . . . . 0.57999999999999996 113.771 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -98.83 173.26 6.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.692 1.997 . . . . 2.3500000000000001 111.673 163.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.2 m -152.64 143.76 23.12 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.398 1.879 . . . . 0.71999999999999997 107.889 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -156.94 167.23 31.08 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.554 0.946 . . . . 1.9399999999999999 113.554 -167.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.1 mtt -94.55 154.62 17.3 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.98 0.912 . . . . 5.7400000000000002 110.877 160.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.67 157.04 34.47 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.613 1.165 . . . . 4.6200000000000001 110.307 -173.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -103.25 139.67 38.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.684 1.193 . . . . 2.6600000000000001 110.81 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.4 t -136.76 125.87 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.063 -1.458 . . . . 2.27 107.063 162.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 60.79 22.29 12.32 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.672 1.589 . . . . 3.3300000000000001 114.162 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.08 8.45 87.4 Favored Glycine 0 CA--C 1.538 1.475 0 O-C-N 120.051 -1.656 . . . . 1.8200000000000001 113.861 -171.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -108.35 124.26 50.08 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 127.235 2.214 . . . . 3.1499999999999999 108.192 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.31 119.35 20.08 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.273 -1.33 . . . . 4.7000000000000002 110.198 -175.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.8 m -121.61 -178.6 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 128.313 2.645 . . . . 2.6299999999999999 109.975 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.7 mtm -125.89 162.55 24.93 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.84 1.256 . . . . 3.9399999999999999 111.142 174.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.43 176.75 32.92 Favored Glycine 0 N--CA 1.462 0.417 0 CA-C-O 121.774 0.652 . . . . 0.65000000000000002 113.361 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.0 ttm -159.44 137.11 10.03 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.598 1.959 . . . . 0.81000000000000005 108.969 -173.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -138.91 153.23 71.66 Favored Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 125.949 1.7 . . . . 7.75 109.399 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.62 152.21 25.8 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.923 1.749 . . . . 0.76000000000000001 109.501 170.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.57 151.84 75.23 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 124.128 0.971 . . . . 0.68000000000000005 110.621 -176.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.8 -25.99 5.91 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.166 2.577 . . . . 0.90000000000000002 112.882 -167.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -176.79 164.76 2.43 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.67 1.588 . . . . 2.46 111.602 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.2 mt -109.06 152.19 25.37 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.653 1.181 . . . . 0.90000000000000002 109.982 160.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -117.69 141.6 48.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.748 1.219 . . . . 1.8899999999999999 110.074 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.437 HG21 HD12 ' A' ' 22' ' ' LEU . 35.4 t -137.32 128.27 16.16 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 113.754 1.02 . . . . 0.95999999999999996 113.754 171.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.19 158.43 41.44 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.125 3.217 . . . . 1.0900000000000001 112.574 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.82 133.66 46.06 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.135 3.224 . . . . 1.1200000000000001 112.764 -175.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.14 -12.84 0.55 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 128.721 2.808 . . . . 1.6899999999999999 113.872 -175.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.48 166.42 51.0 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.719 1.628 . . . . 1.3500000000000001 113.116 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -122.53 146.02 47.79 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.715 1.606 . . . . 4.8399999999999999 111.785 172.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 69' ' ' VAL . 21.3 t -152.96 89.77 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 124.801 1.241 . . . . 4.0499999999999998 110.146 170.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.04 147.57 44.93 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.294 -0.867 . . . . 4.79 109.59 -172.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.74 127.25 31.04 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.276 1.036 . . . . 2.46 109.419 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.35 122.49 87.65 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 117.305 -1.331 . . . . 3.3199999999999998 109.979 -168.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -61.86 -10.62 17.88 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.747 2.964 . . . . 2.5600000000000001 114.618 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -125.92 0.39 7.78 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 117.355 -1.803 . . . . 2.2999999999999998 116.143 166.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.56 -20.4 1.24 Allowed Glycine 0 N--CA 1.481 1.676 0 CA-C-N 120.674 2.237 . . . . 1.97 118.483 -172.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -150.81 135.66 17.4 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.166 1.983 . . . . 2.3700000000000001 111.557 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -158.04 152.77 25.0 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.019 0.928 . . . . 0.64000000000000001 110.602 -173.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.508 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 92.0 m-85 -79.16 145.84 33.46 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.661 -0.866 . . . . 1.8799999999999999 108.661 161.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 tpt -106.64 124.14 49.17 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 126.73 2.012 . . . . 0.95999999999999996 108.627 168.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -107.48 133.43 51.97 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.807 1.643 . . . . 0.57999999999999996 109.462 -173.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.57 148.87 49.24 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.186 0.995 . . . . 2.1699999999999999 111.473 176.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.17 40.15 30.07 Favored Glycine 0 N--CA 1.468 0.823 0 C-N-CA 123.766 0.698 . . . . 0.87 113.539 169.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 pp -56.98 156.29 7.02 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 116.075 1.88 . . . . 1.71 116.075 -177.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -111.42 -19.8 12.46 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 112.298 -2.228 . . . . 1.8799999999999999 112.684 -170.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -145.59 136.55 12.45 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 128.102 2.561 . . . . 6.1100000000000003 108.004 165.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.43 137.33 39.32 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.212 2.608 . . . . 1.7 110.955 -176.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.73 84.74 2.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.992 2.117 . . . . 2.6400000000000001 110.055 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -86.36 169.81 12.59 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.467 1.507 . . . . 3.8999999999999999 111.629 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.93 112.62 3.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.814 -1.084 . . . . 1.6200000000000001 111.892 -175.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.31 0.18 28.08 Favored Glycine 0 CA--C 1.539 1.536 0 N-CA-C 117.188 1.635 . . . . 2.1000000000000001 117.188 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -92.14 180.0 5.42 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.777 1.289 . . . . 2.3199999999999998 113.756 -169.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.54 77.57 1.18 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.57 1.948 . . . . 5.4100000000000001 113.498 -162.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 77.0 t -95.22 127.73 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.66 -1.275 . . . . 1.29 111.979 -169.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -78.25 136.48 37.78 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.995 0.918 . . . . 2.4300000000000002 112.568 173.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.23 151.59 35.45 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.15 0.976 . . . . 1.8100000000000001 111.744 155.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -104.22 141.68 35.85 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.62 2.768 . . . . 2.23 107.933 160.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.02 130.95 54.57 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.852 1.261 . . . . 1.0 108.833 172.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.8 mt -100.68 111.02 23.19 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.131 0.973 . . . . 0.80000000000000004 109.593 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -98.77 141.3 31.74 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.104 1.361 . . . . 2.0299999999999998 110.863 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.47 125.94 7.53 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.753 1.621 . . . . 1.6799999999999999 112.729 -172.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.74 33.79 20.72 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.065 -0.853 . . . . 2.6099999999999999 114.026 -175.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.3 14.13 74.95 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 116.596 1.399 . . . . 2.9300000000000002 116.596 162.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -88.89 123.65 33.46 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.588 1.694 . . . . 3.4199999999999999 111.414 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.8 t -115.83 131.22 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 O-C-N 124.07 0.857 . . . . 2.5299999999999998 111.38 -173.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.5 tp -124.75 122.92 38.82 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.11 1.364 . . . . 2.4100000000000001 111.073 177.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.89 148.84 32.6 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.405 -0.81 . . . . 2.3199999999999998 112.305 171.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -146.66 157.61 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.642 1.577 . . . . 2.2599999999999998 109.29 163.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.8 t -104.97 136.84 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.118 1.367 . . . . 2.0099999999999998 109.696 173.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.9 mp -125.25 130.67 24.08 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.916 1.687 . . . . 2.73 110.762 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.68 138.71 38.74 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.004 1.803 . . . . 1.22 109.842 164.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.9 t -77.92 141.41 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 O-C-N 120.699 -1.251 . . . . 1.1899999999999999 108.485 162.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.53 -174.24 2.55 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.989 1.716 . . . . 6.96 113.45 -177.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -126.34 151.57 47.4 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.524 1.13 . . . . 2.5099999999999998 110.407 166.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.178 0 C-N-CA 129.637 3.175 . . . . 8.8200000000000003 109.936 -165.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.3 pm0 . . . . . 0 CA--C 1.537 0.448 0 CA-C-O 120.599 0.238 . . . . 7.1799999999999997 110.543 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.89 172.23 38.0 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 121.338 -0.851 . . . . 1.3200000000000001 113.337 159.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.9 p90 -155.8 153.28 29.57 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.112 1.365 . . . . 1.9099999999999999 112.234 164.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.38 139.94 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.16 -0.963 . . . . 1.0700000000000001 108.556 173.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -75.71 109.16 9.07 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.876 0.87 . . . . 4.7000000000000002 111.768 -178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -47.29 130.26 13.08 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.569 1.548 . . . . 2.8399999999999999 111.469 171.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -154.92 167.5 13.92 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 124.465 1.106 . . . . 2.29 113.51 162.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -94.39 -1.73 2.83 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 124.268 3.312 . . . . 2.1400000000000001 114.071 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.71 -168.02 26.36 Favored Glycine 0 CA--C 1.542 1.774 0 C-N-CA 124.788 1.185 . . . . 1.5 115.517 -167.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.79 -10.23 16.95 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 124.817 3.678 . . . . 1.3400000000000001 114.328 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -135.04 158.68 43.73 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.845 2.458 . . . . 2.4300000000000002 113.83 -170.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.82 -175.04 5.14 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.399 2.28 . . . . 0.66000000000000003 112.344 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.28 151.47 47.64 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.777 2.431 . . . . 0.82999999999999996 107.726 172.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.94 144.68 51.01 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.552 1.069 . . . . 0.78000000000000003 112.268 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.485 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 65.6 m-85 -124.21 143.24 50.63 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.439 1.896 . . . . 2.3399999999999999 110.661 -178.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -173.23 166.33 4.86 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.942 1.697 . . . . 3.1099999999999999 111.832 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 t -102.75 160.12 14.87 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.719 1.208 . . . . 2.7599999999999998 113.436 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.6 tp -129.69 129.26 44.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.491 1.517 . . . . 3.8700000000000001 109.808 169.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -117.61 142.48 47.16 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.11 0.564 . . . . 3.3399999999999999 109.809 157.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -94.84 110.46 49.73 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.162 0.985 . . . . 1.49 109.371 173.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -84.62 -9.12 9.2 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.287 2.658 . . . . 1.01 114.48 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.99 177.14 47.77 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 122.564 1.091 . . . . 1.2 113.101 -172.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -89.71 -6.5 56.02 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.614 1.165 . . . . 4.0999999999999996 112.043 174.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.69 160.17 45.47 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 127.63 2.372 . . . . 1.99 110.823 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -77.16 148.98 27.87 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.636 2.224 . . . . 1.02 111.476 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.7 mp -110.8 152.46 26.61 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.63 1.572 . . . . 2.5899999999999999 109.509 172.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -138.77 113.94 9.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 113.674 -1.603 . . . . 2.4100000000000001 109.574 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.3 tt -86.88 123.9 32.52 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.684 1.194 . . . . 1.9199999999999999 108.311 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.1 m -115.31 -14.65 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.413 1.085 . . . . 0.52000000000000002 111.994 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.15 -174.64 28.11 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 125.708 1.623 . . . . 0.54000000000000004 113.879 -174.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.418 ' HB2' ' CE1' ' A' ' 84' ' ' PHE . . . -149.42 -176.35 5.35 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.838 1.655 . . . . 0.72999999999999998 111.542 175.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -153.67 168.82 24.94 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.023 1.729 . . . . 6.2999999999999998 109.03 164.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 t -165.73 148.07 6.44 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 126.028 1.731 . . . . 0.83999999999999997 108.381 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.06 -0.22 9.73 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.597 2.198 . . . . 0.95999999999999996 113.232 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.67 43.46 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.651 1.58 . . . . 0.79000000000000004 113.656 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.02 135.3 5.32 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.368 1.067 . . . . 1.21 110.409 160.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -83.68 -26.41 29.86 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.508 1.123 . . . . 3.7200000000000002 113.219 174.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -108.64 132.2 54.14 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 108.074 -1.084 . . . . 4.7999999999999998 108.074 160.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -116.23 141.37 34.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.298 -1.001 . . . . 1.1399999999999999 108.298 150.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -132.6 153.43 51.05 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.397 1.879 . . . . 2.9199999999999999 108.461 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.4 tp -109.59 120.38 42.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.644 0.778 . . . . 1.1799999999999999 110.18 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -121.87 161.52 22.62 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.803 1.241 . . . . 0.62 112.753 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.51 160.63 29.04 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.149 -0.932 . . . . 3.5499999999999998 110.886 161.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.402 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 25.6 m -132.36 123.77 27.43 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.98 1.712 . . . . 1.1899999999999999 107.189 -175.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -113.72 170.61 8.13 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.121 1.768 . . . . 2.1699999999999999 112.522 -174.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 50.6 ttp -99.64 141.67 32.13 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.527 1.131 . . . . 3.1099999999999999 110.284 164.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -133.55 161.02 35.72 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.429 1.892 . . . . 4.8799999999999999 110.108 170.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -90.18 147.9 23.29 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.483 1.113 . . . . 2.4199999999999999 109.11 154.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.41 137.7 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.713 -1.217 . . . . 2.98 107.713 149.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.453 ' HB2' ' HE2' ' A' ' 56' ' ' LYS . 25.5 mt-10 61.9 9.8 3.19 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 115.921 1.823 . . . . 3.1400000000000001 115.921 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.0 5.95 59.39 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 124.657 1.122 . . . . 1.6399999999999999 115.194 -171.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 54' ' ' GLU . 44.9 pttt -121.91 134.23 54.86 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.409 2.284 . . . . 3.21 110.585 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -73.05 131.59 42.3 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.54 2.336 . . . . 4.1500000000000004 109.406 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 m -138.5 166.41 23.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 127.447 2.299 . . . . 2.1499999999999999 109.702 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -129.42 129.67 44.98 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.204 1.002 . . . . 3.1600000000000001 110.812 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.67 175.25 16.46 Favored Glycine 0 N--CA 1.467 0.748 0 C-N-CA 125.677 1.608 . . . . 0.78000000000000003 111.88 -176.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.7 ttm -139.13 156.8 46.88 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.225 1.41 . . . . 0.73999999999999999 110.077 -172.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -161.33 151.1 14.06 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.36 1.464 . . . . 6.5899999999999999 110.837 -175.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.33 153.49 45.37 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.17 1.913 . . . . 0.64000000000000001 110.607 172.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.3 m -137.5 153.04 74.1 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 124.683 1.193 . . . . 0.62 109.895 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -82.36 -28.36 1.9 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.866 2.378 . . . . 0.62 113.287 -166.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -175.25 167.19 3.42 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.497 1.519 . . . . 2.02 111.982 -176.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.2 mt -115.14 148.67 38.72 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.267 1.827 . . . . 0.75 110.418 165.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -115.06 138.91 50.34 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.74 1.216 . . . . 1.74 108.858 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.4 t -140.29 124.84 10.95 Favored Pre-proline 0 N--CA 1.471 0.578 0 N-CA-C 112.92 0.711 . . . . 0.81000000000000005 112.92 170.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.33 161.25 44.9 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.855 3.037 . . . . 0.95999999999999996 111.67 178.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -58.16 136.75 76.79 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.664 2.909 . . . . 0.95999999999999996 111.893 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.78 -9.05 1.14 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 127.363 2.265 . . . . 3.0299999999999998 113.099 -178.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.14 146.27 29.1 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.226 1.394 . . . . 1.21 113.142 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.36 140.44 45.94 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.747 2.019 . . . . 4.1100000000000003 109.529 171.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.8 t -145.89 123.85 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.451 1.9 . . . . 3.48 108.234 175.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -109.03 141.76 40.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.745 1.218 . . . . 5.1900000000000004 110.935 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -79.0 65.91 4.3 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.487 1.115 . . . . 2.0800000000000001 109.328 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.432 ' H ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -53.23 136.57 49.66 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-O 118.288 -0.863 . . . . 5.2800000000000002 112.149 -167.478 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.485 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 33.9 Cg_endo -62.75 -20.9 72.35 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.89 3.06 . . . . 2.3999999999999999 116.973 -158.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.76 -3.66 87.94 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-O 118.734 -1.036 . . . . 2.6099999999999999 115.093 173.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 48' ' ' THR . . . -129.5 -108.07 1.3 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.504 1.526 . . . . 1.8999999999999999 113.615 -174.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -71.87 142.66 49.56 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.745 -0.856 . . . . 2.1299999999999999 110.594 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -162.78 168.15 21.87 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.461 1.104 . . . . 0.54000000000000004 110.251 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.418 ' CE1' ' HB2' ' A' ' 35' ' ' ALA . 97.3 m-85 -93.79 147.26 23.22 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.468 -0.568 . . . . 2.04 109.468 163.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.8 tpt -102.32 136.53 41.99 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.887 1.275 . . . . 0.68000000000000005 109.67 166.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -117.72 128.03 54.49 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.179 1.391 . . . . 0.77000000000000002 109.264 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.67 145.35 50.61 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.036 0.934 . . . . 2.21 110.235 173.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.63 51.56 11.66 Favored Glycine 0 N--CA 1.469 0.872 0 O-C-N 121.701 -0.624 . . . . 0.81999999999999995 112.409 174.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.26 155.97 10.66 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 115.064 1.505 . . . . 1.5900000000000001 115.064 173.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.5 -7.13 12.84 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 113.973 -1.467 . . . . 2.7999999999999998 113.707 -176.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -139.93 168.61 14.35 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 128.22 2.608 . . . . 4.7300000000000004 108.775 166.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -58.7 160.92 16.14 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.578 1.519 . . . . 2.21 110.935 161.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.2 103.4 6.22 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.218 1.007 . . . . 2.79 110.147 161.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.5 mmtm -115.34 158.91 21.74 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.723 2.409 . . . . 6.7400000000000002 112.155 174.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.64 120.18 10.1 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.695 -0.854 . . . . 1.6299999999999999 108.695 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.53 -0.73 53.13 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.156 1.36 . . . . 1.3799999999999999 115.141 -174.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.42 -174.66 5.29 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.574 1.687 . . . . 2.8599999999999999 110.272 161.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -155.71 145.56 21.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.834 2.054 . . . . 3.2000000000000002 107.789 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.4 t -148.54 130.35 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 125.785 1.634 . . . . 1.0600000000000001 109.922 -163.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -79.05 138.82 38.15 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.868 -0.606 . . . . 3.3999999999999999 111.316 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -123.83 132.3 53.75 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.909 1.283 . . . . 3.0899999999999999 110.468 171.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.24 140.22 30.05 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.446 1.898 . . . . 2.4300000000000002 108.669 165.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -107.28 130.18 54.79 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.396 1.878 . . . . 1.04 107.926 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.8 mt -109.74 126.94 54.25 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.907 1.283 . . . . 0.98999999999999999 110.678 -176.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -119.97 151.76 38.47 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.484 1.114 . . . . 2.02 112.917 -171.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.43 151.57 19.75 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.283 1.033 . . . . 2.0600000000000001 112.798 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.18 16.87 75.42 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.884 -0.954 . . . . 3.4199999999999999 114.738 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.19 78.08 0.93 Allowed Glycine 0 CA--C 1.529 0.959 0 CA-C-N 118.876 1.338 . . . . 2.2599999999999998 113.461 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -152.23 141.09 21.05 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.516 2.726 . . . . 3.4700000000000002 110.872 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.3 t -138.76 147.88 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.959 1.704 . . . . 2.0 108.092 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 tt -150.56 116.83 5.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.924 0.889 . . . . 2.6499999999999999 110.598 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.44 122.06 37.76 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.905 0.705 . . . . 3.98 112.905 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -105.31 175.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 126.699 1.999 . . . . 2.2799999999999998 110.604 166.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.7 t -138.8 132.41 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.102 0.961 . . . . 1.9399999999999999 109.364 173.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -125.01 149.93 64.9 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.731 1.612 . . . . 3.02 109.703 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.18 159.09 48.65 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.334 2.023 . . . . 1.03 110.642 163.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 42.1 t -90.97 134.77 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.374 -1.713 . . . . 1.03 106.374 156.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -136.5 174.43 10.62 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.369 0.667 . . . . 3.8199999999999998 111.769 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.6 55.23 1.61 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.538 1.535 . . . . 2.4300000000000002 113.643 -170.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.143 1 C-N-CA 131.739 4.016 . . . . 7.4299999999999997 114.41 161.653 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 . . . . . 0 CA--C 1.54 0.585 0 CA-C-O 121.843 0.83 . . . . 4.4500000000000002 111.297 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.47 171.9 42.33 Favored Glycine 0 C--N 1.336 0.535 0 O-C-N 121.792 -0.568 . . . . 1.24 114.326 179.199 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -152.54 144.3 23.58 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.483 1.113 . . . . 1.9299999999999999 111.032 166.124 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.6 t -88.96 133.4 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 107.635 -1.246 . . . . 1.0800000000000001 107.635 175.185 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.84 115.23 27.92 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.145 0.578 . . . . 3.7599999999999998 109.629 -172.061 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -62.88 151.65 38.57 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.91 1.284 . . . . 2.1600000000000001 113.408 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.8 t -162.86 151.41 12.13 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.997 1.719 . . . . 2.48 110.207 164.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.1 -12.84 21.32 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.801 2.334 . . . . 2.0 112.647 166.806 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.85 138.86 18.0 Favored Glycine 0 CA--C 1.537 1.46 0 N-CA-C 110.125 -1.19 . . . . 2.5099999999999998 110.125 168.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.33 -26.98 20.04 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.048 2.499 . . . . 2.21 114.818 -167.049 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -84.16 138.58 32.92 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.992 1.269 . . . . 4.4400000000000004 110.829 171.75 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.76 -176.4 3.97 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.036 1.735 . . . . 0.59999999999999998 112.178 -166.403 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.72 149.36 37.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.921 1.288 . . . . 0.69999999999999996 109.71 175.523 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.35 152.9 47.53 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.248 1.023 . . . . 0.60999999999999999 113.627 -175.225 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -129.7 143.52 50.86 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.05 2.14 . . . . 2.5499999999999998 108.634 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.52 170.48 14.32 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.474 1.51 . . . . 2.52 111.827 -178.612 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.1 m -112.13 130.42 55.9 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 124.455 1.102 . . . . 2.1800000000000002 110.983 -166.759 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.83 123.0 47.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.418 1.487 . . . . 3.1000000000000001 107.744 168.137 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -126.95 134.0 50.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.993 -1.484 . . . . 4.5800000000000001 106.993 161.328 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -94.21 105.51 17.96 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.031 0.933 . . . . 2.0099999999999998 110.514 -176.502 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.14 -11.91 16.09 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.515 2.143 . . . . 1.9199999999999999 113.427 176.58 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.8 178.26 53.25 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 119.204 0.911 . . . . 1.76 111.782 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -107.24 -0.06 22.89 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 126.772 2.029 . . . . 3.5600000000000001 111.745 -173.117 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.8 157.99 66.95 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 128.301 2.641 . . . . 2.4300000000000002 109.353 175.26 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.69 159.75 41.97 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.369 2.046 . . . . 1.46 112.137 -170.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.1 mt -112.91 149.28 33.4 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.378 1.471 . . . . 1.8500000000000001 110.279 170.225 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.4 ttp-105 -128.92 110.8 12.41 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 112.989 -1.914 . . . . 2.7799999999999998 109.325 173.727 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.1 tp -94.4 114.5 26.55 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 126.097 1.759 . . . . 1.8700000000000001 108.891 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -114.11 -16.82 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.335 1.054 . . . . 0.56999999999999995 112.064 -169.65 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.93 -175.55 28.98 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.877 1.703 . . . . 0.46000000000000002 113.031 -176.072 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.74 -178.61 6.44 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.566 1.546 . . . . 0.5 110.845 173.708 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 -147.02 -179.25 6.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.978 1.711 . . . . 5.1900000000000004 109.245 156.691 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 t -170.83 148.49 2.61 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 127.316 2.246 . . . . 0.78000000000000003 107.806 174.626 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.54 -11.49 24.38 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.825 2.35 . . . . 0.79000000000000004 113.258 -178.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.9 m -110.89 58.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.502 1.521 . . . . 0.96999999999999997 110.883 172.479 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.57 172.02 16.08 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.944 1.697 . . . . 1.27 110.034 167.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -118.28 -21.41 8.14 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.937 0.895 . . . . 3.5600000000000001 111.844 159.457 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -143.17 150.79 39.88 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 126.15 1.78 . . . . 6.1200000000000001 108.439 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.39 148.17 20.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 C-N-CA 125.803 1.641 . . . . 1.1299999999999999 107.346 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -135.67 139.79 43.99 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.02 1.728 . . . . 4.0999999999999996 107.963 -167.052 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.7 tp -102.02 120.07 39.82 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 120.391 1.451 . . . . 1.25 110.942 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.401 ' CE1' ' HB2' ' A' ' 85' ' ' MET . 58.7 m170 -123.93 160.31 27.81 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.794 1.638 . . . . 0.69999999999999996 115.258 -174.397 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.402 ' CB ' ' CE1' ' A' ' 82' ' ' TYR . 15.4 pt-20 -103.66 146.9 27.89 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.791 2.436 . . . . 2.3599999999999999 111.24 158.151 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 100.0 m -107.15 148.57 28.68 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 106.323 -1.732 . . . . 0.85999999999999999 106.323 156.471 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -158.49 -179.49 8.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.639 1.176 . . . . 2.0600000000000001 112.671 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.3 mmt -107.78 143.38 36.41 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.055 1.342 . . . . 5.3300000000000001 114.002 -178.671 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.73 143.87 33.74 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.708 2.003 . . . . 6.0700000000000003 111.803 178.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -99.27 130.93 45.6 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.146 0.978 . . . . 3.3599999999999999 109.011 156.456 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.5 t -139.98 131.8 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 107.696 -1.224 . . . . 2.0499999999999998 107.696 172.193 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 59.81 20.92 9.78 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.03 1.732 . . . . 3.8100000000000001 114.552 -173.849 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.53 25.77 73.38 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.484 -1.385 . . . . 2.75 113.105 -168.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -118.65 123.91 46.12 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.014 1.726 . . . . 2.7400000000000002 108.248 173.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.616 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -73.72 121.85 21.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.037 1.735 . . . . 3.8999999999999999 110.793 170.02 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 m -145.64 156.58 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 128.096 2.558 . . . . 2.46 109.764 -172.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 37.8 mtp -95.73 146.27 24.65 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.289 -0.882 . . . . 3.7000000000000002 112.19 173.002 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.86 168.87 13.72 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.66 1.6 . . . . 0.70999999999999996 111.436 175.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.8 ttm -150.48 142.6 24.07 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.831 1.252 . . . . 0.79000000000000004 109.596 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.3 mtm180 -143.0 157.45 60.85 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 125.598 1.559 . . . . 5.6500000000000004 109.792 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.74 157.15 39.76 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.015 1.81 . . . . 0.88 111.243 163.105 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.6 m -138.7 153.41 72.2 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 126.032 1.733 . . . . 0.79000000000000004 109.402 176.234 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.56 -22.97 2.91 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.968 2.446 . . . . 0.73999999999999999 113.821 -163.585 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -179.74 165.6 1.3 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.711 1.604 . . . . 2.0299999999999998 111.899 -179.333 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -111.54 155.11 23.79 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.869 1.668 . . . . 0.93999999999999995 110.224 164.06 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -115.99 146.45 42.12 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.622 1.169 . . . . 2.2999999999999998 109.227 173.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.0 t -140.22 125.06 11.13 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 113.115 0.783 . . . . 1.4099999999999999 113.115 170.26 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.14 159.47 40.82 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.945 3.097 . . . . 1.52 112.049 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.07 138.1 65.62 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.921 3.08 . . . . 1.6899999999999999 112.607 -178.501 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.8 mptt 66.23 -6.58 0.47 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 128.264 2.626 . . . . 2.4500000000000002 114.122 -175.302 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.97 167.49 34.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.789 1.662 . . . . 1.52 112.65 176.257 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -132.91 157.93 43.87 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.164 0.985 . . . . 4.5700000000000003 113.526 175.665 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.3 t -145.59 138.75 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 127.95 2.5 . . . . 3.2999999999999998 107.129 172.72 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.1 134.4 34.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.296 -1.001 . . . . 4.0300000000000002 108.296 -173.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.76 162.0 27.26 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 125.177 1.391 . . . . 2.6899999999999999 111.379 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.33 154.1 13.98 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 119.884 -1.76 . . . . 4.2599999999999998 115.047 -178.052 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.59 -38.78 80.12 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 124.577 3.518 . . . . 2.4500000000000002 115.089 -174.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.05 9.84 6.34 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 119.203 -0.776 . . . . 1.6399999999999999 114.374 175.58 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.52 -132.85 1.4 Allowed Glycine 0 C--N 1.339 0.723 0 C-N-CA 124.909 1.242 . . . . 1.78 114.401 -176.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.402 ' CE1' ' CB ' ' A' ' 47' ' ' GLU . 3.5 m-30 -72.98 139.61 46.81 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 121.51 -0.994 . . . . 2.2000000000000002 111.483 -169.049 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 -161.19 157.8 26.38 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.093 1.357 . . . . 0.72999999999999998 111.986 -169.834 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.66 146.79 26.68 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.452 -0.78 . . . . 2.25 109.722 166.088 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.401 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 2.6 tpt -98.19 134.83 40.71 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.379 1.472 . . . . 0.67000000000000004 108.54 161.563 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -110.09 140.99 43.56 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.624 1.169 . . . . 0.73999999999999999 109.51 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.06 140.54 43.87 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.184 0.809 . . . . 2.02 113.184 -178.496 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.39 49.25 15.83 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.878 0.751 . . . . 0.90000000000000002 114.37 168.593 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.54 150.0 12.8 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 116.553 2.057 . . . . 1.5600000000000001 116.553 -177.084 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -103.53 2.22 33.27 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 113.509 -1.678 . . . . 2.1899999999999999 113.111 -174.247 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -151.38 151.12 28.46 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 127.573 2.349 . . . . 5.29 108.622 172.48 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -66.93 156.03 68.11 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 N-CA-C 108.307 -1.459 . . . . 2.1099999999999999 108.307 152.02 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 pp -151.4 155.25 38.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.032 1.733 . . . . 2.48 107.408 -175.521 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -138.72 156.53 47.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 123.451 1.595 . . . . 5.1799999999999997 114.111 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.6 121.0 11.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.143 -0.935 . . . . 1.5900000000000001 109.444 173.287 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.55 49.69 1.38 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.885 1.231 . . . . 1.5900000000000001 112.45 -167.849 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -148.8 -175.04 4.79 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 129.781 3.232 . . . . 2.4300000000000002 109.339 175.329 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -144.61 140.61 28.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.464 2.305 . . . . 4.0300000000000002 106.69 179.193 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.7 t -142.61 139.74 28.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 126.289 1.836 . . . . 1.01 109.349 -170.632 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.403 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 21.9 mt-10 -78.72 144.26 35.44 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.075 0.55 . . . . 2.6299999999999999 111.683 177.075 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.38 139.57 50.7 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.89 0.852 . . . . 1.6799999999999999 110.104 150.579 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.85 152.21 19.05 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.507 1.523 . . . . 2.1099999999999999 108.982 162.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 mp -122.01 130.94 53.72 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.812 1.645 . . . . 1.04 109.253 -176.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.5 mt -110.44 118.29 35.87 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.792 1.237 . . . . 0.79000000000000004 110.408 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -114.58 160.45 19.26 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.967 1.307 . . . . 2.4199999999999999 111.287 -178.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.14 146.45 50.51 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.513 -0.742 . . . . 1.8799999999999999 111.844 167.528 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.98 23.95 28.64 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.185 0.898 . . . . 3.1699999999999999 115.041 176.636 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.04 6.6 83.03 Favored Glycine 0 N--CA 1.478 1.438 0 CA-C-N 118.479 1.14 . . . . 2.2999999999999998 113.592 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -79.97 115.4 19.53 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.247 1.019 . . . . 3.2200000000000002 111.398 -177.485 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.41 145.17 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.282 1.433 . . . . 2.2999999999999998 109.523 165.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.8 tp -143.23 175.4 9.92 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.916 1.686 . . . . 2.48 109.334 175.058 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.403 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 0.8 OUTLIER -155.4 156.71 35.85 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.358 0.873 . . . . 2.23 113.358 170.994 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.9 t -144.08 162.52 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.681 1.992 . . . . 2.25 108.398 179.363 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.7 t -118.24 144.41 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.104 1.362 . . . . 1.6599999999999999 108.647 -179.326 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.82 142.13 14.59 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.2 1.0 . . . . 2.1699999999999999 112.441 -168.68 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.63 156.43 65.69 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.934 3.089 . . . . 0.71999999999999997 113.242 179.587 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.14 118.32 39.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.301 -0.999 . . . . 0.84999999999999998 108.301 167.585 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -109.92 -178.74 3.61 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.286 1.035 . . . . 4.1799999999999997 110.719 168.534 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.01 179.91 7.41 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 117.059 2.244 . . . . 3.29 117.059 -156.569 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.872 0 CA-C-O 116.62 -1.657 . . . . 9.4299999999999997 112.623 172.179 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 107.341 -1.355 . . . . 4.5099999999999998 107.341 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.38 173.24 32.51 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 119.526 1.057 . . . . 1.53 113.04 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.42 ' HE1' ' CB ' ' A' ' 118' ' ' GLU . 3.4 t-105 -156.87 161.05 39.69 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.835 1.654 . . . . 7.4299999999999997 111.651 178.428 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.2 t -130.48 132.53 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.127 1.371 . . . . 1.29 109.053 173.026 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -91.2 112.96 25.09 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.354 0.597 . . . . 4.9900000000000002 110.467 -174.637 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -57.76 147.13 28.99 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.952 2.101 . . . . 3.2999999999999998 114.133 179.437 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 t -162.67 150.82 11.88 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.344 1.458 . . . . 2.6800000000000002 109.641 162.395 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -83.81 45.98 1.92 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.013 3.142 . . . . 2.4100000000000001 111.188 171.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -124.25 167.92 16.48 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.481 1.515 . . . . 1.3 113.855 -174.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.72 -20.77 22.53 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.715 2.943 . . . . 1.1799999999999999 114.064 -177.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.3 152.24 48.32 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.55 1.54 . . . . 3.0699999999999998 113.467 -176.236 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.47 -174.37 4.58 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.689 1.996 . . . . 0.65000000000000002 112.31 -171.324 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.02 136.08 43.81 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.657 1.583 . . . . 0.81000000000000005 109.329 172.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.26 123.99 46.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.612 1.565 . . . . 0.84999999999999998 111.627 -176.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -106.02 65.48 0.7 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.853 1.661 . . . . 2.7999999999999998 109.397 -173.377 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp -73.29 148.71 43.31 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.189 -0.944 . . . . 2.1400000000000001 113.239 -170.082 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.5 t -83.23 139.63 33.0 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.102 -0.999 . . . . 3.5699999999999998 110.347 168.82 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.83 131.44 56.83 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.728 1.611 . . . . 2.9399999999999999 107.942 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -120.56 131.31 54.6 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.173 1.389 . . . . 4.2699999999999996 109.656 173.32 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -107.38 100.36 33.22 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.993 -0.743 . . . . 1.51 108.993 161.116 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.98 -9.26 15.54 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.027 2.484 . . . . 1.3799999999999999 113.393 174.702 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.69 -179.51 51.31 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 122.433 1.019 . . . . 1.21 113.033 -175.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -106.35 -3.51 21.03 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 127.776 2.431 . . . . 2.9900000000000002 111.717 -172.532 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -119.25 159.18 46.35 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 127.89 2.476 . . . . 1.8700000000000001 110.202 172.775 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.75 146.11 20.77 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.741 2.294 . . . . 0.96999999999999997 111.167 -175.078 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mp -103.93 153.49 20.74 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.532 1.133 . . . . 2.7200000000000002 110.711 173.77 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.69 112.66 12.74 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.098 1.359 . . . . 3.2000000000000002 110.0 178.603 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.9 tp -91.98 113.28 25.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.762 1.625 . . . . 1.75 108.86 -177.186 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.5 m -111.41 -15.55 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.855 1.262 . . . . 0.76000000000000001 111.668 -170.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.59 -178.17 31.39 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.916 1.722 . . . . 0.71999999999999997 113.694 -176.723 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.05 -179.61 8.31 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.886 1.674 . . . . 0.77000000000000002 112.41 168.303 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -157.34 152.56 26.1 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.331 2.252 . . . . 5.6500000000000004 108.532 177.872 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -159.74 150.21 15.44 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 117.837 -1.077 . . . . 1.01 110.936 177.868 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.96 0.08 7.71 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.393 3.395 . . . . 1.27 113.66 174.034 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.2 m -116.32 49.86 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.979 1.312 . . . . 1.77 110.791 166.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.75 164.65 35.65 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.398 1.094 . . . . 1.1299999999999999 112.012 161.194 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -104.05 -30.62 10.15 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 127.648 2.379 . . . . 4.1200000000000001 111.371 163.612 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 -149.55 140.03 22.43 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.751 1.62 . . . . 5.6900000000000004 109.459 172.226 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 p -100.05 167.34 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.028 1.331 . . . . 1.6799999999999999 109.204 174.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.79 150.76 35.96 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.8 2.04 . . . . 4.2999999999999998 108.069 176.464 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.5 tp -120.8 114.67 21.96 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.572 1.078 . . . . 1.1599999999999999 111.258 -172.056 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -122.77 157.36 32.54 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 115.091 1.515 . . . . 0.71999999999999997 115.091 -170.926 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.74 -178.6 4.3 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.129 2.171 . . . . 3.0499999999999998 111.75 158.434 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.7 m -145.34 148.41 33.37 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 107.904 -1.147 . . . . 0.79000000000000004 107.904 162.248 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -152.08 167.56 28.08 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 123.193 1.473 . . . . 2.3799999999999999 114.802 -170.694 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.6 ttp -100.81 140.62 34.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.398 1.479 . . . . 3.25 110.745 172.867 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.79 176.01 10.2 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.599 1.56 . . . . 6.8099999999999996 112.063 178.1 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -146.15 133.48 20.65 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.076 1.751 . . . . 2.1699999999999999 106.743 -179.345 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 m -149.84 135.86 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.784 1.634 . . . . 2.6800000000000002 107.447 -169.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 60.88 12.41 3.83 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.734 1.614 . . . . 4.3200000000000003 114.19 -172.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.9 20.69 55.19 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.096 0.855 . . . . 1.7 114.302 -171.801 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -132.83 135.5 45.68 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.935 1.294 . . . . 4.4400000000000004 111.216 174.519 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -71.19 143.92 50.32 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.021 2.528 . . . . 4.2000000000000002 110.904 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.1 p -156.7 172.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 126.666 1.986 . . . . 2.3900000000000001 109.932 -172.567 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 64.1 mtt -114.0 153.22 29.73 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.077 0.951 . . . . 2.71 111.158 167.076 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.21 175.02 20.05 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 126.427 1.965 . . . . 0.68000000000000005 111.766 176.761 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 ttm -150.17 146.01 26.62 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.631 1.573 . . . . 0.80000000000000004 109.368 174.84 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.57 146.86 23.4 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 124.364 1.066 . . . . 5.6399999999999997 111.109 -169.404 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -78.43 153.57 27.37 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.032 1.821 . . . . 0.82999999999999996 111.515 171.904 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.1 m -140.77 152.03 64.61 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 125.843 1.657 . . . . 0.76000000000000001 110.777 -175.148 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.74 -23.85 6.59 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.546 2.831 . . . . 0.71999999999999997 113.504 -167.057 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -178.29 163.54 1.64 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.68 1.992 . . . . 1.9399999999999999 110.442 179.487 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.6 mt -110.25 157.16 19.75 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.211 1.404 . . . . 0.64000000000000001 110.057 164.202 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -118.58 146.64 44.45 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.084 0.954 . . . . 2.3300000000000001 110.32 168.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.78 128.98 17.14 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.489 0.716 . . . . 1.1000000000000001 110.982 172.051 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -71.42 165.03 33.74 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.107 3.205 . . . . 1.29 112.318 -176.673 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.31 141.68 96.36 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.637 2.891 . . . . 1.3200000000000001 112.733 178.304 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt 66.05 0.64 1.67 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.554 1.942 . . . . 2.1699999999999999 113.592 -176.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.51 126.81 7.64 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.587 1.565 . . . . 1.6000000000000001 113.881 -174.368 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -88.31 123.13 32.59 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.886 1.274 . . . . 6.4900000000000002 107.642 156.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.7 t -149.65 98.07 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.892 0.877 . . . . 3.4500000000000002 109.614 175.702 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 0.8 OUTLIER -75.54 142.46 42.78 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.865 -0.522 . . . . 3.02 110.751 -177.068 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -65.16 95.39 0.18 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.248 -1.389 . . . . 2.3700000000000001 107.248 159.083 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.98 150.45 37.44 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.529 1.132 . . . . 4.0 113.93 -164.014 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.25 142.62 92.16 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.791 2.328 . . . . 3.3500000000000001 110.187 174.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.73 -2.73 85.46 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-O 118.709 -1.05 . . . . 1.51 114.163 -168.556 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.78 -127.69 1.36 Allowed Glycine 0 C--N 1.34 0.759 0 CA-C-N 118.892 1.346 . . . . 1.6599999999999999 113.114 172.322 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -72.99 140.54 47.42 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.655 -0.909 . . . . 2.1499999999999999 112.695 -164.335 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -163.54 158.97 21.4 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.284 1.034 . . . . 0.81999999999999995 113.405 -176.138 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -87.11 136.65 32.85 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.853 -0.529 . . . . 2.0 110.678 166.063 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.2 tpt -84.06 138.76 32.9 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.488 1.115 . . . . 0.67000000000000004 108.496 159.573 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -117.84 134.77 54.6 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.099 1.36 . . . . 0.65000000000000002 108.63 179.312 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 mp -132.86 137.43 46.7 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 122.991 0.516 . . . . 1.74 111.918 177.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.64 47.74 7.72 Favored Glycine 0 N--CA 1.467 0.709 0 C-N-CA 125.208 1.385 . . . . 0.81000000000000005 113.162 171.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.51 147.37 14.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.634 1.716 . . . . 1.3300000000000001 115.634 -177.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -104.04 -3.79 24.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.937 -1.483 . . . . 2.52 113.907 -172.116 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -149.24 139.23 13.2 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.331 1.453 . . . . 5.3799999999999999 112.021 171.937 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.75 135.08 15.6 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.526 2.818 . . . . 2.2400000000000002 109.651 173.374 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.7 mp -93.59 -167.94 1.8 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.032 1.333 . . . . 3.8199999999999998 110.789 -168.96 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -134.13 172.74 12.42 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 127.478 2.311 . . . . 3.9900000000000002 108.843 164.458 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.51 129.31 34.43 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 118.113 -1.435 . . . . 1.23 107.871 138.476 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.93 58.64 1.23 Allowed Glycine 0 CA--C 1.528 0.846 0 O-C-N 124.301 1.001 . . . . 1.3600000000000001 111.654 -168.298 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -141.37 175.73 9.42 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.323 1.449 . . . . 2.9900000000000002 111.317 161.774 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.28 87.41 1.96 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.906 2.482 . . . . 3.3999999999999999 109.827 -170.25 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 91.2 t -113.18 144.29 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 120.586 -1.321 . . . . 1.5 112.119 -156.71 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -79.0 141.35 37.55 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.999 1.111 . . . . 2.5899999999999999 113.999 -167.6 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.426 HD23 HD12 ' A' ' 115' ' ' LEU . 2.6 mm? -125.11 143.5 50.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.565 1.546 . . . . 2.6699999999999999 108.834 159.549 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -114.5 123.02 48.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.345 2.258 . . . . 2.1800000000000002 107.899 172.657 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.3 mp -98.69 127.25 44.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.665 1.986 . . . . 1.48 109.931 -169.054 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.7 mt -104.96 112.61 25.81 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.437 1.113 . . . . 0.65000000000000002 110.612 -178.264 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -101.02 154.88 18.33 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.789 1.236 . . . . 2.04 110.508 178.101 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.25 141.34 14.99 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.443 -0.798 . . . . 1.7 110.771 170.019 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.52 -1.19 81.47 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.693 -1.06 . . . . 3.0499999999999998 114.399 -171.642 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.57 13.08 61.83 Favored Glycine 0 N--CA 1.473 1.106 0 CA-C-N 119.038 1.419 . . . . 3.2799999999999998 114.361 173.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.57 134.82 38.16 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.948 -1.325 . . . . 5.9400000000000004 111.047 -179.101 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -113.22 140.6 32.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 126.228 1.811 . . . . 2.29 110.191 172.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.1 tp -145.64 126.68 14.61 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.496 1.119 . . . . 2.1000000000000001 110.921 176.637 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -85.8 139.41 31.32 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.043 0.757 . . . . 1.98 113.043 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.01 161.93 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 127.67 2.388 . . . . 2.3199999999999998 110.847 164.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 83.7 t -121.53 135.62 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.585 1.154 . . . . 1.6299999999999999 108.824 174.171 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.426 HD12 HD23 ' A' ' 101' ' ' LEU . 47.2 mt -131.41 132.32 23.49 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.886 1.275 . . . . 2.0899999999999999 110.972 -169.552 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -57.19 141.82 94.46 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 124.168 3.245 . . . . 1.8200000000000001 114.75 172.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.6 t -114.14 128.9 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.685 1.194 . . . . 1.1899999999999999 111.603 175.297 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.42 ' CB ' ' HE1' ' A' ' 7' ' ' TRP . 4.2 tt0 -156.72 163.64 39.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.92 1.688 . . . . 3.6200000000000001 112.147 -179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.05 104.72 16.69 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.27 1.028 . . . . 2.75 110.43 176.526 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 . . . . . 0 C--O 1.247 0.922 0 C-N-CA 126.093 1.757 . . . . 9.9199999999999999 108.033 178.493 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 109.277 -0.638 . . . . 6.96 109.277 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -131.19 -175.24 13.93 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.445 1.974 . . . . 1.0 111.116 176.802 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.5 p90 -135.27 -178.49 5.13 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.231 1.515 . . . . 1.9099999999999999 113.402 -168.153 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.72 152.25 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 126.774 2.03 . . . . 2.1099999999999999 112.114 -178.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 -71.77 -26.41 62.42 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 116.11 1.893 . . . . 5.3700000000000001 116.11 -174.433 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.0 t80 71.75 157.05 0.17 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.066 2.547 . . . . 1.98 111.978 -160.434 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -155.53 149.04 18.66 Favored Pre-proline 0 CA--C 1.538 0.488 0 O-C-N 121.535 -0.728 . . . . 2.4900000000000002 111.217 162.87 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -85.7 -2.67 9.07 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.649 2.899 . . . . 2.0099999999999998 112.018 167.182 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -121.01 -179.99 16.22 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.672 1.606 . . . . 1.0900000000000001 114.065 -175.099 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.56 -18.1 48.65 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.439 3.426 . . . . 1.23 113.986 -174.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -114.61 137.77 51.47 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.055 2.142 . . . . 2.1499999999999999 113.863 -178.677 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.28 -177.26 5.38 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.79 2.436 . . . . 0.5 111.738 -172.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.38 149.24 30.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.143 1.377 . . . . 0.65000000000000002 110.862 178.763 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.18 147.21 51.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.893 1.277 . . . . 0.57999999999999996 113.832 -174.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -128.32 43.11 3.2 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 127.424 2.29 . . . . 2.9900000000000002 114.703 -168.622 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -73.0 150.58 42.33 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 119.569 -1.957 . . . . 2.8300000000000001 115.598 -168.16 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 m -96.27 149.4 21.71 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.831 1.653 . . . . 1.8600000000000001 109.16 173.183 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.47 166.47 33.44 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.671 1.589 . . . . 2.8300000000000001 112.153 -176.433 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -128.79 140.97 51.46 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.91 2.084 . . . . 4.2400000000000002 112.334 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -96.52 99.57 5.72 Favored Pre-proline 0 CA--C 1.542 0.667 0 O-C-N 121.478 -0.764 . . . . 1.6000000000000001 109.354 158.929 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.65 -12.11 12.52 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.493 2.128 . . . . 1.27 113.71 176.136 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.78 178.35 53.71 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-O 122.552 1.084 . . . . 1.21 112.936 -175.749 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -104.75 0.91 28.73 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.87 2.468 . . . . 2.9300000000000002 112.318 -173.689 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mp -125.48 160.8 53.84 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 127.767 2.427 . . . . 4.0199999999999996 108.798 174.079 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.65 155.75 21.1 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.231 1.954 . . . . 0.98999999999999999 111.732 -167.689 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.75 147.76 28.23 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.88 1.272 . . . . 2.3199999999999998 110.224 170.587 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.0 ttp180 -136.64 103.92 5.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.016 -1.902 . . . . 3.9199999999999999 109.297 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.548 HD21 ' CZ ' ' A' ' 84' ' ' PHE . 6.5 tt -84.85 110.05 18.55 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.478 1.911 . . . . 2.1699999999999999 108.847 -175.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.9 m -106.34 -20.88 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.764 1.226 . . . . 0.46999999999999997 111.932 -174.515 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.48 -175.76 31.83 Favored Glycine 0 C--N 1.343 0.947 0 C-N-CA 125.004 1.287 . . . . 0.42999999999999999 114.13 -173.516 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.43 -177.28 5.98 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.754 2.021 . . . . 0.47999999999999998 111.0 173.383 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.412 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 11.5 mtt180 -157.95 170.78 21.55 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.89 2.476 . . . . 4.7599999999999998 107.626 171.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 t -173.44 149.74 1.71 Allowed Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 125.294 1.438 . . . . 0.57999999999999996 110.364 174.292 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.54 -8.12 21.28 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.773 2.316 . . . . 0.71999999999999997 114.037 172.648 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.3 m -118.87 49.39 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.545 1.138 . . . . 0.72999999999999998 113.295 174.721 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.23 151.34 17.39 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.643 1.177 . . . . 0.87 110.704 161.515 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -95.7 -30.77 13.56 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.382 1.473 . . . . 3.3500000000000001 111.948 169.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.6 mtp-105 -133.08 141.15 48.05 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.693 1.597 . . . . 5.1100000000000003 108.915 171.5 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -125.3 148.6 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.157 1.383 . . . . 1.1499999999999999 109.558 168.652 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -137.45 151.46 48.52 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.649 1.98 . . . . 2.8700000000000001 109.736 178.315 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.8 tp -104.61 118.51 36.75 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.492 0.717 . . . . 1.0700000000000001 110.56 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -124.53 148.87 47.5 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 123.084 1.421 . . . . 0.58999999999999997 113.914 -174.506 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -89.08 176.38 7.01 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 113.889 -1.505 . . . . 2.46 111.521 162.74 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 64.9 m -155.01 136.47 14.18 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 105.457 -2.053 . . . . 0.80000000000000004 105.457 175.175 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -149.43 161.52 41.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 122.952 1.358 . . . . 2.0099999999999998 114.184 -166.771 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -87.41 136.22 33.03 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.333 -1.303 . . . . 3.6099999999999999 110.588 172.705 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.01 143.22 20.28 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.204 1.002 . . . . 4.9299999999999997 113.699 -177.501 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.55 130.9 36.54 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 125.655 1.582 . . . . 3.0699999999999998 111.63 172.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.5 t -141.45 134.8 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 126.066 1.746 . . . . 2.1299999999999999 107.274 169.733 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 65.9 16.76 10.61 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.645 1.178 . . . . 3.9199999999999999 113.352 -176.424 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.24 21.05 68.27 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 121.188 -0.945 . . . . 1.51 113.396 -171.64 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -138.86 133.33 31.84 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.169 1.787 . . . . 3.29 109.717 -170.144 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.405 ' H ' ' HG2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -76.31 117.09 17.62 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.109 1.364 . . . . 4.1399999999999997 113.506 -178.641 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -117.14 174.06 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 128.669 2.787 . . . . 2.1499999999999999 109.103 170.489 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.41 130.34 56.42 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.946 0.898 . . . . 3.1600000000000001 109.901 177.422 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.31 172.91 15.01 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.573 1.083 . . . . 0.52000000000000002 113.286 -179.328 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ttm -148.78 143.07 26.13 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.573 1.549 . . . . 0.66000000000000003 109.765 177.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -144.92 152.19 51.12 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.369 1.868 . . . . 7.6200000000000001 109.143 -176.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -80.83 150.71 18.59 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.593 2.195 . . . . 0.59999999999999998 110.206 170.374 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.24 155.49 80.84 Favored Pre-proline 0 N--CA 1.48 1.05 0 C-N-CA 124.496 1.119 . . . . 0.66000000000000003 110.379 -177.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.76 -30.04 2.53 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.746 2.297 . . . . 0.56999999999999995 112.713 -170.72 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -176.2 164.73 2.76 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.735 1.614 . . . . 2.1000000000000001 112.042 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.5 mt -109.03 158.73 17.45 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.04 1.336 . . . . 0.69999999999999996 109.282 161.391 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -139.74 144.66 37.57 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.96 0.904 . . . . 2.21 111.242 174.707 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.2 t -146.74 140.1 14.82 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.447 1.099 . . . . 1.5 112.323 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.64 170.62 8.15 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 124.417 3.411 . . . . 1.4399999999999999 114.092 176.734 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.96 150.12 80.12 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.616 3.544 . . . . 1.1799999999999999 113.774 171.788 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt 68.49 -7.24 0.72 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.912 2.085 . . . . 1.96 115.085 176.252 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.81 149.34 32.95 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.438 1.018 . . . . 1.2 112.683 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 mtt-85 -86.8 162.03 18.03 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 122.003 -0.704 . . . . 6.3099999999999996 110.155 161.388 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.1 150.44 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.054 1.741 . . . . 4.04 108.724 172.518 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.75 137.9 30.1 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.945 0.898 . . . . 3.29 110.344 161.578 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -78.54 80.72 4.91 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 122.283 1.04 . . . . 2.0099999999999998 108.336 170.203 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.404 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -59.39 136.57 88.9 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 115.403 -0.817 . . . . 3.2799999999999998 112.908 -177.083 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -60.84 -25.62 81.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.236 2.624 . . . . 2.0699999999999998 112.553 176.284 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.7 9.66 28.68 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 117.652 -1.638 . . . . 1.8700000000000001 114.722 174.23 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.65 -10.55 0.03 OUTLIER Glycine 0 C--N 1.346 1.107 0 N-CA-C 121.56 3.384 . . . . 2.1299999999999999 121.56 167.467 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -143.99 145.3 32.13 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 121.124 2.462 . . . . 2.02 112.843 172.195 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -158.68 152.0 22.82 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.599 0.76 . . . . 0.56000000000000005 110.816 175.66 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.548 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 61.9 m-85 -78.7 141.56 37.81 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.418 -0.956 . . . . 1.6499999999999999 108.418 160.062 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.0 tpt -99.42 130.23 45.67 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.399 1.88 . . . . 0.60999999999999999 108.489 168.67 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.9 mp -111.61 139.61 46.9 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.47 1.508 . . . . 0.55000000000000004 108.357 -179.262 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.2 mp -137.82 143.73 41.15 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.418 1.087 . . . . 1.52 109.576 175.655 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.91 42.42 45.32 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.957 -0.457 . . . . 1.0 111.957 -178.542 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.35 141.9 28.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 122.865 1.317 . . . . 1.3400000000000001 113.342 170.837 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -100.65 0.78 39.8 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.084 -1.416 . . . . 2.3900000000000001 113.05 -171.334 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -123.86 146.63 51.32 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 126.959 2.104 . . . . 5.1500000000000004 107.821 167.013 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -62.34 120.27 7.74 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 N-CA-C 105.166 -2.667 . . . . 1.6799999999999999 105.166 149.472 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 tp -76.79 79.95 3.4 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 122.177 0.989 . . . . 2.5 111.387 -157.077 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . 0.268 5.6 tmtt? -64.74 114.5 4.5 Favored 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 120.368 -1.458 . . . . 6.1799999999999997 110.949 -169.334 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.71 114.83 1.25 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.216 1.406 . . . . 1.6899999999999999 111.443 170.483 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.67 44.81 6.3 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.201 1.381 . . . . 1.6000000000000001 112.699 -169.783 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -101.3 -177.22 3.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.919 1.688 . . . . 3.0099999999999998 109.209 145.219 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -130.68 125.5 34.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 129.328 3.051 . . . . 3.8900000000000001 103.91 178.064 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.9 t -128.66 122.25 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.381 1.873 . . . . 1.01 108.985 -171.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -81.8 146.66 29.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.933 0.873 . . . . 2.25 112.582 171.133 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.77 138.03 54.22 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.665 1.586 . . . . 1.6499999999999999 109.77 163.433 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 14.5 m-20 -78.32 149.0 33.55 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.343 1.857 . . . . 2.71 108.125 158.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.2 mp -127.16 132.59 50.48 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.667 1.587 . . . . 1.0 108.482 175.682 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.5 mt -105.95 118.43 36.58 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.806 1.242 . . . . 0.68999999999999995 109.456 -175.258 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -116.55 118.23 32.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.422 1.489 . . . . 1.9199999999999999 111.786 -172.671 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.86 20.84 1.75 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.5 1.92 . . . . 2.8300000000000001 114.277 176.621 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.28 -61.73 4.13 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.208 1.385 . . . . 4.4199999999999999 112.286 -167.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.94 4.68 60.74 Favored Glycine 0 N--CA 1.474 1.21 0 N-CA-C 117.089 1.596 . . . . 2.04 117.089 -166.193 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -131.99 140.06 48.83 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.481 1.64 . . . . 3.4500000000000002 112.178 175.333 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.17 146.88 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.361 1.464 . . . . 2.1000000000000001 109.334 171.767 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 tt -150.7 160.88 43.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.91 2.484 . . . . 1.96 107.593 176.545 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -144.89 152.94 41.03 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.027 1.285 . . . . 1.76 114.436 175.984 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.51 157.79 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.416 1.486 . . . . 2.2799999999999998 109.409 -174.4 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 66.6 t -87.39 161.76 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.951 1.3 . . . . 1.8100000000000001 109.127 175.626 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.25 140.08 11.42 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 126.239 1.816 . . . . 2.4399999999999999 110.223 164.168 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.97 146.2 64.31 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.247 2.632 . . . . 0.72999999999999998 111.987 174.109 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.77 116.56 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.768 -0.827 . . . . 1.1699999999999999 108.768 167.357 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -137.05 176.57 8.6 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.798 1.639 . . . . 4.4100000000000001 110.116 -177.771 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -113.36 136.72 52.46 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.298 1.039 . . . . 2.5 111.518 174.367 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.277 19.9 ptt-85 . . . . . 0 N--CA 1.485 1.297 0 C-N-CA 131.175 3.79 . . . . 9.4100000000000001 111.415 168.68 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 CA--C 1.543 0.688 0 CA-C-O 121.203 0.525 . . . . 7.8600000000000003 110.408 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.51 -175.33 19.59 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 125.1 1.333 . . . . 1.4399999999999999 112.565 177.82 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -141.59 175.29 9.81 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.995 1.109 . . . . 2.1000000000000001 113.995 178.471 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.6 t -111.93 126.12 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 126.284 1.833 . . . . 1.8100000000000001 106.166 162.202 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.6 ttp85 -87.19 131.77 34.08 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.296 -1.001 . . . . 5.5099999999999998 108.296 171.143 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -57.35 117.59 4.26 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.122 0.569 . . . . 2.3599999999999999 110.98 -175.639 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.5 m -174.68 106.11 0.27 Allowed Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 128.851 2.86 . . . . 4.6200000000000001 107.036 167.052 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -93.42 -125.53 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.603 3.535 . . . . 6.0599999999999996 109.515 -176.314 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.73 -155.41 30.5 Favored Glycine 0 CA--C 1.543 1.785 0 O-C-N 121.425 -0.797 . . . . 2.5800000000000001 113.164 178.423 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.82 -31.19 13.21 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.914 2.409 . . . . 3.71 112.091 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.09 123.36 21.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.889 1.675 . . . . 4.2400000000000002 111.049 169.306 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.18 -179.04 4.96 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.131 1.772 . . . . 0.85999999999999999 111.336 172.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.96 135.93 29.86 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 121.052 -1.03 . . . . 0.80000000000000004 111.097 -176.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.78 146.14 51.98 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.819 1.648 . . . . 0.90000000000000002 112.05 -176.54 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -135.89 62.78 1.61 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.19 0.996 . . . . 3.3900000000000001 111.488 -157.062 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.06 162.71 24.0 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.468 -0.787 . . . . 1.79 113.015 -173.608 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.6 m -125.78 145.83 50.04 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.782 1.633 . . . . 2.27 107.571 171.064 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.47 164.62 38.39 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.96 1.304 . . . . 4.6299999999999999 110.176 174.947 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -127.94 154.98 44.95 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.391 1.076 . . . . 3.96 110.594 168.454 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -101.35 95.1 4.61 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 124.552 1.141 . . . . 1.3600000000000001 109.221 171.334 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.92 -19.18 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.151 1.9 . . . . 1.6699999999999999 113.28 -177.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.46 -177.02 51.47 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-O 122.351 0.973 . . . . 1.46 112.455 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -112.85 2.85 16.08 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.517 1.927 . . . . 4.1699999999999999 112.389 -170.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -98.38 157.04 35.06 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.634 1.974 . . . . 2.3300000000000001 110.243 164.082 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.57 148.63 14.32 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.243 2.628 . . . . 0.89000000000000001 111.179 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.1 mt -102.65 146.04 28.77 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 122.8 1.286 . . . . 1.9399999999999999 111.87 170.819 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.9 ttp-105 -129.77 109.61 11.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 111.984 -2.371 . . . . 2.3500000000000001 108.967 176.841 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -95.41 111.66 23.51 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.402 1.881 . . . . 2.4900000000000002 108.606 -174.039 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -111.21 -21.26 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.145 0.978 . . . . 0.62 112.033 -168.725 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.54 -174.26 30.14 Favored Glycine 0 C--N 1.344 1.018 0 C-N-CA 124.596 1.093 . . . . 0.56999999999999995 114.277 -174.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.16 -178.79 6.4 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.563 1.545 . . . . 0.70999999999999996 111.466 170.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -151.6 167.07 29.24 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.804 2.442 . . . . 4.6900000000000004 107.746 164.354 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 t -174.07 149.23 1.45 Allowed Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 125.164 1.386 . . . . 0.76000000000000001 108.536 -171.604 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.18 -3.5 13.49 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.185 2.59 . . . . 0.82999999999999996 114.281 177.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.4 m -119.4 28.39 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 115.22 1.563 . . . . 1.1100000000000001 115.22 -174.009 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.33 167.03 31.72 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.781 1.632 . . . . 1.1200000000000001 111.481 173.221 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -96.67 -31.13 12.86 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.458 1.503 . . . . 3.0699999999999998 111.056 173.278 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -139.1 153.35 48.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 129.889 3.276 . . . . 5.0199999999999996 108.034 -173.311 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.5 p -155.07 121.76 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 124.896 1.279 . . . . 1.74 109.775 178.569 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -140.66 129.95 23.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.143 -0.935 . . . . 4.1399999999999997 109.795 -165.314 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.459 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.7 pt? -82.23 140.43 33.67 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 123.261 1.505 . . . . 1.8400000000000001 113.285 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -117.11 157.16 26.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.612 2.365 . . . . 0.81999999999999995 112.304 175.397 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -95.33 149.01 21.83 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.642 1.977 . . . . 2.6000000000000001 109.541 158.182 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.0 m -115.62 149.63 37.98 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.369 1.868 . . . . 0.82999999999999996 106.012 159.654 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -158.93 177.39 11.2 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.817 0.847 . . . . 1.98 113.146 -177.026 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 76.1 mtm -108.76 144.22 36.86 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.234 1.414 . . . . 3.3799999999999999 111.612 172.439 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -139.78 146.95 40.11 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.418 1.487 . . . . 5.3399999999999999 111.597 173.618 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -93.94 140.48 29.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.725 1.21 . . . . 2.25 108.167 156.575 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.8 t -138.83 119.2 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.175 1.39 . . . . 2.2000000000000002 107.252 170.363 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 62.46 20.08 11.64 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.087 1.355 . . . . 3.4500000000000002 113.95 -177.404 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.83 15.4 75.41 Favored Glycine 0 N--CA 1.477 1.413 0 O-C-N 120.47 -1.394 . . . . 1.5 113.504 -170.456 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -117.02 115.71 25.95 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.696 2.398 . . . . 3.4700000000000002 108.314 -179.587 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.442 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -93.72 131.26 39.22 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.588 1.155 . . . . 4.3799999999999999 111.47 -170.62 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.9 p -155.32 148.96 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.9 1.68 . . . . 2.6600000000000001 109.99 -168.112 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.9 mtt -89.22 155.48 19.37 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.521 0.728 . . . . 2.5099999999999998 111.956 176.433 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.5 176.05 20.82 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 124.612 1.101 . . . . 0.57999999999999996 112.714 179.186 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ttm -153.83 144.81 22.74 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 126.058 1.743 . . . . 0.71999999999999997 109.205 -178.497 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -151.0 157.99 35.05 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 125.658 1.583 . . . . 4.8399999999999999 109.472 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -73.6 157.26 48.82 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.146 1.897 . . . . 0.87 111.266 168.481 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.17 158.81 71.85 Favored Pre-proline 0 N--CA 1.481 1.12 0 CA-C-O 118.53 -0.747 . . . . 1.1799999999999999 110.729 173.873 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -83.18 -24.98 2.9 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.277 2.651 . . . . 0.94999999999999996 113.355 -170.166 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -179.39 164.61 1.35 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.88 2.072 . . . . 2.3500000000000001 110.781 -178.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.2 mt -109.43 154.3 22.8 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.757 1.223 . . . . 0.68999999999999995 110.26 163.626 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -115.53 140.4 49.2 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.25 1.02 . . . . 1.9199999999999999 108.987 170.701 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.3 t -141.86 129.04 11.47 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 123.886 0.874 . . . . 1.25 111.365 174.324 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.45 170.42 16.24 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.428 2.752 . . . . 1.1000000000000001 112.545 -178.199 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -57.63 139.54 90.57 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.142 2.561 . . . . 1.51 111.172 166.356 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm 65.22 0.75 1.37 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.279 1.831 . . . . 2.6000000000000001 114.524 -174.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.56 177.54 52.75 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.291 1.9 . . . . 1.8799999999999999 112.395 171.477 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.6 ptt85 -131.83 132.94 44.14 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.515 1.126 . . . . 8.2300000000000004 112.876 -172.432 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.88 73.29 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 127.071 2.148 . . . . 5.29 109.094 -174.465 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.33 117.87 35.12 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.605 1.962 . . . . 3.7599999999999998 110.064 -172.075 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.29 58.03 0.61 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.493 1.917 . . . . 2.73 111.58 -171.695 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.519 ' H ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -61.97 146.59 91.39 Favored Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 125.973 1.709 . . . . 3.3900000000000001 115.364 178.533 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -61.12 -33.5 91.06 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 124.319 3.346 . . . . 2.8500000000000001 114.782 -177.502 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.25 5.25 44.08 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.153 0.882 . . . . 1.46 114.182 177.533 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.22 -124.96 0.97 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.955 1.264 . . . . 1.6100000000000001 111.591 170.293 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -71.11 138.01 49.35 Favored 'General case' 0 C--O 1.219 -0.527 0 O-C-N 121.653 -0.91 . . . . 2.1200000000000001 111.274 -174.07 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -159.93 158.16 30.26 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.416 0.687 . . . . 0.59999999999999998 112.451 -176.021 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -89.71 137.49 32.29 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.181 -0.949 . . . . 1.8600000000000001 111.737 174.783 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.9 tpt -97.35 127.69 43.53 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.416 1.886 . . . . 0.70999999999999996 109.146 163.348 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.78 121.81 44.8 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.939 1.296 . . . . 0.81999999999999995 108.525 -178.629 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.8 136.52 52.49 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.155 0.582 . . . . 2.6699999999999999 110.875 -163.329 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.32 38.44 62.7 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.867 -0.521 . . . . 1.05 112.554 -170.584 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.87 148.02 0.87 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 116.546 2.054 . . . . 2.0299999999999998 116.546 176.774 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -99.74 1.75 43.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.816 -1.538 . . . . 1.8 113.705 -177.128 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -159.32 150.53 16.34 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 125.658 1.583 . . . . 4.96 111.027 -177.105 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.91 83.85 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.016 2.477 . . . . 3.0 107.812 164.1 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 96.94 0.09 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.503 1.521 . . . . 2.6899999999999999 111.923 -172.426 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.48 161.34 13.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.09 -1.868 . . . . 4.2699999999999996 112.606 -173.949 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.71 133.17 54.42 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.037 0.935 . . . . 1.6799999999999999 110.389 177.5 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.92 55.61 3.52 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 114.176 -1.374 . . . . 2.8500000000000001 111.077 -170.653 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -138.33 -178.02 5.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.233 2.213 . . . . 2.4199999999999999 108.3 163.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -156.37 132.53 9.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.278 2.231 . . . . 3.46 105.571 -167.57 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.6 t -142.0 132.21 24.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 125.249 1.42 . . . . 0.96999999999999997 109.466 -164.035 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -77.13 145.59 37.69 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 122.685 0.394 . . . . 2.4199999999999999 111.131 172.329 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.54 137.44 54.73 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 122.662 1.22 . . . . 1.7 111.122 151.322 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -87.3 139.78 30.21 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.365 2.266 . . . . 2.0800000000000001 108.028 155.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -110.4 141.21 43.78 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.367 1.467 . . . . 0.81000000000000005 109.952 173.714 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -112.42 113.92 26.36 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.958 1.303 . . . . 0.64000000000000001 109.579 178.221 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -115.14 152.68 32.15 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.623 1.569 . . . . 2.1800000000000002 111.094 178.196 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.23 137.55 55.81 Favored 'General case' 0 CA--C 1.548 0.865 0 CA-C-O 122.293 1.044 . . . . 2.3700000000000001 113.795 -178.602 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.23 56.97 4.93 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.266 0.936 . . . . 3.5600000000000001 113.239 176.445 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.47 11.84 80.1 Favored Glycine 0 N--CA 1.473 1.158 0 N-CA-C 115.784 1.074 . . . . 2.1600000000000001 115.784 168.574 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -94.68 114.97 26.97 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.043 1.421 . . . . 2.9900000000000002 111.356 -174.356 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.65 136.12 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.134 1.374 . . . . 1.8999999999999999 109.537 177.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 tt -145.42 125.32 13.51 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.85 0.86 . . . . 2.5499999999999998 111.033 -168.202 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -101.09 134.68 43.73 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.792 1.237 . . . . 2.4100000000000001 112.144 -178.468 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.8 t -147.11 168.3 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 126.412 1.885 . . . . 2.5499999999999998 109.71 173.553 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.94 155.84 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 119.672 1.123 . . . . 1.8999999999999999 111.01 -170.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.9 mt -141.29 117.52 7.39 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.212 1.805 . . . . 2.52 110.129 -174.437 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.46 146.46 62.14 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.705 2.27 . . . . 1.0900000000000001 110.432 168.818 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.4 t -94.79 115.81 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.845 0.858 . . . . 1.23 109.209 170.876 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -129.81 137.73 50.64 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.428 1.091 . . . . 4.21 112.01 -170.916 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.43 83.46 5.43 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.994 -1.066 . . . . 3.8100000000000001 110.693 170.065 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.408 0 C-N-CA 127.249 2.22 . . . . 9.1300000000000008 110.848 -175.817 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 . . . . . 0 C--O 1.238 0.458 0 N-CA-C 106.001 -1.851 . . . . 6.4199999999999999 106.001 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -118.69 -170.95 14.94 Favored Glycine 0 N--CA 1.462 0.387 0 CA-C-O 122.436 1.02 . . . . 0.92000000000000004 112.038 -172.697 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 41.0 p90 -134.11 162.98 30.61 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.598 -0.801 . . . . 2.0499999999999998 111.325 167.206 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.46 139.03 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.894 1.278 . . . . 1.3999999999999999 109.147 173.49 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -58.0 112.73 1.6 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.743 1.617 . . . . 6.1399999999999997 112.555 -177.672 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.59 132.36 51.45 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.324 2.249 . . . . 3.0699999999999998 111.455 166.175 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -179.05 154.55 0.79 Allowed Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.535 1.934 . . . . 2.7999999999999998 112.867 166.392 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -88.28 40.69 0.58 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 125.23 3.953 . . . . 2.2999999999999998 111.055 166.316 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -114.88 157.37 15.03 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.948 1.261 . . . . 1.27 113.019 -172.085 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -71.77 -18.52 28.41 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.133 3.222 . . . . 1.45 113.923 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -108.17 164.82 11.97 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.541 1.936 . . . . 2.8700000000000001 112.629 170.253 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.3 -171.72 3.72 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.474 2.709 . . . . 0.60999999999999999 111.107 170.447 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -155.19 133.89 12.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.639 1.976 . . . . 0.85999999999999999 108.867 -175.715 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.42 132.57 54.97 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.267 1.394 . . . . 0.94999999999999996 111.351 -176.637 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -114.84 32.04 6.27 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.673 1.731 . . . . 2.7000000000000002 115.673 -167.061 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.642 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.5 pt? -64.93 158.88 24.17 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 115.972 1.841 . . . . 2.3199999999999998 115.972 -172.306 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.8 m -79.74 126.6 31.15 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.519 1.128 . . . . 1.75 109.679 166.191 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.9 tp -99.08 127.91 45.11 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.262 1.425 . . . . 4.2699999999999996 108.898 168.859 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.71 154.74 42.0 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.628 0.728 . . . . 3.3999999999999999 111.676 175.356 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -119.12 97.93 50.69 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.388 1.075 . . . . 1.53 109.088 169.246 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.6 -10.76 14.42 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.08 2.52 . . . . 1.21 113.03 177.05 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.93 -173.38 48.81 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.795 1.188 . . . . 1.26 113.115 -176.154 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -112.82 1.17 15.45 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.606 1.963 . . . . 3.2599999999999998 112.368 -168.844 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -124.45 161.86 45.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 128.013 2.525 . . . . 2.2799999999999998 110.256 174.122 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -81.01 141.91 13.42 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.484 2.122 . . . . 1.3999999999999999 111.898 -173.964 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.98 149.33 25.24 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.145 1.378 . . . . 2.71 110.134 174.055 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 42.4 ttm105 -135.44 103.3 5.43 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.633 1.173 . . . . 2.75 110.157 178.591 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.426 HD13 ' C ' ' A' ' 32' ' ' LEU . 2.5 tm? -79.4 114.66 18.51 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.24 1.816 . . . . 2.5800000000000001 108.047 -178.34 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.2 m -110.1 -19.47 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.254 1.022 . . . . 0.60999999999999999 112.408 -177.405 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.24 -175.8 29.58 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 125.509 1.528 . . . . 0.5 113.889 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.91 -179.87 6.02 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.965 0.906 . . . . 0.51000000000000001 111.035 166.004 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -137.32 177.4 7.9 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.313 1.445 . . . . 4.1100000000000003 107.845 155.054 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 t -175.7 148.88 1.02 Allowed Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 128.151 2.58 . . . . 0.69999999999999996 106.394 177.258 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.44 -9.46 20.16 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.591 2.194 . . . . 0.78000000000000003 112.21 178.55 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.3 m -112.96 51.82 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.679 1.591 . . . . 0.85999999999999999 111.586 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.01 158.16 30.05 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.056 1.343 . . . . 1.01 111.64 167.167 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -98.57 -33.81 10.83 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.987 1.715 . . . . 2.6699999999999999 110.152 160.745 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -128.65 130.12 46.8 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.619 1.968 . . . . 5.1600000000000001 109.53 177.255 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -128.43 128.93 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.404 1.081 . . . . 1.4299999999999999 108.993 166.378 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -144.39 137.57 27.16 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.165 0.986 . . . . 3.1600000000000001 110.442 -162.967 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 20.7 tp -91.85 125.17 36.46 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.663 -0.648 . . . . 1.3700000000000001 112.324 -167.458 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -122.41 160.28 25.79 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.896 1.678 . . . . 0.77000000000000002 114.119 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.48 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 17.6 pt-20 -120.27 147.68 44.67 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.696 1.598 . . . . 3.9199999999999999 110.189 161.499 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.3 m -108.54 139.14 43.72 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 107.54 -1.282 . . . . 0.81999999999999995 107.54 172.545 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -130.22 170.77 13.65 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.567 1.947 . . . . 2.0899999999999999 111.895 -172.386 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.8 mtt -103.36 141.58 35.69 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.518 1.127 . . . . 3.9700000000000002 111.909 172.158 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -141.47 145.02 34.71 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.078 1.351 . . . . 6.9000000000000004 112.52 174.423 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -79.93 134.51 36.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.769 -1.197 . . . . 2.5699999999999998 107.769 146.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.3 t -146.41 136.86 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 106.894 -1.521 . . . . 2.75 106.894 164.637 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 66.31 13.84 9.39 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.64 1.576 . . . . 5.5300000000000002 113.927 -177.932 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.03 27.11 67.13 Favored Glycine 0 N--CA 1.476 1.309 0 O-C-N 120.946 -1.096 . . . . 2.7400000000000002 113.017 -168.31 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -130.93 143.68 50.91 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 126.861 2.065 . . . . 4.6299999999999999 109.098 178.638 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -81.35 119.61 23.89 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.308 1.843 . . . . 4.0899999999999999 109.458 178.821 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.7 m -139.3 169.91 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.343 1.857 . . . . 2.5299999999999998 110.976 -177.813 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 53.6 mtm -134.14 137.84 44.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.039 1.335 . . . . 2.8100000000000001 110.75 174.464 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.44 174.83 21.57 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 125.786 1.66 . . . . 1.03 111.627 -177.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.25 141.63 47.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.329 1.064 . . . . 1.6200000000000001 111.832 -179.166 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -122.24 156.08 60.81 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 125.343 1.457 . . . . 6.6699999999999999 110.19 173.291 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.26 159.0 44.44 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.021 1.814 . . . . 0.79000000000000004 111.575 170.29 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.68 156.21 78.84 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 126.215 1.806 . . . . 1.3100000000000001 110.49 177.194 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.57 -24.13 6.54 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.51 2.806 . . . . 0.68999999999999995 112.859 -175.546 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -176.68 165.36 2.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.08 1.752 . . . . 1.9299999999999999 111.703 -178.662 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -109.56 160.1 16.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.118 1.367 . . . . 0.80000000000000004 109.53 155.62 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -134.84 148.42 50.15 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.235 1.014 . . . . 2.25 109.91 174.944 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 t -142.32 128.46 10.77 Favored Pre-proline 0 CA--C 1.541 0.596 0 O-C-N 123.817 0.698 . . . . 1.1299999999999999 112.086 178.231 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.11 162.53 41.48 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.776 2.984 . . . . 1.4299999999999999 111.458 176.673 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.44 141.28 97.01 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.224 2.616 . . . . 1.3999999999999999 113.02 -178.177 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt 70.14 -2.32 2.13 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.469 2.308 . . . . 2.1200000000000001 114.265 -178.643 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.6 158.35 43.13 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.581 1.562 . . . . 1.1499999999999999 114.316 -179.232 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.95 143.63 51.01 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.133 1.773 . . . . 6.2000000000000002 109.592 167.993 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.7 t -143.61 131.87 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 106.313 -1.736 . . . . 3.3300000000000001 106.313 174.0 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.417 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . 7.2 mt-10 -120.22 128.44 53.36 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.61 1.095 . . . . 3.9399999999999999 110.77 -170.416 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 83' ' ' HIS . 4.6 mp -77.65 58.06 1.73 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.48 1.512 . . . . 2.2799999999999998 111.229 -178.513 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 76' ' ' GLU . 0.2 OUTLIER -63.54 150.18 90.69 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 114.795 1.406 . . . . 5.0 114.795 -178.553 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -58.06 151.11 60.5 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.456 2.104 . . . . 2.6299999999999999 109.888 169.634 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.29 -9.52 33.39 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.355 -1.247 . . . . 1.8600000000000001 114.206 -171.271 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -135.01 -129.62 2.9 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 119.443 1.622 . . . . 1.5800000000000001 114.444 175.029 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.48 ' CE1' ' HB3' ' A' ' 47' ' ' GLU . 80.8 m-85 -71.97 141.03 49.4 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.543 -0.975 . . . . 2.0099999999999998 110.703 -177.88 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 77' ' ' LEU . 46.5 p-80 -164.41 156.74 16.66 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.962 1.305 . . . . 0.76000000000000001 110.88 -176.771 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.479 ' CE2' HD21 ' A' ' 20' ' ' LEU . 98.3 m-85 -82.42 145.24 29.97 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.24 -0.652 . . . . 1.77 109.24 161.043 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 tpt -96.56 132.99 41.61 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.919 1.288 . . . . 0.81999999999999995 108.42 164.054 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 mp -109.37 140.01 43.61 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.758 1.223 . . . . 0.85999999999999999 109.363 176.169 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.3 mt -141.74 142.91 33.28 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.747 1.619 . . . . 1.9299999999999999 110.107 -176.657 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 68.47 36.71 84.44 Favored Glycine 0 CA--C 1.532 1.098 0 O-C-N 121.894 -0.504 . . . . 0.93999999999999995 112.993 177.794 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.11 145.57 13.08 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 123.609 1.671 . . . . 1.4199999999999999 115.231 -178.506 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -93.15 -7.67 44.73 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 113.762 -1.563 . . . . 1.8200000000000001 113.031 -174.161 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -142.67 145.06 32.53 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 127.469 2.307 . . . . 5.3700000000000001 107.495 169.292 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -66.25 151.2 84.03 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.152 1.901 . . . . 2.0899999999999999 108.822 158.524 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mp -117.46 112.41 20.6 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 125.977 1.711 . . . . 2.6200000000000001 107.596 -165.063 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -86.11 171.02 11.67 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.332 0.587 . . . . 4.0899999999999999 112.078 179.079 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.81 137.31 58.21 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.396 -0.964 . . . . 1.1799999999999999 108.396 153.559 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.81 23.05 75.98 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 116.44 1.336 . . . . 1.4099999999999999 116.44 173.341 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -93.42 -170.24 2.33 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.662 1.731 . . . . 2.3300000000000001 111.74 169.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 10.6 pt-20 -154.66 138.31 16.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 128.264 2.626 . . . . 3.1400000000000001 106.647 -173.722 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.6 t -149.09 136.1 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.804 1.641 . . . . 0.96999999999999997 110.027 -163.196 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -77.31 147.76 36.04 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.104 0.478 . . . . 2.8399999999999999 110.83 173.37 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.408 HD22 HD22 ' A' ' 20' ' ' LEU . 1.3 mp -127.3 149.93 49.81 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.878 1.271 . . . . 1.6100000000000001 108.747 159.405 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -107.39 150.55 26.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.661 0.784 . . . . 2.2400000000000002 108.935 158.01 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.3 mp -109.81 133.48 53.11 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.399 1.48 . . . . 1.0 109.267 172.096 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.4 mt -103.55 112.18 24.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.176 1.39 . . . . 0.65000000000000002 109.559 -179.064 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -106.14 111.53 24.18 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.924 1.69 . . . . 2.1400000000000001 111.572 -175.304 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 49.76 32.58 5.38 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.774 1.63 . . . . 3.3900000000000001 112.948 -178.366 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.43 -71.1 1.84 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.41 1.481 . . . . 5.1200000000000001 112.212 -171.908 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.44 9.46 21.21 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 117.146 1.618 . . . . 2.2400000000000002 117.146 -163.373 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -130.9 134.28 46.63 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.721 1.76 . . . . 4.3200000000000003 110.463 169.51 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.7 p -125.22 145.09 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.048 1.339 . . . . 2.2400000000000002 110.977 178.342 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.8 tp -139.92 126.47 20.36 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.254 1.422 . . . . 2.3100000000000001 109.588 178.775 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -84.27 141.38 31.0 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.061 0.393 . . . . 2.21 112.061 173.618 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.19 -179.91 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 127.203 2.201 . . . . 2.6000000000000001 110.361 167.084 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.5 t -138.31 155.43 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.515 1.526 . . . . 1.71 106.979 171.176 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.27 153.29 26.62 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.954 1.302 . . . . 1.97 111.231 171.314 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 43.0 Cg_endo -63.95 168.17 12.63 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.75 2.967 . . . . 1.03 112.842 171.66 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.6 t -112.36 128.73 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.039 1.336 . . . . 0.97999999999999998 108.712 169.525 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -154.41 178.53 9.95 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.257 1.823 . . . . 4.4000000000000004 112.946 177.048 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.55 162.26 29.71 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.849 1.426 . . . . 4.0499999999999998 114.849 -167.228 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 117.744 -1.122 . . . . 7.7800000000000002 109.886 171.069 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 112.294 0.479 . . . . 5.0700000000000003 112.294 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -150.28 164.88 29.81 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.99 1.281 . . . . 1.27 114.122 171.906 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -157.2 151.47 25.01 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.615 2.366 . . . . 2.2799999999999998 110.638 176.285 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.9 t -97.62 145.55 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 120.957 -1.089 . . . . 1.02 109.868 -178.765 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.77 -15.64 63.73 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.024 1.49 . . . . 4.6799999999999997 115.024 -172.782 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 77.57 145.88 0.09 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.053 2.141 . . . . 3.5699999999999998 114.116 -171.539 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.4 t -178.66 133.78 0.3 Allowed Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 128.27 2.628 . . . . 2.7200000000000002 110.808 165.576 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -82.51 -11.42 10.56 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.224 2.616 . . . . 3.1899999999999999 112.202 172.5 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.34 169.37 31.72 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.958 1.266 . . . . 1.45 112.212 178.617 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.59 -15.9 52.39 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.597 3.531 . . . . 1.54 114.779 -170.751 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -100.99 140.55 35.13 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.248 1.419 . . . . 2.6699999999999999 112.428 173.642 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.44 -177.42 5.94 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.285 1.834 . . . . 0.55000000000000004 111.926 172.312 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.26 147.18 25.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.598 1.959 . . . . 0.79000000000000004 110.02 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.99 149.82 47.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.745 1.017 . . . . 0.81000000000000005 113.745 -172.744 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -117.19 142.73 46.67 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.161 1.784 . . . . 3.0099999999999998 109.862 174.515 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.84 160.12 14.25 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.399 1.08 . . . . 2.8599999999999999 113.208 178.171 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.408 HG23 ' HB3' ' A' ' 76' ' ' GLU . 22.9 m -136.95 147.04 46.11 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 125.129 1.371 . . . . 1.95 110.167 -171.447 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.51 134.11 10.87 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.987 1.315 . . . . 5.5199999999999996 109.498 -178.046 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.29 154.16 18.78 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.211 0.914 . . . . 5.2999999999999998 112.376 177.104 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -105.28 83.34 0.88 Allowed Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.71 1.204 . . . . 1.5900000000000001 110.132 171.983 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -71.65 -4.68 15.52 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.476 2.117 . . . . 1.8400000000000001 113.437 176.359 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.79 169.73 49.06 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-O 123.284 1.491 . . . . 1.24 112.811 177.641 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -101.25 -2.24 31.69 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 127.54 2.336 . . . . 2.8500000000000001 112.518 -171.219 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -116.71 159.59 39.89 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.931 2.092 . . . . 3.9700000000000002 109.459 169.755 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.97 170.77 14.91 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.844 2.363 . . . . 1.6399999999999999 112.206 -166.536 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.4 mt -117.07 147.88 42.0 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 123.243 1.497 . . . . 1.96 110.945 165.843 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -138.54 109.65 6.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 111.449 -2.614 . . . . 3.1400000000000001 108.97 166.819 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 tp -84.95 110.21 18.72 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.033 1.733 . . . . 1.6000000000000001 108.826 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.81 -14.77 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.155 0.982 . . . . 0.57999999999999996 112.059 -176.967 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.34 -179.03 31.95 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-O 122.324 0.958 . . . . 0.47999999999999998 114.276 -178.54 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -144.64 -179.15 6.39 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.98 1.712 . . . . 0.46999999999999997 109.588 162.668 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -153.27 -178.97 7.31 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.917 1.287 . . . . 4.96 108.568 156.164 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 t -171.53 153.0 3.37 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 125.986 1.714 . . . . 0.57999999999999996 108.056 -172.604 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.11 -3.16 13.2 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.151 1.901 . . . . 0.66000000000000003 113.847 174.175 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.5 m -119.15 39.26 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.796 1.239 . . . . 0.73999999999999999 114.267 -176.013 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.36 167.26 29.29 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.134 1.374 . . . . 1.1100000000000001 110.721 169.674 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -98.47 -50.97 4.1 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.72 1.608 . . . . 2.6499999999999999 110.023 171.415 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -114.99 139.33 49.93 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 127.215 2.206 . . . . 4.6299999999999999 107.293 171.054 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.1 149.55 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.521 -0.763 . . . . 1.0900000000000001 109.003 154.923 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -127.94 151.79 48.68 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.675 1.99 . . . . 2.9700000000000002 107.54 166.781 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -100.73 138.34 37.91 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.082 1.31 . . . . 1.76 112.102 160.465 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -123.79 160.21 27.84 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.066 2.146 . . . . 0.70999999999999996 112.235 -178.921 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -104.36 178.58 4.52 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 112.491 -2.141 . . . . 3.46 111.397 166.101 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.8 m -148.34 139.15 23.0 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.285 -1.376 . . . . 0.73999999999999999 107.285 163.859 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -148.37 178.54 8.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.983 1.313 . . . . 2.1200000000000001 112.4 -168.864 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -110.04 145.49 36.96 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.332 1.453 . . . . 4.4800000000000004 113.117 179.331 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.8 mtp85 -127.43 152.81 47.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.445 1.498 . . . . 4.6900000000000004 110.711 166.299 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.411 ' OE1' ' HE2' ' A' ' 57' ' ' LYS . 3.1 tp10 -91.75 143.31 26.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.536 -0.912 . . . . 2.52 108.536 147.913 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 50.6 t -140.27 127.7 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 106.937 -1.505 . . . . 2.0499999999999998 106.937 158.714 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 65.03 25.64 12.63 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.24 1.016 . . . . 4.3799999999999999 113.715 173.404 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.11 9.1 85.64 Favored Glycine 0 CA--C 1.538 1.471 0 O-C-N 120.536 -1.352 . . . . 1.6200000000000001 113.94 -173.52 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -122.21 119.25 30.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.17 2.188 . . . . 2.9399999999999999 108.746 -170.759 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.476 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -89.04 116.52 27.38 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.655 1.982 . . . . 4.2300000000000004 111.401 -173.033 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.1 t -149.13 139.69 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.962 2.105 . . . . 2.98 109.328 -166.112 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -84.08 170.86 13.44 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.586 1.328 . . . . 2.5099999999999998 114.586 -172.059 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.55 165.63 29.13 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 126.807 2.146 . . . . 0.5 112.694 177.427 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 ttm -148.11 141.38 25.15 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.979 1.712 . . . . 0.82999999999999996 109.705 177.785 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -148.18 159.6 39.24 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.695 1.998 . . . . 5.0099999999999998 109.749 -176.71 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.81 153.02 53.29 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.276 1.984 . . . . 0.93999999999999995 111.358 168.274 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.89 159.45 56.14 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 123.734 0.814 . . . . 1.0600000000000001 109.898 174.51 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.63 -25.88 3.45 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.856 2.371 . . . . 0.68999999999999995 112.951 -172.063 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -179.64 167.17 1.4 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.092 2.157 . . . . 2.2000000000000002 110.73 -178.206 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.2 mt -112.1 152.18 28.56 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.24 1.016 . . . . 0.55000000000000004 110.179 162.122 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -120.48 139.32 53.05 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.216 1.406 . . . . 2.1899999999999999 110.042 -176.943 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.4 t -146.05 135.65 11.59 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 113.147 0.795 . . . . 1.5900000000000001 113.147 176.419 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.26 168.87 23.77 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.479 2.786 . . . . 1.53 112.189 176.79 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -59.76 140.9 95.59 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.71 2.273 . . . . 1.6899999999999999 110.959 165.074 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt 66.33 1.86 2.19 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.773 1.629 . . . . 2.0299999999999998 113.577 -176.412 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.85 -175.65 51.07 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.644 2.069 . . . . 1.8899999999999999 111.533 166.44 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -147.43 150.46 34.68 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 114.253 1.205 . . . . 5.6600000000000001 114.253 175.694 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.1 t -98.23 106.13 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 128.243 2.617 . . . . 5.4900000000000002 107.405 -174.659 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.408 ' HB3' HG23 ' A' ' 21' ' ' THR . 0.0 OUTLIER -126.14 110.38 13.42 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 122.199 0.999 . . . . 3.9399999999999999 111.204 -179.416 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mp -83.49 78.7 9.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.006 -1.479 . . . . 2.29 107.006 167.945 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -73.0 140.67 80.8 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 113.777 -1.556 . . . . 3.6099999999999999 112.992 -175.113 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -61.12 142.54 97.23 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.712 2.275 . . . . 3.48 110.81 -179.558 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.84 -12.93 58.34 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.222 -1.321 . . . . 2.0899999999999999 114.786 -177.053 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.68 -109.53 1.45 Allowed Glycine 0 N--CA 1.474 1.173 0 CA-C-N 119.154 1.477 . . . . 1.8700000000000001 111.62 172.878 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 47' ' ' GLU . 97.3 m-85 -75.54 137.07 40.6 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.832 -0.805 . . . . 2.1000000000000001 111.957 -172.405 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -161.37 152.37 18.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.548 -0.751 . . . . 0.64000000000000001 111.267 -171.091 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 52.8 m-85 -83.94 140.36 31.98 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.392 -0.818 . . . . 2.2599999999999998 109.879 166.927 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.3 tpt -100.51 131.28 46.5 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.255 1.822 . . . . 0.63 108.183 167.67 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 mp -109.48 126.6 53.68 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.801 1.24 . . . . 0.83999999999999997 108.184 -179.061 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.83 128.03 49.86 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.953 1.301 . . . . 2.98 109.281 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.93 51.91 5.2 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.578 1.085 . . . . 0.81000000000000005 113.24 176.797 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.6 mt -47.33 155.98 0.29 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.846 1.424 . . . . 2.8300000000000001 114.846 176.285 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -108.61 4.38 23.91 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.853 -1.067 . . . . 1.78 113.691 -177.875 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -161.31 163.1 20.77 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 129.43 3.092 . . . . 5.2300000000000004 108.12 176.731 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.09 118.33 5.57 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.708 1.605 . . . . 1.75 108.617 165.913 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mp -80.15 57.14 2.62 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.14 1.376 . . . . 2.98 109.917 175.577 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -59.47 167.17 2.04 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 120.519 -1.363 . . . . 4.3499999999999996 111.964 174.31 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.34 128.98 33.81 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.393 1.092 . . . . 1.8300000000000001 110.025 161.806 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.13 34.59 36.91 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.017 1.294 . . . . 2.46 114.092 177.898 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -90.79 -176.85 4.81 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.65 1.225 . . . . 2.2000000000000002 109.92 153.992 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -144.66 153.93 42.26 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 127.712 2.405 . . . . 3.7599999999999998 106.904 171.344 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.4 t -149.03 157.66 6.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 128.509 2.724 . . . . 1.4199999999999999 108.791 -163.328 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -120.61 152.85 37.61 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.096 0.474 . . . . 2.29 112.079 158.794 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mp -126.24 137.54 53.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.784 2.033 . . . . 1.6799999999999999 109.869 171.955 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -90.1 148.3 23.09 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.092 1.357 . . . . 1.8799999999999999 110.135 161.184 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -112.47 115.81 29.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.331 1.852 . . . . 0.85999999999999999 109.59 172.883 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.1 mt -93.94 111.36 23.05 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.728 1.211 . . . . 0.68000000000000005 110.221 -176.912 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -110.19 124.5 51.69 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.571 0.748 . . . . 1.8600000000000001 111.362 -177.822 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.95 -17.69 63.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.624 0.972 . . . . 1.9299999999999999 113.624 176.382 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.07 38.08 1.33 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.248 1.404 . . . . 5.4699999999999998 113.653 175.184 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.97 28.08 72.25 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 125.754 1.645 . . . . 3.5600000000000001 114.851 174.759 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -140.14 152.71 46.31 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.027 1.414 . . . . 3.8700000000000001 113.359 -168.971 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.3 t -141.72 144.31 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.861 1.264 . . . . 2.1099999999999999 107.697 163.093 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 22.6 mt -139.93 168.04 20.74 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.45 1.9 . . . . 3.0499999999999998 108.274 170.767 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.5 pttp -147.42 151.87 37.18 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.199 1.185 . . . . 1.8500000000000001 114.199 177.806 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.91 141.14 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 127.083 2.153 . . . . 2.2200000000000002 110.923 -171.497 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.5 p -91.8 145.92 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.823 1.249 . . . . 2.46 109.408 166.267 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -157.34 142.76 12.46 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.049 1.34 . . . . 2.7200000000000002 112.105 -174.1 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.6 166.01 27.96 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 124.083 3.189 . . . . 1.21 111.444 172.371 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.7 t -107.68 115.67 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.302 1.041 . . . . 1.0600000000000001 109.17 169.698 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -127.1 153.63 45.75 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.905 1.282 . . . . 4.75 111.812 -170.434 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.6 58.8 4.47 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.794 1.035 . . . . 2.3900000000000001 113.794 -159.035 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.26 -0.876 . . . . 7.9199999999999999 112.285 174.202 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 . . . . . 0 CA--C 1.549 0.937 0 CA-C-O 121.303 0.573 . . . . 6.8200000000000003 111.787 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.7 169.09 26.16 Favored Glycine 0 C--N 1.337 0.609 0 O-C-N 119.714 -1.866 . . . . 1.1299999999999999 113.287 -174.428 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -155.85 174.92 14.62 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.051 1.13 . . . . 1.79 114.051 -176.737 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.6 t -119.1 139.46 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 127.332 2.253 . . . . 1.1499999999999999 109.779 177.688 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -97.36 109.66 22.37 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.009 1.324 . . . . 4.3799999999999999 110.684 171.564 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -52.58 150.05 5.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.461 1.104 . . . . 3.1600000000000001 110.935 168.189 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 m -162.06 147.65 10.37 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 125.097 1.359 . . . . 3.02 109.865 166.323 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -81.4 44.39 1.73 Allowed 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 124.671 3.581 . . . . 3.2799999999999998 112.011 179.73 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -122.52 160.96 16.9 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.677 1.608 . . . . 2.1600000000000001 112.93 -176.862 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.81 -17.49 56.22 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.584 2.856 . . . . 2.02 112.791 172.131 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -110.53 146.44 36.03 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.103 1.761 . . . . 3.2999999999999998 113.565 164.426 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.08 -178.81 3.65 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.188 1.795 . . . . 0.63 110.275 163.631 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.94 145.36 34.43 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.57 1.077 . . . . 0.93999999999999995 111.135 177.95 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.5 148.87 44.79 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.964 1.098 . . . . 0.97999999999999998 113.964 -175.644 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -127.89 77.39 1.75 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.732 2.413 . . . . 2.3900000000000001 110.414 -173.634 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -74.16 158.65 33.79 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.817 -1.177 . . . . 1.99 112.077 178.95 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.6 m -118.24 146.93 43.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.252 -1.018 . . . . 2.0099999999999998 108.252 157.345 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.429 ' CD1' ' H ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -154.35 -174.76 5.1 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.264 1.826 . . . . 5.8300000000000001 108.427 171.433 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.429 ' H ' ' CD1' ' A' ' 22' ' ' LEU . 37.3 mt-10 -138.69 146.4 41.53 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 120.69 -1.256 . . . . 3.6200000000000001 110.416 -174.304 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -95.31 102.26 9.3 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.666 0.786 . . . . 1.46 109.067 156.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.84 -12.92 14.63 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.725 2.283 . . . . 2.0 113.35 176.958 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.04 -175.72 50.93 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-O 122.424 1.013 . . . . 1.9099999999999999 113.339 -172.819 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -111.09 -1.16 16.34 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.165 2.186 . . . . 4.0999999999999996 112.038 -172.367 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -111.82 158.9 35.34 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 127.771 2.428 . . . . 2.0600000000000001 110.198 171.129 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.11 146.65 18.13 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.518 2.145 . . . . 1.1599999999999999 111.581 -174.26 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.426 HD12 ' CD1' ' A' ' 105' ' ' PHE . 2.4 mm? -113.75 161.94 16.9 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.868 1.667 . . . . 2.4399999999999999 110.931 176.002 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -154.81 119.54 4.85 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.517 -1.22 . . . . 1.8300000000000001 111.012 -167.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.0 tp -101.21 108.95 20.74 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.273 1.829 . . . . 2.1400000000000001 110.404 -173.352 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.1 m -109.38 -20.56 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.351 1.06 . . . . 0.81999999999999995 112.12 -167.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.09 -174.36 29.78 Favored Glycine 0 C--N 1.343 0.963 0 C-N-CA 125.059 1.314 . . . . 0.72999999999999998 113.367 -174.924 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.0 -179.67 7.19 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.066 0.946 . . . . 0.82999999999999996 112.025 169.08 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -153.14 145.25 23.8 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.201 1.8 . . . . 5.4000000000000004 107.634 178.529 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -164.11 151.19 10.2 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 119.416 1.007 . . . . 0.81000000000000005 109.477 -172.988 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.0 -4.2 13.74 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.137 2.558 . . . . 0.88 114.428 175.816 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.23 30.3 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 115.212 1.56 . . . . 0.87 115.212 -175.189 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -174.88 167.95 3.59 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 128.357 2.663 . . . . 1.1899999999999999 108.313 174.277 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -119.94 -45.9 2.46 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.2 0.909 . . . . 6.1699999999999999 111.248 169.619 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.7 mtt-85 -78.6 141.46 38.03 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.585 -1.265 . . . . 4.6900000000000004 107.585 164.387 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -158.52 74.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 127.806 2.442 . . . . 2.4700000000000002 110.027 -174.469 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -99.97 131.64 45.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 111.766 -2.47 . . . . 4.9199999999999999 110.72 -169.981 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.5 pt? -90.1 136.51 33.0 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 123.753 1.739 . . . . 2.1200000000000001 114.026 -176.806 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -115.1 160.85 19.16 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 127.143 2.177 . . . . 0.80000000000000004 110.856 174.901 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.12 -177.86 4.28 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.236 -1.802 . . . . 3.3900000000000001 111.202 156.776 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.8 m -152.82 141.18 20.62 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.174 1.389 . . . . 0.60999999999999999 107.829 170.306 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -151.04 170.41 19.44 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.929 1.455 . . . . 2.2400000000000002 114.929 -168.667 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.0 ttp -109.75 142.47 40.94 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.369 1.868 . . . . 3.2999999999999998 109.479 169.477 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -151.92 159.23 43.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.682 1.993 . . . . 8.4600000000000009 111.391 -175.608 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -91.28 147.47 23.02 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.193 1.397 . . . . 2.5 111.897 170.198 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.6 t -140.54 120.33 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.389 1.475 . . . . 1.8899999999999999 107.956 166.923 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 64.44 8.64 4.41 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 127.371 2.268 . . . . 2.8999999999999999 114.763 -178.019 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.92 23.23 33.37 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 123.958 0.79 . . . . 1.79 113.89 -168.049 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.1 132.62 53.11 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.772 1.229 . . . . 2.54 109.634 166.549 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 138.89 44.87 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.079 1.352 . . . . 6.4000000000000004 110.636 -178.86 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.576 HG22 ' H ' ' A' ' 59' ' ' MET . 9.8 p -154.26 -179.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 C-N-CA 126.882 2.073 . . . . 2.2599999999999998 109.328 -177.479 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.576 ' H ' HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -116.75 166.4 12.18 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 121.299 -0.875 . . . . 3.23 112.28 -176.686 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.66 171.22 29.77 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.972 1.749 . . . . 0.53000000000000003 111.994 -179.291 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 ttm -155.4 138.44 15.49 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 126.646 1.979 . . . . 0.63 109.227 173.829 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -144.65 149.94 45.29 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 127.645 2.378 . . . . 8.5600000000000005 109.424 -172.025 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.1 154.87 52.52 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.574 2.183 . . . . 0.59999999999999998 110.019 176.377 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.14 151.6 75.5 Favored Pre-proline 0 N--CA 1.483 1.213 0 CA-C-O 117.974 -1.012 . . . . 0.65000000000000002 110.71 175.053 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.38 -23.77 9.8 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.192 2.595 . . . . 0.77000000000000002 112.873 -169.575 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -179.55 165.58 1.36 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.472 2.309 . . . . 2.21 109.85 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.0 mt -109.15 150.52 27.75 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.004 0.922 . . . . 0.69999999999999996 110.044 165.137 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -109.71 143.82 38.95 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.297 1.039 . . . . 2.0800000000000001 109.149 178.059 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.6 t -140.3 125.25 11.16 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 122.971 0.509 . . . . 0.98999999999999999 112.093 173.974 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.81 168.35 20.5 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.95 2.433 . . . . 1.28 111.697 179.079 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -55.25 140.12 81.32 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.027 2.485 . . . . 1.6899999999999999 111.43 168.84 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt 67.68 0.91 2.41 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.721 1.609 . . . . 2.4199999999999999 113.616 -177.183 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.62 156.96 45.22 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.902 1.715 . . . . 1.8 112.45 -179.048 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.9 mtm105 -104.99 132.51 51.14 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.025 1.33 . . . . 6.9400000000000004 109.581 -178.48 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.9 t -93.42 55.33 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 127.589 2.356 . . . . 5.3300000000000001 108.248 -173.611 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.71 93.02 8.69 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.641 1.976 . . . . 3.9199999999999999 109.742 -175.223 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' A' ' 83' ' ' HIS . 1.5 tp -52.21 -56.23 16.02 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.326 1.45 . . . . 3.3900000000000001 111.608 -164.66 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? 112.09 128.37 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 128.977 2.911 . . . . 3.02 114.429 161.516 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.62 -45.91 12.88 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.891 2.394 . . . . 1.97 110.847 174.065 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.72 40.69 3.07 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.938 -0.924 . . . . 1.8100000000000001 112.37 172.315 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.4 -117.5 0.56 Allowed Glycine 0 C--N 1.337 0.638 0 CA-C-N 118.139 0.97 . . . . 1.77 113.783 175.029 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -76.5 137.1 39.41 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 123.399 1.571 . . . . 1.8300000000000001 113.646 -163.77 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.598 ' HA ' HD23 ' A' ' 77' ' ' LEU . 53.0 p-80 -158.17 138.54 12.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.301 -1.318 . . . . 0.82999999999999996 113.424 -173.66 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -77.03 135.24 38.64 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.018 -1.104 . . . . 2.54 108.018 167.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.8 mtp -99.64 117.69 34.54 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.651 0.739 . . . . 1.71 110.619 160.103 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -86.71 107.74 18.36 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.608 1.963 . . . . 1.23 107.426 -176.716 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.0 mp -111.35 141.5 44.81 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.09 1.756 . . . . 1.8100000000000001 111.005 -173.899 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.44 42.44 41.32 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 111.459 -0.656 . . . . 0.94999999999999996 111.459 178.509 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . 0.258 0.5 OUTLIER -44.01 138.84 2.68 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 123.479 1.609 . . . . 1.8700000000000001 115.324 176.828 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -101.12 -12.71 18.58 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.051 -1.886 . . . . 4.5899999999999999 112.893 -173.137 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -143.8 150.59 50.59 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 128.305 2.642 . . . . 5.71 108.2 172.681 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -72.37 150.58 52.66 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.597 2.198 . . . . 1.8 110.082 167.911 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.9 mp -108.8 143.79 37.5 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.087 2.155 . . . . 2.6200000000000001 106.395 176.173 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.52 162.5 15.05 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.466 2.306 . . . . 4.0300000000000002 110.424 170.796 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.54 125.8 26.87 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.43 -0.794 . . . . 1.9399999999999999 109.171 157.399 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.86 32.0 6.72 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.866 1.222 . . . . 1.71 115.025 173.241 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -112.16 -167.49 1.19 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.488 1.115 . . . . 2.1200000000000001 112.801 175.909 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 8.7 pt-20 -147.11 147.94 31.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 128.116 2.567 . . . . 3.1299999999999999 107.233 172.685 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.9 t -146.31 126.69 6.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 127.823 2.449 . . . . 1.1599999999999999 108.667 -165.354 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.45 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -90.11 154.45 19.78 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 122.732 1.253 . . . . 2.48 113.75 176.224 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.7 tt -156.82 144.87 19.42 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.125 1.77 . . . . 2.3900000000000001 109.945 176.042 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.08 140.86 39.24 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.696 1.598 . . . . 3.3500000000000001 110.55 170.802 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.1 mp -84.91 127.7 34.29 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.388 1.475 . . . . 1.1799999999999999 109.64 174.98 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.6 mt -90.75 104.86 17.39 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.696 -0.853 . . . . 0.83999999999999997 108.696 168.691 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.426 ' CD1' HD12 ' A' ' 30' ' ' LEU . 96.2 m-85 -97.69 149.27 22.46 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.187 0.995 . . . . 2.3500000000000001 111.101 172.59 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.57 129.05 34.9 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.518 0.933 . . . . 2.1699999999999999 113.518 -174.627 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.32 62.03 2.84 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.663 1.125 . . . . 3.1499999999999999 113.542 174.335 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.19 13.18 81.44 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 115.709 1.044 . . . . 2.4199999999999999 115.709 167.751 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -97.07 122.19 39.79 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.794 1.297 . . . . 3.0800000000000001 110.56 -179.267 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.8 t -137.0 128.83 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.152 0.981 . . . . 2.1400000000000001 109.977 -176.249 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -140.43 127.62 21.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.564 1.146 . . . . 2.98 111.811 -176.138 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.45 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 24.4 ttmm -83.25 140.59 32.42 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.179 1.392 . . . . 2.7400000000000002 113.766 -178.867 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.36 153.9 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.446 1.898 . . . . 2.4199999999999999 109.971 163.307 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.31 127.57 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 107.337 -1.357 . . . . 1.8700000000000001 107.337 163.014 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.4 mt -125.44 129.46 24.42 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.256 1.422 . . . . 1.8999999999999999 108.668 -170.795 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 60.6 Cg_endo -70.65 153.06 65.07 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.159 2.573 . . . . 1.04 112.147 172.675 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.4 t -103.91 112.3 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.445 1.498 . . . . 1.05 109.904 173.743 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -100.38 178.66 4.68 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.802 1.241 . . . . 4.9100000000000001 109.896 160.43 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.33 158.66 43.91 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.935 0.894 . . . . 2.8500000000000001 112.158 -171.247 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.352 0 C-N-CA 126.817 2.047 . . . . 9.1999999999999993 110.639 176.153 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.588 0 CA-C-O 121.789 0.804 . . . . 5.0599999999999996 111.362 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.18 -175.25 32.0 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 128.456 2.932 . . . . 0.92000000000000004 110.98 174.319 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -116.43 157.03 25.78 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.665 0.987 . . . . 2.2400000000000002 113.665 175.88 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.2 t -89.46 141.97 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 O-C-N 120.877 -1.139 . . . . 1.23 108.163 157.888 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.0 ttt85 -77.15 131.43 38.29 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.988 -0.445 . . . . 4.5099999999999998 111.894 -173.817 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -45.02 135.06 5.57 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.412 1.485 . . . . 2.0299999999999998 112.067 166.186 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.0 t -176.68 129.68 0.35 Allowed Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.188 1.395 . . . . 2.5899999999999999 112.448 172.951 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -91.19 0.76 4.77 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.133 3.222 . . . . 2.3399999999999999 112.413 165.324 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.19 -175.33 46.44 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.644 1.116 . . . . 1.1299999999999999 113.374 -173.535 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -69.02 -22.13 35.9 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.161 2.574 . . . . 1.5900000000000001 113.057 -178.911 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.6 p30 -128.38 166.06 19.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.302 1.841 . . . . 2.3900000000000001 114.076 -178.657 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.44 -177.2 6.3 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 128.258 2.623 . . . . 0.56999999999999995 111.045 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.75 171.09 10.38 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.294 1.837 . . . . 1.1399999999999999 108.925 169.624 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.5 160.7 43.59 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.759 1.223 . . . . 0.69999999999999996 111.557 174.472 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -155.34 144.95 21.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.841 -1.072 . . . . 8.4299999999999997 111.558 -161.019 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -161.89 156.51 22.62 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.393 1.477 . . . . 2.23 111.375 -172.083 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.1 m -83.95 146.07 28.22 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.081 0.953 . . . . 1.98 108.857 162.254 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.49 114.27 23.22 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.639 0.775 . . . . 3.25 109.449 170.064 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -104.88 145.62 30.14 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.988 1.315 . . . . 3.6800000000000002 109.093 168.655 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.21 73.49 1.33 Allowed Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.088 0.955 . . . . 3.0600000000000001 110.986 177.735 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.3 -19.3 62.02 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.902 2.401 . . . . 1.4199999999999999 114.659 -174.23 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.42 -179.95 51.43 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-O 122.885 1.269 . . . . 1.23 113.066 174.642 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -103.27 -2.48 27.1 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.87 2.068 . . . . 2.8900000000000001 112.151 -169.005 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -122.48 155.79 61.93 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 128.099 2.56 . . . . 1.98 109.782 175.547 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.63 140.65 21.34 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.777 2.318 . . . . 1.22 111.086 -172.186 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.8 mt -93.31 150.01 20.8 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 123.21 1.481 . . . . 2.0800000000000001 112.029 172.275 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -134.89 113.87 11.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 112.303 -2.226 . . . . 1.98 110.165 177.387 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.8 tp -95.86 111.57 23.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.669 1.588 . . . . 2.1600000000000001 108.93 -177.13 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.2 m -107.22 -19.81 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.548 1.139 . . . . 0.91000000000000003 112.273 -169.867 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.42 -174.61 28.36 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.384 1.468 . . . . 0.84999999999999998 113.22 177.487 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.57 -176.73 4.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.764 1.626 . . . . 0.87 109.348 167.456 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.12 175.23 13.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.767 1.627 . . . . 5.0199999999999996 108.42 161.811 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.9 t -171.57 156.14 4.2 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 125.657 1.583 . . . . 0.76000000000000001 108.417 -173.904 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.91 -10.55 14.06 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.805 1.67 . . . . 0.91000000000000003 112.895 171.925 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.6 46.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.232 1.013 . . . . 0.91000000000000003 113.461 -176.384 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.58 153.28 14.96 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.216 1.406 . . . . 1.0 110.68 164.704 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -88.39 -47.22 8.53 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.649 1.18 . . . . 2.8599999999999999 110.229 172.511 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -104.89 133.7 49.25 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 126.33 1.852 . . . . 6.6600000000000001 107.53 166.755 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.11 148.0 22.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.812 -1.181 . . . . 1.28 107.812 150.357 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -156.81 149.3 23.37 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 126.26 1.824 . . . . 3.04 107.73 -172.189 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.7 pt? -100.48 139.92 35.48 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 122.894 1.33 . . . . 1.75 112.614 173.097 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -119.93 149.75 41.61 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.724 2.009 . . . . 0.88 111.5 178.619 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -86.62 162.38 18.0 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.335 1.454 . . . . 2.6699999999999999 110.925 162.849 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.9 m -129.26 130.45 46.24 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 106.409 -1.701 . . . . 1.0 106.409 167.972 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -135.44 168.46 19.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.698 1.135 . . . . 2.1299999999999999 113.949 -174.347 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.7 ttm -100.25 146.13 27.26 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.601 1.56 . . . . 3.8399999999999999 109.972 165.218 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.75 153.66 32.61 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.627 1.171 . . . . 4.8700000000000001 110.475 -171.777 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -95.26 137.81 33.81 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.124 0.97 . . . . 3.6099999999999999 109.871 169.431 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.0 t -130.8 119.32 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 106.703 -1.591 . . . . 2.6200000000000001 106.703 164.548 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 60.88 18.0 8.33 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 116.154 1.909 . . . . 5.46 116.154 178.004 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.38 2.69 67.78 Favored Glycine 0 N--CA 1.479 1.552 0 O-C-N 120.826 -1.171 . . . . 2.21 114.354 -171.474 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.23 125.56 52.38 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.464 1.906 . . . . 3.75 109.852 176.529 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -74.95 119.17 18.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.667 -1.606 . . . . 5.3799999999999999 109.45 -179.651 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.0 m -122.53 177.72 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 127.594 2.358 . . . . 2.1899999999999999 109.674 177.68 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 56.5 mtt -118.0 158.45 24.92 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.232 1.013 . . . . 2.77 111.243 167.816 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.82 -177.38 25.5 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 126.16 1.838 . . . . 0.68999999999999995 112.243 -176.447 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.9 ttm -157.57 142.94 17.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.856 1.662 . . . . 0.84999999999999998 109.426 -171.656 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.15 159.18 43.25 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 127.327 2.251 . . . . 8.1999999999999993 109.545 -174.361 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -84.65 144.9 10.2 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.129 2.553 . . . . 0.84999999999999998 111.343 173.285 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.7 m -133.51 162.38 58.02 Favored Pre-proline 0 N--CA 1.486 1.368 0 CA-C-O 118.317 -0.849 . . . . 0.94999999999999996 111.749 -175.892 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -89.89 -25.06 0.53 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.282 1.988 . . . . 0.90000000000000002 114.215 -163.087 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -178.76 166.34 1.68 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.865 1.266 . . . . 2.1299999999999999 112.96 -177.677 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.9 mt -114.81 153.14 30.95 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.892 1.677 . . . . 0.87 110.837 165.567 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -120.2 142.96 48.52 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.489 1.516 . . . . 1.8899999999999999 109.448 177.828 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.7 t -138.57 139.22 23.9 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.469 0.708 . . . . 1.05 112.139 172.022 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -84.86 156.15 11.64 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 124.392 3.395 . . . . 1.4399999999999999 112.869 177.643 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.58 143.77 82.49 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.979 3.12 . . . . 1.27 113.94 -173.234 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt 68.7 -11.28 0.43 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.234 2.614 . . . . 1.75 114.763 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.98 168.49 50.94 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.787 1.184 . . . . 1.8300000000000001 112.752 172.554 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.87 151.24 49.31 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.969 0.908 . . . . 5.04 110.646 162.488 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.2 t -136.19 174.6 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 129.338 3.055 . . . . 3.7999999999999998 106.038 175.312 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -154.14 161.12 42.09 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 119.738 -1.851 . . . . 4.0099999999999998 108.593 171.247 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 83' ' ' HIS . 2.3 mp -56.0 -43.75 77.99 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.091 1.145 . . . . 3.71 114.091 -164.798 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt 71.43 110.88 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 128.632 2.773 . . . . 5.3499999999999996 111.236 -178.707 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -62.87 -34.79 70.76 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.886 1.724 . . . . 2.7999999999999998 111.683 -176.504 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.48 43.07 2.85 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.235 1.397 . . . . 2.1800000000000002 113.253 164.602 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.66 -36.04 0.06 OUTLIER Glycine 0 C--O 1.219 -0.799 0 N-CA-C 120.698 3.039 . . . . 2.5699999999999998 120.698 162.352 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -144.64 146.22 32.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 119.549 1.674 . . . . 2.1299999999999999 113.236 168.647 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.649 ' HA ' HD23 ' A' ' 77' ' ' LEU . 56.6 p-80 -161.76 153.2 18.61 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.413 -0.804 . . . . 0.75 111.096 175.278 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -78.72 141.44 37.87 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.693 -0.484 . . . . 1.8999999999999999 109.693 167.856 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -105.73 134.75 48.35 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.027 1.731 . . . . 0.81000000000000005 109.242 165.465 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -111.1 122.91 49.09 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.518 1.527 . . . . 0.76000000000000001 108.468 176.932 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.0 mp -120.98 138.3 54.21 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.612 0.765 . . . . 1.79 109.335 176.84 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.12 45.42 11.62 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.319 -0.712 . . . . 0.94999999999999996 112.543 178.422 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 pp -53.67 154.75 3.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 123.271 1.51 . . . . 1.3500000000000001 114.82 176.513 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -109.69 -10.47 14.81 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 113.224 -1.807 . . . . 2.1899999999999999 113.541 -175.13 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 mtp-105 -145.16 143.64 21.06 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 126.775 2.03 . . . . 4.7999999999999998 108.19 169.545 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -68.69 151.3 74.81 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.405 2.07 . . . . 1.8300000000000001 109.698 171.02 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 64.8 mt -116.73 92.35 3.84 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.019 0.928 . . . . 2.2000000000000002 110.131 -166.588 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.6 pttm -83.63 164.03 19.96 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.54 -0.725 . . . . 5.3200000000000003 112.126 170.675 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.27 126.21 26.76 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.314 -0.866 . . . . 1.3600000000000001 108.676 168.775 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.23 33.12 50.14 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.428 1.013 . . . . 1.4199999999999999 113.81 179.187 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -81.74 179.86 7.66 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.482 1.141 . . . . 2.71 108.483 143.893 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -134.54 150.61 50.77 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.085 -1.82 . . . . 3.8799999999999999 106.085 164.23 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 49.8 t -138.25 133.51 43.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 126.443 1.897 . . . . 0.95999999999999996 110.239 -173.599 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -78.84 137.05 37.51 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.177 -0.465 . . . . 2.73 110.815 172.738 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.75 133.9 54.93 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.92 1.288 . . . . 1.6699999999999999 110.684 168.251 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -84.87 141.67 30.27 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 125.483 1.513 . . . . 2.7200000000000002 108.799 158.957 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -110.28 126.33 54.07 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.454 1.502 . . . . 1.1200000000000001 109.026 168.8 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.2 mt -104.36 117.86 35.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.897 1.279 . . . . 0.88 110.061 -178.68 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -116.73 149.11 40.41 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.781 1.232 . . . . 2.0099999999999998 111.839 -174.468 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.7 139.35 58.32 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.249 1.203 . . . . 2.04 114.249 -172.294 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.39 45.5 29.8 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.195 -0.781 . . . . 3.2000000000000002 113.255 175.876 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.46 35.74 11.59 Favored Glycine 0 N--CA 1.47 0.917 0 N-CA-C 116.074 1.19 . . . . 1.72 116.074 163.587 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -122.81 145.98 47.94 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.832 1.816 . . . . 3.2999999999999998 112.579 172.32 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.7 t -143.6 142.47 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.009 1.323 . . . . 2.04 108.955 177.281 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 42.1 tp -143.43 119.74 10.89 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.795 0.838 . . . . 2.8799999999999999 110.874 -178.905 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 125.76 38.27 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.767 0.827 . . . . 2.9199999999999999 111.62 178.334 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.468 HG12 ' H ' ' A' ' 114' ' ' VAL . 0.3 OUTLIER -138.77 -174.46 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.851 1.66 . . . . 3.1299999999999999 109.954 176.438 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.468 ' H ' HG12 ' A' ' 113' ' ' VAL . 11.3 t -137.2 150.04 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.431 1.492 . . . . 2.0899999999999999 109.565 -168.626 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.6 mt -142.8 143.74 26.87 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 127.366 2.266 . . . . 1.95 109.048 -176.739 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.32 162.12 43.53 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.027 2.484 . . . . 0.80000000000000004 111.443 168.291 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 85.1 t -94.03 122.32 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 121.744 -0.598 . . . . 0.89000000000000001 110.227 165.795 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.11 164.76 18.78 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.356 1.862 . . . . 4.4900000000000002 110.731 178.166 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.46 67.8 1.08 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.526 1.306 . . . . 2.2799999999999998 114.526 -154.241 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 . . . . . 0 C--O 1.251 1.132 1 C-N-CA 133.154 4.582 . . . . 8.5099999999999998 113.049 170.974 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 . . . . . 0 CA--C 1.549 0.942 0 N-CA-C 109.391 -0.596 . . . . 4.7800000000000002 109.391 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.69 177.75 40.6 Favored Glycine 0 N--CA 1.469 0.892 0 O-C-N 121.189 -0.944 . . . . 0.94999999999999996 114.42 -165.291 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -155.62 138.49 15.33 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.108 1.363 . . . . 2.04 112.097 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.1 t -77.56 142.81 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 120.447 -1.408 . . . . 0.97999999999999998 107.343 167.361 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 -85.0 127.13 34.06 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.661 -0.649 . . . . 6.6500000000000004 110.373 -178.0 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -44.77 141.47 2.09 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.09 1.356 . . . . 2.0299999999999998 112.109 172.71 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.5 t -148.11 148.99 31.27 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 122.877 0.471 . . . . 2.79 111.502 165.904 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.0 -23.83 8.87 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.299 2.0 . . . . 2.3399999999999999 112.899 172.624 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -125.38 -156.64 9.4 Favored Glycine 0 CA--C 1.544 1.878 0 C-N-CA 125.332 1.444 . . . . 1.48 115.76 -160.495 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.24 -14.47 10.67 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.873 3.715 . . . . 1.52 115.171 -167.757 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -122.49 151.35 41.41 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.05 2.14 . . . . 2.4100000000000001 112.746 -178.949 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.16 -176.77 6.16 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.435 1.894 . . . . 0.90000000000000002 112.986 -163.701 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.79 158.52 44.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.568 1.947 . . . . 0.83999999999999997 109.343 174.956 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.56 134.85 31.16 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.706 1.139 . . . . 0.59999999999999998 112.965 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -107.61 135.79 48.46 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.55 1.54 . . . . 3.04 108.37 172.547 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 pp -150.72 156.44 41.31 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.437 -1.414 . . . . 1.79 113.347 -166.701 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.4 m -119.03 146.73 44.81 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.397 1.879 . . . . 2.0 109.864 179.379 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 tt -149.6 162.67 39.74 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 128.355 2.662 . . . . 4.6399999999999997 106.989 155.262 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -134.49 133.52 40.47 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.598 -1.314 . . . . 4.1399999999999997 111.053 163.707 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -76.96 111.76 18.44 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 127.298 2.239 . . . . 1.77 110.251 -174.721 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.51 -20.22 41.72 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.166 1.911 . . . . 1.6000000000000001 113.338 177.921 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.06 129.88 3.24 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 124.753 1.168 . . . . 2.9700000000000002 115.897 154.199 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -175.38 -46.41 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 130.831 3.652 . . . . 6.96 105.623 -169.303 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 28' ' ' LEU . 2.5 pt? -126.86 163.01 44.02 Favored Pre-proline 0 C--O 1.24 0.597 0 C-N-CA 127.075 2.15 . . . . 3.8799999999999999 112.052 177.596 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -81.03 144.44 14.94 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.127 2.551 . . . . 1.3700000000000001 109.43 166.215 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.4 mt -98.58 147.54 24.69 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 122.442 1.115 . . . . 1.8799999999999999 110.815 174.983 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -132.57 104.77 6.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 111.775 -2.466 . . . . 2.3799999999999999 110.638 172.061 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.8 tp -88.19 100.51 13.03 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.228 1.411 . . . . 1.8700000000000001 108.914 -173.121 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -101.95 -18.59 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 125.272 1.429 . . . . 0.54000000000000004 112.42 -169.639 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.82 -179.59 31.89 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 124.201 0.905 . . . . 0.47999999999999998 112.956 177.379 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.91 -178.21 5.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.099 1.36 . . . . 0.52000000000000002 109.701 166.685 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.62 -178.42 7.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.022 2.129 . . . . 5.2400000000000002 108.09 165.645 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 t -178.77 154.82 0.85 Allowed Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 127.52 2.328 . . . . 0.77000000000000002 108.796 -176.323 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.63 -8.64 23.81 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.046 1.83 . . . . 0.89000000000000001 113.802 169.409 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.54 44.6 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 114.108 1.151 . . . . 1.01 114.108 -173.055 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.99 147.29 13.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.365 1.066 . . . . 1.1299999999999999 111.107 166.129 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.71 -38.48 13.83 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.038 1.735 . . . . 2.79 111.991 173.788 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.409 HH21 ' CD ' ' A' ' 44' ' ' GLU . 26.7 mtp85 -124.7 149.29 47.38 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 127.668 2.387 . . . . 5.5999999999999996 109.175 177.959 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -157.23 120.52 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 125.642 1.577 . . . . 1.27 110.586 -174.02 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.409 ' CD ' HH21 ' A' ' 42' ' ' ARG . 2.5 mp0 -139.11 132.19 29.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.884 -1.053 . . . . 4.4699999999999998 110.962 -164.474 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.7 tp -81.62 125.56 30.7 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.922 0.489 . . . . 1.5 111.755 -173.891 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -121.02 155.65 33.88 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.747 1.619 . . . . 0.56000000000000005 113.464 175.049 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.99 -176.77 3.34 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.537 1.935 . . . . 3.4399999999999999 110.528 166.415 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.4 m -150.35 143.74 25.05 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.922 1.289 . . . . 0.80000000000000004 108.007 171.836 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -148.34 168.85 21.51 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.346 1.609 . . . . 2.5699999999999998 115.346 -170.686 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.6 mtp -110.92 145.17 38.8 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.283 1.433 . . . . 4.4299999999999997 111.206 162.575 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -137.14 149.4 47.27 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.697 1.999 . . . . 5.3399999999999999 109.985 171.585 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -89.79 140.49 29.54 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.501 -0.926 . . . . 2.7200000000000002 108.501 153.645 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.4 t -140.97 121.71 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 106.112 -1.81 . . . . 2.2599999999999998 106.112 171.597 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 66.89 22.54 10.15 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.93 0.892 . . . . 3.71 112.798 176.596 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.83 19.43 77.68 Favored Glycine 0 N--CA 1.477 1.394 0 O-C-N 120.627 -1.296 . . . . 1.7 113.337 -173.237 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -132.6 127.91 36.01 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.426 1.891 . . . . 2.5299999999999998 108.89 -178.408 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -79.33 125.45 29.52 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.845 0.858 . . . . 5.7199999999999998 112.524 -175.271 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.3 t -121.54 134.05 66.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 128.65 2.78 . . . . 2.3300000000000001 108.583 -176.016 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 37.3 mtt -98.11 149.02 22.95 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.82 0.848 . . . . 2.4199999999999999 110.266 169.179 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.32 -179.13 30.22 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-O 121.917 0.732 . . . . 0.84999999999999998 113.668 -175.039 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ttm -159.88 147.57 16.81 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 125.926 1.69 . . . . 0.70999999999999996 109.886 -171.93 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.59 152.84 23.49 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 113.602 -1.636 . . . . 5.3499999999999996 109.52 -163.956 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -83.33 157.87 14.81 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.289 1.993 . . . . 0.80000000000000004 111.555 176.607 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.97 157.09 54.87 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 125.779 1.632 . . . . 1.01 110.429 -178.49 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.76 -31.77 0.53 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.19 2.593 . . . . 0.63 113.389 -166.819 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -173.39 167.12 4.74 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.087 1.755 . . . . 2.2400000000000002 110.886 -178.601 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.8 mt -110.22 155.2 22.33 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.463 1.105 . . . . 0.68999999999999995 110.936 162.415 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -117.62 137.99 52.25 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.318 1.447 . . . . 2.1499999999999999 108.851 175.995 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.3 t -149.44 132.16 8.06 Favored Pre-proline 0 N--CA 1.476 0.845 0 N-CA-C 113.499 0.926 . . . . 1.0600000000000001 113.499 173.711 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.4 169.55 21.42 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 124.1 3.2 . . . . 1.21 114.234 -177.415 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.04 146.38 96.18 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.93 3.087 . . . . 1.3 111.806 168.201 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.6 mmtt 70.37 -7.73 0.97 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.217 1.807 . . . . 1.5800000000000001 114.089 -176.223 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.42 148.69 20.75 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.386 1.469 . . . . 1.22 113.511 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.95 129.21 34.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.121 1.369 . . . . 4.2699999999999996 111.805 177.113 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.7 t -108.05 80.98 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 128.19 2.596 . . . . 5.9400000000000004 108.469 -165.123 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -138.58 123.04 18.4 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.727 0.775 . . . . 4.1200000000000001 112.994 -158.068 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -80.55 84.19 6.19 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-O 122.857 1.313 . . . . 2.0299999999999998 108.45 175.58 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.29 145.85 97.64 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 113.249 -1.796 . . . . 4.0099999999999998 114.83 -171.749 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -55.81 143.32 81.53 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 123.567 2.845 . . . . 4.0899999999999999 110.693 176.863 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.54 -5.49 44.85 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 116.772 -2.127 . . . . 1.6000000000000001 115.811 176.585 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.81 -22.64 0.33 Allowed Glycine 0 N--CA 1.475 1.292 0 N-CA-C 119.713 2.645 . . . . 2.1800000000000002 119.713 178.085 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -152.47 141.83 21.57 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.683 1.742 . . . . 2.1600000000000001 113.078 179.624 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -162.83 155.46 19.04 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.197 1.399 . . . . 0.62 110.977 174.814 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -84.55 134.5 34.41 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.968 -1.123 . . . . 2.2599999999999998 107.968 163.141 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -82.71 134.06 35.15 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.736 1.214 . . . . 0.64000000000000001 108.06 164.016 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 mp -117.27 135.49 53.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.519 1.128 . . . . 0.85999999999999999 109.345 -179.566 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 mp -132.61 148.89 52.37 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.966 0.906 . . . . 1.6399999999999999 110.975 178.731 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.17 39.58 31.6 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 123.543 0.592 . . . . 1.02 113.836 173.424 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.38 156.41 7.83 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 116.365 1.987 . . . . 1.49 116.365 179.382 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -112.35 -16.14 13.0 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 113.018 -1.901 . . . . 1.95 113.409 -170.102 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -128.47 173.67 5.32 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 129.878 3.271 . . . . 6.7999999999999998 110.95 177.321 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -63.78 -176.75 0.37 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.438 2.092 . . . . 3.1499999999999999 110.917 155.599 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.434 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -167.24 66.32 0.09 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.344 2.658 . . . . 3.1400000000000001 108.287 179.223 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.434 ' HD3' ' H ' ' A' ' 93' ' ' LEU . 2.4 mptt -99.65 164.84 11.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.773 1.229 . . . . 7.3600000000000003 111.06 179.277 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.27 122.01 13.42 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.502 1.121 . . . . 1.29 110.727 -174.537 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.07 4.15 63.25 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.231 1.396 . . . . 1.54 114.574 179.275 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -79.96 -175.05 4.75 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.644 1.222 . . . . 2.4399999999999999 110.501 164.944 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -156.28 139.9 15.97 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.948 1.699 . . . . 3.0899999999999999 108.644 -174.532 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.0 t -146.79 134.98 15.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 126.526 1.93 . . . . 0.93000000000000005 110.874 -163.821 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -78.32 136.13 37.65 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.62 1.168 . . . . 2.7999999999999998 111.176 173.933 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 mp -121.13 136.76 54.92 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.196 0.998 . . . . 1.73 111.688 160.313 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -86.3 145.41 26.93 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.201 2.201 . . . . 2.4900000000000002 110.216 164.423 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -116.52 126.52 53.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.491 1.917 . . . . 0.81999999999999995 109.439 172.295 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.1 mt -103.26 111.75 24.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.308 1.443 . . . . 0.56999999999999995 110.225 -177.176 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -110.44 105.26 14.17 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.901 1.28 . . . . 1.98 112.471 -171.188 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 56.36 18.0 3.18 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.283 1.833 . . . . 2.9300000000000002 114.372 175.83 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.97 -57.88 3.12 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.368 1.461 . . . . 3.8500000000000001 112.085 -166.918 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.97 19.51 2.11 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.66 1.6 . . . . 3.0 116.799 -172.021 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.17 147.97 19.89 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.957 2.903 . . . . 3.0600000000000001 112.047 167.145 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.3 t -143.15 150.09 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.332 1.453 . . . . 2.2400000000000002 108.307 176.508 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.56 171.16 18.55 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.131 1.772 . . . . 3.1800000000000002 108.793 173.449 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -154.89 154.98 33.51 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.694 0.998 . . . . 2.1600000000000001 113.694 179.648 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.4 t -149.11 154.72 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.702 1.201 . . . . 2.1699999999999999 109.578 -172.945 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.81 133.54 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.101 0.96 . . . . 1.8500000000000001 109.319 177.365 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -120.77 147.6 46.34 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 126.507 1.923 . . . . 3.0899999999999999 108.346 175.194 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.23 168.03 15.1 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.51 2.807 . . . . 0.76000000000000001 111.704 163.842 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.7 t -108.27 122.98 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.483 1.113 . . . . 0.93999999999999995 110.827 170.188 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -119.5 152.46 36.91 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.878 1.271 . . . . 4.6500000000000004 113.763 -174.926 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.96 152.4 33.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.597 1.559 . . . . 2.3500000000000001 114.08 -175.026 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.977 0 C-N-CA 129.211 3.004 . . . . 8.0700000000000003 116.33 -165.904 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 . . . . . 0 CA--C 1.543 0.711 0 CA-C-O 121.05 0.452 . . . . 5.9800000000000004 110.063 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.73 172.81 52.22 Favored Glycine 0 C--O 1.221 -0.66 0 O-C-N 121.423 -0.798 . . . . 1.48 112.721 167.611 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -149.61 144.57 26.26 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.828 -0.807 . . . . 2.0299999999999998 110.445 161.757 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -93.82 128.8 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.586 -0.894 . . . . 1.3799999999999999 108.586 177.596 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -74.15 106.7 5.93 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.123 0.569 . . . . 4.3399999999999999 111.609 -170.613 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -43.44 132.74 4.53 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.03 1.332 . . . . 2.3999999999999999 111.421 171.821 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.7 m -151.33 138.27 11.88 Favored Pre-proline 0 CA--C 1.539 0.555 0 O-C-N 120.976 -1.078 . . . . 2.73 111.503 175.315 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -86.29 48.18 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.405 3.403 . . . . 2.21 111.076 178.657 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.49 -179.0 30.28 Favored Glycine 0 CA--C 1.539 1.536 0 N-CA-C 115.774 1.07 . . . . 1.25 115.774 -168.168 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.48 -15.88 21.9 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.624 3.55 . . . . 1.1699999999999999 114.112 -176.042 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -134.62 170.67 15.44 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.801 2.04 . . . . 2.2000000000000002 113.195 -175.596 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.65 -179.3 8.03 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.732 2.013 . . . . 0.58999999999999997 112.413 -177.544 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.95 162.96 20.12 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.49 1.516 . . . . 0.64000000000000001 110.064 165.677 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.65 146.67 33.41 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.126 1.33 . . . . 0.56000000000000005 113.525 174.667 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -115.71 160.95 19.41 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.228 1.811 . . . . 2.96 111.178 173.762 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.4 tp -146.58 138.7 24.85 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.477 1.911 . . . . 2.9900000000000002 109.765 -170.429 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.9 m -131.47 133.6 45.32 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.377 1.471 . . . . 2.3700000000000001 107.196 160.387 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.5 tp -159.67 -178.17 6.9 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 128.149 2.58 . . . . 5.4199999999999999 108.89 -176.712 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -135.16 151.81 51.02 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.277 1.831 . . . . 3.3700000000000001 112.457 171.195 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -91.84 106.89 18.94 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.558 1.543 . . . . 1.73 108.33 168.493 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.72 -13.07 14.76 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.998 1.799 . . . . 1.3799999999999999 113.543 177.51 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.41 173.35 55.23 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-O 123.059 1.366 . . . . 1.1599999999999999 112.754 -175.421 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -100.71 -2.41 32.59 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 128.189 2.595 . . . . 2.8900000000000001 111.478 -179.248 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -113.64 156.09 44.03 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 127.843 2.457 . . . . 2.0600000000000001 110.346 171.588 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.81 151.84 24.88 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.826 2.35 . . . . 0.88 111.312 -175.093 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt -99.29 154.04 18.48 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 122.591 1.186 . . . . 1.76 111.405 168.134 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.1 ttp180 -140.96 111.03 6.6 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 113.532 -1.667 . . . . 2.3700000000000001 110.041 177.37 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.58 111.26 23.61 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.981 1.712 . . . . 1.78 109.576 -171.073 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 m -113.38 -18.29 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.444 1.098 . . . . 0.89000000000000001 112.645 -168.219 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.6 -174.49 29.42 Favored Glycine 0 N--CA 1.469 0.843 0 C-N-CA 125.364 1.459 . . . . 0.68000000000000005 112.837 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.46 -178.0 5.93 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.413 1.085 . . . . 0.67000000000000004 111.535 169.452 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -157.15 177.95 10.9 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 128.19 2.596 . . . . 5.3700000000000001 108.246 164.864 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -177.68 155.42 1.08 Allowed Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 126.738 2.015 . . . . 1.1399999999999999 108.674 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.53 -9.19 24.54 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.752 2.301 . . . . 1.24 114.032 167.791 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.44 48.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 125.063 1.345 . . . . 1.21 114.155 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.47 163.29 30.48 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.337 1.055 . . . . 1.0700000000000001 112.53 164.013 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -96.2 -33.24 12.1 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.085 2.154 . . . . 2.8399999999999999 111.483 170.926 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.0 mtp85 -155.48 156.74 35.78 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 128.446 2.698 . . . . 6.7599999999999998 108.999 -176.564 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.1 p -158.45 107.8 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 125.553 1.541 . . . . 1.77 111.157 -172.629 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -123.78 137.63 54.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.996 -1.456 . . . . 4.9299999999999997 111.068 -167.358 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.6 tp -88.09 126.07 34.91 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.331 1.452 . . . . 1.5 111.958 -169.322 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 37.6 m170 -119.42 158.34 26.4 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.228 1.811 . . . . 0.66000000000000003 113.171 176.535 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -102.31 158.74 15.98 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 113.819 -1.537 . . . . 2.3199999999999998 110.61 157.525 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.0 m -113.42 135.38 53.94 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 106.032 -1.84 . . . . 0.97999999999999998 106.032 159.965 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -128.87 166.67 18.64 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.493 1.14 . . . . 2.1299999999999999 113.582 -175.844 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 61.0 mtt -100.57 146.27 27.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.126 1.37 . . . . 4.4400000000000004 110.655 167.876 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.55 150.32 26.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.789 0.836 . . . . 5.0199999999999996 111.665 -176.413 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -103.88 127.68 51.39 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.119 1.368 . . . . 3.21 107.787 166.756 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.3 t -146.56 138.24 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 106.064 -1.828 . . . . 2.6699999999999999 106.064 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 66.58 22.19 10.58 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 119.002 0.819 . . . . 3.27 112.07 177.23 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.31 18.57 79.95 Favored Glycine 0 N--CA 1.475 1.258 0 O-C-N 121.101 -1.0 . . . . 1.72 113.523 -173.983 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -141.23 132.63 26.77 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.822 1.649 . . . . 3.0499999999999998 110.833 -168.704 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -70.68 129.4 39.04 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.586 1.554 . . . . 4.5199999999999996 111.435 173.076 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.6 m -138.32 169.47 18.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 129.188 2.995 . . . . 2.6400000000000001 109.515 -177.947 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 49.6 mtm -116.39 146.01 42.81 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.431 1.092 . . . . 2.5 110.712 168.938 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.73 -177.13 14.73 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 126.016 1.77 . . . . 0.82999999999999996 111.916 -178.845 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.1 ttm -150.55 148.9 29.24 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.512 1.525 . . . . 0.98999999999999999 108.746 -177.645 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -155.86 155.45 29.39 Favored Pre-proline 0 N--CA 1.476 0.85 0 CA-C-O 118.309 -0.853 . . . . 5.9500000000000002 111.327 172.689 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -70.35 153.42 66.23 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.93 1.753 . . . . 0.81000000000000005 110.805 172.93 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.4 m -140.47 151.2 63.27 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 125.145 1.378 . . . . 0.84999999999999998 109.767 -179.542 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.81 -26.28 3.79 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.897 2.398 . . . . 0.75 113.178 -164.02 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -174.82 165.65 3.63 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.584 1.554 . . . . 2.04 112.209 -179.272 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.7 mt -108.33 154.6 21.59 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.008 1.323 . . . . 0.56000000000000005 110.346 161.677 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -110.36 147.89 33.05 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.166 1.386 . . . . 1.8600000000000001 109.186 172.76 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.7 t -144.24 133.65 11.49 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 123.259 0.624 . . . . 1.02 112.122 169.602 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.19 168.18 21.55 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.049 2.5 . . . . 1.1799999999999999 112.881 176.819 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.0 144.83 96.72 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.888 3.059 . . . . 1.0600000000000001 111.845 167.245 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt 66.74 -7.19 0.47 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.877 1.671 . . . . 1.8600000000000001 114.207 179.844 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.92 165.78 51.32 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.526 1.536 . . . . 1.1599999999999999 112.299 -179.904 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -82.75 135.74 34.9 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 121.886 0.85 . . . . 4.9800000000000004 110.146 172.572 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.3 t -98.94 81.74 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 127.786 2.435 . . . . 6.5099999999999998 105.822 -176.119 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -138.37 129.26 26.81 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.07 1.414 . . . . 3.8999999999999999 112.674 -161.754 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 83' ' ' HIS . 8.5 mp -71.19 167.55 19.12 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 113.459 -1.7 . . . . 3.4700000000000002 109.276 167.462 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.59 133.37 21.9 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 120.205 -1.559 . . . . 3.8799999999999999 108.018 179.315 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.53 -17.88 60.55 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.036 2.49 . . . . 3.6699999999999999 114.525 -171.832 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.48 -21.15 4.46 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 124.551 1.072 . . . . 3.0800000000000001 115.257 164.911 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.85 -110.53 0.57 Allowed Glycine 0 N--CA 1.473 1.126 0 C-N-CA 125.475 1.512 . . . . 1.9399999999999999 111.933 -176.58 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -68.69 139.17 55.4 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.641 0.734 . . . . 1.8200000000000001 111.653 -171.588 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.462 ' HA ' HD23 ' A' ' 77' ' ' LEU . 56.5 p-80 -159.43 143.98 15.27 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.517 1.127 . . . . 0.81999999999999995 110.63 -174.451 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -78.28 156.01 29.9 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.14 -0.689 . . . . 1.72 109.14 166.283 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.2 mtp -117.8 129.76 55.87 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 122.874 0.47 . . . . 1.73 111.459 159.472 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.07 136.62 43.36 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.441 1.896 . . . . 0.70999999999999996 108.243 -172.729 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mp -124.49 152.43 43.4 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.354 1.061 . . . . 1.6699999999999999 110.939 -177.233 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.34 -36.11 2.59 Favored Glycine 0 N--CA 1.469 0.852 0 C-N-CA 125.112 1.339 . . . . 2.5699999999999998 113.712 175.615 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 68.95 -32.39 0.22 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 128.496 2.718 . . . . 3.5299999999999998 116.883 166.05 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 66.37 -23.85 0.1 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 129.637 3.175 . . . . 1.98 115.519 178.595 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -145.42 146.51 30.18 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.688 1.995 . . . . 6.7300000000000004 111.508 -171.076 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.53 155.75 36.05 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.357 2.705 . . . . 2.6099999999999999 109.525 158.867 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -166.53 160.2 15.06 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.097 1.759 . . . . 3.3599999999999999 109.386 -170.271 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -174.45 2.5 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.991 1.317 . . . . 6.0499999999999998 111.068 168.077 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.04 169.39 3.39 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 120.841 -1.162 . . . . 1.6200000000000001 109.522 154.281 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.56 35.34 90.96 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.038 1.304 . . . . 1.3100000000000001 113.58 178.542 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -105.45 -177.88 3.49 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.222 1.009 . . . . 3.3399999999999999 108.866 167.334 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -134.57 143.52 47.42 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.202 1.801 . . . . 3.6800000000000002 106.824 169.922 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.2 t -142.18 138.11 30.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 128.476 2.71 . . . . 1.02 109.226 -172.659 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -98.7 154.23 18.13 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.395 0.887 . . . . 2.4199999999999999 113.395 172.783 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.19 132.58 30.12 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.055 1.742 . . . . 2.1600000000000001 110.839 -177.334 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -78.62 130.25 35.69 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.576 1.55 . . . . 2.5800000000000001 108.782 163.832 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.2 mp -97.56 126.7 43.0 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.221 1.008 . . . . 0.95999999999999996 109.087 166.527 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.0 mt -96.66 109.75 22.32 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.265 1.026 . . . . 0.95999999999999996 109.173 176.481 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -105.63 143.53 33.65 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.685 1.194 . . . . 1.8899999999999999 111.109 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.41 145.48 51.52 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.829 0.852 . . . . 1.6399999999999999 113.118 -177.53 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.92 30.94 56.85 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 118.645 -1.086 . . . . 3.4900000000000002 113.852 172.378 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.97 44.27 5.45 Favored Glycine 0 N--CA 1.471 1.033 0 CA-C-N 118.421 1.111 . . . . 2.0800000000000001 115.094 168.376 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -131.63 145.03 51.47 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.587 1.193 . . . . 3.8199999999999998 112.031 174.491 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 94.1 t -143.8 146.51 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.103 1.361 . . . . 2.25 109.066 176.952 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tt -147.17 120.21 8.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.967 1.307 . . . . 2.2799999999999998 109.276 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp -94.39 112.64 24.43 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.902 -0.499 . . . . 2.3700000000000001 111.657 179.081 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.3 m -89.69 166.24 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 125.594 1.558 . . . . 2.3799999999999999 111.43 176.825 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.7 p -126.84 143.18 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.039 0.936 . . . . 2.9700000000000002 109.17 165.602 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.92 154.05 25.57 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.881 1.672 . . . . 2.4300000000000002 112.17 -171.171 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.39 162.38 40.84 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.353 2.702 . . . . 1.23 114.002 174.285 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.0 t -103.58 124.46 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.535 1.534 . . . . 1.0900000000000001 108.148 164.471 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -152.95 173.91 14.79 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.947 1.299 . . . . 4.5899999999999999 109.965 -178.624 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.93 167.76 15.63 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.961 1.467 . . . . 3.8199999999999998 114.961 -172.5 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.606 ' HG3' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.231 0 C-N-CA 128.914 2.886 . . . . 8.4199999999999999 108.671 150.572 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 . . . . . 0 CA--C 1.544 0.735 0 CA-C-O 121.697 0.761 . . . . 5.5599999999999996 110.625 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -145.19 166.96 27.47 Favored Glycine 0 N--CA 1.47 0.916 0 O-C-N 120.714 -1.241 . . . . 1.3100000000000001 111.882 -175.517 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -155.29 167.74 29.37 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.93 1.456 . . . . 1.72 114.93 -175.919 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.2 t -119.41 137.78 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 126.428 1.891 . . . . 0.96999999999999997 110.628 -177.606 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.469 ' O ' ' HD3' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -46.99 -31.76 3.43 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 118.178 2.658 . . . . 4.1399999999999997 118.178 -158.281 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 70.47 136.25 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 125.481 1.513 . . . . 3.1000000000000001 112.902 -164.348 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.5 t 176.52 151.45 0.35 Allowed Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 128.749 2.82 . . . . 2.7400000000000002 110.726 166.353 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.69 -7.59 18.64 Favored 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 122.937 2.424 . . . . 2.6899999999999999 113.586 164.938 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.49 172.99 49.33 Favored Glycine 0 CA--C 1.543 1.795 0 C-N-CA 124.834 1.207 . . . . 1.28 115.552 -172.122 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.95 -15.8 11.64 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 125.237 3.958 . . . . 1.3 115.018 -171.64 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -125.04 149.48 47.73 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.076 2.15 . . . . 2.25 112.657 179.093 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.17 -176.22 5.85 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.453 1.501 . . . . 0.56000000000000005 112.599 -166.012 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.62 162.15 37.37 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.791 2.036 . . . . 0.71999999999999997 109.732 177.874 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.07 141.57 30.14 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.693 1.133 . . . . 0.53000000000000003 113.378 -178.492 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -130.48 62.88 1.58 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.428 1.891 . . . . 2.6899999999999999 111.891 -163.019 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -81.24 158.63 24.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.651 1.215 . . . . 1.9299999999999999 114.12 179.354 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.78 101.83 14.22 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.096 1.758 . . . . 2.96 109.447 -179.161 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.86 114.46 20.49 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.325 -0.62 . . . . 3.0299999999999998 109.325 178.486 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -122.68 125.68 46.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.198 1.799 . . . . 4.0700000000000003 108.08 174.694 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -91.1 118.87 68.82 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.869 0.868 . . . . 1.55 109.303 178.954 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.35 -12.29 29.55 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.632 2.222 . . . . 1.5900000000000001 113.878 177.903 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.81 115.94 0.22 Allowed Glycine 0 C--N 1.338 0.671 0 C-N-CA 126.943 2.211 . . . . 2.8300000000000001 113.247 171.666 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 t0 176.08 -42.46 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 105.231 -2.137 . . . . 8.5800000000000001 105.231 -141.846 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -165.78 178.22 1.37 Allowed Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 130.212 3.405 . . . . 4.54 108.557 170.129 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.15 127.48 8.43 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 N-CA-C 107.315 -1.84 . . . . 1.1200000000000001 107.315 156.297 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.0 mt -86.5 145.65 26.71 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.578 -1.192 . . . . 2.04 110.526 -177.132 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.1 100.96 5.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 112.257 -2.247 . . . . 3.4500000000000002 109.073 174.632 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.17 108.58 12.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.885 -1.524 . . . . 2.3900000000000001 106.885 176.227 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -103.86 -23.1 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.129 0.972 . . . . 0.59999999999999998 111.619 -174.743 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.59 -179.05 33.17 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 124.406 1.003 . . . . 0.46999999999999997 114.213 -175.464 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.72 -176.63 6.01 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.953 0.901 . . . . 0.53000000000000003 112.894 173.548 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -157.44 165.96 34.28 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.456 2.302 . . . . 4.7800000000000002 108.111 -173.512 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -166.0 153.75 9.52 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.375 1.07 . . . . 0.60999999999999999 109.527 168.017 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.37 -8.18 18.11 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.205 1.937 . . . . 0.66000000000000003 113.211 167.897 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.83 50.15 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.005 1.322 . . . . 0.76000000000000001 113.17 -179.84 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.08 123.38 1.16 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.977 1.311 . . . . 1.3500000000000001 110.247 160.191 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.59 -24.07 63.63 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.571 0.952 . . . . 3.7200000000000002 113.571 173.581 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -141.31 142.39 33.84 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.813 1.245 . . . . 5.5800000000000001 109.898 174.428 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.27 145.85 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.599 1.56 . . . . 1.27 109.287 171.236 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -114.98 158.76 21.61 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.187 1.795 . . . . 3.48 109.157 163.696 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.1 tp -112.02 119.1 37.32 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 122.965 0.506 . . . . 1.0600000000000001 110.546 170.117 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -122.92 163.04 21.1 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.008 1.323 . . . . 0.63 114.117 -174.304 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -115.34 -178.02 3.28 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.825 1.65 . . . . 3.4199999999999999 113.901 159.023 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.2 m -154.88 141.49 18.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.133 1.773 . . . . 0.80000000000000004 108.92 179.259 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -148.93 170.49 18.2 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.705 1.202 . . . . 2.0299999999999998 112.842 -165.627 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.9 mtt -95.63 147.55 23.47 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.296 1.038 . . . . 4.25 110.582 167.655 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.95 156.01 33.79 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.761 1.224 . . . . 4.54 110.713 -175.084 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' OE1' ' HE3' ' A' ' 57' ' ' LYS . 3.6 tp10 -104.55 137.87 41.74 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.779 1.232 . . . . 2.6899999999999999 109.938 169.615 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.7 t -131.54 118.37 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 106.694 -1.595 . . . . 2.1400000000000001 106.694 163.026 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 62.77 33.17 15.58 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.282 1.033 . . . . 3.5499999999999998 113.265 175.353 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.58 5.56 86.13 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 120.5 -1.375 . . . . 1.6200000000000001 113.692 -175.212 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -115.34 124.85 52.31 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.333 1.853 . . . . 2.7000000000000002 110.132 -176.604 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HE3' ' OE1' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -57.36 128.51 37.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.093 2.157 . . . . 4.0599999999999996 109.859 179.668 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.39 151.41 35.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 127.967 2.507 . . . . 2.9700000000000002 107.971 175.471 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 36.6 mtt -115.39 129.73 56.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.144 0.578 . . . . 2.5299999999999998 109.563 160.429 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.31 175.69 16.41 Favored Glycine 0 N--CA 1.466 0.663 0 C-N-CA 124.293 0.949 . . . . 0.66000000000000003 112.732 -172.166 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.1 ttm -152.21 139.02 18.9 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.498 1.519 . . . . 0.68999999999999995 110.677 -172.292 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -146.06 151.31 44.65 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 125.783 1.633 . . . . 7.9199999999999999 110.982 -177.067 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.77 150.7 50.48 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.447 2.098 . . . . 0.68999999999999995 110.637 172.619 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.51 147.89 61.65 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.846 1.258 . . . . 0.68000000000000005 110.057 -176.443 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.96 -19.87 13.57 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.983 3.122 . . . . 0.71999999999999997 113.342 -164.98 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -177.2 168.5 2.35 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.355 2.262 . . . . 2.1699999999999999 109.461 178.266 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.8 mt -111.65 153.52 26.25 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.874 1.27 . . . . 0.58999999999999997 109.04 159.327 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -124.23 142.09 51.53 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.741 0.816 . . . . 2.5699999999999998 110.284 177.689 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.6 t -141.27 129.81 12.36 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 123.664 0.786 . . . . 1.01 111.362 174.678 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.79 158.31 46.87 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.832 3.021 . . . . 1.0700000000000001 112.116 178.787 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.49 137.99 77.56 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.541 2.828 . . . . 1.1699999999999999 112.305 -177.177 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt 73.88 -13.08 0.79 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.188 2.195 . . . . 2.1400000000000001 114.237 -177.038 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.73 179.32 44.37 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.659 1.6 . . . . 1.3200000000000001 114.819 -176.97 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -126.41 156.16 41.03 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.56 1.544 . . . . 3.96 112.054 175.692 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.0 t -149.29 116.84 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.573 1.549 . . . . 4.04 107.763 154.349 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -76.69 142.98 40.34 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.941 -1.099 . . . . 3.1699999999999999 112.348 -179.576 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 mp -71.53 73.41 0.75 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 123.338 1.542 . . . . 2.1899999999999999 108.04 160.254 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -69.49 142.62 92.13 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.921 1.688 . . . . 5.46 113.688 -171.279 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -66.88 -4.52 11.45 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.947 3.098 . . . . 2.2999999999999998 114.501 178.993 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.32 51.53 0.77 Allowed Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.534 1.54 . . . . 1.6699999999999999 110.57 165.835 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.01 -123.26 1.05 Allowed Glycine 0 N--CA 1.464 0.537 0 C-N-CA 124.196 0.903 . . . . 1.5900000000000001 113.913 -177.166 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -73.25 136.84 44.65 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 121.573 0.701 . . . . 2.21 111.392 -169.13 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -162.62 156.28 20.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.774 -0.648 . . . . 0.54000000000000004 111.288 -179.352 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -81.45 146.46 30.24 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.714 -0.476 . . . . 1.95 109.714 164.627 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 tpt -100.05 130.84 46.25 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.206 -1.035 . . . . 0.65000000000000002 108.206 161.016 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -113.41 138.95 49.34 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.19 1.396 . . . . 0.56000000000000005 109.574 -178.292 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mp -137.66 146.41 43.82 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.046 1.338 . . . . 1.71 110.794 179.15 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.18 44.43 66.37 Favored Glycine 0 N--CA 1.472 1.051 0 O-C-N 121.691 -0.631 . . . . 0.85999999999999999 112.342 176.338 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 pp -62.14 151.3 36.18 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 123.194 1.473 . . . . 1.24 114.785 178.56 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.31 -2.22 18.01 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 113.748 -1.569 . . . . 2.52 112.971 -177.121 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -137.21 131.83 17.78 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 126.529 1.932 . . . . 5.2199999999999998 107.695 153.751 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -63.03 154.2 68.74 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.858 1.705 . . . . 2.29 108.137 160.407 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.6 mt -111.97 97.41 6.66 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.682 1.193 . . . . 2.5 109.7 -155.693 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 136.65 34.94 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.474 1.11 . . . . 3.9500000000000002 111.774 173.716 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.59 121.3 6.84 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.779 -1.101 . . . . 1.53 108.527 164.165 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.68 -2.35 52.83 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.872 1.701 . . . . 1.6000000000000001 116.037 -176.825 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -82.17 -170.67 3.01 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.906 1.853 . . . . 2.3900000000000001 112.327 168.327 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -147.87 136.44 21.69 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 129.194 2.998 . . . . 3.4500000000000002 106.598 -172.28 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.4 t -140.07 132.69 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.804 1.642 . . . . 1.0900000000000001 111.618 -175.684 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -79.56 143.82 34.45 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.318 0.647 . . . . 2.8799999999999999 112.409 172.138 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mp -127.67 139.67 52.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.026 1.33 . . . . 1.6499999999999999 110.987 161.535 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -102.23 122.85 45.0 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 127.533 2.333 . . . . 2.8700000000000001 108.359 174.238 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -104.29 116.67 32.57 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.418 1.008 . . . . 1.0600000000000001 111.123 -167.786 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -84.92 105.28 15.57 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.897 0.879 . . . . 0.81999999999999995 110.319 -177.387 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -103.11 106.41 16.92 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.889 1.676 . . . . 2.0800000000000001 111.172 -179.23 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 56.33 20.63 4.79 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.491 1.916 . . . . 2.3300000000000001 113.711 177.334 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.22 -56.64 3.65 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.381 1.467 . . . . 4.04 112.485 -171.454 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.02 -10.12 77.26 Favored Glycine 0 CA--C 1.533 1.214 0 N-CA-C 116.118 1.207 . . . . 2.0 116.118 -169.486 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -125.47 145.1 50.23 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.944 1.298 . . . . 4.6900000000000004 111.077 171.779 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.7 p -144.1 146.29 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 125.836 1.654 . . . . 1.9199999999999999 110.474 173.328 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.8 tt -156.29 134.85 11.61 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.644 1.978 . . . . 2.0699999999999998 108.226 -175.446 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -101.05 153.91 19.15 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.148 1.166 . . . . 2.5600000000000001 114.148 176.079 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.4 t -135.82 158.66 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.568 1.947 . . . . 1.98 108.525 175.04 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.7 p -129.98 128.64 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.102 0.961 . . . . 2.3900000000000001 110.046 -177.929 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.99 144.24 43.01 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.671 1.188 . . . . 1.97 111.493 -168.368 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -62.52 155.59 57.29 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.27 2.647 . . . . 0.73999999999999999 112.666 176.545 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 67.4 t -91.59 125.14 44.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 107.475 -1.306 . . . . 0.88 107.475 165.16 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -153.45 167.21 30.2 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.01 1.724 . . . . 3.9399999999999999 110.565 175.188 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.78 152.71 37.3 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.264 1.209 . . . . 3.7999999999999998 114.264 -165.96 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.554 1.942 . . . . 9.1500000000000004 114.713 166.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.144 0 N-CA-C 108.764 -1.735 . . . . 9.1899999999999995 108.764 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.9 t 131.71 -116.46 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 130.029 3.332 . . . . 8.2100000000000009 103.497 -158.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -132.59 112.82 12.39 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.699 1.2 . . . . 8.4600000000000009 109.211 158.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.859 ' H ' HG21 ' A' ' 21' ' ' THR 0.422 0.4 OUTLIER 82.9 -2.42 1.28 Allowed 'General case' 0 N--CA 1.489 1.478 1 C-N-CA 135.744 5.618 . . . . 5.5899999999999999 115.428 -11.728 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -124.5 -179.45 4.49 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.037 1.335 . . . . 5.4800000000000004 113.038 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.98 -176.9 28.65 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 126.807 2.146 . . . . 1.01 112.787 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.8 p90 -148.11 146.34 28.76 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.953 1.301 . . . . 1.75 110.412 171.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.5 t -90.2 142.59 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.369 -0.974 . . . . 1.1299999999999999 108.369 170.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 64.3 ttt-85 -85.78 131.52 34.3 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.991 0.516 . . . . 3.5099999999999998 112.332 -173.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -40.84 137.36 1.22 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.032 2.133 . . . . 2.02 112.782 169.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -175.81 126.6 0.36 Allowed Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 127.142 2.177 . . . . 2.7599999999999998 111.037 165.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -87.13 0.1 7.62 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.928 3.086 . . . . 2.5699999999999998 112.131 164.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.54 -166.27 40.96 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.141 1.353 . . . . 1.3799999999999999 112.852 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.08 -24.52 23.63 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.67 2.246 . . . . 1.6599999999999999 113.546 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -138.87 163.2 32.91 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.198 1.399 . . . . 2.1400000000000001 113.923 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.28 -175.74 5.48 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 130.324 3.45 . . . . 0.51000000000000001 109.394 -172.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.37 156.87 43.05 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.844 2.057 . . . . 0.60999999999999999 109.169 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.89 133.54 33.97 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.711 1.141 . . . . 0.52000000000000002 112.817 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 43.2 m-85 -115.79 140.98 48.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.798 2.039 . . . . 2.3199999999999998 110.332 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -168.13 156.43 8.78 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.915 1.234 . . . . 1.77 113.318 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.859 HG21 ' H ' ' A' ' 4' ' ' THR . 86.5 m -95.24 108.52 20.67 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.418 1.087 . . . . 2.0099999999999998 111.119 -176.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.8 130.28 34.53 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.446 0.566 . . . . 2.71 109.909 173.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -131.98 135.19 46.37 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.69 1.596 . . . . 4.3399999999999999 109.582 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -105.78 110.25 63.97 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 125.139 1.375 . . . . 1.3799999999999999 110.319 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.34 -11.56 10.7 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.901 2.401 . . . . 1.02 113.927 176.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.43 174.87 50.76 Favored Glycine 0 C--N 1.338 0.693 0 CA-C-O 122.964 1.313 . . . . 1.2 112.969 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.04 -4.42 32.51 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.45 2.7 . . . . 2.8700000000000001 111.309 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -119.44 156.83 52.84 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 128.247 2.619 . . . . 1.8999999999999999 109.9 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.87 143.78 26.79 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.867 2.378 . . . . 0.82999999999999996 110.964 -174.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.3 mt -102.84 150.92 23.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 122.767 1.27 . . . . 1.79 110.036 170.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -142.63 109.83 5.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.577 -2.101 . . . . 2.1600000000000001 112.833 -172.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.0 tp -87.82 107.09 18.5 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.33 1.852 . . . . 1.8300000000000001 109.951 -175.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.8 m -108.49 -18.12 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.155 0.982 . . . . 0.51000000000000001 112.455 -172.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.31 -178.4 31.34 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 125.273 1.416 . . . . 0.60999999999999999 113.106 -175.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.17 179.82 8.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.673 0.749 . . . . 0.68999999999999995 111.826 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -156.37 166.01 34.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.766 2.426 . . . . 3.96 107.815 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -175.43 151.24 1.27 Allowed Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 125.788 1.635 . . . . 0.76000000000000001 108.447 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.6 -7.89 14.74 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.939 2.426 . . . . 0.82999999999999996 112.993 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.0 m -114.16 41.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.6 1.16 . . . . 0.94999999999999996 113.434 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.18 164.25 35.29 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.527 -0.733 . . . . 1.1200000000000001 112.532 166.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -100.75 -46.39 5.17 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.266 2.227 . . . . 3.21 110.664 169.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -103.18 138.24 40.26 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.223 1.409 . . . . 5.0599999999999996 108.341 163.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -99.58 152.61 4.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.3 -1.0 . . . . 1.3400000000000001 108.3 142.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -135.41 147.7 49.08 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.02 1.728 . . . . 2.9300000000000002 108.31 166.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.6 tp -102.97 118.76 37.54 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.557 0.743 . . . . 1.05 110.651 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.417 ' CE1' ' HB2' ' A' ' 85' ' ' MET . 55.3 m170 -121.93 156.67 32.89 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 123.242 1.496 . . . . 0.53000000000000003 113.899 -173.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -98.3 177.82 5.25 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.551 1.941 . . . . 2.3900000000000001 111.577 160.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.1 m -152.89 149.97 28.82 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.297 1.839 . . . . 0.77000000000000002 106.996 166.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -158.3 165.74 34.06 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.058 0.943 . . . . 2.1400000000000001 113.054 -168.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 59.5 ttp -95.19 143.49 26.57 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.166 1.386 . . . . 3.0499999999999998 110.371 167.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.49 150.68 35.02 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.6 1.16 . . . . 4.3499999999999996 110.849 -173.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -108.45 137.89 45.67 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.411 1.484 . . . . 2.0699999999999998 110.262 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.8 t -139.63 128.23 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 106.7 -1.593 . . . . 2.0099999999999998 106.7 166.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.433 ' HB2' ' HE3' ' A' ' 56' ' ' LYS . 34.6 mt-10 61.49 19.1 10.02 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.085 1.354 . . . . 2.9900000000000002 114.401 -175.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.25 11.29 85.07 Favored Glycine 0 N--CA 1.48 1.609 0 O-C-N 120.242 -1.536 . . . . 1.6100000000000001 113.585 -169.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.433 ' HE3' ' HB2' ' A' ' 54' ' ' GLU . 23.5 mtmt -110.47 118.83 37.32 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.531 2.333 . . . . 2.6600000000000001 108.728 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 120.19 34.29 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.689 -1.141 . . . . 3.8300000000000001 112.376 -166.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.8 m -121.35 -178.4 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 128.705 2.802 . . . . 2.0499999999999998 109.872 -176.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 60.9 mtt -116.06 162.94 16.67 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.359 1.064 . . . . 2.4900000000000002 111.165 168.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.61 175.06 32.86 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 124.791 1.186 . . . . 0.56999999999999995 112.591 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.3 ttm -154.78 145.29 22.19 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.055 1.742 . . . . 0.60999999999999999 109.213 -170.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -148.24 153.98 41.76 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 125.736 1.614 . . . . 5.1699999999999999 109.175 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.89 154.11 42.81 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.854 1.702 . . . . 0.59999999999999998 110.399 165.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -139.46 154.35 71.52 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.458 1.503 . . . . 0.64000000000000001 110.513 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.02 -27.66 4.41 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.106 2.538 . . . . 0.52000000000000002 112.949 -167.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -176.24 164.74 2.74 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.648 1.579 . . . . 1.96 111.817 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 mt -114.03 152.22 31.3 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.215 1.406 . . . . 0.60999999999999999 110.014 166.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -111.93 145.93 38.69 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.756 1.222 . . . . 2.02 109.407 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.2 t -134.44 119.8 14.37 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.655 0.782 . . . . 1.1100000000000001 111.124 165.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.29 159.1 54.19 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.33 2.687 . . . . 0.93000000000000005 111.565 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -60.4 138.57 81.59 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.754 2.969 . . . . 0.96999999999999997 112.192 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt 64.91 -4.26 0.5 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.304 1.841 . . . . 1.6200000000000001 113.991 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.08 -177.4 39.2 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 127.28 2.371 . . . . 1.1599999999999999 113.114 -176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.22 152.53 33.42 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.279 1.032 . . . . 3.9900000000000002 112.146 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.4 t -152.71 123.46 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.771 1.629 . . . . 3.7200000000000002 107.752 174.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.451 ' HG3' HG23 ' A' ' 21' ' ' THR . 6.9 mp0 -84.31 141.44 30.92 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.704 -0.622 . . . . 2.98 111.351 175.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.92 80.84 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.332 -0.988 . . . . 2.2000000000000002 108.332 147.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.08 148.95 46.39 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.1 1.36 . . . . 3.0899999999999999 112.386 -174.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.422 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 59.2 Cg_endo -63.3 -24.35 71.87 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.251 2.634 . . . . 1.99 113.806 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.84 21.72 4.58 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.942 -0.921 . . . . 1.6299999999999999 114.115 170.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.95 -118.39 0.69 Allowed Glycine 0 CA--C 1.53 1.015 0 CA-C-N 118.979 1.39 . . . . 1.8700000000000001 114.654 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -71.91 140.42 49.23 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.352 -1.087 . . . . 1.8700000000000001 112.552 -164.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -162.64 156.22 20.39 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.206 1.002 . . . . 0.51000000000000001 112.259 -173.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -82.99 140.51 32.7 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.851 -0.53 . . . . 1.5900000000000001 109.623 165.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.417 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 3.1 tpt -93.14 131.94 37.73 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.261 1.024 . . . . 0.62 108.769 161.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 mp -110.9 125.23 53.43 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.654 -1.239 . . . . 0.58999999999999997 107.654 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 mp -130.82 142.62 50.4 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.305 0.642 . . . . 1.8600000000000001 110.364 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.43 43.29 16.1 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.154 0.883 . . . . 0.84999999999999998 112.96 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -56.76 154.51 9.03 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 116.102 1.89 . . . . 1.3799999999999999 116.102 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -116.53 -16.83 10.75 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 113.515 -1.675 . . . . 1.98 113.076 -170.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -113.12 127.38 26.9 Favored Pre-proline 0 N--CA 1.472 0.628 0 N-CA-C 105.896 -1.89 . . . . 5.4299999999999997 105.896 155.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.39 110.02 1.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 N-CA-C 105.369 -2.589 . . . . 2.2200000000000002 105.369 158.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.48 147.15 39.76 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 124.518 2.104 . . . . 2.0499999999999998 111.567 -156.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -156.27 166.04 34.62 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 111.665 -2.516 . . . . 3.8300000000000001 112.815 -151.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.92 126.05 25.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.007 0.923 . . . . 1.1899999999999999 109.636 -175.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.08 0.98 70.43 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 117.702 -1.61 . . . . 1.26 115.64 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -79.9 -167.83 1.4 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.319 2.06 . . . . 2.23 112.568 169.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.52 121.78 3.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.148 2.979 . . . . 5.7699999999999996 106.095 -148.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 49.3 t -148.83 133.45 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.602 1.161 . . . . 0.96999999999999997 111.702 -170.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -79.12 144.59 34.38 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 112.211 0.448 . . . . 2.5099999999999998 112.211 168.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mp -120.23 142.31 49.14 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.829 0.823 . . . . 1.6000000000000001 110.507 153.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -104.8 136.34 44.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 129.265 3.026 . . . . 1.99 107.485 166.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 mp -128.12 109.75 11.82 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 120.503 1.501 . . . . 2.0099999999999998 108.903 -172.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.1 mt -79.34 110.34 14.53 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.094 1.357 . . . . 0.67000000000000004 109.453 -170.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -103.48 137.44 41.56 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.309 1.444 . . . . 2.0600000000000001 110.612 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.04 127.23 30.52 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.871 1.063 . . . . 2.1200000000000001 113.871 -169.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.64 70.13 1.35 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.638 1.114 . . . . 3.4500000000000002 112.093 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.65 24.5 72.37 Favored Glycine 0 N--CA 1.471 1.03 0 N-CA-C 115.563 0.985 . . . . 2.0899999999999999 115.563 166.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -126.28 155.84 41.3 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.304 1.552 . . . . 3.4700000000000002 112.353 -173.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.12 151.46 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.813 1.245 . . . . 2.3199999999999998 110.753 171.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.1 tp -120.48 141.98 49.7 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.091 1.357 . . . . 3.1299999999999999 109.786 167.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -106.79 134.35 50.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.582 1.153 . . . . 2.2000000000000002 109.908 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.74 153.59 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.099 1.359 . . . . 2.7200000000000002 110.165 167.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.22 126.39 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.683 -1.228 . . . . 1.8600000000000001 107.683 165.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.1 mt -122.1 146.75 47.38 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 126.234 1.814 . . . . 1.97 110.074 -174.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.78 164.54 35.28 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.973 2.449 . . . . 0.89000000000000001 111.377 165.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.22 139.38 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.689 0.796 . . . . 0.76000000000000001 110.482 169.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.97 147.22 40.15 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.667 1.587 . . . . 3.7400000000000002 113.093 -171.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.59 58.3 4.14 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.054 1.742 . . . . 2.3799999999999999 111.832 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 . . . . . 0 C--O 1.249 1.072 0 C-N-CA 125.956 1.703 . . . . 7.4699999999999998 112.672 -162.195 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.876 0 N-CA-C 107.463 -2.255 . . . . 8.9499999999999993 107.463 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.2 t -62.82 176.94 0.61 Allowed 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 117.139 0.469 . . . . 9.2599999999999998 110.657 144.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -70.05 -28.42 65.45 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.878 -1.139 . . . . 12.56 111.795 168.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 t -136.44 133.01 36.18 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 127.101 2.16 . . . . 6.96 109.222 171.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.401 ' H ' ' CG2' ' A' ' 21' ' ' THR . 0.7 OUTLIER -100.72 119.11 38.12 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.975 2.11 . . . . 5.21 109.909 -174.15 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.59 172.86 37.88 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 120.515 1.507 . . . . 0.87 115.552 159.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -148.98 147.06 28.14 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.016 1.326 . . . . 1.96 111.276 169.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.8 t -95.03 126.87 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.08 -1.081 . . . . 1.3500000000000001 108.08 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -74.31 123.18 24.11 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.912 0.386 . . . . 4.8399999999999999 111.423 -170.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -46.99 142.18 3.68 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.956 1.302 . . . . 1.8899999999999999 111.538 163.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.1 m -155.31 152.23 24.38 Favored Pre-proline 0 CA--C 1.545 0.783 0 O-C-N 120.865 -1.147 . . . . 2.5299999999999998 111.111 161.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -95.18 43.11 0.16 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.147 3.232 . . . . 2.71 111.707 -176.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.61 -168.85 25.16 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.27 1.268 . . . . 1.1699999999999999 116.27 -167.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.98 -16.23 16.09 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.283 3.322 . . . . 1.24 114.328 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -125.24 162.57 24.41 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.052 1.741 . . . . 2.4100000000000001 114.124 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.95 -177.2 6.4 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.181 2.592 . . . . 0.5 111.236 -175.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.08 167.33 21.74 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.352 2.261 . . . . 0.72999999999999998 108.448 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.74 141.27 33.25 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.375 0.989 . . . . 0.56999999999999995 111.738 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.452 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 20.2 m-85 -128.02 114.37 17.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.256 1.822 . . . . 2.48 108.842 -171.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -163.26 165.36 24.36 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.851 -1.155 . . . . 2.71 112.901 -167.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.401 ' CG2' ' H ' ' A' ' 5' ' ' GLU . 5.0 t -92.77 141.14 28.78 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 123.189 1.471 . . . . 3.29 113.366 -177.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.36 123.81 38.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 113.357 -1.747 . . . . 3.5 106.996 164.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -111.62 145.05 39.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.869 0.842 . . . . 3.9900000000000002 110.944 169.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.88 64.8 18.4 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.07 0.948 . . . . 3.48 110.277 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -63.23 -21.79 72.28 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.632 2.888 . . . . 1.3799999999999999 114.414 -173.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.09 -173.09 38.09 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 122.72 1.178 . . . . 1.22 113.001 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -109.74 -1.19 18.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.905 1.682 . . . . 2.8300000000000001 112.684 -164.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -121.68 155.25 60.11 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 127.417 2.287 . . . . 2.0600000000000001 110.091 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.63 139.57 18.13 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.713 2.275 . . . . 1.01 111.245 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt -95.05 153.54 17.6 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 123.306 1.527 . . . . 1.6000000000000001 112.676 174.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 ttp-105 -137.06 102.93 4.99 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 112.609 -2.087 . . . . 2.4900000000000002 110.901 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.37 113.57 20.83 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 124.443 1.097 . . . . 1.98 110.497 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.31 -19.53 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 125.124 1.37 . . . . 0.65000000000000002 111.855 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.61 -175.47 29.58 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 122.531 1.073 . . . . 0.52000000000000002 115.362 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.459 ' HB2' ' CE1' ' A' ' 84' ' ' PHE . . . -139.08 -179.18 5.7 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.917 1.687 . . . . 0.56000000000000005 110.236 164.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -159.84 146.6 16.27 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.928 1.691 . . . . 4.3899999999999997 106.999 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 t -162.55 151.06 12.26 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 125.038 1.335 . . . . 0.72999999999999998 108.436 -175.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.91 -13.45 31.79 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.682 1.588 . . . . 0.68000000000000005 113.378 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 m -112.31 36.14 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 113.788 1.033 . . . . 0.85999999999999999 113.788 -172.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.15 140.39 10.29 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.343 1.457 . . . . 1.03 109.134 170.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -95.63 -40.0 9.63 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.233 1.413 . . . . 3.6099999999999999 110.292 -176.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -104.4 129.1 52.35 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.959 1.704 . . . . 5.8200000000000003 107.758 155.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.07 139.31 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.069 -1.085 . . . . 1.25 108.069 154.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.91 155.89 47.1 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.834 2.054 . . . . 3.2599999999999998 108.295 -174.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.3 tp -114.23 121.4 43.59 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.976 0.91 . . . . 1.0 109.785 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.405 ' CE1' ' HB2' ' A' ' 85' ' ' MET . 50.2 m170 -124.23 161.32 26.02 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 123.736 1.731 . . . . 0.72999999999999998 114.488 -175.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -104.22 155.16 18.96 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.085 2.554 . . . . 2.5899999999999999 111.21 160.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.9 m -122.02 147.19 46.38 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 105.902 -1.888 . . . . 0.84999999999999998 105.902 159.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -157.39 178.28 10.48 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.188 0.904 . . . . 2.3900000000000001 112.819 -174.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 63.0 ttp -111.66 135.21 52.56 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.572 1.549 . . . . 3.6200000000000001 111.5 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -110.4 143.99 39.84 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.513 1.525 . . . . 4.7699999999999996 110.862 161.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -87.45 145.4 26.29 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.556 1.143 . . . . 2.9900000000000002 108.707 149.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.4 t -143.92 120.8 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.227 1.811 . . . . 2.73 106.701 161.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 63.94 18.12 10.99 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.483 1.513 . . . . 4.21 115.024 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.21 21.22 67.99 Favored Glycine 0 N--CA 1.478 1.482 0 O-C-N 120.6 -1.313 . . . . 2.6000000000000001 113.052 -168.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -120.36 127.99 52.82 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.253 2.221 . . . . 3.21 107.592 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -98.46 126.81 44.14 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.735 1.214 . . . . 5.2999999999999998 111.779 -171.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.29 141.88 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 126.415 1.886 . . . . 2.2200000000000002 109.644 -175.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 60.1 mtm -92.19 156.52 17.27 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.422 0.897 . . . . 2.9500000000000002 113.422 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.67 172.06 22.08 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 126.359 1.933 . . . . 0.81000000000000005 112.332 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.5 ttm -146.53 145.66 30.23 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.231 1.812 . . . . 0.75 109.587 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -149.35 156.57 39.64 Favored Pre-proline 0 N--CA 1.471 0.603 0 C-N-CA 125.218 1.407 . . . . 5.0199999999999996 110.12 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.99 156.54 38.65 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.469 2.113 . . . . 0.92000000000000004 110.638 166.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.6 m -137.57 153.51 74.33 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 125.357 1.463 . . . . 0.92000000000000004 110.964 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.11 -24.85 6.42 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.502 2.801 . . . . 0.96999999999999997 113.024 -171.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -176.35 164.82 2.69 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.029 1.732 . . . . 2.2799999999999998 111.67 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.4 mt -108.87 153.69 23.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.404 1.482 . . . . 0.70999999999999996 110.579 163.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -114.3 144.19 43.65 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.395 1.478 . . . . 2.1699999999999999 109.763 176.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.7 t -139.91 139.74 22.44 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.465 0.706 . . . . 1.0600000000000001 112.488 169.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -84.02 156.43 13.24 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.38 3.387 . . . . 1.1200000000000001 112.531 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.22 143.49 94.33 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.306 2.671 . . . . 1.0700000000000001 113.246 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt 69.97 0.2 2.98 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.775 2.43 . . . . 1.77 114.16 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.56 151.53 34.44 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.41 1.481 . . . . 1.24 114.106 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -111.46 132.12 54.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.425 2.29 . . . . 4.6299999999999999 106.547 160.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.5 t -142.59 119.01 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.746 1.219 . . . . 3.5 108.774 -177.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -115.15 128.69 56.36 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.899 0.857 . . . . 3.98 113.24 -159.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.16 77.12 0.52 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.632 2.373 . . . . 2.21 111.163 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.65 145.01 97.74 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 126.462 1.905 . . . . 6.25 113.525 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.452 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 30.4 Cg_endo -57.89 -42.88 54.12 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.301 2.667 . . . . 2.9900000000000002 113.335 175.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.46 31.49 1.88 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.454 1.025 . . . . 1.5800000000000001 113.533 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.12 -131.99 1.44 Allowed Glycine 0 N--CA 1.471 0.969 0 C-N-CA 125.493 1.52 . . . . 1.6200000000000001 113.175 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -70.39 139.21 51.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.906 0.853 . . . . 2.1400000000000001 110.981 -172.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -162.02 158.3 24.79 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.836 1.255 . . . . 0.57999999999999996 111.973 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.459 ' CE1' ' HB2' ' A' ' 35' ' ' ALA . 98.5 m-85 -84.63 151.74 24.28 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.697 -0.627 . . . . 2.0699999999999998 110.786 168.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.405 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 3.2 tpt -112.06 130.98 55.7 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.531 1.132 . . . . 0.60999999999999999 109.687 166.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -111.98 118.87 36.64 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.943 1.297 . . . . 0.62 107.869 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.6 mp -119.51 138.92 52.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.47 1.108 . . . . 1.7 109.739 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.22 37.26 32.58 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.73 -0.483 . . . . 0.87 113.006 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -48.3 154.93 0.55 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 116.571 2.063 . . . . 1.3 116.571 177.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -119.97 -18.77 8.09 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.155 -1.384 . . . . 2.7000000000000002 113.949 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -97.01 140.96 22.39 Favored Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 108.539 -0.912 . . . . 5.3499999999999996 108.539 160.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -82.6 57.58 6.14 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.624 2.883 . . . . 3.0699999999999998 109.914 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.4 mt -23.14 104.56 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 129.044 2.938 . . . . 2.2000000000000002 116.8 -159.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm -119.54 157.96 27.28 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.187 1.795 . . . . 6.5700000000000003 114.871 170.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.14 133.88 38.92 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 113.528 -1.669 . . . . 1.76 109.675 169.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.46 1.33 86.16 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 117.485 -1.73 . . . . 1.78 115.848 -175.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -75.28 178.11 6.05 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 120.899 2.349 . . . . 2.3999999999999999 111.145 166.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -146.2 129.74 16.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.795 2.838 . . . . 5.2199999999999998 104.827 -159.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.0 t -144.33 121.63 5.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 123.99 0.916 . . . . 1.04 110.358 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -78.81 154.55 29.79 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.262 0.554 . . . . 2.8300000000000001 111.364 167.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.2 tt -149.91 142.8 24.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 122.82 1.295 . . . . 2.8500000000000001 110.808 169.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.0 104.33 11.8 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 129.54 3.136 . . . . 2.4199999999999999 107.061 -169.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -82.46 129.37 34.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.158 0.983 . . . . 0.95999999999999996 109.622 -172.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.0 mt -106.02 123.96 48.82 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.61 1.164 . . . . 0.83999999999999997 111.441 -171.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -122.6 144.98 48.76 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.945 1.298 . . . . 2.04 112.31 -170.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.66 151.06 21.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.878 0.871 . . . . 1.9199999999999999 111.974 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.16 8.86 87.0 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 119.011 -0.883 . . . . 3.5699999999999998 114.618 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.8 66.06 1.61 Allowed Glycine 0 N--CA 1.469 0.892 0 CA-C-N 119.184 1.492 . . . . 2.4500000000000002 113.326 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -138.45 152.98 48.82 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.929 1.692 . . . . 3.79 111.455 170.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.39 148.57 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.124 1.37 . . . . 2.4399999999999999 111.178 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 tt -140.2 116.22 10.41 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.597 1.159 . . . . 3.4199999999999999 109.244 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -93.58 136.25 34.04 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.93 -1.106 . . . . 2.4100000000000001 112.054 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.8 t -131.43 165.27 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.982 1.713 . . . . 2.1299999999999999 108.751 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.9 t -129.34 129.98 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.276 1.43 . . . . 1.71 108.781 172.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.5 mt -123.65 145.57 47.64 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 127.554 2.342 . . . . 2.1699999999999999 110.063 -174.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.9 154.66 58.33 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.648 2.232 . . . . 0.85999999999999999 110.475 166.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.7 t -92.88 125.28 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.224 -1.028 . . . . 1.03 108.224 167.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -152.61 167.96 27.17 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.668 1.223 . . . . 5.2199999999999998 114.059 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -103.57 104.55 14.62 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.305 1.594 . . . . 2.23 115.305 -166.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 . . . . . 0 N--CA 1.483 1.203 1 C-N-CA 133.973 4.909 . . . . 7.6299999999999999 112.555 162.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.957 0 N-CA-C 107.371 -2.291 . . . . 11.99 107.371 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 m -76.98 145.1 38.29 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 115.325 1.602 . . . . 12.5 115.325 -145.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.56 136.61 49.41 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.006 1.722 . . . . 10.449999999999999 111.524 -168.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.4 p -84.15 58.47 4.78 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.312 1.845 . . . . 7.4500000000000002 112.113 -170.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -97.35 60.97 1.66 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.328 1.051 . . . . 6.2800000000000002 110.913 -174.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.08 -178.86 34.46 Favored Glycine 0 N--CA 1.465 0.581 0 O-C-N 121.186 -0.947 . . . . 1.6799999999999999 113.287 -173.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 26.0 p90 -152.0 148.67 28.0 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.825 0.85 . . . . 1.9199999999999999 112.998 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.03 145.96 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.883 -1.154 . . . . 1.3899999999999999 107.883 170.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -86.85 127.9 35.04 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.811 0.671 . . . . 4.4699999999999998 112.811 -167.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -48.79 151.0 1.29 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.956 1.302 . . . . 2.73 112.766 168.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 t -163.19 148.23 9.32 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 122.895 0.478 . . . . 2.3900000000000001 111.597 166.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -86.21 -6.4 8.28 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.2 2.6 . . . . 1.96 112.109 166.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.16 178.24 20.6 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.946 1.26 . . . . 1.1100000000000001 114.004 -173.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.6 -15.8 33.96 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.122 3.215 . . . . 1.28 113.527 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -110.01 142.67 41.1 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.796 2.038 . . . . 2.3999999999999999 113.841 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.69 -176.17 5.4 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 129.066 2.946 . . . . 0.5 110.848 -172.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.99 159.88 41.41 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.955 2.102 . . . . 0.83999999999999997 109.391 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.46 137.05 48.43 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.08 1.309 . . . . 0.68999999999999995 112.482 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -116.71 71.83 0.8 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.298 1.839 . . . . 2.5600000000000001 109.6 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -83.54 157.54 22.31 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.737 -1.227 . . . . 1.6899999999999999 111.685 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.78 131.53 36.38 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.263 -0.898 . . . . 2.4500000000000002 109.676 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.24 129.53 52.04 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.847 0.459 . . . . 3.0699999999999998 110.057 175.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -119.9 144.07 47.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.58 1.952 . . . . 3.7599999999999998 107.638 167.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.02 79.1 0.53 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.71 0.804 . . . . 3.3100000000000001 110.683 171.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.69 -6.03 18.29 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.346 2.03 . . . . 1.6000000000000001 115.733 -174.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.96 160.61 33.93 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 119.535 1.061 . . . . 1.4099999999999999 111.686 170.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.19 1.5 40.34 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.526 1.93 . . . . 3.8100000000000001 112.162 174.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mp -123.48 156.19 64.52 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 127.03 2.132 . . . . 4.4800000000000004 108.643 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.81 143.99 16.95 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.975 2.45 . . . . 1.25 111.04 -167.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.8 mt -100.47 150.32 22.77 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 123.076 1.417 . . . . 1.6799999999999999 112.844 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -127.1 106.3 9.17 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 112.218 -2.265 . . . . 1.8899999999999999 110.62 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.441 HD11 ' CZ ' ' A' ' 84' ' ' PHE . 2.7 tm? -85.87 110.97 19.78 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.658 1.983 . . . . 2.4500000000000002 108.752 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.89 -19.85 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.254 1.022 . . . . 0.76000000000000001 112.055 -171.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.7 -177.21 32.59 Favored Glycine 0 C--N 1.343 0.94 0 C-N-CA 124.989 1.281 . . . . 0.68999999999999995 113.887 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.43 -178.78 5.66 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.709 1.204 . . . . 0.76000000000000001 110.096 161.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -150.81 158.67 44.42 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.229 2.611 . . . . 4.7300000000000004 107.072 172.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 t -169.5 153.11 5.06 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 126.438 1.895 . . . . 0.66000000000000003 107.281 -171.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.58 -12.7 15.14 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.901 1.734 . . . . 0.83999999999999997 112.921 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.42 45.34 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.061 0.945 . . . . 0.81000000000000005 112.983 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.43 144.45 14.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.296 1.039 . . . . 0.97999999999999998 111.491 164.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -86.49 -45.83 10.75 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.869 1.268 . . . . 2.9199999999999999 111.328 171.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -109.93 134.38 52.15 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.816 1.247 . . . . 5.0499999999999998 108.025 168.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -119.77 135.27 60.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 125.497 1.519 . . . . 1.0900000000000001 108.299 166.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -126.66 154.23 44.33 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.747 2.019 . . . . 3.0099999999999998 108.759 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.0 tp -111.18 124.44 52.2 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.741 0.816 . . . . 1.1200000000000001 109.776 174.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -123.44 161.52 24.64 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.403 1.881 . . . . 0.66000000000000003 114.262 -175.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.78 -179.2 3.87 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.721 2.409 . . . . 3.0299999999999998 111.773 162.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.1 m -157.49 145.87 19.28 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.367 1.867 . . . . 0.91000000000000003 107.645 170.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -153.42 172.93 16.33 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.183 1.393 . . . . 1.97 112.552 -168.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.4 mtm -103.44 143.64 32.44 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.905 0.882 . . . . 2.9900000000000002 110.561 167.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -149.21 146.32 27.56 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.245 1.818 . . . . 8.8100000000000005 111.144 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -86.91 145.97 26.35 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.75 1.22 . . . . 2.75 111.787 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 p -169.81 138.01 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 126.217 1.807 . . . . 3.0 108.273 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 72.92 -3.58 2.38 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 127.612 2.365 . . . . 4.9100000000000001 114.818 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.99 33.19 24.46 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.277 0.942 . . . . 2.1000000000000001 112.599 -161.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -141.47 144.39 34.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.838 2.455 . . . . 4.4100000000000001 108.126 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.92 120.68 29.49 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.481 0.712 . . . . 7.4800000000000004 110.604 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.451 HG12 ' H ' ' A' ' 59' ' ' MET . 39.8 t -125.12 -179.67 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 127.308 2.243 . . . . 2.29 107.982 -175.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.451 ' H ' HG12 ' A' ' 58' ' ' VAL . 8.3 mtm -113.78 159.97 19.2 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.583 -1.323 . . . . 4.1200000000000001 112.835 175.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.43 165.74 25.17 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 125.726 1.631 . . . . 0.77000000000000002 111.059 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.9 ttm -148.78 141.86 24.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.573 1.949 . . . . 0.81000000000000005 108.453 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -150.11 151.21 31.44 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.938 1.695 . . . . 5.7699999999999996 109.266 -170.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.04 155.23 42.74 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.071 1.847 . . . . 0.56000000000000005 110.922 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.31 152.53 75.26 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.982 1.313 . . . . 0.77000000000000002 110.008 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.82 -21.64 10.94 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.294 2.663 . . . . 0.69999999999999996 112.865 -171.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -174.88 174.23 2.59 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.743 2.017 . . . . 1.9099999999999999 110.756 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.4 mt -119.81 154.31 34.44 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.527 1.931 . . . . 0.48999999999999999 109.671 160.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -112.87 145.13 41.23 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.917 1.287 . . . . 1.71 109.41 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 t -137.61 139.13 26.14 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.288 0.635 . . . . 0.97999999999999998 112.689 171.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -83.6 156.19 14.02 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 124.201 3.267 . . . . 1.28 112.311 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.31 138.81 68.21 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.413 3.409 . . . . 1.27 115.109 -170.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt 67.15 -2.7 1.13 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.818 2.447 . . . . 3.1899999999999999 115.455 173.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.76 176.29 54.6 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 127.431 2.443 . . . . 1.46 112.634 167.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.27 144.53 21.01 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.27 1.428 . . . . 4.1900000000000004 111.279 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.9 t -154.13 127.39 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 126.366 1.866 . . . . 4.1699999999999999 107.738 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.51 149.8 31.36 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.879 0.763 . . . . 5.0899999999999999 111.603 172.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mp -73.8 73.86 1.58 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.796 1.284 . . . . 2.2200000000000002 108.737 165.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -63.88 143.46 98.13 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 114.39 -1.277 . . . . 5.04 113.138 -170.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -63.67 -21.11 70.0 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.346 2.697 . . . . 2.3100000000000001 113.982 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.57 48.2 2.33 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.248 0.928 . . . . 1.77 112.14 171.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.59 -121.6 1.04 Allowed Glycine 0 N--CA 1.468 0.802 0 C-N-CA 124.876 1.226 . . . . 1.52 114.085 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -74.21 134.35 42.73 Favored 'General case' 0 C--O 1.22 -0.494 0 O-C-N 121.928 -0.748 . . . . 2.1200000000000001 112.432 -170.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -161.66 163.51 29.81 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.84 0.856 . . . . 0.60999999999999999 111.358 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.441 ' CZ ' HD11 ' A' ' 32' ' ' LEU . 96.4 m-85 -90.72 150.22 21.72 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.287 -0.883 . . . . 2.25 110.629 168.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.6 tpt -104.79 134.07 48.54 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.35 1.06 . . . . 0.58999999999999997 109.338 164.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -117.62 130.95 56.7 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.411 1.484 . . . . 0.52000000000000002 108.076 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 mp -136.02 140.9 44.21 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.932 0.787 . . . . 1.77 111.992 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.74 44.91 11.43 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 123.744 0.688 . . . . 0.76000000000000001 111.776 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.01 148.27 11.03 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 123.452 1.596 . . . . 1.28 115.049 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -105.01 -7.43 19.23 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.517 -1.674 . . . . 1.78 112.841 -176.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -144.14 138.06 14.59 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 127.61 2.364 . . . . 6.1900000000000004 108.062 162.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.05 144.21 75.0 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.163 1.909 . . . . 1.9399999999999999 108.308 164.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.427 ' H ' HD23 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -121.13 120.85 36.48 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.826 1.65 . . . . 2.75 109.87 -166.419 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -120.4 169.9 9.87 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.429 1.891 . . . . 3.7599999999999998 114.234 -160.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.05 103.56 1.89 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.38 1.072 . . . . 1.75 111.553 -170.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.03 12.67 39.05 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 118.507 -1.163 . . . . 1.8100000000000001 114.906 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -82.69 -172.87 4.31 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.742 1.271 . . . . 2.2400000000000002 111.456 166.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 40.1 mt-10 -146.65 138.95 24.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.714 2.806 . . . . 4.0 106.161 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.0 t -137.97 121.73 21.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 125.04 1.336 . . . . 1.1799999999999999 109.51 -173.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -84.57 150.49 25.18 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 122.242 1.02 . . . . 3.1699999999999999 113.192 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.57 144.02 20.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.231 1.413 . . . . 3.5 114.231 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -104.98 114.34 28.49 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 128.066 2.546 . . . . 2.6899999999999999 109.62 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.13 127.79 32.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.596 1.158 . . . . 1.4299999999999999 108.802 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.3 mt -103.54 112.21 25.02 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.005 0.922 . . . . 0.93999999999999995 109.882 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -108.16 146.81 32.19 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.437 1.495 . . . . 2.0899999999999999 111.237 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.84 124.37 11.01 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.342 1.057 . . . . 1.8700000000000001 113.089 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.2 70.75 1.22 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.457 1.027 . . . . 2.9300000000000002 113.267 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.8 4.06 57.18 Favored Glycine 0 N--CA 1.476 1.331 0 N-CA-C 117.011 1.564 . . . . 2.2000000000000002 117.011 163.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -93.47 110.69 22.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.55 1.675 . . . . 3.1499999999999999 111.024 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.63 135.3 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.048 1.339 . . . . 1.99 109.319 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.1 tp -137.01 115.29 11.72 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.443 1.097 . . . . 2.1800000000000002 110.571 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -79.77 131.8 36.0 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.762 -0.586 . . . . 2.2000000000000002 112.316 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.3 t -124.87 169.85 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 128.509 2.724 . . . . 2.1000000000000001 107.658 172.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.9 t -144.55 134.87 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.583 1.553 . . . . 1.8999999999999999 108.094 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -131.11 152.34 80.47 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.185 0.994 . . . . 4.2699999999999996 110.52 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 57.3 Cg_endo -63.97 168.42 12.21 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 124.018 3.145 . . . . 0.83999999999999997 112.955 171.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.5 t -108.56 128.62 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.28 1.032 . . . . 1.1399999999999999 110.996 173.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -120.57 147.11 45.62 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.459 1.504 . . . . 5.1200000000000001 112.402 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.87 71.85 2.54 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.78 1.232 . . . . 2.71 111.766 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 127.276 2.231 . . . . 8.1699999999999999 110.647 -178.81 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.386 0 N-CA-C 107.288 -2.325 . . . . 14.449999999999999 107.288 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.8 m -60.59 179.29 0.17 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 119.959 -0.696 . . . . 12.56 110.96 142.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -66.64 178.53 1.27 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.697 0.799 . . . . 9.9800000000000004 111.381 163.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.9 t -168.82 147.4 4.05 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 127.002 2.121 . . . . 6.9699999999999998 107.396 171.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -93.16 59.49 3.08 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.743 0.701 . . . . 6.7000000000000002 109.318 171.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.84 169.48 15.21 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 121.621 -0.674 . . . . 1.1899999999999999 114.779 -168.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -157.18 151.49 25.07 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.029 1.732 . . . . 2.0699999999999998 112.125 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.4 t -87.22 121.4 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 107.486 -1.302 . . . . 1.28 107.486 164.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.24 118.23 20.26 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.488 0.715 . . . . 3.6899999999999999 109.876 -175.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -55.85 153.71 8.13 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.186 1.395 . . . . 2.1000000000000001 113.835 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.9 t -163.89 147.04 7.87 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.143 1.377 . . . . 2.0699999999999998 110.395 173.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -86.85 6.37 5.37 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.889 3.059 . . . . 1.99 112.665 171.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.14 -170.19 15.72 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.15 1.357 . . . . 1.21 115.082 -168.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.78 -17.78 42.05 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.867 3.045 . . . . 1.76 113.717 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -138.22 156.16 47.96 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 116.048 1.87 . . . . 2.25 116.048 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.7 -178.73 5.26 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 131.01 3.724 . . . . 0.97999999999999998 109.59 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.31 161.64 33.02 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.39 1.476 . . . . 0.81000000000000005 108.442 168.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.04 135.73 50.27 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.197 0.999 . . . . 0.78000000000000003 110.067 172.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -127.08 132.41 50.65 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.671 1.988 . . . . 2.6600000000000001 107.673 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pp -170.07 149.86 3.65 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.413 1.006 . . . . 1.96 113.408 -164.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.6 m -79.15 121.84 25.52 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.023 1.729 . . . . 2.25 111.267 172.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.18 125.37 29.76 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.754 -0.832 . . . . 3.1800000000000002 108.754 157.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -95.77 142.46 28.02 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.65 1.18 . . . . 3.8999999999999999 107.943 161.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.44 72.51 2.53 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.217 1.007 . . . . 3.21 109.882 174.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.31 -20.11 61.97 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.979 2.453 . . . . 1.3100000000000001 114.692 -172.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.67 -177.95 47.63 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 122.952 1.307 . . . . 1.25 113.096 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -104.96 -1.9 25.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.769 2.028 . . . . 2.8599999999999999 112.204 -168.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -122.23 155.87 61.08 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 127.804 2.442 . . . . 2.0499999999999998 109.973 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.98 140.45 20.24 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.781 2.321 . . . . 1.3600000000000001 111.048 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.2 mt -93.87 151.16 19.78 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 123.197 1.475 . . . . 1.8200000000000001 112.115 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.4 ttp-105 -135.53 106.71 6.74 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 112.589 -2.096 . . . . 2.25 110.568 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.6 tp -91.94 108.17 19.73 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.022 1.729 . . . . 1.8600000000000001 109.95 -172.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -100.81 -20.94 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.107 1.363 . . . . 0.58999999999999997 111.399 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.06 -178.31 31.97 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.006 1.289 . . . . 0.67000000000000004 114.708 -176.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -156.27 -178.11 7.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.242 2.217 . . . . 0.89000000000000001 110.437 172.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -160.84 151.76 18.63 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.494 1.043 . . . . 4.9900000000000002 109.439 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -150.06 153.91 36.09 Favored Pre-proline 0 N--CA 1.472 0.645 0 O-C-N 121.101 -1.0 . . . . 0.78000000000000003 109.836 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.58 -7.89 21.6 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.665 2.244 . . . . 1.02 113.604 171.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 m -124.25 44.9 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 114.246 1.202 . . . . 0.95999999999999996 114.246 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.36 175.2 14.31 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.56 1.544 . . . . 1.3 109.3 164.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -114.45 -60.15 1.92 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.028 0.931 . . . . 3.5 108.826 160.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.6 mtp85 -82.35 106.83 14.54 Favored 'General case' 0 N--CA 1.458 -0.059 0 O-C-N 121.244 -0.91 . . . . 5.7300000000000004 108.799 168.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.73 152.55 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 107.904 -1.147 . . . . 1.3999999999999999 107.904 148.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -156.39 115.5 3.46 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.469 0.577 . . . . 3.0 111.31 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.1 tp -80.83 118.96 22.8 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.882 -1.136 . . . . 1.0800000000000001 111.753 -174.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -125.24 152.96 43.89 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 123.219 1.485 . . . . 0.51000000000000001 114.483 -172.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -95.31 177.11 5.95 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.36 1.864 . . . . 2.3900000000000001 111.307 162.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.6 m -156.03 144.08 19.77 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.998 2.119 . . . . 0.70999999999999996 106.6 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -160.04 163.38 34.01 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.723 1.379 . . . . 2.21 114.723 -165.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.88 145.33 27.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.852 1.261 . . . . 5.0499999999999998 111.169 164.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.42 147.23 21.89 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.515 -0.741 . . . . 4.6200000000000001 112.259 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -105.66 142.23 35.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 126.63 1.972 . . . . 2.7799999999999998 111.84 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.2 t -144.95 133.54 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.566 1.946 . . . . 2.54 106.903 166.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 68.49 1.1 2.82 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 126.609 1.963 . . . . 3.0 114.71 -172.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.71 18.33 61.94 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.431 1.015 . . . . 2.2599999999999998 113.572 -163.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -120.55 134.85 55.23 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.75 2.42 . . . . 2.8100000000000001 108.282 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.63 142.45 28.24 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 125.545 1.538 . . . . 3.8300000000000001 114.052 -173.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.16 169.6 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 129.241 3.016 . . . . 2.71 107.259 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.0 mtp -117.33 139.83 50.34 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.194 -0.941 . . . . 3.3300000000000001 110.728 165.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.98 -179.81 16.07 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.487 1.041 . . . . 0.56999999999999995 113.772 -175.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ttm -152.89 144.88 23.73 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.617 1.967 . . . . 0.58999999999999997 109.1 -176.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -146.11 156.95 50.63 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 126.022 1.729 . . . . 5.1500000000000004 108.924 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.89 156.34 43.48 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 121.886 1.724 . . . . 0.58999999999999997 110.667 166.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.7 m -139.12 152.16 69.27 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 124.799 1.24 . . . . 0.56999999999999995 110.543 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.3 -29.33 7.88 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.862 2.375 . . . . 0.53000000000000003 112.175 -168.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -174.39 165.45 3.94 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.53 1.532 . . . . 2.0899999999999999 111.867 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.8 mt -109.48 154.12 23.1 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.109 1.364 . . . . 0.60999999999999999 110.386 164.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -113.49 147.35 38.06 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.975 1.31 . . . . 2.0499999999999998 109.962 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.6 t -140.78 140.25 21.52 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.85 0.86 . . . . 0.92000000000000004 111.959 169.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -88.1 155.9 7.03 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.648 3.565 . . . . 1.3200000000000001 112.846 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.39 142.76 80.29 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.992 3.128 . . . . 1.2 113.75 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt 67.61 -9.65 0.42 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.763 2.425 . . . . 1.8700000000000001 114.251 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.46 160.92 46.14 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.788 1.185 . . . . 1.54 111.98 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -116.63 140.87 48.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.752 0.821 . . . . 5.2300000000000004 109.302 160.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.3 t -148.32 143.92 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.875 2.07 . . . . 3.71 106.895 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.21 150.51 39.96 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.288 1.404 . . . . 4.0199999999999996 114.76 -165.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.2 mp -66.73 75.25 0.11 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.208 -1.405 . . . . 1.8899999999999999 107.208 151.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.8 140.54 74.59 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 114.466 -1.243 . . . . 3.1600000000000001 111.538 -167.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -55.52 -35.55 92.6 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.901 2.401 . . . . 2.02 112.321 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.68 6.9 57.01 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 116.88 -2.067 . . . . 1.8500000000000001 116.27 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.19 -8.56 0.02 OUTLIER Glycine 0 N--CA 1.478 1.441 0 N-CA-C 122.331 3.692 . . . . 2.1099999999999999 122.331 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -145.43 143.74 30.23 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 122.188 2.994 . . . . 2.0600000000000001 113.163 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -162.26 157.77 23.39 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.508 0.723 . . . . 0.48999999999999999 111.369 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 60.7 m-85 -82.99 138.64 33.68 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 107.945 -1.132 . . . . 1.6399999999999999 107.945 158.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -79.2 134.79 36.67 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.203 1.401 . . . . 0.88 108.051 156.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 mp -116.61 125.87 52.43 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 106.591 -1.633 . . . . 1.0600000000000001 106.591 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.4 tt -147.46 136.22 22.0 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.759 -0.588 . . . . 2.1499999999999999 110.325 -167.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.25 47.36 8.32 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.129 -0.788 . . . . 1.03 111.129 -167.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mt -50.64 150.54 2.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 123.044 1.402 . . . . 3.27 112.706 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -106.83 -2.4 21.46 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.065 -1.425 . . . . 2.3500000000000001 113.256 -169.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -153.29 154.27 30.5 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.652 1.181 . . . . 6.4400000000000004 111.682 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.35 94.67 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.476 2.117 . . . . 2.54 107.667 160.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.15 164.93 15.44 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 125.826 1.651 . . . . 2.6600000000000001 109.358 176.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -146.71 165.2 30.34 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 112.764 -2.016 . . . . 4.2199999999999998 113.751 -160.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.9 118.54 10.53 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.701 -1.136 . . . . 1.4299999999999999 108.777 166.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.9 10.13 43.84 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.378 -1.234 . . . . 1.4199999999999999 115.974 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -86.24 -175.28 5.45 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.647 1.724 . . . . 2.1400000000000001 112.122 165.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -146.46 156.22 43.13 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 130.056 3.342 . . . . 5.1900000000000004 107.556 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 78.6 t -156.06 128.04 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 127.487 2.315 . . . . 1.1899999999999999 109.812 -170.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -91.81 130.61 37.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.079 0.466 . . . . 4.8399999999999999 110.536 168.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.5 tt -111.78 136.75 50.63 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.914 1.685 . . . . 2.8399999999999999 110.821 173.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -87.32 150.28 23.95 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.744 2.018 . . . . 2.3399999999999999 110.004 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.419 HD11 HG22 ' A' ' 113' ' ' VAL . 5.3 mp -123.83 134.44 53.6 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.059 1.344 . . . . 1.22 110.408 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.7 mt -112.78 118.13 34.09 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.011 1.324 . . . . 0.64000000000000001 110.324 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -112.31 149.59 32.2 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.821 1.248 . . . . 1.9199999999999999 110.906 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.95 149.22 27.8 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.474 0.71 . . . . 1.9399999999999999 112.191 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.25 12.47 84.56 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 119.123 -0.821 . . . . 3.5 114.844 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.68 63.55 1.83 Allowed Glycine 0 N--CA 1.471 1.004 0 CA-C-N 118.965 1.383 . . . . 2.3700000000000001 113.581 172.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -135.78 147.69 48.46 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.744 1.618 . . . . 3.9199999999999999 111.611 169.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.2 t -138.34 146.69 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.437 1.095 . . . . 2.0299999999999998 110.189 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.0 tp -145.38 169.88 17.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.209 1.804 . . . . 2.1400000000000001 110.128 -177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -128.55 144.65 51.19 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.282 1.216 . . . . 2.4199999999999999 114.282 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.419 HG22 HD11 ' A' ' 103' ' ' LEU . 11.6 m -130.7 162.44 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 126.057 1.743 . . . . 2.4900000000000002 110.978 168.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 86.5 t -121.28 141.29 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.918 2.087 . . . . 2.21 107.113 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.1 mt -152.94 106.08 2.66 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 125.11 1.364 . . . . 2.0699999999999998 109.718 -160.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.53 149.92 89.11 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.904 2.403 . . . . 0.92000000000000004 110.822 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.5 t -91.83 116.87 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.646 -0.872 . . . . 1.1100000000000001 108.646 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.94 149.88 27.75 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.5 1.12 . . . . 3.29 111.358 -153.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -106.23 91.97 3.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.125 0.97 . . . . 2.27 113.102 -164.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 125.925 1.69 . . . . 8.0700000000000003 110.195 167.875 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.228 0 N-CA-C 105.681 -2.968 . . . . 10.449999999999999 105.681 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.0 m 59.55 176.14 0.08 Allowed 'General case' 0 N--CA 1.481 1.115 0 O-C-N 124.759 0.917 . . . . 10.59 110.902 -133.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -69.76 148.73 48.8 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.778 -0.452 . . . . 10.789999999999999 109.778 162.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.6 t -158.18 12.99 0.19 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.942 2.097 . . . . 5.4800000000000004 111.14 169.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -158.55 161.87 37.35 Favored 'General case' 0 CA--C 1.542 0.649 1 C-N-CA 131.857 4.063 . . . . 7.3600000000000003 103.826 -175.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.77 -175.49 41.32 Favored Glycine 0 N--CA 1.463 0.49 0 C-N-CA 124.239 0.923 . . . . 1.1499999999999999 115.402 -168.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -142.21 -179.26 6.15 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.904 1.682 . . . . 1.8300000000000001 111.572 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.7 142.87 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 121.114 -0.991 . . . . 1.49 109.804 174.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.44 HH11 ' HG3' ' A' ' 9' ' ' ARG . 1.0 OUTLIER -86.69 126.64 34.69 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.766 0.426 . . . . 3.96 112.08 -176.051 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -50.54 139.12 16.44 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.416 1.886 . . . . 2.1200000000000001 113.458 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 m -157.55 149.11 16.97 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.556 1.142 . . . . 2.3199999999999998 110.588 163.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -84.53 42.72 1.21 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.416 3.411 . . . . 1.8899999999999999 110.762 167.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.95 158.56 15.09 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.605 1.097 . . . . 1.3200000000000001 114.502 -164.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.37 -13.99 25.32 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.848 3.032 . . . . 1.1899999999999999 112.574 165.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -135.22 155.33 50.83 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 129.398 3.079 . . . . 2.21 112.62 -175.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.94 -176.29 5.47 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.072 1.749 . . . . 0.56999999999999995 112.138 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -154.56 130.14 9.91 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.709 1.604 . . . . 0.94999999999999996 110.385 -177.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.29 141.5 49.94 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.627 1.171 . . . . 0.54000000000000004 113.28 -169.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.425 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 39.9 m-85 -126.18 115.48 19.83 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.896 1.678 . . . . 2.4300000000000002 109.986 -170.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.259 0.0 OUTLIER -159.73 -174.87 4.83 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.591 1.7 . . . . 2.9199999999999999 115.591 -166.491 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.1 m -108.45 135.24 50.07 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.451 1.1 . . . . 2.0899999999999999 111.34 -158.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.71 108.86 17.35 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.803 1.241 . . . . 3.6899999999999999 108.394 171.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -99.32 138.6 36.18 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.014 0.926 . . . . 3.9500000000000002 109.174 170.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -109.33 89.17 6.76 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 122.902 0.481 . . . . 1.51 109.924 161.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.41 -9.24 20.14 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.545 2.163 . . . . 1.0700000000000001 113.065 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.95 -175.54 49.24 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 124.766 1.174 . . . . 1.2 113.195 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -111.81 -4.21 14.7 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.959 2.103 . . . . 3.27 112.41 -166.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mp -125.94 163.34 40.11 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 127.713 2.405 . . . . 3.9900000000000002 108.664 174.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.62 145.79 18.59 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.38 2.054 . . . . 1.28 111.273 -171.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mp -105.21 148.24 27.16 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.62 1.168 . . . . 2.8900000000000001 110.058 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -139.35 103.21 4.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.801 -1.545 . . . . 3.2000000000000002 109.703 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.0 tt -80.96 119.53 23.6 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 124.527 1.131 . . . . 2.3599999999999999 108.207 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.1 m -111.08 -12.53 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.291 1.036 . . . . 0.82999999999999996 111.258 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.45 -176.21 30.24 Favored Glycine 0 C--N 1.343 0.936 0 C-N-CA 125.316 1.436 . . . . 0.66000000000000003 114.085 -174.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.408 ' HB2' ' CE1' ' A' ' 84' ' ' PHE . . . -154.72 -179.5 8.06 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.93 1.692 . . . . 0.66000000000000003 110.069 173.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.02 -177.99 6.98 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 125.85 1.66 . . . . 5.3099999999999996 109.143 165.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 t -179.62 153.7 0.69 Allowed Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 128.043 2.537 . . . . 0.66000000000000003 106.46 -169.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -73.71 -16.58 23.66 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 120.77 1.311 . . . . 0.80000000000000004 112.602 172.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.3 m -113.19 41.5 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 114.631 1.345 . . . . 0.78000000000000003 114.631 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.14 142.48 4.1 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.22 -0.925 . . . . 1.1200000000000001 111.828 168.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -74.65 -57.02 4.19 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.912 0.885 . . . . 2.71 110.095 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -85.02 139.99 31.36 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.91 1.284 . . . . 5.3700000000000001 108.385 163.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 p -108.91 153.89 10.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.368 -1.287 . . . . 1.1599999999999999 108.207 140.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -135.02 151.86 51.18 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.704 2.002 . . . . 3.0 108.294 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.2 tp -106.53 124.46 49.64 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.288 0.635 . . . . 1.1000000000000001 109.892 173.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.2 m170 -123.95 159.77 29.02 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.277 1.431 . . . . 0.54000000000000004 114.131 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.58 159.39 22.98 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.388 1.875 . . . . 2.3100000000000001 110.743 163.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 m -135.33 145.33 47.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.079 1.751 . . . . 0.82999999999999996 106.796 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -157.97 171.0 21.04 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.18 0.99 . . . . 1.99 113.54 -167.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.6 ttp -100.7 135.99 41.28 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.265 1.826 . . . . 3.1699999999999999 110.134 168.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.14 138.45 40.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.636 1.175 . . . . 5.6500000000000004 110.731 171.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -92.43 126.32 37.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.411 1.484 . . . . 3.4300000000000002 112.9 -177.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 m -136.01 142.57 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.722 1.609 . . . . 2.4900000000000002 108.249 169.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 70.15 -3.18 1.86 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 126.003 1.721 . . . . 4.1299999999999999 115.065 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.43 22.82 39.04 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.769 1.176 . . . . 2.0899999999999999 113.791 -161.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt -133.97 132.31 40.01 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.722 2.409 . . . . 3.73 109.56 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -67.36 121.36 15.57 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 120.575 -1.328 . . . . 4.75 112.28 170.189 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.7 m -97.94 171.36 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.703 1.201 . . . . 2.25 108.759 151.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 70.0 mtm -111.23 156.63 21.17 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.477 0.711 . . . . 3.46 111.103 164.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.39 176.04 23.07 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.898 1.237 . . . . 0.57999999999999996 112.288 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.0 ttm -151.41 143.47 23.94 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.836 1.654 . . . . 0.64000000000000001 109.748 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -148.97 154.03 39.2 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.624 1.57 . . . . 5.5899999999999999 109.604 -173.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -76.67 161.03 34.25 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.425 2.084 . . . . 0.59999999999999998 111.364 172.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.25 155.83 64.61 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.692 1.597 . . . . 0.79000000000000004 110.977 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -82.62 -27.82 1.99 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.592 2.861 . . . . 0.71999999999999997 113.375 -169.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -174.44 165.4 3.9 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.178 1.391 . . . . 2.1699999999999999 111.916 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 mt -114.82 158.47 21.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.484 1.914 . . . . 0.89000000000000001 109.727 161.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -141.33 148.13 39.24 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.908 0.883 . . . . 2.2599999999999998 111.353 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -145.68 131.92 9.66 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.104 0.962 . . . . 1.1699999999999999 112.438 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.4 161.71 41.92 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.578 3.519 . . . . 1.6699999999999999 112.83 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.36 140.96 79.45 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.065 3.177 . . . . 1.47 113.435 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 67.73 -1.65 1.59 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.135 2.174 . . . . 2.0299999999999998 113.818 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.95 164.2 38.73 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.721 1.629 . . . . 1.49 111.952 171.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.03 139.77 20.76 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.693 1.197 . . . . 4.25 110.439 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.2 t -152.85 144.95 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.216 1.807 . . . . 3.75 108.34 -165.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -126.31 145.05 50.58 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 122.034 0.921 . . . . 4.3300000000000001 113.464 -168.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 mp -75.75 74.09 2.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.097 2.559 . . . . 1.98 109.495 171.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.438 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -64.0 146.5 97.26 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.175 0.99 . . . . 3.23 112.798 176.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.425 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 36.2 Cg_endo -60.43 -36.93 84.71 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.683 2.256 . . . . 2.3300000000000001 113.37 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.89 44.33 2.77 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.162 0.887 . . . . 1.6799999999999999 113.498 171.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.63 -124.3 1.14 Allowed Glycine 0 C--N 1.338 0.669 0 C-N-CA 125.44 1.495 . . . . 1.5900000000000001 113.018 176.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -73.28 139.74 46.33 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.816 -0.814 . . . . 2.3799999999999999 112.314 -171.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -162.19 166.97 24.86 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.326 1.45 . . . . 0.68999999999999995 111.708 -174.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 35' ' ' ALA . 95.0 m-85 -95.04 148.4 22.38 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.885 -0.509 . . . . 1.72 110.112 167.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.3 tpt -105.28 139.81 39.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.589 1.556 . . . . 0.60999999999999999 109.347 165.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -113.5 135.26 54.09 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.461 1.504 . . . . 0.71999999999999997 108.344 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.89 133.19 41.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.649 0.78 . . . . 2.1099999999999999 110.663 174.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.11 50.88 4.17 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 124.148 0.88 . . . . 0.79000000000000004 113.013 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.9 mt -52.31 156.84 1.58 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.674 1.731 . . . . 2.5299999999999998 115.674 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -116.89 -25.09 7.38 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.861 -1.063 . . . . 1.8200000000000001 113.68 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -114.49 138.68 23.25 Favored Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 126.649 1.98 . . . . 5.7400000000000002 107.075 158.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.88 133.49 31.53 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 N-CA-C 107.097 -1.924 . . . . 1.6599999999999999 107.097 162.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.25 78.92 1.31 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.294 0.637 . . . . 2.8300000000000001 110.439 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -68.7 163.87 22.93 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.948 0.88 . . . . 4.5599999999999996 112.502 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.89 117.44 10.56 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.435 -1.32 . . . . 2.25 107.435 168.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.86 14.55 59.27 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 117.903 -1.498 . . . . 1.8600000000000001 115.227 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.56 175.18 5.79 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.957 1.879 . . . . 2.7000000000000002 109.378 155.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.44 171.56 8.45 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.455 -1.683 . . . . 5.5099999999999998 106.455 150.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.4 t -138.17 119.89 17.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 C-N-CA 128.775 2.83 . . . . 1.9199999999999999 107.505 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.81 141.68 36.0 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.399 0.68 . . . . 3.5299999999999998 109.857 167.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.28 139.23 53.48 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.863 1.265 . . . . 1.71 110.951 171.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.02 149.54 23.94 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 129.698 3.199 . . . . 2.04 110.303 158.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -127.93 119.81 26.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.592 1.957 . . . . 0.80000000000000004 108.537 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.2 mt -103.58 121.14 42.3 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.307 1.043 . . . . 0.67000000000000004 111.147 -171.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -114.5 144.52 43.22 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.039 1.336 . . . . 2.0800000000000001 112.361 -174.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.86 144.63 48.2 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.411 -0.813 . . . . 1.8400000000000001 110.963 169.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.81 27.36 38.44 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 118.828 -0.984 . . . . 3.48 114.015 -174.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.99 36.24 32.58 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 124.703 1.144 . . . . 1.8799999999999999 115.243 163.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -129.65 143.59 50.89 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.39 1.095 . . . . 3.3799999999999999 112.897 -168.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.6 p -133.01 150.89 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.828 1.651 . . . . 2.0099999999999998 111.034 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 31.4 tp -144.43 159.62 42.43 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.334 2.254 . . . . 2.29 108.764 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -126.85 167.99 15.07 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.335 0.971 . . . . 3.0800000000000001 113.439 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.9 m -149.05 159.33 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 127.111 2.164 . . . . 2.6400000000000001 110.73 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.9 t -118.86 123.52 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.466 1.106 . . . . 1.6399999999999999 110.148 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.9 mt -124.9 123.89 25.51 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.701 1.2 . . . . 2.0899999999999999 110.083 -170.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.37 155.37 36.7 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.927 2.418 . . . . 1.01 111.504 174.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.4 t -94.94 115.11 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.427 0.632 . . . . 1.0600000000000001 111.062 172.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -93.95 130.16 40.15 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.504 1.122 . . . . 4.0499999999999998 111.249 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.34 152.01 22.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.261 1.024 . . . . 4.54 108.528 151.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 . . . . . 0 C--O 1.245 0.857 0 C-N-CA 127.322 2.249 . . . . 9.3000000000000007 109.62 -175.243 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.547 0 CA-C-O 118.24 -1.311 . . . . 12.91 109.847 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.8 p -170.08 166.46 9.1 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.896 1.348 . . . . 10.19 111.752 -172.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -124.98 -176.47 3.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.69 1.996 . . . . 9.1999999999999993 110.585 168.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.93 137.77 17.08 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.578 1.551 . . . . 7.6600000000000001 110.2 -173.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -78.76 169.59 17.99 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.495 1.518 . . . . 4.9100000000000001 112.766 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.29 -178.19 27.49 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 125.142 1.353 . . . . 1.01 112.064 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -155.67 164.77 38.17 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.537 0.94 . . . . 1.8600000000000001 113.537 171.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.4 t -106.86 141.25 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.337 1.455 . . . . 0.97999999999999998 108.751 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -74.69 -1.63 22.7 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.416 1.636 . . . . 4.3600000000000003 115.416 -172.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 64.16 172.38 0.18 Allowed 'General case' 0 CA--C 1.554 1.129 0 CA-C-N 119.919 1.236 . . . . 2.2000000000000002 111.567 -170.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.4 t -160.24 154.52 19.98 Favored Pre-proline 0 N--CA 1.468 0.457 0 O-C-N 120.275 -1.515 . . . . 3.0800000000000001 110.38 163.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -85.23 -3.48 9.49 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.576 2.85 . . . . 2.0800000000000001 112.312 161.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.15 -173.51 13.35 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.426 1.488 . . . . 1.45 114.587 -173.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.23 -18.83 20.48 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.948 3.099 . . . . 1.8500000000000001 113.849 -175.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -104.77 143.44 33.12 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.485 1.914 . . . . 2.6600000000000001 113.868 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.61 -178.86 7.3 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.59 1.956 . . . . 0.66000000000000003 112.405 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.34 134.33 25.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.924 2.089 . . . . 0.75 108.661 177.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.81 138.01 53.63 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.888 1.275 . . . . 0.84999999999999998 111.314 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -116.81 64.57 0.72 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.707 1.603 . . . . 2.4199999999999999 111.209 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.26 155.75 40.33 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.125 1.157 . . . . 2.1600000000000001 114.125 -172.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.5 m -92.66 147.21 23.06 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.556 1.143 . . . . 2.1499999999999999 109.769 166.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 tp -130.86 114.11 14.88 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.282 2.233 . . . . 3.4700000000000002 110.135 173.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -98.79 121.34 40.61 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.798 1.639 . . . . 5.1900000000000004 110.122 170.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -95.68 104.09 15.02 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 120.89 -1.132 . . . . 1.8200000000000001 110.101 165.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -83.18 -10.15 10.26 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.961 2.441 . . . . 1.28 113.443 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.66 171.4 54.64 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 123.154 1.419 . . . . 1.3 113.166 -173.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.41 -6.1 34.79 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 128.609 2.764 . . . . 3.2799999999999998 112.171 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.5 mt -117.76 162.59 28.25 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 127.49 2.316 . . . . 3.6499999999999999 109.178 171.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -81.51 153.23 17.93 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.66 2.24 . . . . 1.1799999999999999 111.211 -172.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.8 mt -102.32 155.08 18.47 Favored 'General case' 0 C--O 1.227 -0.101 0 CA-C-O 122.758 1.266 . . . . 1.9399999999999999 110.374 166.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -140.24 118.89 12.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 113.661 -1.609 . . . . 1.9099999999999999 109.624 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.2 tp -100.53 108.79 20.81 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.902 1.281 . . . . 1.6699999999999999 109.909 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 m -104.38 -17.84 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.15 0.98 . . . . 0.59999999999999998 111.833 -173.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.99 -179.04 31.63 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 125.412 1.482 . . . . 0.56000000000000005 112.304 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.96 178.16 7.55 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.073 1.349 . . . . 0.88 109.926 165.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -157.38 178.65 10.07 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.005 1.722 . . . . 6.4900000000000002 108.18 176.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 t 177.29 152.05 0.4 Allowed Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 126.642 1.977 . . . . 0.84999999999999998 109.527 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.06 -10.49 27.33 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.731 2.287 . . . . 1.03 114.22 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.3 m -116.72 41.43 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.691 0.997 . . . . 0.85999999999999999 113.691 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.84 144.97 23.83 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.259 -0.9 . . . . 1.01 110.87 162.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -93.21 -47.46 6.93 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.07 1.348 . . . . 3.71 111.447 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.11 161.23 19.77 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.313 1.845 . . . . 6.96 107.659 168.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.74 138.66 10.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 126.178 1.791 . . . . 1.48 108.979 -173.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.55 145.52 48.79 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.884 1.674 . . . . 3.0499999999999998 109.873 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.8 tp -101.35 120.21 39.92 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.216 1.006 . . . . 1.0700000000000001 110.783 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -123.53 155.38 37.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.102 1.761 . . . . 0.58999999999999997 113.65 -174.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -99.97 162.69 12.83 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.153 -1.385 . . . . 2.4700000000000002 111.685 156.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 m -121.61 136.76 54.93 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.153 1.781 . . . . 0.68000000000000005 106.571 162.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -134.83 176.16 8.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.965 1.306 . . . . 1.9199999999999999 112.895 -175.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.5 ptm -123.62 146.04 48.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.012 1.325 . . . . 3.2000000000000002 112.863 167.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.19 138.9 24.18 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.855 2.062 . . . . 6.0899999999999999 110.122 -176.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -95.13 121.88 37.22 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.833 1.253 . . . . 3.4100000000000001 110.809 175.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.2 m -88.67 -120.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.973 -1.121 . . . . 3.5699999999999998 107.973 172.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.07 37.67 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 130.106 3.362 . . . . 4.3499999999999996 116.429 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.81 22.1 68.02 Favored Glycine 0 CA--C 1.528 0.879 0 O-C-N 119.182 -2.199 . . . . 2.3599999999999999 111.504 -164.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.87 132.26 56.74 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.767 2.027 . . . . 6.6100000000000003 108.264 174.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.83 131.76 34.49 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.944 1.298 . . . . 8.3100000000000005 110.822 -175.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.58 150.6 20.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 124.369 1.068 . . . . 2.4500000000000002 110.663 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -111.34 136.89 49.81 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.641 1.176 . . . . 2.9399999999999999 110.27 -175.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.12 -176.67 14.52 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 124.968 1.27 . . . . 0.56999999999999995 112.262 -174.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ttm -152.85 146.62 25.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.175 1.39 . . . . 0.63 108.914 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -156.5 152.84 23.63 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 123.779 0.832 . . . . 5.9500000000000002 110.815 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.29 152.39 55.51 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.953 1.769 . . . . 0.56999999999999995 111.176 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.99 153.62 71.87 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.847 1.659 . . . . 0.67000000000000004 109.747 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.63 -25.3 3.76 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.961 2.44 . . . . 0.56000000000000005 113.279 -166.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -177.18 164.61 2.23 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.729 1.611 . . . . 1.8100000000000001 111.751 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.7 mt -111.79 153.96 25.78 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.424 1.49 . . . . 0.56999999999999995 109.967 163.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -110.11 147.25 34.01 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.388 1.075 . . . . 2.1499999999999999 109.2 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.5 t -139.85 129.53 13.84 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 113.018 0.747 . . . . 1.1100000000000001 113.018 170.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -71.1 164.97 33.91 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.484 2.79 . . . . 1.25 112.494 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -59.63 143.48 99.65 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.347 2.698 . . . . 1.23 111.929 172.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt 67.02 -4.06 0.86 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.318 1.847 . . . . 2.0899999999999999 114.26 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.36 134.8 13.15 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.713 1.625 . . . . 1.3899999999999999 113.088 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -97.84 138.89 34.52 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.646 1.178 . . . . 5.3300000000000001 110.139 164.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.3 t -144.9 132.12 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.059 1.343 . . . . 3.1200000000000001 108.0 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.49 136.48 49.56 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.6 0.714 . . . . 3.25 110.827 172.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mp -71.19 78.13 0.7 Allowed 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 125.45 1.5 . . . . 2.5099999999999998 109.1 165.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -76.08 156.13 84.17 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.248 1.419 . . . . 3.6000000000000001 114.159 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.79 -18.29 62.03 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.571 2.18 . . . . 2.0699999999999998 113.093 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.22 36.18 2.18 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.154 -0.804 . . . . 2.5099999999999998 112.819 166.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.71 -118.88 0.91 Allowed Glycine 0 C--N 1.344 0.974 0 C-N-CA 124.751 1.167 . . . . 1.79 115.066 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -72.15 142.07 49.1 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 121.812 -0.817 . . . . 1.9299999999999999 111.937 -165.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -161.98 171.35 17.75 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.354 1.062 . . . . 0.76000000000000001 112.251 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -107.33 133.4 51.93 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.14 0.576 . . . . 2.0 110.758 170.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.1 tpt -82.08 128.64 34.33 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.23 1.412 . . . . 0.75 109.324 163.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.4 mp -116.6 134.32 54.97 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.838 1.255 . . . . 0.96999999999999997 108.971 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.8 mt -135.58 132.94 37.78 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.752 0.821 . . . . 2.0899999999999999 110.738 -170.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.49 36.56 26.23 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.606 -1.108 . . . . 0.91000000000000003 114.065 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -45.05 150.62 0.38 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 116.528 2.047 . . . . 1.3100000000000001 116.528 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -106.74 7.13 30.25 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 113.713 -1.585 . . . . 2.3199999999999998 113.901 -169.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.9 ptm85 -145.32 147.6 34.5 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.959 1.304 . . . . 4.7800000000000002 111.627 167.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.07 149.64 71.54 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.297 1.998 . . . . 1.8899999999999999 108.435 158.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.72 134.54 25.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.462 1.105 . . . . 3.9500000000000002 110.512 -156.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.5 mmtm -103.32 171.99 7.06 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.068 1.347 . . . . 3.7999999999999998 111.489 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.58 134.6 46.54 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.822 -1.177 . . . . 1.1899999999999999 107.822 148.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.24 21.91 16.36 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.44 1.495 . . . . 1.23 115.405 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -105.79 -174.96 2.66 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.412 1.606 . . . . 1.8600000000000001 111.815 168.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -147.45 131.63 17.39 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 129.747 3.219 . . . . 5.5800000000000001 105.344 -169.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.1 t -140.5 130.5 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.093 0.957 . . . . 0.94999999999999996 110.985 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -76.09 141.66 41.94 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.326 1.051 . . . . 2.71 110.052 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 mp -128.15 136.81 51.63 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.816 0.846 . . . . 1.76 111.969 167.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -90.77 134.19 34.62 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 127.131 2.172 . . . . 2.54 109.339 173.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.73 118.01 35.49 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 119.702 1.137 . . . . 0.93000000000000005 110.065 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 72.2 mt -90.42 102.18 14.92 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.577 -0.897 . . . . 0.88 108.577 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -92.43 142.65 27.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.467 0.707 . . . . 2.5499999999999998 111.274 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.15 124.0 10.64 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.54 1.136 . . . . 1.5900000000000001 112.109 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.1 46.99 19.8 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.712 -1.049 . . . . 2.9900000000000002 114.296 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.84 25.29 25.36 Favored Glycine 0 N--CA 1.475 1.246 0 N-CA-C 117.172 1.629 . . . . 1.8899999999999999 117.172 156.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.57 148.1 39.96 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.453 1.626 . . . . 3.8999999999999999 111.221 168.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -140.28 151.63 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.786 1.234 . . . . 1.8300000000000001 110.935 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.9 tp -155.38 138.09 15.2 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.874 1.669 . . . . 2.48 109.548 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -110.21 115.71 30.21 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.692 0.678 . . . . 1.96 112.504 -173.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.6 m -89.31 178.12 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.057 1.743 . . . . 2.2999999999999998 111.592 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.7 p -142.42 145.28 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.078 1.351 . . . . 2.3799999999999999 109.041 170.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.4 143.75 13.82 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.078 0.951 . . . . 2.27 113.126 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.54 156.69 63.23 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.965 3.11 . . . . 0.90000000000000002 112.953 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.7 t -106.34 124.93 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.513 1.525 . . . . 0.90000000000000002 109.314 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -146.83 155.21 42.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.267 1.827 . . . . 3.8500000000000001 110.541 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -112.55 129.5 56.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.083 0.953 . . . . 2.7400000000000002 113.011 -165.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 C-N-CA 126.379 1.872 . . . . 7.6399999999999997 111.968 167.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.191 0 N-CA-C 106.084 -2.806 . . . . 12.199999999999999 106.084 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.5 p -65.1 175.74 1.5 Allowed 'General case' 0 CA--C 1.549 0.933 0 O-C-N 123.773 0.337 . . . . 12.74 111.733 133.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -144.24 -97.68 0.11 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.403 1.481 . . . . 8.3800000000000008 110.928 171.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 174.95 108.37 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.844 2.458 . . . . 6.8799999999999999 110.785 -174.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -156.76 73.23 0.76 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.579 1.152 . . . . 7.2300000000000004 108.554 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.35 165.71 33.96 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.866 1.698 . . . . 0.91000000000000003 112.407 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 21.8 p90 -155.65 152.11 28.27 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.319 1.448 . . . . 1.72 111.971 174.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.0 t -89.39 137.87 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.388 -0.82 . . . . 1.3400000000000001 109.021 171.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -62.53 -4.6 2.02 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.121 1.768 . . . . 4.1500000000000004 115.729 -168.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 72.6 159.89 0.22 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.569 1.948 . . . . 2.71 111.154 -167.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.9 t -168.87 135.71 1.53 Allowed Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 121.155 -0.966 . . . . 2.4500000000000002 111.077 163.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -81.42 -6.88 12.81 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.271 2.648 . . . . 1.9399999999999999 112.235 169.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.59 171.99 15.06 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.48 1.515 . . . . 1.04 113.551 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.76 -13.45 34.31 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.944 3.763 . . . . 1.27 115.454 -172.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -123.41 144.4 49.51 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.639 1.575 . . . . 3.6699999999999999 112.256 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.69 -176.49 4.67 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.367 1.867 . . . . 0.45000000000000001 112.012 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.97 154.3 39.18 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.694 1.997 . . . . 0.76000000000000001 108.504 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.51 146.48 42.02 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.75 1.22 . . . . 0.79000000000000004 114.227 -173.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.464 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 30.2 m-85 -120.7 143.6 48.66 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.867 2.067 . . . . 2.4500000000000002 110.184 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pp -171.38 151.62 3.11 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.441 1.275 . . . . 2.0299999999999998 114.441 -175.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.4 m -79.13 144.27 34.67 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.923 1.689 . . . . 1.96 111.359 174.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.5 126.99 54.97 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 129.502 3.121 . . . . 3.54 108.057 168.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -118.94 127.46 53.5 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.802 1.241 . . . . 4.2400000000000002 109.663 168.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -100.46 93.44 2.76 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 123.606 0.762 . . . . 1.4299999999999999 110.061 170.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.54 -8.89 18.52 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.025 1.817 . . . . 1.3600000000000001 112.983 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.42 162.45 34.83 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 122.684 1.158 . . . . 1.23 111.643 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -94.53 3.27 55.33 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.352 2.661 . . . . 2.9900000000000002 112.046 -170.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -122.21 154.32 61.87 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 129.242 3.017 . . . . 1.98 109.678 174.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.78 147.01 30.59 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.759 2.306 . . . . 0.85999999999999999 111.024 -172.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.6 mt -104.2 147.93 26.9 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 122.465 1.126 . . . . 1.95 110.537 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -136.73 99.04 3.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.562 -2.108 . . . . 2.2599999999999998 110.725 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.2 tp -80.73 106.43 12.73 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.669 1.588 . . . . 2.0 109.727 -173.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -99.19 -21.18 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.771 1.229 . . . . 0.81000000000000005 112.209 -175.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.16 -177.16 31.98 Favored Glycine 0 C--N 1.343 0.947 0 C-N-CA 124.96 1.266 . . . . 0.73999999999999999 114.937 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.07 -177.24 5.35 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.562 1.945 . . . . 0.73999999999999999 111.131 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.429 HH12 HG11 ' A' ' 110' ' ' VAL . 40.9 mtt85 -146.55 -179.42 6.76 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.809 2.044 . . . . 6.6500000000000004 108.062 158.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t -174.77 152.08 1.54 Allowed Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 127.12 2.168 . . . . 0.81999999999999995 108.299 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.78 -6.29 15.94 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.025 1.817 . . . . 0.98999999999999999 113.899 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.434 HG22 HG11 ' A' ' 99' ' ' VAL . 35.7 m -115.23 45.31 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.532 1.133 . . . . 0.90000000000000002 112.854 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.33 171.76 19.81 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.665 1.186 . . . . 1.28 111.8 168.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -104.96 -23.49 12.97 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 128.464 2.706 . . . . 2.8300000000000001 111.221 166.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -152.26 160.49 43.34 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.44 2.296 . . . . 6.5899999999999999 110.858 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.2 p -156.93 117.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 125.815 1.646 . . . . 1.8 110.301 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -131.28 130.68 43.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.954 -1.021 . . . . 5.0 111.352 -166.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 31.3 tp -83.3 122.51 28.54 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.958 0.903 . . . . 1.3999999999999999 111.746 -168.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.3 m170 -124.75 160.78 27.87 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.618 1.567 . . . . 0.68999999999999995 113.356 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -107.18 154.17 21.59 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 113.467 -1.697 . . . . 2.3700000000000001 110.721 157.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.0 m -111.18 138.33 47.75 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.265 1.826 . . . . 1.04 106.521 162.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -133.78 174.19 10.72 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.191 1.396 . . . . 2.0 112.968 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.0 ttp -113.0 143.0 45.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.628 1.571 . . . . 3.52 109.833 166.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -138.31 152.67 48.72 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.135 1.374 . . . . 4.7699999999999996 112.036 171.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -95.84 146.93 24.17 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.104 1.762 . . . . 2.2000000000000002 110.602 163.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 m -147.93 130.71 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.885 2.074 . . . . 2.2599999999999998 108.837 162.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 62.98 15.84 8.74 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.577 1.551 . . . . 3.3500000000000001 114.34 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.71 16.79 69.63 Favored Glycine 0 N--CA 1.479 1.513 0 O-C-N 121.054 -1.029 . . . . 1.6799999999999999 113.741 -169.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.9 mtmt -119.27 122.17 41.3 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.974 2.11 . . . . 3.46 108.071 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.47 128.43 38.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.869 1.268 . . . . 3.6899999999999999 111.76 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 t -143.69 141.73 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 127.208 2.203 . . . . 2.7599999999999998 108.662 -174.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 50.6 mtp -83.54 162.93 20.72 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.358 0.663 . . . . 3.3300000000000001 112.655 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.56 -177.47 28.83 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 125.118 1.342 . . . . 0.91000000000000003 112.397 -177.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.1 ttm -154.79 148.25 25.16 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.531 1.133 . . . . 0.92000000000000004 109.844 -172.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -155.89 153.7 26.36 Favored Pre-proline 0 N--CA 1.474 0.736 0 C-N-CA 123.779 0.832 . . . . 6.1699999999999999 111.475 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.77 156.56 39.65 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.499 2.133 . . . . 0.68000000000000005 111.262 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.7 m -138.88 153.03 71.54 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 125.114 1.366 . . . . 0.65000000000000002 110.148 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.32 -24.7 5.27 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.656 2.904 . . . . 0.75 113.337 -167.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -174.99 167.0 3.58 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.621 1.968 . . . . 2.1299999999999999 110.929 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.4 mt -109.6 153.34 24.31 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.526 1.13 . . . . 0.72999999999999998 110.31 159.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -108.94 143.65 37.91 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.234 1.014 . . . . 1.8600000000000001 109.167 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.7 t -136.88 124.3 14.28 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.386 0.674 . . . . 0.95999999999999996 110.989 165.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -69.82 164.51 34.33 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.773 2.982 . . . . 0.95999999999999996 111.643 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.66 147.89 92.49 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.017 2.478 . . . . 0.96999999999999997 113.301 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt 69.73 -14.04 0.37 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.335 2.654 . . . . 1.74 114.219 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.62 172.63 42.9 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.18 1.372 . . . . 1.4199999999999999 113.572 -171.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.68 143.94 35.37 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.89 0.876 . . . . 4.4400000000000004 111.119 168.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.5 t -151.17 158.49 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 127.379 2.272 . . . . 3.7999999999999998 107.213 -168.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.43 152.74 42.91 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 121.075 1.761 . . . . 3.77 114.088 176.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.1 mp -59.95 91.16 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 107.311 -1.366 . . . . 1.9099999999999999 107.311 155.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -49.93 126.0 18.8 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 125.351 1.46 . . . . 3.4700000000000002 111.831 -165.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 19.7 Cg_endo -60.96 -13.75 29.04 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.878 2.385 . . . . 2.71 116.678 -172.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.39 -1.39 29.5 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-N 120.101 1.319 . . . . 2.7200000000000002 115.277 167.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.94 -103.8 1.2 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.359 1.933 . . . . 1.9399999999999999 112.466 -168.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -72.49 139.12 47.45 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.269 -1.136 . . . . 2.0 112.059 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -160.22 149.74 17.72 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.561 1.144 . . . . 0.59999999999999998 110.519 -173.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -83.25 130.09 35.05 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.298 -1.001 . . . . 1.6200000000000001 108.298 165.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -80.04 133.08 36.11 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.279 0.945 . . . . 0.65000000000000002 108.832 163.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 mp -109.56 126.92 54.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.342 1.057 . . . . 0.57999999999999996 109.369 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -118.89 130.1 55.55 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 124.227 1.011 . . . . 3.3900000000000001 109.647 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.54 54.74 3.87 Favored Glycine 0 N--CA 1.476 1.363 0 C-N-CA 123.744 0.688 . . . . 0.76000000000000001 114.662 167.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.34 158.68 4.06 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 117.673 2.471 . . . . 1.55 117.673 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -116.29 -25.62 7.48 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 113.08 -1.873 . . . . 1.76 112.855 -171.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -117.81 151.83 49.2 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 129.48 3.112 . . . . 7.0499999999999998 107.811 159.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.99 140.66 38.52 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.229 1.953 . . . . 1.8 108.611 164.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.6 mp -95.74 89.21 5.23 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.158 0.504 . . . . 2.4399999999999999 110.259 -175.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -75.21 174.16 9.85 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.268 0.556 . . . . 5.0700000000000003 111.758 167.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.72 146.45 44.41 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.501 -1.296 . . . . 1.3500000000000001 107.501 165.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.32 34.5 63.96 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 117.866 -1.519 . . . . 1.6000000000000001 114.163 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -94.73 174.04 7.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.14 1.47 . . . . 2.6499999999999999 109.185 157.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -135.5 127.77 30.14 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 105.092 -2.188 . . . . 4.3499999999999996 105.092 169.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.434 HG11 HG22 ' A' ' 39' ' ' VAL . 10.7 t -152.45 140.05 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.944 1.298 . . . . 2.04 110.331 -175.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -78.3 154.67 30.69 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 113.394 0.887 . . . . 3.6400000000000001 113.394 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.9 137.36 51.79 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.264 -1.334 . . . . 1.8100000000000001 110.4 149.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.41 150.6 31.28 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.582 1.153 . . . . 2.5899999999999999 108.611 159.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.0 mp -123.86 127.69 48.39 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.025 1.33 . . . . 1.02 110.209 175.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.3 mt -110.65 114.12 27.26 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.99 1.716 . . . . 1.1200000000000001 110.226 -172.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -113.21 123.59 50.55 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.759 1.224 . . . . 1.95 111.613 -172.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 48.01 32.13 2.75 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.308 1.843 . . . . 2.25 113.502 176.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.25 -73.96 2.35 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.107 1.337 . . . . 4.9699999999999998 112.689 -172.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.15 -26.36 44.62 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 116.44 1.336 . . . . 2.0699999999999998 116.44 -161.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -83.81 109.46 17.56 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.58 1.69 . . . . 4.8200000000000003 111.716 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.429 HG11 HH12 ' A' ' 36' ' ' ARG . 58.8 t -98.52 134.46 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.399 1.48 . . . . 1.78 110.712 174.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -136.68 171.62 14.22 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.811 1.644 . . . . 3.3599999999999999 109.606 166.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -149.6 143.96 25.88 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.786 -1.196 . . . . 2.02 112.007 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.84 150.57 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.137 0.975 . . . . 2.3500000000000001 110.011 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.83 133.51 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.523 1.529 . . . . 1.6499999999999999 107.641 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.4 mt -139.07 145.58 45.76 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.422 1.089 . . . . 2.5600000000000001 109.918 -173.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.14 162.46 35.61 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.796 2.331 . . . . 0.72999999999999998 112.444 167.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 42.6 t -112.07 122.5 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.189 -1.411 . . . . 0.98999999999999999 107.189 165.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -146.48 154.54 41.69 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.467 1.507 . . . . 4.4800000000000004 110.391 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.03 141.85 28.4 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.484 0.92 . . . . 2.3500000000000001 113.484 -168.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.541 ' HB2' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.976 0 C-N-CA 126.157 1.783 . . . . 8.5999999999999996 112.103 169.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.01 0 N-CA-C 104.748 -3.341 . . . . 12.539999999999999 104.748 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p 168.5 163.44 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 O-C-N 124.771 0.924 . . . . 11.65 109.383 -139.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -158.96 145.61 17.05 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.797 1.239 . . . . 7.9000000000000004 113.928 -170.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.0 p -104.73 63.17 0.72 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.245 1.418 . . . . 7.5199999999999996 111.922 -165.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -77.88 76.05 4.41 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 123.078 1.418 . . . . 6.3700000000000001 112.065 -174.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.98 179.03 21.62 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 121.161 -0.962 . . . . 1.0 111.393 173.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.3 p90 -148.94 157.06 43.14 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.778 0.831 . . . . 1.78 112.053 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.2 t -97.56 143.65 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 107.65 -1.241 . . . . 1.3 107.65 173.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -73.87 127.27 32.4 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.438 -0.789 . . . . 4.7800000000000002 110.816 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -36.02 148.49 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.675 1.99 . . . . 2.52 113.333 155.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.9 t -160.25 146.75 11.96 Favored Pre-proline 0 CA--C 1.536 0.439 0 O-C-N 120.884 -1.135 . . . . 2.3100000000000001 112.333 166.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -85.89 -6.81 8.52 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.18 2.587 . . . . 2.0 112.693 170.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -137.58 -176.58 14.53 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.73 1.157 . . . . 1.1200000000000001 114.423 -172.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.3 -17.92 44.56 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.483 3.455 . . . . 1.49 115.097 -169.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -97.85 142.07 30.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.19 1.396 . . . . 2.8100000000000001 112.64 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.14 -176.48 5.69 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.484 1.514 . . . . 0.68999999999999995 111.944 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.21 152.3 32.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.675 1.59 . . . . 0.71999999999999997 109.708 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.08 124.27 47.65 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.09 1.314 . . . . 0.81999999999999995 111.773 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -102.16 57.39 0.81 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.812 1.645 . . . . 2.8100000000000001 109.635 173.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -75.12 162.93 28.08 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.057 0.943 . . . . 1.9299999999999999 113.163 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 99.0 m -143.58 137.38 28.33 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.892 1.677 . . . . 2.5 110.869 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.616 HD21 HG11 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -135.1 156.52 48.87 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.255 2.222 . . . . 4.9400000000000004 109.018 169.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -84.79 160.89 20.15 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.196 1.362 . . . . 3.3900000000000001 110.507 154.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -97.86 94.33 2.09 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 109.042 -0.725 . . . . 1.8 109.042 155.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.98 -6.27 14.96 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.063 2.509 . . . . 1.8600000000000001 113.433 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.33 164.52 52.53 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-O 122.722 1.179 . . . . 1.76 112.082 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -87.02 -5.89 58.92 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.661 1.584 . . . . 3.7799999999999998 111.742 175.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 pp -116.04 159.13 40.57 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 127.666 2.387 . . . . 2.5600000000000001 111.198 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.01 145.29 22.07 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.576 2.184 . . . . 1.3400000000000001 111.046 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.1 mt -99.33 142.84 30.29 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 123.018 1.39 . . . . 2.46 111.727 170.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.42 ' HD2' ' CD2' ' A' ' 66' ' ' PHE . 16.4 tpp85 -131.47 98.38 4.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 112.119 -2.31 . . . . 1.97 109.474 -174.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.9 tp -91.39 109.27 20.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.565 1.546 . . . . 1.8999999999999999 109.691 -171.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.7 m -103.68 -22.07 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.826 0.85 . . . . 0.56999999999999995 112.084 -173.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.88 -177.08 30.65 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.466 1.508 . . . . 0.52000000000000002 114.288 -173.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.35 178.38 8.83 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.8 1.64 . . . . 0.52000000000000002 112.269 171.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.8 161.08 36.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.54 2.336 . . . . 6.2199999999999998 109.12 174.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 t -176.25 154.08 1.33 Allowed Pre-proline 0 N--CA 1.471 0.6 0 C-N-CA 128.08 2.552 . . . . 0.70999999999999996 107.176 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.16 -20.16 19.27 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.85 1.7 . . . . 0.93999999999999995 112.499 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.6 m -99.1 35.27 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.799 0.809 . . . . 0.83999999999999997 112.899 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.14 143.05 16.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.982 1.313 . . . . 1.03 109.234 166.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -91.51 -49.42 6.32 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.63 1.572 . . . . 3.8100000000000001 110.592 -176.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.99 160.15 22.53 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.468 1.907 . . . . 6.4800000000000004 107.665 167.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.1 p -142.52 145.45 23.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 126.067 1.747 . . . . 1.3500000000000001 108.049 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -129.47 148.74 51.41 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.057 1.743 . . . . 3.0600000000000001 108.771 174.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.5 tp -101.16 121.28 41.54 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.349 -0.845 . . . . 0.97999999999999998 109.911 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.1 m170 -123.61 154.28 39.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.436 1.494 . . . . 0.55000000000000004 113.871 -174.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -100.68 179.8 4.31 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.341 1.456 . . . . 2.1499999999999999 112.098 162.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.5 m -145.63 128.44 16.32 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 106.665 -1.606 . . . . 0.65000000000000002 106.665 172.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -129.16 167.96 16.84 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 114.357 1.243 . . . . 2.2599999999999998 114.357 -166.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -109.2 147.6 32.28 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.864 1.666 . . . . 4.9900000000000002 110.994 171.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.55 151.76 24.69 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.776 0.83 . . . . 5.1600000000000001 112.004 -174.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -103.72 143.29 32.99 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.702 1.601 . . . . 2.2599999999999998 109.671 167.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -158.99 139.97 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.613 1.165 . . . . 3.0899999999999999 108.336 167.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 62.25 27.17 16.29 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.334 1.053 . . . . 3.4500000000000002 111.844 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.99 18.2 78.99 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 120.912 -1.118 . . . . 1.6899999999999999 113.605 -175.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -132.48 129.33 39.04 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.046 1.338 . . . . 2.5499999999999998 110.179 -174.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.599 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -71.29 130.09 40.51 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.311 2.244 . . . . 3.98 111.315 173.493 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.1 m -141.43 175.12 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 129.171 2.988 . . . . 2.25 110.235 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.25 162.9 21.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.079 1.351 . . . . 3.6800000000000002 111.172 177.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.3 -178.14 29.25 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.089 1.328 . . . . 0.52000000000000002 113.704 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.3 ttm -154.82 148.49 25.39 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.507 1.923 . . . . 0.59999999999999998 108.286 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -160.43 156.4 22.64 Favored Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 124.814 1.246 . . . . 5.7599999999999998 110.471 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.64 155.44 44.68 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.254 1.969 . . . . 0.59999999999999998 111.519 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.99 154.72 70.76 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.655 1.582 . . . . 0.68000000000000005 110.156 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.69 -24.49 3.44 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.178 2.585 . . . . 0.56999999999999995 113.367 -167.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.42 ' CD2' ' HD2' ' A' ' 31' ' ' ARG . 50.6 p90 -178.24 163.05 1.61 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.334 1.853 . . . . 1.8600000000000001 111.073 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.1 mt -109.6 153.01 24.78 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.006 1.323 . . . . 0.68999999999999995 110.377 166.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -121.39 137.33 54.75 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.288 1.435 . . . . 2.0899999999999999 109.194 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.9 t -140.32 130.99 13.89 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 123.667 0.787 . . . . 1.3500000000000001 111.544 175.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.3 163.76 37.53 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.356 2.704 . . . . 1.3100000000000001 112.39 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -60.03 140.36 92.25 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.42 2.747 . . . . 1.55 111.012 171.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp 65.78 0.75 1.6 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.137 1.375 . . . . 3.2799999999999998 113.374 -175.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.11 -175.18 41.9 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.225 1.869 . . . . 1.77 109.907 163.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -139.19 138.45 36.91 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.712 -0.876 . . . . 7.4699999999999998 112.865 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -93.04 57.23 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 128.189 2.595 . . . . 5.21 108.43 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -81.4 125.3 30.24 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.136 0.974 . . . . 3.6099999999999999 108.859 163.272 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 83' ' ' HIS . 5.1 mp -72.48 -53.94 10.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.162 -0.472 . . . . 3.1400000000000001 110.477 175.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.314 0.0 OUTLIER 79.94 123.55 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.081 0 C-N-CA 128.157 2.583 . . . . 3.3599999999999999 114.228 176.698 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.41 -15.19 48.68 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.065 2.51 . . . . 2.1600000000000001 113.9 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.86 5.12 84.86 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 117.073 -1.959 . . . . 1.5 114.745 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.49 -24.14 0.02 OUTLIER Glycine 0 C--N 1.348 1.23 0 N-CA-C 121.596 3.398 . . . . 2.0699999999999998 121.596 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -145.77 147.62 32.09 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.022 1.911 . . . . 2.0699999999999998 113.215 171.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.581 ' HA ' HD23 ' A' ' 77' ' ' LEU . 50.2 p-80 -162.18 155.41 20.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.12 0.968 . . . . 0.63 110.889 177.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -80.32 137.16 36.55 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.108 0.867 . . . . 1.8899999999999999 109.119 158.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.8 tpt -85.21 129.73 34.75 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.881 1.272 . . . . 0.69999999999999996 108.43 162.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -111.62 126.41 54.98 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.466 1.107 . . . . 0.57999999999999996 108.866 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.96 128.63 55.91 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.243 1.017 . . . . 2.8999999999999999 109.432 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.48 44.48 10.91 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 118.561 -1.133 . . . . 0.94999999999999996 114.834 169.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -43.52 149.82 0.25 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 117.734 2.494 . . . . 1.3700000000000001 117.734 176.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -115.82 -22.56 9.04 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 114.19 -1.368 . . . . 2.8599999999999999 114.526 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -91.38 168.62 13.05 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 107.553 -1.277 . . . . 5.7000000000000002 107.553 149.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -63.38 177.93 1.41 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 121.153 1.236 . . . . 2.6600000000000001 109.907 148.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.0 mt -129.13 95.08 3.96 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.135 -0.978 . . . . 2.5600000000000001 109.314 167.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -99.33 159.44 15.0 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.967 0.889 . . . . 5.6699999999999999 112.829 176.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.74 130.62 44.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.275 -1.329 . . . . 1.45 107.915 159.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.92 0.68 83.23 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.484 1.992 . . . . 1.4399999999999999 116.797 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.412 ' HB3' ' H ' ' A' ' 98' ' ' GLU . 33.9 mt-10 -81.48 -171.46 3.31 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.482 2.141 . . . . 2.6600000000000001 113.312 175.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 97' ' ' GLU . 16.5 pt-20 -152.51 124.98 8.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 128.62 2.768 . . . . 5.0099999999999998 105.899 -155.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 38.1 t -144.02 125.34 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 O-C-N 121.578 -0.701 . . . . 1.1299999999999999 110.333 -173.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -79.56 151.21 30.8 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.497 -0.774 . . . . 3.0299999999999998 111.325 168.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.23 147.22 34.5 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.828 2.051 . . . . 1.99 110.793 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -121.53 108.0 13.09 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 128.946 2.898 . . . . 2.2000000000000002 108.312 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.0 mp -83.98 128.09 34.31 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.355 -0.84 . . . . 0.98999999999999999 110.584 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.6 mt -97.82 103.41 15.35 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.362 1.065 . . . . 0.69999999999999996 110.557 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -98.02 143.11 28.93 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.675 1.19 . . . . 2.23 111.435 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.64 131.69 39.39 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.282 1.033 . . . . 2.0099999999999998 112.421 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.18 41.93 7.27 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.801 -0.999 . . . . 2.9500000000000002 113.938 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.16 7.21 88.61 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 116.018 1.167 . . . . 2.1299999999999999 116.018 165.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -90.43 112.62 24.31 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.963 1.382 . . . . 3.3199999999999998 111.382 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.13 134.15 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.917 1.287 . . . . 2.23 109.999 173.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.0 tp -128.49 111.01 12.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.776 0.83 . . . . 1.9099999999999999 111.465 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -81.76 135.16 35.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.417 0.687 . . . . 2.1699999999999999 112.354 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.616 HG11 HD21 ' A' ' 22' ' ' LEU . 7.7 m -144.84 162.2 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 127.458 2.303 . . . . 2.02 111.019 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.2 t -131.91 132.45 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.625 0.77 . . . . 1.6399999999999999 109.881 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.89 153.69 64.54 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 126.251 1.82 . . . . 1.8500000000000001 110.142 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.04 167.11 27.62 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.674 2.916 . . . . 0.73999999999999999 112.278 175.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.85 135.29 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.786 1.234 . . . . 0.89000000000000001 109.358 167.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -150.26 165.45 32.92 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 115.991 1.849 . . . . 4.2999999999999998 115.991 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.14 149.55 27.91 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 116.963 2.209 . . . . 2.6099999999999999 116.963 -159.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.186 1 C-N-CA 134.05 4.94 . . . . 8.4800000000000004 108.462 161.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.375 0 N-CA-C 109.48 -1.448 . . . . 11.970000000000001 109.48 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.1 p -171.35 167.85 6.75 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.5 1.15 . . . . 9.1600000000000001 112.364 -165.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -87.24 172.31 9.99 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.045 1.338 . . . . 9.1600000000000001 111.851 170.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.05 163.04 34.67 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.42 2.688 . . . . 6.8600000000000003 107.566 170.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -133.23 152.18 51.93 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.965 1.706 . . . . 7.0599999999999996 107.947 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.85 164.24 31.23 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 123.541 0.591 . . . . 1.3300000000000001 111.961 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -108.36 168.58 9.21 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.147 0.979 . . . . 2.0899999999999999 112.206 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.8 t -90.88 131.52 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.083 0.953 . . . . 1.25 109.011 167.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 107.67 11.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.972 0.909 . . . . 4.9000000000000004 108.828 171.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -42.78 149.69 0.18 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.317 1.847 . . . . 2.0600000000000001 114.806 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.6 t -152.51 151.56 27.31 Favored Pre-proline 0 CA--C 1.538 0.492 0 O-C-N 121.132 -0.98 . . . . 2.8500000000000001 111.08 163.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -88.32 -2.66 6.88 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.429 2.753 . . . . 2.3100000000000001 111.968 164.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.7 -179.38 20.0 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.929 1.252 . . . . 1.3700000000000001 114.716 -170.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.81 -17.21 37.46 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.635 3.556 . . . . 1.45 114.635 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -110.28 153.9 24.2 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.495 1.518 . . . . 2.3900000000000001 113.738 172.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.39 -178.47 6.68 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 128.132 2.573 . . . . 0.70999999999999996 110.647 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.13 152.74 36.65 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.338 1.455 . . . . 0.65000000000000002 110.448 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.62 146.61 36.42 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.239 1.2 . . . . 0.56000000000000005 114.239 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -117.51 29.74 7.69 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 115.663 1.727 . . . . 2.8999999999999999 115.663 -167.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -49.74 161.88 0.2 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 117.876 2.547 . . . . 1.8799999999999999 117.876 -169.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 15.8 m -79.64 119.81 23.1 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.448 0.642 . . . . 2.0099999999999998 111.589 172.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.467 HD12 HG21 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -83.35 139.24 33.14 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.55 -0.907 . . . . 3.75 108.55 164.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -147.39 172.45 13.9 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.368 0.667 . . . . 6.1500000000000004 111.551 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -155.71 110.38 2.17 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.338 1.455 . . . . 1.3799999999999999 110.74 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.7 -5.82 4.39 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.844 3.03 . . . . 1.3899999999999999 114.292 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.99 178.23 41.99 Favored Glycine 0 C--N 1.341 0.818 0 CA-C-N 119.55 1.068 . . . . 1.1799999999999999 112.956 -174.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -101.25 3.2 40.66 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.408 2.283 . . . . 3.29 112.323 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -118.74 160.21 41.27 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 127.116 2.166 . . . . 2.0600000000000001 110.254 171.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.75 142.26 15.87 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.344 2.03 . . . . 1.0600000000000001 111.422 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.471 HD12 ' CD1' ' A' ' 105' ' ' PHE . 1.9 mm? -102.95 157.11 17.2 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.359 1.464 . . . . 2.5299999999999998 111.975 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -152.99 104.54 2.84 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.02 -1.446 . . . . 2.0699999999999998 111.649 -169.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.2 tt -83.03 123.64 29.67 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.702 1.201 . . . . 2.3999999999999999 108.61 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 m -110.91 -15.12 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.665 0.786 . . . . 0.69999999999999996 111.662 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.48 -177.12 30.28 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 125.6 1.571 . . . . 0.52000000000000002 114.051 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.9 -179.55 7.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.46 1.504 . . . . 0.56000000000000005 111.699 171.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -155.92 173.26 17.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.605 2.362 . . . . 6.3099999999999996 109.212 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 t 178.54 146.75 0.36 Allowed Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 129.106 2.963 . . . . 0.81999999999999995 106.87 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.0 -15.62 36.26 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 121.736 1.624 . . . . 1.3 113.544 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.0 22.17 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.609 1.164 . . . . 1.22 113.288 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.75 138.47 28.83 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.786 1.176 . . . . 1.02 110.382 169.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -83.21 -41.03 18.88 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.007 0.923 . . . . 3.8100000000000001 111.062 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -131.16 152.84 50.03 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 128.537 2.735 . . . . 6.6900000000000004 106.396 -175.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.6 p -146.57 146.27 18.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 124.555 1.142 . . . . 1.4299999999999999 108.772 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -132.36 145.36 51.19 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.97 1.708 . . . . 3.1200000000000001 108.841 175.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.4 tp -99.63 118.79 36.93 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.809 -0.557 . . . . 0.97999999999999998 109.639 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.0 m170 -122.53 154.12 38.31 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.245 1.418 . . . . 0.63 114.068 -174.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -102.04 163.66 12.12 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.354 -1.294 . . . . 2.3100000000000001 111.622 161.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.4 m -120.88 130.63 53.99 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 105.906 -1.887 . . . . 0.88 105.906 163.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -127.37 168.52 14.71 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.518 1.303 . . . . 2.0800000000000001 114.518 -170.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -109.49 148.21 31.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.853 1.661 . . . . 4.9900000000000002 111.425 170.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.58 148.48 24.37 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.414 1.086 . . . . 5.04 110.56 -174.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -98.53 140.02 33.39 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.564 1.145 . . . . 2.9300000000000002 109.895 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.1 t -137.81 118.41 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.353 1.061 . . . . 2.2999999999999998 108.241 168.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 66.49 15.14 10.02 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 126.191 1.796 . . . . 4.1299999999999999 114.85 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.6 21.64 55.7 Favored Glycine 0 CA--C 1.535 1.32 0 O-C-N 121.356 -0.84 . . . . 2.5800000000000001 112.943 -166.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.5 mttt -124.53 113.53 18.22 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.604 1.562 . . . . 3.3900000000000001 109.133 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.8 123.01 28.94 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.604 -0.685 . . . . 5.7300000000000004 110.519 -171.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.29 179.76 3.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 128.451 2.7 . . . . 2.6000000000000001 110.764 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.83 162.56 31.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.88 1.272 . . . . 2.5699999999999998 111.862 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.35 -176.54 27.65 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.53 1.538 . . . . 0.64000000000000001 113.662 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.0 ttm -150.8 148.02 27.99 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.195 1.798 . . . . 0.88 108.873 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -158.65 157.34 28.49 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 124.659 1.184 . . . . 5.8600000000000003 111.131 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.99 154.77 53.04 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.011 1.807 . . . . 0.67000000000000004 111.699 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.45 156.5 74.99 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 126.283 1.833 . . . . 0.76000000000000001 110.091 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.44 -26.76 3.09 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.023 2.482 . . . . 0.60999999999999999 113.371 -167.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -175.3 164.68 3.24 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.501 1.521 . . . . 2.1000000000000001 111.231 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.4 mt -113.33 153.92 27.7 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.897 1.679 . . . . 0.72999999999999998 110.119 164.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -136.34 147.99 47.68 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.355 0.662 . . . . 2.2599999999999998 111.836 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.467 HG21 HD12 ' A' ' 22' ' ' LEU . 88.0 t -141.56 131.47 12.79 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.161 0.985 . . . . 0.82999999999999996 112.366 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -69.97 161.98 43.9 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.742 2.962 . . . . 0.92000000000000004 111.704 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.24 140.91 81.64 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.598 2.866 . . . . 0.97999999999999998 113.517 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp 66.94 2.88 2.85 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.476 1.91 . . . . 1.75 114.552 176.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.78 160.31 31.16 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.843 1.687 . . . . 1.2 114.24 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.19 146.04 33.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.333 1.053 . . . . 4.1600000000000001 110.85 168.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.2 t -155.81 132.92 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 125.491 1.516 . . . . 4.46 108.642 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 2.8 mp0 -83.21 141.66 31.74 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.137 1.335 . . . . 3.7400000000000002 111.102 176.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mp -46.49 -43.57 16.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.989 1.316 . . . . 2.9399999999999999 112.007 -177.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 108.13 128.56 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 128.019 2.528 . . . . 3.8399999999999999 111.019 158.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -59.98 116.16 3.12 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 N-CA-C 107.463 -1.783 . . . . 2.7000000000000002 107.463 165.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.78 26.07 59.27 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 116.98 -2.011 . . . . 2.0099999999999998 116.463 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.58 -42.74 0.04 OUTLIER Glycine 0 N--CA 1.482 1.729 0 N-CA-C 119.252 2.461 . . . . 1.79 119.252 166.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -137.2 145.94 44.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.745 1.26 . . . . 1.9199999999999999 110.753 160.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -160.56 153.02 20.67 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.176 -0.953 . . . . 0.72999999999999998 109.339 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -78.72 151.02 32.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.82 -0.807 . . . . 2.27 108.82 162.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.3 tpt -101.0 129.42 46.84 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.912 1.685 . . . . 0.77000000000000002 107.391 159.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.84 137.62 49.55 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.671 1.188 . . . . 0.66000000000000003 108.479 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -139.44 146.61 40.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.516 1.127 . . . . 2.3599999999999999 112.69 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.78 26.94 68.05 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.464 1.03 . . . . 1.3300000000000001 113.728 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.5 148.12 2.99 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 117.07 2.248 . . . . 1.48 117.07 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -120.7 2.48 10.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 112.065 -2.334 . . . . 2.3100000000000001 113.494 -165.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -145.25 144.51 23.55 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 127.094 2.158 . . . . 6.0300000000000002 108.22 164.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.07 158.3 45.81 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.111 2.541 . . . . 1.74 110.343 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -106.18 99.55 9.13 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.973 1.709 . . . . 2.8100000000000001 109.294 -169.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.445 ' H ' ' HZ3' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -82.91 132.69 35.15 Favored 'General case' 0 C--N 1.332 -0.155 0 O-C-N 120.446 -1.409 . . . . 4.2800000000000002 112.423 175.146 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.7 115.55 1.69 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 113.923 -1.49 . . . . 1.8600000000000001 109.889 169.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.92 -3.74 45.26 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 117.673 -1.626 . . . . 1.8799999999999999 115.736 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -76.41 -178.58 4.69 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 120.242 2.021 . . . . 2.7599999999999998 111.661 167.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -140.66 139.05 34.74 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 129.236 3.014 . . . . 3.5299999999999998 105.535 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.66 126.63 44.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 126.616 1.966 . . . . 1.02 108.504 -173.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -78.29 139.6 38.86 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.836 0.826 . . . . 3.8199999999999998 111.857 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.38 146.47 39.42 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.125 1.37 . . . . 3.1899999999999999 109.321 163.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -102.46 139.23 38.33 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.04 2.536 . . . . 2.6400000000000001 108.859 171.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.2 mp -109.37 138.06 46.3 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.592 1.557 . . . . 0.87 110.395 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.4 mt -112.14 110.06 20.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.687 1.195 . . . . 0.63 110.917 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.471 ' CD1' HD12 ' A' ' 30' ' ' LEU . 97.6 m-85 -107.62 151.8 25.15 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.359 1.464 . . . . 2.04 112.505 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.82 114.61 1.47 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.899 1.28 . . . . 1.75 113.538 -174.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.42 69.32 1.4 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.928 1.252 . . . . 2.8100000000000001 112.965 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.28 7.92 73.58 Favored Glycine 0 N--CA 1.476 1.311 0 N-CA-C 116.291 1.277 . . . . 2.02 116.291 164.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -96.56 125.98 41.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.861 1.331 . . . . 3.6099999999999999 111.309 -171.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.99 141.98 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 124.297 0.998 . . . . 1.8999999999999999 110.893 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.3 tp -140.59 159.8 41.41 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.491 2.316 . . . . 2.1000000000000001 108.6 177.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -132.83 145.18 50.74 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.983 0.913 . . . . 2.1400000000000001 111.992 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.12 160.31 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 127.299 2.24 . . . . 2.6099999999999999 110.836 -172.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.2 t -130.03 94.62 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.034 0.921 . . . . 2.25 110.618 -158.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.8 mt -98.55 123.78 48.84 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-O 118.062 -0.971 . . . . 2.3999999999999999 111.051 -168.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.13 153.98 73.52 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.11 1.873 . . . . 0.97999999999999998 111.041 170.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 90.1 t -92.99 121.09 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.305 0.642 . . . . 1.49 109.986 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -117.78 135.82 53.8 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.372 1.069 . . . . 3.4900000000000002 110.59 167.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.93 57.46 4.34 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.202 -0.936 . . . . 4.0899999999999999 112.74 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.335 0 CA-C-O 115.926 -1.988 . . . . 7.2000000000000002 112.605 -171.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.299 0 N-CA-C 106.448 -2.661 . . . . 12.92 106.448 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.9 p -60.5 169.84 1.6 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 119.18 -1.008 . . . . 11.66 110.352 130.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -143.87 118.68 9.9 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.151 -1.055 . . . . 9.5999999999999996 108.151 175.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 78.7 p -79.56 86.23 5.23 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.987 0.915 . . . . 7.2599999999999998 110.294 -173.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -146.26 -173.69 4.25 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.544 2.338 . . . . 5.8399999999999999 108.019 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.29 176.01 28.74 Favored Glycine 0 CA--C 1.527 0.793 0 O-C-N 121.324 -0.86 . . . . 1.52 112.385 169.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -157.64 172.08 19.18 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.53 1.132 . . . . 2.0600000000000001 112.073 154.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 10' ' ' PHE . 10.2 t -105.53 139.02 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.534 1.133 . . . . 1.1200000000000001 109.323 172.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.0 ttp85 -60.47 -35.36 75.7 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.882 1.067 . . . . 3.79 113.882 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.436 ' H ' HG12 ' A' ' 8' ' ' VAL . 6.2 t80 64.89 158.95 0.1 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.79 2.036 . . . . 3.1600000000000001 110.343 -157.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 m -166.07 147.65 5.92 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 126.195 1.798 . . . . 3.1200000000000001 109.017 162.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -83.58 49.74 3.01 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.591 3.527 . . . . 2.9399999999999999 111.682 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.17 179.09 25.31 Favored Glycine 0 CA--C 1.537 1.423 0 N-CA-C 115.892 1.117 . . . . 1.29 115.892 -171.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.92 -20.15 19.91 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 124.073 3.182 . . . . 1.27 112.52 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -112.09 145.92 38.89 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.413 1.885 . . . . 2.4700000000000002 113.646 173.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -131.28 -177.68 4.5 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.637 1.975 . . . . 0.65000000000000002 110.802 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.54 148.65 31.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.771 1.228 . . . . 0.62 110.417 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.03 150.91 49.38 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.385 1.254 . . . . 0.56999999999999995 114.385 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -127.3 52.61 1.8 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.838 2.055 . . . . 2.4900000000000002 111.43 -165.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.35 162.14 25.92 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.367 1.247 . . . . 2.1000000000000001 114.367 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.06 124.3 29.7 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.389 1.076 . . . . 3.9300000000000002 110.847 166.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.73 119.84 29.58 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.624 -1.621 . . . . 3.8199999999999998 106.624 163.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -135.87 144.02 45.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.028 0.918 . . . . 4.2300000000000004 113.12 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -120.76 90.31 46.2 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 114.507 -1.224 . . . . 1.73 110.821 -172.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.56 -7.94 20.94 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.341 2.027 . . . . 2.2599999999999998 112.886 172.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.15 -178.11 51.52 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 122.407 1.004 . . . . 1.8200000000000001 112.858 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -111.5 -1.57 15.81 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.223 2.209 . . . . 4.0300000000000002 111.83 -167.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -132.58 159.89 70.57 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 128.415 2.686 . . . . 2.23 109.339 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.45 156.87 57.68 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.434 2.089 . . . . 0.80000000000000004 111.879 -167.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mp -114.38 152.9 30.77 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.606 1.562 . . . . 2.5600000000000001 110.181 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -141.79 106.29 4.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 112.665 -2.061 . . . . 1.8700000000000001 110.969 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.5 tp -90.14 109.17 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.083 1.353 . . . . 1.8999999999999999 109.194 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 m -104.27 -18.37 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.041 0.937 . . . . 0.69999999999999996 111.692 -173.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.63 -177.78 29.2 Favored Glycine 0 C--N 1.344 0.997 0 C-N-CA 125.951 1.739 . . . . 0.56999999999999995 113.02 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.57 178.29 7.88 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.4 1.48 . . . . 0.57999999999999996 110.687 171.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -158.6 150.31 21.11 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.851 2.06 . . . . 4.8799999999999999 108.261 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -162.31 148.84 10.79 Favored Pre-proline 0 N--CA 1.478 0.937 0 O-C-N 120.984 -1.073 . . . . 0.90000000000000002 109.34 -171.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.46 -1.25 10.77 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.634 2.89 . . . . 0.69999999999999996 114.62 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.6 m -134.36 47.46 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 125.089 1.355 . . . . 0.91000000000000003 112.676 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.87 178.78 9.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.242 1.417 . . . . 1.3100000000000001 109.97 162.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -127.45 -34.04 2.29 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.774 1.63 . . . . 3.8300000000000001 112.01 168.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -121.26 149.78 42.36 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 106.567 -1.642 . . . . 6.1600000000000001 106.567 172.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.51 141.64 18.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 125.014 1.326 . . . . 1.22 110.005 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -134.52 147.54 50.34 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.601 1.96 . . . . 3.2200000000000002 109.068 -173.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.464 HD13 ' CZ ' ' A' ' 84' ' ' PHE . 36.7 tp -101.73 120.79 40.91 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.547 -0.721 . . . . 1.27 109.842 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.5 m170 -121.26 150.09 41.9 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 123.486 1.612 . . . . 0.64000000000000001 114.447 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -96.0 173.5 7.4 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 113.275 -1.784 . . . . 2.3500000000000001 111.218 162.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.2 m -150.39 146.64 26.82 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 106.453 -1.684 . . . . 0.67000000000000004 106.453 173.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -161.72 171.46 17.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.959 0.885 . . . . 2.0 113.378 -167.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.0 ttp -105.11 142.05 35.57 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.134 1.774 . . . . 3.4500000000000002 110.453 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -157.36 151.02 24.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.228 1.411 . . . . 8.5600000000000005 112.73 -173.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.47 133.38 35.39 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.494 0.718 . . . . 2.9199999999999999 111.222 172.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t -141.82 134.79 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 105.443 -2.058 . . . . 2.2400000000000002 105.443 162.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 70.93 4.17 4.95 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.39 1.876 . . . . 4.4900000000000002 114.255 -170.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.21 22.86 69.9 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 121.473 -0.767 . . . . 1.6399999999999999 113.109 -163.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -124.48 131.33 53.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.612 1.965 . . . . 3.8300000000000001 109.76 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.89 92.63 1.27 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.495 1.118 . . . . 6.2599999999999998 112.591 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.4 m -94.49 -174.94 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 127.177 2.191 . . . . 2.5 109.47 171.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -117.7 167.81 11.02 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.36 0.664 . . . . 2.96 111.937 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.46 169.63 31.64 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 125.683 1.611 . . . . 0.60999999999999999 112.28 -176.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ttm -149.16 147.43 28.43 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.71 2.004 . . . . 0.70999999999999996 107.971 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -148.33 153.69 41.04 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 125.966 1.707 . . . . 5.71 108.88 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.06 154.55 42.29 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 121.69 1.593 . . . . 0.65000000000000002 110.352 164.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 m -137.11 154.77 76.1 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 125.34 1.456 . . . . 0.72999999999999998 109.87 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.2 -27.03 4.69 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.58 2.186 . . . . 0.76000000000000001 112.745 -166.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -175.17 168.37 3.39 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.363 1.465 . . . . 2.0299999999999998 111.98 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.7 mt -111.13 153.72 25.33 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.276 1.431 . . . . 0.79000000000000004 110.871 161.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -124.88 141.4 52.14 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.861 1.664 . . . . 2.21 110.043 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.0 t -146.52 134.69 10.7 Favored Pre-proline 0 N--CA 1.482 1.151 0 N-CA-C 113.426 0.899 . . . . 0.91000000000000003 113.426 173.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.74 163.36 39.33 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 124.443 3.429 . . . . 1.28 113.558 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.02 145.06 78.39 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.86 3.04 . . . . 1.6699999999999999 114.18 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt 69.21 -5.1 1.14 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.08 2.552 . . . . 3.1000000000000001 114.657 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.03 168.4 34.0 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.411 1.482 . . . . 1.8999999999999999 113.243 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -144.24 148.95 35.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.713 0.805 . . . . 6.5099999999999998 112.231 162.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.9 t -155.71 100.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.456 1.902 . . . . 3.8300000000000001 108.631 -168.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.89 171.55 15.03 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 121.876 0.846 . . . . 3.6800000000000002 112.236 -169.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 mp -82.56 70.02 9.44 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.152 -1.592 . . . . 2.0499999999999998 110.133 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.482 ' H ' ' CD ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -36.6 119.86 0.76 Allowed Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 127.167 2.187 . . . . 4.3300000000000001 113.307 172.757 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.99 -9.36 22.12 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.817 3.012 . . . . 2.29 115.635 -154.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.33 -2.16 55.68 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 117.836 -1.536 . . . . 1.8999999999999999 114.34 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.68 -17.47 0.49 Allowed Glycine 0 N--CA 1.479 1.542 0 CA-C-N 119.946 1.873 . . . . 1.98 117.776 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -145.12 145.03 31.23 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.128 1.464 . . . . 2.4700000000000002 112.24 170.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -161.31 155.59 22.76 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.598 1.559 . . . . 0.82999999999999996 109.941 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.464 ' CZ ' HD13 ' A' ' 45' ' ' LEU . 73.7 m-85 -79.45 150.97 31.1 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.259 -0.901 . . . . 2.3900000000000001 108.862 157.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.6 tpt -100.12 130.84 46.31 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.11 1.764 . . . . 0.63 108.335 162.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.8 mp -116.01 135.54 53.86 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.388 1.475 . . . . 0.68000000000000005 108.32 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mp -135.78 146.02 47.15 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.747 0.703 . . . . 1.6899999999999999 111.633 -176.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.66 40.23 32.41 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.306 -0.719 . . . . 1.02 113.225 172.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.23 148.31 3.6 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 115.799 1.778 . . . . 1.54 115.799 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -104.05 -4.52 23.16 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.481 -1.691 . . . . 2.4700000000000002 113.592 -170.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -146.63 156.09 48.74 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.92 2.088 . . . . 6.4800000000000004 109.112 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -67.38 163.73 33.43 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.853 1.702 . . . . 2.2799999999999998 109.022 153.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 pp -160.86 152.1 19.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.575 1.55 . . . . 2.3500000000000001 108.298 -172.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -147.79 168.31 22.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 123.123 1.44 . . . . 4.7300000000000004 114.715 -174.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.43 135.34 56.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.053 -0.976 . . . . 1.3300000000000001 111.212 172.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.83 -1.14 74.3 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.72 1.629 . . . . 2.0699999999999998 114.365 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -85.76 -176.91 6.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.869 1.335 . . . . 2.5 112.244 171.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -138.44 140.0 39.09 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 129.459 3.104 . . . . 3.5499999999999998 105.768 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.3 t -141.06 133.36 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.216 1.806 . . . . 0.96999999999999997 109.773 -172.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -95.58 158.01 15.64 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 122.491 1.139 . . . . 2.2999999999999998 113.478 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.17 151.8 31.47 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.964 1.305 . . . . 3.54 112.841 169.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.64 137.12 36.2 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 127.26 2.224 . . . . 2.5600000000000001 109.516 169.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.21 133.94 37.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.804 1.641 . . . . 1.1899999999999999 109.113 170.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 56.3 mt -106.2 104.65 14.39 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.732 1.213 . . . . 0.90000000000000002 108.934 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -91.97 163.37 14.03 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.562 0.696 . . . . 2.1099999999999999 111.484 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.54 117.69 5.18 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.934 -0.479 . . . . 1.55 110.947 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.67 -135.94 16.73 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.835 0.731 . . . . 3.23 112.204 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.57 41.74 2.86 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.426 1.012 . . . . 2.3399999999999999 115.481 -165.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -134.48 123.22 23.62 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.441 1.62 . . . . 3.8799999999999999 112.085 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.3 t -136.64 138.56 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.806 1.642 . . . . 2.5099999999999998 107.677 168.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.9 tp -159.14 133.45 7.76 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.488 1.115 . . . . 2.4300000000000002 111.581 -170.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -98.1 149.0 22.97 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.631 1.715 . . . . 1.99 115.631 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.9 t -125.0 165.88 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 129.237 3.015 . . . . 2.1299999999999999 107.994 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 t -142.18 142.36 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.247 1.819 . . . . 1.95 107.832 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.01 159.48 30.27 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 114.134 1.161 . . . . 2.8500000000000001 114.134 -173.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -77.81 160.58 30.84 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.1 3.2 . . . . 0.85999999999999999 114.671 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.0 t -103.61 130.1 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.525 1.53 . . . . 0.98999999999999999 110.829 171.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.42 ' CD ' ' HE ' ' A' ' 120' ' ' ARG . 11.8 pt-20 -95.21 -172.52 2.69 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.621 1.968 . . . . 5.9699999999999998 111.432 172.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -126.41 117.66 23.4 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.712 -1.243 . . . . 2.5299999999999998 112.014 154.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.42 ' HE ' ' CD ' ' A' ' 118' ' ' GLU . 42.4 mtm180 . . . . . 0 C--O 1.248 1.008 0 C-N-CA 126.781 2.033 . . . . 7.5599999999999996 111.5 161.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.915 0 CA-C-O 117.22 -1.878 . . . . 11.07 111.478 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . 0.257 96.7 p 103.8 -97.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 131.091 3.756 . . . . 10.210000000000001 110.119 -166.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -66.41 120.64 13.68 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.825 -1.172 . . . . 10.48 109.576 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 m 92.61 37.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 128.54 2.736 . . . . 6.5499999999999998 110.886 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -148.32 -168.1 2.99 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.719 2.008 . . . . 5.1600000000000001 110.416 -166.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.49 175.83 17.37 Favored Glycine 0 N--CA 1.473 1.155 0 N-CA-C 116.87 1.508 . . . . 0.87 116.87 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -151.35 142.91 23.58 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.389 2.275 . . . . 1.73 110.966 169.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.7 t -94.4 141.72 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 120.448 -1.407 . . . . 1.27 109.773 175.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.0 ttm-85 -73.12 118.13 15.7 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.514 0.726 . . . . 5.9800000000000004 111.567 -172.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -68.19 138.51 55.68 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.534 -0.729 . . . . 2.5499999999999998 110.558 159.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -167.72 149.75 5.27 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.703 1.601 . . . . 3.52 109.977 164.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -82.03 47.93 2.66 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 125.216 3.944 . . . . 3.2799999999999998 111.756 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.34 158.52 20.49 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.872 1.701 . . . . 1.8400000000000001 112.605 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.36 -19.08 33.72 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.729 2.953 . . . . 1.3600000000000001 112.822 174.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -106.96 160.74 15.3 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.213 1.805 . . . . 2.96 112.908 167.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.34 -173.58 4.61 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.686 2.795 . . . . 0.53000000000000003 110.287 -176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.48 160.29 41.82 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.348 1.459 . . . . 0.71999999999999997 109.821 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.32 137.5 53.49 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.71 1.141 . . . . 0.72999999999999998 112.976 174.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 79' ' ' PRO . 61.7 m-85 -113.06 138.72 49.48 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.691 1.996 . . . . 2.6499999999999999 110.032 172.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.267 0.0 OUTLIER -165.99 145.14 6.06 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.528 1.307 . . . . 2.5600000000000001 114.528 177.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.3 m -80.98 130.09 34.85 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.345 1.058 . . . . 2.04 109.536 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.4 tp -119.09 142.37 47.94 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.319 1.848 . . . . 3.1400000000000001 109.843 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -128.13 149.71 50.3 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.751 1.22 . . . . 3.52 110.966 170.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -103.9 102.01 28.73 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.07 0.948 . . . . 1.4399999999999999 109.459 169.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.76 -10.19 19.93 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.495 2.13 . . . . 1.01 113.359 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.59 178.61 53.29 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-O 122.76 1.2 . . . . 1.1200000000000001 113.018 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -105.44 -3.65 22.31 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.818 2.447 . . . . 2.7799999999999998 111.659 -174.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -121.2 156.27 57.55 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 127.9 2.48 . . . . 1.9199999999999999 109.501 173.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.86 151.77 24.66 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.922 2.414 . . . . 0.84999999999999998 111.992 -169.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.2 mt -104.57 146.99 28.12 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.154 0.982 . . . . 1.55 111.101 169.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -134.09 111.67 10.54 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.01 -1.45 . . . . 2.0099999999999998 110.788 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -92.23 106.95 18.85 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 127.555 2.342 . . . . 2.5899999999999999 109.974 -173.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -107.26 -17.92 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.729 1.211 . . . . 0.65000000000000002 111.765 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.66 -175.24 29.37 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 125.726 1.631 . . . . 0.65000000000000002 114.33 -175.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -157.05 -177.34 6.54 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.197 1.399 . . . . 0.73999999999999999 112.681 177.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -154.48 165.43 36.46 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 127.434 2.294 . . . . 4.54 107.309 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 t -169.15 147.29 3.27 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 125.509 1.524 . . . . 0.91000000000000003 107.426 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.59 -17.42 38.35 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.31 1.34 . . . . 1.0700000000000001 111.865 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.6 m -111.17 40.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.185 1.394 . . . . 1.1499999999999999 113.258 -172.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.78 169.29 23.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.411 1.084 . . . . 1.1299999999999999 110.588 167.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -108.55 -63.14 1.37 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.454 1.502 . . . . 4.0300000000000002 107.304 164.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -84.34 124.1 30.91 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 121.502 -0.749 . . . . 6.9199999999999999 109.054 166.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.404 HG21 ' HB3' ' A' ' 35' ' ' ALA . 4.6 p -94.64 158.21 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.796 -1.093 . . . . 1.46 108.696 149.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.39 157.13 42.01 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.86 2.464 . . . . 4.2699999999999996 107.446 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.6 tp -124.67 112.98 17.4 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.926 1.239 . . . . 1.1100000000000001 112.17 -171.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.2 m170 -122.18 158.01 30.31 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 123.476 1.608 . . . . 0.66000000000000003 114.661 -171.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.69 -176.42 3.26 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.463 1.905 . . . . 3.1400000000000001 111.297 159.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -156.75 145.01 19.61 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.123 1.769 . . . . 0.84999999999999998 106.798 167.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -153.13 -177.63 6.43 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.103 0.961 . . . . 2.0 113.003 -165.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -118.89 143.32 47.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.131 1.772 . . . . 4.25 111.446 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -154.78 160.33 41.22 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.401 1.88 . . . . 4.7999999999999998 110.145 -172.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -116.57 142.61 46.66 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.883 1.673 . . . . 2.9100000000000001 110.526 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.269 1.3 t -95.73 -126.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 107.753 -1.203 . . . . 2.8100000000000001 107.753 161.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -70.67 44.26 0.08 Allowed 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 125.792 1.637 . . . . 2.9500000000000002 114.81 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.06 18.15 80.19 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 120.271 -1.518 . . . . 1.95 111.738 -160.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -96.28 106.04 18.2 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 121.997 -0.707 . . . . 2.7799999999999998 109.399 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.59 124.29 26.95 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.276 0.63 . . . . 7.5199999999999996 109.951 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.538 HG22 ' H ' ' A' ' 59' ' ' MET . 8.7 p -142.78 175.9 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 126.003 1.721 . . . . 2.5499999999999998 110.079 -174.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.538 ' H ' HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -124.88 149.16 47.83 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.619 1.168 . . . . 3.0299999999999998 110.654 -175.15 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.99 167.86 21.56 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.507 1.527 . . . . 0.69999999999999996 112.188 -174.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.0 ttm -150.63 137.1 18.77 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.059 1.344 . . . . 0.65000000000000002 110.581 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -145.4 150.51 44.6 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.429 1.892 . . . . 8.1300000000000008 110.066 -173.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -76.48 155.58 36.25 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.977 1.785 . . . . 0.66000000000000003 110.283 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.67 147.78 66.93 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 124.219 1.008 . . . . 0.87 110.213 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -71.44 -22.6 24.67 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.438 2.759 . . . . 0.66000000000000003 111.958 -173.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -172.96 172.61 3.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.421 1.888 . . . . 1.8799999999999999 111.246 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.4 mt -115.01 161.06 18.85 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.265 1.826 . . . . 0.69999999999999996 109.013 156.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -133.2 151.21 51.95 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.341 -0.849 . . . . 2.0099999999999998 112.072 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.1 t -138.19 129.13 15.61 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 123.785 0.834 . . . . 1.0700000000000001 111.815 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.89 164.67 34.84 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.379 2.72 . . . . 0.94999999999999996 111.365 174.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.35 140.82 90.24 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.007 2.471 . . . . 1.02 112.485 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt 67.07 -2.75 1.1 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.848 2.059 . . . . 1.6100000000000001 114.135 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.99 170.64 43.7 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.864 1.697 . . . . 1.22 114.024 -177.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -122.3 154.35 37.72 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.262 1.425 . . . . 5.4199999999999999 111.388 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.2 t -141.36 137.04 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.734 1.613 . . . . 3.6099999999999999 107.262 159.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.416 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -103.57 136.27 43.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.627 0.727 . . . . 3.75 109.942 168.645 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.52 101.39 3.54 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 105.951 -1.87 . . . . 2.3199999999999998 105.951 158.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HE2' ' O ' ' A' ' 76' ' ' GLU . 6.1 ptpt -113.7 152.3 45.39 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.787 2.035 . . . . 3.0099999999999998 114.36 -158.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 19' ' ' TYR . 10.4 Cg_endo -49.19 -57.69 2.2 Favored 'Trans proline' 0 C--N 1.356 0.97 1 C-N-CA 125.437 4.091 . . . . 2.0099999999999998 113.667 -173.501 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.81 57.91 5.0 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.217 -0.768 . . . . 1.79 112.728 173.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.1 -126.52 1.6 Allowed Glycine 0 N--CA 1.467 0.766 0 C-N-CA 124.256 0.931 . . . . 1.9299999999999999 114.828 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -71.05 141.91 50.88 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.845 -0.797 . . . . 1.97 112.707 -159.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -161.87 152.79 17.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.995 -0.548 . . . . 0.58999999999999997 111.681 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 69.4 m-85 -77.35 142.79 39.18 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 108.283 -1.006 . . . . 1.8999999999999999 108.283 163.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.1 tpt -92.37 135.59 33.91 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.293 1.037 . . . . 0.75 108.47 162.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.1 mp -117.85 138.79 51.86 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.925 1.29 . . . . 0.55000000000000004 108.509 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mp -138.56 148.15 43.86 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.544 1.137 . . . . 1.5600000000000001 110.041 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.42 40.45 19.21 Favored Glycine 0 N--CA 1.47 0.96 0 CA-C-O 119.876 -0.402 . . . . 0.94999999999999996 112.79 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -43.82 143.13 1.12 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 115.719 1.748 . . . . 1.46 115.719 174.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -110.47 -3.57 15.98 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 113.653 -1.612 . . . . 2.5600000000000001 114.472 -168.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -137.62 153.43 74.18 Favored Pre-proline 0 N--CA 1.473 0.704 0 C-N-CA 125.921 1.688 . . . . 5.8499999999999996 109.56 170.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -68.65 144.94 61.97 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.111 1.874 . . . . 2.3999999999999999 108.583 162.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.8 mp -125.62 116.92 22.47 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.538 0.735 . . . . 2.7999999999999998 109.747 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.82 15.55 26.6 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 116.205 1.928 . . . . 5.7999999999999998 116.205 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 60.41 157.55 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.137 2.575 . . . . 1.5800000000000001 111.338 -166.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.47 42.38 99.01 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 120.759 -1.213 . . . . 1.3200000000000001 110.563 -170.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -100.18 179.89 4.34 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.744 1.617 . . . . 2.4100000000000001 107.574 169.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.82 150.79 33.01 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 128.104 2.562 . . . . 5.0999999999999996 106.908 163.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.5 t -149.05 143.53 18.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 128.784 2.833 . . . . 1.24 108.811 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -98.69 146.3 26.01 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.997 -0.439 . . . . 3.0099999999999998 111.493 168.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.78 133.14 56.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.469 1.108 . . . . 2.5299999999999998 109.23 160.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.73 143.17 26.57 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.357 2.663 . . . . 2.2000000000000002 107.239 162.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.93 127.39 51.79 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.386 1.474 . . . . 1.3200000000000001 110.19 177.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.0 mt -102.25 117.3 34.46 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.754 1.622 . . . . 0.68999999999999995 109.844 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -107.67 155.23 20.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.391 1.076 . . . . 1.99 111.296 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.93 146.77 25.68 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.16 -0.473 . . . . 1.8799999999999999 110.415 162.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.63 7.53 66.66 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-O 119.127 -0.818 . . . . 3.1400000000000001 114.59 -173.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.36 6.4 88.93 Favored Glycine 0 N--CA 1.474 1.169 0 CA-C-N 118.886 1.343 . . . . 2.1899999999999999 114.163 175.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -79.48 133.34 36.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.724 1.21 . . . . 6.8499999999999996 111.58 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.6 p -113.22 151.39 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.225 1.81 . . . . 2.0 109.766 166.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 tt -158.9 135.11 9.09 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.84 1.656 . . . . 2.0600000000000001 109.481 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -103.27 163.0 12.52 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.313 1.227 . . . . 2.1200000000000001 114.313 176.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.3 m -134.41 146.29 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 128.803 2.841 . . . . 2.0699999999999998 109.136 168.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.4 p -109.31 138.35 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.899 1.28 . . . . 3.04 109.457 176.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.98 154.93 28.6 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 123.631 0.772 . . . . 2.0699999999999998 113.066 -168.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.22 169.93 19.49 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.806 2.337 . . . . 0.98999999999999999 112.787 171.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 70.1 t -104.5 131.25 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.478 1.511 . . . . 0.91000000000000003 108.635 159.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -134.37 174.89 10.03 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.817 0.847 . . . . 4.6100000000000003 112.55 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -95.07 57.22 2.03 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 116.265 1.95 . . . . 2.46 116.265 -143.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.251 23.1 mtp-105 . . . . . 0 N--CA 1.49 1.526 0 C-N-CA 131.611 3.965 . . . . 9.3699999999999992 114.523 161.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.799 0 N-CA-C 108.387 -1.885 . . . . 12.75 108.387 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -81.72 124.83 29.95 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.308 0.855 . . . . 13.119999999999999 113.308 -155.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -71.92 -18.58 62.01 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.083 0.772 . . . . 11.01 113.083 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 42.1 p 57.53 19.51 5.37 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.997 2.119 . . . . 8.0099999999999998 115.169 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -78.0 90.13 4.18 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.414 -1.328 . . . . 5.79 107.414 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.01 170.12 34.81 Favored Glycine 0 N--CA 1.463 0.438 0 C-N-CA 124.872 1.225 . . . . 1.05 111.873 176.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.6 p90 -159.03 141.57 14.1 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.296 1.038 . . . . 1.9199999999999999 111.922 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.12 142.24 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 107.882 -1.155 . . . . 1.2 107.882 166.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.407 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -89.1 15.33 8.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.676 1.19 . . . . 3.6400000000000001 114.176 -175.182 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.3 t80 64.98 164.03 0.15 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.278 1.431 . . . . 2.5499999999999998 113.37 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 m -172.6 154.0 2.91 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 127.187 2.195 . . . . 2.1000000000000001 110.973 157.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -87.41 30.51 0.46 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 124.509 3.472 . . . . 2.0 112.08 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.24 178.95 31.6 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.716 1.151 . . . . 1.1599999999999999 114.163 -171.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.48 -21.72 29.76 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.135 3.223 . . . . 1.49 113.546 -173.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -88.05 148.73 24.36 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.969 1.307 . . . . 2.3500000000000001 111.932 173.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.46 -178.66 6.55 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.201 1.401 . . . . 0.65000000000000002 111.353 165.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.52 150.64 40.71 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.688 1.595 . . . . 0.97999999999999998 108.702 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.65 143.27 29.72 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.223 1.194 . . . . 1.1699999999999999 114.223 -175.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -111.27 156.22 21.82 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.032 2.133 . . . . 2.5600000000000001 111.276 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -169.59 158.35 7.69 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.597 1.559 . . . . 2.0499999999999998 113.671 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 p -93.18 107.47 19.27 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.007 2.123 . . . . 2.5299999999999998 110.862 173.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.611 HD12 HG21 ' A' ' 69' ' ' VAL . 0.6 OUTLIER -79.46 139.01 37.77 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.336 1.454 . . . . 3.2599999999999998 109.089 176.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.415 ' N ' HD13 ' A' ' 22' ' ' LEU . 11.7 pt-20 -114.62 160.68 19.03 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.678 1.191 . . . . 5.3899999999999997 112.244 177.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -135.82 109.96 10.12 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 123.687 0.795 . . . . 1.49 109.611 158.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -88.25 -8.45 5.56 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.281 2.654 . . . . 1.3600000000000001 114.951 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.95 178.04 33.13 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 119.783 1.174 . . . . 1.24 112.482 -176.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -93.29 0.57 57.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.546 2.338 . . . . 3.5600000000000001 112.485 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -113.46 156.96 42.58 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 127.33 2.252 . . . . 1.9399999999999999 110.583 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.31 145.56 24.15 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.719 2.279 . . . . 0.97999999999999998 111.183 -176.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.471 HD12 ' CD2' ' A' ' 105' ' ' PHE . 2.9 mm? -107.34 157.7 17.74 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 124.716 1.207 . . . . 2.4199999999999999 110.565 172.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -147.22 110.34 4.79 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 113.459 -1.7 . . . . 2.3199999999999998 110.677 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.26 112.51 24.07 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.47 1.908 . . . . 2.0499999999999998 109.39 -176.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.4 m -108.62 -20.38 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.956 1.302 . . . . 0.73999999999999999 111.642 -172.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.28 -175.06 28.79 Favored Glycine 0 C--N 1.346 1.088 0 C-N-CA 125.43 1.491 . . . . 0.68000000000000005 113.798 -174.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.66 -177.3 5.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.747 2.019 . . . . 0.62 111.241 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -155.85 169.52 24.22 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.327 2.251 . . . . 4.3799999999999999 109.029 170.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.7 t -175.96 150.96 1.13 Allowed Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 126.92 2.088 . . . . 0.73999999999999999 108.007 173.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.4 -17.65 26.93 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.676 1.584 . . . . 0.76000000000000001 112.734 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.9 m -97.05 52.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.737 1.215 . . . . 0.77000000000000002 112.131 174.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.68 167.33 30.74 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.329 1.051 . . . . 1.3899999999999999 112.203 166.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -102.01 -39.19 7.43 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.851 2.06 . . . . 4.9900000000000002 110.492 162.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -146.04 169.59 18.35 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.378 1.871 . . . . 4.6600000000000001 110.128 169.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.14 145.27 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.586 1.554 . . . . 1.1499999999999999 108.321 -177.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -128.68 151.26 49.72 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.479 1.912 . . . . 3.1600000000000001 108.208 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -103.66 136.91 42.49 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.115 0.87 . . . . 1.8700000000000001 112.088 160.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -120.74 152.95 37.64 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.707 2.003 . . . . 0.94999999999999996 112.667 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -97.2 163.25 12.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.374 1.47 . . . . 2.3100000000000001 109.634 162.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.6 m -115.99 143.12 45.88 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.213 -1.403 . . . . 1.24 107.213 162.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -139.93 172.14 13.2 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.003 1.112 . . . . 2.3300000000000001 114.003 -173.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 85.7 mtp -113.35 143.7 44.0 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.868 1.667 . . . . 3.5499999999999998 110.99 166.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -146.76 146.97 30.47 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.953 1.701 . . . . 6.7599999999999998 110.441 172.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -94.01 141.97 27.92 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 125.145 1.378 . . . . 2.4300000000000002 110.957 171.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 m -139.59 126.96 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.532 1.133 . . . . 2.29 108.917 167.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 64.7 10.86 6.32 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.722 1.609 . . . . 3.7200000000000002 115.062 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.87 26.43 41.64 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 123.907 0.765 . . . . 2.3700000000000001 113.278 -166.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -124.76 123.44 40.0 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.514 1.926 . . . . 3.54 109.045 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.85 121.18 25.09 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.926 0.89 . . . . 5.9800000000000004 111.463 -175.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.6 t -121.64 160.14 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 127.386 2.274 . . . . 2.5600000000000001 108.601 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.7 mtp -121.25 156.56 32.22 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.547 1.539 . . . . 2.6699999999999999 110.337 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.99 -175.57 26.2 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.203 0.906 . . . . 0.63 113.585 -172.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.1 ttm -153.33 151.05 29.54 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.404 1.882 . . . . 0.85999999999999999 108.691 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.97 158.08 18.25 Favored Pre-proline 0 N--CA 1.477 0.895 0 CA-C-O 117.736 -1.126 . . . . 5.6699999999999999 111.3 175.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.55 146.26 49.11 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.979 1.786 . . . . 1.1200000000000001 112.647 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.64 159.51 43.83 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 125.104 1.362 . . . . 1.3899999999999999 110.397 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.74 -30.8 2.19 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.616 2.211 . . . . 1.0600000000000001 112.465 -172.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -179.15 165.28 1.47 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.398 1.879 . . . . 2.0899999999999999 111.148 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt -110.37 152.96 25.61 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.504 1.121 . . . . 0.82999999999999996 110.216 163.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -110.33 145.71 37.0 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.722 1.209 . . . . 1.78 108.716 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.611 HG21 HD12 ' A' ' 22' ' ' LEU . 61.8 t -138.16 127.24 14.62 Favored Pre-proline 0 N--CA 1.473 0.688 0 N-CA-C 112.594 0.59 . . . . 0.83999999999999997 112.594 169.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.88 159.17 48.79 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.049 3.166 . . . . 1.0600000000000001 112.402 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.47 142.52 95.31 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 124.337 3.358 . . . . 1.1000000000000001 113.847 -175.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp 64.54 -3.41 0.53 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.646 1.978 . . . . 1.96 114.637 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.64 174.58 55.15 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.824 1.678 . . . . 1.28 114.089 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.66 126.4 6.91 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.387 1.475 . . . . 4.1200000000000001 108.963 173.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.9 t -147.32 145.34 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.131 1.772 . . . . 4.1399999999999997 107.836 -163.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.3 142.0 35.84 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.349 -0.844 . . . . 3.79 112.545 -167.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mp -69.55 79.7 0.41 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.891 -1.152 . . . . 2.0600000000000001 107.891 151.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.99 147.1 85.79 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 112.943 0.72 . . . . 4.1200000000000001 112.943 -171.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -57.83 133.41 55.9 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.63 1.553 . . . . 3.6800000000000002 109.13 162.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.58 -12.54 66.17 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 116.637 -2.202 . . . . 1.72 115.657 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.43 -31.67 0.07 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 120.498 2.959 . . . . 2.0499999999999998 120.498 175.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -144.06 139.31 28.88 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.619 2.209 . . . . 2.3399999999999999 112.491 175.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -163.13 153.62 16.3 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.236 -0.29 . . . . 0.88 111.345 -176.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -79.48 142.5 35.78 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.596 -0.52 . . . . 2.6499999999999999 109.596 164.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.6 tpt -105.68 127.03 52.82 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 126.334 1.854 . . . . 0.92000000000000004 107.143 165.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -105.63 131.84 52.51 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.116 0.967 . . . . 0.84999999999999998 108.732 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.43 131.93 55.0 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.199 0.999 . . . . 3.5299999999999998 110.367 -175.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.62 47.13 28.45 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.552 1.072 . . . . 0.80000000000000004 114.203 170.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.73 149.31 4.75 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 116.112 1.893 . . . . 1.3500000000000001 116.112 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -104.86 3.91 31.51 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 113.897 -1.502 . . . . 1.98 113.67 -171.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.9 mmt-85 -145.2 139.39 15.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 127.928 2.491 . . . . 6.0999999999999996 108.25 167.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -64.14 155.3 65.8 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 N-CA-C 107.659 -1.708 . . . . 1.73 107.659 154.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.3 121.18 17.58 Favored 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 108.058 -1.09 . . . . 2.8199999999999998 108.058 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.47 ' HE2' ' OE1' ' A' ' 97' ' ' GLU 0.299 0.0 OUTLIER -87.64 13.18 10.87 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 116.032 1.864 . . . . 5.6500000000000004 116.032 -168.998 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 62.81 154.06 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.993 2.917 . . . . 1.77 111.495 -163.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.98 51.17 55.57 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 109.839 -1.305 . . . . 1.6699999999999999 109.839 -166.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.47 ' OE1' ' HE2' ' A' ' 94' ' ' LYS . 6.3 mm-40 -116.86 -177.6 3.23 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.761 2.025 . . . . 2.3799999999999999 107.774 173.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -155.66 135.59 12.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.357 1.863 . . . . 3.27 107.744 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -151.23 151.13 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.765 1.626 . . . . 3.0699999999999998 109.661 -177.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.6 150.05 32.81 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.842 1.052 . . . . 2.96 113.842 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mp -125.68 140.96 52.28 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.129 1.772 . . . . 1.99 110.238 169.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.67 148.32 23.95 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.95 1.7 . . . . 2.3300000000000001 108.882 164.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.7 mp -120.97 133.62 55.28 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.84 1.256 . . . . 1.0800000000000001 109.679 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.6 mt -110.31 122.65 48.19 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.32 1.448 . . . . 0.70999999999999996 110.3 -174.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.471 ' CD2' HD12 ' A' ' 30' ' ' LEU . 97.9 m-85 -120.03 150.7 40.13 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.995 0.918 . . . . 1.99 111.591 -173.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.3 135.83 56.51 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.6 -0.687 . . . . 2.1699999999999999 111.759 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.6 31.53 21.33 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.798 -1.001 . . . . 3.1800000000000002 114.448 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.99 8.78 87.05 Favored Glycine 0 N--CA 1.474 1.233 0 CA-C-N 118.572 1.186 . . . . 1.8 115.984 167.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -88.04 138.2 31.66 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.686 1.243 . . . . 3.7599999999999998 112.006 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.5 p -131.98 145.75 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 125.784 1.634 . . . . 1.95 110.103 175.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.4 tt -146.09 121.56 10.35 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.0 0.92 . . . . 2.6400000000000001 110.67 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.99 134.67 34.3 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.659 0.784 . . . . 3.0899999999999999 112.867 176.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.2 m -120.19 160.7 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.497 1.919 . . . . 2.27 110.116 165.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 52.9 t -115.45 132.49 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 107.688 -1.227 . . . . 1.72 107.688 167.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.3 mt -135.81 144.13 47.46 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.206 1.002 . . . . 2.46 112.076 -171.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.68 174.42 12.68 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.212 3.275 . . . . 0.81999999999999995 113.054 170.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.1 t -122.42 129.63 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.755 2.022 . . . . 0.79000000000000004 110.127 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.6 167.64 11.14 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.059 2.144 . . . . 3.9900000000000002 110.271 171.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.93 -177.66 4.79 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 116.686 2.106 . . . . 2.6299999999999999 116.686 -159.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.714 0 C-N-CA 127.519 2.328 . . . . 11.06 110.139 148.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.986 0 N-CA-C 110.456 -1.057 . . . . 8.9600000000000009 110.456 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m 93.46 -130.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 128.767 2.827 . . . . 8.2699999999999996 111.39 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -77.06 45.4 0.44 Allowed 'General case' 0 N--CA 1.475 0.8 0 O-C-N 119.898 -1.751 . . . . 10.0 111.387 168.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -174.72 53.64 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.518 1 C-N-CA 131.989 4.116 . . . . 7.25 105.35 -162.123 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -154.92 160.48 41.19 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.945 1.698 . . . . 5.3600000000000003 109.311 -172.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.2 -178.84 20.33 Favored Glycine 0 N--CA 1.466 0.661 0 C-N-CA 123.571 0.605 . . . . 0.93999999999999995 113.458 -167.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 23.3 p90 -152.23 154.99 36.87 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.153 0.981 . . . . 1.73 112.161 176.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.8 t -90.31 144.8 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.908 1.283 . . . . 0.93999999999999995 107.989 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -82.26 129.32 34.82 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.285 0.493 . . . . 6.2800000000000002 111.147 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -41.51 133.93 2.46 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.078 2.151 . . . . 1.9099999999999999 112.69 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.5 t -173.99 127.11 0.45 Allowed Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.128 1.771 . . . . 2.73 110.587 169.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -88.88 3.12 5.8 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.023 3.149 . . . . 3.0600000000000001 112.457 167.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.74 -172.57 45.3 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.742 1.163 . . . . 1.46 113.041 -173.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.11 -22.7 40.74 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.871 2.381 . . . . 1.24 113.209 -176.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -132.5 167.42 20.01 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.488 1.515 . . . . 2.2400000000000002 114.174 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.48 -174.03 4.69 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 128.658 2.783 . . . . 0.53000000000000003 110.859 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.35 148.89 32.83 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.273 1.429 . . . . 0.70999999999999996 110.137 173.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.24 145.05 51.76 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.327 1.232 . . . . 0.55000000000000004 114.327 -173.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -116.78 43.2 2.3 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.723 2.009 . . . . 2.4399999999999999 112.89 -170.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.45 HD22 HD22 ' A' ' 101' ' ' LEU . 2.4 pp -68.39 162.06 26.2 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.385 1.254 . . . . 2.2000000000000002 114.385 -169.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.1 m -94.65 139.61 30.98 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.067 0.947 . . . . 2.0 112.821 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.85 127.64 56.08 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.684 1.194 . . . . 2.9900000000000002 110.235 167.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -131.11 136.7 48.61 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.229 1.812 . . . . 3.5699999999999998 106.186 171.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -108.29 93.03 10.57 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 122.601 0.361 . . . . 1.46 110.754 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.5 -12.92 20.54 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.425 2.083 . . . . 1.1799999999999999 113.159 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.98 -177.29 51.45 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-O 122.352 0.973 . . . . 1.22 112.577 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -109.94 0.26 18.51 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.969 2.108 . . . . 2.9700000000000002 112.47 -173.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 pp -115.54 159.58 38.0 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 127.701 2.4 . . . . 2.2000000000000002 110.401 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.14 139.5 15.05 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.252 1.968 . . . . 0.88 110.799 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.1 mt -93.36 149.02 21.54 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 122.249 1.023 . . . . 1.9199999999999999 110.478 170.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -137.96 102.15 4.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.805 -1.998 . . . . 2.0699999999999998 111.237 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.5 tp -84.8 104.12 14.48 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.535 1.534 . . . . 1.78 109.902 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.3 m -100.03 -21.9 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.003 1.321 . . . . 0.46999999999999997 112.185 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.45 -177.67 32.75 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.908 1.242 . . . . 0.46999999999999997 114.035 -172.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.34 -179.56 8.05 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.057 1.343 . . . . 0.56000000000000005 112.581 171.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -158.81 143.06 15.59 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.471 1.908 . . . . 4.7999999999999998 108.083 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.55 149.17 25.49 Favored Pre-proline 0 N--CA 1.481 1.077 0 CA-C-N 121.312 1.869 . . . . 0.81000000000000005 110.647 168.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -62.81 -10.47 20.08 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.67 2.247 . . . . 1.05 114.032 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.55 34.69 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 113.647 0.981 . . . . 1.0600000000000001 113.647 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.63 115.69 1.44 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.111 1.765 . . . . 1.9199999999999999 108.836 159.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -69.51 -34.8 74.82 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.202 1.186 . . . . 2.8300000000000001 114.202 -175.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -135.58 92.2 2.8 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 107.167 -1.419 . . . . 7.5899999999999999 107.167 -166.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -85.65 166.46 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.95 0.9 . . . . 1.48 110.464 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.1 149.96 26.66 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.571 1.948 . . . . 4.4000000000000004 108.229 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.2 tp -121.01 110.83 16.73 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.014 1.279 . . . . 1.02 111.09 -171.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 63.4 m170 -121.05 151.11 40.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 123.102 1.429 . . . . 0.66000000000000003 114.316 -170.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -93.41 177.82 5.91 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 113.463 -1.699 . . . . 2.52 111.337 156.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.9 m -146.1 127.47 14.92 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.419 1.888 . . . . 0.68999999999999995 105.989 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -131.37 169.25 16.28 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.073 0.949 . . . . 1.8899999999999999 113.131 -162.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.0 mtt -99.87 141.86 32.12 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.674 1.19 . . . . 3.48 110.233 167.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -146.48 176.84 9.5 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.102 1.761 . . . . 6.1399999999999997 111.329 173.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -141.07 138.57 33.68 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.036 1.734 . . . . 2.54 108.547 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.5 m -143.74 144.83 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 127.372 2.269 . . . . 2.1899999999999999 108.028 167.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 56.86 20.79 5.51 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 115.493 1.664 . . . . 3.3999999999999999 115.493 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.31 19.0 77.42 Favored Glycine 0 CA--C 1.537 1.458 0 O-C-N 121.041 -1.037 . . . . 1.6200000000000001 114.056 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -110.47 118.52 36.47 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.916 1.686 . . . . 2.71 107.487 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -71.55 118.93 14.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.404 1.082 . . . . 4.9699999999999998 108.349 171.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.09 176.6 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.889 1.675 . . . . 2.3599999999999999 111.188 -172.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 77.0 mtm -127.29 163.65 23.47 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.009 1.323 . . . . 2.5499999999999998 111.275 172.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.69 -176.68 28.13 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.37 1.462 . . . . 0.47999999999999998 112.207 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.0 ttm -147.28 149.57 33.11 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.972 1.309 . . . . 0.59999999999999998 109.489 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -163.1 158.25 18.09 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 124.379 1.072 . . . . 6.2400000000000002 111.948 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.44 151.37 33.16 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.465 2.11 . . . . 0.78000000000000003 113.578 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.76 151.5 64.34 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 125.855 1.662 . . . . 0.95999999999999996 109.944 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.13 -28.93 10.37 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.052 2.501 . . . . 0.83999999999999997 112.161 -174.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -175.51 168.06 3.23 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.456 1.902 . . . . 2.2400000000000002 111.207 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.7 mt -111.18 150.06 30.05 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.888 1.275 . . . . 0.64000000000000001 110.534 162.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -113.53 141.18 47.45 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.729 1.211 . . . . 1.9399999999999999 108.694 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.6 t -139.16 124.02 11.61 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-O 119.162 -0.447 . . . . 0.97999999999999998 111.243 166.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.77 162.74 41.11 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.743 2.962 . . . . 0.90000000000000002 111.649 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.02 144.77 99.59 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.67 2.913 . . . . 1.0600000000000001 112.594 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.5 mptt 65.2 -8.67 0.24 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.54 2.336 . . . . 1.9199999999999999 115.157 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.68 166.02 50.29 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.532 1.539 . . . . 1.1100000000000001 112.844 174.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -144.77 144.54 31.23 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.639 1.175 . . . . 5.8200000000000003 110.559 170.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -156.83 125.32 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.496 1.918 . . . . 3.71 107.586 -174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -91.79 157.4 16.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.464 0.706 . . . . 4.0099999999999998 111.829 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.79 73.24 0.57 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.725 1.25 . . . . 2.0899999999999999 108.647 164.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -57.02 129.98 79.18 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.183 1.393 . . . . 4.7599999999999998 111.452 -174.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -58.28 -32.48 96.05 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.797 2.331 . . . . 2.0099999999999998 112.159 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.35 57.62 4.42 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 119.377 -0.679 . . . . 2.5299999999999998 112.078 165.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.31 -11.39 2.02 Favored Glycine 0 N--CA 1.473 1.125 0 N-CA-C 119.685 2.634 . . . . 2.0600000000000001 119.685 158.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -144.39 146.84 32.75 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.995 2.398 . . . . 2.3700000000000001 112.721 171.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -162.21 155.53 20.59 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.047 0.939 . . . . 0.67000000000000004 110.858 172.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.407 ' CE2' HD21 ' A' ' 20' ' ' LEU . 73.2 m-85 -79.33 140.93 37.38 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.543 -0.91 . . . . 1.6200000000000001 108.543 157.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.4 tpt -87.05 132.47 33.8 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.301 1.441 . . . . 0.68999999999999995 107.665 161.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 mp -114.34 119.74 37.99 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.009 -1.108 . . . . 0.63 108.009 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.96 148.07 42.56 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.48 0.712 . . . . 1.6000000000000001 109.877 172.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.03 48.58 31.96 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 119.391 -0.672 . . . . 1.0600000000000001 112.28 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pp -61.54 155.56 21.78 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 115.042 1.497 . . . . 1.29 115.042 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.34 -4.41 9.92 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 114.062 -1.426 . . . . 1.8799999999999999 114.107 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -115.83 114.78 41.66 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 106.442 -1.688 . . . . 4.8099999999999996 106.442 152.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.62 122.2 9.36 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 N-CA-C 105.38 -2.585 . . . . 2.27 105.38 158.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.2 mt -87.15 178.06 7.01 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 124.576 2.132 . . . . 2.21 112.821 -152.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -127.82 -169.62 2.09 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 129.329 3.052 . . . . 4.2800000000000002 109.929 169.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.0 155.58 17.04 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 106.635 -1.617 . . . . 1.6899999999999999 106.635 146.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.65 1.98 89.51 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.435 -1.203 . . . . 1.6399999999999999 115.771 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -78.72 -176.21 4.8 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.579 1.689 . . . . 2.3399999999999999 110.289 159.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 17.1 pt-20 -155.09 149.88 26.6 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 128.285 2.634 . . . . 3.3700000000000001 107.122 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.1 t -145.65 122.22 3.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 125.909 1.684 . . . . 1.2 109.325 -166.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -81.51 154.5 26.26 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.788 0.804 . . . . 2.46 112.251 167.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.45 HD22 HD22 ' A' ' 20' ' ' LEU . 5.6 tt -154.97 132.67 11.36 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.263 1.425 . . . . 3.1299999999999999 111.023 -177.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.47 130.4 36.97 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.76 2.424 . . . . 2.9100000000000001 108.509 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.0 mp -100.74 119.56 38.8 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.421 1.088 . . . . 0.96999999999999997 109.219 175.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 86.4 mt -87.41 108.71 19.12 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.812 0.815 . . . . 0.88 109.734 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -104.53 116.58 32.34 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.409 1.483 . . . . 2.1600000000000001 111.048 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 54.36 24.78 5.39 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.006 1.722 . . . . 2.79 113.392 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.72 -59.37 2.11 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.962 1.744 . . . . 4.7999999999999998 112.867 -171.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -84.55 9.21 65.57 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 116.399 1.32 . . . . 2.3799999999999999 116.399 -167.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -136.66 152.53 50.51 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.296 1.838 . . . . 5.0999999999999996 111.967 171.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.5 p -148.47 147.14 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 125.069 1.348 . . . . 2.21 111.158 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.4 tp -156.33 132.86 10.15 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.263 1.825 . . . . 2.8999999999999999 108.281 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -96.53 146.61 24.65 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.908 1.447 . . . . 2.1499999999999999 114.908 176.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.7 t -130.2 168.1 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 126.986 2.114 . . . . 2.7200000000000002 108.268 175.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 t -130.88 147.27 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.6 1.56 . . . . 1.8899999999999999 108.431 -171.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.92 146.2 17.85 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.892 1.277 . . . . 2.0899999999999999 110.976 -177.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 57.6 Cg_endo -66.51 164.31 29.23 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.4 3.4 . . . . 0.89000000000000001 112.394 172.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.2 t -105.54 135.97 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.151 1.38 . . . . 1.0700000000000001 108.768 165.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -147.3 164.03 34.54 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.653 1.181 . . . . 3.5 111.503 -175.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.67 -176.27 3.23 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 127.228 2.211 . . . . 2.6899999999999999 115.699 -160.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.436 ' C ' HH11 ' A' ' 120' ' ' ARG . 11.0 tpt85 . . . . . 0 N--CA 1.48 1.069 0 C-N-CA 127.65 2.38 . . . . 8.4000000000000004 113.243 -175.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.172 0 N-CA-C 106.952 -2.459 . . . . 11.289999999999999 106.952 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 m -55.7 127.86 32.01 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 116.906 -1.918 . . . . 11.02 106.564 126.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -79.79 123.27 27.56 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.202 0.815 . . . . 11.48 113.202 -158.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.0 t -170.23 42.93 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.813 2.445 . . . . 6.6100000000000003 110.249 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -128.26 178.43 6.26 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.849 2.06 . . . . 5.1699999999999999 108.567 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -94.65 -177.11 38.44 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 123.58 0.61 . . . . 0.95999999999999996 114.429 -170.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -144.55 154.34 42.77 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.095 1.146 . . . . 2.1299999999999999 114.095 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.58 135.9 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.537 -0.912 . . . . 0.95999999999999996 108.537 170.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -70.56 -10.95 60.52 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.956 1.836 . . . . 3.6800000000000002 115.956 -162.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 63.82 169.82 0.16 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.078 1.351 . . . . 2.3700000000000001 111.723 -170.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -166.77 162.99 11.1 Favored Pre-proline 0 CA--C 1.542 0.644 0 O-C-N 120.773 -1.205 . . . . 2.25 112.221 160.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -85.09 11.45 3.37 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.248 3.299 . . . . 2.3900000000000001 112.823 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -150.37 -165.69 12.86 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 124.451 1.024 . . . . 1.1000000000000001 115.368 -170.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -80.58 -20.43 8.05 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.625 3.55 . . . . 1.23 115.06 -169.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -99.39 164.79 11.96 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.955 1.302 . . . . 2.8799999999999999 112.98 169.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.63 -177.02 6.27 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.792 2.437 . . . . 0.5 111.077 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.72 165.71 26.27 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.552 2.341 . . . . 0.68999999999999995 108.47 173.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.85 156.34 37.43 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.265 1.209 . . . . 0.60999999999999999 114.265 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -140.66 143.59 35.21 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.443 1.897 . . . . 2.4100000000000001 110.325 -173.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.419 ' HA ' ' HA3' ' A' ' 6' ' ' GLY 0.263 0.0 OUTLIER -163.39 166.83 22.46 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.676 1.19 . . . . 2.4100000000000001 113.45 -177.723 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.6 m -91.78 123.62 35.3 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 127.255 2.222 . . . . 1.8700000000000001 109.373 -174.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.3 126.72 46.66 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.707 -0.849 . . . . 3.1299999999999999 108.707 165.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -126.2 120.78 30.93 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.469 -1.308 . . . . 3.9100000000000001 107.469 161.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -92.45 115.49 64.87 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.464 -0.779 . . . . 1.48 108.94 170.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -87.98 -9.79 5.26 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.318 2.678 . . . . 1.3100000000000001 114.822 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.52 159.39 27.09 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 119.65 1.114 . . . . 1.6000000000000001 111.914 -175.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.81 7.61 6.79 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 128.346 2.658 . . . . 3.7000000000000002 112.485 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -125.92 150.24 68.43 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 128.592 2.757 . . . . 1.95 109.367 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.44 149.52 27.53 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.852 2.368 . . . . 0.95999999999999996 111.306 -171.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.2 mt -102.75 153.19 20.39 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 122.809 1.29 . . . . 1.6000000000000001 110.431 164.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 ttp-105 -140.21 103.14 4.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.197 -1.82 . . . . 2.4500000000000002 110.45 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.5 tt -80.38 113.62 18.7 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 109.13 -0.693 . . . . 2.2599999999999998 109.13 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -104.31 -20.15 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.385 1.074 . . . . 0.63 111.771 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.05 -176.24 30.87 Favored Glycine 0 C--N 1.343 0.956 0 C-N-CA 124.808 1.194 . . . . 0.57999999999999996 114.71 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.5 -177.61 6.18 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.182 1.393 . . . . 0.60999999999999999 111.884 174.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -156.2 176.71 12.32 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.896 2.479 . . . . 4.2300000000000004 107.261 163.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -167.87 151.41 5.88 Favored Pre-proline 0 N--CA 1.466 0.329 0 C-N-CA 128.348 2.659 . . . . 0.73999999999999999 106.9 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.95 -5.22 16.64 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.386 2.058 . . . . 1.01 113.108 174.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.61 49.24 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.632 1.173 . . . . 0.89000000000000001 113.501 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.99 151.67 14.44 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.492 0.717 . . . . 0.89000000000000001 112.374 163.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -89.73 -44.25 10.14 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.069 1.747 . . . . 3.0600000000000001 110.951 168.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -114.15 130.79 56.59 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.193 1.797 . . . . 5.6699999999999999 108.255 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -109.14 149.81 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.322 -0.992 . . . . 1.24 108.322 154.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -134.06 148.67 51.08 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.606 1.562 . . . . 2.9100000000000001 108.369 171.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.4 tp -100.98 118.65 37.41 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.637 -0.505 . . . . 1.04 109.637 175.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 48.1 m170 -119.92 162.5 19.07 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 123.819 1.771 . . . . 0.69999999999999996 113.284 -177.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.438 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 15.9 pt-20 -110.99 153.2 25.89 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 112.889 -1.959 . . . . 2.8300000000000001 112.055 155.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.0 m -109.67 152.39 25.65 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 106.251 -1.759 . . . . 0.91000000000000003 106.251 160.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -149.88 171.49 16.69 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.174 0.99 . . . . 2.1499999999999999 111.771 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 57.3 ttm -102.06 143.39 31.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.726 1.21 . . . . 3.9399999999999999 109.566 168.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.32 157.56 43.19 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.875 1.27 . . . . 4.4900000000000002 111.369 -172.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.92 176.38 8.73 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.129 1.372 . . . . 2.6200000000000001 114.599 178.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.0 p 159.76 123.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 1 C-N-CA 132.334 4.254 . . . . 3.7200000000000002 106.974 -164.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 64.63 9.93 5.53 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 117.248 2.314 . . . . 3.1499999999999999 117.248 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.77 7.34 60.11 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 120.745 -1.222 . . . . 2.3700000000000001 113.28 -171.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -112.37 100.84 9.1 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.24 1.816 . . . . 2.8599999999999999 109.213 -162.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -79.49 114.34 18.34 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.194 -0.941 . . . . 4.0499999999999998 108.995 -173.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.1 t -126.82 133.52 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.169 1.788 . . . . 2.6899999999999999 108.769 -173.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 60.2 mtm -88.25 128.17 35.47 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.82 0.848 . . . . 3.2400000000000002 110.688 175.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.72 177.71 16.5 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 124.957 1.265 . . . . 0.63 112.631 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.6 ttm -157.52 137.66 12.61 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.589 1.155 . . . . 0.72999999999999998 111.974 -172.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -146.81 150.01 38.05 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.864 1.666 . . . . 8.4900000000000002 111.038 -177.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.56 151.8 53.26 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.38 2.053 . . . . 0.75 110.12 169.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.78 154.75 76.61 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 125.293 1.437 . . . . 0.76000000000000001 110.638 -175.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.66 -25.9 4.15 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.2 2.6 . . . . 0.63 113.189 -166.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -177.77 161.68 1.65 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.144 1.778 . . . . 1.97 111.433 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.69 153.83 22.88 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.429 1.492 . . . . 0.70999999999999996 109.62 163.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -105.52 152.36 23.14 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.929 0.891 . . . . 1.8600000000000001 110.685 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.3 124.01 13.62 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 123.301 0.64 . . . . 1.46 110.263 163.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.35 165.03 31.88 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.181 2.587 . . . . 1.01 111.181 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.92 138.85 76.23 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.516 2.144 . . . . 1.23 112.848 175.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.26 15.3 mtmt 57.66 36.82 27.07 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.355 1.462 . . . . 2.9500000000000002 113.606 171.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.29 140.06 11.48 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.561 2.029 . . . . 1.1799999999999999 114.84 -172.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.1 ttt85 -87.52 138.11 31.75 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.851 2.06 . . . . 4.3700000000000001 110.439 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.5 t -148.93 142.58 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 127.421 2.288 . . . . 3.27 107.313 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -142.35 147.5 36.39 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 120.537 1.517 . . . . 4.2599999999999998 113.463 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mp -82.59 168.08 17.68 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.044 2.138 . . . . 2.5800000000000001 111.168 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -169.82 157.9 6.5 Favored Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 125.868 1.667 . . . . 2.9199999999999999 113.667 -176.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.18 -47.24 15.38 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 124.19 3.26 . . . . 3.1200000000000001 113.254 176.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.02 36.11 1.47 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.851 1.215 . . . . 1.6000000000000001 113.66 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.3 -134.1 2.51 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 125.107 1.337 . . . . 1.6100000000000001 113.456 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.438 ' CE1' ' HB3' ' A' ' 47' ' ' GLU . 97.1 m-85 -71.05 136.63 48.41 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.897 -0.766 . . . . 2.0299999999999998 111.658 -169.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.5 p-80 -162.08 154.68 19.81 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.826 1.25 . . . . 0.68999999999999995 112.465 -170.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -84.32 146.57 27.66 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.855 -0.528 . . . . 2.4399999999999999 109.753 168.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.6 tpt -100.4 136.51 40.17 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.739 1.216 . . . . 0.63 108.9 162.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.5 mp -118.59 139.87 50.8 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.032 1.333 . . . . 0.52000000000000002 109.148 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mp -140.2 146.63 38.95 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.693 0.797 . . . . 1.75 110.699 171.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.59 37.09 24.46 Favored Glycine 0 N--CA 1.473 1.106 0 O-C-N 122.073 -0.392 . . . . 1.1100000000000001 112.904 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.27 146.12 9.8 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.856 1.662 . . . . 1.29 115.467 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -109.1 -23.49 11.62 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 113.646 -1.615 . . . . 1.99 113.255 -168.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -97.61 142.67 24.92 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.056 0.942 . . . . 5.8300000000000001 109.19 158.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.69 79.54 3.32 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.279 2.652 . . . . 2.5 109.439 173.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 72.8 mt -42.63 122.93 2.46 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 127.604 2.362 . . . . 2.25 115.13 -167.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -119.97 156.8 30.13 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 127.078 2.151 . . . . 6.0499999999999998 113.357 165.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.26 135.98 56.75 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.784 -1.098 . . . . 1.4399999999999999 108.435 171.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.13 1.56 72.39 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.052 1.31 . . . . 1.78 115.117 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -74.97 -173.09 1.81 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.012 1.406 . . . . 2.3700000000000001 112.834 169.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -139.05 125.52 20.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.99 3.316 . . . . 5.0999999999999996 105.354 -165.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.2 t -145.18 128.42 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 O-C-N 121.298 -0.876 . . . . 1.1799999999999999 110.957 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.82 143.58 35.87 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.421 -0.809 . . . . 2.48 110.658 169.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mp -118.27 134.33 55.12 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.876 0.871 . . . . 1.78 109.569 156.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -93.44 139.4 30.75 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.185 2.594 . . . . 2.7799999999999998 108.355 169.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.4 mp -118.43 129.02 55.16 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.729 1.612 . . . . 0.91000000000000003 109.743 -173.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.8 mt -106.28 114.81 29.16 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.371 1.468 . . . . 0.75 110.518 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -112.24 115.06 28.2 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.067 1.347 . . . . 1.8999999999999999 111.841 -172.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 48.53 26.94 1.3 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.519 1.928 . . . . 3.0299999999999998 114.223 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.33 -59.49 4.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.42 1.486 . . . . 4.4000000000000004 112.861 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.63 3.42 68.79 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 116.987 1.555 . . . . 2.21 116.987 -165.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -136.1 143.36 44.54 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.702 1.751 . . . . 3.4300000000000002 112.519 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.4 t -134.34 147.43 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.473 1.509 . . . . 2.29 109.659 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -153.78 166.52 32.62 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.936 2.494 . . . . 1.8899999999999999 108.094 175.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -144.35 160.55 40.85 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.878 1.217 . . . . 1.74 113.679 171.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.66 158.21 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.525 1.53 . . . . 2.3799999999999999 108.886 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.5 p -114.63 132.72 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.325 1.05 . . . . 2.4500000000000002 110.003 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -124.93 148.89 61.32 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 126.975 2.11 . . . . 3.29 108.713 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.15 161.73 44.9 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.742 2.295 . . . . 0.85999999999999999 111.775 162.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.4 t -96.59 137.61 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.847 0.859 . . . . 1.1399999999999999 109.41 168.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.54 141.31 29.4 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.884 1.674 . . . . 3.8199999999999998 111.036 177.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -95.39 86.35 4.48 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.674 1.189 . . . . 2.3100000000000001 112.051 -169.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 . . . . . 0 C--O 1.246 0.881 0 C-N-CA 124.87 1.268 . . . . 8.1799999999999997 111.153 -173.934 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.355 0 N-CA-C 108.503 -1.839 . . . . 14.69 108.503 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.0 m -145.42 147.48 32.27 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.68 1.24 . . . . 10.880000000000001 110.365 -169.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -143.14 143.08 31.67 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.971 0.908 . . . . 10.380000000000001 111.126 -173.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.8 t -135.79 -10.99 2.06 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.757 1.623 . . . . 5.4800000000000004 112.753 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -99.54 171.72 7.76 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.415 1.486 . . . . 6.2199999999999998 112.231 174.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.0 -177.54 23.26 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.809 1.671 . . . . 1.0 111.714 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -148.98 157.61 43.55 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 115.351 1.611 . . . . 1.8799999999999999 115.351 -173.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.0 t -92.89 134.73 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.958 1.303 . . . . 1.3400000000000001 108.631 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.9 tpp85 -69.16 118.87 12.6 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.144 0.977 . . . . 4.8300000000000001 111.872 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -66.64 142.32 57.5 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.87 1.268 . . . . 1.8500000000000001 111.414 162.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -174.48 161.48 2.7 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 126.451 1.9 . . . . 2.9199999999999999 110.684 170.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -84.55 38.2 0.67 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.998 3.132 . . . . 2.4900000000000002 112.122 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.85 151.52 18.21 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 124.942 1.258 . . . . 1.46 115.122 -165.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.29 -22.11 14.65 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.253 2.635 . . . . 1.25 111.841 166.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -105.99 158.58 16.69 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 127.272 2.229 . . . . 2.3100000000000001 112.072 165.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.38 -171.79 3.92 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.027 2.131 . . . . 0.73999999999999999 110.752 -173.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.34 159.86 43.58 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.188 1.395 . . . . 1.1100000000000001 109.707 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.75 131.21 37.3 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.65 1.114 . . . . 0.88 112.778 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -123.0 81.96 1.94 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.664 1.986 . . . . 2.8100000000000001 110.28 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -92.24 158.08 16.33 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.664 1.186 . . . . 1.9099999999999999 113.923 -173.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.7 m -119.89 144.33 47.46 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.725 1.61 . . . . 2.1299999999999999 108.443 162.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.9 tp -158.57 171.7 19.65 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.574 2.75 . . . . 5.0300000000000002 107.517 173.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -136.23 144.75 45.02 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 120.391 -1.443 . . . . 4.4199999999999999 108.382 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -97.59 106.7 34.82 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 125.381 1.472 . . . . 1.3999999999999999 109.493 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -81.62 -7.3 12.59 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.731 2.287 . . . . 1.3500000000000001 114.083 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.64 168.5 54.78 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-O 123.108 1.393 . . . . 1.4399999999999999 113.228 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.436 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 16.6 m-20 -101.44 -2.38 30.94 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 128.606 2.763 . . . . 3.0499999999999998 111.648 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 pp -117.03 159.16 42.12 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 127.665 2.386 . . . . 2.1800000000000002 110.342 171.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.87 138.07 12.95 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.873 2.382 . . . . 1.0800000000000001 111.025 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.55 156.68 16.33 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 123.185 1.469 . . . . 2.1600000000000001 111.834 176.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -152.01 98.26 2.42 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.104 -1.862 . . . . 2.8599999999999999 110.246 -164.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.473 HD21 ' CZ ' ' A' ' 84' ' ' PHE . 5.4 tt -85.59 115.75 23.47 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.945 1.698 . . . . 2.2799999999999998 107.403 -177.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.93 -16.39 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.202 1.001 . . . . 0.72999999999999998 111.969 -174.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.18 -176.53 31.34 Favored Glycine 0 C--N 1.342 0.881 0 C-N-CA 125.887 1.708 . . . . 0.65000000000000002 113.392 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -153.74 178.03 10.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.39 1.476 . . . . 0.68999999999999995 112.785 166.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -151.42 159.04 44.42 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 129.622 3.169 . . . . 4.4699999999999998 108.568 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 t -173.79 152.23 1.97 Allowed Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 128.111 2.565 . . . . 0.60999999999999999 107.229 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.92 -15.88 20.71 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.688 1.592 . . . . 0.97999999999999998 113.513 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.12 32.54 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.319 1.047 . . . . 0.75 112.326 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.93 140.12 17.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.608 0.763 . . . . 0.90000000000000002 109.395 165.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -85.93 -33.89 21.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.038 1.335 . . . . 3.79 110.847 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -139.06 144.45 38.79 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.066 2.146 . . . . 6.9400000000000004 106.597 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.2 p -135.92 146.84 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.109 1.364 . . . . 1.5600000000000001 109.338 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.413 ' CD ' ' HE2' ' A' ' 46' ' ' HIS . 13.5 tt0 -135.49 146.97 48.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.755 2.022 . . . . 3.9900000000000002 108.781 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.8 tp -109.12 115.65 30.45 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.697 1.135 . . . . 1.1699999999999999 111.1 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.413 ' HE2' ' CD ' ' A' ' 44' ' ' GLU . 65.6 m170 -116.4 154.65 29.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.497 1.519 . . . . 0.73999999999999999 113.923 -175.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' CD ' ' HD2' ' A' ' 62' ' ' ARG . 6.5 pt-20 -95.86 179.86 4.95 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.806 1.243 . . . . 2.21 111.442 159.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 84.1 m -137.69 134.81 35.83 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.351 -1.352 . . . . 0.93999999999999995 107.351 164.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -129.7 163.81 25.33 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.165 1.172 . . . . 2.1499999999999999 114.165 -168.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -106.5 150.22 26.32 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.458 1.503 . . . . 3.7599999999999998 111.4 167.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.67 157.66 35.59 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.055 0.942 . . . . 4.3499999999999996 111.217 -168.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -110.32 146.83 35.05 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.174 1.79 . . . . 2.7200000000000002 108.415 167.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.2 129.42 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 107.748 -1.205 . . . . 2.9700000000000002 107.748 161.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 61.97 32.99 17.61 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.161 0.984 . . . . 4.5300000000000002 112.298 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.73 8.69 82.14 Favored Glycine 0 CA--C 1.536 1.384 0 O-C-N 120.575 -1.328 . . . . 2.02 114.019 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -121.11 129.63 53.38 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.391 1.876 . . . . 2.77 109.174 -172.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -69.34 134.9 49.64 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.992 2.117 . . . . 4.3700000000000001 109.492 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.5 p -146.36 170.79 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 125.895 1.678 . . . . 2.6200000000000001 109.835 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 32.2 mtm -131.85 159.32 38.91 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.768 1.627 . . . . 2.5699999999999998 110.684 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.13 -174.9 27.43 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.924 1.25 . . . . 0.89000000000000001 113.956 -173.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.3 ttm -155.74 145.69 21.42 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.169 1.787 . . . . 0.79000000000000004 108.565 -174.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.479 ' HD2' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -162.46 154.0 15.33 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.573 1.149 . . . . 5.3200000000000003 111.59 -178.159 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.79 157.53 35.28 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.143 1.896 . . . . 0.58999999999999997 112.976 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.34 156.78 67.18 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 126.487 1.915 . . . . 0.72999999999999998 110.211 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.5 -21.82 4.13 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.743 2.962 . . . . 0.70999999999999996 113.892 -169.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -177.0 164.61 2.3 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.626 1.97 . . . . 2.04 110.368 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.9 mt -110.31 153.44 24.88 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.342 1.057 . . . . 0.82999999999999996 109.962 166.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -122.07 146.52 47.12 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.466 1.106 . . . . 2.6600000000000001 110.875 174.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.1 t -140.13 131.42 14.29 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.898 1.279 . . . . 0.83999999999999997 109.756 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.46 166.27 27.8 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.115 2.543 . . . . 0.98999999999999999 112.182 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -58.41 139.85 92.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.164 2.576 . . . . 1.25 111.235 171.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.436 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 61.3 mmtt 65.1 3.96 2.37 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.977 1.311 . . . . 1.6899999999999999 113.286 -175.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.11 176.54 53.08 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 127.107 2.289 . . . . 1.4299999999999999 114.73 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 -98.66 129.98 45.16 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.441 1.496 . . . . 3.7000000000000002 112.84 -174.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.8 t -108.12 57.59 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.63 1.572 . . . . 6.0300000000000002 108.947 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -101.65 127.6 48.32 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.038 0.935 . . . . 3.1600000000000001 109.331 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' A' ' 83' ' ' HIS . 3.7 mp -67.82 -37.43 81.92 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.247 1.019 . . . . 3.1000000000000001 111.219 173.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.2 tptt 91.91 126.35 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 127.176 2.19 . . . . 4.1200000000000001 111.385 171.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.82 29.38 0.21 Allowed 'Trans proline' 0 CA--C 1.551 1.338 0 C-N-CA 125.027 3.818 . . . . 2.8100000000000001 115.037 -177.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.03 26.13 0.03 OUTLIER Glycine 0 CA--C 1.539 1.532 0 C-N-CA 127.05 2.262 . . . . 1.6899999999999999 115.284 -174.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.28 -29.59 0.02 OUTLIER Glycine 0 N--CA 1.481 1.683 0 N-CA-C 119.208 2.443 . . . . 2.2999999999999998 119.208 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -142.23 151.24 41.92 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.493 1.517 . . . . 2.25 111.422 159.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.527 ' HA ' HD23 ' A' ' 77' ' ' LEU . 44.3 p-80 -163.2 157.3 20.27 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.797 -1.189 . . . . 0.77000000000000002 111.998 175.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 70.8 m-85 -78.43 139.55 38.73 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.073 -0.651 . . . . 2.5899999999999999 109.397 161.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -91.72 131.02 37.4 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.773 1.629 . . . . 0.64000000000000001 108.116 159.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 mp -113.64 143.29 44.83 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.973 1.309 . . . . 0.69999999999999996 109.071 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mt -137.96 139.4 39.71 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.239 1.016 . . . . 2.1600000000000001 111.355 -176.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.57 38.84 36.58 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.924 -0.931 . . . . 0.93000000000000005 113.897 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.61 150.89 0.91 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 117.17 2.285 . . . . 1.3899999999999999 117.17 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -115.76 -13.28 11.41 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 113.746 -1.57 . . . . 2.6699999999999999 114.269 -172.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -119.57 154.26 54.46 Favored Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 125.954 1.702 . . . . 5.6699999999999999 108.902 168.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -70.66 149.3 60.93 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.662 2.241 . . . . 2.3999999999999999 110.067 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.5 mt -89.54 115.06 26.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 122.87 1.319 . . . . 3.0800000000000001 107.672 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -116.65 172.02 7.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.621 -1.627 . . . . 4.6699999999999999 110.473 169.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.45 136.79 39.41 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.832 -1.544 . . . . 1.6299999999999999 106.832 145.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.1 45.24 9.09 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 123.161 0.41 . . . . 2.1299999999999999 113.721 174.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -111.64 177.71 4.56 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.35 0.575 . . . . 2.8199999999999998 110.775 148.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -146.35 134.81 21.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.1 2.16 . . . . 3.3599999999999999 108.146 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.8 t -139.49 136.09 40.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 127.768 2.427 . . . . 1.3200000000000001 109.636 -160.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -84.11 145.74 28.26 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.754 0.787 . . . . 3.0800000000000001 112.808 173.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mp -121.79 146.83 46.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.907 2.083 . . . . 1.76 109.862 163.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -117.91 111.62 19.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.379 2.272 . . . . 2.3100000000000001 107.844 168.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.3 mp -83.0 140.23 32.84 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.864 0.866 . . . . 0.96999999999999997 109.352 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.8 mt -105.23 109.38 21.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.454 1.102 . . . . 0.72999999999999998 110.098 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -97.63 150.52 21.06 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.758 1.223 . . . . 1.95 111.117 172.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.43 126.62 22.02 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.287 1.435 . . . . 1.6000000000000001 113.487 -169.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.43 49.0 6.98 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.086 -0.841 . . . . 2.6899999999999999 112.649 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.17 12.1 84.36 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 116.174 1.23 . . . . 2.6499999999999999 116.174 165.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -92.14 102.99 15.52 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.333 1.567 . . . . 3.98 111.128 -168.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.3 p -93.18 139.45 18.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 O-C-N 124.603 1.19 . . . . 2.1600000000000001 111.818 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 123.39 19.95 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.467 0.707 . . . . 2.5800000000000001 111.514 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -89.84 129.51 36.21 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.273 1.429 . . . . 1.99 111.473 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.18 143.97 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.952 1.301 . . . . 1.8200000000000001 109.935 168.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.0 p -112.77 134.89 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.358 1.063 . . . . 2.3599999999999999 110.023 176.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 mp -138.87 148.71 59.11 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.967 1.307 . . . . 2.77 110.535 -167.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.66 153.12 79.09 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.468 2.112 . . . . 1.04 111.934 169.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.31 120.95 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.012 -1.477 . . . . 1.3999999999999999 107.012 165.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -153.46 165.66 35.13 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 122.805 1.288 . . . . 5.3499999999999996 113.703 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.29 155.5 28.48 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.75 -1.114 . . . . 3.27 113.859 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.168 0 C-N-CA 131.248 3.819 . . . . 7.8499999999999996 107.374 157.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.401 0 N-CA-C 108.805 -1.718 . . . . 12.43 108.805 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 p -88.72 -32.6 17.86 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.714 1.257 . . . . 12.33 114.235 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -140.01 163.37 32.87 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.455 1.102 . . . . 10.039999999999999 111.674 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.9 t -135.34 20.06 3.39 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.702 2.001 . . . . 5.46 111.586 169.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -99.98 171.69 7.69 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.029 1.731 . . . . 6.4000000000000004 109.751 175.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.06 176.17 19.43 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.565 -1.014 . . . . 0.97999999999999998 110.565 170.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -155.58 -178.65 7.43 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.387 0.613 . . . . 1.74 112.568 -176.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.8 t -112.88 134.69 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.112 1.765 . . . . 1.4199999999999999 109.184 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -21.79 38.5 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.082 1.512 . . . . 5.5700000000000003 115.082 -172.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 82.9 t80 69.99 146.98 0.06 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 128.884 2.874 . . . . 2.5099999999999998 113.792 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.3 m -170.93 154.81 4.36 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.79 2.036 . . . . 2.2799999999999998 111.886 173.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -82.68 -24.6 3.4 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.75 2.967 . . . . 2.1699999999999999 112.865 169.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.08 148.54 24.47 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 109.843 -1.303 . . . . 2.3100000000000001 109.843 166.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.87 -38.9 9.16 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.974 2.449 . . . . 2.8300000000000001 114.523 -163.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -80.03 139.51 36.93 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 123.352 1.549 . . . . 4.3300000000000001 112.779 -175.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.8 -175.31 5.31 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.341 1.457 . . . . 0.88 112.502 -156.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.86 156.83 43.81 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.997 1.719 . . . . 0.79000000000000004 109.932 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.4 143.92 39.99 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.175 0.805 . . . . 0.63 113.175 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.438 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 31.0 m-85 -125.53 75.45 1.48 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.408 1.883 . . . . 2.3799999999999999 110.918 -168.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.83 162.92 28.6 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.816 -1.178 . . . . 1.8600000000000001 113.965 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 68.3 m -121.1 141.64 50.6 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.386 1.075 . . . . 2.27 109.223 157.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.64 -179.35 7.53 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 128.473 2.709 . . . . 5.4400000000000004 107.776 175.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -138.89 157.36 46.19 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.16 -0.963 . . . . 3.8700000000000001 111.847 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -103.65 95.11 6.91 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 126.072 1.749 . . . . 1.3700000000000001 109.469 165.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.0 -3.94 12.47 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.009 2.473 . . . . 1.1699999999999999 114.337 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.26 160.41 31.9 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-O 122.456 1.031 . . . . 1.4099999999999999 111.759 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -87.23 10.02 18.36 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.815 2.446 . . . . 3.8999999999999999 112.179 175.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -116.01 152.88 48.14 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 128.812 2.845 . . . . 2.1699999999999999 109.744 171.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.38 153.58 24.11 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.22 2.614 . . . . 0.82999999999999996 111.489 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.9 mt -111.8 146.9 36.83 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 123.296 1.522 . . . . 1.71 111.774 167.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -133.85 103.63 5.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 112.263 -2.244 . . . . 2.0600000000000001 110.04 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -82.7 109.73 17.13 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.185 1.394 . . . . 2.5899999999999999 108.296 -174.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 m -105.65 -22.04 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.305 1.042 . . . . 0.5 111.908 -172.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.15 -176.72 31.52 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 125.279 1.419 . . . . 0.47999999999999998 113.737 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -154.27 179.16 9.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.263 1.425 . . . . 0.57999999999999996 111.679 168.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -146.19 174.33 11.42 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.783 2.033 . . . . 5.4699999999999998 108.998 164.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 t -170.86 149.53 2.84 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 127.721 2.409 . . . . 0.73999999999999999 108.149 175.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.91 -3.66 14.13 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.746 2.298 . . . . 1.05 113.682 176.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 m -121.74 57.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.843 1.257 . . . . 1.22 112.339 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.09 173.83 16.13 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.544 1.138 . . . . 1.5700000000000001 112.005 162.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -114.87 -51.95 2.72 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.277 1.831 . . . . 2.7200000000000002 109.446 165.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -101.66 132.13 47.52 Favored 'General case' 0 C--N 1.342 0.243 0 O-C-N 121.319 -0.863 . . . . 5.25 109.489 161.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -97.06 150.65 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.108 -0.951 . . . . 1.3 108.458 140.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -136.17 154.02 51.09 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.1 1.76 . . . . 3.0 109.013 169.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.8 tp -110.66 117.31 33.14 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.364 0.665 . . . . 1.0900000000000001 111.235 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -125.29 149.34 48.15 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.784 1.234 . . . . 0.72999999999999998 114.177 -172.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -87.51 169.92 11.78 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.507 1.923 . . . . 2.5699999999999998 112.15 163.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.1 m -148.25 146.16 28.52 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 106.711 -1.589 . . . . 1.01 106.711 173.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -157.99 163.09 38.12 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.116 1.154 . . . . 2.2799999999999998 114.116 -170.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.6 ttp -91.53 148.85 21.99 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.49 1.116 . . . . 3.1099999999999999 109.346 161.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.09 167.18 30.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.285 1.834 . . . . 4.4199999999999999 110.258 -170.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -124.53 135.21 52.99 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.586 1.554 . . . . 2.5 110.553 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 t -136.8 120.33 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.035 -0.728 . . . . 2.0499999999999998 109.035 165.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 65.96 26.25 10.97 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.757 2.023 . . . . 3.1699999999999999 112.962 -176.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.25 10.71 85.77 Favored Glycine 0 CA--C 1.536 1.364 0 O-C-N 120.218 -1.551 . . . . 2.1099999999999999 113.366 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -110.25 116.46 31.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.796 1.638 . . . . 3.3100000000000001 110.355 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.493 ' H ' ' HE2' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -58.66 129.25 41.2 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.961 2.104 . . . . 4.1799999999999997 110.407 174.354 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.8 p -156.72 146.01 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.369 1.867 . . . . 2.4900000000000002 109.752 -174.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.21 161.16 14.07 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.765 0.826 . . . . 3.2799999999999998 111.882 -174.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.44 -179.47 30.59 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 123.976 0.798 . . . . 0.58999999999999997 114.294 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.8 ttm -159.92 148.48 17.31 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.675 1.99 . . . . 0.81000000000000005 109.09 -173.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.1 mtm105 -150.69 156.01 36.05 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.545 1.538 . . . . 5.1699999999999999 109.993 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -77.05 152.94 31.96 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.03 1.82 . . . . 0.63 110.82 168.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.3 m -139.1 151.85 68.67 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.897 1.279 . . . . 0.73999999999999999 110.542 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.39 -24.01 11.08 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.27 2.647 . . . . 0.71999999999999997 112.624 -170.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -173.04 172.96 3.8 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.098 1.759 . . . . 1.9199999999999999 110.912 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.1 mt -118.56 154.93 31.78 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.228 1.811 . . . . 0.70999999999999996 109.819 161.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -114.63 140.59 48.69 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.203 1.001 . . . . 1.8700000000000001 110.281 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.4 t -137.71 127.51 15.29 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 123.565 0.746 . . . . 0.85999999999999999 110.913 167.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.66 169.95 16.3 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.849 3.032 . . . . 0.97999999999999998 111.941 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.06 143.17 96.9 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.112 2.541 . . . . 1.1599999999999999 113.003 173.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm 64.15 8.28 3.97 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.549 1.54 . . . . 2.4100000000000001 113.794 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.99 163.8 38.3 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 127.149 2.309 . . . . 1.2 113.639 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.4 mtt-85 -93.62 148.45 22.09 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.802 0.841 . . . . 5.5800000000000001 110.567 174.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.7 t -118.08 57.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.704 2.002 . . . . 5.5199999999999996 107.564 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -89.2 129.2 35.82 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.017 -0.734 . . . . 2.8999999999999999 109.017 168.082 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 83' ' ' HIS . 2.6 tp -74.78 -24.56 58.69 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 112.925 0.713 . . . . 3.1299999999999999 112.925 -164.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? 76.97 100.89 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 127.319 2.248 . . . . 4.0 110.342 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.438 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 35.0 Cg_endo -60.92 -29.46 88.11 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 121.829 1.686 . . . . 2.27 114.153 -175.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.88 10.5 70.09 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.148 -1.918 . . . . 1.51 115.07 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.47 -25.66 0.03 OUTLIER Glycine 0 N--CA 1.475 1.28 0 N-CA-C 121.414 3.326 . . . . 2.27 121.414 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -140.29 147.92 40.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 121.337 2.569 . . . . 2.1800000000000002 113.17 164.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.524 ' HA ' HD23 ' A' ' 77' ' ' LEU . 54.8 p-80 -158.48 152.54 23.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.668 -1.151 . . . . 0.72999999999999998 112.209 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 75.7 m-85 -78.25 139.08 38.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.094 -0.706 . . . . 2.23 109.094 161.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -88.04 129.45 35.27 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.745 -1.206 . . . . 0.79000000000000004 107.745 159.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 mp -108.74 127.43 53.99 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.06 -1.089 . . . . 0.51000000000000001 108.06 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.42 143.42 50.75 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.75 0.82 . . . . 1.6399999999999999 110.591 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.17 45.81 47.01 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.291 -0.727 . . . . 0.81999999999999995 113.737 176.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pp -54.39 147.94 12.77 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 123.52 1.629 . . . . 1.3799999999999999 114.954 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -103.79 -5.78 22.11 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 113.328 -1.76 . . . . 2.02 113.242 -169.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -148.57 144.47 18.51 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 127.585 2.354 . . . . 7.9400000000000004 109.402 171.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.56 152.54 17.59 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 124.069 3.179 . . . . 2.0499999999999998 111.281 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.645 ' H ' HD23 ' A' ' 93' ' ' LEU . 2.0 pt? -120.06 142.16 49.11 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.849 2.46 . . . . 3.6200000000000001 110.152 -166.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -96.2 -165.8 1.33 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 125.647 1.579 . . . . 3.9399999999999999 110.21 159.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.18 139.01 36.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 107.92 -1.141 . . . . 1.52 107.92 148.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.45 4.55 34.85 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.66 1.6 . . . . 1.8200000000000001 115.501 -170.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.19 174.51 11.49 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.065 1.346 . . . . 2.8500000000000001 110.579 171.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -136.3 149.09 48.27 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.175 1.79 . . . . 4.0199999999999996 106.22 156.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.1 t -145.06 134.56 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.571 1.948 . . . . 1.1399999999999999 110.195 -165.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -78.9 135.09 36.89 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.842 1.257 . . . . 3.3900000000000001 112.208 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mp -123.41 145.01 49.12 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.155 1.382 . . . . 1.71 111.153 162.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -109.25 133.99 52.33 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.562 1.945 . . . . 2.8100000000000001 108.578 170.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 mp -108.5 131.44 54.81 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.883 0.873 . . . . 0.80000000000000004 109.686 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.2 mt -106.52 114.77 29.08 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.206 1.003 . . . . 0.69999999999999996 109.844 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -113.36 121.11 43.38 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.981 1.713 . . . . 2.0299999999999998 111.498 -175.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.96 22.45 2.43 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.598 1.959 . . . . 2.6099999999999999 114.475 174.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.77 -58.39 3.46 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.127 1.346 . . . . 4.2199999999999998 112.66 -169.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.38 0.73 79.46 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 116.821 1.489 . . . . 2.1299999999999999 116.821 -167.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -130.94 140.15 50.14 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.774 1.787 . . . . 3.71 112.344 173.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.0 p -127.73 147.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.42 1.888 . . . . 2.25 110.347 172.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.1 tp -150.73 124.48 9.15 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.039 1.336 . . . . 2.0600000000000001 110.236 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -113.25 135.75 53.5 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.266 0.626 . . . . 2.6400000000000001 112.579 -172.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.4 t -146.45 163.93 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.465 1.506 . . . . 3.23 108.956 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -114.56 138.03 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.179 1.392 . . . . 2.2999999999999998 109.113 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mp -124.22 151.57 66.16 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.841 1.256 . . . . 2.6000000000000001 110.562 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -69.06 155.43 68.27 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.229 2.62 . . . . 1.23 111.489 172.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.6 t -106.41 81.73 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 107.499 -1.297 . . . . 1.46 107.499 161.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.19 156.09 27.09 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.748 -1.205 . . . . 4.0499999999999998 107.748 140.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -83.43 178.98 7.79 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.05 1.34 . . . . 3.6800000000000002 110.849 172.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.268 12.1 ptt-85 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 114.78 -2.533 . . . . 9.4700000000000006 113.494 162.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 113' ' ' VAL . . . . . . . . 0 N--CA 1.471 0.969 0 CA-C-O 118.915 -0.936 . . . . 15.93 110.903 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.2 m -129.67 138.01 50.95 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 106.242 -1.762 . . . . 14.06 106.242 167.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 46.72 -122.16 1.22 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 118.263 -0.875 . . . . 11.81 108.934 -163.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.2 m 104.6 69.26 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 129.891 3.276 . . . . 7.8499999999999996 108.675 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -81.19 70.36 8.01 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.989 0.915 . . . . 7.21 109.799 177.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.82 -179.93 32.16 Favored Glycine 0 N--CA 1.471 0.999 0 O-C-N 120.717 -1.239 . . . . 1.0 114.689 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.5 p90 -141.87 165.82 26.41 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.418 1.487 . . . . 2.02 112.206 172.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.6 t -106.14 135.56 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.044 -1.095 . . . . 1.0700000000000001 108.044 166.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.04 113.95 15.3 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 120.766 0.317 . . . . 3.7200000000000002 110.278 175.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -61.36 135.71 57.79 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.658 -0.497 . . . . 2.9900000000000002 109.658 156.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.2 m -160.59 139.84 7.92 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.991 1.317 . . . . 3.6400000000000001 108.952 167.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -85.08 48.23 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.692 3.595 . . . . 3.1200000000000001 112.353 -168.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -124.09 -175.45 14.39 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.411 1.482 . . . . 1.75 112.897 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.78 -17.46 20.13 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.673 2.915 . . . . 1.77 113.516 174.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -122.16 167.33 13.3 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.728 2.011 . . . . 3.3700000000000001 113.431 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.34 -176.06 5.15 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 127.127 2.171 . . . . 0.83999999999999997 111.739 175.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.22 150.7 44.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.718 2.007 . . . . 0.82999999999999996 108.658 176.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.47 138.41 48.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.153 0.888 . . . . 0.87 111.308 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -129.02 133.55 47.78 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.057 1.743 . . . . 2.3500000000000001 110.656 -171.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 pp -165.7 152.12 9.7 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.149 0.886 . . . . 2.3700000000000001 113.1 -170.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 62.6 m -77.22 120.85 22.86 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.355 -0.841 . . . . 3.2599999999999998 109.035 171.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.14 118.97 23.0 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.541 -1.281 . . . . 3.3100000000000001 107.541 168.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -111.44 126.9 55.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.875 1.67 . . . . 4.0899999999999999 109.07 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -103.62 98.7 13.38 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 121.652 -0.655 . . . . 1.3799999999999999 111.552 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.17 -7.27 17.09 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.903 2.402 . . . . 1.3700000000000001 114.112 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.76 172.35 53.18 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-O 122.658 1.143 . . . . 1.1899999999999999 112.656 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -103.78 -4.52 23.52 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.21 2.604 . . . . 3.0699999999999998 111.837 -174.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.664 ' H ' HD23 ' A' ' 28' ' ' LEU . 2.6 pt? -116.55 162.41 26.9 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 129.106 2.963 . . . . 2.8900000000000001 109.577 172.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.12 142.59 24.76 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.131 1.888 . . . . 0.83999999999999997 109.991 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.494 HD12 ' CD1' ' A' ' 105' ' ' PHE . 1.1 mm? -105.67 158.04 16.99 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.076 1.351 . . . . 2.2999999999999998 111.308 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -149.42 107.45 3.72 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.154 -1.385 . . . . 2.5899999999999999 111.434 -171.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.5 tp -90.39 109.65 20.76 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 127.051 2.14 . . . . 1.8400000000000001 109.272 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -106.77 -17.76 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.445 1.098 . . . . 0.69999999999999996 112.238 -171.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.87 -175.38 28.73 Favored Glycine 0 C--N 1.344 0.985 0 C-N-CA 125.878 1.704 . . . . 0.45000000000000001 113.089 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.76 -176.91 5.45 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.532 1.533 . . . . 0.52000000000000002 110.794 168.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.71 175.87 13.34 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.418 2.687 . . . . 4.5899999999999999 108.2 169.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.0 159.3 7.85 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 127.135 2.174 . . . . 0.96999999999999997 107.267 168.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.56 -9.68 16.67 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.638 2.225 . . . . 0.93999999999999995 115.168 166.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.75 41.36 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 114.821 1.415 . . . . 0.89000000000000001 114.821 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.46 149.91 8.65 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.314 1.446 . . . . 2.0699999999999998 110.133 161.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -123.17 -58.78 1.62 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.817 1.247 . . . . 3.3799999999999999 111.376 -173.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -78.21 68.17 4.17 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 120.887 -1.133 . . . . 4.9299999999999997 108.989 168.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.7 p -78.03 150.47 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.054 -0.975 . . . . 1.1100000000000001 108.857 168.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.97 158.36 37.77 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.065 2.146 . . . . 4.75 107.038 -164.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -134.47 133.3 40.27 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 123.794 1.759 . . . . 1.75 114.102 171.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -120.41 149.13 42.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 112.728 -2.033 . . . . 0.77000000000000002 111.188 -171.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.65 -178.9 7.0 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.293 -1.321 . . . . 2.8999999999999999 110.837 155.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.7 m -153.22 138.68 17.65 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.893 1.277 . . . . 0.92000000000000004 108.465 172.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -147.73 164.27 34.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 122.84 1.305 . . . . 2.2799999999999998 113.45 -171.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.5 ttm -97.32 138.71 34.37 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.313 1.445 . . . . 3.8900000000000001 109.758 172.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -149.08 161.51 41.8 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.431 1.271 . . . . 8.9000000000000004 114.431 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.479 ' CD ' ' HZ2' ' A' ' 57' ' ' LYS . 3.6 tp10 -83.27 151.91 25.39 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.627 1.571 . . . . 3.2400000000000002 110.53 162.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.9 t -139.4 117.39 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.17 1.788 . . . . 2.6699999999999999 106.642 152.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 62.68 21.54 12.78 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.819 1.414 . . . . 3.9100000000000001 114.819 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.26 0.53 82.59 Favored Glycine 0 N--CA 1.48 1.612 0 O-C-N 120.378 -1.451 . . . . 2.3999999999999999 114.034 -170.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -104.27 119.88 39.94 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.139 2.576 . . . . 4.0899999999999999 107.644 -175.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.479 ' HZ2' ' CD ' ' A' ' 52' ' ' GLU . 42.6 mttp -88.05 126.11 34.92 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.28 1.432 . . . . 5.1900000000000004 110.03 -167.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.56 HG22 ' H ' ' A' ' 59' ' ' MET . 8.8 p -154.43 -178.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.732 1.613 . . . . 2.6699999999999999 109.691 -165.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.56 ' H ' HG22 ' A' ' 58' ' ' VAL . 39.2 mmm -119.31 161.87 19.72 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.451 1.101 . . . . 3.0899999999999999 111.176 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -142.81 168.61 25.9 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 126.322 1.915 . . . . 0.65000000000000002 111.509 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.7 ttm -157.67 132.43 8.58 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.328 1.451 . . . . 0.73999999999999999 109.226 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -145.43 148.99 39.34 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 126.476 1.91 . . . . 8.1400000000000006 109.704 -170.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.89 155.43 34.36 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.105 1.87 . . . . 0.78000000000000003 111.118 -176.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.4 m -131.41 151.6 79.04 Favored Pre-proline 0 N--CA 1.477 0.895 0 CA-C-O 118.453 -0.784 . . . . 0.83999999999999997 110.709 176.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.89 -20.6 11.64 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.397 2.732 . . . . 0.56999999999999995 113.165 -167.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -179.29 164.0 1.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.04 2.136 . . . . 1.98 110.467 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.6 mt -110.4 154.65 23.28 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.88 0.872 . . . . 0.55000000000000004 110.57 162.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -134.6 146.17 49.34 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.329 0.652 . . . . 1.96 110.736 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.4 t -142.83 132.14 11.84 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 124.244 0.965 . . . . 0.88 112.681 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.33 160.53 48.49 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.499 2.799 . . . . 0.88 111.912 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -60.53 139.8 88.0 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.491 2.794 . . . . 0.92000000000000004 112.141 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.8 mptt 66.02 -6.42 0.46 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 127.7 2.4 . . . . 1.8400000000000001 114.168 -174.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.59 153.73 37.23 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.759 1.647 . . . . 1.3799999999999999 113.202 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -107.23 147.16 30.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.15 0.98 . . . . 3.8199999999999998 109.647 163.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.9 t -145.14 125.9 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.907 1.683 . . . . 4.0899999999999999 107.013 166.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -93.77 130.91 39.6 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.708 1.003 . . . . 4.6500000000000004 113.708 -168.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -75.96 68.73 2.5 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.155 0.979 . . . . 1.9399999999999999 109.507 157.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 78' ' ' LYS . 8.0 pttp -90.64 156.58 45.02 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 125.705 1.602 . . . . 3.96 113.675 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.28 -20.99 71.92 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.743 2.295 . . . . 2.6600000000000001 113.103 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.5 52.78 3.87 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-N 119.106 0.866 . . . . 3.1099999999999999 111.813 163.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.69 -117.9 2.08 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.472 1.511 . . . . 1.4399999999999999 115.679 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -74.44 143.83 44.53 Favored 'General case' 0 C--O 1.224 -0.276 0 O-C-N 121.574 -0.957 . . . . 2.23 112.741 -161.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -161.8 154.28 19.9 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.454 -0.779 . . . . 0.80000000000000004 113.024 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -78.08 136.22 37.86 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.296 -0.631 . . . . 1.95 109.296 166.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.9 tpt -97.94 133.45 42.41 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 107.801 -1.185 . . . . 0.83999999999999997 107.801 163.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -114.68 115.77 27.63 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.758 1.223 . . . . 0.85999999999999999 108.29 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mp -120.08 155.34 33.17 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.826 0.822 . . . . 1.6699999999999999 110.19 168.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.08 45.81 24.51 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 116.004 -0.544 . . . . 1.5800000000000001 112.458 176.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.36 153.11 4.17 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 123.03 1.395 . . . . 1.6699999999999999 113.99 169.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -113.78 -12.17 12.79 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.011 -1.45 . . . . 2.0099999999999998 113.029 -171.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -145.65 151.71 47.15 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 127.095 2.158 . . . . 5.0300000000000002 108.542 174.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.88 154.5 72.78 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.664 2.243 . . . . 2.1099999999999999 109.816 167.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 pp -148.18 143.69 27.23 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 126.172 1.789 . . . . 2.1899999999999999 108.996 -168.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -127.35 173.02 10.13 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.925 1.69 . . . . 3.8799999999999999 111.754 -168.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.31 130.76 35.77 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.323 -0.991 . . . . 1.26 108.323 162.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.24 5.64 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.999 1.285 . . . . 1.8100000000000001 114.02 -176.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -129.16 -178.34 4.6 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.757 1.223 . . . . 2.3700000000000001 110.11 169.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -136.48 142.58 43.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.669 1.988 . . . . 4.9900000000000002 107.083 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.3 t -152.79 134.77 5.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 128.194 2.598 . . . . 1.4399999999999999 108.572 -168.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -93.17 156.12 17.04 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.241 1.2 . . . . 2.8700000000000001 114.241 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mp -115.07 162.74 16.59 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.11 1.764 . . . . 1.8500000000000001 110.82 165.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -121.87 125.46 46.48 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 129.656 3.182 . . . . 3.1200000000000001 107.163 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -104.18 129.04 51.92 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.307 -1.496 . . . . 1.02 110.181 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.5 mt -102.71 108.32 19.53 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.954 1.302 . . . . 0.90000000000000002 110.173 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.494 ' CD1' HD12 ' A' ' 30' ' ' LEU . 92.4 m-85 -96.22 154.28 17.34 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.899 0.88 . . . . 1.9399999999999999 110.562 174.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.93 135.72 29.91 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.616 0.767 . . . . 2.0 111.212 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.04 -6.53 69.27 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.437 1.018 . . . . 2.9900000000000002 114.348 -173.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.82 14.64 42.44 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-N 118.485 1.143 . . . . 3.3300000000000001 114.572 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 52.8 tttt -77.32 126.42 30.9 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.118 1.459 . . . . 6.1100000000000003 111.126 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 49.7 t -100.97 131.57 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.084 1.754 . . . . 2.73 109.491 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.1 tp -128.27 114.34 16.79 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.603 1.161 . . . . 2.1299999999999999 109.251 169.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.496 ' HZ2' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -106.36 134.56 49.31 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.298 1.222 . . . . 2.1400000000000001 114.298 -175.574 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.5 ' HA ' ' HA2' ' A' ' 1' ' ' GLY . 13.2 m -139.62 148.16 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 127.852 2.461 . . . . 2.1099999999999999 110.04 -152.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.4 t -118.05 124.47 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-N 120.096 1.316 . . . . 1.6899999999999999 110.563 -165.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.99 143.37 47.58 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.992 1.317 . . . . 2.25 110.868 -169.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.34 149.43 35.33 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.192 2.594 . . . . 0.93999999999999995 111.917 165.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.1 t -102.28 124.78 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.941 0.896 . . . . 0.91000000000000003 109.179 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -150.7 155.82 40.08 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.971 1.308 . . . . 3.5699999999999998 111.691 -174.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.95 59.35 3.18 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.088 0.955 . . . . 2.3700000000000001 113.206 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.99 0 C-N-CA 126.275 1.83 . . . . 9.6999999999999993 111.873 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.246 0 N-CA-C 105.971 -2.852 . . . . 12.83 105.971 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 p 161.91 141.48 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.162 -1.051 . . . . 10.77 108.162 -135.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -69.68 161.36 29.87 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.003 0.921 . . . . 10.470000000000001 111.535 170.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.3 p -140.36 63.02 1.48 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.765 2.026 . . . . 6.3300000000000001 108.916 169.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -143.67 -169.09 3.0 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 129.678 3.191 . . . . 5.4800000000000004 108.943 -166.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.41 ' CA ' ' HA ' ' A' ' 20' ' ' LEU . . . -85.4 171.85 46.26 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 121.252 -0.905 . . . . 1.9299999999999999 113.868 161.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -155.42 162.35 40.79 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.664 2.386 . . . . 2.04 110.71 167.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.6 t -112.71 139.91 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.673 -1.267 . . . . 0.96999999999999997 110.264 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.34 124.63 29.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.596 0.359 . . . . 4.7800000000000002 110.96 176.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -36.14 145.2 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.996 2.518 . . . . 1.75 115.039 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.4 t -163.22 140.19 5.78 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 121.427 -0.796 . . . . 2.7799999999999998 112.996 166.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -92.02 -8.9 2.75 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.276 3.317 . . . . 2.8100000000000001 112.56 167.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.05 -179.38 24.23 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.458 1.504 . . . . 1.4199999999999999 113.791 -169.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.49 -20.33 36.23 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 124.23 3.287 . . . . 1.27 114.58 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -113.17 162.95 15.37 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.176 1.39 . . . . 2.3799999999999999 113.855 172.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.9 -177.46 6.63 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.881 2.472 . . . . 0.57999999999999996 111.262 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.49 136.07 27.28 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.817 1.247 . . . . 0.81000000000000005 110.363 174.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.83 143.18 49.01 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.717 1.207 . . . . 0.55000000000000004 112.676 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -115.59 128.87 56.26 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.863 1.665 . . . . 2.4100000000000001 109.433 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.41 ' HA ' ' CA ' ' A' ' 6' ' ' GLY 0.27 3.7 pp -123.77 153.05 41.51 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.409 1.263 . . . . 2.23 114.409 176.529 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.9 m -86.85 129.14 35.0 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.666 -1.235 . . . . 1.7 107.666 161.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.66 117.87 35.61 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.981 1.312 . . . . 3.0699999999999998 108.87 -176.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -98.58 134.13 41.96 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.356 0.662 . . . . 3.77 110.655 175.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -121.58 96.91 47.23 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.131 0.973 . . . . 1.45 111.151 164.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.39 -3.28 9.36 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.332 2.688 . . . . 1.3700000000000001 114.44 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.81 161.86 23.9 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 119.95 1.25 . . . . 1.6000000000000001 111.957 -176.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.08 3.7 14.27 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 128.12 2.568 . . . . 3.02 112.803 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -118.39 153.59 51.84 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 128.037 2.535 . . . . 2.29 110.494 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.67 142.14 17.88 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.842 2.362 . . . . 0.91000000000000003 110.473 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.3 mt -104.99 148.42 26.75 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 122.974 1.369 . . . . 1.76 111.562 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.7 ttp-105 -139.31 103.13 4.66 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 111.835 -2.439 . . . . 2.3100000000000001 111.506 -176.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.8 tt -81.88 115.17 20.95 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 124.424 1.09 . . . . 2.46 109.404 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.6 m -103.13 -20.63 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.039 1.336 . . . . 0.90000000000000002 112.457 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.97 -175.47 27.93 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 126.105 1.812 . . . . 0.73999999999999999 113.028 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.42 -178.96 5.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.721 0.808 . . . . 0.68999999999999995 110.725 167.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -149.77 178.68 8.65 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.94 2.496 . . . . 4.6500000000000004 107.145 159.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -176.9 152.68 1.05 Allowed Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 127.364 2.266 . . . . 0.81999999999999995 107.838 -174.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.57 -11.23 30.64 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.407 2.071 . . . . 1.1000000000000001 113.779 170.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.06 47.12 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 114.237 1.199 . . . . 1.0 114.237 -175.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.76 152.65 11.83 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.429 1.892 . . . . 1.0700000000000001 109.145 164.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -101.3 -31.28 11.05 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.348 0.522 . . . . 4.5 111.857 167.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -113.73 133.71 55.19 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 126.283 1.833 . . . . 4.7300000000000004 108.66 168.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.4 p -139.56 127.29 25.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 124.752 1.221 . . . . 1.23 108.844 172.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -146.79 119.91 8.84 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.332 1.053 . . . . 3.5099999999999998 108.85 -163.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.401 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.6 pt? -83.3 136.84 34.23 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 123.442 1.591 . . . . 2.04 114.31 -177.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -120.78 154.09 36.16 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.333 2.253 . . . . 0.68000000000000005 111.307 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -92.05 160.39 15.25 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.742 1.217 . . . . 2.23 110.15 155.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.1 m -103.62 141.32 36.25 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 106.96 -1.496 . . . . 1.1299999999999999 106.96 150.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -140.35 166.03 25.81 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 122.474 1.13 . . . . 1.98 113.616 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.0 mtm -95.18 141.77 28.4 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.696 1.198 . . . . 5.1399999999999997 112.304 -176.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -142.25 153.32 43.86 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 115.409 1.633 . . . . 5.0899999999999999 115.409 168.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -87.5 146.25 25.89 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.97 1.308 . . . . 3.0499999999999998 108.808 146.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.2 m -130.61 -10.03 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 116.946 2.202 . . . . 3.5299999999999998 116.946 169.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -162.98 22.77 0.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.174 1.39 . . . . 3.7400000000000002 112.728 -167.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.93 4.15 46.88 Favored Glycine 0 N--CA 1.482 1.744 0 O-C-N 119.958 -1.714 . . . . 1.8899999999999999 112.767 -159.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -120.12 134.5 55.24 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 129.055 2.942 . . . . 2.5899999999999999 107.76 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -75.1 146.46 41.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.051 2.14 . . . . 4.8899999999999997 109.475 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.4 p -155.03 168.45 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 126.635 1.974 . . . . 2.5600000000000001 109.538 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.7 mmm -122.93 144.39 49.26 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.071 1.349 . . . . 3.6400000000000001 110.101 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.73 179.23 16.21 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.554 1.549 . . . . 0.70999999999999996 112.075 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ttm -142.11 141.55 32.71 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.798 1.639 . . . . 0.67000000000000004 108.693 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.21 134.84 10.96 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 125.705 1.602 . . . . 6.6900000000000004 109.006 -164.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.28 143.37 35.21 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 CA-C-N 121.537 1.585 . . . . 0.76000000000000001 110.36 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.8 m -129.02 152.81 79.93 Favored Pre-proline 0 N--CA 1.481 1.125 0 CA-C-O 118.617 -0.706 . . . . 0.83999999999999997 111.262 -173.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.25 -26.06 4.43 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.04 2.494 . . . . 0.73999999999999999 112.782 -165.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -176.83 166.08 2.51 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.065 1.346 . . . . 1.97 112.079 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.2 mt -117.2 150.89 37.99 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.596 1.958 . . . . 0.62 111.463 166.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -113.57 145.06 41.84 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.839 1.256 . . . . 2.0299999999999998 110.328 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.2 t -137.91 126.89 14.71 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 124.019 0.927 . . . . 0.87 110.638 162.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.35 166.4 25.57 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 124.027 3.151 . . . . 0.93000000000000005 111.893 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.69 148.14 92.32 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.259 2.64 . . . . 1.1200000000000001 114.176 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.289 19.1 mtmt 49.16 43.24 22.47 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.67 1.988 . . . . 2.7200000000000002 114.13 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.35 169.06 24.69 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 127.738 2.59 . . . . 1.78 111.587 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.51 135.18 19.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.395 0.678 . . . . 4.5599999999999996 110.834 175.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -151.45 137.41 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.39 1.476 . . . . 4.1699999999999999 109.092 -162.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.99 158.24 15.52 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.684 1.231 . . . . 2.96 113.611 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.88 -32.99 74.81 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.78 2.032 . . . . 3.5899999999999999 114.208 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt 99.18 130.49 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.415 0 C-N-CA 131.424 3.89 . . . . 3.6000000000000001 111.142 174.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.32 -5.12 10.58 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.704 2.936 . . . . 3.0099999999999998 115.584 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.4 -11.91 6.48 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-O 117.761 -1.577 . . . . 2.8900000000000001 115.168 167.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.13 -110.5 3.31 Favored Glycine 0 N--CA 1.474 1.177 0 CA-C-N 119.958 1.879 . . . . 1.8700000000000001 112.641 -172.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -73.16 145.61 46.22 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 122.035 -0.686 . . . . 2.0899999999999999 110.656 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.7 p-80 -163.92 153.11 14.05 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.814 -0.554 . . . . 0.60999999999999999 111.383 -177.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -80.43 131.81 35.64 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.441 -0.948 . . . . 1.79 108.441 164.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.9 tpt -84.55 129.63 34.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.056 -1.461 . . . . 0.73999999999999999 107.056 157.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.0 mp -107.49 131.22 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.087 -1.079 . . . . 0.55000000000000004 108.087 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mp -130.25 145.81 51.79 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.908 1.283 . . . . 1.52 110.138 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.8 40.82 93.81 Favored Glycine 0 CA--C 1.528 0.896 0 O-C-N 121.649 -0.657 . . . . 1.0800000000000001 111.494 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.68 145.98 32.45 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 122.909 1.337 . . . . 1.3300000000000001 113.689 175.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -101.8 -6.81 23.16 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.793 -1.548 . . . . 3.7400000000000002 112.396 -172.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -132.98 139.06 33.3 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.802 1.641 . . . . 5.2699999999999996 108.763 154.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -63.6 142.72 85.17 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 N-CA-C 107.285 -1.852 . . . . 2.0800000000000001 107.285 156.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.1 mt -104.76 95.96 6.24 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.584 1.554 . . . . 2.46 109.975 -157.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.69 135.55 36.57 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.26 1.024 . . . . 3.9399999999999999 111.293 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.51 106.49 0.66 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.954 1.302 . . . . 1.6499999999999999 110.462 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.02 -0.02 21.09 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.872 1.701 . . . . 1.6000000000000001 115.032 -170.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -81.11 -176.4 5.93 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.149 1.475 . . . . 2.21 112.346 169.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -141.7 138.92 32.77 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 129.422 3.089 . . . . 3.3100000000000001 106.249 -168.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 79.0 t -150.62 158.04 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 128.827 2.851 . . . . 1.27 108.805 -167.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -123.25 154.45 38.79 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.504 0.722 . . . . 4.1100000000000003 110.613 164.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.89 135.8 55.1 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.556 1.142 . . . . 1.9099999999999999 109.488 160.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.32 140.52 29.41 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.422 2.289 . . . . 2.3700000000000001 109.175 166.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.05 119.19 37.62 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.247 1.819 . . . . 1.1399999999999999 110.06 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.7 mt -90.25 105.28 17.7 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.479 1.112 . . . . 1.1299999999999999 109.594 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -99.78 144.05 29.3 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.075 1.35 . . . . 2.0099999999999998 111.036 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.05 123.58 10.82 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.552 1.141 . . . . 1.7 114.042 -168.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.45 72.71 0.88 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.782 1.182 . . . . 3.0899999999999999 112.816 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.17 19.81 77.59 Favored Glycine 0 N--CA 1.473 1.11 0 N-CA-C 116.013 1.165 . . . . 2.23 116.013 166.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -106.96 139.41 41.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.171 1.486 . . . . 4.6600000000000001 111.114 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.0 p -147.01 147.22 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.717 0.807 . . . . 2.3599999999999999 112.413 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 24.3 tp -156.69 175.78 13.6 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.204 2.602 . . . . 2.46 108.253 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -147.8 155.97 42.23 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.747 -1.221 . . . . 3.0299999999999998 113.169 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.6 t -140.2 157.78 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.635 1.574 . . . . 2.54 109.571 -175.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.2 t -95.63 145.04 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.619 1.968 . . . . 2.5499999999999998 110.993 -170.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mp -145.11 120.18 5.77 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 126.09 1.756 . . . . 2.6000000000000001 111.164 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.65 165.74 26.54 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.541 2.16 . . . . 0.95999999999999996 110.456 161.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.4 t -100.26 141.36 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 O-C-N 121.279 -0.888 . . . . 1.1699999999999999 111.231 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -122.42 146.22 47.56 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.045 2.138 . . . . 4.9699999999999998 111.197 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.24 105.4 12.4 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.547 -0.721 . . . . 2.4399999999999999 112.089 167.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 . . . . . 0 C--O 1.25 1.091 0 C-N-CA 129.715 3.206 . . . . 7.1699999999999999 108.299 170.117 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.916 0 N-CA-C 108.364 -1.894 . . . . 13.16 108.364 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 p -176.34 145.33 0.58 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 126.029 1.732 . . . . 12.720000000000001 108.047 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -139.66 18.21 2.52 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.954 1.094 . . . . 11.66 113.954 -164.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 79.66 12.81 1.11 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.877 1.671 . . . . 8.4399999999999995 112.247 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -82.42 67.96 8.66 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.795 1.238 . . . . 5.8099999999999996 110.353 -172.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.74 179.93 33.11 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 124.654 1.121 . . . . 1.3999999999999999 113.232 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.8 p90 -156.69 153.55 28.65 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.035 0.754 . . . . 2.2400000000000002 113.035 169.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.1 t -100.53 136.69 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.388 0.675 . . . . 1.1200000000000001 109.331 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -72.56 109.2 6.05 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.755 0.822 . . . . 5.9000000000000004 109.962 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.35 134.54 8.85 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.408 1.483 . . . . 2.27 112.864 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.8 t -150.5 143.84 16.83 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 114.676 1.362 . . . . 2.75 114.676 167.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -86.58 -4.62 8.29 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.54 2.826 . . . . 2.77 112.052 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.46 -176.03 25.1 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.216 1.388 . . . . 1.52 114.129 -169.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.52 -14.55 30.68 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.267 3.312 . . . . 1.4099999999999999 114.362 -175.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -131.07 153.34 49.41 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.184 2.194 . . . . 2.46 114.308 -172.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.13 -176.12 5.73 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 127.628 2.371 . . . . 0.5 113.261 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.18 157.64 45.89 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.928 2.091 . . . . 0.57999999999999996 109.595 172.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.81 152.57 46.65 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.524 1.056 . . . . 0.55000000000000004 113.027 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -139.85 146.81 39.82 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.4 2.28 . . . . 2.3399999999999999 110.686 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -172.92 172.55 3.99 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.077 1.51 . . . . 2.2799999999999998 115.077 -170.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.24 143.03 39.24 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 129.323 3.049 . . . . 2.8999999999999999 110.569 -175.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.437 HD12 HG21 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -137.73 110.68 7.72 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.617 -0.512 . . . . 3.21 109.617 171.42 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -123.82 140.34 53.08 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.803 1.241 . . . . 3.4500000000000002 111.29 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -104.44 112.04 65.31 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.634 0.774 . . . . 1.4199999999999999 111.472 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -82.73 -19.53 6.05 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.948 2.432 . . . . 1.3400000000000001 114.276 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.35 -177.12 51.73 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 119.029 0.831 . . . . 1.1599999999999999 112.022 -174.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -107.79 0.86 22.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.375 1.87 . . . . 2.9900000000000002 111.764 -174.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -118.94 160.24 41.52 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 128.287 2.635 . . . . 2.0499999999999998 109.726 171.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.61 147.72 32.09 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.679 2.253 . . . . 1.1399999999999999 110.947 -176.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.9 mt -103.81 149.53 24.96 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 122.518 1.151 . . . . 1.7 110.943 173.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -133.8 106.9 7.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 112.348 -2.206 . . . . 2.4300000000000002 110.669 -176.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.508 HD21 ' CZ ' ' A' ' 84' ' ' PHE . 2.9 tt -81.25 115.67 20.76 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.253 1.021 . . . . 1.9099999999999999 108.652 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.17 -18.22 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.077 0.951 . . . . 0.80000000000000004 112.298 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.34 -173.95 27.41 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 126.059 1.79 . . . . 0.68999999999999995 112.701 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -143.94 -174.85 4.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.728 1.611 . . . . 0.71999999999999997 110.641 166.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.19 178.62 10.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.761 2.424 . . . . 5.0099999999999998 108.654 171.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -178.4 154.93 0.92 Allowed Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 127.03 2.132 . . . . 0.72999999999999998 107.939 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.16 -6.9 17.73 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.082 1.855 . . . . 0.72999999999999998 113.042 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.0 m -124.91 46.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 114.062 1.134 . . . . 0.84999999999999998 114.062 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.18 156.23 14.35 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.556 1.142 . . . . 0.95999999999999996 111.854 167.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -92.83 -26.25 17.76 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.525 1.93 . . . . 2.9300000000000002 112.816 170.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -143.24 140.29 30.62 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 129.378 3.071 . . . . 7.21 107.836 -168.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -157.2 59.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 125.101 2.381 . . . . 3.0299999999999998 111.954 -165.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.61 135.24 35.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 111.453 -2.612 . . . . 5.25 112.72 -162.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 31.9 tp -86.06 121.33 28.51 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.974 1.309 . . . . 1.3799999999999999 111.95 -165.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -123.38 153.86 39.77 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.363 1.465 . . . . 0.57999999999999996 113.771 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -98.83 173.26 6.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.692 1.997 . . . . 2.3500000000000001 111.673 163.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.2 m -152.64 143.76 23.12 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.398 1.879 . . . . 0.71999999999999997 107.889 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -156.94 167.23 31.08 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.554 0.946 . . . . 1.9399999999999999 113.554 -167.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.1 mtt -94.55 154.62 17.3 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.98 0.912 . . . . 5.7400000000000002 110.877 160.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.67 157.04 34.47 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.613 1.165 . . . . 4.6200000000000001 110.307 -173.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -103.25 139.67 38.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.684 1.193 . . . . 2.6600000000000001 110.81 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.4 t -136.76 125.87 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.063 -1.458 . . . . 2.27 107.063 162.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 60.79 22.29 12.32 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.672 1.589 . . . . 3.3300000000000001 114.162 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.08 8.45 87.4 Favored Glycine 0 CA--C 1.538 1.475 0 O-C-N 120.051 -1.656 . . . . 1.8200000000000001 113.861 -171.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -108.35 124.26 50.08 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 127.235 2.214 . . . . 3.1499999999999999 108.192 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.31 119.35 20.08 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.273 -1.33 . . . . 4.7000000000000002 110.198 -175.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.8 m -121.61 -178.6 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 128.313 2.645 . . . . 2.6299999999999999 109.975 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.7 mtm -125.89 162.55 24.93 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.84 1.256 . . . . 3.9399999999999999 111.142 174.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.43 176.75 32.92 Favored Glycine 0 N--CA 1.462 0.417 0 CA-C-O 121.774 0.652 . . . . 0.65000000000000002 113.361 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.0 ttm -159.44 137.11 10.03 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.598 1.959 . . . . 0.81000000000000005 108.969 -173.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -138.91 153.23 71.66 Favored Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 125.949 1.7 . . . . 7.75 109.399 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.62 152.21 25.8 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.923 1.749 . . . . 0.76000000000000001 109.501 170.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.57 151.84 75.23 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 124.128 0.971 . . . . 0.68000000000000005 110.621 -176.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.8 -25.99 5.91 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.166 2.577 . . . . 0.90000000000000002 112.882 -167.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -176.79 164.76 2.43 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.67 1.588 . . . . 2.46 111.602 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.2 mt -109.06 152.19 25.37 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.653 1.181 . . . . 0.90000000000000002 109.982 160.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -117.69 141.6 48.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.748 1.219 . . . . 1.8899999999999999 110.074 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.437 HG21 HD12 ' A' ' 22' ' ' LEU . 35.4 t -137.32 128.27 16.16 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 113.754 1.02 . . . . 0.95999999999999996 113.754 171.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.19 158.43 41.44 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.125 3.217 . . . . 1.0900000000000001 112.574 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.82 133.66 46.06 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.135 3.224 . . . . 1.1200000000000001 112.764 -175.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.14 -12.84 0.55 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 128.721 2.808 . . . . 1.6899999999999999 113.872 -175.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.48 166.42 51.0 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.719 1.628 . . . . 1.3500000000000001 113.116 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -122.53 146.02 47.79 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.715 1.606 . . . . 4.8399999999999999 111.785 172.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 69' ' ' VAL . 21.3 t -152.96 89.77 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 124.801 1.241 . . . . 4.0499999999999998 110.146 170.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.04 147.57 44.93 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.294 -0.867 . . . . 4.79 109.59 -172.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.74 127.25 31.04 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.276 1.036 . . . . 2.46 109.419 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.35 122.49 87.65 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 117.305 -1.331 . . . . 3.3199999999999998 109.979 -168.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -61.86 -10.62 17.88 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.747 2.964 . . . . 2.5600000000000001 114.618 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -125.92 0.39 7.78 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 117.355 -1.803 . . . . 2.2999999999999998 116.143 166.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.56 -20.4 1.24 Allowed Glycine 0 N--CA 1.481 1.676 0 CA-C-N 120.674 2.237 . . . . 1.97 118.483 -172.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -150.81 135.66 17.4 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.166 1.983 . . . . 2.3700000000000001 111.557 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -158.04 152.77 25.0 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.019 0.928 . . . . 0.64000000000000001 110.602 -173.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.508 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 92.0 m-85 -79.16 145.84 33.46 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.661 -0.866 . . . . 1.8799999999999999 108.661 161.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 tpt -106.64 124.14 49.17 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 126.73 2.012 . . . . 0.95999999999999996 108.627 168.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -107.48 133.43 51.97 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.807 1.643 . . . . 0.57999999999999996 109.462 -173.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.57 148.87 49.24 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.186 0.995 . . . . 2.1699999999999999 111.473 176.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.17 40.15 30.07 Favored Glycine 0 N--CA 1.468 0.823 0 C-N-CA 123.766 0.698 . . . . 0.87 113.539 169.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 pp -56.98 156.29 7.02 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 116.075 1.88 . . . . 1.71 116.075 -177.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -111.42 -19.8 12.46 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 112.298 -2.228 . . . . 1.8799999999999999 112.684 -170.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -145.59 136.55 12.45 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 128.102 2.561 . . . . 6.1100000000000003 108.004 165.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.43 137.33 39.32 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.212 2.608 . . . . 1.7 110.955 -176.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.73 84.74 2.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.992 2.117 . . . . 2.6400000000000001 110.055 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -86.36 169.81 12.59 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.467 1.507 . . . . 3.8999999999999999 111.629 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.93 112.62 3.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.814 -1.084 . . . . 1.6200000000000001 111.892 -175.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.31 0.18 28.08 Favored Glycine 0 CA--C 1.539 1.536 0 N-CA-C 117.188 1.635 . . . . 2.1000000000000001 117.188 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -92.14 180.0 5.42 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.777 1.289 . . . . 2.3199999999999998 113.756 -169.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.54 77.57 1.18 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.57 1.948 . . . . 5.4100000000000001 113.498 -162.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 77.0 t -95.22 127.73 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.66 -1.275 . . . . 1.29 111.979 -169.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -78.25 136.48 37.78 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.995 0.918 . . . . 2.4300000000000002 112.568 173.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.23 151.59 35.45 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.15 0.976 . . . . 1.8100000000000001 111.744 155.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -104.22 141.68 35.85 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.62 2.768 . . . . 2.23 107.933 160.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.02 130.95 54.57 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.852 1.261 . . . . 1.0 108.833 172.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.8 mt -100.68 111.02 23.19 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.131 0.973 . . . . 0.80000000000000004 109.593 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -98.77 141.3 31.74 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.104 1.361 . . . . 2.0299999999999998 110.863 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.47 125.94 7.53 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.753 1.621 . . . . 1.6799999999999999 112.729 -172.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.74 33.79 20.72 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.065 -0.853 . . . . 2.6099999999999999 114.026 -175.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.3 14.13 74.95 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 116.596 1.399 . . . . 2.9300000000000002 116.596 162.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -88.89 123.65 33.46 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.588 1.694 . . . . 3.4199999999999999 111.414 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.8 t -115.83 131.22 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 O-C-N 124.07 0.857 . . . . 2.5299999999999998 111.38 -173.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.5 tp -124.75 122.92 38.82 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.11 1.364 . . . . 2.4100000000000001 111.073 177.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.89 148.84 32.6 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.405 -0.81 . . . . 2.3199999999999998 112.305 171.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -146.66 157.61 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.642 1.577 . . . . 2.2599999999999998 109.29 163.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.8 t -104.97 136.84 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.118 1.367 . . . . 2.0099999999999998 109.696 173.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.9 mp -125.25 130.67 24.08 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.916 1.687 . . . . 2.73 110.762 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.68 138.71 38.74 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.004 1.803 . . . . 1.22 109.842 164.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.9 t -77.92 141.41 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 O-C-N 120.699 -1.251 . . . . 1.1899999999999999 108.485 162.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.53 -174.24 2.55 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.989 1.716 . . . . 6.96 113.45 -177.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -126.34 151.57 47.4 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.524 1.13 . . . . 2.5099999999999998 110.407 166.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.178 0 C-N-CA 129.637 3.175 . . . . 8.8200000000000003 109.936 -165.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.092 0 N-CA-C 107.311 -2.316 . . . . 11.18 107.311 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m -142.47 178.84 7.32 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.601 0.963 . . . . 9.4600000000000009 113.601 -150.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -63.74 159.79 18.54 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.26 -0.427 . . . . 7.9900000000000002 110.943 159.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.6 p -123.62 106.41 10.54 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.601 1.56 . . . . 6.54 111.164 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.3 pm0 -77.6 121.77 24.39 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.191 0.996 . . . . 7.1799999999999997 110.543 174.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.89 172.23 38.0 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 121.338 -0.851 . . . . 1.3200000000000001 113.337 159.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.9 p90 -155.8 153.28 29.57 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.112 1.365 . . . . 1.9099999999999999 112.234 164.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.38 139.94 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.16 -0.963 . . . . 1.0700000000000001 108.556 173.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -75.71 109.16 9.07 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.876 0.87 . . . . 4.7000000000000002 111.768 -178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -47.29 130.26 13.08 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.569 1.548 . . . . 2.8399999999999999 111.469 171.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -154.92 167.5 13.92 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 124.465 1.106 . . . . 2.29 113.51 162.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -94.39 -1.73 2.83 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 124.268 3.312 . . . . 2.1400000000000001 114.071 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.71 -168.02 26.36 Favored Glycine 0 CA--C 1.542 1.774 0 C-N-CA 124.788 1.185 . . . . 1.5 115.517 -167.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.79 -10.23 16.95 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 124.817 3.678 . . . . 1.3400000000000001 114.328 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -135.04 158.68 43.73 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.845 2.458 . . . . 2.4300000000000002 113.83 -170.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.82 -175.04 5.14 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.399 2.28 . . . . 0.66000000000000003 112.344 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.28 151.47 47.64 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.777 2.431 . . . . 0.82999999999999996 107.726 172.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.94 144.68 51.01 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.552 1.069 . . . . 0.78000000000000003 112.268 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.485 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 65.6 m-85 -124.21 143.24 50.63 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.439 1.896 . . . . 2.3399999999999999 110.661 -178.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -173.23 166.33 4.86 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.942 1.697 . . . . 3.1099999999999999 111.832 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 t -102.75 160.12 14.87 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.719 1.208 . . . . 2.7599999999999998 113.436 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.6 tp -129.69 129.26 44.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.491 1.517 . . . . 3.8700000000000001 109.808 169.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -117.61 142.48 47.16 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.11 0.564 . . . . 3.3399999999999999 109.809 157.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -94.84 110.46 49.73 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.162 0.985 . . . . 1.49 109.371 173.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -84.62 -9.12 9.2 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.287 2.658 . . . . 1.01 114.48 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.99 177.14 47.77 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 122.564 1.091 . . . . 1.2 113.101 -172.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -89.71 -6.5 56.02 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.614 1.165 . . . . 4.0999999999999996 112.043 174.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.69 160.17 45.47 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 127.63 2.372 . . . . 1.99 110.823 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -77.16 148.98 27.87 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.636 2.224 . . . . 1.02 111.476 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.7 mp -110.8 152.46 26.61 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.63 1.572 . . . . 2.5899999999999999 109.509 172.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -138.77 113.94 9.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 113.674 -1.603 . . . . 2.4100000000000001 109.574 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.3 tt -86.88 123.9 32.52 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.684 1.194 . . . . 1.9199999999999999 108.311 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.1 m -115.31 -14.65 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.413 1.085 . . . . 0.52000000000000002 111.994 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.15 -174.64 28.11 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 125.708 1.623 . . . . 0.54000000000000004 113.879 -174.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.418 ' HB2' ' CE1' ' A' ' 84' ' ' PHE . . . -149.42 -176.35 5.35 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.838 1.655 . . . . 0.72999999999999998 111.542 175.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -153.67 168.82 24.94 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.023 1.729 . . . . 6.2999999999999998 109.03 164.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 t -165.73 148.07 6.44 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 126.028 1.731 . . . . 0.83999999999999997 108.381 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.06 -0.22 9.73 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.597 2.198 . . . . 0.95999999999999996 113.232 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.67 43.46 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.651 1.58 . . . . 0.79000000000000004 113.656 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.02 135.3 5.32 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.368 1.067 . . . . 1.21 110.409 160.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -83.68 -26.41 29.86 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.508 1.123 . . . . 3.7200000000000002 113.219 174.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -108.64 132.2 54.14 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 108.074 -1.084 . . . . 4.7999999999999998 108.074 160.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -116.23 141.37 34.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.298 -1.001 . . . . 1.1399999999999999 108.298 150.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -132.6 153.43 51.05 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.397 1.879 . . . . 2.9199999999999999 108.461 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.4 tp -109.59 120.38 42.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.644 0.778 . . . . 1.1799999999999999 110.18 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -121.87 161.52 22.62 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.803 1.241 . . . . 0.62 112.753 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.51 160.63 29.04 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.149 -0.932 . . . . 3.5499999999999998 110.886 161.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.402 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 25.6 m -132.36 123.77 27.43 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.98 1.712 . . . . 1.1899999999999999 107.189 -175.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -113.72 170.61 8.13 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.121 1.768 . . . . 2.1699999999999999 112.522 -174.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 50.6 ttp -99.64 141.67 32.13 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.527 1.131 . . . . 3.1099999999999999 110.284 164.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -133.55 161.02 35.72 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.429 1.892 . . . . 4.8799999999999999 110.108 170.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -90.18 147.9 23.29 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.483 1.113 . . . . 2.4199999999999999 109.11 154.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.41 137.7 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.713 -1.217 . . . . 2.98 107.713 149.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.453 ' HB2' ' HE2' ' A' ' 56' ' ' LYS . 25.5 mt-10 61.9 9.8 3.19 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 115.921 1.823 . . . . 3.1400000000000001 115.921 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.0 5.95 59.39 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 124.657 1.122 . . . . 1.6399999999999999 115.194 -171.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 54' ' ' GLU . 44.9 pttt -121.91 134.23 54.86 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.409 2.284 . . . . 3.21 110.585 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -73.05 131.59 42.3 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.54 2.336 . . . . 4.1500000000000004 109.406 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 m -138.5 166.41 23.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 127.447 2.299 . . . . 2.1499999999999999 109.702 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -129.42 129.67 44.98 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.204 1.002 . . . . 3.1600000000000001 110.812 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.67 175.25 16.46 Favored Glycine 0 N--CA 1.467 0.748 0 C-N-CA 125.677 1.608 . . . . 0.78000000000000003 111.88 -176.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.7 ttm -139.13 156.8 46.88 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.225 1.41 . . . . 0.73999999999999999 110.077 -172.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -161.33 151.1 14.06 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.36 1.464 . . . . 6.5899999999999999 110.837 -175.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.33 153.49 45.37 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.17 1.913 . . . . 0.64000000000000001 110.607 172.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.3 m -137.5 153.04 74.1 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 124.683 1.193 . . . . 0.62 109.895 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -82.36 -28.36 1.9 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.866 2.378 . . . . 0.62 113.287 -166.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -175.25 167.19 3.42 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.497 1.519 . . . . 2.02 111.982 -176.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.2 mt -115.14 148.67 38.72 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.267 1.827 . . . . 0.75 110.418 165.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -115.06 138.91 50.34 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.74 1.216 . . . . 1.74 108.858 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.4 t -140.29 124.84 10.95 Favored Pre-proline 0 N--CA 1.471 0.578 0 N-CA-C 112.92 0.711 . . . . 0.81000000000000005 112.92 170.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.33 161.25 44.9 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.855 3.037 . . . . 0.95999999999999996 111.67 178.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -58.16 136.75 76.79 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.664 2.909 . . . . 0.95999999999999996 111.893 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.78 -9.05 1.14 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 127.363 2.265 . . . . 3.0299999999999998 113.099 -178.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.14 146.27 29.1 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.226 1.394 . . . . 1.21 113.142 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.36 140.44 45.94 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.747 2.019 . . . . 4.1100000000000003 109.529 171.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.8 t -145.89 123.85 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.451 1.9 . . . . 3.48 108.234 175.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -109.03 141.76 40.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.745 1.218 . . . . 5.1900000000000004 110.935 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -79.0 65.91 4.3 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.487 1.115 . . . . 2.0800000000000001 109.328 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.432 ' H ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -53.23 136.57 49.66 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-O 118.288 -0.863 . . . . 5.2800000000000002 112.149 -167.478 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.485 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 33.9 Cg_endo -62.75 -20.9 72.35 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.89 3.06 . . . . 2.3999999999999999 116.973 -158.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.76 -3.66 87.94 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-O 118.734 -1.036 . . . . 2.6099999999999999 115.093 173.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 48' ' ' THR . . . -129.5 -108.07 1.3 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.504 1.526 . . . . 1.8999999999999999 113.615 -174.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -71.87 142.66 49.56 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.745 -0.856 . . . . 2.1299999999999999 110.594 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -162.78 168.15 21.87 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.461 1.104 . . . . 0.54000000000000004 110.251 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.418 ' CE1' ' HB2' ' A' ' 35' ' ' ALA . 97.3 m-85 -93.79 147.26 23.22 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.468 -0.568 . . . . 2.04 109.468 163.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.8 tpt -102.32 136.53 41.99 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.887 1.275 . . . . 0.68000000000000005 109.67 166.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -117.72 128.03 54.49 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.179 1.391 . . . . 0.77000000000000002 109.264 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.67 145.35 50.61 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.036 0.934 . . . . 2.21 110.235 173.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.63 51.56 11.66 Favored Glycine 0 N--CA 1.469 0.872 0 O-C-N 121.701 -0.624 . . . . 0.81999999999999995 112.409 174.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.26 155.97 10.66 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 115.064 1.505 . . . . 1.5900000000000001 115.064 173.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.5 -7.13 12.84 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 113.973 -1.467 . . . . 2.7999999999999998 113.707 -176.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -139.93 168.61 14.35 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 128.22 2.608 . . . . 4.7300000000000004 108.775 166.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -58.7 160.92 16.14 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.578 1.519 . . . . 2.21 110.935 161.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.2 103.4 6.22 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.218 1.007 . . . . 2.79 110.147 161.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.5 mmtm -115.34 158.91 21.74 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.723 2.409 . . . . 6.7400000000000002 112.155 174.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.64 120.18 10.1 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.695 -0.854 . . . . 1.6299999999999999 108.695 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.53 -0.73 53.13 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.156 1.36 . . . . 1.3799999999999999 115.141 -174.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.42 -174.66 5.29 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.574 1.687 . . . . 2.8599999999999999 110.272 161.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -155.71 145.56 21.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.834 2.054 . . . . 3.2000000000000002 107.789 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.4 t -148.54 130.35 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 125.785 1.634 . . . . 1.0600000000000001 109.922 -163.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -79.05 138.82 38.15 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.868 -0.606 . . . . 3.3999999999999999 111.316 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -123.83 132.3 53.75 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.909 1.283 . . . . 3.0899999999999999 110.468 171.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.24 140.22 30.05 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.446 1.898 . . . . 2.4300000000000002 108.669 165.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -107.28 130.18 54.79 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.396 1.878 . . . . 1.04 107.926 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.8 mt -109.74 126.94 54.25 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.907 1.283 . . . . 0.98999999999999999 110.678 -176.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -119.97 151.76 38.47 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.484 1.114 . . . . 2.02 112.917 -171.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.43 151.57 19.75 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.283 1.033 . . . . 2.0600000000000001 112.798 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.18 16.87 75.42 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.884 -0.954 . . . . 3.4199999999999999 114.738 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.19 78.08 0.93 Allowed Glycine 0 CA--C 1.529 0.959 0 CA-C-N 118.876 1.338 . . . . 2.2599999999999998 113.461 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -152.23 141.09 21.05 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.516 2.726 . . . . 3.4700000000000002 110.872 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.3 t -138.76 147.88 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.959 1.704 . . . . 2.0 108.092 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 tt -150.56 116.83 5.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.924 0.889 . . . . 2.6499999999999999 110.598 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.44 122.06 37.76 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.905 0.705 . . . . 3.98 112.905 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -105.31 175.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 126.699 1.999 . . . . 2.2799999999999998 110.604 166.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.7 t -138.8 132.41 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.102 0.961 . . . . 1.9399999999999999 109.364 173.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -125.01 149.93 64.9 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.731 1.612 . . . . 3.02 109.703 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.18 159.09 48.65 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.334 2.023 . . . . 1.03 110.642 163.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 42.1 t -90.97 134.77 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.374 -1.713 . . . . 1.03 106.374 156.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -136.5 174.43 10.62 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.369 0.667 . . . . 3.8199999999999998 111.769 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.6 55.23 1.61 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.538 1.535 . . . . 2.4300000000000002 113.643 -170.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.143 1 C-N-CA 131.739 4.016 . . . . 7.4299999999999997 114.41 161.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.402 0 N-CA-C 107.515 -2.234 . . . . 11.51 107.515 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -61.24 142.93 56.46 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 115.646 -2.422 . . . . 10.41 107.243 123.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 69.91 136.72 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.628 1.971 . . . . 10.0 112.912 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.51 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 19.0 p -143.44 19.6 1.88 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.159 1.784 . . . . 6.6500000000000004 112.351 -179.268 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 4' ' ' THR . 17.2 mp0 -105.72 -174.03 2.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.469 1.908 . . . . 4.4500000000000002 111.297 -165.49 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.47 171.9 42.33 Favored Glycine 0 C--N 1.336 0.535 0 O-C-N 121.792 -0.568 . . . . 1.24 114.326 179.199 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -152.54 144.3 23.58 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.483 1.113 . . . . 1.9299999999999999 111.032 166.124 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.6 t -88.96 133.4 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 107.635 -1.246 . . . . 1.0800000000000001 107.635 175.185 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.84 115.23 27.92 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.145 0.578 . . . . 3.7599999999999998 109.629 -172.061 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -62.88 151.65 38.57 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.91 1.284 . . . . 2.1600000000000001 113.408 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.8 t -162.86 151.41 12.13 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.997 1.719 . . . . 2.48 110.207 164.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.1 -12.84 21.32 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.801 2.334 . . . . 2.0 112.647 166.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.85 138.86 18.0 Favored Glycine 0 CA--C 1.537 1.46 0 N-CA-C 110.125 -1.19 . . . . 2.5099999999999998 110.125 168.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.33 -26.98 20.04 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.048 2.499 . . . . 2.21 114.818 -167.049 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -84.16 138.58 32.92 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.992 1.269 . . . . 4.4400000000000004 110.829 171.75 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.76 -176.4 3.97 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.036 1.735 . . . . 0.59999999999999998 112.178 -166.403 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.72 149.36 37.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.921 1.288 . . . . 0.69999999999999996 109.71 175.523 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.35 152.9 47.53 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.248 1.023 . . . . 0.60999999999999999 113.627 -175.225 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -129.7 143.52 50.86 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.05 2.14 . . . . 2.5499999999999998 108.634 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.52 170.48 14.32 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.474 1.51 . . . . 2.52 111.827 -178.612 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.1 m -112.13 130.42 55.9 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 124.455 1.102 . . . . 2.1800000000000002 110.983 -166.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.83 123.0 47.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.418 1.487 . . . . 3.1000000000000001 107.744 168.137 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -126.95 134.0 50.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.993 -1.484 . . . . 4.5800000000000001 106.993 161.328 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -94.21 105.51 17.96 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.031 0.933 . . . . 2.0099999999999998 110.514 -176.502 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.14 -11.91 16.09 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.515 2.143 . . . . 1.9199999999999999 113.427 176.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.8 178.26 53.25 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 119.204 0.911 . . . . 1.76 111.782 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -107.24 -0.06 22.89 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 126.772 2.029 . . . . 3.5600000000000001 111.745 -173.117 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.8 157.99 66.95 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 128.301 2.641 . . . . 2.4300000000000002 109.353 175.26 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.69 159.75 41.97 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.369 2.046 . . . . 1.46 112.137 -170.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.1 mt -112.91 149.28 33.4 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.378 1.471 . . . . 1.8500000000000001 110.279 170.225 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.4 ttp-105 -128.92 110.8 12.41 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 112.989 -1.914 . . . . 2.7799999999999998 109.325 173.727 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.1 tp -94.4 114.5 26.55 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 126.097 1.759 . . . . 1.8700000000000001 108.891 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -114.11 -16.82 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.335 1.054 . . . . 0.56999999999999995 112.064 -169.65 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.93 -175.55 28.98 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.877 1.703 . . . . 0.46000000000000002 113.031 -176.072 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.74 -178.61 6.44 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.566 1.546 . . . . 0.5 110.845 173.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 -147.02 -179.25 6.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.978 1.711 . . . . 5.1900000000000004 109.245 156.691 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 t -170.83 148.49 2.61 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 127.316 2.246 . . . . 0.78000000000000003 107.806 174.626 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.54 -11.49 24.38 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.825 2.35 . . . . 0.79000000000000004 113.258 -178.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.9 m -110.89 58.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.502 1.521 . . . . 0.96999999999999997 110.883 172.479 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.57 172.02 16.08 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.944 1.697 . . . . 1.27 110.034 167.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -118.28 -21.41 8.14 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.937 0.895 . . . . 3.5600000000000001 111.844 159.457 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -143.17 150.79 39.88 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 126.15 1.78 . . . . 6.1200000000000001 108.439 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.39 148.17 20.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 C-N-CA 125.803 1.641 . . . . 1.1299999999999999 107.346 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -135.67 139.79 43.99 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.02 1.728 . . . . 4.0999999999999996 107.963 -167.052 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.7 tp -102.02 120.07 39.82 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 120.391 1.451 . . . . 1.25 110.942 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.401 ' CE1' ' HB2' ' A' ' 85' ' ' MET . 58.7 m170 -123.93 160.31 27.81 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.794 1.638 . . . . 0.69999999999999996 115.258 -174.397 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' CB ' ' CE1' ' A' ' 82' ' ' TYR . 15.4 pt-20 -103.66 146.9 27.89 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.791 2.436 . . . . 2.3599999999999999 111.24 158.151 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 100.0 m -107.15 148.57 28.68 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 106.323 -1.732 . . . . 0.85999999999999999 106.323 156.471 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -158.49 -179.49 8.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.639 1.176 . . . . 2.0600000000000001 112.671 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.3 mmt -107.78 143.38 36.41 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.055 1.342 . . . . 5.3300000000000001 114.002 -178.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.73 143.87 33.74 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.708 2.003 . . . . 6.0700000000000003 111.803 178.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -99.27 130.93 45.6 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.146 0.978 . . . . 3.3599999999999999 109.011 156.456 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.5 t -139.98 131.8 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 107.696 -1.224 . . . . 2.0499999999999998 107.696 172.193 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 59.81 20.92 9.78 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.03 1.732 . . . . 3.8100000000000001 114.552 -173.849 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.53 25.77 73.38 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.484 -1.385 . . . . 2.75 113.105 -168.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -118.65 123.91 46.12 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.014 1.726 . . . . 2.7400000000000002 108.248 173.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.616 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -73.72 121.85 21.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.037 1.735 . . . . 3.8999999999999999 110.793 170.02 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 m -145.64 156.58 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 128.096 2.558 . . . . 2.46 109.764 -172.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 37.8 mtp -95.73 146.27 24.65 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.289 -0.882 . . . . 3.7000000000000002 112.19 173.002 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.86 168.87 13.72 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.66 1.6 . . . . 0.70999999999999996 111.436 175.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.8 ttm -150.48 142.6 24.07 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.831 1.252 . . . . 0.79000000000000004 109.596 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.3 mtm180 -143.0 157.45 60.85 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 125.598 1.559 . . . . 5.6500000000000004 109.792 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.74 157.15 39.76 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.015 1.81 . . . . 0.88 111.243 163.105 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.6 m -138.7 153.41 72.2 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 126.032 1.733 . . . . 0.79000000000000004 109.402 176.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.56 -22.97 2.91 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.968 2.446 . . . . 0.73999999999999999 113.821 -163.585 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -179.74 165.6 1.3 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.711 1.604 . . . . 2.0299999999999998 111.899 -179.333 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -111.54 155.11 23.79 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.869 1.668 . . . . 0.93999999999999995 110.224 164.06 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -115.99 146.45 42.12 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.622 1.169 . . . . 2.2999999999999998 109.227 173.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.0 t -140.22 125.06 11.13 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 113.115 0.783 . . . . 1.4099999999999999 113.115 170.26 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.14 159.47 40.82 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.945 3.097 . . . . 1.52 112.049 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.07 138.1 65.62 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.921 3.08 . . . . 1.6899999999999999 112.607 -178.501 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.8 mptt 66.23 -6.58 0.47 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 128.264 2.626 . . . . 2.4500000000000002 114.122 -175.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.97 167.49 34.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.789 1.662 . . . . 1.52 112.65 176.257 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -132.91 157.93 43.87 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.164 0.985 . . . . 4.5700000000000003 113.526 175.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.3 t -145.59 138.75 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 127.95 2.5 . . . . 3.2999999999999998 107.129 172.72 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.1 134.4 34.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.296 -1.001 . . . . 4.0300000000000002 108.296 -173.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.76 162.0 27.26 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 125.177 1.391 . . . . 2.6899999999999999 111.379 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.33 154.1 13.98 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 119.884 -1.76 . . . . 4.2599999999999998 115.047 -178.052 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.59 -38.78 80.12 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 124.577 3.518 . . . . 2.4500000000000002 115.089 -174.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.05 9.84 6.34 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 119.203 -0.776 . . . . 1.6399999999999999 114.374 175.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.52 -132.85 1.4 Allowed Glycine 0 C--N 1.339 0.723 0 C-N-CA 124.909 1.242 . . . . 1.78 114.401 -176.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.402 ' CE1' ' CB ' ' A' ' 47' ' ' GLU . 3.5 m-30 -72.98 139.61 46.81 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 121.51 -0.994 . . . . 2.2000000000000002 111.483 -169.049 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 -161.19 157.8 26.38 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.093 1.357 . . . . 0.72999999999999998 111.986 -169.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.66 146.79 26.68 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.452 -0.78 . . . . 2.25 109.722 166.088 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.401 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 2.6 tpt -98.19 134.83 40.71 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.379 1.472 . . . . 0.67000000000000004 108.54 161.563 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -110.09 140.99 43.56 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.624 1.169 . . . . 0.73999999999999999 109.51 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.06 140.54 43.87 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.184 0.809 . . . . 2.02 113.184 -178.496 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.39 49.25 15.83 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.878 0.751 . . . . 0.90000000000000002 114.37 168.593 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.54 150.0 12.8 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 116.553 2.057 . . . . 1.5600000000000001 116.553 -177.084 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -103.53 2.22 33.27 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 113.509 -1.678 . . . . 2.1899999999999999 113.111 -174.247 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -151.38 151.12 28.46 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 127.573 2.349 . . . . 5.29 108.622 172.48 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -66.93 156.03 68.11 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 N-CA-C 108.307 -1.459 . . . . 2.1099999999999999 108.307 152.02 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 pp -151.4 155.25 38.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.032 1.733 . . . . 2.48 107.408 -175.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -138.72 156.53 47.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 123.451 1.595 . . . . 5.1799999999999997 114.111 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.6 121.0 11.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.143 -0.935 . . . . 1.5900000000000001 109.444 173.287 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.55 49.69 1.38 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.885 1.231 . . . . 1.5900000000000001 112.45 -167.849 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -148.8 -175.04 4.79 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 129.781 3.232 . . . . 2.4300000000000002 109.339 175.329 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -144.61 140.61 28.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.464 2.305 . . . . 4.0300000000000002 106.69 179.193 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.7 t -142.61 139.74 28.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 126.289 1.836 . . . . 1.01 109.349 -170.632 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.403 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 21.9 mt-10 -78.72 144.26 35.44 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.075 0.55 . . . . 2.6299999999999999 111.683 177.075 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.38 139.57 50.7 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.89 0.852 . . . . 1.6799999999999999 110.104 150.579 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.85 152.21 19.05 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.507 1.523 . . . . 2.1099999999999999 108.982 162.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 mp -122.01 130.94 53.72 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.812 1.645 . . . . 1.04 109.253 -176.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.5 mt -110.44 118.29 35.87 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.792 1.237 . . . . 0.79000000000000004 110.408 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -114.58 160.45 19.26 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.967 1.307 . . . . 2.4199999999999999 111.287 -178.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.14 146.45 50.51 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.513 -0.742 . . . . 1.8799999999999999 111.844 167.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.98 23.95 28.64 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.185 0.898 . . . . 3.1699999999999999 115.041 176.636 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.04 6.6 83.03 Favored Glycine 0 N--CA 1.478 1.438 0 CA-C-N 118.479 1.14 . . . . 2.2999999999999998 113.592 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -79.97 115.4 19.53 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.247 1.019 . . . . 3.2200000000000002 111.398 -177.485 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.41 145.17 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.282 1.433 . . . . 2.2999999999999998 109.523 165.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.8 tp -143.23 175.4 9.92 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.916 1.686 . . . . 2.48 109.334 175.058 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.403 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 0.8 OUTLIER -155.4 156.71 35.85 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.358 0.873 . . . . 2.23 113.358 170.994 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.9 t -144.08 162.52 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.681 1.992 . . . . 2.25 108.398 179.363 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.7 t -118.24 144.41 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.104 1.362 . . . . 1.6599999999999999 108.647 -179.326 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.82 142.13 14.59 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.2 1.0 . . . . 2.1699999999999999 112.441 -168.68 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.63 156.43 65.69 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.934 3.089 . . . . 0.71999999999999997 113.242 179.587 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.14 118.32 39.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.301 -0.999 . . . . 0.84999999999999998 108.301 167.585 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -109.92 -178.74 3.61 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.286 1.035 . . . . 4.1799999999999997 110.719 168.534 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.01 179.91 7.41 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 117.059 2.244 . . . . 3.29 117.059 -156.569 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.872 0 CA-C-O 116.62 -1.657 . . . . 9.4299999999999997 112.623 172.179 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.206 0 N-CA-C 106.052 -2.819 . . . . 9.7599999999999998 106.052 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 p -52.1 171.9 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 121.469 0.652 . . . . 7.96 111.875 134.75 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -166.08 -43.68 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.325 1.85 . . . . 10.19 109.011 -178.523 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.5 p -69.64 122.09 18.42 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 107.945 -1.132 . . . . 8.9800000000000004 107.945 140.478 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -157.41 168.74 26.47 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.262 2.625 . . . . 4.5099999999999998 107.341 178.093 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.38 173.24 32.51 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 119.526 1.057 . . . . 1.53 113.04 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.42 ' HE1' ' CB ' ' A' ' 118' ' ' GLU . 3.4 t-105 -156.87 161.05 39.69 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.835 1.654 . . . . 7.4299999999999997 111.651 178.428 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.2 t -130.48 132.53 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.127 1.371 . . . . 1.29 109.053 173.026 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -91.2 112.96 25.09 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.354 0.597 . . . . 4.9900000000000002 110.467 -174.637 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -57.76 147.13 28.99 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.952 2.101 . . . . 3.2999999999999998 114.133 179.437 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 t -162.67 150.82 11.88 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.344 1.458 . . . . 2.6800000000000002 109.641 162.395 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -83.81 45.98 1.92 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.013 3.142 . . . . 2.4100000000000001 111.188 171.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -124.25 167.92 16.48 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.481 1.515 . . . . 1.3 113.855 -174.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.72 -20.77 22.53 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.715 2.943 . . . . 1.1799999999999999 114.064 -177.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.3 152.24 48.32 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.55 1.54 . . . . 3.0699999999999998 113.467 -176.236 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.47 -174.37 4.58 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.689 1.996 . . . . 0.65000000000000002 112.31 -171.324 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.02 136.08 43.81 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.657 1.583 . . . . 0.81000000000000005 109.329 172.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.26 123.99 46.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.612 1.565 . . . . 0.84999999999999998 111.627 -176.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -106.02 65.48 0.7 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.853 1.661 . . . . 2.7999999999999998 109.397 -173.377 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp -73.29 148.71 43.31 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.189 -0.944 . . . . 2.1400000000000001 113.239 -170.082 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.5 t -83.23 139.63 33.0 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.102 -0.999 . . . . 3.5699999999999998 110.347 168.82 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.83 131.44 56.83 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.728 1.611 . . . . 2.9399999999999999 107.942 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -120.56 131.31 54.6 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.173 1.389 . . . . 4.2699999999999996 109.656 173.32 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -107.38 100.36 33.22 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.993 -0.743 . . . . 1.51 108.993 161.116 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.98 -9.26 15.54 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.027 2.484 . . . . 1.3799999999999999 113.393 174.702 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.69 -179.51 51.31 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 122.433 1.019 . . . . 1.21 113.033 -175.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -106.35 -3.51 21.03 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 127.776 2.431 . . . . 2.9900000000000002 111.717 -172.532 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -119.25 159.18 46.35 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 127.89 2.476 . . . . 1.8700000000000001 110.202 172.775 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.75 146.11 20.77 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.741 2.294 . . . . 0.96999999999999997 111.167 -175.078 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mp -103.93 153.49 20.74 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.532 1.133 . . . . 2.7200000000000002 110.711 173.77 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.69 112.66 12.74 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.098 1.359 . . . . 3.2000000000000002 110.0 178.603 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.9 tp -91.98 113.28 25.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.762 1.625 . . . . 1.75 108.86 -177.186 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.5 m -111.41 -15.55 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.855 1.262 . . . . 0.76000000000000001 111.668 -170.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.59 -178.17 31.39 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.916 1.722 . . . . 0.71999999999999997 113.694 -176.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.05 -179.61 8.31 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.886 1.674 . . . . 0.77000000000000002 112.41 168.303 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -157.34 152.56 26.1 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.331 2.252 . . . . 5.6500000000000004 108.532 177.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -159.74 150.21 15.44 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 117.837 -1.077 . . . . 1.01 110.936 177.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.96 0.08 7.71 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.393 3.395 . . . . 1.27 113.66 174.034 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.2 m -116.32 49.86 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.979 1.312 . . . . 1.77 110.791 166.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.75 164.65 35.65 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.398 1.094 . . . . 1.1299999999999999 112.012 161.194 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -104.05 -30.62 10.15 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 127.648 2.379 . . . . 4.1200000000000001 111.371 163.612 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 -149.55 140.03 22.43 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.751 1.62 . . . . 5.6900000000000004 109.459 172.226 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 p -100.05 167.34 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.028 1.331 . . . . 1.6799999999999999 109.204 174.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.79 150.76 35.96 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.8 2.04 . . . . 4.2999999999999998 108.069 176.464 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.5 tp -120.8 114.67 21.96 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.572 1.078 . . . . 1.1599999999999999 111.258 -172.056 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -122.77 157.36 32.54 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 115.091 1.515 . . . . 0.71999999999999997 115.091 -170.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.74 -178.6 4.3 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.129 2.171 . . . . 3.0499999999999998 111.75 158.434 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.7 m -145.34 148.41 33.37 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 107.904 -1.147 . . . . 0.79000000000000004 107.904 162.248 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -152.08 167.56 28.08 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 123.193 1.473 . . . . 2.3799999999999999 114.802 -170.694 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.6 ttp -100.81 140.62 34.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.398 1.479 . . . . 3.25 110.745 172.867 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.79 176.01 10.2 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.599 1.56 . . . . 6.8099999999999996 112.063 178.1 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -146.15 133.48 20.65 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.076 1.751 . . . . 2.1699999999999999 106.743 -179.345 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 m -149.84 135.86 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.784 1.634 . . . . 2.6800000000000002 107.447 -169.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 60.88 12.41 3.83 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.734 1.614 . . . . 4.3200000000000003 114.19 -172.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.9 20.69 55.19 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.096 0.855 . . . . 1.7 114.302 -171.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -132.83 135.5 45.68 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.935 1.294 . . . . 4.4400000000000004 111.216 174.519 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -71.19 143.92 50.32 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.021 2.528 . . . . 4.2000000000000002 110.904 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.1 p -156.7 172.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 126.666 1.986 . . . . 2.3900000000000001 109.932 -172.567 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 64.1 mtt -114.0 153.22 29.73 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.077 0.951 . . . . 2.71 111.158 167.076 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.21 175.02 20.05 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 126.427 1.965 . . . . 0.68000000000000005 111.766 176.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 ttm -150.17 146.01 26.62 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.631 1.573 . . . . 0.80000000000000004 109.368 174.84 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.57 146.86 23.4 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 124.364 1.066 . . . . 5.6399999999999997 111.109 -169.404 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -78.43 153.57 27.37 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.032 1.821 . . . . 0.82999999999999996 111.515 171.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.1 m -140.77 152.03 64.61 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 125.843 1.657 . . . . 0.76000000000000001 110.777 -175.148 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.74 -23.85 6.59 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.546 2.831 . . . . 0.71999999999999997 113.504 -167.057 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -178.29 163.54 1.64 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.68 1.992 . . . . 1.9399999999999999 110.442 179.487 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.6 mt -110.25 157.16 19.75 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.211 1.404 . . . . 0.64000000000000001 110.057 164.202 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -118.58 146.64 44.45 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.084 0.954 . . . . 2.3300000000000001 110.32 168.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.78 128.98 17.14 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.489 0.716 . . . . 1.1000000000000001 110.982 172.051 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -71.42 165.03 33.74 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.107 3.205 . . . . 1.29 112.318 -176.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.31 141.68 96.36 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.637 2.891 . . . . 1.3200000000000001 112.733 178.304 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt 66.05 0.64 1.67 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.554 1.942 . . . . 2.1699999999999999 113.592 -176.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.51 126.81 7.64 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.587 1.565 . . . . 1.6000000000000001 113.881 -174.368 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -88.31 123.13 32.59 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.886 1.274 . . . . 6.4900000000000002 107.642 156.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.7 t -149.65 98.07 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.892 0.877 . . . . 3.4500000000000002 109.614 175.702 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 0.8 OUTLIER -75.54 142.46 42.78 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.865 -0.522 . . . . 3.02 110.751 -177.068 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -65.16 95.39 0.18 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.248 -1.389 . . . . 2.3700000000000001 107.248 159.083 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.98 150.45 37.44 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.529 1.132 . . . . 4.0 113.93 -164.014 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.25 142.62 92.16 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.791 2.328 . . . . 3.3500000000000001 110.187 174.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.73 -2.73 85.46 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-O 118.709 -1.05 . . . . 1.51 114.163 -168.556 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.78 -127.69 1.36 Allowed Glycine 0 C--N 1.34 0.759 0 CA-C-N 118.892 1.346 . . . . 1.6599999999999999 113.114 172.322 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -72.99 140.54 47.42 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.655 -0.909 . . . . 2.1499999999999999 112.695 -164.335 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -163.54 158.97 21.4 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.284 1.034 . . . . 0.81999999999999995 113.405 -176.138 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -87.11 136.65 32.85 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.853 -0.529 . . . . 2.0 110.678 166.063 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.2 tpt -84.06 138.76 32.9 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.488 1.115 . . . . 0.67000000000000004 108.496 159.573 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -117.84 134.77 54.6 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.099 1.36 . . . . 0.65000000000000002 108.63 179.312 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 mp -132.86 137.43 46.7 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 122.991 0.516 . . . . 1.74 111.918 177.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.64 47.74 7.72 Favored Glycine 0 N--CA 1.467 0.709 0 C-N-CA 125.208 1.385 . . . . 0.81000000000000005 113.162 171.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.51 147.37 14.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.634 1.716 . . . . 1.3300000000000001 115.634 -177.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -104.04 -3.79 24.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.937 -1.483 . . . . 2.52 113.907 -172.116 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -149.24 139.23 13.2 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.331 1.453 . . . . 5.3799999999999999 112.021 171.937 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.75 135.08 15.6 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.526 2.818 . . . . 2.2400000000000002 109.651 173.374 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.7 mp -93.59 -167.94 1.8 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.032 1.333 . . . . 3.8199999999999998 110.789 -168.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -134.13 172.74 12.42 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 127.478 2.311 . . . . 3.9900000000000002 108.843 164.458 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.51 129.31 34.43 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 118.113 -1.435 . . . . 1.23 107.871 138.476 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.93 58.64 1.23 Allowed Glycine 0 CA--C 1.528 0.846 0 O-C-N 124.301 1.001 . . . . 1.3600000000000001 111.654 -168.298 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -141.37 175.73 9.42 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.323 1.449 . . . . 2.9900000000000002 111.317 161.774 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.28 87.41 1.96 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.906 2.482 . . . . 3.3999999999999999 109.827 -170.25 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 91.2 t -113.18 144.29 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 120.586 -1.321 . . . . 1.5 112.119 -156.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -79.0 141.35 37.55 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.999 1.111 . . . . 2.5899999999999999 113.999 -167.6 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.426 HD23 HD12 ' A' ' 115' ' ' LEU . 2.6 mm? -125.11 143.5 50.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.565 1.546 . . . . 2.6699999999999999 108.834 159.549 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -114.5 123.02 48.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.345 2.258 . . . . 2.1800000000000002 107.899 172.657 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.3 mp -98.69 127.25 44.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.665 1.986 . . . . 1.48 109.931 -169.054 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.7 mt -104.96 112.61 25.81 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.437 1.113 . . . . 0.65000000000000002 110.612 -178.264 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -101.02 154.88 18.33 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.789 1.236 . . . . 2.04 110.508 178.101 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.25 141.34 14.99 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.443 -0.798 . . . . 1.7 110.771 170.019 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.52 -1.19 81.47 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.693 -1.06 . . . . 3.0499999999999998 114.399 -171.642 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.57 13.08 61.83 Favored Glycine 0 N--CA 1.473 1.106 0 CA-C-N 119.038 1.419 . . . . 3.2799999999999998 114.361 173.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.57 134.82 38.16 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.948 -1.325 . . . . 5.9400000000000004 111.047 -179.101 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -113.22 140.6 32.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 126.228 1.811 . . . . 2.29 110.191 172.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.1 tp -145.64 126.68 14.61 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.496 1.119 . . . . 2.1000000000000001 110.921 176.637 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -85.8 139.41 31.32 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.043 0.757 . . . . 1.98 113.043 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.01 161.93 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 127.67 2.388 . . . . 2.3199999999999998 110.847 164.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 83.7 t -121.53 135.62 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.585 1.154 . . . . 1.6299999999999999 108.824 174.171 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.426 HD12 HD23 ' A' ' 101' ' ' LEU . 47.2 mt -131.41 132.32 23.49 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.886 1.275 . . . . 2.0899999999999999 110.972 -169.552 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -57.19 141.82 94.46 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 124.168 3.245 . . . . 1.8200000000000001 114.75 172.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.6 t -114.14 128.9 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.685 1.194 . . . . 1.1899999999999999 111.603 175.297 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.42 ' CB ' ' HE1' ' A' ' 7' ' ' TRP . 4.2 tt0 -156.72 163.64 39.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.92 1.688 . . . . 3.6200000000000001 112.147 -179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.05 104.72 16.69 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.27 1.028 . . . . 2.75 110.43 176.526 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 . . . . . 0 C--O 1.247 0.922 0 C-N-CA 126.093 1.757 . . . . 9.9199999999999999 108.033 178.493 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.271 0 N-CA-C 105.623 -2.991 . . . . 12.34 105.623 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -56.05 160.38 2.86 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 117.512 0.656 . . . . 10.56 109.831 136.038 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -89.84 157.19 18.02 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.569 0.748 . . . . 10.539999999999999 111.838 177.819 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 p -154.04 -57.28 0.11 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.217 1.807 . . . . 6.0599999999999996 107.303 -174.509 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -91.89 177.96 6.03 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.758 2.023 . . . . 6.96 109.277 153.712 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -131.19 -175.24 13.93 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.445 1.974 . . . . 1.0 111.116 176.802 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.5 p90 -135.27 -178.49 5.13 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.231 1.515 . . . . 1.9099999999999999 113.402 -168.153 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.72 152.25 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 126.774 2.03 . . . . 2.1099999999999999 112.114 -178.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 -71.77 -26.41 62.42 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 116.11 1.893 . . . . 5.3700000000000001 116.11 -174.433 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.0 t80 71.75 157.05 0.17 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.066 2.547 . . . . 1.98 111.978 -160.434 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -155.53 149.04 18.66 Favored Pre-proline 0 CA--C 1.538 0.488 0 O-C-N 121.535 -0.728 . . . . 2.4900000000000002 111.217 162.87 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -85.7 -2.67 9.07 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.649 2.899 . . . . 2.0099999999999998 112.018 167.182 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -121.01 -179.99 16.22 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.672 1.606 . . . . 1.0900000000000001 114.065 -175.099 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.56 -18.1 48.65 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.439 3.426 . . . . 1.23 113.986 -174.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -114.61 137.77 51.47 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.055 2.142 . . . . 2.1499999999999999 113.863 -178.677 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.28 -177.26 5.38 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.79 2.436 . . . . 0.5 111.738 -172.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.38 149.24 30.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.143 1.377 . . . . 0.65000000000000002 110.862 178.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.18 147.21 51.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.893 1.277 . . . . 0.57999999999999996 113.832 -174.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -128.32 43.11 3.2 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 127.424 2.29 . . . . 2.9900000000000002 114.703 -168.622 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -73.0 150.58 42.33 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 119.569 -1.957 . . . . 2.8300000000000001 115.598 -168.16 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 m -96.27 149.4 21.71 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.831 1.653 . . . . 1.8600000000000001 109.16 173.183 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.47 166.47 33.44 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.671 1.589 . . . . 2.8300000000000001 112.153 -176.433 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -128.79 140.97 51.46 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.91 2.084 . . . . 4.2400000000000002 112.334 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -96.52 99.57 5.72 Favored Pre-proline 0 CA--C 1.542 0.667 0 O-C-N 121.478 -0.764 . . . . 1.6000000000000001 109.354 158.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.65 -12.11 12.52 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.493 2.128 . . . . 1.27 113.71 176.136 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.78 178.35 53.71 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-O 122.552 1.084 . . . . 1.21 112.936 -175.749 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -104.75 0.91 28.73 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.87 2.468 . . . . 2.9300000000000002 112.318 -173.689 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mp -125.48 160.8 53.84 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 127.767 2.427 . . . . 4.0199999999999996 108.798 174.079 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.65 155.75 21.1 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.231 1.954 . . . . 0.98999999999999999 111.732 -167.689 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.75 147.76 28.23 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.88 1.272 . . . . 2.3199999999999998 110.224 170.587 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.0 ttp180 -136.64 103.92 5.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.016 -1.902 . . . . 3.9199999999999999 109.297 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.548 HD21 ' CZ ' ' A' ' 84' ' ' PHE . 6.5 tt -84.85 110.05 18.55 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.478 1.911 . . . . 2.1699999999999999 108.847 -175.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.9 m -106.34 -20.88 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.764 1.226 . . . . 0.46999999999999997 111.932 -174.515 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.48 -175.76 31.83 Favored Glycine 0 C--N 1.343 0.947 0 C-N-CA 125.004 1.287 . . . . 0.42999999999999999 114.13 -173.516 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.43 -177.28 5.98 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.754 2.021 . . . . 0.47999999999999998 111.0 173.383 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.412 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 11.5 mtt180 -157.95 170.78 21.55 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.89 2.476 . . . . 4.7599999999999998 107.626 171.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 t -173.44 149.74 1.71 Allowed Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 125.294 1.438 . . . . 0.57999999999999996 110.364 174.292 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.54 -8.12 21.28 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.773 2.316 . . . . 0.71999999999999997 114.037 172.648 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.3 m -118.87 49.39 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.545 1.138 . . . . 0.72999999999999998 113.295 174.721 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.23 151.34 17.39 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.643 1.177 . . . . 0.87 110.704 161.515 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -95.7 -30.77 13.56 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.382 1.473 . . . . 3.3500000000000001 111.948 169.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.6 mtp-105 -133.08 141.15 48.05 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.693 1.597 . . . . 5.1100000000000003 108.915 171.5 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -125.3 148.6 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.157 1.383 . . . . 1.1499999999999999 109.558 168.652 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -137.45 151.46 48.52 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.649 1.98 . . . . 2.8700000000000001 109.736 178.315 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.8 tp -104.61 118.51 36.75 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.492 0.717 . . . . 1.0700000000000001 110.56 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -124.53 148.87 47.5 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 123.084 1.421 . . . . 0.58999999999999997 113.914 -174.506 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -89.08 176.38 7.01 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 113.889 -1.505 . . . . 2.46 111.521 162.74 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 64.9 m -155.01 136.47 14.18 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 105.457 -2.053 . . . . 0.80000000000000004 105.457 175.175 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -149.43 161.52 41.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 122.952 1.358 . . . . 2.0099999999999998 114.184 -166.771 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -87.41 136.22 33.03 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.333 -1.303 . . . . 3.6099999999999999 110.588 172.705 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.01 143.22 20.28 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.204 1.002 . . . . 4.9299999999999997 113.699 -177.501 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.55 130.9 36.54 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 125.655 1.582 . . . . 3.0699999999999998 111.63 172.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.5 t -141.45 134.8 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 126.066 1.746 . . . . 2.1299999999999999 107.274 169.733 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 65.9 16.76 10.61 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.645 1.178 . . . . 3.9199999999999999 113.352 -176.424 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.24 21.05 68.27 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 121.188 -0.945 . . . . 1.51 113.396 -171.64 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -138.86 133.33 31.84 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.169 1.787 . . . . 3.29 109.717 -170.144 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.405 ' H ' ' HG2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -76.31 117.09 17.62 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.109 1.364 . . . . 4.1399999999999997 113.506 -178.641 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -117.14 174.06 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 128.669 2.787 . . . . 2.1499999999999999 109.103 170.489 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.41 130.34 56.42 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.946 0.898 . . . . 3.1600000000000001 109.901 177.422 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.31 172.91 15.01 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.573 1.083 . . . . 0.52000000000000002 113.286 -179.328 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ttm -148.78 143.07 26.13 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.573 1.549 . . . . 0.66000000000000003 109.765 177.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -144.92 152.19 51.12 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.369 1.868 . . . . 7.6200000000000001 109.143 -176.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -80.83 150.71 18.59 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.593 2.195 . . . . 0.59999999999999998 110.206 170.374 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.24 155.49 80.84 Favored Pre-proline 0 N--CA 1.48 1.05 0 C-N-CA 124.496 1.119 . . . . 0.66000000000000003 110.379 -177.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.76 -30.04 2.53 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.746 2.297 . . . . 0.56999999999999995 112.713 -170.72 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -176.2 164.73 2.76 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.735 1.614 . . . . 2.1000000000000001 112.042 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.5 mt -109.03 158.73 17.45 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.04 1.336 . . . . 0.69999999999999996 109.282 161.391 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -139.74 144.66 37.57 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.96 0.904 . . . . 2.21 111.242 174.707 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.2 t -146.74 140.1 14.82 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.447 1.099 . . . . 1.5 112.323 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.64 170.62 8.15 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 124.417 3.411 . . . . 1.4399999999999999 114.092 176.734 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.96 150.12 80.12 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.616 3.544 . . . . 1.1799999999999999 113.774 171.788 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt 68.49 -7.24 0.72 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.912 2.085 . . . . 1.96 115.085 176.252 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.81 149.34 32.95 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.438 1.018 . . . . 1.2 112.683 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 mtt-85 -86.8 162.03 18.03 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 122.003 -0.704 . . . . 6.3099999999999996 110.155 161.388 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.1 150.44 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.054 1.741 . . . . 4.04 108.724 172.518 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.75 137.9 30.1 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.945 0.898 . . . . 3.29 110.344 161.578 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -78.54 80.72 4.91 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 122.283 1.04 . . . . 2.0099999999999998 108.336 170.203 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.404 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -59.39 136.57 88.9 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 115.403 -0.817 . . . . 3.2799999999999998 112.908 -177.083 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -60.84 -25.62 81.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.236 2.624 . . . . 2.0699999999999998 112.553 176.284 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.7 9.66 28.68 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 117.652 -1.638 . . . . 1.8700000000000001 114.722 174.23 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.65 -10.55 0.03 OUTLIER Glycine 0 C--N 1.346 1.107 0 N-CA-C 121.56 3.384 . . . . 2.1299999999999999 121.56 167.467 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -143.99 145.3 32.13 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 121.124 2.462 . . . . 2.02 112.843 172.195 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -158.68 152.0 22.82 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.599 0.76 . . . . 0.56000000000000005 110.816 175.66 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.548 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 61.9 m-85 -78.7 141.56 37.81 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.418 -0.956 . . . . 1.6499999999999999 108.418 160.062 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.0 tpt -99.42 130.23 45.67 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.399 1.88 . . . . 0.60999999999999999 108.489 168.67 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.9 mp -111.61 139.61 46.9 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.47 1.508 . . . . 0.55000000000000004 108.357 -179.262 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.2 mp -137.82 143.73 41.15 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.418 1.087 . . . . 1.52 109.576 175.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.91 42.42 45.32 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.957 -0.457 . . . . 1.0 111.957 -178.542 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.35 141.9 28.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 122.865 1.317 . . . . 1.3400000000000001 113.342 170.837 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -100.65 0.78 39.8 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.084 -1.416 . . . . 2.3900000000000001 113.05 -171.334 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -123.86 146.63 51.32 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 126.959 2.104 . . . . 5.1500000000000004 107.821 167.013 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -62.34 120.27 7.74 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 N-CA-C 105.166 -2.667 . . . . 1.6799999999999999 105.166 149.472 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 tp -76.79 79.95 3.4 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 122.177 0.989 . . . . 2.5 111.387 -157.077 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . 0.268 5.6 tmtt? -64.74 114.5 4.5 Favored 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 120.368 -1.458 . . . . 6.1799999999999997 110.949 -169.334 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.71 114.83 1.25 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.216 1.406 . . . . 1.6899999999999999 111.443 170.483 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.67 44.81 6.3 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.201 1.381 . . . . 1.6000000000000001 112.699 -169.783 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -101.3 -177.22 3.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.919 1.688 . . . . 3.0099999999999998 109.209 145.219 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -130.68 125.5 34.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 129.328 3.051 . . . . 3.8900000000000001 103.91 178.064 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.9 t -128.66 122.25 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.381 1.873 . . . . 1.01 108.985 -171.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -81.8 146.66 29.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.933 0.873 . . . . 2.25 112.582 171.133 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.77 138.03 54.22 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.665 1.586 . . . . 1.6499999999999999 109.77 163.433 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 14.5 m-20 -78.32 149.0 33.55 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.343 1.857 . . . . 2.71 108.125 158.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.2 mp -127.16 132.59 50.48 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.667 1.587 . . . . 1.0 108.482 175.682 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.5 mt -105.95 118.43 36.58 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.806 1.242 . . . . 0.68999999999999995 109.456 -175.258 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -116.55 118.23 32.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.422 1.489 . . . . 1.9199999999999999 111.786 -172.671 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.86 20.84 1.75 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.5 1.92 . . . . 2.8300000000000001 114.277 176.621 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.28 -61.73 4.13 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.208 1.385 . . . . 4.4199999999999999 112.286 -167.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.94 4.68 60.74 Favored Glycine 0 N--CA 1.474 1.21 0 N-CA-C 117.089 1.596 . . . . 2.04 117.089 -166.193 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -131.99 140.06 48.83 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.481 1.64 . . . . 3.4500000000000002 112.178 175.333 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.17 146.88 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.361 1.464 . . . . 2.1000000000000001 109.334 171.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 tt -150.7 160.88 43.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.91 2.484 . . . . 1.96 107.593 176.545 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -144.89 152.94 41.03 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.027 1.285 . . . . 1.76 114.436 175.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.51 157.79 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.416 1.486 . . . . 2.2799999999999998 109.409 -174.4 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 66.6 t -87.39 161.76 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.951 1.3 . . . . 1.8100000000000001 109.127 175.626 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.25 140.08 11.42 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 126.239 1.816 . . . . 2.4399999999999999 110.223 164.168 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.97 146.2 64.31 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.247 2.632 . . . . 0.72999999999999998 111.987 174.109 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.77 116.56 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.768 -0.827 . . . . 1.1699999999999999 108.768 167.357 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -137.05 176.57 8.6 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.798 1.639 . . . . 4.4100000000000001 110.116 -177.771 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -113.36 136.72 52.46 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.298 1.039 . . . . 2.5 111.518 174.367 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.277 19.9 ptt-85 . . . . . 0 N--CA 1.485 1.297 0 C-N-CA 131.175 3.79 . . . . 9.4100000000000001 111.415 168.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.111 0 N-CA-C 107.418 -2.273 . . . . 10.470000000000001 107.418 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.8 p -52.3 130.06 29.89 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 117.576 -1.65 . . . . 9.5299999999999994 107.639 129.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -108.42 150.12 27.83 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.852 0.861 . . . . 10.460000000000001 110.695 -175.41 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.0 p -147.59 123.77 10.84 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.756 1.622 . . . . 6.0300000000000002 108.181 -179.028 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -83.81 179.42 7.57 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 123.872 0.732 . . . . 7.8600000000000003 110.408 173.308 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.51 -175.33 19.59 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 125.1 1.333 . . . . 1.4399999999999999 112.565 177.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -141.59 175.29 9.81 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.995 1.109 . . . . 2.1000000000000001 113.995 178.471 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.6 t -111.93 126.12 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 126.284 1.833 . . . . 1.8100000000000001 106.166 162.202 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.6 ttp85 -87.19 131.77 34.08 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.296 -1.001 . . . . 5.5099999999999998 108.296 171.143 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -57.35 117.59 4.26 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.122 0.569 . . . . 2.3599999999999999 110.98 -175.639 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.5 m -174.68 106.11 0.27 Allowed Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 128.851 2.86 . . . . 4.6200000000000001 107.036 167.052 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -93.42 -125.53 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.603 3.535 . . . . 6.0599999999999996 109.515 -176.314 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.73 -155.41 30.5 Favored Glycine 0 CA--C 1.543 1.785 0 O-C-N 121.425 -0.797 . . . . 2.5800000000000001 113.164 178.423 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.82 -31.19 13.21 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.914 2.409 . . . . 3.71 112.091 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.09 123.36 21.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.889 1.675 . . . . 4.2400000000000002 111.049 169.306 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.18 -179.04 4.96 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.131 1.772 . . . . 0.85999999999999999 111.336 172.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.96 135.93 29.86 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 121.052 -1.03 . . . . 0.80000000000000004 111.097 -176.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.78 146.14 51.98 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.819 1.648 . . . . 0.90000000000000002 112.05 -176.54 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -135.89 62.78 1.61 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.19 0.996 . . . . 3.3900000000000001 111.488 -157.062 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.06 162.71 24.0 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.468 -0.787 . . . . 1.79 113.015 -173.608 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.6 m -125.78 145.83 50.04 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.782 1.633 . . . . 2.27 107.571 171.064 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.47 164.62 38.39 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.96 1.304 . . . . 4.6299999999999999 110.176 174.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -127.94 154.98 44.95 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.391 1.076 . . . . 3.96 110.594 168.454 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -101.35 95.1 4.61 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 124.552 1.141 . . . . 1.3600000000000001 109.221 171.334 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.92 -19.18 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.151 1.9 . . . . 1.6699999999999999 113.28 -177.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.46 -177.02 51.47 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-O 122.351 0.973 . . . . 1.46 112.455 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -112.85 2.85 16.08 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.517 1.927 . . . . 4.1699999999999999 112.389 -170.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -98.38 157.04 35.06 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.634 1.974 . . . . 2.3300000000000001 110.243 164.082 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.57 148.63 14.32 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.243 2.628 . . . . 0.89000000000000001 111.179 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.1 mt -102.65 146.04 28.77 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 122.8 1.286 . . . . 1.9399999999999999 111.87 170.819 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.9 ttp-105 -129.77 109.61 11.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 111.984 -2.371 . . . . 2.3500000000000001 108.967 176.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -95.41 111.66 23.51 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.402 1.881 . . . . 2.4900000000000002 108.606 -174.039 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -111.21 -21.26 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.145 0.978 . . . . 0.62 112.033 -168.725 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.54 -174.26 30.14 Favored Glycine 0 C--N 1.344 1.018 0 C-N-CA 124.596 1.093 . . . . 0.56999999999999995 114.277 -174.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.16 -178.79 6.4 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.563 1.545 . . . . 0.70999999999999996 111.466 170.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -151.6 167.07 29.24 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.804 2.442 . . . . 4.6900000000000004 107.746 164.354 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 t -174.07 149.23 1.45 Allowed Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 125.164 1.386 . . . . 0.76000000000000001 108.536 -171.604 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.18 -3.5 13.49 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.185 2.59 . . . . 0.82999999999999996 114.281 177.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.4 m -119.4 28.39 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 115.22 1.563 . . . . 1.1100000000000001 115.22 -174.009 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.33 167.03 31.72 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.781 1.632 . . . . 1.1200000000000001 111.481 173.221 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -96.67 -31.13 12.86 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.458 1.503 . . . . 3.0699999999999998 111.056 173.278 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -139.1 153.35 48.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 129.889 3.276 . . . . 5.0199999999999996 108.034 -173.311 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.5 p -155.07 121.76 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 124.896 1.279 . . . . 1.74 109.775 178.569 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -140.66 129.95 23.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.143 -0.935 . . . . 4.1399999999999997 109.795 -165.314 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.459 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.7 pt? -82.23 140.43 33.67 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 123.261 1.505 . . . . 1.8400000000000001 113.285 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -117.11 157.16 26.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.612 2.365 . . . . 0.81999999999999995 112.304 175.397 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -95.33 149.01 21.83 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.642 1.977 . . . . 2.6000000000000001 109.541 158.182 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.0 m -115.62 149.63 37.98 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.369 1.868 . . . . 0.82999999999999996 106.012 159.654 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -158.93 177.39 11.2 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.817 0.847 . . . . 1.98 113.146 -177.026 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 76.1 mtm -108.76 144.22 36.86 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.234 1.414 . . . . 3.3799999999999999 111.612 172.439 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -139.78 146.95 40.11 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.418 1.487 . . . . 5.3399999999999999 111.597 173.618 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -93.94 140.48 29.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.725 1.21 . . . . 2.25 108.167 156.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.8 t -138.83 119.2 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.175 1.39 . . . . 2.2000000000000002 107.252 170.363 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 62.46 20.08 11.64 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.087 1.355 . . . . 3.4500000000000002 113.95 -177.404 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.83 15.4 75.41 Favored Glycine 0 N--CA 1.477 1.413 0 O-C-N 120.47 -1.394 . . . . 1.5 113.504 -170.456 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -117.02 115.71 25.95 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.696 2.398 . . . . 3.4700000000000002 108.314 -179.587 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.442 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -93.72 131.26 39.22 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.588 1.155 . . . . 4.3799999999999999 111.47 -170.62 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.9 p -155.32 148.96 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.9 1.68 . . . . 2.6600000000000001 109.99 -168.112 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.9 mtt -89.22 155.48 19.37 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.521 0.728 . . . . 2.5099999999999998 111.956 176.433 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.5 176.05 20.82 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 124.612 1.101 . . . . 0.57999999999999996 112.714 179.186 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ttm -153.83 144.81 22.74 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 126.058 1.743 . . . . 0.71999999999999997 109.205 -178.497 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -151.0 157.99 35.05 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 125.658 1.583 . . . . 4.8399999999999999 109.472 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -73.6 157.26 48.82 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.146 1.897 . . . . 0.87 111.266 168.481 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.17 158.81 71.85 Favored Pre-proline 0 N--CA 1.481 1.12 0 CA-C-O 118.53 -0.747 . . . . 1.1799999999999999 110.729 173.873 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -83.18 -24.98 2.9 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.277 2.651 . . . . 0.94999999999999996 113.355 -170.166 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -179.39 164.61 1.35 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.88 2.072 . . . . 2.3500000000000001 110.781 -178.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.2 mt -109.43 154.3 22.8 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.757 1.223 . . . . 0.68999999999999995 110.26 163.626 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -115.53 140.4 49.2 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.25 1.02 . . . . 1.9199999999999999 108.987 170.701 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.3 t -141.86 129.04 11.47 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 123.886 0.874 . . . . 1.25 111.365 174.324 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.45 170.42 16.24 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.428 2.752 . . . . 1.1000000000000001 112.545 -178.199 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -57.63 139.54 90.57 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.142 2.561 . . . . 1.51 111.172 166.356 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm 65.22 0.75 1.37 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.279 1.831 . . . . 2.6000000000000001 114.524 -174.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.56 177.54 52.75 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.291 1.9 . . . . 1.8799999999999999 112.395 171.477 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.6 ptt85 -131.83 132.94 44.14 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.515 1.126 . . . . 8.2300000000000004 112.876 -172.432 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.88 73.29 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 127.071 2.148 . . . . 5.29 109.094 -174.465 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.33 117.87 35.12 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.605 1.962 . . . . 3.7599999999999998 110.064 -172.075 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.29 58.03 0.61 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.493 1.917 . . . . 2.73 111.58 -171.695 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.519 ' H ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -61.97 146.59 91.39 Favored Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 125.973 1.709 . . . . 3.3900000000000001 115.364 178.533 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -61.12 -33.5 91.06 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 124.319 3.346 . . . . 2.8500000000000001 114.782 -177.502 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.25 5.25 44.08 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.153 0.882 . . . . 1.46 114.182 177.533 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.22 -124.96 0.97 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.955 1.264 . . . . 1.6100000000000001 111.591 170.293 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -71.11 138.01 49.35 Favored 'General case' 0 C--O 1.219 -0.527 0 O-C-N 121.653 -0.91 . . . . 2.1200000000000001 111.274 -174.07 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -159.93 158.16 30.26 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.416 0.687 . . . . 0.59999999999999998 112.451 -176.021 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -89.71 137.49 32.29 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.181 -0.949 . . . . 1.8600000000000001 111.737 174.783 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.9 tpt -97.35 127.69 43.53 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.416 1.886 . . . . 0.70999999999999996 109.146 163.348 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.78 121.81 44.8 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.939 1.296 . . . . 0.81999999999999995 108.525 -178.629 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.8 136.52 52.49 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.155 0.582 . . . . 2.6699999999999999 110.875 -163.329 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.32 38.44 62.7 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.867 -0.521 . . . . 1.05 112.554 -170.584 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.87 148.02 0.87 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 116.546 2.054 . . . . 2.0299999999999998 116.546 176.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -99.74 1.75 43.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.816 -1.538 . . . . 1.8 113.705 -177.128 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -159.32 150.53 16.34 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 125.658 1.583 . . . . 4.96 111.027 -177.105 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.91 83.85 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.016 2.477 . . . . 3.0 107.812 164.1 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 96.94 0.09 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.503 1.521 . . . . 2.6899999999999999 111.923 -172.426 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.48 161.34 13.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.09 -1.868 . . . . 4.2699999999999996 112.606 -173.949 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.71 133.17 54.42 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.037 0.935 . . . . 1.6799999999999999 110.389 177.5 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.92 55.61 3.52 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 114.176 -1.374 . . . . 2.8500000000000001 111.077 -170.653 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -138.33 -178.02 5.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.233 2.213 . . . . 2.4199999999999999 108.3 163.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -156.37 132.53 9.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.278 2.231 . . . . 3.46 105.571 -167.57 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.6 t -142.0 132.21 24.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 125.249 1.42 . . . . 0.96999999999999997 109.466 -164.035 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -77.13 145.59 37.69 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 122.685 0.394 . . . . 2.4199999999999999 111.131 172.329 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.54 137.44 54.73 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 122.662 1.22 . . . . 1.7 111.122 151.322 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -87.3 139.78 30.21 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.365 2.266 . . . . 2.0800000000000001 108.028 155.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -110.4 141.21 43.78 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.367 1.467 . . . . 0.81000000000000005 109.952 173.714 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -112.42 113.92 26.36 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.958 1.303 . . . . 0.64000000000000001 109.579 178.221 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -115.14 152.68 32.15 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.623 1.569 . . . . 2.1800000000000002 111.094 178.196 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.23 137.55 55.81 Favored 'General case' 0 CA--C 1.548 0.865 0 CA-C-O 122.293 1.044 . . . . 2.3700000000000001 113.795 -178.602 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.23 56.97 4.93 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.266 0.936 . . . . 3.5600000000000001 113.239 176.445 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.47 11.84 80.1 Favored Glycine 0 N--CA 1.473 1.158 0 N-CA-C 115.784 1.074 . . . . 2.1600000000000001 115.784 168.574 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -94.68 114.97 26.97 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.043 1.421 . . . . 2.9900000000000002 111.356 -174.356 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.65 136.12 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.134 1.374 . . . . 1.8999999999999999 109.537 177.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 tt -145.42 125.32 13.51 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.85 0.86 . . . . 2.5499999999999998 111.033 -168.202 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -101.09 134.68 43.73 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.792 1.237 . . . . 2.4100000000000001 112.144 -178.468 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.8 t -147.11 168.3 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 126.412 1.885 . . . . 2.5499999999999998 109.71 173.553 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.94 155.84 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 119.672 1.123 . . . . 1.8999999999999999 111.01 -170.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.9 mt -141.29 117.52 7.39 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.212 1.805 . . . . 2.52 110.129 -174.437 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.46 146.46 62.14 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.705 2.27 . . . . 1.0900000000000001 110.432 168.818 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.4 t -94.79 115.81 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.845 0.858 . . . . 1.23 109.209 170.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -129.81 137.73 50.64 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.428 1.091 . . . . 4.21 112.01 -170.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.43 83.46 5.43 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.994 -1.066 . . . . 3.8100000000000001 110.693 170.065 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.408 0 C-N-CA 127.249 2.22 . . . . 9.1300000000000008 110.848 -175.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.209 0 N-CA-C 106.101 -2.8 . . . . 12.529999999999999 106.101 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 p 167.6 143.17 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 118.446 -0.788 . . . . 10.460000000000001 109.805 -137.405 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -109.8 158.02 18.57 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.5 1.12 . . . . 10.25 111.744 -178.054 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.6 t -167.19 25.51 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 127.659 2.384 . . . . 5.4900000000000002 111.042 168.398 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -150.34 164.84 34.79 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 127.344 2.257 . . . . 6.4199999999999999 106.001 173.49 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -118.69 -170.95 14.94 Favored Glycine 0 N--CA 1.462 0.387 0 CA-C-O 122.436 1.02 . . . . 0.92000000000000004 112.038 -172.697 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 41.0 p90 -134.11 162.98 30.61 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.598 -0.801 . . . . 2.0499999999999998 111.325 167.206 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.46 139.03 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.894 1.278 . . . . 1.3999999999999999 109.147 173.49 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -58.0 112.73 1.6 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.743 1.617 . . . . 6.1399999999999997 112.555 -177.672 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.59 132.36 51.45 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.324 2.249 . . . . 3.0699999999999998 111.455 166.175 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -179.05 154.55 0.79 Allowed Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.535 1.934 . . . . 2.7999999999999998 112.867 166.392 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -88.28 40.69 0.58 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 125.23 3.953 . . . . 2.2999999999999998 111.055 166.316 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -114.88 157.37 15.03 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.948 1.261 . . . . 1.27 113.019 -172.085 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -71.77 -18.52 28.41 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.133 3.222 . . . . 1.45 113.923 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -108.17 164.82 11.97 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.541 1.936 . . . . 2.8700000000000001 112.629 170.253 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.3 -171.72 3.72 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.474 2.709 . . . . 0.60999999999999999 111.107 170.447 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -155.19 133.89 12.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.639 1.976 . . . . 0.85999999999999999 108.867 -175.715 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.42 132.57 54.97 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.267 1.394 . . . . 0.94999999999999996 111.351 -176.637 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -114.84 32.04 6.27 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.673 1.731 . . . . 2.7000000000000002 115.673 -167.061 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.642 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.5 pt? -64.93 158.88 24.17 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 115.972 1.841 . . . . 2.3199999999999998 115.972 -172.306 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.8 m -79.74 126.6 31.15 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.519 1.128 . . . . 1.75 109.679 166.191 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.9 tp -99.08 127.91 45.11 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.262 1.425 . . . . 4.2699999999999996 108.898 168.859 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.71 154.74 42.0 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.628 0.728 . . . . 3.3999999999999999 111.676 175.356 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -119.12 97.93 50.69 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.388 1.075 . . . . 1.53 109.088 169.246 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.6 -10.76 14.42 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.08 2.52 . . . . 1.21 113.03 177.05 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.93 -173.38 48.81 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.795 1.188 . . . . 1.26 113.115 -176.154 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -112.82 1.17 15.45 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.606 1.963 . . . . 3.2599999999999998 112.368 -168.844 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -124.45 161.86 45.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 128.013 2.525 . . . . 2.2799999999999998 110.256 174.122 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -81.01 141.91 13.42 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.484 2.122 . . . . 1.3999999999999999 111.898 -173.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.98 149.33 25.24 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.145 1.378 . . . . 2.71 110.134 174.055 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 42.4 ttm105 -135.44 103.3 5.43 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.633 1.173 . . . . 2.75 110.157 178.591 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.426 HD13 ' C ' ' A' ' 32' ' ' LEU . 2.5 tm? -79.4 114.66 18.51 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.24 1.816 . . . . 2.5800000000000001 108.047 -178.34 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.2 m -110.1 -19.47 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.254 1.022 . . . . 0.60999999999999999 112.408 -177.405 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.24 -175.8 29.58 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 125.509 1.528 . . . . 0.5 113.889 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.91 -179.87 6.02 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.965 0.906 . . . . 0.51000000000000001 111.035 166.004 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -137.32 177.4 7.9 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.313 1.445 . . . . 4.1100000000000003 107.845 155.054 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 t -175.7 148.88 1.02 Allowed Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 128.151 2.58 . . . . 0.69999999999999996 106.394 177.258 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.44 -9.46 20.16 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.591 2.194 . . . . 0.78000000000000003 112.21 178.55 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.3 m -112.96 51.82 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.679 1.591 . . . . 0.85999999999999999 111.586 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.01 158.16 30.05 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.056 1.343 . . . . 1.01 111.64 167.167 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -98.57 -33.81 10.83 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.987 1.715 . . . . 2.6699999999999999 110.152 160.745 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -128.65 130.12 46.8 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.619 1.968 . . . . 5.1600000000000001 109.53 177.255 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -128.43 128.93 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.404 1.081 . . . . 1.4299999999999999 108.993 166.378 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -144.39 137.57 27.16 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.165 0.986 . . . . 3.1600000000000001 110.442 -162.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 20.7 tp -91.85 125.17 36.46 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.663 -0.648 . . . . 1.3700000000000001 112.324 -167.458 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -122.41 160.28 25.79 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.896 1.678 . . . . 0.77000000000000002 114.119 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.48 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 17.6 pt-20 -120.27 147.68 44.67 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.696 1.598 . . . . 3.9199999999999999 110.189 161.499 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.3 m -108.54 139.14 43.72 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 107.54 -1.282 . . . . 0.81999999999999995 107.54 172.545 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -130.22 170.77 13.65 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.567 1.947 . . . . 2.0899999999999999 111.895 -172.386 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.8 mtt -103.36 141.58 35.69 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.518 1.127 . . . . 3.9700000000000002 111.909 172.158 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -141.47 145.02 34.71 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.078 1.351 . . . . 6.9000000000000004 112.52 174.423 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -79.93 134.51 36.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.769 -1.197 . . . . 2.5699999999999998 107.769 146.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.3 t -146.41 136.86 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 106.894 -1.521 . . . . 2.75 106.894 164.637 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 66.31 13.84 9.39 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.64 1.576 . . . . 5.5300000000000002 113.927 -177.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.03 27.11 67.13 Favored Glycine 0 N--CA 1.476 1.309 0 O-C-N 120.946 -1.096 . . . . 2.7400000000000002 113.017 -168.31 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -130.93 143.68 50.91 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 126.861 2.065 . . . . 4.6299999999999999 109.098 178.638 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -81.35 119.61 23.89 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.308 1.843 . . . . 4.0899999999999999 109.458 178.821 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.7 m -139.3 169.91 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.343 1.857 . . . . 2.5299999999999998 110.976 -177.813 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 53.6 mtm -134.14 137.84 44.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.039 1.335 . . . . 2.8100000000000001 110.75 174.464 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.44 174.83 21.57 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 125.786 1.66 . . . . 1.03 111.627 -177.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.25 141.63 47.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.329 1.064 . . . . 1.6200000000000001 111.832 -179.166 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -122.24 156.08 60.81 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 125.343 1.457 . . . . 6.6699999999999999 110.19 173.291 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.26 159.0 44.44 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.021 1.814 . . . . 0.79000000000000004 111.575 170.29 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.68 156.21 78.84 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 126.215 1.806 . . . . 1.3100000000000001 110.49 177.194 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.57 -24.13 6.54 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.51 2.806 . . . . 0.68999999999999995 112.859 -175.546 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -176.68 165.36 2.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.08 1.752 . . . . 1.9299999999999999 111.703 -178.662 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -109.56 160.1 16.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.118 1.367 . . . . 0.80000000000000004 109.53 155.62 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -134.84 148.42 50.15 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.235 1.014 . . . . 2.25 109.91 174.944 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 t -142.32 128.46 10.77 Favored Pre-proline 0 CA--C 1.541 0.596 0 O-C-N 123.817 0.698 . . . . 1.1299999999999999 112.086 178.231 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.11 162.53 41.48 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.776 2.984 . . . . 1.4299999999999999 111.458 176.673 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.44 141.28 97.01 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.224 2.616 . . . . 1.3999999999999999 113.02 -178.177 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt 70.14 -2.32 2.13 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.469 2.308 . . . . 2.1200000000000001 114.265 -178.643 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.6 158.35 43.13 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.581 1.562 . . . . 1.1499999999999999 114.316 -179.232 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.95 143.63 51.01 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.133 1.773 . . . . 6.2000000000000002 109.592 167.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.7 t -143.61 131.87 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 106.313 -1.736 . . . . 3.3300000000000001 106.313 174.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.417 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . 7.2 mt-10 -120.22 128.44 53.36 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.61 1.095 . . . . 3.9399999999999999 110.77 -170.416 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 83' ' ' HIS . 4.6 mp -77.65 58.06 1.73 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.48 1.512 . . . . 2.2799999999999998 111.229 -178.513 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 76' ' ' GLU . 0.2 OUTLIER -63.54 150.18 90.69 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 114.795 1.406 . . . . 5.0 114.795 -178.553 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -58.06 151.11 60.5 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.456 2.104 . . . . 2.6299999999999999 109.888 169.634 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.29 -9.52 33.39 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.355 -1.247 . . . . 1.8600000000000001 114.206 -171.271 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -135.01 -129.62 2.9 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 119.443 1.622 . . . . 1.5800000000000001 114.444 175.029 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.48 ' CE1' ' HB3' ' A' ' 47' ' ' GLU . 80.8 m-85 -71.97 141.03 49.4 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.543 -0.975 . . . . 2.0099999999999998 110.703 -177.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 77' ' ' LEU . 46.5 p-80 -164.41 156.74 16.66 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.962 1.305 . . . . 0.76000000000000001 110.88 -176.771 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.479 ' CE2' HD21 ' A' ' 20' ' ' LEU . 98.3 m-85 -82.42 145.24 29.97 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.24 -0.652 . . . . 1.77 109.24 161.043 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 tpt -96.56 132.99 41.61 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.919 1.288 . . . . 0.81999999999999995 108.42 164.054 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 mp -109.37 140.01 43.61 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.758 1.223 . . . . 0.85999999999999999 109.363 176.169 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.3 mt -141.74 142.91 33.28 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.747 1.619 . . . . 1.9299999999999999 110.107 -176.657 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 68.47 36.71 84.44 Favored Glycine 0 CA--C 1.532 1.098 0 O-C-N 121.894 -0.504 . . . . 0.93999999999999995 112.993 177.794 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.11 145.57 13.08 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 123.609 1.671 . . . . 1.4199999999999999 115.231 -178.506 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -93.15 -7.67 44.73 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 113.762 -1.563 . . . . 1.8200000000000001 113.031 -174.161 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -142.67 145.06 32.53 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 127.469 2.307 . . . . 5.3700000000000001 107.495 169.292 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -66.25 151.2 84.03 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.152 1.901 . . . . 2.0899999999999999 108.822 158.524 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mp -117.46 112.41 20.6 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 125.977 1.711 . . . . 2.6200000000000001 107.596 -165.063 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -86.11 171.02 11.67 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.332 0.587 . . . . 4.0899999999999999 112.078 179.079 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.81 137.31 58.21 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.396 -0.964 . . . . 1.1799999999999999 108.396 153.559 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.81 23.05 75.98 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 116.44 1.336 . . . . 1.4099999999999999 116.44 173.341 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -93.42 -170.24 2.33 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.662 1.731 . . . . 2.3300000000000001 111.74 169.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 10.6 pt-20 -154.66 138.31 16.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 128.264 2.626 . . . . 3.1400000000000001 106.647 -173.722 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.6 t -149.09 136.1 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.804 1.641 . . . . 0.96999999999999997 110.027 -163.196 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -77.31 147.76 36.04 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.104 0.478 . . . . 2.8399999999999999 110.83 173.37 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.408 HD22 HD22 ' A' ' 20' ' ' LEU . 1.3 mp -127.3 149.93 49.81 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.878 1.271 . . . . 1.6100000000000001 108.747 159.405 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -107.39 150.55 26.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.661 0.784 . . . . 2.2400000000000002 108.935 158.01 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.3 mp -109.81 133.48 53.11 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.399 1.48 . . . . 1.0 109.267 172.096 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.4 mt -103.55 112.18 24.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.176 1.39 . . . . 0.65000000000000002 109.559 -179.064 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -106.14 111.53 24.18 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.924 1.69 . . . . 2.1400000000000001 111.572 -175.304 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 49.76 32.58 5.38 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.774 1.63 . . . . 3.3900000000000001 112.948 -178.366 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.43 -71.1 1.84 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.41 1.481 . . . . 5.1200000000000001 112.212 -171.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.44 9.46 21.21 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 117.146 1.618 . . . . 2.2400000000000002 117.146 -163.373 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -130.9 134.28 46.63 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.721 1.76 . . . . 4.3200000000000003 110.463 169.51 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.7 p -125.22 145.09 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.048 1.339 . . . . 2.2400000000000002 110.977 178.342 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.8 tp -139.92 126.47 20.36 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.254 1.422 . . . . 2.3100000000000001 109.588 178.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -84.27 141.38 31.0 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.061 0.393 . . . . 2.21 112.061 173.618 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.19 -179.91 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 127.203 2.201 . . . . 2.6000000000000001 110.361 167.084 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.5 t -138.31 155.43 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.515 1.526 . . . . 1.71 106.979 171.176 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.27 153.29 26.62 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.954 1.302 . . . . 1.97 111.231 171.314 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 43.0 Cg_endo -63.95 168.17 12.63 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.75 2.967 . . . . 1.03 112.842 171.66 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.6 t -112.36 128.73 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.039 1.336 . . . . 0.97999999999999998 108.712 169.525 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -154.41 178.53 9.95 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.257 1.823 . . . . 4.4000000000000004 112.946 177.048 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.55 162.26 29.71 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.849 1.426 . . . . 4.0499999999999998 114.849 -167.228 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 117.744 -1.122 . . . . 7.7800000000000002 109.886 171.069 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.5 0 CA-C-O 118.409 -1.217 . . . . 9.2400000000000002 111.243 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.3 m 147.5 -40.48 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.268 1 C-N-CA 133.247 4.619 . . . . 10.25 111.457 176.342 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -151.26 44.04 0.79 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.029 1.732 . . . . 11.68 112.286 -173.667 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.7 t -163.52 31.72 0.09 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.963 1.705 . . . . 5.6299999999999999 113.308 -170.884 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.49 178.24 10.45 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.601 1.96 . . . . 5.0700000000000003 112.294 -172.581 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -150.28 164.88 29.81 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.99 1.281 . . . . 1.27 114.122 171.906 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -157.2 151.47 25.01 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.615 2.366 . . . . 2.2799999999999998 110.638 176.285 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.9 t -97.62 145.55 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 120.957 -1.089 . . . . 1.02 109.868 -178.765 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.77 -15.64 63.73 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.024 1.49 . . . . 4.6799999999999997 115.024 -172.782 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 77.57 145.88 0.09 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.053 2.141 . . . . 3.5699999999999998 114.116 -171.539 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.4 t -178.66 133.78 0.3 Allowed Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 128.27 2.628 . . . . 2.7200000000000002 110.808 165.576 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -82.51 -11.42 10.56 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.224 2.616 . . . . 3.1899999999999999 112.202 172.5 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.34 169.37 31.72 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.958 1.266 . . . . 1.45 112.212 178.617 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.59 -15.9 52.39 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.597 3.531 . . . . 1.54 114.779 -170.751 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -100.99 140.55 35.13 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.248 1.419 . . . . 2.6699999999999999 112.428 173.642 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.44 -177.42 5.94 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.285 1.834 . . . . 0.55000000000000004 111.926 172.312 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.26 147.18 25.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.598 1.959 . . . . 0.79000000000000004 110.02 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.99 149.82 47.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.745 1.017 . . . . 0.81000000000000005 113.745 -172.744 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -117.19 142.73 46.67 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.161 1.784 . . . . 3.0099999999999998 109.862 174.515 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.84 160.12 14.25 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.399 1.08 . . . . 2.8599999999999999 113.208 178.171 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.408 HG23 ' HB3' ' A' ' 76' ' ' GLU . 22.9 m -136.95 147.04 46.11 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 125.129 1.371 . . . . 1.95 110.167 -171.447 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.51 134.11 10.87 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.987 1.315 . . . . 5.5199999999999996 109.498 -178.046 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.29 154.16 18.78 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.211 0.914 . . . . 5.2999999999999998 112.376 177.104 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -105.28 83.34 0.88 Allowed Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.71 1.204 . . . . 1.5900000000000001 110.132 171.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -71.65 -4.68 15.52 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.476 2.117 . . . . 1.8400000000000001 113.437 176.359 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.79 169.73 49.06 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-O 123.284 1.491 . . . . 1.24 112.811 177.641 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -101.25 -2.24 31.69 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 127.54 2.336 . . . . 2.8500000000000001 112.518 -171.219 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -116.71 159.59 39.89 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.931 2.092 . . . . 3.9700000000000002 109.459 169.755 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.97 170.77 14.91 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.844 2.363 . . . . 1.6399999999999999 112.206 -166.536 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.4 mt -117.07 147.88 42.0 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 123.243 1.497 . . . . 1.96 110.945 165.843 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -138.54 109.65 6.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 111.449 -2.614 . . . . 3.1400000000000001 108.97 166.819 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 tp -84.95 110.21 18.72 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.033 1.733 . . . . 1.6000000000000001 108.826 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.81 -14.77 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.155 0.982 . . . . 0.57999999999999996 112.059 -176.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.34 -179.03 31.95 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-O 122.324 0.958 . . . . 0.47999999999999998 114.276 -178.54 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -144.64 -179.15 6.39 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.98 1.712 . . . . 0.46999999999999997 109.588 162.668 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -153.27 -178.97 7.31 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.917 1.287 . . . . 4.96 108.568 156.164 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 t -171.53 153.0 3.37 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 125.986 1.714 . . . . 0.57999999999999996 108.056 -172.604 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.11 -3.16 13.2 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.151 1.901 . . . . 0.66000000000000003 113.847 174.175 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.5 m -119.15 39.26 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.796 1.239 . . . . 0.73999999999999999 114.267 -176.013 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.36 167.26 29.29 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.134 1.374 . . . . 1.1100000000000001 110.721 169.674 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -98.47 -50.97 4.1 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.72 1.608 . . . . 2.6499999999999999 110.023 171.415 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -114.99 139.33 49.93 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 127.215 2.206 . . . . 4.6299999999999999 107.293 171.054 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.1 149.55 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.521 -0.763 . . . . 1.0900000000000001 109.003 154.923 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -127.94 151.79 48.68 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.675 1.99 . . . . 2.9700000000000002 107.54 166.781 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -100.73 138.34 37.91 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.082 1.31 . . . . 1.76 112.102 160.465 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -123.79 160.21 27.84 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.066 2.146 . . . . 0.70999999999999996 112.235 -178.921 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -104.36 178.58 4.52 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 112.491 -2.141 . . . . 3.46 111.397 166.101 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.8 m -148.34 139.15 23.0 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.285 -1.376 . . . . 0.73999999999999999 107.285 163.859 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -148.37 178.54 8.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.983 1.313 . . . . 2.1200000000000001 112.4 -168.864 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -110.04 145.49 36.96 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.332 1.453 . . . . 4.4800000000000004 113.117 179.331 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.8 mtp85 -127.43 152.81 47.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.445 1.498 . . . . 4.6900000000000004 110.711 166.299 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.411 ' OE1' ' HE2' ' A' ' 57' ' ' LYS . 3.1 tp10 -91.75 143.31 26.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.536 -0.912 . . . . 2.52 108.536 147.913 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 50.6 t -140.27 127.7 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 106.937 -1.505 . . . . 2.0499999999999998 106.937 158.714 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 65.03 25.64 12.63 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.24 1.016 . . . . 4.3799999999999999 113.715 173.404 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.11 9.1 85.64 Favored Glycine 0 CA--C 1.538 1.471 0 O-C-N 120.536 -1.352 . . . . 1.6200000000000001 113.94 -173.52 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -122.21 119.25 30.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.17 2.188 . . . . 2.9399999999999999 108.746 -170.759 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.476 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -89.04 116.52 27.38 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.655 1.982 . . . . 4.2300000000000004 111.401 -173.033 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.1 t -149.13 139.69 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.962 2.105 . . . . 2.98 109.328 -166.112 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -84.08 170.86 13.44 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.586 1.328 . . . . 2.5099999999999998 114.586 -172.059 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.55 165.63 29.13 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 126.807 2.146 . . . . 0.5 112.694 177.427 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 ttm -148.11 141.38 25.15 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.979 1.712 . . . . 0.82999999999999996 109.705 177.785 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -148.18 159.6 39.24 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.695 1.998 . . . . 5.0099999999999998 109.749 -176.71 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.81 153.02 53.29 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.276 1.984 . . . . 0.93999999999999995 111.358 168.274 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.89 159.45 56.14 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 123.734 0.814 . . . . 1.0600000000000001 109.898 174.51 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.63 -25.88 3.45 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.856 2.371 . . . . 0.68999999999999995 112.951 -172.063 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -179.64 167.17 1.4 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.092 2.157 . . . . 2.2000000000000002 110.73 -178.206 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.2 mt -112.1 152.18 28.56 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.24 1.016 . . . . 0.55000000000000004 110.179 162.122 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -120.48 139.32 53.05 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.216 1.406 . . . . 2.1899999999999999 110.042 -176.943 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.4 t -146.05 135.65 11.59 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 113.147 0.795 . . . . 1.5900000000000001 113.147 176.419 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.26 168.87 23.77 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.479 2.786 . . . . 1.53 112.189 176.79 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -59.76 140.9 95.59 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.71 2.273 . . . . 1.6899999999999999 110.959 165.074 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt 66.33 1.86 2.19 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.773 1.629 . . . . 2.0299999999999998 113.577 -176.412 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.85 -175.65 51.07 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.644 2.069 . . . . 1.8899999999999999 111.533 166.44 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -147.43 150.46 34.68 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 114.253 1.205 . . . . 5.6600000000000001 114.253 175.694 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.1 t -98.23 106.13 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 128.243 2.617 . . . . 5.4900000000000002 107.405 -174.659 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.408 ' HB3' HG23 ' A' ' 21' ' ' THR . 0.0 OUTLIER -126.14 110.38 13.42 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 122.199 0.999 . . . . 3.9399999999999999 111.204 -179.416 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mp -83.49 78.7 9.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.006 -1.479 . . . . 2.29 107.006 167.945 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -73.0 140.67 80.8 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 113.777 -1.556 . . . . 3.6099999999999999 112.992 -175.113 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -61.12 142.54 97.23 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.712 2.275 . . . . 3.48 110.81 -179.558 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.84 -12.93 58.34 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.222 -1.321 . . . . 2.0899999999999999 114.786 -177.053 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.68 -109.53 1.45 Allowed Glycine 0 N--CA 1.474 1.173 0 CA-C-N 119.154 1.477 . . . . 1.8700000000000001 111.62 172.878 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 47' ' ' GLU . 97.3 m-85 -75.54 137.07 40.6 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.832 -0.805 . . . . 2.1000000000000001 111.957 -172.405 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -161.37 152.37 18.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.548 -0.751 . . . . 0.64000000000000001 111.267 -171.091 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 52.8 m-85 -83.94 140.36 31.98 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.392 -0.818 . . . . 2.2599999999999998 109.879 166.927 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.3 tpt -100.51 131.28 46.5 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.255 1.822 . . . . 0.63 108.183 167.67 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 mp -109.48 126.6 53.68 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.801 1.24 . . . . 0.83999999999999997 108.184 -179.061 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.83 128.03 49.86 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.953 1.301 . . . . 2.98 109.281 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.93 51.91 5.2 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.578 1.085 . . . . 0.81000000000000005 113.24 176.797 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.6 mt -47.33 155.98 0.29 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.846 1.424 . . . . 2.8300000000000001 114.846 176.285 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -108.61 4.38 23.91 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.853 -1.067 . . . . 1.78 113.691 -177.875 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -161.31 163.1 20.77 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 129.43 3.092 . . . . 5.2300000000000004 108.12 176.731 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.09 118.33 5.57 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.708 1.605 . . . . 1.75 108.617 165.913 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mp -80.15 57.14 2.62 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.14 1.376 . . . . 2.98 109.917 175.577 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -59.47 167.17 2.04 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 120.519 -1.363 . . . . 4.3499999999999996 111.964 174.31 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.34 128.98 33.81 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.393 1.092 . . . . 1.8300000000000001 110.025 161.806 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.13 34.59 36.91 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.017 1.294 . . . . 2.46 114.092 177.898 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -90.79 -176.85 4.81 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.65 1.225 . . . . 2.2000000000000002 109.92 153.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -144.66 153.93 42.26 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 127.712 2.405 . . . . 3.7599999999999998 106.904 171.344 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.4 t -149.03 157.66 6.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 128.509 2.724 . . . . 1.4199999999999999 108.791 -163.328 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -120.61 152.85 37.61 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.096 0.474 . . . . 2.29 112.079 158.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mp -126.24 137.54 53.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.784 2.033 . . . . 1.6799999999999999 109.869 171.955 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -90.1 148.3 23.09 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.092 1.357 . . . . 1.8799999999999999 110.135 161.184 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -112.47 115.81 29.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.331 1.852 . . . . 0.85999999999999999 109.59 172.883 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.1 mt -93.94 111.36 23.05 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.728 1.211 . . . . 0.68000000000000005 110.221 -176.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -110.19 124.5 51.69 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.571 0.748 . . . . 1.8600000000000001 111.362 -177.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.95 -17.69 63.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.624 0.972 . . . . 1.9299999999999999 113.624 176.382 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.07 38.08 1.33 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.248 1.404 . . . . 5.4699999999999998 113.653 175.184 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.97 28.08 72.25 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 125.754 1.645 . . . . 3.5600000000000001 114.851 174.759 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -140.14 152.71 46.31 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.027 1.414 . . . . 3.8700000000000001 113.359 -168.971 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.3 t -141.72 144.31 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.861 1.264 . . . . 2.1099999999999999 107.697 163.093 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 22.6 mt -139.93 168.04 20.74 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.45 1.9 . . . . 3.0499999999999998 108.274 170.767 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.5 pttp -147.42 151.87 37.18 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.199 1.185 . . . . 1.8500000000000001 114.199 177.806 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.91 141.14 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 127.083 2.153 . . . . 2.2200000000000002 110.923 -171.497 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.5 p -91.8 145.92 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.823 1.249 . . . . 2.46 109.408 166.267 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -157.34 142.76 12.46 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.049 1.34 . . . . 2.7200000000000002 112.105 -174.1 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.6 166.01 27.96 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 124.083 3.189 . . . . 1.21 111.444 172.371 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.7 t -107.68 115.67 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.302 1.041 . . . . 1.0600000000000001 109.17 169.698 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -127.1 153.63 45.75 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.905 1.282 . . . . 4.75 111.812 -170.434 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.6 58.8 4.47 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.794 1.035 . . . . 2.3900000000000001 113.794 -159.035 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.26 -0.876 . . . . 7.9199999999999999 112.285 174.202 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.79 0 N-CA-C 108.619 -1.792 . . . . 12.42 108.619 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.6 p -150.11 59.11 0.97 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.455 1.102 . . . . 12.140000000000001 110.098 170.579 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -60.39 -15.8 29.52 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 117.833 2.531 . . . . 10.970000000000001 117.833 -159.646 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.8 m 69.46 19.89 7.4 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 120.42 1.464 . . . . 7.21 113.508 163.051 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -76.38 57.16 1.15 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.827 1.651 . . . . 6.8200000000000003 111.787 -177.818 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.7 169.09 26.16 Favored Glycine 0 C--N 1.337 0.609 0 O-C-N 119.714 -1.866 . . . . 1.1299999999999999 113.287 -174.428 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -155.85 174.92 14.62 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.051 1.13 . . . . 1.79 114.051 -176.737 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.6 t -119.1 139.46 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 127.332 2.253 . . . . 1.1499999999999999 109.779 177.688 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -97.36 109.66 22.37 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.009 1.324 . . . . 4.3799999999999999 110.684 171.564 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -52.58 150.05 5.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.461 1.104 . . . . 3.1600000000000001 110.935 168.189 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 m -162.06 147.65 10.37 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 125.097 1.359 . . . . 3.02 109.865 166.323 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -81.4 44.39 1.73 Allowed 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 124.671 3.581 . . . . 3.2799999999999998 112.011 179.73 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -122.52 160.96 16.9 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.677 1.608 . . . . 2.1600000000000001 112.93 -176.862 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.81 -17.49 56.22 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.584 2.856 . . . . 2.02 112.791 172.131 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -110.53 146.44 36.03 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.103 1.761 . . . . 3.2999999999999998 113.565 164.426 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.08 -178.81 3.65 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.188 1.795 . . . . 0.63 110.275 163.631 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.94 145.36 34.43 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.57 1.077 . . . . 0.93999999999999995 111.135 177.95 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.5 148.87 44.79 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.964 1.098 . . . . 0.97999999999999998 113.964 -175.644 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -127.89 77.39 1.75 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.732 2.413 . . . . 2.3900000000000001 110.414 -173.634 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -74.16 158.65 33.79 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.817 -1.177 . . . . 1.99 112.077 178.95 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.6 m -118.24 146.93 43.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.252 -1.018 . . . . 2.0099999999999998 108.252 157.345 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.429 ' CD1' ' H ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -154.35 -174.76 5.1 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.264 1.826 . . . . 5.8300000000000001 108.427 171.433 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.429 ' H ' ' CD1' ' A' ' 22' ' ' LEU . 37.3 mt-10 -138.69 146.4 41.53 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 120.69 -1.256 . . . . 3.6200000000000001 110.416 -174.304 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -95.31 102.26 9.3 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.666 0.786 . . . . 1.46 109.067 156.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.84 -12.92 14.63 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.725 2.283 . . . . 2.0 113.35 176.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.04 -175.72 50.93 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-O 122.424 1.013 . . . . 1.9099999999999999 113.339 -172.819 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -111.09 -1.16 16.34 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.165 2.186 . . . . 4.0999999999999996 112.038 -172.367 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -111.82 158.9 35.34 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 127.771 2.428 . . . . 2.0600000000000001 110.198 171.129 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.11 146.65 18.13 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.518 2.145 . . . . 1.1599999999999999 111.581 -174.26 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.426 HD12 ' CD1' ' A' ' 105' ' ' PHE . 2.4 mm? -113.75 161.94 16.9 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.868 1.667 . . . . 2.4399999999999999 110.931 176.002 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -154.81 119.54 4.85 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.517 -1.22 . . . . 1.8300000000000001 111.012 -167.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.0 tp -101.21 108.95 20.74 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.273 1.829 . . . . 2.1400000000000001 110.404 -173.352 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.1 m -109.38 -20.56 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.351 1.06 . . . . 0.81999999999999995 112.12 -167.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.09 -174.36 29.78 Favored Glycine 0 C--N 1.343 0.963 0 C-N-CA 125.059 1.314 . . . . 0.72999999999999998 113.367 -174.924 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.0 -179.67 7.19 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.066 0.946 . . . . 0.82999999999999996 112.025 169.08 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -153.14 145.25 23.8 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.201 1.8 . . . . 5.4000000000000004 107.634 178.529 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -164.11 151.19 10.2 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 119.416 1.007 . . . . 0.81000000000000005 109.477 -172.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.0 -4.2 13.74 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.137 2.558 . . . . 0.88 114.428 175.816 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.23 30.3 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 115.212 1.56 . . . . 0.87 115.212 -175.189 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -174.88 167.95 3.59 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 128.357 2.663 . . . . 1.1899999999999999 108.313 174.277 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -119.94 -45.9 2.46 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.2 0.909 . . . . 6.1699999999999999 111.248 169.619 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.7 mtt-85 -78.6 141.46 38.03 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.585 -1.265 . . . . 4.6900000000000004 107.585 164.387 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -158.52 74.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 127.806 2.442 . . . . 2.4700000000000002 110.027 -174.469 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -99.97 131.64 45.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 111.766 -2.47 . . . . 4.9199999999999999 110.72 -169.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.5 pt? -90.1 136.51 33.0 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 123.753 1.739 . . . . 2.1200000000000001 114.026 -176.806 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -115.1 160.85 19.16 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 127.143 2.177 . . . . 0.80000000000000004 110.856 174.901 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.12 -177.86 4.28 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.236 -1.802 . . . . 3.3900000000000001 111.202 156.776 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.8 m -152.82 141.18 20.62 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.174 1.389 . . . . 0.60999999999999999 107.829 170.306 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -151.04 170.41 19.44 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.929 1.455 . . . . 2.2400000000000002 114.929 -168.667 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.0 ttp -109.75 142.47 40.94 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.369 1.868 . . . . 3.2999999999999998 109.479 169.477 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -151.92 159.23 43.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.682 1.993 . . . . 8.4600000000000009 111.391 -175.608 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -91.28 147.47 23.02 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.193 1.397 . . . . 2.5 111.897 170.198 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.6 t -140.54 120.33 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.389 1.475 . . . . 1.8899999999999999 107.956 166.923 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 64.44 8.64 4.41 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 127.371 2.268 . . . . 2.8999999999999999 114.763 -178.019 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.92 23.23 33.37 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 123.958 0.79 . . . . 1.79 113.89 -168.049 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.1 132.62 53.11 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.772 1.229 . . . . 2.54 109.634 166.549 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 138.89 44.87 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.079 1.352 . . . . 6.4000000000000004 110.636 -178.86 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.576 HG22 ' H ' ' A' ' 59' ' ' MET . 9.8 p -154.26 -179.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 C-N-CA 126.882 2.073 . . . . 2.2599999999999998 109.328 -177.479 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.576 ' H ' HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -116.75 166.4 12.18 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 121.299 -0.875 . . . . 3.23 112.28 -176.686 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.66 171.22 29.77 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.972 1.749 . . . . 0.53000000000000003 111.994 -179.291 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 ttm -155.4 138.44 15.49 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 126.646 1.979 . . . . 0.63 109.227 173.829 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -144.65 149.94 45.29 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 127.645 2.378 . . . . 8.5600000000000005 109.424 -172.025 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.1 154.87 52.52 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.574 2.183 . . . . 0.59999999999999998 110.019 176.377 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.14 151.6 75.5 Favored Pre-proline 0 N--CA 1.483 1.213 0 CA-C-O 117.974 -1.012 . . . . 0.65000000000000002 110.71 175.053 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.38 -23.77 9.8 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.192 2.595 . . . . 0.77000000000000002 112.873 -169.575 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -179.55 165.58 1.36 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.472 2.309 . . . . 2.21 109.85 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.0 mt -109.15 150.52 27.75 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.004 0.922 . . . . 0.69999999999999996 110.044 165.137 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -109.71 143.82 38.95 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.297 1.039 . . . . 2.0800000000000001 109.149 178.059 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.6 t -140.3 125.25 11.16 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 122.971 0.509 . . . . 0.98999999999999999 112.093 173.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.81 168.35 20.5 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.95 2.433 . . . . 1.28 111.697 179.079 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -55.25 140.12 81.32 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.027 2.485 . . . . 1.6899999999999999 111.43 168.84 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt 67.68 0.91 2.41 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.721 1.609 . . . . 2.4199999999999999 113.616 -177.183 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.62 156.96 45.22 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.902 1.715 . . . . 1.8 112.45 -179.048 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.9 mtm105 -104.99 132.51 51.14 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.025 1.33 . . . . 6.9400000000000004 109.581 -178.48 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.9 t -93.42 55.33 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 127.589 2.356 . . . . 5.3300000000000001 108.248 -173.611 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.71 93.02 8.69 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.641 1.976 . . . . 3.9199999999999999 109.742 -175.223 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' A' ' 83' ' ' HIS . 1.5 tp -52.21 -56.23 16.02 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.326 1.45 . . . . 3.3900000000000001 111.608 -164.66 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? 112.09 128.37 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 128.977 2.911 . . . . 3.02 114.429 161.516 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.62 -45.91 12.88 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.891 2.394 . . . . 1.97 110.847 174.065 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.72 40.69 3.07 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.938 -0.924 . . . . 1.8100000000000001 112.37 172.315 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.4 -117.5 0.56 Allowed Glycine 0 C--N 1.337 0.638 0 CA-C-N 118.139 0.97 . . . . 1.77 113.783 175.029 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -76.5 137.1 39.41 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 123.399 1.571 . . . . 1.8300000000000001 113.646 -163.77 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.598 ' HA ' HD23 ' A' ' 77' ' ' LEU . 53.0 p-80 -158.17 138.54 12.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.301 -1.318 . . . . 0.82999999999999996 113.424 -173.66 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -77.03 135.24 38.64 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.018 -1.104 . . . . 2.54 108.018 167.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.8 mtp -99.64 117.69 34.54 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.651 0.739 . . . . 1.71 110.619 160.103 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -86.71 107.74 18.36 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.608 1.963 . . . . 1.23 107.426 -176.716 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.0 mp -111.35 141.5 44.81 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.09 1.756 . . . . 1.8100000000000001 111.005 -173.899 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.44 42.44 41.32 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 111.459 -0.656 . . . . 0.94999999999999996 111.459 178.509 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . 0.258 0.5 OUTLIER -44.01 138.84 2.68 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 123.479 1.609 . . . . 1.8700000000000001 115.324 176.828 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -101.12 -12.71 18.58 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.051 -1.886 . . . . 4.5899999999999999 112.893 -173.137 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -143.8 150.59 50.59 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 128.305 2.642 . . . . 5.71 108.2 172.681 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -72.37 150.58 52.66 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.597 2.198 . . . . 1.8 110.082 167.911 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.9 mp -108.8 143.79 37.5 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.087 2.155 . . . . 2.6200000000000001 106.395 176.173 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.52 162.5 15.05 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.466 2.306 . . . . 4.0300000000000002 110.424 170.796 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.54 125.8 26.87 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.43 -0.794 . . . . 1.9399999999999999 109.171 157.399 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.86 32.0 6.72 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.866 1.222 . . . . 1.71 115.025 173.241 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -112.16 -167.49 1.19 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.488 1.115 . . . . 2.1200000000000001 112.801 175.909 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 8.7 pt-20 -147.11 147.94 31.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 128.116 2.567 . . . . 3.1299999999999999 107.233 172.685 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.9 t -146.31 126.69 6.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 127.823 2.449 . . . . 1.1599999999999999 108.667 -165.354 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.45 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -90.11 154.45 19.78 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 122.732 1.253 . . . . 2.48 113.75 176.224 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.7 tt -156.82 144.87 19.42 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.125 1.77 . . . . 2.3900000000000001 109.945 176.042 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.08 140.86 39.24 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.696 1.598 . . . . 3.3500000000000001 110.55 170.802 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.1 mp -84.91 127.7 34.29 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.388 1.475 . . . . 1.1799999999999999 109.64 174.98 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.6 mt -90.75 104.86 17.39 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.696 -0.853 . . . . 0.83999999999999997 108.696 168.691 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.426 ' CD1' HD12 ' A' ' 30' ' ' LEU . 96.2 m-85 -97.69 149.27 22.46 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.187 0.995 . . . . 2.3500000000000001 111.101 172.59 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.57 129.05 34.9 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.518 0.933 . . . . 2.1699999999999999 113.518 -174.627 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.32 62.03 2.84 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.663 1.125 . . . . 3.1499999999999999 113.542 174.335 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.19 13.18 81.44 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 115.709 1.044 . . . . 2.4199999999999999 115.709 167.751 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -97.07 122.19 39.79 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.794 1.297 . . . . 3.0800000000000001 110.56 -179.267 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.8 t -137.0 128.83 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.152 0.981 . . . . 2.1400000000000001 109.977 -176.249 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -140.43 127.62 21.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.564 1.146 . . . . 2.98 111.811 -176.138 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.45 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 24.4 ttmm -83.25 140.59 32.42 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.179 1.392 . . . . 2.7400000000000002 113.766 -178.867 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.36 153.9 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.446 1.898 . . . . 2.4199999999999999 109.971 163.307 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.31 127.57 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 107.337 -1.357 . . . . 1.8700000000000001 107.337 163.014 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.4 mt -125.44 129.46 24.42 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.256 1.422 . . . . 1.8999999999999999 108.668 -170.795 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 60.6 Cg_endo -70.65 153.06 65.07 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.159 2.573 . . . . 1.04 112.147 172.675 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.4 t -103.91 112.3 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.445 1.498 . . . . 1.05 109.904 173.743 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -100.38 178.66 4.68 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.802 1.241 . . . . 4.9100000000000001 109.896 160.43 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.33 158.66 43.91 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.935 0.894 . . . . 2.8500000000000001 112.158 -171.247 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.352 0 C-N-CA 126.817 2.047 . . . . 9.1999999999999993 110.639 176.153 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.316 0 N-CA-C 108.355 -1.898 . . . . 11.140000000000001 108.355 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.1 t -59.56 142.92 51.65 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 117.049 -1.86 . . . . 9.5700000000000003 107.352 129.365 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -159.48 -16.1 0.06 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 117.102 2.26 . . . . 14.19 117.102 -153.315 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.05 4.81 44.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.957 1.303 . . . . 8.9000000000000004 112.071 -166.391 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.24 116.43 10.59 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.789 0.804 . . . . 5.0599999999999996 111.362 -148.639 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.18 -175.25 32.0 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 128.456 2.932 . . . . 0.92000000000000004 110.98 174.319 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -116.43 157.03 25.78 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.665 0.987 . . . . 2.2400000000000002 113.665 175.88 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.2 t -89.46 141.97 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 O-C-N 120.877 -1.139 . . . . 1.23 108.163 157.888 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.0 ttt85 -77.15 131.43 38.29 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.988 -0.445 . . . . 4.5099999999999998 111.894 -173.817 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -45.02 135.06 5.57 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.412 1.485 . . . . 2.0299999999999998 112.067 166.186 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.0 t -176.68 129.68 0.35 Allowed Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.188 1.395 . . . . 2.5899999999999999 112.448 172.951 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -91.19 0.76 4.77 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.133 3.222 . . . . 2.3399999999999999 112.413 165.324 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.19 -175.33 46.44 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.644 1.116 . . . . 1.1299999999999999 113.374 -173.535 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -69.02 -22.13 35.9 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.161 2.574 . . . . 1.5900000000000001 113.057 -178.911 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.6 p30 -128.38 166.06 19.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.302 1.841 . . . . 2.3900000000000001 114.076 -178.657 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.44 -177.2 6.3 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 128.258 2.623 . . . . 0.56999999999999995 111.045 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.75 171.09 10.38 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.294 1.837 . . . . 1.1399999999999999 108.925 169.624 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.5 160.7 43.59 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.759 1.223 . . . . 0.69999999999999996 111.557 174.472 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -155.34 144.95 21.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.841 -1.072 . . . . 8.4299999999999997 111.558 -161.019 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -161.89 156.51 22.62 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.393 1.477 . . . . 2.23 111.375 -172.083 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.1 m -83.95 146.07 28.22 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.081 0.953 . . . . 1.98 108.857 162.254 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.49 114.27 23.22 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.639 0.775 . . . . 3.25 109.449 170.064 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -104.88 145.62 30.14 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.988 1.315 . . . . 3.6800000000000002 109.093 168.655 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.21 73.49 1.33 Allowed Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.088 0.955 . . . . 3.0600000000000001 110.986 177.735 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.3 -19.3 62.02 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.902 2.401 . . . . 1.4199999999999999 114.659 -174.23 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.42 -179.95 51.43 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-O 122.885 1.269 . . . . 1.23 113.066 174.642 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -103.27 -2.48 27.1 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.87 2.068 . . . . 2.8900000000000001 112.151 -169.005 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -122.48 155.79 61.93 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 128.099 2.56 . . . . 1.98 109.782 175.547 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.63 140.65 21.34 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.777 2.318 . . . . 1.22 111.086 -172.186 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.8 mt -93.31 150.01 20.8 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 123.21 1.481 . . . . 2.0800000000000001 112.029 172.275 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -134.89 113.87 11.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 112.303 -2.226 . . . . 1.98 110.165 177.387 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.8 tp -95.86 111.57 23.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.669 1.588 . . . . 2.1600000000000001 108.93 -177.13 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.2 m -107.22 -19.81 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.548 1.139 . . . . 0.91000000000000003 112.273 -169.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.42 -174.61 28.36 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.384 1.468 . . . . 0.84999999999999998 113.22 177.487 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.57 -176.73 4.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.764 1.626 . . . . 0.87 109.348 167.456 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.12 175.23 13.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.767 1.627 . . . . 5.0199999999999996 108.42 161.811 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.9 t -171.57 156.14 4.2 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 125.657 1.583 . . . . 0.76000000000000001 108.417 -173.904 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.91 -10.55 14.06 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.805 1.67 . . . . 0.91000000000000003 112.895 171.925 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.6 46.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.232 1.013 . . . . 0.91000000000000003 113.461 -176.384 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.58 153.28 14.96 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.216 1.406 . . . . 1.0 110.68 164.704 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -88.39 -47.22 8.53 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.649 1.18 . . . . 2.8599999999999999 110.229 172.511 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -104.89 133.7 49.25 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 126.33 1.852 . . . . 6.6600000000000001 107.53 166.755 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.11 148.0 22.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.812 -1.181 . . . . 1.28 107.812 150.357 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -156.81 149.3 23.37 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 126.26 1.824 . . . . 3.04 107.73 -172.189 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.7 pt? -100.48 139.92 35.48 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 122.894 1.33 . . . . 1.75 112.614 173.097 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -119.93 149.75 41.61 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.724 2.009 . . . . 0.88 111.5 178.619 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -86.62 162.38 18.0 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.335 1.454 . . . . 2.6699999999999999 110.925 162.849 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.9 m -129.26 130.45 46.24 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 106.409 -1.701 . . . . 1.0 106.409 167.972 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -135.44 168.46 19.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.698 1.135 . . . . 2.1299999999999999 113.949 -174.347 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.7 ttm -100.25 146.13 27.26 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.601 1.56 . . . . 3.8399999999999999 109.972 165.218 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.75 153.66 32.61 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.627 1.171 . . . . 4.8700000000000001 110.475 -171.777 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -95.26 137.81 33.81 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.124 0.97 . . . . 3.6099999999999999 109.871 169.431 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.0 t -130.8 119.32 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 106.703 -1.591 . . . . 2.6200000000000001 106.703 164.548 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 60.88 18.0 8.33 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 116.154 1.909 . . . . 5.46 116.154 178.004 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.38 2.69 67.78 Favored Glycine 0 N--CA 1.479 1.552 0 O-C-N 120.826 -1.171 . . . . 2.21 114.354 -171.474 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.23 125.56 52.38 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.464 1.906 . . . . 3.75 109.852 176.529 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -74.95 119.17 18.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.667 -1.606 . . . . 5.3799999999999999 109.45 -179.651 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.0 m -122.53 177.72 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 127.594 2.358 . . . . 2.1899999999999999 109.674 177.68 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 56.5 mtt -118.0 158.45 24.92 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.232 1.013 . . . . 2.77 111.243 167.816 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.82 -177.38 25.5 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 126.16 1.838 . . . . 0.68999999999999995 112.243 -176.447 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.9 ttm -157.57 142.94 17.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.856 1.662 . . . . 0.84999999999999998 109.426 -171.656 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.15 159.18 43.25 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 127.327 2.251 . . . . 8.1999999999999993 109.545 -174.361 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -84.65 144.9 10.2 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.129 2.553 . . . . 0.84999999999999998 111.343 173.285 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.7 m -133.51 162.38 58.02 Favored Pre-proline 0 N--CA 1.486 1.368 0 CA-C-O 118.317 -0.849 . . . . 0.94999999999999996 111.749 -175.892 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -89.89 -25.06 0.53 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.282 1.988 . . . . 0.90000000000000002 114.215 -163.087 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -178.76 166.34 1.68 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.865 1.266 . . . . 2.1299999999999999 112.96 -177.677 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.9 mt -114.81 153.14 30.95 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.892 1.677 . . . . 0.87 110.837 165.567 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -120.2 142.96 48.52 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.489 1.516 . . . . 1.8899999999999999 109.448 177.828 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.7 t -138.57 139.22 23.9 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.469 0.708 . . . . 1.05 112.139 172.022 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -84.86 156.15 11.64 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 124.392 3.395 . . . . 1.4399999999999999 112.869 177.643 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.58 143.77 82.49 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.979 3.12 . . . . 1.27 113.94 -173.234 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt 68.7 -11.28 0.43 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.234 2.614 . . . . 1.75 114.763 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.98 168.49 50.94 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.787 1.184 . . . . 1.8300000000000001 112.752 172.554 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.87 151.24 49.31 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.969 0.908 . . . . 5.04 110.646 162.488 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.2 t -136.19 174.6 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 129.338 3.055 . . . . 3.7999999999999998 106.038 175.312 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -154.14 161.12 42.09 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 119.738 -1.851 . . . . 4.0099999999999998 108.593 171.247 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 83' ' ' HIS . 2.3 mp -56.0 -43.75 77.99 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.091 1.145 . . . . 3.71 114.091 -164.798 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt 71.43 110.88 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 128.632 2.773 . . . . 5.3499999999999996 111.236 -178.707 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -62.87 -34.79 70.76 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.886 1.724 . . . . 2.7999999999999998 111.683 -176.504 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.48 43.07 2.85 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.235 1.397 . . . . 2.1800000000000002 113.253 164.602 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.66 -36.04 0.06 OUTLIER Glycine 0 C--O 1.219 -0.799 0 N-CA-C 120.698 3.039 . . . . 2.5699999999999998 120.698 162.352 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -144.64 146.22 32.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 119.549 1.674 . . . . 2.1299999999999999 113.236 168.647 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.649 ' HA ' HD23 ' A' ' 77' ' ' LEU . 56.6 p-80 -161.76 153.2 18.61 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.413 -0.804 . . . . 0.75 111.096 175.278 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -78.72 141.44 37.87 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.693 -0.484 . . . . 1.8999999999999999 109.693 167.856 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -105.73 134.75 48.35 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.027 1.731 . . . . 0.81000000000000005 109.242 165.465 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -111.1 122.91 49.09 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.518 1.527 . . . . 0.76000000000000001 108.468 176.932 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.0 mp -120.98 138.3 54.21 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.612 0.765 . . . . 1.79 109.335 176.84 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.12 45.42 11.62 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.319 -0.712 . . . . 0.94999999999999996 112.543 178.422 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 pp -53.67 154.75 3.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 123.271 1.51 . . . . 1.3500000000000001 114.82 176.513 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -109.69 -10.47 14.81 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 113.224 -1.807 . . . . 2.1899999999999999 113.541 -175.13 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 mtp-105 -145.16 143.64 21.06 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 126.775 2.03 . . . . 4.7999999999999998 108.19 169.545 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -68.69 151.3 74.81 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.405 2.07 . . . . 1.8300000000000001 109.698 171.02 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 64.8 mt -116.73 92.35 3.84 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.019 0.928 . . . . 2.2000000000000002 110.131 -166.588 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.6 pttm -83.63 164.03 19.96 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.54 -0.725 . . . . 5.3200000000000003 112.126 170.675 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.27 126.21 26.76 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.314 -0.866 . . . . 1.3600000000000001 108.676 168.775 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.23 33.12 50.14 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.428 1.013 . . . . 1.4199999999999999 113.81 179.187 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -81.74 179.86 7.66 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.482 1.141 . . . . 2.71 108.483 143.893 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -134.54 150.61 50.77 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.085 -1.82 . . . . 3.8799999999999999 106.085 164.23 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 49.8 t -138.25 133.51 43.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 126.443 1.897 . . . . 0.95999999999999996 110.239 -173.599 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -78.84 137.05 37.51 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.177 -0.465 . . . . 2.73 110.815 172.738 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.75 133.9 54.93 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.92 1.288 . . . . 1.6699999999999999 110.684 168.251 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -84.87 141.67 30.27 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 125.483 1.513 . . . . 2.7200000000000002 108.799 158.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -110.28 126.33 54.07 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.454 1.502 . . . . 1.1200000000000001 109.026 168.8 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.2 mt -104.36 117.86 35.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.897 1.279 . . . . 0.88 110.061 -178.68 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -116.73 149.11 40.41 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.781 1.232 . . . . 2.0099999999999998 111.839 -174.468 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.7 139.35 58.32 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.249 1.203 . . . . 2.04 114.249 -172.294 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.39 45.5 29.8 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.195 -0.781 . . . . 3.2000000000000002 113.255 175.876 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.46 35.74 11.59 Favored Glycine 0 N--CA 1.47 0.917 0 N-CA-C 116.074 1.19 . . . . 1.72 116.074 163.587 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -122.81 145.98 47.94 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.832 1.816 . . . . 3.2999999999999998 112.579 172.32 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.7 t -143.6 142.47 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.009 1.323 . . . . 2.04 108.955 177.281 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 42.1 tp -143.43 119.74 10.89 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.795 0.838 . . . . 2.8799999999999999 110.874 -178.905 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 125.76 38.27 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.767 0.827 . . . . 2.9199999999999999 111.62 178.334 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.468 HG12 ' H ' ' A' ' 114' ' ' VAL . 0.3 OUTLIER -138.77 -174.46 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.851 1.66 . . . . 3.1299999999999999 109.954 176.438 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.468 ' H ' HG12 ' A' ' 113' ' ' VAL . 11.3 t -137.2 150.04 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.431 1.492 . . . . 2.0899999999999999 109.565 -168.626 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.6 mt -142.8 143.74 26.87 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 127.366 2.266 . . . . 1.95 109.048 -176.739 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.32 162.12 43.53 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.027 2.484 . . . . 0.80000000000000004 111.443 168.291 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 85.1 t -94.03 122.32 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 121.744 -0.598 . . . . 0.89000000000000001 110.227 165.795 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.11 164.76 18.78 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.356 1.862 . . . . 4.4900000000000002 110.731 178.166 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.46 67.8 1.08 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.526 1.306 . . . . 2.2799999999999998 114.526 -154.241 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 . . . . . 0 C--O 1.251 1.132 1 C-N-CA 133.154 4.582 . . . . 8.5099999999999998 113.049 170.974 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.344 0 N-CA-C 108.534 -1.827 . . . . 8.5700000000000003 108.534 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.0 t -71.48 -126.54 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 106.73 -1.582 . . . . 10.59 106.73 131.38 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -75.61 113.47 13.09 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 120.422 -1.424 . . . . 11.16 107.234 137.057 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -163.67 58.57 0.17 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.136 1.374 . . . . 8.0 108.514 -172.08 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -127.49 -176.21 3.68 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.165 1.386 . . . . 4.7800000000000002 109.391 -171.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.69 177.75 40.6 Favored Glycine 0 N--CA 1.469 0.892 0 O-C-N 121.189 -0.944 . . . . 0.94999999999999996 114.42 -165.291 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -155.62 138.49 15.33 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.108 1.363 . . . . 2.04 112.097 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.1 t -77.56 142.81 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 120.447 -1.408 . . . . 0.97999999999999998 107.343 167.361 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 -85.0 127.13 34.06 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.661 -0.649 . . . . 6.6500000000000004 110.373 -178.0 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -44.77 141.47 2.09 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.09 1.356 . . . . 2.0299999999999998 112.109 172.71 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.5 t -148.11 148.99 31.27 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 122.877 0.471 . . . . 2.79 111.502 165.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.0 -23.83 8.87 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.299 2.0 . . . . 2.3399999999999999 112.899 172.624 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -125.38 -156.64 9.4 Favored Glycine 0 CA--C 1.544 1.878 0 C-N-CA 125.332 1.444 . . . . 1.48 115.76 -160.495 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.24 -14.47 10.67 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.873 3.715 . . . . 1.52 115.171 -167.757 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -122.49 151.35 41.41 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.05 2.14 . . . . 2.4100000000000001 112.746 -178.949 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.16 -176.77 6.16 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.435 1.894 . . . . 0.90000000000000002 112.986 -163.701 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.79 158.52 44.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.568 1.947 . . . . 0.83999999999999997 109.343 174.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.56 134.85 31.16 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.706 1.139 . . . . 0.59999999999999998 112.965 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -107.61 135.79 48.46 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.55 1.54 . . . . 3.04 108.37 172.547 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 pp -150.72 156.44 41.31 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.437 -1.414 . . . . 1.79 113.347 -166.701 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.4 m -119.03 146.73 44.81 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.397 1.879 . . . . 2.0 109.864 179.379 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 tt -149.6 162.67 39.74 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 128.355 2.662 . . . . 4.6399999999999997 106.989 155.262 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -134.49 133.52 40.47 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.598 -1.314 . . . . 4.1399999999999997 111.053 163.707 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -76.96 111.76 18.44 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 127.298 2.239 . . . . 1.77 110.251 -174.721 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.51 -20.22 41.72 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.166 1.911 . . . . 1.6000000000000001 113.338 177.921 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.06 129.88 3.24 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 124.753 1.168 . . . . 2.9700000000000002 115.897 154.199 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -175.38 -46.41 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 130.831 3.652 . . . . 6.96 105.623 -169.303 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 28' ' ' LEU . 2.5 pt? -126.86 163.01 44.02 Favored Pre-proline 0 C--O 1.24 0.597 0 C-N-CA 127.075 2.15 . . . . 3.8799999999999999 112.052 177.596 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -81.03 144.44 14.94 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.127 2.551 . . . . 1.3700000000000001 109.43 166.215 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.4 mt -98.58 147.54 24.69 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 122.442 1.115 . . . . 1.8799999999999999 110.815 174.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -132.57 104.77 6.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 111.775 -2.466 . . . . 2.3799999999999999 110.638 172.061 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.8 tp -88.19 100.51 13.03 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.228 1.411 . . . . 1.8700000000000001 108.914 -173.121 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -101.95 -18.59 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 125.272 1.429 . . . . 0.54000000000000004 112.42 -169.639 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.82 -179.59 31.89 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 124.201 0.905 . . . . 0.47999999999999998 112.956 177.379 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.91 -178.21 5.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.099 1.36 . . . . 0.52000000000000002 109.701 166.685 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.62 -178.42 7.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.022 2.129 . . . . 5.2400000000000002 108.09 165.645 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 t -178.77 154.82 0.85 Allowed Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 127.52 2.328 . . . . 0.77000000000000002 108.796 -176.323 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.63 -8.64 23.81 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.046 1.83 . . . . 0.89000000000000001 113.802 169.409 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.54 44.6 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 114.108 1.151 . . . . 1.01 114.108 -173.055 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.99 147.29 13.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.365 1.066 . . . . 1.1299999999999999 111.107 166.129 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.71 -38.48 13.83 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.038 1.735 . . . . 2.79 111.991 173.788 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.409 HH21 ' CD ' ' A' ' 44' ' ' GLU . 26.7 mtp85 -124.7 149.29 47.38 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 127.668 2.387 . . . . 5.5999999999999996 109.175 177.959 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -157.23 120.52 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 125.642 1.577 . . . . 1.27 110.586 -174.02 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.409 ' CD ' HH21 ' A' ' 42' ' ' ARG . 2.5 mp0 -139.11 132.19 29.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.884 -1.053 . . . . 4.4699999999999998 110.962 -164.474 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.7 tp -81.62 125.56 30.7 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.922 0.489 . . . . 1.5 111.755 -173.891 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -121.02 155.65 33.88 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.747 1.619 . . . . 0.56000000000000005 113.464 175.049 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.99 -176.77 3.34 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.537 1.935 . . . . 3.4399999999999999 110.528 166.415 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.4 m -150.35 143.74 25.05 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.922 1.289 . . . . 0.80000000000000004 108.007 171.836 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -148.34 168.85 21.51 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.346 1.609 . . . . 2.5699999999999998 115.346 -170.686 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.6 mtp -110.92 145.17 38.8 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.283 1.433 . . . . 4.4299999999999997 111.206 162.575 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -137.14 149.4 47.27 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.697 1.999 . . . . 5.3399999999999999 109.985 171.585 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -89.79 140.49 29.54 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.501 -0.926 . . . . 2.7200000000000002 108.501 153.645 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.4 t -140.97 121.71 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 106.112 -1.81 . . . . 2.2599999999999998 106.112 171.597 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 66.89 22.54 10.15 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.93 0.892 . . . . 3.71 112.798 176.596 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.83 19.43 77.68 Favored Glycine 0 N--CA 1.477 1.394 0 O-C-N 120.627 -1.296 . . . . 1.7 113.337 -173.237 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -132.6 127.91 36.01 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.426 1.891 . . . . 2.5299999999999998 108.89 -178.408 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -79.33 125.45 29.52 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.845 0.858 . . . . 5.7199999999999998 112.524 -175.271 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.3 t -121.54 134.05 66.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 128.65 2.78 . . . . 2.3300000000000001 108.583 -176.016 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 37.3 mtt -98.11 149.02 22.95 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.82 0.848 . . . . 2.4199999999999999 110.266 169.179 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.32 -179.13 30.22 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-O 121.917 0.732 . . . . 0.84999999999999998 113.668 -175.039 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ttm -159.88 147.57 16.81 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 125.926 1.69 . . . . 0.70999999999999996 109.886 -171.93 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.59 152.84 23.49 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 113.602 -1.636 . . . . 5.3499999999999996 109.52 -163.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -83.33 157.87 14.81 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.289 1.993 . . . . 0.80000000000000004 111.555 176.607 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.97 157.09 54.87 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 125.779 1.632 . . . . 1.01 110.429 -178.49 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.76 -31.77 0.53 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.19 2.593 . . . . 0.63 113.389 -166.819 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -173.39 167.12 4.74 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.087 1.755 . . . . 2.2400000000000002 110.886 -178.601 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.8 mt -110.22 155.2 22.33 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.463 1.105 . . . . 0.68999999999999995 110.936 162.415 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -117.62 137.99 52.25 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.318 1.447 . . . . 2.1499999999999999 108.851 175.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.3 t -149.44 132.16 8.06 Favored Pre-proline 0 N--CA 1.476 0.845 0 N-CA-C 113.499 0.926 . . . . 1.0600000000000001 113.499 173.711 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.4 169.55 21.42 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 124.1 3.2 . . . . 1.21 114.234 -177.415 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.04 146.38 96.18 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.93 3.087 . . . . 1.3 111.806 168.201 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.6 mmtt 70.37 -7.73 0.97 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.217 1.807 . . . . 1.5800000000000001 114.089 -176.223 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.42 148.69 20.75 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.386 1.469 . . . . 1.22 113.511 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.95 129.21 34.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.121 1.369 . . . . 4.2699999999999996 111.805 177.113 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.7 t -108.05 80.98 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 128.19 2.596 . . . . 5.9400000000000004 108.469 -165.123 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -138.58 123.04 18.4 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.727 0.775 . . . . 4.1200000000000001 112.994 -158.068 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -80.55 84.19 6.19 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-O 122.857 1.313 . . . . 2.0299999999999998 108.45 175.58 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.29 145.85 97.64 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 113.249 -1.796 . . . . 4.0099999999999998 114.83 -171.749 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -55.81 143.32 81.53 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 123.567 2.845 . . . . 4.0899999999999999 110.693 176.863 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.54 -5.49 44.85 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 116.772 -2.127 . . . . 1.6000000000000001 115.811 176.585 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.81 -22.64 0.33 Allowed Glycine 0 N--CA 1.475 1.292 0 N-CA-C 119.713 2.645 . . . . 2.1800000000000002 119.713 178.085 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -152.47 141.83 21.57 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.683 1.742 . . . . 2.1600000000000001 113.078 179.624 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -162.83 155.46 19.04 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.197 1.399 . . . . 0.62 110.977 174.814 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -84.55 134.5 34.41 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.968 -1.123 . . . . 2.2599999999999998 107.968 163.141 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -82.71 134.06 35.15 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.736 1.214 . . . . 0.64000000000000001 108.06 164.016 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 mp -117.27 135.49 53.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.519 1.128 . . . . 0.85999999999999999 109.345 -179.566 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 mp -132.61 148.89 52.37 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.966 0.906 . . . . 1.6399999999999999 110.975 178.731 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.17 39.58 31.6 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 123.543 0.592 . . . . 1.02 113.836 173.424 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.38 156.41 7.83 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 116.365 1.987 . . . . 1.49 116.365 179.382 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -112.35 -16.14 13.0 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 113.018 -1.901 . . . . 1.95 113.409 -170.102 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -128.47 173.67 5.32 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 129.878 3.271 . . . . 6.7999999999999998 110.95 177.321 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -63.78 -176.75 0.37 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.438 2.092 . . . . 3.1499999999999999 110.917 155.599 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.434 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -167.24 66.32 0.09 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.344 2.658 . . . . 3.1400000000000001 108.287 179.223 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.434 ' HD3' ' H ' ' A' ' 93' ' ' LEU . 2.4 mptt -99.65 164.84 11.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.773 1.229 . . . . 7.3600000000000003 111.06 179.277 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.27 122.01 13.42 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.502 1.121 . . . . 1.29 110.727 -174.537 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.07 4.15 63.25 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.231 1.396 . . . . 1.54 114.574 179.275 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -79.96 -175.05 4.75 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.644 1.222 . . . . 2.4399999999999999 110.501 164.944 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -156.28 139.9 15.97 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.948 1.699 . . . . 3.0899999999999999 108.644 -174.532 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.0 t -146.79 134.98 15.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 126.526 1.93 . . . . 0.93000000000000005 110.874 -163.821 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -78.32 136.13 37.65 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.62 1.168 . . . . 2.7999999999999998 111.176 173.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 mp -121.13 136.76 54.92 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.196 0.998 . . . . 1.73 111.688 160.313 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -86.3 145.41 26.93 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.201 2.201 . . . . 2.4900000000000002 110.216 164.423 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -116.52 126.52 53.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.491 1.917 . . . . 0.81999999999999995 109.439 172.295 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.1 mt -103.26 111.75 24.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.308 1.443 . . . . 0.56999999999999995 110.225 -177.176 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -110.44 105.26 14.17 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.901 1.28 . . . . 1.98 112.471 -171.188 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 56.36 18.0 3.18 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.283 1.833 . . . . 2.9300000000000002 114.372 175.83 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.97 -57.88 3.12 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.368 1.461 . . . . 3.8500000000000001 112.085 -166.918 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.97 19.51 2.11 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.66 1.6 . . . . 3.0 116.799 -172.021 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.17 147.97 19.89 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.957 2.903 . . . . 3.0600000000000001 112.047 167.145 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.3 t -143.15 150.09 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.332 1.453 . . . . 2.2400000000000002 108.307 176.508 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.56 171.16 18.55 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.131 1.772 . . . . 3.1800000000000002 108.793 173.449 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -154.89 154.98 33.51 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.694 0.998 . . . . 2.1600000000000001 113.694 179.648 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.4 t -149.11 154.72 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.702 1.201 . . . . 2.1699999999999999 109.578 -172.945 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.81 133.54 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.101 0.96 . . . . 1.8500000000000001 109.319 177.365 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -120.77 147.6 46.34 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 126.507 1.923 . . . . 3.0899999999999999 108.346 175.194 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.23 168.03 15.1 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.51 2.807 . . . . 0.76000000000000001 111.704 163.842 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.7 t -108.27 122.98 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.483 1.113 . . . . 0.93999999999999995 110.827 170.188 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -119.5 152.46 36.91 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.878 1.271 . . . . 4.6500000000000004 113.763 -174.926 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.96 152.4 33.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.597 1.559 . . . . 2.3500000000000001 114.08 -175.026 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.977 0 C-N-CA 129.211 3.004 . . . . 8.0700000000000003 116.33 -165.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.341 0 N-CA-C 105.511 -3.035 . . . . 13.85 105.511 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -50.14 161.54 0.27 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.332 0.566 . . . . 11.98 111.116 136.441 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -76.18 170.79 15.64 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.477 0.711 . . . . 12.210000000000001 111.158 169.19 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 p -139.67 -52.71 0.53 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.187 2.195 . . . . 6.5599999999999996 110.807 -169.4 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -134.69 -175.42 3.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.747 2.419 . . . . 5.9800000000000004 110.063 -169.396 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.73 172.81 52.22 Favored Glycine 0 C--O 1.221 -0.66 0 O-C-N 121.423 -0.798 . . . . 1.48 112.721 167.611 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -149.61 144.57 26.26 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.828 -0.807 . . . . 2.0299999999999998 110.445 161.757 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -93.82 128.8 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.586 -0.894 . . . . 1.3799999999999999 108.586 177.596 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -74.15 106.7 5.93 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.123 0.569 . . . . 4.3399999999999999 111.609 -170.613 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -43.44 132.74 4.53 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.03 1.332 . . . . 2.3999999999999999 111.421 171.821 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.7 m -151.33 138.27 11.88 Favored Pre-proline 0 CA--C 1.539 0.555 0 O-C-N 120.976 -1.078 . . . . 2.73 111.503 175.315 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -86.29 48.18 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.405 3.403 . . . . 2.21 111.076 178.657 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.49 -179.0 30.28 Favored Glycine 0 CA--C 1.539 1.536 0 N-CA-C 115.774 1.07 . . . . 1.25 115.774 -168.168 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.48 -15.88 21.9 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.624 3.55 . . . . 1.1699999999999999 114.112 -176.042 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -134.62 170.67 15.44 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.801 2.04 . . . . 2.2000000000000002 113.195 -175.596 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.65 -179.3 8.03 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.732 2.013 . . . . 0.58999999999999997 112.413 -177.544 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.95 162.96 20.12 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.49 1.516 . . . . 0.64000000000000001 110.064 165.677 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.65 146.67 33.41 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.126 1.33 . . . . 0.56000000000000005 113.525 174.667 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -115.71 160.95 19.41 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.228 1.811 . . . . 2.96 111.178 173.762 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.4 tp -146.58 138.7 24.85 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.477 1.911 . . . . 2.9900000000000002 109.765 -170.429 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.9 m -131.47 133.6 45.32 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.377 1.471 . . . . 2.3700000000000001 107.196 160.387 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.5 tp -159.67 -178.17 6.9 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 128.149 2.58 . . . . 5.4199999999999999 108.89 -176.712 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -135.16 151.81 51.02 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.277 1.831 . . . . 3.3700000000000001 112.457 171.195 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -91.84 106.89 18.94 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.558 1.543 . . . . 1.73 108.33 168.493 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.72 -13.07 14.76 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.998 1.799 . . . . 1.3799999999999999 113.543 177.51 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.41 173.35 55.23 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-O 123.059 1.366 . . . . 1.1599999999999999 112.754 -175.421 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -100.71 -2.41 32.59 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 128.189 2.595 . . . . 2.8900000000000001 111.478 -179.248 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -113.64 156.09 44.03 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 127.843 2.457 . . . . 2.0600000000000001 110.346 171.588 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.81 151.84 24.88 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.826 2.35 . . . . 0.88 111.312 -175.093 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt -99.29 154.04 18.48 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 122.591 1.186 . . . . 1.76 111.405 168.134 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.1 ttp180 -140.96 111.03 6.6 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 113.532 -1.667 . . . . 2.3700000000000001 110.041 177.37 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.58 111.26 23.61 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.981 1.712 . . . . 1.78 109.576 -171.073 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 m -113.38 -18.29 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.444 1.098 . . . . 0.89000000000000001 112.645 -168.219 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.6 -174.49 29.42 Favored Glycine 0 N--CA 1.469 0.843 0 C-N-CA 125.364 1.459 . . . . 0.68000000000000005 112.837 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.46 -178.0 5.93 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.413 1.085 . . . . 0.67000000000000004 111.535 169.452 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -157.15 177.95 10.9 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 128.19 2.596 . . . . 5.3700000000000001 108.246 164.864 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -177.68 155.42 1.08 Allowed Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 126.738 2.015 . . . . 1.1399999999999999 108.674 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.53 -9.19 24.54 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.752 2.301 . . . . 1.24 114.032 167.791 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.44 48.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 125.063 1.345 . . . . 1.21 114.155 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.47 163.29 30.48 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.337 1.055 . . . . 1.0700000000000001 112.53 164.013 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -96.2 -33.24 12.1 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.085 2.154 . . . . 2.8399999999999999 111.483 170.926 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.0 mtp85 -155.48 156.74 35.78 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 128.446 2.698 . . . . 6.7599999999999998 108.999 -176.564 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.1 p -158.45 107.8 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 125.553 1.541 . . . . 1.77 111.157 -172.629 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -123.78 137.63 54.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.996 -1.456 . . . . 4.9299999999999997 111.068 -167.358 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.6 tp -88.09 126.07 34.91 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.331 1.452 . . . . 1.5 111.958 -169.322 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 37.6 m170 -119.42 158.34 26.4 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.228 1.811 . . . . 0.66000000000000003 113.171 176.535 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -102.31 158.74 15.98 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 113.819 -1.537 . . . . 2.3199999999999998 110.61 157.525 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.0 m -113.42 135.38 53.94 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 106.032 -1.84 . . . . 0.97999999999999998 106.032 159.965 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -128.87 166.67 18.64 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.493 1.14 . . . . 2.1299999999999999 113.582 -175.844 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 61.0 mtt -100.57 146.27 27.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.126 1.37 . . . . 4.4400000000000004 110.655 167.876 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.55 150.32 26.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.789 0.836 . . . . 5.0199999999999996 111.665 -176.413 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -103.88 127.68 51.39 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.119 1.368 . . . . 3.21 107.787 166.756 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.3 t -146.56 138.24 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 106.064 -1.828 . . . . 2.6699999999999999 106.064 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 66.58 22.19 10.58 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 119.002 0.819 . . . . 3.27 112.07 177.23 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.31 18.57 79.95 Favored Glycine 0 N--CA 1.475 1.258 0 O-C-N 121.101 -1.0 . . . . 1.72 113.523 -173.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -141.23 132.63 26.77 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.822 1.649 . . . . 3.0499999999999998 110.833 -168.704 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -70.68 129.4 39.04 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.586 1.554 . . . . 4.5199999999999996 111.435 173.076 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.6 m -138.32 169.47 18.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 129.188 2.995 . . . . 2.6400000000000001 109.515 -177.947 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 49.6 mtm -116.39 146.01 42.81 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.431 1.092 . . . . 2.5 110.712 168.938 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.73 -177.13 14.73 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 126.016 1.77 . . . . 0.82999999999999996 111.916 -178.845 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.1 ttm -150.55 148.9 29.24 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.512 1.525 . . . . 0.98999999999999999 108.746 -177.645 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -155.86 155.45 29.39 Favored Pre-proline 0 N--CA 1.476 0.85 0 CA-C-O 118.309 -0.853 . . . . 5.9500000000000002 111.327 172.689 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -70.35 153.42 66.23 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.93 1.753 . . . . 0.81000000000000005 110.805 172.93 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.4 m -140.47 151.2 63.27 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 125.145 1.378 . . . . 0.84999999999999998 109.767 -179.542 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.81 -26.28 3.79 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.897 2.398 . . . . 0.75 113.178 -164.02 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -174.82 165.65 3.63 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.584 1.554 . . . . 2.04 112.209 -179.272 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.7 mt -108.33 154.6 21.59 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.008 1.323 . . . . 0.56000000000000005 110.346 161.677 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -110.36 147.89 33.05 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.166 1.386 . . . . 1.8600000000000001 109.186 172.76 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.7 t -144.24 133.65 11.49 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 123.259 0.624 . . . . 1.02 112.122 169.602 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.19 168.18 21.55 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.049 2.5 . . . . 1.1799999999999999 112.881 176.819 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.0 144.83 96.72 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.888 3.059 . . . . 1.0600000000000001 111.845 167.245 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt 66.74 -7.19 0.47 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.877 1.671 . . . . 1.8600000000000001 114.207 179.844 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.92 165.78 51.32 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.526 1.536 . . . . 1.1599999999999999 112.299 -179.904 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -82.75 135.74 34.9 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 121.886 0.85 . . . . 4.9800000000000004 110.146 172.572 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.3 t -98.94 81.74 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 127.786 2.435 . . . . 6.5099999999999998 105.822 -176.119 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -138.37 129.26 26.81 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.07 1.414 . . . . 3.8999999999999999 112.674 -161.754 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 83' ' ' HIS . 8.5 mp -71.19 167.55 19.12 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 113.459 -1.7 . . . . 3.4700000000000002 109.276 167.462 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.59 133.37 21.9 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 120.205 -1.559 . . . . 3.8799999999999999 108.018 179.315 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.53 -17.88 60.55 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.036 2.49 . . . . 3.6699999999999999 114.525 -171.832 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.48 -21.15 4.46 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 124.551 1.072 . . . . 3.0800000000000001 115.257 164.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.85 -110.53 0.57 Allowed Glycine 0 N--CA 1.473 1.126 0 C-N-CA 125.475 1.512 . . . . 1.9399999999999999 111.933 -176.58 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -68.69 139.17 55.4 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.641 0.734 . . . . 1.8200000000000001 111.653 -171.588 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.462 ' HA ' HD23 ' A' ' 77' ' ' LEU . 56.5 p-80 -159.43 143.98 15.27 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.517 1.127 . . . . 0.81999999999999995 110.63 -174.451 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -78.28 156.01 29.9 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.14 -0.689 . . . . 1.72 109.14 166.283 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.2 mtp -117.8 129.76 55.87 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 122.874 0.47 . . . . 1.73 111.459 159.472 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.07 136.62 43.36 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.441 1.896 . . . . 0.70999999999999996 108.243 -172.729 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mp -124.49 152.43 43.4 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.354 1.061 . . . . 1.6699999999999999 110.939 -177.233 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.34 -36.11 2.59 Favored Glycine 0 N--CA 1.469 0.852 0 C-N-CA 125.112 1.339 . . . . 2.5699999999999998 113.712 175.615 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 68.95 -32.39 0.22 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 128.496 2.718 . . . . 3.5299999999999998 116.883 166.05 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 66.37 -23.85 0.1 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 129.637 3.175 . . . . 1.98 115.519 178.595 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -145.42 146.51 30.18 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.688 1.995 . . . . 6.7300000000000004 111.508 -171.076 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.53 155.75 36.05 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.357 2.705 . . . . 2.6099999999999999 109.525 158.867 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -166.53 160.2 15.06 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.097 1.759 . . . . 3.3599999999999999 109.386 -170.271 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -174.45 2.5 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.991 1.317 . . . . 6.0499999999999998 111.068 168.077 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.04 169.39 3.39 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 120.841 -1.162 . . . . 1.6200000000000001 109.522 154.281 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.56 35.34 90.96 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.038 1.304 . . . . 1.3100000000000001 113.58 178.542 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -105.45 -177.88 3.49 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.222 1.009 . . . . 3.3399999999999999 108.866 167.334 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -134.57 143.52 47.42 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.202 1.801 . . . . 3.6800000000000002 106.824 169.922 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.2 t -142.18 138.11 30.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 128.476 2.71 . . . . 1.02 109.226 -172.659 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -98.7 154.23 18.13 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.395 0.887 . . . . 2.4199999999999999 113.395 172.783 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.19 132.58 30.12 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.055 1.742 . . . . 2.1600000000000001 110.839 -177.334 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -78.62 130.25 35.69 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.576 1.55 . . . . 2.5800000000000001 108.782 163.832 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.2 mp -97.56 126.7 43.0 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.221 1.008 . . . . 0.95999999999999996 109.087 166.527 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.0 mt -96.66 109.75 22.32 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.265 1.026 . . . . 0.95999999999999996 109.173 176.481 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -105.63 143.53 33.65 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.685 1.194 . . . . 1.8899999999999999 111.109 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.41 145.48 51.52 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.829 0.852 . . . . 1.6399999999999999 113.118 -177.53 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.92 30.94 56.85 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 118.645 -1.086 . . . . 3.4900000000000002 113.852 172.378 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.97 44.27 5.45 Favored Glycine 0 N--CA 1.471 1.033 0 CA-C-N 118.421 1.111 . . . . 2.0800000000000001 115.094 168.376 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -131.63 145.03 51.47 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.587 1.193 . . . . 3.8199999999999998 112.031 174.491 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 94.1 t -143.8 146.51 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.103 1.361 . . . . 2.25 109.066 176.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tt -147.17 120.21 8.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.967 1.307 . . . . 2.2799999999999998 109.276 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp -94.39 112.64 24.43 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.902 -0.499 . . . . 2.3700000000000001 111.657 179.081 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.3 m -89.69 166.24 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 125.594 1.558 . . . . 2.3799999999999999 111.43 176.825 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.7 p -126.84 143.18 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.039 0.936 . . . . 2.9700000000000002 109.17 165.602 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.92 154.05 25.57 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.881 1.672 . . . . 2.4300000000000002 112.17 -171.171 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.39 162.38 40.84 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.353 2.702 . . . . 1.23 114.002 174.285 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.0 t -103.58 124.46 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.535 1.534 . . . . 1.0900000000000001 108.148 164.471 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -152.95 173.91 14.79 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.947 1.299 . . . . 4.5899999999999999 109.965 -178.624 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.93 167.76 15.63 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.961 1.467 . . . . 3.8199999999999998 114.961 -172.5 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.606 ' HG3' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.231 0 C-N-CA 128.914 2.886 . . . . 8.4199999999999999 108.671 150.572 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.144 0 N-CA-C 107.009 -2.436 . . . . 9.6300000000000008 107.009 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p 175.79 162.52 0.32 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 117.778 0.789 . . . . 9.1300000000000008 109.053 -134.064 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -126.89 -25.39 3.34 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.606 1.163 . . . . 8.3000000000000007 112.987 170.602 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.9 m 119.82 68.48 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.943 1 C-N-CA 132.236 4.214 . . . . 7.4000000000000004 108.007 -171.709 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -78.13 57.65 1.86 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.056 1.743 . . . . 5.5599999999999996 110.625 178.321 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -145.19 166.96 27.47 Favored Glycine 0 N--CA 1.47 0.916 0 O-C-N 120.714 -1.241 . . . . 1.3100000000000001 111.882 -175.517 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -155.29 167.74 29.37 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.93 1.456 . . . . 1.72 114.93 -175.919 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.2 t -119.41 137.78 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 126.428 1.891 . . . . 0.96999999999999997 110.628 -177.606 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.469 ' O ' ' HD3' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -46.99 -31.76 3.43 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 118.178 2.658 . . . . 4.1399999999999997 118.178 -158.281 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 70.47 136.25 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 125.481 1.513 . . . . 3.1000000000000001 112.902 -164.348 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.5 t 176.52 151.45 0.35 Allowed Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 128.749 2.82 . . . . 2.7400000000000002 110.726 166.353 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.69 -7.59 18.64 Favored 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 122.937 2.424 . . . . 2.6899999999999999 113.586 164.938 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.49 172.99 49.33 Favored Glycine 0 CA--C 1.543 1.795 0 C-N-CA 124.834 1.207 . . . . 1.28 115.552 -172.122 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.95 -15.8 11.64 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 125.237 3.958 . . . . 1.3 115.018 -171.64 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -125.04 149.48 47.73 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.076 2.15 . . . . 2.25 112.657 179.093 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.17 -176.22 5.85 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.453 1.501 . . . . 0.56000000000000005 112.599 -166.012 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.62 162.15 37.37 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.791 2.036 . . . . 0.71999999999999997 109.732 177.874 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.07 141.57 30.14 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.693 1.133 . . . . 0.53000000000000003 113.378 -178.492 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -130.48 62.88 1.58 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.428 1.891 . . . . 2.6899999999999999 111.891 -163.019 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -81.24 158.63 24.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.651 1.215 . . . . 1.9299999999999999 114.12 179.354 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.78 101.83 14.22 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.096 1.758 . . . . 2.96 109.447 -179.161 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.86 114.46 20.49 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.325 -0.62 . . . . 3.0299999999999998 109.325 178.486 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -122.68 125.68 46.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.198 1.799 . . . . 4.0700000000000003 108.08 174.694 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -91.1 118.87 68.82 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.869 0.868 . . . . 1.55 109.303 178.954 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.35 -12.29 29.55 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.632 2.222 . . . . 1.5900000000000001 113.878 177.903 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.81 115.94 0.22 Allowed Glycine 0 C--N 1.338 0.671 0 C-N-CA 126.943 2.211 . . . . 2.8300000000000001 113.247 171.666 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 t0 176.08 -42.46 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 105.231 -2.137 . . . . 8.5800000000000001 105.231 -141.846 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -165.78 178.22 1.37 Allowed Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 130.212 3.405 . . . . 4.54 108.557 170.129 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.15 127.48 8.43 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 N-CA-C 107.315 -1.84 . . . . 1.1200000000000001 107.315 156.297 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.0 mt -86.5 145.65 26.71 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.578 -1.192 . . . . 2.04 110.526 -177.132 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.1 100.96 5.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 112.257 -2.247 . . . . 3.4500000000000002 109.073 174.632 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.17 108.58 12.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.885 -1.524 . . . . 2.3900000000000001 106.885 176.227 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -103.86 -23.1 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.129 0.972 . . . . 0.59999999999999998 111.619 -174.743 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.59 -179.05 33.17 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 124.406 1.003 . . . . 0.46999999999999997 114.213 -175.464 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.72 -176.63 6.01 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.953 0.901 . . . . 0.53000000000000003 112.894 173.548 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -157.44 165.96 34.28 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.456 2.302 . . . . 4.7800000000000002 108.111 -173.512 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -166.0 153.75 9.52 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.375 1.07 . . . . 0.60999999999999999 109.527 168.017 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.37 -8.18 18.11 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.205 1.937 . . . . 0.66000000000000003 113.211 167.897 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.83 50.15 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.005 1.322 . . . . 0.76000000000000001 113.17 -179.84 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.08 123.38 1.16 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.977 1.311 . . . . 1.3500000000000001 110.247 160.191 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.59 -24.07 63.63 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.571 0.952 . . . . 3.7200000000000002 113.571 173.581 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -141.31 142.39 33.84 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.813 1.245 . . . . 5.5800000000000001 109.898 174.428 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.27 145.85 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.599 1.56 . . . . 1.27 109.287 171.236 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -114.98 158.76 21.61 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.187 1.795 . . . . 3.48 109.157 163.696 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.1 tp -112.02 119.1 37.32 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 122.965 0.506 . . . . 1.0600000000000001 110.546 170.117 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -122.92 163.04 21.1 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.008 1.323 . . . . 0.63 114.117 -174.304 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -115.34 -178.02 3.28 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.825 1.65 . . . . 3.4199999999999999 113.901 159.023 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.2 m -154.88 141.49 18.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.133 1.773 . . . . 0.80000000000000004 108.92 179.259 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -148.93 170.49 18.2 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.705 1.202 . . . . 2.0299999999999998 112.842 -165.627 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.9 mtt -95.63 147.55 23.47 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.296 1.038 . . . . 4.25 110.582 167.655 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.95 156.01 33.79 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.761 1.224 . . . . 4.54 110.713 -175.084 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' OE1' ' HE3' ' A' ' 57' ' ' LYS . 3.6 tp10 -104.55 137.87 41.74 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.779 1.232 . . . . 2.6899999999999999 109.938 169.615 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.7 t -131.54 118.37 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 106.694 -1.595 . . . . 2.1400000000000001 106.694 163.026 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 62.77 33.17 15.58 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.282 1.033 . . . . 3.5499999999999998 113.265 175.353 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.58 5.56 86.13 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 120.5 -1.375 . . . . 1.6200000000000001 113.692 -175.212 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -115.34 124.85 52.31 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.333 1.853 . . . . 2.7000000000000002 110.132 -176.604 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HE3' ' OE1' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -57.36 128.51 37.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.093 2.157 . . . . 4.0599999999999996 109.859 179.668 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.39 151.41 35.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 127.967 2.507 . . . . 2.9700000000000002 107.971 175.471 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 36.6 mtt -115.39 129.73 56.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.144 0.578 . . . . 2.5299999999999998 109.563 160.429 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.31 175.69 16.41 Favored Glycine 0 N--CA 1.466 0.663 0 C-N-CA 124.293 0.949 . . . . 0.66000000000000003 112.732 -172.166 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.1 ttm -152.21 139.02 18.9 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.498 1.519 . . . . 0.68999999999999995 110.677 -172.292 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -146.06 151.31 44.65 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 125.783 1.633 . . . . 7.9199999999999999 110.982 -177.067 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.77 150.7 50.48 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.447 2.098 . . . . 0.68999999999999995 110.637 172.619 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.51 147.89 61.65 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.846 1.258 . . . . 0.68000000000000005 110.057 -176.443 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.96 -19.87 13.57 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.983 3.122 . . . . 0.71999999999999997 113.342 -164.98 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -177.2 168.5 2.35 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.355 2.262 . . . . 2.1699999999999999 109.461 178.266 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.8 mt -111.65 153.52 26.25 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.874 1.27 . . . . 0.58999999999999997 109.04 159.327 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -124.23 142.09 51.53 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.741 0.816 . . . . 2.5699999999999998 110.284 177.689 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.6 t -141.27 129.81 12.36 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 123.664 0.786 . . . . 1.01 111.362 174.678 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.79 158.31 46.87 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.832 3.021 . . . . 1.0700000000000001 112.116 178.787 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.49 137.99 77.56 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.541 2.828 . . . . 1.1699999999999999 112.305 -177.177 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt 73.88 -13.08 0.79 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.188 2.195 . . . . 2.1400000000000001 114.237 -177.038 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.73 179.32 44.37 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.659 1.6 . . . . 1.3200000000000001 114.819 -176.97 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -126.41 156.16 41.03 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.56 1.544 . . . . 3.96 112.054 175.692 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.0 t -149.29 116.84 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.573 1.549 . . . . 4.04 107.763 154.349 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -76.69 142.98 40.34 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.941 -1.099 . . . . 3.1699999999999999 112.348 -179.576 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 mp -71.53 73.41 0.75 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 123.338 1.542 . . . . 2.1899999999999999 108.04 160.254 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -69.49 142.62 92.13 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.921 1.688 . . . . 5.46 113.688 -171.279 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -66.88 -4.52 11.45 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.947 3.098 . . . . 2.2999999999999998 114.501 178.993 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.32 51.53 0.77 Allowed Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.534 1.54 . . . . 1.6699999999999999 110.57 165.835 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.01 -123.26 1.05 Allowed Glycine 0 N--CA 1.464 0.537 0 C-N-CA 124.196 0.903 . . . . 1.5900000000000001 113.913 -177.166 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -73.25 136.84 44.65 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 121.573 0.701 . . . . 2.21 111.392 -169.13 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -162.62 156.28 20.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.774 -0.648 . . . . 0.54000000000000004 111.288 -179.352 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -81.45 146.46 30.24 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.714 -0.476 . . . . 1.95 109.714 164.627 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 tpt -100.05 130.84 46.25 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.206 -1.035 . . . . 0.65000000000000002 108.206 161.016 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -113.41 138.95 49.34 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.19 1.396 . . . . 0.56000000000000005 109.574 -178.292 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mp -137.66 146.41 43.82 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.046 1.338 . . . . 1.71 110.794 179.15 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.18 44.43 66.37 Favored Glycine 0 N--CA 1.472 1.051 0 O-C-N 121.691 -0.631 . . . . 0.85999999999999999 112.342 176.338 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 pp -62.14 151.3 36.18 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 123.194 1.473 . . . . 1.24 114.785 178.56 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.31 -2.22 18.01 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 113.748 -1.569 . . . . 2.52 112.971 -177.121 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -137.21 131.83 17.78 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 126.529 1.932 . . . . 5.2199999999999998 107.695 153.751 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -63.03 154.2 68.74 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.858 1.705 . . . . 2.29 108.137 160.407 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.6 mt -111.97 97.41 6.66 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.682 1.193 . . . . 2.5 109.7 -155.693 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 136.65 34.94 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.474 1.11 . . . . 3.9500000000000002 111.774 173.716 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.59 121.3 6.84 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.779 -1.101 . . . . 1.53 108.527 164.165 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.68 -2.35 52.83 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.872 1.701 . . . . 1.6000000000000001 116.037 -176.825 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -82.17 -170.67 3.01 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.906 1.853 . . . . 2.3900000000000001 112.327 168.327 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -147.87 136.44 21.69 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 129.194 2.998 . . . . 3.4500000000000002 106.598 -172.28 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.4 t -140.07 132.69 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.804 1.642 . . . . 1.0900000000000001 111.618 -175.684 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -79.56 143.82 34.45 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.318 0.647 . . . . 2.8799999999999999 112.409 172.138 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mp -127.67 139.67 52.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.026 1.33 . . . . 1.6499999999999999 110.987 161.535 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -102.23 122.85 45.0 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 127.533 2.333 . . . . 2.8700000000000001 108.359 174.238 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -104.29 116.67 32.57 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.418 1.008 . . . . 1.0600000000000001 111.123 -167.786 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -84.92 105.28 15.57 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.897 0.879 . . . . 0.81999999999999995 110.319 -177.387 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -103.11 106.41 16.92 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.889 1.676 . . . . 2.0800000000000001 111.172 -179.23 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 56.33 20.63 4.79 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.491 1.916 . . . . 2.3300000000000001 113.711 177.334 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.22 -56.64 3.65 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.381 1.467 . . . . 4.04 112.485 -171.454 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.02 -10.12 77.26 Favored Glycine 0 CA--C 1.533 1.214 0 N-CA-C 116.118 1.207 . . . . 2.0 116.118 -169.486 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -125.47 145.1 50.23 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.944 1.298 . . . . 4.6900000000000004 111.077 171.779 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.7 p -144.1 146.29 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 125.836 1.654 . . . . 1.9199999999999999 110.474 173.328 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.8 tt -156.29 134.85 11.61 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.644 1.978 . . . . 2.0699999999999998 108.226 -175.446 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -101.05 153.91 19.15 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.148 1.166 . . . . 2.5600000000000001 114.148 176.079 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.4 t -135.82 158.66 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.568 1.947 . . . . 1.98 108.525 175.04 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.7 p -129.98 128.64 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.102 0.961 . . . . 2.3900000000000001 110.046 -177.929 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.99 144.24 43.01 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.671 1.188 . . . . 1.97 111.493 -168.368 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -62.52 155.59 57.29 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.27 2.647 . . . . 0.73999999999999999 112.666 176.545 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 67.4 t -91.59 125.14 44.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 107.475 -1.306 . . . . 0.88 107.475 165.16 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -153.45 167.21 30.2 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.01 1.724 . . . . 3.9399999999999999 110.565 175.188 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.78 152.71 37.3 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.264 1.209 . . . . 3.7999999999999998 114.264 -165.96 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.554 1.942 . . . . 9.1500000000000004 114.713 166.979 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 CA--C 1.54 0.571 0 CA-C-O 122.244 1.021 . . . . 5.48 113.038 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.98 -176.9 28.65 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 126.807 2.146 . . . . 1.01 112.787 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.8 p90 -148.11 146.34 28.76 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.953 1.301 . . . . 1.75 110.412 171.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.5 t -90.2 142.59 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.369 -0.974 . . . . 1.13 108.369 170.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 64.3 ttt-85 -85.78 131.52 34.3 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.991 0.516 . . . . 3.51 112.332 -173.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -40.84 137.36 1.22 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.032 2.133 . . . . 2.02 112.782 169.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -175.81 126.6 0.36 Allowed Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 127.142 2.177 . . . . 2.76 111.037 165.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -87.13 0.1 7.62 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.928 3.086 . . . . 2.57 112.131 164.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.54 -166.27 40.96 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.141 1.353 . . . . 1.38 112.852 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.08 -24.52 23.63 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.67 2.246 . . . . 1.66 113.546 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -138.87 163.2 32.91 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.198 1.399 . . . . 2.14 113.923 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.28 -175.74 5.48 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 130.324 3.45 . . . . 0.51 109.394 -172.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.37 156.87 43.05 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.844 2.057 . . . . 0.61 109.169 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.89 133.54 33.97 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.711 1.141 . . . . 0.52 112.817 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 43.2 m-85 -115.79 140.98 48.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.798 2.039 . . . . 2.32 110.332 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -168.13 156.43 8.78 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.915 1.234 . . . . 1.77 113.318 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.451 HG23 ' HG3' ' A' ' 76' ' ' GLU . 86.5 m -95.24 108.52 20.67 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.418 1.087 . . . . 2.01 111.119 -176.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.8 130.28 34.53 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.446 0.566 . . . . 2.71 109.909 173.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -131.98 135.19 46.37 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.69 1.596 . . . . 4.34 109.582 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -105.78 110.25 63.97 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 125.139 1.375 . . . . 1.38 110.319 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.34 -11.56 10.7 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.901 2.401 . . . . 1.02 113.927 176.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.43 174.87 50.76 Favored Glycine 0 C--N 1.338 0.693 0 CA-C-O 122.964 1.313 . . . . 1.2 112.969 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.04 -4.42 32.51 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.45 2.7 . . . . 2.87 111.309 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -119.44 156.83 52.84 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 128.247 2.619 . . . . 1.9 109.9 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.87 143.78 26.79 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.867 2.378 . . . . 0.83 110.964 -174.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.3 mt -102.84 150.92 23.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 122.767 1.27 . . . . 1.79 110.036 170.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -142.63 109.83 5.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.577 -2.101 . . . . 2.16 112.833 -172.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.0 tp -87.82 107.09 18.5 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.33 1.852 . . . . 1.83 109.951 -175.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.8 m -108.49 -18.12 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.155 0.982 . . . . 0.51 112.455 -172.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.31 -178.4 31.34 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 125.273 1.416 . . . . 0.61 113.106 -175.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.17 179.82 8.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.673 0.749 . . . . 0.69 111.826 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -156.37 166.01 34.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.766 2.426 . . . . 3.96 107.815 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -175.43 151.24 1.27 Allowed Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 125.788 1.635 . . . . 0.76 108.447 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.6 -7.89 14.74 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.939 2.426 . . . . 0.83 112.993 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.0 m -114.16 41.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.6 1.16 . . . . 0.95 113.434 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.18 164.25 35.29 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.527 -0.733 . . . . 1.12 112.532 166.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -100.75 -46.39 5.17 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.266 2.227 . . . . 3.21 110.664 169.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -103.18 138.24 40.26 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.223 1.409 . . . . 5.06 108.341 163.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -99.58 152.61 4.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.3 -1.0 . . . . 1.34 108.3 142.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -135.41 147.7 49.08 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.02 1.728 . . . . 2.93 108.31 166.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.6 tp -102.97 118.76 37.54 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.557 0.743 . . . . 1.05 110.651 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.417 ' CE1' ' HB2' ' A' ' 85' ' ' MET . 55.3 m170 -121.93 156.67 32.89 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 123.242 1.496 . . . . 0.53 113.899 -173.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -98.3 177.82 5.25 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.551 1.941 . . . . 2.39 111.577 160.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.1 m -152.89 149.97 28.82 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.297 1.839 . . . . 0.77 106.996 166.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -158.3 165.74 34.06 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.058 0.943 . . . . 2.14 113.054 -168.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 59.5 ttp -95.19 143.49 26.57 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.166 1.386 . . . . 3.05 110.371 167.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.49 150.68 35.02 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.6 1.16 . . . . 4.35 110.849 -173.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -108.45 137.89 45.67 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.411 1.484 . . . . 2.07 110.262 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.8 t -139.63 128.23 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 106.7 -1.593 . . . . 2.01 106.7 166.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.433 ' HB2' ' HE3' ' A' ' 56' ' ' LYS . 34.6 mt-10 61.49 19.1 10.02 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.085 1.354 . . . . 2.99 114.401 -175.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.25 11.29 85.07 Favored Glycine 0 N--CA 1.48 1.609 0 O-C-N 120.242 -1.536 . . . . 1.61 113.585 -169.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.433 ' HE3' ' HB2' ' A' ' 54' ' ' GLU . 23.5 mtmt -110.47 118.83 37.32 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.531 2.333 . . . . 2.66 108.728 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 120.19 34.29 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.689 -1.141 . . . . 3.83 112.376 -166.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.8 m -121.35 -178.4 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 128.705 2.802 . . . . 2.05 109.872 -176.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 60.9 mtt -116.06 162.94 16.67 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.359 1.064 . . . . 2.49 111.165 168.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.61 175.06 32.86 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 124.791 1.186 . . . . 0.57 112.591 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.3 ttm -154.78 145.29 22.19 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.055 1.742 . . . . 0.61 109.213 -170.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -148.24 153.98 41.76 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 125.736 1.614 . . . . 5.17 109.175 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.89 154.11 42.81 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.854 1.702 . . . . 0.6 110.399 165.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -139.46 154.35 71.52 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.458 1.503 . . . . 0.64 110.513 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.02 -27.66 4.41 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.106 2.538 . . . . 0.52 112.949 -167.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -176.24 164.74 2.74 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.648 1.579 . . . . 1.96 111.817 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 mt -114.03 152.22 31.3 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.215 1.406 . . . . 0.61 110.014 166.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -111.93 145.93 38.69 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.756 1.222 . . . . 2.02 109.407 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.2 t -134.44 119.8 14.37 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.655 0.782 . . . . 1.11 111.124 165.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.29 159.1 54.19 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.33 2.687 . . . . 0.93 111.565 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -60.4 138.57 81.59 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.754 2.969 . . . . 0.97 112.192 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt 64.91 -4.26 0.5 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.304 1.841 . . . . 1.62 113.991 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.08 -177.4 39.2 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 127.28 2.371 . . . . 1.16 113.114 -176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.22 152.53 33.42 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.279 1.032 . . . . 3.99 112.146 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.4 t -152.71 123.46 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.771 1.629 . . . . 3.72 107.752 174.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.451 ' HG3' HG23 ' A' ' 21' ' ' THR . 6.9 mp0 -84.31 141.44 30.92 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.704 -0.622 . . . . 2.98 111.351 175.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.92 80.84 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.332 -0.988 . . . . 2.2 108.332 147.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.08 148.95 46.39 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.1 1.36 . . . . 3.09 112.386 -174.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.422 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 59.2 Cg_endo -63.3 -24.35 71.87 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.251 2.634 . . . . 1.99 113.806 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.84 21.72 4.58 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.942 -0.921 . . . . 1.63 114.115 170.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.95 -118.39 0.69 Allowed Glycine 0 CA--C 1.53 1.015 0 CA-C-N 118.979 1.39 . . . . 1.87 114.654 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -71.91 140.42 49.23 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.352 -1.087 . . . . 1.87 112.552 -164.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -162.64 156.22 20.39 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.206 1.002 . . . . 0.51 112.259 -173.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -82.99 140.51 32.7 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.851 -0.53 . . . . 1.59 109.623 165.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.417 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 3.1 tpt -93.14 131.94 37.73 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.261 1.024 . . . . 0.62 108.769 161.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 mp -110.9 125.23 53.43 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.654 -1.239 . . . . 0.59 107.654 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 mp -130.82 142.62 50.4 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.305 0.642 . . . . 1.86 110.364 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.43 43.29 16.1 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.154 0.883 . . . . 0.85 112.96 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -56.76 154.51 9.03 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 116.102 1.89 . . . . 1.38 116.102 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -116.53 -16.83 10.75 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 113.515 -1.675 . . . . 1.98 113.076 -170.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -113.12 127.38 26.9 Favored Pre-proline 0 N--CA 1.472 0.628 0 N-CA-C 105.896 -1.89 . . . . 5.43 105.896 155.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.39 110.02 1.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 N-CA-C 105.369 -2.589 . . . . 2.22 105.369 158.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.48 147.15 39.76 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 124.518 2.104 . . . . 2.05 111.567 -156.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -156.27 166.04 34.62 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 111.665 -2.516 . . . . 3.83 112.815 -151.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.92 126.05 25.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.007 0.923 . . . . 1.19 109.636 -175.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.08 0.98 70.43 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 117.702 -1.61 . . . . 1.26 115.64 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -79.9 -167.83 1.4 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.319 2.06 . . . . 2.23 112.568 169.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.52 121.78 3.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.148 2.979 . . . . 5.77 106.095 -148.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 49.3 t -148.83 133.45 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.602 1.161 . . . . 0.97 111.702 -170.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -79.12 144.59 34.38 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 112.211 0.448 . . . . 2.51 112.211 168.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mp -120.23 142.31 49.14 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.829 0.823 . . . . 1.6 110.507 153.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -104.8 136.34 44.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 129.265 3.026 . . . . 1.99 107.485 166.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 mp -128.12 109.75 11.82 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 120.503 1.501 . . . . 2.01 108.903 -172.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.1 mt -79.34 110.34 14.53 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.094 1.357 . . . . 0.67 109.453 -170.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -103.48 137.44 41.56 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.309 1.444 . . . . 2.06 110.612 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.04 127.23 30.52 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.871 1.063 . . . . 2.12 113.871 -169.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.64 70.13 1.35 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.638 1.114 . . . . 3.45 112.093 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.65 24.5 72.37 Favored Glycine 0 N--CA 1.471 1.03 0 N-CA-C 115.563 0.985 . . . . 2.09 115.563 166.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -126.28 155.84 41.3 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.304 1.552 . . . . 3.47 112.353 -173.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.12 151.46 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.813 1.245 . . . . 2.32 110.753 171.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.1 tp -120.48 141.98 49.7 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.091 1.357 . . . . 3.13 109.786 167.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -106.79 134.35 50.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.582 1.153 . . . . 2.2 109.908 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.74 153.59 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.099 1.359 . . . . 2.72 110.165 167.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.22 126.39 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.683 -1.228 . . . . 1.86 107.683 165.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.1 mt -122.1 146.75 47.38 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 126.234 1.814 . . . . 1.97 110.074 -174.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.78 164.54 35.28 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.973 2.449 . . . . 0.89 111.377 165.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.22 139.38 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.689 0.796 . . . . 0.76 110.482 169.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.97 147.22 40.15 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.667 1.587 . . . . 3.74 113.093 -171.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.59 58.3 4.14 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.054 1.742 . . . . 2.38 111.832 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 . . . . . 0 C--O 1.249 1.072 0 C-N-CA 125.956 1.703 . . . . 7.47 112.672 -162.195 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 118.55 -0.738 . . . . 5.21 109.909 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.59 172.86 37.88 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 120.515 1.507 . . . . 0.87 115.552 159.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -148.98 147.06 28.14 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.016 1.326 . . . . 1.96 111.276 169.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.8 t -95.03 126.87 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.08 -1.081 . . . . 1.35 108.08 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -74.31 123.18 24.11 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.912 0.386 . . . . 4.84 111.423 -170.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -46.99 142.18 3.68 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.956 1.302 . . . . 1.89 111.538 163.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.1 m -155.31 152.23 24.38 Favored Pre-proline 0 CA--C 1.545 0.783 0 O-C-N 120.865 -1.147 . . . . 2.53 111.111 161.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -95.18 43.11 0.16 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.147 3.232 . . . . 2.71 111.707 -176.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.61 -168.85 25.16 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.27 1.268 . . . . 1.17 116.27 -167.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.98 -16.23 16.09 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.283 3.322 . . . . 1.24 114.328 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -125.24 162.57 24.41 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.052 1.741 . . . . 2.41 114.124 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.95 -177.2 6.4 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.181 2.592 . . . . 0.5 111.236 -175.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.08 167.33 21.74 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.352 2.261 . . . . 0.73 108.448 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.74 141.27 33.25 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.375 0.989 . . . . 0.57 111.738 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.452 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 20.2 m-85 -128.02 114.37 17.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.256 1.822 . . . . 2.48 108.842 -171.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -163.26 165.36 24.36 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.851 -1.155 . . . . 2.71 112.901 -167.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 t -92.77 141.14 28.78 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 123.189 1.471 . . . . 3.29 113.366 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.36 123.81 38.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 113.357 -1.747 . . . . 3.5 106.996 164.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -111.62 145.05 39.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.869 0.842 . . . . 3.99 110.944 169.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.88 64.8 18.4 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.07 0.948 . . . . 3.48 110.277 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -63.23 -21.79 72.28 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.632 2.888 . . . . 1.38 114.414 -173.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.09 -173.09 38.09 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 122.72 1.178 . . . . 1.22 113.001 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -109.74 -1.19 18.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.905 1.682 . . . . 2.83 112.684 -164.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -121.68 155.25 60.11 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 127.417 2.287 . . . . 2.06 110.091 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.63 139.57 18.13 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.713 2.275 . . . . 1.01 111.245 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt -95.05 153.54 17.6 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 123.306 1.527 . . . . 1.6 112.676 174.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 ttp-105 -137.06 102.93 4.99 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 112.609 -2.087 . . . . 2.49 110.901 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.37 113.57 20.83 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 124.443 1.097 . . . . 1.98 110.497 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.31 -19.53 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 125.124 1.37 . . . . 0.65 111.855 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.61 -175.47 29.58 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 122.531 1.073 . . . . 0.52 115.362 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.459 ' HB2' ' CE1' ' A' ' 84' ' ' PHE . . . -139.08 -179.18 5.7 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.917 1.687 . . . . 0.56 110.236 164.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -159.84 146.6 16.27 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.928 1.691 . . . . 4.39 106.999 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 t -162.55 151.06 12.26 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 125.038 1.335 . . . . 0.73 108.436 -175.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.91 -13.45 31.79 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.682 1.588 . . . . 0.68 113.378 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 m -112.31 36.14 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 113.788 1.033 . . . . 0.86 113.788 -172.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.15 140.39 10.29 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.343 1.457 . . . . 1.03 109.134 170.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -95.63 -40.0 9.63 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.233 1.413 . . . . 3.61 110.292 -176.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -104.4 129.1 52.35 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.959 1.704 . . . . 5.82 107.758 155.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.07 139.31 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.069 -1.085 . . . . 1.25 108.069 154.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.91 155.89 47.1 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.834 2.054 . . . . 3.26 108.295 -174.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.3 tp -114.23 121.4 43.59 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.976 0.91 . . . . 1.0 109.785 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.405 ' CE1' ' HB2' ' A' ' 85' ' ' MET . 50.2 m170 -124.23 161.32 26.02 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 123.736 1.731 . . . . 0.73 114.488 -175.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -104.22 155.16 18.96 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.085 2.554 . . . . 2.59 111.21 160.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.9 m -122.02 147.19 46.38 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 105.902 -1.888 . . . . 0.85 105.902 159.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -157.39 178.28 10.48 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.188 0.904 . . . . 2.39 112.819 -174.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 63.0 ttp -111.66 135.21 52.56 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.572 1.549 . . . . 3.62 111.5 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -110.4 143.99 39.84 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.513 1.525 . . . . 4.77 110.862 161.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -87.45 145.4 26.29 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.556 1.143 . . . . 2.99 108.707 149.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.4 t -143.92 120.8 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.227 1.811 . . . . 2.73 106.701 161.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 63.94 18.12 10.99 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.483 1.513 . . . . 4.21 115.024 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.21 21.22 67.99 Favored Glycine 0 N--CA 1.478 1.482 0 O-C-N 120.6 -1.313 . . . . 2.6 113.052 -168.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -120.36 127.99 52.82 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.253 2.221 . . . . 3.21 107.592 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -98.46 126.81 44.14 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.735 1.214 . . . . 5.3 111.779 -171.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.29 141.88 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 126.415 1.886 . . . . 2.22 109.644 -175.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 60.1 mtm -92.19 156.52 17.27 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.422 0.897 . . . . 2.95 113.422 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.67 172.06 22.08 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 126.359 1.933 . . . . 0.81 112.332 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.5 ttm -146.53 145.66 30.23 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.231 1.812 . . . . 0.75 109.587 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -149.35 156.57 39.64 Favored Pre-proline 0 N--CA 1.471 0.603 0 C-N-CA 125.218 1.407 . . . . 5.02 110.12 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.99 156.54 38.65 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.469 2.113 . . . . 0.92 110.638 166.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.6 m -137.57 153.51 74.33 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 125.357 1.463 . . . . 0.92 110.964 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.11 -24.85 6.42 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.502 2.801 . . . . 0.97 113.024 -171.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -176.35 164.82 2.69 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.029 1.732 . . . . 2.28 111.67 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.4 mt -108.87 153.69 23.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.404 1.482 . . . . 0.71 110.579 163.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -114.3 144.19 43.65 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.395 1.478 . . . . 2.17 109.763 176.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.7 t -139.91 139.74 22.44 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.465 0.706 . . . . 1.06 112.488 169.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -84.02 156.43 13.24 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.38 3.387 . . . . 1.12 112.531 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.22 143.49 94.33 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.306 2.671 . . . . 1.07 113.246 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt 69.97 0.2 2.98 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.775 2.43 . . . . 1.77 114.16 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.56 151.53 34.44 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.41 1.481 . . . . 1.24 114.106 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -111.46 132.12 54.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.425 2.29 . . . . 4.63 106.547 160.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.5 t -142.59 119.01 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.746 1.219 . . . . 3.5 108.774 -177.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -115.15 128.69 56.36 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.899 0.857 . . . . 3.98 113.24 -159.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.16 77.12 0.52 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.632 2.373 . . . . 2.21 111.163 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.65 145.01 97.74 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 126.462 1.905 . . . . 6.25 113.525 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.452 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 30.4 Cg_endo -57.89 -42.88 54.12 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.301 2.667 . . . . 2.99 113.335 175.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.46 31.49 1.88 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.454 1.025 . . . . 1.58 113.533 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.12 -131.99 1.44 Allowed Glycine 0 N--CA 1.471 0.969 0 C-N-CA 125.493 1.52 . . . . 1.62 113.175 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -70.39 139.21 51.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.906 0.853 . . . . 2.14 110.981 -172.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -162.02 158.3 24.79 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.836 1.255 . . . . 0.58 111.973 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.459 ' CE1' ' HB2' ' A' ' 35' ' ' ALA . 98.5 m-85 -84.63 151.74 24.28 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.697 -0.627 . . . . 2.07 110.786 168.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.405 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 3.2 tpt -112.06 130.98 55.7 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.531 1.132 . . . . 0.61 109.687 166.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -111.98 118.87 36.64 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.943 1.297 . . . . 0.62 107.869 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.6 mp -119.51 138.92 52.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.47 1.108 . . . . 1.7 109.739 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.22 37.26 32.58 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.73 -0.483 . . . . 0.87 113.006 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -48.3 154.93 0.55 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 116.571 2.063 . . . . 1.3 116.571 177.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -119.97 -18.77 8.09 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.155 -1.384 . . . . 2.7 113.949 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -97.01 140.96 22.39 Favored Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 108.539 -0.912 . . . . 5.35 108.539 160.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -82.6 57.58 6.14 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.624 2.883 . . . . 3.07 109.914 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.4 mt -23.14 104.56 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 129.044 2.938 . . . . 2.2 116.8 -159.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm -119.54 157.96 27.28 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.187 1.795 . . . . 6.57 114.871 170.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.14 133.88 38.92 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 113.528 -1.669 . . . . 1.76 109.675 169.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.46 1.33 86.16 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 117.485 -1.73 . . . . 1.78 115.848 -175.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -75.28 178.11 6.05 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 120.899 2.349 . . . . 2.4 111.145 166.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -146.2 129.74 16.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.795 2.838 . . . . 5.22 104.827 -159.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.0 t -144.33 121.63 5.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 123.99 0.916 . . . . 1.04 110.358 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -78.81 154.55 29.79 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.262 0.554 . . . . 2.83 111.364 167.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.2 tt -149.91 142.8 24.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 122.82 1.295 . . . . 2.85 110.808 169.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.0 104.33 11.8 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 129.54 3.136 . . . . 2.42 107.061 -169.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -82.46 129.37 34.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.158 0.983 . . . . 0.96 109.622 -172.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.0 mt -106.02 123.96 48.82 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.61 1.164 . . . . 0.84 111.441 -171.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -122.6 144.98 48.76 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.945 1.298 . . . . 2.04 112.31 -170.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.66 151.06 21.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.878 0.871 . . . . 1.92 111.974 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.16 8.86 87.0 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 119.011 -0.883 . . . . 3.57 114.618 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.8 66.06 1.61 Allowed Glycine 0 N--CA 1.469 0.892 0 CA-C-N 119.184 1.492 . . . . 2.45 113.326 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -138.45 152.98 48.82 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.929 1.692 . . . . 3.79 111.455 170.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.39 148.57 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.124 1.37 . . . . 2.44 111.178 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 tt -140.2 116.22 10.41 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.597 1.159 . . . . 3.42 109.244 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -93.58 136.25 34.04 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.93 -1.106 . . . . 2.41 112.054 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.8 t -131.43 165.27 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.982 1.713 . . . . 2.13 108.751 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.9 t -129.34 129.98 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.276 1.43 . . . . 1.71 108.781 172.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.5 mt -123.65 145.57 47.64 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 127.554 2.342 . . . . 2.17 110.063 -174.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.9 154.66 58.33 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.648 2.232 . . . . 0.86 110.475 166.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.7 t -92.88 125.28 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.224 -1.028 . . . . 1.03 108.224 167.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -152.61 167.96 27.17 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.668 1.223 . . . . 5.22 114.059 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -103.57 104.55 14.62 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.305 1.594 . . . . 2.23 115.305 -166.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 . . . . . 0 N--CA 1.483 1.203 1 C-N-CA 133.973 4.909 . . . . 7.63 112.555 162.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.567 ' N ' ' HG1' ' A' ' 21' ' ' THR . 24.3 mt-10 . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 120.889 0.376 . . . . 6.28 110.913 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.08 -178.86 34.46 Favored Glycine 0 N--CA 1.465 0.581 0 O-C-N 121.186 -0.947 . . . . 1.68 113.287 -173.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 26.0 p90 -152.0 148.67 28.0 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.825 0.85 . . . . 1.92 112.998 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.03 145.96 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.883 -1.154 . . . . 1.39 107.883 170.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -86.85 127.9 35.04 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.811 0.671 . . . . 4.47 112.811 -167.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -48.79 151.0 1.29 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.956 1.302 . . . . 2.73 112.766 168.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 t -163.19 148.23 9.32 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 122.895 0.478 . . . . 2.39 111.597 166.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -86.21 -6.4 8.28 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.2 2.6 . . . . 1.96 112.109 166.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.16 178.24 20.6 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.946 1.26 . . . . 1.11 114.004 -173.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.6 -15.8 33.96 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.122 3.215 . . . . 1.28 113.527 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -110.01 142.67 41.1 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.796 2.038 . . . . 2.4 113.841 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.69 -176.17 5.4 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 129.066 2.946 . . . . 0.5 110.848 -172.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.99 159.88 41.41 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.955 2.102 . . . . 0.84 109.391 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.46 137.05 48.43 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.08 1.309 . . . . 0.69 112.482 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -116.71 71.83 0.8 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.298 1.839 . . . . 2.56 109.6 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -83.54 157.54 22.31 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.737 -1.227 . . . . 1.69 111.685 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.567 ' HG1' ' N ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -90.78 131.53 36.38 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.263 -0.898 . . . . 2.45 109.676 179.013 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.24 129.53 52.04 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.847 0.459 . . . . 3.07 110.057 175.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -119.9 144.07 47.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.58 1.952 . . . . 3.76 107.638 167.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.02 79.1 0.53 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.71 0.804 . . . . 3.31 110.683 171.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.69 -6.03 18.29 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.346 2.03 . . . . 1.6 115.733 -174.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.96 160.61 33.93 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 119.535 1.061 . . . . 1.41 111.686 170.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.19 1.5 40.34 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.526 1.93 . . . . 3.81 112.162 174.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mp -123.48 156.19 64.52 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 127.03 2.132 . . . . 4.48 108.643 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.81 143.99 16.95 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.975 2.45 . . . . 1.25 111.04 -167.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.8 mt -100.47 150.32 22.77 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 123.076 1.417 . . . . 1.68 112.844 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -127.1 106.3 9.17 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 112.218 -2.265 . . . . 1.89 110.62 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.441 HD11 ' CZ ' ' A' ' 84' ' ' PHE . 2.7 tm? -85.87 110.97 19.78 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.658 1.983 . . . . 2.45 108.752 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.89 -19.85 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.254 1.022 . . . . 0.76 112.055 -171.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.7 -177.21 32.59 Favored Glycine 0 C--N 1.343 0.94 0 C-N-CA 124.989 1.281 . . . . 0.69 113.887 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.43 -178.78 5.66 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.709 1.204 . . . . 0.76 110.096 161.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -150.81 158.67 44.42 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.229 2.611 . . . . 4.73 107.072 172.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 t -169.5 153.11 5.06 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 126.438 1.895 . . . . 0.66 107.281 -171.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.58 -12.7 15.14 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.901 1.734 . . . . 0.84 112.921 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.42 45.34 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.061 0.945 . . . . 0.81 112.983 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.43 144.45 14.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.296 1.039 . . . . 0.98 111.491 164.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -86.49 -45.83 10.75 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.869 1.268 . . . . 2.92 111.328 171.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -109.93 134.38 52.15 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.816 1.247 . . . . 5.05 108.025 168.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -119.77 135.27 60.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 125.497 1.519 . . . . 1.09 108.299 166.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -126.66 154.23 44.33 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.747 2.019 . . . . 3.01 108.759 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.0 tp -111.18 124.44 52.2 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.741 0.816 . . . . 1.12 109.776 174.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -123.44 161.52 24.64 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.403 1.881 . . . . 0.66 114.262 -175.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.78 -179.2 3.87 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.721 2.409 . . . . 3.03 111.773 162.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.1 m -157.49 145.87 19.28 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.367 1.867 . . . . 0.91 107.645 170.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -153.42 172.93 16.33 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.183 1.393 . . . . 1.97 112.552 -168.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.4 mtm -103.44 143.64 32.44 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.905 0.882 . . . . 2.99 110.561 167.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -149.21 146.32 27.56 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.245 1.818 . . . . 8.81 111.144 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -86.91 145.97 26.35 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.75 1.22 . . . . 2.75 111.787 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 p -169.81 138.01 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 126.217 1.807 . . . . 3.0 108.273 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 72.92 -3.58 2.38 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 127.612 2.365 . . . . 4.91 114.818 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.99 33.19 24.46 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.277 0.942 . . . . 2.1 112.599 -161.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -141.47 144.39 34.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.838 2.455 . . . . 4.41 108.126 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.92 120.68 29.49 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.481 0.712 . . . . 7.48 110.604 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.451 HG12 ' H ' ' A' ' 59' ' ' MET . 39.8 t -125.12 -179.67 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 127.308 2.243 . . . . 2.29 107.982 -175.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.451 ' H ' HG12 ' A' ' 58' ' ' VAL . 8.3 mtm -113.78 159.97 19.2 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.583 -1.323 . . . . 4.12 112.835 175.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.43 165.74 25.17 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 125.726 1.631 . . . . 0.77 111.059 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.9 ttm -148.78 141.86 24.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.573 1.949 . . . . 0.81 108.453 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -150.11 151.21 31.44 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.938 1.695 . . . . 5.77 109.266 -170.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.04 155.23 42.74 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.071 1.847 . . . . 0.56 110.922 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.31 152.53 75.26 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.982 1.313 . . . . 0.77 110.008 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.82 -21.64 10.94 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.294 2.663 . . . . 0.7 112.865 -171.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -174.88 174.23 2.59 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.743 2.017 . . . . 1.91 110.756 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.4 mt -119.81 154.31 34.44 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.527 1.931 . . . . 0.49 109.671 160.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -112.87 145.13 41.23 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.917 1.287 . . . . 1.71 109.41 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 t -137.61 139.13 26.14 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.288 0.635 . . . . 0.98 112.689 171.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -83.6 156.19 14.02 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 124.201 3.267 . . . . 1.28 112.311 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.31 138.81 68.21 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.413 3.409 . . . . 1.27 115.109 -170.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt 67.15 -2.7 1.13 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.818 2.447 . . . . 3.19 115.455 173.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.76 176.29 54.6 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 127.431 2.443 . . . . 1.46 112.634 167.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.27 144.53 21.01 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.27 1.428 . . . . 4.19 111.279 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.9 t -154.13 127.39 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 126.366 1.866 . . . . 4.17 107.738 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.51 149.8 31.36 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.879 0.763 . . . . 5.09 111.603 172.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mp -73.8 73.86 1.58 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.796 1.284 . . . . 2.22 108.737 165.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -63.88 143.46 98.13 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 114.39 -1.277 . . . . 5.04 113.138 -170.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -63.67 -21.11 70.0 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.346 2.697 . . . . 2.31 113.982 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.57 48.2 2.33 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.248 0.928 . . . . 1.77 112.14 171.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.59 -121.6 1.04 Allowed Glycine 0 N--CA 1.468 0.802 0 C-N-CA 124.876 1.226 . . . . 1.52 114.085 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -74.21 134.35 42.73 Favored 'General case' 0 C--O 1.22 -0.494 0 O-C-N 121.928 -0.748 . . . . 2.12 112.432 -170.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -161.66 163.51 29.81 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.84 0.856 . . . . 0.61 111.358 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.441 ' CZ ' HD11 ' A' ' 32' ' ' LEU . 96.4 m-85 -90.72 150.22 21.72 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.287 -0.883 . . . . 2.25 110.629 168.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.6 tpt -104.79 134.07 48.54 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.35 1.06 . . . . 0.59 109.338 164.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -117.62 130.95 56.7 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.411 1.484 . . . . 0.52 108.076 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 mp -136.02 140.9 44.21 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.932 0.787 . . . . 1.77 111.992 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.74 44.91 11.43 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 123.744 0.688 . . . . 0.76 111.776 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.01 148.27 11.03 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 123.452 1.596 . . . . 1.28 115.049 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -105.01 -7.43 19.23 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.517 -1.674 . . . . 1.78 112.841 -176.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -144.14 138.06 14.59 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 127.61 2.364 . . . . 6.19 108.062 162.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.05 144.21 75.0 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.163 1.909 . . . . 1.94 108.308 164.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.427 ' H ' HD23 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -121.13 120.85 36.48 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.826 1.65 . . . . 2.75 109.87 -166.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -120.4 169.9 9.87 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.429 1.891 . . . . 3.76 114.234 -160.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.05 103.56 1.89 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.38 1.072 . . . . 1.75 111.553 -170.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.03 12.67 39.05 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 118.507 -1.163 . . . . 1.81 114.906 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -82.69 -172.87 4.31 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.742 1.271 . . . . 2.24 111.456 166.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 40.1 mt-10 -146.65 138.95 24.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.714 2.806 . . . . 4.0 106.161 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.0 t -137.97 121.73 21.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 125.04 1.336 . . . . 1.18 109.51 -173.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -84.57 150.49 25.18 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 122.242 1.02 . . . . 3.17 113.192 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.57 144.02 20.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.231 1.413 . . . . 3.5 114.231 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -104.98 114.34 28.49 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 128.066 2.546 . . . . 2.69 109.62 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.13 127.79 32.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.596 1.158 . . . . 1.43 108.802 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.3 mt -103.54 112.21 25.02 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.005 0.922 . . . . 0.94 109.882 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -108.16 146.81 32.19 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.437 1.495 . . . . 2.09 111.237 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.84 124.37 11.01 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.342 1.057 . . . . 1.87 113.089 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.2 70.75 1.22 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.457 1.027 . . . . 2.93 113.267 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.8 4.06 57.18 Favored Glycine 0 N--CA 1.476 1.331 0 N-CA-C 117.011 1.564 . . . . 2.2 117.011 163.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -93.47 110.69 22.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.55 1.675 . . . . 3.15 111.024 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.63 135.3 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.048 1.339 . . . . 1.99 109.319 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.1 tp -137.01 115.29 11.72 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.443 1.097 . . . . 2.18 110.571 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -79.77 131.8 36.0 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.762 -0.586 . . . . 2.2 112.316 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.3 t -124.87 169.85 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 128.509 2.724 . . . . 2.1 107.658 172.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.9 t -144.55 134.87 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.583 1.553 . . . . 1.9 108.094 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -131.11 152.34 80.47 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.185 0.994 . . . . 4.27 110.52 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 57.3 Cg_endo -63.97 168.42 12.21 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 124.018 3.145 . . . . 0.84 112.955 171.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.5 t -108.56 128.62 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.28 1.032 . . . . 1.14 110.996 173.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -120.57 147.11 45.62 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.459 1.504 . . . . 5.12 112.402 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.87 71.85 2.54 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.78 1.232 . . . . 2.71 111.766 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 127.276 2.231 . . . . 8.17 110.647 -178.81 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 . . . . . 0 CA--C 1.541 0.605 0 N-CA-C 109.318 -0.623 . . . . 6.7 109.318 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.84 169.48 15.21 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 121.621 -0.674 . . . . 1.19 114.779 -168.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -157.18 151.49 25.07 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.029 1.732 . . . . 2.07 112.125 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.4 t -87.22 121.4 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 107.486 -1.302 . . . . 1.28 107.486 164.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.24 118.23 20.26 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.488 0.715 . . . . 3.69 109.876 -175.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -55.85 153.71 8.13 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.186 1.395 . . . . 2.1 113.835 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.9 t -163.89 147.04 7.87 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.143 1.377 . . . . 2.07 110.395 173.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -86.85 6.37 5.37 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.889 3.059 . . . . 1.99 112.665 171.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.14 -170.19 15.72 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.15 1.357 . . . . 1.21 115.082 -168.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.78 -17.78 42.05 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.867 3.045 . . . . 1.76 113.717 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -138.22 156.16 47.96 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 116.048 1.87 . . . . 2.25 116.048 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.7 -178.73 5.26 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 131.01 3.724 . . . . 0.98 109.59 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.31 161.64 33.02 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.39 1.476 . . . . 0.81 108.442 168.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.04 135.73 50.27 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.197 0.999 . . . . 0.78 110.067 172.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -127.08 132.41 50.65 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.671 1.988 . . . . 2.66 107.673 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pp -170.07 149.86 3.65 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.413 1.006 . . . . 1.96 113.408 -164.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.6 m -79.15 121.84 25.52 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.023 1.729 . . . . 2.25 111.267 172.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.18 125.37 29.76 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.754 -0.832 . . . . 3.18 108.754 157.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -95.77 142.46 28.02 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.65 1.18 . . . . 3.9 107.943 161.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.44 72.51 2.53 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.217 1.007 . . . . 3.21 109.882 174.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.31 -20.11 61.97 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.979 2.453 . . . . 1.31 114.692 -172.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.67 -177.95 47.63 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 122.952 1.307 . . . . 1.25 113.096 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -104.96 -1.9 25.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.769 2.028 . . . . 2.86 112.204 -168.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -122.23 155.87 61.08 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 127.804 2.442 . . . . 2.05 109.973 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.98 140.45 20.24 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.781 2.321 . . . . 1.36 111.048 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.2 mt -93.87 151.16 19.78 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 123.197 1.475 . . . . 1.82 112.115 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.4 ttp-105 -135.53 106.71 6.74 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 112.589 -2.096 . . . . 2.25 110.568 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.6 tp -91.94 108.17 19.73 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.022 1.729 . . . . 1.86 109.95 -172.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -100.81 -20.94 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.107 1.363 . . . . 0.59 111.399 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.06 -178.31 31.97 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.006 1.289 . . . . 0.67 114.708 -176.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -156.27 -178.11 7.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.242 2.217 . . . . 0.89 110.437 172.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -160.84 151.76 18.63 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.494 1.043 . . . . 4.99 109.439 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -150.06 153.91 36.09 Favored Pre-proline 0 N--CA 1.472 0.645 0 O-C-N 121.101 -1.0 . . . . 0.78 109.836 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.58 -7.89 21.6 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.665 2.244 . . . . 1.02 113.604 171.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 m -124.25 44.9 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 114.246 1.202 . . . . 0.96 114.246 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.36 175.2 14.31 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.56 1.544 . . . . 1.3 109.3 164.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -114.45 -60.15 1.92 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.028 0.931 . . . . 3.5 108.826 160.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.6 mtp85 -82.35 106.83 14.54 Favored 'General case' 0 N--CA 1.458 -0.059 0 O-C-N 121.244 -0.91 . . . . 5.73 108.799 168.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.73 152.55 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 107.904 -1.147 . . . . 1.4 107.904 148.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -156.39 115.5 3.46 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.469 0.577 . . . . 3.0 111.31 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.1 tp -80.83 118.96 22.8 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.882 -1.136 . . . . 1.08 111.753 -174.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -125.24 152.96 43.89 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 123.219 1.485 . . . . 0.51 114.483 -172.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -95.31 177.11 5.95 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.36 1.864 . . . . 2.39 111.307 162.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.6 m -156.03 144.08 19.77 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.998 2.119 . . . . 0.71 106.6 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -160.04 163.38 34.01 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.723 1.379 . . . . 2.21 114.723 -165.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.88 145.33 27.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.852 1.261 . . . . 5.05 111.169 164.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.42 147.23 21.89 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.515 -0.741 . . . . 4.62 112.259 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -105.66 142.23 35.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 126.63 1.972 . . . . 2.78 111.84 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.2 t -144.95 133.54 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.566 1.946 . . . . 2.54 106.903 166.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 68.49 1.1 2.82 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 126.609 1.963 . . . . 3.0 114.71 -172.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.71 18.33 61.94 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.431 1.015 . . . . 2.26 113.572 -163.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -120.55 134.85 55.23 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.75 2.42 . . . . 2.81 108.282 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.63 142.45 28.24 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 125.545 1.538 . . . . 3.83 114.052 -173.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.16 169.6 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 129.241 3.016 . . . . 2.71 107.259 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.0 mtp -117.33 139.83 50.34 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.194 -0.941 . . . . 3.33 110.728 165.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.98 -179.81 16.07 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.487 1.041 . . . . 0.57 113.772 -175.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ttm -152.89 144.88 23.73 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.617 1.967 . . . . 0.59 109.1 -176.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -146.11 156.95 50.63 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 126.022 1.729 . . . . 5.15 108.924 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.89 156.34 43.48 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 121.886 1.724 . . . . 0.59 110.667 166.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.7 m -139.12 152.16 69.27 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 124.799 1.24 . . . . 0.57 110.543 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.3 -29.33 7.88 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.862 2.375 . . . . 0.53 112.175 -168.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -174.39 165.45 3.94 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.53 1.532 . . . . 2.09 111.867 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.8 mt -109.48 154.12 23.1 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.109 1.364 . . . . 0.61 110.386 164.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -113.49 147.35 38.06 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.975 1.31 . . . . 2.05 109.962 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.6 t -140.78 140.25 21.52 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.85 0.86 . . . . 0.92 111.959 169.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -88.1 155.9 7.03 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.648 3.565 . . . . 1.32 112.846 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.39 142.76 80.29 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.992 3.128 . . . . 1.2 113.75 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt 67.61 -9.65 0.42 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.763 2.425 . . . . 1.87 114.251 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.46 160.92 46.14 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.788 1.185 . . . . 1.54 111.98 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -116.63 140.87 48.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.752 0.821 . . . . 5.23 109.302 160.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.3 t -148.32 143.92 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.875 2.07 . . . . 3.71 106.895 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.21 150.51 39.96 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.288 1.404 . . . . 4.02 114.76 -165.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.2 mp -66.73 75.25 0.11 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.208 -1.405 . . . . 1.89 107.208 151.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.8 140.54 74.59 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 114.466 -1.243 . . . . 3.16 111.538 -167.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -55.52 -35.55 92.6 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.901 2.401 . . . . 2.02 112.321 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.68 6.9 57.01 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 116.88 -2.067 . . . . 1.85 116.27 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.19 -8.56 0.02 OUTLIER Glycine 0 N--CA 1.478 1.441 0 N-CA-C 122.331 3.692 . . . . 2.11 122.331 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -145.43 143.74 30.23 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 122.188 2.994 . . . . 2.06 113.163 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -162.26 157.77 23.39 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.508 0.723 . . . . 0.49 111.369 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 60.7 m-85 -82.99 138.64 33.68 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 107.945 -1.132 . . . . 1.64 107.945 158.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -79.2 134.79 36.67 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.203 1.401 . . . . 0.88 108.051 156.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 mp -116.61 125.87 52.43 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 106.591 -1.633 . . . . 1.06 106.591 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.4 tt -147.46 136.22 22.0 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.759 -0.588 . . . . 2.15 110.325 -167.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.25 47.36 8.32 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.129 -0.788 . . . . 1.03 111.129 -167.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mt -50.64 150.54 2.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 123.044 1.402 . . . . 3.27 112.706 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -106.83 -2.4 21.46 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.065 -1.425 . . . . 2.35 113.256 -169.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -153.29 154.27 30.5 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.652 1.181 . . . . 6.44 111.682 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.35 94.67 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.476 2.117 . . . . 2.54 107.667 160.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.15 164.93 15.44 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 125.826 1.651 . . . . 2.66 109.358 176.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -146.71 165.2 30.34 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 112.764 -2.016 . . . . 4.22 113.751 -160.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.9 118.54 10.53 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.701 -1.136 . . . . 1.43 108.777 166.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.9 10.13 43.84 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.378 -1.234 . . . . 1.42 115.974 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -86.24 -175.28 5.45 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.647 1.724 . . . . 2.14 112.122 165.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -146.46 156.22 43.13 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 130.056 3.342 . . . . 5.19 107.556 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 78.6 t -156.06 128.04 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 127.487 2.315 . . . . 1.19 109.812 -170.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -91.81 130.61 37.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.079 0.466 . . . . 4.84 110.536 168.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.5 tt -111.78 136.75 50.63 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.914 1.685 . . . . 2.84 110.821 173.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -87.32 150.28 23.95 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.744 2.018 . . . . 2.34 110.004 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.419 HD11 HG22 ' A' ' 113' ' ' VAL . 5.3 mp -123.83 134.44 53.6 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.059 1.344 . . . . 1.22 110.408 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.7 mt -112.78 118.13 34.09 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.011 1.324 . . . . 0.64 110.324 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -112.31 149.59 32.2 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.821 1.248 . . . . 1.92 110.906 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.95 149.22 27.8 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.474 0.71 . . . . 1.94 112.191 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.25 12.47 84.56 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 119.123 -0.821 . . . . 3.5 114.844 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.68 63.55 1.83 Allowed Glycine 0 N--CA 1.471 1.004 0 CA-C-N 118.965 1.383 . . . . 2.37 113.581 172.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -135.78 147.69 48.46 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.744 1.618 . . . . 3.92 111.611 169.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.2 t -138.34 146.69 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.437 1.095 . . . . 2.03 110.189 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.0 tp -145.38 169.88 17.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.209 1.804 . . . . 2.14 110.128 -177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -128.55 144.65 51.19 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.282 1.216 . . . . 2.42 114.282 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.419 HG22 HD11 ' A' ' 103' ' ' LEU . 11.6 m -130.7 162.44 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 126.057 1.743 . . . . 2.49 110.978 168.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 86.5 t -121.28 141.29 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.918 2.087 . . . . 2.21 107.113 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.1 mt -152.94 106.08 2.66 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 125.11 1.364 . . . . 2.07 109.718 -160.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.53 149.92 89.11 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.904 2.403 . . . . 0.92 110.822 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.5 t -91.83 116.87 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.646 -0.872 . . . . 1.11 108.646 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.94 149.88 27.75 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.5 1.12 . . . . 3.29 111.358 -153.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -106.23 91.97 3.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.125 0.97 . . . . 2.27 113.102 -164.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 125.925 1.69 . . . . 8.07 110.195 167.875 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 103.826 -2.657 . . . . 7.36 103.826 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.77 -175.49 41.32 Favored Glycine 0 N--CA 1.463 0.49 0 C-N-CA 124.239 0.923 . . . . 1.15 115.402 -168.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -142.21 -179.26 6.15 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.904 1.682 . . . . 1.83 111.572 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.7 142.87 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 121.114 -0.991 . . . . 1.49 109.804 174.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.44 ' HG3' HH11 ' A' ' 9' ' ' ARG . 1.0 OUTLIER -86.69 126.64 34.69 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.766 0.426 . . . . 3.96 112.08 -176.051 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -50.54 139.12 16.44 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.416 1.886 . . . . 2.12 113.458 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 m -157.55 149.11 16.97 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.556 1.142 . . . . 2.32 110.588 163.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -84.53 42.72 1.21 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.416 3.411 . . . . 1.89 110.762 167.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.95 158.56 15.09 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.605 1.097 . . . . 1.32 114.502 -164.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.37 -13.99 25.32 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.848 3.032 . . . . 1.19 112.574 165.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -135.22 155.33 50.83 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 129.398 3.079 . . . . 2.21 112.62 -175.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.94 -176.29 5.47 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.072 1.749 . . . . 0.57 112.138 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -154.56 130.14 9.91 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.709 1.604 . . . . 0.95 110.385 -177.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.29 141.5 49.94 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.627 1.171 . . . . 0.54 113.28 -169.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.425 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 39.9 m-85 -126.18 115.48 19.83 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.896 1.678 . . . . 2.43 109.986 -170.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.259 0.0 OUTLIER -159.73 -174.87 4.83 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.591 1.7 . . . . 2.92 115.591 -166.491 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.1 m -108.45 135.24 50.07 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.451 1.1 . . . . 2.09 111.34 -158.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.71 108.86 17.35 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.803 1.241 . . . . 3.69 108.394 171.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -99.32 138.6 36.18 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.014 0.926 . . . . 3.95 109.174 170.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -109.33 89.17 6.76 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 122.902 0.481 . . . . 1.51 109.924 161.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.41 -9.24 20.14 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.545 2.163 . . . . 1.07 113.065 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.95 -175.54 49.24 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 124.766 1.174 . . . . 1.2 113.195 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -111.81 -4.21 14.7 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.959 2.103 . . . . 3.27 112.41 -166.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mp -125.94 163.34 40.11 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 127.713 2.405 . . . . 3.99 108.664 174.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.62 145.79 18.59 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.38 2.054 . . . . 1.28 111.273 -171.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mp -105.21 148.24 27.16 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.62 1.168 . . . . 2.89 110.058 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -139.35 103.21 4.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.801 -1.545 . . . . 3.2 109.703 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.0 tt -80.96 119.53 23.6 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 124.527 1.131 . . . . 2.36 108.207 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.1 m -111.08 -12.53 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.291 1.036 . . . . 0.83 111.258 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.45 -176.21 30.24 Favored Glycine 0 C--N 1.343 0.936 0 C-N-CA 125.316 1.436 . . . . 0.66 114.085 -174.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.408 ' HB2' ' CE1' ' A' ' 84' ' ' PHE . . . -154.72 -179.5 8.06 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.93 1.692 . . . . 0.66 110.069 173.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.02 -177.99 6.98 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 125.85 1.66 . . . . 5.31 109.143 165.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 t -179.62 153.7 0.69 Allowed Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 128.043 2.537 . . . . 0.66 106.46 -169.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -73.71 -16.58 23.66 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 120.77 1.311 . . . . 0.8 112.602 172.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.3 m -113.19 41.5 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 114.631 1.345 . . . . 0.78 114.631 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.14 142.48 4.1 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.22 -0.925 . . . . 1.12 111.828 168.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -74.65 -57.02 4.19 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.912 0.885 . . . . 2.71 110.095 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -85.02 139.99 31.36 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.91 1.284 . . . . 5.37 108.385 163.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 p -108.91 153.89 10.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.368 -1.287 . . . . 1.16 108.207 140.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -135.02 151.86 51.18 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.704 2.002 . . . . 3.0 108.294 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.2 tp -106.53 124.46 49.64 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.288 0.635 . . . . 1.1 109.892 173.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.2 m170 -123.95 159.77 29.02 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.277 1.431 . . . . 0.54 114.131 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.58 159.39 22.98 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.388 1.875 . . . . 2.31 110.743 163.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 m -135.33 145.33 47.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.079 1.751 . . . . 0.83 106.796 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -157.97 171.0 21.04 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.18 0.99 . . . . 1.99 113.54 -167.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.6 ttp -100.7 135.99 41.28 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.265 1.826 . . . . 3.17 110.134 168.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.14 138.45 40.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.636 1.175 . . . . 5.65 110.731 171.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -92.43 126.32 37.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.411 1.484 . . . . 3.43 112.9 -177.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 m -136.01 142.57 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.722 1.609 . . . . 2.49 108.249 169.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 70.15 -3.18 1.86 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 126.003 1.721 . . . . 4.13 115.065 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.43 22.82 39.04 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.769 1.176 . . . . 2.09 113.791 -161.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt -133.97 132.31 40.01 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.722 2.409 . . . . 3.73 109.56 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.421 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -67.36 121.36 15.57 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 120.575 -1.328 . . . . 4.75 112.28 170.189 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.7 m -97.94 171.36 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.703 1.201 . . . . 2.25 108.759 151.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 70.0 mtm -111.23 156.63 21.17 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.477 0.711 . . . . 3.46 111.103 164.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.39 176.04 23.07 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.898 1.237 . . . . 0.58 112.288 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.0 ttm -151.41 143.47 23.94 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.836 1.654 . . . . 0.64 109.748 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -148.97 154.03 39.2 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.624 1.57 . . . . 5.59 109.604 -173.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -76.67 161.03 34.25 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.425 2.084 . . . . 0.6 111.364 172.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.25 155.83 64.61 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.692 1.597 . . . . 0.79 110.977 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -82.62 -27.82 1.99 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.592 2.861 . . . . 0.72 113.375 -169.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -174.44 165.4 3.9 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.178 1.391 . . . . 2.17 111.916 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 mt -114.82 158.47 21.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.484 1.914 . . . . 0.89 109.727 161.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -141.33 148.13 39.24 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.908 0.883 . . . . 2.26 111.353 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -145.68 131.92 9.66 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.104 0.962 . . . . 1.17 112.438 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.4 161.71 41.92 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.578 3.519 . . . . 1.67 112.83 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.36 140.96 79.45 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.065 3.177 . . . . 1.47 113.435 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 67.73 -1.65 1.59 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.135 2.174 . . . . 2.03 113.818 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.95 164.2 38.73 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.721 1.629 . . . . 1.49 111.952 171.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.03 139.77 20.76 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.693 1.197 . . . . 4.25 110.439 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.2 t -152.85 144.95 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.216 1.807 . . . . 3.75 108.34 -165.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -126.31 145.05 50.58 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 122.034 0.921 . . . . 4.33 113.464 -168.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 mp -75.75 74.09 2.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.097 2.559 . . . . 1.98 109.495 171.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.438 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -64.0 146.5 97.26 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.175 0.99 . . . . 3.23 112.798 176.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.425 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 36.2 Cg_endo -60.43 -36.93 84.71 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.683 2.256 . . . . 2.33 113.37 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.89 44.33 2.77 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.162 0.887 . . . . 1.68 113.498 171.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.63 -124.3 1.14 Allowed Glycine 0 C--N 1.338 0.669 0 C-N-CA 125.44 1.495 . . . . 1.59 113.018 176.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -73.28 139.74 46.33 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.816 -0.814 . . . . 2.38 112.314 -171.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -162.19 166.97 24.86 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.326 1.45 . . . . 0.69 111.708 -174.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 35' ' ' ALA . 95.0 m-85 -95.04 148.4 22.38 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.885 -0.509 . . . . 1.72 110.112 167.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.3 tpt -105.28 139.81 39.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.589 1.556 . . . . 0.61 109.347 165.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -113.5 135.26 54.09 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.461 1.504 . . . . 0.72 108.344 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.89 133.19 41.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.649 0.78 . . . . 2.11 110.663 174.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.11 50.88 4.17 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 124.148 0.88 . . . . 0.79 113.013 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.9 mt -52.31 156.84 1.58 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.674 1.731 . . . . 2.53 115.674 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -116.89 -25.09 7.38 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.861 -1.063 . . . . 1.82 113.68 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -114.49 138.68 23.25 Favored Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 126.649 1.98 . . . . 5.74 107.075 158.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.88 133.49 31.53 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 N-CA-C 107.097 -1.924 . . . . 1.66 107.097 162.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.25 78.92 1.31 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.294 0.637 . . . . 2.83 110.439 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -68.7 163.87 22.93 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.948 0.88 . . . . 4.56 112.502 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.89 117.44 10.56 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.435 -1.32 . . . . 2.25 107.435 168.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.86 14.55 59.27 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 117.903 -1.498 . . . . 1.86 115.227 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.56 175.18 5.79 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.957 1.879 . . . . 2.7 109.378 155.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.44 171.56 8.45 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.455 -1.683 . . . . 5.51 106.455 150.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.4 t -138.17 119.89 17.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 C-N-CA 128.775 2.83 . . . . 1.92 107.505 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.81 141.68 36.0 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.399 0.68 . . . . 3.53 109.857 167.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.28 139.23 53.48 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.863 1.265 . . . . 1.71 110.951 171.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.02 149.54 23.94 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 129.698 3.199 . . . . 2.04 110.303 158.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -127.93 119.81 26.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.592 1.957 . . . . 0.8 108.537 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.2 mt -103.58 121.14 42.3 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.307 1.043 . . . . 0.67 111.147 -171.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -114.5 144.52 43.22 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.039 1.336 . . . . 2.08 112.361 -174.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.86 144.63 48.2 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.411 -0.813 . . . . 1.84 110.963 169.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.81 27.36 38.44 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 118.828 -0.984 . . . . 3.48 114.015 -174.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.99 36.24 32.58 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 124.703 1.144 . . . . 1.88 115.243 163.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -129.65 143.59 50.89 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.39 1.095 . . . . 3.38 112.897 -168.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.6 p -133.01 150.89 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.828 1.651 . . . . 2.01 111.034 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 31.4 tp -144.43 159.62 42.43 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.334 2.254 . . . . 2.29 108.764 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -126.85 167.99 15.07 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.335 0.971 . . . . 3.08 113.439 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.9 m -149.05 159.33 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 127.111 2.164 . . . . 2.64 110.73 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.9 t -118.86 123.52 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.466 1.106 . . . . 1.64 110.148 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.9 mt -124.9 123.89 25.51 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.701 1.2 . . . . 2.09 110.083 -170.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.37 155.37 36.7 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.927 2.418 . . . . 1.01 111.504 174.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.4 t -94.94 115.11 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.427 0.632 . . . . 1.06 111.062 172.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -93.95 130.16 40.15 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.504 1.122 . . . . 4.05 111.249 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.34 152.01 22.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.261 1.024 . . . . 4.54 108.528 151.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 . . . . . 0 C--O 1.245 0.857 0 C-N-CA 127.322 2.249 . . . . 9.3 109.62 -175.243 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 CA--C 1.541 0.611 0 CA-C-O 122.611 1.196 . . . . 4.91 112.766 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.29 -178.19 27.49 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 125.142 1.353 . . . . 1.01 112.064 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -155.67 164.77 38.17 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.537 0.94 . . . . 1.86 113.537 171.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.4 t -106.86 141.25 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.337 1.455 . . . . 0.98 108.751 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -74.69 -1.63 22.7 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.416 1.636 . . . . 4.36 115.416 -172.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 64.16 172.38 0.18 Allowed 'General case' 0 CA--C 1.554 1.129 0 CA-C-N 119.919 1.236 . . . . 2.2 111.567 -170.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.4 t -160.24 154.52 19.98 Favored Pre-proline 0 N--CA 1.468 0.457 0 O-C-N 120.275 -1.515 . . . . 3.08 110.38 163.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -85.23 -3.48 9.49 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.576 2.85 . . . . 2.08 112.312 161.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.15 -173.51 13.35 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.426 1.488 . . . . 1.45 114.587 -173.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.23 -18.83 20.48 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.948 3.099 . . . . 1.85 113.849 -175.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -104.77 143.44 33.12 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.485 1.914 . . . . 2.66 113.868 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.61 -178.86 7.3 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.59 1.956 . . . . 0.66 112.405 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.34 134.33 25.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.924 2.089 . . . . 0.75 108.661 177.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.81 138.01 53.63 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.888 1.275 . . . . 0.85 111.314 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -116.81 64.57 0.72 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.707 1.603 . . . . 2.42 111.209 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.26 155.75 40.33 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.125 1.157 . . . . 2.16 114.125 -172.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.5 m -92.66 147.21 23.06 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.556 1.143 . . . . 2.15 109.769 166.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 tp -130.86 114.11 14.88 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.282 2.233 . . . . 3.47 110.135 173.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -98.79 121.34 40.61 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.798 1.639 . . . . 5.19 110.122 170.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -95.68 104.09 15.02 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 120.89 -1.132 . . . . 1.82 110.101 165.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -83.18 -10.15 10.26 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.961 2.441 . . . . 1.28 113.443 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.66 171.4 54.64 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 123.154 1.419 . . . . 1.3 113.166 -173.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.41 -6.1 34.79 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 128.609 2.764 . . . . 3.28 112.171 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.5 mt -117.76 162.59 28.25 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 127.49 2.316 . . . . 3.65 109.178 171.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -81.51 153.23 17.93 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.66 2.24 . . . . 1.18 111.211 -172.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.8 mt -102.32 155.08 18.47 Favored 'General case' 0 C--O 1.227 -0.101 0 CA-C-O 122.758 1.266 . . . . 1.94 110.374 166.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -140.24 118.89 12.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 113.661 -1.609 . . . . 1.91 109.624 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.2 tp -100.53 108.79 20.81 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.902 1.281 . . . . 1.67 109.909 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 m -104.38 -17.84 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.15 0.98 . . . . 0.6 111.833 -173.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.99 -179.04 31.63 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 125.412 1.482 . . . . 0.56 112.304 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.96 178.16 7.55 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.073 1.349 . . . . 0.88 109.926 165.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -157.38 178.65 10.07 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.005 1.722 . . . . 6.49 108.18 176.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 t 177.29 152.05 0.4 Allowed Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 126.642 1.977 . . . . 0.85 109.527 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.06 -10.49 27.33 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.731 2.287 . . . . 1.03 114.22 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.3 m -116.72 41.43 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.691 0.997 . . . . 0.86 113.691 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.84 144.97 23.83 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.259 -0.9 . . . . 1.01 110.87 162.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -93.21 -47.46 6.93 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.07 1.348 . . . . 3.71 111.447 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.11 161.23 19.77 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.313 1.845 . . . . 6.96 107.659 168.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.74 138.66 10.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 126.178 1.791 . . . . 1.48 108.979 -173.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.55 145.52 48.79 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.884 1.674 . . . . 3.05 109.873 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.8 tp -101.35 120.21 39.92 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.216 1.006 . . . . 1.07 110.783 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -123.53 155.38 37.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.102 1.761 . . . . 0.59 113.65 -174.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -99.97 162.69 12.83 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.153 -1.385 . . . . 2.47 111.685 156.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 m -121.61 136.76 54.93 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.153 1.781 . . . . 0.68 106.571 162.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -134.83 176.16 8.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.965 1.306 . . . . 1.92 112.895 -175.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.5 ptm -123.62 146.04 48.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.012 1.325 . . . . 3.2 112.863 167.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.19 138.9 24.18 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.855 2.062 . . . . 6.09 110.122 -176.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -95.13 121.88 37.22 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.833 1.253 . . . . 3.41 110.809 175.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.2 m -88.67 -120.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.973 -1.121 . . . . 3.57 107.973 172.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.07 37.67 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 130.106 3.362 . . . . 4.35 116.429 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.81 22.1 68.02 Favored Glycine 0 CA--C 1.528 0.879 0 O-C-N 119.182 -2.199 . . . . 2.36 111.504 -164.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.87 132.26 56.74 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.767 2.027 . . . . 6.61 108.264 174.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.83 131.76 34.49 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.944 1.298 . . . . 8.31 110.822 -175.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.58 150.6 20.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 124.369 1.068 . . . . 2.45 110.663 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -111.34 136.89 49.81 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.641 1.176 . . . . 2.94 110.27 -175.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.12 -176.67 14.52 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 124.968 1.27 . . . . 0.57 112.262 -174.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ttm -152.85 146.62 25.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.175 1.39 . . . . 0.63 108.914 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -156.5 152.84 23.63 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 123.779 0.832 . . . . 5.95 110.815 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.29 152.39 55.51 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.953 1.769 . . . . 0.57 111.176 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.99 153.62 71.87 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.847 1.659 . . . . 0.67 109.747 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.63 -25.3 3.76 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.961 2.44 . . . . 0.56 113.279 -166.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -177.18 164.61 2.23 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.729 1.611 . . . . 1.81 111.751 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.7 mt -111.79 153.96 25.78 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.424 1.49 . . . . 0.57 109.967 163.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -110.11 147.25 34.01 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.388 1.075 . . . . 2.15 109.2 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.5 t -139.85 129.53 13.84 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 113.018 0.747 . . . . 1.11 113.018 170.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -71.1 164.97 33.91 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.484 2.79 . . . . 1.25 112.494 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -59.63 143.48 99.65 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.347 2.698 . . . . 1.23 111.929 172.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt 67.02 -4.06 0.86 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.318 1.847 . . . . 2.09 114.26 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.36 134.8 13.15 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.713 1.625 . . . . 1.39 113.088 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -97.84 138.89 34.52 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.646 1.178 . . . . 5.33 110.139 164.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.3 t -144.9 132.12 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.059 1.343 . . . . 3.12 108.0 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.49 136.48 49.56 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.6 0.714 . . . . 3.25 110.827 172.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mp -71.19 78.13 0.7 Allowed 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 125.45 1.5 . . . . 2.51 109.1 165.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -76.08 156.13 84.17 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.248 1.419 . . . . 3.6 114.159 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.79 -18.29 62.03 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.571 2.18 . . . . 2.07 113.093 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.22 36.18 2.18 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.154 -0.804 . . . . 2.51 112.819 166.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.71 -118.88 0.91 Allowed Glycine 0 C--N 1.344 0.974 0 C-N-CA 124.751 1.167 . . . . 1.79 115.066 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -72.15 142.07 49.1 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 121.812 -0.817 . . . . 1.93 111.937 -165.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -161.98 171.35 17.75 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.354 1.062 . . . . 0.76 112.251 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -107.33 133.4 51.93 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.14 0.576 . . . . 2.0 110.758 170.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.1 tpt -82.08 128.64 34.33 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.23 1.412 . . . . 0.75 109.324 163.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.4 mp -116.6 134.32 54.97 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.838 1.255 . . . . 0.97 108.971 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.8 mt -135.58 132.94 37.78 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.752 0.821 . . . . 2.09 110.738 -170.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.49 36.56 26.23 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.606 -1.108 . . . . 0.91 114.065 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -45.05 150.62 0.38 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 116.528 2.047 . . . . 1.31 116.528 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -106.74 7.13 30.25 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 113.713 -1.585 . . . . 2.32 113.901 -169.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.9 ptm85 -145.32 147.6 34.5 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.959 1.304 . . . . 4.78 111.627 167.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.07 149.64 71.54 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.297 1.998 . . . . 1.89 108.435 158.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.72 134.54 25.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.462 1.105 . . . . 3.95 110.512 -156.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.5 mmtm -103.32 171.99 7.06 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.068 1.347 . . . . 3.8 111.489 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.58 134.6 46.54 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.822 -1.177 . . . . 1.19 107.822 148.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.24 21.91 16.36 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.44 1.495 . . . . 1.23 115.405 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -105.79 -174.96 2.66 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.412 1.606 . . . . 1.86 111.815 168.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -147.45 131.63 17.39 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 129.747 3.219 . . . . 5.58 105.344 -169.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.1 t -140.5 130.5 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.093 0.957 . . . . 0.95 110.985 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -76.09 141.66 41.94 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.326 1.051 . . . . 2.71 110.052 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 mp -128.15 136.81 51.63 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.816 0.846 . . . . 1.76 111.969 167.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -90.77 134.19 34.62 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 127.131 2.172 . . . . 2.54 109.339 173.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.73 118.01 35.49 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 119.702 1.137 . . . . 0.93 110.065 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 72.2 mt -90.42 102.18 14.92 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.577 -0.897 . . . . 0.88 108.577 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -92.43 142.65 27.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.467 0.707 . . . . 2.55 111.274 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.15 124.0 10.64 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.54 1.136 . . . . 1.59 112.109 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.1 46.99 19.8 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.712 -1.049 . . . . 2.99 114.296 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.84 25.29 25.36 Favored Glycine 0 N--CA 1.475 1.246 0 N-CA-C 117.172 1.629 . . . . 1.89 117.172 156.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.57 148.1 39.96 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.453 1.626 . . . . 3.9 111.221 168.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -140.28 151.63 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.786 1.234 . . . . 1.83 110.935 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.9 tp -155.38 138.09 15.2 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.874 1.669 . . . . 2.48 109.548 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -110.21 115.71 30.21 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.692 0.678 . . . . 1.96 112.504 -173.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.6 m -89.31 178.12 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.057 1.743 . . . . 2.3 111.592 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.7 p -142.42 145.28 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.078 1.351 . . . . 2.38 109.041 170.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.4 143.75 13.82 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.078 0.951 . . . . 2.27 113.126 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.54 156.69 63.23 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.965 3.11 . . . . 0.9 112.953 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.7 t -106.34 124.93 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.513 1.525 . . . . 0.9 109.314 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -146.83 155.21 42.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.267 1.827 . . . . 3.85 110.541 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -112.55 129.5 56.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.083 0.953 . . . . 2.74 113.011 -165.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 C-N-CA 126.379 1.872 . . . . 7.64 111.968 167.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 N--CA 1.468 0.468 0 CA-C-O 122.156 0.979 . . . . 7.23 108.554 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.35 165.71 33.96 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.866 1.698 . . . . 0.91 112.407 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 21.8 p90 -155.65 152.11 28.27 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.319 1.448 . . . . 1.72 111.971 174.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.0 t -89.39 137.87 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.388 -0.82 . . . . 1.34 109.021 171.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -62.53 -4.6 2.02 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.121 1.768 . . . . 4.15 115.729 -168.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 72.6 159.89 0.22 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.569 1.948 . . . . 2.71 111.154 -167.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.9 t -168.87 135.71 1.53 Allowed Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 121.155 -0.966 . . . . 2.45 111.077 163.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -81.42 -6.88 12.81 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.271 2.648 . . . . 1.94 112.235 169.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.59 171.99 15.06 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.48 1.515 . . . . 1.04 113.551 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.76 -13.45 34.31 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.944 3.763 . . . . 1.27 115.454 -172.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -123.41 144.4 49.51 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.639 1.575 . . . . 3.67 112.256 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.69 -176.49 4.67 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.367 1.867 . . . . 0.45 112.012 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.97 154.3 39.18 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.694 1.997 . . . . 0.76 108.504 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.51 146.48 42.02 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.75 1.22 . . . . 0.79 114.227 -173.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.464 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 30.2 m-85 -120.7 143.6 48.66 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.867 2.067 . . . . 2.45 110.184 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pp -171.38 151.62 3.11 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.441 1.275 . . . . 2.03 114.441 -175.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.4 m -79.13 144.27 34.67 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.923 1.689 . . . . 1.96 111.359 174.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.5 126.99 54.97 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 129.502 3.121 . . . . 3.54 108.057 168.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -118.94 127.46 53.5 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.802 1.241 . . . . 4.24 109.663 168.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -100.46 93.44 2.76 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 123.606 0.762 . . . . 1.43 110.061 170.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.54 -8.89 18.52 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.025 1.817 . . . . 1.36 112.983 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.42 162.45 34.83 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 122.684 1.158 . . . . 1.23 111.643 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -94.53 3.27 55.33 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.352 2.661 . . . . 2.99 112.046 -170.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -122.21 154.32 61.87 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 129.242 3.017 . . . . 1.98 109.678 174.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.78 147.01 30.59 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.759 2.306 . . . . 0.86 111.024 -172.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.6 mt -104.2 147.93 26.9 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 122.465 1.126 . . . . 1.95 110.537 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -136.73 99.04 3.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.562 -2.108 . . . . 2.26 110.725 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.2 tp -80.73 106.43 12.73 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.669 1.588 . . . . 2.0 109.727 -173.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -99.19 -21.18 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.771 1.229 . . . . 0.81 112.209 -175.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.16 -177.16 31.98 Favored Glycine 0 C--N 1.343 0.947 0 C-N-CA 124.96 1.266 . . . . 0.74 114.937 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.07 -177.24 5.35 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.562 1.945 . . . . 0.74 111.131 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.429 HH12 HG11 ' A' ' 110' ' ' VAL . 40.9 mtt85 -146.55 -179.42 6.76 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.809 2.044 . . . . 6.65 108.062 158.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t -174.77 152.08 1.54 Allowed Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 127.12 2.168 . . . . 0.82 108.299 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.78 -6.29 15.94 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.025 1.817 . . . . 0.99 113.899 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.434 HG22 HG11 ' A' ' 99' ' ' VAL . 35.7 m -115.23 45.31 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.532 1.133 . . . . 0.9 112.854 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.33 171.76 19.81 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.665 1.186 . . . . 1.28 111.8 168.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -104.96 -23.49 12.97 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 128.464 2.706 . . . . 2.83 111.221 166.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -152.26 160.49 43.34 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.44 2.296 . . . . 6.59 110.858 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.2 p -156.93 117.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 125.815 1.646 . . . . 1.8 110.301 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -131.28 130.68 43.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.954 -1.021 . . . . 5.0 111.352 -166.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 31.3 tp -83.3 122.51 28.54 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.958 0.903 . . . . 1.4 111.746 -168.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.3 m170 -124.75 160.78 27.87 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.618 1.567 . . . . 0.69 113.356 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -107.18 154.17 21.59 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 113.467 -1.697 . . . . 2.37 110.721 157.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.0 m -111.18 138.33 47.75 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.265 1.826 . . . . 1.04 106.521 162.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -133.78 174.19 10.72 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.191 1.396 . . . . 2.0 112.968 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.0 ttp -113.0 143.0 45.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.628 1.571 . . . . 3.52 109.833 166.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -138.31 152.67 48.72 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.135 1.374 . . . . 4.77 112.036 171.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -95.84 146.93 24.17 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.104 1.762 . . . . 2.2 110.602 163.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 m -147.93 130.71 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.885 2.074 . . . . 2.26 108.837 162.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 62.98 15.84 8.74 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.577 1.551 . . . . 3.35 114.34 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.71 16.79 69.63 Favored Glycine 0 N--CA 1.479 1.513 0 O-C-N 121.054 -1.029 . . . . 1.68 113.741 -169.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.9 mtmt -119.27 122.17 41.3 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.974 2.11 . . . . 3.46 108.071 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.47 128.43 38.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.869 1.268 . . . . 3.69 111.76 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 t -143.69 141.73 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 127.208 2.203 . . . . 2.76 108.662 -174.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 50.6 mtp -83.54 162.93 20.72 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.358 0.663 . . . . 3.33 112.655 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.56 -177.47 28.83 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 125.118 1.342 . . . . 0.91 112.397 -177.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.1 ttm -154.79 148.25 25.16 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.531 1.133 . . . . 0.92 109.844 -172.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -155.89 153.7 26.36 Favored Pre-proline 0 N--CA 1.474 0.736 0 C-N-CA 123.779 0.832 . . . . 6.17 111.475 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.77 156.56 39.65 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.499 2.133 . . . . 0.68 111.262 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.7 m -138.88 153.03 71.54 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 125.114 1.366 . . . . 0.65 110.148 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.32 -24.7 5.27 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.656 2.904 . . . . 0.75 113.337 -167.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -174.99 167.0 3.58 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.621 1.968 . . . . 2.13 110.929 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.4 mt -109.6 153.34 24.31 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.526 1.13 . . . . 0.73 110.31 159.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -108.94 143.65 37.91 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.234 1.014 . . . . 1.86 109.167 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.7 t -136.88 124.3 14.28 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.386 0.674 . . . . 0.96 110.989 165.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -69.82 164.51 34.33 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.773 2.982 . . . . 0.96 111.643 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.66 147.89 92.49 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.017 2.478 . . . . 0.97 113.301 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt 69.73 -14.04 0.37 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.335 2.654 . . . . 1.74 114.219 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.62 172.63 42.9 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.18 1.372 . . . . 1.42 113.572 -171.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.68 143.94 35.37 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.89 0.876 . . . . 4.44 111.119 168.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.5 t -151.17 158.49 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 127.379 2.272 . . . . 3.8 107.213 -168.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.43 152.74 42.91 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 121.075 1.761 . . . . 3.77 114.088 176.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.1 mp -59.95 91.16 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 107.311 -1.366 . . . . 1.91 107.311 155.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -49.93 126.0 18.8 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 125.351 1.46 . . . . 3.47 111.831 -165.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 19.7 Cg_endo -60.96 -13.75 29.04 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.878 2.385 . . . . 2.71 116.678 -172.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.39 -1.39 29.5 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-N 120.101 1.319 . . . . 2.72 115.277 167.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.94 -103.8 1.2 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.359 1.933 . . . . 1.94 112.466 -168.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -72.49 139.12 47.45 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.269 -1.136 . . . . 2.0 112.059 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -160.22 149.74 17.72 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.561 1.144 . . . . 0.6 110.519 -173.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -83.25 130.09 35.05 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.298 -1.001 . . . . 1.62 108.298 165.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -80.04 133.08 36.11 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.279 0.945 . . . . 0.65 108.832 163.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 mp -109.56 126.92 54.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.342 1.057 . . . . 0.58 109.369 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -118.89 130.1 55.55 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 124.227 1.011 . . . . 3.39 109.647 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.54 54.74 3.87 Favored Glycine 0 N--CA 1.476 1.363 0 C-N-CA 123.744 0.688 . . . . 0.76 114.662 167.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.34 158.68 4.06 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 117.673 2.471 . . . . 1.55 117.673 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -116.29 -25.62 7.48 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 113.08 -1.873 . . . . 1.76 112.855 -171.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -117.81 151.83 49.2 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 129.48 3.112 . . . . 7.05 107.811 159.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.99 140.66 38.52 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.229 1.953 . . . . 1.8 108.611 164.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.6 mp -95.74 89.21 5.23 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.158 0.504 . . . . 2.44 110.259 -175.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -75.21 174.16 9.85 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.268 0.556 . . . . 5.07 111.758 167.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.72 146.45 44.41 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.501 -1.296 . . . . 1.35 107.501 165.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.32 34.5 63.96 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 117.866 -1.519 . . . . 1.6 114.163 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -94.73 174.04 7.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.14 1.47 . . . . 2.65 109.185 157.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -135.5 127.77 30.14 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 105.092 -2.188 . . . . 4.35 105.092 169.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.434 HG11 HG22 ' A' ' 39' ' ' VAL . 10.7 t -152.45 140.05 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.944 1.298 . . . . 2.04 110.331 -175.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -78.3 154.67 30.69 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 113.394 0.887 . . . . 3.64 113.394 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.9 137.36 51.79 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.264 -1.334 . . . . 1.81 110.4 149.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.41 150.6 31.28 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.582 1.153 . . . . 2.59 108.611 159.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.0 mp -123.86 127.69 48.39 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.025 1.33 . . . . 1.02 110.209 175.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.3 mt -110.65 114.12 27.26 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.99 1.716 . . . . 1.12 110.226 -172.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -113.21 123.59 50.55 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.759 1.224 . . . . 1.95 111.613 -172.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 48.01 32.13 2.75 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.308 1.843 . . . . 2.25 113.502 176.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.25 -73.96 2.35 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.107 1.337 . . . . 4.97 112.689 -172.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.15 -26.36 44.62 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 116.44 1.336 . . . . 2.07 116.44 -161.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -83.81 109.46 17.56 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.58 1.69 . . . . 4.82 111.716 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.429 HG11 HH12 ' A' ' 36' ' ' ARG . 58.8 t -98.52 134.46 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.399 1.48 . . . . 1.78 110.712 174.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -136.68 171.62 14.22 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.811 1.644 . . . . 3.36 109.606 166.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -149.6 143.96 25.88 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.786 -1.196 . . . . 2.02 112.007 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.84 150.57 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.137 0.975 . . . . 2.35 110.011 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.83 133.51 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.523 1.529 . . . . 1.65 107.641 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.4 mt -139.07 145.58 45.76 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.422 1.089 . . . . 2.56 109.918 -173.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.14 162.46 35.61 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.796 2.331 . . . . 0.73 112.444 167.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 42.6 t -112.07 122.5 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.189 -1.411 . . . . 0.99 107.189 165.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -146.48 154.54 41.69 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.467 1.507 . . . . 4.48 110.391 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.03 141.85 28.4 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.484 0.92 . . . . 2.35 113.484 -168.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.541 ' HB2' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.976 0 C-N-CA 126.157 1.783 . . . . 8.6 112.103 169.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 123.078 1.418 . . . . 6.37 112.065 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.98 179.03 21.62 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 121.161 -0.962 . . . . 1.0 111.393 173.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.3 p90 -148.94 157.06 43.14 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.778 0.831 . . . . 1.78 112.053 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.2 t -97.56 143.65 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 107.65 -1.241 . . . . 1.3 107.65 173.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -73.87 127.27 32.4 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.438 -0.789 . . . . 4.78 110.816 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -36.02 148.49 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.675 1.99 . . . . 2.52 113.333 155.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.9 t -160.25 146.75 11.96 Favored Pre-proline 0 CA--C 1.536 0.439 0 O-C-N 120.884 -1.135 . . . . 2.31 112.333 166.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -85.89 -6.81 8.52 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.18 2.587 . . . . 2.0 112.693 170.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -137.58 -176.58 14.53 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.73 1.157 . . . . 1.12 114.423 -172.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.3 -17.92 44.56 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.483 3.455 . . . . 1.49 115.097 -169.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -97.85 142.07 30.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.19 1.396 . . . . 2.81 112.64 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.14 -176.48 5.69 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.484 1.514 . . . . 0.69 111.944 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.21 152.3 32.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.675 1.59 . . . . 0.72 109.708 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.08 124.27 47.65 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.09 1.314 . . . . 0.82 111.773 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -102.16 57.39 0.81 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.812 1.645 . . . . 2.81 109.635 173.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -75.12 162.93 28.08 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.057 0.943 . . . . 1.93 113.163 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 99.0 m -143.58 137.38 28.33 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.892 1.677 . . . . 2.5 110.869 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.616 HD21 HG11 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -135.1 156.52 48.87 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.255 2.222 . . . . 4.94 109.018 169.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -84.79 160.89 20.15 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.196 1.362 . . . . 3.39 110.507 154.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -97.86 94.33 2.09 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 109.042 -0.725 . . . . 1.8 109.042 155.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.98 -6.27 14.96 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.063 2.509 . . . . 1.86 113.433 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.33 164.52 52.53 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-O 122.722 1.179 . . . . 1.76 112.082 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -87.02 -5.89 58.92 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.661 1.584 . . . . 3.78 111.742 175.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 pp -116.04 159.13 40.57 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 127.666 2.387 . . . . 2.56 111.198 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.01 145.29 22.07 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.576 2.184 . . . . 1.34 111.046 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.1 mt -99.33 142.84 30.29 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 123.018 1.39 . . . . 2.46 111.727 170.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.42 ' HD2' ' CD2' ' A' ' 66' ' ' PHE . 16.4 tpp85 -131.47 98.38 4.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 112.119 -2.31 . . . . 1.97 109.474 -174.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.9 tp -91.39 109.27 20.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.565 1.546 . . . . 1.9 109.691 -171.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.7 m -103.68 -22.07 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.826 0.85 . . . . 0.57 112.084 -173.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.88 -177.08 30.65 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.466 1.508 . . . . 0.52 114.288 -173.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.35 178.38 8.83 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.8 1.64 . . . . 0.52 112.269 171.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.8 161.08 36.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.54 2.336 . . . . 6.22 109.12 174.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 t -176.25 154.08 1.33 Allowed Pre-proline 0 N--CA 1.471 0.6 0 C-N-CA 128.08 2.552 . . . . 0.71 107.176 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.16 -20.16 19.27 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.85 1.7 . . . . 0.94 112.499 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.6 m -99.1 35.27 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.799 0.809 . . . . 0.84 112.899 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.14 143.05 16.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.982 1.313 . . . . 1.03 109.234 166.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -91.51 -49.42 6.32 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.63 1.572 . . . . 3.81 110.592 -176.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.99 160.15 22.53 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.468 1.907 . . . . 6.48 107.665 167.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.1 p -142.52 145.45 23.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 126.067 1.747 . . . . 1.35 108.049 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -129.47 148.74 51.41 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.057 1.743 . . . . 3.06 108.771 174.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.5 tp -101.16 121.28 41.54 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.349 -0.845 . . . . 0.98 109.911 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.1 m170 -123.61 154.28 39.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.436 1.494 . . . . 0.55 113.871 -174.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -100.68 179.8 4.31 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.341 1.456 . . . . 2.15 112.098 162.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.5 m -145.63 128.44 16.32 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 106.665 -1.606 . . . . 0.65 106.665 172.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -129.16 167.96 16.84 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 114.357 1.243 . . . . 2.26 114.357 -166.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -109.2 147.6 32.28 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.864 1.666 . . . . 4.99 110.994 171.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.55 151.76 24.69 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.776 0.83 . . . . 5.16 112.004 -174.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -103.72 143.29 32.99 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.702 1.601 . . . . 2.26 109.671 167.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -158.99 139.97 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.613 1.165 . . . . 3.09 108.336 167.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 62.25 27.17 16.29 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.334 1.053 . . . . 3.45 111.844 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.99 18.2 78.99 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 120.912 -1.118 . . . . 1.69 113.605 -175.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -132.48 129.33 39.04 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.046 1.338 . . . . 2.55 110.179 -174.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.599 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -71.29 130.09 40.51 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.311 2.244 . . . . 3.98 111.315 173.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.1 m -141.43 175.12 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 129.171 2.988 . . . . 2.25 110.235 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.25 162.9 21.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.079 1.351 . . . . 3.68 111.172 177.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.3 -178.14 29.25 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.089 1.328 . . . . 0.52 113.704 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.3 ttm -154.82 148.49 25.39 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.507 1.923 . . . . 0.6 108.286 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -160.43 156.4 22.64 Favored Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 124.814 1.246 . . . . 5.76 110.471 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.64 155.44 44.68 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.254 1.969 . . . . 0.6 111.519 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.99 154.72 70.76 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.655 1.582 . . . . 0.68 110.156 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.69 -24.49 3.44 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.178 2.585 . . . . 0.57 113.367 -167.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.42 ' CD2' ' HD2' ' A' ' 31' ' ' ARG . 50.6 p90 -178.24 163.05 1.61 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.334 1.853 . . . . 1.86 111.073 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.1 mt -109.6 153.01 24.78 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.006 1.323 . . . . 0.69 110.377 166.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -121.39 137.33 54.75 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.288 1.435 . . . . 2.09 109.194 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.9 t -140.32 130.99 13.89 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 123.667 0.787 . . . . 1.35 111.544 175.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.3 163.76 37.53 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.356 2.704 . . . . 1.31 112.39 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -60.03 140.36 92.25 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.42 2.747 . . . . 1.55 111.012 171.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp 65.78 0.75 1.6 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.137 1.375 . . . . 3.28 113.374 -175.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.11 -175.18 41.9 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.225 1.869 . . . . 1.77 109.907 163.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -139.19 138.45 36.91 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.712 -0.876 . . . . 7.47 112.865 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -93.04 57.23 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 128.189 2.595 . . . . 5.21 108.43 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -81.4 125.3 30.24 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.136 0.974 . . . . 3.61 108.859 163.272 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 83' ' ' HIS . 5.1 mp -72.48 -53.94 10.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.162 -0.472 . . . . 3.14 110.477 175.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.314 0.0 OUTLIER 79.94 123.55 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.081 0 C-N-CA 128.157 2.583 . . . . 3.36 114.228 176.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.41 -15.19 48.68 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.065 2.51 . . . . 2.16 113.9 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.86 5.12 84.86 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 117.073 -1.959 . . . . 1.5 114.745 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.49 -24.14 0.02 OUTLIER Glycine 0 C--N 1.348 1.23 0 N-CA-C 121.596 3.398 . . . . 2.07 121.596 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -145.77 147.62 32.09 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.022 1.911 . . . . 2.07 113.215 171.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.581 ' HA ' HD23 ' A' ' 77' ' ' LEU . 50.2 p-80 -162.18 155.41 20.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.12 0.968 . . . . 0.63 110.889 177.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -80.32 137.16 36.55 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.108 0.867 . . . . 1.89 109.119 158.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.8 tpt -85.21 129.73 34.75 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.881 1.272 . . . . 0.7 108.43 162.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -111.62 126.41 54.98 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.466 1.107 . . . . 0.58 108.866 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.96 128.63 55.91 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.243 1.017 . . . . 2.9 109.432 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.48 44.48 10.91 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 118.561 -1.133 . . . . 0.95 114.834 169.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -43.52 149.82 0.25 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 117.734 2.494 . . . . 1.37 117.734 176.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -115.82 -22.56 9.04 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 114.19 -1.368 . . . . 2.86 114.526 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -91.38 168.62 13.05 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 107.553 -1.277 . . . . 5.7 107.553 149.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -63.38 177.93 1.41 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 121.153 1.236 . . . . 2.66 109.907 148.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.0 mt -129.13 95.08 3.96 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.135 -0.978 . . . . 2.56 109.314 167.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -99.33 159.44 15.0 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.967 0.889 . . . . 5.67 112.829 176.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.74 130.62 44.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.275 -1.329 . . . . 1.45 107.915 159.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.92 0.68 83.23 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.484 1.992 . . . . 1.44 116.797 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.412 ' HB3' ' H ' ' A' ' 98' ' ' GLU . 33.9 mt-10 -81.48 -171.46 3.31 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.482 2.141 . . . . 2.66 113.312 175.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 97' ' ' GLU . 16.5 pt-20 -152.51 124.98 8.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 128.62 2.768 . . . . 5.01 105.899 -155.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 38.1 t -144.02 125.34 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 O-C-N 121.578 -0.701 . . . . 1.13 110.333 -173.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -79.56 151.21 30.8 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.497 -0.774 . . . . 3.03 111.325 168.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.23 147.22 34.5 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.828 2.051 . . . . 1.99 110.793 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -121.53 108.0 13.09 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 128.946 2.898 . . . . 2.2 108.312 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.0 mp -83.98 128.09 34.31 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.355 -0.84 . . . . 0.99 110.584 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.6 mt -97.82 103.41 15.35 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.362 1.065 . . . . 0.7 110.557 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -98.02 143.11 28.93 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.675 1.19 . . . . 2.23 111.435 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.64 131.69 39.39 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.282 1.033 . . . . 2.01 112.421 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.18 41.93 7.27 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.801 -0.999 . . . . 2.95 113.938 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.16 7.21 88.61 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 116.018 1.167 . . . . 2.13 116.018 165.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -90.43 112.62 24.31 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.963 1.382 . . . . 3.32 111.382 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.13 134.15 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.917 1.287 . . . . 2.23 109.999 173.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.0 tp -128.49 111.01 12.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.776 0.83 . . . . 1.91 111.465 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -81.76 135.16 35.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.417 0.687 . . . . 2.17 112.354 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.616 HG11 HD21 ' A' ' 22' ' ' LEU . 7.7 m -144.84 162.2 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 127.458 2.303 . . . . 2.02 111.019 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.2 t -131.91 132.45 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.625 0.77 . . . . 1.64 109.881 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.89 153.69 64.54 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 126.251 1.82 . . . . 1.85 110.142 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.04 167.11 27.62 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.674 2.916 . . . . 0.74 112.278 175.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.85 135.29 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.786 1.234 . . . . 0.89 109.358 167.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -150.26 165.45 32.92 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 115.991 1.849 . . . . 4.3 115.991 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.14 149.55 27.91 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 116.963 2.209 . . . . 2.61 116.963 -159.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.186 1 C-N-CA 134.05 4.94 . . . . 8.48 108.462 161.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 107.947 -1.131 . . . . 7.06 107.947 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.85 164.24 31.23 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 123.541 0.591 . . . . 1.33 111.961 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -108.36 168.58 9.21 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.147 0.979 . . . . 2.09 112.206 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.8 t -90.88 131.52 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.083 0.953 . . . . 1.25 109.011 167.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 107.67 11.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.972 0.909 . . . . 4.9 108.828 171.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -42.78 149.69 0.18 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.317 1.847 . . . . 2.06 114.806 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.6 t -152.51 151.56 27.31 Favored Pre-proline 0 CA--C 1.538 0.492 0 O-C-N 121.132 -0.98 . . . . 2.85 111.08 163.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -88.32 -2.66 6.88 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.429 2.753 . . . . 2.31 111.968 164.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.7 -179.38 20.0 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.929 1.252 . . . . 1.37 114.716 -170.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.81 -17.21 37.46 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.635 3.556 . . . . 1.45 114.635 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -110.28 153.9 24.2 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.495 1.518 . . . . 2.39 113.738 172.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.39 -178.47 6.68 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 128.132 2.573 . . . . 0.71 110.647 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.13 152.74 36.65 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.338 1.455 . . . . 0.65 110.448 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.62 146.61 36.42 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.239 1.2 . . . . 0.56 114.239 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -117.51 29.74 7.69 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 115.663 1.727 . . . . 2.9 115.663 -167.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -49.74 161.88 0.2 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 117.876 2.547 . . . . 1.88 117.876 -169.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 15.8 m -79.64 119.81 23.1 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.448 0.642 . . . . 2.01 111.589 172.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.467 HD12 HG21 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -83.35 139.24 33.14 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.55 -0.907 . . . . 3.75 108.55 164.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -147.39 172.45 13.9 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.368 0.667 . . . . 6.15 111.551 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -155.71 110.38 2.17 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.338 1.455 . . . . 1.38 110.74 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.7 -5.82 4.39 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.844 3.03 . . . . 1.39 114.292 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.99 178.23 41.99 Favored Glycine 0 C--N 1.341 0.818 0 CA-C-N 119.55 1.068 . . . . 1.18 112.956 -174.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -101.25 3.2 40.66 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.408 2.283 . . . . 3.29 112.323 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -118.74 160.21 41.27 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 127.116 2.166 . . . . 2.06 110.254 171.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.75 142.26 15.87 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.344 2.03 . . . . 1.06 111.422 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.471 HD12 ' CD1' ' A' ' 105' ' ' PHE . 1.9 mm? -102.95 157.11 17.2 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.359 1.464 . . . . 2.53 111.975 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -152.99 104.54 2.84 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.02 -1.446 . . . . 2.07 111.649 -169.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.2 tt -83.03 123.64 29.67 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.702 1.201 . . . . 2.4 108.61 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 m -110.91 -15.12 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.665 0.786 . . . . 0.7 111.662 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.48 -177.12 30.28 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 125.6 1.571 . . . . 0.52 114.051 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.9 -179.55 7.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.46 1.504 . . . . 0.56 111.699 171.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -155.92 173.26 17.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.605 2.362 . . . . 6.31 109.212 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 t 178.54 146.75 0.36 Allowed Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 129.106 2.963 . . . . 0.82 106.87 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.0 -15.62 36.26 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 121.736 1.624 . . . . 1.3 113.544 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.0 22.17 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.609 1.164 . . . . 1.22 113.288 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.75 138.47 28.83 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.786 1.176 . . . . 1.02 110.382 169.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -83.21 -41.03 18.88 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.007 0.923 . . . . 3.81 111.062 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -131.16 152.84 50.03 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 128.537 2.735 . . . . 6.69 106.396 -175.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.6 p -146.57 146.27 18.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 124.555 1.142 . . . . 1.43 108.772 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -132.36 145.36 51.19 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.97 1.708 . . . . 3.12 108.841 175.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.4 tp -99.63 118.79 36.93 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.809 -0.557 . . . . 0.98 109.639 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.0 m170 -122.53 154.12 38.31 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.245 1.418 . . . . 0.63 114.068 -174.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -102.04 163.66 12.12 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.354 -1.294 . . . . 2.31 111.622 161.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.4 m -120.88 130.63 53.99 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 105.906 -1.887 . . . . 0.88 105.906 163.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -127.37 168.52 14.71 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.518 1.303 . . . . 2.08 114.518 -170.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -109.49 148.21 31.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.853 1.661 . . . . 4.99 111.425 170.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.58 148.48 24.37 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.414 1.086 . . . . 5.04 110.56 -174.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -98.53 140.02 33.39 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.564 1.145 . . . . 2.93 109.895 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.1 t -137.81 118.41 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.353 1.061 . . . . 2.3 108.241 168.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 66.49 15.14 10.02 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 126.191 1.796 . . . . 4.13 114.85 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.6 21.64 55.7 Favored Glycine 0 CA--C 1.535 1.32 0 O-C-N 121.356 -0.84 . . . . 2.58 112.943 -166.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.5 mttt -124.53 113.53 18.22 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.604 1.562 . . . . 3.39 109.133 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.8 123.01 28.94 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.604 -0.685 . . . . 5.73 110.519 -171.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.29 179.76 3.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 128.451 2.7 . . . . 2.6 110.764 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.83 162.56 31.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.88 1.272 . . . . 2.57 111.862 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.35 -176.54 27.65 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.53 1.538 . . . . 0.64 113.662 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.0 ttm -150.8 148.02 27.99 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.195 1.798 . . . . 0.88 108.873 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -158.65 157.34 28.49 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 124.659 1.184 . . . . 5.86 111.131 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.99 154.77 53.04 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.011 1.807 . . . . 0.67 111.699 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.45 156.5 74.99 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 126.283 1.833 . . . . 0.76 110.091 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.44 -26.76 3.09 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.023 2.482 . . . . 0.61 113.371 -167.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -175.3 164.68 3.24 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.501 1.521 . . . . 2.1 111.231 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.4 mt -113.33 153.92 27.7 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.897 1.679 . . . . 0.73 110.119 164.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -136.34 147.99 47.68 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.355 0.662 . . . . 2.26 111.836 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.467 HG21 HD12 ' A' ' 22' ' ' LEU . 88.0 t -141.56 131.47 12.79 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.161 0.985 . . . . 0.83 112.366 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -69.97 161.98 43.9 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.742 2.962 . . . . 0.92 111.704 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.24 140.91 81.64 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.598 2.866 . . . . 0.98 113.517 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp 66.94 2.88 2.85 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.476 1.91 . . . . 1.75 114.552 176.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.78 160.31 31.16 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.843 1.687 . . . . 1.2 114.24 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.19 146.04 33.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.333 1.053 . . . . 4.16 110.85 168.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.2 t -155.81 132.92 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 125.491 1.516 . . . . 4.46 108.642 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 2.8 mp0 -83.21 141.66 31.74 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.137 1.335 . . . . 3.74 111.102 176.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mp -46.49 -43.57 16.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.989 1.316 . . . . 2.94 112.007 -177.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 108.13 128.56 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 128.019 2.528 . . . . 3.84 111.019 158.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -59.98 116.16 3.12 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 N-CA-C 107.463 -1.783 . . . . 2.7 107.463 165.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.78 26.07 59.27 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 116.98 -2.011 . . . . 2.01 116.463 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.58 -42.74 0.04 OUTLIER Glycine 0 N--CA 1.482 1.729 0 N-CA-C 119.252 2.461 . . . . 1.79 119.252 166.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -137.2 145.94 44.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.745 1.26 . . . . 1.92 110.753 160.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -160.56 153.02 20.67 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.176 -0.953 . . . . 0.73 109.339 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -78.72 151.02 32.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.82 -0.807 . . . . 2.27 108.82 162.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.3 tpt -101.0 129.42 46.84 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.912 1.685 . . . . 0.77 107.391 159.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.84 137.62 49.55 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.671 1.188 . . . . 0.66 108.479 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -139.44 146.61 40.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.516 1.127 . . . . 2.36 112.69 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.78 26.94 68.05 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.464 1.03 . . . . 1.33 113.728 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.5 148.12 2.99 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 117.07 2.248 . . . . 1.48 117.07 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -120.7 2.48 10.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 112.065 -2.334 . . . . 2.31 113.494 -165.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -145.25 144.51 23.55 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 127.094 2.158 . . . . 6.03 108.22 164.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.07 158.3 45.81 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.111 2.541 . . . . 1.74 110.343 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -106.18 99.55 9.13 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.973 1.709 . . . . 2.81 109.294 -169.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.445 ' HZ3' ' H ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -82.91 132.69 35.15 Favored 'General case' 0 C--N 1.332 -0.155 0 O-C-N 120.446 -1.409 . . . . 4.28 112.423 175.146 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.7 115.55 1.69 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 113.923 -1.49 . . . . 1.86 109.889 169.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.92 -3.74 45.26 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 117.673 -1.626 . . . . 1.88 115.736 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -76.41 -178.58 4.69 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 120.242 2.021 . . . . 2.76 111.661 167.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -140.66 139.05 34.74 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 129.236 3.014 . . . . 3.53 105.535 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.66 126.63 44.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 126.616 1.966 . . . . 1.02 108.504 -173.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -78.29 139.6 38.86 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.836 0.826 . . . . 3.82 111.857 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.38 146.47 39.42 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.125 1.37 . . . . 3.19 109.321 163.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -102.46 139.23 38.33 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.04 2.536 . . . . 2.64 108.859 171.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.2 mp -109.37 138.06 46.3 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.592 1.557 . . . . 0.87 110.395 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.4 mt -112.14 110.06 20.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.687 1.195 . . . . 0.63 110.917 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.471 ' CD1' HD12 ' A' ' 30' ' ' LEU . 97.6 m-85 -107.62 151.8 25.15 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.359 1.464 . . . . 2.04 112.505 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.82 114.61 1.47 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.899 1.28 . . . . 1.75 113.538 -174.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.42 69.32 1.4 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.928 1.252 . . . . 2.81 112.965 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.28 7.92 73.58 Favored Glycine 0 N--CA 1.476 1.311 0 N-CA-C 116.291 1.277 . . . . 2.02 116.291 164.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -96.56 125.98 41.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.861 1.331 . . . . 3.61 111.309 -171.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.99 141.98 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 124.297 0.998 . . . . 1.9 110.893 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.3 tp -140.59 159.8 41.41 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.491 2.316 . . . . 2.1 108.6 177.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -132.83 145.18 50.74 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.983 0.913 . . . . 2.14 111.992 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.12 160.31 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 127.299 2.24 . . . . 2.61 110.836 -172.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.2 t -130.03 94.62 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.034 0.921 . . . . 2.25 110.618 -158.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.8 mt -98.55 123.78 48.84 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-O 118.062 -0.971 . . . . 2.4 111.051 -168.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.13 153.98 73.52 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.11 1.873 . . . . 0.98 111.041 170.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 90.1 t -92.99 121.09 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.305 0.642 . . . . 1.49 109.986 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -117.78 135.82 53.8 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.372 1.069 . . . . 3.49 110.59 167.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.93 57.46 4.34 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.202 -0.936 . . . . 4.09 112.74 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.335 0 CA-C-O 115.926 -1.988 . . . . 7.2 112.605 -171.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 . . . . . 0 CA--C 1.542 0.663 0 N-CA-C 108.019 -1.104 . . . . 5.84 108.019 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.29 176.01 28.74 Favored Glycine 0 CA--C 1.527 0.793 0 O-C-N 121.324 -0.86 . . . . 1.52 112.385 169.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -157.64 172.08 19.18 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.53 1.132 . . . . 2.06 112.073 154.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 10' ' ' PHE . 10.2 t -105.53 139.02 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.534 1.133 . . . . 1.12 109.323 172.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.0 ttp85 -60.47 -35.36 75.7 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.882 1.067 . . . . 3.79 113.882 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.436 ' H ' HG12 ' A' ' 8' ' ' VAL . 6.2 t80 64.89 158.95 0.1 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.79 2.036 . . . . 3.16 110.343 -157.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 m -166.07 147.65 5.92 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 126.195 1.798 . . . . 3.12 109.017 162.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -83.58 49.74 3.01 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.591 3.527 . . . . 2.94 111.682 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.17 179.09 25.31 Favored Glycine 0 CA--C 1.537 1.423 0 N-CA-C 115.892 1.117 . . . . 1.29 115.892 -171.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.92 -20.15 19.91 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 124.073 3.182 . . . . 1.27 112.52 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -112.09 145.92 38.89 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.413 1.885 . . . . 2.47 113.646 173.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -131.28 -177.68 4.5 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.637 1.975 . . . . 0.65 110.802 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.54 148.65 31.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.771 1.228 . . . . 0.62 110.417 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.03 150.91 49.38 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.385 1.254 . . . . 0.57 114.385 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -127.3 52.61 1.8 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.838 2.055 . . . . 2.49 111.43 -165.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.35 162.14 25.92 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.367 1.247 . . . . 2.1 114.367 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.06 124.3 29.7 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.389 1.076 . . . . 3.93 110.847 166.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.73 119.84 29.58 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.624 -1.621 . . . . 3.82 106.624 163.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -135.87 144.02 45.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.028 0.918 . . . . 4.23 113.12 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -120.76 90.31 46.2 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 114.507 -1.224 . . . . 1.73 110.821 -172.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.56 -7.94 20.94 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.341 2.027 . . . . 2.26 112.886 172.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.15 -178.11 51.52 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 122.407 1.004 . . . . 1.82 112.858 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -111.5 -1.57 15.81 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.223 2.209 . . . . 4.03 111.83 -167.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -132.58 159.89 70.57 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 128.415 2.686 . . . . 2.23 109.339 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.45 156.87 57.68 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.434 2.089 . . . . 0.8 111.879 -167.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mp -114.38 152.9 30.77 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.606 1.562 . . . . 2.56 110.181 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -141.79 106.29 4.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 112.665 -2.061 . . . . 1.87 110.969 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.5 tp -90.14 109.17 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.083 1.353 . . . . 1.9 109.194 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 m -104.27 -18.37 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.041 0.937 . . . . 0.7 111.692 -173.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.63 -177.78 29.2 Favored Glycine 0 C--N 1.344 0.997 0 C-N-CA 125.951 1.739 . . . . 0.57 113.02 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.57 178.29 7.88 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.4 1.48 . . . . 0.58 110.687 171.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -158.6 150.31 21.11 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.851 2.06 . . . . 4.88 108.261 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -162.31 148.84 10.79 Favored Pre-proline 0 N--CA 1.478 0.937 0 O-C-N 120.984 -1.073 . . . . 0.9 109.34 -171.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.46 -1.25 10.77 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.634 2.89 . . . . 0.7 114.62 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.6 m -134.36 47.46 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 125.089 1.355 . . . . 0.91 112.676 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.87 178.78 9.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.242 1.417 . . . . 1.31 109.97 162.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -127.45 -34.04 2.29 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.774 1.63 . . . . 3.83 112.01 168.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -121.26 149.78 42.36 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 106.567 -1.642 . . . . 6.16 106.567 172.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.51 141.64 18.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 125.014 1.326 . . . . 1.22 110.005 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -134.52 147.54 50.34 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.601 1.96 . . . . 3.22 109.068 -173.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.464 HD13 ' CZ ' ' A' ' 84' ' ' PHE . 36.7 tp -101.73 120.79 40.91 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.547 -0.721 . . . . 1.27 109.842 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.5 m170 -121.26 150.09 41.9 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 123.486 1.612 . . . . 0.64 114.447 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -96.0 173.5 7.4 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 113.275 -1.784 . . . . 2.35 111.218 162.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.2 m -150.39 146.64 26.82 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 106.453 -1.684 . . . . 0.67 106.453 173.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -161.72 171.46 17.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.959 0.885 . . . . 2.0 113.378 -167.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.0 ttp -105.11 142.05 35.57 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.134 1.774 . . . . 3.45 110.453 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -157.36 151.02 24.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.228 1.411 . . . . 8.56 112.73 -173.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.47 133.38 35.39 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.494 0.718 . . . . 2.92 111.222 172.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t -141.82 134.79 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 105.443 -2.058 . . . . 2.24 105.443 162.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 70.93 4.17 4.95 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.39 1.876 . . . . 4.49 114.255 -170.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.21 22.86 69.9 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 121.473 -0.767 . . . . 1.64 113.109 -163.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -124.48 131.33 53.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.612 1.965 . . . . 3.83 109.76 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.89 92.63 1.27 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.495 1.118 . . . . 6.26 112.591 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.4 m -94.49 -174.94 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 127.177 2.191 . . . . 2.5 109.47 171.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -117.7 167.81 11.02 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.36 0.664 . . . . 2.96 111.937 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.46 169.63 31.64 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 125.683 1.611 . . . . 0.61 112.28 -176.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ttm -149.16 147.43 28.43 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.71 2.004 . . . . 0.71 107.971 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -148.33 153.69 41.04 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 125.966 1.707 . . . . 5.71 108.88 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.06 154.55 42.29 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 121.69 1.593 . . . . 0.65 110.352 164.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 m -137.11 154.77 76.1 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 125.34 1.456 . . . . 0.73 109.87 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.2 -27.03 4.69 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.58 2.186 . . . . 0.76 112.745 -166.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -175.17 168.37 3.39 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.363 1.465 . . . . 2.03 111.98 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.7 mt -111.13 153.72 25.33 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.276 1.431 . . . . 0.79 110.871 161.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -124.88 141.4 52.14 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.861 1.664 . . . . 2.21 110.043 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.0 t -146.52 134.69 10.7 Favored Pre-proline 0 N--CA 1.482 1.151 0 N-CA-C 113.426 0.899 . . . . 0.91 113.426 173.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.74 163.36 39.33 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 124.443 3.429 . . . . 1.28 113.558 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.02 145.06 78.39 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.86 3.04 . . . . 1.67 114.18 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt 69.21 -5.1 1.14 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.08 2.552 . . . . 3.1 114.657 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.03 168.4 34.0 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.411 1.482 . . . . 1.9 113.243 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -144.24 148.95 35.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.713 0.805 . . . . 6.51 112.231 162.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.9 t -155.71 100.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.456 1.902 . . . . 3.83 108.631 -168.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.89 171.55 15.03 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 121.876 0.846 . . . . 3.68 112.236 -169.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 mp -82.56 70.02 9.44 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.152 -1.592 . . . . 2.05 110.133 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.482 ' CD ' ' H ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -36.6 119.86 0.76 Allowed Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 127.167 2.187 . . . . 4.33 113.307 172.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.99 -9.36 22.12 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.817 3.012 . . . . 2.29 115.635 -154.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.33 -2.16 55.68 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 117.836 -1.536 . . . . 1.9 114.34 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.68 -17.47 0.49 Allowed Glycine 0 N--CA 1.479 1.542 0 CA-C-N 119.946 1.873 . . . . 1.98 117.776 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -145.12 145.03 31.23 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.128 1.464 . . . . 2.47 112.24 170.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -161.31 155.59 22.76 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.598 1.559 . . . . 0.83 109.941 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.464 ' CZ ' HD13 ' A' ' 45' ' ' LEU . 73.7 m-85 -79.45 150.97 31.1 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.259 -0.901 . . . . 2.39 108.862 157.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.6 tpt -100.12 130.84 46.31 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.11 1.764 . . . . 0.63 108.335 162.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.8 mp -116.01 135.54 53.86 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.388 1.475 . . . . 0.68 108.32 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mp -135.78 146.02 47.15 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.747 0.703 . . . . 1.69 111.633 -176.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.66 40.23 32.41 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.306 -0.719 . . . . 1.02 113.225 172.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.23 148.31 3.6 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 115.799 1.778 . . . . 1.54 115.799 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -104.05 -4.52 23.16 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.481 -1.691 . . . . 2.47 113.592 -170.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -146.63 156.09 48.74 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.92 2.088 . . . . 6.48 109.112 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -67.38 163.73 33.43 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.853 1.702 . . . . 2.28 109.022 153.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 pp -160.86 152.1 19.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.575 1.55 . . . . 2.35 108.298 -172.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -147.79 168.31 22.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 123.123 1.44 . . . . 4.73 114.715 -174.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.43 135.34 56.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.053 -0.976 . . . . 1.33 111.212 172.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.83 -1.14 74.3 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.72 1.629 . . . . 2.07 114.365 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -85.76 -176.91 6.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.869 1.335 . . . . 2.5 112.244 171.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -138.44 140.0 39.09 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 129.459 3.104 . . . . 3.55 105.768 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.3 t -141.06 133.36 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.216 1.806 . . . . 0.97 109.773 -172.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -95.58 158.01 15.64 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 122.491 1.139 . . . . 2.3 113.478 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.17 151.8 31.47 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.964 1.305 . . . . 3.54 112.841 169.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.64 137.12 36.2 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 127.26 2.224 . . . . 2.56 109.516 169.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.21 133.94 37.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.804 1.641 . . . . 1.19 109.113 170.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 56.3 mt -106.2 104.65 14.39 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.732 1.213 . . . . 0.9 108.934 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -91.97 163.37 14.03 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.562 0.696 . . . . 2.11 111.484 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.54 117.69 5.18 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.934 -0.479 . . . . 1.55 110.947 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.67 -135.94 16.73 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.835 0.731 . . . . 3.23 112.204 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.57 41.74 2.86 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.426 1.012 . . . . 2.34 115.481 -165.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -134.48 123.22 23.62 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.441 1.62 . . . . 3.88 112.085 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.3 t -136.64 138.56 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.806 1.642 . . . . 2.51 107.677 168.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.9 tp -159.14 133.45 7.76 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.488 1.115 . . . . 2.43 111.581 -170.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -98.1 149.0 22.97 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.631 1.715 . . . . 1.99 115.631 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.9 t -125.0 165.88 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 129.237 3.015 . . . . 2.13 107.994 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 t -142.18 142.36 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.247 1.819 . . . . 1.95 107.832 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.01 159.48 30.27 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 114.134 1.161 . . . . 2.85 114.134 -173.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -77.81 160.58 30.84 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.1 3.2 . . . . 0.86 114.671 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.0 t -103.61 130.1 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.525 1.53 . . . . 0.99 110.829 171.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.42 ' CD ' ' HE ' ' A' ' 120' ' ' ARG . 11.8 pt-20 -95.21 -172.52 2.69 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.621 1.968 . . . . 5.97 111.432 172.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -126.41 117.66 23.4 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.712 -1.243 . . . . 2.53 112.014 154.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.42 ' HE ' ' CD ' ' A' ' 118' ' ' GLU . 42.4 mtm180 . . . . . 0 C--O 1.248 1.008 0 C-N-CA 126.781 2.033 . . . . 7.56 111.5 161.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 . . . . . 0 CA--C 1.547 0.836 0 CA-C-O 119.173 -0.441 . . . . 5.16 110.416 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.49 175.83 17.37 Favored Glycine 0 N--CA 1.473 1.155 0 N-CA-C 116.87 1.508 . . . . 0.87 116.87 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -151.35 142.91 23.58 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.389 2.275 . . . . 1.73 110.966 169.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.7 t -94.4 141.72 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 120.448 -1.407 . . . . 1.27 109.773 175.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.0 ttm-85 -73.12 118.13 15.7 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.514 0.726 . . . . 5.98 111.567 -172.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -68.19 138.51 55.68 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.534 -0.729 . . . . 2.55 110.558 159.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -167.72 149.75 5.27 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.703 1.601 . . . . 3.52 109.977 164.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -82.03 47.93 2.66 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 125.216 3.944 . . . . 3.28 111.756 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.34 158.52 20.49 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.872 1.701 . . . . 1.84 112.605 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.36 -19.08 33.72 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.729 2.953 . . . . 1.36 112.822 174.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -106.96 160.74 15.3 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.213 1.805 . . . . 2.96 112.908 167.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.34 -173.58 4.61 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.686 2.795 . . . . 0.53 110.287 -176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.48 160.29 41.82 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.348 1.459 . . . . 0.72 109.821 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.32 137.5 53.49 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.71 1.141 . . . . 0.73 112.976 174.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 79' ' ' PRO . 61.7 m-85 -113.06 138.72 49.48 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.691 1.996 . . . . 2.65 110.032 172.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.267 0.0 OUTLIER -165.99 145.14 6.06 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.528 1.307 . . . . 2.56 114.528 177.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.3 m -80.98 130.09 34.85 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.345 1.058 . . . . 2.04 109.536 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.4 tp -119.09 142.37 47.94 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.319 1.848 . . . . 3.14 109.843 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -128.13 149.71 50.3 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.751 1.22 . . . . 3.52 110.966 170.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -103.9 102.01 28.73 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.07 0.948 . . . . 1.44 109.459 169.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.76 -10.19 19.93 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.495 2.13 . . . . 1.01 113.359 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.59 178.61 53.29 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-O 122.76 1.2 . . . . 1.12 113.018 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -105.44 -3.65 22.31 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.818 2.447 . . . . 2.78 111.659 -174.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -121.2 156.27 57.55 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 127.9 2.48 . . . . 1.92 109.501 173.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.86 151.77 24.66 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.922 2.414 . . . . 0.85 111.992 -169.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.2 mt -104.57 146.99 28.12 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.154 0.982 . . . . 1.55 111.101 169.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -134.09 111.67 10.54 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.01 -1.45 . . . . 2.01 110.788 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -92.23 106.95 18.85 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 127.555 2.342 . . . . 2.59 109.974 -173.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -107.26 -17.92 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.729 1.211 . . . . 0.65 111.765 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.66 -175.24 29.37 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 125.726 1.631 . . . . 0.65 114.33 -175.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -157.05 -177.34 6.54 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.197 1.399 . . . . 0.74 112.681 177.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -154.48 165.43 36.46 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 127.434 2.294 . . . . 4.54 107.309 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 t -169.15 147.29 3.27 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 125.509 1.524 . . . . 0.91 107.426 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.59 -17.42 38.35 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.31 1.34 . . . . 1.07 111.865 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.6 m -111.17 40.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.185 1.394 . . . . 1.15 113.258 -172.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.78 169.29 23.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.411 1.084 . . . . 1.13 110.588 167.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -108.55 -63.14 1.37 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.454 1.502 . . . . 4.03 107.304 164.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -84.34 124.1 30.91 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 121.502 -0.749 . . . . 6.92 109.054 166.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.404 HG21 ' HB3' ' A' ' 35' ' ' ALA . 4.6 p -94.64 158.21 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.796 -1.093 . . . . 1.46 108.696 149.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.39 157.13 42.01 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.86 2.464 . . . . 4.27 107.446 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.6 tp -124.67 112.98 17.4 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.926 1.239 . . . . 1.11 112.17 -171.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.2 m170 -122.18 158.01 30.31 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 123.476 1.608 . . . . 0.66 114.661 -171.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.69 -176.42 3.26 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.463 1.905 . . . . 3.14 111.297 159.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -156.75 145.01 19.61 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.123 1.769 . . . . 0.85 106.798 167.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -153.13 -177.63 6.43 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.103 0.961 . . . . 2.0 113.003 -165.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -118.89 143.32 47.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.131 1.772 . . . . 4.25 111.446 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -154.78 160.33 41.22 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.401 1.88 . . . . 4.8 110.145 -172.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -116.57 142.61 46.66 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.883 1.673 . . . . 2.91 110.526 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.269 1.3 t -95.73 -126.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 107.753 -1.203 . . . . 2.81 107.753 161.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -70.67 44.26 0.08 Allowed 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 125.792 1.637 . . . . 2.95 114.81 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.06 18.15 80.19 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 120.271 -1.518 . . . . 1.95 111.738 -160.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -96.28 106.04 18.2 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 121.997 -0.707 . . . . 2.78 109.399 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.59 124.29 26.95 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.276 0.63 . . . . 7.52 109.951 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.538 HG22 ' H ' ' A' ' 59' ' ' MET . 8.7 p -142.78 175.9 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 126.003 1.721 . . . . 2.55 110.079 -174.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.538 ' H ' HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -124.88 149.16 47.83 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.619 1.168 . . . . 3.03 110.654 -175.15 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.99 167.86 21.56 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.507 1.527 . . . . 0.7 112.188 -174.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.0 ttm -150.63 137.1 18.77 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.059 1.344 . . . . 0.65 110.581 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -145.4 150.51 44.6 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.429 1.892 . . . . 8.13 110.066 -173.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -76.48 155.58 36.25 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.977 1.785 . . . . 0.66 110.283 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.67 147.78 66.93 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 124.219 1.008 . . . . 0.87 110.213 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -71.44 -22.6 24.67 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.438 2.759 . . . . 0.66 111.958 -173.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -172.96 172.61 3.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.421 1.888 . . . . 1.88 111.246 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.4 mt -115.01 161.06 18.85 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.265 1.826 . . . . 0.7 109.013 156.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -133.2 151.21 51.95 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.341 -0.849 . . . . 2.01 112.072 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.1 t -138.19 129.13 15.61 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 123.785 0.834 . . . . 1.07 111.815 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.89 164.67 34.84 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.379 2.72 . . . . 0.95 111.365 174.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.35 140.82 90.24 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.007 2.471 . . . . 1.02 112.485 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt 67.07 -2.75 1.1 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.848 2.059 . . . . 1.61 114.135 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.99 170.64 43.7 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.864 1.697 . . . . 1.22 114.024 -177.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -122.3 154.35 37.72 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.262 1.425 . . . . 5.42 111.388 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.2 t -141.36 137.04 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.734 1.613 . . . . 3.61 107.262 159.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.416 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -103.57 136.27 43.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.627 0.727 . . . . 3.75 109.942 168.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.52 101.39 3.54 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 105.951 -1.87 . . . . 2.32 105.951 158.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HE2' ' O ' ' A' ' 76' ' ' GLU . 6.1 ptpt -113.7 152.3 45.39 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.787 2.035 . . . . 3.01 114.36 -158.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 19' ' ' TYR . 10.4 Cg_endo -49.19 -57.69 2.2 Favored 'Trans proline' 0 C--N 1.356 0.97 1 C-N-CA 125.437 4.091 . . . . 2.01 113.667 -173.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.81 57.91 5.0 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.217 -0.768 . . . . 1.79 112.728 173.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.1 -126.52 1.6 Allowed Glycine 0 N--CA 1.467 0.766 0 C-N-CA 124.256 0.931 . . . . 1.93 114.828 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -71.05 141.91 50.88 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.845 -0.797 . . . . 1.97 112.707 -159.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -161.87 152.79 17.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.995 -0.548 . . . . 0.59 111.681 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 69.4 m-85 -77.35 142.79 39.18 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 108.283 -1.006 . . . . 1.9 108.283 163.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.1 tpt -92.37 135.59 33.91 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.293 1.037 . . . . 0.75 108.47 162.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.1 mp -117.85 138.79 51.86 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.925 1.29 . . . . 0.55 108.509 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mp -138.56 148.15 43.86 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.544 1.137 . . . . 1.56 110.041 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.42 40.45 19.21 Favored Glycine 0 N--CA 1.47 0.96 0 CA-C-O 119.876 -0.402 . . . . 0.95 112.79 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -43.82 143.13 1.12 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 115.719 1.748 . . . . 1.46 115.719 174.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -110.47 -3.57 15.98 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 113.653 -1.612 . . . . 2.56 114.472 -168.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -137.62 153.43 74.18 Favored Pre-proline 0 N--CA 1.473 0.704 0 C-N-CA 125.921 1.688 . . . . 5.85 109.56 170.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -68.65 144.94 61.97 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.111 1.874 . . . . 2.4 108.583 162.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.8 mp -125.62 116.92 22.47 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.538 0.735 . . . . 2.8 109.747 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.82 15.55 26.6 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 116.205 1.928 . . . . 5.8 116.205 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 60.41 157.55 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.137 2.575 . . . . 1.58 111.338 -166.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.47 42.38 99.01 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 120.759 -1.213 . . . . 1.32 110.563 -170.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -100.18 179.89 4.34 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.744 1.617 . . . . 2.41 107.574 169.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.82 150.79 33.01 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 128.104 2.562 . . . . 5.1 106.908 163.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.5 t -149.05 143.53 18.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 128.784 2.833 . . . . 1.24 108.811 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -98.69 146.3 26.01 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.997 -0.439 . . . . 3.01 111.493 168.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.78 133.14 56.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.469 1.108 . . . . 2.53 109.23 160.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.73 143.17 26.57 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.357 2.663 . . . . 2.2 107.239 162.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.93 127.39 51.79 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.386 1.474 . . . . 1.32 110.19 177.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.0 mt -102.25 117.3 34.46 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.754 1.622 . . . . 0.69 109.844 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -107.67 155.23 20.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.391 1.076 . . . . 1.99 111.296 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.93 146.77 25.68 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.16 -0.473 . . . . 1.88 110.415 162.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.63 7.53 66.66 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-O 119.127 -0.818 . . . . 3.14 114.59 -173.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.36 6.4 88.93 Favored Glycine 0 N--CA 1.474 1.169 0 CA-C-N 118.886 1.343 . . . . 2.19 114.163 175.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -79.48 133.34 36.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.724 1.21 . . . . 6.85 111.58 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.6 p -113.22 151.39 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.225 1.81 . . . . 2.0 109.766 166.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 tt -158.9 135.11 9.09 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.84 1.656 . . . . 2.06 109.481 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -103.27 163.0 12.52 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.313 1.227 . . . . 2.12 114.313 176.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.3 m -134.41 146.29 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 128.803 2.841 . . . . 2.07 109.136 168.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.4 p -109.31 138.35 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.899 1.28 . . . . 3.04 109.457 176.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.98 154.93 28.6 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 123.631 0.772 . . . . 2.07 113.066 -168.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.22 169.93 19.49 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.806 2.337 . . . . 0.99 112.787 171.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 70.1 t -104.5 131.25 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.478 1.511 . . . . 0.91 108.635 159.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -134.37 174.89 10.03 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.817 0.847 . . . . 4.61 112.55 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -95.07 57.22 2.03 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 116.265 1.95 . . . . 2.46 116.265 -143.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.251 23.1 mtp-105 . . . . . 0 N--CA 1.49 1.526 0 C-N-CA 131.611 3.965 . . . . 9.37 114.523 161.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 107.414 -1.328 . . . . 5.79 107.414 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.01 170.12 34.81 Favored Glycine 0 N--CA 1.463 0.438 0 C-N-CA 124.872 1.225 . . . . 1.05 111.873 176.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.6 p90 -159.03 141.57 14.1 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.296 1.038 . . . . 1.92 111.922 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.12 142.24 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 107.882 -1.155 . . . . 1.2 107.882 166.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.407 ' O ' ' HD2' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -89.1 15.33 8.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.676 1.19 . . . . 3.64 114.176 -175.182 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.3 t80 64.98 164.03 0.15 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.278 1.431 . . . . 2.55 113.37 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 m -172.6 154.0 2.91 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 127.187 2.195 . . . . 2.1 110.973 157.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -87.41 30.51 0.46 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 124.509 3.472 . . . . 2.0 112.08 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.24 178.95 31.6 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.716 1.151 . . . . 1.16 114.163 -171.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.48 -21.72 29.76 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.135 3.223 . . . . 1.49 113.546 -173.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -88.05 148.73 24.36 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.969 1.307 . . . . 2.35 111.932 173.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.46 -178.66 6.55 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.201 1.401 . . . . 0.65 111.353 165.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.52 150.64 40.71 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.688 1.595 . . . . 0.98 108.702 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.65 143.27 29.72 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.223 1.194 . . . . 1.17 114.223 -175.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -111.27 156.22 21.82 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.032 2.133 . . . . 2.56 111.276 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -169.59 158.35 7.69 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.597 1.559 . . . . 2.05 113.671 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 p -93.18 107.47 19.27 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.007 2.123 . . . . 2.53 110.862 173.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.611 HD12 HG21 ' A' ' 69' ' ' VAL . 0.6 OUTLIER -79.46 139.01 37.77 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.336 1.454 . . . . 3.26 109.089 176.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.415 ' N ' HD13 ' A' ' 22' ' ' LEU . 11.7 pt-20 -114.62 160.68 19.03 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.678 1.191 . . . . 5.39 112.244 177.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -135.82 109.96 10.12 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 123.687 0.795 . . . . 1.49 109.611 158.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -88.25 -8.45 5.56 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.281 2.654 . . . . 1.36 114.951 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.95 178.04 33.13 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 119.783 1.174 . . . . 1.24 112.482 -176.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -93.29 0.57 57.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.546 2.338 . . . . 3.56 112.485 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -113.46 156.96 42.58 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 127.33 2.252 . . . . 1.94 110.583 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.31 145.56 24.15 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.719 2.279 . . . . 0.98 111.183 -176.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.471 HD12 ' CD2' ' A' ' 105' ' ' PHE . 2.9 mm? -107.34 157.7 17.74 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 124.716 1.207 . . . . 2.42 110.565 172.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -147.22 110.34 4.79 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 113.459 -1.7 . . . . 2.32 110.677 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.26 112.51 24.07 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.47 1.908 . . . . 2.05 109.39 -176.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.4 m -108.62 -20.38 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.956 1.302 . . . . 0.74 111.642 -172.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.28 -175.06 28.79 Favored Glycine 0 C--N 1.346 1.088 0 C-N-CA 125.43 1.491 . . . . 0.68 113.798 -174.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.66 -177.3 5.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.747 2.019 . . . . 0.62 111.241 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -155.85 169.52 24.22 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.327 2.251 . . . . 4.38 109.029 170.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.7 t -175.96 150.96 1.13 Allowed Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 126.92 2.088 . . . . 0.74 108.007 173.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.4 -17.65 26.93 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.676 1.584 . . . . 0.76 112.734 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.9 m -97.05 52.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.737 1.215 . . . . 0.77 112.131 174.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.68 167.33 30.74 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.329 1.051 . . . . 1.39 112.203 166.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -102.01 -39.19 7.43 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.851 2.06 . . . . 4.99 110.492 162.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -146.04 169.59 18.35 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.378 1.871 . . . . 4.66 110.128 169.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.14 145.27 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.586 1.554 . . . . 1.15 108.321 -177.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -128.68 151.26 49.72 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.479 1.912 . . . . 3.16 108.208 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -103.66 136.91 42.49 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.115 0.87 . . . . 1.87 112.088 160.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -120.74 152.95 37.64 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.707 2.003 . . . . 0.95 112.667 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -97.2 163.25 12.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.374 1.47 . . . . 2.31 109.634 162.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.6 m -115.99 143.12 45.88 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.213 -1.403 . . . . 1.24 107.213 162.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -139.93 172.14 13.2 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.003 1.112 . . . . 2.33 114.003 -173.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 85.7 mtp -113.35 143.7 44.0 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.868 1.667 . . . . 3.55 110.99 166.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -146.76 146.97 30.47 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.953 1.701 . . . . 6.76 110.441 172.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -94.01 141.97 27.92 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 125.145 1.378 . . . . 2.43 110.957 171.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 m -139.59 126.96 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.532 1.133 . . . . 2.29 108.917 167.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 64.7 10.86 6.32 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.722 1.609 . . . . 3.72 115.062 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.87 26.43 41.64 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 123.907 0.765 . . . . 2.37 113.278 -166.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -124.76 123.44 40.0 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.514 1.926 . . . . 3.54 109.045 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.85 121.18 25.09 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.926 0.89 . . . . 5.98 111.463 -175.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.6 t -121.64 160.14 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 127.386 2.274 . . . . 2.56 108.601 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.7 mtp -121.25 156.56 32.22 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.547 1.539 . . . . 2.67 110.337 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.99 -175.57 26.2 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.203 0.906 . . . . 0.63 113.585 -172.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.1 ttm -153.33 151.05 29.54 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.404 1.882 . . . . 0.86 108.691 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.97 158.08 18.25 Favored Pre-proline 0 N--CA 1.477 0.895 0 CA-C-O 117.736 -1.126 . . . . 5.67 111.3 175.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.55 146.26 49.11 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.979 1.786 . . . . 1.12 112.647 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.64 159.51 43.83 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 125.104 1.362 . . . . 1.39 110.397 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.74 -30.8 2.19 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.616 2.211 . . . . 1.06 112.465 -172.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -179.15 165.28 1.47 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.398 1.879 . . . . 2.09 111.148 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt -110.37 152.96 25.61 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.504 1.121 . . . . 0.83 110.216 163.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -110.33 145.71 37.0 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.722 1.209 . . . . 1.78 108.716 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.611 HG21 HD12 ' A' ' 22' ' ' LEU . 61.8 t -138.16 127.24 14.62 Favored Pre-proline 0 N--CA 1.473 0.688 0 N-CA-C 112.594 0.59 . . . . 0.84 112.594 169.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.88 159.17 48.79 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.049 3.166 . . . . 1.06 112.402 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.47 142.52 95.31 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 124.337 3.358 . . . . 1.1 113.847 -175.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp 64.54 -3.41 0.53 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.646 1.978 . . . . 1.96 114.637 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.64 174.58 55.15 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.824 1.678 . . . . 1.28 114.089 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.66 126.4 6.91 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.387 1.475 . . . . 4.12 108.963 173.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.9 t -147.32 145.34 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.131 1.772 . . . . 4.14 107.836 -163.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.3 142.0 35.84 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.349 -0.844 . . . . 3.79 112.545 -167.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mp -69.55 79.7 0.41 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.891 -1.152 . . . . 2.06 107.891 151.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.99 147.1 85.79 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 112.943 0.72 . . . . 4.12 112.943 -171.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -57.83 133.41 55.9 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.63 1.553 . . . . 3.68 109.13 162.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.58 -12.54 66.17 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 116.637 -2.202 . . . . 1.72 115.657 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.43 -31.67 0.07 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 120.498 2.959 . . . . 2.05 120.498 175.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -144.06 139.31 28.88 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.619 2.209 . . . . 2.34 112.491 175.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -163.13 153.62 16.3 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.236 -0.29 . . . . 0.88 111.345 -176.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -79.48 142.5 35.78 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.596 -0.52 . . . . 2.65 109.596 164.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.6 tpt -105.68 127.03 52.82 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 126.334 1.854 . . . . 0.92 107.143 165.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -105.63 131.84 52.51 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.116 0.967 . . . . 0.85 108.732 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.43 131.93 55.0 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.199 0.999 . . . . 3.53 110.367 -175.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.62 47.13 28.45 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.552 1.072 . . . . 0.8 114.203 170.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.73 149.31 4.75 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 116.112 1.893 . . . . 1.35 116.112 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -104.86 3.91 31.51 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 113.897 -1.502 . . . . 1.98 113.67 -171.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.9 mmt-85 -145.2 139.39 15.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 127.928 2.491 . . . . 6.1 108.25 167.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -64.14 155.3 65.8 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 N-CA-C 107.659 -1.708 . . . . 1.73 107.659 154.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.3 121.18 17.58 Favored 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 108.058 -1.09 . . . . 2.82 108.058 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.47 ' HE2' ' OE1' ' A' ' 97' ' ' GLU 0.299 0.0 OUTLIER -87.64 13.18 10.87 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 116.032 1.864 . . . . 5.65 116.032 -168.998 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 62.81 154.06 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.993 2.917 . . . . 1.77 111.495 -163.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.98 51.17 55.57 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 109.839 -1.305 . . . . 1.67 109.839 -166.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.47 ' OE1' ' HE2' ' A' ' 94' ' ' LYS . 6.3 mm-40 -116.86 -177.6 3.23 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.761 2.025 . . . . 2.38 107.774 173.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -155.66 135.59 12.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.357 1.863 . . . . 3.27 107.744 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -151.23 151.13 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.765 1.626 . . . . 3.07 109.661 -177.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.6 150.05 32.81 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.842 1.052 . . . . 2.96 113.842 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mp -125.68 140.96 52.28 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.129 1.772 . . . . 1.99 110.238 169.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.67 148.32 23.95 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.95 1.7 . . . . 2.33 108.882 164.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.7 mp -120.97 133.62 55.28 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.84 1.256 . . . . 1.08 109.679 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.6 mt -110.31 122.65 48.19 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.32 1.448 . . . . 0.71 110.3 -174.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.471 ' CD2' HD12 ' A' ' 30' ' ' LEU . 97.9 m-85 -120.03 150.7 40.13 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.995 0.918 . . . . 1.99 111.591 -173.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.3 135.83 56.51 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.6 -0.687 . . . . 2.17 111.759 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.6 31.53 21.33 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.798 -1.001 . . . . 3.18 114.448 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.99 8.78 87.05 Favored Glycine 0 N--CA 1.474 1.233 0 CA-C-N 118.572 1.186 . . . . 1.8 115.984 167.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -88.04 138.2 31.66 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.686 1.243 . . . . 3.76 112.006 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.5 p -131.98 145.75 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 125.784 1.634 . . . . 1.95 110.103 175.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.4 tt -146.09 121.56 10.35 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.0 0.92 . . . . 2.64 110.67 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.99 134.67 34.3 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.659 0.784 . . . . 3.09 112.867 176.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.2 m -120.19 160.7 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.497 1.919 . . . . 2.27 110.116 165.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 52.9 t -115.45 132.49 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 107.688 -1.227 . . . . 1.72 107.688 167.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.3 mt -135.81 144.13 47.46 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.206 1.002 . . . . 2.46 112.076 -171.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.68 174.42 12.68 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.212 3.275 . . . . 0.82 113.054 170.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.1 t -122.42 129.63 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.755 2.022 . . . . 0.79 110.127 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.6 167.64 11.14 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.059 2.144 . . . . 3.99 110.271 171.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.93 -177.66 4.79 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 116.686 2.106 . . . . 2.63 116.686 -159.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.714 0 C-N-CA 127.519 2.328 . . . . 11.06 110.139 148.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 . . . . . 0 CA--C 1.538 0.508 0 N-CA-C 109.311 -0.626 . . . . 5.36 109.311 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.2 -178.84 20.33 Favored Glycine 0 N--CA 1.466 0.661 0 C-N-CA 123.571 0.605 . . . . 0.94 113.458 -167.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 23.3 p90 -152.23 154.99 36.87 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.153 0.981 . . . . 1.73 112.161 176.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.8 t -90.31 144.8 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.908 1.283 . . . . 0.94 107.989 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -82.26 129.32 34.82 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.285 0.493 . . . . 6.28 111.147 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -41.51 133.93 2.46 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.078 2.151 . . . . 1.91 112.69 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.5 t -173.99 127.11 0.45 Allowed Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.128 1.771 . . . . 2.73 110.587 169.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -88.88 3.12 5.8 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.023 3.149 . . . . 3.06 112.457 167.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.74 -172.57 45.3 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.742 1.163 . . . . 1.46 113.041 -173.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.11 -22.7 40.74 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.871 2.381 . . . . 1.24 113.209 -176.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -132.5 167.42 20.01 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.488 1.515 . . . . 2.24 114.174 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.48 -174.03 4.69 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 128.658 2.783 . . . . 0.53 110.859 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.35 148.89 32.83 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.273 1.429 . . . . 0.71 110.137 173.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.24 145.05 51.76 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.327 1.232 . . . . 0.55 114.327 -173.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -116.78 43.2 2.3 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.723 2.009 . . . . 2.44 112.89 -170.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.45 HD22 HD22 ' A' ' 101' ' ' LEU . 2.4 pp -68.39 162.06 26.2 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.385 1.254 . . . . 2.2 114.385 -169.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.1 m -94.65 139.61 30.98 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.067 0.947 . . . . 2.0 112.821 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.85 127.64 56.08 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.684 1.194 . . . . 2.99 110.235 167.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -131.11 136.7 48.61 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.229 1.812 . . . . 3.57 106.186 171.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -108.29 93.03 10.57 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 122.601 0.361 . . . . 1.46 110.754 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.5 -12.92 20.54 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.425 2.083 . . . . 1.18 113.159 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.98 -177.29 51.45 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-O 122.352 0.973 . . . . 1.22 112.577 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -109.94 0.26 18.51 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.969 2.108 . . . . 2.97 112.47 -173.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 pp -115.54 159.58 38.0 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 127.701 2.4 . . . . 2.2 110.401 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.14 139.5 15.05 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.252 1.968 . . . . 0.88 110.799 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.1 mt -93.36 149.02 21.54 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 122.249 1.023 . . . . 1.92 110.478 170.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -137.96 102.15 4.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.805 -1.998 . . . . 2.07 111.237 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.5 tp -84.8 104.12 14.48 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.535 1.534 . . . . 1.78 109.902 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.3 m -100.03 -21.9 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.003 1.321 . . . . 0.47 112.185 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.45 -177.67 32.75 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.908 1.242 . . . . 0.47 114.035 -172.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.34 -179.56 8.05 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.057 1.343 . . . . 0.56 112.581 171.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -158.81 143.06 15.59 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.471 1.908 . . . . 4.8 108.083 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.55 149.17 25.49 Favored Pre-proline 0 N--CA 1.481 1.077 0 CA-C-N 121.312 1.869 . . . . 0.81 110.647 168.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -62.81 -10.47 20.08 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.67 2.247 . . . . 1.05 114.032 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.55 34.69 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 113.647 0.981 . . . . 1.06 113.647 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.63 115.69 1.44 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.111 1.765 . . . . 1.92 108.836 159.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -69.51 -34.8 74.82 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.202 1.186 . . . . 2.83 114.202 -175.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -135.58 92.2 2.8 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 107.167 -1.419 . . . . 7.59 107.167 -166.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -85.65 166.46 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.95 0.9 . . . . 1.48 110.464 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.1 149.96 26.66 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.571 1.948 . . . . 4.4 108.229 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.2 tp -121.01 110.83 16.73 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.014 1.279 . . . . 1.02 111.09 -171.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 63.4 m170 -121.05 151.11 40.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 123.102 1.429 . . . . 0.66 114.316 -170.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -93.41 177.82 5.91 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 113.463 -1.699 . . . . 2.52 111.337 156.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.9 m -146.1 127.47 14.92 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.419 1.888 . . . . 0.69 105.989 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -131.37 169.25 16.28 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.073 0.949 . . . . 1.89 113.131 -162.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.0 mtt -99.87 141.86 32.12 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.674 1.19 . . . . 3.48 110.233 167.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -146.48 176.84 9.5 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.102 1.761 . . . . 6.14 111.329 173.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -141.07 138.57 33.68 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.036 1.734 . . . . 2.54 108.547 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.5 m -143.74 144.83 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 127.372 2.269 . . . . 2.19 108.028 167.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 56.86 20.79 5.51 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 115.493 1.664 . . . . 3.4 115.493 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.31 19.0 77.42 Favored Glycine 0 CA--C 1.537 1.458 0 O-C-N 121.041 -1.037 . . . . 1.62 114.056 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -110.47 118.52 36.47 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.916 1.686 . . . . 2.71 107.487 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -71.55 118.93 14.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.404 1.082 . . . . 4.97 108.349 171.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.09 176.6 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.889 1.675 . . . . 2.36 111.188 -172.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 77.0 mtm -127.29 163.65 23.47 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.009 1.323 . . . . 2.55 111.275 172.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.69 -176.68 28.13 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.37 1.462 . . . . 0.48 112.207 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.0 ttm -147.28 149.57 33.11 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.972 1.309 . . . . 0.6 109.489 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -163.1 158.25 18.09 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 124.379 1.072 . . . . 6.24 111.948 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.44 151.37 33.16 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.465 2.11 . . . . 0.78 113.578 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.76 151.5 64.34 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 125.855 1.662 . . . . 0.96 109.944 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.13 -28.93 10.37 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.052 2.501 . . . . 0.84 112.161 -174.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -175.51 168.06 3.23 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.456 1.902 . . . . 2.24 111.207 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.7 mt -111.18 150.06 30.05 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.888 1.275 . . . . 0.64 110.534 162.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -113.53 141.18 47.45 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.729 1.211 . . . . 1.94 108.694 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.6 t -139.16 124.02 11.61 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-O 119.162 -0.447 . . . . 0.98 111.243 166.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.77 162.74 41.11 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.743 2.962 . . . . 0.9 111.649 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.02 144.77 99.59 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.67 2.913 . . . . 1.06 112.594 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.5 mptt 65.2 -8.67 0.24 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.54 2.336 . . . . 1.92 115.157 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.68 166.02 50.29 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.532 1.539 . . . . 1.11 112.844 174.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -144.77 144.54 31.23 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.639 1.175 . . . . 5.82 110.559 170.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -156.83 125.32 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.496 1.918 . . . . 3.71 107.586 -174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -91.79 157.4 16.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.464 0.706 . . . . 4.01 111.829 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.79 73.24 0.57 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.725 1.25 . . . . 2.09 108.647 164.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -57.02 129.98 79.18 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.183 1.393 . . . . 4.76 111.452 -174.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -58.28 -32.48 96.05 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.797 2.331 . . . . 2.01 112.159 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.35 57.62 4.42 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 119.377 -0.679 . . . . 2.53 112.078 165.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.31 -11.39 2.02 Favored Glycine 0 N--CA 1.473 1.125 0 N-CA-C 119.685 2.634 . . . . 2.06 119.685 158.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -144.39 146.84 32.75 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.995 2.398 . . . . 2.37 112.721 171.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -162.21 155.53 20.59 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.047 0.939 . . . . 0.67 110.858 172.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.407 ' CE2' HD21 ' A' ' 20' ' ' LEU . 73.2 m-85 -79.33 140.93 37.38 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.543 -0.91 . . . . 1.62 108.543 157.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.4 tpt -87.05 132.47 33.8 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.301 1.441 . . . . 0.69 107.665 161.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 mp -114.34 119.74 37.99 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.009 -1.108 . . . . 0.63 108.009 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.96 148.07 42.56 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.48 0.712 . . . . 1.6 109.877 172.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.03 48.58 31.96 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 119.391 -0.672 . . . . 1.06 112.28 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pp -61.54 155.56 21.78 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 115.042 1.497 . . . . 1.29 115.042 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.34 -4.41 9.92 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 114.062 -1.426 . . . . 1.88 114.107 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -115.83 114.78 41.66 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 106.442 -1.688 . . . . 4.81 106.442 152.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.62 122.2 9.36 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 N-CA-C 105.38 -2.585 . . . . 2.27 105.38 158.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.2 mt -87.15 178.06 7.01 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 124.576 2.132 . . . . 2.21 112.821 -152.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -127.82 -169.62 2.09 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 129.329 3.052 . . . . 4.28 109.929 169.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.0 155.58 17.04 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 106.635 -1.617 . . . . 1.69 106.635 146.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.65 1.98 89.51 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.435 -1.203 . . . . 1.64 115.771 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -78.72 -176.21 4.8 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.579 1.689 . . . . 2.34 110.289 159.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 17.1 pt-20 -155.09 149.88 26.6 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 128.285 2.634 . . . . 3.37 107.122 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.1 t -145.65 122.22 3.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 125.909 1.684 . . . . 1.2 109.325 -166.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -81.51 154.5 26.26 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.788 0.804 . . . . 2.46 112.251 167.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.45 HD22 HD22 ' A' ' 20' ' ' LEU . 5.6 tt -154.97 132.67 11.36 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.263 1.425 . . . . 3.13 111.023 -177.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.47 130.4 36.97 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.76 2.424 . . . . 2.91 108.509 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.0 mp -100.74 119.56 38.8 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.421 1.088 . . . . 0.97 109.219 175.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 86.4 mt -87.41 108.71 19.12 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.812 0.815 . . . . 0.88 109.734 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -104.53 116.58 32.34 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.409 1.483 . . . . 2.16 111.048 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 54.36 24.78 5.39 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.006 1.722 . . . . 2.79 113.392 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.72 -59.37 2.11 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.962 1.744 . . . . 4.8 112.867 -171.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -84.55 9.21 65.57 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 116.399 1.32 . . . . 2.38 116.399 -167.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -136.66 152.53 50.51 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.296 1.838 . . . . 5.1 111.967 171.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.5 p -148.47 147.14 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 125.069 1.348 . . . . 2.21 111.158 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.4 tp -156.33 132.86 10.15 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.263 1.825 . . . . 2.9 108.281 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -96.53 146.61 24.65 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.908 1.447 . . . . 2.15 114.908 176.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.7 t -130.2 168.1 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 126.986 2.114 . . . . 2.72 108.268 175.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 t -130.88 147.27 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.6 1.56 . . . . 1.89 108.431 -171.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.92 146.2 17.85 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.892 1.277 . . . . 2.09 110.976 -177.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 57.6 Cg_endo -66.51 164.31 29.23 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.4 3.4 . . . . 0.89 112.394 172.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.2 t -105.54 135.97 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.151 1.38 . . . . 1.07 108.768 165.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -147.3 164.03 34.54 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.653 1.181 . . . . 3.5 111.503 -175.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.67 -176.27 3.23 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 127.228 2.211 . . . . 2.69 115.699 -160.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.436 ' C ' HH11 ' A' ' 120' ' ' ARG . 11.0 tpt85 . . . . . 0 N--CA 1.48 1.069 0 C-N-CA 127.65 2.38 . . . . 8.4 113.243 -175.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 108.567 -0.901 . . . . 5.17 108.567 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -94.65 -177.11 38.44 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 123.58 0.61 . . . . 0.96 114.429 -170.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -144.55 154.34 42.77 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.095 1.146 . . . . 2.13 114.095 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.58 135.9 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.537 -0.912 . . . . 0.96 108.537 170.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -70.56 -10.95 60.52 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.956 1.836 . . . . 3.68 115.956 -162.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 63.82 169.82 0.16 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.078 1.351 . . . . 2.37 111.723 -170.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -166.77 162.99 11.1 Favored Pre-proline 0 CA--C 1.542 0.644 0 O-C-N 120.773 -1.205 . . . . 2.25 112.221 160.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -85.09 11.45 3.37 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.248 3.299 . . . . 2.39 112.823 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -150.37 -165.69 12.86 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 124.451 1.024 . . . . 1.1 115.368 -170.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -80.58 -20.43 8.05 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.625 3.55 . . . . 1.23 115.06 -169.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -99.39 164.79 11.96 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.955 1.302 . . . . 2.88 112.98 169.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.63 -177.02 6.27 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.792 2.437 . . . . 0.5 111.077 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.72 165.71 26.27 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.552 2.341 . . . . 0.69 108.47 173.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.85 156.34 37.43 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.265 1.209 . . . . 0.61 114.265 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -140.66 143.59 35.21 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.443 1.897 . . . . 2.41 110.325 -173.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.419 ' HA ' ' HA3' ' A' ' 6' ' ' GLY 0.263 0.0 OUTLIER -163.39 166.83 22.46 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.676 1.19 . . . . 2.41 113.45 -177.723 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.6 m -91.78 123.62 35.3 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 127.255 2.222 . . . . 1.87 109.373 -174.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.3 126.72 46.66 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.707 -0.849 . . . . 3.13 108.707 165.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -126.2 120.78 30.93 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.469 -1.308 . . . . 3.91 107.469 161.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -92.45 115.49 64.87 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.464 -0.779 . . . . 1.48 108.94 170.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -87.98 -9.79 5.26 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.318 2.678 . . . . 1.31 114.822 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.52 159.39 27.09 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 119.65 1.114 . . . . 1.6 111.914 -175.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.81 7.61 6.79 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 128.346 2.658 . . . . 3.7 112.485 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -125.92 150.24 68.43 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 128.592 2.757 . . . . 1.95 109.367 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.44 149.52 27.53 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.852 2.368 . . . . 0.96 111.306 -171.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.2 mt -102.75 153.19 20.39 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 122.809 1.29 . . . . 1.6 110.431 164.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 ttp-105 -140.21 103.14 4.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.197 -1.82 . . . . 2.45 110.45 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.5 tt -80.38 113.62 18.7 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 109.13 -0.693 . . . . 2.26 109.13 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -104.31 -20.15 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.385 1.074 . . . . 0.63 111.771 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.05 -176.24 30.87 Favored Glycine 0 C--N 1.343 0.956 0 C-N-CA 124.808 1.194 . . . . 0.58 114.71 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.5 -177.61 6.18 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.182 1.393 . . . . 0.61 111.884 174.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -156.2 176.71 12.32 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.896 2.479 . . . . 4.23 107.261 163.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -167.87 151.41 5.88 Favored Pre-proline 0 N--CA 1.466 0.329 0 C-N-CA 128.348 2.659 . . . . 0.74 106.9 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.95 -5.22 16.64 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.386 2.058 . . . . 1.01 113.108 174.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.61 49.24 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.632 1.173 . . . . 0.89 113.501 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.99 151.67 14.44 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.492 0.717 . . . . 0.89 112.374 163.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -89.73 -44.25 10.14 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.069 1.747 . . . . 3.06 110.951 168.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -114.15 130.79 56.59 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.193 1.797 . . . . 5.67 108.255 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -109.14 149.81 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.322 -0.992 . . . . 1.24 108.322 154.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -134.06 148.67 51.08 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.606 1.562 . . . . 2.91 108.369 171.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.4 tp -100.98 118.65 37.41 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.637 -0.505 . . . . 1.04 109.637 175.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 48.1 m170 -119.92 162.5 19.07 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 123.819 1.771 . . . . 0.7 113.284 -177.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.438 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 15.9 pt-20 -110.99 153.2 25.89 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 112.889 -1.959 . . . . 2.83 112.055 155.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.0 m -109.67 152.39 25.65 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 106.251 -1.759 . . . . 0.91 106.251 160.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -149.88 171.49 16.69 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.174 0.99 . . . . 2.15 111.771 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 57.3 ttm -102.06 143.39 31.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.726 1.21 . . . . 3.94 109.566 168.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.32 157.56 43.19 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.875 1.27 . . . . 4.49 111.369 -172.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.92 176.38 8.73 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.129 1.372 . . . . 2.62 114.599 178.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.0 p 159.76 123.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 1 C-N-CA 132.334 4.254 . . . . 3.72 106.974 -164.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 64.63 9.93 5.53 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 117.248 2.314 . . . . 3.15 117.248 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.77 7.34 60.11 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 120.745 -1.222 . . . . 2.37 113.28 -171.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -112.37 100.84 9.1 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.24 1.816 . . . . 2.86 109.213 -162.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -79.49 114.34 18.34 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.194 -0.941 . . . . 4.05 108.995 -173.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.1 t -126.82 133.52 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.169 1.788 . . . . 2.69 108.769 -173.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 60.2 mtm -88.25 128.17 35.47 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.82 0.848 . . . . 3.24 110.688 175.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.72 177.71 16.5 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 124.957 1.265 . . . . 0.63 112.631 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.6 ttm -157.52 137.66 12.61 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.589 1.155 . . . . 0.73 111.974 -172.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -146.81 150.01 38.05 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.864 1.666 . . . . 8.49 111.038 -177.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.56 151.8 53.26 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.38 2.053 . . . . 0.75 110.12 169.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.78 154.75 76.61 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 125.293 1.437 . . . . 0.76 110.638 -175.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.66 -25.9 4.15 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.2 2.6 . . . . 0.63 113.189 -166.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -177.77 161.68 1.65 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.144 1.778 . . . . 1.97 111.433 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.69 153.83 22.88 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.429 1.492 . . . . 0.71 109.62 163.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -105.52 152.36 23.14 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.929 0.891 . . . . 1.86 110.685 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.3 124.01 13.62 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 123.301 0.64 . . . . 1.46 110.263 163.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.35 165.03 31.88 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.181 2.587 . . . . 1.01 111.181 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.92 138.85 76.23 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.516 2.144 . . . . 1.23 112.848 175.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.26 15.3 mtmt 57.66 36.82 27.07 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.355 1.462 . . . . 2.95 113.606 171.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.29 140.06 11.48 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.561 2.029 . . . . 1.18 114.84 -172.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.1 ttt85 -87.52 138.11 31.75 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.851 2.06 . . . . 4.37 110.439 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.5 t -148.93 142.58 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 127.421 2.288 . . . . 3.27 107.313 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -142.35 147.5 36.39 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 120.537 1.517 . . . . 4.26 113.463 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mp -82.59 168.08 17.68 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.044 2.138 . . . . 2.58 111.168 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -169.82 157.9 6.5 Favored Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 125.868 1.667 . . . . 2.92 113.667 -176.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.18 -47.24 15.38 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 124.19 3.26 . . . . 3.12 113.254 176.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.02 36.11 1.47 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.851 1.215 . . . . 1.6 113.66 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.3 -134.1 2.51 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 125.107 1.337 . . . . 1.61 113.456 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.438 ' CE1' ' HB3' ' A' ' 47' ' ' GLU . 97.1 m-85 -71.05 136.63 48.41 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.897 -0.766 . . . . 2.03 111.658 -169.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.5 p-80 -162.08 154.68 19.81 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.826 1.25 . . . . 0.69 112.465 -170.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -84.32 146.57 27.66 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.855 -0.528 . . . . 2.44 109.753 168.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.6 tpt -100.4 136.51 40.17 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.739 1.216 . . . . 0.63 108.9 162.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.5 mp -118.59 139.87 50.8 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.032 1.333 . . . . 0.52 109.148 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mp -140.2 146.63 38.95 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.693 0.797 . . . . 1.75 110.699 171.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.59 37.09 24.46 Favored Glycine 0 N--CA 1.473 1.106 0 O-C-N 122.073 -0.392 . . . . 1.11 112.904 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.27 146.12 9.8 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.856 1.662 . . . . 1.29 115.467 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -109.1 -23.49 11.62 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 113.646 -1.615 . . . . 1.99 113.255 -168.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -97.61 142.67 24.92 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.056 0.942 . . . . 5.83 109.19 158.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.69 79.54 3.32 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.279 2.652 . . . . 2.5 109.439 173.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 72.8 mt -42.63 122.93 2.46 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 127.604 2.362 . . . . 2.25 115.13 -167.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -119.97 156.8 30.13 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 127.078 2.151 . . . . 6.05 113.357 165.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.26 135.98 56.75 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.784 -1.098 . . . . 1.44 108.435 171.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.13 1.56 72.39 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.052 1.31 . . . . 1.78 115.117 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -74.97 -173.09 1.81 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.012 1.406 . . . . 2.37 112.834 169.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -139.05 125.52 20.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.99 3.316 . . . . 5.1 105.354 -165.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.2 t -145.18 128.42 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 O-C-N 121.298 -0.876 . . . . 1.18 110.957 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.82 143.58 35.87 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.421 -0.809 . . . . 2.48 110.658 169.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mp -118.27 134.33 55.12 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.876 0.871 . . . . 1.78 109.569 156.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -93.44 139.4 30.75 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.185 2.594 . . . . 2.78 108.355 169.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.4 mp -118.43 129.02 55.16 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.729 1.612 . . . . 0.91 109.743 -173.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.8 mt -106.28 114.81 29.16 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.371 1.468 . . . . 0.75 110.518 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -112.24 115.06 28.2 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.067 1.347 . . . . 1.9 111.841 -172.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 48.53 26.94 1.3 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.519 1.928 . . . . 3.03 114.223 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.33 -59.49 4.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.42 1.486 . . . . 4.4 112.861 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.63 3.42 68.79 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 116.987 1.555 . . . . 2.21 116.987 -165.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -136.1 143.36 44.54 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.702 1.751 . . . . 3.43 112.519 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.4 t -134.34 147.43 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.473 1.509 . . . . 2.29 109.659 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -153.78 166.52 32.62 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.936 2.494 . . . . 1.89 108.094 175.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -144.35 160.55 40.85 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.878 1.217 . . . . 1.74 113.679 171.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.66 158.21 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.525 1.53 . . . . 2.38 108.886 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.5 p -114.63 132.72 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.325 1.05 . . . . 2.45 110.003 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -124.93 148.89 61.32 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 126.975 2.11 . . . . 3.29 108.713 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.15 161.73 44.9 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.742 2.295 . . . . 0.86 111.775 162.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.4 t -96.59 137.61 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.847 0.859 . . . . 1.14 109.41 168.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.54 141.31 29.4 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.884 1.674 . . . . 3.82 111.036 177.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -95.39 86.35 4.48 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.674 1.189 . . . . 2.31 112.051 -169.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 . . . . . 0 C--O 1.246 0.881 0 C-N-CA 124.87 1.268 . . . . 8.18 111.153 -173.934 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 CA--C 1.544 0.749 0 CA-C-O 121.873 0.844 . . . . 6.22 112.231 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.0 -177.54 23.26 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.809 1.671 . . . . 1.0 111.714 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -148.98 157.61 43.55 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 115.351 1.611 . . . . 1.88 115.351 -173.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.0 t -92.89 134.73 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.958 1.303 . . . . 1.34 108.631 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.9 tpp85 -69.16 118.87 12.6 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.144 0.977 . . . . 4.83 111.872 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -66.64 142.32 57.5 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.87 1.268 . . . . 1.85 111.414 162.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -174.48 161.48 2.7 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 126.451 1.9 . . . . 2.92 110.684 170.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -84.55 38.2 0.67 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.998 3.132 . . . . 2.49 112.122 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.85 151.52 18.21 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 124.942 1.258 . . . . 1.46 115.122 -165.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.29 -22.11 14.65 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.253 2.635 . . . . 1.25 111.841 166.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -105.99 158.58 16.69 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 127.272 2.229 . . . . 2.31 112.072 165.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.38 -171.79 3.92 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.027 2.131 . . . . 0.74 110.752 -173.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.34 159.86 43.58 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.188 1.395 . . . . 1.11 109.707 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.75 131.21 37.3 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.65 1.114 . . . . 0.88 112.778 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -123.0 81.96 1.94 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.664 1.986 . . . . 2.81 110.28 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -92.24 158.08 16.33 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.664 1.186 . . . . 1.91 113.923 -173.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.7 m -119.89 144.33 47.46 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.725 1.61 . . . . 2.13 108.443 162.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.9 tp -158.57 171.7 19.65 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.574 2.75 . . . . 5.03 107.517 173.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -136.23 144.75 45.02 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 120.391 -1.443 . . . . 4.42 108.382 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -97.59 106.7 34.82 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 125.381 1.472 . . . . 1.4 109.493 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -81.62 -7.3 12.59 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.731 2.287 . . . . 1.35 114.083 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.64 168.5 54.78 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-O 123.108 1.393 . . . . 1.44 113.228 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.436 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 16.6 m-20 -101.44 -2.38 30.94 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 128.606 2.763 . . . . 3.05 111.648 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 pp -117.03 159.16 42.12 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 127.665 2.386 . . . . 2.18 110.342 171.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.87 138.07 12.95 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.873 2.382 . . . . 1.08 111.025 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.55 156.68 16.33 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 123.185 1.469 . . . . 2.16 111.834 176.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -152.01 98.26 2.42 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.104 -1.862 . . . . 2.86 110.246 -164.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.473 HD21 ' CZ ' ' A' ' 84' ' ' PHE . 5.4 tt -85.59 115.75 23.47 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.945 1.698 . . . . 2.28 107.403 -177.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.93 -16.39 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.202 1.001 . . . . 0.73 111.969 -174.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.18 -176.53 31.34 Favored Glycine 0 C--N 1.342 0.881 0 C-N-CA 125.887 1.708 . . . . 0.65 113.392 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -153.74 178.03 10.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.39 1.476 . . . . 0.69 112.785 166.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -151.42 159.04 44.42 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 129.622 3.169 . . . . 4.47 108.568 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 t -173.79 152.23 1.97 Allowed Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 128.111 2.565 . . . . 0.61 107.229 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.92 -15.88 20.71 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.688 1.592 . . . . 0.98 113.513 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.12 32.54 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.319 1.047 . . . . 0.75 112.326 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.93 140.12 17.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.608 0.763 . . . . 0.9 109.395 165.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -85.93 -33.89 21.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.038 1.335 . . . . 3.79 110.847 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -139.06 144.45 38.79 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.066 2.146 . . . . 6.94 106.597 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.2 p -135.92 146.84 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.109 1.364 . . . . 1.56 109.338 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -135.49 146.97 48.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.755 2.022 . . . . 3.99 108.781 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.8 tp -109.12 115.65 30.45 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.697 1.135 . . . . 1.17 111.1 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 65.6 m170 -116.4 154.65 29.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.497 1.519 . . . . 0.74 113.923 -175.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.479 ' CD ' ' HD2' ' A' ' 62' ' ' ARG . 6.5 pt-20 -95.86 179.86 4.95 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.806 1.243 . . . . 2.21 111.442 159.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 84.1 m -137.69 134.81 35.83 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.351 -1.352 . . . . 0.94 107.351 164.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -129.7 163.81 25.33 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.165 1.172 . . . . 2.15 114.165 -168.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -106.5 150.22 26.32 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.458 1.503 . . . . 3.76 111.4 167.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.67 157.66 35.59 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.055 0.942 . . . . 4.35 111.217 -168.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -110.32 146.83 35.05 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.174 1.79 . . . . 2.72 108.415 167.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.2 129.42 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 107.748 -1.205 . . . . 2.97 107.748 161.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 61.97 32.99 17.61 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.161 0.984 . . . . 4.53 112.298 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.73 8.69 82.14 Favored Glycine 0 CA--C 1.536 1.384 0 O-C-N 120.575 -1.328 . . . . 2.02 114.019 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -121.11 129.63 53.38 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.391 1.876 . . . . 2.77 109.174 -172.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -69.34 134.9 49.64 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.992 2.117 . . . . 4.37 109.492 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.5 p -146.36 170.79 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 125.895 1.678 . . . . 2.62 109.835 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 32.2 mtm -131.85 159.32 38.91 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.768 1.627 . . . . 2.57 110.684 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.13 -174.9 27.43 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.924 1.25 . . . . 0.89 113.956 -173.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.3 ttm -155.74 145.69 21.42 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.169 1.787 . . . . 0.79 108.565 -174.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.479 ' HD2' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -162.46 154.0 15.33 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.573 1.149 . . . . 5.32 111.59 -178.159 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.79 157.53 35.28 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.143 1.896 . . . . 0.59 112.976 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.34 156.78 67.18 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 126.487 1.915 . . . . 0.73 110.211 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.5 -21.82 4.13 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.743 2.962 . . . . 0.71 113.892 -169.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -177.0 164.61 2.3 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.626 1.97 . . . . 2.04 110.368 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.9 mt -110.31 153.44 24.88 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.342 1.057 . . . . 0.83 109.962 166.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -122.07 146.52 47.12 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.466 1.106 . . . . 2.66 110.875 174.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.1 t -140.13 131.42 14.29 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.898 1.279 . . . . 0.84 109.756 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.46 166.27 27.8 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.115 2.543 . . . . 0.99 112.182 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -58.41 139.85 92.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.164 2.576 . . . . 1.25 111.235 171.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.436 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 61.3 mmtt 65.1 3.96 2.37 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.977 1.311 . . . . 1.69 113.286 -175.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.11 176.54 53.08 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 127.107 2.289 . . . . 1.43 114.73 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 -98.66 129.98 45.16 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.441 1.496 . . . . 3.7 112.84 -174.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.8 t -108.12 57.59 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.63 1.572 . . . . 6.03 108.947 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -101.65 127.6 48.32 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.038 0.935 . . . . 3.16 109.331 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' A' ' 83' ' ' HIS . 3.7 mp -67.82 -37.43 81.92 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.247 1.019 . . . . 3.1 111.219 173.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.2 tptt 91.91 126.35 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 127.176 2.19 . . . . 4.12 111.385 171.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.82 29.38 0.21 Allowed 'Trans proline' 0 CA--C 1.551 1.338 0 C-N-CA 125.027 3.818 . . . . 2.81 115.037 -177.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.03 26.13 0.03 OUTLIER Glycine 0 CA--C 1.539 1.532 0 C-N-CA 127.05 2.262 . . . . 1.69 115.284 -174.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.28 -29.59 0.02 OUTLIER Glycine 0 N--CA 1.481 1.683 0 N-CA-C 119.208 2.443 . . . . 2.3 119.208 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -142.23 151.24 41.92 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.493 1.517 . . . . 2.25 111.422 159.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.527 ' HA ' HD23 ' A' ' 77' ' ' LEU . 44.3 p-80 -163.2 157.3 20.27 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.797 -1.189 . . . . 0.77 111.998 175.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 70.8 m-85 -78.43 139.55 38.73 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.073 -0.651 . . . . 2.59 109.397 161.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -91.72 131.02 37.4 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.773 1.629 . . . . 0.64 108.116 159.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 mp -113.64 143.29 44.83 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.973 1.309 . . . . 0.7 109.071 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mt -137.96 139.4 39.71 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.239 1.016 . . . . 2.16 111.355 -176.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.57 38.84 36.58 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.924 -0.931 . . . . 0.93 113.897 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.61 150.89 0.91 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 117.17 2.285 . . . . 1.39 117.17 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -115.76 -13.28 11.41 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 113.746 -1.57 . . . . 2.67 114.269 -172.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -119.57 154.26 54.46 Favored Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 125.954 1.702 . . . . 5.67 108.902 168.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -70.66 149.3 60.93 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.662 2.241 . . . . 2.4 110.067 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.5 mt -89.54 115.06 26.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 122.87 1.319 . . . . 3.08 107.672 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -116.65 172.02 7.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.621 -1.627 . . . . 4.67 110.473 169.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.45 136.79 39.41 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.832 -1.544 . . . . 1.63 106.832 145.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.1 45.24 9.09 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 123.161 0.41 . . . . 2.13 113.721 174.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -111.64 177.71 4.56 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.35 0.575 . . . . 2.82 110.775 148.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -146.35 134.81 21.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.1 2.16 . . . . 3.36 108.146 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.8 t -139.49 136.09 40.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 127.768 2.427 . . . . 1.32 109.636 -160.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -84.11 145.74 28.26 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.754 0.787 . . . . 3.08 112.808 173.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mp -121.79 146.83 46.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.907 2.083 . . . . 1.76 109.862 163.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -117.91 111.62 19.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.379 2.272 . . . . 2.31 107.844 168.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.3 mp -83.0 140.23 32.84 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.864 0.866 . . . . 0.97 109.352 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.8 mt -105.23 109.38 21.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.454 1.102 . . . . 0.73 110.098 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -97.63 150.52 21.06 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.758 1.223 . . . . 1.95 111.117 172.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.43 126.62 22.02 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.287 1.435 . . . . 1.6 113.487 -169.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.43 49.0 6.98 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.086 -0.841 . . . . 2.69 112.649 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.17 12.1 84.36 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 116.174 1.23 . . . . 2.65 116.174 165.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -92.14 102.99 15.52 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.333 1.567 . . . . 3.98 111.128 -168.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.3 p -93.18 139.45 18.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 O-C-N 124.603 1.19 . . . . 2.16 111.818 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 123.39 19.95 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.467 0.707 . . . . 2.58 111.514 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -89.84 129.51 36.21 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.273 1.429 . . . . 1.99 111.473 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.18 143.97 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.952 1.301 . . . . 1.82 109.935 168.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.0 p -112.77 134.89 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.358 1.063 . . . . 2.36 110.023 176.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 mp -138.87 148.71 59.11 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.967 1.307 . . . . 2.77 110.535 -167.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.66 153.12 79.09 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.468 2.112 . . . . 1.04 111.934 169.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.31 120.95 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.012 -1.477 . . . . 1.4 107.012 165.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -153.46 165.66 35.13 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 122.805 1.288 . . . . 5.35 113.703 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.29 155.5 28.48 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.75 -1.114 . . . . 3.27 113.859 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.168 0 C-N-CA 131.248 3.819 . . . . 7.85 107.374 157.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 121.871 0.843 . . . . 6.4 109.751 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.06 176.17 19.43 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.565 -1.014 . . . . 0.98 110.565 170.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -155.58 -178.65 7.43 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.387 0.613 . . . . 1.74 112.568 -176.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.8 t -112.88 134.69 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.112 1.765 . . . . 1.42 109.184 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -21.79 38.5 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.082 1.512 . . . . 5.57 115.082 -172.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 82.9 t80 69.99 146.98 0.06 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 128.884 2.874 . . . . 2.51 113.792 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.3 m -170.93 154.81 4.36 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.79 2.036 . . . . 2.28 111.886 173.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -82.68 -24.6 3.4 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.75 2.967 . . . . 2.17 112.865 169.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.08 148.54 24.47 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 109.843 -1.303 . . . . 2.31 109.843 166.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.87 -38.9 9.16 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.974 2.449 . . . . 2.83 114.523 -163.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -80.03 139.51 36.93 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 123.352 1.549 . . . . 4.33 112.779 -175.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.8 -175.31 5.31 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.341 1.457 . . . . 0.88 112.502 -156.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.86 156.83 43.81 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.997 1.719 . . . . 0.79 109.932 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.4 143.92 39.99 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.175 0.805 . . . . 0.63 113.175 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.438 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 31.0 m-85 -125.53 75.45 1.48 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.408 1.883 . . . . 2.38 110.918 -168.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.83 162.92 28.6 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.816 -1.178 . . . . 1.86 113.965 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 68.3 m -121.1 141.64 50.6 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.386 1.075 . . . . 2.27 109.223 157.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.64 -179.35 7.53 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 128.473 2.709 . . . . 5.44 107.776 175.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -138.89 157.36 46.19 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.16 -0.963 . . . . 3.87 111.847 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -103.65 95.11 6.91 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 126.072 1.749 . . . . 1.37 109.469 165.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.0 -3.94 12.47 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.009 2.473 . . . . 1.17 114.337 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.26 160.41 31.9 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-O 122.456 1.031 . . . . 1.41 111.759 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -87.23 10.02 18.36 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.815 2.446 . . . . 3.9 112.179 175.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -116.01 152.88 48.14 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 128.812 2.845 . . . . 2.17 109.744 171.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.38 153.58 24.11 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.22 2.614 . . . . 0.83 111.489 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.9 mt -111.8 146.9 36.83 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 123.296 1.522 . . . . 1.71 111.774 167.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -133.85 103.63 5.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 112.263 -2.244 . . . . 2.06 110.04 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -82.7 109.73 17.13 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.185 1.394 . . . . 2.59 108.296 -174.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 m -105.65 -22.04 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.305 1.042 . . . . 0.5 111.908 -172.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.15 -176.72 31.52 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 125.279 1.419 . . . . 0.48 113.737 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -154.27 179.16 9.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.263 1.425 . . . . 0.58 111.679 168.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -146.19 174.33 11.42 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.783 2.033 . . . . 5.47 108.998 164.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 t -170.86 149.53 2.84 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 127.721 2.409 . . . . 0.74 108.149 175.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.91 -3.66 14.13 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.746 2.298 . . . . 1.05 113.682 176.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 m -121.74 57.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.843 1.257 . . . . 1.22 112.339 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.09 173.83 16.13 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.544 1.138 . . . . 1.57 112.005 162.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -114.87 -51.95 2.72 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.277 1.831 . . . . 2.72 109.446 165.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -101.66 132.13 47.52 Favored 'General case' 0 C--N 1.342 0.243 0 O-C-N 121.319 -0.863 . . . . 5.25 109.489 161.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -97.06 150.65 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.108 -0.951 . . . . 1.3 108.458 140.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -136.17 154.02 51.09 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.1 1.76 . . . . 3.0 109.013 169.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.8 tp -110.66 117.31 33.14 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.364 0.665 . . . . 1.09 111.235 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -125.29 149.34 48.15 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.784 1.234 . . . . 0.73 114.177 -172.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -87.51 169.92 11.78 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.507 1.923 . . . . 2.57 112.15 163.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.1 m -148.25 146.16 28.52 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 106.711 -1.589 . . . . 1.01 106.711 173.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -157.99 163.09 38.12 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.116 1.154 . . . . 2.28 114.116 -170.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.6 ttp -91.53 148.85 21.99 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.49 1.116 . . . . 3.11 109.346 161.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.09 167.18 30.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.285 1.834 . . . . 4.42 110.258 -170.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -124.53 135.21 52.99 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.586 1.554 . . . . 2.5 110.553 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 t -136.8 120.33 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.035 -0.728 . . . . 2.05 109.035 165.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 65.96 26.25 10.97 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.757 2.023 . . . . 3.17 112.962 -176.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.25 10.71 85.77 Favored Glycine 0 CA--C 1.536 1.364 0 O-C-N 120.218 -1.551 . . . . 2.11 113.366 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -110.25 116.46 31.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.796 1.638 . . . . 3.31 110.355 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.493 ' H ' ' HE2' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -58.66 129.25 41.2 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.961 2.104 . . . . 4.18 110.407 174.354 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.8 p -156.72 146.01 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.369 1.867 . . . . 2.49 109.752 -174.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.21 161.16 14.07 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.765 0.826 . . . . 3.28 111.882 -174.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.44 -179.47 30.59 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 123.976 0.798 . . . . 0.59 114.294 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.8 ttm -159.92 148.48 17.31 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.675 1.99 . . . . 0.81 109.09 -173.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.1 mtm105 -150.69 156.01 36.05 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.545 1.538 . . . . 5.17 109.993 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -77.05 152.94 31.96 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.03 1.82 . . . . 0.63 110.82 168.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.3 m -139.1 151.85 68.67 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.897 1.279 . . . . 0.74 110.542 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.39 -24.01 11.08 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.27 2.647 . . . . 0.72 112.624 -170.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -173.04 172.96 3.8 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.098 1.759 . . . . 1.92 110.912 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.1 mt -118.56 154.93 31.78 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.228 1.811 . . . . 0.71 109.819 161.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -114.63 140.59 48.69 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.203 1.001 . . . . 1.87 110.281 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.4 t -137.71 127.51 15.29 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 123.565 0.746 . . . . 0.86 110.913 167.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.66 169.95 16.3 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.849 3.032 . . . . 0.98 111.941 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.06 143.17 96.9 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.112 2.541 . . . . 1.16 113.003 173.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm 64.15 8.28 3.97 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.549 1.54 . . . . 2.41 113.794 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.99 163.8 38.3 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 127.149 2.309 . . . . 1.2 113.639 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.4 mtt-85 -93.62 148.45 22.09 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.802 0.841 . . . . 5.58 110.567 174.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.7 t -118.08 57.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.704 2.002 . . . . 5.52 107.564 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -89.2 129.2 35.82 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.017 -0.734 . . . . 2.9 109.017 168.082 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 83' ' ' HIS . 2.6 tp -74.78 -24.56 58.69 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 112.925 0.713 . . . . 3.13 112.925 -164.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? 76.97 100.89 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 127.319 2.248 . . . . 4.0 110.342 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.438 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 35.0 Cg_endo -60.92 -29.46 88.11 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 121.829 1.686 . . . . 2.27 114.153 -175.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.88 10.5 70.09 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.148 -1.918 . . . . 1.51 115.07 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.47 -25.66 0.03 OUTLIER Glycine 0 N--CA 1.475 1.28 0 N-CA-C 121.414 3.326 . . . . 2.27 121.414 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -140.29 147.92 40.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 121.337 2.569 . . . . 2.18 113.17 164.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.524 ' HA ' HD23 ' A' ' 77' ' ' LEU . 54.8 p-80 -158.48 152.54 23.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.668 -1.151 . . . . 0.73 112.209 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 75.7 m-85 -78.25 139.08 38.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.094 -0.706 . . . . 2.23 109.094 161.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -88.04 129.45 35.27 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.745 -1.206 . . . . 0.79 107.745 159.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 mp -108.74 127.43 53.99 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.06 -1.089 . . . . 0.51 108.06 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.42 143.42 50.75 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.75 0.82 . . . . 1.64 110.591 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.17 45.81 47.01 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.291 -0.727 . . . . 0.82 113.737 176.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pp -54.39 147.94 12.77 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 123.52 1.629 . . . . 1.38 114.954 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -103.79 -5.78 22.11 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 113.328 -1.76 . . . . 2.02 113.242 -169.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -148.57 144.47 18.51 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 127.585 2.354 . . . . 7.94 109.402 171.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.56 152.54 17.59 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 124.069 3.179 . . . . 2.05 111.281 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.645 ' H ' HD23 ' A' ' 93' ' ' LEU . 2.0 pt? -120.06 142.16 49.11 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.849 2.46 . . . . 3.62 110.152 -166.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -96.2 -165.8 1.33 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 125.647 1.579 . . . . 3.94 110.21 159.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.18 139.01 36.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 107.92 -1.141 . . . . 1.52 107.92 148.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.45 4.55 34.85 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.66 1.6 . . . . 1.82 115.501 -170.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.19 174.51 11.49 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.065 1.346 . . . . 2.85 110.579 171.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -136.3 149.09 48.27 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.175 1.79 . . . . 4.02 106.22 156.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.1 t -145.06 134.56 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.571 1.948 . . . . 1.14 110.195 -165.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -78.9 135.09 36.89 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.842 1.257 . . . . 3.39 112.208 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mp -123.41 145.01 49.12 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.155 1.382 . . . . 1.71 111.153 162.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -109.25 133.99 52.33 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.562 1.945 . . . . 2.81 108.578 170.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 mp -108.5 131.44 54.81 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.883 0.873 . . . . 0.8 109.686 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.2 mt -106.52 114.77 29.08 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.206 1.003 . . . . 0.7 109.844 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -113.36 121.11 43.38 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.981 1.713 . . . . 2.03 111.498 -175.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.96 22.45 2.43 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.598 1.959 . . . . 2.61 114.475 174.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.77 -58.39 3.46 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.127 1.346 . . . . 4.22 112.66 -169.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.38 0.73 79.46 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 116.821 1.489 . . . . 2.13 116.821 -167.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -130.94 140.15 50.14 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.774 1.787 . . . . 3.71 112.344 173.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.0 p -127.73 147.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.42 1.888 . . . . 2.25 110.347 172.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.1 tp -150.73 124.48 9.15 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.039 1.336 . . . . 2.06 110.236 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -113.25 135.75 53.5 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.266 0.626 . . . . 2.64 112.579 -172.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.4 t -146.45 163.93 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.465 1.506 . . . . 3.23 108.956 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -114.56 138.03 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.179 1.392 . . . . 2.3 109.113 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mp -124.22 151.57 66.16 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.841 1.256 . . . . 2.6 110.562 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -69.06 155.43 68.27 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.229 2.62 . . . . 1.23 111.489 172.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.6 t -106.41 81.73 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 107.499 -1.297 . . . . 1.46 107.499 161.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.19 156.09 27.09 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.748 -1.205 . . . . 4.05 107.748 140.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -83.43 178.98 7.79 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.05 1.34 . . . . 3.68 110.849 172.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.268 12.1 ptt-85 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 114.78 -2.533 . . . . 9.47 113.494 162.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 CA--C 1.545 0.774 0 CA-C-O 121.545 0.688 . . . . 7.21 109.799 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.82 -179.93 32.16 Favored Glycine 0 N--CA 1.471 0.999 0 O-C-N 120.717 -1.239 . . . . 1.0 114.689 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.5 p90 -141.87 165.82 26.41 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.418 1.487 . . . . 2.02 112.206 172.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.6 t -106.14 135.56 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.044 -1.095 . . . . 1.07 108.044 166.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.04 113.95 15.3 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 120.766 0.317 . . . . 3.72 110.278 175.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -61.36 135.71 57.79 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.658 -0.497 . . . . 2.99 109.658 156.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.2 m -160.59 139.84 7.92 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.991 1.317 . . . . 3.64 108.952 167.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -85.08 48.23 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.692 3.595 . . . . 3.12 112.353 -168.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -124.09 -175.45 14.39 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.411 1.482 . . . . 1.75 112.897 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.78 -17.46 20.13 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.673 2.915 . . . . 1.77 113.516 174.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -122.16 167.33 13.3 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.728 2.011 . . . . 3.37 113.431 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.34 -176.06 5.15 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 127.127 2.171 . . . . 0.84 111.739 175.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.22 150.7 44.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.718 2.007 . . . . 0.83 108.658 176.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.47 138.41 48.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.153 0.888 . . . . 0.87 111.308 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -129.02 133.55 47.78 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.057 1.743 . . . . 2.35 110.656 -171.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 pp -165.7 152.12 9.7 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.149 0.886 . . . . 2.37 113.1 -170.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 62.6 m -77.22 120.85 22.86 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.355 -0.841 . . . . 3.26 109.035 171.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.14 118.97 23.0 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.541 -1.281 . . . . 3.31 107.541 168.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -111.44 126.9 55.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.875 1.67 . . . . 4.09 109.07 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -103.62 98.7 13.38 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 121.652 -0.655 . . . . 1.38 111.552 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.17 -7.27 17.09 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.903 2.402 . . . . 1.37 114.112 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.76 172.35 53.18 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-O 122.658 1.143 . . . . 1.19 112.656 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -103.78 -4.52 23.52 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.21 2.604 . . . . 3.07 111.837 -174.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.664 ' H ' HD23 ' A' ' 28' ' ' LEU . 2.6 pt? -116.55 162.41 26.9 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 129.106 2.963 . . . . 2.89 109.577 172.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.12 142.59 24.76 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.131 1.888 . . . . 0.84 109.991 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.494 HD12 ' CD1' ' A' ' 105' ' ' PHE . 1.1 mm? -105.67 158.04 16.99 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.076 1.351 . . . . 2.3 111.308 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -149.42 107.45 3.72 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.154 -1.385 . . . . 2.59 111.434 -171.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.5 tp -90.39 109.65 20.76 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 127.051 2.14 . . . . 1.84 109.272 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -106.77 -17.76 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.445 1.098 . . . . 0.7 112.238 -171.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.87 -175.38 28.73 Favored Glycine 0 C--N 1.344 0.985 0 C-N-CA 125.878 1.704 . . . . 0.45 113.089 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.76 -176.91 5.45 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.532 1.533 . . . . 0.52 110.794 168.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.71 175.87 13.34 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.418 2.687 . . . . 4.59 108.2 169.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.0 159.3 7.85 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 127.135 2.174 . . . . 0.97 107.267 168.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.56 -9.68 16.67 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.638 2.225 . . . . 0.94 115.168 166.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.75 41.36 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 114.821 1.415 . . . . 0.89 114.821 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.46 149.91 8.65 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.314 1.446 . . . . 2.07 110.133 161.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -123.17 -58.78 1.62 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.817 1.247 . . . . 3.38 111.376 -173.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -78.21 68.17 4.17 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 120.887 -1.133 . . . . 4.93 108.989 168.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.7 p -78.03 150.47 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.054 -0.975 . . . . 1.11 108.857 168.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.97 158.36 37.77 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.065 2.146 . . . . 4.75 107.038 -164.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -134.47 133.3 40.27 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 123.794 1.759 . . . . 1.75 114.102 171.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -120.41 149.13 42.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 112.728 -2.033 . . . . 0.77 111.188 -171.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.65 -178.9 7.0 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.293 -1.321 . . . . 2.9 110.837 155.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.7 m -153.22 138.68 17.65 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.893 1.277 . . . . 0.92 108.465 172.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -147.73 164.27 34.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 122.84 1.305 . . . . 2.28 113.45 -171.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.5 ttm -97.32 138.71 34.37 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.313 1.445 . . . . 3.89 109.758 172.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -149.08 161.51 41.8 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.431 1.271 . . . . 8.9 114.431 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.479 ' CD ' ' HZ2' ' A' ' 57' ' ' LYS . 3.6 tp10 -83.27 151.91 25.39 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.627 1.571 . . . . 3.24 110.53 162.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.9 t -139.4 117.39 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.17 1.788 . . . . 2.67 106.642 152.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 62.68 21.54 12.78 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.819 1.414 . . . . 3.91 114.819 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.26 0.53 82.59 Favored Glycine 0 N--CA 1.48 1.612 0 O-C-N 120.378 -1.451 . . . . 2.4 114.034 -170.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -104.27 119.88 39.94 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.139 2.576 . . . . 4.09 107.644 -175.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.479 ' HZ2' ' CD ' ' A' ' 52' ' ' GLU . 42.6 mttp -88.05 126.11 34.92 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.28 1.432 . . . . 5.19 110.03 -167.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.56 HG22 ' H ' ' A' ' 59' ' ' MET . 8.8 p -154.43 -178.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.732 1.613 . . . . 2.67 109.691 -165.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.56 ' H ' HG22 ' A' ' 58' ' ' VAL . 39.2 mmm -119.31 161.87 19.72 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.451 1.101 . . . . 3.09 111.176 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -142.81 168.61 25.9 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 126.322 1.915 . . . . 0.65 111.509 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.7 ttm -157.67 132.43 8.58 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.328 1.451 . . . . 0.74 109.226 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -145.43 148.99 39.34 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 126.476 1.91 . . . . 8.14 109.704 -170.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.89 155.43 34.36 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.105 1.87 . . . . 0.78 111.118 -176.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.4 m -131.41 151.6 79.04 Favored Pre-proline 0 N--CA 1.477 0.895 0 CA-C-O 118.453 -0.784 . . . . 0.84 110.709 176.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.89 -20.6 11.64 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.397 2.732 . . . . 0.57 113.165 -167.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -179.29 164.0 1.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.04 2.136 . . . . 1.98 110.467 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.6 mt -110.4 154.65 23.28 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.88 0.872 . . . . 0.55 110.57 162.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -134.6 146.17 49.34 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.329 0.652 . . . . 1.96 110.736 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.4 t -142.83 132.14 11.84 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 124.244 0.965 . . . . 0.88 112.681 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.33 160.53 48.49 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.499 2.799 . . . . 0.88 111.912 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -60.53 139.8 88.0 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.491 2.794 . . . . 0.92 112.141 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.8 mptt 66.02 -6.42 0.46 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 127.7 2.4 . . . . 1.84 114.168 -174.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.59 153.73 37.23 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.759 1.647 . . . . 1.38 113.202 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -107.23 147.16 30.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.15 0.98 . . . . 3.82 109.647 163.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.9 t -145.14 125.9 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.907 1.683 . . . . 4.09 107.013 166.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -93.77 130.91 39.6 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.708 1.003 . . . . 4.65 113.708 -168.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -75.96 68.73 2.5 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.155 0.979 . . . . 1.94 109.507 157.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 78' ' ' LYS . 8.0 pttp -90.64 156.58 45.02 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 125.705 1.602 . . . . 3.96 113.675 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.28 -20.99 71.92 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.743 2.295 . . . . 2.66 113.103 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.5 52.78 3.87 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-N 119.106 0.866 . . . . 3.11 111.813 163.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.69 -117.9 2.08 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.472 1.511 . . . . 1.44 115.679 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -74.44 143.83 44.53 Favored 'General case' 0 C--O 1.224 -0.276 0 O-C-N 121.574 -0.957 . . . . 2.23 112.741 -161.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -161.8 154.28 19.9 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.454 -0.779 . . . . 0.8 113.024 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -78.08 136.22 37.86 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.296 -0.631 . . . . 1.95 109.296 166.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.9 tpt -97.94 133.45 42.41 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 107.801 -1.185 . . . . 0.84 107.801 163.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -114.68 115.77 27.63 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.758 1.223 . . . . 0.86 108.29 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mp -120.08 155.34 33.17 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.826 0.822 . . . . 1.67 110.19 168.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.08 45.81 24.51 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 116.004 -0.544 . . . . 1.58 112.458 176.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.36 153.11 4.17 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 123.03 1.395 . . . . 1.67 113.99 169.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -113.78 -12.17 12.79 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.011 -1.45 . . . . 2.01 113.029 -171.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -145.65 151.71 47.15 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 127.095 2.158 . . . . 5.03 108.542 174.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.88 154.5 72.78 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.664 2.243 . . . . 2.11 109.816 167.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 pp -148.18 143.69 27.23 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 126.172 1.789 . . . . 2.19 108.996 -168.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -127.35 173.02 10.13 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.925 1.69 . . . . 3.88 111.754 -168.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.31 130.76 35.77 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.323 -0.991 . . . . 1.26 108.323 162.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.24 5.64 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.999 1.285 . . . . 1.81 114.02 -176.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -129.16 -178.34 4.6 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.757 1.223 . . . . 2.37 110.11 169.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -136.48 142.58 43.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.669 1.988 . . . . 4.99 107.083 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.3 t -152.79 134.77 5.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 128.194 2.598 . . . . 1.44 108.572 -168.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -93.17 156.12 17.04 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.241 1.2 . . . . 2.87 114.241 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mp -115.07 162.74 16.59 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.11 1.764 . . . . 1.85 110.82 165.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -121.87 125.46 46.48 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 129.656 3.182 . . . . 3.12 107.163 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -104.18 129.04 51.92 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.307 -1.496 . . . . 1.02 110.181 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.5 mt -102.71 108.32 19.53 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.954 1.302 . . . . 0.9 110.173 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.494 ' CD1' HD12 ' A' ' 30' ' ' LEU . 92.4 m-85 -96.22 154.28 17.34 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.899 0.88 . . . . 1.94 110.562 174.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.93 135.72 29.91 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.616 0.767 . . . . 2.0 111.212 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.04 -6.53 69.27 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.437 1.018 . . . . 2.99 114.348 -173.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.82 14.64 42.44 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-N 118.485 1.143 . . . . 3.33 114.572 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 52.8 tttt -77.32 126.42 30.9 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.118 1.459 . . . . 6.11 111.126 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 49.7 t -100.97 131.57 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.084 1.754 . . . . 2.73 109.491 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.1 tp -128.27 114.34 16.79 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.603 1.161 . . . . 2.13 109.251 169.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.496 ' HZ2' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -106.36 134.56 49.31 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.298 1.222 . . . . 2.14 114.298 -175.574 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.2 m -139.62 148.16 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 127.852 2.461 . . . . 2.11 110.04 -152.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.4 t -118.05 124.47 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-N 120.096 1.316 . . . . 1.69 110.563 -165.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.99 143.37 47.58 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.992 1.317 . . . . 2.25 110.868 -169.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.34 149.43 35.33 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.192 2.594 . . . . 0.94 111.917 165.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.1 t -102.28 124.78 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.941 0.896 . . . . 0.91 109.179 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -150.7 155.82 40.08 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.971 1.308 . . . . 3.57 111.691 -174.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.95 59.35 3.18 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.088 0.955 . . . . 2.37 113.206 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.99 0 C-N-CA 126.275 1.83 . . . . 9.7 111.873 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 108.943 -0.762 . . . . 5.48 108.943 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.41 ' CA ' ' HA ' ' A' ' 20' ' ' LEU . . . -85.4 171.85 46.26 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 121.252 -0.905 . . . . 1.93 113.868 161.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -155.42 162.35 40.79 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.664 2.386 . . . . 2.04 110.71 167.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.6 t -112.71 139.91 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.673 -1.267 . . . . 0.97 110.264 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.34 124.63 29.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.596 0.359 . . . . 4.78 110.96 176.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -36.14 145.2 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.996 2.518 . . . . 1.75 115.039 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.4 t -163.22 140.19 5.78 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 121.427 -0.796 . . . . 2.78 112.996 166.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -92.02 -8.9 2.75 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.276 3.317 . . . . 2.81 112.56 167.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.05 -179.38 24.23 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.458 1.504 . . . . 1.42 113.791 -169.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.49 -20.33 36.23 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 124.23 3.287 . . . . 1.27 114.58 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -113.17 162.95 15.37 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.176 1.39 . . . . 2.38 113.855 172.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.9 -177.46 6.63 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.881 2.472 . . . . 0.58 111.262 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.49 136.07 27.28 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.817 1.247 . . . . 0.81 110.363 174.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.83 143.18 49.01 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.717 1.207 . . . . 0.55 112.676 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -115.59 128.87 56.26 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.863 1.665 . . . . 2.41 109.433 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.41 ' HA ' ' CA ' ' A' ' 6' ' ' GLY 0.27 3.7 pp -123.77 153.05 41.51 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.409 1.263 . . . . 2.23 114.409 176.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.9 m -86.85 129.14 35.0 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.666 -1.235 . . . . 1.7 107.666 161.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.66 117.87 35.61 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.981 1.312 . . . . 3.07 108.87 -176.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -98.58 134.13 41.96 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.356 0.662 . . . . 3.77 110.655 175.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -121.58 96.91 47.23 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.131 0.973 . . . . 1.45 111.151 164.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.39 -3.28 9.36 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.332 2.688 . . . . 1.37 114.44 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.81 161.86 23.9 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 119.95 1.25 . . . . 1.6 111.957 -176.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.08 3.7 14.27 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 128.12 2.568 . . . . 3.02 112.803 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -118.39 153.59 51.84 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 128.037 2.535 . . . . 2.29 110.494 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.67 142.14 17.88 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.842 2.362 . . . . 0.91 110.473 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.3 mt -104.99 148.42 26.75 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 122.974 1.369 . . . . 1.76 111.562 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.7 ttp-105 -139.31 103.13 4.66 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 111.835 -2.439 . . . . 2.31 111.506 -176.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.8 tt -81.88 115.17 20.95 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 124.424 1.09 . . . . 2.46 109.404 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.6 m -103.13 -20.63 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.039 1.336 . . . . 0.9 112.457 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.97 -175.47 27.93 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 126.105 1.812 . . . . 0.74 113.028 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.42 -178.96 5.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.721 0.808 . . . . 0.69 110.725 167.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -149.77 178.68 8.65 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.94 2.496 . . . . 4.65 107.145 159.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -176.9 152.68 1.05 Allowed Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 127.364 2.266 . . . . 0.82 107.838 -174.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.57 -11.23 30.64 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.407 2.071 . . . . 1.1 113.779 170.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.06 47.12 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 114.237 1.199 . . . . 1.0 114.237 -175.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.76 152.65 11.83 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.429 1.892 . . . . 1.07 109.145 164.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -101.3 -31.28 11.05 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.348 0.522 . . . . 4.5 111.857 167.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -113.73 133.71 55.19 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 126.283 1.833 . . . . 4.73 108.66 168.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.4 p -139.56 127.29 25.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 124.752 1.221 . . . . 1.23 108.844 172.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -146.79 119.91 8.84 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.332 1.053 . . . . 3.51 108.85 -163.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.401 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.6 pt? -83.3 136.84 34.23 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 123.442 1.591 . . . . 2.04 114.31 -177.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -120.78 154.09 36.16 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.333 2.253 . . . . 0.68 111.307 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -92.05 160.39 15.25 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.742 1.217 . . . . 2.23 110.15 155.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.1 m -103.62 141.32 36.25 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 106.96 -1.496 . . . . 1.13 106.96 150.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -140.35 166.03 25.81 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 122.474 1.13 . . . . 1.98 113.616 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.0 mtm -95.18 141.77 28.4 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.696 1.198 . . . . 5.14 112.304 -176.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -142.25 153.32 43.86 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 115.409 1.633 . . . . 5.09 115.409 168.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -87.5 146.25 25.89 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.97 1.308 . . . . 3.05 108.808 146.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.2 m -130.61 -10.03 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 116.946 2.202 . . . . 3.53 116.946 169.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -162.98 22.77 0.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.174 1.39 . . . . 3.74 112.728 -167.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.93 4.15 46.88 Favored Glycine 0 N--CA 1.482 1.744 0 O-C-N 119.958 -1.714 . . . . 1.89 112.767 -159.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -120.12 134.5 55.24 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 129.055 2.942 . . . . 2.59 107.76 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -75.1 146.46 41.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.051 2.14 . . . . 4.89 109.475 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.4 p -155.03 168.45 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 126.635 1.974 . . . . 2.56 109.538 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.7 mmm -122.93 144.39 49.26 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.071 1.349 . . . . 3.64 110.101 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.73 179.23 16.21 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.554 1.549 . . . . 0.71 112.075 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ttm -142.11 141.55 32.71 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.798 1.639 . . . . 0.67 108.693 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.21 134.84 10.96 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 125.705 1.602 . . . . 6.69 109.006 -164.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.28 143.37 35.21 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 CA-C-N 121.537 1.585 . . . . 0.76 110.36 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.8 m -129.02 152.81 79.93 Favored Pre-proline 0 N--CA 1.481 1.125 0 CA-C-O 118.617 -0.706 . . . . 0.84 111.262 -173.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.25 -26.06 4.43 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.04 2.494 . . . . 0.74 112.782 -165.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -176.83 166.08 2.51 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.065 1.346 . . . . 1.97 112.079 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.2 mt -117.2 150.89 37.99 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.596 1.958 . . . . 0.62 111.463 166.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -113.57 145.06 41.84 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.839 1.256 . . . . 2.03 110.328 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.2 t -137.91 126.89 14.71 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 124.019 0.927 . . . . 0.87 110.638 162.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.35 166.4 25.57 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 124.027 3.151 . . . . 0.93 111.893 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.69 148.14 92.32 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.259 2.64 . . . . 1.12 114.176 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.289 19.1 mtmt 49.16 43.24 22.47 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.67 1.988 . . . . 2.72 114.13 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.35 169.06 24.69 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 127.738 2.59 . . . . 1.78 111.587 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.51 135.18 19.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.395 0.678 . . . . 4.56 110.834 175.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -151.45 137.41 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.39 1.476 . . . . 4.17 109.092 -162.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.99 158.24 15.52 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.684 1.231 . . . . 2.96 113.611 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.88 -32.99 74.81 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.78 2.032 . . . . 3.59 114.208 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt 99.18 130.49 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.415 0 C-N-CA 131.424 3.89 . . . . 3.6 111.142 174.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.32 -5.12 10.58 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.704 2.936 . . . . 3.01 115.584 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.4 -11.91 6.48 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-O 117.761 -1.577 . . . . 2.89 115.168 167.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.13 -110.5 3.31 Favored Glycine 0 N--CA 1.474 1.177 0 CA-C-N 119.958 1.879 . . . . 1.87 112.641 -172.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -73.16 145.61 46.22 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 122.035 -0.686 . . . . 2.09 110.656 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.7 p-80 -163.92 153.11 14.05 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.814 -0.554 . . . . 0.61 111.383 -177.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -80.43 131.81 35.64 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.441 -0.948 . . . . 1.79 108.441 164.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.9 tpt -84.55 129.63 34.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.056 -1.461 . . . . 0.74 107.056 157.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.0 mp -107.49 131.22 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.087 -1.079 . . . . 0.55 108.087 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mp -130.25 145.81 51.79 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.908 1.283 . . . . 1.52 110.138 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.8 40.82 93.81 Favored Glycine 0 CA--C 1.528 0.896 0 O-C-N 121.649 -0.657 . . . . 1.08 111.494 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.68 145.98 32.45 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 122.909 1.337 . . . . 1.33 113.689 175.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -101.8 -6.81 23.16 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.793 -1.548 . . . . 3.74 112.396 -172.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -132.98 139.06 33.3 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.802 1.641 . . . . 5.27 108.763 154.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -63.6 142.72 85.17 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 N-CA-C 107.285 -1.852 . . . . 2.08 107.285 156.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.1 mt -104.76 95.96 6.24 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.584 1.554 . . . . 2.46 109.975 -157.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.69 135.55 36.57 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.26 1.024 . . . . 3.94 111.293 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.51 106.49 0.66 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.954 1.302 . . . . 1.65 110.462 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.02 -0.02 21.09 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.872 1.701 . . . . 1.6 115.032 -170.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -81.11 -176.4 5.93 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.149 1.475 . . . . 2.21 112.346 169.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -141.7 138.92 32.77 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 129.422 3.089 . . . . 3.31 106.249 -168.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 79.0 t -150.62 158.04 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 128.827 2.851 . . . . 1.27 108.805 -167.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -123.25 154.45 38.79 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.504 0.722 . . . . 4.11 110.613 164.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.89 135.8 55.1 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.556 1.142 . . . . 1.91 109.488 160.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.32 140.52 29.41 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.422 2.289 . . . . 2.37 109.175 166.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.05 119.19 37.62 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.247 1.819 . . . . 1.14 110.06 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.7 mt -90.25 105.28 17.7 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.479 1.112 . . . . 1.13 109.594 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -99.78 144.05 29.3 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.075 1.35 . . . . 2.01 111.036 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.05 123.58 10.82 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.552 1.141 . . . . 1.7 114.042 -168.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.45 72.71 0.88 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.782 1.182 . . . . 3.09 112.816 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.17 19.81 77.59 Favored Glycine 0 N--CA 1.473 1.11 0 N-CA-C 116.013 1.165 . . . . 2.23 116.013 166.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -106.96 139.41 41.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.171 1.486 . . . . 4.66 111.114 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.0 p -147.01 147.22 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.717 0.807 . . . . 2.36 112.413 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 24.3 tp -156.69 175.78 13.6 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.204 2.602 . . . . 2.46 108.253 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -147.8 155.97 42.23 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.747 -1.221 . . . . 3.03 113.169 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.6 t -140.2 157.78 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.635 1.574 . . . . 2.54 109.571 -175.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.2 t -95.63 145.04 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.619 1.968 . . . . 2.55 110.993 -170.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mp -145.11 120.18 5.77 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 126.09 1.756 . . . . 2.6 111.164 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.65 165.74 26.54 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.541 2.16 . . . . 0.96 110.456 161.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.4 t -100.26 141.36 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 O-C-N 121.279 -0.888 . . . . 1.17 111.231 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -122.42 146.22 47.56 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.045 2.138 . . . . 4.97 111.197 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.24 105.4 12.4 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.547 -0.721 . . . . 2.44 112.089 167.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 . . . . . 0 C--O 1.25 1.091 0 C-N-CA 129.715 3.206 . . . . 7.17 108.299 170.117 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 . . . . . 0 CA--C 1.542 0.642 0 CA-C-O 122.365 1.079 . . . . 5.81 110.353 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.74 179.93 33.11 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 124.654 1.121 . . . . 1.4 113.232 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.8 p90 -156.69 153.55 28.65 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.035 0.754 . . . . 2.24 113.035 169.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.1 t -100.53 136.69 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.388 0.675 . . . . 1.12 109.331 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -72.56 109.2 6.05 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.755 0.822 . . . . 5.9 109.962 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.35 134.54 8.85 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.408 1.483 . . . . 2.27 112.864 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.8 t -150.5 143.84 16.83 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 114.676 1.362 . . . . 2.75 114.676 167.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -86.58 -4.62 8.29 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.54 2.826 . . . . 2.77 112.052 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.46 -176.03 25.1 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.216 1.388 . . . . 1.52 114.129 -169.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.52 -14.55 30.68 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.267 3.312 . . . . 1.41 114.362 -175.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -131.07 153.34 49.41 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.184 2.194 . . . . 2.46 114.308 -172.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.13 -176.12 5.73 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 127.628 2.371 . . . . 0.5 113.261 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.18 157.64 45.89 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.928 2.091 . . . . 0.58 109.595 172.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.81 152.57 46.65 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.524 1.056 . . . . 0.55 113.027 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -139.85 146.81 39.82 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.4 2.28 . . . . 2.34 110.686 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -172.92 172.55 3.99 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.077 1.51 . . . . 2.28 115.077 -170.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.24 143.03 39.24 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 129.323 3.049 . . . . 2.9 110.569 -175.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.437 HD12 HG21 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -137.73 110.68 7.72 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.617 -0.512 . . . . 3.21 109.617 171.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -123.82 140.34 53.08 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.803 1.241 . . . . 3.45 111.29 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -104.44 112.04 65.31 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.634 0.774 . . . . 1.42 111.472 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -82.73 -19.53 6.05 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.948 2.432 . . . . 1.34 114.276 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.35 -177.12 51.73 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 119.029 0.831 . . . . 1.16 112.022 -174.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -107.79 0.86 22.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.375 1.87 . . . . 2.99 111.764 -174.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -118.94 160.24 41.52 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 128.287 2.635 . . . . 2.05 109.726 171.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.61 147.72 32.09 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.679 2.253 . . . . 1.14 110.947 -176.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.9 mt -103.81 149.53 24.96 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 122.518 1.151 . . . . 1.7 110.943 173.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -133.8 106.9 7.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 112.348 -2.206 . . . . 2.43 110.669 -176.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.508 HD21 ' CZ ' ' A' ' 84' ' ' PHE . 2.9 tt -81.25 115.67 20.76 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.253 1.021 . . . . 1.91 108.652 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.17 -18.22 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.077 0.951 . . . . 0.8 112.298 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.34 -173.95 27.41 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 126.059 1.79 . . . . 0.69 112.701 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -143.94 -174.85 4.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.728 1.611 . . . . 0.72 110.641 166.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.19 178.62 10.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.761 2.424 . . . . 5.01 108.654 171.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -178.4 154.93 0.92 Allowed Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 127.03 2.132 . . . . 0.73 107.939 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.16 -6.9 17.73 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.082 1.855 . . . . 0.73 113.042 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.0 m -124.91 46.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 114.062 1.134 . . . . 0.85 114.062 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.18 156.23 14.35 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.556 1.142 . . . . 0.96 111.854 167.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -92.83 -26.25 17.76 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.525 1.93 . . . . 2.93 112.816 170.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -143.24 140.29 30.62 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 129.378 3.071 . . . . 7.21 107.836 -168.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -157.2 59.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 125.101 2.381 . . . . 3.03 111.954 -165.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.61 135.24 35.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 111.453 -2.612 . . . . 5.25 112.72 -162.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 31.9 tp -86.06 121.33 28.51 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.974 1.309 . . . . 1.38 111.95 -165.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -123.38 153.86 39.77 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.363 1.465 . . . . 0.58 113.771 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -98.83 173.26 6.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.692 1.997 . . . . 2.35 111.673 163.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.2 m -152.64 143.76 23.12 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.398 1.879 . . . . 0.72 107.889 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -156.94 167.23 31.08 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.554 0.946 . . . . 1.94 113.554 -167.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.1 mtt -94.55 154.62 17.3 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.98 0.912 . . . . 5.74 110.877 160.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.67 157.04 34.47 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.613 1.165 . . . . 4.62 110.307 -173.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -103.25 139.67 38.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.684 1.193 . . . . 2.66 110.81 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.4 t -136.76 125.87 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.063 -1.458 . . . . 2.27 107.063 162.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 60.79 22.29 12.32 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.672 1.589 . . . . 3.33 114.162 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.08 8.45 87.4 Favored Glycine 0 CA--C 1.538 1.475 0 O-C-N 120.051 -1.656 . . . . 1.82 113.861 -171.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -108.35 124.26 50.08 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 127.235 2.214 . . . . 3.15 108.192 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.31 119.35 20.08 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.273 -1.33 . . . . 4.7 110.198 -175.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.8 m -121.61 -178.6 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 128.313 2.645 . . . . 2.63 109.975 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.7 mtm -125.89 162.55 24.93 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.84 1.256 . . . . 3.94 111.142 174.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.43 176.75 32.92 Favored Glycine 0 N--CA 1.462 0.417 0 CA-C-O 121.774 0.652 . . . . 0.65 113.361 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.0 ttm -159.44 137.11 10.03 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.598 1.959 . . . . 0.81 108.969 -173.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -138.91 153.23 71.66 Favored Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 125.949 1.7 . . . . 7.75 109.399 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.62 152.21 25.8 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.923 1.749 . . . . 0.76 109.501 170.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.57 151.84 75.23 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 124.128 0.971 . . . . 0.68 110.621 -176.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.8 -25.99 5.91 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.166 2.577 . . . . 0.9 112.882 -167.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -176.79 164.76 2.43 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.67 1.588 . . . . 2.46 111.602 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.2 mt -109.06 152.19 25.37 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.653 1.181 . . . . 0.9 109.982 160.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -117.69 141.6 48.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.748 1.219 . . . . 1.89 110.074 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.437 HG21 HD12 ' A' ' 22' ' ' LEU . 35.4 t -137.32 128.27 16.16 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 113.754 1.02 . . . . 0.96 113.754 171.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.19 158.43 41.44 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.125 3.217 . . . . 1.09 112.574 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.82 133.66 46.06 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.135 3.224 . . . . 1.12 112.764 -175.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.14 -12.84 0.55 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 128.721 2.808 . . . . 1.69 113.872 -175.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.48 166.42 51.0 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.719 1.628 . . . . 1.35 113.116 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -122.53 146.02 47.79 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.715 1.606 . . . . 4.84 111.785 172.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 69' ' ' VAL . 21.3 t -152.96 89.77 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 124.801 1.241 . . . . 4.05 110.146 170.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.04 147.57 44.93 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.294 -0.867 . . . . 4.79 109.59 -172.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.74 127.25 31.04 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.276 1.036 . . . . 2.46 109.419 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.35 122.49 87.65 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 117.305 -1.331 . . . . 3.32 109.979 -168.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -61.86 -10.62 17.88 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.747 2.964 . . . . 2.56 114.618 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -125.92 0.39 7.78 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 117.355 -1.803 . . . . 2.3 116.143 166.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.56 -20.4 1.24 Allowed Glycine 0 N--CA 1.481 1.676 0 CA-C-N 120.674 2.237 . . . . 1.97 118.483 -172.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -150.81 135.66 17.4 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.166 1.983 . . . . 2.37 111.557 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -158.04 152.77 25.0 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.019 0.928 . . . . 0.64 110.602 -173.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.508 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 92.0 m-85 -79.16 145.84 33.46 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.661 -0.866 . . . . 1.88 108.661 161.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 tpt -106.64 124.14 49.17 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 126.73 2.012 . . . . 0.96 108.627 168.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -107.48 133.43 51.97 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.807 1.643 . . . . 0.58 109.462 -173.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.57 148.87 49.24 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.186 0.995 . . . . 2.17 111.473 176.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.17 40.15 30.07 Favored Glycine 0 N--CA 1.468 0.823 0 C-N-CA 123.766 0.698 . . . . 0.87 113.539 169.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 pp -56.98 156.29 7.02 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 116.075 1.88 . . . . 1.71 116.075 -177.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -111.42 -19.8 12.46 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 112.298 -2.228 . . . . 1.88 112.684 -170.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -145.59 136.55 12.45 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 128.102 2.561 . . . . 6.11 108.004 165.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.43 137.33 39.32 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.212 2.608 . . . . 1.7 110.955 -176.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.73 84.74 2.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.992 2.117 . . . . 2.64 110.055 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -86.36 169.81 12.59 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.467 1.507 . . . . 3.9 111.629 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.93 112.62 3.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.814 -1.084 . . . . 1.62 111.892 -175.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.31 0.18 28.08 Favored Glycine 0 CA--C 1.539 1.536 0 N-CA-C 117.188 1.635 . . . . 2.1 117.188 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -92.14 180.0 5.42 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.777 1.289 . . . . 2.32 113.756 -169.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.54 77.57 1.18 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.57 1.948 . . . . 5.41 113.498 -162.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 77.0 t -95.22 127.73 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.66 -1.275 . . . . 1.29 111.979 -169.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -78.25 136.48 37.78 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.995 0.918 . . . . 2.43 112.568 173.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.23 151.59 35.45 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.15 0.976 . . . . 1.81 111.744 155.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -104.22 141.68 35.85 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.62 2.768 . . . . 2.23 107.933 160.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.02 130.95 54.57 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.852 1.261 . . . . 1.0 108.833 172.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.8 mt -100.68 111.02 23.19 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.131 0.973 . . . . 0.8 109.593 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -98.77 141.3 31.74 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.104 1.361 . . . . 2.03 110.863 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.47 125.94 7.53 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.753 1.621 . . . . 1.68 112.729 -172.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.74 33.79 20.72 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.065 -0.853 . . . . 2.61 114.026 -175.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.3 14.13 74.95 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 116.596 1.399 . . . . 2.93 116.596 162.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -88.89 123.65 33.46 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.588 1.694 . . . . 3.42 111.414 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.8 t -115.83 131.22 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 O-C-N 124.07 0.857 . . . . 2.53 111.38 -173.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.5 tp -124.75 122.92 38.82 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.11 1.364 . . . . 2.41 111.073 177.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.89 148.84 32.6 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.405 -0.81 . . . . 2.32 112.305 171.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -146.66 157.61 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.642 1.577 . . . . 2.26 109.29 163.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.8 t -104.97 136.84 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.118 1.367 . . . . 2.01 109.696 173.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.9 mp -125.25 130.67 24.08 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.916 1.687 . . . . 2.73 110.762 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.68 138.71 38.74 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.004 1.803 . . . . 1.22 109.842 164.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.9 t -77.92 141.41 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 O-C-N 120.699 -1.251 . . . . 1.19 108.485 162.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.53 -174.24 2.55 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.989 1.716 . . . . 6.96 113.45 -177.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -126.34 151.57 47.4 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.524 1.13 . . . . 2.51 110.407 166.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.178 0 C-N-CA 129.637 3.175 . . . . 8.82 109.936 -165.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.3 pm0 . . . . . 0 CA--C 1.537 0.448 0 CA-C-O 120.599 0.238 . . . . 7.18 110.543 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.89 172.23 38.0 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 121.338 -0.851 . . . . 1.32 113.337 159.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.9 p90 -155.8 153.28 29.57 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.112 1.365 . . . . 1.91 112.234 164.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.38 139.94 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.16 -0.963 . . . . 1.07 108.556 173.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -75.71 109.16 9.07 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.876 0.87 . . . . 4.7 111.768 -178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -47.29 130.26 13.08 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.569 1.548 . . . . 2.84 111.469 171.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -154.92 167.5 13.92 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 124.465 1.106 . . . . 2.29 113.51 162.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -94.39 -1.73 2.83 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 124.268 3.312 . . . . 2.14 114.071 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.71 -168.02 26.36 Favored Glycine 0 CA--C 1.542 1.774 0 C-N-CA 124.788 1.185 . . . . 1.5 115.517 -167.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.79 -10.23 16.95 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 124.817 3.678 . . . . 1.34 114.328 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -135.04 158.68 43.73 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.845 2.458 . . . . 2.43 113.83 -170.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.82 -175.04 5.14 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.399 2.28 . . . . 0.66 112.344 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.28 151.47 47.64 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.777 2.431 . . . . 0.83 107.726 172.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.94 144.68 51.01 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.552 1.069 . . . . 0.78 112.268 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.485 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 65.6 m-85 -124.21 143.24 50.63 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.439 1.896 . . . . 2.34 110.661 -178.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -173.23 166.33 4.86 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.942 1.697 . . . . 3.11 111.832 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 t -102.75 160.12 14.87 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.719 1.208 . . . . 2.76 113.436 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.6 tp -129.69 129.26 44.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.491 1.517 . . . . 3.87 109.808 169.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -117.61 142.48 47.16 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.11 0.564 . . . . 3.34 109.809 157.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -94.84 110.46 49.73 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.162 0.985 . . . . 1.49 109.371 173.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -84.62 -9.12 9.2 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.287 2.658 . . . . 1.01 114.48 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.99 177.14 47.77 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 122.564 1.091 . . . . 1.2 113.101 -172.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -89.71 -6.5 56.02 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.614 1.165 . . . . 4.1 112.043 174.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.69 160.17 45.47 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 127.63 2.372 . . . . 1.99 110.823 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -77.16 148.98 27.87 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.636 2.224 . . . . 1.02 111.476 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.7 mp -110.8 152.46 26.61 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.63 1.572 . . . . 2.59 109.509 172.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -138.77 113.94 9.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 113.674 -1.603 . . . . 2.41 109.574 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.3 tt -86.88 123.9 32.52 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.684 1.194 . . . . 1.92 108.311 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.1 m -115.31 -14.65 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.413 1.085 . . . . 0.52 111.994 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.15 -174.64 28.11 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 125.708 1.623 . . . . 0.54 113.879 -174.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.418 ' HB2' ' CE1' ' A' ' 84' ' ' PHE . . . -149.42 -176.35 5.35 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.838 1.655 . . . . 0.73 111.542 175.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -153.67 168.82 24.94 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.023 1.729 . . . . 6.3 109.03 164.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 t -165.73 148.07 6.44 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 126.028 1.731 . . . . 0.84 108.381 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.06 -0.22 9.73 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.597 2.198 . . . . 0.96 113.232 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.67 43.46 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.651 1.58 . . . . 0.79 113.656 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.02 135.3 5.32 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.368 1.067 . . . . 1.21 110.409 160.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -83.68 -26.41 29.86 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.508 1.123 . . . . 3.72 113.219 174.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -108.64 132.2 54.14 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 108.074 -1.084 . . . . 4.8 108.074 160.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -116.23 141.37 34.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.298 -1.001 . . . . 1.14 108.298 150.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -132.6 153.43 51.05 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.397 1.879 . . . . 2.92 108.461 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.4 tp -109.59 120.38 42.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.644 0.778 . . . . 1.18 110.18 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -121.87 161.52 22.62 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.803 1.241 . . . . 0.62 112.753 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.51 160.63 29.04 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.149 -0.932 . . . . 3.55 110.886 161.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.402 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 25.6 m -132.36 123.77 27.43 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.98 1.712 . . . . 1.19 107.189 -175.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -113.72 170.61 8.13 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.121 1.768 . . . . 2.17 112.522 -174.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 50.6 ttp -99.64 141.67 32.13 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.527 1.131 . . . . 3.11 110.284 164.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -133.55 161.02 35.72 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.429 1.892 . . . . 4.88 110.108 170.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -90.18 147.9 23.29 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.483 1.113 . . . . 2.42 109.11 154.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.41 137.7 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.713 -1.217 . . . . 2.98 107.713 149.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.453 ' HB2' ' HE2' ' A' ' 56' ' ' LYS . 25.5 mt-10 61.9 9.8 3.19 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 115.921 1.823 . . . . 3.14 115.921 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.0 5.95 59.39 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 124.657 1.122 . . . . 1.64 115.194 -171.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 54' ' ' GLU . 44.9 pttt -121.91 134.23 54.86 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.409 2.284 . . . . 3.21 110.585 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -73.05 131.59 42.3 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.54 2.336 . . . . 4.15 109.406 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 m -138.5 166.41 23.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 127.447 2.299 . . . . 2.15 109.702 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -129.42 129.67 44.98 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.204 1.002 . . . . 3.16 110.812 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.67 175.25 16.46 Favored Glycine 0 N--CA 1.467 0.748 0 C-N-CA 125.677 1.608 . . . . 0.78 111.88 -176.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.7 ttm -139.13 156.8 46.88 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.225 1.41 . . . . 0.74 110.077 -172.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -161.33 151.1 14.06 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.36 1.464 . . . . 6.59 110.837 -175.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.33 153.49 45.37 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.17 1.913 . . . . 0.64 110.607 172.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.3 m -137.5 153.04 74.1 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 124.683 1.193 . . . . 0.62 109.895 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -82.36 -28.36 1.9 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.866 2.378 . . . . 0.62 113.287 -166.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -175.25 167.19 3.42 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.497 1.519 . . . . 2.02 111.982 -176.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.2 mt -115.14 148.67 38.72 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.267 1.827 . . . . 0.75 110.418 165.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -115.06 138.91 50.34 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.74 1.216 . . . . 1.74 108.858 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.4 t -140.29 124.84 10.95 Favored Pre-proline 0 N--CA 1.471 0.578 0 N-CA-C 112.92 0.711 . . . . 0.81 112.92 170.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.33 161.25 44.9 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.855 3.037 . . . . 0.96 111.67 178.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -58.16 136.75 76.79 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.664 2.909 . . . . 0.96 111.893 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.78 -9.05 1.14 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 127.363 2.265 . . . . 3.03 113.099 -178.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.14 146.27 29.1 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.226 1.394 . . . . 1.21 113.142 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.36 140.44 45.94 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.747 2.019 . . . . 4.11 109.529 171.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.8 t -145.89 123.85 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.451 1.9 . . . . 3.48 108.234 175.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -109.03 141.76 40.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.745 1.218 . . . . 5.19 110.935 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -79.0 65.91 4.3 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.487 1.115 . . . . 2.08 109.328 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.432 ' H ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -53.23 136.57 49.66 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-O 118.288 -0.863 . . . . 5.28 112.149 -167.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.485 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 33.9 Cg_endo -62.75 -20.9 72.35 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.89 3.06 . . . . 2.4 116.973 -158.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.76 -3.66 87.94 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-O 118.734 -1.036 . . . . 2.61 115.093 173.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 48' ' ' THR . . . -129.5 -108.07 1.3 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.504 1.526 . . . . 1.9 113.615 -174.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -71.87 142.66 49.56 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.745 -0.856 . . . . 2.13 110.594 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -162.78 168.15 21.87 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.461 1.104 . . . . 0.54 110.251 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.418 ' CE1' ' HB2' ' A' ' 35' ' ' ALA . 97.3 m-85 -93.79 147.26 23.22 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.468 -0.568 . . . . 2.04 109.468 163.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.8 tpt -102.32 136.53 41.99 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.887 1.275 . . . . 0.68 109.67 166.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -117.72 128.03 54.49 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.179 1.391 . . . . 0.77 109.264 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.67 145.35 50.61 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.036 0.934 . . . . 2.21 110.235 173.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.63 51.56 11.66 Favored Glycine 0 N--CA 1.469 0.872 0 O-C-N 121.701 -0.624 . . . . 0.82 112.409 174.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.26 155.97 10.66 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 115.064 1.505 . . . . 1.59 115.064 173.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.5 -7.13 12.84 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 113.973 -1.467 . . . . 2.8 113.707 -176.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -139.93 168.61 14.35 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 128.22 2.608 . . . . 4.73 108.775 166.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -58.7 160.92 16.14 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.578 1.519 . . . . 2.21 110.935 161.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.2 103.4 6.22 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.218 1.007 . . . . 2.79 110.147 161.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.5 mmtm -115.34 158.91 21.74 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.723 2.409 . . . . 6.74 112.155 174.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.64 120.18 10.1 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.695 -0.854 . . . . 1.63 108.695 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.53 -0.73 53.13 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.156 1.36 . . . . 1.38 115.141 -174.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.42 -174.66 5.29 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.574 1.687 . . . . 2.86 110.272 161.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -155.71 145.56 21.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.834 2.054 . . . . 3.2 107.789 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.4 t -148.54 130.35 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 125.785 1.634 . . . . 1.06 109.922 -163.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -79.05 138.82 38.15 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.868 -0.606 . . . . 3.4 111.316 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -123.83 132.3 53.75 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.909 1.283 . . . . 3.09 110.468 171.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.24 140.22 30.05 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.446 1.898 . . . . 2.43 108.669 165.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -107.28 130.18 54.79 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.396 1.878 . . . . 1.04 107.926 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.8 mt -109.74 126.94 54.25 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.907 1.283 . . . . 0.99 110.678 -176.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -119.97 151.76 38.47 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.484 1.114 . . . . 2.02 112.917 -171.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.43 151.57 19.75 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.283 1.033 . . . . 2.06 112.798 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.18 16.87 75.42 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.884 -0.954 . . . . 3.42 114.738 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.19 78.08 0.93 Allowed Glycine 0 CA--C 1.529 0.959 0 CA-C-N 118.876 1.338 . . . . 2.26 113.461 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -152.23 141.09 21.05 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.516 2.726 . . . . 3.47 110.872 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.3 t -138.76 147.88 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.959 1.704 . . . . 2.0 108.092 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 tt -150.56 116.83 5.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.924 0.889 . . . . 2.65 110.598 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.44 122.06 37.76 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.905 0.705 . . . . 3.98 112.905 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -105.31 175.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 126.699 1.999 . . . . 2.28 110.604 166.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.7 t -138.8 132.41 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.102 0.961 . . . . 1.94 109.364 173.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -125.01 149.93 64.9 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.731 1.612 . . . . 3.02 109.703 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.18 159.09 48.65 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.334 2.023 . . . . 1.03 110.642 163.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 42.1 t -90.97 134.77 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.374 -1.713 . . . . 1.03 106.374 156.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -136.5 174.43 10.62 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.369 0.667 . . . . 3.82 111.769 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.6 55.23 1.61 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.538 1.535 . . . . 2.43 113.643 -170.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.143 1 C-N-CA 131.739 4.016 . . . . 7.43 114.41 161.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 . . . . . 0 CA--C 1.54 0.585 0 CA-C-O 121.843 0.83 . . . . 4.45 111.297 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.47 171.9 42.33 Favored Glycine 0 C--N 1.336 0.535 0 O-C-N 121.792 -0.568 . . . . 1.24 114.326 179.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -152.54 144.3 23.58 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.483 1.113 . . . . 1.93 111.032 166.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.6 t -88.96 133.4 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 107.635 -1.246 . . . . 1.08 107.635 175.185 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.84 115.23 27.92 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.145 0.578 . . . . 3.76 109.629 -172.061 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -62.88 151.65 38.57 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.91 1.284 . . . . 2.16 113.408 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.8 t -162.86 151.41 12.13 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.997 1.719 . . . . 2.48 110.207 164.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.1 -12.84 21.32 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.801 2.334 . . . . 2.0 112.647 166.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.85 138.86 18.0 Favored Glycine 0 CA--C 1.537 1.46 0 N-CA-C 110.125 -1.19 . . . . 2.51 110.125 168.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.33 -26.98 20.04 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.048 2.499 . . . . 2.21 114.818 -167.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -84.16 138.58 32.92 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.992 1.269 . . . . 4.44 110.829 171.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.76 -176.4 3.97 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.036 1.735 . . . . 0.6 112.178 -166.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.72 149.36 37.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.921 1.288 . . . . 0.7 109.71 175.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.35 152.9 47.53 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.248 1.023 . . . . 0.61 113.627 -175.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -129.7 143.52 50.86 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.05 2.14 . . . . 2.55 108.634 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.52 170.48 14.32 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.474 1.51 . . . . 2.52 111.827 -178.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.1 m -112.13 130.42 55.9 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 124.455 1.102 . . . . 2.18 110.983 -166.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.83 123.0 47.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.418 1.487 . . . . 3.1 107.744 168.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -126.95 134.0 50.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.993 -1.484 . . . . 4.58 106.993 161.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -94.21 105.51 17.96 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.031 0.933 . . . . 2.01 110.514 -176.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.14 -11.91 16.09 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.515 2.143 . . . . 1.92 113.427 176.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.8 178.26 53.25 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 119.204 0.911 . . . . 1.76 111.782 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -107.24 -0.06 22.89 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 126.772 2.029 . . . . 3.56 111.745 -173.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.8 157.99 66.95 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 128.301 2.641 . . . . 2.43 109.353 175.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.69 159.75 41.97 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.369 2.046 . . . . 1.46 112.137 -170.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.1 mt -112.91 149.28 33.4 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.378 1.471 . . . . 1.85 110.279 170.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.4 ttp-105 -128.92 110.8 12.41 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 112.989 -1.914 . . . . 2.78 109.325 173.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.1 tp -94.4 114.5 26.55 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 126.097 1.759 . . . . 1.87 108.891 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -114.11 -16.82 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.335 1.054 . . . . 0.57 112.064 -169.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.93 -175.55 28.98 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.877 1.703 . . . . 0.46 113.031 -176.072 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.74 -178.61 6.44 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.566 1.546 . . . . 0.5 110.845 173.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 -147.02 -179.25 6.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.978 1.711 . . . . 5.19 109.245 156.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 t -170.83 148.49 2.61 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 127.316 2.246 . . . . 0.78 107.806 174.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.54 -11.49 24.38 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.825 2.35 . . . . 0.79 113.258 -178.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.9 m -110.89 58.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.502 1.521 . . . . 0.97 110.883 172.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.57 172.02 16.08 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.944 1.697 . . . . 1.27 110.034 167.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -118.28 -21.41 8.14 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.937 0.895 . . . . 3.56 111.844 159.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -143.17 150.79 39.88 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 126.15 1.78 . . . . 6.12 108.439 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.39 148.17 20.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 C-N-CA 125.803 1.641 . . . . 1.13 107.346 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -135.67 139.79 43.99 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.02 1.728 . . . . 4.1 107.963 -167.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.7 tp -102.02 120.07 39.82 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 120.391 1.451 . . . . 1.25 110.942 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.401 ' CE1' ' HB2' ' A' ' 85' ' ' MET . 58.7 m170 -123.93 160.31 27.81 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.794 1.638 . . . . 0.7 115.258 -174.397 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.402 ' CB ' ' CE1' ' A' ' 82' ' ' TYR . 15.4 pt-20 -103.66 146.9 27.89 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.791 2.436 . . . . 2.36 111.24 158.151 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 100.0 m -107.15 148.57 28.68 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 106.323 -1.732 . . . . 0.86 106.323 156.471 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -158.49 -179.49 8.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.639 1.176 . . . . 2.06 112.671 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.3 mmt -107.78 143.38 36.41 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.055 1.342 . . . . 5.33 114.002 -178.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.73 143.87 33.74 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.708 2.003 . . . . 6.07 111.803 178.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -99.27 130.93 45.6 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.146 0.978 . . . . 3.36 109.011 156.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.5 t -139.98 131.8 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 107.696 -1.224 . . . . 2.05 107.696 172.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 59.81 20.92 9.78 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.03 1.732 . . . . 3.81 114.552 -173.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.53 25.77 73.38 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.484 -1.385 . . . . 2.75 113.105 -168.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -118.65 123.91 46.12 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.014 1.726 . . . . 2.74 108.248 173.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.616 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -73.72 121.85 21.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.037 1.735 . . . . 3.9 110.793 170.02 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 m -145.64 156.58 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 128.096 2.558 . . . . 2.46 109.764 -172.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 37.8 mtp -95.73 146.27 24.65 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.289 -0.882 . . . . 3.7 112.19 173.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.86 168.87 13.72 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.66 1.6 . . . . 0.71 111.436 175.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.8 ttm -150.48 142.6 24.07 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.831 1.252 . . . . 0.79 109.596 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.3 mtm180 -143.0 157.45 60.85 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 125.598 1.559 . . . . 5.65 109.792 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.74 157.15 39.76 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.015 1.81 . . . . 0.88 111.243 163.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.6 m -138.7 153.41 72.2 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 126.032 1.733 . . . . 0.79 109.402 176.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.56 -22.97 2.91 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.968 2.446 . . . . 0.74 113.821 -163.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -179.74 165.6 1.3 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.711 1.604 . . . . 2.03 111.899 -179.333 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -111.54 155.11 23.79 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.869 1.668 . . . . 0.94 110.224 164.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -115.99 146.45 42.12 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.622 1.169 . . . . 2.3 109.227 173.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.0 t -140.22 125.06 11.13 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 113.115 0.783 . . . . 1.41 113.115 170.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.14 159.47 40.82 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.945 3.097 . . . . 1.52 112.049 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.07 138.1 65.62 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.921 3.08 . . . . 1.69 112.607 -178.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.8 mptt 66.23 -6.58 0.47 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 128.264 2.626 . . . . 2.45 114.122 -175.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.97 167.49 34.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.789 1.662 . . . . 1.52 112.65 176.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -132.91 157.93 43.87 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.164 0.985 . . . . 4.57 113.526 175.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.3 t -145.59 138.75 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 127.95 2.5 . . . . 3.3 107.129 172.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.1 134.4 34.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.296 -1.001 . . . . 4.03 108.296 -173.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.76 162.0 27.26 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 125.177 1.391 . . . . 2.69 111.379 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.33 154.1 13.98 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 119.884 -1.76 . . . . 4.26 115.047 -178.052 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.59 -38.78 80.12 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 124.577 3.518 . . . . 2.45 115.089 -174.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.05 9.84 6.34 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 119.203 -0.776 . . . . 1.64 114.374 175.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.52 -132.85 1.4 Allowed Glycine 0 C--N 1.339 0.723 0 C-N-CA 124.909 1.242 . . . . 1.78 114.401 -176.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.402 ' CE1' ' CB ' ' A' ' 47' ' ' GLU . 3.5 m-30 -72.98 139.61 46.81 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 121.51 -0.994 . . . . 2.2 111.483 -169.049 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 -161.19 157.8 26.38 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.093 1.357 . . . . 0.73 111.986 -169.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.66 146.79 26.68 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.452 -0.78 . . . . 2.25 109.722 166.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.401 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 2.6 tpt -98.19 134.83 40.71 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.379 1.472 . . . . 0.67 108.54 161.563 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -110.09 140.99 43.56 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.624 1.169 . . . . 0.74 109.51 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.06 140.54 43.87 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.184 0.809 . . . . 2.02 113.184 -178.496 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.39 49.25 15.83 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.878 0.751 . . . . 0.9 114.37 168.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.54 150.0 12.8 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 116.553 2.057 . . . . 1.56 116.553 -177.084 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -103.53 2.22 33.27 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 113.509 -1.678 . . . . 2.19 113.111 -174.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -151.38 151.12 28.46 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 127.573 2.349 . . . . 5.29 108.622 172.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -66.93 156.03 68.11 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 N-CA-C 108.307 -1.459 . . . . 2.11 108.307 152.02 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 pp -151.4 155.25 38.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.032 1.733 . . . . 2.48 107.408 -175.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -138.72 156.53 47.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 123.451 1.595 . . . . 5.18 114.111 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.6 121.0 11.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.143 -0.935 . . . . 1.59 109.444 173.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.55 49.69 1.38 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.885 1.231 . . . . 1.59 112.45 -167.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -148.8 -175.04 4.79 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 129.781 3.232 . . . . 2.43 109.339 175.329 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -144.61 140.61 28.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.464 2.305 . . . . 4.03 106.69 179.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.7 t -142.61 139.74 28.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 126.289 1.836 . . . . 1.01 109.349 -170.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.403 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 21.9 mt-10 -78.72 144.26 35.44 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.075 0.55 . . . . 2.63 111.683 177.075 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.38 139.57 50.7 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.89 0.852 . . . . 1.68 110.104 150.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.85 152.21 19.05 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.507 1.523 . . . . 2.11 108.982 162.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 mp -122.01 130.94 53.72 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.812 1.645 . . . . 1.04 109.253 -176.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.5 mt -110.44 118.29 35.87 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.792 1.237 . . . . 0.79 110.408 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -114.58 160.45 19.26 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.967 1.307 . . . . 2.42 111.287 -178.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.14 146.45 50.51 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.513 -0.742 . . . . 1.88 111.844 167.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.98 23.95 28.64 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.185 0.898 . . . . 3.17 115.041 176.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.04 6.6 83.03 Favored Glycine 0 N--CA 1.478 1.438 0 CA-C-N 118.479 1.14 . . . . 2.3 113.592 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -79.97 115.4 19.53 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.247 1.019 . . . . 3.22 111.398 -177.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.41 145.17 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.282 1.433 . . . . 2.3 109.523 165.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.8 tp -143.23 175.4 9.92 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.916 1.686 . . . . 2.48 109.334 175.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.403 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 0.8 OUTLIER -155.4 156.71 35.85 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.358 0.873 . . . . 2.23 113.358 170.994 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.9 t -144.08 162.52 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.681 1.992 . . . . 2.25 108.398 179.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.7 t -118.24 144.41 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.104 1.362 . . . . 1.66 108.647 -179.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.82 142.13 14.59 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.2 1.0 . . . . 2.17 112.441 -168.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.63 156.43 65.69 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.934 3.089 . . . . 0.72 113.242 179.587 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.14 118.32 39.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.301 -0.999 . . . . 0.85 108.301 167.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -109.92 -178.74 3.61 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.286 1.035 . . . . 4.18 110.719 168.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.01 179.91 7.41 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 117.059 2.244 . . . . 3.29 117.059 -156.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.872 0 CA-C-O 116.62 -1.657 . . . . 9.43 112.623 172.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 107.341 -1.355 . . . . 4.51 107.341 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.38 173.24 32.51 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 119.526 1.057 . . . . 1.53 113.04 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.42 ' HE1' ' CB ' ' A' ' 118' ' ' GLU . 3.4 t-105 -156.87 161.05 39.69 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.835 1.654 . . . . 7.43 111.651 178.428 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.2 t -130.48 132.53 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.127 1.371 . . . . 1.29 109.053 173.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -91.2 112.96 25.09 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.354 0.597 . . . . 4.99 110.467 -174.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -57.76 147.13 28.99 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.952 2.101 . . . . 3.3 114.133 179.437 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 t -162.67 150.82 11.88 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.344 1.458 . . . . 2.68 109.641 162.395 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -83.81 45.98 1.92 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.013 3.142 . . . . 2.41 111.188 171.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -124.25 167.92 16.48 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.481 1.515 . . . . 1.3 113.855 -174.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.72 -20.77 22.53 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.715 2.943 . . . . 1.18 114.064 -177.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.3 152.24 48.32 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.55 1.54 . . . . 3.07 113.467 -176.236 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.47 -174.37 4.58 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.689 1.996 . . . . 0.65 112.31 -171.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.02 136.08 43.81 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.657 1.583 . . . . 0.81 109.329 172.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.26 123.99 46.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.612 1.565 . . . . 0.85 111.627 -176.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -106.02 65.48 0.7 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.853 1.661 . . . . 2.8 109.397 -173.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp -73.29 148.71 43.31 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.189 -0.944 . . . . 2.14 113.239 -170.082 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.5 t -83.23 139.63 33.0 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.102 -0.999 . . . . 3.57 110.347 168.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.83 131.44 56.83 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.728 1.611 . . . . 2.94 107.942 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -120.56 131.31 54.6 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.173 1.389 . . . . 4.27 109.656 173.32 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -107.38 100.36 33.22 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.993 -0.743 . . . . 1.51 108.993 161.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.98 -9.26 15.54 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.027 2.484 . . . . 1.38 113.393 174.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.69 -179.51 51.31 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 122.433 1.019 . . . . 1.21 113.033 -175.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -106.35 -3.51 21.03 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 127.776 2.431 . . . . 2.99 111.717 -172.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -119.25 159.18 46.35 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 127.89 2.476 . . . . 1.87 110.202 172.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.75 146.11 20.77 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.741 2.294 . . . . 0.97 111.167 -175.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mp -103.93 153.49 20.74 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.532 1.133 . . . . 2.72 110.711 173.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.69 112.66 12.74 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.098 1.359 . . . . 3.2 110.0 178.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.9 tp -91.98 113.28 25.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.762 1.625 . . . . 1.75 108.86 -177.186 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.5 m -111.41 -15.55 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.855 1.262 . . . . 0.76 111.668 -170.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.59 -178.17 31.39 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.916 1.722 . . . . 0.72 113.694 -176.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.05 -179.61 8.31 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.886 1.674 . . . . 0.77 112.41 168.303 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -157.34 152.56 26.1 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.331 2.252 . . . . 5.65 108.532 177.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -159.74 150.21 15.44 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 117.837 -1.077 . . . . 1.01 110.936 177.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.96 0.08 7.71 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.393 3.395 . . . . 1.27 113.66 174.034 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.2 m -116.32 49.86 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.979 1.312 . . . . 1.77 110.791 166.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.75 164.65 35.65 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.398 1.094 . . . . 1.13 112.012 161.194 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -104.05 -30.62 10.15 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 127.648 2.379 . . . . 4.12 111.371 163.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 -149.55 140.03 22.43 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.751 1.62 . . . . 5.69 109.459 172.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 p -100.05 167.34 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.028 1.331 . . . . 1.68 109.204 174.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.79 150.76 35.96 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.8 2.04 . . . . 4.3 108.069 176.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.5 tp -120.8 114.67 21.96 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.572 1.078 . . . . 1.16 111.258 -172.056 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -122.77 157.36 32.54 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 115.091 1.515 . . . . 0.72 115.091 -170.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.74 -178.6 4.3 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.129 2.171 . . . . 3.05 111.75 158.434 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.7 m -145.34 148.41 33.37 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 107.904 -1.147 . . . . 0.79 107.904 162.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -152.08 167.56 28.08 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 123.193 1.473 . . . . 2.38 114.802 -170.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.6 ttp -100.81 140.62 34.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.398 1.479 . . . . 3.25 110.745 172.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.79 176.01 10.2 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.599 1.56 . . . . 6.81 112.063 178.1 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -146.15 133.48 20.65 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.076 1.751 . . . . 2.17 106.743 -179.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 m -149.84 135.86 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.784 1.634 . . . . 2.68 107.447 -169.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 60.88 12.41 3.83 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.734 1.614 . . . . 4.32 114.19 -172.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.9 20.69 55.19 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.096 0.855 . . . . 1.7 114.302 -171.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -132.83 135.5 45.68 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.935 1.294 . . . . 4.44 111.216 174.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -71.19 143.92 50.32 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.021 2.528 . . . . 4.2 110.904 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.1 p -156.7 172.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 126.666 1.986 . . . . 2.39 109.932 -172.567 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 64.1 mtt -114.0 153.22 29.73 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.077 0.951 . . . . 2.71 111.158 167.076 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.21 175.02 20.05 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 126.427 1.965 . . . . 0.68 111.766 176.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 ttm -150.17 146.01 26.62 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.631 1.573 . . . . 0.8 109.368 174.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.57 146.86 23.4 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 124.364 1.066 . . . . 5.64 111.109 -169.404 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -78.43 153.57 27.37 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.032 1.821 . . . . 0.83 111.515 171.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.1 m -140.77 152.03 64.61 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 125.843 1.657 . . . . 0.76 110.777 -175.148 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.74 -23.85 6.59 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.546 2.831 . . . . 0.72 113.504 -167.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -178.29 163.54 1.64 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.68 1.992 . . . . 1.94 110.442 179.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.6 mt -110.25 157.16 19.75 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.211 1.404 . . . . 0.64 110.057 164.202 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -118.58 146.64 44.45 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.084 0.954 . . . . 2.33 110.32 168.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.78 128.98 17.14 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.489 0.716 . . . . 1.1 110.982 172.051 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -71.42 165.03 33.74 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.107 3.205 . . . . 1.29 112.318 -176.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.31 141.68 96.36 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.637 2.891 . . . . 1.32 112.733 178.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt 66.05 0.64 1.67 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.554 1.942 . . . . 2.17 113.592 -176.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.51 126.81 7.64 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.587 1.565 . . . . 1.6 113.881 -174.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -88.31 123.13 32.59 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.886 1.274 . . . . 6.49 107.642 156.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.7 t -149.65 98.07 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.892 0.877 . . . . 3.45 109.614 175.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 0.8 OUTLIER -75.54 142.46 42.78 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.865 -0.522 . . . . 3.02 110.751 -177.068 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -65.16 95.39 0.18 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.248 -1.389 . . . . 2.37 107.248 159.083 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.98 150.45 37.44 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.529 1.132 . . . . 4.0 113.93 -164.014 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.25 142.62 92.16 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.791 2.328 . . . . 3.35 110.187 174.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.73 -2.73 85.46 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-O 118.709 -1.05 . . . . 1.51 114.163 -168.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.78 -127.69 1.36 Allowed Glycine 0 C--N 1.34 0.759 0 CA-C-N 118.892 1.346 . . . . 1.66 113.114 172.322 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -72.99 140.54 47.42 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.655 -0.909 . . . . 2.15 112.695 -164.335 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -163.54 158.97 21.4 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.284 1.034 . . . . 0.82 113.405 -176.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -87.11 136.65 32.85 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.853 -0.529 . . . . 2.0 110.678 166.063 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.2 tpt -84.06 138.76 32.9 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.488 1.115 . . . . 0.67 108.496 159.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -117.84 134.77 54.6 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.099 1.36 . . . . 0.65 108.63 179.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 mp -132.86 137.43 46.7 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 122.991 0.516 . . . . 1.74 111.918 177.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.64 47.74 7.72 Favored Glycine 0 N--CA 1.467 0.709 0 C-N-CA 125.208 1.385 . . . . 0.81 113.162 171.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.51 147.37 14.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.634 1.716 . . . . 1.33 115.634 -177.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -104.04 -3.79 24.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.937 -1.483 . . . . 2.52 113.907 -172.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -149.24 139.23 13.2 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.331 1.453 . . . . 5.38 112.021 171.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.75 135.08 15.6 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.526 2.818 . . . . 2.24 109.651 173.374 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.7 mp -93.59 -167.94 1.8 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.032 1.333 . . . . 3.82 110.789 -168.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -134.13 172.74 12.42 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 127.478 2.311 . . . . 3.99 108.843 164.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.51 129.31 34.43 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 118.113 -1.435 . . . . 1.23 107.871 138.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.93 58.64 1.23 Allowed Glycine 0 CA--C 1.528 0.846 0 O-C-N 124.301 1.001 . . . . 1.36 111.654 -168.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -141.37 175.73 9.42 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.323 1.449 . . . . 2.99 111.317 161.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.28 87.41 1.96 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.906 2.482 . . . . 3.4 109.827 -170.25 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 91.2 t -113.18 144.29 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 120.586 -1.321 . . . . 1.5 112.119 -156.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -79.0 141.35 37.55 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.999 1.111 . . . . 2.59 113.999 -167.6 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.426 HD23 HD12 ' A' ' 115' ' ' LEU . 2.6 mm? -125.11 143.5 50.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.565 1.546 . . . . 2.67 108.834 159.549 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -114.5 123.02 48.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.345 2.258 . . . . 2.18 107.899 172.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.3 mp -98.69 127.25 44.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.665 1.986 . . . . 1.48 109.931 -169.054 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.7 mt -104.96 112.61 25.81 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.437 1.113 . . . . 0.65 110.612 -178.264 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -101.02 154.88 18.33 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.789 1.236 . . . . 2.04 110.508 178.101 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.25 141.34 14.99 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.443 -0.798 . . . . 1.7 110.771 170.019 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.52 -1.19 81.47 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.693 -1.06 . . . . 3.05 114.399 -171.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.57 13.08 61.83 Favored Glycine 0 N--CA 1.473 1.106 0 CA-C-N 119.038 1.419 . . . . 3.28 114.361 173.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.57 134.82 38.16 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.948 -1.325 . . . . 5.94 111.047 -179.101 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -113.22 140.6 32.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 126.228 1.811 . . . . 2.29 110.191 172.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.1 tp -145.64 126.68 14.61 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.496 1.119 . . . . 2.1 110.921 176.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -85.8 139.41 31.32 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.043 0.757 . . . . 1.98 113.043 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.01 161.93 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 127.67 2.388 . . . . 2.32 110.847 164.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 83.7 t -121.53 135.62 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.585 1.154 . . . . 1.63 108.824 174.171 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.426 HD12 HD23 ' A' ' 101' ' ' LEU . 47.2 mt -131.41 132.32 23.49 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.886 1.275 . . . . 2.09 110.972 -169.552 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -57.19 141.82 94.46 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 124.168 3.245 . . . . 1.82 114.75 172.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.6 t -114.14 128.9 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.685 1.194 . . . . 1.19 111.603 175.297 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.42 ' CB ' ' HE1' ' A' ' 7' ' ' TRP . 4.2 tt0 -156.72 163.64 39.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.92 1.688 . . . . 3.62 112.147 -179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.05 104.72 16.69 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.27 1.028 . . . . 2.75 110.43 176.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 . . . . . 0 C--O 1.247 0.922 0 C-N-CA 126.093 1.757 . . . . 9.92 108.033 178.493 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 109.277 -0.638 . . . . 6.96 109.277 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -131.19 -175.24 13.93 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.445 1.974 . . . . 1.0 111.116 176.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.5 p90 -135.27 -178.49 5.13 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.231 1.515 . . . . 1.91 113.402 -168.153 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.72 152.25 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 126.774 2.03 . . . . 2.11 112.114 -178.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 -71.77 -26.41 62.42 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 116.11 1.893 . . . . 5.37 116.11 -174.433 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.0 t80 71.75 157.05 0.17 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.066 2.547 . . . . 1.98 111.978 -160.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -155.53 149.04 18.66 Favored Pre-proline 0 CA--C 1.538 0.488 0 O-C-N 121.535 -0.728 . . . . 2.49 111.217 162.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -85.7 -2.67 9.07 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.649 2.899 . . . . 2.01 112.018 167.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -121.01 -179.99 16.22 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.672 1.606 . . . . 1.09 114.065 -175.099 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.56 -18.1 48.65 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.439 3.426 . . . . 1.23 113.986 -174.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -114.61 137.77 51.47 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.055 2.142 . . . . 2.15 113.863 -178.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.28 -177.26 5.38 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.79 2.436 . . . . 0.5 111.738 -172.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.38 149.24 30.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.143 1.377 . . . . 0.65 110.862 178.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.18 147.21 51.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.893 1.277 . . . . 0.58 113.832 -174.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -128.32 43.11 3.2 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 127.424 2.29 . . . . 2.99 114.703 -168.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -73.0 150.58 42.33 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 119.569 -1.957 . . . . 2.83 115.598 -168.16 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 m -96.27 149.4 21.71 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.831 1.653 . . . . 1.86 109.16 173.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.47 166.47 33.44 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.671 1.589 . . . . 2.83 112.153 -176.433 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -128.79 140.97 51.46 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.91 2.084 . . . . 4.24 112.334 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -96.52 99.57 5.72 Favored Pre-proline 0 CA--C 1.542 0.667 0 O-C-N 121.478 -0.764 . . . . 1.6 109.354 158.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.65 -12.11 12.52 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.493 2.128 . . . . 1.27 113.71 176.136 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.78 178.35 53.71 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-O 122.552 1.084 . . . . 1.21 112.936 -175.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -104.75 0.91 28.73 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.87 2.468 . . . . 2.93 112.318 -173.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mp -125.48 160.8 53.84 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 127.767 2.427 . . . . 4.02 108.798 174.079 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.65 155.75 21.1 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.231 1.954 . . . . 0.99 111.732 -167.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.75 147.76 28.23 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.88 1.272 . . . . 2.32 110.224 170.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.0 ttp180 -136.64 103.92 5.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.016 -1.902 . . . . 3.92 109.297 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.548 HD21 ' CZ ' ' A' ' 84' ' ' PHE . 6.5 tt -84.85 110.05 18.55 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.478 1.911 . . . . 2.17 108.847 -175.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.9 m -106.34 -20.88 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.764 1.226 . . . . 0.47 111.932 -174.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.48 -175.76 31.83 Favored Glycine 0 C--N 1.343 0.947 0 C-N-CA 125.004 1.287 . . . . 0.43 114.13 -173.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.43 -177.28 5.98 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.754 2.021 . . . . 0.48 111.0 173.383 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.412 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 11.5 mtt180 -157.95 170.78 21.55 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.89 2.476 . . . . 4.76 107.626 171.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 t -173.44 149.74 1.71 Allowed Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 125.294 1.438 . . . . 0.58 110.364 174.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.54 -8.12 21.28 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.773 2.316 . . . . 0.72 114.037 172.648 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.3 m -118.87 49.39 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.545 1.138 . . . . 0.73 113.295 174.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.23 151.34 17.39 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.643 1.177 . . . . 0.87 110.704 161.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -95.7 -30.77 13.56 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.382 1.473 . . . . 3.35 111.948 169.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.6 mtp-105 -133.08 141.15 48.05 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.693 1.597 . . . . 5.11 108.915 171.5 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -125.3 148.6 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.157 1.383 . . . . 1.15 109.558 168.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -137.45 151.46 48.52 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.649 1.98 . . . . 2.87 109.736 178.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.8 tp -104.61 118.51 36.75 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.492 0.717 . . . . 1.07 110.56 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -124.53 148.87 47.5 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 123.084 1.421 . . . . 0.59 113.914 -174.506 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -89.08 176.38 7.01 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 113.889 -1.505 . . . . 2.46 111.521 162.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 64.9 m -155.01 136.47 14.18 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 105.457 -2.053 . . . . 0.8 105.457 175.175 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -149.43 161.52 41.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 122.952 1.358 . . . . 2.01 114.184 -166.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -87.41 136.22 33.03 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.333 -1.303 . . . . 3.61 110.588 172.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.01 143.22 20.28 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.204 1.002 . . . . 4.93 113.699 -177.501 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.55 130.9 36.54 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 125.655 1.582 . . . . 3.07 111.63 172.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.5 t -141.45 134.8 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 126.066 1.746 . . . . 2.13 107.274 169.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 65.9 16.76 10.61 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.645 1.178 . . . . 3.92 113.352 -176.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.24 21.05 68.27 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 121.188 -0.945 . . . . 1.51 113.396 -171.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -138.86 133.33 31.84 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.169 1.787 . . . . 3.29 109.717 -170.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.405 ' H ' ' HG2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -76.31 117.09 17.62 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.109 1.364 . . . . 4.14 113.506 -178.641 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -117.14 174.06 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 128.669 2.787 . . . . 2.15 109.103 170.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.41 130.34 56.42 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.946 0.898 . . . . 3.16 109.901 177.422 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.31 172.91 15.01 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.573 1.083 . . . . 0.52 113.286 -179.328 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ttm -148.78 143.07 26.13 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.573 1.549 . . . . 0.66 109.765 177.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -144.92 152.19 51.12 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.369 1.868 . . . . 7.62 109.143 -176.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -80.83 150.71 18.59 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.593 2.195 . . . . 0.6 110.206 170.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.24 155.49 80.84 Favored Pre-proline 0 N--CA 1.48 1.05 0 C-N-CA 124.496 1.119 . . . . 0.66 110.379 -177.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.76 -30.04 2.53 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.746 2.297 . . . . 0.57 112.713 -170.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -176.2 164.73 2.76 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.735 1.614 . . . . 2.1 112.042 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.5 mt -109.03 158.73 17.45 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.04 1.336 . . . . 0.7 109.282 161.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -139.74 144.66 37.57 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.96 0.904 . . . . 2.21 111.242 174.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.2 t -146.74 140.1 14.82 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.447 1.099 . . . . 1.5 112.323 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.64 170.62 8.15 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 124.417 3.411 . . . . 1.44 114.092 176.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.96 150.12 80.12 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.616 3.544 . . . . 1.18 113.774 171.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt 68.49 -7.24 0.72 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.912 2.085 . . . . 1.96 115.085 176.252 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.81 149.34 32.95 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.438 1.018 . . . . 1.2 112.683 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 mtt-85 -86.8 162.03 18.03 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 122.003 -0.704 . . . . 6.31 110.155 161.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.1 150.44 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.054 1.741 . . . . 4.04 108.724 172.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.75 137.9 30.1 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.945 0.898 . . . . 3.29 110.344 161.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -78.54 80.72 4.91 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 122.283 1.04 . . . . 2.01 108.336 170.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.404 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -59.39 136.57 88.9 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 115.403 -0.817 . . . . 3.28 112.908 -177.083 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -60.84 -25.62 81.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.236 2.624 . . . . 2.07 112.553 176.284 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.7 9.66 28.68 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 117.652 -1.638 . . . . 1.87 114.722 174.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.65 -10.55 0.03 OUTLIER Glycine 0 C--N 1.346 1.107 0 N-CA-C 121.56 3.384 . . . . 2.13 121.56 167.467 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -143.99 145.3 32.13 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 121.124 2.462 . . . . 2.02 112.843 172.195 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -158.68 152.0 22.82 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.599 0.76 . . . . 0.56 110.816 175.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.548 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 61.9 m-85 -78.7 141.56 37.81 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.418 -0.956 . . . . 1.65 108.418 160.062 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.0 tpt -99.42 130.23 45.67 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.399 1.88 . . . . 0.61 108.489 168.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.9 mp -111.61 139.61 46.9 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.47 1.508 . . . . 0.55 108.357 -179.262 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.2 mp -137.82 143.73 41.15 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.418 1.087 . . . . 1.52 109.576 175.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.91 42.42 45.32 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.957 -0.457 . . . . 1.0 111.957 -178.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.35 141.9 28.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 122.865 1.317 . . . . 1.34 113.342 170.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -100.65 0.78 39.8 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.084 -1.416 . . . . 2.39 113.05 -171.334 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -123.86 146.63 51.32 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 126.959 2.104 . . . . 5.15 107.821 167.013 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -62.34 120.27 7.74 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 N-CA-C 105.166 -2.667 . . . . 1.68 105.166 149.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 tp -76.79 79.95 3.4 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 122.177 0.989 . . . . 2.5 111.387 -157.077 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . 0.268 5.6 tmtt? -64.74 114.5 4.5 Favored 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 120.368 -1.458 . . . . 6.18 110.949 -169.334 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.71 114.83 1.25 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.216 1.406 . . . . 1.69 111.443 170.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.67 44.81 6.3 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.201 1.381 . . . . 1.6 112.699 -169.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -101.3 -177.22 3.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.919 1.688 . . . . 3.01 109.209 145.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -130.68 125.5 34.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 129.328 3.051 . . . . 3.89 103.91 178.064 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.9 t -128.66 122.25 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.381 1.873 . . . . 1.01 108.985 -171.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -81.8 146.66 29.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.933 0.873 . . . . 2.25 112.582 171.133 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.77 138.03 54.22 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.665 1.586 . . . . 1.65 109.77 163.433 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 14.5 m-20 -78.32 149.0 33.55 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.343 1.857 . . . . 2.71 108.125 158.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.2 mp -127.16 132.59 50.48 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.667 1.587 . . . . 1.0 108.482 175.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.5 mt -105.95 118.43 36.58 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.806 1.242 . . . . 0.69 109.456 -175.258 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -116.55 118.23 32.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.422 1.489 . . . . 1.92 111.786 -172.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.86 20.84 1.75 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.5 1.92 . . . . 2.83 114.277 176.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.28 -61.73 4.13 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.208 1.385 . . . . 4.42 112.286 -167.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.94 4.68 60.74 Favored Glycine 0 N--CA 1.474 1.21 0 N-CA-C 117.089 1.596 . . . . 2.04 117.089 -166.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -131.99 140.06 48.83 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.481 1.64 . . . . 3.45 112.178 175.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.17 146.88 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.361 1.464 . . . . 2.1 109.334 171.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 tt -150.7 160.88 43.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.91 2.484 . . . . 1.96 107.593 176.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -144.89 152.94 41.03 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.027 1.285 . . . . 1.76 114.436 175.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.51 157.79 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.416 1.486 . . . . 2.28 109.409 -174.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 66.6 t -87.39 161.76 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.951 1.3 . . . . 1.81 109.127 175.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.25 140.08 11.42 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 126.239 1.816 . . . . 2.44 110.223 164.168 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.97 146.2 64.31 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.247 2.632 . . . . 0.73 111.987 174.109 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.77 116.56 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.768 -0.827 . . . . 1.17 108.768 167.357 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -137.05 176.57 8.6 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.798 1.639 . . . . 4.41 110.116 -177.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -113.36 136.72 52.46 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.298 1.039 . . . . 2.5 111.518 174.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.277 19.9 ptt-85 . . . . . 0 N--CA 1.485 1.297 0 C-N-CA 131.175 3.79 . . . . 9.41 111.415 168.68 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 CA--C 1.543 0.688 0 CA-C-O 121.203 0.525 . . . . 7.86 110.408 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.51 -175.33 19.59 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 125.1 1.333 . . . . 1.44 112.565 177.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -141.59 175.29 9.81 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.995 1.109 . . . . 2.1 113.995 178.471 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.6 t -111.93 126.12 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 126.284 1.833 . . . . 1.81 106.166 162.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.6 ttp85 -87.19 131.77 34.08 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.296 -1.001 . . . . 5.51 108.296 171.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -57.35 117.59 4.26 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.122 0.569 . . . . 2.36 110.98 -175.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.5 m -174.68 106.11 0.27 Allowed Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 128.851 2.86 . . . . 4.62 107.036 167.052 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -93.42 -125.53 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.603 3.535 . . . . 6.06 109.515 -176.314 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.73 -155.41 30.5 Favored Glycine 0 CA--C 1.543 1.785 0 O-C-N 121.425 -0.797 . . . . 2.58 113.164 178.423 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.82 -31.19 13.21 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.914 2.409 . . . . 3.71 112.091 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.09 123.36 21.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.889 1.675 . . . . 4.24 111.049 169.306 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.18 -179.04 4.96 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.131 1.772 . . . . 0.86 111.336 172.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.96 135.93 29.86 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 121.052 -1.03 . . . . 0.8 111.097 -176.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.78 146.14 51.98 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.819 1.648 . . . . 0.9 112.05 -176.54 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -135.89 62.78 1.61 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.19 0.996 . . . . 3.39 111.488 -157.062 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.06 162.71 24.0 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.468 -0.787 . . . . 1.79 113.015 -173.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.6 m -125.78 145.83 50.04 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.782 1.633 . . . . 2.27 107.571 171.064 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.47 164.62 38.39 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.96 1.304 . . . . 4.63 110.176 174.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -127.94 154.98 44.95 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.391 1.076 . . . . 3.96 110.594 168.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -101.35 95.1 4.61 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 124.552 1.141 . . . . 1.36 109.221 171.334 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.92 -19.18 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.151 1.9 . . . . 1.67 113.28 -177.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.46 -177.02 51.47 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-O 122.351 0.973 . . . . 1.46 112.455 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -112.85 2.85 16.08 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.517 1.927 . . . . 4.17 112.389 -170.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -98.38 157.04 35.06 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.634 1.974 . . . . 2.33 110.243 164.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.57 148.63 14.32 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.243 2.628 . . . . 0.89 111.179 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.1 mt -102.65 146.04 28.77 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 122.8 1.286 . . . . 1.94 111.87 170.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.9 ttp-105 -129.77 109.61 11.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 111.984 -2.371 . . . . 2.35 108.967 176.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -95.41 111.66 23.51 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.402 1.881 . . . . 2.49 108.606 -174.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -111.21 -21.26 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.145 0.978 . . . . 0.62 112.033 -168.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.54 -174.26 30.14 Favored Glycine 0 C--N 1.344 1.018 0 C-N-CA 124.596 1.093 . . . . 0.57 114.277 -174.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.16 -178.79 6.4 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.563 1.545 . . . . 0.71 111.466 170.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -151.6 167.07 29.24 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.804 2.442 . . . . 4.69 107.746 164.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 t -174.07 149.23 1.45 Allowed Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 125.164 1.386 . . . . 0.76 108.536 -171.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.18 -3.5 13.49 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.185 2.59 . . . . 0.83 114.281 177.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.4 m -119.4 28.39 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 115.22 1.563 . . . . 1.11 115.22 -174.009 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.33 167.03 31.72 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.781 1.632 . . . . 1.12 111.481 173.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -96.67 -31.13 12.86 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.458 1.503 . . . . 3.07 111.056 173.278 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -139.1 153.35 48.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 129.889 3.276 . . . . 5.02 108.034 -173.311 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.5 p -155.07 121.76 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 124.896 1.279 . . . . 1.74 109.775 178.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -140.66 129.95 23.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.143 -0.935 . . . . 4.14 109.795 -165.314 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.459 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.7 pt? -82.23 140.43 33.67 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 123.261 1.505 . . . . 1.84 113.285 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -117.11 157.16 26.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.612 2.365 . . . . 0.82 112.304 175.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -95.33 149.01 21.83 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.642 1.977 . . . . 2.6 109.541 158.182 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.0 m -115.62 149.63 37.98 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.369 1.868 . . . . 0.83 106.012 159.654 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -158.93 177.39 11.2 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.817 0.847 . . . . 1.98 113.146 -177.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 76.1 mtm -108.76 144.22 36.86 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.234 1.414 . . . . 3.38 111.612 172.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -139.78 146.95 40.11 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.418 1.487 . . . . 5.34 111.597 173.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -93.94 140.48 29.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.725 1.21 . . . . 2.25 108.167 156.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.8 t -138.83 119.2 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.175 1.39 . . . . 2.2 107.252 170.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 62.46 20.08 11.64 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.087 1.355 . . . . 3.45 113.95 -177.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.83 15.4 75.41 Favored Glycine 0 N--CA 1.477 1.413 0 O-C-N 120.47 -1.394 . . . . 1.5 113.504 -170.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -117.02 115.71 25.95 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.696 2.398 . . . . 3.47 108.314 -179.587 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.442 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -93.72 131.26 39.22 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.588 1.155 . . . . 4.38 111.47 -170.62 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.9 p -155.32 148.96 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.9 1.68 . . . . 2.66 109.99 -168.112 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.9 mtt -89.22 155.48 19.37 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.521 0.728 . . . . 2.51 111.956 176.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.5 176.05 20.82 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 124.612 1.101 . . . . 0.58 112.714 179.186 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ttm -153.83 144.81 22.74 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 126.058 1.743 . . . . 0.72 109.205 -178.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -151.0 157.99 35.05 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 125.658 1.583 . . . . 4.84 109.472 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -73.6 157.26 48.82 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.146 1.897 . . . . 0.87 111.266 168.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.17 158.81 71.85 Favored Pre-proline 0 N--CA 1.481 1.12 0 CA-C-O 118.53 -0.747 . . . . 1.18 110.729 173.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -83.18 -24.98 2.9 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.277 2.651 . . . . 0.95 113.355 -170.166 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -179.39 164.61 1.35 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.88 2.072 . . . . 2.35 110.781 -178.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.2 mt -109.43 154.3 22.8 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.757 1.223 . . . . 0.69 110.26 163.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -115.53 140.4 49.2 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.25 1.02 . . . . 1.92 108.987 170.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.3 t -141.86 129.04 11.47 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 123.886 0.874 . . . . 1.25 111.365 174.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.45 170.42 16.24 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.428 2.752 . . . . 1.1 112.545 -178.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -57.63 139.54 90.57 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.142 2.561 . . . . 1.51 111.172 166.356 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm 65.22 0.75 1.37 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.279 1.831 . . . . 2.6 114.524 -174.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.56 177.54 52.75 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.291 1.9 . . . . 1.88 112.395 171.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.6 ptt85 -131.83 132.94 44.14 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.515 1.126 . . . . 8.23 112.876 -172.432 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.88 73.29 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 127.071 2.148 . . . . 5.29 109.094 -174.465 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.33 117.87 35.12 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.605 1.962 . . . . 3.76 110.064 -172.075 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.29 58.03 0.61 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.493 1.917 . . . . 2.73 111.58 -171.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.519 ' H ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -61.97 146.59 91.39 Favored Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 125.973 1.709 . . . . 3.39 115.364 178.533 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -61.12 -33.5 91.06 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 124.319 3.346 . . . . 2.85 114.782 -177.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.25 5.25 44.08 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.153 0.882 . . . . 1.46 114.182 177.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.22 -124.96 0.97 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.955 1.264 . . . . 1.61 111.591 170.293 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -71.11 138.01 49.35 Favored 'General case' 0 C--O 1.219 -0.527 0 O-C-N 121.653 -0.91 . . . . 2.12 111.274 -174.07 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -159.93 158.16 30.26 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.416 0.687 . . . . 0.6 112.451 -176.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -89.71 137.49 32.29 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.181 -0.949 . . . . 1.86 111.737 174.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.9 tpt -97.35 127.69 43.53 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.416 1.886 . . . . 0.71 109.146 163.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.78 121.81 44.8 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.939 1.296 . . . . 0.82 108.525 -178.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.8 136.52 52.49 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.155 0.582 . . . . 2.67 110.875 -163.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.32 38.44 62.7 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.867 -0.521 . . . . 1.05 112.554 -170.584 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.87 148.02 0.87 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 116.546 2.054 . . . . 2.03 116.546 176.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -99.74 1.75 43.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.816 -1.538 . . . . 1.8 113.705 -177.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -159.32 150.53 16.34 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 125.658 1.583 . . . . 4.96 111.027 -177.105 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.91 83.85 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.016 2.477 . . . . 3.0 107.812 164.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 96.94 0.09 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.503 1.521 . . . . 2.69 111.923 -172.426 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.48 161.34 13.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.09 -1.868 . . . . 4.27 112.606 -173.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.71 133.17 54.42 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.037 0.935 . . . . 1.68 110.389 177.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.92 55.61 3.52 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 114.176 -1.374 . . . . 2.85 111.077 -170.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -138.33 -178.02 5.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.233 2.213 . . . . 2.42 108.3 163.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -156.37 132.53 9.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.278 2.231 . . . . 3.46 105.571 -167.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.6 t -142.0 132.21 24.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 125.249 1.42 . . . . 0.97 109.466 -164.035 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -77.13 145.59 37.69 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 122.685 0.394 . . . . 2.42 111.131 172.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.54 137.44 54.73 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 122.662 1.22 . . . . 1.7 111.122 151.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -87.3 139.78 30.21 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.365 2.266 . . . . 2.08 108.028 155.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -110.4 141.21 43.78 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.367 1.467 . . . . 0.81 109.952 173.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -112.42 113.92 26.36 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.958 1.303 . . . . 0.64 109.579 178.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -115.14 152.68 32.15 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.623 1.569 . . . . 2.18 111.094 178.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.23 137.55 55.81 Favored 'General case' 0 CA--C 1.548 0.865 0 CA-C-O 122.293 1.044 . . . . 2.37 113.795 -178.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.23 56.97 4.93 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.266 0.936 . . . . 3.56 113.239 176.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.47 11.84 80.1 Favored Glycine 0 N--CA 1.473 1.158 0 N-CA-C 115.784 1.074 . . . . 2.16 115.784 168.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -94.68 114.97 26.97 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.043 1.421 . . . . 2.99 111.356 -174.356 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.65 136.12 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.134 1.374 . . . . 1.9 109.537 177.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 tt -145.42 125.32 13.51 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.85 0.86 . . . . 2.55 111.033 -168.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -101.09 134.68 43.73 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.792 1.237 . . . . 2.41 112.144 -178.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.8 t -147.11 168.3 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 126.412 1.885 . . . . 2.55 109.71 173.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.94 155.84 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 119.672 1.123 . . . . 1.9 111.01 -170.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.9 mt -141.29 117.52 7.39 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.212 1.805 . . . . 2.52 110.129 -174.437 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.46 146.46 62.14 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.705 2.27 . . . . 1.09 110.432 168.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.4 t -94.79 115.81 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.845 0.858 . . . . 1.23 109.209 170.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -129.81 137.73 50.64 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.428 1.091 . . . . 4.21 112.01 -170.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.43 83.46 5.43 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.994 -1.066 . . . . 3.81 110.693 170.065 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.408 0 C-N-CA 127.249 2.22 . . . . 9.13 110.848 -175.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 . . . . . 0 C--O 1.238 0.458 0 N-CA-C 106.001 -1.851 . . . . 6.42 106.001 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -118.69 -170.95 14.94 Favored Glycine 0 N--CA 1.462 0.387 0 CA-C-O 122.436 1.02 . . . . 0.92 112.038 -172.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 41.0 p90 -134.11 162.98 30.61 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.598 -0.801 . . . . 2.05 111.325 167.206 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.46 139.03 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.894 1.278 . . . . 1.4 109.147 173.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -58.0 112.73 1.6 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.743 1.617 . . . . 6.14 112.555 -177.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.59 132.36 51.45 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.324 2.249 . . . . 3.07 111.455 166.175 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -179.05 154.55 0.79 Allowed Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.535 1.934 . . . . 2.8 112.867 166.392 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -88.28 40.69 0.58 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 125.23 3.953 . . . . 2.3 111.055 166.316 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -114.88 157.37 15.03 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.948 1.261 . . . . 1.27 113.019 -172.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -71.77 -18.52 28.41 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.133 3.222 . . . . 1.45 113.923 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -108.17 164.82 11.97 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.541 1.936 . . . . 2.87 112.629 170.253 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.3 -171.72 3.72 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.474 2.709 . . . . 0.61 111.107 170.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -155.19 133.89 12.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.639 1.976 . . . . 0.86 108.867 -175.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.42 132.57 54.97 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.267 1.394 . . . . 0.95 111.351 -176.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -114.84 32.04 6.27 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.673 1.731 . . . . 2.7 115.673 -167.061 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.642 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.5 pt? -64.93 158.88 24.17 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 115.972 1.841 . . . . 2.32 115.972 -172.306 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.8 m -79.74 126.6 31.15 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.519 1.128 . . . . 1.75 109.679 166.191 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.9 tp -99.08 127.91 45.11 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.262 1.425 . . . . 4.27 108.898 168.859 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.71 154.74 42.0 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.628 0.728 . . . . 3.4 111.676 175.356 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -119.12 97.93 50.69 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.388 1.075 . . . . 1.53 109.088 169.246 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.6 -10.76 14.42 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.08 2.52 . . . . 1.21 113.03 177.05 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.93 -173.38 48.81 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.795 1.188 . . . . 1.26 113.115 -176.154 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -112.82 1.17 15.45 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.606 1.963 . . . . 3.26 112.368 -168.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -124.45 161.86 45.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 128.013 2.525 . . . . 2.28 110.256 174.122 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -81.01 141.91 13.42 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.484 2.122 . . . . 1.4 111.898 -173.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.98 149.33 25.24 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.145 1.378 . . . . 2.71 110.134 174.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 42.4 ttm105 -135.44 103.3 5.43 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.633 1.173 . . . . 2.75 110.157 178.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.426 HD13 ' C ' ' A' ' 32' ' ' LEU . 2.5 tm? -79.4 114.66 18.51 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.24 1.816 . . . . 2.58 108.047 -178.34 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.2 m -110.1 -19.47 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.254 1.022 . . . . 0.61 112.408 -177.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.24 -175.8 29.58 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 125.509 1.528 . . . . 0.5 113.889 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.91 -179.87 6.02 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.965 0.906 . . . . 0.51 111.035 166.004 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -137.32 177.4 7.9 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.313 1.445 . . . . 4.11 107.845 155.054 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 t -175.7 148.88 1.02 Allowed Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 128.151 2.58 . . . . 0.7 106.394 177.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.44 -9.46 20.16 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.591 2.194 . . . . 0.78 112.21 178.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.3 m -112.96 51.82 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.679 1.591 . . . . 0.86 111.586 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.01 158.16 30.05 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.056 1.343 . . . . 1.01 111.64 167.167 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -98.57 -33.81 10.83 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.987 1.715 . . . . 2.67 110.152 160.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -128.65 130.12 46.8 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.619 1.968 . . . . 5.16 109.53 177.255 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -128.43 128.93 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.404 1.081 . . . . 1.43 108.993 166.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -144.39 137.57 27.16 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.165 0.986 . . . . 3.16 110.442 -162.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 20.7 tp -91.85 125.17 36.46 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.663 -0.648 . . . . 1.37 112.324 -167.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -122.41 160.28 25.79 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.896 1.678 . . . . 0.77 114.119 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.48 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 17.6 pt-20 -120.27 147.68 44.67 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.696 1.598 . . . . 3.92 110.189 161.499 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.3 m -108.54 139.14 43.72 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 107.54 -1.282 . . . . 0.82 107.54 172.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -130.22 170.77 13.65 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.567 1.947 . . . . 2.09 111.895 -172.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.8 mtt -103.36 141.58 35.69 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.518 1.127 . . . . 3.97 111.909 172.158 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -141.47 145.02 34.71 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.078 1.351 . . . . 6.9 112.52 174.423 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -79.93 134.51 36.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.769 -1.197 . . . . 2.57 107.769 146.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.3 t -146.41 136.86 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 106.894 -1.521 . . . . 2.75 106.894 164.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 66.31 13.84 9.39 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.64 1.576 . . . . 5.53 113.927 -177.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.03 27.11 67.13 Favored Glycine 0 N--CA 1.476 1.309 0 O-C-N 120.946 -1.096 . . . . 2.74 113.017 -168.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -130.93 143.68 50.91 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 126.861 2.065 . . . . 4.63 109.098 178.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -81.35 119.61 23.89 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.308 1.843 . . . . 4.09 109.458 178.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.7 m -139.3 169.91 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.343 1.857 . . . . 2.53 110.976 -177.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 53.6 mtm -134.14 137.84 44.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.039 1.335 . . . . 2.81 110.75 174.464 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.44 174.83 21.57 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 125.786 1.66 . . . . 1.03 111.627 -177.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.25 141.63 47.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.329 1.064 . . . . 1.62 111.832 -179.166 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -122.24 156.08 60.81 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 125.343 1.457 . . . . 6.67 110.19 173.291 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.26 159.0 44.44 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.021 1.814 . . . . 0.79 111.575 170.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.68 156.21 78.84 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 126.215 1.806 . . . . 1.31 110.49 177.194 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.57 -24.13 6.54 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.51 2.806 . . . . 0.69 112.859 -175.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -176.68 165.36 2.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.08 1.752 . . . . 1.93 111.703 -178.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -109.56 160.1 16.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.118 1.367 . . . . 0.8 109.53 155.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -134.84 148.42 50.15 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.235 1.014 . . . . 2.25 109.91 174.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 t -142.32 128.46 10.77 Favored Pre-proline 0 CA--C 1.541 0.596 0 O-C-N 123.817 0.698 . . . . 1.13 112.086 178.231 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.11 162.53 41.48 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.776 2.984 . . . . 1.43 111.458 176.673 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.44 141.28 97.01 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.224 2.616 . . . . 1.4 113.02 -178.177 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt 70.14 -2.32 2.13 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.469 2.308 . . . . 2.12 114.265 -178.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.6 158.35 43.13 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.581 1.562 . . . . 1.15 114.316 -179.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.95 143.63 51.01 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.133 1.773 . . . . 6.2 109.592 167.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.7 t -143.61 131.87 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 106.313 -1.736 . . . . 3.33 106.313 174.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.417 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . 7.2 mt-10 -120.22 128.44 53.36 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.61 1.095 . . . . 3.94 110.77 -170.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 83' ' ' HIS . 4.6 mp -77.65 58.06 1.73 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.48 1.512 . . . . 2.28 111.229 -178.513 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 76' ' ' GLU . 0.2 OUTLIER -63.54 150.18 90.69 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 114.795 1.406 . . . . 5.0 114.795 -178.553 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -58.06 151.11 60.5 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.456 2.104 . . . . 2.63 109.888 169.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.29 -9.52 33.39 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.355 -1.247 . . . . 1.86 114.206 -171.271 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -135.01 -129.62 2.9 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 119.443 1.622 . . . . 1.58 114.444 175.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.48 ' CE1' ' HB3' ' A' ' 47' ' ' GLU . 80.8 m-85 -71.97 141.03 49.4 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.543 -0.975 . . . . 2.01 110.703 -177.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 77' ' ' LEU . 46.5 p-80 -164.41 156.74 16.66 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.962 1.305 . . . . 0.76 110.88 -176.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.479 ' CE2' HD21 ' A' ' 20' ' ' LEU . 98.3 m-85 -82.42 145.24 29.97 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.24 -0.652 . . . . 1.77 109.24 161.043 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 tpt -96.56 132.99 41.61 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.919 1.288 . . . . 0.82 108.42 164.054 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 mp -109.37 140.01 43.61 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.758 1.223 . . . . 0.86 109.363 176.169 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.3 mt -141.74 142.91 33.28 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.747 1.619 . . . . 1.93 110.107 -176.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 68.47 36.71 84.44 Favored Glycine 0 CA--C 1.532 1.098 0 O-C-N 121.894 -0.504 . . . . 0.94 112.993 177.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.11 145.57 13.08 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 123.609 1.671 . . . . 1.42 115.231 -178.506 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -93.15 -7.67 44.73 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 113.762 -1.563 . . . . 1.82 113.031 -174.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -142.67 145.06 32.53 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 127.469 2.307 . . . . 5.37 107.495 169.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -66.25 151.2 84.03 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.152 1.901 . . . . 2.09 108.822 158.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mp -117.46 112.41 20.6 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 125.977 1.711 . . . . 2.62 107.596 -165.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -86.11 171.02 11.67 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.332 0.587 . . . . 4.09 112.078 179.079 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.81 137.31 58.21 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.396 -0.964 . . . . 1.18 108.396 153.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.81 23.05 75.98 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 116.44 1.336 . . . . 1.41 116.44 173.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -93.42 -170.24 2.33 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.662 1.731 . . . . 2.33 111.74 169.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 10.6 pt-20 -154.66 138.31 16.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 128.264 2.626 . . . . 3.14 106.647 -173.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.6 t -149.09 136.1 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.804 1.641 . . . . 0.97 110.027 -163.196 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -77.31 147.76 36.04 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.104 0.478 . . . . 2.84 110.83 173.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.408 HD22 HD22 ' A' ' 20' ' ' LEU . 1.3 mp -127.3 149.93 49.81 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.878 1.271 . . . . 1.61 108.747 159.405 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -107.39 150.55 26.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.661 0.784 . . . . 2.24 108.935 158.01 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.3 mp -109.81 133.48 53.11 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.399 1.48 . . . . 1.0 109.267 172.096 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.4 mt -103.55 112.18 24.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.176 1.39 . . . . 0.65 109.559 -179.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -106.14 111.53 24.18 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.924 1.69 . . . . 2.14 111.572 -175.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 49.76 32.58 5.38 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.774 1.63 . . . . 3.39 112.948 -178.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.43 -71.1 1.84 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.41 1.481 . . . . 5.12 112.212 -171.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.44 9.46 21.21 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 117.146 1.618 . . . . 2.24 117.146 -163.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -130.9 134.28 46.63 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.721 1.76 . . . . 4.32 110.463 169.51 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.7 p -125.22 145.09 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.048 1.339 . . . . 2.24 110.977 178.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.8 tp -139.92 126.47 20.36 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.254 1.422 . . . . 2.31 109.588 178.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -84.27 141.38 31.0 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.061 0.393 . . . . 2.21 112.061 173.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.19 -179.91 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 127.203 2.201 . . . . 2.6 110.361 167.084 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.5 t -138.31 155.43 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.515 1.526 . . . . 1.71 106.979 171.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.27 153.29 26.62 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.954 1.302 . . . . 1.97 111.231 171.314 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 43.0 Cg_endo -63.95 168.17 12.63 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.75 2.967 . . . . 1.03 112.842 171.66 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.6 t -112.36 128.73 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.039 1.336 . . . . 0.98 108.712 169.525 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -154.41 178.53 9.95 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.257 1.823 . . . . 4.4 112.946 177.048 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.55 162.26 29.71 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.849 1.426 . . . . 4.05 114.849 -167.228 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 117.744 -1.122 . . . . 7.78 109.886 171.069 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 112.294 0.479 . . . . 5.07 112.294 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -150.28 164.88 29.81 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.99 1.281 . . . . 1.27 114.122 171.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -157.2 151.47 25.01 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.615 2.366 . . . . 2.28 110.638 176.285 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.9 t -97.62 145.55 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 120.957 -1.089 . . . . 1.02 109.868 -178.765 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.77 -15.64 63.73 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.024 1.49 . . . . 4.68 115.024 -172.782 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 77.57 145.88 0.09 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.053 2.141 . . . . 3.57 114.116 -171.539 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.4 t -178.66 133.78 0.3 Allowed Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 128.27 2.628 . . . . 2.72 110.808 165.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -82.51 -11.42 10.56 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.224 2.616 . . . . 3.19 112.202 172.5 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.34 169.37 31.72 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.958 1.266 . . . . 1.45 112.212 178.617 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.59 -15.9 52.39 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.597 3.531 . . . . 1.54 114.779 -170.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -100.99 140.55 35.13 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.248 1.419 . . . . 2.67 112.428 173.642 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.44 -177.42 5.94 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.285 1.834 . . . . 0.55 111.926 172.312 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.26 147.18 25.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.598 1.959 . . . . 0.79 110.02 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.99 149.82 47.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.745 1.017 . . . . 0.81 113.745 -172.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -117.19 142.73 46.67 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.161 1.784 . . . . 3.01 109.862 174.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.84 160.12 14.25 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.399 1.08 . . . . 2.86 113.208 178.171 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.408 HG23 ' HB3' ' A' ' 76' ' ' GLU . 22.9 m -136.95 147.04 46.11 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 125.129 1.371 . . . . 1.95 110.167 -171.447 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.51 134.11 10.87 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.987 1.315 . . . . 5.52 109.498 -178.046 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.29 154.16 18.78 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.211 0.914 . . . . 5.3 112.376 177.104 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -105.28 83.34 0.88 Allowed Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.71 1.204 . . . . 1.59 110.132 171.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -71.65 -4.68 15.52 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.476 2.117 . . . . 1.84 113.437 176.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.79 169.73 49.06 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-O 123.284 1.491 . . . . 1.24 112.811 177.641 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -101.25 -2.24 31.69 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 127.54 2.336 . . . . 2.85 112.518 -171.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -116.71 159.59 39.89 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.931 2.092 . . . . 3.97 109.459 169.755 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.97 170.77 14.91 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.844 2.363 . . . . 1.64 112.206 -166.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.4 mt -117.07 147.88 42.0 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 123.243 1.497 . . . . 1.96 110.945 165.843 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -138.54 109.65 6.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 111.449 -2.614 . . . . 3.14 108.97 166.819 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 tp -84.95 110.21 18.72 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.033 1.733 . . . . 1.6 108.826 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.81 -14.77 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.155 0.982 . . . . 0.58 112.059 -176.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.34 -179.03 31.95 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-O 122.324 0.958 . . . . 0.48 114.276 -178.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -144.64 -179.15 6.39 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.98 1.712 . . . . 0.47 109.588 162.668 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -153.27 -178.97 7.31 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.917 1.287 . . . . 4.96 108.568 156.164 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 t -171.53 153.0 3.37 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 125.986 1.714 . . . . 0.58 108.056 -172.604 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.11 -3.16 13.2 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.151 1.901 . . . . 0.66 113.847 174.175 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.5 m -119.15 39.26 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.796 1.239 . . . . 0.74 114.267 -176.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.36 167.26 29.29 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.134 1.374 . . . . 1.11 110.721 169.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -98.47 -50.97 4.1 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.72 1.608 . . . . 2.65 110.023 171.415 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -114.99 139.33 49.93 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 127.215 2.206 . . . . 4.63 107.293 171.054 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.1 149.55 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.521 -0.763 . . . . 1.09 109.003 154.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -127.94 151.79 48.68 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.675 1.99 . . . . 2.97 107.54 166.781 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -100.73 138.34 37.91 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.082 1.31 . . . . 1.76 112.102 160.465 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -123.79 160.21 27.84 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.066 2.146 . . . . 0.71 112.235 -178.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -104.36 178.58 4.52 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 112.491 -2.141 . . . . 3.46 111.397 166.101 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.8 m -148.34 139.15 23.0 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.285 -1.376 . . . . 0.74 107.285 163.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -148.37 178.54 8.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.983 1.313 . . . . 2.12 112.4 -168.864 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -110.04 145.49 36.96 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.332 1.453 . . . . 4.48 113.117 179.331 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.8 mtp85 -127.43 152.81 47.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.445 1.498 . . . . 4.69 110.711 166.299 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.411 ' OE1' ' HE2' ' A' ' 57' ' ' LYS . 3.1 tp10 -91.75 143.31 26.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.536 -0.912 . . . . 2.52 108.536 147.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 50.6 t -140.27 127.7 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 106.937 -1.505 . . . . 2.05 106.937 158.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 65.03 25.64 12.63 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.24 1.016 . . . . 4.38 113.715 173.404 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.11 9.1 85.64 Favored Glycine 0 CA--C 1.538 1.471 0 O-C-N 120.536 -1.352 . . . . 1.62 113.94 -173.52 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -122.21 119.25 30.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.17 2.188 . . . . 2.94 108.746 -170.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.476 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -89.04 116.52 27.38 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.655 1.982 . . . . 4.23 111.401 -173.033 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.1 t -149.13 139.69 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.962 2.105 . . . . 2.98 109.328 -166.112 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -84.08 170.86 13.44 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.586 1.328 . . . . 2.51 114.586 -172.059 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.55 165.63 29.13 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 126.807 2.146 . . . . 0.5 112.694 177.427 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 ttm -148.11 141.38 25.15 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.979 1.712 . . . . 0.83 109.705 177.785 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -148.18 159.6 39.24 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.695 1.998 . . . . 5.01 109.749 -176.71 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.81 153.02 53.29 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.276 1.984 . . . . 0.94 111.358 168.274 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.89 159.45 56.14 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 123.734 0.814 . . . . 1.06 109.898 174.51 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.63 -25.88 3.45 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.856 2.371 . . . . 0.69 112.951 -172.063 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -179.64 167.17 1.4 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.092 2.157 . . . . 2.2 110.73 -178.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.2 mt -112.1 152.18 28.56 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.24 1.016 . . . . 0.55 110.179 162.122 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -120.48 139.32 53.05 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.216 1.406 . . . . 2.19 110.042 -176.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.4 t -146.05 135.65 11.59 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 113.147 0.795 . . . . 1.59 113.147 176.419 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.26 168.87 23.77 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.479 2.786 . . . . 1.53 112.189 176.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -59.76 140.9 95.59 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.71 2.273 . . . . 1.69 110.959 165.074 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt 66.33 1.86 2.19 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.773 1.629 . . . . 2.03 113.577 -176.412 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.85 -175.65 51.07 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.644 2.069 . . . . 1.89 111.533 166.44 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -147.43 150.46 34.68 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 114.253 1.205 . . . . 5.66 114.253 175.694 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.1 t -98.23 106.13 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 128.243 2.617 . . . . 5.49 107.405 -174.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.408 ' HB3' HG23 ' A' ' 21' ' ' THR . 0.0 OUTLIER -126.14 110.38 13.42 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 122.199 0.999 . . . . 3.94 111.204 -179.416 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mp -83.49 78.7 9.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.006 -1.479 . . . . 2.29 107.006 167.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -73.0 140.67 80.8 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 113.777 -1.556 . . . . 3.61 112.992 -175.113 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -61.12 142.54 97.23 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.712 2.275 . . . . 3.48 110.81 -179.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.84 -12.93 58.34 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.222 -1.321 . . . . 2.09 114.786 -177.053 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.68 -109.53 1.45 Allowed Glycine 0 N--CA 1.474 1.173 0 CA-C-N 119.154 1.477 . . . . 1.87 111.62 172.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 47' ' ' GLU . 97.3 m-85 -75.54 137.07 40.6 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.832 -0.805 . . . . 2.1 111.957 -172.405 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -161.37 152.37 18.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.548 -0.751 . . . . 0.64 111.267 -171.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 52.8 m-85 -83.94 140.36 31.98 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.392 -0.818 . . . . 2.26 109.879 166.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.3 tpt -100.51 131.28 46.5 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.255 1.822 . . . . 0.63 108.183 167.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 mp -109.48 126.6 53.68 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.801 1.24 . . . . 0.84 108.184 -179.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.83 128.03 49.86 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.953 1.301 . . . . 2.98 109.281 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.93 51.91 5.2 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.578 1.085 . . . . 0.81 113.24 176.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.6 mt -47.33 155.98 0.29 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.846 1.424 . . . . 2.83 114.846 176.285 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -108.61 4.38 23.91 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.853 -1.067 . . . . 1.78 113.691 -177.875 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -161.31 163.1 20.77 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 129.43 3.092 . . . . 5.23 108.12 176.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.09 118.33 5.57 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.708 1.605 . . . . 1.75 108.617 165.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mp -80.15 57.14 2.62 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.14 1.376 . . . . 2.98 109.917 175.577 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -59.47 167.17 2.04 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 120.519 -1.363 . . . . 4.35 111.964 174.31 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.34 128.98 33.81 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.393 1.092 . . . . 1.83 110.025 161.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.13 34.59 36.91 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.017 1.294 . . . . 2.46 114.092 177.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -90.79 -176.85 4.81 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.65 1.225 . . . . 2.2 109.92 153.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -144.66 153.93 42.26 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 127.712 2.405 . . . . 3.76 106.904 171.344 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.4 t -149.03 157.66 6.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 128.509 2.724 . . . . 1.42 108.791 -163.328 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -120.61 152.85 37.61 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.096 0.474 . . . . 2.29 112.079 158.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mp -126.24 137.54 53.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.784 2.033 . . . . 1.68 109.869 171.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -90.1 148.3 23.09 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.092 1.357 . . . . 1.88 110.135 161.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -112.47 115.81 29.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.331 1.852 . . . . 0.86 109.59 172.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.1 mt -93.94 111.36 23.05 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.728 1.211 . . . . 0.68 110.221 -176.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -110.19 124.5 51.69 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.571 0.748 . . . . 1.86 111.362 -177.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.95 -17.69 63.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.624 0.972 . . . . 1.93 113.624 176.382 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.07 38.08 1.33 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.248 1.404 . . . . 5.47 113.653 175.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.97 28.08 72.25 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 125.754 1.645 . . . . 3.56 114.851 174.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -140.14 152.71 46.31 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.027 1.414 . . . . 3.87 113.359 -168.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.3 t -141.72 144.31 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.861 1.264 . . . . 2.11 107.697 163.093 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 22.6 mt -139.93 168.04 20.74 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.45 1.9 . . . . 3.05 108.274 170.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.5 pttp -147.42 151.87 37.18 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.199 1.185 . . . . 1.85 114.199 177.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.91 141.14 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 127.083 2.153 . . . . 2.22 110.923 -171.497 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.5 p -91.8 145.92 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.823 1.249 . . . . 2.46 109.408 166.267 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -157.34 142.76 12.46 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.049 1.34 . . . . 2.72 112.105 -174.1 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.6 166.01 27.96 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 124.083 3.189 . . . . 1.21 111.444 172.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.7 t -107.68 115.67 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.302 1.041 . . . . 1.06 109.17 169.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -127.1 153.63 45.75 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.905 1.282 . . . . 4.75 111.812 -170.434 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.6 58.8 4.47 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.794 1.035 . . . . 2.39 113.794 -159.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.26 -0.876 . . . . 7.92 112.285 174.202 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 . . . . . 0 CA--C 1.549 0.937 0 CA-C-O 121.303 0.573 . . . . 6.82 111.787 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.7 169.09 26.16 Favored Glycine 0 C--N 1.337 0.609 0 O-C-N 119.714 -1.866 . . . . 1.13 113.287 -174.428 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -155.85 174.92 14.62 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.051 1.13 . . . . 1.79 114.051 -176.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.6 t -119.1 139.46 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 127.332 2.253 . . . . 1.15 109.779 177.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -97.36 109.66 22.37 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.009 1.324 . . . . 4.38 110.684 171.564 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -52.58 150.05 5.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.461 1.104 . . . . 3.16 110.935 168.189 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 m -162.06 147.65 10.37 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 125.097 1.359 . . . . 3.02 109.865 166.323 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -81.4 44.39 1.73 Allowed 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 124.671 3.581 . . . . 3.28 112.011 179.73 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -122.52 160.96 16.9 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.677 1.608 . . . . 2.16 112.93 -176.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.81 -17.49 56.22 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.584 2.856 . . . . 2.02 112.791 172.131 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -110.53 146.44 36.03 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.103 1.761 . . . . 3.3 113.565 164.426 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.08 -178.81 3.65 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.188 1.795 . . . . 0.63 110.275 163.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.94 145.36 34.43 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.57 1.077 . . . . 0.94 111.135 177.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.5 148.87 44.79 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.964 1.098 . . . . 0.98 113.964 -175.644 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -127.89 77.39 1.75 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.732 2.413 . . . . 2.39 110.414 -173.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -74.16 158.65 33.79 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.817 -1.177 . . . . 1.99 112.077 178.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.6 m -118.24 146.93 43.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.252 -1.018 . . . . 2.01 108.252 157.345 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.429 ' CD1' ' H ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -154.35 -174.76 5.1 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.264 1.826 . . . . 5.83 108.427 171.433 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.429 ' H ' ' CD1' ' A' ' 22' ' ' LEU . 37.3 mt-10 -138.69 146.4 41.53 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 120.69 -1.256 . . . . 3.62 110.416 -174.304 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -95.31 102.26 9.3 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.666 0.786 . . . . 1.46 109.067 156.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.84 -12.92 14.63 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.725 2.283 . . . . 2.0 113.35 176.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.04 -175.72 50.93 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-O 122.424 1.013 . . . . 1.91 113.339 -172.819 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -111.09 -1.16 16.34 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.165 2.186 . . . . 4.1 112.038 -172.367 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -111.82 158.9 35.34 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 127.771 2.428 . . . . 2.06 110.198 171.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.11 146.65 18.13 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.518 2.145 . . . . 1.16 111.581 -174.26 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.426 HD12 ' CD1' ' A' ' 105' ' ' PHE . 2.4 mm? -113.75 161.94 16.9 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.868 1.667 . . . . 2.44 110.931 176.002 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -154.81 119.54 4.85 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.517 -1.22 . . . . 1.83 111.012 -167.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.0 tp -101.21 108.95 20.74 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.273 1.829 . . . . 2.14 110.404 -173.352 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.1 m -109.38 -20.56 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.351 1.06 . . . . 0.82 112.12 -167.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.09 -174.36 29.78 Favored Glycine 0 C--N 1.343 0.963 0 C-N-CA 125.059 1.314 . . . . 0.73 113.367 -174.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.0 -179.67 7.19 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.066 0.946 . . . . 0.83 112.025 169.08 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -153.14 145.25 23.8 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.201 1.8 . . . . 5.4 107.634 178.529 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -164.11 151.19 10.2 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 119.416 1.007 . . . . 0.81 109.477 -172.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.0 -4.2 13.74 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.137 2.558 . . . . 0.88 114.428 175.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.23 30.3 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 115.212 1.56 . . . . 0.87 115.212 -175.189 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -174.88 167.95 3.59 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 128.357 2.663 . . . . 1.19 108.313 174.277 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -119.94 -45.9 2.46 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.2 0.909 . . . . 6.17 111.248 169.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.7 mtt-85 -78.6 141.46 38.03 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.585 -1.265 . . . . 4.69 107.585 164.387 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -158.52 74.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 127.806 2.442 . . . . 2.47 110.027 -174.469 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -99.97 131.64 45.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 111.766 -2.47 . . . . 4.92 110.72 -169.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.5 pt? -90.1 136.51 33.0 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 123.753 1.739 . . . . 2.12 114.026 -176.806 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -115.1 160.85 19.16 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 127.143 2.177 . . . . 0.8 110.856 174.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.12 -177.86 4.28 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.236 -1.802 . . . . 3.39 111.202 156.776 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.8 m -152.82 141.18 20.62 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.174 1.389 . . . . 0.61 107.829 170.306 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -151.04 170.41 19.44 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.929 1.455 . . . . 2.24 114.929 -168.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.0 ttp -109.75 142.47 40.94 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.369 1.868 . . . . 3.3 109.479 169.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -151.92 159.23 43.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.682 1.993 . . . . 8.46 111.391 -175.608 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -91.28 147.47 23.02 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.193 1.397 . . . . 2.5 111.897 170.198 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.6 t -140.54 120.33 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.389 1.475 . . . . 1.89 107.956 166.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 64.44 8.64 4.41 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 127.371 2.268 . . . . 2.9 114.763 -178.019 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.92 23.23 33.37 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 123.958 0.79 . . . . 1.79 113.89 -168.049 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.1 132.62 53.11 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.772 1.229 . . . . 2.54 109.634 166.549 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 138.89 44.87 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.079 1.352 . . . . 6.4 110.636 -178.86 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.576 HG22 ' H ' ' A' ' 59' ' ' MET . 9.8 p -154.26 -179.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 C-N-CA 126.882 2.073 . . . . 2.26 109.328 -177.479 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.576 ' H ' HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -116.75 166.4 12.18 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 121.299 -0.875 . . . . 3.23 112.28 -176.686 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.66 171.22 29.77 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.972 1.749 . . . . 0.53 111.994 -179.291 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 ttm -155.4 138.44 15.49 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 126.646 1.979 . . . . 0.63 109.227 173.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -144.65 149.94 45.29 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 127.645 2.378 . . . . 8.56 109.424 -172.025 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.1 154.87 52.52 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.574 2.183 . . . . 0.6 110.019 176.377 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.14 151.6 75.5 Favored Pre-proline 0 N--CA 1.483 1.213 0 CA-C-O 117.974 -1.012 . . . . 0.65 110.71 175.053 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.38 -23.77 9.8 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.192 2.595 . . . . 0.77 112.873 -169.575 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -179.55 165.58 1.36 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.472 2.309 . . . . 2.21 109.85 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.0 mt -109.15 150.52 27.75 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.004 0.922 . . . . 0.7 110.044 165.137 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -109.71 143.82 38.95 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.297 1.039 . . . . 2.08 109.149 178.059 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.6 t -140.3 125.25 11.16 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 122.971 0.509 . . . . 0.99 112.093 173.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.81 168.35 20.5 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.95 2.433 . . . . 1.28 111.697 179.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -55.25 140.12 81.32 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.027 2.485 . . . . 1.69 111.43 168.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt 67.68 0.91 2.41 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.721 1.609 . . . . 2.42 113.616 -177.183 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.62 156.96 45.22 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.902 1.715 . . . . 1.8 112.45 -179.048 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.9 mtm105 -104.99 132.51 51.14 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.025 1.33 . . . . 6.94 109.581 -178.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.9 t -93.42 55.33 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 127.589 2.356 . . . . 5.33 108.248 -173.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.71 93.02 8.69 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.641 1.976 . . . . 3.92 109.742 -175.223 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' A' ' 83' ' ' HIS . 1.5 tp -52.21 -56.23 16.02 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.326 1.45 . . . . 3.39 111.608 -164.66 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? 112.09 128.37 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 128.977 2.911 . . . . 3.02 114.429 161.516 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.62 -45.91 12.88 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.891 2.394 . . . . 1.97 110.847 174.065 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.72 40.69 3.07 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.938 -0.924 . . . . 1.81 112.37 172.315 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.4 -117.5 0.56 Allowed Glycine 0 C--N 1.337 0.638 0 CA-C-N 118.139 0.97 . . . . 1.77 113.783 175.029 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -76.5 137.1 39.41 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 123.399 1.571 . . . . 1.83 113.646 -163.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.598 ' HA ' HD23 ' A' ' 77' ' ' LEU . 53.0 p-80 -158.17 138.54 12.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.301 -1.318 . . . . 0.83 113.424 -173.66 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -77.03 135.24 38.64 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.018 -1.104 . . . . 2.54 108.018 167.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.8 mtp -99.64 117.69 34.54 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.651 0.739 . . . . 1.71 110.619 160.103 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -86.71 107.74 18.36 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.608 1.963 . . . . 1.23 107.426 -176.716 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.0 mp -111.35 141.5 44.81 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.09 1.756 . . . . 1.81 111.005 -173.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.44 42.44 41.32 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 111.459 -0.656 . . . . 0.95 111.459 178.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . 0.258 0.5 OUTLIER -44.01 138.84 2.68 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 123.479 1.609 . . . . 1.87 115.324 176.828 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -101.12 -12.71 18.58 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.051 -1.886 . . . . 4.59 112.893 -173.137 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -143.8 150.59 50.59 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 128.305 2.642 . . . . 5.71 108.2 172.681 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -72.37 150.58 52.66 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.597 2.198 . . . . 1.8 110.082 167.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.9 mp -108.8 143.79 37.5 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.087 2.155 . . . . 2.62 106.395 176.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.52 162.5 15.05 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.466 2.306 . . . . 4.03 110.424 170.796 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.54 125.8 26.87 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.43 -0.794 . . . . 1.94 109.171 157.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.86 32.0 6.72 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.866 1.222 . . . . 1.71 115.025 173.241 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -112.16 -167.49 1.19 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.488 1.115 . . . . 2.12 112.801 175.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 8.7 pt-20 -147.11 147.94 31.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 128.116 2.567 . . . . 3.13 107.233 172.685 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.9 t -146.31 126.69 6.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 127.823 2.449 . . . . 1.16 108.667 -165.354 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.45 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -90.11 154.45 19.78 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 122.732 1.253 . . . . 2.48 113.75 176.224 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.7 tt -156.82 144.87 19.42 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.125 1.77 . . . . 2.39 109.945 176.042 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.08 140.86 39.24 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.696 1.598 . . . . 3.35 110.55 170.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.1 mp -84.91 127.7 34.29 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.388 1.475 . . . . 1.18 109.64 174.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.6 mt -90.75 104.86 17.39 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.696 -0.853 . . . . 0.84 108.696 168.691 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.426 ' CD1' HD12 ' A' ' 30' ' ' LEU . 96.2 m-85 -97.69 149.27 22.46 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.187 0.995 . . . . 2.35 111.101 172.59 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.57 129.05 34.9 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.518 0.933 . . . . 2.17 113.518 -174.627 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.32 62.03 2.84 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.663 1.125 . . . . 3.15 113.542 174.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.19 13.18 81.44 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 115.709 1.044 . . . . 2.42 115.709 167.751 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -97.07 122.19 39.79 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.794 1.297 . . . . 3.08 110.56 -179.267 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.8 t -137.0 128.83 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.152 0.981 . . . . 2.14 109.977 -176.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -140.43 127.62 21.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.564 1.146 . . . . 2.98 111.811 -176.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.45 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 24.4 ttmm -83.25 140.59 32.42 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.179 1.392 . . . . 2.74 113.766 -178.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.36 153.9 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.446 1.898 . . . . 2.42 109.971 163.307 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.31 127.57 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 107.337 -1.357 . . . . 1.87 107.337 163.014 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.4 mt -125.44 129.46 24.42 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.256 1.422 . . . . 1.9 108.668 -170.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 60.6 Cg_endo -70.65 153.06 65.07 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.159 2.573 . . . . 1.04 112.147 172.675 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.4 t -103.91 112.3 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.445 1.498 . . . . 1.05 109.904 173.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -100.38 178.66 4.68 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.802 1.241 . . . . 4.91 109.896 160.43 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.33 158.66 43.91 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.935 0.894 . . . . 2.85 112.158 -171.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.352 0 C-N-CA 126.817 2.047 . . . . 9.2 110.639 176.153 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.588 0 CA-C-O 121.789 0.804 . . . . 5.06 111.362 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.18 -175.25 32.0 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 128.456 2.932 . . . . 0.92 110.98 174.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -116.43 157.03 25.78 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.665 0.987 . . . . 2.24 113.665 175.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.2 t -89.46 141.97 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 O-C-N 120.877 -1.139 . . . . 1.23 108.163 157.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.0 ttt85 -77.15 131.43 38.29 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.988 -0.445 . . . . 4.51 111.894 -173.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -45.02 135.06 5.57 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.412 1.485 . . . . 2.03 112.067 166.186 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.0 t -176.68 129.68 0.35 Allowed Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.188 1.395 . . . . 2.59 112.448 172.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -91.19 0.76 4.77 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.133 3.222 . . . . 2.34 112.413 165.324 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.19 -175.33 46.44 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.644 1.116 . . . . 1.13 113.374 -173.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -69.02 -22.13 35.9 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.161 2.574 . . . . 1.59 113.057 -178.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.6 p30 -128.38 166.06 19.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.302 1.841 . . . . 2.39 114.076 -178.657 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.44 -177.2 6.3 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 128.258 2.623 . . . . 0.57 111.045 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.75 171.09 10.38 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.294 1.837 . . . . 1.14 108.925 169.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.5 160.7 43.59 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.759 1.223 . . . . 0.7 111.557 174.472 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -155.34 144.95 21.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.841 -1.072 . . . . 8.43 111.558 -161.019 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -161.89 156.51 22.62 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.393 1.477 . . . . 2.23 111.375 -172.083 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.1 m -83.95 146.07 28.22 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.081 0.953 . . . . 1.98 108.857 162.254 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.49 114.27 23.22 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.639 0.775 . . . . 3.25 109.449 170.064 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -104.88 145.62 30.14 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.988 1.315 . . . . 3.68 109.093 168.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.21 73.49 1.33 Allowed Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.088 0.955 . . . . 3.06 110.986 177.735 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.3 -19.3 62.02 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.902 2.401 . . . . 1.42 114.659 -174.23 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.42 -179.95 51.43 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-O 122.885 1.269 . . . . 1.23 113.066 174.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -103.27 -2.48 27.1 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.87 2.068 . . . . 2.89 112.151 -169.005 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -122.48 155.79 61.93 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 128.099 2.56 . . . . 1.98 109.782 175.547 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.63 140.65 21.34 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.777 2.318 . . . . 1.22 111.086 -172.186 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.8 mt -93.31 150.01 20.8 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 123.21 1.481 . . . . 2.08 112.029 172.275 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -134.89 113.87 11.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 112.303 -2.226 . . . . 1.98 110.165 177.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.8 tp -95.86 111.57 23.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.669 1.588 . . . . 2.16 108.93 -177.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.2 m -107.22 -19.81 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.548 1.139 . . . . 0.91 112.273 -169.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.42 -174.61 28.36 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.384 1.468 . . . . 0.85 113.22 177.487 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.57 -176.73 4.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.764 1.626 . . . . 0.87 109.348 167.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.12 175.23 13.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.767 1.627 . . . . 5.02 108.42 161.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.9 t -171.57 156.14 4.2 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 125.657 1.583 . . . . 0.76 108.417 -173.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.91 -10.55 14.06 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.805 1.67 . . . . 0.91 112.895 171.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.6 46.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.232 1.013 . . . . 0.91 113.461 -176.384 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.58 153.28 14.96 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.216 1.406 . . . . 1.0 110.68 164.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -88.39 -47.22 8.53 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.649 1.18 . . . . 2.86 110.229 172.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -104.89 133.7 49.25 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 126.33 1.852 . . . . 6.66 107.53 166.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.11 148.0 22.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.812 -1.181 . . . . 1.28 107.812 150.357 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -156.81 149.3 23.37 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 126.26 1.824 . . . . 3.04 107.73 -172.189 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.7 pt? -100.48 139.92 35.48 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 122.894 1.33 . . . . 1.75 112.614 173.097 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -119.93 149.75 41.61 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.724 2.009 . . . . 0.88 111.5 178.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -86.62 162.38 18.0 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.335 1.454 . . . . 2.67 110.925 162.849 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.9 m -129.26 130.45 46.24 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 106.409 -1.701 . . . . 1.0 106.409 167.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -135.44 168.46 19.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.698 1.135 . . . . 2.13 113.949 -174.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.7 ttm -100.25 146.13 27.26 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.601 1.56 . . . . 3.84 109.972 165.218 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.75 153.66 32.61 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.627 1.171 . . . . 4.87 110.475 -171.777 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -95.26 137.81 33.81 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.124 0.97 . . . . 3.61 109.871 169.431 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.0 t -130.8 119.32 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 106.703 -1.591 . . . . 2.62 106.703 164.548 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 60.88 18.0 8.33 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 116.154 1.909 . . . . 5.46 116.154 178.004 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.38 2.69 67.78 Favored Glycine 0 N--CA 1.479 1.552 0 O-C-N 120.826 -1.171 . . . . 2.21 114.354 -171.474 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.23 125.56 52.38 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.464 1.906 . . . . 3.75 109.852 176.529 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -74.95 119.17 18.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.667 -1.606 . . . . 5.38 109.45 -179.651 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.0 m -122.53 177.72 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 127.594 2.358 . . . . 2.19 109.674 177.68 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 56.5 mtt -118.0 158.45 24.92 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.232 1.013 . . . . 2.77 111.243 167.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.82 -177.38 25.5 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 126.16 1.838 . . . . 0.69 112.243 -176.447 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.9 ttm -157.57 142.94 17.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.856 1.662 . . . . 0.85 109.426 -171.656 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.15 159.18 43.25 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 127.327 2.251 . . . . 8.2 109.545 -174.361 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -84.65 144.9 10.2 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.129 2.553 . . . . 0.85 111.343 173.285 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.7 m -133.51 162.38 58.02 Favored Pre-proline 0 N--CA 1.486 1.368 0 CA-C-O 118.317 -0.849 . . . . 0.95 111.749 -175.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -89.89 -25.06 0.53 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.282 1.988 . . . . 0.9 114.215 -163.087 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -178.76 166.34 1.68 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.865 1.266 . . . . 2.13 112.96 -177.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.9 mt -114.81 153.14 30.95 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.892 1.677 . . . . 0.87 110.837 165.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -120.2 142.96 48.52 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.489 1.516 . . . . 1.89 109.448 177.828 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.7 t -138.57 139.22 23.9 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.469 0.708 . . . . 1.05 112.139 172.022 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -84.86 156.15 11.64 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 124.392 3.395 . . . . 1.44 112.869 177.643 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.58 143.77 82.49 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.979 3.12 . . . . 1.27 113.94 -173.234 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt 68.7 -11.28 0.43 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.234 2.614 . . . . 1.75 114.763 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.98 168.49 50.94 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.787 1.184 . . . . 1.83 112.752 172.554 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.87 151.24 49.31 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.969 0.908 . . . . 5.04 110.646 162.488 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.2 t -136.19 174.6 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 129.338 3.055 . . . . 3.8 106.038 175.312 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -154.14 161.12 42.09 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 119.738 -1.851 . . . . 4.01 108.593 171.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 83' ' ' HIS . 2.3 mp -56.0 -43.75 77.99 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.091 1.145 . . . . 3.71 114.091 -164.798 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt 71.43 110.88 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 128.632 2.773 . . . . 5.35 111.236 -178.707 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -62.87 -34.79 70.76 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.886 1.724 . . . . 2.8 111.683 -176.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.48 43.07 2.85 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.235 1.397 . . . . 2.18 113.253 164.602 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.66 -36.04 0.06 OUTLIER Glycine 0 C--O 1.219 -0.799 0 N-CA-C 120.698 3.039 . . . . 2.57 120.698 162.352 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -144.64 146.22 32.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 119.549 1.674 . . . . 2.13 113.236 168.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.649 ' HA ' HD23 ' A' ' 77' ' ' LEU . 56.6 p-80 -161.76 153.2 18.61 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.413 -0.804 . . . . 0.75 111.096 175.278 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -78.72 141.44 37.87 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.693 -0.484 . . . . 1.9 109.693 167.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -105.73 134.75 48.35 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.027 1.731 . . . . 0.81 109.242 165.465 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -111.1 122.91 49.09 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.518 1.527 . . . . 0.76 108.468 176.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.0 mp -120.98 138.3 54.21 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.612 0.765 . . . . 1.79 109.335 176.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.12 45.42 11.62 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.319 -0.712 . . . . 0.95 112.543 178.422 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 pp -53.67 154.75 3.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 123.271 1.51 . . . . 1.35 114.82 176.513 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -109.69 -10.47 14.81 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 113.224 -1.807 . . . . 2.19 113.541 -175.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 mtp-105 -145.16 143.64 21.06 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 126.775 2.03 . . . . 4.8 108.19 169.545 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -68.69 151.3 74.81 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.405 2.07 . . . . 1.83 109.698 171.02 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 64.8 mt -116.73 92.35 3.84 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.019 0.928 . . . . 2.2 110.131 -166.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.6 pttm -83.63 164.03 19.96 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.54 -0.725 . . . . 5.32 112.126 170.675 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.27 126.21 26.76 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.314 -0.866 . . . . 1.36 108.676 168.775 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.23 33.12 50.14 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.428 1.013 . . . . 1.42 113.81 179.187 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -81.74 179.86 7.66 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.482 1.141 . . . . 2.71 108.483 143.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -134.54 150.61 50.77 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.085 -1.82 . . . . 3.88 106.085 164.23 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 49.8 t -138.25 133.51 43.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 126.443 1.897 . . . . 0.96 110.239 -173.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -78.84 137.05 37.51 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.177 -0.465 . . . . 2.73 110.815 172.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.75 133.9 54.93 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.92 1.288 . . . . 1.67 110.684 168.251 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -84.87 141.67 30.27 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 125.483 1.513 . . . . 2.72 108.799 158.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -110.28 126.33 54.07 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.454 1.502 . . . . 1.12 109.026 168.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.2 mt -104.36 117.86 35.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.897 1.279 . . . . 0.88 110.061 -178.68 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -116.73 149.11 40.41 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.781 1.232 . . . . 2.01 111.839 -174.468 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.7 139.35 58.32 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.249 1.203 . . . . 2.04 114.249 -172.294 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.39 45.5 29.8 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.195 -0.781 . . . . 3.2 113.255 175.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.46 35.74 11.59 Favored Glycine 0 N--CA 1.47 0.917 0 N-CA-C 116.074 1.19 . . . . 1.72 116.074 163.587 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -122.81 145.98 47.94 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.832 1.816 . . . . 3.3 112.579 172.32 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.7 t -143.6 142.47 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.009 1.323 . . . . 2.04 108.955 177.281 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 42.1 tp -143.43 119.74 10.89 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.795 0.838 . . . . 2.88 110.874 -178.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 125.76 38.27 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.767 0.827 . . . . 2.92 111.62 178.334 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.468 HG12 ' H ' ' A' ' 114' ' ' VAL . 0.3 OUTLIER -138.77 -174.46 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.851 1.66 . . . . 3.13 109.954 176.438 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.468 ' H ' HG12 ' A' ' 113' ' ' VAL . 11.3 t -137.2 150.04 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.431 1.492 . . . . 2.09 109.565 -168.626 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.6 mt -142.8 143.74 26.87 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 127.366 2.266 . . . . 1.95 109.048 -176.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.32 162.12 43.53 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.027 2.484 . . . . 0.8 111.443 168.291 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 85.1 t -94.03 122.32 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 121.744 -0.598 . . . . 0.89 110.227 165.795 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.11 164.76 18.78 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.356 1.862 . . . . 4.49 110.731 178.166 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.46 67.8 1.08 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.526 1.306 . . . . 2.28 114.526 -154.241 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 . . . . . 0 C--O 1.251 1.132 1 C-N-CA 133.154 4.582 . . . . 8.51 113.049 170.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 . . . . . 0 CA--C 1.549 0.942 0 N-CA-C 109.391 -0.596 . . . . 4.78 109.391 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.69 177.75 40.6 Favored Glycine 0 N--CA 1.469 0.892 0 O-C-N 121.189 -0.944 . . . . 0.95 114.42 -165.291 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -155.62 138.49 15.33 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.108 1.363 . . . . 2.04 112.097 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.1 t -77.56 142.81 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 120.447 -1.408 . . . . 0.98 107.343 167.361 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 -85.0 127.13 34.06 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.661 -0.649 . . . . 6.65 110.373 -178.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -44.77 141.47 2.09 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.09 1.356 . . . . 2.03 112.109 172.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.5 t -148.11 148.99 31.27 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 122.877 0.471 . . . . 2.79 111.502 165.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.0 -23.83 8.87 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.299 2.0 . . . . 2.34 112.899 172.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -125.38 -156.64 9.4 Favored Glycine 0 CA--C 1.544 1.878 0 C-N-CA 125.332 1.444 . . . . 1.48 115.76 -160.495 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.24 -14.47 10.67 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.873 3.715 . . . . 1.52 115.171 -167.757 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -122.49 151.35 41.41 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.05 2.14 . . . . 2.41 112.746 -178.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.16 -176.77 6.16 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.435 1.894 . . . . 0.9 112.986 -163.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.79 158.52 44.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.568 1.947 . . . . 0.84 109.343 174.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.56 134.85 31.16 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.706 1.139 . . . . 0.6 112.965 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -107.61 135.79 48.46 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.55 1.54 . . . . 3.04 108.37 172.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 pp -150.72 156.44 41.31 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.437 -1.414 . . . . 1.79 113.347 -166.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.4 m -119.03 146.73 44.81 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.397 1.879 . . . . 2.0 109.864 179.379 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 tt -149.6 162.67 39.74 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 128.355 2.662 . . . . 4.64 106.989 155.262 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -134.49 133.52 40.47 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.598 -1.314 . . . . 4.14 111.053 163.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -76.96 111.76 18.44 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 127.298 2.239 . . . . 1.77 110.251 -174.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.51 -20.22 41.72 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.166 1.911 . . . . 1.6 113.338 177.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.06 129.88 3.24 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 124.753 1.168 . . . . 2.97 115.897 154.199 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -175.38 -46.41 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 130.831 3.652 . . . . 6.96 105.623 -169.303 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 28' ' ' LEU . 2.5 pt? -126.86 163.01 44.02 Favored Pre-proline 0 C--O 1.24 0.597 0 C-N-CA 127.075 2.15 . . . . 3.88 112.052 177.596 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -81.03 144.44 14.94 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.127 2.551 . . . . 1.37 109.43 166.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.4 mt -98.58 147.54 24.69 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 122.442 1.115 . . . . 1.88 110.815 174.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -132.57 104.77 6.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 111.775 -2.466 . . . . 2.38 110.638 172.061 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.8 tp -88.19 100.51 13.03 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.228 1.411 . . . . 1.87 108.914 -173.121 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -101.95 -18.59 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 125.272 1.429 . . . . 0.54 112.42 -169.639 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.82 -179.59 31.89 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 124.201 0.905 . . . . 0.48 112.956 177.379 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.91 -178.21 5.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.099 1.36 . . . . 0.52 109.701 166.685 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.62 -178.42 7.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.022 2.129 . . . . 5.24 108.09 165.645 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 t -178.77 154.82 0.85 Allowed Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 127.52 2.328 . . . . 0.77 108.796 -176.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.63 -8.64 23.81 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.046 1.83 . . . . 0.89 113.802 169.409 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.54 44.6 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 114.108 1.151 . . . . 1.01 114.108 -173.055 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.99 147.29 13.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.365 1.066 . . . . 1.13 111.107 166.129 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.71 -38.48 13.83 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.038 1.735 . . . . 2.79 111.991 173.788 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.409 HH21 ' CD ' ' A' ' 44' ' ' GLU . 26.7 mtp85 -124.7 149.29 47.38 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 127.668 2.387 . . . . 5.6 109.175 177.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -157.23 120.52 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 125.642 1.577 . . . . 1.27 110.586 -174.02 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.409 ' CD ' HH21 ' A' ' 42' ' ' ARG . 2.5 mp0 -139.11 132.19 29.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.884 -1.053 . . . . 4.47 110.962 -164.474 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.7 tp -81.62 125.56 30.7 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.922 0.489 . . . . 1.5 111.755 -173.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -121.02 155.65 33.88 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.747 1.619 . . . . 0.56 113.464 175.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.99 -176.77 3.34 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.537 1.935 . . . . 3.44 110.528 166.415 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.4 m -150.35 143.74 25.05 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.922 1.289 . . . . 0.8 108.007 171.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -148.34 168.85 21.51 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.346 1.609 . . . . 2.57 115.346 -170.686 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.6 mtp -110.92 145.17 38.8 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.283 1.433 . . . . 4.43 111.206 162.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -137.14 149.4 47.27 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.697 1.999 . . . . 5.34 109.985 171.585 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -89.79 140.49 29.54 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.501 -0.926 . . . . 2.72 108.501 153.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.4 t -140.97 121.71 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 106.112 -1.81 . . . . 2.26 106.112 171.597 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 66.89 22.54 10.15 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.93 0.892 . . . . 3.71 112.798 176.596 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.83 19.43 77.68 Favored Glycine 0 N--CA 1.477 1.394 0 O-C-N 120.627 -1.296 . . . . 1.7 113.337 -173.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -132.6 127.91 36.01 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.426 1.891 . . . . 2.53 108.89 -178.408 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -79.33 125.45 29.52 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.845 0.858 . . . . 5.72 112.524 -175.271 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.3 t -121.54 134.05 66.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 128.65 2.78 . . . . 2.33 108.583 -176.016 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 37.3 mtt -98.11 149.02 22.95 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.82 0.848 . . . . 2.42 110.266 169.179 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.32 -179.13 30.22 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-O 121.917 0.732 . . . . 0.85 113.668 -175.039 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ttm -159.88 147.57 16.81 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 125.926 1.69 . . . . 0.71 109.886 -171.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.59 152.84 23.49 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 113.602 -1.636 . . . . 5.35 109.52 -163.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -83.33 157.87 14.81 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.289 1.993 . . . . 0.8 111.555 176.607 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.97 157.09 54.87 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 125.779 1.632 . . . . 1.01 110.429 -178.49 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.76 -31.77 0.53 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.19 2.593 . . . . 0.63 113.389 -166.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -173.39 167.12 4.74 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.087 1.755 . . . . 2.24 110.886 -178.601 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.8 mt -110.22 155.2 22.33 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.463 1.105 . . . . 0.69 110.936 162.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -117.62 137.99 52.25 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.318 1.447 . . . . 2.15 108.851 175.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.3 t -149.44 132.16 8.06 Favored Pre-proline 0 N--CA 1.476 0.845 0 N-CA-C 113.499 0.926 . . . . 1.06 113.499 173.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.4 169.55 21.42 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 124.1 3.2 . . . . 1.21 114.234 -177.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.04 146.38 96.18 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.93 3.087 . . . . 1.3 111.806 168.201 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.6 mmtt 70.37 -7.73 0.97 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.217 1.807 . . . . 1.58 114.089 -176.223 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.42 148.69 20.75 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.386 1.469 . . . . 1.22 113.511 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.95 129.21 34.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.121 1.369 . . . . 4.27 111.805 177.113 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.7 t -108.05 80.98 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 128.19 2.596 . . . . 5.94 108.469 -165.123 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -138.58 123.04 18.4 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.727 0.775 . . . . 4.12 112.994 -158.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -80.55 84.19 6.19 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-O 122.857 1.313 . . . . 2.03 108.45 175.58 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.29 145.85 97.64 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 113.249 -1.796 . . . . 4.01 114.83 -171.749 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -55.81 143.32 81.53 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 123.567 2.845 . . . . 4.09 110.693 176.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.54 -5.49 44.85 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 116.772 -2.127 . . . . 1.6 115.811 176.585 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.81 -22.64 0.33 Allowed Glycine 0 N--CA 1.475 1.292 0 N-CA-C 119.713 2.645 . . . . 2.18 119.713 178.085 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -152.47 141.83 21.57 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.683 1.742 . . . . 2.16 113.078 179.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -162.83 155.46 19.04 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.197 1.399 . . . . 0.62 110.977 174.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -84.55 134.5 34.41 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.968 -1.123 . . . . 2.26 107.968 163.141 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -82.71 134.06 35.15 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.736 1.214 . . . . 0.64 108.06 164.016 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 mp -117.27 135.49 53.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.519 1.128 . . . . 0.86 109.345 -179.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 mp -132.61 148.89 52.37 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.966 0.906 . . . . 1.64 110.975 178.731 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.17 39.58 31.6 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 123.543 0.592 . . . . 1.02 113.836 173.424 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.38 156.41 7.83 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 116.365 1.987 . . . . 1.49 116.365 179.382 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -112.35 -16.14 13.0 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 113.018 -1.901 . . . . 1.95 113.409 -170.102 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -128.47 173.67 5.32 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 129.878 3.271 . . . . 6.8 110.95 177.321 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -63.78 -176.75 0.37 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.438 2.092 . . . . 3.15 110.917 155.599 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.434 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -167.24 66.32 0.09 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.344 2.658 . . . . 3.14 108.287 179.223 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.434 ' HD3' ' H ' ' A' ' 93' ' ' LEU . 2.4 mptt -99.65 164.84 11.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.773 1.229 . . . . 7.36 111.06 179.277 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.27 122.01 13.42 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.502 1.121 . . . . 1.29 110.727 -174.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.07 4.15 63.25 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.231 1.396 . . . . 1.54 114.574 179.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -79.96 -175.05 4.75 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.644 1.222 . . . . 2.44 110.501 164.944 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -156.28 139.9 15.97 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.948 1.699 . . . . 3.09 108.644 -174.532 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.0 t -146.79 134.98 15.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 126.526 1.93 . . . . 0.93 110.874 -163.821 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -78.32 136.13 37.65 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.62 1.168 . . . . 2.8 111.176 173.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 mp -121.13 136.76 54.92 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.196 0.998 . . . . 1.73 111.688 160.313 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -86.3 145.41 26.93 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.201 2.201 . . . . 2.49 110.216 164.423 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -116.52 126.52 53.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.491 1.917 . . . . 0.82 109.439 172.295 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.1 mt -103.26 111.75 24.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.308 1.443 . . . . 0.57 110.225 -177.176 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -110.44 105.26 14.17 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.901 1.28 . . . . 1.98 112.471 -171.188 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 56.36 18.0 3.18 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.283 1.833 . . . . 2.93 114.372 175.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.97 -57.88 3.12 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.368 1.461 . . . . 3.85 112.085 -166.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.97 19.51 2.11 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.66 1.6 . . . . 3.0 116.799 -172.021 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.17 147.97 19.89 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.957 2.903 . . . . 3.06 112.047 167.145 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.3 t -143.15 150.09 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.332 1.453 . . . . 2.24 108.307 176.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.56 171.16 18.55 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.131 1.772 . . . . 3.18 108.793 173.449 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -154.89 154.98 33.51 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.694 0.998 . . . . 2.16 113.694 179.648 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.4 t -149.11 154.72 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.702 1.201 . . . . 2.17 109.578 -172.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.81 133.54 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.101 0.96 . . . . 1.85 109.319 177.365 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -120.77 147.6 46.34 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 126.507 1.923 . . . . 3.09 108.346 175.194 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.23 168.03 15.1 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.51 2.807 . . . . 0.76 111.704 163.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.7 t -108.27 122.98 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.483 1.113 . . . . 0.94 110.827 170.188 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -119.5 152.46 36.91 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.878 1.271 . . . . 4.65 113.763 -174.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.96 152.4 33.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.597 1.559 . . . . 2.35 114.08 -175.026 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.977 0 C-N-CA 129.211 3.004 . . . . 8.07 116.33 -165.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 . . . . . 0 CA--C 1.543 0.711 0 CA-C-O 121.05 0.452 . . . . 5.98 110.063 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.73 172.81 52.22 Favored Glycine 0 C--O 1.221 -0.66 0 O-C-N 121.423 -0.798 . . . . 1.48 112.721 167.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -149.61 144.57 26.26 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.828 -0.807 . . . . 2.03 110.445 161.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -93.82 128.8 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.586 -0.894 . . . . 1.38 108.586 177.596 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -74.15 106.7 5.93 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.123 0.569 . . . . 4.34 111.609 -170.613 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -43.44 132.74 4.53 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.03 1.332 . . . . 2.4 111.421 171.821 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.7 m -151.33 138.27 11.88 Favored Pre-proline 0 CA--C 1.539 0.555 0 O-C-N 120.976 -1.078 . . . . 2.73 111.503 175.315 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -86.29 48.18 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.405 3.403 . . . . 2.21 111.076 178.657 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.49 -179.0 30.28 Favored Glycine 0 CA--C 1.539 1.536 0 N-CA-C 115.774 1.07 . . . . 1.25 115.774 -168.168 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.48 -15.88 21.9 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.624 3.55 . . . . 1.17 114.112 -176.042 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -134.62 170.67 15.44 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.801 2.04 . . . . 2.2 113.195 -175.596 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.65 -179.3 8.03 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.732 2.013 . . . . 0.59 112.413 -177.544 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.95 162.96 20.12 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.49 1.516 . . . . 0.64 110.064 165.677 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.65 146.67 33.41 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.126 1.33 . . . . 0.56 113.525 174.667 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -115.71 160.95 19.41 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.228 1.811 . . . . 2.96 111.178 173.762 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.4 tp -146.58 138.7 24.85 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.477 1.911 . . . . 2.99 109.765 -170.429 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.9 m -131.47 133.6 45.32 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.377 1.471 . . . . 2.37 107.196 160.387 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.5 tp -159.67 -178.17 6.9 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 128.149 2.58 . . . . 5.42 108.89 -176.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -135.16 151.81 51.02 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.277 1.831 . . . . 3.37 112.457 171.195 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -91.84 106.89 18.94 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.558 1.543 . . . . 1.73 108.33 168.493 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.72 -13.07 14.76 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.998 1.799 . . . . 1.38 113.543 177.51 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.41 173.35 55.23 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-O 123.059 1.366 . . . . 1.16 112.754 -175.421 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -100.71 -2.41 32.59 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 128.189 2.595 . . . . 2.89 111.478 -179.248 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -113.64 156.09 44.03 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 127.843 2.457 . . . . 2.06 110.346 171.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.81 151.84 24.88 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.826 2.35 . . . . 0.88 111.312 -175.093 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt -99.29 154.04 18.48 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 122.591 1.186 . . . . 1.76 111.405 168.134 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.1 ttp180 -140.96 111.03 6.6 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 113.532 -1.667 . . . . 2.37 110.041 177.37 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.58 111.26 23.61 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.981 1.712 . . . . 1.78 109.576 -171.073 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 m -113.38 -18.29 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.444 1.098 . . . . 0.89 112.645 -168.219 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.6 -174.49 29.42 Favored Glycine 0 N--CA 1.469 0.843 0 C-N-CA 125.364 1.459 . . . . 0.68 112.837 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.46 -178.0 5.93 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.413 1.085 . . . . 0.67 111.535 169.452 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -157.15 177.95 10.9 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 128.19 2.596 . . . . 5.37 108.246 164.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -177.68 155.42 1.08 Allowed Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 126.738 2.015 . . . . 1.14 108.674 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.53 -9.19 24.54 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.752 2.301 . . . . 1.24 114.032 167.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.44 48.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 125.063 1.345 . . . . 1.21 114.155 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.47 163.29 30.48 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.337 1.055 . . . . 1.07 112.53 164.013 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -96.2 -33.24 12.1 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.085 2.154 . . . . 2.84 111.483 170.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.0 mtp85 -155.48 156.74 35.78 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 128.446 2.698 . . . . 6.76 108.999 -176.564 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.1 p -158.45 107.8 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 125.553 1.541 . . . . 1.77 111.157 -172.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -123.78 137.63 54.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.996 -1.456 . . . . 4.93 111.068 -167.358 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.6 tp -88.09 126.07 34.91 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.331 1.452 . . . . 1.5 111.958 -169.322 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 37.6 m170 -119.42 158.34 26.4 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.228 1.811 . . . . 0.66 113.171 176.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -102.31 158.74 15.98 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 113.819 -1.537 . . . . 2.32 110.61 157.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.0 m -113.42 135.38 53.94 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 106.032 -1.84 . . . . 0.98 106.032 159.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -128.87 166.67 18.64 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.493 1.14 . . . . 2.13 113.582 -175.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 61.0 mtt -100.57 146.27 27.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.126 1.37 . . . . 4.44 110.655 167.876 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.55 150.32 26.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.789 0.836 . . . . 5.02 111.665 -176.413 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -103.88 127.68 51.39 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.119 1.368 . . . . 3.21 107.787 166.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.3 t -146.56 138.24 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 106.064 -1.828 . . . . 2.67 106.064 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 66.58 22.19 10.58 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 119.002 0.819 . . . . 3.27 112.07 177.23 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.31 18.57 79.95 Favored Glycine 0 N--CA 1.475 1.258 0 O-C-N 121.101 -1.0 . . . . 1.72 113.523 -173.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -141.23 132.63 26.77 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.822 1.649 . . . . 3.05 110.833 -168.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -70.68 129.4 39.04 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.586 1.554 . . . . 4.52 111.435 173.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.6 m -138.32 169.47 18.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 129.188 2.995 . . . . 2.64 109.515 -177.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 49.6 mtm -116.39 146.01 42.81 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.431 1.092 . . . . 2.5 110.712 168.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.73 -177.13 14.73 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 126.016 1.77 . . . . 0.83 111.916 -178.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.1 ttm -150.55 148.9 29.24 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.512 1.525 . . . . 0.99 108.746 -177.645 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -155.86 155.45 29.39 Favored Pre-proline 0 N--CA 1.476 0.85 0 CA-C-O 118.309 -0.853 . . . . 5.95 111.327 172.689 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -70.35 153.42 66.23 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.93 1.753 . . . . 0.81 110.805 172.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.4 m -140.47 151.2 63.27 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 125.145 1.378 . . . . 0.85 109.767 -179.542 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.81 -26.28 3.79 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.897 2.398 . . . . 0.75 113.178 -164.02 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -174.82 165.65 3.63 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.584 1.554 . . . . 2.04 112.209 -179.272 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.7 mt -108.33 154.6 21.59 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.008 1.323 . . . . 0.56 110.346 161.677 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -110.36 147.89 33.05 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.166 1.386 . . . . 1.86 109.186 172.76 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.7 t -144.24 133.65 11.49 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 123.259 0.624 . . . . 1.02 112.122 169.602 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.19 168.18 21.55 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.049 2.5 . . . . 1.18 112.881 176.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.0 144.83 96.72 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.888 3.059 . . . . 1.06 111.845 167.245 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt 66.74 -7.19 0.47 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.877 1.671 . . . . 1.86 114.207 179.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.92 165.78 51.32 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.526 1.536 . . . . 1.16 112.299 -179.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -82.75 135.74 34.9 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 121.886 0.85 . . . . 4.98 110.146 172.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.3 t -98.94 81.74 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 127.786 2.435 . . . . 6.51 105.822 -176.119 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -138.37 129.26 26.81 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.07 1.414 . . . . 3.9 112.674 -161.754 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 83' ' ' HIS . 8.5 mp -71.19 167.55 19.12 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 113.459 -1.7 . . . . 3.47 109.276 167.462 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.59 133.37 21.9 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 120.205 -1.559 . . . . 3.88 108.018 179.315 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.53 -17.88 60.55 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.036 2.49 . . . . 3.67 114.525 -171.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.48 -21.15 4.46 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 124.551 1.072 . . . . 3.08 115.257 164.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.85 -110.53 0.57 Allowed Glycine 0 N--CA 1.473 1.126 0 C-N-CA 125.475 1.512 . . . . 1.94 111.933 -176.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -68.69 139.17 55.4 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.641 0.734 . . . . 1.82 111.653 -171.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.462 ' HA ' HD23 ' A' ' 77' ' ' LEU . 56.5 p-80 -159.43 143.98 15.27 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.517 1.127 . . . . 0.82 110.63 -174.451 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -78.28 156.01 29.9 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.14 -0.689 . . . . 1.72 109.14 166.283 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.2 mtp -117.8 129.76 55.87 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 122.874 0.47 . . . . 1.73 111.459 159.472 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.07 136.62 43.36 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.441 1.896 . . . . 0.71 108.243 -172.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mp -124.49 152.43 43.4 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.354 1.061 . . . . 1.67 110.939 -177.233 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.34 -36.11 2.59 Favored Glycine 0 N--CA 1.469 0.852 0 C-N-CA 125.112 1.339 . . . . 2.57 113.712 175.615 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 68.95 -32.39 0.22 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 128.496 2.718 . . . . 3.53 116.883 166.05 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 66.37 -23.85 0.1 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 129.637 3.175 . . . . 1.98 115.519 178.595 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -145.42 146.51 30.18 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.688 1.995 . . . . 6.73 111.508 -171.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.53 155.75 36.05 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.357 2.705 . . . . 2.61 109.525 158.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -166.53 160.2 15.06 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.097 1.759 . . . . 3.36 109.386 -170.271 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -174.45 2.5 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.991 1.317 . . . . 6.05 111.068 168.077 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.04 169.39 3.39 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 120.841 -1.162 . . . . 1.62 109.522 154.281 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.56 35.34 90.96 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.038 1.304 . . . . 1.31 113.58 178.542 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -105.45 -177.88 3.49 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.222 1.009 . . . . 3.34 108.866 167.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -134.57 143.52 47.42 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.202 1.801 . . . . 3.68 106.824 169.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.2 t -142.18 138.11 30.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 128.476 2.71 . . . . 1.02 109.226 -172.659 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -98.7 154.23 18.13 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.395 0.887 . . . . 2.42 113.395 172.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.19 132.58 30.12 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.055 1.742 . . . . 2.16 110.839 -177.334 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -78.62 130.25 35.69 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.576 1.55 . . . . 2.58 108.782 163.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.2 mp -97.56 126.7 43.0 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.221 1.008 . . . . 0.96 109.087 166.527 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.0 mt -96.66 109.75 22.32 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.265 1.026 . . . . 0.96 109.173 176.481 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -105.63 143.53 33.65 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.685 1.194 . . . . 1.89 111.109 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.41 145.48 51.52 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.829 0.852 . . . . 1.64 113.118 -177.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.92 30.94 56.85 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 118.645 -1.086 . . . . 3.49 113.852 172.378 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.97 44.27 5.45 Favored Glycine 0 N--CA 1.471 1.033 0 CA-C-N 118.421 1.111 . . . . 2.08 115.094 168.376 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -131.63 145.03 51.47 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.587 1.193 . . . . 3.82 112.031 174.491 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 94.1 t -143.8 146.51 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.103 1.361 . . . . 2.25 109.066 176.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tt -147.17 120.21 8.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.967 1.307 . . . . 2.28 109.276 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp -94.39 112.64 24.43 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.902 -0.499 . . . . 2.37 111.657 179.081 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.3 m -89.69 166.24 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 125.594 1.558 . . . . 2.38 111.43 176.825 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.7 p -126.84 143.18 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.039 0.936 . . . . 2.97 109.17 165.602 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.92 154.05 25.57 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.881 1.672 . . . . 2.43 112.17 -171.171 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.39 162.38 40.84 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.353 2.702 . . . . 1.23 114.002 174.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.0 t -103.58 124.46 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.535 1.534 . . . . 1.09 108.148 164.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -152.95 173.91 14.79 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.947 1.299 . . . . 4.59 109.965 -178.624 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.93 167.76 15.63 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.961 1.467 . . . . 3.82 114.961 -172.5 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.606 ' HG3' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.231 0 C-N-CA 128.914 2.886 . . . . 8.42 108.671 150.572 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 . . . . . 0 CA--C 1.544 0.735 0 CA-C-O 121.697 0.761 . . . . 5.56 110.625 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -145.19 166.96 27.47 Favored Glycine 0 N--CA 1.47 0.916 0 O-C-N 120.714 -1.241 . . . . 1.31 111.882 -175.517 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -155.29 167.74 29.37 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.93 1.456 . . . . 1.72 114.93 -175.919 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.2 t -119.41 137.78 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 126.428 1.891 . . . . 0.97 110.628 -177.606 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.469 ' HD3' ' O ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -46.99 -31.76 3.43 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 118.178 2.658 . . . . 4.14 118.178 -158.281 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 70.47 136.25 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 125.481 1.513 . . . . 3.1 112.902 -164.348 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.5 t 176.52 151.45 0.35 Allowed Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 128.749 2.82 . . . . 2.74 110.726 166.353 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.69 -7.59 18.64 Favored 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 122.937 2.424 . . . . 2.69 113.586 164.938 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.49 172.99 49.33 Favored Glycine 0 CA--C 1.543 1.795 0 C-N-CA 124.834 1.207 . . . . 1.28 115.552 -172.122 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.95 -15.8 11.64 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 125.237 3.958 . . . . 1.3 115.018 -171.64 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -125.04 149.48 47.73 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.076 2.15 . . . . 2.25 112.657 179.093 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.17 -176.22 5.85 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.453 1.501 . . . . 0.56 112.599 -166.012 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.62 162.15 37.37 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.791 2.036 . . . . 0.72 109.732 177.874 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.07 141.57 30.14 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.693 1.133 . . . . 0.53 113.378 -178.492 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -130.48 62.88 1.58 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.428 1.891 . . . . 2.69 111.891 -163.019 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -81.24 158.63 24.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.651 1.215 . . . . 1.93 114.12 179.354 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.78 101.83 14.22 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.096 1.758 . . . . 2.96 109.447 -179.161 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.86 114.46 20.49 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.325 -0.62 . . . . 3.03 109.325 178.486 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -122.68 125.68 46.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.198 1.799 . . . . 4.07 108.08 174.694 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -91.1 118.87 68.82 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.869 0.868 . . . . 1.55 109.303 178.954 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.35 -12.29 29.55 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.632 2.222 . . . . 1.59 113.878 177.903 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.81 115.94 0.22 Allowed Glycine 0 C--N 1.338 0.671 0 C-N-CA 126.943 2.211 . . . . 2.83 113.247 171.666 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 t0 176.08 -42.46 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 105.231 -2.137 . . . . 8.58 105.231 -141.846 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -165.78 178.22 1.37 Allowed Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 130.212 3.405 . . . . 4.54 108.557 170.129 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.15 127.48 8.43 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 N-CA-C 107.315 -1.84 . . . . 1.12 107.315 156.297 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.0 mt -86.5 145.65 26.71 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.578 -1.192 . . . . 2.04 110.526 -177.132 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.1 100.96 5.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 112.257 -2.247 . . . . 3.45 109.073 174.632 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.17 108.58 12.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.885 -1.524 . . . . 2.39 106.885 176.227 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -103.86 -23.1 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.129 0.972 . . . . 0.6 111.619 -174.743 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.59 -179.05 33.17 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 124.406 1.003 . . . . 0.47 114.213 -175.464 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.72 -176.63 6.01 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.953 0.901 . . . . 0.53 112.894 173.548 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -157.44 165.96 34.28 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.456 2.302 . . . . 4.78 108.111 -173.512 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -166.0 153.75 9.52 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.375 1.07 . . . . 0.61 109.527 168.017 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.37 -8.18 18.11 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.205 1.937 . . . . 0.66 113.211 167.897 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.83 50.15 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.005 1.322 . . . . 0.76 113.17 -179.84 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.08 123.38 1.16 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.977 1.311 . . . . 1.35 110.247 160.191 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.59 -24.07 63.63 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.571 0.952 . . . . 3.72 113.571 173.581 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -141.31 142.39 33.84 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.813 1.245 . . . . 5.58 109.898 174.428 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.27 145.85 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.599 1.56 . . . . 1.27 109.287 171.236 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -114.98 158.76 21.61 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.187 1.795 . . . . 3.48 109.157 163.696 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.1 tp -112.02 119.1 37.32 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 122.965 0.506 . . . . 1.06 110.546 170.117 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -122.92 163.04 21.1 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.008 1.323 . . . . 0.63 114.117 -174.304 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -115.34 -178.02 3.28 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.825 1.65 . . . . 3.42 113.901 159.023 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.2 m -154.88 141.49 18.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.133 1.773 . . . . 0.8 108.92 179.259 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -148.93 170.49 18.2 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.705 1.202 . . . . 2.03 112.842 -165.627 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.9 mtt -95.63 147.55 23.47 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.296 1.038 . . . . 4.25 110.582 167.655 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.95 156.01 33.79 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.761 1.224 . . . . 4.54 110.713 -175.084 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' OE1' ' HE3' ' A' ' 57' ' ' LYS . 3.6 tp10 -104.55 137.87 41.74 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.779 1.232 . . . . 2.69 109.938 169.615 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.7 t -131.54 118.37 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 106.694 -1.595 . . . . 2.14 106.694 163.026 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 62.77 33.17 15.58 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.282 1.033 . . . . 3.55 113.265 175.353 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.58 5.56 86.13 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 120.5 -1.375 . . . . 1.62 113.692 -175.212 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -115.34 124.85 52.31 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.333 1.853 . . . . 2.7 110.132 -176.604 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HE3' ' OE1' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -57.36 128.51 37.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.093 2.157 . . . . 4.06 109.859 179.668 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.39 151.41 35.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 127.967 2.507 . . . . 2.97 107.971 175.471 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 36.6 mtt -115.39 129.73 56.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.144 0.578 . . . . 2.53 109.563 160.429 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.31 175.69 16.41 Favored Glycine 0 N--CA 1.466 0.663 0 C-N-CA 124.293 0.949 . . . . 0.66 112.732 -172.166 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.1 ttm -152.21 139.02 18.9 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.498 1.519 . . . . 0.69 110.677 -172.292 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -146.06 151.31 44.65 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 125.783 1.633 . . . . 7.92 110.982 -177.067 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.77 150.7 50.48 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.447 2.098 . . . . 0.69 110.637 172.619 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.51 147.89 61.65 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.846 1.258 . . . . 0.68 110.057 -176.443 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.96 -19.87 13.57 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.983 3.122 . . . . 0.72 113.342 -164.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -177.2 168.5 2.35 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.355 2.262 . . . . 2.17 109.461 178.266 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.8 mt -111.65 153.52 26.25 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.874 1.27 . . . . 0.59 109.04 159.327 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -124.23 142.09 51.53 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.741 0.816 . . . . 2.57 110.284 177.689 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.6 t -141.27 129.81 12.36 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 123.664 0.786 . . . . 1.01 111.362 174.678 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.79 158.31 46.87 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.832 3.021 . . . . 1.07 112.116 178.787 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.49 137.99 77.56 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.541 2.828 . . . . 1.17 112.305 -177.177 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt 73.88 -13.08 0.79 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.188 2.195 . . . . 2.14 114.237 -177.038 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.73 179.32 44.37 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.659 1.6 . . . . 1.32 114.819 -176.97 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -126.41 156.16 41.03 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.56 1.544 . . . . 3.96 112.054 175.692 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.0 t -149.29 116.84 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.573 1.549 . . . . 4.04 107.763 154.349 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -76.69 142.98 40.34 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.941 -1.099 . . . . 3.17 112.348 -179.576 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 mp -71.53 73.41 0.75 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 123.338 1.542 . . . . 2.19 108.04 160.254 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -69.49 142.62 92.13 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.921 1.688 . . . . 5.46 113.688 -171.279 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -66.88 -4.52 11.45 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.947 3.098 . . . . 2.3 114.501 178.993 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.32 51.53 0.77 Allowed Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.534 1.54 . . . . 1.67 110.57 165.835 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.01 -123.26 1.05 Allowed Glycine 0 N--CA 1.464 0.537 0 C-N-CA 124.196 0.903 . . . . 1.59 113.913 -177.166 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -73.25 136.84 44.65 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 121.573 0.701 . . . . 2.21 111.392 -169.13 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -162.62 156.28 20.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.774 -0.648 . . . . 0.54 111.288 -179.352 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -81.45 146.46 30.24 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.714 -0.476 . . . . 1.95 109.714 164.627 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 tpt -100.05 130.84 46.25 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.206 -1.035 . . . . 0.65 108.206 161.016 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -113.41 138.95 49.34 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.19 1.396 . . . . 0.56 109.574 -178.292 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mp -137.66 146.41 43.82 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.046 1.338 . . . . 1.71 110.794 179.15 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.18 44.43 66.37 Favored Glycine 0 N--CA 1.472 1.051 0 O-C-N 121.691 -0.631 . . . . 0.86 112.342 176.338 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 pp -62.14 151.3 36.18 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 123.194 1.473 . . . . 1.24 114.785 178.56 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.31 -2.22 18.01 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 113.748 -1.569 . . . . 2.52 112.971 -177.121 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -137.21 131.83 17.78 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 126.529 1.932 . . . . 5.22 107.695 153.751 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -63.03 154.2 68.74 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.858 1.705 . . . . 2.29 108.137 160.407 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.6 mt -111.97 97.41 6.66 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.682 1.193 . . . . 2.5 109.7 -155.693 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 136.65 34.94 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.474 1.11 . . . . 3.95 111.774 173.716 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.59 121.3 6.84 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.779 -1.101 . . . . 1.53 108.527 164.165 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.68 -2.35 52.83 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.872 1.701 . . . . 1.6 116.037 -176.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -82.17 -170.67 3.01 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.906 1.853 . . . . 2.39 112.327 168.327 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -147.87 136.44 21.69 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 129.194 2.998 . . . . 3.45 106.598 -172.28 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.4 t -140.07 132.69 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.804 1.642 . . . . 1.09 111.618 -175.684 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -79.56 143.82 34.45 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.318 0.647 . . . . 2.88 112.409 172.138 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mp -127.67 139.67 52.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.026 1.33 . . . . 1.65 110.987 161.535 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -102.23 122.85 45.0 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 127.533 2.333 . . . . 2.87 108.359 174.238 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -104.29 116.67 32.57 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.418 1.008 . . . . 1.06 111.123 -167.786 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -84.92 105.28 15.57 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.897 0.879 . . . . 0.82 110.319 -177.387 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -103.11 106.41 16.92 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.889 1.676 . . . . 2.08 111.172 -179.23 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 56.33 20.63 4.79 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.491 1.916 . . . . 2.33 113.711 177.334 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.22 -56.64 3.65 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.381 1.467 . . . . 4.04 112.485 -171.454 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.02 -10.12 77.26 Favored Glycine 0 CA--C 1.533 1.214 0 N-CA-C 116.118 1.207 . . . . 2.0 116.118 -169.486 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -125.47 145.1 50.23 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.944 1.298 . . . . 4.69 111.077 171.779 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.7 p -144.1 146.29 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 125.836 1.654 . . . . 1.92 110.474 173.328 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.8 tt -156.29 134.85 11.61 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.644 1.978 . . . . 2.07 108.226 -175.446 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -101.05 153.91 19.15 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.148 1.166 . . . . 2.56 114.148 176.079 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.4 t -135.82 158.66 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.568 1.947 . . . . 1.98 108.525 175.04 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.7 p -129.98 128.64 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.102 0.961 . . . . 2.39 110.046 -177.929 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.99 144.24 43.01 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.671 1.188 . . . . 1.97 111.493 -168.368 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -62.52 155.59 57.29 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.27 2.647 . . . . 0.74 112.666 176.545 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 67.4 t -91.59 125.14 44.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 107.475 -1.306 . . . . 0.88 107.475 165.16 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -153.45 167.21 30.2 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.01 1.724 . . . . 3.94 110.565 175.188 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.78 152.71 37.3 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.264 1.209 . . . . 3.8 114.264 -165.96 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.554 1.942 . . . . 9.15 114.713 166.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.144 0 N-CA-C 108.764 -1.735 . . . . 9.19 108.764 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.9 t 131.71 -116.46 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 130.029 3.332 . . . . 8.21 103.497 -158.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -132.59 112.82 12.39 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.699 1.2 . . . . 8.46 109.211 158.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.859 ' H ' HG21 ' A' ' 21' ' ' THR 0.422 0.4 OUTLIER 82.9 -2.42 1.28 Allowed 'General case' 0 N--CA 1.489 1.478 1 C-N-CA 135.744 5.618 . . . . 5.59 115.428 -11.728 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -124.5 -179.45 4.49 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.037 1.335 . . . . 5.48 113.038 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.98 -176.9 28.65 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 126.807 2.146 . . . . 1.01 112.787 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.8 p90 -148.11 146.34 28.76 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.953 1.301 . . . . 1.75 110.412 171.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.5 t -90.2 142.59 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.369 -0.974 . . . . 1.13 108.369 170.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 64.3 ttt-85 -85.78 131.52 34.3 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.991 0.516 . . . . 3.51 112.332 -173.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -40.84 137.36 1.22 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.032 2.133 . . . . 2.02 112.782 169.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t -175.81 126.6 0.36 Allowed Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 127.142 2.177 . . . . 2.76 111.037 165.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -87.13 0.1 7.62 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.928 3.086 . . . . 2.57 112.131 164.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.54 -166.27 40.96 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.141 1.353 . . . . 1.38 112.852 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.08 -24.52 23.63 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.67 2.246 . . . . 1.66 113.546 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -138.87 163.2 32.91 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.198 1.399 . . . . 2.14 113.923 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.28 -175.74 5.48 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 130.324 3.45 . . . . 0.51 109.394 -172.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.37 156.87 43.05 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.844 2.057 . . . . 0.61 109.169 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.89 133.54 33.97 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.711 1.141 . . . . 0.52 112.817 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 43.2 m-85 -115.79 140.98 48.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.798 2.039 . . . . 2.32 110.332 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -168.13 156.43 8.78 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.915 1.234 . . . . 1.77 113.318 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.859 HG21 ' H ' ' A' ' 4' ' ' THR . 86.5 m -95.24 108.52 20.67 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.418 1.087 . . . . 2.01 111.119 -176.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.8 130.28 34.53 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.446 0.566 . . . . 2.71 109.909 173.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -131.98 135.19 46.37 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.69 1.596 . . . . 4.34 109.582 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -105.78 110.25 63.97 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 125.139 1.375 . . . . 1.38 110.319 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.34 -11.56 10.7 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.901 2.401 . . . . 1.02 113.927 176.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.43 174.87 50.76 Favored Glycine 0 C--N 1.338 0.693 0 CA-C-O 122.964 1.313 . . . . 1.2 112.969 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.04 -4.42 32.51 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.45 2.7 . . . . 2.87 111.309 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -119.44 156.83 52.84 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 128.247 2.619 . . . . 1.9 109.9 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.87 143.78 26.79 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.867 2.378 . . . . 0.83 110.964 -174.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.3 mt -102.84 150.92 23.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 122.767 1.27 . . . . 1.79 110.036 170.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -142.63 109.83 5.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.577 -2.101 . . . . 2.16 112.833 -172.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.0 tp -87.82 107.09 18.5 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.33 1.852 . . . . 1.83 109.951 -175.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.8 m -108.49 -18.12 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.155 0.982 . . . . 0.51 112.455 -172.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.31 -178.4 31.34 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 125.273 1.416 . . . . 0.61 113.106 -175.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.17 179.82 8.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.673 0.749 . . . . 0.69 111.826 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -156.37 166.01 34.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.766 2.426 . . . . 3.96 107.815 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -175.43 151.24 1.27 Allowed Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 125.788 1.635 . . . . 0.76 108.447 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.6 -7.89 14.74 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.939 2.426 . . . . 0.83 112.993 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.0 m -114.16 41.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.6 1.16 . . . . 0.95 113.434 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.18 164.25 35.29 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.527 -0.733 . . . . 1.12 112.532 166.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -100.75 -46.39 5.17 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.266 2.227 . . . . 3.21 110.664 169.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -103.18 138.24 40.26 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.223 1.409 . . . . 5.06 108.341 163.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -99.58 152.61 4.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.3 -1.0 . . . . 1.34 108.3 142.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -135.41 147.7 49.08 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.02 1.728 . . . . 2.93 108.31 166.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.6 tp -102.97 118.76 37.54 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.557 0.743 . . . . 1.05 110.651 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.417 ' CE1' ' HB2' ' A' ' 85' ' ' MET . 55.3 m170 -121.93 156.67 32.89 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 123.242 1.496 . . . . 0.53 113.899 -173.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -98.3 177.82 5.25 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.551 1.941 . . . . 2.39 111.577 160.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.1 m -152.89 149.97 28.82 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.297 1.839 . . . . 0.77 106.996 166.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -158.3 165.74 34.06 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.058 0.943 . . . . 2.14 113.054 -168.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 59.5 ttp -95.19 143.49 26.57 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.166 1.386 . . . . 3.05 110.371 167.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.49 150.68 35.02 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.6 1.16 . . . . 4.35 110.849 -173.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -108.45 137.89 45.67 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.411 1.484 . . . . 2.07 110.262 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.8 t -139.63 128.23 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 106.7 -1.593 . . . . 2.01 106.7 166.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.433 ' HB2' ' HE3' ' A' ' 56' ' ' LYS . 34.6 mt-10 61.49 19.1 10.02 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.085 1.354 . . . . 2.99 114.401 -175.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.25 11.29 85.07 Favored Glycine 0 N--CA 1.48 1.609 0 O-C-N 120.242 -1.536 . . . . 1.61 113.585 -169.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.433 ' HE3' ' HB2' ' A' ' 54' ' ' GLU . 23.5 mtmt -110.47 118.83 37.32 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.531 2.333 . . . . 2.66 108.728 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 120.19 34.29 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.689 -1.141 . . . . 3.83 112.376 -166.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.8 m -121.35 -178.4 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 128.705 2.802 . . . . 2.05 109.872 -176.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 60.9 mtt -116.06 162.94 16.67 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.359 1.064 . . . . 2.49 111.165 168.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.61 175.06 32.86 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 124.791 1.186 . . . . 0.57 112.591 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.3 ttm -154.78 145.29 22.19 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.055 1.742 . . . . 0.61 109.213 -170.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -148.24 153.98 41.76 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 125.736 1.614 . . . . 5.17 109.175 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.89 154.11 42.81 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.854 1.702 . . . . 0.6 110.399 165.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -139.46 154.35 71.52 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.458 1.503 . . . . 0.64 110.513 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.02 -27.66 4.41 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.106 2.538 . . . . 0.52 112.949 -167.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -176.24 164.74 2.74 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.648 1.579 . . . . 1.96 111.817 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 mt -114.03 152.22 31.3 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.215 1.406 . . . . 0.61 110.014 166.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -111.93 145.93 38.69 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.756 1.222 . . . . 2.02 109.407 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.2 t -134.44 119.8 14.37 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.655 0.782 . . . . 1.11 111.124 165.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.29 159.1 54.19 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.33 2.687 . . . . 0.93 111.565 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -60.4 138.57 81.59 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.754 2.969 . . . . 0.97 112.192 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt 64.91 -4.26 0.5 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.304 1.841 . . . . 1.62 113.991 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.08 -177.4 39.2 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 127.28 2.371 . . . . 1.16 113.114 -176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.22 152.53 33.42 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.279 1.032 . . . . 3.99 112.146 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.4 t -152.71 123.46 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.771 1.629 . . . . 3.72 107.752 174.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.451 ' HG3' HG23 ' A' ' 21' ' ' THR . 6.9 mp0 -84.31 141.44 30.92 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.704 -0.622 . . . . 2.98 111.351 175.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.92 80.84 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.332 -0.988 . . . . 2.2 108.332 147.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.08 148.95 46.39 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.1 1.36 . . . . 3.09 112.386 -174.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.422 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 59.2 Cg_endo -63.3 -24.35 71.87 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.251 2.634 . . . . 1.99 113.806 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.84 21.72 4.58 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.942 -0.921 . . . . 1.63 114.115 170.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.95 -118.39 0.69 Allowed Glycine 0 CA--C 1.53 1.015 0 CA-C-N 118.979 1.39 . . . . 1.87 114.654 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -71.91 140.42 49.23 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.352 -1.087 . . . . 1.87 112.552 -164.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -162.64 156.22 20.39 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.206 1.002 . . . . 0.51 112.259 -173.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -82.99 140.51 32.7 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.851 -0.53 . . . . 1.59 109.623 165.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.417 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 3.1 tpt -93.14 131.94 37.73 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.261 1.024 . . . . 0.62 108.769 161.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 mp -110.9 125.23 53.43 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.654 -1.239 . . . . 0.59 107.654 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 mp -130.82 142.62 50.4 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.305 0.642 . . . . 1.86 110.364 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.43 43.29 16.1 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.154 0.883 . . . . 0.85 112.96 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -56.76 154.51 9.03 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 116.102 1.89 . . . . 1.38 116.102 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -116.53 -16.83 10.75 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 113.515 -1.675 . . . . 1.98 113.076 -170.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -113.12 127.38 26.9 Favored Pre-proline 0 N--CA 1.472 0.628 0 N-CA-C 105.896 -1.89 . . . . 5.43 105.896 155.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.39 110.02 1.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 N-CA-C 105.369 -2.589 . . . . 2.22 105.369 158.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.48 147.15 39.76 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 124.518 2.104 . . . . 2.05 111.567 -156.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -156.27 166.04 34.62 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 111.665 -2.516 . . . . 3.83 112.815 -151.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.92 126.05 25.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.007 0.923 . . . . 1.19 109.636 -175.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.08 0.98 70.43 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 117.702 -1.61 . . . . 1.26 115.64 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -79.9 -167.83 1.4 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.319 2.06 . . . . 2.23 112.568 169.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.52 121.78 3.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.148 2.979 . . . . 5.77 106.095 -148.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 49.3 t -148.83 133.45 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.602 1.161 . . . . 0.97 111.702 -170.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -79.12 144.59 34.38 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 112.211 0.448 . . . . 2.51 112.211 168.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mp -120.23 142.31 49.14 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.829 0.823 . . . . 1.6 110.507 153.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -104.8 136.34 44.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 129.265 3.026 . . . . 1.99 107.485 166.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 mp -128.12 109.75 11.82 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 120.503 1.501 . . . . 2.01 108.903 -172.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.1 mt -79.34 110.34 14.53 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.094 1.357 . . . . 0.67 109.453 -170.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -103.48 137.44 41.56 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.309 1.444 . . . . 2.06 110.612 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.04 127.23 30.52 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.871 1.063 . . . . 2.12 113.871 -169.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.64 70.13 1.35 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.638 1.114 . . . . 3.45 112.093 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.65 24.5 72.37 Favored Glycine 0 N--CA 1.471 1.03 0 N-CA-C 115.563 0.985 . . . . 2.09 115.563 166.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -126.28 155.84 41.3 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.304 1.552 . . . . 3.47 112.353 -173.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.12 151.46 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.813 1.245 . . . . 2.32 110.753 171.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.1 tp -120.48 141.98 49.7 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.091 1.357 . . . . 3.13 109.786 167.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -106.79 134.35 50.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.582 1.153 . . . . 2.2 109.908 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.74 153.59 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.099 1.359 . . . . 2.72 110.165 167.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.22 126.39 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.683 -1.228 . . . . 1.86 107.683 165.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.1 mt -122.1 146.75 47.38 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 126.234 1.814 . . . . 1.97 110.074 -174.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.78 164.54 35.28 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.973 2.449 . . . . 0.89 111.377 165.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.22 139.38 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.689 0.796 . . . . 0.76 110.482 169.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.97 147.22 40.15 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.667 1.587 . . . . 3.74 113.093 -171.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.59 58.3 4.14 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.054 1.742 . . . . 2.38 111.832 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 . . . . . 0 C--O 1.249 1.072 0 C-N-CA 125.956 1.703 . . . . 7.47 112.672 -162.195 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.876 0 N-CA-C 107.463 -2.255 . . . . 8.95 107.463 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.2 t -62.82 176.94 0.61 Allowed 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 117.139 0.469 . . . . 9.26 110.657 144.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -70.05 -28.42 65.45 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.878 -1.139 . . . . 12.56 111.795 168.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 t -136.44 133.01 36.18 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 127.101 2.16 . . . . 6.96 109.222 171.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.401 ' H ' ' CG2' ' A' ' 21' ' ' THR . 0.7 OUTLIER -100.72 119.11 38.12 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.975 2.11 . . . . 5.21 109.909 -174.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.59 172.86 37.88 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 120.515 1.507 . . . . 0.87 115.552 159.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -148.98 147.06 28.14 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.016 1.326 . . . . 1.96 111.276 169.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.8 t -95.03 126.87 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.08 -1.081 . . . . 1.35 108.08 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -74.31 123.18 24.11 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.912 0.386 . . . . 4.84 111.423 -170.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -46.99 142.18 3.68 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.956 1.302 . . . . 1.89 111.538 163.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.1 m -155.31 152.23 24.38 Favored Pre-proline 0 CA--C 1.545 0.783 0 O-C-N 120.865 -1.147 . . . . 2.53 111.111 161.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -95.18 43.11 0.16 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.147 3.232 . . . . 2.71 111.707 -176.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.61 -168.85 25.16 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.27 1.268 . . . . 1.17 116.27 -167.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.98 -16.23 16.09 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.283 3.322 . . . . 1.24 114.328 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -125.24 162.57 24.41 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.052 1.741 . . . . 2.41 114.124 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.95 -177.2 6.4 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.181 2.592 . . . . 0.5 111.236 -175.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.08 167.33 21.74 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.352 2.261 . . . . 0.73 108.448 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.74 141.27 33.25 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.375 0.989 . . . . 0.57 111.738 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.452 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 20.2 m-85 -128.02 114.37 17.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.256 1.822 . . . . 2.48 108.842 -171.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -163.26 165.36 24.36 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.851 -1.155 . . . . 2.71 112.901 -167.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.401 ' CG2' ' H ' ' A' ' 5' ' ' GLU . 5.0 t -92.77 141.14 28.78 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 123.189 1.471 . . . . 3.29 113.366 -177.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.36 123.81 38.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 113.357 -1.747 . . . . 3.5 106.996 164.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -111.62 145.05 39.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.869 0.842 . . . . 3.99 110.944 169.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.88 64.8 18.4 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.07 0.948 . . . . 3.48 110.277 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -63.23 -21.79 72.28 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.632 2.888 . . . . 1.38 114.414 -173.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.09 -173.09 38.09 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 122.72 1.178 . . . . 1.22 113.001 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -109.74 -1.19 18.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.905 1.682 . . . . 2.83 112.684 -164.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -121.68 155.25 60.11 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 127.417 2.287 . . . . 2.06 110.091 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.63 139.57 18.13 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.713 2.275 . . . . 1.01 111.245 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt -95.05 153.54 17.6 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 123.306 1.527 . . . . 1.6 112.676 174.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 ttp-105 -137.06 102.93 4.99 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 112.609 -2.087 . . . . 2.49 110.901 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.37 113.57 20.83 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 124.443 1.097 . . . . 1.98 110.497 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.31 -19.53 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 125.124 1.37 . . . . 0.65 111.855 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.61 -175.47 29.58 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 122.531 1.073 . . . . 0.52 115.362 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.459 ' HB2' ' CE1' ' A' ' 84' ' ' PHE . . . -139.08 -179.18 5.7 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.917 1.687 . . . . 0.56 110.236 164.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -159.84 146.6 16.27 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.928 1.691 . . . . 4.39 106.999 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 t -162.55 151.06 12.26 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 125.038 1.335 . . . . 0.73 108.436 -175.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.91 -13.45 31.79 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.682 1.588 . . . . 0.68 113.378 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 m -112.31 36.14 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 113.788 1.033 . . . . 0.86 113.788 -172.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.15 140.39 10.29 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.343 1.457 . . . . 1.03 109.134 170.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -95.63 -40.0 9.63 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.233 1.413 . . . . 3.61 110.292 -176.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -104.4 129.1 52.35 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.959 1.704 . . . . 5.82 107.758 155.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.07 139.31 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.069 -1.085 . . . . 1.25 108.069 154.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.91 155.89 47.1 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.834 2.054 . . . . 3.26 108.295 -174.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.3 tp -114.23 121.4 43.59 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.976 0.91 . . . . 1.0 109.785 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.405 ' CE1' ' HB2' ' A' ' 85' ' ' MET . 50.2 m170 -124.23 161.32 26.02 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 123.736 1.731 . . . . 0.73 114.488 -175.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -104.22 155.16 18.96 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.085 2.554 . . . . 2.59 111.21 160.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.9 m -122.02 147.19 46.38 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 105.902 -1.888 . . . . 0.85 105.902 159.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -157.39 178.28 10.48 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.188 0.904 . . . . 2.39 112.819 -174.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 63.0 ttp -111.66 135.21 52.56 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.572 1.549 . . . . 3.62 111.5 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -110.4 143.99 39.84 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.513 1.525 . . . . 4.77 110.862 161.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -87.45 145.4 26.29 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.556 1.143 . . . . 2.99 108.707 149.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.4 t -143.92 120.8 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.227 1.811 . . . . 2.73 106.701 161.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 63.94 18.12 10.99 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.483 1.513 . . . . 4.21 115.024 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.21 21.22 67.99 Favored Glycine 0 N--CA 1.478 1.482 0 O-C-N 120.6 -1.313 . . . . 2.6 113.052 -168.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -120.36 127.99 52.82 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.253 2.221 . . . . 3.21 107.592 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -98.46 126.81 44.14 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.735 1.214 . . . . 5.3 111.779 -171.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.0 p -144.29 141.88 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 126.415 1.886 . . . . 2.22 109.644 -175.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 60.1 mtm -92.19 156.52 17.27 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.422 0.897 . . . . 2.95 113.422 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.67 172.06 22.08 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 126.359 1.933 . . . . 0.81 112.332 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.5 ttm -146.53 145.66 30.23 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.231 1.812 . . . . 0.75 109.587 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -149.35 156.57 39.64 Favored Pre-proline 0 N--CA 1.471 0.603 0 C-N-CA 125.218 1.407 . . . . 5.02 110.12 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.99 156.54 38.65 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.469 2.113 . . . . 0.92 110.638 166.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.6 m -137.57 153.51 74.33 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 125.357 1.463 . . . . 0.92 110.964 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.11 -24.85 6.42 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.502 2.801 . . . . 0.97 113.024 -171.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -176.35 164.82 2.69 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.029 1.732 . . . . 2.28 111.67 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.4 mt -108.87 153.69 23.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.404 1.482 . . . . 0.71 110.579 163.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -114.3 144.19 43.65 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.395 1.478 . . . . 2.17 109.763 176.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.7 t -139.91 139.74 22.44 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.465 0.706 . . . . 1.06 112.488 169.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -84.02 156.43 13.24 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.38 3.387 . . . . 1.12 112.531 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -62.22 143.49 94.33 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.306 2.671 . . . . 1.07 113.246 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt 69.97 0.2 2.98 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.775 2.43 . . . . 1.77 114.16 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.56 151.53 34.44 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.41 1.481 . . . . 1.24 114.106 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -111.46 132.12 54.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.425 2.29 . . . . 4.63 106.547 160.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.5 t -142.59 119.01 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.746 1.219 . . . . 3.5 108.774 -177.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -115.15 128.69 56.36 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.899 0.857 . . . . 3.98 113.24 -159.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.16 77.12 0.52 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.632 2.373 . . . . 2.21 111.163 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.65 145.01 97.74 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 126.462 1.905 . . . . 6.25 113.525 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.452 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 30.4 Cg_endo -57.89 -42.88 54.12 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.301 2.667 . . . . 2.99 113.335 175.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.46 31.49 1.88 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.454 1.025 . . . . 1.58 113.533 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.12 -131.99 1.44 Allowed Glycine 0 N--CA 1.471 0.969 0 C-N-CA 125.493 1.52 . . . . 1.62 113.175 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -70.39 139.21 51.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.906 0.853 . . . . 2.14 110.981 -172.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -162.02 158.3 24.79 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.836 1.255 . . . . 0.58 111.973 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.459 ' CE1' ' HB2' ' A' ' 35' ' ' ALA . 98.5 m-85 -84.63 151.74 24.28 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.697 -0.627 . . . . 2.07 110.786 168.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.405 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 3.2 tpt -112.06 130.98 55.7 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.531 1.132 . . . . 0.61 109.687 166.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -111.98 118.87 36.64 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.943 1.297 . . . . 0.62 107.869 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.6 mp -119.51 138.92 52.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.47 1.108 . . . . 1.7 109.739 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.22 37.26 32.58 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.73 -0.483 . . . . 0.87 113.006 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -48.3 154.93 0.55 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 116.571 2.063 . . . . 1.3 116.571 177.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -119.97 -18.77 8.09 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.155 -1.384 . . . . 2.7 113.949 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -97.01 140.96 22.39 Favored Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 108.539 -0.912 . . . . 5.35 108.539 160.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -82.6 57.58 6.14 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.624 2.883 . . . . 3.07 109.914 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.4 mt -23.14 104.56 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 129.044 2.938 . . . . 2.2 116.8 -159.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm -119.54 157.96 27.28 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.187 1.795 . . . . 6.57 114.871 170.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.14 133.88 38.92 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 113.528 -1.669 . . . . 1.76 109.675 169.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.46 1.33 86.16 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 117.485 -1.73 . . . . 1.78 115.848 -175.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -75.28 178.11 6.05 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 120.899 2.349 . . . . 2.4 111.145 166.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -146.2 129.74 16.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.795 2.838 . . . . 5.22 104.827 -159.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.0 t -144.33 121.63 5.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 123.99 0.916 . . . . 1.04 110.358 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -78.81 154.55 29.79 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.262 0.554 . . . . 2.83 111.364 167.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.2 tt -149.91 142.8 24.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 122.82 1.295 . . . . 2.85 110.808 169.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.0 104.33 11.8 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 129.54 3.136 . . . . 2.42 107.061 -169.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -82.46 129.37 34.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.158 0.983 . . . . 0.96 109.622 -172.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.0 mt -106.02 123.96 48.82 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.61 1.164 . . . . 0.84 111.441 -171.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -122.6 144.98 48.76 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.945 1.298 . . . . 2.04 112.31 -170.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.66 151.06 21.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.878 0.871 . . . . 1.92 111.974 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.16 8.86 87.0 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 119.011 -0.883 . . . . 3.57 114.618 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.8 66.06 1.61 Allowed Glycine 0 N--CA 1.469 0.892 0 CA-C-N 119.184 1.492 . . . . 2.45 113.326 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -138.45 152.98 48.82 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.929 1.692 . . . . 3.79 111.455 170.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.39 148.57 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.124 1.37 . . . . 2.44 111.178 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 tt -140.2 116.22 10.41 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.597 1.159 . . . . 3.42 109.244 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -93.58 136.25 34.04 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.93 -1.106 . . . . 2.41 112.054 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.8 t -131.43 165.27 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.982 1.713 . . . . 2.13 108.751 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.9 t -129.34 129.98 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.276 1.43 . . . . 1.71 108.781 172.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.5 mt -123.65 145.57 47.64 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 127.554 2.342 . . . . 2.17 110.063 -174.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.9 154.66 58.33 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.648 2.232 . . . . 0.86 110.475 166.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.7 t -92.88 125.28 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.224 -1.028 . . . . 1.03 108.224 167.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -152.61 167.96 27.17 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.668 1.223 . . . . 5.22 114.059 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -103.57 104.55 14.62 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.305 1.594 . . . . 2.23 115.305 -166.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 . . . . . 0 N--CA 1.483 1.203 1 C-N-CA 133.973 4.909 . . . . 7.63 112.555 162.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.957 0 N-CA-C 107.371 -2.291 . . . . 11.99 107.371 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 m -76.98 145.1 38.29 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 115.325 1.602 . . . . 12.5 115.325 -145.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.56 136.61 49.41 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.006 1.722 . . . . 10.45 111.524 -168.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.4 p -84.15 58.47 4.78 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.312 1.845 . . . . 7.45 112.113 -170.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -97.35 60.97 1.66 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.328 1.051 . . . . 6.28 110.913 -174.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.08 -178.86 34.46 Favored Glycine 0 N--CA 1.465 0.581 0 O-C-N 121.186 -0.947 . . . . 1.68 113.287 -173.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 26.0 p90 -152.0 148.67 28.0 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.825 0.85 . . . . 1.92 112.998 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.03 145.96 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.883 -1.154 . . . . 1.39 107.883 170.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -86.85 127.9 35.04 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.811 0.671 . . . . 4.47 112.811 -167.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -48.79 151.0 1.29 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.956 1.302 . . . . 2.73 112.766 168.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 t -163.19 148.23 9.32 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 122.895 0.478 . . . . 2.39 111.597 166.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -86.21 -6.4 8.28 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.2 2.6 . . . . 1.96 112.109 166.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.16 178.24 20.6 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.946 1.26 . . . . 1.11 114.004 -173.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.6 -15.8 33.96 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.122 3.215 . . . . 1.28 113.527 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -110.01 142.67 41.1 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.796 2.038 . . . . 2.4 113.841 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.69 -176.17 5.4 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 129.066 2.946 . . . . 0.5 110.848 -172.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.99 159.88 41.41 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.955 2.102 . . . . 0.84 109.391 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.46 137.05 48.43 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.08 1.309 . . . . 0.69 112.482 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -116.71 71.83 0.8 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.298 1.839 . . . . 2.56 109.6 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -83.54 157.54 22.31 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.737 -1.227 . . . . 1.69 111.685 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.78 131.53 36.38 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.263 -0.898 . . . . 2.45 109.676 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.24 129.53 52.04 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.847 0.459 . . . . 3.07 110.057 175.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -119.9 144.07 47.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.58 1.952 . . . . 3.76 107.638 167.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.02 79.1 0.53 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.71 0.804 . . . . 3.31 110.683 171.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.69 -6.03 18.29 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.346 2.03 . . . . 1.6 115.733 -174.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.96 160.61 33.93 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 119.535 1.061 . . . . 1.41 111.686 170.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.19 1.5 40.34 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.526 1.93 . . . . 3.81 112.162 174.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mp -123.48 156.19 64.52 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 127.03 2.132 . . . . 4.48 108.643 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.81 143.99 16.95 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.975 2.45 . . . . 1.25 111.04 -167.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.8 mt -100.47 150.32 22.77 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 123.076 1.417 . . . . 1.68 112.844 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -127.1 106.3 9.17 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 112.218 -2.265 . . . . 1.89 110.62 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.441 HD11 ' CZ ' ' A' ' 84' ' ' PHE . 2.7 tm? -85.87 110.97 19.78 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.658 1.983 . . . . 2.45 108.752 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.89 -19.85 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.254 1.022 . . . . 0.76 112.055 -171.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.7 -177.21 32.59 Favored Glycine 0 C--N 1.343 0.94 0 C-N-CA 124.989 1.281 . . . . 0.69 113.887 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.43 -178.78 5.66 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.709 1.204 . . . . 0.76 110.096 161.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -150.81 158.67 44.42 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.229 2.611 . . . . 4.73 107.072 172.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 t -169.5 153.11 5.06 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 126.438 1.895 . . . . 0.66 107.281 -171.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.58 -12.7 15.14 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.901 1.734 . . . . 0.84 112.921 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.42 45.34 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.061 0.945 . . . . 0.81 112.983 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.43 144.45 14.01 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.296 1.039 . . . . 0.98 111.491 164.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -86.49 -45.83 10.75 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.869 1.268 . . . . 2.92 111.328 171.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -109.93 134.38 52.15 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.816 1.247 . . . . 5.05 108.025 168.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -119.77 135.27 60.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 125.497 1.519 . . . . 1.09 108.299 166.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -126.66 154.23 44.33 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.747 2.019 . . . . 3.01 108.759 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.0 tp -111.18 124.44 52.2 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.741 0.816 . . . . 1.12 109.776 174.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -123.44 161.52 24.64 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.403 1.881 . . . . 0.66 114.262 -175.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.78 -179.2 3.87 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.721 2.409 . . . . 3.03 111.773 162.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.1 m -157.49 145.87 19.28 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.367 1.867 . . . . 0.91 107.645 170.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -153.42 172.93 16.33 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.183 1.393 . . . . 1.97 112.552 -168.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.4 mtm -103.44 143.64 32.44 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.905 0.882 . . . . 2.99 110.561 167.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -149.21 146.32 27.56 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.245 1.818 . . . . 8.81 111.144 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -86.91 145.97 26.35 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.75 1.22 . . . . 2.75 111.787 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 p -169.81 138.01 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 126.217 1.807 . . . . 3.0 108.273 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 72.92 -3.58 2.38 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 127.612 2.365 . . . . 4.91 114.818 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.99 33.19 24.46 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.277 0.942 . . . . 2.1 112.599 -161.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -141.47 144.39 34.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.838 2.455 . . . . 4.41 108.126 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.92 120.68 29.49 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.481 0.712 . . . . 7.48 110.604 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.451 HG12 ' H ' ' A' ' 59' ' ' MET . 39.8 t -125.12 -179.67 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 127.308 2.243 . . . . 2.29 107.982 -175.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.451 ' H ' HG12 ' A' ' 58' ' ' VAL . 8.3 mtm -113.78 159.97 19.2 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.583 -1.323 . . . . 4.12 112.835 175.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.43 165.74 25.17 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 125.726 1.631 . . . . 0.77 111.059 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.9 ttm -148.78 141.86 24.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.573 1.949 . . . . 0.81 108.453 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -150.11 151.21 31.44 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.938 1.695 . . . . 5.77 109.266 -170.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.04 155.23 42.74 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.071 1.847 . . . . 0.56 110.922 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.31 152.53 75.26 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.982 1.313 . . . . 0.77 110.008 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.82 -21.64 10.94 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.294 2.663 . . . . 0.7 112.865 -171.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -174.88 174.23 2.59 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.743 2.017 . . . . 1.91 110.756 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.4 mt -119.81 154.31 34.44 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.527 1.931 . . . . 0.49 109.671 160.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -112.87 145.13 41.23 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.917 1.287 . . . . 1.71 109.41 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 t -137.61 139.13 26.14 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.288 0.635 . . . . 0.98 112.689 171.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -83.6 156.19 14.02 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 124.201 3.267 . . . . 1.28 112.311 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.31 138.81 68.21 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.413 3.409 . . . . 1.27 115.109 -170.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt 67.15 -2.7 1.13 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.818 2.447 . . . . 3.19 115.455 173.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.76 176.29 54.6 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 127.431 2.443 . . . . 1.46 112.634 167.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.27 144.53 21.01 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.27 1.428 . . . . 4.19 111.279 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.9 t -154.13 127.39 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 126.366 1.866 . . . . 4.17 107.738 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.51 149.8 31.36 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.879 0.763 . . . . 5.09 111.603 172.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mp -73.8 73.86 1.58 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.796 1.284 . . . . 2.22 108.737 165.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -63.88 143.46 98.13 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 114.39 -1.277 . . . . 5.04 113.138 -170.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -63.67 -21.11 70.0 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.346 2.697 . . . . 2.31 113.982 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.57 48.2 2.33 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.248 0.928 . . . . 1.77 112.14 171.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.59 -121.6 1.04 Allowed Glycine 0 N--CA 1.468 0.802 0 C-N-CA 124.876 1.226 . . . . 1.52 114.085 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -74.21 134.35 42.73 Favored 'General case' 0 C--O 1.22 -0.494 0 O-C-N 121.928 -0.748 . . . . 2.12 112.432 -170.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -161.66 163.51 29.81 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.84 0.856 . . . . 0.61 111.358 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.441 ' CZ ' HD11 ' A' ' 32' ' ' LEU . 96.4 m-85 -90.72 150.22 21.72 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.287 -0.883 . . . . 2.25 110.629 168.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.6 tpt -104.79 134.07 48.54 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.35 1.06 . . . . 0.59 109.338 164.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -117.62 130.95 56.7 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.411 1.484 . . . . 0.52 108.076 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 mp -136.02 140.9 44.21 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.932 0.787 . . . . 1.77 111.992 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.74 44.91 11.43 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 123.744 0.688 . . . . 0.76 111.776 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.01 148.27 11.03 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 123.452 1.596 . . . . 1.28 115.049 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -105.01 -7.43 19.23 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.517 -1.674 . . . . 1.78 112.841 -176.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -144.14 138.06 14.59 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 127.61 2.364 . . . . 6.19 108.062 162.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.05 144.21 75.0 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.163 1.909 . . . . 1.94 108.308 164.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.427 ' H ' HD23 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -121.13 120.85 36.48 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.826 1.65 . . . . 2.75 109.87 -166.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -120.4 169.9 9.87 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.429 1.891 . . . . 3.76 114.234 -160.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.05 103.56 1.89 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.38 1.072 . . . . 1.75 111.553 -170.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.03 12.67 39.05 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 118.507 -1.163 . . . . 1.81 114.906 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -82.69 -172.87 4.31 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.742 1.271 . . . . 2.24 111.456 166.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 40.1 mt-10 -146.65 138.95 24.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.714 2.806 . . . . 4.0 106.161 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.0 t -137.97 121.73 21.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 125.04 1.336 . . . . 1.18 109.51 -173.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -84.57 150.49 25.18 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 122.242 1.02 . . . . 3.17 113.192 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.57 144.02 20.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.231 1.413 . . . . 3.5 114.231 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -104.98 114.34 28.49 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 128.066 2.546 . . . . 2.69 109.62 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.13 127.79 32.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.596 1.158 . . . . 1.43 108.802 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.3 mt -103.54 112.21 25.02 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.005 0.922 . . . . 0.94 109.882 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -108.16 146.81 32.19 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.437 1.495 . . . . 2.09 111.237 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.84 124.37 11.01 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.342 1.057 . . . . 1.87 113.089 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.2 70.75 1.22 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.457 1.027 . . . . 2.93 113.267 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.8 4.06 57.18 Favored Glycine 0 N--CA 1.476 1.331 0 N-CA-C 117.011 1.564 . . . . 2.2 117.011 163.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -93.47 110.69 22.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.55 1.675 . . . . 3.15 111.024 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.63 135.3 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.048 1.339 . . . . 1.99 109.319 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.1 tp -137.01 115.29 11.72 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.443 1.097 . . . . 2.18 110.571 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -79.77 131.8 36.0 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.762 -0.586 . . . . 2.2 112.316 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.3 t -124.87 169.85 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 128.509 2.724 . . . . 2.1 107.658 172.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.9 t -144.55 134.87 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.583 1.553 . . . . 1.9 108.094 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -131.11 152.34 80.47 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.185 0.994 . . . . 4.27 110.52 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 57.3 Cg_endo -63.97 168.42 12.21 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 124.018 3.145 . . . . 0.84 112.955 171.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.5 t -108.56 128.62 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.28 1.032 . . . . 1.14 110.996 173.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -120.57 147.11 45.62 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.459 1.504 . . . . 5.12 112.402 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.87 71.85 2.54 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.78 1.232 . . . . 2.71 111.766 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 127.276 2.231 . . . . 8.17 110.647 -178.81 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.386 0 N-CA-C 107.288 -2.325 . . . . 14.45 107.288 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.8 m -60.59 179.29 0.17 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 119.959 -0.696 . . . . 12.56 110.96 142.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -66.64 178.53 1.27 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.697 0.799 . . . . 9.98 111.381 163.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.9 t -168.82 147.4 4.05 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 127.002 2.121 . . . . 6.97 107.396 171.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -93.16 59.49 3.08 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.743 0.701 . . . . 6.7 109.318 171.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.84 169.48 15.21 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 121.621 -0.674 . . . . 1.19 114.779 -168.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -157.18 151.49 25.07 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.029 1.732 . . . . 2.07 112.125 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.4 t -87.22 121.4 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 107.486 -1.302 . . . . 1.28 107.486 164.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.24 118.23 20.26 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.488 0.715 . . . . 3.69 109.876 -175.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -55.85 153.71 8.13 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.186 1.395 . . . . 2.1 113.835 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.9 t -163.89 147.04 7.87 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.143 1.377 . . . . 2.07 110.395 173.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -86.85 6.37 5.37 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.889 3.059 . . . . 1.99 112.665 171.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.14 -170.19 15.72 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.15 1.357 . . . . 1.21 115.082 -168.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.78 -17.78 42.05 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.867 3.045 . . . . 1.76 113.717 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -138.22 156.16 47.96 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 116.048 1.87 . . . . 2.25 116.048 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.7 -178.73 5.26 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 131.01 3.724 . . . . 0.98 109.59 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.31 161.64 33.02 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.39 1.476 . . . . 0.81 108.442 168.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.04 135.73 50.27 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.197 0.999 . . . . 0.78 110.067 172.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -127.08 132.41 50.65 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.671 1.988 . . . . 2.66 107.673 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pp -170.07 149.86 3.65 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.413 1.006 . . . . 1.96 113.408 -164.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.6 m -79.15 121.84 25.52 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.023 1.729 . . . . 2.25 111.267 172.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.18 125.37 29.76 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.754 -0.832 . . . . 3.18 108.754 157.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -95.77 142.46 28.02 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.65 1.18 . . . . 3.9 107.943 161.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.44 72.51 2.53 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.217 1.007 . . . . 3.21 109.882 174.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.31 -20.11 61.97 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.979 2.453 . . . . 1.31 114.692 -172.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.67 -177.95 47.63 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 122.952 1.307 . . . . 1.25 113.096 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -104.96 -1.9 25.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.769 2.028 . . . . 2.86 112.204 -168.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -122.23 155.87 61.08 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 127.804 2.442 . . . . 2.05 109.973 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.98 140.45 20.24 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.781 2.321 . . . . 1.36 111.048 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.2 mt -93.87 151.16 19.78 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 123.197 1.475 . . . . 1.82 112.115 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.4 ttp-105 -135.53 106.71 6.74 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 112.589 -2.096 . . . . 2.25 110.568 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.6 tp -91.94 108.17 19.73 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.022 1.729 . . . . 1.86 109.95 -172.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -100.81 -20.94 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.107 1.363 . . . . 0.59 111.399 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.06 -178.31 31.97 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.006 1.289 . . . . 0.67 114.708 -176.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -156.27 -178.11 7.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.242 2.217 . . . . 0.89 110.437 172.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -160.84 151.76 18.63 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.494 1.043 . . . . 4.99 109.439 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -150.06 153.91 36.09 Favored Pre-proline 0 N--CA 1.472 0.645 0 O-C-N 121.101 -1.0 . . . . 0.78 109.836 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.58 -7.89 21.6 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.665 2.244 . . . . 1.02 113.604 171.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 m -124.25 44.9 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 114.246 1.202 . . . . 0.96 114.246 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.36 175.2 14.31 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.56 1.544 . . . . 1.3 109.3 164.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -114.45 -60.15 1.92 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.028 0.931 . . . . 3.5 108.826 160.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.6 mtp85 -82.35 106.83 14.54 Favored 'General case' 0 N--CA 1.458 -0.059 0 O-C-N 121.244 -0.91 . . . . 5.73 108.799 168.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.73 152.55 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 107.904 -1.147 . . . . 1.4 107.904 148.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -156.39 115.5 3.46 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.469 0.577 . . . . 3.0 111.31 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.1 tp -80.83 118.96 22.8 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.882 -1.136 . . . . 1.08 111.753 -174.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -125.24 152.96 43.89 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 123.219 1.485 . . . . 0.51 114.483 -172.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -95.31 177.11 5.95 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.36 1.864 . . . . 2.39 111.307 162.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.6 m -156.03 144.08 19.77 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.998 2.119 . . . . 0.71 106.6 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -160.04 163.38 34.01 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.723 1.379 . . . . 2.21 114.723 -165.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.88 145.33 27.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.852 1.261 . . . . 5.05 111.169 164.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.42 147.23 21.89 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.515 -0.741 . . . . 4.62 112.259 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -105.66 142.23 35.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 126.63 1.972 . . . . 2.78 111.84 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.2 t -144.95 133.54 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.566 1.946 . . . . 2.54 106.903 166.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 68.49 1.1 2.82 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 126.609 1.963 . . . . 3.0 114.71 -172.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.71 18.33 61.94 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.431 1.015 . . . . 2.26 113.572 -163.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -120.55 134.85 55.23 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.75 2.42 . . . . 2.81 108.282 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.63 142.45 28.24 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 125.545 1.538 . . . . 3.83 114.052 -173.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.16 169.6 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 129.241 3.016 . . . . 2.71 107.259 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.0 mtp -117.33 139.83 50.34 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.194 -0.941 . . . . 3.33 110.728 165.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.98 -179.81 16.07 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.487 1.041 . . . . 0.57 113.772 -175.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ttm -152.89 144.88 23.73 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.617 1.967 . . . . 0.59 109.1 -176.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -146.11 156.95 50.63 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 126.022 1.729 . . . . 5.15 108.924 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.89 156.34 43.48 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 121.886 1.724 . . . . 0.59 110.667 166.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.7 m -139.12 152.16 69.27 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 124.799 1.24 . . . . 0.57 110.543 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.3 -29.33 7.88 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.862 2.375 . . . . 0.53 112.175 -168.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -174.39 165.45 3.94 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.53 1.532 . . . . 2.09 111.867 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.8 mt -109.48 154.12 23.1 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.109 1.364 . . . . 0.61 110.386 164.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -113.49 147.35 38.06 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.975 1.31 . . . . 2.05 109.962 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.6 t -140.78 140.25 21.52 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.85 0.86 . . . . 0.92 111.959 169.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -88.1 155.9 7.03 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.648 3.565 . . . . 1.32 112.846 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.39 142.76 80.29 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.992 3.128 . . . . 1.2 113.75 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt 67.61 -9.65 0.42 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.763 2.425 . . . . 1.87 114.251 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.46 160.92 46.14 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.788 1.185 . . . . 1.54 111.98 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -116.63 140.87 48.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.752 0.821 . . . . 5.23 109.302 160.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.3 t -148.32 143.92 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.875 2.07 . . . . 3.71 106.895 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.21 150.51 39.96 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.288 1.404 . . . . 4.02 114.76 -165.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.2 mp -66.73 75.25 0.11 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.208 -1.405 . . . . 1.89 107.208 151.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.8 140.54 74.59 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 114.466 -1.243 . . . . 3.16 111.538 -167.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -55.52 -35.55 92.6 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.901 2.401 . . . . 2.02 112.321 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.68 6.9 57.01 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 116.88 -2.067 . . . . 1.85 116.27 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.19 -8.56 0.02 OUTLIER Glycine 0 N--CA 1.478 1.441 0 N-CA-C 122.331 3.692 . . . . 2.11 122.331 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -145.43 143.74 30.23 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 122.188 2.994 . . . . 2.06 113.163 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -162.26 157.77 23.39 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.508 0.723 . . . . 0.49 111.369 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 60.7 m-85 -82.99 138.64 33.68 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 107.945 -1.132 . . . . 1.64 107.945 158.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -79.2 134.79 36.67 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.203 1.401 . . . . 0.88 108.051 156.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 mp -116.61 125.87 52.43 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 106.591 -1.633 . . . . 1.06 106.591 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.4 tt -147.46 136.22 22.0 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.759 -0.588 . . . . 2.15 110.325 -167.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.25 47.36 8.32 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.129 -0.788 . . . . 1.03 111.129 -167.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mt -50.64 150.54 2.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 123.044 1.402 . . . . 3.27 112.706 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -106.83 -2.4 21.46 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.065 -1.425 . . . . 2.35 113.256 -169.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -153.29 154.27 30.5 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.652 1.181 . . . . 6.44 111.682 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.35 94.67 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.476 2.117 . . . . 2.54 107.667 160.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.15 164.93 15.44 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 125.826 1.651 . . . . 2.66 109.358 176.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -146.71 165.2 30.34 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 112.764 -2.016 . . . . 4.22 113.751 -160.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.9 118.54 10.53 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.701 -1.136 . . . . 1.43 108.777 166.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.9 10.13 43.84 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.378 -1.234 . . . . 1.42 115.974 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -86.24 -175.28 5.45 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.647 1.724 . . . . 2.14 112.122 165.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -146.46 156.22 43.13 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 130.056 3.342 . . . . 5.19 107.556 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 78.6 t -156.06 128.04 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 127.487 2.315 . . . . 1.19 109.812 -170.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -91.81 130.61 37.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.079 0.466 . . . . 4.84 110.536 168.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.5 tt -111.78 136.75 50.63 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.914 1.685 . . . . 2.84 110.821 173.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -87.32 150.28 23.95 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.744 2.018 . . . . 2.34 110.004 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.419 HD11 HG22 ' A' ' 113' ' ' VAL . 5.3 mp -123.83 134.44 53.6 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.059 1.344 . . . . 1.22 110.408 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.7 mt -112.78 118.13 34.09 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.011 1.324 . . . . 0.64 110.324 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -112.31 149.59 32.2 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.821 1.248 . . . . 1.92 110.906 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.95 149.22 27.8 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.474 0.71 . . . . 1.94 112.191 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.25 12.47 84.56 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 119.123 -0.821 . . . . 3.5 114.844 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.68 63.55 1.83 Allowed Glycine 0 N--CA 1.471 1.004 0 CA-C-N 118.965 1.383 . . . . 2.37 113.581 172.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -135.78 147.69 48.46 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.744 1.618 . . . . 3.92 111.611 169.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.2 t -138.34 146.69 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.437 1.095 . . . . 2.03 110.189 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.0 tp -145.38 169.88 17.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.209 1.804 . . . . 2.14 110.128 -177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -128.55 144.65 51.19 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.282 1.216 . . . . 2.42 114.282 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.419 HG22 HD11 ' A' ' 103' ' ' LEU . 11.6 m -130.7 162.44 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 126.057 1.743 . . . . 2.49 110.978 168.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 86.5 t -121.28 141.29 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.918 2.087 . . . . 2.21 107.113 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.1 mt -152.94 106.08 2.66 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 125.11 1.364 . . . . 2.07 109.718 -160.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.53 149.92 89.11 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.904 2.403 . . . . 0.92 110.822 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.5 t -91.83 116.87 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.646 -0.872 . . . . 1.11 108.646 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.94 149.88 27.75 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.5 1.12 . . . . 3.29 111.358 -153.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -106.23 91.97 3.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.125 0.97 . . . . 2.27 113.102 -164.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 125.925 1.69 . . . . 8.07 110.195 167.875 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.228 0 N-CA-C 105.681 -2.968 . . . . 10.45 105.681 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.0 m 59.55 176.14 0.08 Allowed 'General case' 0 N--CA 1.481 1.115 0 O-C-N 124.759 0.917 . . . . 10.59 110.902 -133.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -69.76 148.73 48.8 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.778 -0.452 . . . . 10.79 109.778 162.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.6 t -158.18 12.99 0.19 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.942 2.097 . . . . 5.48 111.14 169.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -158.55 161.87 37.35 Favored 'General case' 0 CA--C 1.542 0.649 1 C-N-CA 131.857 4.063 . . . . 7.36 103.826 -175.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.77 -175.49 41.32 Favored Glycine 0 N--CA 1.463 0.49 0 C-N-CA 124.239 0.923 . . . . 1.15 115.402 -168.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -142.21 -179.26 6.15 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.904 1.682 . . . . 1.83 111.572 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.7 142.87 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 121.114 -0.991 . . . . 1.49 109.804 174.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.44 ' HG3' HH11 ' A' ' 9' ' ' ARG . 1.0 OUTLIER -86.69 126.64 34.69 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.766 0.426 . . . . 3.96 112.08 -176.051 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -50.54 139.12 16.44 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.416 1.886 . . . . 2.12 113.458 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 m -157.55 149.11 16.97 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.556 1.142 . . . . 2.32 110.588 163.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -84.53 42.72 1.21 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.416 3.411 . . . . 1.89 110.762 167.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.95 158.56 15.09 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.605 1.097 . . . . 1.32 114.502 -164.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.37 -13.99 25.32 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.848 3.032 . . . . 1.19 112.574 165.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -135.22 155.33 50.83 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 129.398 3.079 . . . . 2.21 112.62 -175.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.94 -176.29 5.47 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.072 1.749 . . . . 0.57 112.138 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -154.56 130.14 9.91 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.709 1.604 . . . . 0.95 110.385 -177.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.29 141.5 49.94 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.627 1.171 . . . . 0.54 113.28 -169.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.425 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 39.9 m-85 -126.18 115.48 19.83 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.896 1.678 . . . . 2.43 109.986 -170.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.259 0.0 OUTLIER -159.73 -174.87 4.83 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.591 1.7 . . . . 2.92 115.591 -166.491 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.1 m -108.45 135.24 50.07 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.451 1.1 . . . . 2.09 111.34 -158.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.71 108.86 17.35 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.803 1.241 . . . . 3.69 108.394 171.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -99.32 138.6 36.18 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.014 0.926 . . . . 3.95 109.174 170.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -109.33 89.17 6.76 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 122.902 0.481 . . . . 1.51 109.924 161.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.41 -9.24 20.14 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.545 2.163 . . . . 1.07 113.065 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.95 -175.54 49.24 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 124.766 1.174 . . . . 1.2 113.195 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -111.81 -4.21 14.7 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.959 2.103 . . . . 3.27 112.41 -166.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mp -125.94 163.34 40.11 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 127.713 2.405 . . . . 3.99 108.664 174.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.62 145.79 18.59 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.38 2.054 . . . . 1.28 111.273 -171.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mp -105.21 148.24 27.16 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.62 1.168 . . . . 2.89 110.058 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -139.35 103.21 4.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.801 -1.545 . . . . 3.2 109.703 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.0 tt -80.96 119.53 23.6 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 124.527 1.131 . . . . 2.36 108.207 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.1 m -111.08 -12.53 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.291 1.036 . . . . 0.83 111.258 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.45 -176.21 30.24 Favored Glycine 0 C--N 1.343 0.936 0 C-N-CA 125.316 1.436 . . . . 0.66 114.085 -174.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.408 ' HB2' ' CE1' ' A' ' 84' ' ' PHE . . . -154.72 -179.5 8.06 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.93 1.692 . . . . 0.66 110.069 173.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.02 -177.99 6.98 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 125.85 1.66 . . . . 5.31 109.143 165.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 t -179.62 153.7 0.69 Allowed Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 128.043 2.537 . . . . 0.66 106.46 -169.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -73.71 -16.58 23.66 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 120.77 1.311 . . . . 0.8 112.602 172.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.3 m -113.19 41.5 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 114.631 1.345 . . . . 0.78 114.631 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.14 142.48 4.1 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.22 -0.925 . . . . 1.12 111.828 168.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -74.65 -57.02 4.19 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.912 0.885 . . . . 2.71 110.095 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -85.02 139.99 31.36 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.91 1.284 . . . . 5.37 108.385 163.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 p -108.91 153.89 10.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.368 -1.287 . . . . 1.16 108.207 140.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -135.02 151.86 51.18 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.704 2.002 . . . . 3.0 108.294 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.2 tp -106.53 124.46 49.64 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.288 0.635 . . . . 1.1 109.892 173.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.2 m170 -123.95 159.77 29.02 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.277 1.431 . . . . 0.54 114.131 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.58 159.39 22.98 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.388 1.875 . . . . 2.31 110.743 163.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 m -135.33 145.33 47.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.079 1.751 . . . . 0.83 106.796 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -157.97 171.0 21.04 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.18 0.99 . . . . 1.99 113.54 -167.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.6 ttp -100.7 135.99 41.28 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.265 1.826 . . . . 3.17 110.134 168.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.14 138.45 40.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.636 1.175 . . . . 5.65 110.731 171.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -92.43 126.32 37.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.411 1.484 . . . . 3.43 112.9 -177.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 m -136.01 142.57 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.722 1.609 . . . . 2.49 108.249 169.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 70.15 -3.18 1.86 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 126.003 1.721 . . . . 4.13 115.065 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.43 22.82 39.04 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.769 1.176 . . . . 2.09 113.791 -161.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt -133.97 132.31 40.01 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.722 2.409 . . . . 3.73 109.56 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -67.36 121.36 15.57 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 120.575 -1.328 . . . . 4.75 112.28 170.189 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.7 m -97.94 171.36 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.703 1.201 . . . . 2.25 108.759 151.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 70.0 mtm -111.23 156.63 21.17 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.477 0.711 . . . . 3.46 111.103 164.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.39 176.04 23.07 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.898 1.237 . . . . 0.58 112.288 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.0 ttm -151.41 143.47 23.94 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.836 1.654 . . . . 0.64 109.748 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -148.97 154.03 39.2 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.624 1.57 . . . . 5.59 109.604 -173.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -76.67 161.03 34.25 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.425 2.084 . . . . 0.6 111.364 172.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.25 155.83 64.61 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.692 1.597 . . . . 0.79 110.977 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -82.62 -27.82 1.99 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.592 2.861 . . . . 0.72 113.375 -169.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -174.44 165.4 3.9 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.178 1.391 . . . . 2.17 111.916 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 mt -114.82 158.47 21.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.484 1.914 . . . . 0.89 109.727 161.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -141.33 148.13 39.24 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.908 0.883 . . . . 2.26 111.353 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -145.68 131.92 9.66 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.104 0.962 . . . . 1.17 112.438 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.4 161.71 41.92 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.578 3.519 . . . . 1.67 112.83 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.36 140.96 79.45 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.065 3.177 . . . . 1.47 113.435 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 67.73 -1.65 1.59 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.135 2.174 . . . . 2.03 113.818 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.95 164.2 38.73 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.721 1.629 . . . . 1.49 111.952 171.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.03 139.77 20.76 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.693 1.197 . . . . 4.25 110.439 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.2 t -152.85 144.95 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.216 1.807 . . . . 3.75 108.34 -165.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -126.31 145.05 50.58 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 122.034 0.921 . . . . 4.33 113.464 -168.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.1 mp -75.75 74.09 2.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.097 2.559 . . . . 1.98 109.495 171.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.438 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -64.0 146.5 97.26 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.175 0.99 . . . . 3.23 112.798 176.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.425 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 36.2 Cg_endo -60.43 -36.93 84.71 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.683 2.256 . . . . 2.33 113.37 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.89 44.33 2.77 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.162 0.887 . . . . 1.68 113.498 171.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.63 -124.3 1.14 Allowed Glycine 0 C--N 1.338 0.669 0 C-N-CA 125.44 1.495 . . . . 1.59 113.018 176.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -73.28 139.74 46.33 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.816 -0.814 . . . . 2.38 112.314 -171.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -162.19 166.97 24.86 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.326 1.45 . . . . 0.69 111.708 -174.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 35' ' ' ALA . 95.0 m-85 -95.04 148.4 22.38 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.885 -0.509 . . . . 1.72 110.112 167.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.3 tpt -105.28 139.81 39.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.589 1.556 . . . . 0.61 109.347 165.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -113.5 135.26 54.09 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.461 1.504 . . . . 0.72 108.344 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.89 133.19 41.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.649 0.78 . . . . 2.11 110.663 174.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.11 50.88 4.17 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 124.148 0.88 . . . . 0.79 113.013 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.9 mt -52.31 156.84 1.58 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.674 1.731 . . . . 2.53 115.674 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -116.89 -25.09 7.38 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.861 -1.063 . . . . 1.82 113.68 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -114.49 138.68 23.25 Favored Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 126.649 1.98 . . . . 5.74 107.075 158.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.88 133.49 31.53 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 N-CA-C 107.097 -1.924 . . . . 1.66 107.097 162.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.25 78.92 1.31 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.294 0.637 . . . . 2.83 110.439 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -68.7 163.87 22.93 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.948 0.88 . . . . 4.56 112.502 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.89 117.44 10.56 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.435 -1.32 . . . . 2.25 107.435 168.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.86 14.55 59.27 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 117.903 -1.498 . . . . 1.86 115.227 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.56 175.18 5.79 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.957 1.879 . . . . 2.7 109.378 155.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.44 171.56 8.45 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.455 -1.683 . . . . 5.51 106.455 150.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.4 t -138.17 119.89 17.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 C-N-CA 128.775 2.83 . . . . 1.92 107.505 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.81 141.68 36.0 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.399 0.68 . . . . 3.53 109.857 167.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.28 139.23 53.48 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.863 1.265 . . . . 1.71 110.951 171.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -88.02 149.54 23.94 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 129.698 3.199 . . . . 2.04 110.303 158.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -127.93 119.81 26.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.592 1.957 . . . . 0.8 108.537 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.2 mt -103.58 121.14 42.3 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.307 1.043 . . . . 0.67 111.147 -171.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -114.5 144.52 43.22 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.039 1.336 . . . . 2.08 112.361 -174.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.86 144.63 48.2 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.411 -0.813 . . . . 1.84 110.963 169.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.81 27.36 38.44 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 118.828 -0.984 . . . . 3.48 114.015 -174.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.99 36.24 32.58 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 124.703 1.144 . . . . 1.88 115.243 163.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -129.65 143.59 50.89 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.39 1.095 . . . . 3.38 112.897 -168.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.6 p -133.01 150.89 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.828 1.651 . . . . 2.01 111.034 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 31.4 tp -144.43 159.62 42.43 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.334 2.254 . . . . 2.29 108.764 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -126.85 167.99 15.07 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.335 0.971 . . . . 3.08 113.439 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.9 m -149.05 159.33 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 127.111 2.164 . . . . 2.64 110.73 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.9 t -118.86 123.52 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.466 1.106 . . . . 1.64 110.148 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.9 mt -124.9 123.89 25.51 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.701 1.2 . . . . 2.09 110.083 -170.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.37 155.37 36.7 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.927 2.418 . . . . 1.01 111.504 174.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.4 t -94.94 115.11 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.427 0.632 . . . . 1.06 111.062 172.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -93.95 130.16 40.15 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.504 1.122 . . . . 4.05 111.249 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.34 152.01 22.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.261 1.024 . . . . 4.54 108.528 151.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 . . . . . 0 C--O 1.245 0.857 0 C-N-CA 127.322 2.249 . . . . 9.3 109.62 -175.243 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.547 0 CA-C-O 118.24 -1.311 . . . . 12.91 109.847 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.8 p -170.08 166.46 9.1 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.896 1.348 . . . . 10.19 111.752 -172.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -124.98 -176.47 3.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.69 1.996 . . . . 9.2 110.585 168.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.93 137.77 17.08 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.578 1.551 . . . . 7.66 110.2 -173.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -78.76 169.59 17.99 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.495 1.518 . . . . 4.91 112.766 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.29 -178.19 27.49 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 125.142 1.353 . . . . 1.01 112.064 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -155.67 164.77 38.17 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.537 0.94 . . . . 1.86 113.537 171.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.4 t -106.86 141.25 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.337 1.455 . . . . 0.98 108.751 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -74.69 -1.63 22.7 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.416 1.636 . . . . 4.36 115.416 -172.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 64.16 172.38 0.18 Allowed 'General case' 0 CA--C 1.554 1.129 0 CA-C-N 119.919 1.236 . . . . 2.2 111.567 -170.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.4 t -160.24 154.52 19.98 Favored Pre-proline 0 N--CA 1.468 0.457 0 O-C-N 120.275 -1.515 . . . . 3.08 110.38 163.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -85.23 -3.48 9.49 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.576 2.85 . . . . 2.08 112.312 161.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.15 -173.51 13.35 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.426 1.488 . . . . 1.45 114.587 -173.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.23 -18.83 20.48 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.948 3.099 . . . . 1.85 113.849 -175.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -104.77 143.44 33.12 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.485 1.914 . . . . 2.66 113.868 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.61 -178.86 7.3 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.59 1.956 . . . . 0.66 112.405 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.34 134.33 25.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.924 2.089 . . . . 0.75 108.661 177.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.81 138.01 53.63 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.888 1.275 . . . . 0.85 111.314 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -116.81 64.57 0.72 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.707 1.603 . . . . 2.42 111.209 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.26 155.75 40.33 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.125 1.157 . . . . 2.16 114.125 -172.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.5 m -92.66 147.21 23.06 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.556 1.143 . . . . 2.15 109.769 166.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 tp -130.86 114.11 14.88 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.282 2.233 . . . . 3.47 110.135 173.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -98.79 121.34 40.61 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.798 1.639 . . . . 5.19 110.122 170.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -95.68 104.09 15.02 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 120.89 -1.132 . . . . 1.82 110.101 165.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -83.18 -10.15 10.26 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.961 2.441 . . . . 1.28 113.443 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.66 171.4 54.64 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 123.154 1.419 . . . . 1.3 113.166 -173.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.41 -6.1 34.79 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 128.609 2.764 . . . . 3.28 112.171 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.5 mt -117.76 162.59 28.25 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 127.49 2.316 . . . . 3.65 109.178 171.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -81.51 153.23 17.93 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.66 2.24 . . . . 1.18 111.211 -172.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.8 mt -102.32 155.08 18.47 Favored 'General case' 0 C--O 1.227 -0.101 0 CA-C-O 122.758 1.266 . . . . 1.94 110.374 166.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -140.24 118.89 12.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 113.661 -1.609 . . . . 1.91 109.624 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.2 tp -100.53 108.79 20.81 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.902 1.281 . . . . 1.67 109.909 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 m -104.38 -17.84 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.15 0.98 . . . . 0.6 111.833 -173.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.99 -179.04 31.63 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 125.412 1.482 . . . . 0.56 112.304 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.96 178.16 7.55 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.073 1.349 . . . . 0.88 109.926 165.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -157.38 178.65 10.07 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.005 1.722 . . . . 6.49 108.18 176.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 t 177.29 152.05 0.4 Allowed Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 126.642 1.977 . . . . 0.85 109.527 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.06 -10.49 27.33 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.731 2.287 . . . . 1.03 114.22 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.3 m -116.72 41.43 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.691 0.997 . . . . 0.86 113.691 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.84 144.97 23.83 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.259 -0.9 . . . . 1.01 110.87 162.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -93.21 -47.46 6.93 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.07 1.348 . . . . 3.71 111.447 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.11 161.23 19.77 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.313 1.845 . . . . 6.96 107.659 168.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.74 138.66 10.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 126.178 1.791 . . . . 1.48 108.979 -173.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.55 145.52 48.79 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.884 1.674 . . . . 3.05 109.873 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.8 tp -101.35 120.21 39.92 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.216 1.006 . . . . 1.07 110.783 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -123.53 155.38 37.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.102 1.761 . . . . 0.59 113.65 -174.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -99.97 162.69 12.83 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.153 -1.385 . . . . 2.47 111.685 156.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 m -121.61 136.76 54.93 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.153 1.781 . . . . 0.68 106.571 162.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -134.83 176.16 8.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.965 1.306 . . . . 1.92 112.895 -175.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.5 ptm -123.62 146.04 48.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.012 1.325 . . . . 3.2 112.863 167.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.19 138.9 24.18 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.855 2.062 . . . . 6.09 110.122 -176.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -95.13 121.88 37.22 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.833 1.253 . . . . 3.41 110.809 175.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.2 m -88.67 -120.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.973 -1.121 . . . . 3.57 107.973 172.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.07 37.67 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 130.106 3.362 . . . . 4.35 116.429 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.81 22.1 68.02 Favored Glycine 0 CA--C 1.528 0.879 0 O-C-N 119.182 -2.199 . . . . 2.36 111.504 -164.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.87 132.26 56.74 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.767 2.027 . . . . 6.61 108.264 174.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.83 131.76 34.49 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.944 1.298 . . . . 8.31 110.822 -175.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.58 150.6 20.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 124.369 1.068 . . . . 2.45 110.663 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -111.34 136.89 49.81 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.641 1.176 . . . . 2.94 110.27 -175.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.12 -176.67 14.52 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 124.968 1.27 . . . . 0.57 112.262 -174.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ttm -152.85 146.62 25.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.175 1.39 . . . . 0.63 108.914 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -156.5 152.84 23.63 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 123.779 0.832 . . . . 5.95 110.815 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.29 152.39 55.51 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.953 1.769 . . . . 0.57 111.176 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.99 153.62 71.87 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.847 1.659 . . . . 0.67 109.747 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.63 -25.3 3.76 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.961 2.44 . . . . 0.56 113.279 -166.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -177.18 164.61 2.23 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.729 1.611 . . . . 1.81 111.751 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.7 mt -111.79 153.96 25.78 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.424 1.49 . . . . 0.57 109.967 163.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -110.11 147.25 34.01 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.388 1.075 . . . . 2.15 109.2 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.5 t -139.85 129.53 13.84 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 113.018 0.747 . . . . 1.11 113.018 170.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -71.1 164.97 33.91 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.484 2.79 . . . . 1.25 112.494 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -59.63 143.48 99.65 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.347 2.698 . . . . 1.23 111.929 172.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt 67.02 -4.06 0.86 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.318 1.847 . . . . 2.09 114.26 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.36 134.8 13.15 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.713 1.625 . . . . 1.39 113.088 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -97.84 138.89 34.52 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.646 1.178 . . . . 5.33 110.139 164.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.3 t -144.9 132.12 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.059 1.343 . . . . 3.12 108.0 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.49 136.48 49.56 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.6 0.714 . . . . 3.25 110.827 172.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mp -71.19 78.13 0.7 Allowed 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 125.45 1.5 . . . . 2.51 109.1 165.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -76.08 156.13 84.17 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.248 1.419 . . . . 3.6 114.159 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.79 -18.29 62.03 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.571 2.18 . . . . 2.07 113.093 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.22 36.18 2.18 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.154 -0.804 . . . . 2.51 112.819 166.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.71 -118.88 0.91 Allowed Glycine 0 C--N 1.344 0.974 0 C-N-CA 124.751 1.167 . . . . 1.79 115.066 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -72.15 142.07 49.1 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 121.812 -0.817 . . . . 1.93 111.937 -165.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -161.98 171.35 17.75 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.354 1.062 . . . . 0.76 112.251 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -107.33 133.4 51.93 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.14 0.576 . . . . 2.0 110.758 170.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.1 tpt -82.08 128.64 34.33 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.23 1.412 . . . . 0.75 109.324 163.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.4 mp -116.6 134.32 54.97 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.838 1.255 . . . . 0.97 108.971 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.8 mt -135.58 132.94 37.78 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.752 0.821 . . . . 2.09 110.738 -170.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.49 36.56 26.23 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.606 -1.108 . . . . 0.91 114.065 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -45.05 150.62 0.38 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 116.528 2.047 . . . . 1.31 116.528 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -106.74 7.13 30.25 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 113.713 -1.585 . . . . 2.32 113.901 -169.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.9 ptm85 -145.32 147.6 34.5 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.959 1.304 . . . . 4.78 111.627 167.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.07 149.64 71.54 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.297 1.998 . . . . 1.89 108.435 158.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.72 134.54 25.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.462 1.105 . . . . 3.95 110.512 -156.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.5 mmtm -103.32 171.99 7.06 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.068 1.347 . . . . 3.8 111.489 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.58 134.6 46.54 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.822 -1.177 . . . . 1.19 107.822 148.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.24 21.91 16.36 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.44 1.495 . . . . 1.23 115.405 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -105.79 -174.96 2.66 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.412 1.606 . . . . 1.86 111.815 168.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -147.45 131.63 17.39 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 129.747 3.219 . . . . 5.58 105.344 -169.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.1 t -140.5 130.5 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.093 0.957 . . . . 0.95 110.985 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -76.09 141.66 41.94 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.326 1.051 . . . . 2.71 110.052 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 mp -128.15 136.81 51.63 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.816 0.846 . . . . 1.76 111.969 167.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -90.77 134.19 34.62 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 127.131 2.172 . . . . 2.54 109.339 173.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.73 118.01 35.49 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 119.702 1.137 . . . . 0.93 110.065 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 72.2 mt -90.42 102.18 14.92 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.577 -0.897 . . . . 0.88 108.577 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -92.43 142.65 27.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.467 0.707 . . . . 2.55 111.274 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.15 124.0 10.64 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.54 1.136 . . . . 1.59 112.109 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.1 46.99 19.8 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.712 -1.049 . . . . 2.99 114.296 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.84 25.29 25.36 Favored Glycine 0 N--CA 1.475 1.246 0 N-CA-C 117.172 1.629 . . . . 1.89 117.172 156.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.57 148.1 39.96 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.453 1.626 . . . . 3.9 111.221 168.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -140.28 151.63 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.786 1.234 . . . . 1.83 110.935 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.9 tp -155.38 138.09 15.2 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.874 1.669 . . . . 2.48 109.548 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -110.21 115.71 30.21 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.692 0.678 . . . . 1.96 112.504 -173.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.6 m -89.31 178.12 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.057 1.743 . . . . 2.3 111.592 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.7 p -142.42 145.28 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.078 1.351 . . . . 2.38 109.041 170.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.4 143.75 13.82 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.078 0.951 . . . . 2.27 113.126 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.54 156.69 63.23 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.965 3.11 . . . . 0.9 112.953 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.7 t -106.34 124.93 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.513 1.525 . . . . 0.9 109.314 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -146.83 155.21 42.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.267 1.827 . . . . 3.85 110.541 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -112.55 129.5 56.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.083 0.953 . . . . 2.74 113.011 -165.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 C-N-CA 126.379 1.872 . . . . 7.64 111.968 167.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.191 0 N-CA-C 106.084 -2.806 . . . . 12.2 106.084 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.5 p -65.1 175.74 1.5 Allowed 'General case' 0 CA--C 1.549 0.933 0 O-C-N 123.773 0.337 . . . . 12.74 111.733 133.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -144.24 -97.68 0.11 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.403 1.481 . . . . 8.38 110.928 171.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 174.95 108.37 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.844 2.458 . . . . 6.88 110.785 -174.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -156.76 73.23 0.76 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.579 1.152 . . . . 7.23 108.554 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.35 165.71 33.96 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.866 1.698 . . . . 0.91 112.407 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 21.8 p90 -155.65 152.11 28.27 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.319 1.448 . . . . 1.72 111.971 174.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.0 t -89.39 137.87 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.388 -0.82 . . . . 1.34 109.021 171.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -62.53 -4.6 2.02 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.121 1.768 . . . . 4.15 115.729 -168.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 72.6 159.89 0.22 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.569 1.948 . . . . 2.71 111.154 -167.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.9 t -168.87 135.71 1.53 Allowed Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 121.155 -0.966 . . . . 2.45 111.077 163.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -81.42 -6.88 12.81 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.271 2.648 . . . . 1.94 112.235 169.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.59 171.99 15.06 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.48 1.515 . . . . 1.04 113.551 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.76 -13.45 34.31 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.944 3.763 . . . . 1.27 115.454 -172.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -123.41 144.4 49.51 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.639 1.575 . . . . 3.67 112.256 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.69 -176.49 4.67 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.367 1.867 . . . . 0.45 112.012 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.97 154.3 39.18 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.694 1.997 . . . . 0.76 108.504 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.51 146.48 42.02 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.75 1.22 . . . . 0.79 114.227 -173.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.464 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 30.2 m-85 -120.7 143.6 48.66 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.867 2.067 . . . . 2.45 110.184 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pp -171.38 151.62 3.11 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.441 1.275 . . . . 2.03 114.441 -175.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.4 m -79.13 144.27 34.67 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.923 1.689 . . . . 1.96 111.359 174.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.5 126.99 54.97 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 129.502 3.121 . . . . 3.54 108.057 168.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -118.94 127.46 53.5 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.802 1.241 . . . . 4.24 109.663 168.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -100.46 93.44 2.76 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 123.606 0.762 . . . . 1.43 110.061 170.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.54 -8.89 18.52 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.025 1.817 . . . . 1.36 112.983 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.42 162.45 34.83 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 122.684 1.158 . . . . 1.23 111.643 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -94.53 3.27 55.33 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.352 2.661 . . . . 2.99 112.046 -170.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -122.21 154.32 61.87 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 129.242 3.017 . . . . 1.98 109.678 174.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.78 147.01 30.59 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.759 2.306 . . . . 0.86 111.024 -172.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.6 mt -104.2 147.93 26.9 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 122.465 1.126 . . . . 1.95 110.537 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -136.73 99.04 3.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.562 -2.108 . . . . 2.26 110.725 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.2 tp -80.73 106.43 12.73 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.669 1.588 . . . . 2.0 109.727 -173.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -99.19 -21.18 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.771 1.229 . . . . 0.81 112.209 -175.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.16 -177.16 31.98 Favored Glycine 0 C--N 1.343 0.947 0 C-N-CA 124.96 1.266 . . . . 0.74 114.937 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.07 -177.24 5.35 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.562 1.945 . . . . 0.74 111.131 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.429 HH12 HG11 ' A' ' 110' ' ' VAL . 40.9 mtt85 -146.55 -179.42 6.76 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.809 2.044 . . . . 6.65 108.062 158.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t -174.77 152.08 1.54 Allowed Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 127.12 2.168 . . . . 0.82 108.299 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.78 -6.29 15.94 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.025 1.817 . . . . 0.99 113.899 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.434 HG22 HG11 ' A' ' 99' ' ' VAL . 35.7 m -115.23 45.31 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.532 1.133 . . . . 0.9 112.854 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.33 171.76 19.81 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.665 1.186 . . . . 1.28 111.8 168.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -104.96 -23.49 12.97 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 128.464 2.706 . . . . 2.83 111.221 166.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -152.26 160.49 43.34 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.44 2.296 . . . . 6.59 110.858 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.2 p -156.93 117.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 125.815 1.646 . . . . 1.8 110.301 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -131.28 130.68 43.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.954 -1.021 . . . . 5.0 111.352 -166.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 31.3 tp -83.3 122.51 28.54 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.958 0.903 . . . . 1.4 111.746 -168.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.3 m170 -124.75 160.78 27.87 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.618 1.567 . . . . 0.69 113.356 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -107.18 154.17 21.59 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 113.467 -1.697 . . . . 2.37 110.721 157.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.0 m -111.18 138.33 47.75 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.265 1.826 . . . . 1.04 106.521 162.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -133.78 174.19 10.72 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.191 1.396 . . . . 2.0 112.968 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.0 ttp -113.0 143.0 45.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.628 1.571 . . . . 3.52 109.833 166.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -138.31 152.67 48.72 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.135 1.374 . . . . 4.77 112.036 171.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -95.84 146.93 24.17 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.104 1.762 . . . . 2.2 110.602 163.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 m -147.93 130.71 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.885 2.074 . . . . 2.26 108.837 162.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 62.98 15.84 8.74 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.577 1.551 . . . . 3.35 114.34 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.71 16.79 69.63 Favored Glycine 0 N--CA 1.479 1.513 0 O-C-N 121.054 -1.029 . . . . 1.68 113.741 -169.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.9 mtmt -119.27 122.17 41.3 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.974 2.11 . . . . 3.46 108.071 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.47 128.43 38.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.869 1.268 . . . . 3.69 111.76 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 t -143.69 141.73 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 127.208 2.203 . . . . 2.76 108.662 -174.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 50.6 mtp -83.54 162.93 20.72 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.358 0.663 . . . . 3.33 112.655 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.56 -177.47 28.83 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 125.118 1.342 . . . . 0.91 112.397 -177.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.1 ttm -154.79 148.25 25.16 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.531 1.133 . . . . 0.92 109.844 -172.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -155.89 153.7 26.36 Favored Pre-proline 0 N--CA 1.474 0.736 0 C-N-CA 123.779 0.832 . . . . 6.17 111.475 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.77 156.56 39.65 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.499 2.133 . . . . 0.68 111.262 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.7 m -138.88 153.03 71.54 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 125.114 1.366 . . . . 0.65 110.148 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.32 -24.7 5.27 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.656 2.904 . . . . 0.75 113.337 -167.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -174.99 167.0 3.58 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.621 1.968 . . . . 2.13 110.929 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.4 mt -109.6 153.34 24.31 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.526 1.13 . . . . 0.73 110.31 159.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -108.94 143.65 37.91 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.234 1.014 . . . . 1.86 109.167 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.7 t -136.88 124.3 14.28 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.386 0.674 . . . . 0.96 110.989 165.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -69.82 164.51 34.33 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.773 2.982 . . . . 0.96 111.643 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.66 147.89 92.49 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.017 2.478 . . . . 0.97 113.301 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt 69.73 -14.04 0.37 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.335 2.654 . . . . 1.74 114.219 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.62 172.63 42.9 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.18 1.372 . . . . 1.42 113.572 -171.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.68 143.94 35.37 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.89 0.876 . . . . 4.44 111.119 168.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.5 t -151.17 158.49 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 127.379 2.272 . . . . 3.8 107.213 -168.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.43 152.74 42.91 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 121.075 1.761 . . . . 3.77 114.088 176.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.1 mp -59.95 91.16 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 107.311 -1.366 . . . . 1.91 107.311 155.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -49.93 126.0 18.8 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 125.351 1.46 . . . . 3.47 111.831 -165.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 19.7 Cg_endo -60.96 -13.75 29.04 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.878 2.385 . . . . 2.71 116.678 -172.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.39 -1.39 29.5 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-N 120.101 1.319 . . . . 2.72 115.277 167.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.94 -103.8 1.2 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.359 1.933 . . . . 1.94 112.466 -168.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -72.49 139.12 47.45 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.269 -1.136 . . . . 2.0 112.059 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -160.22 149.74 17.72 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.561 1.144 . . . . 0.6 110.519 -173.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -83.25 130.09 35.05 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.298 -1.001 . . . . 1.62 108.298 165.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -80.04 133.08 36.11 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.279 0.945 . . . . 0.65 108.832 163.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 mp -109.56 126.92 54.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.342 1.057 . . . . 0.58 109.369 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -118.89 130.1 55.55 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 124.227 1.011 . . . . 3.39 109.647 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.54 54.74 3.87 Favored Glycine 0 N--CA 1.476 1.363 0 C-N-CA 123.744 0.688 . . . . 0.76 114.662 167.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.34 158.68 4.06 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 117.673 2.471 . . . . 1.55 117.673 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -116.29 -25.62 7.48 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 113.08 -1.873 . . . . 1.76 112.855 -171.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -117.81 151.83 49.2 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 129.48 3.112 . . . . 7.05 107.811 159.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.99 140.66 38.52 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.229 1.953 . . . . 1.8 108.611 164.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.6 mp -95.74 89.21 5.23 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.158 0.504 . . . . 2.44 110.259 -175.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -75.21 174.16 9.85 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.268 0.556 . . . . 5.07 111.758 167.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.72 146.45 44.41 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.501 -1.296 . . . . 1.35 107.501 165.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.32 34.5 63.96 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 117.866 -1.519 . . . . 1.6 114.163 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -94.73 174.04 7.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.14 1.47 . . . . 2.65 109.185 157.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -135.5 127.77 30.14 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 105.092 -2.188 . . . . 4.35 105.092 169.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.434 HG11 HG22 ' A' ' 39' ' ' VAL . 10.7 t -152.45 140.05 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.944 1.298 . . . . 2.04 110.331 -175.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -78.3 154.67 30.69 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 113.394 0.887 . . . . 3.64 113.394 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.9 137.36 51.79 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.264 -1.334 . . . . 1.81 110.4 149.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.41 150.6 31.28 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.582 1.153 . . . . 2.59 108.611 159.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.0 mp -123.86 127.69 48.39 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.025 1.33 . . . . 1.02 110.209 175.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.3 mt -110.65 114.12 27.26 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.99 1.716 . . . . 1.12 110.226 -172.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -113.21 123.59 50.55 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.759 1.224 . . . . 1.95 111.613 -172.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 48.01 32.13 2.75 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.308 1.843 . . . . 2.25 113.502 176.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.25 -73.96 2.35 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.107 1.337 . . . . 4.97 112.689 -172.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.15 -26.36 44.62 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 116.44 1.336 . . . . 2.07 116.44 -161.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -83.81 109.46 17.56 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.58 1.69 . . . . 4.82 111.716 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.429 HG11 HH12 ' A' ' 36' ' ' ARG . 58.8 t -98.52 134.46 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.399 1.48 . . . . 1.78 110.712 174.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -136.68 171.62 14.22 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.811 1.644 . . . . 3.36 109.606 166.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -149.6 143.96 25.88 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.786 -1.196 . . . . 2.02 112.007 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.84 150.57 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.137 0.975 . . . . 2.35 110.011 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.83 133.51 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.523 1.529 . . . . 1.65 107.641 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.4 mt -139.07 145.58 45.76 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.422 1.089 . . . . 2.56 109.918 -173.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.14 162.46 35.61 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.796 2.331 . . . . 0.73 112.444 167.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 42.6 t -112.07 122.5 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.189 -1.411 . . . . 0.99 107.189 165.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -146.48 154.54 41.69 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.467 1.507 . . . . 4.48 110.391 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.03 141.85 28.4 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.484 0.92 . . . . 2.35 113.484 -168.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.541 ' HB2' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.976 0 C-N-CA 126.157 1.783 . . . . 8.6 112.103 169.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.01 0 N-CA-C 104.748 -3.341 . . . . 12.54 104.748 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p 168.5 163.44 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 O-C-N 124.771 0.924 . . . . 11.65 109.383 -139.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -158.96 145.61 17.05 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.797 1.239 . . . . 7.9 113.928 -170.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.0 p -104.73 63.17 0.72 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.245 1.418 . . . . 7.52 111.922 -165.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -77.88 76.05 4.41 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 123.078 1.418 . . . . 6.37 112.065 -174.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.98 179.03 21.62 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 121.161 -0.962 . . . . 1.0 111.393 173.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.3 p90 -148.94 157.06 43.14 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.778 0.831 . . . . 1.78 112.053 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.2 t -97.56 143.65 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 107.65 -1.241 . . . . 1.3 107.65 173.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -73.87 127.27 32.4 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.438 -0.789 . . . . 4.78 110.816 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -36.02 148.49 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.675 1.99 . . . . 2.52 113.333 155.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.9 t -160.25 146.75 11.96 Favored Pre-proline 0 CA--C 1.536 0.439 0 O-C-N 120.884 -1.135 . . . . 2.31 112.333 166.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -85.89 -6.81 8.52 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.18 2.587 . . . . 2.0 112.693 170.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -137.58 -176.58 14.53 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.73 1.157 . . . . 1.12 114.423 -172.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.3 -17.92 44.56 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.483 3.455 . . . . 1.49 115.097 -169.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -97.85 142.07 30.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.19 1.396 . . . . 2.81 112.64 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.14 -176.48 5.69 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.484 1.514 . . . . 0.69 111.944 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.21 152.3 32.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.675 1.59 . . . . 0.72 109.708 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.08 124.27 47.65 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.09 1.314 . . . . 0.82 111.773 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -102.16 57.39 0.81 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.812 1.645 . . . . 2.81 109.635 173.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -75.12 162.93 28.08 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.057 0.943 . . . . 1.93 113.163 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 99.0 m -143.58 137.38 28.33 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.892 1.677 . . . . 2.5 110.869 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.616 HD21 HG11 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -135.1 156.52 48.87 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.255 2.222 . . . . 4.94 109.018 169.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -84.79 160.89 20.15 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.196 1.362 . . . . 3.39 110.507 154.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -97.86 94.33 2.09 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 109.042 -0.725 . . . . 1.8 109.042 155.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.98 -6.27 14.96 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.063 2.509 . . . . 1.86 113.433 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.33 164.52 52.53 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-O 122.722 1.179 . . . . 1.76 112.082 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -87.02 -5.89 58.92 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.661 1.584 . . . . 3.78 111.742 175.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 pp -116.04 159.13 40.57 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 127.666 2.387 . . . . 2.56 111.198 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.01 145.29 22.07 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.576 2.184 . . . . 1.34 111.046 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.1 mt -99.33 142.84 30.29 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 123.018 1.39 . . . . 2.46 111.727 170.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.42 ' HD2' ' CD2' ' A' ' 66' ' ' PHE . 16.4 tpp85 -131.47 98.38 4.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 112.119 -2.31 . . . . 1.97 109.474 -174.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.9 tp -91.39 109.27 20.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.565 1.546 . . . . 1.9 109.691 -171.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.7 m -103.68 -22.07 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.826 0.85 . . . . 0.57 112.084 -173.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.88 -177.08 30.65 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.466 1.508 . . . . 0.52 114.288 -173.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.35 178.38 8.83 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.8 1.64 . . . . 0.52 112.269 171.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.8 161.08 36.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.54 2.336 . . . . 6.22 109.12 174.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 t -176.25 154.08 1.33 Allowed Pre-proline 0 N--CA 1.471 0.6 0 C-N-CA 128.08 2.552 . . . . 0.71 107.176 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.16 -20.16 19.27 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.85 1.7 . . . . 0.94 112.499 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.6 m -99.1 35.27 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.799 0.809 . . . . 0.84 112.899 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.14 143.05 16.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.982 1.313 . . . . 1.03 109.234 166.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -91.51 -49.42 6.32 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.63 1.572 . . . . 3.81 110.592 -176.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.99 160.15 22.53 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.468 1.907 . . . . 6.48 107.665 167.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.1 p -142.52 145.45 23.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 126.067 1.747 . . . . 1.35 108.049 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -129.47 148.74 51.41 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.057 1.743 . . . . 3.06 108.771 174.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.5 tp -101.16 121.28 41.54 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.349 -0.845 . . . . 0.98 109.911 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.1 m170 -123.61 154.28 39.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.436 1.494 . . . . 0.55 113.871 -174.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -100.68 179.8 4.31 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.341 1.456 . . . . 2.15 112.098 162.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.5 m -145.63 128.44 16.32 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 106.665 -1.606 . . . . 0.65 106.665 172.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -129.16 167.96 16.84 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 114.357 1.243 . . . . 2.26 114.357 -166.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -109.2 147.6 32.28 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.864 1.666 . . . . 4.99 110.994 171.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.55 151.76 24.69 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.776 0.83 . . . . 5.16 112.004 -174.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -103.72 143.29 32.99 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.702 1.601 . . . . 2.26 109.671 167.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -158.99 139.97 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.613 1.165 . . . . 3.09 108.336 167.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 62.25 27.17 16.29 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.334 1.053 . . . . 3.45 111.844 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.99 18.2 78.99 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 120.912 -1.118 . . . . 1.69 113.605 -175.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -132.48 129.33 39.04 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.046 1.338 . . . . 2.55 110.179 -174.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.599 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -71.29 130.09 40.51 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.311 2.244 . . . . 3.98 111.315 173.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.1 m -141.43 175.12 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 129.171 2.988 . . . . 2.25 110.235 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.25 162.9 21.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.079 1.351 . . . . 3.68 111.172 177.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.3 -178.14 29.25 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.089 1.328 . . . . 0.52 113.704 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.3 ttm -154.82 148.49 25.39 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.507 1.923 . . . . 0.6 108.286 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -160.43 156.4 22.64 Favored Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 124.814 1.246 . . . . 5.76 110.471 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.64 155.44 44.68 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.254 1.969 . . . . 0.6 111.519 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.99 154.72 70.76 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.655 1.582 . . . . 0.68 110.156 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.69 -24.49 3.44 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.178 2.585 . . . . 0.57 113.367 -167.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.42 ' CD2' ' HD2' ' A' ' 31' ' ' ARG . 50.6 p90 -178.24 163.05 1.61 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.334 1.853 . . . . 1.86 111.073 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.1 mt -109.6 153.01 24.78 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.006 1.323 . . . . 0.69 110.377 166.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -121.39 137.33 54.75 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.288 1.435 . . . . 2.09 109.194 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.9 t -140.32 130.99 13.89 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 123.667 0.787 . . . . 1.35 111.544 175.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.3 163.76 37.53 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.356 2.704 . . . . 1.31 112.39 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -60.03 140.36 92.25 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.42 2.747 . . . . 1.55 111.012 171.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp 65.78 0.75 1.6 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.137 1.375 . . . . 3.28 113.374 -175.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.11 -175.18 41.9 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.225 1.869 . . . . 1.77 109.907 163.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -139.19 138.45 36.91 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.712 -0.876 . . . . 7.47 112.865 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -93.04 57.23 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 128.189 2.595 . . . . 5.21 108.43 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -81.4 125.3 30.24 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.136 0.974 . . . . 3.61 108.859 163.272 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 83' ' ' HIS . 5.1 mp -72.48 -53.94 10.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.162 -0.472 . . . . 3.14 110.477 175.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.314 0.0 OUTLIER 79.94 123.55 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.081 0 C-N-CA 128.157 2.583 . . . . 3.36 114.228 176.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.41 -15.19 48.68 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 123.065 2.51 . . . . 2.16 113.9 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.86 5.12 84.86 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 117.073 -1.959 . . . . 1.5 114.745 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.49 -24.14 0.02 OUTLIER Glycine 0 C--N 1.348 1.23 0 N-CA-C 121.596 3.398 . . . . 2.07 121.596 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -145.77 147.62 32.09 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.022 1.911 . . . . 2.07 113.215 171.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.581 ' HA ' HD23 ' A' ' 77' ' ' LEU . 50.2 p-80 -162.18 155.41 20.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.12 0.968 . . . . 0.63 110.889 177.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -80.32 137.16 36.55 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.108 0.867 . . . . 1.89 109.119 158.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.8 tpt -85.21 129.73 34.75 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.881 1.272 . . . . 0.7 108.43 162.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -111.62 126.41 54.98 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.466 1.107 . . . . 0.58 108.866 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.96 128.63 55.91 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.243 1.017 . . . . 2.9 109.432 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.48 44.48 10.91 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 118.561 -1.133 . . . . 0.95 114.834 169.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -43.52 149.82 0.25 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 117.734 2.494 . . . . 1.37 117.734 176.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -115.82 -22.56 9.04 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 114.19 -1.368 . . . . 2.86 114.526 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -91.38 168.62 13.05 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 107.553 -1.277 . . . . 5.7 107.553 149.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -63.38 177.93 1.41 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 121.153 1.236 . . . . 2.66 109.907 148.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.0 mt -129.13 95.08 3.96 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.135 -0.978 . . . . 2.56 109.314 167.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -99.33 159.44 15.0 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.967 0.889 . . . . 5.67 112.829 176.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.74 130.62 44.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.275 -1.329 . . . . 1.45 107.915 159.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.92 0.68 83.23 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.484 1.992 . . . . 1.44 116.797 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.412 ' HB3' ' H ' ' A' ' 98' ' ' GLU . 33.9 mt-10 -81.48 -171.46 3.31 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.482 2.141 . . . . 2.66 113.312 175.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 97' ' ' GLU . 16.5 pt-20 -152.51 124.98 8.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 128.62 2.768 . . . . 5.01 105.899 -155.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 38.1 t -144.02 125.34 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 O-C-N 121.578 -0.701 . . . . 1.13 110.333 -173.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -79.56 151.21 30.8 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.497 -0.774 . . . . 3.03 111.325 168.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.23 147.22 34.5 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.828 2.051 . . . . 1.99 110.793 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -121.53 108.0 13.09 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 128.946 2.898 . . . . 2.2 108.312 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.0 mp -83.98 128.09 34.31 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.355 -0.84 . . . . 0.99 110.584 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.6 mt -97.82 103.41 15.35 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.362 1.065 . . . . 0.7 110.557 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -98.02 143.11 28.93 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.675 1.19 . . . . 2.23 111.435 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.64 131.69 39.39 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.282 1.033 . . . . 2.01 112.421 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.18 41.93 7.27 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.801 -0.999 . . . . 2.95 113.938 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.16 7.21 88.61 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 116.018 1.167 . . . . 2.13 116.018 165.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -90.43 112.62 24.31 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.963 1.382 . . . . 3.32 111.382 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.13 134.15 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.917 1.287 . . . . 2.23 109.999 173.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.0 tp -128.49 111.01 12.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.776 0.83 . . . . 1.91 111.465 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -81.76 135.16 35.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.417 0.687 . . . . 2.17 112.354 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.616 HG11 HD21 ' A' ' 22' ' ' LEU . 7.7 m -144.84 162.2 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 127.458 2.303 . . . . 2.02 111.019 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.2 t -131.91 132.45 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.625 0.77 . . . . 1.64 109.881 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.89 153.69 64.54 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 126.251 1.82 . . . . 1.85 110.142 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.04 167.11 27.62 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.674 2.916 . . . . 0.74 112.278 175.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.85 135.29 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.786 1.234 . . . . 0.89 109.358 167.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -150.26 165.45 32.92 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 115.991 1.849 . . . . 4.3 115.991 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.14 149.55 27.91 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 116.963 2.209 . . . . 2.61 116.963 -159.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.186 1 C-N-CA 134.05 4.94 . . . . 8.48 108.462 161.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.375 0 N-CA-C 109.48 -1.448 . . . . 11.97 109.48 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.1 p -171.35 167.85 6.75 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.5 1.15 . . . . 9.16 112.364 -165.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -87.24 172.31 9.99 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.045 1.338 . . . . 9.16 111.851 170.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.05 163.04 34.67 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.42 2.688 . . . . 6.86 107.566 170.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -133.23 152.18 51.93 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.965 1.706 . . . . 7.06 107.947 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.85 164.24 31.23 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 123.541 0.591 . . . . 1.33 111.961 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -108.36 168.58 9.21 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.147 0.979 . . . . 2.09 112.206 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.8 t -90.88 131.52 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.083 0.953 . . . . 1.25 109.011 167.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 107.67 11.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.972 0.909 . . . . 4.9 108.828 171.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -42.78 149.69 0.18 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.317 1.847 . . . . 2.06 114.806 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.6 t -152.51 151.56 27.31 Favored Pre-proline 0 CA--C 1.538 0.492 0 O-C-N 121.132 -0.98 . . . . 2.85 111.08 163.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -88.32 -2.66 6.88 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.429 2.753 . . . . 2.31 111.968 164.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.7 -179.38 20.0 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.929 1.252 . . . . 1.37 114.716 -170.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.81 -17.21 37.46 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.635 3.556 . . . . 1.45 114.635 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -110.28 153.9 24.2 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.495 1.518 . . . . 2.39 113.738 172.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.39 -178.47 6.68 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 128.132 2.573 . . . . 0.71 110.647 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.13 152.74 36.65 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.338 1.455 . . . . 0.65 110.448 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.62 146.61 36.42 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.239 1.2 . . . . 0.56 114.239 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -117.51 29.74 7.69 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 115.663 1.727 . . . . 2.9 115.663 -167.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -49.74 161.88 0.2 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 117.876 2.547 . . . . 1.88 117.876 -169.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 15.8 m -79.64 119.81 23.1 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.448 0.642 . . . . 2.01 111.589 172.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.467 HD12 HG21 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -83.35 139.24 33.14 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.55 -0.907 . . . . 3.75 108.55 164.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -147.39 172.45 13.9 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.368 0.667 . . . . 6.15 111.551 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -155.71 110.38 2.17 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.338 1.455 . . . . 1.38 110.74 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -90.7 -5.82 4.39 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.844 3.03 . . . . 1.39 114.292 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.99 178.23 41.99 Favored Glycine 0 C--N 1.341 0.818 0 CA-C-N 119.55 1.068 . . . . 1.18 112.956 -174.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -101.25 3.2 40.66 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.408 2.283 . . . . 3.29 112.323 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -118.74 160.21 41.27 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 127.116 2.166 . . . . 2.06 110.254 171.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.75 142.26 15.87 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.344 2.03 . . . . 1.06 111.422 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.471 HD12 ' CD1' ' A' ' 105' ' ' PHE . 1.9 mm? -102.95 157.11 17.2 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.359 1.464 . . . . 2.53 111.975 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -152.99 104.54 2.84 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.02 -1.446 . . . . 2.07 111.649 -169.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.2 tt -83.03 123.64 29.67 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.702 1.201 . . . . 2.4 108.61 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 m -110.91 -15.12 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.665 0.786 . . . . 0.7 111.662 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.48 -177.12 30.28 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 125.6 1.571 . . . . 0.52 114.051 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.9 -179.55 7.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.46 1.504 . . . . 0.56 111.699 171.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -155.92 173.26 17.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.605 2.362 . . . . 6.31 109.212 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 t 178.54 146.75 0.36 Allowed Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 129.106 2.963 . . . . 0.82 106.87 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.0 -15.62 36.26 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 121.736 1.624 . . . . 1.3 113.544 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.0 22.17 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.609 1.164 . . . . 1.22 113.288 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.75 138.47 28.83 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.786 1.176 . . . . 1.02 110.382 169.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -83.21 -41.03 18.88 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.007 0.923 . . . . 3.81 111.062 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -131.16 152.84 50.03 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 128.537 2.735 . . . . 6.69 106.396 -175.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.6 p -146.57 146.27 18.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 124.555 1.142 . . . . 1.43 108.772 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -132.36 145.36 51.19 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.97 1.708 . . . . 3.12 108.841 175.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.4 tp -99.63 118.79 36.93 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.809 -0.557 . . . . 0.98 109.639 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.0 m170 -122.53 154.12 38.31 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.245 1.418 . . . . 0.63 114.068 -174.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -102.04 163.66 12.12 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.354 -1.294 . . . . 2.31 111.622 161.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.4 m -120.88 130.63 53.99 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 105.906 -1.887 . . . . 0.88 105.906 163.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -127.37 168.52 14.71 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.518 1.303 . . . . 2.08 114.518 -170.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -109.49 148.21 31.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.853 1.661 . . . . 4.99 111.425 170.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.58 148.48 24.37 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.414 1.086 . . . . 5.04 110.56 -174.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -98.53 140.02 33.39 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.564 1.145 . . . . 2.93 109.895 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.1 t -137.81 118.41 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.353 1.061 . . . . 2.3 108.241 168.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 66.49 15.14 10.02 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 126.191 1.796 . . . . 4.13 114.85 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.6 21.64 55.7 Favored Glycine 0 CA--C 1.535 1.32 0 O-C-N 121.356 -0.84 . . . . 2.58 112.943 -166.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.5 mttt -124.53 113.53 18.22 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.604 1.562 . . . . 3.39 109.133 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.8 123.01 28.94 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.604 -0.685 . . . . 5.73 110.519 -171.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.29 179.76 3.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 128.451 2.7 . . . . 2.6 110.764 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.83 162.56 31.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.88 1.272 . . . . 2.57 111.862 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.35 -176.54 27.65 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.53 1.538 . . . . 0.64 113.662 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.0 ttm -150.8 148.02 27.99 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.195 1.798 . . . . 0.88 108.873 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -158.65 157.34 28.49 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 124.659 1.184 . . . . 5.86 111.131 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.99 154.77 53.04 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.011 1.807 . . . . 0.67 111.699 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.45 156.5 74.99 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 126.283 1.833 . . . . 0.76 110.091 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.44 -26.76 3.09 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.023 2.482 . . . . 0.61 113.371 -167.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -175.3 164.68 3.24 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.501 1.521 . . . . 2.1 111.231 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.4 mt -113.33 153.92 27.7 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.897 1.679 . . . . 0.73 110.119 164.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -136.34 147.99 47.68 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.355 0.662 . . . . 2.26 111.836 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.467 HG21 HD12 ' A' ' 22' ' ' LEU . 88.0 t -141.56 131.47 12.79 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.161 0.985 . . . . 0.83 112.366 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -69.97 161.98 43.9 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.742 2.962 . . . . 0.92 111.704 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.24 140.91 81.64 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.598 2.866 . . . . 0.98 113.517 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp 66.94 2.88 2.85 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.476 1.91 . . . . 1.75 114.552 176.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.78 160.31 31.16 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.843 1.687 . . . . 1.2 114.24 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.19 146.04 33.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.333 1.053 . . . . 4.16 110.85 168.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.2 t -155.81 132.92 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 125.491 1.516 . . . . 4.46 108.642 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 2.8 mp0 -83.21 141.66 31.74 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.137 1.335 . . . . 3.74 111.102 176.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mp -46.49 -43.57 16.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.989 1.316 . . . . 2.94 112.007 -177.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 108.13 128.56 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 128.019 2.528 . . . . 3.84 111.019 158.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -59.98 116.16 3.12 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 N-CA-C 107.463 -1.783 . . . . 2.7 107.463 165.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.78 26.07 59.27 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 116.98 -2.011 . . . . 2.01 116.463 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.58 -42.74 0.04 OUTLIER Glycine 0 N--CA 1.482 1.729 0 N-CA-C 119.252 2.461 . . . . 1.79 119.252 166.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -137.2 145.94 44.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.745 1.26 . . . . 1.92 110.753 160.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -160.56 153.02 20.67 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.176 -0.953 . . . . 0.73 109.339 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -78.72 151.02 32.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.82 -0.807 . . . . 2.27 108.82 162.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.3 tpt -101.0 129.42 46.84 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.912 1.685 . . . . 0.77 107.391 159.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.84 137.62 49.55 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.671 1.188 . . . . 0.66 108.479 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -139.44 146.61 40.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.516 1.127 . . . . 2.36 112.69 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.78 26.94 68.05 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.464 1.03 . . . . 1.33 113.728 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.5 148.12 2.99 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 117.07 2.248 . . . . 1.48 117.07 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -120.7 2.48 10.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 112.065 -2.334 . . . . 2.31 113.494 -165.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -145.25 144.51 23.55 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 127.094 2.158 . . . . 6.03 108.22 164.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.07 158.3 45.81 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.111 2.541 . . . . 1.74 110.343 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -106.18 99.55 9.13 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.973 1.709 . . . . 2.81 109.294 -169.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.445 ' HZ3' ' H ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -82.91 132.69 35.15 Favored 'General case' 0 C--N 1.332 -0.155 0 O-C-N 120.446 -1.409 . . . . 4.28 112.423 175.146 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.7 115.55 1.69 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 113.923 -1.49 . . . . 1.86 109.889 169.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.92 -3.74 45.26 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 117.673 -1.626 . . . . 1.88 115.736 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -76.41 -178.58 4.69 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 120.242 2.021 . . . . 2.76 111.661 167.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -140.66 139.05 34.74 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 129.236 3.014 . . . . 3.53 105.535 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.66 126.63 44.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 126.616 1.966 . . . . 1.02 108.504 -173.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -78.29 139.6 38.86 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.836 0.826 . . . . 3.82 111.857 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.38 146.47 39.42 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.125 1.37 . . . . 3.19 109.321 163.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -102.46 139.23 38.33 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.04 2.536 . . . . 2.64 108.859 171.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.2 mp -109.37 138.06 46.3 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.592 1.557 . . . . 0.87 110.395 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.4 mt -112.14 110.06 20.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.687 1.195 . . . . 0.63 110.917 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.471 ' CD1' HD12 ' A' ' 30' ' ' LEU . 97.6 m-85 -107.62 151.8 25.15 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.359 1.464 . . . . 2.04 112.505 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.82 114.61 1.47 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.899 1.28 . . . . 1.75 113.538 -174.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.42 69.32 1.4 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.928 1.252 . . . . 2.81 112.965 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.28 7.92 73.58 Favored Glycine 0 N--CA 1.476 1.311 0 N-CA-C 116.291 1.277 . . . . 2.02 116.291 164.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -96.56 125.98 41.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.861 1.331 . . . . 3.61 111.309 -171.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.99 141.98 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 124.297 0.998 . . . . 1.9 110.893 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.3 tp -140.59 159.8 41.41 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.491 2.316 . . . . 2.1 108.6 177.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -132.83 145.18 50.74 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.983 0.913 . . . . 2.14 111.992 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.12 160.31 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 127.299 2.24 . . . . 2.61 110.836 -172.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.2 t -130.03 94.62 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 122.034 0.921 . . . . 2.25 110.618 -158.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.8 mt -98.55 123.78 48.84 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-O 118.062 -0.971 . . . . 2.4 111.051 -168.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.13 153.98 73.52 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.11 1.873 . . . . 0.98 111.041 170.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 90.1 t -92.99 121.09 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.305 0.642 . . . . 1.49 109.986 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -117.78 135.82 53.8 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.372 1.069 . . . . 3.49 110.59 167.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.93 57.46 4.34 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.202 -0.936 . . . . 4.09 112.74 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.335 0 CA-C-O 115.926 -1.988 . . . . 7.2 112.605 -171.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.299 0 N-CA-C 106.448 -2.661 . . . . 12.92 106.448 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.9 p -60.5 169.84 1.6 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 119.18 -1.008 . . . . 11.66 110.352 130.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -143.87 118.68 9.9 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.151 -1.055 . . . . 9.6 108.151 175.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 78.7 p -79.56 86.23 5.23 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.987 0.915 . . . . 7.26 110.294 -173.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -146.26 -173.69 4.25 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.544 2.338 . . . . 5.84 108.019 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.29 176.01 28.74 Favored Glycine 0 CA--C 1.527 0.793 0 O-C-N 121.324 -0.86 . . . . 1.52 112.385 169.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -157.64 172.08 19.18 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.53 1.132 . . . . 2.06 112.073 154.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 10' ' ' PHE . 10.2 t -105.53 139.02 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.534 1.133 . . . . 1.12 109.323 172.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.0 ttp85 -60.47 -35.36 75.7 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.882 1.067 . . . . 3.79 113.882 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.436 ' H ' HG12 ' A' ' 8' ' ' VAL . 6.2 t80 64.89 158.95 0.1 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.79 2.036 . . . . 3.16 110.343 -157.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 m -166.07 147.65 5.92 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 126.195 1.798 . . . . 3.12 109.017 162.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -83.58 49.74 3.01 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.591 3.527 . . . . 2.94 111.682 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.17 179.09 25.31 Favored Glycine 0 CA--C 1.537 1.423 0 N-CA-C 115.892 1.117 . . . . 1.29 115.892 -171.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.92 -20.15 19.91 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 124.073 3.182 . . . . 1.27 112.52 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -112.09 145.92 38.89 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.413 1.885 . . . . 2.47 113.646 173.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -131.28 -177.68 4.5 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.637 1.975 . . . . 0.65 110.802 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.54 148.65 31.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.771 1.228 . . . . 0.62 110.417 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.03 150.91 49.38 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.385 1.254 . . . . 0.57 114.385 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -127.3 52.61 1.8 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.838 2.055 . . . . 2.49 111.43 -165.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.35 162.14 25.92 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.367 1.247 . . . . 2.1 114.367 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.06 124.3 29.7 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.389 1.076 . . . . 3.93 110.847 166.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.73 119.84 29.58 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.624 -1.621 . . . . 3.82 106.624 163.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -135.87 144.02 45.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.028 0.918 . . . . 4.23 113.12 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -120.76 90.31 46.2 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 114.507 -1.224 . . . . 1.73 110.821 -172.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.56 -7.94 20.94 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.341 2.027 . . . . 2.26 112.886 172.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.15 -178.11 51.52 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 122.407 1.004 . . . . 1.82 112.858 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -111.5 -1.57 15.81 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.223 2.209 . . . . 4.03 111.83 -167.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -132.58 159.89 70.57 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 128.415 2.686 . . . . 2.23 109.339 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.45 156.87 57.68 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.434 2.089 . . . . 0.8 111.879 -167.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mp -114.38 152.9 30.77 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.606 1.562 . . . . 2.56 110.181 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -141.79 106.29 4.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 112.665 -2.061 . . . . 1.87 110.969 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.5 tp -90.14 109.17 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.083 1.353 . . . . 1.9 109.194 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 m -104.27 -18.37 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.041 0.937 . . . . 0.7 111.692 -173.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.63 -177.78 29.2 Favored Glycine 0 C--N 1.344 0.997 0 C-N-CA 125.951 1.739 . . . . 0.57 113.02 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.57 178.29 7.88 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.4 1.48 . . . . 0.58 110.687 171.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -158.6 150.31 21.11 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.851 2.06 . . . . 4.88 108.261 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -162.31 148.84 10.79 Favored Pre-proline 0 N--CA 1.478 0.937 0 O-C-N 120.984 -1.073 . . . . 0.9 109.34 -171.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.46 -1.25 10.77 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.634 2.89 . . . . 0.7 114.62 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.6 m -134.36 47.46 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 125.089 1.355 . . . . 0.91 112.676 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.87 178.78 9.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.242 1.417 . . . . 1.31 109.97 162.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -127.45 -34.04 2.29 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.774 1.63 . . . . 3.83 112.01 168.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -121.26 149.78 42.36 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 106.567 -1.642 . . . . 6.16 106.567 172.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.51 141.64 18.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 125.014 1.326 . . . . 1.22 110.005 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -134.52 147.54 50.34 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.601 1.96 . . . . 3.22 109.068 -173.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.464 HD13 ' CZ ' ' A' ' 84' ' ' PHE . 36.7 tp -101.73 120.79 40.91 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.547 -0.721 . . . . 1.27 109.842 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.5 m170 -121.26 150.09 41.9 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 123.486 1.612 . . . . 0.64 114.447 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -96.0 173.5 7.4 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 113.275 -1.784 . . . . 2.35 111.218 162.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.2 m -150.39 146.64 26.82 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 106.453 -1.684 . . . . 0.67 106.453 173.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -161.72 171.46 17.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.959 0.885 . . . . 2.0 113.378 -167.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.0 ttp -105.11 142.05 35.57 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.134 1.774 . . . . 3.45 110.453 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -157.36 151.02 24.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.228 1.411 . . . . 8.56 112.73 -173.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.47 133.38 35.39 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.494 0.718 . . . . 2.92 111.222 172.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t -141.82 134.79 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 105.443 -2.058 . . . . 2.24 105.443 162.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 70.93 4.17 4.95 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.39 1.876 . . . . 4.49 114.255 -170.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.21 22.86 69.9 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 121.473 -0.767 . . . . 1.64 113.109 -163.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -124.48 131.33 53.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.612 1.965 . . . . 3.83 109.76 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.89 92.63 1.27 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.495 1.118 . . . . 6.26 112.591 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.4 m -94.49 -174.94 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 127.177 2.191 . . . . 2.5 109.47 171.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -117.7 167.81 11.02 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.36 0.664 . . . . 2.96 111.937 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.46 169.63 31.64 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 125.683 1.611 . . . . 0.61 112.28 -176.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ttm -149.16 147.43 28.43 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.71 2.004 . . . . 0.71 107.971 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -148.33 153.69 41.04 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 125.966 1.707 . . . . 5.71 108.88 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.06 154.55 42.29 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 121.69 1.593 . . . . 0.65 110.352 164.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 m -137.11 154.77 76.1 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 125.34 1.456 . . . . 0.73 109.87 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.2 -27.03 4.69 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.58 2.186 . . . . 0.76 112.745 -166.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -175.17 168.37 3.39 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.363 1.465 . . . . 2.03 111.98 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.7 mt -111.13 153.72 25.33 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.276 1.431 . . . . 0.79 110.871 161.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -124.88 141.4 52.14 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.861 1.664 . . . . 2.21 110.043 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.0 t -146.52 134.69 10.7 Favored Pre-proline 0 N--CA 1.482 1.151 0 N-CA-C 113.426 0.899 . . . . 0.91 113.426 173.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.74 163.36 39.33 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 124.443 3.429 . . . . 1.28 113.558 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.02 145.06 78.39 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.86 3.04 . . . . 1.67 114.18 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt 69.21 -5.1 1.14 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.08 2.552 . . . . 3.1 114.657 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.03 168.4 34.0 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.411 1.482 . . . . 1.9 113.243 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -144.24 148.95 35.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.713 0.805 . . . . 6.51 112.231 162.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.9 t -155.71 100.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.456 1.902 . . . . 3.83 108.631 -168.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.89 171.55 15.03 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 121.876 0.846 . . . . 3.68 112.236 -169.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 mp -82.56 70.02 9.44 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.152 -1.592 . . . . 2.05 110.133 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.482 ' CD ' ' H ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -36.6 119.86 0.76 Allowed Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 127.167 2.187 . . . . 4.33 113.307 172.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.99 -9.36 22.12 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.817 3.012 . . . . 2.29 115.635 -154.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.33 -2.16 55.68 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 117.836 -1.536 . . . . 1.9 114.34 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.68 -17.47 0.49 Allowed Glycine 0 N--CA 1.479 1.542 0 CA-C-N 119.946 1.873 . . . . 1.98 117.776 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -145.12 145.03 31.23 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.128 1.464 . . . . 2.47 112.24 170.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -161.31 155.59 22.76 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.598 1.559 . . . . 0.83 109.941 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.464 ' CZ ' HD13 ' A' ' 45' ' ' LEU . 73.7 m-85 -79.45 150.97 31.1 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.259 -0.901 . . . . 2.39 108.862 157.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.6 tpt -100.12 130.84 46.31 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.11 1.764 . . . . 0.63 108.335 162.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.8 mp -116.01 135.54 53.86 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.388 1.475 . . . . 0.68 108.32 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mp -135.78 146.02 47.15 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.747 0.703 . . . . 1.69 111.633 -176.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.66 40.23 32.41 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.306 -0.719 . . . . 1.02 113.225 172.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.23 148.31 3.6 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 115.799 1.778 . . . . 1.54 115.799 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -104.05 -4.52 23.16 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.481 -1.691 . . . . 2.47 113.592 -170.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -146.63 156.09 48.74 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.92 2.088 . . . . 6.48 109.112 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -67.38 163.73 33.43 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.853 1.702 . . . . 2.28 109.022 153.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 pp -160.86 152.1 19.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.575 1.55 . . . . 2.35 108.298 -172.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -147.79 168.31 22.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 123.123 1.44 . . . . 4.73 114.715 -174.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.43 135.34 56.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.053 -0.976 . . . . 1.33 111.212 172.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.83 -1.14 74.3 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.72 1.629 . . . . 2.07 114.365 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -85.76 -176.91 6.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.869 1.335 . . . . 2.5 112.244 171.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -138.44 140.0 39.09 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 129.459 3.104 . . . . 3.55 105.768 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.3 t -141.06 133.36 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.216 1.806 . . . . 0.97 109.773 -172.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -95.58 158.01 15.64 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 122.491 1.139 . . . . 2.3 113.478 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.17 151.8 31.47 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.964 1.305 . . . . 3.54 112.841 169.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.64 137.12 36.2 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 127.26 2.224 . . . . 2.56 109.516 169.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.21 133.94 37.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.804 1.641 . . . . 1.19 109.113 170.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 56.3 mt -106.2 104.65 14.39 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.732 1.213 . . . . 0.9 108.934 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -91.97 163.37 14.03 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.562 0.696 . . . . 2.11 111.484 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.54 117.69 5.18 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.934 -0.479 . . . . 1.55 110.947 176.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.67 -135.94 16.73 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.835 0.731 . . . . 3.23 112.204 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.57 41.74 2.86 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.426 1.012 . . . . 2.34 115.481 -165.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -134.48 123.22 23.62 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.441 1.62 . . . . 3.88 112.085 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.3 t -136.64 138.56 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.806 1.642 . . . . 2.51 107.677 168.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.9 tp -159.14 133.45 7.76 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.488 1.115 . . . . 2.43 111.581 -170.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -98.1 149.0 22.97 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.631 1.715 . . . . 1.99 115.631 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.9 t -125.0 165.88 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 129.237 3.015 . . . . 2.13 107.994 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 t -142.18 142.36 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.247 1.819 . . . . 1.95 107.832 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.01 159.48 30.27 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 114.134 1.161 . . . . 2.85 114.134 -173.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -77.81 160.58 30.84 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.1 3.2 . . . . 0.86 114.671 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.0 t -103.61 130.1 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.525 1.53 . . . . 0.99 110.829 171.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.42 ' CD ' ' HE ' ' A' ' 120' ' ' ARG . 11.8 pt-20 -95.21 -172.52 2.69 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.621 1.968 . . . . 5.97 111.432 172.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -126.41 117.66 23.4 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.712 -1.243 . . . . 2.53 112.014 154.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.42 ' HE ' ' CD ' ' A' ' 118' ' ' GLU . 42.4 mtm180 . . . . . 0 C--O 1.248 1.008 0 C-N-CA 126.781 2.033 . . . . 7.56 111.5 161.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.915 0 CA-C-O 117.22 -1.878 . . . . 11.07 111.478 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . 0.257 96.7 p 103.8 -97.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 131.091 3.756 . . . . 10.21 110.119 -166.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -66.41 120.64 13.68 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.825 -1.172 . . . . 10.48 109.576 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 m 92.61 37.06 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 128.54 2.736 . . . . 6.55 110.886 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -148.32 -168.1 2.99 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.719 2.008 . . . . 5.16 110.416 -166.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.49 175.83 17.37 Favored Glycine 0 N--CA 1.473 1.155 0 N-CA-C 116.87 1.508 . . . . 0.87 116.87 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -151.35 142.91 23.58 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.389 2.275 . . . . 1.73 110.966 169.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.7 t -94.4 141.72 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 120.448 -1.407 . . . . 1.27 109.773 175.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.0 ttm-85 -73.12 118.13 15.7 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.514 0.726 . . . . 5.98 111.567 -172.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -68.19 138.51 55.68 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.534 -0.729 . . . . 2.55 110.558 159.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -167.72 149.75 5.27 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.703 1.601 . . . . 3.52 109.977 164.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -82.03 47.93 2.66 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 125.216 3.944 . . . . 3.28 111.756 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.34 158.52 20.49 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.872 1.701 . . . . 1.84 112.605 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.36 -19.08 33.72 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.729 2.953 . . . . 1.36 112.822 174.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -106.96 160.74 15.3 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.213 1.805 . . . . 2.96 112.908 167.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.34 -173.58 4.61 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.686 2.795 . . . . 0.53 110.287 -176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.48 160.29 41.82 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.348 1.459 . . . . 0.72 109.821 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.32 137.5 53.49 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.71 1.141 . . . . 0.73 112.976 174.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 79' ' ' PRO . 61.7 m-85 -113.06 138.72 49.48 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.691 1.996 . . . . 2.65 110.032 172.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.267 0.0 OUTLIER -165.99 145.14 6.06 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.528 1.307 . . . . 2.56 114.528 177.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.3 m -80.98 130.09 34.85 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.345 1.058 . . . . 2.04 109.536 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.4 tp -119.09 142.37 47.94 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.319 1.848 . . . . 3.14 109.843 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -128.13 149.71 50.3 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.751 1.22 . . . . 3.52 110.966 170.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -103.9 102.01 28.73 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.07 0.948 . . . . 1.44 109.459 169.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.76 -10.19 19.93 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.495 2.13 . . . . 1.01 113.359 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.59 178.61 53.29 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-O 122.76 1.2 . . . . 1.12 113.018 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -105.44 -3.65 22.31 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.818 2.447 . . . . 2.78 111.659 -174.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -121.2 156.27 57.55 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 127.9 2.48 . . . . 1.92 109.501 173.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.86 151.77 24.66 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.922 2.414 . . . . 0.85 111.992 -169.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.2 mt -104.57 146.99 28.12 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.154 0.982 . . . . 1.55 111.101 169.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -134.09 111.67 10.54 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.01 -1.45 . . . . 2.01 110.788 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -92.23 106.95 18.85 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 127.555 2.342 . . . . 2.59 109.974 -173.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -107.26 -17.92 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.729 1.211 . . . . 0.65 111.765 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.66 -175.24 29.37 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 125.726 1.631 . . . . 0.65 114.33 -175.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -157.05 -177.34 6.54 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.197 1.399 . . . . 0.74 112.681 177.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -154.48 165.43 36.46 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 127.434 2.294 . . . . 4.54 107.309 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 t -169.15 147.29 3.27 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 125.509 1.524 . . . . 0.91 107.426 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.59 -17.42 38.35 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.31 1.34 . . . . 1.07 111.865 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.6 m -111.17 40.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.185 1.394 . . . . 1.15 113.258 -172.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.78 169.29 23.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.411 1.084 . . . . 1.13 110.588 167.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -108.55 -63.14 1.37 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.454 1.502 . . . . 4.03 107.304 164.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -84.34 124.1 30.91 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 121.502 -0.749 . . . . 6.92 109.054 166.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.404 HG21 ' HB3' ' A' ' 35' ' ' ALA . 4.6 p -94.64 158.21 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.796 -1.093 . . . . 1.46 108.696 149.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.39 157.13 42.01 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.86 2.464 . . . . 4.27 107.446 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.6 tp -124.67 112.98 17.4 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.926 1.239 . . . . 1.11 112.17 -171.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.2 m170 -122.18 158.01 30.31 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 123.476 1.608 . . . . 0.66 114.661 -171.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.69 -176.42 3.26 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.463 1.905 . . . . 3.14 111.297 159.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -156.75 145.01 19.61 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.123 1.769 . . . . 0.85 106.798 167.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -153.13 -177.63 6.43 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.103 0.961 . . . . 2.0 113.003 -165.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -118.89 143.32 47.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.131 1.772 . . . . 4.25 111.446 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -154.78 160.33 41.22 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.401 1.88 . . . . 4.8 110.145 -172.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -116.57 142.61 46.66 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.883 1.673 . . . . 2.91 110.526 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.269 1.3 t -95.73 -126.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 107.753 -1.203 . . . . 2.81 107.753 161.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -70.67 44.26 0.08 Allowed 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 125.792 1.637 . . . . 2.95 114.81 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.06 18.15 80.19 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 120.271 -1.518 . . . . 1.95 111.738 -160.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -96.28 106.04 18.2 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 121.997 -0.707 . . . . 2.78 109.399 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.59 124.29 26.95 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.276 0.63 . . . . 7.52 109.951 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.538 HG22 ' H ' ' A' ' 59' ' ' MET . 8.7 p -142.78 175.9 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 126.003 1.721 . . . . 2.55 110.079 -174.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.538 ' H ' HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -124.88 149.16 47.83 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.619 1.168 . . . . 3.03 110.654 -175.15 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.99 167.86 21.56 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.507 1.527 . . . . 0.7 112.188 -174.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.0 ttm -150.63 137.1 18.77 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.059 1.344 . . . . 0.65 110.581 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -145.4 150.51 44.6 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.429 1.892 . . . . 8.13 110.066 -173.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -76.48 155.58 36.25 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.977 1.785 . . . . 0.66 110.283 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.67 147.78 66.93 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 124.219 1.008 . . . . 0.87 110.213 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -71.44 -22.6 24.67 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.438 2.759 . . . . 0.66 111.958 -173.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -172.96 172.61 3.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.421 1.888 . . . . 1.88 111.246 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.4 mt -115.01 161.06 18.85 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.265 1.826 . . . . 0.7 109.013 156.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -133.2 151.21 51.95 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.341 -0.849 . . . . 2.01 112.072 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.1 t -138.19 129.13 15.61 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 123.785 0.834 . . . . 1.07 111.815 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.89 164.67 34.84 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.379 2.72 . . . . 0.95 111.365 174.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.35 140.82 90.24 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.007 2.471 . . . . 1.02 112.485 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt 67.07 -2.75 1.1 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.848 2.059 . . . . 1.61 114.135 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.99 170.64 43.7 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.864 1.697 . . . . 1.22 114.024 -177.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -122.3 154.35 37.72 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.262 1.425 . . . . 5.42 111.388 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.2 t -141.36 137.04 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.734 1.613 . . . . 3.61 107.262 159.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.416 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -103.57 136.27 43.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.627 0.727 . . . . 3.75 109.942 168.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.52 101.39 3.54 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 105.951 -1.87 . . . . 2.32 105.951 158.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HE2' ' O ' ' A' ' 76' ' ' GLU . 6.1 ptpt -113.7 152.3 45.39 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.787 2.035 . . . . 3.01 114.36 -158.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 19' ' ' TYR . 10.4 Cg_endo -49.19 -57.69 2.2 Favored 'Trans proline' 0 C--N 1.356 0.97 1 C-N-CA 125.437 4.091 . . . . 2.01 113.667 -173.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.81 57.91 5.0 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.217 -0.768 . . . . 1.79 112.728 173.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.1 -126.52 1.6 Allowed Glycine 0 N--CA 1.467 0.766 0 C-N-CA 124.256 0.931 . . . . 1.93 114.828 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -71.05 141.91 50.88 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.845 -0.797 . . . . 1.97 112.707 -159.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -161.87 152.79 17.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.995 -0.548 . . . . 0.59 111.681 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 69.4 m-85 -77.35 142.79 39.18 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 108.283 -1.006 . . . . 1.9 108.283 163.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.1 tpt -92.37 135.59 33.91 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.293 1.037 . . . . 0.75 108.47 162.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.1 mp -117.85 138.79 51.86 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.925 1.29 . . . . 0.55 108.509 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mp -138.56 148.15 43.86 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.544 1.137 . . . . 1.56 110.041 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.42 40.45 19.21 Favored Glycine 0 N--CA 1.47 0.96 0 CA-C-O 119.876 -0.402 . . . . 0.95 112.79 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -43.82 143.13 1.12 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 115.719 1.748 . . . . 1.46 115.719 174.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -110.47 -3.57 15.98 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 113.653 -1.612 . . . . 2.56 114.472 -168.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -137.62 153.43 74.18 Favored Pre-proline 0 N--CA 1.473 0.704 0 C-N-CA 125.921 1.688 . . . . 5.85 109.56 170.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -68.65 144.94 61.97 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.111 1.874 . . . . 2.4 108.583 162.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.8 mp -125.62 116.92 22.47 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.538 0.735 . . . . 2.8 109.747 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.82 15.55 26.6 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 116.205 1.928 . . . . 5.8 116.205 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 60.41 157.55 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.137 2.575 . . . . 1.58 111.338 -166.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.47 42.38 99.01 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 120.759 -1.213 . . . . 1.32 110.563 -170.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -100.18 179.89 4.34 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.744 1.617 . . . . 2.41 107.574 169.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.82 150.79 33.01 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 128.104 2.562 . . . . 5.1 106.908 163.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.5 t -149.05 143.53 18.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 128.784 2.833 . . . . 1.24 108.811 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -98.69 146.3 26.01 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.997 -0.439 . . . . 3.01 111.493 168.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.78 133.14 56.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.469 1.108 . . . . 2.53 109.23 160.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.73 143.17 26.57 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.357 2.663 . . . . 2.2 107.239 162.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.93 127.39 51.79 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.386 1.474 . . . . 1.32 110.19 177.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.0 mt -102.25 117.3 34.46 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.754 1.622 . . . . 0.69 109.844 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -107.67 155.23 20.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.391 1.076 . . . . 1.99 111.296 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.93 146.77 25.68 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.16 -0.473 . . . . 1.88 110.415 162.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.63 7.53 66.66 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-O 119.127 -0.818 . . . . 3.14 114.59 -173.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.36 6.4 88.93 Favored Glycine 0 N--CA 1.474 1.169 0 CA-C-N 118.886 1.343 . . . . 2.19 114.163 175.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -79.48 133.34 36.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.724 1.21 . . . . 6.85 111.58 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.6 p -113.22 151.39 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.225 1.81 . . . . 2.0 109.766 166.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 tt -158.9 135.11 9.09 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.84 1.656 . . . . 2.06 109.481 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -103.27 163.0 12.52 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.313 1.227 . . . . 2.12 114.313 176.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.3 m -134.41 146.29 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 128.803 2.841 . . . . 2.07 109.136 168.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.4 p -109.31 138.35 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.899 1.28 . . . . 3.04 109.457 176.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.98 154.93 28.6 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 123.631 0.772 . . . . 2.07 113.066 -168.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.22 169.93 19.49 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.806 2.337 . . . . 0.99 112.787 171.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 70.1 t -104.5 131.25 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.478 1.511 . . . . 0.91 108.635 159.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -134.37 174.89 10.03 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.817 0.847 . . . . 4.61 112.55 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -95.07 57.22 2.03 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 116.265 1.95 . . . . 2.46 116.265 -143.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.251 23.1 mtp-105 . . . . . 0 N--CA 1.49 1.526 0 C-N-CA 131.611 3.965 . . . . 9.37 114.523 161.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.799 0 N-CA-C 108.387 -1.885 . . . . 12.75 108.387 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -81.72 124.83 29.95 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.308 0.855 . . . . 13.12 113.308 -155.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -71.92 -18.58 62.01 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.083 0.772 . . . . 11.01 113.083 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 42.1 p 57.53 19.51 5.37 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.997 2.119 . . . . 8.01 115.169 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -78.0 90.13 4.18 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.414 -1.328 . . . . 5.79 107.414 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.01 170.12 34.81 Favored Glycine 0 N--CA 1.463 0.438 0 C-N-CA 124.872 1.225 . . . . 1.05 111.873 176.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.6 p90 -159.03 141.57 14.1 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.296 1.038 . . . . 1.92 111.922 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.12 142.24 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 107.882 -1.155 . . . . 1.2 107.882 166.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.407 ' O ' ' HD2' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -89.1 15.33 8.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.676 1.19 . . . . 3.64 114.176 -175.182 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.3 t80 64.98 164.03 0.15 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.278 1.431 . . . . 2.55 113.37 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 m -172.6 154.0 2.91 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 127.187 2.195 . . . . 2.1 110.973 157.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -87.41 30.51 0.46 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 124.509 3.472 . . . . 2.0 112.08 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.24 178.95 31.6 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.716 1.151 . . . . 1.16 114.163 -171.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.48 -21.72 29.76 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.135 3.223 . . . . 1.49 113.546 -173.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -88.05 148.73 24.36 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.969 1.307 . . . . 2.35 111.932 173.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.46 -178.66 6.55 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.201 1.401 . . . . 0.65 111.353 165.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.52 150.64 40.71 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.688 1.595 . . . . 0.98 108.702 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.65 143.27 29.72 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.223 1.194 . . . . 1.17 114.223 -175.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -111.27 156.22 21.82 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.032 2.133 . . . . 2.56 111.276 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -169.59 158.35 7.69 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.597 1.559 . . . . 2.05 113.671 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 p -93.18 107.47 19.27 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.007 2.123 . . . . 2.53 110.862 173.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.611 HD12 HG21 ' A' ' 69' ' ' VAL . 0.6 OUTLIER -79.46 139.01 37.77 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.336 1.454 . . . . 3.26 109.089 176.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.415 ' N ' HD13 ' A' ' 22' ' ' LEU . 11.7 pt-20 -114.62 160.68 19.03 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.678 1.191 . . . . 5.39 112.244 177.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -135.82 109.96 10.12 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 123.687 0.795 . . . . 1.49 109.611 158.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -88.25 -8.45 5.56 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.281 2.654 . . . . 1.36 114.951 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.95 178.04 33.13 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 119.783 1.174 . . . . 1.24 112.482 -176.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -93.29 0.57 57.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.546 2.338 . . . . 3.56 112.485 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -113.46 156.96 42.58 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 127.33 2.252 . . . . 1.94 110.583 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.31 145.56 24.15 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.719 2.279 . . . . 0.98 111.183 -176.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.471 HD12 ' CD2' ' A' ' 105' ' ' PHE . 2.9 mm? -107.34 157.7 17.74 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 124.716 1.207 . . . . 2.42 110.565 172.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -147.22 110.34 4.79 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 113.459 -1.7 . . . . 2.32 110.677 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.26 112.51 24.07 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.47 1.908 . . . . 2.05 109.39 -176.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.4 m -108.62 -20.38 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.956 1.302 . . . . 0.74 111.642 -172.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.28 -175.06 28.79 Favored Glycine 0 C--N 1.346 1.088 0 C-N-CA 125.43 1.491 . . . . 0.68 113.798 -174.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.66 -177.3 5.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.747 2.019 . . . . 0.62 111.241 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -155.85 169.52 24.22 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.327 2.251 . . . . 4.38 109.029 170.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.7 t -175.96 150.96 1.13 Allowed Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 126.92 2.088 . . . . 0.74 108.007 173.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.4 -17.65 26.93 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.676 1.584 . . . . 0.76 112.734 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.9 m -97.05 52.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.737 1.215 . . . . 0.77 112.131 174.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.68 167.33 30.74 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.329 1.051 . . . . 1.39 112.203 166.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -102.01 -39.19 7.43 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.851 2.06 . . . . 4.99 110.492 162.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -146.04 169.59 18.35 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.378 1.871 . . . . 4.66 110.128 169.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.14 145.27 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.586 1.554 . . . . 1.15 108.321 -177.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -128.68 151.26 49.72 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.479 1.912 . . . . 3.16 108.208 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -103.66 136.91 42.49 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.115 0.87 . . . . 1.87 112.088 160.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -120.74 152.95 37.64 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.707 2.003 . . . . 0.95 112.667 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -97.2 163.25 12.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.374 1.47 . . . . 2.31 109.634 162.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.6 m -115.99 143.12 45.88 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.213 -1.403 . . . . 1.24 107.213 162.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -139.93 172.14 13.2 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.003 1.112 . . . . 2.33 114.003 -173.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 85.7 mtp -113.35 143.7 44.0 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.868 1.667 . . . . 3.55 110.99 166.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -146.76 146.97 30.47 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.953 1.701 . . . . 6.76 110.441 172.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -94.01 141.97 27.92 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 125.145 1.378 . . . . 2.43 110.957 171.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 m -139.59 126.96 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.532 1.133 . . . . 2.29 108.917 167.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 64.7 10.86 6.32 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.722 1.609 . . . . 3.72 115.062 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.87 26.43 41.64 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 123.907 0.765 . . . . 2.37 113.278 -166.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -124.76 123.44 40.0 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.514 1.926 . . . . 3.54 109.045 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.85 121.18 25.09 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.926 0.89 . . . . 5.98 111.463 -175.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.6 t -121.64 160.14 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 127.386 2.274 . . . . 2.56 108.601 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.7 mtp -121.25 156.56 32.22 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.547 1.539 . . . . 2.67 110.337 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.99 -175.57 26.2 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.203 0.906 . . . . 0.63 113.585 -172.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.1 ttm -153.33 151.05 29.54 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.404 1.882 . . . . 0.86 108.691 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.97 158.08 18.25 Favored Pre-proline 0 N--CA 1.477 0.895 0 CA-C-O 117.736 -1.126 . . . . 5.67 111.3 175.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.55 146.26 49.11 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.979 1.786 . . . . 1.12 112.647 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.64 159.51 43.83 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 125.104 1.362 . . . . 1.39 110.397 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.74 -30.8 2.19 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.616 2.211 . . . . 1.06 112.465 -172.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -179.15 165.28 1.47 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.398 1.879 . . . . 2.09 111.148 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt -110.37 152.96 25.61 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.504 1.121 . . . . 0.83 110.216 163.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -110.33 145.71 37.0 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.722 1.209 . . . . 1.78 108.716 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.611 HG21 HD12 ' A' ' 22' ' ' LEU . 61.8 t -138.16 127.24 14.62 Favored Pre-proline 0 N--CA 1.473 0.688 0 N-CA-C 112.594 0.59 . . . . 0.84 112.594 169.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.88 159.17 48.79 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.049 3.166 . . . . 1.06 112.402 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.47 142.52 95.31 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 124.337 3.358 . . . . 1.1 113.847 -175.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp 64.54 -3.41 0.53 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.646 1.978 . . . . 1.96 114.637 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.64 174.58 55.15 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.824 1.678 . . . . 1.28 114.089 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.66 126.4 6.91 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.387 1.475 . . . . 4.12 108.963 173.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.9 t -147.32 145.34 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.131 1.772 . . . . 4.14 107.836 -163.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.3 142.0 35.84 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.349 -0.844 . . . . 3.79 112.545 -167.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mp -69.55 79.7 0.41 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.891 -1.152 . . . . 2.06 107.891 151.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.99 147.1 85.79 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 112.943 0.72 . . . . 4.12 112.943 -171.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -57.83 133.41 55.9 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.63 1.553 . . . . 3.68 109.13 162.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.58 -12.54 66.17 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 116.637 -2.202 . . . . 1.72 115.657 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.43 -31.67 0.07 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 120.498 2.959 . . . . 2.05 120.498 175.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -144.06 139.31 28.88 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.619 2.209 . . . . 2.34 112.491 175.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -163.13 153.62 16.3 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.236 -0.29 . . . . 0.88 111.345 -176.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -79.48 142.5 35.78 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.596 -0.52 . . . . 2.65 109.596 164.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.6 tpt -105.68 127.03 52.82 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 126.334 1.854 . . . . 0.92 107.143 165.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -105.63 131.84 52.51 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.116 0.967 . . . . 0.85 108.732 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.43 131.93 55.0 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.199 0.999 . . . . 3.53 110.367 -175.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.62 47.13 28.45 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.552 1.072 . . . . 0.8 114.203 170.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.73 149.31 4.75 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 116.112 1.893 . . . . 1.35 116.112 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -104.86 3.91 31.51 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 113.897 -1.502 . . . . 1.98 113.67 -171.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.9 mmt-85 -145.2 139.39 15.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 127.928 2.491 . . . . 6.1 108.25 167.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -64.14 155.3 65.8 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 N-CA-C 107.659 -1.708 . . . . 1.73 107.659 154.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.3 121.18 17.58 Favored 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 108.058 -1.09 . . . . 2.82 108.058 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.47 ' HE2' ' OE1' ' A' ' 97' ' ' GLU 0.299 0.0 OUTLIER -87.64 13.18 10.87 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 116.032 1.864 . . . . 5.65 116.032 -168.998 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 62.81 154.06 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.993 2.917 . . . . 1.77 111.495 -163.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.98 51.17 55.57 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 109.839 -1.305 . . . . 1.67 109.839 -166.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.47 ' OE1' ' HE2' ' A' ' 94' ' ' LYS . 6.3 mm-40 -116.86 -177.6 3.23 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.761 2.025 . . . . 2.38 107.774 173.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -155.66 135.59 12.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.357 1.863 . . . . 3.27 107.744 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -151.23 151.13 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.765 1.626 . . . . 3.07 109.661 -177.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.6 150.05 32.81 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.842 1.052 . . . . 2.96 113.842 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mp -125.68 140.96 52.28 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.129 1.772 . . . . 1.99 110.238 169.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.67 148.32 23.95 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.95 1.7 . . . . 2.33 108.882 164.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.7 mp -120.97 133.62 55.28 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.84 1.256 . . . . 1.08 109.679 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.6 mt -110.31 122.65 48.19 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.32 1.448 . . . . 0.71 110.3 -174.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.471 ' CD2' HD12 ' A' ' 30' ' ' LEU . 97.9 m-85 -120.03 150.7 40.13 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.995 0.918 . . . . 1.99 111.591 -173.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.3 135.83 56.51 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.6 -0.687 . . . . 2.17 111.759 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.6 31.53 21.33 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.798 -1.001 . . . . 3.18 114.448 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.99 8.78 87.05 Favored Glycine 0 N--CA 1.474 1.233 0 CA-C-N 118.572 1.186 . . . . 1.8 115.984 167.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -88.04 138.2 31.66 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.686 1.243 . . . . 3.76 112.006 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.5 p -131.98 145.75 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 125.784 1.634 . . . . 1.95 110.103 175.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.4 tt -146.09 121.56 10.35 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.0 0.92 . . . . 2.64 110.67 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.99 134.67 34.3 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.659 0.784 . . . . 3.09 112.867 176.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.2 m -120.19 160.7 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.497 1.919 . . . . 2.27 110.116 165.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 52.9 t -115.45 132.49 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 107.688 -1.227 . . . . 1.72 107.688 167.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.3 mt -135.81 144.13 47.46 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.206 1.002 . . . . 2.46 112.076 -171.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.68 174.42 12.68 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.212 3.275 . . . . 0.82 113.054 170.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.1 t -122.42 129.63 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.755 2.022 . . . . 0.79 110.127 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.6 167.64 11.14 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.059 2.144 . . . . 3.99 110.271 171.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.93 -177.66 4.79 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 116.686 2.106 . . . . 2.63 116.686 -159.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.714 0 C-N-CA 127.519 2.328 . . . . 11.06 110.139 148.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.986 0 N-CA-C 110.456 -1.057 . . . . 8.96 110.456 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m 93.46 -130.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 128.767 2.827 . . . . 8.27 111.39 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -77.06 45.4 0.44 Allowed 'General case' 0 N--CA 1.475 0.8 0 O-C-N 119.898 -1.751 . . . . 10.0 111.387 168.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -174.72 53.64 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.518 1 C-N-CA 131.989 4.116 . . . . 7.25 105.35 -162.123 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -154.92 160.48 41.19 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.945 1.698 . . . . 5.36 109.311 -172.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.2 -178.84 20.33 Favored Glycine 0 N--CA 1.466 0.661 0 C-N-CA 123.571 0.605 . . . . 0.94 113.458 -167.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 23.3 p90 -152.23 154.99 36.87 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.153 0.981 . . . . 1.73 112.161 176.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.8 t -90.31 144.8 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.908 1.283 . . . . 0.94 107.989 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -82.26 129.32 34.82 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.285 0.493 . . . . 6.28 111.147 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -41.51 133.93 2.46 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.078 2.151 . . . . 1.91 112.69 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.5 t -173.99 127.11 0.45 Allowed Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.128 1.771 . . . . 2.73 110.587 169.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -88.88 3.12 5.8 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.023 3.149 . . . . 3.06 112.457 167.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.74 -172.57 45.3 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.742 1.163 . . . . 1.46 113.041 -173.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.11 -22.7 40.74 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.871 2.381 . . . . 1.24 113.209 -176.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -132.5 167.42 20.01 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.488 1.515 . . . . 2.24 114.174 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.48 -174.03 4.69 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 128.658 2.783 . . . . 0.53 110.859 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.35 148.89 32.83 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.273 1.429 . . . . 0.71 110.137 173.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.24 145.05 51.76 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.327 1.232 . . . . 0.55 114.327 -173.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -116.78 43.2 2.3 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.723 2.009 . . . . 2.44 112.89 -170.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.45 HD22 HD22 ' A' ' 101' ' ' LEU . 2.4 pp -68.39 162.06 26.2 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.385 1.254 . . . . 2.2 114.385 -169.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.1 m -94.65 139.61 30.98 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.067 0.947 . . . . 2.0 112.821 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.85 127.64 56.08 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.684 1.194 . . . . 2.99 110.235 167.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -131.11 136.7 48.61 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.229 1.812 . . . . 3.57 106.186 171.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -108.29 93.03 10.57 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 122.601 0.361 . . . . 1.46 110.754 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.5 -12.92 20.54 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.425 2.083 . . . . 1.18 113.159 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.98 -177.29 51.45 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-O 122.352 0.973 . . . . 1.22 112.577 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -109.94 0.26 18.51 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.969 2.108 . . . . 2.97 112.47 -173.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 pp -115.54 159.58 38.0 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 127.701 2.4 . . . . 2.2 110.401 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.14 139.5 15.05 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.252 1.968 . . . . 0.88 110.799 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.1 mt -93.36 149.02 21.54 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 122.249 1.023 . . . . 1.92 110.478 170.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -137.96 102.15 4.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.805 -1.998 . . . . 2.07 111.237 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.5 tp -84.8 104.12 14.48 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.535 1.534 . . . . 1.78 109.902 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.3 m -100.03 -21.9 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.003 1.321 . . . . 0.47 112.185 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.45 -177.67 32.75 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.908 1.242 . . . . 0.47 114.035 -172.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.34 -179.56 8.05 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.057 1.343 . . . . 0.56 112.581 171.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -158.81 143.06 15.59 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.471 1.908 . . . . 4.8 108.083 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.55 149.17 25.49 Favored Pre-proline 0 N--CA 1.481 1.077 0 CA-C-N 121.312 1.869 . . . . 0.81 110.647 168.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -62.81 -10.47 20.08 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.67 2.247 . . . . 1.05 114.032 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.55 34.69 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 113.647 0.981 . . . . 1.06 113.647 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.63 115.69 1.44 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.111 1.765 . . . . 1.92 108.836 159.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -69.51 -34.8 74.82 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.202 1.186 . . . . 2.83 114.202 -175.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -135.58 92.2 2.8 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 107.167 -1.419 . . . . 7.59 107.167 -166.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -85.65 166.46 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.95 0.9 . . . . 1.48 110.464 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.1 149.96 26.66 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.571 1.948 . . . . 4.4 108.229 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.2 tp -121.01 110.83 16.73 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.014 1.279 . . . . 1.02 111.09 -171.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 63.4 m170 -121.05 151.11 40.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 123.102 1.429 . . . . 0.66 114.316 -170.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -93.41 177.82 5.91 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 113.463 -1.699 . . . . 2.52 111.337 156.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.9 m -146.1 127.47 14.92 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.419 1.888 . . . . 0.69 105.989 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -131.37 169.25 16.28 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.073 0.949 . . . . 1.89 113.131 -162.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.0 mtt -99.87 141.86 32.12 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.674 1.19 . . . . 3.48 110.233 167.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -146.48 176.84 9.5 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.102 1.761 . . . . 6.14 111.329 173.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -141.07 138.57 33.68 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.036 1.734 . . . . 2.54 108.547 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.5 m -143.74 144.83 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 127.372 2.269 . . . . 2.19 108.028 167.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 56.86 20.79 5.51 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 115.493 1.664 . . . . 3.4 115.493 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.31 19.0 77.42 Favored Glycine 0 CA--C 1.537 1.458 0 O-C-N 121.041 -1.037 . . . . 1.62 114.056 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -110.47 118.52 36.47 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.916 1.686 . . . . 2.71 107.487 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -71.55 118.93 14.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.404 1.082 . . . . 4.97 108.349 171.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.09 176.6 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.889 1.675 . . . . 2.36 111.188 -172.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 77.0 mtm -127.29 163.65 23.47 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.009 1.323 . . . . 2.55 111.275 172.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.69 -176.68 28.13 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.37 1.462 . . . . 0.48 112.207 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.0 ttm -147.28 149.57 33.11 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.972 1.309 . . . . 0.6 109.489 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -163.1 158.25 18.09 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 124.379 1.072 . . . . 6.24 111.948 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.44 151.37 33.16 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.465 2.11 . . . . 0.78 113.578 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.76 151.5 64.34 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 125.855 1.662 . . . . 0.96 109.944 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.13 -28.93 10.37 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.052 2.501 . . . . 0.84 112.161 -174.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -175.51 168.06 3.23 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.456 1.902 . . . . 2.24 111.207 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.7 mt -111.18 150.06 30.05 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.888 1.275 . . . . 0.64 110.534 162.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -113.53 141.18 47.45 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.729 1.211 . . . . 1.94 108.694 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.6 t -139.16 124.02 11.61 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-O 119.162 -0.447 . . . . 0.98 111.243 166.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.77 162.74 41.11 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.743 2.962 . . . . 0.9 111.649 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.02 144.77 99.59 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.67 2.913 . . . . 1.06 112.594 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.5 mptt 65.2 -8.67 0.24 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.54 2.336 . . . . 1.92 115.157 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.68 166.02 50.29 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.532 1.539 . . . . 1.11 112.844 174.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -144.77 144.54 31.23 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.639 1.175 . . . . 5.82 110.559 170.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -156.83 125.32 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.496 1.918 . . . . 3.71 107.586 -174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -91.79 157.4 16.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.464 0.706 . . . . 4.01 111.829 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.79 73.24 0.57 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.725 1.25 . . . . 2.09 108.647 164.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -57.02 129.98 79.18 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.183 1.393 . . . . 4.76 111.452 -174.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -58.28 -32.48 96.05 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.797 2.331 . . . . 2.01 112.159 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.35 57.62 4.42 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 119.377 -0.679 . . . . 2.53 112.078 165.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.31 -11.39 2.02 Favored Glycine 0 N--CA 1.473 1.125 0 N-CA-C 119.685 2.634 . . . . 2.06 119.685 158.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -144.39 146.84 32.75 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.995 2.398 . . . . 2.37 112.721 171.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -162.21 155.53 20.59 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.047 0.939 . . . . 0.67 110.858 172.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.407 ' CE2' HD21 ' A' ' 20' ' ' LEU . 73.2 m-85 -79.33 140.93 37.38 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.543 -0.91 . . . . 1.62 108.543 157.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.4 tpt -87.05 132.47 33.8 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.301 1.441 . . . . 0.69 107.665 161.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 mp -114.34 119.74 37.99 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.009 -1.108 . . . . 0.63 108.009 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.96 148.07 42.56 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.48 0.712 . . . . 1.6 109.877 172.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.03 48.58 31.96 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 119.391 -0.672 . . . . 1.06 112.28 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pp -61.54 155.56 21.78 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 115.042 1.497 . . . . 1.29 115.042 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.34 -4.41 9.92 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 114.062 -1.426 . . . . 1.88 114.107 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -115.83 114.78 41.66 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 106.442 -1.688 . . . . 4.81 106.442 152.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.62 122.2 9.36 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 N-CA-C 105.38 -2.585 . . . . 2.27 105.38 158.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.2 mt -87.15 178.06 7.01 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 124.576 2.132 . . . . 2.21 112.821 -152.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -127.82 -169.62 2.09 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 129.329 3.052 . . . . 4.28 109.929 169.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.0 155.58 17.04 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 106.635 -1.617 . . . . 1.69 106.635 146.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.65 1.98 89.51 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.435 -1.203 . . . . 1.64 115.771 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -78.72 -176.21 4.8 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.579 1.689 . . . . 2.34 110.289 159.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 17.1 pt-20 -155.09 149.88 26.6 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 128.285 2.634 . . . . 3.37 107.122 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.1 t -145.65 122.22 3.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 125.909 1.684 . . . . 1.2 109.325 -166.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -81.51 154.5 26.26 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.788 0.804 . . . . 2.46 112.251 167.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.45 HD22 HD22 ' A' ' 20' ' ' LEU . 5.6 tt -154.97 132.67 11.36 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.263 1.425 . . . . 3.13 111.023 -177.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.47 130.4 36.97 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.76 2.424 . . . . 2.91 108.509 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.0 mp -100.74 119.56 38.8 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.421 1.088 . . . . 0.97 109.219 175.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 86.4 mt -87.41 108.71 19.12 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.812 0.815 . . . . 0.88 109.734 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -104.53 116.58 32.34 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.409 1.483 . . . . 2.16 111.048 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 54.36 24.78 5.39 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.006 1.722 . . . . 2.79 113.392 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.72 -59.37 2.11 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.962 1.744 . . . . 4.8 112.867 -171.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -84.55 9.21 65.57 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 116.399 1.32 . . . . 2.38 116.399 -167.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -136.66 152.53 50.51 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.296 1.838 . . . . 5.1 111.967 171.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.5 p -148.47 147.14 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 125.069 1.348 . . . . 2.21 111.158 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.4 tp -156.33 132.86 10.15 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.263 1.825 . . . . 2.9 108.281 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -96.53 146.61 24.65 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.908 1.447 . . . . 2.15 114.908 176.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.7 t -130.2 168.1 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 126.986 2.114 . . . . 2.72 108.268 175.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 t -130.88 147.27 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.6 1.56 . . . . 1.89 108.431 -171.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.92 146.2 17.85 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.892 1.277 . . . . 2.09 110.976 -177.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 57.6 Cg_endo -66.51 164.31 29.23 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.4 3.4 . . . . 0.89 112.394 172.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.2 t -105.54 135.97 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.151 1.38 . . . . 1.07 108.768 165.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -147.3 164.03 34.54 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.653 1.181 . . . . 3.5 111.503 -175.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.67 -176.27 3.23 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 127.228 2.211 . . . . 2.69 115.699 -160.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.436 ' C ' HH11 ' A' ' 120' ' ' ARG . 11.0 tpt85 . . . . . 0 N--CA 1.48 1.069 0 C-N-CA 127.65 2.38 . . . . 8.4 113.243 -175.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.172 0 N-CA-C 106.952 -2.459 . . . . 11.29 106.952 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 m -55.7 127.86 32.01 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 116.906 -1.918 . . . . 11.02 106.564 126.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -79.79 123.27 27.56 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.202 0.815 . . . . 11.48 113.202 -158.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.0 t -170.23 42.93 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.813 2.445 . . . . 6.61 110.249 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -128.26 178.43 6.26 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.849 2.06 . . . . 5.17 108.567 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -94.65 -177.11 38.44 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 123.58 0.61 . . . . 0.96 114.429 -170.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -144.55 154.34 42.77 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.095 1.146 . . . . 2.13 114.095 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.58 135.9 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.537 -0.912 . . . . 0.96 108.537 170.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -70.56 -10.95 60.52 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.956 1.836 . . . . 3.68 115.956 -162.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 63.82 169.82 0.16 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.078 1.351 . . . . 2.37 111.723 -170.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -166.77 162.99 11.1 Favored Pre-proline 0 CA--C 1.542 0.644 0 O-C-N 120.773 -1.205 . . . . 2.25 112.221 160.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -85.09 11.45 3.37 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.248 3.299 . . . . 2.39 112.823 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -150.37 -165.69 12.86 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 124.451 1.024 . . . . 1.1 115.368 -170.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -80.58 -20.43 8.05 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.625 3.55 . . . . 1.23 115.06 -169.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -99.39 164.79 11.96 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.955 1.302 . . . . 2.88 112.98 169.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.63 -177.02 6.27 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.792 2.437 . . . . 0.5 111.077 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.72 165.71 26.27 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.552 2.341 . . . . 0.69 108.47 173.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.85 156.34 37.43 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.265 1.209 . . . . 0.61 114.265 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -140.66 143.59 35.21 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.443 1.897 . . . . 2.41 110.325 -173.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.419 ' HA ' ' HA3' ' A' ' 6' ' ' GLY 0.263 0.0 OUTLIER -163.39 166.83 22.46 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.676 1.19 . . . . 2.41 113.45 -177.723 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.6 m -91.78 123.62 35.3 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 127.255 2.222 . . . . 1.87 109.373 -174.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.3 126.72 46.66 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.707 -0.849 . . . . 3.13 108.707 165.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -126.2 120.78 30.93 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.469 -1.308 . . . . 3.91 107.469 161.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -92.45 115.49 64.87 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.464 -0.779 . . . . 1.48 108.94 170.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -87.98 -9.79 5.26 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.318 2.678 . . . . 1.31 114.822 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.52 159.39 27.09 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 119.65 1.114 . . . . 1.6 111.914 -175.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.81 7.61 6.79 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 128.346 2.658 . . . . 3.7 112.485 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -125.92 150.24 68.43 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 128.592 2.757 . . . . 1.95 109.367 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.44 149.52 27.53 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.852 2.368 . . . . 0.96 111.306 -171.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.2 mt -102.75 153.19 20.39 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 122.809 1.29 . . . . 1.6 110.431 164.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 ttp-105 -140.21 103.14 4.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.197 -1.82 . . . . 2.45 110.45 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.5 tt -80.38 113.62 18.7 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 109.13 -0.693 . . . . 2.26 109.13 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -104.31 -20.15 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.385 1.074 . . . . 0.63 111.771 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.05 -176.24 30.87 Favored Glycine 0 C--N 1.343 0.956 0 C-N-CA 124.808 1.194 . . . . 0.58 114.71 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.5 -177.61 6.18 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.182 1.393 . . . . 0.61 111.884 174.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -156.2 176.71 12.32 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.896 2.479 . . . . 4.23 107.261 163.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -167.87 151.41 5.88 Favored Pre-proline 0 N--CA 1.466 0.329 0 C-N-CA 128.348 2.659 . . . . 0.74 106.9 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.95 -5.22 16.64 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.386 2.058 . . . . 1.01 113.108 174.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.61 49.24 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.632 1.173 . . . . 0.89 113.501 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.99 151.67 14.44 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.492 0.717 . . . . 0.89 112.374 163.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -89.73 -44.25 10.14 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.069 1.747 . . . . 3.06 110.951 168.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -114.15 130.79 56.59 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.193 1.797 . . . . 5.67 108.255 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -109.14 149.81 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.322 -0.992 . . . . 1.24 108.322 154.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -134.06 148.67 51.08 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.606 1.562 . . . . 2.91 108.369 171.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.4 tp -100.98 118.65 37.41 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.637 -0.505 . . . . 1.04 109.637 175.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 48.1 m170 -119.92 162.5 19.07 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 123.819 1.771 . . . . 0.7 113.284 -177.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.438 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 15.9 pt-20 -110.99 153.2 25.89 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 112.889 -1.959 . . . . 2.83 112.055 155.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.0 m -109.67 152.39 25.65 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 106.251 -1.759 . . . . 0.91 106.251 160.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -149.88 171.49 16.69 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.174 0.99 . . . . 2.15 111.771 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 57.3 ttm -102.06 143.39 31.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.726 1.21 . . . . 3.94 109.566 168.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.32 157.56 43.19 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.875 1.27 . . . . 4.49 111.369 -172.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.92 176.38 8.73 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.129 1.372 . . . . 2.62 114.599 178.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.0 p 159.76 123.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 1 C-N-CA 132.334 4.254 . . . . 3.72 106.974 -164.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 64.63 9.93 5.53 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 117.248 2.314 . . . . 3.15 117.248 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.77 7.34 60.11 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 120.745 -1.222 . . . . 2.37 113.28 -171.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -112.37 100.84 9.1 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.24 1.816 . . . . 2.86 109.213 -162.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -79.49 114.34 18.34 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.194 -0.941 . . . . 4.05 108.995 -173.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.1 t -126.82 133.52 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.169 1.788 . . . . 2.69 108.769 -173.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 60.2 mtm -88.25 128.17 35.47 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.82 0.848 . . . . 3.24 110.688 175.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.72 177.71 16.5 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 124.957 1.265 . . . . 0.63 112.631 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.6 ttm -157.52 137.66 12.61 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.589 1.155 . . . . 0.73 111.974 -172.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -146.81 150.01 38.05 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.864 1.666 . . . . 8.49 111.038 -177.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.56 151.8 53.26 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.38 2.053 . . . . 0.75 110.12 169.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.78 154.75 76.61 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 125.293 1.437 . . . . 0.76 110.638 -175.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.66 -25.9 4.15 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.2 2.6 . . . . 0.63 113.189 -166.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -177.77 161.68 1.65 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.144 1.778 . . . . 1.97 111.433 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.69 153.83 22.88 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.429 1.492 . . . . 0.71 109.62 163.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -105.52 152.36 23.14 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.929 0.891 . . . . 1.86 110.685 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.3 124.01 13.62 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 123.301 0.64 . . . . 1.46 110.263 163.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.35 165.03 31.88 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.181 2.587 . . . . 1.01 111.181 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.92 138.85 76.23 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.516 2.144 . . . . 1.23 112.848 175.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.26 15.3 mtmt 57.66 36.82 27.07 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.355 1.462 . . . . 2.95 113.606 171.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.29 140.06 11.48 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.561 2.029 . . . . 1.18 114.84 -172.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.1 ttt85 -87.52 138.11 31.75 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.851 2.06 . . . . 4.37 110.439 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.5 t -148.93 142.58 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 127.421 2.288 . . . . 3.27 107.313 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -142.35 147.5 36.39 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 120.537 1.517 . . . . 4.26 113.463 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mp -82.59 168.08 17.68 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.044 2.138 . . . . 2.58 111.168 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -169.82 157.9 6.5 Favored Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 125.868 1.667 . . . . 2.92 113.667 -176.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.18 -47.24 15.38 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 124.19 3.26 . . . . 3.12 113.254 176.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.02 36.11 1.47 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.851 1.215 . . . . 1.6 113.66 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.3 -134.1 2.51 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 125.107 1.337 . . . . 1.61 113.456 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.438 ' CE1' ' HB3' ' A' ' 47' ' ' GLU . 97.1 m-85 -71.05 136.63 48.41 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.897 -0.766 . . . . 2.03 111.658 -169.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.5 p-80 -162.08 154.68 19.81 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.826 1.25 . . . . 0.69 112.465 -170.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -84.32 146.57 27.66 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.855 -0.528 . . . . 2.44 109.753 168.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.6 tpt -100.4 136.51 40.17 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.739 1.216 . . . . 0.63 108.9 162.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.5 mp -118.59 139.87 50.8 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.032 1.333 . . . . 0.52 109.148 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mp -140.2 146.63 38.95 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.693 0.797 . . . . 1.75 110.699 171.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.59 37.09 24.46 Favored Glycine 0 N--CA 1.473 1.106 0 O-C-N 122.073 -0.392 . . . . 1.11 112.904 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.27 146.12 9.8 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.856 1.662 . . . . 1.29 115.467 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -109.1 -23.49 11.62 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 113.646 -1.615 . . . . 1.99 113.255 -168.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -97.61 142.67 24.92 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.056 0.942 . . . . 5.83 109.19 158.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.69 79.54 3.32 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.279 2.652 . . . . 2.5 109.439 173.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 72.8 mt -42.63 122.93 2.46 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 127.604 2.362 . . . . 2.25 115.13 -167.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -119.97 156.8 30.13 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 127.078 2.151 . . . . 6.05 113.357 165.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.26 135.98 56.75 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.784 -1.098 . . . . 1.44 108.435 171.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.13 1.56 72.39 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.052 1.31 . . . . 1.78 115.117 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -74.97 -173.09 1.81 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.012 1.406 . . . . 2.37 112.834 169.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -139.05 125.52 20.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.99 3.316 . . . . 5.1 105.354 -165.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.2 t -145.18 128.42 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 O-C-N 121.298 -0.876 . . . . 1.18 110.957 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.82 143.58 35.87 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.421 -0.809 . . . . 2.48 110.658 169.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mp -118.27 134.33 55.12 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.876 0.871 . . . . 1.78 109.569 156.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -93.44 139.4 30.75 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.185 2.594 . . . . 2.78 108.355 169.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.4 mp -118.43 129.02 55.16 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.729 1.612 . . . . 0.91 109.743 -173.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.8 mt -106.28 114.81 29.16 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.371 1.468 . . . . 0.75 110.518 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -112.24 115.06 28.2 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.067 1.347 . . . . 1.9 111.841 -172.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 48.53 26.94 1.3 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.519 1.928 . . . . 3.03 114.223 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.33 -59.49 4.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.42 1.486 . . . . 4.4 112.861 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.63 3.42 68.79 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 116.987 1.555 . . . . 2.21 116.987 -165.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -136.1 143.36 44.54 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.702 1.751 . . . . 3.43 112.519 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.4 t -134.34 147.43 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.473 1.509 . . . . 2.29 109.659 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -153.78 166.52 32.62 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.936 2.494 . . . . 1.89 108.094 175.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -144.35 160.55 40.85 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.878 1.217 . . . . 1.74 113.679 171.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.66 158.21 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.525 1.53 . . . . 2.38 108.886 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.5 p -114.63 132.72 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.325 1.05 . . . . 2.45 110.003 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -124.93 148.89 61.32 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 126.975 2.11 . . . . 3.29 108.713 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.15 161.73 44.9 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.742 2.295 . . . . 0.86 111.775 162.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.4 t -96.59 137.61 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.847 0.859 . . . . 1.14 109.41 168.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.54 141.31 29.4 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.884 1.674 . . . . 3.82 111.036 177.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -95.39 86.35 4.48 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.674 1.189 . . . . 2.31 112.051 -169.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 . . . . . 0 C--O 1.246 0.881 0 C-N-CA 124.87 1.268 . . . . 8.18 111.153 -173.934 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.355 0 N-CA-C 108.503 -1.839 . . . . 14.69 108.503 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.0 m -145.42 147.48 32.27 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.68 1.24 . . . . 10.88 110.365 -169.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -143.14 143.08 31.67 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.971 0.908 . . . . 10.38 111.126 -173.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.8 t -135.79 -10.99 2.06 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.757 1.623 . . . . 5.48 112.753 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -99.54 171.72 7.76 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.415 1.486 . . . . 6.22 112.231 174.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.0 -177.54 23.26 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.809 1.671 . . . . 1.0 111.714 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -148.98 157.61 43.55 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 115.351 1.611 . . . . 1.88 115.351 -173.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.0 t -92.89 134.73 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.958 1.303 . . . . 1.34 108.631 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.9 tpp85 -69.16 118.87 12.6 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.144 0.977 . . . . 4.83 111.872 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -66.64 142.32 57.5 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.87 1.268 . . . . 1.85 111.414 162.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -174.48 161.48 2.7 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 126.451 1.9 . . . . 2.92 110.684 170.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -84.55 38.2 0.67 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.998 3.132 . . . . 2.49 112.122 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.85 151.52 18.21 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 124.942 1.258 . . . . 1.46 115.122 -165.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.29 -22.11 14.65 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.253 2.635 . . . . 1.25 111.841 166.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -105.99 158.58 16.69 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 127.272 2.229 . . . . 2.31 112.072 165.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.38 -171.79 3.92 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.027 2.131 . . . . 0.74 110.752 -173.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.34 159.86 43.58 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.188 1.395 . . . . 1.11 109.707 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.75 131.21 37.3 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.65 1.114 . . . . 0.88 112.778 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -123.0 81.96 1.94 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.664 1.986 . . . . 2.81 110.28 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -92.24 158.08 16.33 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.664 1.186 . . . . 1.91 113.923 -173.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.7 m -119.89 144.33 47.46 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.725 1.61 . . . . 2.13 108.443 162.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.9 tp -158.57 171.7 19.65 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.574 2.75 . . . . 5.03 107.517 173.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -136.23 144.75 45.02 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 120.391 -1.443 . . . . 4.42 108.382 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -97.59 106.7 34.82 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 125.381 1.472 . . . . 1.4 109.493 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -81.62 -7.3 12.59 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.731 2.287 . . . . 1.35 114.083 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.64 168.5 54.78 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-O 123.108 1.393 . . . . 1.44 113.228 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.436 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 16.6 m-20 -101.44 -2.38 30.94 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 128.606 2.763 . . . . 3.05 111.648 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 pp -117.03 159.16 42.12 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 127.665 2.386 . . . . 2.18 110.342 171.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.87 138.07 12.95 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.873 2.382 . . . . 1.08 111.025 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.55 156.68 16.33 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 123.185 1.469 . . . . 2.16 111.834 176.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -152.01 98.26 2.42 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.104 -1.862 . . . . 2.86 110.246 -164.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.473 HD21 ' CZ ' ' A' ' 84' ' ' PHE . 5.4 tt -85.59 115.75 23.47 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.945 1.698 . . . . 2.28 107.403 -177.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.93 -16.39 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.202 1.001 . . . . 0.73 111.969 -174.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.18 -176.53 31.34 Favored Glycine 0 C--N 1.342 0.881 0 C-N-CA 125.887 1.708 . . . . 0.65 113.392 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -153.74 178.03 10.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.39 1.476 . . . . 0.69 112.785 166.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -151.42 159.04 44.42 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 129.622 3.169 . . . . 4.47 108.568 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 t -173.79 152.23 1.97 Allowed Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 128.111 2.565 . . . . 0.61 107.229 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.92 -15.88 20.71 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.688 1.592 . . . . 0.98 113.513 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.12 32.54 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.319 1.047 . . . . 0.75 112.326 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.93 140.12 17.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.608 0.763 . . . . 0.9 109.395 165.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -85.93 -33.89 21.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.038 1.335 . . . . 3.79 110.847 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -139.06 144.45 38.79 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.066 2.146 . . . . 6.94 106.597 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.2 p -135.92 146.84 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.109 1.364 . . . . 1.56 109.338 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.413 ' CD ' ' HE2' ' A' ' 46' ' ' HIS . 13.5 tt0 -135.49 146.97 48.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.755 2.022 . . . . 3.99 108.781 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.8 tp -109.12 115.65 30.45 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.697 1.135 . . . . 1.17 111.1 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.413 ' HE2' ' CD ' ' A' ' 44' ' ' GLU . 65.6 m170 -116.4 154.65 29.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.497 1.519 . . . . 0.74 113.923 -175.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' CD ' ' HD2' ' A' ' 62' ' ' ARG . 6.5 pt-20 -95.86 179.86 4.95 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.806 1.243 . . . . 2.21 111.442 159.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 84.1 m -137.69 134.81 35.83 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.351 -1.352 . . . . 0.94 107.351 164.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -129.7 163.81 25.33 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.165 1.172 . . . . 2.15 114.165 -168.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -106.5 150.22 26.32 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.458 1.503 . . . . 3.76 111.4 167.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.67 157.66 35.59 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.055 0.942 . . . . 4.35 111.217 -168.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -110.32 146.83 35.05 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.174 1.79 . . . . 2.72 108.415 167.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.2 129.42 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 107.748 -1.205 . . . . 2.97 107.748 161.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 61.97 32.99 17.61 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.161 0.984 . . . . 4.53 112.298 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.73 8.69 82.14 Favored Glycine 0 CA--C 1.536 1.384 0 O-C-N 120.575 -1.328 . . . . 2.02 114.019 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -121.11 129.63 53.38 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.391 1.876 . . . . 2.77 109.174 -172.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -69.34 134.9 49.64 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.992 2.117 . . . . 4.37 109.492 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.5 p -146.36 170.79 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 125.895 1.678 . . . . 2.62 109.835 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 32.2 mtm -131.85 159.32 38.91 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.768 1.627 . . . . 2.57 110.684 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.13 -174.9 27.43 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.924 1.25 . . . . 0.89 113.956 -173.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.3 ttm -155.74 145.69 21.42 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.169 1.787 . . . . 0.79 108.565 -174.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.479 ' HD2' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -162.46 154.0 15.33 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.573 1.149 . . . . 5.32 111.59 -178.159 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.79 157.53 35.28 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.143 1.896 . . . . 0.59 112.976 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.34 156.78 67.18 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 126.487 1.915 . . . . 0.73 110.211 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.5 -21.82 4.13 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.743 2.962 . . . . 0.71 113.892 -169.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -177.0 164.61 2.3 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.626 1.97 . . . . 2.04 110.368 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.9 mt -110.31 153.44 24.88 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.342 1.057 . . . . 0.83 109.962 166.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -122.07 146.52 47.12 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.466 1.106 . . . . 2.66 110.875 174.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.1 t -140.13 131.42 14.29 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.898 1.279 . . . . 0.84 109.756 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.46 166.27 27.8 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.115 2.543 . . . . 0.99 112.182 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -58.41 139.85 92.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.164 2.576 . . . . 1.25 111.235 171.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.436 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 61.3 mmtt 65.1 3.96 2.37 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.977 1.311 . . . . 1.69 113.286 -175.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.11 176.54 53.08 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 127.107 2.289 . . . . 1.43 114.73 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 -98.66 129.98 45.16 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.441 1.496 . . . . 3.7 112.84 -174.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.8 t -108.12 57.59 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.63 1.572 . . . . 6.03 108.947 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -101.65 127.6 48.32 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.038 0.935 . . . . 3.16 109.331 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' A' ' 83' ' ' HIS . 3.7 mp -67.82 -37.43 81.92 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.247 1.019 . . . . 3.1 111.219 173.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.2 tptt 91.91 126.35 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 127.176 2.19 . . . . 4.12 111.385 171.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.82 29.38 0.21 Allowed 'Trans proline' 0 CA--C 1.551 1.338 0 C-N-CA 125.027 3.818 . . . . 2.81 115.037 -177.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.03 26.13 0.03 OUTLIER Glycine 0 CA--C 1.539 1.532 0 C-N-CA 127.05 2.262 . . . . 1.69 115.284 -174.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.28 -29.59 0.02 OUTLIER Glycine 0 N--CA 1.481 1.683 0 N-CA-C 119.208 2.443 . . . . 2.3 119.208 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -142.23 151.24 41.92 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.493 1.517 . . . . 2.25 111.422 159.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.527 ' HA ' HD23 ' A' ' 77' ' ' LEU . 44.3 p-80 -163.2 157.3 20.27 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.797 -1.189 . . . . 0.77 111.998 175.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 70.8 m-85 -78.43 139.55 38.73 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.073 -0.651 . . . . 2.59 109.397 161.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -91.72 131.02 37.4 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.773 1.629 . . . . 0.64 108.116 159.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 mp -113.64 143.29 44.83 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.973 1.309 . . . . 0.7 109.071 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mt -137.96 139.4 39.71 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.239 1.016 . . . . 2.16 111.355 -176.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.57 38.84 36.58 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.924 -0.931 . . . . 0.93 113.897 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.61 150.89 0.91 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 117.17 2.285 . . . . 1.39 117.17 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -115.76 -13.28 11.41 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 113.746 -1.57 . . . . 2.67 114.269 -172.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -119.57 154.26 54.46 Favored Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 125.954 1.702 . . . . 5.67 108.902 168.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -70.66 149.3 60.93 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.662 2.241 . . . . 2.4 110.067 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.5 mt -89.54 115.06 26.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 122.87 1.319 . . . . 3.08 107.672 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -116.65 172.02 7.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.621 -1.627 . . . . 4.67 110.473 169.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.45 136.79 39.41 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.832 -1.544 . . . . 1.63 106.832 145.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.1 45.24 9.09 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 123.161 0.41 . . . . 2.13 113.721 174.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -111.64 177.71 4.56 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.35 0.575 . . . . 2.82 110.775 148.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -146.35 134.81 21.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.1 2.16 . . . . 3.36 108.146 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.8 t -139.49 136.09 40.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 127.768 2.427 . . . . 1.32 109.636 -160.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -84.11 145.74 28.26 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.754 0.787 . . . . 3.08 112.808 173.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mp -121.79 146.83 46.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.907 2.083 . . . . 1.76 109.862 163.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -117.91 111.62 19.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.379 2.272 . . . . 2.31 107.844 168.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.3 mp -83.0 140.23 32.84 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.864 0.866 . . . . 0.97 109.352 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.8 mt -105.23 109.38 21.34 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.454 1.102 . . . . 0.73 110.098 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -97.63 150.52 21.06 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.758 1.223 . . . . 1.95 111.117 172.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.43 126.62 22.02 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.287 1.435 . . . . 1.6 113.487 -169.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.43 49.0 6.98 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.086 -0.841 . . . . 2.69 112.649 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.17 12.1 84.36 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 116.174 1.23 . . . . 2.65 116.174 165.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -92.14 102.99 15.52 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.333 1.567 . . . . 3.98 111.128 -168.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.3 p -93.18 139.45 18.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 O-C-N 124.603 1.19 . . . . 2.16 111.818 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 123.39 19.95 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.467 0.707 . . . . 2.58 111.514 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -89.84 129.51 36.21 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.273 1.429 . . . . 1.99 111.473 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.18 143.97 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.952 1.301 . . . . 1.82 109.935 168.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.0 p -112.77 134.89 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.358 1.063 . . . . 2.36 110.023 176.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.5 mp -138.87 148.71 59.11 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.967 1.307 . . . . 2.77 110.535 -167.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.66 153.12 79.09 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.468 2.112 . . . . 1.04 111.934 169.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.31 120.95 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.012 -1.477 . . . . 1.4 107.012 165.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -153.46 165.66 35.13 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 122.805 1.288 . . . . 5.35 113.703 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.29 155.5 28.48 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.75 -1.114 . . . . 3.27 113.859 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.168 0 C-N-CA 131.248 3.819 . . . . 7.85 107.374 157.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.401 0 N-CA-C 108.805 -1.718 . . . . 12.43 108.805 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 p -88.72 -32.6 17.86 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.714 1.257 . . . . 12.33 114.235 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -140.01 163.37 32.87 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.455 1.102 . . . . 10.04 111.674 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.9 t -135.34 20.06 3.39 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.702 2.001 . . . . 5.46 111.586 169.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -99.98 171.69 7.69 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.029 1.731 . . . . 6.4 109.751 175.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.06 176.17 19.43 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.565 -1.014 . . . . 0.98 110.565 170.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -155.58 -178.65 7.43 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.387 0.613 . . . . 1.74 112.568 -176.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.8 t -112.88 134.69 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.112 1.765 . . . . 1.42 109.184 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -21.79 38.5 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.082 1.512 . . . . 5.57 115.082 -172.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 82.9 t80 69.99 146.98 0.06 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 128.884 2.874 . . . . 2.51 113.792 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.3 m -170.93 154.81 4.36 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.79 2.036 . . . . 2.28 111.886 173.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -82.68 -24.6 3.4 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.75 2.967 . . . . 2.17 112.865 169.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.08 148.54 24.47 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 109.843 -1.303 . . . . 2.31 109.843 166.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.87 -38.9 9.16 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.974 2.449 . . . . 2.83 114.523 -163.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -80.03 139.51 36.93 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 123.352 1.549 . . . . 4.33 112.779 -175.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.8 -175.31 5.31 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.341 1.457 . . . . 0.88 112.502 -156.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.86 156.83 43.81 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.997 1.719 . . . . 0.79 109.932 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.4 143.92 39.99 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.175 0.805 . . . . 0.63 113.175 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.438 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 31.0 m-85 -125.53 75.45 1.48 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.408 1.883 . . . . 2.38 110.918 -168.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.83 162.92 28.6 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.816 -1.178 . . . . 1.86 113.965 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 68.3 m -121.1 141.64 50.6 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.386 1.075 . . . . 2.27 109.223 157.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.64 -179.35 7.53 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 128.473 2.709 . . . . 5.44 107.776 175.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -138.89 157.36 46.19 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.16 -0.963 . . . . 3.87 111.847 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -103.65 95.11 6.91 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 126.072 1.749 . . . . 1.37 109.469 165.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.0 -3.94 12.47 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.009 2.473 . . . . 1.17 114.337 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.26 160.41 31.9 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-O 122.456 1.031 . . . . 1.41 111.759 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -87.23 10.02 18.36 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.815 2.446 . . . . 3.9 112.179 175.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -116.01 152.88 48.14 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 128.812 2.845 . . . . 2.17 109.744 171.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.38 153.58 24.11 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.22 2.614 . . . . 0.83 111.489 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.9 mt -111.8 146.9 36.83 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 123.296 1.522 . . . . 1.71 111.774 167.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -133.85 103.63 5.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 112.263 -2.244 . . . . 2.06 110.04 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -82.7 109.73 17.13 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.185 1.394 . . . . 2.59 108.296 -174.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 m -105.65 -22.04 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.305 1.042 . . . . 0.5 111.908 -172.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.15 -176.72 31.52 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 125.279 1.419 . . . . 0.48 113.737 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -154.27 179.16 9.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.263 1.425 . . . . 0.58 111.679 168.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -146.19 174.33 11.42 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.783 2.033 . . . . 5.47 108.998 164.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 t -170.86 149.53 2.84 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 127.721 2.409 . . . . 0.74 108.149 175.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.91 -3.66 14.13 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.746 2.298 . . . . 1.05 113.682 176.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 m -121.74 57.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.843 1.257 . . . . 1.22 112.339 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.09 173.83 16.13 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.544 1.138 . . . . 1.57 112.005 162.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -114.87 -51.95 2.72 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.277 1.831 . . . . 2.72 109.446 165.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -101.66 132.13 47.52 Favored 'General case' 0 C--N 1.342 0.243 0 O-C-N 121.319 -0.863 . . . . 5.25 109.489 161.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -97.06 150.65 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.108 -0.951 . . . . 1.3 108.458 140.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -136.17 154.02 51.09 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.1 1.76 . . . . 3.0 109.013 169.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.8 tp -110.66 117.31 33.14 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.364 0.665 . . . . 1.09 111.235 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -125.29 149.34 48.15 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.784 1.234 . . . . 0.73 114.177 -172.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -87.51 169.92 11.78 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.507 1.923 . . . . 2.57 112.15 163.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.1 m -148.25 146.16 28.52 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 106.711 -1.589 . . . . 1.01 106.711 173.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -157.99 163.09 38.12 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.116 1.154 . . . . 2.28 114.116 -170.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.6 ttp -91.53 148.85 21.99 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.49 1.116 . . . . 3.11 109.346 161.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.09 167.18 30.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.285 1.834 . . . . 4.42 110.258 -170.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -124.53 135.21 52.99 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.586 1.554 . . . . 2.5 110.553 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 t -136.8 120.33 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.035 -0.728 . . . . 2.05 109.035 165.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 65.96 26.25 10.97 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.757 2.023 . . . . 3.17 112.962 -176.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.25 10.71 85.77 Favored Glycine 0 CA--C 1.536 1.364 0 O-C-N 120.218 -1.551 . . . . 2.11 113.366 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -110.25 116.46 31.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.796 1.638 . . . . 3.31 110.355 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.493 ' H ' ' HE2' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -58.66 129.25 41.2 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.961 2.104 . . . . 4.18 110.407 174.354 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.8 p -156.72 146.01 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.369 1.867 . . . . 2.49 109.752 -174.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.21 161.16 14.07 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.765 0.826 . . . . 3.28 111.882 -174.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.44 -179.47 30.59 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 123.976 0.798 . . . . 0.59 114.294 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.8 ttm -159.92 148.48 17.31 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.675 1.99 . . . . 0.81 109.09 -173.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.1 mtm105 -150.69 156.01 36.05 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.545 1.538 . . . . 5.17 109.993 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -77.05 152.94 31.96 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.03 1.82 . . . . 0.63 110.82 168.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.3 m -139.1 151.85 68.67 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.897 1.279 . . . . 0.74 110.542 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.39 -24.01 11.08 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.27 2.647 . . . . 0.72 112.624 -170.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -173.04 172.96 3.8 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.098 1.759 . . . . 1.92 110.912 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.1 mt -118.56 154.93 31.78 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.228 1.811 . . . . 0.71 109.819 161.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -114.63 140.59 48.69 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.203 1.001 . . . . 1.87 110.281 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.4 t -137.71 127.51 15.29 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 123.565 0.746 . . . . 0.86 110.913 167.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.66 169.95 16.3 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.849 3.032 . . . . 0.98 111.941 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.06 143.17 96.9 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.112 2.541 . . . . 1.16 113.003 173.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm 64.15 8.28 3.97 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.549 1.54 . . . . 2.41 113.794 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.99 163.8 38.3 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 127.149 2.309 . . . . 1.2 113.639 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.4 mtt-85 -93.62 148.45 22.09 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.802 0.841 . . . . 5.58 110.567 174.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.7 t -118.08 57.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.704 2.002 . . . . 5.52 107.564 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -89.2 129.2 35.82 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.017 -0.734 . . . . 2.9 109.017 168.082 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 83' ' ' HIS . 2.6 tp -74.78 -24.56 58.69 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 112.925 0.713 . . . . 3.13 112.925 -164.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? 76.97 100.89 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 127.319 2.248 . . . . 4.0 110.342 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.438 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 35.0 Cg_endo -60.92 -29.46 88.11 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 121.829 1.686 . . . . 2.27 114.153 -175.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.88 10.5 70.09 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.148 -1.918 . . . . 1.51 115.07 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.47 -25.66 0.03 OUTLIER Glycine 0 N--CA 1.475 1.28 0 N-CA-C 121.414 3.326 . . . . 2.27 121.414 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -140.29 147.92 40.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 121.337 2.569 . . . . 2.18 113.17 164.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.524 ' HA ' HD23 ' A' ' 77' ' ' LEU . 54.8 p-80 -158.48 152.54 23.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.668 -1.151 . . . . 0.73 112.209 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 75.7 m-85 -78.25 139.08 38.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.094 -0.706 . . . . 2.23 109.094 161.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -88.04 129.45 35.27 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.745 -1.206 . . . . 0.79 107.745 159.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 mp -108.74 127.43 53.99 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.06 -1.089 . . . . 0.51 108.06 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.42 143.42 50.75 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.75 0.82 . . . . 1.64 110.591 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.17 45.81 47.01 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.291 -0.727 . . . . 0.82 113.737 176.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pp -54.39 147.94 12.77 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 123.52 1.629 . . . . 1.38 114.954 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -103.79 -5.78 22.11 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 113.328 -1.76 . . . . 2.02 113.242 -169.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 -148.57 144.47 18.51 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 127.585 2.354 . . . . 7.94 109.402 171.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.56 152.54 17.59 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 124.069 3.179 . . . . 2.05 111.281 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.645 ' H ' HD23 ' A' ' 93' ' ' LEU . 2.0 pt? -120.06 142.16 49.11 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.849 2.46 . . . . 3.62 110.152 -166.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -96.2 -165.8 1.33 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 125.647 1.579 . . . . 3.94 110.21 159.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.18 139.01 36.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 107.92 -1.141 . . . . 1.52 107.92 148.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.45 4.55 34.85 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.66 1.6 . . . . 1.82 115.501 -170.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.19 174.51 11.49 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.065 1.346 . . . . 2.85 110.579 171.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -136.3 149.09 48.27 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.175 1.79 . . . . 4.02 106.22 156.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.1 t -145.06 134.56 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.571 1.948 . . . . 1.14 110.195 -165.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -78.9 135.09 36.89 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.842 1.257 . . . . 3.39 112.208 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mp -123.41 145.01 49.12 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.155 1.382 . . . . 1.71 111.153 162.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -109.25 133.99 52.33 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.562 1.945 . . . . 2.81 108.578 170.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 mp -108.5 131.44 54.81 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.883 0.873 . . . . 0.8 109.686 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.2 mt -106.52 114.77 29.08 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.206 1.003 . . . . 0.7 109.844 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -113.36 121.11 43.38 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.981 1.713 . . . . 2.03 111.498 -175.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.96 22.45 2.43 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.598 1.959 . . . . 2.61 114.475 174.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.77 -58.39 3.46 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.127 1.346 . . . . 4.22 112.66 -169.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.38 0.73 79.46 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 116.821 1.489 . . . . 2.13 116.821 -167.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -130.94 140.15 50.14 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.774 1.787 . . . . 3.71 112.344 173.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.0 p -127.73 147.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.42 1.888 . . . . 2.25 110.347 172.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.1 tp -150.73 124.48 9.15 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.039 1.336 . . . . 2.06 110.236 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -113.25 135.75 53.5 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.266 0.626 . . . . 2.64 112.579 -172.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.4 t -146.45 163.93 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.465 1.506 . . . . 3.23 108.956 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -114.56 138.03 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.179 1.392 . . . . 2.3 109.113 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mp -124.22 151.57 66.16 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.841 1.256 . . . . 2.6 110.562 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -69.06 155.43 68.27 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.229 2.62 . . . . 1.23 111.489 172.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.6 t -106.41 81.73 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 107.499 -1.297 . . . . 1.46 107.499 161.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.19 156.09 27.09 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.748 -1.205 . . . . 4.05 107.748 140.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -83.43 178.98 7.79 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.05 1.34 . . . . 3.68 110.849 172.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.268 12.1 ptt-85 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 114.78 -2.533 . . . . 9.47 113.494 162.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 113' ' ' VAL . . . . . . . . 0 N--CA 1.471 0.969 0 CA-C-O 118.915 -0.936 . . . . 15.93 110.903 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.2 m -129.67 138.01 50.95 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 106.242 -1.762 . . . . 14.06 106.242 167.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 46.72 -122.16 1.22 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 118.263 -0.875 . . . . 11.81 108.934 -163.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.2 m 104.6 69.26 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 129.891 3.276 . . . . 7.85 108.675 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -81.19 70.36 8.01 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.989 0.915 . . . . 7.21 109.799 177.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.82 -179.93 32.16 Favored Glycine 0 N--CA 1.471 0.999 0 O-C-N 120.717 -1.239 . . . . 1.0 114.689 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.5 p90 -141.87 165.82 26.41 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.418 1.487 . . . . 2.02 112.206 172.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.6 t -106.14 135.56 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.044 -1.095 . . . . 1.07 108.044 166.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.04 113.95 15.3 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 120.766 0.317 . . . . 3.72 110.278 175.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -61.36 135.71 57.79 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.658 -0.497 . . . . 2.99 109.658 156.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.2 m -160.59 139.84 7.92 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.991 1.317 . . . . 3.64 108.952 167.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -85.08 48.23 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.692 3.595 . . . . 3.12 112.353 -168.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -124.09 -175.45 14.39 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.411 1.482 . . . . 1.75 112.897 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.78 -17.46 20.13 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.673 2.915 . . . . 1.77 113.516 174.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -122.16 167.33 13.3 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.728 2.011 . . . . 3.37 113.431 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.34 -176.06 5.15 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 127.127 2.171 . . . . 0.84 111.739 175.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.22 150.7 44.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.718 2.007 . . . . 0.83 108.658 176.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.47 138.41 48.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.153 0.888 . . . . 0.87 111.308 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -129.02 133.55 47.78 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.057 1.743 . . . . 2.35 110.656 -171.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 pp -165.7 152.12 9.7 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.149 0.886 . . . . 2.37 113.1 -170.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 62.6 m -77.22 120.85 22.86 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.355 -0.841 . . . . 3.26 109.035 171.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.14 118.97 23.0 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.541 -1.281 . . . . 3.31 107.541 168.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -111.44 126.9 55.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.875 1.67 . . . . 4.09 109.07 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -103.62 98.7 13.38 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 121.652 -0.655 . . . . 1.38 111.552 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.17 -7.27 17.09 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.903 2.402 . . . . 1.37 114.112 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.76 172.35 53.18 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-O 122.658 1.143 . . . . 1.19 112.656 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -103.78 -4.52 23.52 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.21 2.604 . . . . 3.07 111.837 -174.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.664 ' H ' HD23 ' A' ' 28' ' ' LEU . 2.6 pt? -116.55 162.41 26.9 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 129.106 2.963 . . . . 2.89 109.577 172.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.12 142.59 24.76 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.131 1.888 . . . . 0.84 109.991 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.494 HD12 ' CD1' ' A' ' 105' ' ' PHE . 1.1 mm? -105.67 158.04 16.99 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.076 1.351 . . . . 2.3 111.308 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -149.42 107.45 3.72 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.154 -1.385 . . . . 2.59 111.434 -171.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.5 tp -90.39 109.65 20.76 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 127.051 2.14 . . . . 1.84 109.272 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -106.77 -17.76 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.445 1.098 . . . . 0.7 112.238 -171.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.87 -175.38 28.73 Favored Glycine 0 C--N 1.344 0.985 0 C-N-CA 125.878 1.704 . . . . 0.45 113.089 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.76 -176.91 5.45 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.532 1.533 . . . . 0.52 110.794 168.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.71 175.87 13.34 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.418 2.687 . . . . 4.59 108.2 169.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.0 159.3 7.85 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 127.135 2.174 . . . . 0.97 107.267 168.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.56 -9.68 16.67 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.638 2.225 . . . . 0.94 115.168 166.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.75 41.36 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 114.821 1.415 . . . . 0.89 114.821 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.46 149.91 8.65 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.314 1.446 . . . . 2.07 110.133 161.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -123.17 -58.78 1.62 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.817 1.247 . . . . 3.38 111.376 -173.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -78.21 68.17 4.17 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 120.887 -1.133 . . . . 4.93 108.989 168.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.7 p -78.03 150.47 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.054 -0.975 . . . . 1.11 108.857 168.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.97 158.36 37.77 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.065 2.146 . . . . 4.75 107.038 -164.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -134.47 133.3 40.27 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 123.794 1.759 . . . . 1.75 114.102 171.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -120.41 149.13 42.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 112.728 -2.033 . . . . 0.77 111.188 -171.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.65 -178.9 7.0 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.293 -1.321 . . . . 2.9 110.837 155.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.7 m -153.22 138.68 17.65 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.893 1.277 . . . . 0.92 108.465 172.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -147.73 164.27 34.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 122.84 1.305 . . . . 2.28 113.45 -171.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.5 ttm -97.32 138.71 34.37 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.313 1.445 . . . . 3.89 109.758 172.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -149.08 161.51 41.8 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.431 1.271 . . . . 8.9 114.431 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.479 ' CD ' ' HZ2' ' A' ' 57' ' ' LYS . 3.6 tp10 -83.27 151.91 25.39 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.627 1.571 . . . . 3.24 110.53 162.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.9 t -139.4 117.39 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.17 1.788 . . . . 2.67 106.642 152.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 62.68 21.54 12.78 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.819 1.414 . . . . 3.91 114.819 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.26 0.53 82.59 Favored Glycine 0 N--CA 1.48 1.612 0 O-C-N 120.378 -1.451 . . . . 2.4 114.034 -170.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -104.27 119.88 39.94 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.139 2.576 . . . . 4.09 107.644 -175.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.479 ' HZ2' ' CD ' ' A' ' 52' ' ' GLU . 42.6 mttp -88.05 126.11 34.92 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.28 1.432 . . . . 5.19 110.03 -167.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.56 HG22 ' H ' ' A' ' 59' ' ' MET . 8.8 p -154.43 -178.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.732 1.613 . . . . 2.67 109.691 -165.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.56 ' H ' HG22 ' A' ' 58' ' ' VAL . 39.2 mmm -119.31 161.87 19.72 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.451 1.101 . . . . 3.09 111.176 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -142.81 168.61 25.9 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 126.322 1.915 . . . . 0.65 111.509 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.7 ttm -157.67 132.43 8.58 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.328 1.451 . . . . 0.74 109.226 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -145.43 148.99 39.34 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 126.476 1.91 . . . . 8.14 109.704 -170.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.89 155.43 34.36 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.105 1.87 . . . . 0.78 111.118 -176.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.4 m -131.41 151.6 79.04 Favored Pre-proline 0 N--CA 1.477 0.895 0 CA-C-O 118.453 -0.784 . . . . 0.84 110.709 176.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.89 -20.6 11.64 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.397 2.732 . . . . 0.57 113.165 -167.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -179.29 164.0 1.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.04 2.136 . . . . 1.98 110.467 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.6 mt -110.4 154.65 23.28 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.88 0.872 . . . . 0.55 110.57 162.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -134.6 146.17 49.34 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.329 0.652 . . . . 1.96 110.736 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.4 t -142.83 132.14 11.84 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 124.244 0.965 . . . . 0.88 112.681 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.33 160.53 48.49 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.499 2.799 . . . . 0.88 111.912 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -60.53 139.8 88.0 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.491 2.794 . . . . 0.92 112.141 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.8 mptt 66.02 -6.42 0.46 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 127.7 2.4 . . . . 1.84 114.168 -174.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.59 153.73 37.23 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.759 1.647 . . . . 1.38 113.202 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -107.23 147.16 30.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.15 0.98 . . . . 3.82 109.647 163.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.9 t -145.14 125.9 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.907 1.683 . . . . 4.09 107.013 166.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -93.77 130.91 39.6 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.708 1.003 . . . . 4.65 113.708 -168.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -75.96 68.73 2.5 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.155 0.979 . . . . 1.94 109.507 157.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 78' ' ' LYS . 8.0 pttp -90.64 156.58 45.02 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 125.705 1.602 . . . . 3.96 113.675 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.28 -20.99 71.92 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.743 2.295 . . . . 2.66 113.103 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.5 52.78 3.87 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-N 119.106 0.866 . . . . 3.11 111.813 163.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.69 -117.9 2.08 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.472 1.511 . . . . 1.44 115.679 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -74.44 143.83 44.53 Favored 'General case' 0 C--O 1.224 -0.276 0 O-C-N 121.574 -0.957 . . . . 2.23 112.741 -161.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -161.8 154.28 19.9 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.454 -0.779 . . . . 0.8 113.024 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -78.08 136.22 37.86 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.296 -0.631 . . . . 1.95 109.296 166.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.9 tpt -97.94 133.45 42.41 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 107.801 -1.185 . . . . 0.84 107.801 163.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -114.68 115.77 27.63 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.758 1.223 . . . . 0.86 108.29 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mp -120.08 155.34 33.17 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.826 0.822 . . . . 1.67 110.19 168.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.08 45.81 24.51 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 116.004 -0.544 . . . . 1.58 112.458 176.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.36 153.11 4.17 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 123.03 1.395 . . . . 1.67 113.99 169.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -113.78 -12.17 12.79 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.011 -1.45 . . . . 2.01 113.029 -171.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -145.65 151.71 47.15 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 127.095 2.158 . . . . 5.03 108.542 174.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.88 154.5 72.78 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.664 2.243 . . . . 2.11 109.816 167.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 pp -148.18 143.69 27.23 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 126.172 1.789 . . . . 2.19 108.996 -168.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -127.35 173.02 10.13 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.925 1.69 . . . . 3.88 111.754 -168.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.31 130.76 35.77 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.323 -0.991 . . . . 1.26 108.323 162.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.24 5.64 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.999 1.285 . . . . 1.81 114.02 -176.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -129.16 -178.34 4.6 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.757 1.223 . . . . 2.37 110.11 169.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -136.48 142.58 43.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.669 1.988 . . . . 4.99 107.083 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.3 t -152.79 134.77 5.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 128.194 2.598 . . . . 1.44 108.572 -168.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -93.17 156.12 17.04 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.241 1.2 . . . . 2.87 114.241 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mp -115.07 162.74 16.59 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.11 1.764 . . . . 1.85 110.82 165.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -121.87 125.46 46.48 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 129.656 3.182 . . . . 3.12 107.163 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -104.18 129.04 51.92 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.307 -1.496 . . . . 1.02 110.181 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.5 mt -102.71 108.32 19.53 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.954 1.302 . . . . 0.9 110.173 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.494 ' CD1' HD12 ' A' ' 30' ' ' LEU . 92.4 m-85 -96.22 154.28 17.34 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.899 0.88 . . . . 1.94 110.562 174.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.93 135.72 29.91 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.616 0.767 . . . . 2.0 111.212 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.04 -6.53 69.27 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.437 1.018 . . . . 2.99 114.348 -173.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.82 14.64 42.44 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-N 118.485 1.143 . . . . 3.33 114.572 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 52.8 tttt -77.32 126.42 30.9 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.118 1.459 . . . . 6.11 111.126 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 49.7 t -100.97 131.57 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.084 1.754 . . . . 2.73 109.491 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.1 tp -128.27 114.34 16.79 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.603 1.161 . . . . 2.13 109.251 169.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.496 ' HZ2' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -106.36 134.56 49.31 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.298 1.222 . . . . 2.14 114.298 -175.574 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.5 ' HA ' ' HA2' ' A' ' 1' ' ' GLY . 13.2 m -139.62 148.16 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 127.852 2.461 . . . . 2.11 110.04 -152.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.4 t -118.05 124.47 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-N 120.096 1.316 . . . . 1.69 110.563 -165.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.99 143.37 47.58 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.992 1.317 . . . . 2.25 110.868 -169.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.34 149.43 35.33 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.192 2.594 . . . . 0.94 111.917 165.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.1 t -102.28 124.78 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.941 0.896 . . . . 0.91 109.179 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -150.7 155.82 40.08 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.971 1.308 . . . . 3.57 111.691 -174.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.95 59.35 3.18 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.088 0.955 . . . . 2.37 113.206 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.99 0 C-N-CA 126.275 1.83 . . . . 9.7 111.873 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.246 0 N-CA-C 105.971 -2.852 . . . . 12.83 105.971 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 p 161.91 141.48 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.162 -1.051 . . . . 10.77 108.162 -135.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -69.68 161.36 29.87 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.003 0.921 . . . . 10.47 111.535 170.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.3 p -140.36 63.02 1.48 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.765 2.026 . . . . 6.33 108.916 169.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -143.67 -169.09 3.0 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 129.678 3.191 . . . . 5.48 108.943 -166.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.41 ' CA ' ' HA ' ' A' ' 20' ' ' LEU . . . -85.4 171.85 46.26 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 121.252 -0.905 . . . . 1.93 113.868 161.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -155.42 162.35 40.79 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.664 2.386 . . . . 2.04 110.71 167.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.6 t -112.71 139.91 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.673 -1.267 . . . . 0.97 110.264 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.34 124.63 29.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.596 0.359 . . . . 4.78 110.96 176.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -36.14 145.2 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.996 2.518 . . . . 1.75 115.039 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.4 t -163.22 140.19 5.78 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 121.427 -0.796 . . . . 2.78 112.996 166.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -92.02 -8.9 2.75 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.276 3.317 . . . . 2.81 112.56 167.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.05 -179.38 24.23 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.458 1.504 . . . . 1.42 113.791 -169.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.49 -20.33 36.23 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 124.23 3.287 . . . . 1.27 114.58 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -113.17 162.95 15.37 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.176 1.39 . . . . 2.38 113.855 172.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.9 -177.46 6.63 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.881 2.472 . . . . 0.58 111.262 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.49 136.07 27.28 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.817 1.247 . . . . 0.81 110.363 174.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.83 143.18 49.01 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.717 1.207 . . . . 0.55 112.676 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -115.59 128.87 56.26 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.863 1.665 . . . . 2.41 109.433 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.41 ' HA ' ' CA ' ' A' ' 6' ' ' GLY 0.27 3.7 pp -123.77 153.05 41.51 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.409 1.263 . . . . 2.23 114.409 176.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.9 m -86.85 129.14 35.0 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.666 -1.235 . . . . 1.7 107.666 161.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.66 117.87 35.61 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.981 1.312 . . . . 3.07 108.87 -176.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -98.58 134.13 41.96 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.356 0.662 . . . . 3.77 110.655 175.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -121.58 96.91 47.23 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.131 0.973 . . . . 1.45 111.151 164.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.39 -3.28 9.36 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.332 2.688 . . . . 1.37 114.44 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.81 161.86 23.9 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 119.95 1.25 . . . . 1.6 111.957 -176.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.08 3.7 14.27 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 128.12 2.568 . . . . 3.02 112.803 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -118.39 153.59 51.84 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 128.037 2.535 . . . . 2.29 110.494 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.67 142.14 17.88 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.842 2.362 . . . . 0.91 110.473 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.3 mt -104.99 148.42 26.75 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 122.974 1.369 . . . . 1.76 111.562 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.7 ttp-105 -139.31 103.13 4.66 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 111.835 -2.439 . . . . 2.31 111.506 -176.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.8 tt -81.88 115.17 20.95 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 124.424 1.09 . . . . 2.46 109.404 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.6 m -103.13 -20.63 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.039 1.336 . . . . 0.9 112.457 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.97 -175.47 27.93 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 126.105 1.812 . . . . 0.74 113.028 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.42 -178.96 5.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.721 0.808 . . . . 0.69 110.725 167.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -149.77 178.68 8.65 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.94 2.496 . . . . 4.65 107.145 159.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -176.9 152.68 1.05 Allowed Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 127.364 2.266 . . . . 0.82 107.838 -174.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.57 -11.23 30.64 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.407 2.071 . . . . 1.1 113.779 170.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.06 47.12 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 114.237 1.199 . . . . 1.0 114.237 -175.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.76 152.65 11.83 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.429 1.892 . . . . 1.07 109.145 164.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -101.3 -31.28 11.05 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.348 0.522 . . . . 4.5 111.857 167.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -113.73 133.71 55.19 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 126.283 1.833 . . . . 4.73 108.66 168.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.4 p -139.56 127.29 25.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 124.752 1.221 . . . . 1.23 108.844 172.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -146.79 119.91 8.84 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.332 1.053 . . . . 3.51 108.85 -163.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.401 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.6 pt? -83.3 136.84 34.23 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 123.442 1.591 . . . . 2.04 114.31 -177.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -120.78 154.09 36.16 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.333 2.253 . . . . 0.68 111.307 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -92.05 160.39 15.25 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.742 1.217 . . . . 2.23 110.15 155.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.1 m -103.62 141.32 36.25 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 106.96 -1.496 . . . . 1.13 106.96 150.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -140.35 166.03 25.81 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 122.474 1.13 . . . . 1.98 113.616 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.0 mtm -95.18 141.77 28.4 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.696 1.198 . . . . 5.14 112.304 -176.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -142.25 153.32 43.86 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 115.409 1.633 . . . . 5.09 115.409 168.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -87.5 146.25 25.89 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.97 1.308 . . . . 3.05 108.808 146.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.2 m -130.61 -10.03 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 116.946 2.202 . . . . 3.53 116.946 169.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -162.98 22.77 0.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.174 1.39 . . . . 3.74 112.728 -167.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.93 4.15 46.88 Favored Glycine 0 N--CA 1.482 1.744 0 O-C-N 119.958 -1.714 . . . . 1.89 112.767 -159.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -120.12 134.5 55.24 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 129.055 2.942 . . . . 2.59 107.76 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -75.1 146.46 41.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.051 2.14 . . . . 4.89 109.475 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.4 p -155.03 168.45 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 126.635 1.974 . . . . 2.56 109.538 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.7 mmm -122.93 144.39 49.26 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.071 1.349 . . . . 3.64 110.101 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.73 179.23 16.21 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.554 1.549 . . . . 0.71 112.075 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ttm -142.11 141.55 32.71 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.798 1.639 . . . . 0.67 108.693 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.21 134.84 10.96 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 125.705 1.602 . . . . 6.69 109.006 -164.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.28 143.37 35.21 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 CA-C-N 121.537 1.585 . . . . 0.76 110.36 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.8 m -129.02 152.81 79.93 Favored Pre-proline 0 N--CA 1.481 1.125 0 CA-C-O 118.617 -0.706 . . . . 0.84 111.262 -173.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.25 -26.06 4.43 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.04 2.494 . . . . 0.74 112.782 -165.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -176.83 166.08 2.51 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.065 1.346 . . . . 1.97 112.079 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.2 mt -117.2 150.89 37.99 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.596 1.958 . . . . 0.62 111.463 166.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -113.57 145.06 41.84 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.839 1.256 . . . . 2.03 110.328 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.2 t -137.91 126.89 14.71 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 124.019 0.927 . . . . 0.87 110.638 162.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.35 166.4 25.57 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 124.027 3.151 . . . . 0.93 111.893 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.69 148.14 92.32 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.259 2.64 . . . . 1.12 114.176 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.289 19.1 mtmt 49.16 43.24 22.47 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.67 1.988 . . . . 2.72 114.13 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.35 169.06 24.69 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 127.738 2.59 . . . . 1.78 111.587 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.51 135.18 19.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.395 0.678 . . . . 4.56 110.834 175.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -151.45 137.41 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.39 1.476 . . . . 4.17 109.092 -162.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.99 158.24 15.52 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.684 1.231 . . . . 2.96 113.611 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.88 -32.99 74.81 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.78 2.032 . . . . 3.59 114.208 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt 99.18 130.49 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.415 0 C-N-CA 131.424 3.89 . . . . 3.6 111.142 174.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -65.32 -5.12 10.58 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.704 2.936 . . . . 3.01 115.584 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.4 -11.91 6.48 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-O 117.761 -1.577 . . . . 2.89 115.168 167.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.13 -110.5 3.31 Favored Glycine 0 N--CA 1.474 1.177 0 CA-C-N 119.958 1.879 . . . . 1.87 112.641 -172.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -73.16 145.61 46.22 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 122.035 -0.686 . . . . 2.09 110.656 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.7 p-80 -163.92 153.11 14.05 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.814 -0.554 . . . . 0.61 111.383 -177.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -80.43 131.81 35.64 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.441 -0.948 . . . . 1.79 108.441 164.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.9 tpt -84.55 129.63 34.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.056 -1.461 . . . . 0.74 107.056 157.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.0 mp -107.49 131.22 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.087 -1.079 . . . . 0.55 108.087 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mp -130.25 145.81 51.79 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.908 1.283 . . . . 1.52 110.138 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.8 40.82 93.81 Favored Glycine 0 CA--C 1.528 0.896 0 O-C-N 121.649 -0.657 . . . . 1.08 111.494 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.68 145.98 32.45 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 122.909 1.337 . . . . 1.33 113.689 175.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -101.8 -6.81 23.16 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.793 -1.548 . . . . 3.74 112.396 -172.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -132.98 139.06 33.3 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.802 1.641 . . . . 5.27 108.763 154.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -63.6 142.72 85.17 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 N-CA-C 107.285 -1.852 . . . . 2.08 107.285 156.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.1 mt -104.76 95.96 6.24 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.584 1.554 . . . . 2.46 109.975 -157.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.69 135.55 36.57 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.26 1.024 . . . . 3.94 111.293 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.51 106.49 0.66 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.954 1.302 . . . . 1.65 110.462 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.02 -0.02 21.09 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.872 1.701 . . . . 1.6 115.032 -170.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -81.11 -176.4 5.93 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.149 1.475 . . . . 2.21 112.346 169.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -141.7 138.92 32.77 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 129.422 3.089 . . . . 3.31 106.249 -168.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 79.0 t -150.62 158.04 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 128.827 2.851 . . . . 1.27 108.805 -167.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -123.25 154.45 38.79 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.504 0.722 . . . . 4.11 110.613 164.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.89 135.8 55.1 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.556 1.142 . . . . 1.91 109.488 160.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.32 140.52 29.41 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.422 2.289 . . . . 2.37 109.175 166.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.05 119.19 37.62 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.247 1.819 . . . . 1.14 110.06 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.7 mt -90.25 105.28 17.7 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.479 1.112 . . . . 1.13 109.594 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -99.78 144.05 29.3 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.075 1.35 . . . . 2.01 111.036 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.05 123.58 10.82 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.552 1.141 . . . . 1.7 114.042 -168.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.45 72.71 0.88 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.782 1.182 . . . . 3.09 112.816 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.17 19.81 77.59 Favored Glycine 0 N--CA 1.473 1.11 0 N-CA-C 116.013 1.165 . . . . 2.23 116.013 166.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -106.96 139.41 41.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.171 1.486 . . . . 4.66 111.114 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.0 p -147.01 147.22 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.717 0.807 . . . . 2.36 112.413 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 24.3 tp -156.69 175.78 13.6 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.204 2.602 . . . . 2.46 108.253 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -147.8 155.97 42.23 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.747 -1.221 . . . . 3.03 113.169 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.6 t -140.2 157.78 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.635 1.574 . . . . 2.54 109.571 -175.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.2 t -95.63 145.04 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.619 1.968 . . . . 2.55 110.993 -170.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mp -145.11 120.18 5.77 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 126.09 1.756 . . . . 2.6 111.164 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.65 165.74 26.54 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.541 2.16 . . . . 0.96 110.456 161.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.4 t -100.26 141.36 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 O-C-N 121.279 -0.888 . . . . 1.17 111.231 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -122.42 146.22 47.56 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.045 2.138 . . . . 4.97 111.197 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.24 105.4 12.4 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.547 -0.721 . . . . 2.44 112.089 167.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 . . . . . 0 C--O 1.25 1.091 0 C-N-CA 129.715 3.206 . . . . 7.17 108.299 170.117 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.916 0 N-CA-C 108.364 -1.894 . . . . 13.16 108.364 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 p -176.34 145.33 0.58 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 126.029 1.732 . . . . 12.72 108.047 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -139.66 18.21 2.52 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.954 1.094 . . . . 11.66 113.954 -164.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 79.66 12.81 1.11 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.877 1.671 . . . . 8.44 112.247 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -82.42 67.96 8.66 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.795 1.238 . . . . 5.81 110.353 -172.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.74 179.93 33.11 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 124.654 1.121 . . . . 1.4 113.232 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.8 p90 -156.69 153.55 28.65 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.035 0.754 . . . . 2.24 113.035 169.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.1 t -100.53 136.69 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.388 0.675 . . . . 1.12 109.331 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -72.56 109.2 6.05 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.755 0.822 . . . . 5.9 109.962 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.35 134.54 8.85 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.408 1.483 . . . . 2.27 112.864 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.8 t -150.5 143.84 16.83 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 114.676 1.362 . . . . 2.75 114.676 167.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -86.58 -4.62 8.29 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.54 2.826 . . . . 2.77 112.052 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.46 -176.03 25.1 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.216 1.388 . . . . 1.52 114.129 -169.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.52 -14.55 30.68 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.267 3.312 . . . . 1.41 114.362 -175.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -131.07 153.34 49.41 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.184 2.194 . . . . 2.46 114.308 -172.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.13 -176.12 5.73 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 127.628 2.371 . . . . 0.5 113.261 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.18 157.64 45.89 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.928 2.091 . . . . 0.58 109.595 172.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.81 152.57 46.65 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.524 1.056 . . . . 0.55 113.027 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -139.85 146.81 39.82 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.4 2.28 . . . . 2.34 110.686 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -172.92 172.55 3.99 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 115.077 1.51 . . . . 2.28 115.077 -170.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.24 143.03 39.24 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 129.323 3.049 . . . . 2.9 110.569 -175.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.437 HD12 HG21 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -137.73 110.68 7.72 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.617 -0.512 . . . . 3.21 109.617 171.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -123.82 140.34 53.08 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.803 1.241 . . . . 3.45 111.29 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -104.44 112.04 65.31 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.634 0.774 . . . . 1.42 111.472 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -82.73 -19.53 6.05 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.948 2.432 . . . . 1.34 114.276 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.35 -177.12 51.73 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 119.029 0.831 . . . . 1.16 112.022 -174.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -107.79 0.86 22.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.375 1.87 . . . . 2.99 111.764 -174.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -118.94 160.24 41.52 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 128.287 2.635 . . . . 2.05 109.726 171.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.61 147.72 32.09 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.679 2.253 . . . . 1.14 110.947 -176.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.9 mt -103.81 149.53 24.96 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 122.518 1.151 . . . . 1.7 110.943 173.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -133.8 106.9 7.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 112.348 -2.206 . . . . 2.43 110.669 -176.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.508 HD21 ' CZ ' ' A' ' 84' ' ' PHE . 2.9 tt -81.25 115.67 20.76 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.253 1.021 . . . . 1.91 108.652 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.17 -18.22 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.077 0.951 . . . . 0.8 112.298 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.34 -173.95 27.41 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 126.059 1.79 . . . . 0.69 112.701 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -143.94 -174.85 4.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.728 1.611 . . . . 0.72 110.641 166.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.19 178.62 10.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.761 2.424 . . . . 5.01 108.654 171.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -178.4 154.93 0.92 Allowed Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 127.03 2.132 . . . . 0.73 107.939 -174.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.16 -6.9 17.73 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.082 1.855 . . . . 0.73 113.042 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.0 m -124.91 46.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 114.062 1.134 . . . . 0.85 114.062 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.18 156.23 14.35 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.556 1.142 . . . . 0.96 111.854 167.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -92.83 -26.25 17.76 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.525 1.93 . . . . 2.93 112.816 170.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -143.24 140.29 30.62 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 129.378 3.071 . . . . 7.21 107.836 -168.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -157.2 59.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 125.101 2.381 . . . . 3.03 111.954 -165.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.61 135.24 35.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 111.453 -2.612 . . . . 5.25 112.72 -162.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 31.9 tp -86.06 121.33 28.51 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.974 1.309 . . . . 1.38 111.95 -165.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -123.38 153.86 39.77 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.363 1.465 . . . . 0.58 113.771 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -98.83 173.26 6.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.692 1.997 . . . . 2.35 111.673 163.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.2 m -152.64 143.76 23.12 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.398 1.879 . . . . 0.72 107.889 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -156.94 167.23 31.08 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.554 0.946 . . . . 1.94 113.554 -167.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.1 mtt -94.55 154.62 17.3 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.98 0.912 . . . . 5.74 110.877 160.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.67 157.04 34.47 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.613 1.165 . . . . 4.62 110.307 -173.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -103.25 139.67 38.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.684 1.193 . . . . 2.66 110.81 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.4 t -136.76 125.87 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.063 -1.458 . . . . 2.27 107.063 162.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 60.79 22.29 12.32 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.672 1.589 . . . . 3.33 114.162 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.08 8.45 87.4 Favored Glycine 0 CA--C 1.538 1.475 0 O-C-N 120.051 -1.656 . . . . 1.82 113.861 -171.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -108.35 124.26 50.08 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 127.235 2.214 . . . . 3.15 108.192 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.31 119.35 20.08 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.273 -1.33 . . . . 4.7 110.198 -175.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.8 m -121.61 -178.6 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 128.313 2.645 . . . . 2.63 109.975 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.7 mtm -125.89 162.55 24.93 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.84 1.256 . . . . 3.94 111.142 174.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.43 176.75 32.92 Favored Glycine 0 N--CA 1.462 0.417 0 CA-C-O 121.774 0.652 . . . . 0.65 113.361 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.0 ttm -159.44 137.11 10.03 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.598 1.959 . . . . 0.81 108.969 -173.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -138.91 153.23 71.66 Favored Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 125.949 1.7 . . . . 7.75 109.399 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.62 152.21 25.8 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.923 1.749 . . . . 0.76 109.501 170.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.57 151.84 75.23 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 124.128 0.971 . . . . 0.68 110.621 -176.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.8 -25.99 5.91 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.166 2.577 . . . . 0.9 112.882 -167.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -176.79 164.76 2.43 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.67 1.588 . . . . 2.46 111.602 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.2 mt -109.06 152.19 25.37 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.653 1.181 . . . . 0.9 109.982 160.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -117.69 141.6 48.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.748 1.219 . . . . 1.89 110.074 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.437 HG21 HD12 ' A' ' 22' ' ' LEU . 35.4 t -137.32 128.27 16.16 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 113.754 1.02 . . . . 0.96 113.754 171.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.19 158.43 41.44 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.125 3.217 . . . . 1.09 112.574 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.82 133.66 46.06 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.135 3.224 . . . . 1.12 112.764 -175.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.14 -12.84 0.55 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 128.721 2.808 . . . . 1.69 113.872 -175.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.48 166.42 51.0 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.719 1.628 . . . . 1.35 113.116 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -122.53 146.02 47.79 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.715 1.606 . . . . 4.84 111.785 172.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 69' ' ' VAL . 21.3 t -152.96 89.77 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 124.801 1.241 . . . . 4.05 110.146 170.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.04 147.57 44.93 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.294 -0.867 . . . . 4.79 109.59 -172.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.74 127.25 31.04 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.276 1.036 . . . . 2.46 109.419 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.35 122.49 87.65 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 117.305 -1.331 . . . . 3.32 109.979 -168.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -61.86 -10.62 17.88 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.747 2.964 . . . . 2.56 114.618 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -125.92 0.39 7.78 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 117.355 -1.803 . . . . 2.3 116.143 166.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.56 -20.4 1.24 Allowed Glycine 0 N--CA 1.481 1.676 0 CA-C-N 120.674 2.237 . . . . 1.97 118.483 -172.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -150.81 135.66 17.4 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.166 1.983 . . . . 2.37 111.557 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -158.04 152.77 25.0 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.019 0.928 . . . . 0.64 110.602 -173.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.508 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 92.0 m-85 -79.16 145.84 33.46 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.661 -0.866 . . . . 1.88 108.661 161.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 tpt -106.64 124.14 49.17 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 126.73 2.012 . . . . 0.96 108.627 168.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -107.48 133.43 51.97 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.807 1.643 . . . . 0.58 109.462 -173.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.57 148.87 49.24 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.186 0.995 . . . . 2.17 111.473 176.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.17 40.15 30.07 Favored Glycine 0 N--CA 1.468 0.823 0 C-N-CA 123.766 0.698 . . . . 0.87 113.539 169.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 pp -56.98 156.29 7.02 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 116.075 1.88 . . . . 1.71 116.075 -177.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -111.42 -19.8 12.46 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 112.298 -2.228 . . . . 1.88 112.684 -170.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -145.59 136.55 12.45 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 128.102 2.561 . . . . 6.11 108.004 165.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.43 137.33 39.32 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.212 2.608 . . . . 1.7 110.955 -176.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.73 84.74 2.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.992 2.117 . . . . 2.64 110.055 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -86.36 169.81 12.59 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.467 1.507 . . . . 3.9 111.629 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.93 112.62 3.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.814 -1.084 . . . . 1.62 111.892 -175.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.31 0.18 28.08 Favored Glycine 0 CA--C 1.539 1.536 0 N-CA-C 117.188 1.635 . . . . 2.1 117.188 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -92.14 180.0 5.42 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.777 1.289 . . . . 2.32 113.756 -169.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.54 77.57 1.18 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.57 1.948 . . . . 5.41 113.498 -162.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 77.0 t -95.22 127.73 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.66 -1.275 . . . . 1.29 111.979 -169.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -78.25 136.48 37.78 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.995 0.918 . . . . 2.43 112.568 173.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.23 151.59 35.45 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.15 0.976 . . . . 1.81 111.744 155.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -104.22 141.68 35.85 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.62 2.768 . . . . 2.23 107.933 160.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.02 130.95 54.57 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.852 1.261 . . . . 1.0 108.833 172.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.8 mt -100.68 111.02 23.19 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.131 0.973 . . . . 0.8 109.593 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -98.77 141.3 31.74 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.104 1.361 . . . . 2.03 110.863 175.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.47 125.94 7.53 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.753 1.621 . . . . 1.68 112.729 -172.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.74 33.79 20.72 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.065 -0.853 . . . . 2.61 114.026 -175.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.3 14.13 74.95 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 116.596 1.399 . . . . 2.93 116.596 162.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -88.89 123.65 33.46 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.588 1.694 . . . . 3.42 111.414 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.8 t -115.83 131.22 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 O-C-N 124.07 0.857 . . . . 2.53 111.38 -173.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.5 tp -124.75 122.92 38.82 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.11 1.364 . . . . 2.41 111.073 177.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.89 148.84 32.6 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.405 -0.81 . . . . 2.32 112.305 171.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -146.66 157.61 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.642 1.577 . . . . 2.26 109.29 163.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.8 t -104.97 136.84 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.118 1.367 . . . . 2.01 109.696 173.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.9 mp -125.25 130.67 24.08 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.916 1.687 . . . . 2.73 110.762 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.68 138.71 38.74 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.004 1.803 . . . . 1.22 109.842 164.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.9 t -77.92 141.41 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 O-C-N 120.699 -1.251 . . . . 1.19 108.485 162.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.53 -174.24 2.55 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.989 1.716 . . . . 6.96 113.45 -177.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -126.34 151.57 47.4 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.524 1.13 . . . . 2.51 110.407 166.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.178 0 C-N-CA 129.637 3.175 . . . . 8.82 109.936 -165.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.092 0 N-CA-C 107.311 -2.316 . . . . 11.18 107.311 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m -142.47 178.84 7.32 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.601 0.963 . . . . 9.46 113.601 -150.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -63.74 159.79 18.54 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.26 -0.427 . . . . 7.99 110.943 159.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.6 p -123.62 106.41 10.54 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.601 1.56 . . . . 6.54 111.164 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.3 pm0 -77.6 121.77 24.39 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.191 0.996 . . . . 7.18 110.543 174.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.89 172.23 38.0 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 121.338 -0.851 . . . . 1.32 113.337 159.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.9 p90 -155.8 153.28 29.57 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.112 1.365 . . . . 1.91 112.234 164.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.38 139.94 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.16 -0.963 . . . . 1.07 108.556 173.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -75.71 109.16 9.07 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.876 0.87 . . . . 4.7 111.768 -178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -47.29 130.26 13.08 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.569 1.548 . . . . 2.84 111.469 171.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -154.92 167.5 13.92 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 124.465 1.106 . . . . 2.29 113.51 162.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -94.39 -1.73 2.83 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 124.268 3.312 . . . . 2.14 114.071 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.71 -168.02 26.36 Favored Glycine 0 CA--C 1.542 1.774 0 C-N-CA 124.788 1.185 . . . . 1.5 115.517 -167.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.79 -10.23 16.95 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 124.817 3.678 . . . . 1.34 114.328 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -135.04 158.68 43.73 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.845 2.458 . . . . 2.43 113.83 -170.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.82 -175.04 5.14 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.399 2.28 . . . . 0.66 112.344 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.28 151.47 47.64 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.777 2.431 . . . . 0.83 107.726 172.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.94 144.68 51.01 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.552 1.069 . . . . 0.78 112.268 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.485 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 65.6 m-85 -124.21 143.24 50.63 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.439 1.896 . . . . 2.34 110.661 -178.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -173.23 166.33 4.86 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.942 1.697 . . . . 3.11 111.832 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 t -102.75 160.12 14.87 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.719 1.208 . . . . 2.76 113.436 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.6 tp -129.69 129.26 44.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.491 1.517 . . . . 3.87 109.808 169.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -117.61 142.48 47.16 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.11 0.564 . . . . 3.34 109.809 157.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -94.84 110.46 49.73 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.162 0.985 . . . . 1.49 109.371 173.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -84.62 -9.12 9.2 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.287 2.658 . . . . 1.01 114.48 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.99 177.14 47.77 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 122.564 1.091 . . . . 1.2 113.101 -172.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -89.71 -6.5 56.02 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.614 1.165 . . . . 4.1 112.043 174.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.69 160.17 45.47 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 127.63 2.372 . . . . 1.99 110.823 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -77.16 148.98 27.87 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.636 2.224 . . . . 1.02 111.476 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.7 mp -110.8 152.46 26.61 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.63 1.572 . . . . 2.59 109.509 172.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -138.77 113.94 9.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 113.674 -1.603 . . . . 2.41 109.574 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.3 tt -86.88 123.9 32.52 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.684 1.194 . . . . 1.92 108.311 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.1 m -115.31 -14.65 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.413 1.085 . . . . 0.52 111.994 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.15 -174.64 28.11 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 125.708 1.623 . . . . 0.54 113.879 -174.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.418 ' HB2' ' CE1' ' A' ' 84' ' ' PHE . . . -149.42 -176.35 5.35 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.838 1.655 . . . . 0.73 111.542 175.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -153.67 168.82 24.94 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.023 1.729 . . . . 6.3 109.03 164.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 t -165.73 148.07 6.44 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 126.028 1.731 . . . . 0.84 108.381 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.06 -0.22 9.73 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.597 2.198 . . . . 0.96 113.232 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.67 43.46 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.651 1.58 . . . . 0.79 113.656 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.02 135.3 5.32 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.368 1.067 . . . . 1.21 110.409 160.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -83.68 -26.41 29.86 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.508 1.123 . . . . 3.72 113.219 174.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -108.64 132.2 54.14 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 108.074 -1.084 . . . . 4.8 108.074 160.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -116.23 141.37 34.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.298 -1.001 . . . . 1.14 108.298 150.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -132.6 153.43 51.05 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.397 1.879 . . . . 2.92 108.461 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.4 tp -109.59 120.38 42.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.644 0.778 . . . . 1.18 110.18 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -121.87 161.52 22.62 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.803 1.241 . . . . 0.62 112.753 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.51 160.63 29.04 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.149 -0.932 . . . . 3.55 110.886 161.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.402 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 25.6 m -132.36 123.77 27.43 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.98 1.712 . . . . 1.19 107.189 -175.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -113.72 170.61 8.13 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.121 1.768 . . . . 2.17 112.522 -174.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 50.6 ttp -99.64 141.67 32.13 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.527 1.131 . . . . 3.11 110.284 164.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -133.55 161.02 35.72 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.429 1.892 . . . . 4.88 110.108 170.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -90.18 147.9 23.29 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.483 1.113 . . . . 2.42 109.11 154.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.41 137.7 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.713 -1.217 . . . . 2.98 107.713 149.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.453 ' HB2' ' HE2' ' A' ' 56' ' ' LYS . 25.5 mt-10 61.9 9.8 3.19 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 115.921 1.823 . . . . 3.14 115.921 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.0 5.95 59.39 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 124.657 1.122 . . . . 1.64 115.194 -171.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 54' ' ' GLU . 44.9 pttt -121.91 134.23 54.86 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.409 2.284 . . . . 3.21 110.585 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -73.05 131.59 42.3 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.54 2.336 . . . . 4.15 109.406 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 m -138.5 166.41 23.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 127.447 2.299 . . . . 2.15 109.702 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -129.42 129.67 44.98 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.204 1.002 . . . . 3.16 110.812 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.67 175.25 16.46 Favored Glycine 0 N--CA 1.467 0.748 0 C-N-CA 125.677 1.608 . . . . 0.78 111.88 -176.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.7 ttm -139.13 156.8 46.88 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.225 1.41 . . . . 0.74 110.077 -172.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -161.33 151.1 14.06 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.36 1.464 . . . . 6.59 110.837 -175.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.33 153.49 45.37 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.17 1.913 . . . . 0.64 110.607 172.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.3 m -137.5 153.04 74.1 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 124.683 1.193 . . . . 0.62 109.895 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -82.36 -28.36 1.9 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.866 2.378 . . . . 0.62 113.287 -166.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -175.25 167.19 3.42 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.497 1.519 . . . . 2.02 111.982 -176.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.2 mt -115.14 148.67 38.72 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.267 1.827 . . . . 0.75 110.418 165.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -115.06 138.91 50.34 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.74 1.216 . . . . 1.74 108.858 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.4 t -140.29 124.84 10.95 Favored Pre-proline 0 N--CA 1.471 0.578 0 N-CA-C 112.92 0.711 . . . . 0.81 112.92 170.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.33 161.25 44.9 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.855 3.037 . . . . 0.96 111.67 178.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -58.16 136.75 76.79 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.664 2.909 . . . . 0.96 111.893 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.78 -9.05 1.14 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 127.363 2.265 . . . . 3.03 113.099 -178.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.14 146.27 29.1 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.226 1.394 . . . . 1.21 113.142 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.36 140.44 45.94 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.747 2.019 . . . . 4.11 109.529 171.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.8 t -145.89 123.85 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.451 1.9 . . . . 3.48 108.234 175.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -109.03 141.76 40.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.745 1.218 . . . . 5.19 110.935 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -79.0 65.91 4.3 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.487 1.115 . . . . 2.08 109.328 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.432 ' H ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -53.23 136.57 49.66 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-O 118.288 -0.863 . . . . 5.28 112.149 -167.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.485 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 33.9 Cg_endo -62.75 -20.9 72.35 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.89 3.06 . . . . 2.4 116.973 -158.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.76 -3.66 87.94 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-O 118.734 -1.036 . . . . 2.61 115.093 173.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 48' ' ' THR . . . -129.5 -108.07 1.3 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.504 1.526 . . . . 1.9 113.615 -174.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -71.87 142.66 49.56 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.745 -0.856 . . . . 2.13 110.594 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -162.78 168.15 21.87 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.461 1.104 . . . . 0.54 110.251 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.418 ' CE1' ' HB2' ' A' ' 35' ' ' ALA . 97.3 m-85 -93.79 147.26 23.22 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.468 -0.568 . . . . 2.04 109.468 163.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.8 tpt -102.32 136.53 41.99 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.887 1.275 . . . . 0.68 109.67 166.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -117.72 128.03 54.49 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.179 1.391 . . . . 0.77 109.264 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.67 145.35 50.61 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.036 0.934 . . . . 2.21 110.235 173.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.63 51.56 11.66 Favored Glycine 0 N--CA 1.469 0.872 0 O-C-N 121.701 -0.624 . . . . 0.82 112.409 174.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.26 155.97 10.66 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 115.064 1.505 . . . . 1.59 115.064 173.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.5 -7.13 12.84 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 113.973 -1.467 . . . . 2.8 113.707 -176.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -139.93 168.61 14.35 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 128.22 2.608 . . . . 4.73 108.775 166.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -58.7 160.92 16.14 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.578 1.519 . . . . 2.21 110.935 161.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.2 103.4 6.22 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.218 1.007 . . . . 2.79 110.147 161.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.5 mmtm -115.34 158.91 21.74 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.723 2.409 . . . . 6.74 112.155 174.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.64 120.18 10.1 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.695 -0.854 . . . . 1.63 108.695 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.53 -0.73 53.13 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.156 1.36 . . . . 1.38 115.141 -174.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.42 -174.66 5.29 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.574 1.687 . . . . 2.86 110.272 161.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -155.71 145.56 21.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.834 2.054 . . . . 3.2 107.789 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.4 t -148.54 130.35 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 125.785 1.634 . . . . 1.06 109.922 -163.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -79.05 138.82 38.15 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.868 -0.606 . . . . 3.4 111.316 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -123.83 132.3 53.75 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.909 1.283 . . . . 3.09 110.468 171.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.24 140.22 30.05 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.446 1.898 . . . . 2.43 108.669 165.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -107.28 130.18 54.79 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.396 1.878 . . . . 1.04 107.926 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.8 mt -109.74 126.94 54.25 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.907 1.283 . . . . 0.99 110.678 -176.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -119.97 151.76 38.47 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.484 1.114 . . . . 2.02 112.917 -171.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.43 151.57 19.75 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.283 1.033 . . . . 2.06 112.798 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.18 16.87 75.42 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.884 -0.954 . . . . 3.42 114.738 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.19 78.08 0.93 Allowed Glycine 0 CA--C 1.529 0.959 0 CA-C-N 118.876 1.338 . . . . 2.26 113.461 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -152.23 141.09 21.05 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.516 2.726 . . . . 3.47 110.872 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.3 t -138.76 147.88 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.959 1.704 . . . . 2.0 108.092 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 tt -150.56 116.83 5.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.924 0.889 . . . . 2.65 110.598 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.44 122.06 37.76 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.905 0.705 . . . . 3.98 112.905 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -105.31 175.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 126.699 1.999 . . . . 2.28 110.604 166.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.7 t -138.8 132.41 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.102 0.961 . . . . 1.94 109.364 173.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -125.01 149.93 64.9 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.731 1.612 . . . . 3.02 109.703 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.18 159.09 48.65 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.334 2.023 . . . . 1.03 110.642 163.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 42.1 t -90.97 134.77 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.374 -1.713 . . . . 1.03 106.374 156.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -136.5 174.43 10.62 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.369 0.667 . . . . 3.82 111.769 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.6 55.23 1.61 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.538 1.535 . . . . 2.43 113.643 -170.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.143 1 C-N-CA 131.739 4.016 . . . . 7.43 114.41 161.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.402 0 N-CA-C 107.515 -2.234 . . . . 11.51 107.515 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -61.24 142.93 56.46 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 115.646 -2.422 . . . . 10.41 107.243 123.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 69.91 136.72 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.628 1.971 . . . . 10.0 112.912 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.51 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 19.0 p -143.44 19.6 1.88 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.159 1.784 . . . . 6.65 112.351 -179.268 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 4' ' ' THR . 17.2 mp0 -105.72 -174.03 2.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.469 1.908 . . . . 4.45 111.297 -165.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.47 171.9 42.33 Favored Glycine 0 C--N 1.336 0.535 0 O-C-N 121.792 -0.568 . . . . 1.24 114.326 179.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -152.54 144.3 23.58 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.483 1.113 . . . . 1.93 111.032 166.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.6 t -88.96 133.4 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 107.635 -1.246 . . . . 1.08 107.635 175.185 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.84 115.23 27.92 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.145 0.578 . . . . 3.76 109.629 -172.061 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -62.88 151.65 38.57 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.91 1.284 . . . . 2.16 113.408 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.8 t -162.86 151.41 12.13 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.997 1.719 . . . . 2.48 110.207 164.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.1 -12.84 21.32 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.801 2.334 . . . . 2.0 112.647 166.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.85 138.86 18.0 Favored Glycine 0 CA--C 1.537 1.46 0 N-CA-C 110.125 -1.19 . . . . 2.51 110.125 168.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.33 -26.98 20.04 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.048 2.499 . . . . 2.21 114.818 -167.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -84.16 138.58 32.92 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.992 1.269 . . . . 4.44 110.829 171.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.76 -176.4 3.97 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.036 1.735 . . . . 0.6 112.178 -166.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.72 149.36 37.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.921 1.288 . . . . 0.7 109.71 175.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.35 152.9 47.53 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.248 1.023 . . . . 0.61 113.627 -175.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -129.7 143.52 50.86 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.05 2.14 . . . . 2.55 108.634 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.52 170.48 14.32 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.474 1.51 . . . . 2.52 111.827 -178.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.1 m -112.13 130.42 55.9 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 124.455 1.102 . . . . 2.18 110.983 -166.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.83 123.0 47.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.418 1.487 . . . . 3.1 107.744 168.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -126.95 134.0 50.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.993 -1.484 . . . . 4.58 106.993 161.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -94.21 105.51 17.96 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.031 0.933 . . . . 2.01 110.514 -176.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.14 -11.91 16.09 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.515 2.143 . . . . 1.92 113.427 176.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.8 178.26 53.25 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 119.204 0.911 . . . . 1.76 111.782 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -107.24 -0.06 22.89 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 126.772 2.029 . . . . 3.56 111.745 -173.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.8 157.99 66.95 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 128.301 2.641 . . . . 2.43 109.353 175.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.69 159.75 41.97 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.369 2.046 . . . . 1.46 112.137 -170.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.1 mt -112.91 149.28 33.4 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.378 1.471 . . . . 1.85 110.279 170.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.4 ttp-105 -128.92 110.8 12.41 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 112.989 -1.914 . . . . 2.78 109.325 173.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.1 tp -94.4 114.5 26.55 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 126.097 1.759 . . . . 1.87 108.891 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -114.11 -16.82 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.335 1.054 . . . . 0.57 112.064 -169.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.93 -175.55 28.98 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.877 1.703 . . . . 0.46 113.031 -176.072 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.74 -178.61 6.44 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.566 1.546 . . . . 0.5 110.845 173.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 -147.02 -179.25 6.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.978 1.711 . . . . 5.19 109.245 156.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 t -170.83 148.49 2.61 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 127.316 2.246 . . . . 0.78 107.806 174.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.54 -11.49 24.38 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.825 2.35 . . . . 0.79 113.258 -178.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.9 m -110.89 58.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.502 1.521 . . . . 0.97 110.883 172.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.57 172.02 16.08 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.944 1.697 . . . . 1.27 110.034 167.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -118.28 -21.41 8.14 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.937 0.895 . . . . 3.56 111.844 159.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -143.17 150.79 39.88 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 126.15 1.78 . . . . 6.12 108.439 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.39 148.17 20.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 C-N-CA 125.803 1.641 . . . . 1.13 107.346 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -135.67 139.79 43.99 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.02 1.728 . . . . 4.1 107.963 -167.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.7 tp -102.02 120.07 39.82 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 120.391 1.451 . . . . 1.25 110.942 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.401 ' CE1' ' HB2' ' A' ' 85' ' ' MET . 58.7 m170 -123.93 160.31 27.81 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.794 1.638 . . . . 0.7 115.258 -174.397 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' CB ' ' CE1' ' A' ' 82' ' ' TYR . 15.4 pt-20 -103.66 146.9 27.89 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.791 2.436 . . . . 2.36 111.24 158.151 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 100.0 m -107.15 148.57 28.68 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 106.323 -1.732 . . . . 0.86 106.323 156.471 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -158.49 -179.49 8.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.639 1.176 . . . . 2.06 112.671 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.3 mmt -107.78 143.38 36.41 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.055 1.342 . . . . 5.33 114.002 -178.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.73 143.87 33.74 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.708 2.003 . . . . 6.07 111.803 178.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -99.27 130.93 45.6 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.146 0.978 . . . . 3.36 109.011 156.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.5 t -139.98 131.8 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 107.696 -1.224 . . . . 2.05 107.696 172.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 59.81 20.92 9.78 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.03 1.732 . . . . 3.81 114.552 -173.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.53 25.77 73.38 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.484 -1.385 . . . . 2.75 113.105 -168.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -118.65 123.91 46.12 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.014 1.726 . . . . 2.74 108.248 173.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.616 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -73.72 121.85 21.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.037 1.735 . . . . 3.9 110.793 170.02 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 m -145.64 156.58 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 128.096 2.558 . . . . 2.46 109.764 -172.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 37.8 mtp -95.73 146.27 24.65 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.289 -0.882 . . . . 3.7 112.19 173.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.86 168.87 13.72 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.66 1.6 . . . . 0.71 111.436 175.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.8 ttm -150.48 142.6 24.07 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.831 1.252 . . . . 0.79 109.596 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.3 mtm180 -143.0 157.45 60.85 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 125.598 1.559 . . . . 5.65 109.792 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.74 157.15 39.76 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.015 1.81 . . . . 0.88 111.243 163.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.6 m -138.7 153.41 72.2 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 126.032 1.733 . . . . 0.79 109.402 176.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.56 -22.97 2.91 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.968 2.446 . . . . 0.74 113.821 -163.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -179.74 165.6 1.3 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.711 1.604 . . . . 2.03 111.899 -179.333 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -111.54 155.11 23.79 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.869 1.668 . . . . 0.94 110.224 164.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -115.99 146.45 42.12 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.622 1.169 . . . . 2.3 109.227 173.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.0 t -140.22 125.06 11.13 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 113.115 0.783 . . . . 1.41 113.115 170.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.14 159.47 40.82 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.945 3.097 . . . . 1.52 112.049 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.07 138.1 65.62 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.921 3.08 . . . . 1.69 112.607 -178.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.8 mptt 66.23 -6.58 0.47 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 128.264 2.626 . . . . 2.45 114.122 -175.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.97 167.49 34.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.789 1.662 . . . . 1.52 112.65 176.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -132.91 157.93 43.87 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.164 0.985 . . . . 4.57 113.526 175.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.3 t -145.59 138.75 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 127.95 2.5 . . . . 3.3 107.129 172.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.1 134.4 34.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.296 -1.001 . . . . 4.03 108.296 -173.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.76 162.0 27.26 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 125.177 1.391 . . . . 2.69 111.379 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.33 154.1 13.98 Favored Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 119.884 -1.76 . . . . 4.26 115.047 -178.052 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.59 -38.78 80.12 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 124.577 3.518 . . . . 2.45 115.089 -174.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.05 9.84 6.34 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 119.203 -0.776 . . . . 1.64 114.374 175.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.52 -132.85 1.4 Allowed Glycine 0 C--N 1.339 0.723 0 C-N-CA 124.909 1.242 . . . . 1.78 114.401 -176.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.402 ' CE1' ' CB ' ' A' ' 47' ' ' GLU . 3.5 m-30 -72.98 139.61 46.81 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 121.51 -0.994 . . . . 2.2 111.483 -169.049 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 -161.19 157.8 26.38 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.093 1.357 . . . . 0.73 111.986 -169.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.66 146.79 26.68 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.452 -0.78 . . . . 2.25 109.722 166.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.401 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 2.6 tpt -98.19 134.83 40.71 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.379 1.472 . . . . 0.67 108.54 161.563 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -110.09 140.99 43.56 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.624 1.169 . . . . 0.74 109.51 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.06 140.54 43.87 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.184 0.809 . . . . 2.02 113.184 -178.496 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.39 49.25 15.83 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.878 0.751 . . . . 0.9 114.37 168.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.54 150.0 12.8 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 116.553 2.057 . . . . 1.56 116.553 -177.084 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -103.53 2.22 33.27 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 113.509 -1.678 . . . . 2.19 113.111 -174.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -151.38 151.12 28.46 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 127.573 2.349 . . . . 5.29 108.622 172.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -66.93 156.03 68.11 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 N-CA-C 108.307 -1.459 . . . . 2.11 108.307 152.02 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 pp -151.4 155.25 38.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.032 1.733 . . . . 2.48 107.408 -175.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -138.72 156.53 47.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 123.451 1.595 . . . . 5.18 114.111 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.6 121.0 11.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.143 -0.935 . . . . 1.59 109.444 173.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.55 49.69 1.38 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.885 1.231 . . . . 1.59 112.45 -167.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -148.8 -175.04 4.79 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 129.781 3.232 . . . . 2.43 109.339 175.329 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -144.61 140.61 28.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.464 2.305 . . . . 4.03 106.69 179.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.7 t -142.61 139.74 28.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 126.289 1.836 . . . . 1.01 109.349 -170.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.403 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 21.9 mt-10 -78.72 144.26 35.44 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.075 0.55 . . . . 2.63 111.683 177.075 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.38 139.57 50.7 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.89 0.852 . . . . 1.68 110.104 150.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.85 152.21 19.05 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.507 1.523 . . . . 2.11 108.982 162.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 mp -122.01 130.94 53.72 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.812 1.645 . . . . 1.04 109.253 -176.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.5 mt -110.44 118.29 35.87 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.792 1.237 . . . . 0.79 110.408 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -114.58 160.45 19.26 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.967 1.307 . . . . 2.42 111.287 -178.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.14 146.45 50.51 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.513 -0.742 . . . . 1.88 111.844 167.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.98 23.95 28.64 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.185 0.898 . . . . 3.17 115.041 176.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.04 6.6 83.03 Favored Glycine 0 N--CA 1.478 1.438 0 CA-C-N 118.479 1.14 . . . . 2.3 113.592 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -79.97 115.4 19.53 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.247 1.019 . . . . 3.22 111.398 -177.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.41 145.17 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.282 1.433 . . . . 2.3 109.523 165.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.8 tp -143.23 175.4 9.92 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.916 1.686 . . . . 2.48 109.334 175.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.403 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 0.8 OUTLIER -155.4 156.71 35.85 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.358 0.873 . . . . 2.23 113.358 170.994 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.9 t -144.08 162.52 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.681 1.992 . . . . 2.25 108.398 179.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.7 t -118.24 144.41 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.104 1.362 . . . . 1.66 108.647 -179.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.82 142.13 14.59 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.2 1.0 . . . . 2.17 112.441 -168.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.63 156.43 65.69 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.934 3.089 . . . . 0.72 113.242 179.587 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.14 118.32 39.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.301 -0.999 . . . . 0.85 108.301 167.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -109.92 -178.74 3.61 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.286 1.035 . . . . 4.18 110.719 168.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.01 179.91 7.41 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 117.059 2.244 . . . . 3.29 117.059 -156.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.872 0 CA-C-O 116.62 -1.657 . . . . 9.43 112.623 172.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.206 0 N-CA-C 106.052 -2.819 . . . . 9.76 106.052 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 p -52.1 171.9 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 121.469 0.652 . . . . 7.96 111.875 134.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -166.08 -43.68 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.325 1.85 . . . . 10.19 109.011 -178.523 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.5 p -69.64 122.09 18.42 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 107.945 -1.132 . . . . 8.98 107.945 140.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -157.41 168.74 26.47 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.262 2.625 . . . . 4.51 107.341 178.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.38 173.24 32.51 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 119.526 1.057 . . . . 1.53 113.04 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.42 ' HE1' ' CB ' ' A' ' 118' ' ' GLU . 3.4 t-105 -156.87 161.05 39.69 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.835 1.654 . . . . 7.43 111.651 178.428 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.2 t -130.48 132.53 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.127 1.371 . . . . 1.29 109.053 173.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -91.2 112.96 25.09 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.354 0.597 . . . . 4.99 110.467 -174.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -57.76 147.13 28.99 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.952 2.101 . . . . 3.3 114.133 179.437 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 t -162.67 150.82 11.88 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.344 1.458 . . . . 2.68 109.641 162.395 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -83.81 45.98 1.92 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.013 3.142 . . . . 2.41 111.188 171.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -124.25 167.92 16.48 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.481 1.515 . . . . 1.3 113.855 -174.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.72 -20.77 22.53 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.715 2.943 . . . . 1.18 114.064 -177.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.3 152.24 48.32 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.55 1.54 . . . . 3.07 113.467 -176.236 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.47 -174.37 4.58 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.689 1.996 . . . . 0.65 112.31 -171.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.02 136.08 43.81 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.657 1.583 . . . . 0.81 109.329 172.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.26 123.99 46.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.612 1.565 . . . . 0.85 111.627 -176.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -106.02 65.48 0.7 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.853 1.661 . . . . 2.8 109.397 -173.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp -73.29 148.71 43.31 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.189 -0.944 . . . . 2.14 113.239 -170.082 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.5 t -83.23 139.63 33.0 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.102 -0.999 . . . . 3.57 110.347 168.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.83 131.44 56.83 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.728 1.611 . . . . 2.94 107.942 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -120.56 131.31 54.6 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.173 1.389 . . . . 4.27 109.656 173.32 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -107.38 100.36 33.22 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.993 -0.743 . . . . 1.51 108.993 161.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.98 -9.26 15.54 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.027 2.484 . . . . 1.38 113.393 174.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.69 -179.51 51.31 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 122.433 1.019 . . . . 1.21 113.033 -175.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -106.35 -3.51 21.03 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 127.776 2.431 . . . . 2.99 111.717 -172.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -119.25 159.18 46.35 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 127.89 2.476 . . . . 1.87 110.202 172.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.75 146.11 20.77 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.741 2.294 . . . . 0.97 111.167 -175.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mp -103.93 153.49 20.74 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.532 1.133 . . . . 2.72 110.711 173.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.69 112.66 12.74 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.098 1.359 . . . . 3.2 110.0 178.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.9 tp -91.98 113.28 25.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.762 1.625 . . . . 1.75 108.86 -177.186 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.5 m -111.41 -15.55 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.855 1.262 . . . . 0.76 111.668 -170.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.59 -178.17 31.39 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.916 1.722 . . . . 0.72 113.694 -176.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.05 -179.61 8.31 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.886 1.674 . . . . 0.77 112.41 168.303 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -157.34 152.56 26.1 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.331 2.252 . . . . 5.65 108.532 177.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -159.74 150.21 15.44 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 117.837 -1.077 . . . . 1.01 110.936 177.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.96 0.08 7.71 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.393 3.395 . . . . 1.27 113.66 174.034 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.2 m -116.32 49.86 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.979 1.312 . . . . 1.77 110.791 166.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.75 164.65 35.65 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.398 1.094 . . . . 1.13 112.012 161.194 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -104.05 -30.62 10.15 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 127.648 2.379 . . . . 4.12 111.371 163.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 -149.55 140.03 22.43 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.751 1.62 . . . . 5.69 109.459 172.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 p -100.05 167.34 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.028 1.331 . . . . 1.68 109.204 174.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.79 150.76 35.96 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.8 2.04 . . . . 4.3 108.069 176.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.5 tp -120.8 114.67 21.96 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.572 1.078 . . . . 1.16 111.258 -172.056 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -122.77 157.36 32.54 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 115.091 1.515 . . . . 0.72 115.091 -170.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.74 -178.6 4.3 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.129 2.171 . . . . 3.05 111.75 158.434 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.7 m -145.34 148.41 33.37 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 107.904 -1.147 . . . . 0.79 107.904 162.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -152.08 167.56 28.08 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 123.193 1.473 . . . . 2.38 114.802 -170.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.6 ttp -100.81 140.62 34.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.398 1.479 . . . . 3.25 110.745 172.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.79 176.01 10.2 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.599 1.56 . . . . 6.81 112.063 178.1 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -146.15 133.48 20.65 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.076 1.751 . . . . 2.17 106.743 -179.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 m -149.84 135.86 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.784 1.634 . . . . 2.68 107.447 -169.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 60.88 12.41 3.83 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.734 1.614 . . . . 4.32 114.19 -172.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.9 20.69 55.19 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.096 0.855 . . . . 1.7 114.302 -171.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -132.83 135.5 45.68 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.935 1.294 . . . . 4.44 111.216 174.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -71.19 143.92 50.32 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.021 2.528 . . . . 4.2 110.904 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.1 p -156.7 172.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 126.666 1.986 . . . . 2.39 109.932 -172.567 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 64.1 mtt -114.0 153.22 29.73 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.077 0.951 . . . . 2.71 111.158 167.076 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.21 175.02 20.05 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 126.427 1.965 . . . . 0.68 111.766 176.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 ttm -150.17 146.01 26.62 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.631 1.573 . . . . 0.8 109.368 174.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.57 146.86 23.4 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 124.364 1.066 . . . . 5.64 111.109 -169.404 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -78.43 153.57 27.37 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.032 1.821 . . . . 0.83 111.515 171.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.1 m -140.77 152.03 64.61 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 125.843 1.657 . . . . 0.76 110.777 -175.148 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.74 -23.85 6.59 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.546 2.831 . . . . 0.72 113.504 -167.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -178.29 163.54 1.64 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.68 1.992 . . . . 1.94 110.442 179.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.6 mt -110.25 157.16 19.75 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.211 1.404 . . . . 0.64 110.057 164.202 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -118.58 146.64 44.45 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.084 0.954 . . . . 2.33 110.32 168.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.78 128.98 17.14 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.489 0.716 . . . . 1.1 110.982 172.051 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -71.42 165.03 33.74 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.107 3.205 . . . . 1.29 112.318 -176.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.31 141.68 96.36 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.637 2.891 . . . . 1.32 112.733 178.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt 66.05 0.64 1.67 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.554 1.942 . . . . 2.17 113.592 -176.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.51 126.81 7.64 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.587 1.565 . . . . 1.6 113.881 -174.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -88.31 123.13 32.59 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.886 1.274 . . . . 6.49 107.642 156.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.7 t -149.65 98.07 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.892 0.877 . . . . 3.45 109.614 175.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 0.8 OUTLIER -75.54 142.46 42.78 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.865 -0.522 . . . . 3.02 110.751 -177.068 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -65.16 95.39 0.18 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.248 -1.389 . . . . 2.37 107.248 159.083 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.98 150.45 37.44 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.529 1.132 . . . . 4.0 113.93 -164.014 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.25 142.62 92.16 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.791 2.328 . . . . 3.35 110.187 174.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.73 -2.73 85.46 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-O 118.709 -1.05 . . . . 1.51 114.163 -168.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.78 -127.69 1.36 Allowed Glycine 0 C--N 1.34 0.759 0 CA-C-N 118.892 1.346 . . . . 1.66 113.114 172.322 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -72.99 140.54 47.42 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.655 -0.909 . . . . 2.15 112.695 -164.335 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -163.54 158.97 21.4 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.284 1.034 . . . . 0.82 113.405 -176.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -87.11 136.65 32.85 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.853 -0.529 . . . . 2.0 110.678 166.063 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.2 tpt -84.06 138.76 32.9 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.488 1.115 . . . . 0.67 108.496 159.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -117.84 134.77 54.6 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.099 1.36 . . . . 0.65 108.63 179.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 mp -132.86 137.43 46.7 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 122.991 0.516 . . . . 1.74 111.918 177.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.64 47.74 7.72 Favored Glycine 0 N--CA 1.467 0.709 0 C-N-CA 125.208 1.385 . . . . 0.81 113.162 171.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.51 147.37 14.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.634 1.716 . . . . 1.33 115.634 -177.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -104.04 -3.79 24.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.937 -1.483 . . . . 2.52 113.907 -172.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -149.24 139.23 13.2 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.331 1.453 . . . . 5.38 112.021 171.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.75 135.08 15.6 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.526 2.818 . . . . 2.24 109.651 173.374 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.7 mp -93.59 -167.94 1.8 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.032 1.333 . . . . 3.82 110.789 -168.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -134.13 172.74 12.42 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 127.478 2.311 . . . . 3.99 108.843 164.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.51 129.31 34.43 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 118.113 -1.435 . . . . 1.23 107.871 138.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.93 58.64 1.23 Allowed Glycine 0 CA--C 1.528 0.846 0 O-C-N 124.301 1.001 . . . . 1.36 111.654 -168.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -141.37 175.73 9.42 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.323 1.449 . . . . 2.99 111.317 161.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.28 87.41 1.96 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.906 2.482 . . . . 3.4 109.827 -170.25 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 91.2 t -113.18 144.29 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 120.586 -1.321 . . . . 1.5 112.119 -156.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -79.0 141.35 37.55 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.999 1.111 . . . . 2.59 113.999 -167.6 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.426 HD23 HD12 ' A' ' 115' ' ' LEU . 2.6 mm? -125.11 143.5 50.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.565 1.546 . . . . 2.67 108.834 159.549 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -114.5 123.02 48.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.345 2.258 . . . . 2.18 107.899 172.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.3 mp -98.69 127.25 44.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.665 1.986 . . . . 1.48 109.931 -169.054 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.7 mt -104.96 112.61 25.81 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.437 1.113 . . . . 0.65 110.612 -178.264 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -101.02 154.88 18.33 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.789 1.236 . . . . 2.04 110.508 178.101 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.25 141.34 14.99 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.443 -0.798 . . . . 1.7 110.771 170.019 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.52 -1.19 81.47 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.693 -1.06 . . . . 3.05 114.399 -171.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.57 13.08 61.83 Favored Glycine 0 N--CA 1.473 1.106 0 CA-C-N 119.038 1.419 . . . . 3.28 114.361 173.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.57 134.82 38.16 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 120.948 -1.325 . . . . 5.94 111.047 -179.101 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.8 p -113.22 140.6 32.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 126.228 1.811 . . . . 2.29 110.191 172.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.1 tp -145.64 126.68 14.61 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.496 1.119 . . . . 2.1 110.921 176.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -85.8 139.41 31.32 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.043 0.757 . . . . 1.98 113.043 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.01 161.93 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 127.67 2.388 . . . . 2.32 110.847 164.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 83.7 t -121.53 135.62 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.585 1.154 . . . . 1.63 108.824 174.171 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.426 HD12 HD23 ' A' ' 101' ' ' LEU . 47.2 mt -131.41 132.32 23.49 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.886 1.275 . . . . 2.09 110.972 -169.552 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -57.19 141.82 94.46 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 124.168 3.245 . . . . 1.82 114.75 172.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.6 t -114.14 128.9 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.685 1.194 . . . . 1.19 111.603 175.297 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.42 ' CB ' ' HE1' ' A' ' 7' ' ' TRP . 4.2 tt0 -156.72 163.64 39.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.92 1.688 . . . . 3.62 112.147 -179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.05 104.72 16.69 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.27 1.028 . . . . 2.75 110.43 176.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 . . . . . 0 C--O 1.247 0.922 0 C-N-CA 126.093 1.757 . . . . 9.92 108.033 178.493 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.271 0 N-CA-C 105.623 -2.991 . . . . 12.34 105.623 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -56.05 160.38 2.86 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 117.512 0.656 . . . . 10.56 109.831 136.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -89.84 157.19 18.02 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.569 0.748 . . . . 10.54 111.838 177.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 p -154.04 -57.28 0.11 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.217 1.807 . . . . 6.06 107.303 -174.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -91.89 177.96 6.03 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.758 2.023 . . . . 6.96 109.277 153.712 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -131.19 -175.24 13.93 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.445 1.974 . . . . 1.0 111.116 176.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.5 p90 -135.27 -178.49 5.13 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.231 1.515 . . . . 1.91 113.402 -168.153 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.72 152.25 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 126.774 2.03 . . . . 2.11 112.114 -178.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 -71.77 -26.41 62.42 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 116.11 1.893 . . . . 5.37 116.11 -174.433 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.0 t80 71.75 157.05 0.17 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.066 2.547 . . . . 1.98 111.978 -160.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -155.53 149.04 18.66 Favored Pre-proline 0 CA--C 1.538 0.488 0 O-C-N 121.535 -0.728 . . . . 2.49 111.217 162.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -85.7 -2.67 9.07 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.649 2.899 . . . . 2.01 112.018 167.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -121.01 -179.99 16.22 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.672 1.606 . . . . 1.09 114.065 -175.099 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.56 -18.1 48.65 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.439 3.426 . . . . 1.23 113.986 -174.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -114.61 137.77 51.47 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.055 2.142 . . . . 2.15 113.863 -178.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.28 -177.26 5.38 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.79 2.436 . . . . 0.5 111.738 -172.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.38 149.24 30.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.143 1.377 . . . . 0.65 110.862 178.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.18 147.21 51.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.893 1.277 . . . . 0.58 113.832 -174.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -128.32 43.11 3.2 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 127.424 2.29 . . . . 2.99 114.703 -168.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -73.0 150.58 42.33 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 119.569 -1.957 . . . . 2.83 115.598 -168.16 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 m -96.27 149.4 21.71 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.831 1.653 . . . . 1.86 109.16 173.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.47 166.47 33.44 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.671 1.589 . . . . 2.83 112.153 -176.433 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -128.79 140.97 51.46 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.91 2.084 . . . . 4.24 112.334 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -96.52 99.57 5.72 Favored Pre-proline 0 CA--C 1.542 0.667 0 O-C-N 121.478 -0.764 . . . . 1.6 109.354 158.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.65 -12.11 12.52 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.493 2.128 . . . . 1.27 113.71 176.136 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.78 178.35 53.71 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-O 122.552 1.084 . . . . 1.21 112.936 -175.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -104.75 0.91 28.73 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.87 2.468 . . . . 2.93 112.318 -173.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mp -125.48 160.8 53.84 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 127.767 2.427 . . . . 4.02 108.798 174.079 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.65 155.75 21.1 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.231 1.954 . . . . 0.99 111.732 -167.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.75 147.76 28.23 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.88 1.272 . . . . 2.32 110.224 170.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.0 ttp180 -136.64 103.92 5.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.016 -1.902 . . . . 3.92 109.297 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.548 HD21 ' CZ ' ' A' ' 84' ' ' PHE . 6.5 tt -84.85 110.05 18.55 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.478 1.911 . . . . 2.17 108.847 -175.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.9 m -106.34 -20.88 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.764 1.226 . . . . 0.47 111.932 -174.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.48 -175.76 31.83 Favored Glycine 0 C--N 1.343 0.947 0 C-N-CA 125.004 1.287 . . . . 0.43 114.13 -173.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.43 -177.28 5.98 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.754 2.021 . . . . 0.48 111.0 173.383 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.412 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 11.5 mtt180 -157.95 170.78 21.55 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.89 2.476 . . . . 4.76 107.626 171.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 t -173.44 149.74 1.71 Allowed Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 125.294 1.438 . . . . 0.58 110.364 174.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.54 -8.12 21.28 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.773 2.316 . . . . 0.72 114.037 172.648 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.3 m -118.87 49.39 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.545 1.138 . . . . 0.73 113.295 174.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.23 151.34 17.39 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.643 1.177 . . . . 0.87 110.704 161.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -95.7 -30.77 13.56 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.382 1.473 . . . . 3.35 111.948 169.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.6 mtp-105 -133.08 141.15 48.05 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.693 1.597 . . . . 5.11 108.915 171.5 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -125.3 148.6 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.157 1.383 . . . . 1.15 109.558 168.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -137.45 151.46 48.52 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.649 1.98 . . . . 2.87 109.736 178.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.8 tp -104.61 118.51 36.75 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.492 0.717 . . . . 1.07 110.56 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -124.53 148.87 47.5 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 123.084 1.421 . . . . 0.59 113.914 -174.506 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -89.08 176.38 7.01 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 113.889 -1.505 . . . . 2.46 111.521 162.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 64.9 m -155.01 136.47 14.18 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 105.457 -2.053 . . . . 0.8 105.457 175.175 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -149.43 161.52 41.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 122.952 1.358 . . . . 2.01 114.184 -166.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -87.41 136.22 33.03 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.333 -1.303 . . . . 3.61 110.588 172.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.01 143.22 20.28 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.204 1.002 . . . . 4.93 113.699 -177.501 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.55 130.9 36.54 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 125.655 1.582 . . . . 3.07 111.63 172.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.5 t -141.45 134.8 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 126.066 1.746 . . . . 2.13 107.274 169.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 65.9 16.76 10.61 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.645 1.178 . . . . 3.92 113.352 -176.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.24 21.05 68.27 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 121.188 -0.945 . . . . 1.51 113.396 -171.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -138.86 133.33 31.84 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.169 1.787 . . . . 3.29 109.717 -170.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.405 ' H ' ' HG2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -76.31 117.09 17.62 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.109 1.364 . . . . 4.14 113.506 -178.641 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -117.14 174.06 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 128.669 2.787 . . . . 2.15 109.103 170.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.41 130.34 56.42 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.946 0.898 . . . . 3.16 109.901 177.422 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.31 172.91 15.01 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.573 1.083 . . . . 0.52 113.286 -179.328 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ttm -148.78 143.07 26.13 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.573 1.549 . . . . 0.66 109.765 177.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -144.92 152.19 51.12 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.369 1.868 . . . . 7.62 109.143 -176.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -80.83 150.71 18.59 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.593 2.195 . . . . 0.6 110.206 170.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.24 155.49 80.84 Favored Pre-proline 0 N--CA 1.48 1.05 0 C-N-CA 124.496 1.119 . . . . 0.66 110.379 -177.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.76 -30.04 2.53 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.746 2.297 . . . . 0.57 112.713 -170.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -176.2 164.73 2.76 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.735 1.614 . . . . 2.1 112.042 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.5 mt -109.03 158.73 17.45 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.04 1.336 . . . . 0.7 109.282 161.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -139.74 144.66 37.57 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.96 0.904 . . . . 2.21 111.242 174.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.2 t -146.74 140.1 14.82 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.447 1.099 . . . . 1.5 112.323 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.64 170.62 8.15 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 124.417 3.411 . . . . 1.44 114.092 176.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.96 150.12 80.12 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.616 3.544 . . . . 1.18 113.774 171.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt 68.49 -7.24 0.72 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.912 2.085 . . . . 1.96 115.085 176.252 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.81 149.34 32.95 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.438 1.018 . . . . 1.2 112.683 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 mtt-85 -86.8 162.03 18.03 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 122.003 -0.704 . . . . 6.31 110.155 161.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.1 150.44 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.054 1.741 . . . . 4.04 108.724 172.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.75 137.9 30.1 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.945 0.898 . . . . 3.29 110.344 161.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -78.54 80.72 4.91 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 122.283 1.04 . . . . 2.01 108.336 170.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.404 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -59.39 136.57 88.9 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 115.403 -0.817 . . . . 3.28 112.908 -177.083 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -60.84 -25.62 81.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.236 2.624 . . . . 2.07 112.553 176.284 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.7 9.66 28.68 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 117.652 -1.638 . . . . 1.87 114.722 174.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.65 -10.55 0.03 OUTLIER Glycine 0 C--N 1.346 1.107 0 N-CA-C 121.56 3.384 . . . . 2.13 121.56 167.467 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -143.99 145.3 32.13 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 121.124 2.462 . . . . 2.02 112.843 172.195 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -158.68 152.0 22.82 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.599 0.76 . . . . 0.56 110.816 175.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.548 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 61.9 m-85 -78.7 141.56 37.81 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.418 -0.956 . . . . 1.65 108.418 160.062 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.0 tpt -99.42 130.23 45.67 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.399 1.88 . . . . 0.61 108.489 168.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.9 mp -111.61 139.61 46.9 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.47 1.508 . . . . 0.55 108.357 -179.262 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.2 mp -137.82 143.73 41.15 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.418 1.087 . . . . 1.52 109.576 175.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.91 42.42 45.32 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.957 -0.457 . . . . 1.0 111.957 -178.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.35 141.9 28.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 122.865 1.317 . . . . 1.34 113.342 170.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -100.65 0.78 39.8 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.084 -1.416 . . . . 2.39 113.05 -171.334 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -123.86 146.63 51.32 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 126.959 2.104 . . . . 5.15 107.821 167.013 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -62.34 120.27 7.74 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 N-CA-C 105.166 -2.667 . . . . 1.68 105.166 149.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 tp -76.79 79.95 3.4 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 122.177 0.989 . . . . 2.5 111.387 -157.077 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . 0.268 5.6 tmtt? -64.74 114.5 4.5 Favored 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 120.368 -1.458 . . . . 6.18 110.949 -169.334 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.71 114.83 1.25 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.216 1.406 . . . . 1.69 111.443 170.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.67 44.81 6.3 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.201 1.381 . . . . 1.6 112.699 -169.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -101.3 -177.22 3.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.919 1.688 . . . . 3.01 109.209 145.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -130.68 125.5 34.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 129.328 3.051 . . . . 3.89 103.91 178.064 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.9 t -128.66 122.25 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.381 1.873 . . . . 1.01 108.985 -171.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -81.8 146.66 29.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.933 0.873 . . . . 2.25 112.582 171.133 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.77 138.03 54.22 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.665 1.586 . . . . 1.65 109.77 163.433 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 14.5 m-20 -78.32 149.0 33.55 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.343 1.857 . . . . 2.71 108.125 158.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.2 mp -127.16 132.59 50.48 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.667 1.587 . . . . 1.0 108.482 175.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.5 mt -105.95 118.43 36.58 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.806 1.242 . . . . 0.69 109.456 -175.258 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -116.55 118.23 32.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.422 1.489 . . . . 1.92 111.786 -172.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.86 20.84 1.75 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.5 1.92 . . . . 2.83 114.277 176.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.28 -61.73 4.13 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.208 1.385 . . . . 4.42 112.286 -167.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.94 4.68 60.74 Favored Glycine 0 N--CA 1.474 1.21 0 N-CA-C 117.089 1.596 . . . . 2.04 117.089 -166.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -131.99 140.06 48.83 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.481 1.64 . . . . 3.45 112.178 175.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.17 146.88 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.361 1.464 . . . . 2.1 109.334 171.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 tt -150.7 160.88 43.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.91 2.484 . . . . 1.96 107.593 176.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -144.89 152.94 41.03 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.027 1.285 . . . . 1.76 114.436 175.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.51 157.79 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.416 1.486 . . . . 2.28 109.409 -174.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 66.6 t -87.39 161.76 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.951 1.3 . . . . 1.81 109.127 175.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.25 140.08 11.42 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 126.239 1.816 . . . . 2.44 110.223 164.168 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.97 146.2 64.31 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.247 2.632 . . . . 0.73 111.987 174.109 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.77 116.56 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.768 -0.827 . . . . 1.17 108.768 167.357 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -137.05 176.57 8.6 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.798 1.639 . . . . 4.41 110.116 -177.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -113.36 136.72 52.46 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.298 1.039 . . . . 2.5 111.518 174.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.277 19.9 ptt-85 . . . . . 0 N--CA 1.485 1.297 0 C-N-CA 131.175 3.79 . . . . 9.41 111.415 168.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.111 0 N-CA-C 107.418 -2.273 . . . . 10.47 107.418 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.8 p -52.3 130.06 29.89 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 117.576 -1.65 . . . . 9.53 107.639 129.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -108.42 150.12 27.83 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.852 0.861 . . . . 10.46 110.695 -175.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.0 p -147.59 123.77 10.84 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.756 1.622 . . . . 6.03 108.181 -179.028 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -83.81 179.42 7.57 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 123.872 0.732 . . . . 7.86 110.408 173.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.51 -175.33 19.59 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 125.1 1.333 . . . . 1.44 112.565 177.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -141.59 175.29 9.81 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.995 1.109 . . . . 2.1 113.995 178.471 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.6 t -111.93 126.12 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 126.284 1.833 . . . . 1.81 106.166 162.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.6 ttp85 -87.19 131.77 34.08 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.296 -1.001 . . . . 5.51 108.296 171.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -57.35 117.59 4.26 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.122 0.569 . . . . 2.36 110.98 -175.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.5 m -174.68 106.11 0.27 Allowed Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 128.851 2.86 . . . . 4.62 107.036 167.052 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -93.42 -125.53 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.603 3.535 . . . . 6.06 109.515 -176.314 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.73 -155.41 30.5 Favored Glycine 0 CA--C 1.543 1.785 0 O-C-N 121.425 -0.797 . . . . 2.58 113.164 178.423 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.82 -31.19 13.21 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.914 2.409 . . . . 3.71 112.091 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.09 123.36 21.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.889 1.675 . . . . 4.24 111.049 169.306 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.18 -179.04 4.96 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.131 1.772 . . . . 0.86 111.336 172.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.96 135.93 29.86 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 121.052 -1.03 . . . . 0.8 111.097 -176.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.78 146.14 51.98 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.819 1.648 . . . . 0.9 112.05 -176.54 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -135.89 62.78 1.61 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.19 0.996 . . . . 3.39 111.488 -157.062 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.06 162.71 24.0 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.468 -0.787 . . . . 1.79 113.015 -173.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.6 m -125.78 145.83 50.04 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.782 1.633 . . . . 2.27 107.571 171.064 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.47 164.62 38.39 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.96 1.304 . . . . 4.63 110.176 174.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -127.94 154.98 44.95 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.391 1.076 . . . . 3.96 110.594 168.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -101.35 95.1 4.61 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 124.552 1.141 . . . . 1.36 109.221 171.334 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.92 -19.18 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.151 1.9 . . . . 1.67 113.28 -177.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.46 -177.02 51.47 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-O 122.351 0.973 . . . . 1.46 112.455 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -112.85 2.85 16.08 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.517 1.927 . . . . 4.17 112.389 -170.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -98.38 157.04 35.06 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.634 1.974 . . . . 2.33 110.243 164.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.57 148.63 14.32 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.243 2.628 . . . . 0.89 111.179 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.1 mt -102.65 146.04 28.77 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 122.8 1.286 . . . . 1.94 111.87 170.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.9 ttp-105 -129.77 109.61 11.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 111.984 -2.371 . . . . 2.35 108.967 176.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -95.41 111.66 23.51 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.402 1.881 . . . . 2.49 108.606 -174.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -111.21 -21.26 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.145 0.978 . . . . 0.62 112.033 -168.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.54 -174.26 30.14 Favored Glycine 0 C--N 1.344 1.018 0 C-N-CA 124.596 1.093 . . . . 0.57 114.277 -174.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.16 -178.79 6.4 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.563 1.545 . . . . 0.71 111.466 170.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -151.6 167.07 29.24 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.804 2.442 . . . . 4.69 107.746 164.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 t -174.07 149.23 1.45 Allowed Pre-proline 0 N--CA 1.473 0.678 0 C-N-CA 125.164 1.386 . . . . 0.76 108.536 -171.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.18 -3.5 13.49 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.185 2.59 . . . . 0.83 114.281 177.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.4 m -119.4 28.39 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 115.22 1.563 . . . . 1.11 115.22 -174.009 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.33 167.03 31.72 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.781 1.632 . . . . 1.12 111.481 173.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -96.67 -31.13 12.86 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.458 1.503 . . . . 3.07 111.056 173.278 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -139.1 153.35 48.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 129.889 3.276 . . . . 5.02 108.034 -173.311 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.5 p -155.07 121.76 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 124.896 1.279 . . . . 1.74 109.775 178.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -140.66 129.95 23.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.143 -0.935 . . . . 4.14 109.795 -165.314 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.459 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.7 pt? -82.23 140.43 33.67 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 123.261 1.505 . . . . 1.84 113.285 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -117.11 157.16 26.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.612 2.365 . . . . 0.82 112.304 175.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -95.33 149.01 21.83 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.642 1.977 . . . . 2.6 109.541 158.182 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.0 m -115.62 149.63 37.98 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.369 1.868 . . . . 0.83 106.012 159.654 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -158.93 177.39 11.2 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.817 0.847 . . . . 1.98 113.146 -177.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 76.1 mtm -108.76 144.22 36.86 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.234 1.414 . . . . 3.38 111.612 172.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -139.78 146.95 40.11 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.418 1.487 . . . . 5.34 111.597 173.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -93.94 140.48 29.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.725 1.21 . . . . 2.25 108.167 156.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.8 t -138.83 119.2 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.175 1.39 . . . . 2.2 107.252 170.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 62.46 20.08 11.64 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.087 1.355 . . . . 3.45 113.95 -177.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.83 15.4 75.41 Favored Glycine 0 N--CA 1.477 1.413 0 O-C-N 120.47 -1.394 . . . . 1.5 113.504 -170.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -117.02 115.71 25.95 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.696 2.398 . . . . 3.47 108.314 -179.587 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.442 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -93.72 131.26 39.22 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.588 1.155 . . . . 4.38 111.47 -170.62 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.9 p -155.32 148.96 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.9 1.68 . . . . 2.66 109.99 -168.112 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.9 mtt -89.22 155.48 19.37 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.521 0.728 . . . . 2.51 111.956 176.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.5 176.05 20.82 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 124.612 1.101 . . . . 0.58 112.714 179.186 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ttm -153.83 144.81 22.74 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 126.058 1.743 . . . . 0.72 109.205 -178.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -151.0 157.99 35.05 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 125.658 1.583 . . . . 4.84 109.472 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -73.6 157.26 48.82 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.146 1.897 . . . . 0.87 111.266 168.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.17 158.81 71.85 Favored Pre-proline 0 N--CA 1.481 1.12 0 CA-C-O 118.53 -0.747 . . . . 1.18 110.729 173.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -83.18 -24.98 2.9 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.277 2.651 . . . . 0.95 113.355 -170.166 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -179.39 164.61 1.35 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.88 2.072 . . . . 2.35 110.781 -178.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.2 mt -109.43 154.3 22.8 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.757 1.223 . . . . 0.69 110.26 163.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -115.53 140.4 49.2 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.25 1.02 . . . . 1.92 108.987 170.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.3 t -141.86 129.04 11.47 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 123.886 0.874 . . . . 1.25 111.365 174.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.45 170.42 16.24 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.428 2.752 . . . . 1.1 112.545 -178.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -57.63 139.54 90.57 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.142 2.561 . . . . 1.51 111.172 166.356 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm 65.22 0.75 1.37 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.279 1.831 . . . . 2.6 114.524 -174.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.56 177.54 52.75 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.291 1.9 . . . . 1.88 112.395 171.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.6 ptt85 -131.83 132.94 44.14 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.515 1.126 . . . . 8.23 112.876 -172.432 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.88 73.29 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 127.071 2.148 . . . . 5.29 109.094 -174.465 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.33 117.87 35.12 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.605 1.962 . . . . 3.76 110.064 -172.075 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.29 58.03 0.61 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.493 1.917 . . . . 2.73 111.58 -171.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.519 ' H ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -61.97 146.59 91.39 Favored Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 125.973 1.709 . . . . 3.39 115.364 178.533 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -61.12 -33.5 91.06 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 124.319 3.346 . . . . 2.85 114.782 -177.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.25 5.25 44.08 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.153 0.882 . . . . 1.46 114.182 177.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.22 -124.96 0.97 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.955 1.264 . . . . 1.61 111.591 170.293 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -71.11 138.01 49.35 Favored 'General case' 0 C--O 1.219 -0.527 0 O-C-N 121.653 -0.91 . . . . 2.12 111.274 -174.07 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -159.93 158.16 30.26 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.416 0.687 . . . . 0.6 112.451 -176.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -89.71 137.49 32.29 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.181 -0.949 . . . . 1.86 111.737 174.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.9 tpt -97.35 127.69 43.53 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.416 1.886 . . . . 0.71 109.146 163.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.78 121.81 44.8 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.939 1.296 . . . . 0.82 108.525 -178.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.8 136.52 52.49 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.155 0.582 . . . . 2.67 110.875 -163.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.32 38.44 62.7 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.867 -0.521 . . . . 1.05 112.554 -170.584 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.87 148.02 0.87 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 116.546 2.054 . . . . 2.03 116.546 176.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -99.74 1.75 43.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.816 -1.538 . . . . 1.8 113.705 -177.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -159.32 150.53 16.34 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 125.658 1.583 . . . . 4.96 111.027 -177.105 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.91 83.85 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.016 2.477 . . . . 3.0 107.812 164.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 96.94 0.09 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.503 1.521 . . . . 2.69 111.923 -172.426 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.48 161.34 13.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.09 -1.868 . . . . 4.27 112.606 -173.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.71 133.17 54.42 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.037 0.935 . . . . 1.68 110.389 177.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.92 55.61 3.52 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 114.176 -1.374 . . . . 2.85 111.077 -170.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -138.33 -178.02 5.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.233 2.213 . . . . 2.42 108.3 163.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -156.37 132.53 9.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.278 2.231 . . . . 3.46 105.571 -167.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.6 t -142.0 132.21 24.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 125.249 1.42 . . . . 0.97 109.466 -164.035 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -77.13 145.59 37.69 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 122.685 0.394 . . . . 2.42 111.131 172.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.54 137.44 54.73 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 122.662 1.22 . . . . 1.7 111.122 151.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -87.3 139.78 30.21 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.365 2.266 . . . . 2.08 108.028 155.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -110.4 141.21 43.78 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.367 1.467 . . . . 0.81 109.952 173.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -112.42 113.92 26.36 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.958 1.303 . . . . 0.64 109.579 178.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -115.14 152.68 32.15 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.623 1.569 . . . . 2.18 111.094 178.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.23 137.55 55.81 Favored 'General case' 0 CA--C 1.548 0.865 0 CA-C-O 122.293 1.044 . . . . 2.37 113.795 -178.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.23 56.97 4.93 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.266 0.936 . . . . 3.56 113.239 176.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.47 11.84 80.1 Favored Glycine 0 N--CA 1.473 1.158 0 N-CA-C 115.784 1.074 . . . . 2.16 115.784 168.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -94.68 114.97 26.97 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.043 1.421 . . . . 2.99 111.356 -174.356 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.65 136.12 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.134 1.374 . . . . 1.9 109.537 177.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 tt -145.42 125.32 13.51 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.85 0.86 . . . . 2.55 111.033 -168.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -101.09 134.68 43.73 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.792 1.237 . . . . 2.41 112.144 -178.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.8 t -147.11 168.3 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 126.412 1.885 . . . . 2.55 109.71 173.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.94 155.84 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 119.672 1.123 . . . . 1.9 111.01 -170.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.9 mt -141.29 117.52 7.39 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.212 1.805 . . . . 2.52 110.129 -174.437 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.46 146.46 62.14 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.705 2.27 . . . . 1.09 110.432 168.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.4 t -94.79 115.81 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.845 0.858 . . . . 1.23 109.209 170.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -129.81 137.73 50.64 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.428 1.091 . . . . 4.21 112.01 -170.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.43 83.46 5.43 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.994 -1.066 . . . . 3.81 110.693 170.065 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.408 0 C-N-CA 127.249 2.22 . . . . 9.13 110.848 -175.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.209 0 N-CA-C 106.101 -2.8 . . . . 12.53 106.101 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 p 167.6 143.17 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 118.446 -0.788 . . . . 10.46 109.805 -137.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -109.8 158.02 18.57 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.5 1.12 . . . . 10.25 111.744 -178.054 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.6 t -167.19 25.51 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 127.659 2.384 . . . . 5.49 111.042 168.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -150.34 164.84 34.79 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 127.344 2.257 . . . . 6.42 106.001 173.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -118.69 -170.95 14.94 Favored Glycine 0 N--CA 1.462 0.387 0 CA-C-O 122.436 1.02 . . . . 0.92 112.038 -172.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 41.0 p90 -134.11 162.98 30.61 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.598 -0.801 . . . . 2.05 111.325 167.206 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.46 139.03 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.894 1.278 . . . . 1.4 109.147 173.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -58.0 112.73 1.6 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.743 1.617 . . . . 6.14 112.555 -177.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.59 132.36 51.45 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.324 2.249 . . . . 3.07 111.455 166.175 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -179.05 154.55 0.79 Allowed Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.535 1.934 . . . . 2.8 112.867 166.392 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -88.28 40.69 0.58 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 125.23 3.953 . . . . 2.3 111.055 166.316 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -114.88 157.37 15.03 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.948 1.261 . . . . 1.27 113.019 -172.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -71.77 -18.52 28.41 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.133 3.222 . . . . 1.45 113.923 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -108.17 164.82 11.97 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.541 1.936 . . . . 2.87 112.629 170.253 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.3 -171.72 3.72 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.474 2.709 . . . . 0.61 111.107 170.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -155.19 133.89 12.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.639 1.976 . . . . 0.86 108.867 -175.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.42 132.57 54.97 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.267 1.394 . . . . 0.95 111.351 -176.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -114.84 32.04 6.27 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.673 1.731 . . . . 2.7 115.673 -167.061 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.642 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.5 pt? -64.93 158.88 24.17 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 115.972 1.841 . . . . 2.32 115.972 -172.306 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.8 m -79.74 126.6 31.15 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.519 1.128 . . . . 1.75 109.679 166.191 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.9 tp -99.08 127.91 45.11 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.262 1.425 . . . . 4.27 108.898 168.859 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.71 154.74 42.0 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.628 0.728 . . . . 3.4 111.676 175.356 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -119.12 97.93 50.69 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.388 1.075 . . . . 1.53 109.088 169.246 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.6 -10.76 14.42 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.08 2.52 . . . . 1.21 113.03 177.05 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.93 -173.38 48.81 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.795 1.188 . . . . 1.26 113.115 -176.154 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -112.82 1.17 15.45 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.606 1.963 . . . . 3.26 112.368 -168.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -124.45 161.86 45.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 128.013 2.525 . . . . 2.28 110.256 174.122 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -81.01 141.91 13.42 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.484 2.122 . . . . 1.4 111.898 -173.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.98 149.33 25.24 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.145 1.378 . . . . 2.71 110.134 174.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 42.4 ttm105 -135.44 103.3 5.43 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.633 1.173 . . . . 2.75 110.157 178.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.426 HD13 ' C ' ' A' ' 32' ' ' LEU . 2.5 tm? -79.4 114.66 18.51 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.24 1.816 . . . . 2.58 108.047 -178.34 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.2 m -110.1 -19.47 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.254 1.022 . . . . 0.61 112.408 -177.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.24 -175.8 29.58 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 125.509 1.528 . . . . 0.5 113.889 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.91 -179.87 6.02 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.965 0.906 . . . . 0.51 111.035 166.004 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -137.32 177.4 7.9 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.313 1.445 . . . . 4.11 107.845 155.054 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 t -175.7 148.88 1.02 Allowed Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 128.151 2.58 . . . . 0.7 106.394 177.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.44 -9.46 20.16 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.591 2.194 . . . . 0.78 112.21 178.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.3 m -112.96 51.82 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.679 1.591 . . . . 0.86 111.586 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.01 158.16 30.05 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.056 1.343 . . . . 1.01 111.64 167.167 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -98.57 -33.81 10.83 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.987 1.715 . . . . 2.67 110.152 160.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -128.65 130.12 46.8 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.619 1.968 . . . . 5.16 109.53 177.255 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -128.43 128.93 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.404 1.081 . . . . 1.43 108.993 166.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -144.39 137.57 27.16 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.165 0.986 . . . . 3.16 110.442 -162.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 20.7 tp -91.85 125.17 36.46 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.663 -0.648 . . . . 1.37 112.324 -167.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -122.41 160.28 25.79 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.896 1.678 . . . . 0.77 114.119 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.48 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 17.6 pt-20 -120.27 147.68 44.67 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.696 1.598 . . . . 3.92 110.189 161.499 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.3 m -108.54 139.14 43.72 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 107.54 -1.282 . . . . 0.82 107.54 172.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -130.22 170.77 13.65 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.567 1.947 . . . . 2.09 111.895 -172.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.8 mtt -103.36 141.58 35.69 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.518 1.127 . . . . 3.97 111.909 172.158 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -141.47 145.02 34.71 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.078 1.351 . . . . 6.9 112.52 174.423 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -79.93 134.51 36.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.769 -1.197 . . . . 2.57 107.769 146.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.3 t -146.41 136.86 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 106.894 -1.521 . . . . 2.75 106.894 164.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 66.31 13.84 9.39 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.64 1.576 . . . . 5.53 113.927 -177.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.03 27.11 67.13 Favored Glycine 0 N--CA 1.476 1.309 0 O-C-N 120.946 -1.096 . . . . 2.74 113.017 -168.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -130.93 143.68 50.91 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 126.861 2.065 . . . . 4.63 109.098 178.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -81.35 119.61 23.89 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.308 1.843 . . . . 4.09 109.458 178.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.7 m -139.3 169.91 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.343 1.857 . . . . 2.53 110.976 -177.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 53.6 mtm -134.14 137.84 44.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.039 1.335 . . . . 2.81 110.75 174.464 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.44 174.83 21.57 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 125.786 1.66 . . . . 1.03 111.627 -177.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.25 141.63 47.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.329 1.064 . . . . 1.62 111.832 -179.166 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -122.24 156.08 60.81 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 125.343 1.457 . . . . 6.67 110.19 173.291 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.26 159.0 44.44 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.021 1.814 . . . . 0.79 111.575 170.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.68 156.21 78.84 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 126.215 1.806 . . . . 1.31 110.49 177.194 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.57 -24.13 6.54 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.51 2.806 . . . . 0.69 112.859 -175.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -176.68 165.36 2.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.08 1.752 . . . . 1.93 111.703 -178.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -109.56 160.1 16.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.118 1.367 . . . . 0.8 109.53 155.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -134.84 148.42 50.15 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.235 1.014 . . . . 2.25 109.91 174.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 t -142.32 128.46 10.77 Favored Pre-proline 0 CA--C 1.541 0.596 0 O-C-N 123.817 0.698 . . . . 1.13 112.086 178.231 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.11 162.53 41.48 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.776 2.984 . . . . 1.43 111.458 176.673 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.44 141.28 97.01 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.224 2.616 . . . . 1.4 113.02 -178.177 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt 70.14 -2.32 2.13 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.469 2.308 . . . . 2.12 114.265 -178.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.6 158.35 43.13 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.581 1.562 . . . . 1.15 114.316 -179.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.95 143.63 51.01 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.133 1.773 . . . . 6.2 109.592 167.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.7 t -143.61 131.87 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 106.313 -1.736 . . . . 3.33 106.313 174.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.417 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . 7.2 mt-10 -120.22 128.44 53.36 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.61 1.095 . . . . 3.94 110.77 -170.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 83' ' ' HIS . 4.6 mp -77.65 58.06 1.73 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.48 1.512 . . . . 2.28 111.229 -178.513 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 76' ' ' GLU . 0.2 OUTLIER -63.54 150.18 90.69 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 114.795 1.406 . . . . 5.0 114.795 -178.553 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -58.06 151.11 60.5 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.456 2.104 . . . . 2.63 109.888 169.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.29 -9.52 33.39 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.355 -1.247 . . . . 1.86 114.206 -171.271 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -135.01 -129.62 2.9 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 119.443 1.622 . . . . 1.58 114.444 175.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.48 ' CE1' ' HB3' ' A' ' 47' ' ' GLU . 80.8 m-85 -71.97 141.03 49.4 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.543 -0.975 . . . . 2.01 110.703 -177.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 77' ' ' LEU . 46.5 p-80 -164.41 156.74 16.66 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.962 1.305 . . . . 0.76 110.88 -176.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.479 ' CE2' HD21 ' A' ' 20' ' ' LEU . 98.3 m-85 -82.42 145.24 29.97 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.24 -0.652 . . . . 1.77 109.24 161.043 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 tpt -96.56 132.99 41.61 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.919 1.288 . . . . 0.82 108.42 164.054 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 mp -109.37 140.01 43.61 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.758 1.223 . . . . 0.86 109.363 176.169 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.3 mt -141.74 142.91 33.28 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.747 1.619 . . . . 1.93 110.107 -176.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 68.47 36.71 84.44 Favored Glycine 0 CA--C 1.532 1.098 0 O-C-N 121.894 -0.504 . . . . 0.94 112.993 177.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.11 145.57 13.08 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 123.609 1.671 . . . . 1.42 115.231 -178.506 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -93.15 -7.67 44.73 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 113.762 -1.563 . . . . 1.82 113.031 -174.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -142.67 145.06 32.53 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 127.469 2.307 . . . . 5.37 107.495 169.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -66.25 151.2 84.03 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.152 1.901 . . . . 2.09 108.822 158.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mp -117.46 112.41 20.6 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 125.977 1.711 . . . . 2.62 107.596 -165.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -86.11 171.02 11.67 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.332 0.587 . . . . 4.09 112.078 179.079 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.81 137.31 58.21 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.396 -0.964 . . . . 1.18 108.396 153.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.81 23.05 75.98 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 116.44 1.336 . . . . 1.41 116.44 173.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -93.42 -170.24 2.33 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.662 1.731 . . . . 2.33 111.74 169.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 10.6 pt-20 -154.66 138.31 16.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 128.264 2.626 . . . . 3.14 106.647 -173.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.6 t -149.09 136.1 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.804 1.641 . . . . 0.97 110.027 -163.196 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -77.31 147.76 36.04 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.104 0.478 . . . . 2.84 110.83 173.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.408 HD22 HD22 ' A' ' 20' ' ' LEU . 1.3 mp -127.3 149.93 49.81 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.878 1.271 . . . . 1.61 108.747 159.405 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -107.39 150.55 26.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.661 0.784 . . . . 2.24 108.935 158.01 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.3 mp -109.81 133.48 53.11 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.399 1.48 . . . . 1.0 109.267 172.096 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.4 mt -103.55 112.18 24.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.176 1.39 . . . . 0.65 109.559 -179.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -106.14 111.53 24.18 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.924 1.69 . . . . 2.14 111.572 -175.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 49.76 32.58 5.38 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.774 1.63 . . . . 3.39 112.948 -178.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.43 -71.1 1.84 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.41 1.481 . . . . 5.12 112.212 -171.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.44 9.46 21.21 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 117.146 1.618 . . . . 2.24 117.146 -163.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -130.9 134.28 46.63 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.721 1.76 . . . . 4.32 110.463 169.51 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.7 p -125.22 145.09 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.048 1.339 . . . . 2.24 110.977 178.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.8 tp -139.92 126.47 20.36 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.254 1.422 . . . . 2.31 109.588 178.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -84.27 141.38 31.0 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.061 0.393 . . . . 2.21 112.061 173.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.19 -179.91 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 127.203 2.201 . . . . 2.6 110.361 167.084 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.5 t -138.31 155.43 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.515 1.526 . . . . 1.71 106.979 171.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.27 153.29 26.62 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.954 1.302 . . . . 1.97 111.231 171.314 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 43.0 Cg_endo -63.95 168.17 12.63 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.75 2.967 . . . . 1.03 112.842 171.66 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.6 t -112.36 128.73 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.039 1.336 . . . . 0.98 108.712 169.525 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -154.41 178.53 9.95 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.257 1.823 . . . . 4.4 112.946 177.048 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.55 162.26 29.71 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.849 1.426 . . . . 4.05 114.849 -167.228 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 117.744 -1.122 . . . . 7.78 109.886 171.069 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.5 0 CA-C-O 118.409 -1.217 . . . . 9.24 111.243 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.3 m 147.5 -40.48 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.268 1 C-N-CA 133.247 4.619 . . . . 10.25 111.457 176.342 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -151.26 44.04 0.79 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.029 1.732 . . . . 11.68 112.286 -173.667 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.7 t -163.52 31.72 0.09 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.963 1.705 . . . . 5.63 113.308 -170.884 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.49 178.24 10.45 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.601 1.96 . . . . 5.07 112.294 -172.581 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -150.28 164.88 29.81 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.99 1.281 . . . . 1.27 114.122 171.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -157.2 151.47 25.01 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.615 2.366 . . . . 2.28 110.638 176.285 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.9 t -97.62 145.55 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 120.957 -1.089 . . . . 1.02 109.868 -178.765 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.77 -15.64 63.73 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.024 1.49 . . . . 4.68 115.024 -172.782 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 77.57 145.88 0.09 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.053 2.141 . . . . 3.57 114.116 -171.539 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.4 t -178.66 133.78 0.3 Allowed Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 128.27 2.628 . . . . 2.72 110.808 165.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -82.51 -11.42 10.56 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.224 2.616 . . . . 3.19 112.202 172.5 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.34 169.37 31.72 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.958 1.266 . . . . 1.45 112.212 178.617 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.59 -15.9 52.39 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.597 3.531 . . . . 1.54 114.779 -170.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -100.99 140.55 35.13 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.248 1.419 . . . . 2.67 112.428 173.642 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.44 -177.42 5.94 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.285 1.834 . . . . 0.55 111.926 172.312 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.26 147.18 25.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.598 1.959 . . . . 0.79 110.02 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.99 149.82 47.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.745 1.017 . . . . 0.81 113.745 -172.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -117.19 142.73 46.67 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.161 1.784 . . . . 3.01 109.862 174.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.84 160.12 14.25 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.399 1.08 . . . . 2.86 113.208 178.171 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.408 HG23 ' HB3' ' A' ' 76' ' ' GLU . 22.9 m -136.95 147.04 46.11 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 125.129 1.371 . . . . 1.95 110.167 -171.447 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.51 134.11 10.87 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.987 1.315 . . . . 5.52 109.498 -178.046 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.29 154.16 18.78 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.211 0.914 . . . . 5.3 112.376 177.104 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -105.28 83.34 0.88 Allowed Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.71 1.204 . . . . 1.59 110.132 171.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -71.65 -4.68 15.52 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.476 2.117 . . . . 1.84 113.437 176.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.79 169.73 49.06 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-O 123.284 1.491 . . . . 1.24 112.811 177.641 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -101.25 -2.24 31.69 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 127.54 2.336 . . . . 2.85 112.518 -171.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -116.71 159.59 39.89 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.931 2.092 . . . . 3.97 109.459 169.755 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.97 170.77 14.91 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.844 2.363 . . . . 1.64 112.206 -166.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.4 mt -117.07 147.88 42.0 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 123.243 1.497 . . . . 1.96 110.945 165.843 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -138.54 109.65 6.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 111.449 -2.614 . . . . 3.14 108.97 166.819 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 tp -84.95 110.21 18.72 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.033 1.733 . . . . 1.6 108.826 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.81 -14.77 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.155 0.982 . . . . 0.58 112.059 -176.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.34 -179.03 31.95 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-O 122.324 0.958 . . . . 0.48 114.276 -178.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -144.64 -179.15 6.39 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.98 1.712 . . . . 0.47 109.588 162.668 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -153.27 -178.97 7.31 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.917 1.287 . . . . 4.96 108.568 156.164 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 t -171.53 153.0 3.37 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 125.986 1.714 . . . . 0.58 108.056 -172.604 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.11 -3.16 13.2 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.151 1.901 . . . . 0.66 113.847 174.175 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.5 m -119.15 39.26 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.796 1.239 . . . . 0.74 114.267 -176.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.36 167.26 29.29 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.134 1.374 . . . . 1.11 110.721 169.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -98.47 -50.97 4.1 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.72 1.608 . . . . 2.65 110.023 171.415 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -114.99 139.33 49.93 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 127.215 2.206 . . . . 4.63 107.293 171.054 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.1 149.55 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.521 -0.763 . . . . 1.09 109.003 154.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -127.94 151.79 48.68 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.675 1.99 . . . . 2.97 107.54 166.781 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -100.73 138.34 37.91 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.082 1.31 . . . . 1.76 112.102 160.465 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -123.79 160.21 27.84 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.066 2.146 . . . . 0.71 112.235 -178.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -104.36 178.58 4.52 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 112.491 -2.141 . . . . 3.46 111.397 166.101 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.8 m -148.34 139.15 23.0 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.285 -1.376 . . . . 0.74 107.285 163.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -148.37 178.54 8.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.983 1.313 . . . . 2.12 112.4 -168.864 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -110.04 145.49 36.96 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.332 1.453 . . . . 4.48 113.117 179.331 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.8 mtp85 -127.43 152.81 47.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.445 1.498 . . . . 4.69 110.711 166.299 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.411 ' OE1' ' HE2' ' A' ' 57' ' ' LYS . 3.1 tp10 -91.75 143.31 26.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.536 -0.912 . . . . 2.52 108.536 147.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 50.6 t -140.27 127.7 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 106.937 -1.505 . . . . 2.05 106.937 158.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 65.03 25.64 12.63 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.24 1.016 . . . . 4.38 113.715 173.404 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.11 9.1 85.64 Favored Glycine 0 CA--C 1.538 1.471 0 O-C-N 120.536 -1.352 . . . . 1.62 113.94 -173.52 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -122.21 119.25 30.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.17 2.188 . . . . 2.94 108.746 -170.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.476 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -89.04 116.52 27.38 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.655 1.982 . . . . 4.23 111.401 -173.033 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.1 t -149.13 139.69 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.962 2.105 . . . . 2.98 109.328 -166.112 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -84.08 170.86 13.44 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.586 1.328 . . . . 2.51 114.586 -172.059 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.55 165.63 29.13 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 126.807 2.146 . . . . 0.5 112.694 177.427 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 ttm -148.11 141.38 25.15 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.979 1.712 . . . . 0.83 109.705 177.785 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -148.18 159.6 39.24 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.695 1.998 . . . . 5.01 109.749 -176.71 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.81 153.02 53.29 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.276 1.984 . . . . 0.94 111.358 168.274 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.89 159.45 56.14 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 123.734 0.814 . . . . 1.06 109.898 174.51 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.63 -25.88 3.45 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.856 2.371 . . . . 0.69 112.951 -172.063 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -179.64 167.17 1.4 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.092 2.157 . . . . 2.2 110.73 -178.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.2 mt -112.1 152.18 28.56 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.24 1.016 . . . . 0.55 110.179 162.122 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -120.48 139.32 53.05 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.216 1.406 . . . . 2.19 110.042 -176.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.4 t -146.05 135.65 11.59 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 113.147 0.795 . . . . 1.59 113.147 176.419 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.26 168.87 23.77 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.479 2.786 . . . . 1.53 112.189 176.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -59.76 140.9 95.59 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.71 2.273 . . . . 1.69 110.959 165.074 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt 66.33 1.86 2.19 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.773 1.629 . . . . 2.03 113.577 -176.412 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.85 -175.65 51.07 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.644 2.069 . . . . 1.89 111.533 166.44 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -147.43 150.46 34.68 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 114.253 1.205 . . . . 5.66 114.253 175.694 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.1 t -98.23 106.13 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 128.243 2.617 . . . . 5.49 107.405 -174.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.408 ' HB3' HG23 ' A' ' 21' ' ' THR . 0.0 OUTLIER -126.14 110.38 13.42 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 122.199 0.999 . . . . 3.94 111.204 -179.416 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mp -83.49 78.7 9.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.006 -1.479 . . . . 2.29 107.006 167.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -73.0 140.67 80.8 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 113.777 -1.556 . . . . 3.61 112.992 -175.113 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -61.12 142.54 97.23 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.712 2.275 . . . . 3.48 110.81 -179.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.84 -12.93 58.34 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.222 -1.321 . . . . 2.09 114.786 -177.053 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.68 -109.53 1.45 Allowed Glycine 0 N--CA 1.474 1.173 0 CA-C-N 119.154 1.477 . . . . 1.87 111.62 172.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 47' ' ' GLU . 97.3 m-85 -75.54 137.07 40.6 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.832 -0.805 . . . . 2.1 111.957 -172.405 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -161.37 152.37 18.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.548 -0.751 . . . . 0.64 111.267 -171.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 52.8 m-85 -83.94 140.36 31.98 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.392 -0.818 . . . . 2.26 109.879 166.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.3 tpt -100.51 131.28 46.5 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.255 1.822 . . . . 0.63 108.183 167.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 mp -109.48 126.6 53.68 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.801 1.24 . . . . 0.84 108.184 -179.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.83 128.03 49.86 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.953 1.301 . . . . 2.98 109.281 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.93 51.91 5.2 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.578 1.085 . . . . 0.81 113.24 176.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.6 mt -47.33 155.98 0.29 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.846 1.424 . . . . 2.83 114.846 176.285 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -108.61 4.38 23.91 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.853 -1.067 . . . . 1.78 113.691 -177.875 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -161.31 163.1 20.77 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 129.43 3.092 . . . . 5.23 108.12 176.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.09 118.33 5.57 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.708 1.605 . . . . 1.75 108.617 165.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mp -80.15 57.14 2.62 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.14 1.376 . . . . 2.98 109.917 175.577 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -59.47 167.17 2.04 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 120.519 -1.363 . . . . 4.35 111.964 174.31 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.34 128.98 33.81 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.393 1.092 . . . . 1.83 110.025 161.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.13 34.59 36.91 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.017 1.294 . . . . 2.46 114.092 177.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -90.79 -176.85 4.81 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.65 1.225 . . . . 2.2 109.92 153.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -144.66 153.93 42.26 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 127.712 2.405 . . . . 3.76 106.904 171.344 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.4 t -149.03 157.66 6.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 128.509 2.724 . . . . 1.42 108.791 -163.328 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -120.61 152.85 37.61 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.096 0.474 . . . . 2.29 112.079 158.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mp -126.24 137.54 53.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.784 2.033 . . . . 1.68 109.869 171.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -90.1 148.3 23.09 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.092 1.357 . . . . 1.88 110.135 161.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -112.47 115.81 29.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.331 1.852 . . . . 0.86 109.59 172.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.1 mt -93.94 111.36 23.05 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.728 1.211 . . . . 0.68 110.221 -176.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -110.19 124.5 51.69 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.571 0.748 . . . . 1.86 111.362 -177.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.95 -17.69 63.51 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.624 0.972 . . . . 1.93 113.624 176.382 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.07 38.08 1.33 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.248 1.404 . . . . 5.47 113.653 175.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.97 28.08 72.25 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 125.754 1.645 . . . . 3.56 114.851 174.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -140.14 152.71 46.31 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.027 1.414 . . . . 3.87 113.359 -168.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.3 t -141.72 144.31 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.861 1.264 . . . . 2.11 107.697 163.093 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 22.6 mt -139.93 168.04 20.74 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.45 1.9 . . . . 3.05 108.274 170.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.5 pttp -147.42 151.87 37.18 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.199 1.185 . . . . 1.85 114.199 177.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.91 141.14 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 127.083 2.153 . . . . 2.22 110.923 -171.497 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.5 p -91.8 145.92 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.823 1.249 . . . . 2.46 109.408 166.267 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -157.34 142.76 12.46 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.049 1.34 . . . . 2.72 112.105 -174.1 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.6 166.01 27.96 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 124.083 3.189 . . . . 1.21 111.444 172.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.7 t -107.68 115.67 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.302 1.041 . . . . 1.06 109.17 169.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -127.1 153.63 45.75 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.905 1.282 . . . . 4.75 111.812 -170.434 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.6 58.8 4.47 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.794 1.035 . . . . 2.39 113.794 -159.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.26 -0.876 . . . . 7.92 112.285 174.202 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.79 0 N-CA-C 108.619 -1.792 . . . . 12.42 108.619 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.6 p -150.11 59.11 0.97 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.455 1.102 . . . . 12.14 110.098 170.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -60.39 -15.8 29.52 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 117.833 2.531 . . . . 10.97 117.833 -159.646 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.8 m 69.46 19.89 7.4 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 120.42 1.464 . . . . 7.21 113.508 163.051 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -76.38 57.16 1.15 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.827 1.651 . . . . 6.82 111.787 -177.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.7 169.09 26.16 Favored Glycine 0 C--N 1.337 0.609 0 O-C-N 119.714 -1.866 . . . . 1.13 113.287 -174.428 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -155.85 174.92 14.62 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.051 1.13 . . . . 1.79 114.051 -176.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.6 t -119.1 139.46 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 127.332 2.253 . . . . 1.15 109.779 177.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -97.36 109.66 22.37 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.009 1.324 . . . . 4.38 110.684 171.564 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -52.58 150.05 5.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.461 1.104 . . . . 3.16 110.935 168.189 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 m -162.06 147.65 10.37 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 125.097 1.359 . . . . 3.02 109.865 166.323 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -81.4 44.39 1.73 Allowed 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 124.671 3.581 . . . . 3.28 112.011 179.73 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -122.52 160.96 16.9 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.677 1.608 . . . . 2.16 112.93 -176.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.81 -17.49 56.22 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.584 2.856 . . . . 2.02 112.791 172.131 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -110.53 146.44 36.03 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.103 1.761 . . . . 3.3 113.565 164.426 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.08 -178.81 3.65 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.188 1.795 . . . . 0.63 110.275 163.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.94 145.36 34.43 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.57 1.077 . . . . 0.94 111.135 177.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.5 148.87 44.79 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.964 1.098 . . . . 0.98 113.964 -175.644 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -127.89 77.39 1.75 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.732 2.413 . . . . 2.39 110.414 -173.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -74.16 158.65 33.79 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.817 -1.177 . . . . 1.99 112.077 178.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.6 m -118.24 146.93 43.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.252 -1.018 . . . . 2.01 108.252 157.345 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.429 ' CD1' ' H ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -154.35 -174.76 5.1 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.264 1.826 . . . . 5.83 108.427 171.433 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.429 ' H ' ' CD1' ' A' ' 22' ' ' LEU . 37.3 mt-10 -138.69 146.4 41.53 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 120.69 -1.256 . . . . 3.62 110.416 -174.304 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -95.31 102.26 9.3 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.666 0.786 . . . . 1.46 109.067 156.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.84 -12.92 14.63 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.725 2.283 . . . . 2.0 113.35 176.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.04 -175.72 50.93 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-O 122.424 1.013 . . . . 1.91 113.339 -172.819 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -111.09 -1.16 16.34 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.165 2.186 . . . . 4.1 112.038 -172.367 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -111.82 158.9 35.34 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 127.771 2.428 . . . . 2.06 110.198 171.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.11 146.65 18.13 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.518 2.145 . . . . 1.16 111.581 -174.26 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.426 HD12 ' CD1' ' A' ' 105' ' ' PHE . 2.4 mm? -113.75 161.94 16.9 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.868 1.667 . . . . 2.44 110.931 176.002 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -154.81 119.54 4.85 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.517 -1.22 . . . . 1.83 111.012 -167.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.0 tp -101.21 108.95 20.74 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.273 1.829 . . . . 2.14 110.404 -173.352 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.1 m -109.38 -20.56 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.351 1.06 . . . . 0.82 112.12 -167.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.09 -174.36 29.78 Favored Glycine 0 C--N 1.343 0.963 0 C-N-CA 125.059 1.314 . . . . 0.73 113.367 -174.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.0 -179.67 7.19 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.066 0.946 . . . . 0.83 112.025 169.08 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -153.14 145.25 23.8 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.201 1.8 . . . . 5.4 107.634 178.529 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -164.11 151.19 10.2 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 119.416 1.007 . . . . 0.81 109.477 -172.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.0 -4.2 13.74 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.137 2.558 . . . . 0.88 114.428 175.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.23 30.3 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 115.212 1.56 . . . . 0.87 115.212 -175.189 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -174.88 167.95 3.59 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 128.357 2.663 . . . . 1.19 108.313 174.277 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -119.94 -45.9 2.46 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.2 0.909 . . . . 6.17 111.248 169.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.7 mtt-85 -78.6 141.46 38.03 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.585 -1.265 . . . . 4.69 107.585 164.387 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -158.52 74.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 127.806 2.442 . . . . 2.47 110.027 -174.469 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -99.97 131.64 45.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 111.766 -2.47 . . . . 4.92 110.72 -169.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.5 pt? -90.1 136.51 33.0 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 123.753 1.739 . . . . 2.12 114.026 -176.806 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -115.1 160.85 19.16 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 127.143 2.177 . . . . 0.8 110.856 174.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.12 -177.86 4.28 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.236 -1.802 . . . . 3.39 111.202 156.776 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.8 m -152.82 141.18 20.62 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.174 1.389 . . . . 0.61 107.829 170.306 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -151.04 170.41 19.44 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.929 1.455 . . . . 2.24 114.929 -168.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.0 ttp -109.75 142.47 40.94 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.369 1.868 . . . . 3.3 109.479 169.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -151.92 159.23 43.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.682 1.993 . . . . 8.46 111.391 -175.608 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -91.28 147.47 23.02 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.193 1.397 . . . . 2.5 111.897 170.198 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.6 t -140.54 120.33 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.389 1.475 . . . . 1.89 107.956 166.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 64.44 8.64 4.41 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 127.371 2.268 . . . . 2.9 114.763 -178.019 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.92 23.23 33.37 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 123.958 0.79 . . . . 1.79 113.89 -168.049 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.1 132.62 53.11 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.772 1.229 . . . . 2.54 109.634 166.549 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 138.89 44.87 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.079 1.352 . . . . 6.4 110.636 -178.86 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.576 HG22 ' H ' ' A' ' 59' ' ' MET . 9.8 p -154.26 -179.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 C-N-CA 126.882 2.073 . . . . 2.26 109.328 -177.479 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.576 ' H ' HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -116.75 166.4 12.18 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 121.299 -0.875 . . . . 3.23 112.28 -176.686 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.66 171.22 29.77 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.972 1.749 . . . . 0.53 111.994 -179.291 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 ttm -155.4 138.44 15.49 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 126.646 1.979 . . . . 0.63 109.227 173.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -144.65 149.94 45.29 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 127.645 2.378 . . . . 8.56 109.424 -172.025 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.1 154.87 52.52 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.574 2.183 . . . . 0.6 110.019 176.377 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.14 151.6 75.5 Favored Pre-proline 0 N--CA 1.483 1.213 0 CA-C-O 117.974 -1.012 . . . . 0.65 110.71 175.053 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.38 -23.77 9.8 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.192 2.595 . . . . 0.77 112.873 -169.575 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -179.55 165.58 1.36 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.472 2.309 . . . . 2.21 109.85 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.0 mt -109.15 150.52 27.75 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.004 0.922 . . . . 0.7 110.044 165.137 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -109.71 143.82 38.95 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.297 1.039 . . . . 2.08 109.149 178.059 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.6 t -140.3 125.25 11.16 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 122.971 0.509 . . . . 0.99 112.093 173.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.81 168.35 20.5 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.95 2.433 . . . . 1.28 111.697 179.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -55.25 140.12 81.32 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.027 2.485 . . . . 1.69 111.43 168.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt 67.68 0.91 2.41 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.721 1.609 . . . . 2.42 113.616 -177.183 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.62 156.96 45.22 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.902 1.715 . . . . 1.8 112.45 -179.048 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.9 mtm105 -104.99 132.51 51.14 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.025 1.33 . . . . 6.94 109.581 -178.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.9 t -93.42 55.33 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 127.589 2.356 . . . . 5.33 108.248 -173.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.71 93.02 8.69 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.641 1.976 . . . . 3.92 109.742 -175.223 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' A' ' 83' ' ' HIS . 1.5 tp -52.21 -56.23 16.02 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.326 1.45 . . . . 3.39 111.608 -164.66 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? 112.09 128.37 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 128.977 2.911 . . . . 3.02 114.429 161.516 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.62 -45.91 12.88 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.891 2.394 . . . . 1.97 110.847 174.065 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.72 40.69 3.07 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.938 -0.924 . . . . 1.81 112.37 172.315 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.4 -117.5 0.56 Allowed Glycine 0 C--N 1.337 0.638 0 CA-C-N 118.139 0.97 . . . . 1.77 113.783 175.029 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -76.5 137.1 39.41 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 123.399 1.571 . . . . 1.83 113.646 -163.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.598 ' HA ' HD23 ' A' ' 77' ' ' LEU . 53.0 p-80 -158.17 138.54 12.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.301 -1.318 . . . . 0.83 113.424 -173.66 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -77.03 135.24 38.64 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.018 -1.104 . . . . 2.54 108.018 167.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.8 mtp -99.64 117.69 34.54 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.651 0.739 . . . . 1.71 110.619 160.103 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -86.71 107.74 18.36 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.608 1.963 . . . . 1.23 107.426 -176.716 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.0 mp -111.35 141.5 44.81 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.09 1.756 . . . . 1.81 111.005 -173.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.44 42.44 41.32 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 111.459 -0.656 . . . . 0.95 111.459 178.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . 0.258 0.5 OUTLIER -44.01 138.84 2.68 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 123.479 1.609 . . . . 1.87 115.324 176.828 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -101.12 -12.71 18.58 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.051 -1.886 . . . . 4.59 112.893 -173.137 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -143.8 150.59 50.59 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 128.305 2.642 . . . . 5.71 108.2 172.681 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -72.37 150.58 52.66 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.597 2.198 . . . . 1.8 110.082 167.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.9 mp -108.8 143.79 37.5 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.087 2.155 . . . . 2.62 106.395 176.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.52 162.5 15.05 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.466 2.306 . . . . 4.03 110.424 170.796 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.54 125.8 26.87 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.43 -0.794 . . . . 1.94 109.171 157.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.86 32.0 6.72 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.866 1.222 . . . . 1.71 115.025 173.241 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -112.16 -167.49 1.19 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.488 1.115 . . . . 2.12 112.801 175.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 8.7 pt-20 -147.11 147.94 31.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 128.116 2.567 . . . . 3.13 107.233 172.685 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.9 t -146.31 126.69 6.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 127.823 2.449 . . . . 1.16 108.667 -165.354 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.45 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -90.11 154.45 19.78 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 122.732 1.253 . . . . 2.48 113.75 176.224 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.7 tt -156.82 144.87 19.42 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.125 1.77 . . . . 2.39 109.945 176.042 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.08 140.86 39.24 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.696 1.598 . . . . 3.35 110.55 170.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.1 mp -84.91 127.7 34.29 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.388 1.475 . . . . 1.18 109.64 174.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.6 mt -90.75 104.86 17.39 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.696 -0.853 . . . . 0.84 108.696 168.691 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.426 ' CD1' HD12 ' A' ' 30' ' ' LEU . 96.2 m-85 -97.69 149.27 22.46 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.187 0.995 . . . . 2.35 111.101 172.59 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.57 129.05 34.9 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.518 0.933 . . . . 2.17 113.518 -174.627 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.32 62.03 2.84 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.663 1.125 . . . . 3.15 113.542 174.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.19 13.18 81.44 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 115.709 1.044 . . . . 2.42 115.709 167.751 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -97.07 122.19 39.79 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.794 1.297 . . . . 3.08 110.56 -179.267 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.8 t -137.0 128.83 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.152 0.981 . . . . 2.14 109.977 -176.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -140.43 127.62 21.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.564 1.146 . . . . 2.98 111.811 -176.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.45 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 24.4 ttmm -83.25 140.59 32.42 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.179 1.392 . . . . 2.74 113.766 -178.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.36 153.9 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.446 1.898 . . . . 2.42 109.971 163.307 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.31 127.57 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 107.337 -1.357 . . . . 1.87 107.337 163.014 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.4 mt -125.44 129.46 24.42 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.256 1.422 . . . . 1.9 108.668 -170.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 60.6 Cg_endo -70.65 153.06 65.07 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.159 2.573 . . . . 1.04 112.147 172.675 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.4 t -103.91 112.3 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.445 1.498 . . . . 1.05 109.904 173.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -100.38 178.66 4.68 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.802 1.241 . . . . 4.91 109.896 160.43 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.33 158.66 43.91 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.935 0.894 . . . . 2.85 112.158 -171.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.352 0 C-N-CA 126.817 2.047 . . . . 9.2 110.639 176.153 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.316 0 N-CA-C 108.355 -1.898 . . . . 11.14 108.355 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.1 t -59.56 142.92 51.65 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 117.049 -1.86 . . . . 9.57 107.352 129.365 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -159.48 -16.1 0.06 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 117.102 2.26 . . . . 14.19 117.102 -153.315 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.05 4.81 44.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.957 1.303 . . . . 8.9 112.071 -166.391 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.24 116.43 10.59 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.789 0.804 . . . . 5.06 111.362 -148.639 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.18 -175.25 32.0 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 128.456 2.932 . . . . 0.92 110.98 174.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -116.43 157.03 25.78 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.665 0.987 . . . . 2.24 113.665 175.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.2 t -89.46 141.97 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 O-C-N 120.877 -1.139 . . . . 1.23 108.163 157.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.0 ttt85 -77.15 131.43 38.29 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.988 -0.445 . . . . 4.51 111.894 -173.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -45.02 135.06 5.57 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.412 1.485 . . . . 2.03 112.067 166.186 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.0 t -176.68 129.68 0.35 Allowed Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.188 1.395 . . . . 2.59 112.448 172.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -91.19 0.76 4.77 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.133 3.222 . . . . 2.34 112.413 165.324 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.19 -175.33 46.44 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.644 1.116 . . . . 1.13 113.374 -173.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -69.02 -22.13 35.9 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.161 2.574 . . . . 1.59 113.057 -178.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.6 p30 -128.38 166.06 19.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.302 1.841 . . . . 2.39 114.076 -178.657 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.44 -177.2 6.3 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 128.258 2.623 . . . . 0.57 111.045 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.75 171.09 10.38 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.294 1.837 . . . . 1.14 108.925 169.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.5 160.7 43.59 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.759 1.223 . . . . 0.7 111.557 174.472 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -155.34 144.95 21.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.841 -1.072 . . . . 8.43 111.558 -161.019 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -161.89 156.51 22.62 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.393 1.477 . . . . 2.23 111.375 -172.083 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.1 m -83.95 146.07 28.22 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.081 0.953 . . . . 1.98 108.857 162.254 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.49 114.27 23.22 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.639 0.775 . . . . 3.25 109.449 170.064 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -104.88 145.62 30.14 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.988 1.315 . . . . 3.68 109.093 168.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.21 73.49 1.33 Allowed Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.088 0.955 . . . . 3.06 110.986 177.735 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.3 -19.3 62.02 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.902 2.401 . . . . 1.42 114.659 -174.23 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.42 -179.95 51.43 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-O 122.885 1.269 . . . . 1.23 113.066 174.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -103.27 -2.48 27.1 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.87 2.068 . . . . 2.89 112.151 -169.005 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 pp -122.48 155.79 61.93 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 128.099 2.56 . . . . 1.98 109.782 175.547 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.63 140.65 21.34 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.777 2.318 . . . . 1.22 111.086 -172.186 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.8 mt -93.31 150.01 20.8 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 123.21 1.481 . . . . 2.08 112.029 172.275 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -134.89 113.87 11.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 112.303 -2.226 . . . . 1.98 110.165 177.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.8 tp -95.86 111.57 23.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.669 1.588 . . . . 2.16 108.93 -177.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.2 m -107.22 -19.81 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.548 1.139 . . . . 0.91 112.273 -169.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.42 -174.61 28.36 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.384 1.468 . . . . 0.85 113.22 177.487 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.57 -176.73 4.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.764 1.626 . . . . 0.87 109.348 167.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.12 175.23 13.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.767 1.627 . . . . 5.02 108.42 161.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.9 t -171.57 156.14 4.2 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 125.657 1.583 . . . . 0.76 108.417 -173.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.91 -10.55 14.06 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.805 1.67 . . . . 0.91 112.895 171.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.6 46.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.232 1.013 . . . . 0.91 113.461 -176.384 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.58 153.28 14.96 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.216 1.406 . . . . 1.0 110.68 164.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -88.39 -47.22 8.53 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.649 1.18 . . . . 2.86 110.229 172.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -104.89 133.7 49.25 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 126.33 1.852 . . . . 6.66 107.53 166.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.11 148.0 22.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.812 -1.181 . . . . 1.28 107.812 150.357 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -156.81 149.3 23.37 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 126.26 1.824 . . . . 3.04 107.73 -172.189 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.7 pt? -100.48 139.92 35.48 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 122.894 1.33 . . . . 1.75 112.614 173.097 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -119.93 149.75 41.61 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.724 2.009 . . . . 0.88 111.5 178.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -86.62 162.38 18.0 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.335 1.454 . . . . 2.67 110.925 162.849 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.9 m -129.26 130.45 46.24 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 106.409 -1.701 . . . . 1.0 106.409 167.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -135.44 168.46 19.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.698 1.135 . . . . 2.13 113.949 -174.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.7 ttm -100.25 146.13 27.26 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.601 1.56 . . . . 3.84 109.972 165.218 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.75 153.66 32.61 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.627 1.171 . . . . 4.87 110.475 -171.777 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -95.26 137.81 33.81 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.124 0.97 . . . . 3.61 109.871 169.431 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.0 t -130.8 119.32 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 106.703 -1.591 . . . . 2.62 106.703 164.548 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 60.88 18.0 8.33 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 116.154 1.909 . . . . 5.46 116.154 178.004 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.38 2.69 67.78 Favored Glycine 0 N--CA 1.479 1.552 0 O-C-N 120.826 -1.171 . . . . 2.21 114.354 -171.474 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.23 125.56 52.38 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.464 1.906 . . . . 3.75 109.852 176.529 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -74.95 119.17 18.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.667 -1.606 . . . . 5.38 109.45 -179.651 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.0 m -122.53 177.72 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 127.594 2.358 . . . . 2.19 109.674 177.68 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 56.5 mtt -118.0 158.45 24.92 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.232 1.013 . . . . 2.77 111.243 167.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.82 -177.38 25.5 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 126.16 1.838 . . . . 0.69 112.243 -176.447 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.9 ttm -157.57 142.94 17.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.856 1.662 . . . . 0.85 109.426 -171.656 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.15 159.18 43.25 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 127.327 2.251 . . . . 8.2 109.545 -174.361 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -84.65 144.9 10.2 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.129 2.553 . . . . 0.85 111.343 173.285 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.7 m -133.51 162.38 58.02 Favored Pre-proline 0 N--CA 1.486 1.368 0 CA-C-O 118.317 -0.849 . . . . 0.95 111.749 -175.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -89.89 -25.06 0.53 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.282 1.988 . . . . 0.9 114.215 -163.087 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -178.76 166.34 1.68 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.865 1.266 . . . . 2.13 112.96 -177.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.9 mt -114.81 153.14 30.95 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.892 1.677 . . . . 0.87 110.837 165.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -120.2 142.96 48.52 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.489 1.516 . . . . 1.89 109.448 177.828 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.7 t -138.57 139.22 23.9 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.469 0.708 . . . . 1.05 112.139 172.022 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -84.86 156.15 11.64 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 124.392 3.395 . . . . 1.44 112.869 177.643 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.58 143.77 82.49 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.979 3.12 . . . . 1.27 113.94 -173.234 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt 68.7 -11.28 0.43 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.234 2.614 . . . . 1.75 114.763 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.98 168.49 50.94 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.787 1.184 . . . . 1.83 112.752 172.554 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.87 151.24 49.31 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.969 0.908 . . . . 5.04 110.646 162.488 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.2 t -136.19 174.6 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 129.338 3.055 . . . . 3.8 106.038 175.312 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -154.14 161.12 42.09 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 119.738 -1.851 . . . . 4.01 108.593 171.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 83' ' ' HIS . 2.3 mp -56.0 -43.75 77.99 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.091 1.145 . . . . 3.71 114.091 -164.798 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt 71.43 110.88 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 128.632 2.773 . . . . 5.35 111.236 -178.707 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -62.87 -34.79 70.76 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.886 1.724 . . . . 2.8 111.683 -176.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.48 43.07 2.85 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.235 1.397 . . . . 2.18 113.253 164.602 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.66 -36.04 0.06 OUTLIER Glycine 0 C--O 1.219 -0.799 0 N-CA-C 120.698 3.039 . . . . 2.57 120.698 162.352 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -144.64 146.22 32.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 119.549 1.674 . . . . 2.13 113.236 168.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.649 ' HA ' HD23 ' A' ' 77' ' ' LEU . 56.6 p-80 -161.76 153.2 18.61 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.413 -0.804 . . . . 0.75 111.096 175.278 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -78.72 141.44 37.87 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.693 -0.484 . . . . 1.9 109.693 167.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -105.73 134.75 48.35 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.027 1.731 . . . . 0.81 109.242 165.465 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -111.1 122.91 49.09 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.518 1.527 . . . . 0.76 108.468 176.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.0 mp -120.98 138.3 54.21 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.612 0.765 . . . . 1.79 109.335 176.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.12 45.42 11.62 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.319 -0.712 . . . . 0.95 112.543 178.422 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 pp -53.67 154.75 3.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 123.271 1.51 . . . . 1.35 114.82 176.513 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -109.69 -10.47 14.81 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 113.224 -1.807 . . . . 2.19 113.541 -175.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 mtp-105 -145.16 143.64 21.06 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 126.775 2.03 . . . . 4.8 108.19 169.545 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -68.69 151.3 74.81 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.405 2.07 . . . . 1.83 109.698 171.02 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 64.8 mt -116.73 92.35 3.84 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.019 0.928 . . . . 2.2 110.131 -166.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.6 pttm -83.63 164.03 19.96 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.54 -0.725 . . . . 5.32 112.126 170.675 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.27 126.21 26.76 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.314 -0.866 . . . . 1.36 108.676 168.775 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.23 33.12 50.14 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.428 1.013 . . . . 1.42 113.81 179.187 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -81.74 179.86 7.66 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.482 1.141 . . . . 2.71 108.483 143.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -134.54 150.61 50.77 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.085 -1.82 . . . . 3.88 106.085 164.23 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 49.8 t -138.25 133.51 43.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 126.443 1.897 . . . . 0.96 110.239 -173.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -78.84 137.05 37.51 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.177 -0.465 . . . . 2.73 110.815 172.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.75 133.9 54.93 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.92 1.288 . . . . 1.67 110.684 168.251 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -84.87 141.67 30.27 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 125.483 1.513 . . . . 2.72 108.799 158.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -110.28 126.33 54.07 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.454 1.502 . . . . 1.12 109.026 168.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.2 mt -104.36 117.86 35.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.897 1.279 . . . . 0.88 110.061 -178.68 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -116.73 149.11 40.41 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.781 1.232 . . . . 2.01 111.839 -174.468 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.7 139.35 58.32 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.249 1.203 . . . . 2.04 114.249 -172.294 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.39 45.5 29.8 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.195 -0.781 . . . . 3.2 113.255 175.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.46 35.74 11.59 Favored Glycine 0 N--CA 1.47 0.917 0 N-CA-C 116.074 1.19 . . . . 1.72 116.074 163.587 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -122.81 145.98 47.94 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.832 1.816 . . . . 3.3 112.579 172.32 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.7 t -143.6 142.47 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.009 1.323 . . . . 2.04 108.955 177.281 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 42.1 tp -143.43 119.74 10.89 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.795 0.838 . . . . 2.88 110.874 -178.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.49 125.76 38.27 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.767 0.827 . . . . 2.92 111.62 178.334 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.468 HG12 ' H ' ' A' ' 114' ' ' VAL . 0.3 OUTLIER -138.77 -174.46 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.851 1.66 . . . . 3.13 109.954 176.438 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.468 ' H ' HG12 ' A' ' 113' ' ' VAL . 11.3 t -137.2 150.04 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.431 1.492 . . . . 2.09 109.565 -168.626 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.6 mt -142.8 143.74 26.87 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 127.366 2.266 . . . . 1.95 109.048 -176.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.32 162.12 43.53 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.027 2.484 . . . . 0.8 111.443 168.291 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 85.1 t -94.03 122.32 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 121.744 -0.598 . . . . 0.89 110.227 165.795 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.11 164.76 18.78 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.356 1.862 . . . . 4.49 110.731 178.166 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.46 67.8 1.08 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.526 1.306 . . . . 2.28 114.526 -154.241 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 . . . . . 0 C--O 1.251 1.132 1 C-N-CA 133.154 4.582 . . . . 8.51 113.049 170.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.344 0 N-CA-C 108.534 -1.827 . . . . 8.57 108.534 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.0 t -71.48 -126.54 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 106.73 -1.582 . . . . 10.59 106.73 131.38 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -75.61 113.47 13.09 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 120.422 -1.424 . . . . 11.16 107.234 137.057 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -163.67 58.57 0.17 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.136 1.374 . . . . 8.0 108.514 -172.08 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -127.49 -176.21 3.68 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.165 1.386 . . . . 4.78 109.391 -171.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.69 177.75 40.6 Favored Glycine 0 N--CA 1.469 0.892 0 O-C-N 121.189 -0.944 . . . . 0.95 114.42 -165.291 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -155.62 138.49 15.33 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.108 1.363 . . . . 2.04 112.097 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.1 t -77.56 142.81 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 120.447 -1.408 . . . . 0.98 107.343 167.361 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 -85.0 127.13 34.06 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.661 -0.649 . . . . 6.65 110.373 -178.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -44.77 141.47 2.09 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.09 1.356 . . . . 2.03 112.109 172.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.5 t -148.11 148.99 31.27 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 122.877 0.471 . . . . 2.79 111.502 165.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.0 -23.83 8.87 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.299 2.0 . . . . 2.34 112.899 172.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -125.38 -156.64 9.4 Favored Glycine 0 CA--C 1.544 1.878 0 C-N-CA 125.332 1.444 . . . . 1.48 115.76 -160.495 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.24 -14.47 10.67 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.873 3.715 . . . . 1.52 115.171 -167.757 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -122.49 151.35 41.41 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.05 2.14 . . . . 2.41 112.746 -178.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.16 -176.77 6.16 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.435 1.894 . . . . 0.9 112.986 -163.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.79 158.52 44.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.568 1.947 . . . . 0.84 109.343 174.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.56 134.85 31.16 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.706 1.139 . . . . 0.6 112.965 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -107.61 135.79 48.46 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.55 1.54 . . . . 3.04 108.37 172.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 pp -150.72 156.44 41.31 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.437 -1.414 . . . . 1.79 113.347 -166.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.4 m -119.03 146.73 44.81 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.397 1.879 . . . . 2.0 109.864 179.379 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 tt -149.6 162.67 39.74 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 128.355 2.662 . . . . 4.64 106.989 155.262 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -134.49 133.52 40.47 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.598 -1.314 . . . . 4.14 111.053 163.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -76.96 111.76 18.44 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 127.298 2.239 . . . . 1.77 110.251 -174.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.51 -20.22 41.72 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.166 1.911 . . . . 1.6 113.338 177.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.06 129.88 3.24 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 124.753 1.168 . . . . 2.97 115.897 154.199 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -175.38 -46.41 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 130.831 3.652 . . . . 6.96 105.623 -169.303 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 28' ' ' LEU . 2.5 pt? -126.86 163.01 44.02 Favored Pre-proline 0 C--O 1.24 0.597 0 C-N-CA 127.075 2.15 . . . . 3.88 112.052 177.596 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -81.03 144.44 14.94 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.127 2.551 . . . . 1.37 109.43 166.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.4 mt -98.58 147.54 24.69 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 122.442 1.115 . . . . 1.88 110.815 174.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -132.57 104.77 6.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 111.775 -2.466 . . . . 2.38 110.638 172.061 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.8 tp -88.19 100.51 13.03 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.228 1.411 . . . . 1.87 108.914 -173.121 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -101.95 -18.59 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 125.272 1.429 . . . . 0.54 112.42 -169.639 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.82 -179.59 31.89 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 124.201 0.905 . . . . 0.48 112.956 177.379 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.91 -178.21 5.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.099 1.36 . . . . 0.52 109.701 166.685 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.62 -178.42 7.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.022 2.129 . . . . 5.24 108.09 165.645 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 t -178.77 154.82 0.85 Allowed Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 127.52 2.328 . . . . 0.77 108.796 -176.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.63 -8.64 23.81 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.046 1.83 . . . . 0.89 113.802 169.409 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.54 44.6 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 114.108 1.151 . . . . 1.01 114.108 -173.055 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.99 147.29 13.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.365 1.066 . . . . 1.13 111.107 166.129 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.71 -38.48 13.83 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.038 1.735 . . . . 2.79 111.991 173.788 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.409 HH21 ' CD ' ' A' ' 44' ' ' GLU . 26.7 mtp85 -124.7 149.29 47.38 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 127.668 2.387 . . . . 5.6 109.175 177.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -157.23 120.52 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 125.642 1.577 . . . . 1.27 110.586 -174.02 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.409 ' CD ' HH21 ' A' ' 42' ' ' ARG . 2.5 mp0 -139.11 132.19 29.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.884 -1.053 . . . . 4.47 110.962 -164.474 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.7 tp -81.62 125.56 30.7 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.922 0.489 . . . . 1.5 111.755 -173.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -121.02 155.65 33.88 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.747 1.619 . . . . 0.56 113.464 175.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.99 -176.77 3.34 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.537 1.935 . . . . 3.44 110.528 166.415 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.4 m -150.35 143.74 25.05 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.922 1.289 . . . . 0.8 108.007 171.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -148.34 168.85 21.51 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.346 1.609 . . . . 2.57 115.346 -170.686 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.6 mtp -110.92 145.17 38.8 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.283 1.433 . . . . 4.43 111.206 162.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -137.14 149.4 47.27 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.697 1.999 . . . . 5.34 109.985 171.585 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -89.79 140.49 29.54 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.501 -0.926 . . . . 2.72 108.501 153.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.4 t -140.97 121.71 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 106.112 -1.81 . . . . 2.26 106.112 171.597 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 66.89 22.54 10.15 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.93 0.892 . . . . 3.71 112.798 176.596 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.83 19.43 77.68 Favored Glycine 0 N--CA 1.477 1.394 0 O-C-N 120.627 -1.296 . . . . 1.7 113.337 -173.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -132.6 127.91 36.01 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.426 1.891 . . . . 2.53 108.89 -178.408 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -79.33 125.45 29.52 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.845 0.858 . . . . 5.72 112.524 -175.271 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.3 t -121.54 134.05 66.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 128.65 2.78 . . . . 2.33 108.583 -176.016 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 37.3 mtt -98.11 149.02 22.95 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.82 0.848 . . . . 2.42 110.266 169.179 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.32 -179.13 30.22 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-O 121.917 0.732 . . . . 0.85 113.668 -175.039 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ttm -159.88 147.57 16.81 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 125.926 1.69 . . . . 0.71 109.886 -171.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.59 152.84 23.49 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 113.602 -1.636 . . . . 5.35 109.52 -163.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -83.33 157.87 14.81 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.289 1.993 . . . . 0.8 111.555 176.607 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.97 157.09 54.87 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 125.779 1.632 . . . . 1.01 110.429 -178.49 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.76 -31.77 0.53 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.19 2.593 . . . . 0.63 113.389 -166.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -173.39 167.12 4.74 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.087 1.755 . . . . 2.24 110.886 -178.601 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.8 mt -110.22 155.2 22.33 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.463 1.105 . . . . 0.69 110.936 162.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -117.62 137.99 52.25 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.318 1.447 . . . . 2.15 108.851 175.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.3 t -149.44 132.16 8.06 Favored Pre-proline 0 N--CA 1.476 0.845 0 N-CA-C 113.499 0.926 . . . . 1.06 113.499 173.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.4 169.55 21.42 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 124.1 3.2 . . . . 1.21 114.234 -177.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.04 146.38 96.18 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.93 3.087 . . . . 1.3 111.806 168.201 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.6 mmtt 70.37 -7.73 0.97 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.217 1.807 . . . . 1.58 114.089 -176.223 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.42 148.69 20.75 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.386 1.469 . . . . 1.22 113.511 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.95 129.21 34.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.121 1.369 . . . . 4.27 111.805 177.113 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.7 t -108.05 80.98 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 128.19 2.596 . . . . 5.94 108.469 -165.123 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -138.58 123.04 18.4 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.727 0.775 . . . . 4.12 112.994 -158.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -80.55 84.19 6.19 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-O 122.857 1.313 . . . . 2.03 108.45 175.58 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.29 145.85 97.64 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 113.249 -1.796 . . . . 4.01 114.83 -171.749 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -55.81 143.32 81.53 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 123.567 2.845 . . . . 4.09 110.693 176.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.54 -5.49 44.85 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 116.772 -2.127 . . . . 1.6 115.811 176.585 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.81 -22.64 0.33 Allowed Glycine 0 N--CA 1.475 1.292 0 N-CA-C 119.713 2.645 . . . . 2.18 119.713 178.085 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -152.47 141.83 21.57 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.683 1.742 . . . . 2.16 113.078 179.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -162.83 155.46 19.04 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.197 1.399 . . . . 0.62 110.977 174.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -84.55 134.5 34.41 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.968 -1.123 . . . . 2.26 107.968 163.141 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -82.71 134.06 35.15 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.736 1.214 . . . . 0.64 108.06 164.016 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 mp -117.27 135.49 53.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.519 1.128 . . . . 0.86 109.345 -179.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 mp -132.61 148.89 52.37 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.966 0.906 . . . . 1.64 110.975 178.731 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.17 39.58 31.6 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 123.543 0.592 . . . . 1.02 113.836 173.424 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.38 156.41 7.83 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 116.365 1.987 . . . . 1.49 116.365 179.382 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -112.35 -16.14 13.0 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 113.018 -1.901 . . . . 1.95 113.409 -170.102 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -128.47 173.67 5.32 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 129.878 3.271 . . . . 6.8 110.95 177.321 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -63.78 -176.75 0.37 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.438 2.092 . . . . 3.15 110.917 155.599 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.434 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -167.24 66.32 0.09 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.344 2.658 . . . . 3.14 108.287 179.223 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.434 ' HD3' ' H ' ' A' ' 93' ' ' LEU . 2.4 mptt -99.65 164.84 11.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.773 1.229 . . . . 7.36 111.06 179.277 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.27 122.01 13.42 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.502 1.121 . . . . 1.29 110.727 -174.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.07 4.15 63.25 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.231 1.396 . . . . 1.54 114.574 179.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -79.96 -175.05 4.75 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.644 1.222 . . . . 2.44 110.501 164.944 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -156.28 139.9 15.97 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.948 1.699 . . . . 3.09 108.644 -174.532 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.0 t -146.79 134.98 15.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 126.526 1.93 . . . . 0.93 110.874 -163.821 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -78.32 136.13 37.65 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.62 1.168 . . . . 2.8 111.176 173.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 mp -121.13 136.76 54.92 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.196 0.998 . . . . 1.73 111.688 160.313 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -86.3 145.41 26.93 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.201 2.201 . . . . 2.49 110.216 164.423 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -116.52 126.52 53.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.491 1.917 . . . . 0.82 109.439 172.295 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.1 mt -103.26 111.75 24.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.308 1.443 . . . . 0.57 110.225 -177.176 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -110.44 105.26 14.17 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.901 1.28 . . . . 1.98 112.471 -171.188 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 56.36 18.0 3.18 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.283 1.833 . . . . 2.93 114.372 175.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.97 -57.88 3.12 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.368 1.461 . . . . 3.85 112.085 -166.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.97 19.51 2.11 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.66 1.6 . . . . 3.0 116.799 -172.021 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.17 147.97 19.89 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.957 2.903 . . . . 3.06 112.047 167.145 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.3 t -143.15 150.09 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.332 1.453 . . . . 2.24 108.307 176.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.56 171.16 18.55 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.131 1.772 . . . . 3.18 108.793 173.449 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -154.89 154.98 33.51 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.694 0.998 . . . . 2.16 113.694 179.648 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.4 t -149.11 154.72 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.702 1.201 . . . . 2.17 109.578 -172.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.81 133.54 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.101 0.96 . . . . 1.85 109.319 177.365 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -120.77 147.6 46.34 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 126.507 1.923 . . . . 3.09 108.346 175.194 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.23 168.03 15.1 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.51 2.807 . . . . 0.76 111.704 163.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.7 t -108.27 122.98 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.483 1.113 . . . . 0.94 110.827 170.188 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -119.5 152.46 36.91 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.878 1.271 . . . . 4.65 113.763 -174.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.96 152.4 33.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.597 1.559 . . . . 2.35 114.08 -175.026 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.977 0 C-N-CA 129.211 3.004 . . . . 8.07 116.33 -165.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.341 0 N-CA-C 105.511 -3.035 . . . . 13.85 105.511 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -50.14 161.54 0.27 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.332 0.566 . . . . 11.98 111.116 136.441 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -76.18 170.79 15.64 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.477 0.711 . . . . 12.21 111.158 169.19 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 p -139.67 -52.71 0.53 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.187 2.195 . . . . 6.56 110.807 -169.4 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -134.69 -175.42 3.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.747 2.419 . . . . 5.98 110.063 -169.396 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.73 172.81 52.22 Favored Glycine 0 C--O 1.221 -0.66 0 O-C-N 121.423 -0.798 . . . . 1.48 112.721 167.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -149.61 144.57 26.26 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.828 -0.807 . . . . 2.03 110.445 161.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -93.82 128.8 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.586 -0.894 . . . . 1.38 108.586 177.596 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -74.15 106.7 5.93 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.123 0.569 . . . . 4.34 111.609 -170.613 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -43.44 132.74 4.53 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.03 1.332 . . . . 2.4 111.421 171.821 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.7 m -151.33 138.27 11.88 Favored Pre-proline 0 CA--C 1.539 0.555 0 O-C-N 120.976 -1.078 . . . . 2.73 111.503 175.315 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -86.29 48.18 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.405 3.403 . . . . 2.21 111.076 178.657 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.49 -179.0 30.28 Favored Glycine 0 CA--C 1.539 1.536 0 N-CA-C 115.774 1.07 . . . . 1.25 115.774 -168.168 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.48 -15.88 21.9 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.624 3.55 . . . . 1.17 114.112 -176.042 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -134.62 170.67 15.44 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.801 2.04 . . . . 2.2 113.195 -175.596 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.65 -179.3 8.03 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.732 2.013 . . . . 0.59 112.413 -177.544 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.95 162.96 20.12 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.49 1.516 . . . . 0.64 110.064 165.677 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.65 146.67 33.41 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.126 1.33 . . . . 0.56 113.525 174.667 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -115.71 160.95 19.41 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.228 1.811 . . . . 2.96 111.178 173.762 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.4 tp -146.58 138.7 24.85 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.477 1.911 . . . . 2.99 109.765 -170.429 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.9 m -131.47 133.6 45.32 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.377 1.471 . . . . 2.37 107.196 160.387 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.5 tp -159.67 -178.17 6.9 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 128.149 2.58 . . . . 5.42 108.89 -176.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -135.16 151.81 51.02 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.277 1.831 . . . . 3.37 112.457 171.195 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -91.84 106.89 18.94 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.558 1.543 . . . . 1.73 108.33 168.493 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.72 -13.07 14.76 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.998 1.799 . . . . 1.38 113.543 177.51 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.41 173.35 55.23 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-O 123.059 1.366 . . . . 1.16 112.754 -175.421 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -100.71 -2.41 32.59 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 128.189 2.595 . . . . 2.89 111.478 -179.248 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -113.64 156.09 44.03 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 127.843 2.457 . . . . 2.06 110.346 171.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.81 151.84 24.88 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.826 2.35 . . . . 0.88 111.312 -175.093 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt -99.29 154.04 18.48 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 122.591 1.186 . . . . 1.76 111.405 168.134 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.1 ttp180 -140.96 111.03 6.6 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 113.532 -1.667 . . . . 2.37 110.041 177.37 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.58 111.26 23.61 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.981 1.712 . . . . 1.78 109.576 -171.073 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 m -113.38 -18.29 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.444 1.098 . . . . 0.89 112.645 -168.219 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.6 -174.49 29.42 Favored Glycine 0 N--CA 1.469 0.843 0 C-N-CA 125.364 1.459 . . . . 0.68 112.837 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.46 -178.0 5.93 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.413 1.085 . . . . 0.67 111.535 169.452 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -157.15 177.95 10.9 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 128.19 2.596 . . . . 5.37 108.246 164.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -177.68 155.42 1.08 Allowed Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 126.738 2.015 . . . . 1.14 108.674 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.53 -9.19 24.54 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.752 2.301 . . . . 1.24 114.032 167.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.44 48.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 125.063 1.345 . . . . 1.21 114.155 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.47 163.29 30.48 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.337 1.055 . . . . 1.07 112.53 164.013 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -96.2 -33.24 12.1 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.085 2.154 . . . . 2.84 111.483 170.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.0 mtp85 -155.48 156.74 35.78 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 128.446 2.698 . . . . 6.76 108.999 -176.564 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.1 p -158.45 107.8 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 125.553 1.541 . . . . 1.77 111.157 -172.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -123.78 137.63 54.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.996 -1.456 . . . . 4.93 111.068 -167.358 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.6 tp -88.09 126.07 34.91 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.331 1.452 . . . . 1.5 111.958 -169.322 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 37.6 m170 -119.42 158.34 26.4 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.228 1.811 . . . . 0.66 113.171 176.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -102.31 158.74 15.98 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 113.819 -1.537 . . . . 2.32 110.61 157.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.0 m -113.42 135.38 53.94 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 106.032 -1.84 . . . . 0.98 106.032 159.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -128.87 166.67 18.64 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.493 1.14 . . . . 2.13 113.582 -175.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 61.0 mtt -100.57 146.27 27.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.126 1.37 . . . . 4.44 110.655 167.876 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.55 150.32 26.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.789 0.836 . . . . 5.02 111.665 -176.413 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -103.88 127.68 51.39 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.119 1.368 . . . . 3.21 107.787 166.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.3 t -146.56 138.24 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 106.064 -1.828 . . . . 2.67 106.064 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 66.58 22.19 10.58 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 119.002 0.819 . . . . 3.27 112.07 177.23 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.31 18.57 79.95 Favored Glycine 0 N--CA 1.475 1.258 0 O-C-N 121.101 -1.0 . . . . 1.72 113.523 -173.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -141.23 132.63 26.77 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.822 1.649 . . . . 3.05 110.833 -168.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -70.68 129.4 39.04 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.586 1.554 . . . . 4.52 111.435 173.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.6 m -138.32 169.47 18.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 129.188 2.995 . . . . 2.64 109.515 -177.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 49.6 mtm -116.39 146.01 42.81 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.431 1.092 . . . . 2.5 110.712 168.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.73 -177.13 14.73 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 126.016 1.77 . . . . 0.83 111.916 -178.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.1 ttm -150.55 148.9 29.24 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.512 1.525 . . . . 0.99 108.746 -177.645 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -155.86 155.45 29.39 Favored Pre-proline 0 N--CA 1.476 0.85 0 CA-C-O 118.309 -0.853 . . . . 5.95 111.327 172.689 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -70.35 153.42 66.23 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.93 1.753 . . . . 0.81 110.805 172.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.4 m -140.47 151.2 63.27 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 125.145 1.378 . . . . 0.85 109.767 -179.542 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.81 -26.28 3.79 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.897 2.398 . . . . 0.75 113.178 -164.02 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -174.82 165.65 3.63 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.584 1.554 . . . . 2.04 112.209 -179.272 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.7 mt -108.33 154.6 21.59 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.008 1.323 . . . . 0.56 110.346 161.677 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -110.36 147.89 33.05 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.166 1.386 . . . . 1.86 109.186 172.76 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.7 t -144.24 133.65 11.49 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 123.259 0.624 . . . . 1.02 112.122 169.602 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.19 168.18 21.55 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.049 2.5 . . . . 1.18 112.881 176.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.0 144.83 96.72 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.888 3.059 . . . . 1.06 111.845 167.245 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt 66.74 -7.19 0.47 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.877 1.671 . . . . 1.86 114.207 179.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.92 165.78 51.32 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.526 1.536 . . . . 1.16 112.299 -179.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -82.75 135.74 34.9 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 121.886 0.85 . . . . 4.98 110.146 172.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.3 t -98.94 81.74 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 127.786 2.435 . . . . 6.51 105.822 -176.119 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -138.37 129.26 26.81 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 123.07 1.414 . . . . 3.9 112.674 -161.754 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 83' ' ' HIS . 8.5 mp -71.19 167.55 19.12 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 113.459 -1.7 . . . . 3.47 109.276 167.462 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.59 133.37 21.9 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 120.205 -1.559 . . . . 3.88 108.018 179.315 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.53 -17.88 60.55 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.036 2.49 . . . . 3.67 114.525 -171.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.48 -21.15 4.46 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 124.551 1.072 . . . . 3.08 115.257 164.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.85 -110.53 0.57 Allowed Glycine 0 N--CA 1.473 1.126 0 C-N-CA 125.475 1.512 . . . . 1.94 111.933 -176.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -68.69 139.17 55.4 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.641 0.734 . . . . 1.82 111.653 -171.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.462 ' HA ' HD23 ' A' ' 77' ' ' LEU . 56.5 p-80 -159.43 143.98 15.27 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.517 1.127 . . . . 0.82 110.63 -174.451 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -78.28 156.01 29.9 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.14 -0.689 . . . . 1.72 109.14 166.283 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.2 mtp -117.8 129.76 55.87 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 122.874 0.47 . . . . 1.73 111.459 159.472 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.07 136.62 43.36 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.441 1.896 . . . . 0.71 108.243 -172.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mp -124.49 152.43 43.4 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.354 1.061 . . . . 1.67 110.939 -177.233 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.34 -36.11 2.59 Favored Glycine 0 N--CA 1.469 0.852 0 C-N-CA 125.112 1.339 . . . . 2.57 113.712 175.615 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 68.95 -32.39 0.22 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 128.496 2.718 . . . . 3.53 116.883 166.05 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 66.37 -23.85 0.1 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 129.637 3.175 . . . . 1.98 115.519 178.595 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -145.42 146.51 30.18 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.688 1.995 . . . . 6.73 111.508 -171.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.53 155.75 36.05 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.357 2.705 . . . . 2.61 109.525 158.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -166.53 160.2 15.06 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.097 1.759 . . . . 3.36 109.386 -170.271 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -174.45 2.5 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.991 1.317 . . . . 6.05 111.068 168.077 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.04 169.39 3.39 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 120.841 -1.162 . . . . 1.62 109.522 154.281 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.56 35.34 90.96 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.038 1.304 . . . . 1.31 113.58 178.542 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -105.45 -177.88 3.49 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.222 1.009 . . . . 3.34 108.866 167.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -134.57 143.52 47.42 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.202 1.801 . . . . 3.68 106.824 169.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.2 t -142.18 138.11 30.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 128.476 2.71 . . . . 1.02 109.226 -172.659 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -98.7 154.23 18.13 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.395 0.887 . . . . 2.42 113.395 172.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.19 132.58 30.12 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.055 1.742 . . . . 2.16 110.839 -177.334 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -78.62 130.25 35.69 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.576 1.55 . . . . 2.58 108.782 163.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.2 mp -97.56 126.7 43.0 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.221 1.008 . . . . 0.96 109.087 166.527 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.0 mt -96.66 109.75 22.32 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.265 1.026 . . . . 0.96 109.173 176.481 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -105.63 143.53 33.65 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.685 1.194 . . . . 1.89 111.109 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.41 145.48 51.52 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.829 0.852 . . . . 1.64 113.118 -177.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.92 30.94 56.85 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 118.645 -1.086 . . . . 3.49 113.852 172.378 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.97 44.27 5.45 Favored Glycine 0 N--CA 1.471 1.033 0 CA-C-N 118.421 1.111 . . . . 2.08 115.094 168.376 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -131.63 145.03 51.47 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.587 1.193 . . . . 3.82 112.031 174.491 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 94.1 t -143.8 146.51 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.103 1.361 . . . . 2.25 109.066 176.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tt -147.17 120.21 8.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.967 1.307 . . . . 2.28 109.276 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp -94.39 112.64 24.43 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.902 -0.499 . . . . 2.37 111.657 179.081 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.3 m -89.69 166.24 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 125.594 1.558 . . . . 2.38 111.43 176.825 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.7 p -126.84 143.18 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.039 0.936 . . . . 2.97 109.17 165.602 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.92 154.05 25.57 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.881 1.672 . . . . 2.43 112.17 -171.171 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.39 162.38 40.84 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.353 2.702 . . . . 1.23 114.002 174.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.0 t -103.58 124.46 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.535 1.534 . . . . 1.09 108.148 164.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -152.95 173.91 14.79 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.947 1.299 . . . . 4.59 109.965 -178.624 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.93 167.76 15.63 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.961 1.467 . . . . 3.82 114.961 -172.5 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.606 ' HG3' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.231 0 C-N-CA 128.914 2.886 . . . . 8.42 108.671 150.572 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.144 0 N-CA-C 107.009 -2.436 . . . . 9.63 107.009 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p 175.79 162.52 0.32 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 117.778 0.789 . . . . 9.13 109.053 -134.064 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -126.89 -25.39 3.34 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.606 1.163 . . . . 8.3 112.987 170.602 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.9 m 119.82 68.48 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.943 1 C-N-CA 132.236 4.214 . . . . 7.4 108.007 -171.709 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -78.13 57.65 1.86 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.056 1.743 . . . . 5.56 110.625 178.321 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -145.19 166.96 27.47 Favored Glycine 0 N--CA 1.47 0.916 0 O-C-N 120.714 -1.241 . . . . 1.31 111.882 -175.517 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -155.29 167.74 29.37 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.93 1.456 . . . . 1.72 114.93 -175.919 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.2 t -119.41 137.78 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 126.428 1.891 . . . . 0.97 110.628 -177.606 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.469 ' HD3' ' O ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -46.99 -31.76 3.43 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 118.178 2.658 . . . . 4.14 118.178 -158.281 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 70.47 136.25 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 125.481 1.513 . . . . 3.1 112.902 -164.348 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.5 t 176.52 151.45 0.35 Allowed Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 128.749 2.82 . . . . 2.74 110.726 166.353 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.69 -7.59 18.64 Favored 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 122.937 2.424 . . . . 2.69 113.586 164.938 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.49 172.99 49.33 Favored Glycine 0 CA--C 1.543 1.795 0 C-N-CA 124.834 1.207 . . . . 1.28 115.552 -172.122 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.95 -15.8 11.64 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 125.237 3.958 . . . . 1.3 115.018 -171.64 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -125.04 149.48 47.73 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.076 2.15 . . . . 2.25 112.657 179.093 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.17 -176.22 5.85 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.453 1.501 . . . . 0.56 112.599 -166.012 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.62 162.15 37.37 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.791 2.036 . . . . 0.72 109.732 177.874 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.07 141.57 30.14 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.693 1.133 . . . . 0.53 113.378 -178.492 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -130.48 62.88 1.58 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.428 1.891 . . . . 2.69 111.891 -163.019 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -81.24 158.63 24.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.651 1.215 . . . . 1.93 114.12 179.354 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.78 101.83 14.22 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.096 1.758 . . . . 2.96 109.447 -179.161 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.86 114.46 20.49 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.325 -0.62 . . . . 3.03 109.325 178.486 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -122.68 125.68 46.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.198 1.799 . . . . 4.07 108.08 174.694 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -91.1 118.87 68.82 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.869 0.868 . . . . 1.55 109.303 178.954 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.35 -12.29 29.55 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.632 2.222 . . . . 1.59 113.878 177.903 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.81 115.94 0.22 Allowed Glycine 0 C--N 1.338 0.671 0 C-N-CA 126.943 2.211 . . . . 2.83 113.247 171.666 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 t0 176.08 -42.46 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 105.231 -2.137 . . . . 8.58 105.231 -141.846 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -165.78 178.22 1.37 Allowed Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 130.212 3.405 . . . . 4.54 108.557 170.129 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.15 127.48 8.43 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 N-CA-C 107.315 -1.84 . . . . 1.12 107.315 156.297 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.0 mt -86.5 145.65 26.71 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.578 -1.192 . . . . 2.04 110.526 -177.132 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.1 100.96 5.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 112.257 -2.247 . . . . 3.45 109.073 174.632 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.17 108.58 12.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.885 -1.524 . . . . 2.39 106.885 176.227 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -103.86 -23.1 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.129 0.972 . . . . 0.6 111.619 -174.743 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.59 -179.05 33.17 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 124.406 1.003 . . . . 0.47 114.213 -175.464 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.72 -176.63 6.01 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.953 0.901 . . . . 0.53 112.894 173.548 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -157.44 165.96 34.28 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.456 2.302 . . . . 4.78 108.111 -173.512 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -166.0 153.75 9.52 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.375 1.07 . . . . 0.61 109.527 168.017 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.37 -8.18 18.11 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.205 1.937 . . . . 0.66 113.211 167.897 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.83 50.15 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.005 1.322 . . . . 0.76 113.17 -179.84 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.08 123.38 1.16 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.977 1.311 . . . . 1.35 110.247 160.191 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.59 -24.07 63.63 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.571 0.952 . . . . 3.72 113.571 173.581 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -141.31 142.39 33.84 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.813 1.245 . . . . 5.58 109.898 174.428 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.27 145.85 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.599 1.56 . . . . 1.27 109.287 171.236 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -114.98 158.76 21.61 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.187 1.795 . . . . 3.48 109.157 163.696 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.1 tp -112.02 119.1 37.32 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 122.965 0.506 . . . . 1.06 110.546 170.117 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -122.92 163.04 21.1 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.008 1.323 . . . . 0.63 114.117 -174.304 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -115.34 -178.02 3.28 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.825 1.65 . . . . 3.42 113.901 159.023 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.2 m -154.88 141.49 18.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.133 1.773 . . . . 0.8 108.92 179.259 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -148.93 170.49 18.2 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.705 1.202 . . . . 2.03 112.842 -165.627 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.9 mtt -95.63 147.55 23.47 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.296 1.038 . . . . 4.25 110.582 167.655 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.95 156.01 33.79 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.761 1.224 . . . . 4.54 110.713 -175.084 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' OE1' ' HE3' ' A' ' 57' ' ' LYS . 3.6 tp10 -104.55 137.87 41.74 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.779 1.232 . . . . 2.69 109.938 169.615 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.7 t -131.54 118.37 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 106.694 -1.595 . . . . 2.14 106.694 163.026 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 62.77 33.17 15.58 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.282 1.033 . . . . 3.55 113.265 175.353 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.58 5.56 86.13 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 120.5 -1.375 . . . . 1.62 113.692 -175.212 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -115.34 124.85 52.31 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.333 1.853 . . . . 2.7 110.132 -176.604 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HE3' ' OE1' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -57.36 128.51 37.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.093 2.157 . . . . 4.06 109.859 179.668 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.39 151.41 35.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 127.967 2.507 . . . . 2.97 107.971 175.471 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 36.6 mtt -115.39 129.73 56.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.144 0.578 . . . . 2.53 109.563 160.429 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.31 175.69 16.41 Favored Glycine 0 N--CA 1.466 0.663 0 C-N-CA 124.293 0.949 . . . . 0.66 112.732 -172.166 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.1 ttm -152.21 139.02 18.9 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.498 1.519 . . . . 0.69 110.677 -172.292 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -146.06 151.31 44.65 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 125.783 1.633 . . . . 7.92 110.982 -177.067 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.77 150.7 50.48 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.447 2.098 . . . . 0.69 110.637 172.619 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.51 147.89 61.65 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.846 1.258 . . . . 0.68 110.057 -176.443 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.96 -19.87 13.57 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.983 3.122 . . . . 0.72 113.342 -164.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -177.2 168.5 2.35 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.355 2.262 . . . . 2.17 109.461 178.266 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.8 mt -111.65 153.52 26.25 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.874 1.27 . . . . 0.59 109.04 159.327 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -124.23 142.09 51.53 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.741 0.816 . . . . 2.57 110.284 177.689 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.6 t -141.27 129.81 12.36 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 123.664 0.786 . . . . 1.01 111.362 174.678 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.79 158.31 46.87 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.832 3.021 . . . . 1.07 112.116 178.787 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.49 137.99 77.56 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.541 2.828 . . . . 1.17 112.305 -177.177 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt 73.88 -13.08 0.79 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.188 2.195 . . . . 2.14 114.237 -177.038 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.73 179.32 44.37 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.659 1.6 . . . . 1.32 114.819 -176.97 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -126.41 156.16 41.03 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.56 1.544 . . . . 3.96 112.054 175.692 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.0 t -149.29 116.84 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.573 1.549 . . . . 4.04 107.763 154.349 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -76.69 142.98 40.34 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.941 -1.099 . . . . 3.17 112.348 -179.576 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 mp -71.53 73.41 0.75 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 123.338 1.542 . . . . 2.19 108.04 160.254 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -69.49 142.62 92.13 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.921 1.688 . . . . 5.46 113.688 -171.279 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -66.88 -4.52 11.45 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.947 3.098 . . . . 2.3 114.501 178.993 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.32 51.53 0.77 Allowed Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.534 1.54 . . . . 1.67 110.57 165.835 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.01 -123.26 1.05 Allowed Glycine 0 N--CA 1.464 0.537 0 C-N-CA 124.196 0.903 . . . . 1.59 113.913 -177.166 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -73.25 136.84 44.65 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 121.573 0.701 . . . . 2.21 111.392 -169.13 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -162.62 156.28 20.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.774 -0.648 . . . . 0.54 111.288 -179.352 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -81.45 146.46 30.24 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.714 -0.476 . . . . 1.95 109.714 164.627 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 tpt -100.05 130.84 46.25 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.206 -1.035 . . . . 0.65 108.206 161.016 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -113.41 138.95 49.34 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.19 1.396 . . . . 0.56 109.574 -178.292 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mp -137.66 146.41 43.82 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.046 1.338 . . . . 1.71 110.794 179.15 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.18 44.43 66.37 Favored Glycine 0 N--CA 1.472 1.051 0 O-C-N 121.691 -0.631 . . . . 0.86 112.342 176.338 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 pp -62.14 151.3 36.18 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 123.194 1.473 . . . . 1.24 114.785 178.56 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.31 -2.22 18.01 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 113.748 -1.569 . . . . 2.52 112.971 -177.121 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -137.21 131.83 17.78 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 126.529 1.932 . . . . 5.22 107.695 153.751 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -63.03 154.2 68.74 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.858 1.705 . . . . 2.29 108.137 160.407 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.6 mt -111.97 97.41 6.66 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.682 1.193 . . . . 2.5 109.7 -155.693 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 136.65 34.94 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.474 1.11 . . . . 3.95 111.774 173.716 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.59 121.3 6.84 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.779 -1.101 . . . . 1.53 108.527 164.165 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.68 -2.35 52.83 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.872 1.701 . . . . 1.6 116.037 -176.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -82.17 -170.67 3.01 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.906 1.853 . . . . 2.39 112.327 168.327 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -147.87 136.44 21.69 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 129.194 2.998 . . . . 3.45 106.598 -172.28 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.4 t -140.07 132.69 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.804 1.642 . . . . 1.09 111.618 -175.684 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -79.56 143.82 34.45 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.318 0.647 . . . . 2.88 112.409 172.138 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mp -127.67 139.67 52.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.026 1.33 . . . . 1.65 110.987 161.535 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -102.23 122.85 45.0 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 127.533 2.333 . . . . 2.87 108.359 174.238 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -104.29 116.67 32.57 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.418 1.008 . . . . 1.06 111.123 -167.786 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -84.92 105.28 15.57 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.897 0.879 . . . . 0.82 110.319 -177.387 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -103.11 106.41 16.92 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.889 1.676 . . . . 2.08 111.172 -179.23 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 56.33 20.63 4.79 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.491 1.916 . . . . 2.33 113.711 177.334 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.22 -56.64 3.65 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.381 1.467 . . . . 4.04 112.485 -171.454 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.02 -10.12 77.26 Favored Glycine 0 CA--C 1.533 1.214 0 N-CA-C 116.118 1.207 . . . . 2.0 116.118 -169.486 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -125.47 145.1 50.23 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.944 1.298 . . . . 4.69 111.077 171.779 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.7 p -144.1 146.29 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 125.836 1.654 . . . . 1.92 110.474 173.328 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.8 tt -156.29 134.85 11.61 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.644 1.978 . . . . 2.07 108.226 -175.446 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -101.05 153.91 19.15 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.148 1.166 . . . . 2.56 114.148 176.079 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.4 t -135.82 158.66 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.568 1.947 . . . . 1.98 108.525 175.04 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.7 p -129.98 128.64 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.102 0.961 . . . . 2.39 110.046 -177.929 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.99 144.24 43.01 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.671 1.188 . . . . 1.97 111.493 -168.368 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -62.52 155.59 57.29 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.27 2.647 . . . . 0.74 112.666 176.545 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 67.4 t -91.59 125.14 44.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 107.475 -1.306 . . . . 0.88 107.475 165.16 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -153.45 167.21 30.2 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.01 1.724 . . . . 3.94 110.565 175.188 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.78 152.71 37.3 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.264 1.209 . . . . 3.8 114.264 -165.96 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.554 1.942 . . . . 9.15 114.713 166.979 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_